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INTRODUCTION. Optimal PEEP is still a matter of debate in ARDS pa-
tients. PEEP is by nature an expiratory setting aiming at maintaining
lung recruitment reached during the breathing cycle and/or during a
recruitment manoeuver. Decremental PEEP trial after a recruitment
manoeuver is an attractive method to detect optimal PEEP. This latter
can be defined from different variables, lung compliance being one
of them.
OBJECTIVES. To compare three methods to measure lung compli-
ance and to find out which is associated with the optimal PEEP (max-
imal compliance) during a decremental PEEP trial.
METHODS. Female piglets were anesthetized, paralyzed, tracheoto-
mized and mechanically ventilated (Carestation, GE Healthcare) and
acute lung injury was performed by saline lavage. Once PaO2 was
lower than 100 mmHg under 100% FIO2, a recruitment manoeuver
(sustained inflation to 40 cm H2O for 30 seconds) was performed
followed by cycling mechanical ventilation in volume controlled
mode, constant flow inflation, 100% FIO2, tidal volume 6 ml/kg body
weight, respiratory rate 35 breaths/min. PEEP was initially set to 20
cmH2O then decreased by 2 cmH2O-steps lasting 2 minutes each to
2 cmH2O. At each PEEP step, airway pressure, esophageal pressure
and airflow were acquired (Biopac 100), whole lung CT scan was per-
formed during end-expiratory and end-inspiratory pause, and finally
electrical impedance tomography (EIT) (Göttingen University) signal
was acquired. Compliance was inferred using three methods: i) by fit-
ting a R-C model on recorded pressure and flow signals using a least
square method (Clung). ii) by using CT data (Cscan) as ratio of tidal vol-
ume (sum of the difference between inspiration and expiration in
volume of normally aerated, poorly aerated and overaerated lung
compartments) to driving pressure (plateau pressure minus PEEP). iii)
by computing ratio of change in electrical impedance to driving
pressure (CEIT). The relationships between Clung, Cscan and CEIT were
performed by using the coefficients of determination over the 10
PEEP steps in each pig.
RESULTS. Thirteen pigs were analyzed. The table shows for each pig
the values of coefficient of determination between each pair of com-
pliance and the resulting optimal PEEP that maximized compliance.
CONCLUSIONS. Excellent correlation, except for pig B, was observed
between Clung and Cscan and the resulting optimal PEEP were in
agreement with a difference generally less than 2 cmH2O. Poor cor-
relation (r2 ≤ 0.8) between CEIT and Cscan was observed in 4 pigs.
Nevertheless, even iIn these cases the difference between optimal© The Author(s). 2017 Open Access This article
International License (http://creativecommons.o
reproduction in any medium, provided you giv
the Creative Commons license, and indicate ifPEEP computed from CEIT and the two other methods were small (≤2
cmH2O).
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Measurement of Clung, which is easy to manage in adults, strongly
correlated to Cscan and should be used to titrate optimal PEEP in dec-
remental PEEP trial. By contrast measurement of CEIT, which is the
only method possible in neonates, seems less correlated to Cscan.0002
Effect of external negative pressure versus positive end-expiratory
pressure on respiratory mechanics during recruitment of
experimentally induced lung injury
A. Nestorowicz1, A. Fijalkowska-Nestorowicz2, J. Glapinski3, J. Wosko4
1Medical University Lublin, Anaesthesiology and Intensive Therapy,
Lublin, Poland; 2Medical University Lublin, Anaesthesiological and
Intensive Care Nursing, Lublin, Poland; 3Wroclaw University of Science
and Technology, Chair of Electronic and Photonic Metrology, Wroclaw,
Poland; 4University Hospital No 4, Anaesthesiology and Intensive
Therapy, Lublin, Poland
Correspondence: A. Nestorowicz
Intensive Care Medicine Experimental 2017, 5(Suppl 2):0002
INTRODUCTION. Positive end-expiratory pressure (PEEP) improves
gas exchange and respiratory mechanics in patients suffering from
acute lung injury. However, it itself may also induce the risk of lung
overdistension and their damage. Some data suggest that the use of
external negative pressure (eNP) in damaged lungs is less injurious
compared to positive pressure ventilation [1].
OBJECTIVES. To compare the effect of eNP versus PEEP on lung me-
chanics in pigs with acute lung injury.
METHODS. Ten Large White pigs weighting 52 ± 5 kg were included
in the study. Under general anaesthesia the animals were intubated
and ventilation in a volume-controlled mode with FIO2 1.0, VT 8–
10 mL kg−1 and I:E ratio 1:2. Respiratory rate was adjusted tois distributed under the terms of the Creative Commons Attribution 4.0
rg/licenses/by/4.0/), which permits unrestricted use, distribution, and
e appropriate credit to the original author(s) and the source, provide a link to
changes were made.
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 2 of 542maintain PaCO2 wthin 35–45 mm Hg. A continuous infusion of
Ringer´s lactate at the rate of 5–10 mL kg−1 h−1 was administered
throughout the study.
The acute lung injury was produced by repeated bronchoalveolar
lavage using warm 0.9% NaCl until PaO2/FIO2 remainded stable
below 100. Thereafter, each animal was secured in a whole body
size-chamber and endotracheal PEEP followed by eNP were created,
while lung ventilation mode was held unchanged. Peak airway pres-
sure (Pawpeak), airway resistance (R) and dynamic compliance (Cdyn)
were recorded before lung injury and after - at 0, 4, 8, 12, 16 cm H2O
of positive and negative pressure, respectively.
RESULTS. There were no significant differences in Cdyn and R when
either PEEP or eNP was applied. However, PEEP resulted in increase
whereas eNP in decrease of Pawpeak and the obtained results dif-
fered significantly at the negative vs positive pressure of 12 and 16
cm H2O. Both mode of lung recruitment resulted in a spectacular in-
crease of oxygenation (Fig. 1).
CONCLUSIONS. This results demonstrate that both modes of lung re-
cruitment constitutes similar profile of respiratory mechanics, but
eNP decrease whereas PEEP increase Pawpeak.
REFERENCE(S)
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INTRODUCTION. Mechanical ventilation (MV) induces cyclic
changes in RV preload and afterload. However, evaluation of MVeffects on RV and pulmonary circulation during the respiratory
cycle and how these effects change after acute respiratory dis-
tress syndrome (ARDS) is not well known.
OBJECTIVES. To evaluate the cyclic effects of MV on RV and pul-
monary artery function in a porcine model of ARDS.
METHODS. Continuous flow waveform analysis was applied beat
by beat during a period of three minutes in 10 mechanically
ventilated pigs before and after a model of ARDS. The model
was created by means of lung saline lavages followed by two
hours of injurious MV. Applied analysis was based on the de-
scribed effect of MV on RV stroke volume (SV) (Fig. 2), mainly
attributed to preload modification. However, also variables re-
lated with vascular function can be cyclically affected by MV
(Fig. 3). We hypothesized that changes in RV and pulmonary ar-
tery function are also related with the SV changes and that this
relationship is affected by ARDS. To test this hypothesis, slope
and correlation (r2) between variables related with vascular and
ventricle function and SV were calculated along the respiratory
cycle (Fig. 4). Studied variables were pulmonary artery acceler-
ation time (PAAT, time to reach maximum flow normalized to
the ejection time, which is inversely related with pulmonary vas-
cular resistance), flow amplitude (maximum - minimum flow),
and the maximum flow to the time to reach maximum flow ra-
tio (Qmax/Qmaxt), which has been described as a contractility
index. Flow signal was obtained from a sensor placed around
the main pulmonary artery.
RESULTS. After creation of ARDS, mean SV decreased (39 ± 12 ml
vs 30 ± 6 ml, p = 0.014) and its coefficient of variation increased
(0.08 ± 0.03 vs 0.10 ± 0.03, p = 0.016), compared to baseline.
Slopes between flow amplitude and SV (0.19 ± 0.05 vs
0.24 ± 0.09, p = 0.027), and between Qmax/Qmaxt and SV
(1.6 ± 1.12 vs 2.9 ± 1.4, p = 0.008), as well as the correlation be-
tween PAAT and SV (0.21 ± 0.21 vs 0.54 ± 0.28, p = 0.012) and
between Qmax/Qmaxt and SV (0.37 ± 0.21 vs 0.61 ± 0.26,
p = 0.026) increased during ARDS. A non-significant trend to in-
crease in the correlation between flow amplitude and SV
(0.73 ± 0.30 vs 0.86 ± 0.14, p = 0.050) and to a decrease in the
slope between PAAT and SV (−0.004 ± 0.005 vs −0.006 ± 0.004,
p = 0.325) was observed during ARDS.
CONCLUSIONS. ARDS modified the hemodynamic effects of MV
on RV and pulmonary vascular function: changes in SV during a
respiratory cycle were more affected by pulmonary vascular
function and RV contractility. These preliminary results could
help to understand the tidal effects of MV on RV and pulmonary
artery function.
Fig. 4 (abstract 0003) See text for description
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INTRODUCTION. In ARDS patients:
1) prone positioning can reduce mortality, and
2) respiratory system driving pressure is associated with outcome.
Therefore, a reduction in transpulmonary driving pressure (DPL) could
minimise ventilator-induced lung injury, yielding improved outcome
in prone position.
OBJECTIVES. To test the effects of prone positioning on DPL during
protective and ultra-low tidal volume (VT) ventilation. We hypothe-
sized that prone positioning can reduce DPL during mechanical ven-
tilation at both VT sizes.
METHODS. We used a previously described two-hit porcine model of
ARDS, comprising saline lavage followed by injurious mechanical
ventilation. After lung injury, pigs were ventilated in volume-
controlled mode, VT 6 mL/kg and positive end-expiratory pressure
(PEEP) and FIO2 titrated according to the ARDSnet table (PEEPARDSnet).
A decremental PEEP trial was performed from 20 cmH2O to 5 cmH2O
in supine and prone position at VT of 6 mL/kg and 3 mL/kg, identify-
ing the PEEP level with the lowest DPL (PEEPBDP). Each animal was al-
located, by random sequence and in crossover with a latin square
design, to eight treatments: 6 and 3 mL/kg VT at constant minute
ventilation, with PEEPBDP or PEEPARDSnet, in prone and supine pos-
ition. Each change in ventilation settings was preceded by a recruit-
ment manoeuvre[GC1].The primary endpoint was DPL, and secondary
endpoints included gas-exchange and PEEPBDP.
RESULTS. We analysed data from 8 pigs (32 ± 2 kg); after injury
PaO2/FIO2 ratio was 136 ± 22 mmHg. DPL was lower in prone than
supine position at both 6 mL/kg (3.7 ± 1.8 vs. 5.2 ± 1.1 cmH2O,
p = 0.006) and 3 mL/kg (1.6 ± 0.9 vs. 2.6 ± 0.6 cmH2O, p = 0.002)
VT. PEEPBDP was also lower in prone than supine position: 10.3 ± 1.0
vs. 13.3 ± 3.0 cmH2O (p = 0.02) at 6 mL/kg and 10.4 ± 1.4 vs.
12.8 ± 2.1 cmH2O (p = 0.03) at 3 mL/kg. In prone and supine posi-
tions, PaO2 was 266 ± 63 vs. 234 ± 62 mmHg (p = 0.17) at 6 mL/kg
and 219 ± 65 vs. 154 ± 39 cmH2O (p = 0.06) at 3 mL/kg, respect-
ively; PaCO2 was 68 ± 10 vs. 68 ± 17 cmH2O (p = 0.99) at 6 mL/kg
and 90 ± 22 vs. 87 ± 24 cmH2O (p = 0.66) at 3 mL/kg, respectively.
CONCLUSIONS. In our ARDS animal model, prone positioning
allowed a reduction of DPL and PEEP level with the lowest DPL dur-
ing both protective and ultra-low VT ventilation.0005
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INTRODUCTION. Several studies are concordant with animal
models of ventilator-induced diaphragm dysfunction (VIDD) in
demonstrating ultrastructural injury and atrophy of diaphragmatic
fibers, increased oxidative stress, activation of major proteolytic
pathways and mitochondrial dysfunction, which are significantly
correlated with mechanical ventilation (MV) duration. Area frac-
tions of normal and abnormal diaphragm in patients undergoing
MV have not been yet assessed.
OBJECTIVES. To assess and compare area fractions of normal and ab-
normal diaphragm and limb muscles of brain-dead organ donors
(BD), type III Maastricht donors (MS), and stable patients who re-
ceived mechanical ventilation during thoracic surgery (CT).
METHODS. Prospective and observational study in a polyvalent
Spanish ICU. All organ donors admitted in the ICU during 6
months (BD or MS) were included. There was a control group
with patients undergoing resection of a suspected early lung
malignancy. Demographic and temporary variables, comorbidi-
ties, severity on admission and treatment were evaluated. Dia-
phragm biopsy specimens were obtained from the anterior
costal diaphragm lateral to the insertion of the phrenic nerve
and limb muscle from the vastus lateralis as internal control.
Muscle samples were fixed and paraffin embedded and they
were cut and stained with hematoxylin and eosin (H&E). Quanti-
tative evaluation of normal and abnormal (internal nucleus, in-
flammatory cells, lipofuscin, abnormal viable and inflammed/
necrotic) muscle fibers in sections were done following previous
methodologies. Differences between groups were assessed using
chi-square for categorical variables and Student's t-test or
Mann–Whitney test for continuous variables. We considered
p < 0.05 to be significant.
RESULTS. Fifteen patients were included of which 5(33%) were CT,
4(27%) were BD and 6(40%) MS. There were no differences between
groups in age, sex, BMI, and comorbidities. BD patients presented a
lower number of hours of mechanical ventilation with a higher
proportion of controlled modalities than MS [63hrs(33–92) vs
216hrs(107–396);p = 0.010 and 33%(0–46) vs 5%(0–20);p = 0.128].
Diaphragm of BD presented higher percentage of abnormal muscle
fibers than MS donors [19.1%(9.2) vs 2.4(2.3);p = 0.024] and CT sub-
jects [19.1%(9.2) vs 4.5(1.1);p = 0.036]. Diaphragm of BD had lower
percentage of internal nucleus [0%(0) vs 2.4%(1.0);p = 0.036] and MS
diaphragms showed lower percentage of inflammatory cells [0%(0)
vs 0.4%(0.1);p = 0.004] both compared to CT subjects. No differences
were found in limb muscles evaluation of normal/abnormal fibers be-
tween different groups.
CONCLUSIONS. Diaphragm of BD donors presents an impaired
number of abnormal fibers. Although MS donors are undergone
mechanical ventilation during more hours their percentage of ab-
normal diaphragm fibers don't differ from CT subjects. It could
be related with the ability of these patients to realise spontan-
eous breathing efforts.
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INTRODUCTION. Elucidation of early metabolic signatures associated
with the progression of septic shock and responsiveness to support-
ive therapy could be useful in the development of a new therapeutic
strategies.
OBJECTIVES. The primary aim of this study was to verify whether a
different response to therapy was associated with a particular trajec-
tory in metabolite patterns.
METHODS. We examined the plasma metabolome of 21 septic
shock patients (pts) enrolled in the Shockomics clinical trial
(NCT02141607). Responsiveness to therapy was assessed as change
in organ dysfunction assessed by SOFA score, measured at ad-
mission (T1, acute phase) and 48 hours after (T2, post-
resuscitation). A patient was judged as non-responder if both
SOFAT2 was >8 and Δ = SOFAT1- SOFAT2 < 5 (NR, 7 pts); the
remaining as responsive (R, 14 pts). We combined untargeted
and targeted mass spectrometry-based metabolomics strategies
to cover as much as possible the plasma metabolites repertoire.
Firstly, a mass metabolic profiling, performed by direct flow
injection-TOF-MS, was applied as untargeted screening. After-
wards, we performed a targeted analysis using a mass
spectrometry-based quantitative approach with the Biocrates plat-
form coupled to Triple-Quad 5500 LC-MS/MS system, which
allowed to measure specific metabolic classes and the magnitude
of their variation. We built classification models to predict non-
responsiveness to therapy based on sets of metabolites. Explora-
tive analyses by probabilistic graphical models - i.e. Markov Net-
work (MN) - were also performed.
RESULTS. At ICU admission, plasma metabolome was similar
between R and NR. In univariate analysis, NR presented less vari-
ation in metabolite concentration between T1 and T2. Different
classification models using targeted metabolomics to predict NR
status reproducibly reveled the presence of phosphatidylcholines
(PCs) (e.g. lysoPC), alanine and Kynurenine (a metabolite of trypto-
phan). We combined untargeted metabolomics with those metabo-
lites, and the set of features selected from the integrated models
was consistent in showing the importance of PCs and alanine. All
models had good performance (AUC > 0.9). The MNs showed that
the two groups were characterized by different dependencies
among metabolites, and the main differences were represented by
PCs, kynurenine and alanine.
CONCLUSIONS. These findings support the emerging evidence
that lipidome alteration plays an important role in response to in-
fection. In addition, the identification of alanine as a consistent
marker of NR to therapy could represent a possible shift in glu-
cose‐alanine cycle in the liver thus providing a more detailed
characterization of liver dysfunction than clinically available tests.
These results were strengthened by the explorative analyses per-
formed by MNs suggesting that lipid species and alanine are im-
portant regulatory nodes.GRANT ACKNOWLEDGMENT
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INTRODUCTION. Bacteria have evolved sophisticated strategies to
evade immune defense mechanisms. Since our group discovered
that Escherichia coli binds in an opsonin-independent manner to
FcγRIII receptor (CD16) to escape immune system, we have
sought to identify the protein sequence from such bacteria that
is able to mimic IgG1. Using a Phage Display Technique, we re-
cently identified and characterized a peptide of E. coli which is a
ligand to CD16.
The peptide, called wzxe, is a translocase involved in the transbilayer
movement of an trisaccharide-lipid (Lipid III) intermediate in the as-
sembly of Enterobacterial Common Antigen (ECA). Peptide-receptor
interactions induced CD16-mediated immunoreceptor ITAMi signal-
ing, blocking the production of reactive species of oxygen(ROS) and
bacterial killing. This CD16-mediated inhibitory signaling was abro-
gated in a wzxe−/− mutant of E. coli K12 restoring production of ROS
and bacterial killing 2.
OBJECTIVES. To evaluate the role of E. coli peptide wzxe in a murine
sepsis model of bacterial injection.
METHODS. Two group of 20 males mice C57Bl/6, at 10 weeks of age,
were submitted to injection of 3 x 108 E. coli K12 wild type or the
same amount of E coli wzxe−/− mutant. Survival was observed during
96 hours then the mice were sacrificed for cytokines analysis. TNF
alpha, IL-1beta, IL-6, MCP-1 and IL-10 were quantified by ELISA. In
addition, control mice injected with saline were sacrificed in the 4th
day for cytokine dosing.
RESULTS. A higher mortality and increased production of cytokines
were observed in the group of mice injected with E. coli K12 wild
type.
The Kaplan-Meier and log-rank methods were used to analyze mor-
tality. Cytokine values were compared using the Mann–Whitney U-
test. Differences were considered significant when P was < 0.05. All
statistical analysis was performed using Prism 6.0 (GraphPad Soft-
ware, USA).
CONCLUSIONS. In an era of growing resistance to antibiotics, pre-
venting bacteria innate immune evasion could be a good approach
to control infections. Regarding E. coli, peptide wzxe apparently plays
an important role during sepsis, being an interesting therapeutic tar-
get to be explored.
REFERENCE(S).
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Intensive Care Medicine Experimental 2017, 5(Suppl 2):0008INTRODUCTION. Sepsis is a major health problem and much em-
phasis has recently been placed on the role of redox imbalance, oxi-
dative stress, chaperone heat shock proteins (HSP) 72, 90, and
interleukin 27 (IL-27), in intensive care unit (ICU) patients' clinical
course and outcome. Oxidative/antioxidative screening methods
might assist the clinicians in discriminating critically ill septic patients,
or at risk of death, from those with systemic inflammatory response
syndrome (SIRS), and facilitate therapeutic decision-making upon ad-
mission of a patient.
OBJECTIVES. The present study seeks to ascertain whether the ex-
pected increased risk of mortality might be further determined by
the presence of oxidant/antioxidant imbalance and altered IL-27 (a
regulator T-cells having both pro and anti-inflammatory effects), Zn,
glutamine, and HSP levels in septic ICU and pediatric ICU (PICU) pa-
tients, compared to SIRS and healthy controls.
METHODS. This prospective observational study was performed in a
sample of critically ill adult (n = 180) and pediatric patients (n = 44)
with sepsis or SIRS, compared to healthy controls (n = 116). Serum
total oxidant status (TOS) and total antioxidant capacity (TAC) were
measured on day 1 in ICU, using photometric test systems. Plasma
glutamine (chromatography), serum zinc (Zn-Photometry), IL-27 (Elisa
kits) and HSPs (Elisa and flow cytometry) were also analyzed. Clinical
severity scores APACHE II and SOFA were calculated and ICU mortal-
ity was recorded.
RESULTS. A total of 180 adult ICU patients were included in the study.
Mean APACHE II score was 22.5 ± 8 and ICU mortality rate 30.8% (PICU
4,3%). Septic patients had lower TAC, but higher TOS, glutamine, IL-6,
IL-10, HSP72 and HSP90 levels, compared to SIRS and control individ-
uals (p < 0.05). TOS was negatively related to TAS (r = 0.5, p < 0.05).
Serum TOS correlated positively (p < 0.05) and TAS negatively
(p < 0.05) with Zn, IL-27, HSP72/90 and clinical severity scores. For pre-
dicting sepsis among critically ill patients, TAC and TOS achieved a re-
ceiver operating characteristic curve (AUROC) >0.90 (95% CI 0,85-0,97,
p < 0.05). In predicting mortality, TOS, IL-27, and Zn achieved an
AUROC >0.68 (95% CI 0,50-0,85, p < 0.05). A pilot study of 44 pediatric
patients showed the same trend of oxidant/antioxidant imbalance and
lower Zn and glutamine levels in septic children (p < 0.05).
CONCLUSIONS. Oxidant/antioxidant status is significantly impaired in
septic patients compared to SIRS. Decreased antioxidant defense and
increased oxidative stress system, along with alterations in innate im-
mune system integrity and IL-27, may play an important role in
sepsis-related mortality.
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INTRODUCTION. Mitochondrial modulation of cellular bioenergetics
is increasingly viewed as an explanation for the apparent paradox
between clinical/biochemical acute kidney injury (AKI) that occurs
during sepsis, despite a relative lack of cell death, maintenance of
adequate tissue oxygenation and recovery of organ function.1
Previous in vitro studies from our lab show that exposing naïve
kidney tissue to septic serum, thereby removing any haemodynamic
influences, produces mitochondrial dysfunction.2
Fig. 9 (abstract 0010). See text for description
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occurs following exposure to septic serum is driven by the observed
increase in reactive oxygen species (ROS), and, if so, whether these
changes can be inhibited and/or reversed using a targeted mito-
chondrial ROS scavenger.
METHODS. Live naïve kidney slices (200 μm thick) were exposed to
serum from 24-hour sham operated or septic rats and imaged with a
confocal microscope using fluorescent dyes to detect dynamic
changes in mitochondrial function. Mitochondrial membrane poten-
tial (MMP), ROS generation and redox state (NADH) were all probed
over a 90-minute time course. In separate studies, septic (and sham)
serum exposed slices were co-incubated with the mitochondrial ROS
scavenger MitoTEMPO, either at time zero or as a delayed (50 min)
treatment.
RESULTS. The decreases in MMP and NADH, and the increase in
ROS seen following exposure to septic serum were prevented by
co-incubation with MitoTEMPO from time zero (Fig. 8).
Treating septic serum-exposed slices with MitoTEMPO at 50 min
could partly reverse changes in mitochondrial function that had
already begun, and prevent further progression (Fig. 9).
CONCLUSIONS. Our in vitro findings suggest that increased produc-
tion of mitochondrial ROS is a direct cause of mitochondrial dysfunc-
tion in septic AKI, independent of circulatory changes, and this can
be protected/reversed by ROS scavenging. Targeting mitochondrial
ROS may provide therapeutic benefit.
REFERENCES
1 Singer, M. The role of mitochondrial dysfunction in sepsis-
induced multi-organ failure. Virulence 5, 66–72, doi:10.4161/
viru.26907 (2014).
2 Pollen, S., Arulkumaran, N. & Singer, M. Septic serum alters mito-
chondrial function in a kidney slice model of septic acute kidney in-
jury. Intensive Care Medicine Experimental 4, A144, doi:10.1186/
s40635-016-0098-x (2016).
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INTRODUCTION. Intravenous fluid administration is the most per-
formed action in patients undergoing surgery. Hemodilution can
be either intentional with the aim of limiting allogenic blood
transfusions in elective surgery or used for correction of volume
status of the patient. It has been suggested that colloidal solu-
tions may preserve glycocalyx components, by maintaining the
shear stress on endothelial due to an higher viscosity, osmotic
pressure and also to the presence of macromolecules. We sought
to evaluate the impact of hemodilution with either a balanced
colloid, a balanced crystalloid or a normal saline solution on the
glycocalyx components and the vascular barrier permeability.
MATERIAL AND METHODS. Experiments were conducted in 24
fully instrumented, mechanically ventilated and anesthetized rats.
Acute normovolemic hemodilution (ANH) was induced by step-
wise exchange of blood with the plasma expander according to
the following ratio; 1:1 with balanced hydroxyethyl starch (HES
130/0.4), 1:3 with balanced crystalloid or normal saline 0.9%,
untill targeted hematocrit (Hct) levels of Hct 30%, Hct 25%, Hct
20% and Hct 15% were achieved. An hand-held in vivo micro-
scope, CytoCam was placed on the surface of the exposed biceps
femoris. Plasma concentration-time curves of Dextran 40kD-Texas
red, Albumin-Alexa 680 and Dextran 500kd-FITC were fitted for
each experiment separately with a monoexponential function in
order to assess both endothelial barrier function and plasma vol-
ume. At the end of the experiment, the heart, brain, kidney, lung
and liver were harvested to determine their water content using
Fig. 12 (abstract 0011). See text for description
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heparan sulfate as indirect makers of glycocalyx degradation were
measured by the ELISA in plasma samples.
RESULTS. MAP significantly decreased during the hemodilution
process (p < 0.05) whereas CVP and femoral arterial blood flow
(fABF) were maintained. At 15% of hematocrit, lactate levels in-
creased significantly (p < 0.01), accompanied by changes in pH
and bicarbonate levels for balanced crystalloid and normal saline
groups (p < 0.01). Syndecan-1 levels were increased in all groups
at the end of the experiment compared to baseline values re-
spectively (p < 0.0001). Heparan sulfate increased only in saline
group at the different hemodilution thresholds (p < 0.01) only in
the normal saline group. Hyaluronan levels were increased in bal-
anced crystalloid and normal saline groups compared to control
(p < 0.01).
No significant alteration in power of the exponential decay-time
of dyes were observed between the different fluid groups.
Neither was any alteration in the microcirculation nor the presence
of tissue edema measured.
CONCLUSION. ANH per se may jeopardize the endothelial glyco-
calyx layer without inducing significant alterations in vascular
barrier permeability regardless of the fluid composition. Normal
saline appears to be the most unsuitable fluid for use for
hemodilution.Fig. 10 (abstract 0011). No significant alteration in power of the
exponential decay-time of dyes were observed between the different
fluid groups.
Fig. 11 (abstract 0011). Neither was any alteration in the
microcirculation nor the presence of tissue edema measured.0012
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INTRODUCTION. Fluid challenge (FC) is test of cardiac preload re-
serve, but how FC is performed varies widely. Slow FC may decrease
the hemodynamic effect and contrary fast FC may lead to temporary
hypervolemia. Hypervolemia harms endothelial glycocalyx (EG), and
hence the rate of FC may significantly alter FC macro- and microhe-
modynamic effects.
OBJECTIVES. Major objectives of this study was to assess the influence
of fast and slow FC administration on hemodynamic variables and EG.
METHODS. Randomized prospective study performed in a University
hospital was approved by the local ethics committee. Patients under-
going major spinal surgery (group A) and critically ill with septic
shock (group B) in whom a FC was indicated were randomly (1:1
randomization by predefined scheme) assigned to receive either fast
(5-10min) or slow (20-30min) 500ml balanced crystalloid FC. In group
A only one FC per patient was performed, in group B more FC were
allowed if response to previous FC was positive. Intraoperatively pre-
load reserve and volume effect was assessed using standard
hemodynamic variables and pleth-variability index (PVI). In septic
patients the PiCCO2 device was used for hemodynamic monitoring.
Effect on EG was assessed using the intravital microscopy of sublin-
gual circulation using the Glycocheck software (Glycocheck BV,
Netherlands). Hemodynamic (PVI, stroke volume - SV) as well as EG
variables (PBR - perfused boundary region and CD - capillary density)
were monitored before (T0), immediately after (T1), and in 20 mi-
nutes intervals till the end of surgery (T2-4, group A) or after 1 and 2
hours (T2-3, group B). Microcirculatory parameters were assessed as
absolute and relative change to baseline (%BL).
RESULTS. In 50 patients of group A 50 FC (25 fast and 25 slow) were
performed; 26 FC in 15 patients (12 fast and 14 slow) of group B. All
but 6 FC (12%) were positive in group A, whereas 13 (50%) were posi-
tive in group B equally distributed with 7 (54%) positive in fast and 6
(46%) in slow FC. In group A both fast and slow FC increased CD (T1
CD %BL 104 ± 5% and 109 ± 4%), but the effect vanished rapidly in the
slow FC (T2 CD%BL 112 ± 16% vs. 96 ± 19%; p = 0.02). Similar effect
was observed on PBR - post FC increment (T1 PBR %BL 104 ± 19% vs.
108 ± 16%) with significantly prolonged effect in the fast FC (T3
PBR%BL 109 ± 16% vs. 99 ± 15%; p = 0.04). In group B, rate of infusion
Fig. 13 (abstract 0013). See text for description
Fig. 14 (abstract 0013). See text for description
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 8 of 542have neither impact on PBR nor CD. Contrary, significantly higher PBR
(1.9 ± 0.2 vs. 2.1 ± 0.3; p = 0.02) and lower CD (0.7 ± 0.1 vs. 0.6 ± 0.1;
p = 0.02) values were observed in responders in T1.
CONCLUSIONS. In our study a fast 500ml balanced crystalloid FC had
prolonged microcirculatory and hemodynamic effects in surgical pa-
tients than slow FC. In patients with septic shock no changes in
terms of EG were observed.
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INTRODUCTION. Glycocalyx shedding following traumatic hemorrhagic
or septic shock has been linked to increased vascular barrier per-
meability (VBP) (1). Little is known regarding the VBP during non-
traumatic hemorrhagic shock (NTHS). It is not yet elucidated
whether or not there is positive correlation between the fluid
resuscitation-mediated glycocalyx degradation and an increased
VBP (2,3). It would be suggested that a colloidal solution would
better preserve glycocalyx components, by maintaining the shear
stress on endothelial due to an higher viscosity, osmotic pressure
and also to the presence of macromolecules.
OBJECTIVES. The aim of this study was to determine the effects
of different resuscitation fluids on the glycocalyx barrier and its
relation with the VBP in short term of severe hemorrhage.
METHODS. Fully instrumented and hemodynamically monitored
Wistar albino rats were subjected to a pressure-controlled NTHS for
60 min. Same spot of the microcirculatory unit of the biceps femoris
muscle was monitored continuously with hand-held microscope. Rats
were then fluid resuscitated with either Ringer's acetate or balanced
starch solution or NaCl 0.9% till the MAP reaches 80 mmHg.
Glycocalyx shed products (hyaluronan, syndecan-1, heparan) were
determined at baseline and 60 min after fluid resuscitation by ELISA
methods. VBP was assessed with 3 different techniques: plasma
decay of 3 fluorescent dyes (Texas Red-40 KDa and FITC-500 kDa
Dextrans and Alexa 680–70 kDa Albumin), tissue edema (wet/dry
weight ratio) and intravital fluorescence microscopy.
RESULTS. NTHS and associated fluid resuscitation produced signifi-
cant amount of glycocalyx shed products (P < 0.05) partially damp-
ened by the use of balanced colloid. Despite glycocalyx
degradation and microcirculatory functional density alterations
(P < 0.05) we did not show an increase in VBP regardless of the
technique used (plasma decay of fluorescent dyes,).
CONCLUSIONS. In NTHS, even though microcirculation was re-
stored, fluid resuscitation was not associated with increased VBP
despite the presence of glycocalyx degradation. This result chal-
lenges the role of the glycocalyx as a significant contributor to VBP.
Each fluid used has a different impact on the glycocalyx.REFERENCE(S)
1. Kottke MA. Shock 2016; 46:20–36
2. Torres Filho IP. Am J Physiol Heart Circ Physiol 2016;
310:H1468–78
3. Weinbaum S. Annu Rev Biomed Eng 2007; 9:121–67
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Fig. 16 (abstract 0014). See text for description
Fig. 15 (abstract 0013). See text for description
Fig. 17 (abstract 0014). See text for description
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INTRODUCTION. The semi-quantitative score method introduced by
Boerma and co-workers for measuring microcirculatory flow index (MFI)
has been commonly used to evalute the microcirculatory alterations in
critically ill patients using hand-held vital microscopes [1] and sugg-
gested as use for point-of-care assessment [2].MFI is based on scoring a
representative vessel in one of four quadrants of the field of view (FOV)
and calculating the mean value over the four quadrants. There remains
uncertainty, however, about the reliability of the numerical value ob-
tained from this grid-based scoring system.
OBJECTIVES. The aim of this study was to determine if this MFIquadrants
would differ significantly from the MFI per vessel score based on the
measurement of every vessel in the FOV.
METHODS. MFIquadrants is the mean flow score for the four quadrants
of a representative vessel scored in each quadrant. MFIper vessel is the
mean flow scores measured for each vessel in the entire FOV (Fig. 16).
Flow values are scored as 0 no flow, 1 (intermitent flow), 2 sluggish
flow, 3 continuous flow [1]. The total vessel density (TVD), perfused ves-
sel density (PVD), and percentage of perfused vessel (PVD) was also cal-
culated and compared. 126 videos of skeletal muscle from 24 rats in
shock and resuscitation were analyzed to measure the relationship be-
tween the MFIquadrant and MFIper vessel.
RESULTS. The MFIquadrants was 2.29 + 0.74 (range from 0.5 to 3), and MFI-
per vessel was 2.13 + 0.74, range (0.17 to 3). A Bland-Altman plot showed
the mean difference between MFIquadrants and MFIper vessel was − 0.16,
and limits of agreement (bias ± 1.96SD) is from 0.95 to −0.64 (Fig. 17).Moreover, the absolute value of variation between MFIquadrants and MFI-
per vessel was significantly correlated with PPV (P < 0.001), PVD
(P = 0.002), MFIper vessel (P < 0.0001), but not with MFIquadrants (P = 0.085)
and TVD (P = 0.134). The PPV (ROC area 0.81) was the best predictor of a
15% difference between MFIquadrants and MFIper vessel, significantly better
than PVD (ROC area 0.71), TVD(ROC area 0.6) (Fig. 18).
For predicting an 15% difference between MFIquadrants and MFIper vessel,
a PPV threshold of 71% was identified with a sensitivity of 42% and a
specificity of 95%.
CONCLUSIONS. Quantative values of the MFI based on quadrants
should be used with caution under conditions of low PPV (<71%). This
finding is of importance if MFI values are to be used as thresholds for
clinical decision making for point-of-care use at the bedside.
REFERENCE(S)
1. Boerma EC, Mathura KR, van der Voort PH, Spronk PE, Ince C: Quantify-
ing bedside-derived imaging of microcirculatory abnormalities in septic
patients: a prospective validation study. Crit Care 2005, 9: R601-R606.
2. De Backer D, Hollenberg S, Boerma C, Goedhart P, Büchele G,
Ospina-Tascon G, Dobbe I, Ince C: How to evaluate the microcircula-
tion: report of a round table conference. Crit Care 2007, 11:R101.
Fig. 18 (abstract 0014). See text for description
Fig. 19 (abstract 0015). See text for description
Table 2 (Abstract 0015). See text for description
Parameter Value
Number of patients enrolled, N 70
Sex (percent female subjects) 51.4
Age (years) 60.9
Heart rate, N (±SD) 89.1 (±19.5)
Baseline mean arterial pressure, mmHg (±SD) 70.6 (±11.4)
Vasopressor use, N (%) 70 (100)
Mechanical ventilation, N (%) - Passively ventilated, N (%) -
Positive end-expiratory pressure (PEEP) >5mmH2O, N (%)
40 (57.1) - 19 (27.1) - 16 (22.9)
Lactate at enrollment, mg/dl 34.2
Hospitalization days prior to shock onset, N 0.55
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INTRODUCTION. Adequate assessment of fluid responsiveness in un-
differentiated shock has substantial impact on patient outcomes. Sys-
tolic flow time (FT) corrected for heart rate can be used to follow
change in left ventricular preload. Recent data1,2 suggests its possible
value in predicting fluid responsiveness when combined with pre-
load challenge maneuvers such as passive leg raise (PLR).
OBJECTIVES. Evaluation of PLR-induced change in carotid corrected
FT (ccFT) as a predictor of fluid responsiveness in patients with undif-
ferentiated shock.
METHODS. Prospective, non-interventional study included patients
with newly diagnosed undifferentiated shock. Eligible subjects were
adult patients with shock duration < 24 hours, resuscitated with >30cc/
kg of intravenous fluids who had no history of significant cardiovascular
disease or contraindications to perform PLR. Subjects were evaluated
with point-of care (POC) Doppler ultrasound (Logiq e, GE Healthcare,
Wauwatosa, WI) imaging of carotid artery and with stroke volume (SV)
assessment via non-invasive cardiac output monitoring system (NICOM,
Cheetah Medical) before and after PLR maneuver. ccFT was calculated
based on Doppler waveform analysis, and ΔccFT was presented in milli-
seconds (msec) or percent-change (%ΔccFT), Fig. 19. Fluid responsive-
ness was defined as >10% ΔSV as per NICOM protocol.
RESULTS. Presented is preliminary analysis of the first 70 patients. All
patients required vasopressor support, with 40 patients (57.1%) beingon mechanical ventilation. Average length of stay prior to shock onset
was 0.6 days, average age of patients 60.9 years with 51.4% of cohort
being female, Table 2. Average cardiac index improved significantly
with PLR from 3.75 to 4.24L/min/m2 with an average ΔSV 23.7 ± 23.0%,
Table 3. Average ccFT at baseline was 314.0 ± 37.2msec and was in-
creased after PLR to an average 324.0 ± 43.8msec with an average
increase of 10.9 ± 23.0msec in ΔccFT or 3.6 ± 7.6% change in
%ΔccFT. The majority of patients, 49 (70.0%), were fluid responders
based on ΔSV. Fluid responders had higher average ΔccFT
17.7 ± 23.6 msec compared to non-responders, ΔccFT −4.7 ± 10.7msec
(p = 0.000047). ROC curve analysis demonstrated slight improvement
of ΔccFT (AUC = 0.873 [95% CI: 0.86-0.88]) in comparison to %ΔccFT
(AUC = 0.860 [95% CI: 0.85-0.87]), Fig. 20. Using a ΔccFT cutoff of 9
msec, the test has positive predictive value of 95% with sensitivity 73%
and specificity 90%, Table 4.
CONCLUSIONS. POC assessment of ccFT can be simple and broadly
available test that, combined with PLR maneuver, may offer ability to
predict fluid responsiveness in undifferentiated shock.
REFERENCE(S)
1) Blehar et al.Correlation of corrected FT in the carotid artery with
changes in intravascular volume status. J Crit Care. 2014
2) Lafanechere et al.Changes in aortic blood flow induced by PLR
predict fluid responsiveness in critically ill patients. Crit Care. 2006
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Parameter Baseline Value Post PLR challenge
NICOM cardiac index, L/min/m2 3.75 4.24
NICOM SV, ml (±SD) 62.1 (±24.5) 74.9 (31.4)
NICOM ΔSV, % ±SD 23.7 (±23.0)
Fluid responsive, N (%) - NICOM
ΔSV, % ±SD
49 (70) - 32.5 (21.8)
Fluid nonresponsive, N (%) - NICOM
ΔSV, % ±SD
21 (30) - 3.1 (7.0)
Systolic time at baseline, msec (±SD) 263.92 (42.84) 272.70 (46.35)
Corrected FT at baseline, msec (±SD) 314.03 (37.23) 324.02 (43.78)
ΔccFT msec (±SD) and Percent
ΔccFT, % (±SD)
10.94 (22.96) and 3.6 (7.6)
ΔccFT, fluid responsive vs. fluid
non-responsive, msec (±SD)
17.65 (23.6) vs. -4.72
(10.68), p-value= 0.000047
Fig. 20 (abstract 0015). See text for description
Table 4 (Abstract 0015). See text for description
ΔccFT
(msec)
Sensitivity Specificity Positive predictive value
(PPV)
Negative predictive value
(NPV)
1 0.88 0.70 0.88 0.70
3 0.84 0.70 0.88 0.64
5 0.78 0.80 0.91 0.64
9 0.73 0.90 0.95 0.56
11 0.65 0.95 0.97 0.51
13 0.61 0.95 0.97 0.49
15 0.51 0.95 0.96 0.44
17 0.51 0.95 0.96 0.42
19 0.43 1.00 1.00 0.41
Fig. 22 (abstract 0016). 3 months - Patients v Controls
Fig. 21 (abstract 0016). <72 hours - Patients v Controls
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INTRODUCTION. Aneurysmal subarachnoid haemorrhage (SAH) is a
devastating disease often leading to death or poor functional out-
comes. Damage to the brain in the first 72 hours following aneurysm
rupture ("early brain injury") is likely to play a key role in determining
the incidence of morbidity and mortality after SAH. Acute MRI scan-
ning may offer greater insight into early brain injury and help de-
velop novel diagnostic and therapeutic biomarkers.OBJECTIVES. To detect and quantify the impact of SAH on brain
measurements of T1-structural and diffusion-weighted (DWI) MRI
from the first 72 hours to 3 months post-SAH, and to correlate these
with subsequent neurocognitive outcomes.
METHODS. 27 patients with "good grade” SAH (World Federation of
Neurosurgeons Grade I and II) underwent T1-weighted structural and
DWI MRI scanning at 3 time-points post-SAH: < 72 hours, 5–10 days
and 3 months post-SAH. Patient MRI data was assessed longitudinally
as well as being compared with data from age/gender-matched
healthy controls. Patients underwent detailed assessment at 3
months post-SAH to quantify neurocognitive outcomes.
RESULTS. There was a significant global increase in grey matter (GM)
volume measured from T1-weighted MRI in the first 72 hours post-SAH
compared with healthy controls (Fig. 21). These changes were associated
with restricted diffusion, suggesting widespread cytotoxic cerebral
oedema resulting in this apparent increase of GM volume. By 3 months,
structural changes had resolved, except for higher GM volume in pa-
tients compared with healthy controls in cognitive zones of the cerebel-
lum (Crus I & II, and lobule VIIb – Fig. 22). This increase was negatively
correlated with neurocognitive performance (r = 0.389, p = 0.006 Pear-
son's correlation). Retrospectively, patients with subsequent neurocogni-
tive impairment at 3 months already showed higher GM volume at < 72
hours post-SAH in the same cognitive cerebellar regions compared with
patients who did not develop cognitive impairment (Fig. 23). Notably,
cerebellar GM measure during the acute phase made it possible to pre-
dict with 84% sensitivity and 86% specificity those patients who went on
to develop poor neurocognitive outcomes post-SAH.
CONCLUSIONS. Structural and diffusion-weighted MRI are highly sensi-
tive to the global as well as regional impact of cerebral oedema that
occurs acutely following aneurysm rupture and is often undiagnosed.
Results from this study also demonstrate the crucial role of cerebellar
injury in modulating neurocognitive outcomes after “good grade” SAH.
Using an automated approach, a simple T1-weighted structural MRI
scan in the first 72 hours post-SAH can predict subsequent neurocogni-
tive outcome with high accuracy. Damage to the cerebellum acutely
post-SAH may therefore underlie neurocognitive impairment after SAH
and act as a therapeutic and diagnostic marker of early brain injury.
Grant Acknowledgement
MRC (UK)
Fig. 23 (abstract 0016). <72 hours - Impaired vs Non-impaired
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INTRODUCTION. The Eurotherm3235 trial [1] was a high quality ran-
domised controlled trial assessing the efficacy of therapeutic
hypothermia, 32-35°C, (TH) to control intracranial pressure (ICP) fol-
lowing traumatic brain injury (TBI) verses standard care (Control
(CG)). TH was associated with increased mortality at 6 months. To
better understand this result study centres collected additional data
retrospectively.
METHODS. Additional data, including the patients' background, man-
agement and physiology in the 7 days following randomisation, was
collected from medical notes, 24 hour charts and hospital informa-
tion systems between January and July 2016. This was collated into a
secure database and analysed. Data are given as number (%) or
mean daily values (standard deviation) for TH vs. CG.
RESULTS. 286 anonymised forms were received from 33 of 47 cen-
tres (74% of the trial population). 143 patients received TH and 143
were in the CG. Mortality at 6 months was significantly increased
with TH (46 vs. 32 deaths, Hazard ratio 1.624 CI 1.025 - 2.573,
p = 0.039). The cause of death may have differed between the
groups, with an excess of TH patients dying with multi-organ failure,
systemic inflammation or acute lung injury (15 (35.7%) vs. 5 (19.2%)).
The numbers receiving Midazolam (96.0(12.8) vs. 78.7(16.0),
p = 0.046), Alfentanil (37.1(4.7) vs. 27.7(5.2), p = 0.004, Atracurium
(31.1(6.8) vs. 22.0(4.5), p = 0.012) were significantly greater with TH.
TH was associated with increased numbers receiving Vasopressin
(5.7(2.4) vs. 1.9(0.9), p = 0.002) and Dobutamine (7.3(3.1) vs. 2.3(1.0),
p = 0.002). The number of patients with a metabolic acidosis
(45(36.9%) vs. 27(22.1%), p = 0.017) and receiving bicarbonate
(17(13.7%) vs. 5(4.2%), p = 0.018) was greater with TH. Serum lactate
was also greater (1.20(0.10) vs. 1.06(0.11) mmol/l, p = 0.027). Further-
more, the number of patients receiving steroids was greater with TH
(23(17.8%) vs. 9(6.7%), p = 0.01). Small but significant effects of TH
on leucocytes (9.9(0.9) vs. 11.0(0.7) 10^9/l, p = 0.031), neutrophils
(7.8(0.6) vs 9.0(0.7) 10^9/l, p = 0.005) and activated partial thrombo-
plastin time (33.2(2.1) vs. 31.2(1.3) s, p = 0.046) were also found.CONCLUSIONS. This post-hoc explorative study found significant be-
tween groups differences in outcome, management and physiology
associated with TH. In light of Eurotherm3235´s principle finding that
TH was associated with harm, these differences, which have previ-
ously been regarded as simple consequences of TH, could have
pathological significance. Correcting for these differences in future
studies of TH could be important.
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INTRODUCTION. Decompressive craniectomy (DC) is largely used as
treatment for refractory intracranial hypertension after traumatic
brain injury (TBI). DC decision and its impact on clinical evolution has
still unresolved controversies mainly regarding timing of intervention,
patient selection and post-operative management.
OBJECTIVES. To characterize the before and after periods of DC
using multimodal brain monitoring.
METHODS. We retrospectivaly studied 9 TBI patients, admitted to
the Neurocritical Care Unit (NCCU) at Hospital São João, Porto that
were submitted to primary or secondary DC and had brain monitor-
ing during 12 hours before and 24 hours after surgery. At NCCU,
TBI patients admitted are managed with an autoregulation-oriented
CPP protocol. Variables analyzed were Intracranial Pressure (ICP),
ICP dose over 20 mmHg (ICPd > 20), Cerebral Perfusion Pressure
(CPP), optimal CPP (CPPopt), Arterial Blood Pressure (ABP), End-
Tidal CO2 (ETCO2), cerebrovascular pressure reactivity based on ICP
(PRx) and volume-pressure compensatory reserve (RAP).
RESULTS. Data analyzed included seven males and two females
with mean age of 30.3 ± 11.1 years, with admission mean Glas-
gow Coma Scale (GCS) of 6.1 ± 2.1 and Simplified Acute Physi-
ology Score II (SAPSII) of 42.2 ± 14.6. Marshall classification of the
first CT scan was predominantly grade III and before DC was IV.
The mean period from hospital admission to DC was 3.3 ± 2 days.
DC led to significantly decrease in ICP maximum values
(p = 0.011) and lowered ICPd > 20 exposure (p = 0,038), in spite
of non significant decrease of median ICP (Fig. 24). CPP before
and after DC was significantly different (p = 0.038) as it was
CPPopt (p = 0,021) (Fig. 25). Two hours before surgery PRx be-
came positive indicating impairment of autoregulation (AR). The
median values of PRx before and after DC show no statistically
significant differences in spite of documented increase in its vari-
ance (Fig. 26). Furthermore in some patients after DC, PRx
remained >0.25 (used cut-off for AR). Before DC, RAP index was
positive and closer to 1 expressing poor volume-pressure reserve.
After DC RAP decreased with a trend towards to zero (p = 0.008)
representing an improvement in brain compliance. Three months
after hospital admission 67% of patients had Glasgow Outcome
Scale (GOS) ≥3. Mortality rate was 17%.
CONCLUSIONS. ICP, CPP and compensatory reserve improved signifi-
cantly as expected after DC. Sudden impairment of AR before DC
may help to decide the timing of surgery. However, further studies
are warranted to better understand DC influence on clinical decision
and outcome.
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 13 of 542REFERENCES
1. Kramer AH, Deis N, Ruddell S, et al. Decompressive Craniectomy in
Patients with Traumatic Brain Injury: Are the Usual Indications Con-
gruent with Those Evaluated in Clinical Trials? Neurocrit Care 2016
26:10–19.
2. Lazaridis C, Czosnyka M. Cerebral Blood Flow, Brain Tissue Oxygen,
and Metabolic Effects of Decompressive Craniectomy. Neurocrit Care.
2012 16(3):478–484.Fig. 24 (abstract 0018). ICP and ICP dose before and after DC
Fig. 25 (abstract 0018). PRx before and after surgery
Fig. 26 (abstract 0018). CPP and CPPopt0019
Transfusion Requirements after Head Trauma (TRAHT): a
randomized clinical trial
A. Gobatto1,2,3, M. L. Azevedo1, D. J. F. Solla1, W. S. Paiva1,
L. M. Malbouisson1, E. B. Shu1
1Hospital da Clinicas - University of Sao Paulo Medical School, São Paulo,
Brazil; 2Hospital São Rafael, Salvador, Brazil; 3Hospital da CIdade, Salvador,
Brazil
Correspondence: A. Gobatto
Intensive Care Medicine Experimental 2017, 5(Suppl 2):0019
INTRODUCTION. Anemia is frequent among traumatic brain in-
jured (TBI) patients, and it is associated with an increased risk of
poor outcomes. The optimal hemoglobin (Hb) level to trigger
red blood cell (RBC) transfusions in TBI patients is yet to be
defined.OBJECTIVE. To evaluate the feasibility and safety of creating a
hemoglobin gradient between TBI patients submitted to restrict-
ive or liberal transfusion strategies in the ICU, as part of plan-
ning a larger randomized clinical trial.
METHODS. From June 2015 to June 2016, all adult patients with
moderated or severe TBI were randomized either to a restrictive
group, with an Hb transfusion threshold level of 7g/dL, or to a
liberal group, with an Hb transfusion threshold level of 9g/dL.
Transfusion strategies were maintained for up to 14 days or to
ICU discharge. The primary outcome was the mean Hb differ-
ence between groups. Secondary outcomes included transfusion
requirements, intracranial pressure (ICP) management resources
use, transcranial doppler (TCD) parameters, length of stay and
mortality. Patients were followed for 6 months after hospital
discharge.
RESULTS. A total of 44 patients were randomized, 21 patients to
the liberal group and 23 patients to the restrictive group. There
was no baseline difference between the groups. The patients
were predominantly male, 40 (90.9%) patients, mean age was
34.5 ± 13.4 years, and admission median Glasgow coma scale
was 6 (quartiles 4–8). The mean CRASH score 14-day death risk
was 40.7 ± 18.9% in the restrictive group and 39.3 ± 18.4% in
liberal group (p = 0.818). The ICU admission Hb levels (g/dL)
were 10.3 ± 1.6 in restrictive group and 10.1 ± 1.2 in liberal
group (p = 0.550), and the average 14 days Hb level was
8.4 ± 1.0 and 9.3 ± 1.3 (p < 0.001), respectively. During ICU stay,
RBC transfusion was administered to 13 (56.5%) patients in the
restrictive group and to all 23 (100.0%) patients (p = 0.001) in
the liberal group (a total of 35 and 66 RBC units, respectively;
p = 0.022). There was an inverse correlation (−0.265) between
Hb level and middle cerebral artery flow velocity (p < 0.001) at
the side of trauma. This correlation was stronger on the liberal
group (Hb range 7.1-12.6g/dL) when compared to the restrictive
group (Hb 6.2-10.7g/dL). Hospital mortality was higher in the re-
strictive group, seven (30.4%), versus one (4.8%) patient
(p = 0.048).
CONCLUSION. Creating a hemoglobin gradient between the
groups was feasible. The restrictive group had lower hemoglobin
levels and received less RBC transfusions. Mortality was higher in
restrictive group.
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INTRODUCTION. Increased Intracranial pressure (ICP) and low cerebral
perfusion pressure (CPP) remain the two main cerebral hemodynamic
goals to improve outcomes after severe traumatic brain injury (TBI). Yet
debate remains over the actual thresholds, and whether they need to
be individualised based on autoregulation status or other criteria.1,2
Here, we used data from a large cohort to examine the association of
cumulative ICP and CPP burden on outcome after severe TBI. Recent
data from small cohorts has supported such an approach.3
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 14 of 542OBJECTIVES. To determine association of cumulative burdens of
intracranial pressure (ICP) and cerebral perfusion pressure (CPP) with
two-week mortality after severe TBI.
METHODS. Retrospective analysis of prospectively collected data
from the New York State TBI-trac® trauma database. Daily duration of
ICP > 25mmHg (ICPhigh) and CPP < 60mmHg (CPPlow) were recorded.
Cumulative number of hours, averaged daily duration, and %total
days with abnormal value were calculated. Outcome was recorded as
2-week mortality.
RESULTS. 1207 patients were included with 19.1% mortality. Mean cumu-
lative ICPhigh burden was 8.85 hours, ICPhigh days were 25.1% of total days,
averaged daily burden was 1.54 hours. Mean cumulative CPPlow burden
was 16.6 hours with CPPlow days of 45.1% and daily average of 2.95 hours.
In non-survivors compared to survivors, cumulative and averaged daily
hours of ICPhigh (20.33 vs. 6.23 hours; 4.74 vs. 0.81 hours; p < 0.001) and
CPPlow (25.7 vs.14.46 hours; 5.83 vs.2.28 hours, p < 0.001) were significantly
higher. Mortality increased dramatically with ICPhigh > 50% days
(p < 0.001, c-statistic 0.71), or CPPlow > 80% (p < 0.001, c-statistic 0.70). In
multivariate analysis using age, GCS, hypotension, CT and pupillary abnor-
malities, and including ICPhigh > 40% and CPPlow > 80%, model c-statistic
was 0.834. Multivariate logistic regression demonstrated that the likelihood
ratio statistic for cumulative ICPhigh (84.10) was higher than that for CPPlow
(45.97) in predicting mortality.
CONCLUSIONS. Cumulative ICPhigh and CPPlow burdens have a high
correlation with early mortality after severe TBI and warrant further
evaluation in severe TBI patients with intracranial hypertension.
ICPhigh burden appears to impact mortality more than CPPlow burden,
which has not been reported before.
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INTRODUCTION. Bystander cardiopulmonary resuscitation (CPR)
traditionally consists of both ventilations and chest compressions. The
concept of Compression Only CPR (CO-CPR) has emerged since rescue
breaths are difficult to perform, potentially delay the start of CPR, and
interrupt chest compressions. Since 2010 guidelines suggest CO-CPR
for telephone assisted CPR, for untrained bystanders and for
trained bystanders unwilling or unable to perform rescue breaths.
OBJECTIVES. The aim was to describe changes in rates of bystander
CPR, telephone assisted CPR, CO-CPR and survival during 3 different
time-periods of CPR-guidelines on a national level. We hypothesized
that dissemination of CO-CPR would be associated with increased
CPR-rates and similar survival compared to standard CPR.
METHODS. A registry based cohort study including all bystander
witnessed cases of out-of-hospital cardiac arrests reported to the
Swedish Registry for Cardiopulmonary Resuscitation in 2000–2014.
Exposure was categorized as bystander CPR or No-CPR. Bystander
CPR was further categorized into Standard CPR (S-CPR) or CO-CPR.
Primary outcome was 30-day survival.
RESULTS. In total 23 620 patients were included. Total rates of by-
stander CPR increased from 38% in 2000–2005 to 70% in 2011–2014.
CO- CPR increased from 5% in 2000–2005 to 28% in 2011–2014. Any
form of bystander CPR was associated with increased 30-day survivalcompared to no CPR in all time periods studied. Overall there was no
significant difference in survival among patients receiving CO-CPR or
S-CPR (13,6% vs. 12,9% p = 0,3).
CONCLUSIONS. The increase in bystander CPR during the last 15
years in Sweden is mainly attributed to an increase in CO-CPR. 30-
day survival was not different when comparing CO-CPR to S-CPR.
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INTRODUCTION. Although there is increasing acceptance of termin-
ation of resuscitation (TOR) in patients with out-of-hospital cardiac arrest
(OHCA) following futile resuscitation, children are generally excluded
from TOR protocols. Termination of pediatric resuscitation is a difficult
topic for clinicians and patient's family, however, decision to withhold re-
suscitative efforts should be evidence based and free from emotion.
OBJECTIVE. We aimed to develop and validate a TOR rule in pediatric
patients with OHCA, to guide emergency physicians in deciding whether
to withhold further resuscitation efforts or terminate on-going resuscita-
tion soon after patient arrival.
METHODS. We performed retrospective analysis using data from Japan's
nationwide OHCA registry from January 2005 through December 2012,
including pediatric OHCA patients < 18 yrs, transported to hospital by
emergency medical services (EMS). We developed a new TOR rule pre-
dicting mortality at 1 month after cardiac arrest using multivariate logistic
model. Internal validation was performed using split-sample methods.
The derivation set comprised of 9702 patients registered in 2005–2010,
and the validation set comprised 2875 patients registered in 2011–2012.
RESULTS. The overall mortality at 1 month after OHCA was 90.1%.
We developed a new TOR rule including 5 criteria based on the re-
sults of multivariate logistic regression analysis: no prehospital return
of spontaneous circulation (adjusted odds ratio 16.7; 95% confidence
interval [CI] 13.4-20.8), no shockable initial cardiac rhythm (3.25; 2.50-
4.21), time interval from EMS call to hospital arrival > 16 min (2.11;
1.69-2.65), no witness (1.83; 1.54-2.16), and no bystander CPR (1.48;
1.25-1.75). The new TOR rule had a specificity of 0.91 (95%CI 0.89-
0.93) and a positive predictive value of 0.97 (0.97-0.98) in the deriv-
ation set, and a specificity of 0.91 (0.87-0.93) and a positive predictive
value of 0.96 (0.95-0.97) in the validation set.
CONCLUSIONS. We developed and validated a new TOR rule in
pediatric OHCA. This rule might help emergency physicians for coun-
seling family and making medical decisions.
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INTRODUCTION. Prognosis of patients after cardiac arrest (CA) is
still unfavourable despite improving prehospital and hospital care
(10-20% survival to discharge).The anoxic phase of injury is
followed by the reperfucion phase leading to postcardiac arrest
syndrom.The oxidative stress is one of the main causes of post-
cardiac arrest syndrome.There is a data showing that increasing
of the antioxidative protection by the supplementation of selen-
ium in patients in septic shock or severe sepsis might improve
their prognosis.There is no clear data on the impact of this sup-
plementation in patients after CA.
OBJECTIVES. We assumed that because there is a parallel between
circulation impairment in sepsis and after CA and because the most
Table 5 (Abstract 0024). Characteristics according to the absence/presence
Cases without HF (n=72) Cases with HF (n=76) p
LV (vs. aorta) below P_guide, n (%) 56 (77.8) 45 (59.2) 0.025
Coordinates, P_max (cm)
x 5.00±0.83 5.69±0.98 <0.001
y −0.99±1.36 −1.51±1.67 0.041
z 5.25±0.71 5.76±1.09 0.001
Coordinates, P_ao (cm)
x 1.32±0.67 1.63±0.90 0.016
y 1.82±1.43 1.16±1.65 0.011
z 5.55±0.80 5.43±0.87 0.40
Fig. 27 (abstract 0024). A 3D coordinate system
Fig. 28 (abstract 0024). 3D coordinates of (1) P_max and (2) P_ao
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 15 of 542prognosis limiting system is the brain that is full of lipids easilly tar-
geted by oxidative stress, we could decrease the damage by selen-
ium substitution in the same way as proven in septic shock.
METHODS. We randomized 26 patients in 2 groups. The first group was
treated by standart therapy. The second group received selenium intra-
venously (sodium selenite) in addition to the standart therapy. 3mg of
selenium was administered as initial bolus (the first day) in 30 minutes in-
fusion followed by continuous infusion of 2mg of selenium per day for
the next 5 days.We measured the products of reactive oxygen species re-
actions (ROM test and 8-hydroxy-guanosin as marker of the damage of
RNA), serum antioxidative capacity (BAP test),markers of inflammation
and tissue injury and clinical outcome (cerebral performance categories
scale,CPC,incidence of infection).
RESULTS. Patients treated by selenium had less pronounced oxida-
tive stress.The result of ROM test was significantly lower in the selen-
ium treated group in the 3rd,4th and 5th day with greatest difference
in the 4th day (340 vs.418 Carr units,p = 0,03).The result of BAP test
was significantly higher in the selenium treated group in the
1st,2nd,3rd,4th and 5th day with greatest difference in the 3rd day
(2337 vs.1938 μmol/l,p = 0,01). There was significantly lower concen-
tration of 8-hydroxy-guanosin in selenium treated group in the 3rd
day (1,2 vs. 2,3 ng/ml, p = 0,04). There was no difference in the level
of the markers of renal,hepatal or cerebral (neuron specific enolase)
injury and no difference in inflammation markers (leukocytes,CRP,-
procalcitonin,incidence of infection). There was insignificantly better
neurological outcome in the selenium treated group in 1st month
follow up (80 vs. 50% of patients with CPC 1).
CONCLUSIONS. Preliminary results show that intravenously admin-
istered selenium in patients after CA is safe and might decrease
the level of oxidative stress and increase the antioxidative
capacity. Albeit the numerical trend to better neurological out-
come does not mean necessarily positive effect on prognosis it
shows that it does not cause any harm although the dosage of
selenium exceeds the daily recommended dosage for healthy
population.
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INTRODUCTION. Researchers suggested that the 'lowest' part of the
sternum (vs. the 'lower half') should be compressed to maximize the
stroke volume by compressing the maximum diameter of the left
ventricle (LV) rather than the aorta.
OBJECTIVES. To determine the optimum chest compression site
based on the presence/absence of heart failure (HF) by applying
three-dimensional (3D) coordinates on computed tomography (CT).
METHODS. This retrospective, cross-sectional study involved adults who
underwent echocardiography and CT within a day from 2007 to 2017. Pa-
tients who had incomplete CT or HF information, received cardiac medi-
cation between performing echocardiography and CT, or had thoracic
abnormalities were excluded. Cases were classified as with or without HF
through symptom/sign assessment, N-terminal pro-B type natriuretic
peptide testing, and echocardiography. Whether the left ventricle (LV)
was located just beneath the midpoint of lower half of the sternum
(P_guide) was checked via CT. The 3D coordinates were drawn from the
xiphisternal joint's midpoint (0, 0, 0). Leftward, upward, and into-the-
thorax directions were designated as positive (Fig. 27). The 3D coordi-
nates of the maximum LV diameter's midpoint (P_max) and the centre
point of aortic annulus (P_ao) were identified (Fig. 28).
RESULTS. Finally, 148 patients were enrolled (mean age: 63.0 ± 15.1 years),
of whom 87 were females and 76 had HF. HF cases had smallerproportion of LV located beneath the P_guide than normal cases (59.2%
vs 77.8%). P_max of the former was also located more leftwards, lower,
and deeper than the latter (5.69 ± 0.98, −1.51 ± 1.67, 5.76 ± 1.09 cm vs.
5.00 ± 0.83, −0.99 ± 1.36, 5.25 ± 0.71 cm, Table). The aorta (vs. LV) was
compressed at 3 cm above the xiphisternal joint in 81.9% and 85.5% of
normal and HF cases, respectively (Fig. 29).
CONCLUSIONS. The chest needs to be compressed at the lowest pos-
sible part just above the xiphisternal joint, especially for HF patients in
cardiac arrest.
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Fig. 29 (abstract 0024). Effect of hand position on the sternum
Table 6 (Abstract 0025). Prognostic accuracy for poor outcome at
3 months
Time
after CA
Test Specificity,
%
Sensitivity,
%
PP value,
%
NP value,
%
Day 1 Quantitative PLR,
%
92.7 (87.3-
96.3)
50.5 (43.2-
57.8)
89.7 (82.3-
94.8)
59.7 (53.1-
66)
Quantitative NPi,
%
97.5 (93.6-
99.3)
18.7 (14.4-
25.9)
90.7 (77.9-
97.4)
49 (43.4-
54.7)
Absent brainstem
reflexes
65.4 (56.8-
73.4)
55.6 (46.8-
64.1)
61.5 (52.2-
70.1)
59.7 (51.4-
67.7)
Absent motor
response
17 (11.2-
24.3)
93.6 (88.6-
96.9)
55.7 (49.5-
61.8)
70.6 (52.5-
84.9)
Day 2 Quantitative PLR,
%
93.1 (86.4-
97.2)
39.3 (31.5-
47.6)
89.4 (79.4-
95.6)
51.1 (43.7-
58.5)
Quantitative NPi,
%
99.1 (95-
100)
23.6 (17.2-
31)
97.4 (86.2-
99.9)
47.6 (41-
54.3)
Absent brainstem
reflexes
86.7 (78.4-
92.7)
43.3 (34.3-
52.7)
80 (68.2-
88.9)
55.6 (47.3-
63.6)
Absent motor
response
63.8 (53.9-
73)
77.3 69.5-
83.9)
74.1 (66.3-
81)
67.7 (57.5-
76.7)
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INTRODUCTION. Bilateral absence of pupillary reactivity 3 days
after cardiac arrest (CA) predicts poor outcome, however
prognostic accuracy of standard examination may be lower when
performed at an earlier phase and is limited by lack of a quanti-
tative tool.
OBJECTIVES. To examine the accuracy of quantitative pupillometry
(NPi-200® automated infrared pupillometer, NeurOptics, Irvine, CA,
USA) in predicting neurological recovery of post-CA coma and to
compare its prognostic value to that of standard qualitative
neurological examination.
METHODS. A prospective multicentre study was conducted amongst
10 European academic hospitals (clinicaltrials.gov NCT02607878).
Blinded pupillometry tests (Neurological Pupil index [NPi] and % of
Pupillary Light Reactivity [PLR]) were performed in parallel with stand-
ard neurological examination (motor response [GCS-M] and brainstem
reflexes [BSR]) at day 1 and 2 after CA. Outcome was assessed at 3
months using the Cerebral Performance Categories (CPC) score; poor
outcome was defined as CPC 4 (vegetative state) and 5 (death). Statis-
tical analyses were performed by an independent statistician.
RESULTS. From March 2015 to October 2016, 371 consecutive pa-
tients were included in this ongoing study. On day 1, patients
with poor outcome (n = 206; 56%) had lower NPi (3.6 ± 1.5 vs.
4.5 ± 0.3, p < 0.001) and lower PLR (13 [8, 19] vs. 20% [17, 26],
p < 0.001) than patients with good outcome (n = 165; 44%).
Similar results were found on day 2. Low NPi (<3) and PLR
(<13%) had higher specificity and positive predictive value for
predicting 3-month poor outcome than absent BSR and GCS-M,
on both day 1 and day 2 after CA (Table 6).
CONCLUSIONS. These findings indicate that quantitative pupillo-
metry had higher accuracy than standard qualitative neuro-
logical examination in predicting poor outcome in the early ICU
phase after CA. Automated infrared pupillometry may be inte-
grated in multimodal algorithms for coma prognostication fol-
lowing CA.ACKNOWLEDGEMENTS
Automated infrared pupillometers were provided for the purpose of
the study by NeurOptics.New therapies for AKI
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INTRODUCTION. A possible mechanism for acute kidney injury (AKI)
after cardiac surgery is ischemia-reperfusion injury caused by the
Extracorporeal Circulation (ECC) [1], resulting in opening of the mito-
chondrial Permeability Transition Pore (mPTP) [2] in the kidneys,
which in turn can led to cell injury or death [3]. Cyclophilin-D is a key
regulator of the mPTP [4]. Animal studies have shown that ciclos-
porin may block the opening of mPTP by inhibition of cyclophilin-D
[5] in the kidneys and decrease the renal injury [6] if administered
before the ischemia-reperfusion event.
OBJECTIVES. We hypothesised that ciclosporin given as a single dose
before start of ECC in coronary artery bypass grafting (CABG) surgery
will decrease the degree of AKI.
METHODS. The CiPRICS study is an investigator-initiated, double-
blind, randomized, placebo-controlled, single-centre study performed
at Skane University Hospital (Lund, Sweden). The study was approved
by the Regional Ethical Review Board and registered under
NCT02397213 and EudraCT: 2014-004610-29. Before enrolment, oral
and written informed consent was obtained. Between April 2015 and
June 2016, 154 patients with estimated glomerular filtration rate of
15–90 mL/min/1.73m2 planned for elective CABG with ECC were
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 17 of 542enrolled. Study patients were randomized in a 1:1 ratio to receive
2.5 mg/kg ciclosporin or placebo intravenously after anaesthesia in-
duction but before surgery. Primary endpoint was relative plasma
cystatin C changes from the preoperative day to postoperative day 3,
tested with a linear mixed model in the mITT population. Secondary
endpoints included biomarkers of kidney, heart, and brain injury.
Safety data was collected from administration of study drug. An inde-
pendent Data Safety Monitoring Board evaluated the study after 50
and 100 patients had received study drug and recommended the
study to continue without changes in protocol.
RESULTS. The ciclosporin group showed a more pronounced rela-
tive increase from baseline plasma cystatin C to day 3 compared
to placebo (1.36 ± 0.35 vs 1.16 ± 0.31, p < 0.001). The same
pattern was observed for the other renal markers. There were no
differences in clinical outcome or AE/SAE distribution between
the groups.
CONCLUSIONS. Administration of ciclosporin 2.5 mg/kg before sur-
gery did not protect CABG patients from AKI. Instead, ciclosporin
caused a transient decrease in renal function compared to placebo.
REFERENCES
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INTRODUCTION. Early optimization of volume status, maintenance of
adequate perfusion pressure and discontinuation of nephrotoxic
medication before the occurrence of AKI may be the crucial step to
reduce preventable AKI.
OBJECTIVES. To determine the impact of renal biomarker guided im-
plementation of the Kidney Disease Improving Global Outcomes
(KDIGO) guidelines on incidence of acute kidney injury (AKI) after
major non-cardiac surgery in randomized clinical trial.
METHODS. Early administration of KDIGO bundle was compared to
standard ICU care in 121 patients with increased AKI-Risk determined
by elevated urinary [TIMP2 * IGFBP7] biomarkers. Incidence of overall
AKI, severity of AKI; incidence of creatinine increase of >25%, length
of stay, major kidney events (MAKE) at discharge and cost effective-
ness between both groups were evaluated.
RESULTS. The incidence of overall AKI was not statistically different
between both groups, but incidence of moderate and severe AKI
(6.7% versus 19.7%; odds ratio [95%CI] 3.43 [1.0, 11.3], p = 0.04) and
incidence of creatinine increase >25% of baseline value (40.0% ver-
sus 62.3%, OR 2.48 (1.19, 5.15), p = 0.01) were significantly reduced
in the intervention group. Additionally, length of ICU and hospital
stay decreased in the intervention group (p = 0.04) and the interven-
tion significantly attenuated release of cellular stress biomarker
(p = 0.03). There were no significant differences in the need for renal
replacement therapy, in-hospital mortality or in MAKE by hospital
discharge.CONCLUSIONS. Among patients after major non-cardiac surgery early
biomarker- based detection of AKI- risk followed by implementation of
KDIGO bundle reduced AKI severity, postoperative creatinine increase,
length of ICU and hospital stay.
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INTRODUCTION. Mounting evidence suggests that sepsis-induced
morbidity and mortality are due to both immune activation and
immunosuppression. Resistin is an inflammatory cytokine and
uremic toxin. Septic hyperresistinemia (HR) has been associated
with greater disease severity and worse outcome. Septic HR also
impairs neutrophil (PMN) migration, a crucial first-line mechanism
in host defense. Acute kidney injury (AKI) worsens septic HR. Pre-
liminary studies indicate that conventional renal replacement
therapies do not correct HR [1].
OBJECTIVES. Our central hypothesis is that HR causes PMN dys-
function and thereby potentially contributes to sepsis-induced im-
munosuppression. We have demonstrated that HR blocks PMN
migration in vitro, likely due to impaired F-actin formation [1].
Here, we study the effects of resistin on intracellular bacterial kill-
ing and generation of reactive oxygen species (ROS). We also
seek to examine the effects of hemoadsorption on HR and PMN
dysfunction.
METHODS. An in vivo cohort of 13 patients with septic shock and
12 control ICU patients was analyzed for serum resistin levels and
their effects on PMN migration. In vitro, following incubation with
resistin-spiked serum samples, intracellular bacterial killing and
ROS generation in PMNs was measured using a commercially
available kit. P. aeruginosa was used to examine phagocytic and
bacterial killing capacity of PMNs in a standard assay. In vitro
hemoadsorption with both AmberchromeTM columns (AC) and
CytoSorbTM cartridges (CC) were used to test correction of HR.
We further tested AC for their effect on migration and ROS gen-
eration and CC for their effect on bacterial killing.
RESULTS. Patients with septic shock had higher serum resistin
levels than control ICU patients and showed a strong correlation
between HR and inhibition of PMN migration. In vitro, PMNs ex-
posed to resistin exhibited lower intracellular bacterial killing rates
compared to controls. Resistin impaired reactive oxygen species
production in a dose-dependent manner. Hemoadsorption with AC
reduced serum concentrations of resistin and restored PMN migra-
tion and generation of ROS to normal levels. Hemoadsorption with
CC also corrected HR. Exposure of PMNs to resistin impaired intra-
cellular P. aeruginosa killing compared to control. However, when
this same resistin-spiked serum was subsequently treated with CC
prior to exposure to PMNs, intracellular bacterial killing was re-
stored to normal levels.
CONCLUSIONS. Septic HR significantly and reversibly impairs PMN
intracellular bacterial killing and ROS generation. Hemoadsorption
therapy with clinically approved CC may provide a therapeutic option
to improve PMN function during septic HR and ultimately improve
immunosuppression in these disease states.
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INTRODUCTION. Acute Kidney Injury (AKI) is associated with high
morbidity and mortality. Reports have suggested inadequate
management of patients with hospital-acquired AKI (HA-AKI)(1),
leading to subsequent recommended guidance.(2) One way of
improving care for such patients is through electronic alerting
and delivery of best practice care bundles.
OBJECTIVES. To investigate the impact on processes of care of a
comprehensive electronic intervention: combining a prediction
model for those at risk of AKI, an alert for those with new HA-
AKI, alongside a care bundle.
METHODS. A dual-centre before and after with control design (2014–
6) investigated the effects of the intervention on processes of care
for medical ward patients. Methods included a review of electronic
prescribing, coding of AKI patients and a retrospective case note re-
view of a sample of patients with HA-AKI.
RESULTS. From 30,298 patient episodes there were 2,040 cases
of HA-AKI over the study period. At the intervention site signifi-
cantly more episodes of medications were stopped with AKI as
the reason given vs the control site (n = 95 vs 36, P < 0 · 001,
OR 2 · 1 [1 · 41-3 · 10]. Significantly more patients at the inter-
vention site had ACE inhibitors or Angiotensin-receptor blockers
stopped vs control site (308 vs 146, P < 0 · 001, OR 1 · 831
[1 · 493-2 · 247]). ICD-10 coding of AKI increased at both sites
with the intervention site having a larger increase (+21% vs
+17%). Coded AKI mortality at the intervention site significantly
reduced (24% vs 20%, P = 0 · 0057) with no significant change
at control site (20% vs 18% P = 0 · 44).
181 patients notes were reviewed with significant improve-
ments at the intervention site found following the intervention
including improved documentation (in the notes and on dis-
charge), review of medications, monitoring of renal function
and appropriate investigations (See Table 7 and Table 8)
CONCLUSIONS. The introduction of an electronic alert and care bun-
dle significantly improved a number of process measures in this
before-after with control site intervention study.
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Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 19 of 542INTRODUCTION. Acute kidney injury (AKI) represents a public health prob-
lem associated with high rates of morbidity and mortality among critically ill
patients. Furthermore, it has been postulated that continuous venovenous
hemofiltration (CVVH) might benefit critically ill patients with AKI by better
clearing medium molecular weight inflammatory cytokines, whilst practice sur-
veys have shown controversy in mode selection among countries and regions.
OBJECTIVES. To demonstrate in septic patients with sepsis-associated
AKI (SA-AKI), a non-inferiority survival of continuous venovenous
hemodialysis (CVVHD) compared to (CVVH), both techniques associated
with an increased adsorption membrane (AN69-ST-150).
METHODS. A two-center, parallel-group and randomized single-
blinded control trial was performed. Participating centers were two
tertiary-level hospitals in Barcelona. We enrolled 106 critically ill adult
patients with sepsis and AKI who met continuous renal replacement
therapy (CRRT) initiation criteria were included, within the first 72 hours
from intensive care unit (ICU) admission. One-hundred and six patients
were randomly assigned to one of the two strategies [49 patients to
CVVH + adsorption membrane (AN69-ST-150) and 57 patients to
CVVHD + AN69-ST-150]. Patients were started on CRRT at a fixed dose
of 30ml/kg/h during the first 72 hours. Clinical and laboratory data were
collected. Follow-up was assessed at hospital discharge and 90 days.
RESULTS. Overall 90-day mortality was 57% in the CVVH group and 23%
in the CVVHD group (p = 0.04). Mean age was 64 ± 13 years; 66% of pa-
tients were male. The most prevalent comorbidities were: hypertension,
chronic heart failure and diabetes mellitus (in 58%, 35% and 26% of the
patients, respectively). The main etiology of sepsis was intra-abdominal
infection in 40% of patients. Mean SOFA score at ICU admission was
11 ± 3,8 and mean APACHE score was 25 ± 9. At CRRT initiation, 80% of
patients met criteria for stage 3 AKI as stated by the Kidney Disease Im-
proving Global Outcomes (KDIGO) guidelines. There were no differences
between groups neither in terms of the number of extracorporeal circuits
(EC) consumed (5.3 vs 4.5, p = 0.3105), nor in secondary outcomes such
as ICU and hospital length-of-stay (LOS) [14 ± 13 vs 20 ± 49 (p = 0.89),
and 25 ± 30 vs 30 ± 50 (p = 0.65), respectively].
CONCLUSIONS. In patients with SA-AKI, we demonstrated non-
inferiority of CVVHD in terms of survival respect to CVVH in patients
with SA-AKI. There were no differences respect to ICU and hospital
LOS and the number of EC consumed during CRRT.
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INTRODUCTION. Existing risk prediction models may not be practic-
ally applied in the clinical setting given their reliance upon a large
number of physiologic or lab variables not uniformly collected in the
course of clinical care.
OBJECTIVES. This study aims to assess the potential of a simple and
practical score to function as an early predictor of mortality in critically ill
patients. Our primary study objective was to derive and validate a simple
risk prediction score based on demographics and blood laboratory values
consistently measured at ICU admission.METHODS. The PEAR (Platelet, Eosinophil, Age, Red cell distribution
width) score, was constructed with demographics and laboratory mea-
sures immediately available at ICU admission. We included surrogates of
chronic inflammation (red cell distribution width), acute inflammation
(platelets) and extreme acute inflammation (eosinophil count). We per-
formed a retrospective cohort study of 76,091 patients admitted to a
medical or surgical ICU between 1997 and 2012, to 2 large Boston hospi-
tals. All patients had platelet count, eosinophil count and red cell distribu-
tion width determined at ICU admission. The derivation cohort consisted
of ICU patients from Brigham and Women´s Hospital (n = 27,706), and
the validation cohort comprised of ICU patients from Massachusetts Gen-
eral Hospital (n = 48,385). A clinical prediction model was derived and
validated based on logistic regression describing the risk of 90 day mor-
tality as a function of the predictors at ICU admission: Red cell distribution
width, platelet count, eosinophil count, age, gender and patient type (sur-
gical vs. medical). Performance analysis of the PEAR score against APA-
CHE II was completed in a subset of the validation cohort (n = 341).
RESULTS. The derivation cohort (n = 27,706) was 56% male, 53% surgi-
cal ICU with a mean age of 63 years and a 90-day mortality rate of
18.7%. The validation cohort (n = 48,385) was 59% male, 46% surgical
ICU with mean age of 63 years and a 90-day mortality rate of 16.6%.
The AUC for the prediction model was 0.740 in the derivation cohort
and 0.743 in the validation cohort. For both the derivation and valid-
ation cohorts, the Hosmer-Lemeshow χ2 P values indicated good model
fit. In the validation cohort, 90-day mortality was 5.5% in the low-risk
group (0 to 20 risk score points), 9.9% in the intermediate-risk group
(21 to 27 points), 17.6% in the high-risk group (28 to 36 points), and
34.9% in the very high-risk group (>36 points). In the validation cohort
subset, differences in model discrimination between risk score and
APACHE II were not significant (χ2 1.73, P = 0.19).
CONCLUSIONS. Our PEAR score calculated from age, gender, patient
type, red cell distribution width, platelet count and peripheral blood
eosinophil count at ICU admission is a simple, quick and easily
understandable score that may increase clinical utility for risk predic-
tion in ICU patients.
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INTRODUCTION. In the process of prognostication and decision mak-
ing about possible treatment limitations in patients with prolonged in-
tensive care unit (ICU) admission, the extent, duration and temporal
evolution of acute organ dysfunction is often taken into consideration.
However, currently it is unclear way of using repeatedly measured
SOFA scores is most helpful for predicting outcomes in these patients.
OBJECTIVES. To compare different ways of modelling daily SOFA
score data observed during the first week of ICU stay with regard to
the ability to predict poor long-term outcome.
METHODS. Patients admitted to a tertiary mixed ICU, staying at least 7
days, were included. APACHE IV predicted risk of mortality, daily SOFA
scores, and outcome data were extracted from data routinely collected
for national benchmarking and 1 year follow-up. First week SOFA
scores were modelled in 35 different ways, with varying level of com-
plexity (box 1). The main outcome studied was poor outcome at 1 year
follow-up. This was defined as either death at 1 year follow-up or sur-
viving with a EuroQoL-5D 3L health related quality of life index < 0.4.
For each of the box 1 SOFA parameterizations, a logistic regression
Table 9 (Abstract 0032). Study population
N 1170
Sex (female) 410 (35%)
Age at ICU admission 60 [49 - 70]
Admission type -
Elective surgical 163 (13.9%)
Urgent surgical 352 (30.1%)
Medical 655 (56%)
APACHE IV predicted mortality (%) 27 [10 - 53]
SOFA Scores -
Day 1 10 [7 - 12]
Day 2 10 [7 - 13]
Day 3 9 [6 - 12]
Day 4 9 [6 - 12]
Day 5 8 [5 - 11]
Day 6 7 [5 - 11]
Day 7 7 [4 - 10]
ICU length of stay (days) 12.6 [9.1 - 20.2]
Mortality
30 day 278 (24%)
1 year 502 (43%)
Poor outcome (death or low HRQoL*) 662 (57%)
Continuous variables are presented as median (interquartile range); categorical
variables as n (percentage)
ICU Intensive Care Unit, APACHE IV Acute Physiology And Chronic Health Evaluation
fourth edition, SOFA Sequential Organ Failure Assessment, HRQoL health related
quality of life
* low HRQoL was defined as an EuroQoL 5D-3L index below 0.4
Fig. 30 (abstract 0032) Predictive performance for 1 year
poor outcome
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 20 of 542model was constructed with the APACHE IV predicted mortality and
the SOFA parameterization as independent variables. Model fit, discrim-
ination and calibration were assessed by Akaike's information Criterion
(AIC), c-index, and the le Cessie-van Houwelingen global goodness of
fit (CH) statistic, respectively.
RESULTS. The study population consisted of 1170 consecutive ICU pa-
tients with a prolonged stay (table 9). Mortality was 24% (274) and 43%
(502) at day 30 and 1 year respectively. One year poor outcome oc-
curred in 57% (n = 662) of patients. Figure 30 show the AIC, c-index
and CH statistic for each of the SOFA parameterizations. Three consist-
ently high performing SOFA representations were: A) the SOFA scores
of day 1 and 7; B) the SOFA score on day 1, plus the change in SOFA
score between day 1–4 and the change between day 4–7; and C) all in-
dividual SOFA scores of the first seven days. The SOFA representation
using day 1, plus changes between day 1–4 and day 4–7 scored best
when averaging performance over the three performance measures. In
a sensitivity analysis where all analyses were repeated using 30 day or
1 year mortality as outcomes of interest, similar results were found,
with the same top three performing SOFA parameterizations.
CONCLUSIONS. The way first week SOFA scores were combined with
the APACHE IV model to predict 1 year poor outcome in patients ad-
mitted to the ICU for at least 7 days, greatly influenced predictive
performance. Simple computations of organ failure scores consist-
ently outperformed more complex ones.
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Box 1. SOFA parameterizations
SOFA score on a single day
1. A single SOFA score, based on day 1
2. A single SOFA score, based on day 7
SOFA scores on two days
3. Two SOFA scores, based on day 1 and day 7
4. The difference in SOFA score between day 1 and day 4
5. The difference in SOFA score between day 4 and day 7
SOFA scores on three days
6. Both #4 and #5 entered as separate variables
7. #1, #4 and #5 entered all as separate variables
8. #1, #4 and #5 entered all as separate variables with interaction terms between
#1 and #4, and between #1, #4 and #5
SOFA score summary measures based on half a week (first half = day 1 to 3,
second half = day 4 to 7)
9. Maximum SOFA score during days 1 to 3
10. Minimum SOFA score during days 1 to 3
11. Mean SOFA score during days 1 to 3
12. Weighted SOFA score mean (day number is weight) during days 1 to 3
13. Sum of highest SOFA component scores during days 1 to 3 (SOFA totalmax)
14. Maximum SOFA score during days 4 to 7
15. Minimum SOFA score during days 4 to 7
16. Mean SOFA score during days 4 to 7
17. Weighted SOFA score mean (day number is weight) during days 4 to 7
18. Sum of highest SOFA component scores during days 4 to 7 (SOFA totalmax)
SOFA score (summary measures) based on all 7 days
19. Entering all seven SOFA scores as separate variables
20. Maximum SOFA score during days 1 to 7
21. Minimum SOFA score during days 1 to 7
22. Mean SOFA score during days 1 to 7
23. Weighted SOFA score mean (day number is weight) during days 1 to 7
24. Sum of highest SOFA component scores during days 1 to 7 (SOFA totalmax)
25. Delta SOFA score (difference between #25 and #1)
26. Entering both #25 and #1 as separate variables
27. Entering both #25 and #1 as separate variables, with an interaction term
between #25 and #1
28. Entering both #9 and #14 as separate variables
29. Entering both #10 and #15 as separate variables
30. Entering both #11 and #16 as separate variables
31. Entering both #12 and #17 as separate variables
32. Entering both #13 and #18 as separate variables
33. Days with organ failure (SOFA component score >3) per SOFA component
SOFA score trend or repeated measures analyses based on all 7 days
34. Aligned trend analysis: predictors are multiple variables containing the presence/
absence of a specific mutually exclusive prevalent trend (occurring in more than 5%
of patients, without encompassing a shorter trend, and aligned to day 7)
35. Untrained cluster analysis group membership
[box01]
Table 10 (Abstract 0033). Multivariable logistic regression model of
mortali
Covariate Model 1 Beta-
coefficient
Model 1
95% CI
Model 2
Beta-
coefficient
Model 2
95% CI
Model 3
Beta-
coefficient
Model 3
95% CI
Emergency
surgery
0.437 −0.136,
1.010
0.547 0.025,
1.069
0.730 0.439,
1.020
Respiratory
rate
0.060 0.018,
0.102
0.005 0.002,
0.007
0.064 0.041,
0.087
Systolic blood
pressure
−0.019 −0.031,
-0.008
0.002 0.001,
0.004
0.003 −0.002,
0.008
Glasgow
Coma Score
−0.099 −0.139,
-0.059
−0.150 −0.185,
-0.115
−0.128 −0.151,
-0.105
Blood Urea 0.006 0.003,
0.008
0.006 0.004,
0.009
NA -
Haemoglobin −0.093 −0.160,
-0.027
−0.098 −0.161,
-0.034
NA -
Vasoactive
use
1.057 0.5613,
1.5527
NA - NA -
Mechanical
ventilation
1.429 0.9919,
1.8661
NA - NA -
Constant 6.164 4.374,
7.953
0.588 −0.358,
1.534
0.229 −0.061,
0.518
Table 11 (Abstract 0033). Performance of the 3 models and APACHE II
Performance item Model 1 Model 2 Model 3 APACHE II
Score, mean (SD) - - - 17.35 (6.16)
Probability, mean
(SD)
0.20 (0.20) 0.20 (0.16) 0.28 (0.14) 0.26 (0.81)
Optimal cut-off
probability
0.18 0.18 0.26 0.20
Sensitivity (at
optimum cut-off)
0.72 0.70 0.63 0.67
Specificity (at
optimum cut-off)
0.77 0.69 0.67 0.71
AUC (95% CI) 0.812 (0.781-
0.842)
0.767 (0.734-
0.800)
0.689 (0.664-
0.714)
0.707 (0.688-
0.727)
H/L C-statistic (p) 16.91 (p=0.03) 11.31
(p=0.19)
15.94
(p=0.01)
124.84
(P<0.01)
Brier score
(95% CI)
0.13 (0.11-0.14) 0.14 (0.12-
0.15)
0.18 (0.18-
0.19)
0.18 (0.17-
0.18)
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INTRODUCTION. Current critical care prognostic models have
been almost entirely developed in high income countries (HICs)
and are usually based on hospital outcomes, which may not be
feasible in LMIC ICUs due to the lack of electronic records or
follow-up systems (1). Existing prognostic models cannot be
imposed without validation in lower-and middle income countries
(LMICs) as the diseases encountered in these settings (e.g. mal-
aria, snake bite and poisoning), treatment modalities and avail-
able resources may be different (2).
OBJECTIVE. This study proposes a simplified critical care
prognostic model for use at the time of Intensive Care Unit (ICU)
admission.
METHODS. A cohort of ICU admissions were followed up until
discharge in 21 ICUs in 4 countries: Bangladesh, India, Nepal and
Sri Lanka. There were 3855 patients aged 18 and over admitted
to these 21 ICUs.
Initial selection of candidate covariates for model development
was based on their use in existing case-mix prediction models,
perceived clinical importance and the feasibility of measurement
in the settings of the participating ICUs. Multivariate logistic re-
gression was used to develop three models - model 1 with clin-
ical, laboratory and treatment variables, model 2 with clinical and
laboratory variables and a purely clinical model 3 - for ICU mor-
tality prediction.
Internal validation based on bootstrapping (1000 samples) was
used to calculate discrimination (Area Under the Receiver
Operating Characteristic, AUROC) and calibration (Hosmer-
Lemeshow C-Statistic, HL C-S) (3). Comparison was made with the
APACHE II model.
RESULTS. Model 1 retained respiratory rate, systolic blood
pressure, GCS, blood urea, haemoglobin, mechanical ventilation
and vasopressor use on ICU admission. Model 2, named TropICS
(Tropical Intensive Care Score), included emergency surgery,
respiratory rate, systolic blood pressure, GCS, blood urea and
haemoglobin. Model 3 included respiratory rate, emergency
surgery and GCS. AUC was 0.818 (95% CI 0.800-0.835) for model
1, 0.767 (95% CI 0.741-0.792) for TropICS and 0.725 (95% CI
0.688-0.762) for model 3, and. The H-L C- S p-values were less
than 0.05 for models 1 and 3 and 0.18 for TropICS. In compari-
son, for APACHE II, AUC was 0.707 (95% CI- 0.688- 0.726) and H-L
C-S was 124.84 (p < 0.001).
CONCLUSION. This paper proposes TropICS as the first multinational
critical care prognostic model developed in a non-HIC setting.
REFERENCES
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INTRODUCTION. Prognostic models - used in critical care
medicine for mortality predictions, benchmarking and for illness
stratification in clinical trials- have been validated predominantly
in high-income countries1–3 These results may not be reprodu-
cible in low or middle income countries (LMICs) not only because
of different case-mix characteristics but also because of missing
predictor variables.
OBJECTIVES. To systematically review literature on the use of
critical care scoring systems in LMICs and assess their ability to
discriminate between survivors and non-survivors of ICU admis-
sions, their calibration and accuracy, and the manner in which
missing values are handled.
METHODS. The PubMed database was searched in March 2107 to
identify research articles reporting the use and performance of
prognostic models in the evaluation of mortality in ICUs in LMICs.
Studies that were carried out in ICUs in high-income countries
and/or paediatric ICUs, studies that evaluated disease specific
scoring systems, were limited to a specific disease or single prog-
nostic factor or studies published only as abstracts, editorials, let-
ters and systematic and narrative reviews or in a language other
than English were excluded. Quality assessment of the included
studies was carried out in accordance with the critical appraisal
for systematic reviews of prediction models (the CHARMS check-
list4). Results were summarised using descriptive statistics.
RESULT. Fifty-four studies reporting 160 model validations met
the review criteria and were selected for analysis. Three studies
(4 evaluations) described the development of a new prediction
model in a LMIC setting although no external validation was car-
ried out.
The remaining 156 were external validations of APACHE, GCS, MPM,
OSF, SAPS, SOFA and TISS or versions thereof; adaptations to existing
models were attempted on seventeen occasions. Missing value
handling was explicitly mentioned in only 26.9% of the studies. Where
discrimination was reported as AUROC 20.6% (27 validations) and
65.7% (86 validations) reported excellent discrimination and very good/
good discrimination respectively. Only 102 (65.4%) evaluations
reported calibration with 65.7% of these reporting a p > 0.05 for
Hosmer-Lemeshow statistics. Thirteen evaluations that reported excel-
lent discrimination also reported good calibration. Accuracy was re-
ported in 45 evaluations (28.5%) and ranged from 55.20% to 98.5%.
CONCLUSION. Robust interpretations on the applicability of prognostic
models are currently hampered by poor adherence to reporting
guidelines, especially when reporting missing value handling. The
performance of mortality risk prediction models for ICU patients-
predominantly developed in and for HIC settings- in LMIC is at most
moderate, especially with limitations in calibration. This justifies the need
for continued efforts to develop and validate LMIC models with readily
available prognostic variables, perhaps aided by medical registries.0035
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INTRODUCTION. For the decision to start or withhold an intensive
care unit (ICU) treatment, patient prognosis plays an important
role. Most patients consider survival beyond hospital discharge
with sufficient (health related) quality of life (HRQoL) as the
desired result of their ICU treatment. Most current ICU prediction
models, however, were designed to predict hospital survival.
Although some of these models may also be used to provide
insight into long-term HRQoL and survival, an overview of models
available for this purpose is lacking.
OBJECTIVES. To provide an overview of prognostic models that can
potentially be used for predicting the outcomes of ICU patients
beyond hospital discharge.
METHODS. A search was set up using keywords and synonyms
for prediction models, ICU patients, and survival or HRQoL, and
was adapted for the MEDLINE, EMBASE, CINAHL and PsycINFO
databases. The search was performed on the 6th of May 2015.
Studies reporting the development of a prediction model in ICU
patients for the outcome of survival, at least to hospital
discharge, or HRQoL were eligible for inclusion. Screening and
inclusion of search results was performed by two authors
separately (IWS and LMP).
RESULTS. The search and selection led to the inclusion of 63
model development studies out of 8583 unique titles (see Fig.
31). Included studies were published between 1981 and 2015.
Development datasets ranged from 50 to 216626 patients for
individual models, with a median of 679 patients [IQR: 266–
10738]. Most models targeted a general mixed ICU population
(n = 48), but prediction models specifically designed for patients
with non-surgical (medical) admission reasons (n = 8), acute
neurological injuries (n = 2) or for the elderly ICU patient (n = 1)
were also found. Half of the included prediction models (n = 32)
were meant to be used for prognostication on day 1 of ICU ad-
mission. Almost all (n = 58) had in-hospital mortality as outcome
of interest. Only 5 prediction models were developed with func-
tional status or HRQoL incorporated into the outcome, but none
of these were fitted in the general mixed ICU population (1
model for the elderly; 2 for patients with cardiac arrest; 2 for pa-
tients with traumatic brain injury). Ten out of the 63 studies
used long-term outcomes (i.e. beyond 6 months). See Fig. 32 for
more details on study characteristics. External validation was re-
ported for 38 (60.3%) prediction models.
CONCLUSIONS. Prognostic research in ICU patients has traditionally
been focused on predicting short-term mortality rather than long-
term functional outcomes, such as HRQoL. Validation studies are re-
quired to determine whether available prediction models can also be
used for long-term prognostication of ICU patients.
GRANT ACKNOWLEDGMENT
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Intensive Care Medicine Experimental 2017, 5(Suppl 2):0036INTRODUCTION. Iron deficiency (ID) is responsible for anaemia
but also for fatigue and muscle weakness. ID is frequent in
critically ill patients on admission (around 20-40%) and probably
on discharge (due to blood losses leading to iron losses), it may
thus impair the post-ICU rehabilitation. Unfortunately, ID is diffi-
cult to diagnose using conventional markers (1). Hepcidin (Hepc)
is the master regulator of iron metabolism and may indicate ID
when it is low (2).
OBJECTIVES. To determine whether an Hepc dosage on ICU
discharge is predictive of one year mortality and quality of life (QOL)
in ICU patients.
METHODS. Ancillary study based on the prospective observational
FROG-ICU study. Hep was measured using mass spectrometry on
a discharge blood sample (3). We defined ID as an Hepc < 20
ng/l (<10 ng/l for severe ID). One year mortality as well as QOL
using the SF-36 questionnaire was collected by phone interview
and compared in ID and non-ID patients using univariate and
multivariate analysis, adjusted for the principal cofounding factors
(age, gender, diabetes, Liver disease, surgical/medical, septic
shock and discharge Haemoglobin (Hb)).
RESULTS. Among the 1570 patients of the FROG-ICU cohort,
alive on ICU discharge and for whom living status was available,
1282 patients (age, mean ± SD, 59 ± 17 yrs, 456(36%) Women,
SAPS II 48 ± 18) had an Hepc dosage (median[Q1-Q3],
32.15[11.22-64.20] ng/l). The 448(35%) ID patients were more
often women (41.5 vs 31.5%, p = 0.0017), had more liver dis-
ease (10.5 vs 3.9%, p < 0.0001), a lower discharge Hb (9.9[9.1-
11.1] vs 10.2[9.1-11.6] g/dl, p = 0.02), but their renal function
was better (eGFR 88.7[55.7-109.8] vs 80.7[39.9-105.5] ml/min,
p = 0.00053). ID patients were less transfused during their ICU
stay (38.6 vs 47.5%, p = 0.0029). At one year, ID patients had a
higher mortality rate (100(23.1%) vs 130(16.9%) deaths,
p = 0.012). The multivariate analysis adjusted for the main
cofounding factors confirmed that ID is an independent pre-
dictor for one year mortality. A sensitivity analysis, using a
lower threshold for ID found that the 284(22.8%) severe ID pa-
tients had a lower physical QOL (defined as a physical dimen-
sion of the SF-36 score < median) together with a higher one
year mortality (Fig. 33).
CONCLUSIONS. ID (i.e. Hepc < 20 ng/l) is an independent risk
factor for one-year mortality this is in accordance with data
showing a poorer prognosis in ID cardiac patients. An interven-
tional trial is ongoing to assess whether iron treatment of ID di-
agnosed using hepc (compared to treat ID using ferritin) on ICU
discharge reduces post-ICU hospital length of stay, costs and im-
proves Hb and QOL (Hepcidane trial NCT02276690).
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1. Lasocki Crit Care. 2014;18(5):542
2. Lasocki Anesthesiology 2011;114(3):688–94
3. Lefebvre Ann Biol Clin 2017 ;75(1) :9–18
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 24 of 5420037
Omega-3 PUFAs in critically ill patients with acute respiratory
distress syndrome: an updated systematic review and meta-
analysis
P. Laferriere-Langlois1, F. D'Aragon2, W. Manzanares3
1Université de Sherbrooke, Sherbrooke, Canada; 2Université de
Sherbrooke, Anesthesiology, Sherbrooke, Canada; 3Hospital de Clinicas,
Intensive Care Unit, Montevideo, Uruguay
Correspondence: P. Laferriere-Langlois
Intensive Care Medicine Experimental 2017, 5(Suppl 2):0037
INTRODUCTION. Acute respiratory distress syndrome (ARDS), a deadly
complication of critical illness, is characterized by an acute inflammatory
response in the lung parenchyma leading to hypoxemia. Due to its anti-
inflammatory and immunomodulatory properties, omega-3 polyunsatur-
ated fatty acids (n-3 PUFA) have been administered in ARDS patients,
mostly by enteral route as diets enriched with eicosapentaenoic acid
(EPA), γ-linolenic acid, and antioxidants. Clinical benefits of n-3 PUFA
supplementation in ARDS patients remain unclear, as clinical trials have
found conflicting results.
OBJECTIVE. Considering the most recent randomized controlled trials
(RCT) and recent change in administration strategies, the aim of this
updated systematic review and meta-analysis was to evaluate the ben-
efits of n-3 PUFA administration on gas exchange, assessed by PaO2/
FiO2 ratio, and clinical outcomes in critically ill patients with ARDS.
METHODS. We searched Medline, Embase, CINAHL and Cochrane
database for RCT conducted in intensive care unit (ICU) patients with
ARDS comparing the administration of n-3 PUFAs to placebo.
The outcomes assessed were PaO2/FiO2 ratio evaluated early (3–4
days) and late (7–8 days), mortality, ICU/hospital length of stay (LOS),
length of mechanical ventilation (MV) and infectious complications.
Two independent reviewers assessed eligibility, risk of bias and
abstracted data. Authors of trials were contacted when required.
Data was pooled using a random effect model to estimate the
relative risk (RR) or weighted mean difference (WMD). Pre-defined
subgroup analysis included high vs. low risk of bias and sensitivity
analysis restricted to enteral administration and continuous enteral
administration were conducted.
RESULTS. Twelve RCTs (n = 1280 patients) met our inclusion
criteria. N-3 PUFA administration was associated with a significant
improvement in early PaO2/FiO2 ratio (WMD = 49.33; 95% Confi-
dence Interval [CI] 20.88-77.78; P = 0,0007; I2 = 69%), which per-
sisted at days 7–8 (WMD = 27.87,; 95% CI 0.75-54.99; P = 0,04;
I2 = 57%). With n-3 PUFA administration, there were trends to-
wards improvement of ICU LOS (P = 0.08) and duration of MV
(P = 0.06), while mortality, hospital LOS and infectious complica-
tions remained unchanged. Continuous enteral infusion was asso-
ciated with improved mortality (P = 0.02) while analysis restricted
to enteral administration either with or without bolus found im-
proved early PaO2/FiO2 (P = 0.001) and MV duration (P = 0.03).
Trials at higher risk of bias showed a significant reduction in
mortality (P = 0.04), and improvement in late PaO2/FiO2 ratio
(P = 0.003).
CONCLUSIONS. In critically ill patients with ARDS, n-3 PUFA adminis-
tration was associated with an improvement in early and late PaO2/
FiO2 ratio, while statistical trends exist for an improved ICU LOS and
MV duration. In the face of these results, administering n-3 PUFA ap-
pears a reasonable course of action.
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Intensive Care Medicine Experimental 2017, 5(Suppl 2):0038INTRODUCTION. Provision of protein during ICU stay may
attenuate the well-known loss of lean body mass, but the effects
of supplemental amino acids on protein synthesis and breakdown
have been insufficiently described. It has previously been demon-
strated that an intravenous infusion of balanced amino acids im-
proves whole body net protein balance at three hours during the
initial week in ICU [1].
It is unclear if this response can be sustained over a longer time period.
OBJECTIVES. The primary objective was to investigate if an intravenous
amino acid infusion improves net protein balance for 24 hours in
critically ill patients. The secondary objective was monitoring of safety
aspects in terms of amino acid oxidation, urea and amino acid plasma
concentrations.
METHODS. The study was conducted in the surgical-medical ICU of a
tertiary referral hospital. All aspects of care were determined by the at-
tending physician. Feeding rates were unaltered during the study period.
At T = 0 on day one, an infusion of [1-13C]-phenylalanine was added
to ongoing enteral nutrition to quantify the uptake of amino acids
from the enteral nutrition. At T = 120 minutes, primed intravenous
infusions of [ring-2H5]-phenylalanine and [3,3-
2H2]-tyrosine were
started. Baseline blood samples were drawn at expected isotopic
equilibrium after T = 285–300 min. At T = 300 min, an intravenous
amino acid infusion (Glavamin, Fresenius Kabi) was started at a rate
corresponding to 1 g/kg/day and continued for 24 hours. Blood
sampling was repeated at T = 465–480 minutes, after which the
tracer infusions were discontinued.
On day two, enteral and parenteral tracers were administered in
identical order and dose to day one, 24 hours after T = 0. A third set
of blood samples were drawn between T = 285–300 min after the
start of the enteral tracer on day two.
Whole body protein kinetics and protein oxidation were calculated
using a single-pool model.
RESULTS. Eight patients were studied. The supplemental amino acid
infusion resulted in an improved net protein balance over time, from
−1.6 ± 7.9 μmol phe/kg/h at 0h to 6.0 ± 8.8 at 3h and 7.5 ± 5.1 at
24h (p = 0.002). Confirming earlier results protein balance increased
between 0 and 3 h (p = 0.01), and remained unaltered between 3
and 24 h (p = 1.00). The sum of free amino acids in plasma increased
from 3.1 ± 0.6 mmol/L at 0h to 3.2 ± 0.3 at 3h and 3.6 ± 0.5 at 24h
(p = 0.038). Protein oxidation (p = 0.147) and plasma urea (p = 0.053)
were not altered significantly.
CONCLUSIONS. We demonstrated that a supplemental intravenous
amino acid infusion of 1 g/kg/24h improves whole body net protein
balance for up to 24 hours in critically ill patients. The effects on lean
body mass and on regional protein balance, as well as the
implications upon autophagy remain to be established.
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INTRODUCTION. Over the last few years several randomized
controlled trials examining the role of pharmaconutrition in the
critical care setting have shown controversial results. The purpose
of this study was to describe current pharmaconutrition practices in
intensive care units (ICUs) worldwide evaluating the compliance
with the evidence-based Canadian Critical Care Nutrition Clinical
Practice Guidelines (CPG).
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 25 of 542METHODS. We conducted an international, prospective, observational,
cohort study between September 2014-June 2015. Participating sites
enrolled critically ill adult patients on mechanical ventilation within the
first 48 hours of ICU admission and who remained for at least 72 hours
in the ICU. Data on nutrition and pharmaconutrient practices were
collected from admission to ICU discharge or a maximum of 12 days.
Variables related to the CPG are reported as overall averages (or
percentages) with the range of site averages.
RESULTS. 184 adult ICUs from 19 countries contributed 3926
patients to this analysis. Sixty-four percent were male, mean age was
59 (16–102) years old, average APACHE II score was 21.3 (1–55), and
admission SOFA score was 6.2 (0–18).
5.4% of all patients (best site: 75.6%, and worst site: 0.0% of patients)
received glutamine (GLN) by enteral, IV/parenteral or both routes.
Enteral GLN was administered in 4.6%, and IV/parenteral GLN in 1.0%
of patients. Moreover, 30% (0.0%-100%) of burn patients received
enteral GLN, whereas this pharmaconutrient was provided in 4.4% of
trauma patients (0.0%-87.5%). 6.1% of patients received selenium as
single strategy or combined therapy. Most of ICUs avoid using
arginine-enriched enteral formulas which were provided in 5.5% of
patients (0.0%-94.4%). Fish oil (FO) enriched formula was adminis-
tered in 14.7% of all patients, whereas in those with ARDS was pro-
vided in 22.4%. In patients on PN (or EN + PN) soybean oil (SO)
based lipid emulsion (LE) was used in 25.3% of PN days. However, a
SO sparing strategy was used in 35.6% of days, including an olive oil
based LE: 13.0%, a mixture of SO, olive oil, medium chain triglycer-
ides (MCT), and FO: 16.1%.
Conclusions: According to our recent data there is low utilization of
enteral or parenteral pharmaconutrition in ICUs worldwide. The most
frequently used pharmaconutrient is enteral GLN in the context of burn
injury although we await the results of the ongoing Randomized Trial
of Enteral Glutamine to Minimize Thermal Injury (RE-ENERGIZE) trial
before making stronger recommendations for its use. Finally, in
compliance with current guidelines in PN patients alternative lipid
emulsions are more commonly used.
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INTRODUCTION. Critically ill patients lose between 1-2% muscle
mass per day (1). Efforts to ameliorate wasting may improve patient
recovery. Leucine-enriched essential amino acid (L-EAA) has shown
promise in enhancing muscle protein synthesis in older adults and in
disuse atrophy (2).
OBJECTIVES. The aims of this study were to assess recruitment rate
and feasibility of studying a mechanically ventilated trauma population
given a leucine-enriched EAA supplement and to test which outcome
measures could be used in a future randomised controlled trial to as-
sess muscle mass, protein turnover and strength.
METHODS. This randomised study was performed over 6 months in
mechanically ventilated trauma patients as part of a larger project.
Standard enteral feeding was provided, with treatment group
patients receiving a 5g L-EAA powder 5 times per day via the enteral
feeding tube. CRP, albumin, IL-6, IL-10, urinary 3-MH, nitrogen bal-
ance, protein turnover ([1-13C] Leucine stable isotopes) and muscle
depth change on ultrasound was assessed on days 1, 3, 7 and 14 of
study. The MRC Sum score was used upon awakening and at dis-
charge from ICU as a measure of strength and to determine presence
of ICU Acquired Weakness (ICU-AW).RESULTS. Eight patients (9.5% of screened patients) were recruited
over 6 months. L-EAA doses were provided on 91/124 (73%) occa-
sions. Inflammatory and urinary marker data were collected; serial
muscle depth measurements were lacking due to short length of
stay of patients. Protein turnover studies were performed in four
patients, protein balance ranged between −3.9 to −1.73g/24h. MRC-
Sum score could not be performed as patients were not able to re-
spond appropriately to the screening questions.
CONCLUSIONS. We found significant barriers to recruitment, delivery
of the intervention and measurement of the chosen outcomes, this
would need to be addressed in the study design of a future, large
randomised controlled trial. Trauma patient ICU stay was shorter than
anticipated, outcome measures were difficult to perform serially in this
population. Although it was practical to provide L-EAA to patients, we
were limited by short stay, frequent interruptions to testing and by
complexity of protein turnover studies. One researcher conducted this
project; a research assistant would facilitate data collection. The ICU pa-
tient population and outcome measures require careful consideration
for future studies of amino acid or protein supplementation.
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INTRODUCTION. Red blood cells transfusion (RBCT) is a common
intervention among intensive care (ICU) patients; however, RBCT are also
associated with several adverse events. Few tools are available to target
RBCT in this setting. The aim of this study was to evaluate the impact of
the difference between arterial (CaO2) and venous oxygen content
(CvO2) (a-vO2gap) on the outcome of ICU patients receiving RBCT.
OBJECTIVES. To investigate whether the adequacy of transfusion,
defined on the a-vO2gap, could be associated with ICU outcome.
METHODS. Prospective observational study (from January to December
2016) enrolling patients with hemoglobin (Hb) between 7 and 9 g/dL
during the first 24hours after ICU admission. Patients were separated in
two groups, according to the median value of the a-vO2gap (=3.8 mL).
The decision to transfuse on admission was taken by the treating phys-
ician unaware of the study protocol. “Appropriate” transfusion policy
was defined when RBCT was given in patients with high a-vO2gap or
when patients with low a-vO2gap were not transfused; otherwise, pa-
tients were categorized into the “non-appropriate” transfusion policy.
RESULTS. We enrolled 113 patients (23% with sepsis; Table 12); of
those, 48 (42%) were transfused and 65 (58%) received non-
appropriate transfusions policy; ICU mortality was 27%. Patients re-
ceiving non-appropriate transfusion policy showed a significantly
higher 28-day mortality than others (23/65 vs. 8/48; p = 0.02 - HR 2.4
[95%CI: 1.1-4.6]) (Fig. 34). After the adjusted for several confounders,
the odds ratio for mortality was 3.02 [95% CI: 1.2 - 6.2].
CONCLUSIONS. In an unselected population of ICU patients, the a-
vO2gap could be a valuable marker to identify patients who would
benefit from RBCT (Fig. 34).
Table 12 (Abstract 0041). Demographic and clinical characteristics of
patients at ICU admission. Data are expressed as Mean ± SD or median
[IQ]
Fig. 34 (abstract 0041). See text for description
Table 13 (Abstract 0042). Demographics based on treatment group
Low ratio
n=385 (46%)
High ratio
n=401 (48%)
Univariate
P (Wald)
Age (years) median [IQR] 39 [26-55] 35 [25-52] <0.001
Male sex * n (%) 276 (72%) 285 (71%) 0.59
Anticoagulants 10 (2.6%) 9 (2.2%) 0.004
Antiplatelet drugs 17 (4.4%) 15 (3.7%) 0.01
Mechanism (% penetrating) 56 (14%) 57 (14%) 0.06
Intentionality 0.02
Unintentional 218 (57%) 233 (58%)
Assault 40 (10%) 43 (11%)
Self-inflicted 104 (27%) 91 (23%)
Table 14 (Abstract 0042). Outcome and prognostic markers by
treatment group
Low ratio
n=385 (46%)
High ratio
n=401 (48%)
P (Wald)
Death n (%) 131 (34%) 126 (31%) 0.18
IGS II median [IQR] 50 [36-68] 51 [37-69] <0.001
ISS 34 [22-43] 34 [18-45] <0.001
Initial GCS <9 120 (31%) 154 (38%) <0.001
Initial prothrombin ratio (%) 50 [36-64] 47 [31-60] <0.001
Initial lactate (mmol/L) 4.6 [2.7-8.2] 4.5 [2.7-8.1] <0.001
Table 15 (Abstract 0042). Surgery < 24h by treatment group
Low ratio
n=385 (46%)
High ratio
n=401 (48%)
P (Wald)
Orthopaedic 163 (42%) 168 (42%) <0.001
Vascular -radio interventional * 103 (27%) 111 (28%) 0.22
Neurosurgery 18 (4.7%) 29 (7.2%) 0.141
Abdominal * 82 (21%) 96 (24%) 0.27
Thoracic * 24 (6.2%) 30 (7.5%) 0.88
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INTRODUCTION. Transfusion management is a major therapeutic
issue in severe trauma patients. The benefit of a high FFP: RBC
transfusion ratio remains uncertain. [1]
OBJECTIVES. This work aims at studying the effect on survival of a
high FFP: RBC ratio (>0.75) during the first 24 hours in patients with
haemorrhagic shock.
METHODS. Traumabase is a prospective French trauma registry of
over 10,000 patients in 11 trauma centres. This public funded registry
is approved by competent authorities for medical research and
personal information protection. [2] Haemorrhagic shocks were
identified on the following criteria:
(1) ≥ 4 RBCs over the first 6 hours;
(2) patients who died of haemorrhagic shock before receiving 4
RBCs. A 30-day survival analysis was performed using a Cox
proportional hazards model on complete cases and then after
multiple imputations (hazard ratio (HR) results [95% confidence
interval]).The choice of adjustment covariates was made according to
(1) their clinical relevance,
(2) previous knowledge and then
(3) by maximizing the Akaike Information criterion. A value of
p < 0.05 was considered significant.
RESULTS. 836 observations were analyzed (table 13, 14, 15). A survival
curve according to the transfusion ratio is presented in Fig. 35. After
adjustment, the complete-case analysis (n = 543) revealed a protective
effect of the high ratio: HR 0.69 [0.48-0.99] (p = 0.02). After multiple im-
putation (n = 836), this protective effect of the high transfusion ratio
was confirmed: HR 0.73 [0.56-0.95] (p = 0.01). The area under the curve
(AUC) of the final model was 0.84.
CONCLUSIONS. In trauma patients with massive transfusion, a high
FFP: RGC ratio during the first 24 hours appears to be associated
with a better 30-day survival.
REFERENCE(S)
[1] Holcomb JB et al. JAMA. 2015; 313(5):471–482
[2] National Commission on Informatics and Liberty (CNIL)
authorisation № 911461
Fig. 35 (abstract 0042). KM survival curve according to
transfusion ratio
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INTRODUCTION. Deep venous thrombosis remains to be a
frequent and serious complication in the critically ill patients.
Therefore, effective thromboprophylaxis needs to be performed
and subcutaneous (s.c.) low molecular weight heparins (LMWH)
are the most commonly used drugs for this purpose. However,
prophylactic s.c. LMWH dosing regimen used in standard wards,
may not be sufficient for ICU patients, in which the availability of
s.c. applied drugs is limited (positive fluid balance, vasopressor
use, low cardiac output). Moreover, the critically ill tend to
hypercoagulate (inflammatory response, artificial ventilation,
immobilization).
OBJECTIVES. The aim of LOVE project was to test the real
effectiveness of subcutaneously LMWH thromboprophylaxis in ICU
patients in the Czech and Slovak Republic.
METHODS. A pilot, multicenter, prospective, observational study
took place from 23.2. 2015 to 1.3. 2015 and investigated s.c. LMWH
prophylaxis in ICU patients receiving s.c. LMWH for more than 3
days. The effectiveness of s.c. LMWH was evaluated according to
the patient's anti-Xa serum levels, which were measured 3 hrs after
LMWH application. Anti-Xa ≥0,2 kIU/l was considered to be suffi-
cient for effective thromboprophylaxis. Before starting the study,
only two centres monitored anti-Xa serum levels routinely.
RESULTS. In total, 101 patients, of average age 67 (34–83) and
average weight 84 (54–120)kg were involved. 45 patients were
admitted to ICU after surgery, 36 patients were admitted for
internal diseases, 20 patients suffered trauma. Only 15 out of 101
patients had sepsis. Their average 72 hours fluid balance was 15
ml/kg (−17,1 - + 77,8), in 77 patients vasopressor circulatory
support was used on the third day of ICU stay. The average
SOFA score on the third day was 6 (0–11). LMWHs used in thestudy: Nadroparin in 76 patients, Enoxaparin in 20 patients, and
Dalteparin in 5 patients. In 52 patients, s.c. LMWH was applied
once a day, 49 patients received s.c. LMWH twice a day. The
average LMWH dose was 68,7 UI/kg (31–175). Surprisingly, only
55% patients reached the effective anti-Xa serum level on the
third day after ICU admission using standard LMWHs dosing regi-
men. The average LMWH dose of the patients whose antiXa < 0,2,
was significantly different from the patients who reached
antiXa ≥ 0,2 (58,3 UI/kg (21,3- 124,6) vs. 80,9 UI/kg (33,5- 181,8),
p = 0,001), as well as their 72 hours fluid balance (25ml/kg
(−17,1- + 92,7) vs. 12 ml/kg (−19,2 - + 50,7), p = 0,002).
CONCLUSIONS. We found, that in 45% patients involved in LOVE
project, LMWH was underdosed and did not reach sufficient
prophylactic serum level of antiXa ≥0,2. The optimal LMWH dose
seems to be 75–100 UI/kg/24 hrs s.c.. Because in case of inadequate
thromboprophylaxis the risk of deep venous thrombosis and
thrombembolism rises substantially, the LMWH dosing regimens
routinely used on ICUs should be reconsidered carefully, and
guided by serum anti-Xa levels.
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INTRODUCTION. Pneumonia is a known complication that may arise
after cardiac surgery and increases the morbidity and mortality of these
patients. On the other hand, it is known that blood compounds
transfusion of increases the risk infections of postoperative cardiac
surgery patients. Transfusion of fresh frozen plasma (FFP) units are at
increased risk of acute lung injury. Red blood cells (RBC) transfusions
increments the risk of pneumonia after cardiac surgery as described.
OBJECTIVES. The aim of this study is to analyze the relationship
between intraoperative cardiac surgery FFP and RBC transfusions in
the development of pneumonia during ICU stay.
METHODS. Retrospective observational study of a cohort of patients
that underwent to cardiac surgery at our institution between 2006 and
2014. Demographic and clinical variables were collected from de
Hospital Database. FFP and RBC units transfused during intraoperation
procedure and the develop of nosocomial pneumonia were analysed
to determinate their relationship. A multivariate logistic regression
model was used to estimate the Odds Ratio of pneumonia associated
with the FFP and RBC transfusion with confidence interval of 95%,
p < 0.05. Values expressed as mean +/− SD or %.
RESULTS. Out of 3563 patients ; 64.8 males; 67.78+/− 11.13 years old;
BMI 28.36 +/− 6.81 ; Logistic EuroScore 6.36 +/− 4.85; ICU stay 6.58
+/− 15.41 days ; postoperative bleeding at first 24 hours 560.74 +/−
447.95 cc; preoperative haemoglobin 13.58 +/− 5.72 gr/ dL. By pass
time 104.31 +/− 231.75; cross clamp time 71.76 +/− 32.74 minutes.
265 patients were diagnostic of pneumonia during the ICU stay.
These patients were most frequently males, older, less BMI, higher
EuroScore and lower hematocrit and hemoglobin but no significant
differences were found in these variables. Pneumonia group patients
were transfused more FFP (1.31 +/− 1.85 vs 2.27 +/− 1.94 units
p < 0.001) and presented a longer duration of CPB and clamp times
(97.79 +/− 45.8 vs 126.19 +/− 3.52; p < 0.001 and 70.50 +/− 33.44 vs
98.88 +/− 24.09; p < 0.001 respectively. The relative risk of developing
pneumonia was 1.50 for the group that received transfusion of blood
components. In the multivariate analysis patients exposed to FFP
transfusions had a significant OR 1.149 of pneumonia 95% CI (1.046 to
1.261) p < 0.001.No significant differences were found between RBC
transfusion and the development of pneumonia.
CONCLUSIONS. Known deleterious effects that can cause transfusions
of blood components clinical teams should explore strategies to
prevent unnecessary transfusions. The transfusion of FFP demonstrated
in this study that it could increase the morbidity after cardiac surgery.
Further studies are needed to corroborate these results.
Fig. 36 (abstract 0045). Estimated mean trajectories of 7 groups
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INTRODUCTION. Platelets are involved in hemostasis and are a core
component of the acute inflammatory response. No previous work
has systematically examined the association between platelet
trajectory, clinical evolution and outcome.
OBJECTIVES. To identify data-driven groups of platelet trajectories in
acutely ill patients, predict group membership at baseline, and exam-
ine their association with 60-day mortality.
METHODS. From an observational dataset of 54,000 ICU admissions,
we focused on patients surviving at least seven days with at least five
platelet counts over that period. We applied latent class mixed models
to identify groups of trajectories, modeled using third degree
polynomials in time. Because of computational limitations, we split the
data into 8 disjoint subsets and 5-group models were developed for
each subset. Of the five groups, 2 were identified across all subsets (the
“Large” set, N = 7,753). All other patients were pooled into the “Small”
set (N = 3,565). Group assignment was reestimated within the Large
and the Small sets. To study the association between platelet trajectory
groups and 60-day mortality, logistic regression was used with age, sex,
race, burden of chronic illness, baseline organ function (SOFA score), se-
verity of disease (APACHE III), trauma status and surgery as additional
covariates. To evaluate group membership prediction at baseline, multi-
nomial logistic regression was used with platelet counts on the first
and second day after admission, as well as baseline covariates.
RESULTS. 11,318 patients met study criteria. We identified 7 groups of
platelet trajectories (Fig. 36). Trajectory groups were independently
associated with 60-day mortality (p < .001). Compared to group 1, the
odds of death within 60 days were significantly higher in group 2
(OR = 1.16 (1.04-1.30)), group 6 (OR = 2.62 (1.74-3.94)), and group 7
(OR = 1.29 (1.01-1.65)). AUC-ROC was 0.753. Platelet count on the first
day predicts group membership after adjusting for baseline covariates
(p < .001). A 50 increase in first day platelet count decreases the odds
of being in group 2 (OR = 0.50 (0.48-0.52)) relative to group 1. In con-
trast, patients with higher first day platelet counts were more likely to
be in group 3 (OR = 1.76 (1.52-2.03)), group 4 (OR = 1.81 (1.70-1.93)),
group 5 (OR = 2.29 (2.09-2.51)), group 6 (OR = 2.17 (2.01-2.34)), and
group 7 (OR = 1.27 (1.21-1.33)). The accuracy of a model that predicts
group assignment improved from 66.2% to 72.6% when day-2 platelet
count is added in the model.
CONCLUSIONS. Platelet trajectory group in the first week is
independently associated with 60-day mortality, with the first and
second day platelet counts predicting trajectory group membership
with reasonable accuracy. Further analysis will focus on studying
whether platelet trajectories are associated with morbidities such as
late bleeding, embolism, and thrombosis.
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INTRODUCTION. There is a current trend towards lighter or no
sedation of mechanically ventilated patients in the intensive care
unit (ICU). A study has shown advantages of no sedation such as
shorter duration of mechanical ventilation and shorter ICU and
hospital length of stay (1). Non-sedated patients are more awake dur-
ing mechanical ventilation (2), but little is known about how this is
experienced by the patient.
OBJECTIVES.
The aim was to explore patients' experiences of being awake during
critical illness and mechanical ventilation in the ICU.
METHODS. Based on an ethnographic approach, 13 month of
fieldwork following 28 awake, mechanically ventilated patients, in
two ICU´s at a university hospital in Denmark where the no
sedation strategy was implemented in practice. Participants were
patients, who had been mechanically ventilated for at least 3 days
and awake with a score of zero on the Richmond Agitation and
Sedation Scale (RASS) for the majority of the time on mechanical
ventilation. Twenty patients were interviewed during the week
after ICU discharge, and 13 of these patients were interviewed
again 2–4 month after ICU discharge. Interpretive description was
used as an applied inductive approach, and data were analyzed
using qualitative, thematic analysis.
Table 16 (Abstract 0047). Study results
HFNC
30 L/
min 31°
C
HFNC
60 L/
min 31°
C
HFNC
30 L/
min 37°
C
HFNC
60 L/
min 37°
C
P-value
flow
P-value
temp.
P-value
interaction
Comfort
scale
4.1 ± 1.0 3.7 ± 1.3 2.4 ± 1.3 2.4 ± 1.7 0.335 <0.001 0.086
Borg
scale
3.2 ± 2.2 3.0 ± 2.3 3.5 ± 2.2 3.2 ± 2.0 0.509 0.237 0.867
SpO2
(%)
96 ± 3 98 ± 2 96 ± 3 97 ± 2 <0.001 0.529 0.158
RR
(bpm)
24 ± 8 22 ± 6 24 ± 8 23 ± 6 0.022 0.130 0.713
SpO2/
FiO2
223 ±
44
227 ±
43
224 ±
45
227 ±
43
<0.001 0.377 0.124
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familiar in the unfamiliar situation” and “Awareness of surrounding
activities”. Patients had the ability to interact from the first days of
critical illness and sensed agency through initiating, directing and
participating in communication and activities. Patients preferred
competent and compassionate nurses who encountered them with
respect. Patients appreciated nurses, who were attentive and
involved them as individual persons, to feel encouraged and secure
in the unfamiliar setting. Being critically ill and unable to speak with
bodily weakness and in need of technological support, as well as
being ignored by staff and involuntary witnessing other patients'
suffering in the ICU, contributed to a feeling of powerlessness.
CONCLUSIONS. Being awake during mechanical ventilation entailed
new opportunities and challenges for critically ill patients. Patients
experienced being in an interface between agency and powerlessness
as they had the ability to interact, yet were bound by bodily, relational
and contextual factors. This knowledge is important to develop patient-
centered nursing practice in the context of minimal sedation in the ICU.
REFERENCE(S)
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2. Laerkner, E et al. (2016) No-sedation during mechanical ventilation:
impact on patient's consciousness, nursing workload and costs. Nurs-
ing in Critical Care (21) pp. 28–35.
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INTRODUCTION. Comfort is a key feature for adherence to any type of
oxygen therapy and is considered an outcome of nursing treatments1.
In the last few years an increasing number of acute hypoxemic
respiratory failure (AHRF) patients is undergoing oxygen therapy with
high flow nasal cannula (HFNC)2. In the literature there aren't
indications about flow and temperature best level to optimize the
patient's comfort.
OBJECTIVES. To assess the comfort of patients, with PaO2/FiO2 < 300
mmHg, undergoing oxygen therapy with HFNC at different flows and
temperatures.
METHODS. A prospective, randomized, cross-over study was con-
ducted on 40 AHRF patients, admitted to intensive care unit (ICU)
and receiving respiratory support by HFNC per clinical indication.
Two flows (HFNC 60 l/min and 30 l/min) and 2 temperatures (31°C
and 37°C) were randomly applied for 15 minutes (four steps per
patient). We investigated during the last minutes of each step:
comfort by numerical scale from 0 (extreme discomfort) to 5 (very
comfortable), dyspnea by modified Borg scale form 0 (none) to 10
(unbearable), physiologic respiratory parameters. Clinical FiO2 was
left unchanged during all steps. Data of each step were compared
using linear mixed-effects model analysis for repeated measures with
Bonferroni or Tukey post-hoc test.
RESULTS. Forty patients (16 females), with age 57 ± 15 years-old,
suffering from different types of AHRF (SAPS II 36.4 ± 9.4) were been
studied. At enrolment patients had PaO2/FiO2 218 ± 60 mmHg, SpO2
was 97 ± 2% with FiO2 45 ± 10%. The main study results are reported
in the table. The patient comfort level is higher at a lower temperature
(31° C). The same temperature with the highest flow (60 L/min) im-
proves both the SpO2 and the RR, increasing the SpO2/FiO2 ratio.CONCLUSIONS. Oxygen therapy with HFNC at lower temperature
improves the patient's comfort. Titration of HFNC setting to obtain best
comfort might be relevant to exploit the clinical efficacy of the device.
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INTRODUCTION. The development of pneumonia is a significant risk
factor for mortality in patients with blunt chest wall trauma1. Clinical
symptoms are not considered an accurate predictor of outcome
following blunt chest wall trauma3 and there is a lack of research to
identify risk factors for delayed deterioration2.
OBJECTIVES. To identify potential risk factors for development of
pulmonary complications for patients following chest wall trauma.
METHODS. Data was collected from all patients admitted to a large
multi trauma centre in the west midlands with ≥ 3 rib fractures
between November 2015 and August 2016. Development of pulmonary
complications was assessed using the Brooks Brunn tool and analysed
for association with a number of potential risk factors identified from
previous literature. Data was analysed using the fisher exact test.
RESULTS. 71 patients were admitted with ≥ 3 rib fractures during the
study period, of which 33 developed pulmonary complications. ISS
on admission was significantly higher (23.6 vs 18.2, p = 0.0160) in
the group that developed pulmonary complications (See Table 17)
Those patients who developed pulmonary complications were more
likely to be ventilated (Table 18) and had significantly longer
duration of mechanical ventilation (12 v 7 days, p = 0.028) and
incidence of tracheostomy (52% vs 13%, p = 0.002).
CONCLUSIONS. Patients with three or more rib fractures with a high
ISS score are most at risk of developing pulmonary complications.
When pulmonary complications develop, patients are more likely to
require invasive ventilation or NIV and are more likely to have a
tracheostomy. This may aid therapists in prioritising therapy for
patients most at risk in the future.
REFERENCE(S)
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mortality in patients with blunt chest wall trauma: A systematic
review and meta-analysis. Injury. Int.J.Care Injured 2012; 43; 8–17
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Table 17 (Abstract 0048). Patient Demographics
Pulmonary
complications (n=33)
No pulmonary
complications (n=38)
Age 60.4 56.2
Male n (%) 27 (82%) 28 (74%) 0.5704
APACHE II 14.5 12.0 0.09435
ISS 23.6 18.2 <0.05
Respiratory History 6 (18%) 6 (16%) 1.000
Table 18 (Abstract 0048). Outcomes
PPC’s (n=33) No PPC´s (n=38)
NIV 9 (27%) 2 (5%) 0.007
Ventilated 24 (73%) 11 (29%) 0.0001
Tracheostomy 17 (52%) 5 (13%) 0.0002
Ventilator days 12 (36%) 7 (18%) 0.2845
Died 4 (12%) 0 (0%) 0.031
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INTRODUCTION. Mechanically ventilated patients experience speech
incapacity due to the need for an artificial airway. Speech incapacity
has a particularly profound impact for chronically critically ill patients,
who generally are conscious and receiving minimal or no sedation.
The Electrolarynx has a vibrating head that serves as a sound source
which when transmitted through soft tissues of the oropharynx adds
sound to silent articulated speech. It has been shown to facilitate
speech in case reports and feasibility studies, however there are
limited data on speech intelligibility and comprehensibility.
OBJECTIVES. To assess the proportion of tracheostomized patients
able to produce intelligible and comprehensible speech using the
Electrolarynx. Secondary objectives were to measure ease of, and
satisfaction with, communication before and after Electrolarynx
training and anxiety.
METHODS. We included tracheostomized adults unable to tolerate
cuff deflation who were able to follow commands, read English, and
capable of mouthing words. We excluded patients with pre-existing
hearing/speech impairment and with dementia. On study enrolment
we measured baseline anxiety (Faces Anxiety Scale), Ease of Commu-
nication Scale and communication satisfaction (5-point Likert). The
research team gave Electrolarynx instructions and daily practice for
5–15 minutes for 5 days. After training, 2 independent raters (1 fa-
cing, 1 facing away) assessed speech intelligibility using 50 words
from the Assessment of Intelligibility of Dysarthric Speech (AIDS) tool.
Intelligible speech was defined as ≥50% of words identified correctly.
We used 5 X 5 word sentences from the AIDS and rated comprehen-
sibility using a 9-point difficulty scale (9 = extreme difficulty). Testing
was repeated on a subsequent day. We recorded the Electrolarynx Ef-
fectiveness Score (EES) and re-evaluated anxiety, ease of, and satis-
faction with, communication.
RESULTS. From Jan 2015 to Dec 2016, we recruited 24 participants
from a weaning centre and 2 ICUs. Most (63%) were male and
admitted for medical reasons (58%); mean age was 62 years. Mean(SD) intelligibility score was 45% (17%) correct overall; 57% (21%)
facing, 32% (19%) facing away. When rated facing, 68% of participants
scored ≥50% correct. Mean (SD) comprehension difficulty was 6.4 (2.0)
overall; 5.5 (2.5) facing, 7.3 (1.7) facing away. Mean (SD) EES was 2.9
(1.0) overall; 3.2 (1.2) facing, 2.9 (0.9) facing away (3 = improved lip-
reading by producing recognizable sounds). Median anxiety score de-
creased from 3.8 to 2.0 (P = .007). Communication was rated easier
(median score 15 to 12, P = .044) whereas satisfaction remained similar
(median score 2 at both time-points; P = .059).
CONCLUSIONS. The Electrolarynx appears feasible for aiding
intelligible speech in some patients when able to visualize the
patient. Preliminary data suggest it may reduce anxiety and improve
patient perception of communication ease.
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INTRODUCTION. Timing of extubation is critically important in the
intensive care unit (ICU). Sub-optimal extubation timing may increase
patient mortality, cost and ICU length of stay1. Factors such as cough
strength, sputum abundance, respiratory muscle strength and work
of breathing may contribute to the prediction of extubation out-
come.2 Physiotherapists play an important role in peri-extubation
care so are well-placed to assess these factors. Accurate prediction of
extubation outcome could help to inform both physiotherapy and
medical management plans pre- and post-extubation.
OBJECTIVES. To report the accuracy of physiotherapists' prediction
of extubation outcome in the adult ICU.
METHODS. Ethics approval was waived as the project was locally
registered as a service evaluation.
A retrospective case note review was undertaken. All patients
who were extubated during a three month period in the adult ICU
of a large teaching hospital in the United Kingdom were included.
Physiotherapy assessment including stratification of 'risk of
extubation failure' as 'high', 'moderate' or 'low' was undertaken
prior to extubation. Logistic regression analysis was performed to
determine which pre-extubation factors were predictive of extu-
bation outcome.
RESULTS. During the data collection period, 119 patients were
extubated, 68(57%) following a physiotherapy assessment.
Physiotherapy stratification as 'high risk' (OR 4 (95% CI 1.3 to 12);
P = 0.009) and appropriate neurology (OR 0.3 (95% CI 0.09 to
0.96); P = 0.037) were the only pre-extubation factors significantly
associated with extubation failure. Specialised physiotherapists
predicted extubation failure with greater sensitivity but lower spe-
cificity compared with non-specialised physiotherapists and the
logistic regression model (Table 19).
CONCLUSIONS. Patients classified as 'high risk' of extubation failure
by a physiotherapist are significantly more likely to fail extubation.
Specialised physiotherapists should be involved in the decision to
extubate in the adult ICU. Further research is required to determine
the optimal medical and physiotherapy management strategies for
these high risk patients.
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Table 19 (Abstract 0050). Prediction of Extubation Failure
Predictor Sensitivity Specificity Positive
Predictive
Value
Negative
Predictive
Value
Accuracy
All
Physiotherapists
40% (24-54) 86% (79-
92)
56% (34-
75)
76% (70-82) 72% (62-
80)
Specialised
Physiotherapists
100% (57-
100)
68% (55-
68)
50% (28-
50)
100% (80-
100)
76% (55-
76)
Non-specialised
Physiotherapists
22% (8-31) 95% (88-
99)
67% (25-
94)
72% (67-75) 71% (62-
77)
Logistic
Regression Model
28% (15-34) 96% (91-
99)
78% (42-
96)
75% (70-77) 75% (67-
79)
Values are percentage (95% confidence interval)
Table 20 (Abstract 0051). See text for description
Variable Aeroneb
Solo® with a
T-piece
Aeroneb Solo ®
with the
Combihaler ®
M-Neb®
with a T-
pìece
M-Neb® with
the
Combihaler®
MMAD
(μm)Mean (SD)
2.4 (0.0) 2.5 (0.1) 2.4 (0.1) 2.4 (0.2)
GSD, Mean
(SD)
1.9 (0.1) 2.1 (0.3) 2.0 (0.1) 1.7 (0.1)
Inhalable mass
(mg), Mean
(SD)
44.8 (20.2) 68.6 (6.6) 36.1 (17.4) 60.7 (7.5)
FPD (<5% μm),
Mean (SD)
38.8 (17.8) 59.8 (5.9) 31.7 (14.8) 52.6 (7.9)
Recovery rate
(%), Mean (SD)
30 (13) 46 (4) 24 (12) 40 (5)
Duration (min),
Maen (SD)
4.59 (0.3) 4.57 (0.3) 4.22 (1.0) 4.43 (1.1)
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INTRODUCTION. While aminoglycosides and colistin aerosolization
might achieve better diffusion into the alveolar compartment than
intravenous use, the information with other antibiotics is scarce.
OBJECTIVES. To evaluate in vitro performance of aerosol delivery of
Aztreonam lysine (AZLI) during adult MV using two vibrating-mesh
nebulizers: Aeroneb Solo® and M-neb® with and without Combihaler
® spacer.
METHODS. In the model (1) we used a test lung with a ventilator
(Evita XL, Dräger) with following setting: a tidal volume of 450mL, a
respiratory rate of 15/min, a PEEP of 5 cmH2O and, a flow rate of 40
L/min. The bench model was designed to reproduce real life clinical
practice: a 7.5 mm endotracheal tube (ET) and a right-angle elbow
adapter were inserted between the Y-piece and the test lung. The
circuit was heated and humidified until the temperature was stable
at 37°C. Four settings were tested when configuring the nebulizer in
the circuit of the MV: a) Aeroneb solo® with a t-piece; b) Aeroneb
solo® with the Combihaler® spacer; c) M-Neb® with a t-piece and d)
M-Neb® with the Combihaler®. Three experiments were performed
for each condition. Both nebulizers were placed before the Y-piece in
the inspiratory limb and loaded with 150 mg of ALZI in 2 ml of dilu-
ents. The AZLI collected on the filter (inhalable mass) placed after
the ET was quantified by spectrophotometry. The performance of
nebulization was evaluated by: 1) Mass median aerodynamic diam-
eter (MMAD); 2) Geometric standard deviation (GSD), 3) Fine particle
dose (FPD), i.e. drug contained in particles smaller than 5 μm and
considered to reach the lung, 3) Inhalable mass, i.e. fraction of total
particles which is inhaled through the nebulizer, 4) Recovery rate
(RR), i.e. percentage of AZLI mass placed in the nebulizer recovered
on the filter.RESULTS. In vitro aerosol delivery of AZLI during MV showed an
excellent performance with both nebulizers tested, with a MMAD
between 2.4-2.5 μm and 87% of particles smaller than 5
μm.Nebulizer aerosol delivery (assessed by FPD and inhalable mass)
and RR was higher (50% and 70% respectively) for both nebulizers
with the use of Combihaler® spacer (Table 20). In vitro aerosol
delivery performance was similar for both nebulizers used.
CONCLUSIONS. Both Aeroneb Solo® as M-Neb® showed an excellent
aerosol delivery profile for Aztreonam lysine during in vitro mechan-
ical ventilation. A better aerosol delivery performance was obtained
using the Combihaler ® spacer.
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Objectives. Previous studies have shown that healthcare-associated
pneumonia (HCAP) revealed worse clinical outcomes than
community-acquired pneumonia (CAP). We investigated clinical fea-
tures of patients with HCAP and identified the risk factors for HCAP
mortality.
Methods. We conducted a retrospective, observational study of
pneumonia patients who were hospitalized at a tertiary teaching
hospital from March 2012 to February 2014. Identified pathogens
that were not susceptible to β-lactams, macrolides and fluoroquino-
lones were defined as community-acquired pneumonia-drug resist-
ant pathogens (CAP-DRPs). Primary endpoint was 28-day mortality.
Results. Of the 1046 patients, 399 were classified as HCAP and 647
as CAP. HCAP patients were older and had more comorbidities than
CAP patients. Initial pneumonia severity index (PSI) was higher in
patients with HCAP than with CAP. HCAP was associated with not
only an increased rate of CAP-DRPs (HCAP, 57.5%; CAP, 22.6%;
P < 0.001), but also increased rate of inappropriate initial antibiotic
therapy (IIAT) (HCAP, 43.8%; CAP, 17.2%; P < 0.001). HCAP was also
associated with increased 28-day mortality rate (HCAP, 14.5%; CAP,
6.3%; P < 0.001). In multivariable analysis, PSI was an independent
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 32 of 542risk factor of 28-day mortality in HCAP patients (OR 1.02, 95% CI
1.01-1.04). CAP-DRPs and IIAT were not associated with mortality.
Conclusions. Patients with HCAP revealed higher rate of CAP-DRPs,
IIAT and mortality than patients with CAP. But, CAP-DRPs and IIAT
were not associated with mortality. PSI was the main predicting fac-
tor for 28-day mortality in patients with HCAP.0053
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INTRODUCTION. Ventilator Associated Pneumonia (VAP) is a serious
medical condition causing significant morbidity and mortality
among mechanically ventilated patients. The “VAP Bundles of
Care” is a process improvement program designed to lessen the
incidence of VAP.
OBJECTIVES. This study aims to determine the impact of
implementation of “VAP Bundles of Care” program for reducing
episodes of Possible Ventilator Associated Pneumonia (pVAP) in The
Medical City Adult Intensive Care Unit (TMC-ICU) by comparing pVAP
rates pre and post intervention. This study also aims to determine
the association between the implementation of “Bundles of Care”
with secondary outcomes of ventilator days, length of ICU stay,
length of hospital stay among intubated adult patients at the TMC-
ICU from January 2008-December 2015.
METHODS. A Quasi-experimental pretest/post-test research design
with records review was done to compare pre-intervention VAP bun-
dle pVAP rates with post intervention pVAP rates.
RESULTS. A total of 235 patients were included; 124 patients did not
receive “VAP Bundles of Care” while 111 received “VAP Bundles of
Care”. The odds of acquiring pVAP among intubated patients is 0.23
lower when “Bundles of Care” was implemented. This translates to 4.35
higher pVAP rate without the “Bundles of Care” (n = 1/0.23). This
association is significant with a p-value of < 0.001. There is no signifi-
cant difference in secondary outcomes between the two groups.
CONCLUSIONS. This study showed that implementation of the
“Bundles of Care” program for VAP reduced the episodes of pVAP in
the TMC Intensive Care Unit. However it was noted that there was
no significant difference between secondary outcomes of length of
hospitalization, length of ICU stay, and duration of intubation before
and after implementation of the “Bundles of Care”.
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INTRODUCTION. Ventilator associated pneumonia (VAP) is one of the
most important device-associated hospital infections with high mor-
bidity and mortality, prolonged length of stay and increased cost.
OBJECTIVES. The aim of this study was to evaluate the VAP rate,
ventilator use rate and causative microorganisms isolated in VAP
cases in a ten year study period.
METHODS. This study was conducted in the 12-bed anesthesiology
and reanimation intensive care unit (AR-ICU) between 2007 and
2016. VAP rate per 1000 mechanical ventilator-days, device utilization
ratio for mechanical ventilator and pathogens isolated in patients
with VAP were evaluated retrospectively. Hospital infection defini-
tions made according to the CDC criteria. Since 2011, we use a “Ven-
tilator Bundle Checklist” including elevation of the head of the bed
to 30–45 degrees, daily oral care with chlorhexidine, peptic ulcer
prophylaxis, deep venous thrombosis prophylaxis and use of aseptic
aspiration technique when suctioning endotracheal secretions in the
AR-ICU to prevent ventilator associated pneumonia.
RESULTS. During the study period totally 4224 patients were
followed in the AR-ICU for 35701 bed days. In 2007, the VAP rate
was 23.1 per 1,000 mechanical ventilator days and the ventilator
use rate was 0,54. Although the increased ventilator use, VAP rate
was decreased significantly in recent years. The last VAP rate was
9,3 per 1,000 mechanical ventilator days and the ventilator use was
0,63, in 2016. Acinetobacter baumannii was the most commonly iso-
lated microorganism as VAP pathogen at all years (rate: 42,9%-
60,4%) except 2016. The most commonly pathogen of VAP was
Pseudomonas aeruginosa in 2016 (52%) whereas the rate of A. bau-
mannii was (25%).
CONCLUSIONS. In AR-ICU, VAP rate decreased in recent years al-
though high ventilator usage. We think that the reason may be the
adherence to VAP bundle and other infection control measures.
Causative agent of VAP was A. baumannii except the last year.
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INTRODUCTION. Lower respiratory tract infections (RI) in intubated
patients include ventilator-associated tracheobronchitis (VAT) and
ventilator-associated pneumonia (VAP). The use of antibiotics is rec-
ommended in VAP, however the same is not truth in VAT. Studies
demonstrated that antibiotic therapy for VAT may shorten the dur-
ation of mechanical ventilation, but it is uncertain whether it im-
proves other clinical outcomes. The clinical distinction between these
two entities is difficult.
OBJECTIVES. Our aim is to compare patients diagnosed with VAP
and VAT in an intensive care unit (ICU) through a 4-years period; to
access their differences and similarities as a way to conclude if there
are any indicators that can support different approaches.
Table 21 (Abstract 0056). Results
VAP VAT
Cases 29 20
Length of mechanical ventilation until infection
(mean of days)
12.62 16.45 p=0.72
Age (mean) 59 64 p=0.28
APACHE II Score 12.35 10.35 p=0.40
Mortality 33.30% 66.70% p=0.21
Male 60.60% 39.40% p=0.63
Immunosuppression 85.70% 14.30% p=0.11
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 33 of 542METHODS. Retrospective analysis using data from all patients
diagnosed with RI from 2012 to 2015, in an ICU. A univariate analysis
was performed.
RESULTS. 84 patients were included, with a mean age of
60,9 ± 14,9 years. Among these 58,3% were diagnosed with VAT.
Patients with VAP had longer hospitalization (plus 51days) and ICU
stay (plus 5.8days). Higher mortality rates (22.9%vs14.3%), an
increased length of invasive mechanical ventilation (plus 6days) and
antibiotic therapy (plus 3days), and lower paO2/FiO2 ratios were also
observed in this group. In both groups, Pseudomonas aeruginosa
was the most frequently isolated agent. All patients in both groups
were treated with antibiotics. Similar results were found in both
groups for the following variables: c-reactive protein levels, SAPS II
and APACHE II scores, as well as SOFA score and temperature at
diagnosis. It is relevant to state that only 26.5% of the patients in the
VAT group had pneumonia excluded by computed tomography (CT),
whether 48.6% of VAP patients had their diagnosis confirmed by CT.
The only results with statistical difference (p < 0.05) were the
hospitalization and antibiotic therapy lengths, and paO2/FiO2 ratios.
CONCLUSIONS. As expected our results showed worst outcomes in
VAP, however there was no control group to establish if a different
approach to VAT would lead to a different outcome and, likewise,
most of the results were not statistically significant. Further studies
are needed to ascertain the usefulness of different approaches in
diagnosis, management and treatment of VAT and VAP; in addition,
they should determine if the treatment of RI should be guided most
by clinical features or by the differential diagnosis between VAT and
VAP. A prospective study analysing 3 separate groups: VAP, VAT with
antibiotics and VAT without antibiotics should be performed. It is
recommended an independent analysis of several clinical variables
that can influence the outcomes with a higher impact than the
differential diagnosis of VAT/VAP. A bigger sample is needed to
achieve significance in results. We further propose the use of CT in
all patients diagnosed with VAT, if clinically possible, as to better
prevent the presence of VAP in the VAT group.
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INTRODUCTION. Ventilator associated pneumonia (VAP) and
ventilador associated tracheobronchitis (VAT) are two common
pathologies in the intensive care units (ICU). Their early diagnosis,
differentiation between both entities and correct treatment helps
reduce the morbidity and mortality of affected patients.
OBJECTIVES. To explore if in our ICU there are differentiating
characteristics between VAP and VAT.
METHODS. It is a prospective, observational study during the year
2016, carried out in a 24 bed polyvalent ICU of a third level hospital.
Patients with more than 24 hours of admission were included. We
took into account the diagnosis of infection according to CDC
criteria. The data was collected in the ENVIN-HELLICS database. A de-
scription of the main variables included in the study was made. For
the qualitative variables, the relative frequency, absolute frequency
and percentages were determined. For the quantitative variables, the
mean, median, standard deviation and variance were calculated.
RESULTS. A total of 752 patients were studied, with mean age of 58
years, mostly male (65%), with an APACHE II score of 12. Most of
them were patients with medical diseases (46,41%) followed by
coronary heart disease (39,63%). The most frequent risk factors were
urinary catheterization (48,94%), followed by the use of a central
venous catheter (44%) and artifical airway path (37,63%). The mean
length of stay was 9,57 days. Most of the patients included in our
study came from their home (67%), followed by a hospitalized stay
(28%). The most frequent infections were the VAP (39,73%) followedby the VAT (27,40%). The microorganism most frequently found was
Klebsiella pneumoniae (29,23%) followed by Pseudomona aeruginosa
(14,62%), both globally as for both type of respiratory infections. The
rate for VAP was 5,97 VAPs for 1000 days of mechanical ventilation,
as for 4,11 VATs for 1000 days of mechanical ventilation.
CONCLUSIONS. In our ICU we do not find differentiating characteristics
between both pathologies. It is curious that patients with VAT have
more days of mechanical ventilation until the development of the
infection, and they do die more; but with no statistically significant
differences possibly due to the few number of cases compared.
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INTRODUCTION. Soluble urokinase plasminogen activator receptor
(suPAR) and Neopterin are expressed systemic inflammation on
peripheral blood mononuclear cells and neutrophils. In this study
was evaluated to diagnostic parameters in patients with ventilator-
associated pneumonia (VAP).
OBJECTIVES. The aim of this study was to investigate the diagnostic
and prognostic values of serum C-Reactive Protein (CRP), Procalcito-
nin (PCT), suPAR, and Neopterin levels in the patients with VAP.
METHODS. Thirty eight patients diagnosed as VAP in intensive care
unit and 40 patients without VAP in intensive care unit were enrolled
the study. APACHE Acute Physiology and Chronic Health Evaluation
(APACHE) II, Sequential Organ Failure Assessment Score (SOFA), Clinical
Pulmonary Infection Scores (CPISm) of the patients were calculated at
admission and daily PEEP account were measured. The serum levels of
CRP, PCT, suPAR, and Neopterin were measured once in controls and
were measured prior to antimicrobial treatment and on days 3, 5, and
the end of treatment in VAP group. The results were compared
between the groups. Subgroup analysis of the patients with VAP were
performed, scores and levels of biomarkers were compared between
the mortality and non-mortality group. Correlation between the levels
of biomarkers and scores of the patients were investigated.
Table 22 (Abstract 0058). Results
ICU VAP Rate
Warrington 0.17%
Whiston 0.76%
Wirral 0.87%
Leighton 0.94%
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 34 of 542RESULTS. CRP, PCT, Neopterin, and suPAR levels were significantly
higher at all timely measures (except suPAR values at the end of
treatment) in VAP groups than those of controls (p < 0.005). While
CRP and PCT values were significantly higher in mortality group on
the day prior to treatment and days 3, 5 than those of non-mortality
group, suPAR and Neopterin levels were higher on the days 3, 5.
APACHE II and SOFA values were also higher in mortality group. CRP
values > 14.5 ng/mL prior to the treatment and PCT levels > 1.23 ng/
mL at day 5 were found as 100% specific for mortality in VAP group.
CONCLUSIONS. C-reactive protein, PCT, Neopterin, and suPAR values
may be helpful for early diagnosis of VAP in intensive care patients.
High CRP and PCT levels as well as high APACHE II and SOFA scores
may have prognostic value for follow-up of the patients with VAP.
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INTRODUCTION. Ventilator associated pneumonia (VAP) is an
important Intensive Care Unit (ICU) associated infection. VAP is
associated with increased mortality, length of stay & cost. ICUs
should have standardised systems in place to monitor VAP rates1.
Currently there is no unifying definition of VAP & many of the
current definitions in use are complex. Finding an optimal definition
remains controversial. Consequently, data collection between ICUs
has been hampered by inconsistent definitions & methods of data
collection.
OBJECTIVES.
1. Create a simple definition of VAP to standardize data collection
2. Design a daily data collection sheet
3. Carry out a pilot audit
METHODS. Our simplified VAP mnemonic based definition was
based on the American Centre for Disease Control guidelines2.
Inclusion criteria comprised a period of more than 48 hours of
mechanical ventilation with stable or reducing FiO2 & PEEP
requirements. Exclusion criteria included non-infective causes for
increased ventilator support &/or a current VAP.
A VAP was determined by:
Ventilator settings
An increase in FiO2 OR PEEP to achieve designated targets for
patient, sustained over a 24 hr period
And
Associated features (one or more)
· New WCC < 4.0 or >12.0 x109/L or increasing/decreasing from
baseline
· New temperature change
· Positive microbiology consistent with VAP
And
Pneumonia
Evidence of new consolidation on CXR/CT (Not required in ARDS)
We conducted a three month pilot audit at four ICUs across the
Merseyside region (Whiston, Warrington, Leighton & Wirral). A data
collection sheet was filled out each day. The data collection period
was between 29/02/16 & 31/05/16 (93 days in total).
RESULTS. In total, we audited 1626 ventilator days, with 1314
ventilator days meeting the inclusion criteria.
CONCLUSIONS. In conclusion, we have standardised data collection
for the diagnosis of VAP & have continued to use this tool across all
ICUs in the Merseyside region. We found that our VAP rate wassignificantly lower that that quoted in the literature (20%)3.
Although, the Scottish Intensive Care Society have recently quoted
their VAP rate as 2.7/1000 invasive ventilator days4. This may be due
to the patient population, an overestimation of VAP in the literature,
improving clinical care or low sensitivity of our screening tool.
However, if VAP rates are very low, this raises the questions as to
whether measuring them is clinically beneficial. We are comparing
our definition against other VAP scoring tools to assess validity.
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BACKGROUND. Ventilator-associated pneumonia (VAP) is a serious
concern for patients in medical ICU. The risks to patients are signifi-
cant and the monetary costs are considerable. It remains a major
cause of hospital morbidity and mortality despite recent advances in
diagnosis and accuracy of management.
OBJECTIVES. To determine the rate and the risk factors of VAP in a
Tunisian medical ICU.
METHODS. A prospective study was conducted in an 8-bed medical
ICU during 18 months from September 15th, 2015 to march 15th,2017.
All patients who remained in our ICU more than 48H were included.
VAPs were diagnosed based on American Thoracic Society criteria. Risk
factors were analyzed by conditional stepwise logistic regression. P
values of less than 0.05 were regarded as statistically significant.
RESULTS. Among 258 included patients, 162(62.7%) were male with
mean age 60 ± 18years. Acute respiratory failure was the main cause
of admission 191(74%). The mean SAPS II score at admission was
31.7 ± 14. Mechanical ventilation was instituted in 223(87%) patients.
46(18%) patients developed VAP. VAP density incidence was at 14.5/
1000. The most common microorganisms grown in the tracheal
aspirates were: Acinetobacter baumannii 22(59.5%) and Pseudomonas
aeruginosa 5(13.5%).
Univariate analysis showed that: NIV failure (p = 0.002), age (p = 0.009),
Charlson comorbidities index (p = 0.033) and duration of sedation
(p < 0.000) were associated to VAP. NIV as exclusive ventilatory support
was considered a protective factor (p = 0.001).
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 35 of 542Multivariate analysis identified the following independent risk factors
for VAP : Duration of sedation (OR, 1.21 ; 95%CI, [1.06,1.37];
p = 0.003) and NIV failure (OR, 3.76 ; 95%CI, [1.07,13.26] ; p = 0.0039).
CONCLUSION. The present study demonstrated a high density-
incidence of VAP in a Tunisian MICU. Duration of sedation and NIV fail-
ure were the only independently associated factors to VAP occurrence.
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Background. NIV is the first-line treatment for the management of
(AE/CRF) in the intensive care unit. However, the impact of NIV use
on nosocomial infections and mortality remains unclear.
Aim. To evaluate the effect of NIV use in patients admitted for AE/
CRF on VAP and mortality.
Methods. Retrospective observational study conducted in an 8-bed
Tunisian medical ICU during 16 years from January 2000 to December
2015. Were included all consecutive patients admitted for AE/CRF. Were
assessed trends in density incidence of VAP and mortality rates.
Result. Among 4650 ICU admissions, 1245(26,7%) were admitted for
AE/CRF. First line NIV was administered in 374(30%) patients. Figure
37 displays comparative VAP density incidence and mortality within
3 predefined periods.
Conclusion. The steady increase of NIV use did not have a significant
impact on density incidence of VAP neither on mortality rate;
showcasing the need for better management of NIV in the ICU
where periods of organizational difficulties did not allow acquiring
enough experience until the last five years.Fig. 37 (abstract 0060). Trends of VAP and mortality rates in
patients having first line NIV. P1, period 1: 2000–2004; P2, period 2:
2005–2009; P3, period 3: 2010–2015; AE/CRF, acute exacerbation on
chronic respiratory failure; VAP, ventilator associated pneumonia; NIV,
non invasive ventilation; NIVs, NIV success; NIVf, NIV failure; IMV,
Invasive Mechanical Ventilation; VD, Ventilator days0061
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Intensive Care Medicine Experimental 2017, 5(Suppl 2):0061INTRODUCTION. The unnecessary and/or prolonged use of broad-
spectrum antibiotics is associated with the rapid emergence and
dissemination of antibiotic-resistant microorganisms, therefore its
use these should be restricted.
AIM. To analyze the microbiology profile of ICU-acquired respiratory
infections in a mixed ICU and the possibility to use antibiotics recom-
mended for community-acquired pneumonia (CAP) according to ICU
length of stay.
METHODS. Retrospective study on all patients admitted from the
community into a 12 bed mixed-ICU of a tertiary care university hos-
pital for a minimum period of 48 hours, from February 2015 to July
2016 (18 months). Only microbiological documented ICU-acquired re-
spiratory infection were included and categorized as sensitive to CAP
antibiotic treatment recommendations or not. MDR was defined as a
pathogen resistant to at least one antibiotic in three different classes
to which it should be sensitive.
RESULTS. During the study period 286 patients were admitted to the
ICU from the community for more than 48h. They had a mean ± SD
age of 60 ± 16 years, 182 (64%) were male, 60% (n = 171) were
medical admissions and 24% (n = 68) were trauma patients (medical
or surgical admissions). Of these, 39 (14%) developed 46 episodes of
ICU-acquired respiratory infections microbiological documented [8
tracheobronchitis (17%) and 38 pneumonias (83%)]. In this sample
the rate of ventilator-associated infection was 12.1/1000 days of
mechanical ventilation (MV) (10 pneumonias/1000 days of MV and
2.1 tracheobronchitis/1000 days of MV).
Up to three days of ICU admission there were 8 episodes of ICU-
acquired (nosocomial) respiratory infection all sensitive to CAP guide-
lines (there was only one Klebsiella pneumoniae resistant to amoxicillin-
clavulanate but sensitive to non-pseudomonal 3rd generation cephalo-
sporins); the most frequent pathogen was Haemophilus influenzae
(n = 4, 50%) and there was no infection by a MDR pathogen.
After day 4 there were 38 episodes of respiratory infection and the
most frequent pathogens were: Pseudomonas aeruginosa (n = 11, 29%),
Klebsiella pneumoniae (n = 6, 16%) and Acinetobacter baumannii (n = 4,
11%). In the period the proportion of adequate antibiotic therapy
following CAP recommendations would fall to 50% or less. There were
11 (29%) caused by MDR pathogens.
CONCLUSION. In our unit ICU-acquired pneumonia can be treated as
CAP up to 72 hours after ICU admission, in those patients directly ad-
mitted from the community setting, decreasing the use of unneces-
sary broad spectrum antibiotics.
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OBJECTIVES. Analyzing VAP development in tracheostomized patients
according to timing.
MATERIAL AND METHODS. Prospective and observational study
where patients were followed up for 28 days or up to VAP
development after being performed tracheostomy. Patients were
divided into two groups: those who were performed tracheostomy
within 7 days upon ICU admission (early group) and those performed
tracheostomy afterwards (late group).
RESULTS. A total of 250 patients were analyzed. VAP global incidence
was 23.4%. VAP incidence reached 13.6% and 30.3% in the early and
late groups, respectively. No differences were observed regarding
comorbidities, APACHE II-measured severity or the reason for admission
between both groups. VAP direct impact was 9.8 and 14.54 in every
1000 days of MV in the early and late groups, respectively. Figure 38
shows differences between both groups in VAP development (Log
Rank 0.003)
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 36 of 542Multivariate Cox regression identified no other variables related to
VAP development, except performance within the first 7 days: HR
0.42 IC95% (0.23-077), p = 0.005.
CONCLUSIONS. Early tracheostomy in critical patients is a protective
factor against VAP development regardless of the patient´s reason
for admission. It is since the third week after tracheostomy that VAP
risks rocket in the late group relative to the early group. This is
probably related to greater MV needs and more difficult weaning.Table 23 (Abstract 0064). Cross tabulation of Gram stain and
effectiveness
Antibiotic effectiveness
Yes No Total
Change of Gram stain findings Positive 12 1 13
Negative 4 1 5
Total 16 2 180063
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INTRODUCTION. It is estimated that ventilator-associated pneumonia
(VAP) occurs in 10-20% of patients in intensive care1. Despite advances in
prevention strategies, there remains a lack of consensus on standard cri-
teria for clinical diagnosis of VAP. Although surveillance programmes are
available, questions remain about their suitability as a clinical diagnostic
tool2. In this regard, the Cheshire and Mersey Critical Care Network
(CMCCN) have developed a regional audit tool in order to comply with
recommendations published by the Faculty of Intensive Care Medicine1.
OBJECTIVES. To complete and assess a new regional VAP audit tool
provided by the CMCCN.
METHODS. Data were collected between August 2016 and January
2017 at the Royal Liverpool University Hospital Intensive Care Unit.
Information was collated using clinical notes, observation charts and
electronic investigation software (Sunquest ICE©).
Inclusion criteria were mechanical ventilation for greater than 48
hours with static or decreasing FiO2 or PEEP for more than 48 hours.
Exclusion criteria were current non-infected ventilator-associated
event or current VAP without a 48 hour stability period.
Change in ventilator settings, white cell count, temperature, positive
microbiology and evidence of new pulmonary infiltrates were also
recorded.
RESULTS. 1343 ventilator days were identified, of which 1033/1343
were greater than 48 hours and 740/1033 met all other criteria.
The audit identified 8/740 (1.08%) positive cases of VAP.
Fig. 38 (abstract 0062). VAP developmentCONCLUSION. We used this audit tool for an extended period at a
large ICU within CMCCN. Our results identified a VAP frequency of
1.08%, which is much lower than expected. Limitations include
variability in data collection, interpretation of clinical findings (e.g.
radiology report), definition of mechanical ventilation, lack of data on
microorganisms and antimicrobial treatment. The data collected
were insufficient to calculate an accurate incidence rate.
Future research should focus on comparison against three commonly
cited models: American CDC VAE Protocol (2017)2, ECDC HAIICU
Protocol (2015)3 and Clinical Pulmonary Infection Score (CPIS)4.
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INTRODUCTION. Bacteria in Gram stain decrease after antibiotic
administration, while few reports confirmed the relationship between
change of Gram stain findings and antibiotic effectiveness.
OBJECTIVES. To examine if change of Gram stain findings at 24 hours
after antibiotic administration predicts clinical effectiveness of antibiotics.
METHODS. This was a prospective observational study. We enrolled
ICU patients who developed respiratory tract infections and were
planned treatments. Attending physicians decided antibiotics by
assessing tracheal aspirate Gram stain and clinical condition.
Gram stain was performed again 24 hours after initial antibiotic
administration. Three physicians independently assessed it, and
when all of them evaluated bacteria decreased, we defined it
positive. When patients were prescribed the same antibiotic at
day 4 or de-escalated antibiotics, we defined the antibiotics were
clinically effective. Main outcome was concordance ratio between
change of Gram stain findings and clinical effectiveness.
RESULTS. Eighteen cases were enrolled. Fourteen cases showed a
predominant morphotype while 4 cases showed a polymicrobial
pattern. Thirteen were positive in Gram stain, whereas 5 were
not. Among 12 of 13 cases, antibiotics were clinically effective
and positive predictive value was 93%. Negative predictive value
was 20%.
CONCLUSIONS. Gram stain at 24 hours after antibiotic administration
was useful to predict clinical effectiveness of antibiotics.
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BACKGROUND. (NIV) represents a first-line treatment for patients
with acute hypercapnic respiratory failure. When possible this tech-
nique allows a more comfort for patients ; decreases intubation rate
and IMV complications.
AIM. To assess VAP and mortality rates between NIV and IMV.
METHODS. Retrospective, observational, monocentric study conducted
in an 8-bed medical Tunisian ICU from January, 2000 to December,
2015. Were included all consecutive patients admitted for acute on
chronic respiratory failure for whom ventilatory support with either
conventional mechanical ventilation or NIV initiated within the ICU
as first line ventilatory support. Were assessed VAP and mortality
rates between NIV and IMV.
RESULTS. Among the 4650 enrolled patients, 1245(26,7%) patients
were admitted for AE/CRF. Firstline NIV use was in 374(30%). Overall
NIV success rate was at 60,4%. In NIV failure group, mean delay to
intubation was estimated at 2,3 ± 2,1days. VAP density incidence
was higher in NIV failure group, compared to the NIV success group
and the firstline IMV group, respectively, 29,3/1000 ventilator days vs
3,6/1000 ventilator days vs 26,9/1000 ventilator days (P = 0.0001).
This resulted in a higher length of stay for the NIV failure group
14,7 ± 13,1days compared to NIV success group 7,4 ± 4,5days and
the firstline IMV group 11,11 ± 10,9days (p = 0.0001). Similar results
were found regarding mortality rate, which was higher in the NIV
failure group compared to both other groups, 64,2% vs 1,3% vs
48,7% (p = 0.0001).
CONCLUSIONS. Compared to IMV, successful NIV management
presents lower VAP density incidence and mortality rate, however
delayed intubation after initial NIV seems to be a risk factor for VAP
and mortality.
The pathophysiology of sepsis
0066
Longitudinal changes of metabolic and bioenergetic patterns in
critically ill children with sepsis (S) compared to those with SIRS
A. Spanaki1, T. Tavladaki1, H. Dimitriou2, E. Kondili3, A.V. Koslov4, J.C.
Duvigneau5, E. Blevrakis1, S. Dumitrescu4, A. Weidiinger4, D.
Georgopoulos3, G. Briassoulis1
1University Hospital of Heraklion/University of Crete, PICU, Heraklion,
Greece; 2University of Crete, Medical School, Paediatric Haematology
Oncology, Heraklion, Greece; 3University Hospital of Heraklion/University
of Crete, ICU, Heraklion, Greece; 4Ludwig Boltzmann Institute for
Experimental and Clinical Traumatology, Vienna, Austria; 5University of
Veterinary Medicine, Vienna, Austria
Correspondence: A. Spanaki
Intensive Care Medicine Experimental 2017, 5(Suppl 2):0066
INTRODUCTION. Systemic inflammatory response syndrome (SIRS)
and sepsis (S) are associated with cell stress, inflammation, and
metabolic derangements. Studies investigating the kinetics of
metabolic and bioenergetic profiles in S or SIRS are limited.
OBJECTIVES. To compare acute cross-sectional and longitudinal
changes of bioenergetics, inflammation and metabolism in adult and
pediatric septic patients with those with trauma-related SIRS and
healthy-controls (H).
METHODS. 68 children (S/18, SIRS/23, H/27) and 79 adults (S/23,
SIRS/23, H/33) mechanically ventilated were included in the study.
Blood samples were obtained within 24-hours upon admission and
repeated on days 3 and 5. Mean Fluorescence Intensity (MFI) for HSPexpression in monocytes (m) or neutrophils (n) was determined using
4-colour Flow Cytometry. Extracellular (e) HSP72 and 90 were mea-
sured using ELISA and energy-expenditure (EE) by the Gas Module E-
COVX. ATP concentrations were measured by luminescence with a
photometer. The levels of plasma amino acids and NO were deter-
mined by HPLC and Sievers NO-Analyzer, respectively; lipid peroxida-
tion products (TBARS) by a colorimetric test.
RESULTS. On day 1, adult septic patients had lower VO2, VCO2, EE,
metabolic pattern, albumin, mHSP72, and nHSP72 and higher TBARS,
NO, nitrite, BVR, and lactate compared to controls and/or SIRS
(p < 0.05). Among adult septic patients, VO2, VCO2, nitrite, arginine and
metabolic pattern were increased and albumin and BVR decreased
longitudinally (p < 0.05); in SIRS, NO and nitrite were increased while
BVR and ATP decreased from day 1 to 3 and/or 5 (p < 0.05). Septic
children also had lower ATP and mHSP72 compared to controls
and/or SIRS longitudinally (p < 0.05). In pediatric sepsis, TBARS
were decreased on day 3 and BVR on day 5, the day when ATP was
increased (p < 0.05).
CONCLUSIONS. Metabolic patterns and bioenergetics differ between
septic and non-septic critically ill adult and pediatric patients in acute
stress and longitudinally. An acute metabolic and bioenergetics
repression characterizes early-sepsis, following by inconsistent
patterns of recovery by day 5.
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INTRODUCTION. Neuromuscular electric stimulation (NMES) has been
recently shown to acutely mobilize endothelial progenitor cells (EPC),
measures of the endothelial restoration potential, in septic ICU patients.
OBJECTIVE. The aim of the study was to explore the role of muscle
contraction strength as well as the time course of EPCs mobilization.
METHODS. Twenty-two (age: 60 ± 14 yr) ICU septic patients were in-
cluded in the analysis on the role of contraction strength. Eighteen
patients (age: 58 ± 15 yr) were included in the analysis of the time
course of EPCs changes. All patients were randomized to one of two
30-min NMES protocols of different characteristics applied in max-
imally tolerated intensity on vastus lateralis, vastus medialis and per-
oneus longus of both lower extremities. Muscle contraction of the
quadriceps was evaluated with a scale from 0 (no contraction) to 4
(full knee extension) and the 22 patients were divided in two sub-
groups, using 2 (visible contraction) as a cut-off point. Blood was
sampled before and immediately after NMES sessions. In relation to
the 18 patients, blood samples were collected before (tpre) immedi-
ately after (tpost) and 60 min following (tpost60) NMES sessions. EPC
were quantified by cytometry markers CD34+/CD133+/CD45−, CD34
+/CD133+/CD45−/VEGFR2+, and CD34+/CD45−/VEGFR2+. All values
are mean ± SD. EPCs values are in cells / 106 enucleated cells.
RESULTS. In relation to the role of contraction strength, CD34+/CD133
+/CD45− and CD34+/CD45−/VEGFR2+ were overall increased (p < 0.05)
with not any between-subgroup differences observed (p > 0.05).
Regarding the time course of the changes, a significant time effect was
found for all EPC populations (p < 0.05, table 24). Post-hoc analyses
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 38 of 542showed that CD34+/CD133+/CD45− and CD34+/CD45−/VEGFR2+ were
significantly increased from tpre to tpost60 (p < 0.05), while a tendency to
increase from tpre to tpost60 was observed for CD34+/CD133+/CD45
−/VEGFR2+ (p = 0.10).
CONCLUSION. NMES muscle contraction strength did not found to
affect EPC mobilization. NMES acutely increased EPC number and
this effect was maintained for at least 60 min post sessions. The
exact time course of the EPC increase after an NMES session and the
clinical significance of these benefits need to be determined.
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INTRODUCTION. MR-Proadrenomedullin (MR-proADM) is a novel bio-
marker of sepsis. Its levels are increased in septic patients. This bio-
marker can help in predicting mortality in this cohort of patients.
OBJECTIVES. To determine the role of MR-proADM as a predictor of
mortality in septic patients at the moment of sepsis detection.
METHODS. Prospective observational study of 70 adult patients with
activation of an in-hospital sepsis code (SC) in a tertiary center from
28-nov-2016 to 6-mar-2017. At the moment of sepsis detection,
levels of procalcitonin (PCT), MR-ProADM, lactate and C reactive pro-
tein (CRP) were determined. Values of MR-ProADM were blinded to
the investigators. Demographic data, SOFA score, laboratory data,
physiological variables, need for ICU admision, source of infection,
days of hospitalization and intrahospital mortality were recorded.
This study was approved by Ethical Committee (PR(AG)333/2016).
SEPSIS III definitions were used(1). Quantitative variables with normal
distribution have been expressed as mean ± standard deviation,
non-normal distribution as median and interquartil range (25-75%)
and categorical variables as a percentage. T-test and Chi-Square test
was applied when necessary (p < 0.05). Statistical analysis was done
with SPSS 18.0 (SPSS Inc., Chicago, IL, USA).
RESULTS. Of 70 patients, 6 were discarded because they had no
infection. 42 (65.6%) were man with a mean age of 64 (±14.67) years.
SOFA score was 6.94 (±3.48). Septic shock (SSH) was diagnosed in 42
(65.6%) patients, while 17 (26.6%) had sepsis (SS) and 5 (7.8%) had
infection with no organ dysfunction. The source of the sepsis was
* significant difference compared to tpre (p<0.05)intraabdominal in 19 (29.7%) patients, respiratory in 18 (28.1%),
urinary tract 16 (25%). In 2 (3.1%), the source was not identified. At
the moment of sepsis detection, lactate levels were 2.5 (1.6-5.65)
mmol/dL, CRP 21.39 (±12.48) mg/dL, procalcitonin 8.03 (1.99-37.04)
mg/dL and MR-proADM 3.91 (1.99-7.43)nmol/L. 41 (64.1%) patients
were admitted to a critical care area. In-hospital mortality was 28.1%
(18 patients). In SSH, MR-proADM levels were 4.6nmol/L (2.34-9.89)
and in SS were 2.93 nmol/L (1.73-3.92). MR-proADM levels were
higher in non survivors (4.9 vs 3.39; p = 0.035) while PCT (3.17 vs
10.53; p = NS) and PCR (22.71 vs 20.38; p = NS) did not show differ-
ences between survivors and non-survivors. In the subgroup of SSH
patients, non survivors had higher levels (8.49 vs 4.26; p = 0.046), but
not statistic differences were found in the subgroup of SS. Addition-
ally, SOFA score was lower in survivors (6.28 vs 9.18; p = 0.002).
CONCLUSIONS. At the moment of sepsis detection, MR-proADM is
the only biomarker able to predict mortality.
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INTRODUCTION. Advanced glycation end products (AGEs) are stable
products generated by non-enzymatic glycation of proteins due to
the Maillard reaction, driven by oxidative stress; they appear in
plasma and accumulate in tissues. High levels of AGEs have been re-
ported associated to ageing process, smoking, diabetes mellitus,
chronic kidney injury and cardiovascular diseases including heart fail-
ure, myocardial infarction and atrial fibrillation.
The “two hit hypothesis” of inflammation (Schmidt et al.) postulates
that besides chronic upregulated interaction between AGEs and its
receptors, superimposed critical illnesses with associated inflammation
and oxidative stress, further elevates AGEs and its receptors, resulting
in exaggerated and prolonged inflammation.
OBJECTIVES. Our aim was to determine the AGEs levels in the
plasma of septic patients, and to study their association with chronic
risk factors and medical history (age, smoking, diabetes mellitus,
chronic renal failure and cardiovascular diseases). Also, we wanted to
analyze the relationship between AGEs and inflammatory mediators
(TNF-α, IL-1β, IL-6, IL-8, C-reactive protein and Procalcitonin).
METHODS. We included 89 consecutive patients admitted to our ICU
with the diagnosis of sepsis, and checked in their medical history
for age, smoking, diabetes mellitus, chronic kidney injury, and
cardiovascular diseases including heart failure, myocardial infarction
and atrial fibrillation. At day 1 of admission, plasma AGEs were
measured by quantitative fluorescence spectroscopy. Simultaneously,
we measured the next inflammatory mediators: TNF-α, IL-1β, IL-6, IL-8,
CRP and Procalcitonin. Spearman correlation was performed to deter-
mine the relation between AGEs and age. Mann–Whitney test was ap-
plied to study the association between AGEs and risk factors, medical
conditions and inflammatory mediators.
RESULTS. In our cohort of septic patients (mean age 68 ± 13), there
were 72 survivors and 17 non-survivors. We found association between
AGEs and the presence of chronic renal failure (p < 0.001), and be-
tween AGEs and atrial fibrillation (p = 0.013), but not with the other
studied conditions. Besides, we could not find correlation between
plasma AGEs and any of the acute phase inflammatory mediators.
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 39 of 542CONCLUSION. Plasma AGEs at day 1 of the septic process are
associated to the presence of chronic renal failure and to atrial
fibrillation. AGEs could have a pathogenic role in the development of
atrial fibrillation. We did not find correlation between AGEs and
acute phase inflammatory products, which does not support the
“two hit hypothesis” of inflammation previously exposed. Further
studies are required to find out how AGEs and its receptors are
involved in the inflammatory response of the septic process.
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INTRODUCTION. Gastrointestinal motility disorders are a common
clinical sign during the ICU stay of critically ill patients. It is, however,
unclear, whether gastrointestinal motility disorders (possibly associated
with gut barrier dysfunction) are causative for the development of
inflammatory complications (sepsis, death).
OBJECTIVES. This study retrospectively investigated in a patient
cohort with spontaneous intracerebral parenchymatous hemorrhage
the relation between gastrointestinal motility disorders and the
development of sepsis and ICU mortality.
METHODS. Retrospective data analysis of clinical variables documented
in IntelliSpace Critical Care & Anesthesia (ICCA™). The IT-based search of
patients in the database (over the period 2010–2015) using 10 search
items revealed a total of 597 patients,180 thereof were screened, 75
were evaluated. When applicable, clinic variables, such as time until
50% of nutritional needs were achieved, gastric reflux within 24 hours
and time to first defecation were analysed on day 0, 1, 2, 3, 5, 7, 10,
and 14. Statistics: multivariate analysis of prior evaluated variable-
candidates for dichotomous outcome measures sepsis and ICU mortal-
ity. Comparison of variables of patients with gastrointestinal motility
disorders with and without sepsis. Group comparison with Mann–Whit-
ney U test. Significance level at p < 0.05.
RESULTS. Risk factors for sepsis were days in ICU (p = 0.04), chronic
kidney failure (p = 0.04), and detection of gram-positive pathogens
(0.04). Risk factors for ICU mortality were days on ICU (p = 0.01), sed-
ation days (p = 0.02) and medication with ACE inhibitors (p = 0.05). Pa-
tients with sepsis showed a longer time to first defecation (137[100;186]
vs. 100[68;130] h, median[quartile], p = 0.012), and time until 50% of nu-
tritional needs were achieved (84 [63;120] vs. 71 [58;99] h, p = 0.28).
CONCLUSIONS. Variables of gastrointestinal motility disorders could
not be determined as risk factors for sepsis or ICU mortality. Patients
with sepsis, however, more often showed gastrointestinal motility
disorders compared with critically ill patients without sepsis.
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INTRODUCTION. Myocardial depression is a well known phenomenon in
sepsis. Limited studies assessed the right ventricuar (RV) function in sepsis.
OBJECTIVES. Evaluation of RV dimensions and function in patient
with sepsis and its relation to outcome.
METHODS. Twenty patients with sepsis or severe sepsis were included.
Patients with cardiomyopathies, known or suspected pulmonary HTN
were excluded.Within the first 24 hours of admission, the following echocardiographic
parameters were obtained: RV dimensions (basal, mid and
longitudinal), fractional area change (FAC), tricuspid annular plane
excursion velocity (TAPSE), Pulmonary artery systolic pressure
(PASP), peak systolic velocity of the RV free wall by tissue Doppler
(Ś), the presence or absence of regional wall motion abnormalities
(RWMAs) of the RV free wall, in addition to left ventricular (LV)
internal dimensions and EF%.
APACHE II score on admission and its predicted mortality were assessed
RESULTS. The mean age of the study group was 49.9 ± 12.2 years
with 15 females (75%). Sepsis with an identified pathogen (proved
by microbiological culture) was documented in 19 patients (95%).
The following were the sources of infection in order of frequency:
Chest infection (50%), infected surgical wound (15%), intra-abdominal
sepsis and urinary tract infection (10% each), infective endocarditis,
perpural sepsis and suspicious for myocarditis with 2 positive cat-
egories (5% each).
63.1% of culture positive patients were of positive gram staining,
while 36.9% were negative.
All patients showed normal RV internal dimensions, FAC, Ś velocity and
TAPSE, in addition to normal LV internal dimensions and EF%. None of
the studied patients had any evidence of RWMAs of the RV free wall.
Six patients (30%) had pulmonary HTN (PASP > 45 mmHg).
The mean APACHE II score was 16.8 ± 4.18 with average expected
mortality 24% Average Length of ICU stay was 10.7 ± 6.2 days with
no recorded deaths related to sepsis during hospital stay.
Since no in-hospital mortality due to sepsis or severe sepsis, correla-
tions were done between the predicted mortality and the measured
echocardiograophic parameters.
RV Longitudinal diameter and PASP showed significant positive
correlations with expected mortality (r 0.483, P value 0.031 & r 0.644,
P value 0.002 respectively). FAC and TAPSE showed significant
negative correlations with expected mortality (r-0.496, P value
0.026 & r −0.498, P value 0.025 respectively).
CONCLUSIONS. In this small single centered study, patients with
sepsis or severe sepsis did not have any evidence of RV or LV
dilation and/or impaired systolic functions. PASP was elevated in
one third of the study group.
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INTRODUCTION. Hypocholesterolaemia is both a hallmark of sepsis
and a prognosticator. However, the reasons for this fall (decreased
production/ingestion and/or increased utilization) are not known,
neither is the effect of sepsis on tissue cholesterol levels. This may
be highly relevant as cholesterol is a crucial component of the
plasma membrane, including the organization of lipid rafts. Low
membrane levels may impact on adrenergic receptor signalling as
these receptors are located within the lipid rafts. To investigate this,
we used our well-characterized rat model in which survivors and
non-survivors can be identified with high sensitivity/specificity as
early as 6h post-sepsis.
OBJECTIVES. To assess (i) the relationship between plasma and
cardiomyocyte membrane cholesterol concentrations and adrenergic
signalling in heart tissue taken at 24 hours post-sepsis.
METHODS. Awake, instrumented male Wistar rats (325 ± 15g)
received an i.p. injection of faecal slurry with i.v. fluid resuscitation
commenced from 2h. Control animals were treated identically except
did not receive slurry. A heart rate cut-off of 460 bpm at 6h was used
to classify animals into predicted survivors or non-survivors (1). At
either 6 or 24h post-sepsis animals were killed and organs were im-
mediately collected into liquid nitrogen. Cholesterol concentrations
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 40 of 542in membrane preps was measured by an Amplex® Red Cholesterol
Assay (Invitrogen A12216). Alterations in adrenergic signalling at
24h were measured by serine23/24 phosphorylation of troponin I, a
well-known target of adrenergic signalling. Phosphorylation of
Erk1/2 was measured as a surrogate marker of desensitization of
adrenergic receptors and b-arrestin signalling. Results are presented
as mean ± SE, analysed using Student's t-test and considered statis-
tically significant when p < 0.05.
RESULTS. A marked decrease in plasma cholesterol level was seen in
septic animals as early as 6h post-sepsis, more so in non-survivors. At
24h the concentration of cholesterol in heart membrane preparations
was significantly lower in septic animals, also greater in non-survivors.
(Table 25). An increase in myocardial troponin I phosphorylation was
seen at 24h in sepsis survivors only, whereas Erk1/2 phosphorylation at
24h was elevated in survivors and decreased in non-survivors.
CONCLUSIONS. Falls in plasma and heart membrane cholesterol
occur in sepsis and are more exaggerated in non-survivors. These re-
lates to changes in adrenergic signalling, as identified by alterations
in phosphorylation of troponin I and Erk 1/2. The relevance of this
finding warrants further investigation.
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Sham Predicted
survivor
Predicted
non-survivor
Plasma cholesterol (mg/ml) at 6h 2.34 ± 0.1 2.27 ± 0.05 1.95 ± 0,08 ab
Plasma cholesterol (mg/ml) at 24h 2.5 ± 0.13 2.03 ± 0.03
a
1.91 ± 0,03 ab
Heart membrane cholesterol at
24h (mg/mg protein)
0.029 ±
0.003
0.023 ±
0.004 a
0.018 ± 0.004 ab
Myocardial Troponin I
phosphorylation at 24h
100% 204 ±
34.8%
129±12.5%
p=0.075
Myocardial Erk 1/2 phosphorylation
at 24h
100% 401 ±
93,6%
59±11.2% b0073
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INTRODUCTION. The analysis of biological mediators in plasma of
septic patients has provided us relevant information concerning
systemic response of the body to septic process, although the
molecular markers and the pathways that are activated in different cells
and organs are not yet fully understood. A better understanding of the
cellular response will lead to raise new effective therapeutic strategies.
OBJECTIVES. Determine the differences in molecular pathways activation
in different primary cell exposed to septic plasma. Compare the
expression profile of the primary cell to their septic organs.
METHODS. Plasma from septic rats was obtained after 6h and 24h of
induced sepsis by a cecal ligation and puncture. 6 rats healthy male
Sprague–Dawley rats for group weighting 250-300g were used for
this purpose.
We isolated hepatocytes, type II alveolar cells, alveolar macrophages,
blood neutrophils and myocytes from their tissues. For this purpose
10 healthy rats were used.
a p< 0.05 vs control, b p< 0.05 vs survivorsIsolated cells were incubated with media supplemented with 15% of
plasma (septic 6h, septic 24h or control) and collected 6h and 10h after
the incubation. We analyzed different molecular markers by RT-qPCR.
RESULTS. We used 6h plasma to mimic the first stages of a sepsis
and 24h to mimic the established sepsis. We evaluated the response
of the primary cells at two time points to determine the time course
of the different molecular pathways.
Macrophages show increased pro-inflammatory markers TNFα, IL1β, IL6
and iNOS and decreased IL10 at 10h of incubation with both septic
plasmas. No effects were observed in apoptosis. Neutrophils show an in-
crease of TNFα, IL1β, iNOS and IL6 at 6h and 10h of incubation with
plasma of the early sepsis. IL10 was increased with 24h plasma compared
with 6h plasma. We observe increased apoptosis with the 6h septic
plasma. Alveolar type II cells show an increase of TNFα and IL6 and de-
crease of IL10 after 10h of incubation with both septic plasmas. Caspase-3
was significant activated after 6h of incubation with both septic plasmas.
Hepatocytes show minor response to septic plasma; an increase of
iNOS after 10h of incubation with 24h plasma and an increase of Bax
and Smad2 at 6h incubation with plasma obtained in early.
CONCLUSIONS. Pro and anti-inflammatory markers present different
regulation in different primary cells. Alveolar cells and inflammatory
cells (neutrophils and macrophages) exhibit faster and highly activa-
tion in pro-inflammatory markers. Apoptosis is strongly activated in
all the cells exposed to septic plasma, while the differences where in
the extrinsic and intrinsic activation of apoptosis. Hepatocytes and
myocytes present a less pro-inflammatory activation. Study in depth
these pathways might help us to understand the MOF and prevent it
with some specific treatments.
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INTRODUCTION. Sepsis is a common and frequently fatal condition. We
have shown that telemetry derived heart rate changes during early sepsis
allow the prognostication of death with a good sensitivity and specificity
(88% each) in a rat model of fecal peritonitis (mortality of 33%).
OBJECTIVES. To investigate mechanisms of disease in predicted
survivors and predicted non-survivors of a 48 hours rat model of
fecal peritonitis.
METHODS. 63 Male Wistar rats were instrumented with a venous line
and an ECG telemetry transmitter. Sepsis was induced by i.p. injection
of fecal slurry. Animals underwent arterial cannulation either at
baseline (n = 9), or 4 (n = 16) or 24 (n = 6) hours after sepsis induction
for hemodynamic measurements and terminal blood sampling. An
increase in heart rate >50 bpm 4 hours after sepsis induction was used
as a cut off to differentiate predicted survivors from predicted non-
survivors. Changes in heart rate variability (HRV) in 24 septic rats and 8
sham rats were observed for up to 48 hours.
RESULTS. Septic animals were characterized by lethargy, fever,
tachycardia and elevated cytokine (IL-6, TNF, CXCL-1) plasma levels
at 4 hours of sepsis. At 24 hours, lactate and B-type natriuretic pep-
tide levels were elevated. Despite tachycardia troponin levels were
not increased at any time point. Mean arterial blood pressure and ar-
terial blood gases were stable in all groups throughout the experi-
ment. Hematocrit was higher in predicted non-survivors at 4 hours
(45% ± 4, mean ± SD) compared to predicted survivors (34% ± 7;
p = 0.011). The analysis of HRV demonstrated autonomic dysfunction
during early sepsis in non-survivors: the ratio between low and high
frequency (LF/HF) was decreased in non-survivors at 4 hours com-
pared to sepsis-survivors (0.22 (±0.2) vs 1.07 (±0.69); p = 0.018).
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 41 of 542CONCLUSIONS. Although MAP was maintained in predicted non-
survivors, a decrease in intravascular volume was suggested by the
increase of hematocrit. Respiratory failure or renal dysfunction were un-
likely causes of death in septic animals considering the stability of the
blood gas analysis. HRV indicated that autonomic dysfunction during
early sepsis might be a mechanism of death in sepsis non-survivors.
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INTRODUCTION. The vascular endothelium is the first contact and
important barrier during hematogenous spreading of Staphylococcus
aureus, one of the most important pathogen of bacteremia and
sepsis in the intensive care unit. The fundamental understanding of
how S. aureus disrupts this barrier is still limited, and understanding
of the pathogenesis may provide advanced insights toward new
therapeutic strategies.
OBJECTIVES. To investigate the molecular mechanisms of how S.
aureus specifically interacts with vascular endothelial cells and elicit
inflammatory responses.
METHODS. Human aortic endothelial cells (HAECs) were infected
with heat-killed S. aureus (HK-SA). Various inflammatory signaling
pathways were surveyed. We also created an in vivo model of S. aur-
eus sepsis to address this issue.
RESULTS. Our results indicated that HK-SA significantly induced COX-
2 protein expression and mRNA levels, and increased promoter activ-
ity and PGE2 secretion. In addition, HK-SA effectively promoted MMP-
9 dependent cell migration of HAECs, which was inhibited by trans-
fection with siRNA of COX-2, PGE2, and IL-6. Furthermore, incubation
with S. aureus also induced TLR2 but not TLR4 protein and mRNAexpression. Transfection with siRNA of TLR2 significantly inhibited S.
aureus-induced COX-2, IL-6 and MMP-9 expression, suggesting that
TLR2 was a key receptor for S. aureus infection. Inhibition of MAPK
(p38 and ERK1/2) and NF-κB by inhibitors and siRNA effectively atten-
uated S. aureus-induced COX-2, IL-6, MMP-9 expression and cell mi-
gration. Moreover, our in vivo study also showed that S. aureus
infection induced COX-2 expression, C-reactive protein and IL-6 se-
cretion and COX-2 mRNA expression was attenuated by pretreatment
with inhibitors of p38, ERK1/2 and NF-κB.
CONCLUSIONS. These findings provide insight into how S. aureus
sepsis may activate proinflammatory mechanisms of endothelial cells
to elicit subsequent barrier function loss.
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INTRODUCTION. Red blood cell (RBC) rheology (deformability,
aggregation and shape) is altered during inflammatory process,
especially during sepsis. In patients with severe anemia due to
malaria, RBCs are modified by the deposition of IgG and alterations
in the complement regulatory proteins (CR1, CD 55 and CD 59) and
these changes could contribute to the increased erythrophagocytosis
(1). We have already showed an early decreased of RBC membrane
sialic acid (SA) content- a carbohydrate of the RBC membrane-
associated with a decreased RBC deformability in septic patients, as
observed in senescence process (2). This SA decrease could also
increase erythrophagocytosis..
OBJECTIVES. We studied the RBC surface proteins and erythrophagocytosis
in ICU patients with and without sepsis.
METHODS. We, prospectively, studied RBCs from 14 ICU patients
with (n = 9) or without sepsis (n = 5) compared to RBCs from 17
volunteers (V). By flow cytometry techniques, we studied the shape
assessed by the moment (2) and the membrane content of IgG and
in complement regulatory proteins (CR1, CD 55 and CD 59) in the 3
groups. Erythrophagocytosis was visualized directly by fluorescence
microscopy and quantified by flow cytometry method. Values were
expressed in median (25–75 th percentiles)and compared by the
Kruskal Wallis one way of variance test and the Man-Whitney test.
A p < 0.05 was considered as significant.
RESULTS. RBCs from septic were more spherical than non- septic
patients and V (Moment : V: −0.70 (−0.74 - - 0.68), NS: −0.53 (−0.56 -
-0.39), S −0.31 (−0.48 - -0.24), p < 0.001).The complement regulatory
proteins and Ig G were not statistically different between groups (for
example: Ig G depot : V : 0.17 (0.16-0.17); NS: 0.17 (0.16-0.19); S: 0.17
(0.17-0.18), p = 0.53).With the cytometry, the percent of phagocytosis
was higher for the septic patients than the healthy volunteers (6.3%
vs 1.8%), in line with what was observed in microscopy.
CONCLUSIONS. RBCs from septic patients were more spherical and
erythrophagocytosis process was enhanced but complement
receptors at the membrane surface were not different between
groups and thus not responsible of this increased phenomenon.This
latter could be explained by the decreased SA membrane content as
observed in senescence process (2).
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INTRODUCTION. Microcirculatory slow flow combined with plugged
capillaries is a hallmark of sepsis. We developed a new measurement
technique using the Cytocam-Incident Dark Field (IDF) imaging to
obtain recordings in a fixed sublingual area to better understand the
dynamic changes of microcirculation during septic shock.
OBJECTIVES. To use Cytocam imaging to investigate capllary
hemodynamic in a porcine model of sepsis in order to identify
plugged capillary vessels.
METHODS. Experiments were conducted on fully instrumented and
anesthetized 13 female pigs (BW 28.2 ± 1.9 kg). The animals were
divided into 2 groups: with (LPS group n = 10) or without (control
group, n = 3) infusion of LPS (2 mg/kg−1h−1). Measurements were
performed at baseline (t0), during shock (t1), and one hour after
starting fluids infusion (t2). Sublingual microcirculation was measured
using the Cytocam (Braedius Medical, Naarden the Netherlands)
supported by a mechanical arm to allow the operator to keep the
microscope on the same sublingual area. Offline analysis (AVA 3.0
software; MicroVision Medical, Amsterdam, The Netherlands)
involved the quantitative assessment of the functional capillary
density and the velocity of the erythrocytes flowing in the perfused
microvessels. Microcirculatory parameters were described as Perfused
Vessel Density (PVD) and Erythrocyte Flow Velocity (EFV). EFV was
assessed using the Space-Time Diagrams method in specific perfused
capillaries sampled at baseline and identified and measured again at
the successive time points.
RESULTS. Analysis of the Cytocam-IDF images in the fixed area
allowed us to track specific capillaries during the entire experiment.
We observed that normal perfused capillaries at the baseline became
plugged or non-perfused in shock [arrow in Fig. 40]. More import-
antly, these plugged capillary vessels could not be reopened with
fluid resuscitation despite correction of systemic hemodynamic
variables.
CONCLUSIONS. Cytocam-IDF could identify the presence of sepsis-
induced plugging of microcirculatory capillary vessels in one fixed
sublingual area. In addition, our results demonstrated that microcir-
culatory alteration associated with sepsis persisted despite success-
fully normalized systemic hemodynamic variables.
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INTRODUCTION. In systemic inflammation such as sepsis, adrenergic
beta receptor stimulation can modify function of immunocompetent
cells.
OBJECTIVES. This study aims to analyze beta receptor signaling in
human lymphdma cell line and the differentiated neutrophils.
METHODS. Human Caucasian promyelocytic leukaemia cell line (HL-
60) was differentiated into neutrophil-like cell by 1.25% dimethyl sulf-
oxide (DMSO). Free radical was detected inneutrophil-like cell by
rapid and sensitive luminescent assay that measures the level of
hydrogen peroxide (H2O2) ROS-Glo Assay. RT-PCR, immunohisto-
chemistry and tunnel stain were used in the detection of molecular
expression and apoptosis. For statistical analysis, t-test was used.
RESULTS. Neutrophil-like cells were differentiated from HL-60 by
DMSO with Gr-1 and lobulated nucleus. It expressed all subtypes of
adrenergic beta receptor. DOB (10-8 ~ 10-7 M) increased the pro-
duction of reactive oxygen species and apoptosis by 40 times in a
comparison with no adminstration of DOB by 24 hours. Randiorol
and Beta1 receptor antagonist could inhibit the prpduction of re-
active oxygen species and apoptosis reactive by 70%.
CONCLUSIONS. Beta receptor is expressed in neutrophils differentiated
from HL-60. Beta receptor stimulation increases reactive oxygen
species from the neutrophils and induces apoptosis in the neutro-
phils. Beta receptor antagonists can reduce production of reactive
oxygen species.
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INTRODUCTION. Central venous-to-arterial carbon dioxide difference
(PcvaCO2) and the PcvaCO2/arterial-venous oxygen content difference
ratio (PcvaCO2/CavO2) have been proposed as additional tools in the
hemodynamic resuscitation process.
OBJECTIVE. To explore the relationship between global CO2-derived
parameters and microcirculatory oxygenation, evaluated by using
near-infrared spectroscopy (NIRS).
METHODS. Observational study in a 30-bed mixed ICU. Fifty septic
shock patients within the first 24 hours of ICU admission were
studied. After restoration of mean arterial pressure, hemodynamic,
metabolic and microcirculatory parameters were simultaneously
evaluated. Local tissue oxygen saturation (StO2), and local
hemoglobin index (THI) were measured continuously on the thenar
eminence by means of near-infrared spectroscopy (InSpectraTM,
Hutchinson Tech.). A transient vascular occlusion test was per-
formed in order to obtain StO2 deoxygenation rate (DeO2), local
oxygen consumption (nirVO2), and reoxygenation rate (ReO2). Stat-
istical analysis: Three groups according to PcvaCO2 were predefined:
(1) < 6 mmHg, (2) 6–9.9 mmHg, and (3) ≥ 10 mmHg. Three groups
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 43 of 542were also predefined for PcvaCO2/CavO2: (1) < 1, (2) 1–1.8, and
(3) > 1.8. Differences among groups were assessed using the
Kruskal-Wallis test, with a post hoc Mann–Whitney analysis.
RESULTS. At inclusion, PcvaCO2 values inversely correlated with
cardiac index, while PcvaCO2/CavO2 correlated with lactate, and
ScvO2. Progressively lower DeO2, nirVO2, and ReO2 were observed
at higher PcvaCO2/CavO2 values (Fig. 41). Low PcvaCO2 values were
associated with higher StO2 and THI values, whereas no differences
in DeO2, nirVO2 and ReO2 were observed (Fig. 42).
CONCLUSIONS. In a population of early septic shock patients,
increases in the PcvaCO2/CavO2 ratio were associated with alterations
at the microcirculatory level. While PcvaCO2 was related to global and
local flow variables, the PcvaCO2/CavO2 ratio reflected tissue dysoxia
and impaired microvascular reactivity.Fig. 41 (abstract 0079). NIRS-derived parameters for the three
predefined PcvaCO2/CavO2 groups
Fig. 42 (abstract 0079). NIRS-derived parameters for the three
predefined P CO groupscva 2Fluid responsiveness
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INTRODUCTION. The goal of a fluid challenge (FC) is in fine to
increase the stroke volume (SV) or the cardiac index (CI) when an
episode of hypovolemia or a preload dependence status are
observed.Fluid challenge is one of the most common practices in
ICUs, however, the way to assess the response to FC is not
standardized.
OBJECTIVES. The present study aimed to evaluate whether the
trans-thoracic echocardiographic (TTE) assessment of the response
to FC at the end of the infusion or 20 minutes later could affect the
results of the FC.
METHODS. Prospective, observational, multicentre study including
all ICU patients in septic shock requiring a FC. Were excluded
patients with: arrhythmias, poor echogenicity and severe mitral or
aortic regurgitation. The FC was performed administering 500 mL
of crystalloids over 10 min. Fluid responsiveness was defined as a
>15% increase in stroke volume (SV). Were collected MAP, HR and
TTE variables at baseline (T0), at the end of fluid challenge (T10) and
10 (T20) and 20 minutes (T30) after the end of fluid challenge. The
following echocardiographic parameters were recorded: E wave, A
wave, E/A ratio, velocity-time integral (VTI), Ea wave and Sa wave.
Quantitative data are expressed as mean and standard deviation
(SD) or median and interquartile (IQR), according to their distribu-
tion. Qualitative data are expressed as absolute number and fre-
quency (%). Statistical analysis was performed using R software
version 3.0.2.
RESULTS. From May 20th 2014 to January 7th 2016, a total of 143
patients were enrolled in 11 French ICUs (mean age: 64 ± 14 years,
median IGS II: 53 [43–63], median SOFA score: 10 [8–12]). Among the
76/143 (53%) patients responders to FC at T10, 37 patients were
transient responders (TR), i.e. became non-responders at T30 (49%,
95%CI = [37–60]) and 39 (51%, 95%CI = [38–62])) patients were per-
sistent responders (PR), i.e. remained responders at T30. Among the
67 non-responders (NR) at T10, 4 became responders at T30, (6%,
95%CI = [1.9-15.3]). In the subgroup analysis, no statistical difference
in haemodynamic and echocardiographic parameters was found
between non-responders, transient responders and persistent re-
sponders. The present study shows that, after a 15% VTI increase at
the end of the FC, VTI returns to baseline at 30 minutes in half of the
responders. Blood volume status before initiating the fluid infusion
could explain the transient or persistent response to FC observed in
septic patients.
CONCLUSIONS. This study describes, for the first time, three different
responses to FC: non-responders, persistent responders, and transient
responders. Our results suggest that the optimal timing to assess
fluid responsiveness should be investigated in further studies.
GRANT ACKNOWLEDGMENT
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Fig. 43 (abstract 0080). a Proportion of R and NR at the end
(T10), 10 min T(20), 20 min T(30) after the FC. b VTI time course
during FC (T0 to T10) and during the 20 min after the FC (T10–T30).
R responders, NR non-responders, PR persistent responders, TR
transient responders
Table 26 (Abstract 0082). Clinical and Echocardiographic Variables
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INTRODUCTION. In clinical practice, it is frequently experienced that
hemodynamically unstable patients with hypovolemia show
underfilled and hyperdynamic right ventricle to compensate
inadequate preload on echocardiogram. Tricuspid annular plane
systolic excursion (TAPSE) is a parameter easily measured by
transthoracic echocardiogram (TTE) and indicates global RV function,
which describes apex-to-base shortening1. On the other hand, left
ventricular outflow tract velocity time integral (LVOT-VTI) directly re-
flects left ventricular stroke volume and is also easily measured by
TTE. We hypothesized that the hemodynamically unstable patients
who have fluid responsiveness show hyperdynamic right ventricle
unproportionally to low stroke volume, thus, higher TAPSE/LVOT-VTI
ratio compared to those without fluid responsiveness.
OBJECTIVES. The aim of this study is to evaluate the usefulness of
TAPSE/LVOT-VTI ratio and to find the cutoff value of TAPSE/LVOT-VTI
ratio to predict fluid responsiveness in critically ill patients.
METHODS. Patients with the clinical findings of tissue hypoperfusion
for whom the attending physicians decided to conduct rapid fluid
challenge test in the absence of contraindication for fluid infusion
were include in this study. TTE was used to obtain VTI, LVOT
diameter and TAPSE. After baseline hemodynamic measurements
were obtained, an intravenous volume expansion consisting of 500
ml colloid solution was given over 10–20 minutes. The second
hemodynamic measurements were performed within 5 minutes after
volume expansion. A responder was defined as the patients with
increase in stroke volume or cardiac output by 15% or more from
baseline after fluid challenge measured with TTE.
RESULTS. A total of 32 critically ill patients were included so far in
the intensive care unit at Tokyo Bay Urayasu/Ichikawa medical
center. Of 32 patients, 17 patients were responders and 15 patients
were non-responders. Receiver operating characteristic (ROC) curve
was generated for TAPSE(mm)/LVOT-VTI(cm) with a cut off value of
0.95 which showed sensitivity of 88%, specificity of 75% and AUC of
0.84 for fluid responsiveness (95%Cl 0.706-0.978).
CONCLUSIONS. TAPSE/LVOT-VTI ratio may be a useful parameter to
predict fluid responsiveness in critically ill patients.
REFERENCE
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INTRODUCTION. Changes in early relaxation strongly influence
diastolic function. Doppler E-wave Deceleration Time (DT) is deter-
mined by ventricular stiffness and could thus be related to diastolic
filling. Therefore, in patients with diastolic dysfunction, DT could be
related to fluid responsiveness (FR+).
OBJECTIVE. To evaluate the performance of DT during a passive leg
raising test (PLR).
METHODS. Patient with normal systolic function were enrolled to
assess fluid responsiveness using passive leg raising. DT, left
ventricular outflow tract velocity time integral (VTI), maximal E and
A wave velocity where measured by a single operator trained in
echocardiography. FR+ was defined as an increase in VTI > 10%
following PLR. Paired - T test and Student´s t test were used for
statistical analysis.
RESULTS. Twelve patients with a mean age of 68 ± 12 were
included. Five patients were on mechanical ventilation. Three
patients were fluid responsive. Baseline VTI and A-wave were lower
in responders to PLR (table).
The change in DT during PLR was −54 ± 38 (p = 0.003) in the non
responders and −22 ± 53 (p = 0.54) in responders.
CONCLUSION. DT decreases significantly in nonresponders following
a PLR possibly reflecting a higher increase in ventricular filling
pressure, even with a relatively small change in volume, compared
to responders.0083
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INTRODUCTION. The end-expiratory occlusion test (EEO) is a func-
tional hemodynamic test aiming to reveal preload dependency by
increasing venous return after interrupting cyclic ventilation at
end expiration (1). However, insofar only one study demonstrated
Table 27 (Abstract 0083). See text for description
Patients EEO1 EEO1 EEO1 EEO2 EEO2 EEO2 RASS (%)ΔCI
MOSTCARE
post FC
(%)CIΔ
TTE
post
FC
Responsiveness Status Δmax
Inspiratory
Pressure
(cmH20)
ΔCI
(%)
Status Δmax
Inspiratory
Pressure
(cmH20)
ΔCI
(%)
Non-responder Completed −21 13 Completed −18 4 0 8 6,7
Responder Completed −27 4,8 Completed −12 11 0 16,8 18
Non-responder Interrupted NA NA Completed −18 0,73 −1 3 5,5
Non-responder Interrupted NA NA Completed −29 14,4 0 4,8 4,2
Responder Completed −14 8,67 Completed −8 8,4 −2 19 18,4
Responder Completed −54 0,66 Interrupted NA NA −2 17,5 16,8
Non-responder Completed −24 5,6 Interrupted NA NA −1 3,2 4,2
Non-responder Interrupted NA NA Completed −13 3,8 0 6,8 7,4
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 45 of 542that EEO is reliable also in critically ill patients with residual spon-
taneous breathing activity (1). The respiratory effect of interrupt-
ing the inspiratory support during EEO, when diaphragmatic
activity is preserved has never been evaluated. In fact, inspiratory
efforts may alter EEO reliability by reducing pleural pressure and,
hence, increasing venous return to the right ventricle.
OBJECTIVES. Primary aim: to investigate the inspiratory efforts triggered
by EEO application in critically ill patients undergoing pressure support
ventilation (PSV). Secondary aim: to investigate EEO reliability in patients
undergoing PSV.
METHODS. We enrolled 8 patients with a Richmond Agitation
Sedation Scale ranging from −2 (light sedation) and 0 (calm) and
requiring a fluid challenge (FC). The hemodynamic effects of EEO
and FC were assessed by means of the MOSTCARETM system and
transthoracic echocardiography (TTE). Esophageal pressure (Pes)
was measured using a latex balloon-tipped catheter system, con-
nected to a pressure transducer, as previously described (2). Air-
way opening pressure, flow and Pes were displayed together with
the arterial pressure waveforms by specific data acquisition soft-
ware and a dedicated cable for interfacing the two systems (ICU-
Lab System, KleisTEK; Bari, Italy). The dynamic occlusion test was
performed to check the correct position of the balloon (2). The
EEO was performed, as previously described (1), 3 minutes after
the dynamic occlusion test (EEO1) and then repeated again after 3
minutes (EEO2). FC consisted of 500 ml infusion of crystalloids in
10 minutes. FR was defined as an increase in cardiac index ≥15%
after FC administration, measured by means of both the MostCare
and TTE. Receiving operator characteristic (ROC) was constructed
for percent changes in cardiac index (CI) and pulse pressure (PP)
induced by the EEO.
RESULTS. 33.3% of EEOs were interrupted because patient's triggering of
ventilator or cough occurrence. The mean inspiratory pressure recorded
was −21 ± 12 cmH2O, ranging from −8 to −54 cmH2O (Fig. 44). Three
patients were fluid responders (see Table 27). The ROC curves for CI and
PP of the 13 EEO tests completed were not significant (p = 0.89 and
p = 0.75, respectively).
CONCLUSIONS. In a selected population of critically ill patients
undergoing PSV, the EEO application might determine
significant variations in the inspiratory pressure, and hence,
pleural pressure. These preliminary data also suggest that EEO
reliability in lightly sedated critically ill patients undergoing PSV
is still uncertain.
REFERENCES
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INTRODUCTION. Correct assessment of a patient's volume responsiveness
is crucial for guidance of fluid therapy. Dynamic indicators of preload were
identified as most suitable parameters to predict volume responsiveness1–2.
However, so far they only have been assessed systematically from systemic
circulation, although particularly the right heart is sensitive to modifications
of either preload or afterload. Thereby it potentially represents the weakest
link in the chain when it comes to volume administration. Earlier
publications showed that that during mechanical ventilation also changes
in right ventricular stroke volume do occur3–4.
OBJECTIVES. To date no dynamic right ventricular indicators have been
established. Therefore, the aim of this study was to calculate dynamic
indicators of right ventricular preload and assess their ability to
properly predict right ventricular volume responsiveness in an
experimental model.
METHODS. The study was designed as prospective trial in 20 domestic
pigs. Animals were anaesthetized and mechanically ventilated. An
ultrasonic flow probe was fit around the pulmonary artery to enable gold
standard measurement of right ventricular stroke volume. Also a microtip
catheter was directly placed in the pulmonary artery. Hypovolaemia was
induced (withdrawal of blood 20ml/kg bodyweight) and thereafter three
volume loading steps were performed re-transfusing the shed blood. ROC
curves were calculated to assess the ability of dynamic right ventricular
parameters to predict volume response (SVVRV, PPVPA,, SPVPA).An increase
in stroke volume >15% was considered as a positive volume response.
RESULTS. ROC analysis revealed an area under the curve (AUC) of
0.82 (CI 95% 0.72-0.94; p < 0.001) for SVVRV, an AUC of 0.74 (CI 95%
0.59-0.89; p < 0.01) for PPVPA and a AUC of 0.69 (CI 95% 0.53-0.84;
p-value =0.03) for SPVPA.
CONCLUSIONS. In our experimental animal model calculation of
dynamic right ventricular indicators is possible and particularly
SVVRV and PPVPA appear promising in predicting right ventricular
volume responsiveness.
REFERENCES(S)
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INTRODUCTION. Fluid administration is a common treatment in ICU
patients affected by haemodynamic instability, in order to improve
cardiac output and finally optimize tissue perfusion.
OBJECTIVES. This study aimed to assess whether dynamic haemodynamic
parameters such as the variation in central venous pressure (D CVP) and D
systemic perfusion pressure (D PP) after a fluid challenge are reliable tools
to assess patients' fluid status.
METHODS. In this prospective, observational, monocentric trial we
enrolled patients affected by haemodynamic instability, as suggested
by common clinical parameters (HR > 120 bpm, MAP < 70 mmHg,
diuresis < 0,5 ml/Kg/h and blood lactates >4 mmol/l). Exclusion
criteria were age < 18, recent politrauma, moderate and severe left
ventricular dysfunction, hemorrhagic shock and pregnancy. At baseline
clinical characteristics were registered, as well as haemodynamic
respiratory and metabolic parameter as SAP, DAP, MAP, HR, PVC, organ
perfusion pressure (PP = MAP-PVC), data from arterial and venous
blood gas analysis, urinary output; SVI, CI and derived parameters (SVRI,
etc.) were also detected through transpulmonary thermodilutionsystem EV1000 (Edwards Lifescience©TM). Fluid responsiveness was
tested with the infusion of 500 ml of Ringer Lactate solution in 10
minutes. All measurements were repeated at the end of the fluid
bolus and the test considered positive if followed by an increasing
in CI > 12%, categorizing fluid responders (FR) and non fluid
responders (NFR) patients.
RESULTS. We enrolled fourteen patients for a total of 19 measures.
Baseline characteristics were not statistically different between FR
and NFR. The rate of fluid responsiveness was 42%. After the fluid
bolus, in the whole population MAP was significantly higher
(p = 0.049) as well as CVP (9 [4–11] vs 12 [6–14] mmHg, p < 0.001),
SVI (p = 0.014), CI (p = 0.013) and DO2I (p = 0.014) whilst VO2I, O2ERI,
and DPP were not (p = ns); SVRI decreased significantly (p = 0.04). In
FR MAP did not change significantly; otherwise, CVP increased
significantly (8 [5–10] vs 11.5 [6.4-14], p = 0.015), while it did not
change in NFR (9 [4,5-12,7] vs 12 [6–14], p = ns); SVRI decreased
significantly only in FR (2208 vs 1937, p = 0.016).Nevertheless,
DCVP was not significantly different between FR and NFR, as well
as the DPP. In FR DO2I increased significantly after the fluid bolus
(332 [235–369] vs 388 [304–488]ml/min/m2, p = 0.015) but VO2I
and O2ERI did not.
CONCLUSIONS. CVP increased significantly after fluid challenge,
particularly in FR. Moreover, both in the overall population and in
FR the increasing in CI and DO2I was not associated with a
significantly increase in VO2I and O2ERI. Therefore, the question
regarding the appropriateness of fluid expansion in critical patients
remains still open, considering the possible damage due to fluid
overload, and new prospective studies are warranted.
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INTRODUCTION. The passive leg raising (PLR) test is a reversible
and repeatable volume challenge that is used to test preload
responsiveness. During the PLR test, venous blood is transferred
from the legs and the splanchnic territories toward the cardiac
cavities, resulting in an increase in cardiac preload. Nevertheless,
intra-abdominal hypertension (IAH) may impede the PLR-induced
increase in cardiac preload by decreasing the venous return.
OBJECTIVE. We tested whether the reliability of the PLR test is
reduced in case of IAH.
PATIENTS AND METHODS. We included patients with an intra-
abdominal pressure (IAP) ≥12 mmHg. We measured the changes of
cardiac output (CO, PiCCO2 device) before and during a PLR test,
and before and after a subsequent volume expansion (500mL of
saline). A patient was defined as fluid responder if cardiac output
increased ≥ 15% during a volume expansion. IAP was measured
through the bladder pressure.
RESULTS. We included 29 patients (IAP at baseline 20 ± 5 mmHg, 20
fluid responders, 9 fluid non-responders). During PLR, IAP signifi-
cantly decreased in fluid responders (by 34 ± 13%) as well as in
fluid non-responders (by 30 ± 16%). In fluid responders, cardiac
output increased by 7 ± 9% during PLR and by 22 ± 6% during vol-
ume expansion. The PLR test was negative (PLR-induced increase in
cardiac output < 10%) in 15 patients (false negatives) and positive
in 5 patients (true positives). In fluid non-responders, the PLR test
was negative in all patients. The sensitivity and specificity of the
PLR test to detect fluid responsiveness were 25% (95% confidence
interval: 60-98%) and 89 (57–98)%, respectively (area under the re-
ceiver operating characteristics curve: 0.58 ± 0.11).
CONCLUSIONS. Intra-abdominal hypertension is responsible for false
negatives to the PLR test. The PLR test significantly reduces IAP.
Table 28 (Abstract 0088). See text for description
ΔSwave Tricuspid
Vt ≥ 8 ml/kg
ΔSwave Mitral Septum
Vt ≥ 8 ml/kg
ΔSwave Mitral Lateral
Vt ≥ 8 ml/kg
Sensitivity 80% 60% 70%
Specificity 87.5% 87.5% 87.5%
Threshold 17% 14% 14%
ΔSwave Tricuspid
Vt = 6 ml/kg
ΔSwave Mitral Septum
Vt = 6 ml/kg
ΔSwave Mitral Lateral
Vt = 6 ml/kg
Sensitivity 40% 50% 50%
Specificity 87.5% 87.5% 87.5%
Threshold 10% 11% 11%
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INTRODUCTION. A direct measurement of cardiac index is usually
needed to assess the hemodynamic effects of passive leg raising
(PLR) and fluid infusion. Nevertheless, changes in carotid and femoral
blood flow may be proportional to changes in cardiac output.
OBJECTIVES. We tested if Doppler assessment of carotid and femoral
blood flows and of their peak velocities could reflect the changes in
cardiac output during a PLR and a fluid infusion.
METHODS. In 51 critically ill patients, we performed Doppler
measurements of carotid and femoral blood flows and peak systolic
velocities, as well as calibrated pulse contour cardiac index, before
and during the PLR and before and after fluid infusion. Arterial
diameter and velocity time integral or time average velocity were
used to obtain Doppler blood flow values. If cardiac index
increased ≥10% during PLR, the patient was considered as a “PLR
responder”. Fluid infusion (500 mL saline) was performed in PLR
responders only (27 cases).
RESULTS. Considering all changes observed during PLR and fluid
infusion (n = 120), cardiac index increased by 14 ± 15%, carotid
blood flow by 15 ± 35% (n = 59) and femoral blood flow by
23 ± 36% (n = 14). No correlation was found between changes in
cardiac index and changes in carotid and femoral blood flows
(r = 0.07 and r = 0.28, respectively). In PLR responders, cardiac
index increased by 19 ± 11% (n = 27), carotid blood flow by
13 ± 38% (n = 21) and femoral blood flow by 3 ± 12% (n = 3). We
could not obtain a correct Doppler signal of the femoral artery in
38 patients. Neither the changes in carotid (area under the receiver
operating characteristics curve (AUROC): 0.58 ± 0.10) and femoral
blood flows nor the changes in their peak systolic velocities were
able to detect a positive PLR test.
CONCLUSIONS. In our hands, Doppler assessment of carotid and
femoral blood flows and of their peak velocities was not a reliable
method to assess the changes in cardiac index during a PLR or
fluid infusion.
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INTRODUCTION. The role of echocardiography in predicting fluid
responsiveness at bedside is still limited. The transesophagealechocardiography is a highly-skilled technique which was used to
evaluate the aortic blood flow increase after volume expansion (VE)1
or the respiratory changes in left ventricular outflow tract velocities
(VTI)2. Moreover, also the use of the transthoracic echocardiography
(TTE) to measure VTI is not always simply to obtain or reproduce in
ICU patients3. TTE tissue Doppler imaging (TDI) has been proposed
in different ICU setting to investigate diastolic dysfunction or false-
positive pulse pressure variation. Considering that the systolic vel-
ocity wave (S wave) is correlated to the systolic ventricular function,
we postulated that its variation during controlled mechanical venti-
lation (CMV) could be related to preload dependency.
OBJECTIVES. To assess the reliability of the dynamic variation of the
systolic tissue Doppler wave (ΔSwave) to predict fluid responsiveness
in ICU patients undergoing MCV.
METHODS. We studied 18 patients undergoing MCV requiring a VE
(500 ml of crystalloids in 10 minutes). Hemodynamic measurements
were obtained using MOSTCARETM and TTE. All the predefined
validity criteria of pulse pressure variation were respected, according
to the literature4. Study protocol consisted of 3 steps:
1) at baseline the patients were ventilated with a tidal volume (Vt)
of 6 ml/kg;
2) the Vt was increased up to at least 8 ml/kg for 5 minutes;
3) Vt was decreased to baseline values and a VE was
administrated.
At each step, S waves were recorded for tricuspid annulus, septal
and lateral mitral annulus. ΔSwave was calculated post-hoc as the
percentage change between the two highest and two lowest values
of 10 consecutive S waves recorded. ROC curves were constructed
considering a patient showing a CI increase ≥ 15% after VE as fluid-
responder.
RESULTS. 22 patients were enrolled but 4 were excluded because of
technical limitations in obtaining reliable echo images after
increasing Vt, either from tricuspid or mitral annulus. The AUCs of
PPV6 ml/kg and of PPV8 ml/kg were 0.64 (CI95 0.36-0.91) and 0.84 (CI95
0.69-1.00), respectively. The AUC of ΔSwave of the tricuspid valve
was 0.74 (CI95 0.50-0.97) and 0.91 (CI95 0.78-1.0) for a Vt of 6 and ≥ 8
ml/kg, respectively. The AUC of ΔSwave of the mitral septum annulus
was 0.81 (CI95 0.61-1.00) and 0.86 (CI95 0.69-1.02) for a Vt of 6
and ≥ 8 ml/kg, respectively. The AUC of ΔSwave of the mitral lateral
annulus was 0.78 (CI95 0.69-1.02) and 0.86 (CI95 0.69 to 1.02) for a Vt
of 6 and ≥ 8 ml/kg, respectively (see also Table 28).
CONCLUSIONS. These preliminary data show that ΔSwave could be
considered as a promising echographic measurement to predict fluid
responsiveness in ICU patients.
REFERENCES
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INTRODUCTION. Hemodynamic assessment of critically ill patients
often involves the implementation of invasive techniques such as
the placement of a central venous or a pulmonary artery catheter.
Ultrasound measurement of IVC diameter may prove to be a useful,
non-invasive alternative method of estimating volume status. Al-
though in spontaneously breathing patients IVC dimensions seem
to correlate well with CVP, data concerning mechanically ventilated
patients are inconsistent.
OBJECTIVES. The aim of this study was to investigate whether a
relationship between IVC diameter and collapsibility, CVP and pulmonary
artery pressures exists in patients under mechanical ventilation.
METHODS.We performed a post-hoc analysis of prospectively collected
data from 21 mechanically ventilated patients who were admitted to
the ICU. A pulmonary artery catheter was inserted to all patients for
hemodynamic monitoring and values of CVP, PAS, PAD, PAM were re-
corded. Ultrasound measurements of IVC diameter at end-expiration
and at end-inspiration were made using the subxiphoid approach with
the longitudinal plane for IVC imaging (GE LOGIC Q 500 ultrasound
machine) and the IVC collapsibility index (IVCI) was calculated using
the formula:
([IVCmax ‐ IVCmin]/IVCmax)X100%All measurements were made during controlled mechanical ventilation
with Vt = 8ml/kg, R-R = 12/min and PEEP = 5cmH20.
RESULTS. Data from 21 measurements were statistically analyzed
and tested for possible correlation using the Spearmans' Rho test.
Significant correlations were found between IVCI and CVP (R = −0.870,
p = 0.0001), PAS (R = −0.568, p = 0.007), PAD (R = −0.730, p = 0.0001)
and PAM (R = −0.624, p = 0.0024). IVCe was correlated with CVP
(R = +0.878, p = 0.0001), PAS (R = +0.579, p = 0.005), PAD (R = +0.650,
p = 0.001) and PAM (R = +0.548, p = 0.01).
CONCLUSIONS. Respiratory variations of IVC diameter during
mechanical ventilation seem to correlate with CVP as well as with
pulmonary artery pressures. Ultrasound measurement of IVC dimensions
and collapsibility could be a helpful tool in hemodynamic assessment in
mechanically ventilated patients.
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INTRODUCTION. Appropriate fluid supply is crucial in critically ill patients.
Parameters to predict fluid responsiveness (FR) include variabilities of the
arterial pressure curve (e.g. stroke volume variation SVV), filling pressures
(e.g. CVP) and volumes such as GEDVI. However, SVV is only applicable in
case of sinus rhythm AND controlled Ventilation. The use of GEDVI may
be limited due to an overestimation in case of femoral CVC, and filling
pressures are confounded by intraabdominal and airway pressures.
Therefore, − in case of doubt - a volume challenge VC is recommended
as a gold-standard to measure FR. However, the infused volume might
be harmful in non-responders. Therefore, passive leg raising PLR has
been suggested as a reversible auto-transfusion. Furthermore, small
VCs with a limited volume (1–3,5 mL/kg) might replace the standard
VC (usually performed with 7mL/kg).
OBJECTIVES. Regarding a lack of studies comparing all these
methods in one study, we compared the predictive capabilities of
PLR (PLR vs. semi-recumbent-position) to those of CVP, GEDVI with
and without correction for femoral CVC (1), ScvO2 and a small VC (SVC)
with 3.5mL/kg to a conventional VC with 7mL/kg saline over 30min.
METHODS. 34 VCs with 7mL/kg in 27 patients (11f; 16m) were
performed. APACHE-II 22 ± 6. Ventilation: spontaneous 16, assisted
16, controlled 2 patients. CVC jugular 2in 6, femoral in 8 patients.
Transpulmonary thermodilution TPTD was performed before PLR, 5
min after PLR immediately before the VC (TPTD_2), after 15min with
infusion of 3.5mL/kg (TPTD_3) and at the end of the VC (TPTD_4).
Pulse contour (PC) derived parameters such as CI_PC were documented
at intervals of 15s during the PLR and of 5min during the VC.
RESULTS. FR defined as an increase in CI_TPTD_4 of 15% compared
to CI_TPTD_1 (primary endpoint) was significantly predicted by a small
volume challenge (ROC-AUC = 0.837; p = 0.009), GEDVI corrected for
femoral CVC site (ROC-AUC = 0.905; p = 0.002) and ScvO2 (ROC-
AUC = 0.772; p = 0.034). By contrast, CVP (ROC-AUC = 0.673; p = 0.176)
and percentage changes in CI-PC induced by a 120s PLR (ROC-
AUC = 0.619; p = 0.353) were not predictive. Furthermore, GEDV not
corrected for femoral CVC site slightly failed significance (ROC-
AUC = 0,732; p = 0.057). Furthermore, different other read-outs of PLR
such as maximum change in CI_PC during PLR (AUC = 0.551; p = 0.691)
as well as changes in CI_PC after 30s (0.626; p = 0.326), 60s (0.667;
p = 194) and 90s (0.578; p = 0.542) were not predictive for FR.
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 49 of 542Finally, changes in CI_PC 10 minutes (AUC = 0.619; p = 0.353) and 15
minutes (AUC = 0.633; p = 0.301) after start of the small VC did not
predict FR.
CONCLUSIONS.
1.) Small VC, ScvO2 and GEDVI corrected for femoral CVC predicted
FR, whereas PLR and CVP were not predictive.
2.) The predictive capacities of GEDVI were substantially improved by
correction for femoral CVC.
3.) CI_TPTD_3 after 15min of a SVC was superior to CI_PC_15min.
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INTRODUCTION. Passive leg raising (PLR) represents a self-volume
challenge that could predict fluid responsiveness with less limitation
than other methods such as variation of stroke volume and pulse
pressure variation.
OBJECTIVE. To assess the ability of PLR to predict fluid responsiveness
after cardiac surgery.
METHODS. At the moment of intervention, all patients were intubated
on mechanical ventilation (tidal volume 6 ml/kg) and were sedated
with 50 mg fentanyl bolus and received 10 mg cisatracurium before
the protocol started. Exclusion criteria were LVEF < 40%, significant
arrhythmias, active bleeding, norepinephrine dose > 0,5 μg/kg/min,
renal dysfunction and peripheral vascular disease involving femoral
arteries. The decision to perform a fluid challenge was defined based
on the presence of at least one sign of inadequate tissue perfusion:
systolic blood pressure < 90 mmHg or need of vasopressors use,
lactate ≥ 3mmol/L, cardiac index(CI) ≤ 2,5 L/min/m2, ΔCO2 ≥ 6mmHg.
Four consecutive data sets were recorded: at baseline in the 45° semi-
recumbent position; after 60s of PLR; at return to baseline in the 45°
semi-recumbent position; and 10 min after fluid loading (Albumin 4%
500 ml over 10 min).The ventilator settings and vasoactive drugs
remained unchanged during the study. The positive response was de-
fined as an increase in CI of at least 10% after fluid challenge.
RESULTS. A total of 70 patients who underwent coronary artery bypass
grafting were included. Fifty-five (75.6%) patients had an increase in
CI ≥ 10% after fluid expansion and were classified as responders.
Fifteen (21.4%) patients were non-responders. No difference was ob-
served between both groups regarding baseline characteristics: mean
age (63 ± 8 vs 66 ± 7 years, p = 0.184), BMI (kg/m2) (28 ± 4 vs 27 ± 4,
p = 0.324), mean EuroSCORE [2 (1–3) vs 2 (1–3) p = 0,692] and mean
LVEF [58% (49–63) vs 62% (54–66) p = 0.188]. Haemodynamic data at
baseline were similar between the groups: mean arterial pressure
(88 ± 15 vs 89 ± 21, p = 0.795), heart rate (100 ± 15 vs 106 ± 14,
p = 0.234), stroke volume (50 ± 20 vs 51 ± 18, p = 0.922), stroke volume
variation (18 ± 7 vs. 16 ± 7, p = 0.342) and central venous pressure [10
(7–17) vs 8 (5–13), p = 0.199]. Change in CI of 10% in response to PLR
predicted volume responsiveness with a specificity of 89% (95% CI,
0.77 -0.95) and sensitivity of 27% (95% CI, 0.09 - 0.55).
CONCLUSIONS. The increase ≥ 10% in CI induced by PRL predicted
fluid responsiveness with low sensitivity and high specificity after
cardiac surgery. Further studies are needed to determine the better use
of PRL as a noninvasive parameter to predict fluid responsiveness and
guide therapy.
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INTRODUCTION. Bioreactance is a non-invasive method for cardiac
output (CO) monitoring based on the measurement phase shift in
voltage of an oscillating current that occurs when this crosses the
thorax. We previously reported that the technique was inaccurate to
assess the changes in CO during a passive leg raising (PLR) test (1).
OBJECTIVES. In the present study, we tested if a bioreactance device
Starling® (Cheetah Medical, Portland, US) that had been modified to
average CO on a shorter period could track the changes in CO during
PLR and predict fluid responsiveness.
METHODS. In critically ill patients fitted with a PiCCO2 device, we set
up a Starling device that had been modified for averaging cardiac
index (CI) over 8 sec. only (noncommercial version). We recorded CI
measured by PiCCO and by Starling devices before and during a PLR
test and before and after a volume expansion (500mL of saline
during 10 minutes).
RESULTS. We included 26 patients were included in the study in
which 38 PLR tests and 14 volume expansions were performed.
Shock was related to sepsis in 65% of the patients, 73% of patients
received norepinephrine [0.17 (0.09-0.32) mcg/kg/min]. Ninety six
percent of the patients were sedated and under mechanical
ventilation. When considering all pairs of CI measurements
performed by PiCCO with transpulmonary thermodilution and by
Starling (n = 90), the bias was 0.08 L.min-1.m-2. The limits of
agreement (LOA) were −1.86 and 2.01 L.min-1.m-2 (percentage error:
60%). When considering the changes in CI induced by PLR and
volume expansion (n = 52), the polar plot had a mean polar angle of
−14.4° and LOA of −48.8° to 20.1° (exclusion zone: 0.5 L/min). The
concordance rate was 80% between 30° and −30°. The PLR test was
positive (increase in CI ≥10%) in 14 “preload responsive” cases. The
Starling device detected a positive PLR test with a sensitivity of 87
(60–98)% and a specificity of 74 (52–90)% (area under the receiver
operating characteristics curve: 0.77 (0.60-0.94).
CONCLUSIONS. A version of the Starling device modified for
averaging CO on 8 sec detected the effects of PLR with acceptable
accuracy in ICU patients.
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restoration in the paediatric critically ill is challenging. Static and
dynamic indexes of preload commonly used have been demonstrated
not as accurate as in the adult population[1].
Recently, Guytonian approaches to the circulation have been
proposed in order to better understand the response to fluid
resuscitation in the critically ill and to better target volume
expansion in septic shock patients according to guidelines [2].
OBJECTIVES. In order to provide a pathophysiological explanation of
fluid responsiveness, we measured Pmsa, an analogue of the mean
systemic filling pressure in 4 septic shock paediatric patients.
METHODS. Patients, (age 3+/− 4 years, height 97 +/− 39 cm, weight
20 +/− 19 kg) invasively ventilated in the intensive care unit,
received 15 to 20 ml/kg as volume expansion (VE) in 30' and fluid
responders (FR) were defined as the ones who increased CO by
more than 20% as measured using MostCare®(PRAM).
SVV and PeakDeltaVTI as dynamic preload variables were also
recorded.
Pvr, venous return driving pressure (Pvr = Pmsa-CVP) and heart
performance (Eh = Pvr/Pmsa) were also calculated as previously
reported [3].
RESULTS. As expected all patients increased Pmsa after VE
increased both in FR and non FR, Pvr increased significantly in FR
(50.6% +/− 7.9% vs 1.6% +/− 10.9% p = 0.001) and Eh decreased
significantly in non FR (34.9% +/− 22.2%) while increased in FR
(14.4% +/− 4.4%) p = 0.006.
Pvr, was considered a good predictor of FR as it was significantly
less in FR (4.03 mmHg +/− 0.3mmHg) vs non FR (4.55 mmHg +/−
0.27 mmHg).
ROC analysis demonstrated a sensitivity and specificity of 100% in
detecting FR for values of Pvr < 4.15 mmHg. PeakDelta VTI and
SVV% were not able to predict FR vs not FR.
CONCLUSIONS. Guytonian approach to the circulation in paediatric
septic shock is feasible and might provide better insights in order to
address therapies able to restore hemodynamic derangement.
Further studies are needed to confirm this preliminary results.
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INTRODUCTION. Pressure recording analytical method (PRAM) has
been shown to estimate cardiac output (CO) with a good level of
agreement with transthoracic echocardiography (TTE) under static
conditions.
OBJECTIVES. This study aims to assess the agreement between the
CO measured by PRAM and TTE before and after the passive leg
raise (PLR) maneuver.
METHOD. This is a prospective observational study in critically ill
patients. All patients were monitored with MostcareUp/PRAM (Vygon,
Vytech, Padova, Italy). TTE was used to calculate CO before and after
PLR. Cardiac index (CI) values and percent changes in CI values in
response to PLR were recorded for the two methods. Compared withthe baseline, patients who had an increase in CI that was greater than
10% were accepted as fluid responders (FR).
RESULTS. Data of a total of 25 patients were collected. The mean CI
values that were calculated by TTE before and after PLR were
2.68 ± 0.91 L/min/m2 and 3.05 ± 0.98 L/min/m2, respectively. The
mean CI values that were calculated by PRAM before and after PLR
were 2.64 ± 0.81 L/min/m2 and 2.83 ± 1.03 L/min/m2, respectively.
There was significant correlations between the measured CI values
both by TTE and PRAM before and after PLR (r = 0.635, p = 0.001
and r = 0.610, p = 0.001, respectively).The mean percent changes in
CI with TTE and PRAM were 0.18 ± 0.28 and 0.08 ± 0.21, respectively.
Sixteen patients were determined as FR by TTE (64%) and 13
patients were determined as FR by PRAM (52%). The Kappa test
showed that there was a moderate agreement between TTE and
PRAM for predicting fluid responsiveness (k = 0.595; p = 0.002). The
mean biases between the CI values measured by TTE and PRAM
before and after PLR were 0.04 ± 0.77 L/min/m2 and 0.22 ± 0.88 L/
min/m2, respectively.
CONCLUSIONS. This study showed a statistically significant
correlation for CI values measured both by TTE and PRAM. For
predicting fluid responsiveness there was agreement between the
two methods after PLR. Further studies with larger numbers of
patients are needed to assess the agreement of the two methods for
predicting fluid responsiveness.
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INTRODUCTION. The extent of renal dysfunction amongst acute
kidney injury (AKI) survivors is unknown because structured follow-
up is rarely performed. Serum creatinine decrease during prolonged
ICU stay due to loss of muscle mass confounds it as a renal function
marker1. Cystatin C may be a superior marker in critical illness. How
long the catabolic state continues and whether creatinine can be
used in the recovery period is unclear. Do creatinine and cystatin C
give similar estimates of glomerular filtration rate (GFR) in the recov-
ery period?
OBJECTIVES. To quantify the renal function of AKI survivors at 2–7
months using creatinine and cystatin C to estimate GFR. Identify ICU
parameters which best predict AKI survivors renal function at 2-
7months. To compare estimates of GFR using creatinine and cystatin
C obtained a subgroup at 9 months when GFR was also measured
using iohexal.
METHODS. Prospective cohort of AKI patients (RIFLE criteria)
admitted to a mixed ICU during the September 2008 to May 2011.
Patients were recruited at discharge and those under 18 and over
100 were excluded, as were subjects who died during the 3 months
following discharge. Serum Creatinine and Cystatin C measurements
were taken at 3 months. A sub-selection of patients with persisting
renal dysfunction at first-follow-up were invited to return for a sec-
ond 9-month visit, where, in addition to serum Creatinine and Cysta-
tin C, GFR was measured using Iohexal clearance technique.
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 51 of 542RESULTS. 358 AKI patients were included, of these 21 died before
first follow-up and 44 were lost to follow-up; 293 remained. Only pa-
tients with first follow-up between 2 and 7 months (269) were in-
cluded in analysis. Mean creatinine levels at follow up were (94.4
umol/L) and were linearly associated with maximum RIFLE grade in
the ICU. Mean estimated GFR (eGFR) was 73.7 mL/min/1.73m2 using
the Lund Malmo formula. Close to a third, 32.4% of AKI patients, had
creatinine eGFR under 60 mL/min/1.73m2 at follow up. Multivariate
analysis found that discharge creatinine, maximum ICU cystatin C
and baseline creatinine were predictive of creatinine levels at first
follow-up. Mean cystatin C level at first follow up were 1.55 (mg/l)
and was linearly associated with maximum RIFLE during admission.
Mean cystatin C eGFR was 54.1 mL/min/1.73m2 ; 65.9% patients had
cystatin C eGFR under 60 at follow up. Multivariate analysis identified
discharge cystatin C, age and baseline creatinine as covariates associ-
ated with cystatin C at first follow-up. At second follow-up (N = 25)
mean eGFR was 63.9, 47.4 for creatinine and cystatin C and 57.3 mL/
min/1.73m2 for iohexal measured GFR.
CONCLUSIONS. Fewer patients had an eGFR under 60 at follow-up
using serum creatinine than with cystatin C at first follow up. In a
small sub-group with an additional follow-up, cystatin C underesti-
mated and creatinine overestimated GFR compared to iohexol mea-
sured GFR.
REFERENCE
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INTRODUCTION. Hypernatremia has been traditionally associated to
fluid deficits and increased sodium load and treated by replacement
of free water. However recent studies have challenged this
assumption, putting more emphasis on the role of sodium excretion
by the kidneys. Furthermore, a cumulative positive fluid balance has
been associated to worse outcomes and may be a surrogate marker
of increased water and electrolyte load and of the kidney capacity to
effectively handle it. (1–3).
OBJECTIVES. Our aim was to analyze the association between fluid
balance and hypernatremia correction in a population of
hypernatremic critically ill patients.
METHODS. Unicentric, prospective, observational study of critically ill
patients with hypernatremia (defined as serum sodium greater than
145 mEq/l). Patients with chronic kidney injury or in palliative care
were excluded. Patients were categorized in two groups according to
the fluid balance after the hypernatremia diagnosis: positive
cumulative fluid balance (FB+) and negative cumulative fluid balance
(FB-). The patients were followed up daily to sodium correction or
ICU discharge. Clinical outcomes were evaluated at hospital
discharge. The association between fluid balance and hypernatremia
was evaluated by a Cox regression analysis.
RESULTS. During 7 months, 103 hypernatremic critically ill patients
were evaluated. Median (IQR) cumulative fluid balance was 3929
(1527–6945) ml in FB+ patients and −2729 (−4094- -1580) in FB-
patients. There was no difference between FB+ and FB- patients in
mean age (69.5 vs 68.2 years), SAPS3 (56 vs 53) or median serumsodium before hypernatremia development (142 vs 142 mEq/l).
Median (IQR) time for correction of hypernatremia was 3 (2–4) days
for FB+ patients and 1 (1–2) days for FB- patients, p < 0.001. After
adjustment for utilization of hypotonic fluids, acute kidney injury,
utilization of thiazide diuretics and diuresis, a positive cumulative
fluid balance was associated with a lower chance of correction of
hypernatremia [HR (95%CI) = 0.38 (0.19-0.74), p = 0.005).
CONCLUSIONS. Positive fluid balance was associated with increased
time for correction of hypernatremia in critically ill patients. The
mechanisms of this association and whether therapies that target
hypernatremia without increasing fluid balance are benefic should
be evaluated in further studies.
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INTRODUCTION. Deterioration of kidney function in critically ill
patients is of important concern, as it is an early indicator of multi
organ failure and is independently associated with adverse outcome.
Diagnosis of acute kidney injury (AKI) is currently hampered by the
lack of accurate markers to assess kidney function. Conventional
creatinine-based methods to assess glomerular fitration rate (GFR)
are known to be insensitive, late, and inaccurate. Plasma clearance of
iohexol, an iodine contrast agent that is exclusively filtrated in the
glomerulus, has been shown to be equally accurate in determining
the GFR as inulin clearance, the current gold standard. Nevertheless,
iohexol is not used in clinical practice as it is time-consuming and its
determination is laboursome. A promising novel candidate to assess
kidney function is plasma proenkephalin, a stable endogenous opioid
precursor.
OBJECTIVE. To determine to what extent the plasma proenkephalin
concentration reflects the GFR in sepsis patients.
METHODS. In this prospective pilot study, we included 24 septic
patients admitted to our Intensive Care Unit. All patients received an
intravenous bolus of 1 mL iohexol. During the subsequent 6-hour
window, blood was sampled 4 times to determine the 'true GFR'
using a mathematical reconstruction of the iohexol disappearance
curve. The two most frequently used creatinine-based methods, the
endogenous creatinine clearance (ECC) and the Modification of Diet
in Renal Disease (MDRD), were assessed according clinical standards.
Urine was collected cumulatively over the same 6-hour period and
the plasma proenkephalin concentration was determined using a
Sphincotec ELISA.
RESULTS. Patients had a median [IQR] iohexol GFR of 45 [15–75] ml/
min. Both the MDRD and ECC overestimated this true GFR
(bias ± SD) with 14% ± 40 and 30% ± 47, respectively. Using the
MDRD or ECC would have resulted in misclassification of renal
function in 6 (25%) and 8 (33%) patients, respectively. In contrary to
these conventional methods, proenkephalin correlated strongly with
the iohexol GFR (r2 = 0.91; p < 0.001, Fig. 47).
CONCLUSION. Our study underlines the inaccuracy of conventional
creatinine-based methods to assess GFR, which leads to frequent
misclassification of renal function. The pilot results indicate that a
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 52 of 542single measurement of plasma proenkephalin strongly correlates
with the true GFR in sepsis patients. Therefore, plasma proenkephalin
may serve as a more feasible marker to assess kidney function in the
critically ill. Results need to be confirmed in larger cohorts and other
patient groups.Fig. 47 (abstract 0097). See text for description0098
Combined assessment of lactate and glucose early after ICU
admission and its relation with acute kidney injury
P. Freire Jorge, N. Wieringa, E. de Felice, I.C. van der Horst, A. Oude
Lansink, M.W. Nijsten
University Medical Center Groningen, Critical Care, Groningen,
Netherlands
Correspondence: P. Freire Jorge
Intensive Care Medicine Experimental 2017, 5(Suppl 2):0098
INTRODUCTION. In critically ill patients elevated lactate levels in the
presence of an inappropriately low glucose levels can be a sign of
impaired gluconeogenesis. The kidney is an important
gluconeogenetic organ and therefore subtle derangements of lactate
and glucose levels may anticipate and accompany the development
of acute kidney injury (AKI).
OBJECTIVES. Examine the relation between early lactate and glucose
levels after ICU admission and the development of AKI.
METHODS. We retrospectively analyzed all admissions to our 48-bed
teaching hospital ICU from 2011 to 2014. Measurements of lactates
and glucoses were regularly performed with point-of-care analyzers.
We collected lactate and glucoses 6 hours before to 24 hours after
ICU admission. Patients with ICU length of stay of less than 12 hours
or with less than 4 lactate and glucose measurements were ex-
cluded. Mean lactate, glucose, and glucose squared were then
grouped into quintiles. The outcome was the subsequent develop-
ment of AKI grade 1 to 3 in the first 7 days after ICU admission.
RESULTS. We analyzed 92,000 blood samples from 9,074 patients
with a mean age of 61 ± 15 years, 63% males, with an AKI incidence
of 21% (AKI-grade 1, 2 and 3: respectively 10%, 4% 7%) and a
hospital mortality of 11%. Lactate quintiles (≤1.0;1.0-1.3;1.3-1.7;1.7-
2.3;>2.3 mmol/L) and glucose quintiles (≤7.0; 7.0-7.6; 7.6-8.2; 8.2-
9.0;>9.0 mmol/L) were both univariately and positively related with
AKI (p < 0.001). Glucose showed a U-shape relation with AKI and the
combination of the highest lactate quintile with the lowest glucose
quintile showed the highest AKI incidence. In multivariate regression
analysis with APACHE-IV as fixed covariate lactate, glucose, and glu-
cose squared were all significantly associated with AKI (p < 0.001).CONCLUSIONS. The kidney is an important gluconeogenetic organ
and the development of AKI may be preceded by derangements of
gluconeogenesis. A 'normal' glucose in critically ill patients with
elevated lactate should not be considered normal, as this points to
an inability to (re)generate sufficient glucose under stress.
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INTRODUCTION. Obesity plays an important role in increasing the
risks of cardiovascular diseases, kidney injury, metabolic diseases and
death. There is persistent concern about the influence of the degree
of obesity on mortality and morbidity in severe acute pancreatitis
(SAP) patients. There is inconsistent correlation between BMI and
outcome in SAP patients. BMI is the basic method used to determine
obesity, and world health organization (WHO) classifies it as follows:
Normal weight 18.5 to 24.9 Kg/m2, overweight 25 to 29.9 Kg/m2,
obesity grade I 30 to 34.9 Kg/m2, obesity grade II of 35 to 39.9 Kg/
m2 and obesity grade III >40 Kg/m2.
OBJECTIVES. Estimate the relationship between BMI and the
development of acute renal injury (AKI), as well as on mortality in
severe acute pancreatitis patients admitted to an tertiary level
hospital intensive care unit (ICU) in Mexico City.
METHODS. Observational, retrospective study performed between
the period of 2012 to 2015, involving SAP patients. Anthropometric
characteristics were analyzed by BMI and its association with the
development of acute kidney injury (AKI) and mortality. The obtained
data were evaluated through a T-test analysis for independent samples.
RESULTS. 54 patients were analyzed, 36 males and 18 females. 16.67%
with normal weight, 33.33% with overweight, 33.33% with degree I
obesity, 12.96% with degree II obesity and 3.70% with degree III obesity.
The analysis observed an overall mortality of 31.4% and presence of
acute renal injury of 61.1%. The group analysis by Student´s t test
showed a mean BMI of 29.52 kg / m2 in patients survivors and 31.73 kg /
m2 in non survivors, with p = 0.169. On the other hand, the mean BMI
that was associated with AKI were 30.15 kg / m2 and 30.33 kg / m2 in
those without AKI, with p = 0.908. The analysis of variance of degrees of
BMI and survival show the sum of the square = 11.64, 4 degrees of
freedom intergroups and 49 intragroups, through F test we obtain
F = 1.2679 and a critical value for F = 2.5611, and p = 0.2952, so there is
no variation in the 5 degress of BMI in relation to survival.
CONCLUSIONS. In this study we did not found a significant
association between body mass index and the development of acute
renal injury nor prognostic information of mortality in severe acute
pancreatitis patients. Obesity is now considered a risk factor for the
development of multiple diseases, so additional studies, with a larger
sample size, are necessary to evaluate other variables that influence
the prognosis of severe acute pancreatitis.
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Table 29 (Abstract 101). Association between preoperative factors
and AKI
Patients with
AKI, n=19
Patients without
AKI, n=31
p
Age > 60, n (%) 2 (11) 10 (32) 0.10
High blood pressure, n (%) 8(42) 5 (16) 0.05
Diabete mellitus, n (%) 2 (11) 4 (13) 1
Left Ventricular Ejection Fraction <
60%, n (%)
7 (37) 11 (35) 0.92
Moderate to severe pulmonary
hypertension, n (%)
10 (53) 16 (52) 0.94
Male gender, n (%) 11 (58) 19 (61) 0.81
BMI > 24.9 kg/m2, n (%) 11 (58) 11 (35) 0.12
COPD, n (%) 7 (37) 8(26) 0.41
Pulmonary fibrosis, n (%) 5 (26) 12 (39) 0.37
Table 30 (Abstract 101). Association between intraoperative factors
and AKI
Patients with
AKI, n=19
Patients without
AKI, n=31
p
Single lung transplantation, n (%) 4 (21) 12(39) 0.19
ASA score > 3, n (%) 10 (53) 10 (32) 0.15
ECMO support, n (%) 16 (84) 26 (84) 1
Intraoperative catecholamines, n (%) 14 (74) 26 (84) 0.47
Norepinephrine > 2.5 mg/h or
epinephrine, n (%)
4 (21) 10 (32) 0.52
Fluid administration > 30 mL/Kg, n (%) 16 (84) 26 (84) 1
Red blood cell transfusion, n (%) 17 (89) 18 (58) 0.026
Fresh frozen plasma transfusion, n (%) 13 (68) 13 (42) 0.07
Platelet transfusion, n(%) 9 (47) 4 (13) 0.018
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 53 of 542INTRODUCTION. The concept of postintensive care syndrome has
recently been suggested. Although several epidemiological studies
suggested that acute kidney injury (AKI) in ICUs increases the risk of
chronic kidney disease (CKD) development and progression, it is still
unclear whether any AKI biomarker can predict long-term renal out-
comes in ICU survivors.
OBJECTIVES. This study was undertaken to evaluate the possible role
of urinary biomarkers for long-term renal outcome prediction after
ICU discharge.
METHODS. We conducted a retrospective observational study
examining 495 adult patients who had been admitted to the ICU of
the University of Tokyo Hospital. Major adverse kidney events
(MAKE): death, incident end-stage renal disease, and halving of esti-
mated glomerular filtration rate (eGFR), at hospital discharge and
long-term renal outcomes of 30% reduction of eGFR or incident end-
stage renal disease were evaluated.
RESULTS. Among all the enrolled 495 patients, 393 patients
discharged from the hospital without MAKE. Of them, data of eGFR
up two years after ICU discharge was available in 173 patients and
63 patients (36.4%) were positive for long-term renal outcomes. A
step-wise logistic regression analysis demonstrated that male sex
and urinary neutrophil gelatinase-associated lipocalin (NGAL)
measured at ICU admission showed significant associations with
long-term renal outcomes. Receiver operating characteristic curve
analysis showed the area under the curve of 0.66 (95% confidence
interval 0.57-0.74) for prediction of long-term renal outcome by
urinary NGAL.
CONCLUSIONS. Urinary NGAL measured at ICU admission was
significantly associated with long-term renal outcomes after hos-
pital discharge in MAKE-free ICU survivors. Measurement of urinary
NGAL at ICU may be useful to identify a high risk population of kid-
ney disease progression after intensive care.
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INTRODUCTION. Acute kidney injury (AKI) is common after lung
transplantation (LT) and is associated with increased short-term and
long-term mortality, and increased long-term renal morbidity (1).
OBJECTIVES. Our primary goal was to assess the pre-operative, intra-
operative and post-operative factors associated with AKI in the early
post-operative period during ICU stay after LT. Secondary aims were
to examine the incidence of post-operative AKI in our cohort and to
evaluate its impact on the outcome.
METHODS. This was an observational, retrospective, monocentric
study. AKI was defined as a ≥50% increase of serum creatinine
from baseline or renal replacement therapy (RRT). AKI events were
staged using the KDIGO criteria. Follow-up period was length of
hospitalization in ICU. Results are expressed as medians, interquar-
tile range, absolute numbers and percentages. Statistical analyses
were performed using Chi squared and Fischer's exact tests
(p < 0.05 as significance).
RESULTS. Between January 2016 and March 2017, 50 patients (pts)
(60% men, median age 55 [49–49]) underwent LT (68% bilateral LT)
in our institution. Most common diagnoses leading to LT were
pulmonary fibrosis (34%) and COPD (30%). Median ICU length of stay
was 14 days [9–23]. Intraoperative support by extra-corporealmembrane oxygenation (ECMO) was required for 42 pts (84%). Mor-
tality rate at day 28 was 14%. AKI occurred during ICU stay in 19 pts
(37%). According to the KDIGO criteria, Stage 1 AKI was observed in
3 pts (6%), Stage 2 in 3 pts (6%), and Stage 3 in 11 pts (22%) includ-
ing 9 pts (18%) who required RRT. AKI occurred before day-5 after
surgery in 15 pts (79%) or later in 4 pts (21%). There was no signifi-
cant association between AKI and preoperative comorbidities. AKI
was significantly associated with red blood cells and platelets trans-
fusion during surgery (p = 0.026 and p = 0.018, respectively), stage 3
primary graft dysfunction (PGD) (p = 0.043), occurrence of a septic
choc during ICU stay (p = 0.001), mechanical ventilation >7 days
(p = 0.045), and extubation failure (p = 0.026). ICU mortality and at
day-28 were significantly associated with AKI (p = 0.001 and
p = 0.009, respectively). ICU mortality was significantly associated
with the use of RRT (p = 0.0004).
CONCLUSIONS. Incidence of post-operative AKI is high after LT. Intra-
operative blood and/or platelet transfusion, occurrence of a stage 3
PGD, or of a septic shock were significantly associated with AKI. Iden-
tification of patients at high risk of AKI in post-operative period could
encourage physicians to adopt prevention strategies, such as avoid-
ing most nephrotoxic immunosuppressive therapies.
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Table 31 (Abstract 101). Association between postoperative factors
and AKI
Patients with
AKI, n=19
Patients without
AKI, n=31
p
Catecholamines > 3 days, n(%) 11 (58) 15 (48) 0.51
Stage 3 primary graft dysfunction, n (%) 11 (58) 9 (29) 0.043
Acute rejection, n (%) 6 (32) 7 (23) 0.71
Pneumonia in ICU, n (%) 15 (79) 24 (77) 0.82
Septic shock, n (%) 9 (47) 2 (6) 0.001
Extubation failure, n (%) 3 (21) 0 (0) 0.026
Mechanical ventilation > 7 days, n (%) 8 (42) 4 (13) 0.045
Mortality in ICU, n (%) 8 (42) 1 (3) 0.001
Mortality at day 28, n (%) 6 (32) 1 (3) 0.009
Table 32 (Abstract 0103). Respiratory dysfunction in septic shock
Group 1, 35ml/Kg/h, n=52 Group 2, 55ml/Kg/h, n=50
Variables Media (IC95%) Media (IC95%)
PaO2/FiO2>200 165 (140-190) 153 (125-181)
Mechanical Ventilation n=52, 100% n=50, 100%
Group 1= HFVVCHV =
Hemofiltration veno-venous
continouos high volume
Group 2=HFVVCVHV=
Hemofiltration veno-venous
continouos very high volume
Table 33 (Abstract 0103). Respiratory quotient changes and HFVVC
Variables Group 1: 35 ml/Kg/h,
N=52; P50 (P25-P75)
Group 2: 55 ml/
Kg/h, N=50
Total, N=102
*PaO2/FIO2, ICU
Admission
154 (83-230) 144 (77-187) 146 (79-207)
PaO2/FIO2, 24 h 187 (132-250) 160 (108-244) 180 (115-246)
*PaO2/FIO2, 48 h 241 (187-298) 151 (196-268) 225 (167-282)
*PaO2/FIO2, 72 h 271 (220-322) 250 (180-289) 265 (211-302)
*PaO2/FIO2, 96 h 310 (258-283) 276 (207-318) 295 (240-350)
PaO2/FIO2 96 h- ICU
Admission
160 (81-234) 120 (28-207) 142 (59-220)
Mechanical
Ventilation, days
7 (4-12) 9 (4.7-18) 8 (4-16)
ICU: Intensive care
Unit
Group 1: 35 ml/Kg/h.
HFVVCHV:
Hemofiltration
veno-venous
continouos high
volume
Group 2: 55 ml/Kg/h
HFVVCVHV:
Hemofiltration
veno-venous
continouos very
high volume
PaO2/FiO2:
respiratory quotient
*U de Mann-Whitney, p=<0,05
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INTRODUCTION. Acute kidney injury (AKI) is a common complication
after cardiac surgery and is associated with significant morbidity and
mortality. Near infrared technology (NIRS) is a non-invasive and real-time
method to measure both cerebral and regional tissue oxygenation.
OBJECTIVES. The purpose of the present study was to evaluate a
correlation between cerebral SO2 measured intraoperatively and continued
for at least 24 hours postoperatively and AKI in cardiac surgical patients.
METHODS. We retrospectively analysed the prospectively collected
data of 45 adult patients who underwent isolated coronary artery
bypass graft surgery (CABG) with normal renal function (baseline
serum creatinine value < 1.4mg/dL) from January 2014 to May 2014.
Kidney injury was interpreted according to Acute Kidney Injury
Network (AKIN) criterias Cerebral oximetry was measured at different
time points intraoperatively and the first 24 hours postoperatively.
RESULTS. Postoperative AKI occured in 12 (26%) patients. Baseline
cerebral SO2 values were significantly decreased 2 and 6 hours after
cardiopulmonary bypass (CPB). Cerebral SO2 values were significantly
lower in AKI patients compaired to nonAKI patients.
CONCLUSION. This retrospective study shows that lower cerebral SO2
values are correlated with AKI after CABG. We suggest that specific
tissue NIRS measurements in addition to cerebral oximetry are not
necessary and cerebral oximetry alone well predicts postoperative AKI.
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Intensive Care Medicine Experimental 2017, 5(Suppl 2):0103INTRODUCTION. Refractory septic shock mortality is about 50%. In
the early phase of septic shock, hemofiltration can attenuate the
inflammatory cascade, alleviating cell and tissue damage in the lungs
and reducing the mortality due to multiple-organ failure syndrome
OBJECTIVES. In patients with refractory septic shock Hemofiltration
Veno-Venous Continuous High Volume (HFVVCHV, 35 ml / kgr / h) or
Hemofiltration Veno-Venous Continuous Very High Volume (HFVVCVHV,
55 ml / kgr / h) improve pulmonary function (PaO2/FiO2) during the
first 96 hours Intensive Care Unit (ICU) admission
METHODS. 102 refractory septic shock patients, with or without renal
dysfunction and consecutively admitted to the ICU, were treated
with early resuscitation and support bundles, according Surviving
Sepsis Campaign (SSC) 2012, and 36 hours septic shock onset
randomly assigned to group 1 (35 ml / kg / h) or group 2 (55 ml / kg /
h). The variables studied were hemodynamic parameters, vasoactive
drug parameters (dose and time of norepinephrine and hourly fluid
intake), pulmonary (PaO2/FiO2), and renal function.
RESULTS. IIn both groups the paO2/FiO2 improve at 96 hours septic
shock onset, higher in group 1 (100%) than group 1 (54%). The average of
the respiratory quotient in both groups showed signs of Acute Distress
Respiratory Syndrome (ADRS) with PaO2/FiO2 > 200. 100% of patients
had needed Mechanical Ventilation to the admission in UCI. The evolution
of quotient PAO2/FIO2 after 96 hours of the showed a progressive
improvement. These differences between periods of time are significant at
48 hours, being superior in group 1 respect to group 2, as well as the
duration in days of mechanical ventilation (P50). Tables 32 and 33.
Intensive care Unit (ICU) mortality in the series of patients globally
was 19%, higher percentage in group 1 (23%) than in group 2 (16%).
Hospital mortality showed an increase of 8 points.
CONCLUSIONS. In refractory septic shock patients, after the SSC
measures correctly applied in time, an early horizontal treatment with
HFVVCHV and HFVVCVHV improve the pulmonary function (paO2/FiO2)
and prognosis.
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INTRODUCTION. Microcirculatory slow flow combined with plugged
capillaries is a hallmark of sepsis-induced AKI. We developed a new
measurement technique using dynamic contrast-enhanced ultra-
sound (CEUS) to identify these microcirculatory alterations in con-
junction with laser speckle imaging (LSI).
OBJECTIVES. To use CEUS imaging to investigate microbubble
kinetics in a porcine model of sepsis-induced AKI in order to identify
plugged capillary vessels.
METHODS. Experiments were conducted on fully instrumented and
anesthetized 13 female pigs (BW 28.2 ± 1.9 kg). The animals were
divided into 2 groups: with (LPS group n = 10) or without (control
group, n = 3) infusion of LPS (2 mg/kg−1h−1). While the auricular vein
was used for anesthesia and fluid infusion, the left femoral artery was
cannulated for monitoring arterial pressure and arterial blood samples,
the swan-ganz catheter has been inserted in pulmonary artery through
the right jugular vein used for microbubble injection and mix venous
blood samples. The catheter in the right femoral vein was used for fluid
resuscitation. After the retroperitoneal incision, transonic doppler flow
probe was placed around the renal artery of exposed kidney. CEUS im-
aging was performed at baseline (t0), during shock (t1), and one hour
after starting fluids infusion (t2). Cine loops of side-by-side B-mode and
nonlinear contrast mode images were stored as lossless DICOM images
for further offline analysis using MATLAB (The MathWorks, Natick, MA,
USA). We calculated the final plateau intensity, the ratio of this plateau
to the PE, and the difference in arrival time of the maximum contrast
bolus in the artery and the microcirculation, i.e., the difference between
the peak times, referred to as delta time of arrival (ΔT). Since the dis-
tance between the artery and the microcirculation is constant, the ΔT
parameter was used to estimate intrarenal blood velocity.
RESULTS. CEUS effectively visualized renal microcirculatory hypoperfusion
and allowed us to develop new analytical methods to measure dynamic
variations in renal microvascular perfusion during shock and resuscitation.
Plugged capillaries could be quantified by decreased peak enhancement
and an increased ratio of the final plateau intensity to peak enhancement
[Fig. 48]. Reduced intrarenal blood flow could be estimated by measuring
the microbubble transit times between the interlobar arteries and capillary
vessels in the renal cortex. LSI analysis confirmed that these CEUS
parameters were related to cortical renal hypoperfusion.
CONCLUSIONS. These results confirmed the feasibility of dynamic
CEUS imaging to visualize and quantify renal microcirculatory
hypoperfusion by identifying the sepsis-induced plugging of micro-
circulatory capillary vessels.
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INTRODUCTION. The 10th Consensus Conference of the Acute
Dialysis Quality Initiative suggested that combining AKI biomarkers
could have better precision when determining AKI outcome1.
OBJECTIVES. To evaluate the prognostic utility of combining novel
biomarkers of functional and structural renal injury in patients
undergoing cardiac surgery.
METHODS. Prospective, observational and comparative cohort study.
We included adults >18 years undergoing cardiac surgery without
Chronic Kidney Disease who had not received contrast medium. We
took baseline creatinine at the admission. After surgery, we took
structural (urinary NGAL and cystatin, serum creatinine, albuminuria,
and urinary sediment) and functional biomarkers (serum cystatin),
and monitored patients with serum creatinine, urinary volume and
fluid balance until their hospital discharge.
RESULTS. 31 patients were analyzed. Patients with AKI had higher levels
of serum creatinine (1.12 ± 0.34 vs 0.81 ± 0.09; p = 0.002), serum cystatin
[0.82 (0.56-1.65) vs 0.69 (0.40-1.12); p = 0.04] and urinary NGAL [48.3 (1.1-
3103) vs 7.1 (1.2-71.3; p = 0.04]. Patients with persistent AKI had higher
levels of serum cystatin [1.19 (0.78-1.65) VS 0.74 (0.56-1); p = 0.01] and
albuminuria [123 (55–997) vs 25 (6.6-310); p = 0.01]. Patients with severe
AKI (stages II and III) had higher levels of serum creatinine [1.6 (0.9-1.70)
vs 0.95 (0.70 -1.5); p = 0.05] and serum cystatin [1.2 (1–1.65) vs 0.75 (0.56-
0.97); p = 0.002]. The combination of a functional and structural
biomarker was present in 20% of the AKI group, in 80% of the persistent
group, and in 100% of the severe group. We found a low sensitivity
(20%) and good specificity (100%) in the AKI group due to the low
percentage of the biomarkers combination. In the persistent and severe
form of AKI, this combination improves the sensibility (100% and 80%),
specificity (80% and 80%), negative predictive value (100% and 92%) and
accuracy (84% and 80%) when performing diagnostic test analysis.
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 56 of 542CONCLUSIONS. In the persistent and severe form of AKI there is a
higher frequency of functional and structural biomarker combinations
with statistically significant difference. The presence of the combination
improves the sensitivity, specificity, positive predictive value, negative
predictive value and accuracy of the test for severe and persistent AKI.
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INTRODUCTION. Critically ill patients, suffering from serious diseases
such as acute heart failure, severe acute pancreatitis, acute kidney
injury, septic shock, and so on, often require continuous renal
replacement therapy (CRRT) (1). It is well known that, maintenance
hemodialysis (MHD) patients have many comorbidities such as
hypertension, anemia, chronic kidney disease-mineral bone disorder
(CKD-MBD), and are associated with high mortality.
Little is known about the outcome of CRRT in MHD patients, and what
clinical parameters are risk factors of short-term mortality after CRRT.
OBJECTIVES. The aim of this study was to investigate whether MHD
patients are at high risk of short term mortality after CRRT and to
determine a scoring system relating to the mortality.
METHODS. In this study, 308 patients who required CRRT in our facility
from April 2013 to March 2015 were retrospectively analyzed. Indication
for CRRT and CRRT prescription were determined by nephrologists. We
excluded patients who were indicated hemodialysis within 7 days before
CRRT, transferred to other hospital, and lost to follow. Patients were
stratified by two groups, MHD group and Non-MHD (control) group. Stat-
istical analysis was performed using JMP pro for Windows, version 13. A
p value < 0.05 was considered to be statistically significant.
RESULTS. 258 patients are included in our study. Sixty five % of them
were male, mean age was 71 years old. Cumulative incidence of death
for MHD group versus control group was 41.8% versus 26.9% at 7 days
(p = 0.06), 60.4% versus 46.0% at 30 days (p = 0.09), respectively.
Kaplan-Meier analysis revealed that MHD group (log-rank test:
p = 0.02), intubated patients (log-rank test: p < 0.0001), patients
required catecholamine (log-rank test: p < 0.0001) had significant
lower cumulative survival rate at 30-days after CRRT. Logistic regres-
sion analysis revealed that MHD patients were likely to die within 30-
days after CRRT but not statistically significant (unadjusted odds ratio
1.79; 95% CI 0.92 - 3.54). After adjustment for elderly (age over 65
years), catecholamine administration, intubation, and MHD, MHD was
an independent risk factor for 30-days mortality after CRRT (adjusted
odds ratio 2.75; 95% CI 1.31 - 5.94; p = 0.0067).
Based on multivariate logistic regression analysis, we formulated a
scoring system: MHD, Elderly, Intubation, Catecholamine (MEIC) score.
The scoring system was derived as follows: (MHD × 5) + (Elderly
(Age > 65 y) × 3) + (Intubation × 7) + (Catecholamine × 5). The area
under the ROC curve was 0.73 for the MEIC score.
CONCLUSIONS. These results suggested that MHD, intubation,
elderly, catecholamine administration were independent risk factors of
30-days mortality after CRRT. The MEIC score could be a useful scoring
system for the mortality and further investigations are needed to
confirm our results.
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INTRODUCTION. Acute kidney injury is very common in critical
patients. Many patients need renal replacement therapy, and the
mortality of these patients is very high.
OBJECTIVES. To evaluate early prognostic factors in critical patients
who require continuous renal replacement therapy (CRRT).
METHODS. Prospective observational study including patients
admitted in an Intensive Care Unit requiring CRRT. Observational
period was from March 2015 to March 2017. Chi-squared, Fisher
Test, U of Mann–Whitney and logistic regression were used. Data
expressed as frequency (%) and median (interquartile range).
RESULTS. Ninety-eight patients required CRRT during study period,
men 67(68,4%), median age 63(53–70) years, APACHE II 29(24–35) and
SOFA 11(8–14). Main etiology of AKI was multifactorial in 64(65.3%) pa-
tients, followed by sepsis in 26(26,5%) patients. In 73(74,5%) patients
perfusion of furosemide was administered previously.
CRRT was initiated 1(0–4.3) days after ICU admission, and femoral
access was used in 81(82,7%) patients. Treatment dose was
protocolized. SOFA at the beginning of CRRT was 12.5(10–15), and
after 48 hours of therapy, 12(9–15). Almost all the patients,
93(94,9%), received vasoactive support with norepinephrine and
invasive mechanical ventilation, 87(88,8%).
Length of CRRT was 6(2–12,5) days, and length of stay in ICU was
13(7–33) days. Overall ICU mortality was 54,1%, and hospital
mortality rate 61,2%.
According to Charlson Comorbidity Index, a greater mortality was
presented by patients diagnosed with congestive heart failure (6(15%)
vs. 1(1,9%); p = 0,04). All patients diagnosed with leukemia (acute or
chronic) died (8(15,1%) (p = 0.009) vs. 0). According to the AKI etiology,
there were no differences in mortality between groups.
A further analysis of the 83 patients still under CRRT after 48 hours
of treatment was carried, showing that patients with favorable
prognosis presented a SOFA score decrease of two or more points
(OR:1,36 (CI 95%: 1,09-1,7);p = 0.006); being main cause the
hemodynamic component.
CONCLUSIONS. Critical patients who required CRRT presented a high
mortality, being leukemia and congestive heart failure factors of poor
prognosis. A SOFA score decrease in the first 48 hours from therapy
was presented as a factor of good prognosis.
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INTRODUCTION. ICU patients requiring CRRT (ICU/CRRT) have a high
hospital mortality and reduced long term survival (1). A number of
long term follow up studies have been carried out internationally but
to date no such study has been carried out in Ireland.
OBJECTIVES. To examine the 2 year outcome of survivors of ICU/
CRRT in an Irish population.
METHODS. We conducted a retrospective cohort study of all patients
admitted to our ICU in 2013 and 2014 who required CRRT. Data was
obtained from Clinical Information and laboratory systems and
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 57 of 542entered into a database for analysis. Parameters recorded included
age, gender, APACHE 11 score, SOFA score and serum creatinine at
initiation of CRRT and on hospital discharge.
Patients surviving to hospital discharge were followed up to 2 yrs
to determine survival, dialysis dependency. For 69% of survivors,
this information was obtainable from the hospital information and
laboratory systems. For the remaining 31% GP's were contacted by
written communication and follow up phone call. Categorical
variables were compared using chi-square test and continuous vari-
ables were compared using the Mann Whitney U test. The study re-
ceived ethical committee waiver.
Primary outcome was 2 year Mortality. Secondary outcomes included
dialysis dependency and renal function at 2 years.
RESULTS. During the study period there were 686 admission to ICU
and 201 patients (29.3%) were treated with CRRT. Following
exclusion of 5 patients dialysed for reasons other than AKI and 15
patients with pre-exisiting ESRD, 181 were included for further ana-
lysis. 83 (46%) patients survived to hospital discharge The mean
age of survivors was 60.7 yrs (range 18–86), 67% were male. The
median APACHE 11 score was 20 (IQR 17–24), median SOFA score
was 10 (IQR 8–12). 72 patients (87%) were dialysis independent (DI)
at hospital discharge and 11 (13.3%) were dialysis dependent (DD).
There was no significant difference between DD and DI patients
with respect to age, gender, APACHE 11 score or SOFA score. The
number of patients who required mechanical ventilation was sig-
nificantly higher in DD group (63% v. 27% p < 0.05). The overall 2
year mortality was 29%. There was a trend towards greater mortal-
ity in the DD group (40% v 28%) not reaching statistical signifi-
cance. All patients who were dialysis independent at hospital
discharge and survived to 2 years remained dialysis independent.
Two patients were lost to follow-up.
CONCLUSIONS. ICU CRRT is associated with a high hospital mortality
and a significant mortality in the 2 years post discharge. The majority
of survivors of ICU/CRRT were dialysis independent at hospital
discharge and remained so after 2 years. There was a tendency
towards improved long term survival in dialysis independent patients.
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INTRODUCTION. Pulmonary Artery dysfunction and Right Ventricle
(RV) failure worsen outcomes in Acute Respiratory Distress Syndrome
(ARDS) patients. Due to the complexity of pulmonary circulation, a
complete physiopathology description of pulmonary artery and RV
disarrangements caused by ARDS is lacking. Regarding this, Magnetic
Resonance Imaging (MRI) appears as a unique tool being considered
as the gold standard for RV function evaluation.
OBJECTIVES. To evaluate RV and pulmonary artery dysfunction by
means of MRI in a porcine model of ARDS.
METHODS. Seven anesthetized and mechanically ventilated pigs
(≈35kgs) were submitted to lung saline lavages (until reaching aPaO2/O2 Inspired fraction below 200 mmHg) followed by 1.5 hours of
injurious mechanical ventilation (PEEP 0 cmH2O and driving pressure
of 30–35 cmH20). A set of MRI datasets (Cine and Phase contrast)
were acquired in baseline conditions and after the lung injury (with a
delay or stabilization period of 30 minutes) in similar ventilation
settings (PEEP 8 cmH2O and tidal volume 6–8 ml/kg in control
volume ventilation). Acquired images were used for evaluation of RV
function and flow-derived variables of vascular function estimation.
Such variables included wave reflection phenomena evaluation
coming from continuous flow and area analysis and forward and
backward flow wave calculations.
RESULTS. Comparing to baseline conditions, ARDS demonstrated a
non-significant trend to a lower ejection fraction (33 ± 8% vs
28 ± 5%, p = 0.195) and a higher end-systolic volume to stroke vol-
ume ratio (2.2 ± 0.7 vs 2.7 ± 0.7, p = 0.205), a MRI index of
ventricular-arterial coupling. Additionally, time (normalized to the
cardiac period) to backward wave arrival decreased from
0.19 ± 0.09 to 0.12 ± 0.0, p = 0.046 and reflection intensity (back-
ward wave amplitude divided by backward and forward wave amp-
litude sum) increased from 0.24 ± 0.12 to 0.38 ± 0.05, p = 0.011.
Mean pulmonary artery area increased after ARDS from 3.02 ± 0.31 cm2
to 4.34 ± 0.52 cm2, p < 0.001. Finally, a non-significant trend to increase
in pulse wave velocity after ARDS was observed (2.2 ± 0.9 m/s vs
2.7 ± 1.4 m/s, p = 0.470).
CONCLUSIONS. In this porcine model, vascular function worsening
caused by ARDS was non-invasively described by MRI. Of note, wave
reflection phenomena increased after ARDS which can contribute to
an increase in RV afterload. Interestingly, a significant decrease in the
time to backward wave arrival was observed but the higher pulse
wave velocity did not reach statistical significance. Maybe this can
be related with the effect of other variables affecting the time to
reflection arrival such as the distance to the reflection site. This dis-
tance is expected to decrease by the collapse effect that should re-
duce the effective longitudinal vascular length, although this
interesting result would require further investigation. The potential
use of MRI for pulmonary vascular function evaluation in ARDS is
highlighted in this study.
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BACKGROUND. It is questioned whether spontaneous breathing
should be used in early acute respiratory distress syndrome (ARDS),
as it may cause ventilator induced lung injury (VILI), by increasing
the tidal strain/stress and tidal recruitment/derecruitment (R/D).
However, spontaneous breathing has proven to offer beneficial
effects, when used properly. We hypothesized that high positive
end-expiratory pressure (PEEP) during spontaneous breathing
would prevent derecruitment of lung regions, thereby reducing
tidal R/D. We tested this hypothesis in experimental mild ARDS dur-
ing continuous spontaneous breathing supported by Neurally Ad-
justed Ventilator Assist (NAVA).
METHODS. Mild experimental ARDS (PaO2/FIO2-ratio of 200mmHg)
was induced in tracheotomised and anesthetised pigs (n = 5),
ventilated using optimally levelled (1) NAVA. PEEP was gradually
increased in steps of 3 cmH2O, from 0 to 15 cmH2O and thereafter
decreased to 0 cmH2O. Paradiaphragmatic dynamic computed
tomography scans were acquired. Tidal volume, inspiratory time,
peak flow and peak pressure were recorded continuously. Atelectatic
tissue was defined as voxels with Hounsfield unit density of −100 to
+100. R/D was calculated as the difference between end-expiratory
and end-inspiratory atelectasis, in percentage of lung weight.
Fig. 49 (abstract 0111). Gene expression of pro- and anti-
inflammatory markers, neutrophils and monocytes recruitment,
coagulation and apoptosis. Groups: Control (n=8), control + ATIII
(n=8), control+ATIII+Hep (n=8), HCL/LPS (n=8), HCL/LPS+ +ATIII
(n=8), HCL/LPS+ +ATIII+HEP (n=8). *p≤0.05 vs Control: #p≤0.05
vs <HCL/LPS. Gene expression of inflammatory markers, coagulati
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 58 of 542RESULTS. Tidal R/D decreased from 5.7 ± 7.4% to 2.3 ± 1.5% as PEEP
was gradually increased from 0 cmH2O to 15 cmH2O (p < 0,01), and
was increased to 5.5 ± 3.9% as PEEP was gradually decreased to 0
cmH2O (p < 0,01). Mean tidal volume increased from 83 ± 39 ml at
PEEP 0 cmH2O to 386 ± 126 ml at PEEP 15 cmH2O, while the
respiratory rate decreased from 77 ± 20 bpm (PEEP 0) to 4.3 ± 1.9
(PEEP 15).
CONCLUSIONS. In this experimental early mild model of ARDS, tidal
R/D occurred during spontaneous breathing using NAVA. However,
the amount of tidal R/D was reduced by increasing PEEP. This
indicates that PEEP higher than conventionally used clinically, in
spontaneously breathing patients, might be applied in early ARDS in
order to reduce R/D and, possibly, the risk of VILI.
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INTRODUCTION. Acute Lung Injury (ALI) is the result of an acute
respiratory failure that develops from a variety of clinical disorders
and is associated with a high mortality rate. In the first stages of ALI,
proinflammatory mediators inhibit natural anticoagulant factors,
which alter the normal balance between coagulation and fibrinolysis
leading to a procoagulant state (1). Thus, patients with ALI may
benefit from anticoagulant therapy. Recent studies revealed that
local administration of anticoagulants could not only re-establish co-
agulant activity in the lung but also prevent systemic bleedings (2).
OBJECTIVES. Evaluate the potential therapeutic effects of nebulized
antithrombin (ATIII) and heparin in an ALI model.
METHODS. Sprague–Dawley rats (~300g) underwent intratracheal
administration of HCL (1ml/g of HCL 0.1M, pH = 1.2). 2h later
subjects underwent intratracheal administration of lipopolysaccharide
(LPS 30mg/g body weight). Control groups received saline (0.9%)
instead. ATIII (500IU/Kg body weight) alone or together with
heparin (1000IU/Kg body weight) were nebulized through Aeroneb
system (Philips Healthcare) 4h and 28h after HCL. An extra dose of
nebulized heparin was administered 12h after HCL in heparin
groups. Animals were sacrificed 48h after injury. Pro- and anti-
inflammatory mediators as well as neutrophil and macrophages
chemoattractant activity were evaluated in lung tissue using qRT-
PCR. The permeability and the cellular infiltration were quantified
in bronchoalveolar fluid and the integrity of the alveolar epithelium
was evaluated by histology. Statistics: One-way ANOVA and New-
man Keuls post-hoc test (p < 0.05).
RESULTS. A significant increase was observed in IL1beta, IL10, CXCL1,
CCL2 and Caspase-3 in the lung tissue of the ALI group. AT-III and
the combination of AT-III and heparin reduced the expression of all
of them. A tendency was observed for plasminogen (Fig. 49).
CONCLUSIONS. These results indicate that nebulized anticoagulants
are able to attenuate the lung injury through the decrease of
neutrophils and monocytes recruitment and the reduction of
inflammation.
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INTRODUCTION. Mesenchymal stem cells (MSCs) have potential for
re-epithelization and recovery in acute respiratory distress syndrome
(ARDS). In a previous in vitro study, the results showed that the
CXCL12/CXCR7 axis promoted the homing of MSCs, suggesting that
the CXCL12/CXCR7 axis might be one of the key mechanisms under-
ling the therapeutic effect of mouse MSCs in ARDS.
METHODS. mMSCs stable transfected with CXCR7 were transplanted
intratracheally into the ARDS mice induced by lipopolysaccharide.
Lung tissue injury and repair assessment were examined using
haematoxylin and eosin staining, lung injury scoring. Homing of
mMSCs were assayed by labelling and tracing MSCs using NIR815
dye and immunofluorescent staining.
RESULTS. mMSCs overexpressing CXCR7 engraftment led to more
significant effects than the ZsGreen controls, including the homing
of the mMSCs in the lung, improvement in endothelial permeability,
and the pathologic impairment of the lung tissue.
CONCLUSIONS. These results suggest that overexpressing CXCR7 in
mMSCs could further promote their homing to injured lung and
improve the therapeutic effects of mouse MSCs in ARDS mice.
Fig. 50 (abstract 0112). See text for description
Fig. 51 (abstract 0112). See text for description
Fig. 52 (abstract 0113). See text for description
Fig. 53 (abstract 0113). See text for description
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INTRODUCTION. Mesenchymal stem cells (MSCs) have several properties
that make them attractive therapeutic candidates for treatment of acute
disease, but in vivo homing, MSCs does not appear to be highly efficient.
CXCL12/CXCR7 axis not only improves the motility of stem cells, but also
regulates many essential biological processes. The aim of this study is to
evaluate the effects of overexpressing or suppressing CXCR7 on
proliferation and migration abilities of mice mesenchymal stem cells.
METHODS. The lentivirus vector overexpressing and suppressing the
murine CXCR7 gene was transducted into mMSCs. The transfection
efficiency of LV in passage 20 transduced-mMSCs was identified using
fluorescence microscopy, and the percentage of ZsGreen positive cells was
determined by flow cytometry analysis (FCM). CXCR7 mRNA expression in
mMSCs was verified by quantitative real-time PCR, and CXCR7 protein ex-
pression was analyzed by FCM. The effect of CXCR7 on the migration of
mMSCs was evaluated using the scratch assay and the transwell migration
assay. In transwell assay, 50ng/ml CXCL12 was added in two groups to
simulation inflammation microenvironments. The ELISA assay was used to
detect the concentration of VCAM-1, CXCL12 the supernatant.
RESULTS. The efficiencies of the lentiviral vector transduction of
MSC-OE-CXCR7 (overexpression of CXCR7), MSC-OENC-CXCR7 (nor-
mal control of overexpression of CXCR7), MSC-Sh-CXCR7 (suppression
of CXCR7) and MSC-ShNC-CXCR7 (normal control of suppression ofCXCR7) after 20 passages in mMSCs were 91.29%, 91.39%, 91.69% and
91.28% respectively. The CXCR7 mRNA and protein expression were
significantly higher in the MSC-OE-CXCR7 cells than in the MSC-OENC-
CXCR7 cells, and were significantly lower in the MSC-Sh-CXCR7 when
compared with the MSC-ShNC-CXCR7.
Moreover, CXCR7 gene overexpression promoted mMSCs migration.
In contrast, the suppression of CXCR7 inhibited mMSCs migration
when compared with the MSC-ShNC-CXCR7 group.
Overexpression CXCR7 increased MSC-secreted CXCL12 and VCAM-1,
which contributed to the improvement of mMSCs homing.
CONCLUSION. Overexpression CXCR7 improved the homing abilities
of mMSCs, which might attribute mainly to increasement of CXCL12
and VCAM-1 secreted by mMSCs.0114
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INTRODUCTION. Therapeutic hypothermia has been extensively used
in cardiac arrest but there are only a few reports on its effects on
lung function and its use in the acute respiratory distress syndrome
(ARDS). We hypothesized that mild hypothermia, while well
tolerated, reduces the metabolic production of CO2 (VCO2) allowing
decreasing the ventilatory demands and thereby enhancing the
fulfillment of a lung protective ventilation strategy.
Table 36 (Abstract 0114). Abg dring hypothermia experiments
Baseline T36 T35 T34 T33 T32 T31 T34 low
tidal
volume
T31 low
tidal
volume
PaO2
(mmHg)
healthy
156±4 184
±3
194
±4
200
±4
196
±3
214
±4
221
±4
182±4 194±3
PaO2
(mmHg)
septic
80±1 94±2 103
±3
108
±2
118
±5
126
±6
123
±7
99±2 121±5
PaCO2
(mmHg)
healthy
40±1 45±1 42±1 40±1 40±1 39±1 36±1 54±2 55±2
PaCO2
(mmHg)
septic
56±0 54±1 53±1 54±1 52±1 51±1 50±1 73±1 64±1
pHa
healthy
7,45
±0,03
7,45
±0,03
7,46
±0,03
7,47
±0,03
7,49
±0,04
7,50
±0,05
7,51
±0,5
7,37
±0,05
7,37
±0,07
pHa
septic
7,34
±0,06
7,33
±0,03
7,31
±0,03
7,29
±0,04
7,32
±0,03
7,32
±0,05
7,3
±0,08
7,20
±0,06
7,21
±0,06
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 60 of 542OBJECTIVES. To examine the effects of different levels of hypothermia
applied during lung protective ventilation strategy on lung function,
metabolism and gas exchange. In addition we tested the effects of a tidal
volume (Vt) reduction at mild (34°C) and moderate (31°C) hypothermia.
METHODS. Hypothermia was sequentially induced by an intravascular
temperature management system (Icy® IVTM,Zoll) in 4 healthy
(30.1 ± 1.2kg) and 4 septic (endotoxin infusion) (30.4 ± 1.4) pigs
ventilated under protective ventilation settings (Vt 6.5 ± 0.5ml/kg, PEEP
5cmH2O, respiratory rate 30bpm, FIO2 0.4). T° was decreased from
baseline (38.1 ± 0.5°C) to 36°C and then in steps of 1°C until 31°C each
level maintained 30min. Two additional 30 min periods were performed
at 34 and 31°C in order to evaluate the effects of Vt reduction. Stable Vt
and cardiac output were maintained. Physiological measurements
included lung mechanics, hemodynamics, gas exchange and metabolism.
RESULTS. Changes in physiological variables during T° reduction are
depicted in Table 34, 35, 36. At stable ventilation and cardiac output
(coefficient of variation of 0,17), VCO2 decreased by 11.2 ± 1.6% and
5.8 ± 6.6 and VO2 by 5.8 ± 5 and 6.1 ± 8% per °C reduction in healthy
and septic animals respectively. (Figure 54). At mild and moderate
hypothermia Vt was reduced to 5 and 4 ml/kg in the healthy and to 5
ml/kg in the septic animals respectively. This resulted in decreased
plateau and driving pressures of 30% in healthy and 15% in septic
animals. At these settings PaCO2 and pHa remained at acceptable
clinical ranges (Table 36).
CONCLUSIONS. In this experimental model mild hypothermia (34°C)
resulted in clinical relevant reductions in ventilatory demands in
healthy and septic conditions. This may be an effective and promising
early adjuvant intervention to enhance protective ventilation strategy.Table 34 (Abstract 0114). Parameters during hypothermia experiment
Baseline T36 T35 T34 T33 T32 T31 T34 low
tidal
volume
T31 low
tidal
volume
VCO2
healthy
181±13 154±22 136±11 122±15 108
±14
99±14 88±13 97±14 63±13
VCO2
septic
164±24 158±39 137±18 119±11 106
±15
111
±10
106
±10
100±27 86±21
VO2
healthy
206±33 183±20 181±16 166±11 164
±19
139
±13
134
±21
166±10 137±18
VO2
septic
237±34 212±26 176±52 187±56 165
±29
161
±26
152
±28
187±38 139±48
CO
(L/min)
healthy
3,40 ±
0,3
3,79 ±
0,8
3,96 ±
0,7
3,64 ±
0,5
3,59
±0,5
3,57
±0,6
3,35
±0,8
3,70
±0,3
3,64 ±
0,8
CO
(L/min)
septic
3,91±
0,6
4,23±
0,6
4,19±
0,9
3,97±
0,77
3,87±
0,1
3,73±
0,2
3,79±
0,6
4,04±
0,5
3,71±
1,2
Fig. 54 (abstract 0014). VCO2 and VO2 dynamics related to
hypothermia level
Table 35 (Abstract 0114). Lung mechanics during hypothermia experim
Baseline T36 T35 T34 T33 T32 T31 T34 low
tidal
volume
T31 low
tidal
volume
VT (ml)
healthy
241±35 225
±21
221
±23
201
±20
224
±22
221
±22
197
±22
169±17 147,25
±23
VT (ml)
septic
217±29 218
±22
219
±21
219
±23
228
±14
227
±16
227
±16
159,75
±22
167±16
Pplat
(cmH2O)
healthy
12±3,6 11,7
±0,9
11,5
±1,2
9,7
±1,5
11,5
±1,9
11,2
±1,9
11,7
±2,3
10±1,2 9,75±1,5
Pplat
(cmH2O)
septic
15,7
±5.0
17,7±5 17,5
±5,3
16,5
±3,8
20±6,1 20,3
±5,1
20,3
±4,9
16±3,37 17±6,08
Driving
Pressure
(cmH2O)
healthy
7±3.5 6,8
±0,9
6,5
±1,2
6,3
±1,5
6,5
±1,9
6,3
±1,9
6,8
±2,3
5±1,1 4,7±1,5
Driving
Pressure
(cmH2O)
septic
13,5
±3,9
13,5
±4,4
13,3
±4,7
13,8
±4,6
15,4
±5,7
16,4
±4,1
15,6
±4,6
11,2±3,2 12±3,80115
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INTRODUCTION. Catecholamines can proliferate fibroblasts and
progress fibrosis via adrenergic beta receptors.
OBJECTIVES. This study aimed to analyze beta receptor action in
human fibroblasts.
Fig. 55 (abstract 0116). Gene expression of pro and
antiinflammatory markers, chemoattractant mediators and
apoptosis in lung tissue. (n=8); *p≤0.05 vs C; #p≤0.05 vs HCL/LPS
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 61 of 542METHODS. The human fetal lung-derived fibroblast cell line IMR90
were used in this study. Expression of β receptor subtype was exam-
ined by RT-PCR and immunohistochem istry to evaluate fibroblast
proliferation by dobutamine (DOB). A t test was used for the statisti-
cally analysis.
RESULTS. DOB accelerated the proliferation of IMR90 and the
expression of α-smooth muscle actin(SMA)as myofibroblast in a
concentration-dependent manner for 24 to 48 hours by 10−7 M. In
RT-PCR analysis and immunohistochemical staining, IMR-90 expressed
all subtypes of beta receptor. In the intracellular signaling analysis, the
activity of cAMP and EPAC-1 was elevated, and it was suppressed by
H89 and KT5720, whose main action was PKA inhibition. And also, tran-
scription factor analysis showed that IMR-90 sustainably activated tran-
scriptional factor cAMP response element binding protein (CREB) but
not NF-κB and AP-1 after 15 min of dobutamine administration. The
proliferative action of IMR-90 at 48 hours after DOB 10−7 M admin-
istration was significantly inhibited by CREB decoy oligonucleotides
and selective β1 receptor agonist, CGP201712A and randiorol.
CONCLUSIONS. Fibroblasts could accelerate the proliferation and
change the structural formation into myofibroblast by beta receptor
stimulation.
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INTRODUCTION. The lungs of patients with Acute Respiratory Distress
Syndrome (ARDS) present widespread inflammation, coagulation and
impaired fibrinolysis, producing the rupture of the endothelial and
epithelial monolayer (1).
At present there is no effective treatment for ARDS. Cell therapy
could be a promising therapeutic strategy for this disease (2,3). In
our research laboratory, the transplantation of epithelial alveolar type
II cells (ATII) in a model of Acute Lung Injury (ALI) has demonstrated
promising results reducing lung injury. Potentiate immunomodulatory
effect of ATII cells could improve their beneficial effects on ARDS.
OBJECTIVE. Evaluate the effect of genetically modified ATII cells
focused in the control of the inflammatory process in ALI model.
METHODS. Sprague–Dawley rats (~250g) underwent intratracheal
administration of 300 μl HCl (0.1M)and 2 h later of 500 μl
Lipopolysaccharide (LPS 10μg/g body weight). Control animals
received saline (0.9%). Genetically modified ATII cells with IL10, Il4
and IL13 were transplanted 11 h after HCl instillation. Animals were
sacrificed 72 h after injury. The concentration of total proteins and
the cell counts of macrophages, neutrophils and lymphocytes were
assessed in the broncoalveolar lavage. Pro and anti-inflammatory
pathways and markers of neutrophils and monocytes recruitment
were evaluated in lung tissue by qRT-PCR. Data expressed as
media ± SEM, relative to GAPDH and fold over saline group (n = 8
for all the study groups). Statistics: One-Way-ANOVA and Newman
Keuls post-hoc test (Statistical significance: p ≤ 0.05).
RESULTS. Higher levels of macrophages and neutrophils, lung weight
and proteins were found in the HCl/LPS model and could not be
reduced by transplanted modified ATII cells. Proinflammatory
mediators were elevated in the ALI model. The transplantation of
modified ATII cells increased pro and anti-inflammatory markers, me-
diators of recruitment and apoptosis.CONCLUSIONS. Elucidate the pathways involved in the lung injury
development and resolution is of interest to treat ARDS. Potentiate
the immunomodulatory effect of ATII cells increased the recruitment of
cells in to the lung and raised pro and anti-inflammatory pathways.
References
1. Ware LB. (2006) Pathophysiology of acute lung injury and the acute
respiratory distress syndrome. Seminaris in Respiratoryand Critical Care
Medicine 27(4):337–49.
2. Matthay MA, Goolaerts A, Howard JP, Lee JW. Mesenchymal stem cells for
acute lung injury: preclinical evidence, Crit. Care Med. 38, S569–573 (2010).
3. Serrano-Mollar A, Nacher M, Gay-Jordi G et al. Intratracheal transplantation
of alveolar type II cells reverses bleomycin-induced lung fibrosis, Am. J.
Respir. Crit. Care Med. 176, 1261–1268 (2007).
GRANT ACKNOWLEDGMENT
Project supported by ESICM Established Investigator Research Award (2015),
CIBERES and Institut d'Investigació i Innovació Parc Taulí.0117
The protective effect of polydexyribonucleotide (PDRN) on acute
lung injury (ALI)
J.J. Hwang1, C.W. Choi1, J.H. You1, B.S. Chang1, S.Y. Park2, S.S. Paik3, S.H.
Park1
1Kyung Hee University Hospital at Gang-Dong, Department of
Pulmonology and Critical Care Medicine, Seoul, Korea, Republic of;
2Kyung Hee University Medical Center, Department of Pulmonology and
Critical Care Medicine, Seoul, Korea, Republic of; 3Dongnam Institute of
Radiological & Medical Sciences, Pulmonology, Busan, Korea, Republic of
Correspondence: J.J. Hwang
Intensive Care Medicine Experimental 2017, 5(Suppl 2):0117
INTRODUCTION. Acute lung injury (ALI) is an acute inflammatory
syndrome that destroys the endothelium and epithelial barrier of the
lungs due to various causes. PDRN, low molecular weight DNA
complex, is a compound extracted from spermatozoa of salmon.
PDRN has showed anti-inflammatory effect on very diverse inflam-
matory disease by A2 receptor stimulation. Recently, it has been re-
ported that PDRN has ability to inhibit of cell death.
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 62 of 542OBJECTIVES. We investigated whether PDRN could be used for ALI
treatment.
METHODS. 36 male SD rats were classified into control group, ALI
group, and ALI + PDRN treatment group. ALI was induced by intra-
tracheal administration of 5 mg / kg Lipopolysaccharide (LPS).
The PDRN was injected into the abdominal cavity once at a dose of
0.3 ml (concentration of 8 mg/kg) 1 hour after LPS administration.
The rats were sacrificed at 3 hours after PDRN administration.
RESULT. Compared with the control group, in lung tissue,
inflammatory makers in ALI group were significant higher in lung
tissue (TNF-a (1.00 ± 0.00 vs. 1.52 ± 0.08; P = 0.001) and IL-6 (3h:
1.00 ± 0.00 vs. 1.60 ± 0.14; P = 0.003)), and in the BALF (TNF-α (3h:
30.69 ± 3.07 vs. 3326.31 ± 162.06 pg/mL; P = 0.000) and IL-6 (3h:
35.37 ± 3.54 vs. 2495.50 ± 121.58 pg/mL; P = 0.000)). Between ALI
group and ALI + PDRN treat group, ALI + PDRN treated group
showed significant inflammation lowering effect in lung tissue (TNF-α
(1.52 ± 0.08 vs. 1.01 ± 0.03) and IL-6 (1.60 ± 0.12 vs. 0.55 ± 0.02), all
P < 0.05) and in BALF(TNF-α(3326.31 ± 162.06 pg/mL vs.
2112.16 ± 265.92 pg/mL), IL-6 (2495.50 ± 121.58 pg/mL vs.
1545.23 ± 194.54 pg/mL)and improving pathologic change(Lung in-
jury score ALI 1.62 ± 0.18, ALI-PDRN 1.5 ± 0.16 p < 0.02).
CONCLUSION. The protective effect of PDRN on ALI may be
associated with suppression of inflammatory responses. This
demonstrate the possibility of PDRN as a therapeutic agent in acute
lung injury.
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INTRODUCTION. Over the last decades, there have been many
attempts to use exogenous pulmonary surfactant preparations in
acute respiratory distress syndrome (ARDS) therapy. The success of
this treatment has been restricted, probably due to several factors,
one of which may be limited supply of pulmonary surfactant
preparations.
OBJECTIVES. To test whether a new synthetic pulmonary surfactant,
based on 2% (w/w) recombinant Surfactant Protein C (rSP-C33) in
synthetic phospholipids, may be effective in a rabbit model of ARDS.
METHODS. Six adult rabbits were anesthetized, tracheotomized and
ventilated in volume controlled mode. ARDS was induced by
repeated lung lavages followed by injurious ventilation until pO2/
FiO2 reached ~10kPa. We measured arterial pH, paO2, paCO2, HCO3-
, mechanical ventilation and hemodynamic parameters at baseline,
immediately after induction of ARDS, and then every half hour for 3
h. After the establishment of ARDS, rabbits were randomized to
receive (n = 3) rSP-C33 surfactant (2,5 ml/kg of 80 mg phospholipids/
ml) or an air bolus (n = 3), given at two time-points 30 minutes apart
(intra-tracheal administration, half dose in the right lung, half dose in
the left lung). The animals were sacrificed at the end of the experi-
ment. Histological samples from lungs were taken.
RESULTS. rSP-C33 surfactant treatment gives improved pulmonary
gas exchange (P/F Ratio), while it seems to have no influence on pul-
monary dynamic compliance and Plateau Pressure. Immunohisto-
chemical analysis of the samples is in progress.
CONCLUSIONS. The sample size is insufficient to allow detection of
statistically significant differences, but the results show that the
treated group has a better oxygenation compared with the non-
treated group, suggesting that rSP-C33 surfactant is effective. We are
awaiting the results from immunohistochemical analysis in order toanalyse effects on lung histology. Further experiments are needed to
confirm the results obtained, and to study additional parameters.
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INTRODUCTION. Positive end-expiratory pressure (PEEP) may have a
protective effect on lung aeration by enhance alveolar recruitment;
however it may also induce lung hyperinflation and haemodynamic
disturbances [1]. In contrast, external negative pressure (eNP) is
known to improve oxygenation and to be less injurious compared to
positive pressure ventilation.
OBJECTIVES. To assess the haemodynamic effects of eNP compared
to PEEP during recruitment of experimentally induced lung injury.
METHODS. The study was conducted on ten adult Large White pigs
(48–60 kg). Under continuous intravenous anaesthesia with propofol,
the animals were put in a supine position, tracheotomized and
intubated. Mechanical ventilation was administered in a volume-
controlled mode with FIO2 -1.0, VT −8-10 mL kg
−1 and I:E ratio −1:2.
Respiratory rate was adjusted to maintain PaCO2 within 35–45 mm
Hg. A continuous infusion of Ringer´s lactate at the rate of 5–10 mL
kg−1 h−1 was administered throughout the study.
The acute lung injury was produced by repeated bronchoalveolar
lavage using warm 0.9% NaCl until PaO2/FIO2 remainded stable
below 100. Thereafter, each animal was secured in a whole body
size-chamber and endotracheal PEEP followed by eNP were created,
while lung ventilation mode was held constant. Haemodynamic vari-
ables were recorded before and after the lung lavage - during re-
cruitment manoeuvres. Heart rate (HR), mean arterial pressure (MAP),
mean pulmonary artery (MPAP) and pulmonary wedge (PCWP) pres-
sures, cardiac output (CO) and arterial oxygen tension (PaO2) were
compared when either PEEP or eNP were changed from 0 to 16 cm
H2O by steps of 4 cm H2O.
RESULTS. Bronchoalveolar lavage resulted in substantial deterioration
of all measure variables. During lung aeration both mode of
recruitment generated similar haemodynamic changes [Fig. 56],
however a significant differences were recorded in MPAP, PCWP
[Fig. 57] and CO [Fig. 58].
CONCLUSIONS. In a saline lavage lung injury eNP and PEEP generates
similar haemodynamic changes. However, due to differences in
MPAP, PCWP and CO, further studies are needed to confirm the
haemodynamic safety of eNP during lung recruitment.
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INTRODUCTION. Ventilator-associated pneumonia (VAP) is a frequent
intensive care unit (ICU)-acquired infection with worse consequences.
Critically ill patients, especially septic patients, have depressed im-
mune system. Transcriptomic analysis of circulating peripheral blood
leucocytes has demonstrated to be a valuable approach to evaluate
immunity in different infectious diseases and to identify new molecu-
lar markers for diagnosis proposes.
OBJECTIVES. The evaluation of the systemic immune dysfunction of
VAP patients could be useful to understand the pathological events
of this disease and to detect it early. In order to study these
immune alterations in VAP we decided to use a molecular method,
transcriptome microarrays.
METHODS. An observational prospective cohort study enrolling
immune-competent adults with VAP, and no infection patients in
seven medical ICU. A blood sample was collected in the first 24
hours following diagnosis of VAP by using PaxGene tubes. In the MV
Fig. 60 (abstract 0120). Gene expression
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 64 of 542control group, the sample was collected at 6th-7th day under MV (me-
dian day for diagnosis of infection in the VAP group). Clinical data also
was collected; including medical history, physical examination and
hematological, biochemical, radiological and microbiological data.
RESULTS. 41 mechanical ventilated (MV) patients (24 VAP and 17
control MV). ICU-admission reason, patient baseline characteristics
are in Fig. 59. Both comparable in age, gender and comorbidities.
The main reason for orotracheal intubation was low-consciousness
level (72,5%). VAP group showed a lower PaO2/FiO2 ratio and higher
CPIS score compared with non-infected patients. VAP patients stayed
longer under mechanical ventilation (20 vs 12 days) and showed a lon-
ger ICU and hospital stay. Finally, no differences in terms of mortality
were evidenced between both, control and pneumonia group.
1231 genes were identified whose expression levels were significantly
different between the two groups. 680 genes were over-expressed in
VAP patients and 551 genes showed lower transcript levels in this
group. A large proportion of the implicated genes were down-
regulated in patients with VAP. The molecules codified by these genes
are related to immunological synapse, it`s suggested a depression of
the antigen presentation in these patients.
CONCLUSIONS. These results support the idea of being able to be
used the gene expression as biomarkers in the early diagnosis of
ventilator adquired pneumonia.
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INTRODUCTION. The mechanisms and the microscopic distribution
of alveolar volume changes induced by mechanical ventilation are
still under debate for the difficulty of exploring them in vivo without
altering the physiological properties of the respiratory system.
Synchrotron Radiation Computed Tomography (SRCT) allows to
image lung tissue at a higher resolution than conventional CT
without modifying chest wall/lung interaction and to explore
in vivo the microscopic effects of ventilatory parameters, like
Positive End-Expiratory Pressure (PEEP).
OBJECTIVES. To test the effect of different PEEP on pulmonary
microscopic structures characteristics in the core and in the
peripheral areas of the lung.
METHODS. Seven anesthetized and paralyzed New Zealand rabbits
underwent a decremental PEEP trial at 5 levels of PEEP (12, 9, 6, 3
and 0 cmH2O); during the trial, end-expiratory SRCT scans (pixel size:
47.6 μm) were acquired. The PEEP sequence and image acquisition
protocol was repeated after the induction of an experimental ARDS
model (lung lavage + injurious ventilation) in 5 animals. Images were
analyzed using MatLab (Mathworks, Natick, USA) Image Processing
Toolbox after image contrast enhancement. Airspaces (AS) were
automatically segmented based on X-ray density. The average air-
space dimension (AsD), corresponding to the average number of
pixels in each airspace, was evaluated in the peripheral lung (PL)
and in the core lung (CL) for each level of PEEP and in both condi-
tions. A two tails Mann–Whitney test (α = 0.05) was used to evalu-
ate any statistical difference between the AsD in the PL and CL for
each level of PEEP.
RESULTS. In healthy lungs, the AsD was higher in the CL than in the
PL at all PEEP levels. No statistically significant difference was found
at PEEP 0 cmH2O. In injured lungs, an opposite behavior was found,
although without statistical significance. A high standard deviation
was present in injured conditions, reduced at PEEP 12 cmH2O both
for PL and CL.
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 65 of 542CONCLUSIONS. The morphological characteristics of the
microscopical structures of the lung are different between
peripheral and core region both in healthy and in injured
conditions. In healthy lungs, the AsD is bigger in the CL than in
the PL at PEEP higher than 3 cmH2O. In injured conditions, the
AsD of the PL tended to be higher than in the CL. Moreover, a
high inter-animal variability at low PEEP was present, that was
reduced at PEEP 12 cmH2O.
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Intensive Care Medicine Experimental 2017, 5(Suppl 2):0122INTRODUCTION. Air redistribution inside the lung parenchyma - i.e.
pendelluft phenomena - has been described as cause of occult
overstretch in injured lungs during spontaneous breathing efforts [1].
OBJECTIVES. Objective of the current study was to test whether the
pattern of air redistribution in injured lungs during spontaneous
breathing is affected by the respiratory lung volume.
METHODS. Five anesthetized, tracheostomized spontaneous breathing
pigs (25–30 kg) underwent lung lavages to achieve mild ARDS with a
PaO2/FiO2 ratio of 250. High frequency (20 Hz) dynamic CT images
were acquired at different lung volumes obtained by six continuous
airway pressure levels (CPAP - from 15 to 0, in steps of 3 cmH2O).The
images acquired during the inspiratory phase were analyzed. Regions
of interest (ROIs) outlining and image registration were performed to
enable image comparisons. The registered ROIs were sequentially
subtracted to obtain delta volumes (ΔV) both for complete breaths
(total ΔV: end-inspiratory - end-expiratory images) and for consecutive
inspiratory images (partial ΔV: volume ROI (t+1) - volume ROI (t)).
The voxel ΔV distributions were classified in five histogram bins:
– highly negative ΔV (NN: from −5*10−4 to −2.5*10−4 mL),
– negative ΔV (N: from −2.5*10−4 to 0 mL),
– zero ΔV (Z: 0 mL),
– positive ΔV (P: from 0 to +2.5*10−4 mL),
– highly positive ΔV (PP: from +2.5*10−4 to +5*10−4 mL).
Student t-test was applied to determine differences in total ΔV
distributions.
RESULTS. Multiple simultaneous transients of local air redistribution
continuously occurred during the inspiratory phase. Negative regional ΔV
indicated temporary decreases in regional lung volume during inspiration.
The fugacious pendelluft phenomena were more represented at high
lung volumes (high CPAP). By analyzing total ΔV distributions, CPAP lower
than 6 cmH2O significantly changed the pattern of air redistribution, by
reducing the pendelluft phenomena and increasing overinflation (Figure.
*: statistical differences among different CPAP levels).
CONCLUSIONS. The current study demonstrates complex processes
of air redistribution inside the lung parenchyma during spontaneous
breathing.The present results show that pendelluft phenomena are
not necessarily associated with detrimental ventilatory conditions.
Our analysis introduces new understanding of lung aeration with
pendelluft as a potential stabilizer of the lung.
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Table 38 (Abstract 0123). See text for description
Baseline (n=5) T0 (n=5) Tend (n=5) P-value RM-
ANOVA One Way
PaO2 (mmHg) 254±17 248±8 179±110 0,201
PaCO2 (mmHg) 38±3 41±4 43±16 0,766
pH 7,46±0,03 7,43±0,04 7,41±0,13 0,722
PaO2/FiO2 508±34,5 496±16 346±238 0,196
Table 39 (Abstract 0123). See text for description
Baseline
(n=5)
T0
(n=5)
Tend
(n=5)
P-value RM-
ANOVA One Way
Gas/tissue ratio, Right Lung 43,2±10,2 40,8±8,9 30,0±16,8 0,04
Gas/tissue ratio, Left Lung 42,4±8,6 44,3±8,3 33,9±13,8 0,089
Normally aerated tissue,
Right Lung (%)
32,9±24,3 29,6±19,5 20,4±22,2 0,071
Normally aerated tissue,
Left Lung (%)
30,2±22,4 34,9±18,5 22,7±18,9 0,074
Poorly aerated tissue,
Right Lung (%)
60,0±19,7 59,5±12,9 42,7±20,1 0,157
Poorly aerated tissue,
Left Lung (%)
64,4±19,3 55,7±14,2 45,4±23,6 0,179
Nonaerated tissue,
Right Lung (%)
6,9±6,1 10,9±6,7 36,9±30,8 0,05
Nonaerated tissue,
Left Lung (%)
5,3±3,3 9,5±4,5 31,8±28,3 0,07
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INTRODUCTION. Previous studies showed that spontaneous ventilation
coupled with complete block of pulmonary perfusion induces severe
lung injury within 2–5 days [1–2]. In the present study, we aimed to
assess the long-term effects of mechanical ventilation and partial
pulmonary perfusion block.
OBJECTIVE. We investigated the effects on blood gases, respiratory
mechanics and lung edema of prolonged controlled ventilation with
tidal volume of 12 ml/kg and low driving transpulmonary pressure
associated with constant inflation of a Swan-Ganz catheter balloon to
partially occlude lung perfusion.
MATERIAL AND METHODS. We report preliminary data from 5
healthy female pigs (18 ± 5 Kg). After anesthesia and
instrumentation (Baseline), controlled ventilation was started with 12
ml/Kg of tidal volume, PEEP 0 cmH2O, respiratory rate 20 bpm,
I:E = 1:2 and FiO2 50% (T0), then the Swan-Ganz catheter balloon
was filled with water to partially occlude left pulmonary vascular tree
(T0). Ventilation and the Swan-Ganz catheter inflation and position
were left unchanged until sacrifice. Animals were sacrificed at 48 hours
or when diffuse bilateral infiltrates became evident at chest CT scan
(Tend). At Baseline, T0 and Tend, we collected gas exchange, physio-
logic dead space (VdPhys), respiratory mechanics and we performed
chest CT scans at end-expiration and end-inspiration for offline quanti-
tative analysis (Maluna 3.17 software, Göttingen, Germany).
RESULTS. Two animals were sacrificed at 30 and 42 hours, having
developed early diffuse lung injury, while 3 were sacrificed at 48 hours.
Along the study, plateau pressure, driving airway pressure and driving
transpulmonary pressure significantly increased because of steep
bilateral decrease of respiratory system compliance, likely caused by
worsened lung compliance (see Table 37). PaO2 declined, too, albeit
non-significantly (Table 38). Quantitative analysis of CT scan showed
decreased gas/tissue ratio and increased non-aerated lung paren-
chyma, especially in the non-occluded right lung (Table 39).
CONCLUSIONS. The present study generates the hypothesis that in
healthy lungs mechanically ventilated with low transpulmonary
pressure partial occlusion of the left pulmonary perfusion might
induce edema and derecruitment within 48 hours.
REFERENCES
[1] Slutsky AS et al. N Engl J Med 2013;
[2] Kolobow T et al. Inter J Artif Organs 1981Table 37 (Abstract 0123). See text for description
Baseline
(n=5)
T0
(n=5)
Tend
(n=5)
P-value RM-
ANOVA One Way
Plateau pressure (cmH2O) 10±1 11±2 21±11 <0,05
Driving airway Pressure (cmH2O) 9±1 10±2 20±11 <0,05
Driving transpulmonary
pressure (cmH2O)
5±1 6±1 15±10 <0,05
Respiratory system compliance
(ml/cmH2O)
24±5 22±5 12±4 <0,05
Lung compliance (ml/cmH2O) 48±13 39±7 22±16 <0,05
Chest wall compliance (ml/cmH2O) 48±13 52±24 44±15 0,762
Respiratory system compliance,
right side (ml/cmH2O)
11±2 12±3 7±2 0,01
Respiratory system compliance,
left side (ml/cmH2O)
9±2 8±2 5±1 <0,01
Physiologic dead space 0,28±0,09 0,34±0,08 0,48±0,15 0,120Gastrointestinal dysfunction
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INTRODUCTION. Hypernatremia is associated with worse outcomes in
critically ill patients and sodium renal excretion has been identified as
one of its contributing factors. In addition to water administration, the
treatment with thiazides has been suggested as an alternative to
improve sodium renal excretion. However, evidences are scarce and
available studies have been inconclusive. (1–3)
OBJECTIVES. Our aim was to analyze the kinetics of serum sodium in
hypernatremic critically ill patients in whom thiazides were initiated
for the treatment of hypernatremia.
METHODS. Unicentric, prospective, observational study of critically ill
patients with hypernatremia (defined as serum sodium greater than
145 mEq/L) in whom thiazides were initiated for the treatment of
hypernatremia. Patients with chronic kidney injury or in palliative
care were excluded. The main outcome was the comparison of
serum sodium variation before and after the thiazides were initiated.
The patients were followed up to hospital discharge.
RESULTS. During 7 months, 103 hypernatremic critically ill patients
were evaluated and a thiazide was initiated in 14 (13%). Twelve
(86%) patients were male, and the most common admission
diagnosis was respiratory failure with 7 (50%) patients. Mean (SD)
age and SAPS 3 on admission were 67 (22) years and 60.3 (4.7),
respectively and median (IQR) serum sodium and fluid balance
before development of hypernatremia were 142 (141–144) mEq/L
Table 40 (Abstract 0125). Epidemiological characterstics
All
N=800
AGImax
0
N=138
AGImax
1
N=194
AGImax
2
N=217
AGImax
3
N=197
AGImax
4 N=54
P
(adjusted)
Age 45±19 42±17 44±19 44±19 47±19 52±19 0.009
Gender (male) 529(66) 94(68) 126(65) 143(66) 127(64) 39(72) 0.83
APACHE II 17±6 14±6 17±6 17±6 19±6 19±7 0.0000
SOFA24hs 7[4-9] 4[3-6] 6[4-8] 7[5-10] 8[6-10] 10[7-10] 0.0001
Charlson
score
0[0-1] 0[0-1] 0[0-1] 0[0-1] 1[0-2] 2[1-2] 0.0001
Medical/
emergency
surgery/
elective
surgery
admission (%)
55/38/
7
66/30/4 52/41/7 59/33/8 50/42/8 33/63/4 0.000
Vasopressor
use
494(62) 10(7) 115(59) 150(69) 168(85) 51(92) 0.000
ICU length of
stay
14[9-
25]
11[7-17] 15[10-
26]
16[10-
26]
16[10-
27]
18[10-
28]
0.00001
Hospital
mortality
318(40) 7(5) 31(16) 90(41) 143(73) 47(87) 0.000
Table 41 (Abstract 0125). Nutritional variables
All
N=800
AGImax
0
N=138
AGImax
1
N=194
AGImax
2
N=217
AGImax
3
N=197
AGImax
4 N=54
P
(adjusted)
Primary
gastrointestinal
failure
137(17) 2(1) 10(5) 20(9) 64(32) 41(76) 0.000
BMI 23±8 22±7 22±8 23±8 23±8 20±12 0.58
NUTRIC score 4[2-5] 2[1-4] 3[2-5] 4[3-5] 5[4-6] 5[4-6] 0.0001
NUTRIC score
≥5 (High
nutrition risk)
313(39) 15(11) 49(25) 82(38) 128(65) 39(72) 0.000
Cumulative
caloric debt
(1st week)
−3300
[-6000
to
-1200]
−560
[-800 to
-320]
−2000
[-2700
to
-1100]
−4000
[-5500
to
-3000]
−7000
[-9000
to
-5000]
−10000
[-12000
to -7335]
0.0001
Efficacy
(Delivered/
targeted kcal,
%)
68[48-
82]
88[84-
92]
80[75-
84]
65[60-
74]
40[30-
51]
20[10-30] 0.0001
Early enteral
nutrition (≤48
hr)
497(63) 127(92) 136(70) 146(67) 81(42) 7(11) 0.000
Supplemental
Parenteral
Nutrition
65(8) 0(0) 3(2) 4(2) 28(14) 30(57) 0.000
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58.5 (25–75) mg and maximum serum sodium was 150 (148–159)
mEq/L. Thiazides initiation was associated with a decrease in serum
sodium, with mean (SD) serum sodium variation before and after
HCTZ of 3.3 (7.7) mEq/L and −5.6 (6.34) mEq/L, respectively, P = 0.02.
CONCLUSIONS. Initiation of thiazides for the treatment of
hypernatremia was associated to a significant decrease in serum
sodium. A causal association would be addressed by an adequately
powered randomized clinical trial.
REFERENCE(S)
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Care Resusc. 2014;16(2):140–2.
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randomized controlled trial. J Crit Care. 2017;38:225–30.
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INTRODUCTION. Gastrointestinal dysfunction (GID) occurs frequently in
the ICU and has been associated to increased mortality; yet it has not
consistently been analyzed nor has been included in prognostic scores.
OBJECTIVES. To characterize GID and its impact on mortality in
critically ill patients.
METHODS. Prospective multicenter cohort study launched by SATI.
Between 1/1/12-6/1/14, patients admitted to the ICU on mechanical
ventilation ≥48 hr were included. Epidemiological data, vasopressor
use, SOFA24hs, Charlson and NUTRIC scores, BMI, 1
st-week cumulative
caloric debt (1w-CC debt), early enteral nutrition and delivered/
targeted kcal (efficacy) were collected. Acute gastrointestinal Injury
(AGI) score was calculated until day 28; maximum AGI (AGImax) was
identified, and then patients were classified in 5 categories (0 to 4)
according to AGI score1. GID was classified as gastrointestinal
(primary) or secondary. High nutrition risk was considered as NUTRIC
≥52. Hospital mortality was the main endpoint. Variables differing
from survivors and nonsurvivors were entered in a logistic regression
model. ROC curves were built to assess performance of AGImax,
NUTRIC, SOFA24hs and 1w-CC debt on mortality. A p value of 0.05
was considered significant for all comparisons. Adjustement for mul-
tiple comparisons was made if necessary.
RESULTS. This study was carried out in 10 ICUs from Argentina and 800
patients were included. Comparisons between epidemiological and
nutritional variables for AGImax categories are shown in Tables 40 and 41.
Figure 63 displays ROC curves for mortality with different scores. Logistic
regression identified AGImax(OR 1.97[1.51-2.59]), NUTRIC ≥5 (OR 5.28[3.43-
8.13]), vasopressor use (OR 3.77[2.33-6.11]) age (OR 1.01[1.00-1.02]) and1W-CC debt (OR 1.01[1.01-1.02]); all p < 0.01, as main predictors of mor-
tality. Statistical analysis was performed with STATA 13 software.
CONCLUSIONS.
1) In this severely ill cohort of ICU mechanically-ventilated patients
with frequent use of vasopressors, increasing severity of AGImax categor-
ies adequately predicts mortality, which highlights its prognostic accur-
acy. This association was also evident for NUTRIC score and 1w-CCdebt.
2) Discriminative power of AGImax, NUTRIC and 1w-CC debt was ex-
cellent, and significantly better than SOFA24hs.
3) This study underscores the prognostic validity of nutritional scores,
thus supporting their inclusion in global severity scores like SOFA.
1. Reintam et al., ESICM Working Group on Abdominal Problems, ICM
2012;38:384.
2. Heyland et al., Crit Care 2011; 15:R268.
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Fig. 63 (abstract 0125). Discriminative power for mortality
Fig. 64 (abstract 0126). Kaplan-Meier curve: GIF vs no GIF
Table 42 (Abstract 0126). SOFA and GIF predicting 90-day mortality
Variable OR Lower CI 95 % Upper CI 95 % P value
SOFA respiratory 1.097 1.018 1.182 0.015
SOFA haematologic 1.207 1.119 1.303 <0.001
SOFA hepatic 1.172 1.071 1.283 0.001
SOFA cardiovascular 1.499 1.414 1.591 < 0.001
SOFA neurological 1.445 1.377 1.515 < 0.001
SOFA renal 1.342 1.276 1.410 < 0.001
GIF 1.586 1.126 2.233 0.008
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INTRODUCTION. Whereas a unified definition of gastrointestinal
failure (GIF) is still lacking, number of concomitant GI symptoms has
been suggested to identify GIF leading to impaired outcome [1].
OBJECTIVES. To describe the incidence and outcome of GIF in ICU
patients and compare primary versus secondary GIF.
METHODS. We analysed a prospective database including all
consecutive patients treated in a mixed ICU at Tartu University
Hospital in years 2004–2015. Daily data were collected during
patients' ICU stay and follow-up performed for 90-day survival using
National Death Registry. Local Ethics Committee approved the study.
GIF was considered present if a patient experienced ≥ 3 of the fol-
lowing 6 symptoms in one day: maximum gastric residual vol-
ume ≥ 500 mL; absent bowel sounds; vomiting or regurgitation;
diarrhea; suspected or radiologically confirmed bowel distension;
gastrointestinal bleeding [1]. Division into primary (gastrointestinal
pathology leading to GIF) and secondary (GIF due to other condi-
tions) GIF was made based on the origin of the syndrome.
RESULTS. GIF developed in 420 (10,4%) of the 4047 patients studied.
Primary GIF was present in 251 (59,8%) and secondary GIF in 169
(40,2%) patients. Development of GIF was associated with longer
mechanical ventilation (MV; median 9 (IQR 3–22) vs 2 (IQR 1–6) days),
ICU stay (median 11 (IQR 5–25) vs 3 (IQR 1–8) days) and a higher ICU
(34,8 vs 17,6%), 30-day (39,6 vs 26,4%) and 90-day mortality (49,6 vs
31,8%; Fig. 64), P < 0,001 for all.
Patients with primary origin of GIF experienced more gastrointestinal
symptoms than those with secondary GIF (P < 0,05 on days 1–6, 10,
11). As opposed to those with secondary GIF, patients with primary
GIF more frequently had sepsis (54,3 vs 40,7%; P = 0,007) and
surgery on admission day (68,3 vs 46,7%; P < 0,001), whereas no
differences were noted in MV days, ICU stay and ICU, 30- and 90-day
mortality. All SOFA sub-scores on admission day independently pre-
dicted 90-day mortality, adding GIF to this model slightly improved
mortality prediction (Table 42).CONCLUSIONS. Gastrointestinal failure, independent of origin, is
associated with impaired ICU outcome. Similarly to other organ
failures, GIF independently predicts mortality.
REFERENCE(S)
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INTRODUCTION. In 2012 the SEMICYUC published a consensus
document with 82 recommendations for the management of acute
pancreatitis in ICU. Of these we highlight the new classification of
acute pancreatitis based on evolutionary determinants, new surgical
techniques and nutritional recommendations. Based on these
recommendations we have focused in the last 6 years the diagnosis
and treatment of PA.
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 69 of 542OBJECTIVES. Describe the epidemiology of patients with AP in the
last 6 years in our ICU. Assess whether the adoption of the
recommendations of SEMICYUC, has or not impact on the evolution
of this disease.
METHODS. Retrospective descriptive study of 100 patients diagnosed
with acute pancreatitis in the period from 01/01/2011 to 31/12/2016.
We have studied the following variables: etiology, age, sex, APACHE
II, SOFA, PIA, organ failure (respiratory, renal hemodynamics) severity
rating, nutrition, need for mechanical ventilation (MV) or therapies
extrarenal depuration (TDR) days of ICU stay and hospital, and
mortality.
RESULTS.
Etiology: 32´35% alcohol; 38´23% bile; 11´76% post ERCP, 11.78%
indeterminate; 5.88% hypertriglyceridemia.
Age: 58´87 ± 14´55,
APACHE II 15´58 ± 7´48,
SOFA 7´11 ± 4´3,
PIA 14´19 ± 3´74,
ICU stay 2015 15´87 ± 27´26, 2014 13´93 ± 17´65, 2013 12´36 ± 14´
43, 2012 7´35 ± 10´43, 2011 5´61 ± 15´83,
respiratory disfunction no 49´04%, yes 50´96%,
renal disfunction no 32´27%, yes 67´73%,
hemodynamic dysfunction no 37´03%, yes 62,27%.
The most pancreatitis entered in 2011 and 2012 were serious (61´
53% 54´16%) while in 2013 and 2014 the most frequent were
moderate (55´66% and 50%).
Nutrition: Parenteral 43´96% 32´25% absolute, enteral 22´6%.
Need for
mechanical ventilation: 56´86% and
therapy renal clearance 33´74%.
Mortality. 2011 35% 2012 52% 2013 28% 2014 29´41%, 2015 20´12%,
2016 50%
CONCLUSIONS. In the past two years we have entered in ICU more
moderate pancreatitis than severe. After the implementation of the
SEMICYUC recommendations, has decreased overall mortality, but
not ICU stay. Noted that we still use parenteral nutrition despite
enteral via jejunal is a choice with strong recommendation grade
and high-quality evidence.
REFERENCE(S)
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INTRODUCTION. Although most of patients with pneumatosis
intestinalis (PI) has been reported to be asymptomatic, bowel
ischemia should be considered as a cause of PI in critically ill
patients. However, there is a relative paucity of information on the
characteristics of asymptomatic PI in critically ill patients.
OBJECTIVES. Purpose of this study was to clarify the characteristics
of asymptomatic PI, and to assess the usefulness of clinical features
for the differentiation between asymptomatic and bowel ischemia-
related PI.
METHODS. This single-institutional retrospective observational study
collected data from patients of PI between 2013 and 2015. PI was di-
agnosed with CT examination. Bowel ischemia/necrosis was diag-
nosed with operative findings or clinical course in non-operative
patients. Clinical information on admission and at the time of diag-
nosis of PI was recorded.
RESULTS. Of 34 patients, 21 patients were asymptomatic and 13
were associated with bowel ischemia/necrosis. There was nodifference in underlying diseases. In patients with bowel ischemia,
APACHE-II and SOFA scores on admission (32 vs 21, p = 0.01; 11 vs 6,
p = 0.01), C-reactive protein value at detection of PI (10.7 vs 1.5 mg/
dL, p = 0.01, respectively) were higher, and onset of PI (5 vs 33 days,
p = 0.01) was earlier as compared to those of asymptomatic patients.
The rate of proceeding diarrhea and distribution of PI limited to
colon was higher in asymptomatic patients with sensitivity and speci-
ficity: 92%, 71%, and 92%, 71%, respectively. On the other hand, asci-
tes collection (sensitivity and specificity; 92%, 95%), PI in stomach
and duodenum (83%, 71%), and in small intestine (92%, 71%) were
pathognomonic for patients with bowel ischemia. Hospital mortality
was 69% in patients with ischemia and 0% in asymptomatic.
CONCLUSIONS. PI may be relatively common condition in critically ill
patient. Although PI located only in colon with proceeding diarrhea
may be asymptomatic, those presented in upper gastrointestinal
tract with ascites collection may be associated with bowel ischemia,
with high mortality.
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INTRODUCTION. The incidence of acute pancreatitis (AP) ranges
between 5 and 80 per 100,000 population. In Europe more patients
tend to have biliary tract-related pancreatitis and less frequently alco-
hol, trauma or ERCP-related pancreatitis. About 25% of the patients
with AP develop severe acute pancreatitis (SAP), which is strongly as-
sociated with organ failure and local complications such as pancre-
atic or peripancreatic necrosis and formation of pseudocyst. Overall
mortality has decreased but still ranges 15%-25%.
OBJECTIVES. To analyze the epidemiological characteristics of
patients admitted to the intensive care unit with diagnosis of SAP.
METHODS. Retrospective cohort study including patients admitted
to the ICU of a referral hospital with the diagnosis of SAP between
2005 and 2015. Demographic variables, severity score (APACHE II),
etiology, ICU and hospital mortality were collected from medical
records. Quantitative variables were compared by Student´s T or
Mann–Whitney test, as appropriate. The qualitative ones were
compared by chi-square or Fisher´s test depending on data. Data
were expressed as means and standard deviation (SD), odds ratio
(OR) and 95% confidence intervals (95CI). p values < 0.05 were con-
sidered statistically significant.
RESULTS. 115 patients with SAP were admitted to the ICU, 54.8%
males. 21.7% had a history of cholelithiasis, 7.8% had previous
pancreatitis and 7.8% history of chronic alcoholism.
Among the etiology, biliary was the most frequent (39.1%) followed
by indeterminate (21%), alcoholic (13.9%), ERCP-related (9.6%), hyper-
triglyceridemic (7%) and drug-induced (3.5%).
In terms of mortality according to etiology, higher mortality was
observed in edematous pancreatitis (36.6%) compare to necrotizing
pancreatitis (21.6%) without reaching statistical significance.
Higher mortality was observed in patients who received total
parenteral nutrition (TPN) (60.7%) compared to those with enteral
nutrition (OR: 8, 95CI: 3.1-20.8, p value: 0.00), without differences
between nasogastric and nasojejunal feeding.
Pancreatic fluid collections were observed in 90.9% in ERCP-related
pancreatitis without reaching statistical significance. 56.7% of pa-
tients with alcoholic related pancreatitis required percutaneous drain-
age of the fluid collections (OR, 3.4, 95CI: 1.16-10.11).
CONCLUSIONS. In the patients included in our study biliary tract-
related pancreatitis is the most frequent etiology of SAP. We found
no difference in mortality among the different etiologies.
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 70 of 542Higher mortality was observed in edematous pancreatitis but without
reaching statistical significance.TPN was associated with higher
mortality compared to enteral nutrition.
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INTRODUCTION. Although the measurement of free cortisol remains
ideal in assessment of hypothalamic pituitary adrenal function, it is
not routinely measured. Cortisol in saliva correlates well with the
biologically active free cortisol in the circulation.
OBJECTIVES. The aim of this study was to investigate the utility of
morning basal and ACTH-stimulated salivary cortisol in critically ill pa-
tients and compare the results with non-critically ill patients.
METHODS. We prospectively enrolled 49 mechanically ventilated
patients with various illnesses and 120 patients from the outpatient
clinic. Serum and saliva samples were drawn between 8 am and
10 am. The salivary samples were inadequate in 14 critically ill
patients (28.5%) and these patients were excluded in the final
analysis. Salivary cortisol levels were measured using an enzyme
immunoassay kit.
RESULTS. Critically ill patients (n = 34) were significantly older and
had lower BMI, serum albumin and higher serum creatinine
compared to the non-critically ill patients (n = 120). After adjust-
ments for these parameters, both basal and stimulated salivary and
serum cortisol levels were higher in critically ill patients. Increment
of salivary cortisol, but not serum cortisol were higher in the critic-
ally ill patients. In critically ill patients, there was significant correla-
tions among serum albumin, basal salivary cortisol, increment of
serum cortisol and the patient's APACHE II scores. Increment of
serum cortisol was the only significantly different variable between
the APACHE II score ≥25 group and the APACHE II score < 25
group. Receiver-operating characteristic (ROC) analysis allowed the
cutoff level of delta serum cortisol to be 8.2 mg/dL (sensitivity,
76.5%; specificity, 64.7%; AUC = 0.753).
CONCLUSIONS. Both basal and stimulated salivary and serum
cortisol levels were higher in critically ill patients. Increment of serum
cortisol was significantly higher in the APACHE II >25 group.
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OBJECTIVE. To explore the value of early enteral nutrition in the
treatment of severe burn patients.
METHODS. Choose 52 severe burn patients who are hospitalized in
Suzhou ICU and fit inclusion criteria from August to September in
2014 to make retrospective analysis. According to starting time, they
are divided into early enteral nutrition group (EEN group, n = 28)
and non-early enteral nutrition group (NEEN group, n = 24). To com-
pare the amount of intake energy to object energy, the amount of
enteral and parenteral nutrient intake to total energy respectively
when two group patients are burned from 1st to 7th day, at 14thday, 21st day and 28th day. And also, to compare scores of Acute
physiology and chronic health evaluation (APACHE II), prealbumin,
creatinine, urea nitrogen when two group patients are treated at 3rd
day, 7th day, 14th day, 28th day, primary operation time in 28 days
and operation numbers as clinical data.
RESULTS. Two group patients are both given enteral nutrition when
hospitalized in 3 days. In 7 days, their total intake energy are both
lower than object energy, and EEN group is much lower. At 14th day,
21st day and 28th day, their total intake energy are both meet
object needed energy. And increase trend of EEN group is much
stable. Their enteral nutrient intake is roughly equal to parenteral
nutrient intake from 4th day, and take enteral way as first in 7 days.
After treatment, scores of APACHE II are both improved, and scores
of two group patients at 3rd day, 7th day, 14th day, and 28th day
are both better than hospitalized in ICU(P < 0.05). Scores of APACHE
II for EEN group at 7th day, 14th day, and 28th day are better than
NEEN group. Prealbumin numbers for EEN group at 28th day are
better than NEEN group(P < 0.05). And creatinine, urea nitrogen at
3rd day, 7th day, 14th day, 28th day, primary operation time in 28
days and total operation numbers for two group patients have no
statistical differences. Also, the incidence of enteral nutrient adverse
reaction for two group patients have no statistical differences.
CONCLUSIONS. Using early enteral nutrition in therapies for severe
burn patients can make energy intake more stably, reduce disease
severity of patients, improve plasma albumin numbers at 28th day,
and will not increase the incidence of adverse reaction.
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INTRODUCTION. The central nervous system (CNS) and gastrointestinal
tract (GIT) are linked through neuro-endocrine pathways and humoral
mediators. Critically ill patients frequently receive acid suppressing
agents to reduce the likelihood of GIT bleeding caused by physiologic
stress; however, acid suppression during physiologic stress may alter
GIT microbiota and CNS activity.
OBJECTIVES. To comparatively evaluate the GIT microbiota and the
gene expression of neurocognitive mediators between esomeprazole
and placebo in a murine model of physiologic stress.
METHODS. Twenty-four male C57BL/6J mice were randomly assigned
to physiologic stress induced by hypothermic immobilization or con-
trol environment for three hours daily and either esomeprazole 2
mg/kg or saline by intraperitoneal injection daily. After three days,
mice were sacrificed and stomach, ileum, colon, frontal lobe, and the
hippocampus were harvested. Broad-range analysis of 16S rRNA
genes of GIT samples was used to determine microbiome profiles
and RNA-seq was performed to determine expression profiles of
mRNA with enrichment analyses.
RESULTS. The mucosa of stressed mice showed mild gastritis. Both
stress (p < 0.001) and esomeprazole (p = 0.006) had significant,
independent effects on the stomach microbiota to alter the
distribution of commensal organisms. Esomeprazole, but not stress,
produced modest changes in the microbiota of the ileum (p = 0.056)
and colon (p = 0.022). Stress induced differential expression of 5
genes in the frontal lobe, but no genes in the hippocampus. The
addition of esomeprazole to stress induced differential expression
of 124 genes in the hippocampus, the majority of which were
down-regulated. The biological processes were most affected by
these 124 genes included synaptic transmissions; locomotor be-
havior; associative learning; sensory perception to pain; feeding
behavior; peristalsis; dopamine receptor signaling and synapse; re-
sponse to hypoxia; and response to drugs such as ethanol, nico-
tine, amphetamine, and cocaine. Stress and esomeprazole had
limited effect on the frontal lobe.
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 71 of 542CONCLUSIONS. Acute physiologic stress has region-specific effects
on the GIT microbiota. Distribution of commensal organisms is al-
tered with stress and the effect is heightened with acid suppression.
Acute stress alone has limited impact on CNS gene expression. The
addition of acid suppression, however, has region-specific effects on
CNS gene expression with the greatest impact in the hippocampus.
Several key biological processes for neuro-cognition are affected. Fur-
ther studies are needed to validate these results, determine associa-
tions between microbiota disturbances and altered gene expression,
and assess associations between altered gene expression and bio-
chemical aberrations and neuro-cognitive / behavioral outcomes.
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INTRODUCTION. The stress response induced by critical illness leads
to a catabolic state in ICU patients. The first observations that
catabolism was accompanied by an increased excretion of
intracellular ions, were made as early as the beginning of the 20th
century. Recently, it was demonstrated that critically ill patients have
a negative potassium balance, presumably resulting from the
catabolic process as well, reflecting loss of lean body mass. However,
there is not much information about the relation with other ions.
Since both potassium and phosphate reside mainly intracellular, we
hypothesized that potassium and phosphate excretion are related.
We also explored the relationship of potassium and phosphate
excretion with sodium and chloride excretion, both ions that reside
mainly in the extracellular compartment.
OBJECTIVE. To compare potassium, sodium, chloride and phosphate
excretions and identify which ions are most strongly related in
critically ill patients.
METHODS. This study was a retrospective, observational study from
September 2015 to April 2016, evaluating all patients with at least
one adequate urinary measurement during the first three ICU days in
our university teaching hospital. The first ICU admission of the last
hospital admission was evaluated. Daily electrolyte excretions were
measured in 24-h urine collections and mean electrolyte excretions
were calculated for each patient. Patients who had AKI class 3 ac-
cording to the KDIGO criteria were excluded.
RESULTS. A total of 1382 ICU patients were included with 4294 urine
collections. Mean ± SD potassium, phosphate, sodium and chloride
excretion were 57 ± 31, 18 ± 13, 92 ± 86, 103 ± 87 mmol/day
respectively. Potassium excretion was most strongly associated with
phosphate excretion (R = +0.63, p < 0.001). Sodium excretion was
most strongly correlated with chloride excretion (R = +0.95,
p < 0.001). Potassium excretion was also associated with sodium and
chloride excretion (R = +0.45 and R = +0.54, p < 0.001). The
correlation between phosphate and both sodium and chloride
excretion was weaker but also significant (R = +0.29, p < 0.001).
CONCLUSIONS. Potassium and phosphate excretion were most
closely related in critically ill patients, most likely due to their
intracellular nature. Likewise the extracellular ions sodium and
chloride were most strongly related. The relation of sodium and
chloride with potassium excretion may be explained by the renalexchange of potassium and sodium and the administration of
potassium chloride. Additional balance studies combined with a
more detailed urine excretion analysis will most likely result in a
better understanding of the association of potassium and phosphate
excretion with catabolism and of sodium and chloride excretion with
infusion-related extracellular volume expansion.
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INTRODUCTION. Appropriate delivery of nutritional support is
fundamental to the care of the critically unwell patient. Regular
interruptions to enteral feeding and medications due to Nasogastric
Tube (NGT) displacement can be a frequent and avoidable occurrence
in ICU patients.
OBJECTIVES. Evaluate the frequency and duration of enteral feeding
interruptions and missed medications due to NGT displacement.
METHODS. Data were retrospectively collected from a tertiary ICU
over a 3-month period (patients admitted to a single combined ICU/
HDU between 1st of January and 1st of March 2016). Data collected
included the number of enteral feed interruptions due to NGT dis-
placement, specific reasons for tube dislodgement, duration of
missed enteral feeding as well as the type and number of medica-
tions missed.
RESULTS. There were 519 patients admitted to the study ICU. Of
these, 133 patients (26%) had a NGT in place for enteral nutrition.
Overall there were 124 displaced NGTs over this time period; an
average of 3 displaced tubes per patient. Forty-four patients (33%)
had enteral feeding interrupted due to NGT displacement. The max-
imum number of dislodgements on one patient was 13 leading to a
total 154 hours without nutrition which resulted in a deficit of
15,400kcal over a 73 day period (~210kcal/day, >10% estimated en-
ergy requirements). NGT pulled out by patient accounted for 49% of
these displacements with migrated tubes accounting for 31%. Other
reasons for dislodgement were NGTs removed due to blocking
(13%), no aspirate (2%), not stated (4%) and 1 NGT was leaking. 64%
of NGT displacements occurred in non-sedated patients. Total
number of hours of missed enteral feeding was 1315 hours (an
average 30 hours per patient). 264 medication doses were missed.
Medications missed included beta-blockers, anti-hypertensives and
lactulose (in an encephalopathic patient). The average length of
stay the in ICU for patients who had at least one NGT displacement
was 25 days.
CONCLUSIONS. NGT displacement is common amongst ICU patients,
particularly those who are not sedated, and a frequent cause of
interruption to nutritional support and medication administration in
ICU/HDU patients.
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INTRODUCTION. Recent ESCIM1 guidelines suggest measuring gastric
residual volume (GRV) 6 hourly (Grade 2B) upon commencement of
enteral nutrition (EN) and delaying this if aspirates are >500ml.
ASPEN & SCCM2,3 practice guidelines conclude that high GRV alone
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 72 of 542cannot be correlated with aspiration pneumonia, ICU mortality or ICU
length of stay and only when considered with other markers of
patient illness does the correlation with worsening patient outcome
emerge. Despite this there remains some ambiguity with regards to
the value of GRV once enteral feed is established with practice
differing amongst ICUs.
OBJECTIVES. To assess incidence of high GRV amongst critically ill
patients and their ICU outcome in a single centre and appraise
current practice of response to high GRVs.
METHODS. All patients admitted to Royal Surrey County Hospital ICU
in 2016 requiring mechanical ventilation for more than 24 hours
and receiving EN were identified via IntelliVue Clinical Information
Portfolio (ICIP). These patient's electronic records were reviewed for
GRVs and if exceeding 500ml their subsequent management
reviewed. ICU stay outcome was recorded as improved, worse or
deceased.
RESULTS. 252 patients were identified during screening. 177 were
analysed for rates of enteral nutrition. We identified a 52.5% EN rate
via naso/oro-gastric tube. A GRV of greater than 500ml was found in
12% of these patients, increasing to 17.2% if a GRV of 400ml was to
be deemed significant. Management of those patients with high GRV
consisted of reduction or cessation of EN followed by a slow re-
introduction. TPN was required in only one patient following re-
corded high GRVs. Prescription of single agent prokinetic was vari-
able and at clinician discretion. ICU outcome for those with a GRV
>500ml include a mortality rate of 45.4% with all other patients im-
proved at discharge. This compares to a mortality rate of 24.2% for
the unit for patients requiring mechanical ventilation for >24 hours.
CONCLUSIONS. Monitoring GRV is not a mandatory requirement in
many ICUs however we found the practice of doing so directly
affects the prescription of subsequent EN. Furthermore the presence
of high GRVs may yet be shown to have value in such areas as
patient prognosis, documented results such as this may be stimulus
for further research.
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INTRODUCTION. Despite ESPEN1, ASPEN2 and recent ESCIM3
guidelines, there remains some ambiguity as to the safety and
tolerance in enteral feeding (EF) critically ill patients who are
haemodynamically unstable requiring vasopressor support (VPS).
OBJECTIVES. To
(i) critically appraise current evidence on the safety and tolerance of
EF in patients on VPS and
(ii) Review opinion of UK ICU dietitians and their clinical practice.
METHODS. EMBASE, CINAHL & MEDLINE databases were searched
limited to 2007–2017, human, adult, English published studies, which
reviewed VPS in critically unwell EF patients. A 9 question online
survey of dietitians was conducted to determine opinion and
practice in UK ICUs.
RESULTS.
(i) Literature search provided a total of 3 cohort studies4–6, which
were suitable for critical appraisal. All were retrospective analysis of
American databases. All concluded that provision of EF is safe andtolerated in patients on VPS, although there may be a cut off dose at
which EF is withheld or dose reduced.
(ii) Electronic survey results from 34 anonymous respondents found
that 53% of respondents do assess VPS in EF critically ill patients. 6%
going as far as to specify a VPS dose at which the rate of EF is
reduced. 44% of respondents did not use VPS in isolation to advise a
reduction in, or cessation of EF, instead respondents cited assessing
alternative parameters of feed tolerance. 20% of respondents
reduced and 14% withheld EF if patient requirements for VPS were
“high” or “increasing”. 53% of practitioners expressed concern with
patients on more than one VPS agent.
CONCLUSIONS. Although UK dietetic practice is varied, EF
hemodynamically unstable patients on VPS is safe and tolerated.
Further prospective research is required to result in consistent
practice especially with regards to tailoring nutrition with
vasopressor support in mind.
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INTRODUCTION. Although many studies support the obesity paradox
in cardiac surgery patients, an increased risk for postoperative
complications in extremely obese patients has also been reported.
OBJECTIVES. To investigate whether staging obesity in categories II-
severe and III- morbid (WHO classification) has any value in predict-
ing early postoperative morbidity and mortality after cardiac surgery
procedures.
METHODS. This study was based on our departments' prospectively
collected data. From June 2012 to March 2017 a total of 2084
patients underwent cardiac surgery with the use of cardiopulmonary
bypass. We categorized these patients in obesity stages according to
WHO classification based on BMI. The following factors were compared
between the severely obese and the morbidly obese patients: Sternal
wound infections, septicemia, pneumonia, postoperative respiratory
complications requiring non invasive ventilation (NIV), re-intubation,
acute kidney injury based on RIFLE criteria, multiple organ dysfunction
syndrome (MODS), atrial fibrillation, and mortality. We used x2 test for
statistical analysis.
RESULTS. A total of 704 (33.8%) consisted the obesity category
(BMI > 30 kg/m2). We studied 2 groups: 142(47 females) severely
obese patients -Group A, mean age 63.5 ± 10.4, prognostic Euroscore
II 2 ± 3.2 (BMI 35–39.9 kg/m2) and 40(15 females) morbidly obese
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 73 of 542patients-Group B, mean age 61,8 ± 11.5, Euroscore II 1.65 ± 1.25 (BMI
≥40 kg/m2)- group B. Results are shown in table 43.
CONCLUSIONS. Morbidly obese patients have higher incidence of
pneumonia, acute kidney injury and higher mortality compared with
severely obese cardiac surgery patients.
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2015;4:e002140Table 43 (Abstract 0137). Results
Group A Group B x2, p value
Pneumonia,(n,%) 3(2.1%) 3(7.5%) 4.12, p<0.05
AKI 15(10.6%) 30(75%) 4.42, p<0.05
Deaths 4(2.8%) 3(7.5%) 5.15, p<0.05
Table 44 (Abstract 0138). Demographic datas
Groups CICU
n=112
ICU1
n=64
ICU2
n=38
PACU
n=12
p
value
Incidence density (n/1000) 11.3 12.7 11.3 0.8 NE
Night occurrence n (%) 47 (42.7) 21 (33.9) 18 (47.4) 4 (36.3) 0.54
Age mean (SD) 73.1 (11.7) 68.1
(12.0)
71,8
(12.4)
66.8
(17.2)
0.07
Male sexe n (%) 80 (71.4) 41 (65) 23 (60.5) 7 (58.3) 0.53
Myocardial ischemic disease
n (%)
91 (81.3) 39 (61.9) 21 (55.3) 7 (58.3) 0.004
Respiratory insufficiency n
(%)
13 (11.8) 13 (21.7) 7 (19.9) 2 (16.7) 0.38
Renal insufficiency n (%) 34 (31.5) 19 (31.7) 10 (27) 6 (54) 0.39
Cancer n (%) 3 (2.8) 4 (6.6) 11 (29.9) 3 (25) 0.0001
SAPS2 mean (SD) 50.9 (8.3) 56.1 (8.8) 59.2 (9.8) 50 (16.6) 0.0007
Fig. 65 (abstract 0138). See text for description
Fig. 66 (abstract 0138). See text for descriptionCardiac arrest 1
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INTRODUCTION. Reports on cardiac arrests occurring in ICUs (ICUCA)
are seldom. Current knowledge supports that ICUCA have a better
hospital survival rate (HSR) due to continuous monitoring, presence of
CA witness, shorter time to CPR and higher CPR skill of ICU staff (1–3).
No study investigates the performance of different ICUs inside the
same institution. We conducted a retrospective observational study
to assess the incidence and outcome of ICUCA in the 4 ICU and
monitored areas of our institution in order to assess the actual
survival rate and outcome factors of each unit.
METHODS. ICUCA was defined by chest compression and/or
defibrillation performed in ICU. All ICUCA were treated by ICU staff and
attending physicians. Datas recorded through a dedicated follow-up
form were: demographic data, medical history, location, pre-CPR venti-
lation and vasopressors use, event time sequence, initial cardiac rhythm
(VF, VT, PEA, Asystole), first treatment attempt, duration of CPR, number
of EES, type of IV treatment, immediate survival rate (ISR); and for CPR-
Survivors: SAPS II score, duration of post-arrest ventilation, duration of
ICU stay, treatments applied and hospital survival rate (HSR). 4 groups
were defined by location: CICU, ICU1 (Cardiac surgery, CS), ICU2 (Ab-
dominal surgery AS) and PACU. Groups were compared using Chi2 and
Kruskall-Wallis tests as indicated with p < 0.05 considered significant.
RESULTS. From 01/01/2009 to 12/31/2016, 226 ICUCA were treated.
Overall ISR was 65.9% and HSR was 41.1%. Incidence density (n/
1000) by location is described in Table 44. There was no differences
between groups for age, gender, time to CPR. Myocardial ischemic
disease was more frequent in CICU and Cancer disease was
predominant in ICU2 and PACU.
Initial rhythm was predominantly shockable (VT+ VF) in CICU (53.6%)
and ICU1 (46.9%) and non-shockable (PEA + Asystole) in ICU2
(53.1%) and PACU (71.1%) (p < 0.04). ISR was not different while HSR
was significantly different between groups.
ISR and HSR varied according to the intensity of care prior to CA
with the lowest survival rate for patients with ventilation and
hemodynamic support.
CPR duration for patients who died after CPR was similar in the 4
groups.
CONCLUSION. Significant differences in HSR may be present
between ICUs in the same institution independantly of patients age,
comorbidities, time to CPR and night occurrence. For similarincidence density of ICUCA, AS patients have a worse prognosis than
CS patients in our institution. Intensity of care (ventilation and
hemodynamic support), and cancer disease portends poor outcome.
CPR skills and staff commitment appear homogeneous over the 4
locations. The very low HSR of patients with invasive ventilation and
hemodynamic support is an important information regarding post-
ICUCA decision-making discussions.
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INTRODUCTION. Patients with out-of-hospital cardiac arrest (OHCA)
who cannot achieve early return of spontaneous circulation (ROSC)
are neurologically devastated. Alternative novel approaches including
extracorporeal CPR can increase intact survival in patients refractory
to conventional CPR, but also commit certain patients to “bridge to
nowhere”. Patients selection is crucial but we don't know who may
benefit from novel therapies after prolonged CPR.
OBJECTIVES. To create a model for predicting intact survival after
refractory OHCA to identify candidates for novel therapies.
METHODS. We performed retrospective analysis using data from
Japan's nationwide OHCA registry from January 2005 through
December 2012, which includes adult OHCA patients with time interval
from EMS call to hospital arrival > 30 minutes and without prehospital
ROSC. We created the prediction scores of intact survival at 1 month
after prolonged CPR, using the β coefficients of prognostic factors from
multivariable logistic models. Internal validation was performed using
split-sample methods. The derivation cohort comprised of 260539 pa-
tients registered in 2005–2010, and the validation cohort comprised
111355 patients registered in 2011–2012.
RESULTS. The overall intact survival rate was 0.3% (n = 1162/
371894). The characteristics of OHCA patients were similar between
the derivation and validation cohort. The most accurate model was
created based on multivariable logistic regression, including
age < 71 yrs, first documented rhythm (VF, PEA, Asystole), delivered
countershock > 1 time, witness and no-flow status (unwitnessed, no-
flow interval < 2 min or > = 2min), interval from EMS call to EMS ar-
rival < 11 min, with prediction score varying from 0 to 22 points. The
C statistic for this model was 0.77 (95%CI, 0.75-0.79) in the derivation
cohort and 0.83 (0.81-0.85) in the validation cohort. The calibration
plots and goodness-of-fit test revealed good predictive accuracy of
this model (p = 0.17). In patients with prediction score > 16 points,
the negative predictive value for intact survival was 99.8%.
CONCLUSIONS. The new prediction model for refractory OHCA has
been derived and validated. This model may help clinicians decide
whether to apply novel therapies or terminate resuscitation efforts in
OHCA patients refractory to conventional CPR.REFERENCE(S)
Park SB, Yang JH, Park TK, et al. Developing a risk prediction model for
survival to discharge in cardiac arrest patients who undergo
extracorporeal membrane oxygenation. Int J Cardiol 2014. 177:1031–5.
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INTRODUCTION. In patients resuscitated from an ischemic
ventricular fibrillation or tachycardia (VF/VT), the incidence of
recurrent arrhythmia is unclear and the indication of prophylactic
anti-arrhythmic (AA) treatments is debated during the post-
resuscitation period.
OBJECTIVES. To evaluate the incidence of arrhythmia in patients
resuscitated from a VF/VT caused by an acute coronary syndrome
(ACS), according to the use of AA prophylactic treatments.
METHODS. The PROCAT registry captures all data from patients
admitted in a tertiary hospital center after a resuscitated cardiac arrest
(CA). We selected patients with an initial VF/VT caused by an ACS and
who were treated with early percutaneous coronary intervention (PCI).
The primary endpoint was the occurrence of arrhythmia between ICU
admission and discharge. All arrhythmia resulting in CA recurrence,
severe arterial hypotension or acute respiratory failure were classified
as major, and all other arrhythmia as minor. We compared prophylactic
AA recipients and non-recipients groups using exact Fisher or Kruskal-
Wallis test. Multivariate logistic regression identified factors associated
with the occurrence of major arrhythmia.
RESULTS. Between 01/2007 and 12/2016, 256 consecutive CA
patients were included in the analysis. All patients underwent a
successful PCI of the infarct-related artery on hospital arrival. A
prophylactic AA treatment (amiodarone in 35 pts) was administered
in 36 of them (14%). Characteristics and outcome of patients who
did or did not receive a prophylactic AA treatment are described in
the Table.
There was no significant difference in the incidence of major or
minor arrhythmia between the 2 groups. In multivariate analysis,
prophylactic AA treatment was not associated with recurrence of
major arrhythmia (OR 0.55 (0.12-2.47), p = 0.44). Factors significantly
associated with recurrence of severe arrhythmia were public location
of CA (OR 0.12 [0.04-0.44]; p = 0.001) and male gender (OR 0.22
[0.08-0.57]; p = 0.02).
CONCLUSIONS. Despite early coronary reperfusion, more than 10%
of patients experienced a recurrent severe arrhythmia during the
post-resuscitation period, even in those treated with prophylactic
anti-arrhythmic treatments. This incidence is much higher than what
is reported in common ACS and further studies are needed to ex-
plore protective strategies.
Table 45 (Abstract 0140). Characteristics and outcome of patients
AA (n=36) No AA (n=220) p-value
Age (yrs), median(Q1-Q3) 59 (50-66) 59 (51-70) 0.51
Male gender, n(%) 30 (83) 175 (80) 0.82
Public location, n(%) 16 (44) 108 (49) 0.72
Bystander-CPR, n(%) 26 (72) 154 (72) 1
CA to ROSC, minutes median(Q1-Q3) 27 (10-34) 20 (12-31) 0.49
Induced hypothermia, n(%) 32 (89) 198 (90) 0.77
Major arrhythmia, n(%) 4 (11) 25 (11) 1
Minor arrhythmia, n(%) 7 (19) 43 (20) 1
In-hospital mortality rate, n(%) 19 (53) 95 (43) 0.37
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INTRODUCTION. Optimal haemodynamic goals during intensive care
after out-of-hospital cardiac arrest are not clear. Previous studies
have reported associations between lower heart rate and good out-
come1,2 during intensive care but possibly influenced by targeted
temperature management (TTM), vasoactive medications and a
greater degree of organ dysfunction.1
OBJECTIVES. To test the associations between heart rate and one-
year neurologic outcome using a large prospective database, includ-
ing patients treated with and without therapeutic hypothermia (TH).
METHODS. We analyzed heart rate and outcome data of 504
postresuscitation patients included between 1.3.2010 and 28.2.2011
in the prospective FINNRESUSCI study3. Continuous heart rate data
of the first 72 hours in intensive care were converted into 10- or 15-
minute medians and time-weighted mean heart rates were calcu-
lated. One-year neurologic outcome was dichotomised by the Cere-
bral Performance Category to good (1–2) or poor (3–5).
RESULTS. ICU mortality was 21.2% (107/504), and one-year mortality
was 44.0% (222/504). Of 504, 202 (40.1%) had good neurologic out-
come at one year. The lowest heart rate (HR) in patients with good
and poor neurologic outcome was, 45 (IQR 39–52) beats per minute
(bpm) and 50 (IQR 40–63) bpm respectively. The highest heart rate
was 115 (IQR 102–131) bpm and 124 (IQR 108–142) bpm, and time-
weighted mean heart rate (48 h) 69 (IQR 59–75) bpm and 77 (IQR
66–90) bpm; p < 0.001 for all. In multivariable regression analyses
(five separate models) higher time-weighted HR for 0–48 h, higher
time-weighted HR for 0–72 h, a higher percentage of heart rate re-
cordings below 60 bpm, 80 bpm, and 100 bpm during the first 48
hours were all independently associated with poor neurological out-
come at one year (p < 0.05 for all).
CONCLUSIONS. Lower heart rate during first 48 hours in ICU was
associated with better one-year neurologic outcome in both TTM
and non-TTM patients. Whether heart rate is more a prognostic indi-
cator or a variable, which can be modulated by treatment strategies,
needs future prospective trials.
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INTRODUCTION. Demographic shift poses challenges not only for in-
hospital care, but also to prehospital emergency services. It is import-
ant to realize that older adults are very diverse and that baseline co-
morbidities and functional status are crucial factors for clinical
outcomes (1).
OBJECTIVES. To investigate the reasons of not initiating and
terminating out-of-hospital CPR in nursing homes residents vs. pa-
tients outside nursing homes ≥ 65 years old.
METHODS. After Ethics Committee approval, a retrospective analysis
of the protocols of our prehospital physician staffed emergency
service (EMS) location in Munich, Germany of 2014–2016. Statistical
calculation was done using Mann–Whitney-U test and chi square test
as appropriate using IBM SPSS Statistics 23.0 (SPSS, Chicago, IL, USA).
RESULTS. 8882 cases were assessed; after exclusion false alarms
(n = 423), cases without documented age (n = 89) and cases with
age < 65 (n = 4204), 4166 were analysed. Patients baseline
characteristics were significantly different between patients in a
nursing home vs. patients outside (table 46).
There were 162 circulatory arrests where CPR was not initiated without
a difference between the groups (table 47). However, there was a
significant difference in the reasons not initiating CPR: While non-
nursing home CPRs were not initiated in 81% because the delay was
too long, this only occurred in 33% of nursing home residents (RR 0.1
[0.0-0.3], p < 0.001). In nursing home residents, however, a patient´s
provision or order resulted in omission of CPR attempts in 52% of cases
vs. 12% of cases outside nursing homes (RR 8.0 [3.0-21.7], p < 0.001).
CPR was initiated in 208 cases, without differences between the
groups. In 44% of cases outside nursing homes and 72% at nursing
homes, resuscitation attempts were stopped and patient declared
dead, a significant difference between groups (RR 1.0 [0.7-1.5],
p = 0.004). Reasons for terminating CPR attempts were documented
rarely; most likely stabilization of patients just could not be achieved.
CONCLUSIONS. Delay of CPR is still a major problem. Even if delays
are less common in nursing homes, where supervision is present, the
rate of 33% is still high. New technology (monitoring systems) might
be able to reduce this factor in the future. Second, people living in
nursing homes, are more likely to have a patient´s provision (or at
least the provision is disclosed to the EMS personnel via the nursing
home personnel more often). However, in the cases where CPR was
initiated, the outcome of nursing home patients was worse. An
advanced planning of strategy might be necessary to determine
treatment strategies (e.g. comfort care) of nursing home patients to
avoid futile care.
REFERENCE(S)
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complicate the management of patients suffering from convulsive
status epilepticus (CSE). Prevention of this complication would
require an adequate identification of related risk factors.
OBJECTIVES. To describe clinical characteristics and outcome and to
identify early predictors for CA during CSE management.
METHODS. We studied all consecutive patients admitted
between 2000 and 2015 in17 French ICUs after successful
resuscitation of a CA that occurred during the initial
management of CSE. These cases (CSE with CA) were compared
with controls coming from a single center registry of CSE
patients with no cardiac arrest (CSE w/o CA). We collected
baseline characteristics regarding medical history, management
and etiology of CSE. We compared characteristics of these 2
groups according to occurrence of CA using univariate and
multivariate logistic regression to identify potential risk factors
for CA during CSE management.
RESULTS. Overall 284 CSE patients were studied: 49 CSE with CA and
235 CSE with CA. In overall population, patients were mainly male
gender 154/284 (59%) with median age of 59 (IQR, 46–70) y.o. The
median time from seizure to medical team arrival was 30 (IQR, 0–73)
minutes with a total seizure duration median of 85 (IQR, 42–184)
minutes. Benzodiazepines were given as first line therapy in 257/284
(93%) and 161/284 (57%) received another “classic” anticonvulsant as
first or second line therapy.
Among the 49 CSE patients with CA, the arrest occurred in a median
time of 25 (IQR, 5–85) minsafter medical team arrival. The first
recorded rhythm was asystole in 25 (51%) patients, pulseless
electrical activity in 13 (27%), ventricular fibrillation/tachycardia in 4
(8%), and other rhythm in 7 (14%). Survival at hospital discharge was
observed in 216/235 (92%) in CSE w/o CA compared with19/49
(39%) in CSE with CA. One-year favorable outcome (CPC score 1 or 2)
was observed in 13/49 (28%) CSE with CA.
Using multivariate analysis, independent positive predictors of CA
occurrence were pulse oximetry < 97% at scene (OR, 2.66; 95%CI,
1.03-7.26, p = 0.04), drug poisoning as the cause of CSE (OR, 4.13;
95%CI, 1.27-13.53, p = 0.02), and complications occurring during
early management (OR, 11.98; 95%CI, 4.67-34.69, p < 0.0001),
whereas having at least one comorbidity among cardiac, respiratory
and neurological (other than epilepsy) was a negative predictor of
CA (OR, 0.28; 95%CI, 0.10-0.80, p = 0.02).
CONCLUSIONS. In critically ill patients managed for convulsive status
epilepticus, relative hypoxemia at scene, early management
complications at scene and drug poisoning as the cause of CSE were
strong early predictors of cardiac arrest occurrence, suggesting areas
for improvement.0144
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INTRODUCTION. Prognostication following cardiac arrest is a
challenging and emotive topic. Clinicians must balance the risk of
withdrawing care when there is a chance of recovery with that of
treatment futility when there is none. Our neurophysiology
department has provided neuroprognostication (NP) support with
electroencephalogram (EEG) and Somatosensory Evoked Potentials
(SSEPs) since 2012.
We present a retrospective analysis of 95 cases managed with the
assistance of neurophysiology following cardiac arrest in a tertiary
centre in the South West of the UK between 2012 and 2016.
METHODS. Every EEG and/or SSEP investigations carried out on ICU
following cardiac arrest (in or out of hospital) was extracted and
analysed. The system proposed by Synek to stratify EEG severity was
used (Guerit et al.).
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admitted following cardiac arrest and 95 had neurophysiology
testing, of whom 91 underwent both EEG and SSEP.
The cardiac arrest population admitted to our unit have an ICU
and hospital mortality of 49% and 55% respectively, an average
age of 63 years, 74% are male. Those who underwent NP had an
average age of 60 years, 80% were male. 92% were admitted
post out of hospital arrest. All patients received therapeutic
hypothermia. NP was undertaken following rewarming. Overall
mortality in the NP group was 93%. Hospital mortality by NP
finding is shown in Fig. 68.
Of the EEGs performed none were Synek grade 1 or 2, 13% were
grade 3, 74% grade 4, and 13% grade 5. All patients with a poor
EEG grade (4 or 5) and absent SSEPs died (Fig. 68).
Grade 4 or 5 EEG had a sensitivity of 89% at predicting mortality,
a specificity of 50% and a false negative rate (FNR) of 0.1. The
odds ratio (OR) of death with an EEG grade 4/5, adjusted for
SSEPs, was 7.75 (CI 1.1-52, p = 0.21). AUROC for grade 4/5 EEG
predicting death was 0.70.
49% of SSEPs demonstrated bilaterally present signal. 10% were
non-diagnostic. Absent SSEPs had a sensitivity of 49% and specifi-
city of 100% for predicting mortality. AUROC was 0.74 for absent
SSEP predicting death. No patient with absent SSEPs survived.
Hospital mortality despite present SSEPs was 85%.
CONCLUSION. In our case series, 12% of cardiac arrests
underwent neuroprognostication. All survivors had bilaterally
present SSEPs but 85% of patients with present SSEPs did not
survive. Combing EEG and SSEPs findings identified those with
the best survival.
The use of retrospective data, particularly the absence of SSEPs is
problematic given the self-fulfilling prophecy of neuroprognostica-
tion. We propose to examine the notes of those with present SSEPs
who died in order to understand which other factors impact
outcome.
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Neurophysiology (2009) 39, 71–83.Fig. 69 (abstract 0145). Kaplan-Meier curves
SSEPs present bilaterally SSEPs absent bilaterally
Uncertain EEG (Synek 
grade 3)
57.1% 100%
Poor EEG (Synek grade 4 
or 5) 91.2% 100%
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INTRODUCTION. Although extracorporeal cardiopulmonary
resuscitation (ECPR) for cardiac arrest has been reported to be more
effective than conventional cardiopulmonary resuscitation recently,
patients underwent ECPR are at high risk of refractory circulatoryshock during the weaning of veno-arterial extracorporeal membrane
oxygenation (ECMO) support.
OBJECTIVES. This study aimed to examine the impact of the intra-
aortic balloon pump (IABP) on the survival rate of patients who
underwent ECPR.
METHODS. In this retrospective cohort study, conducted in a
Japanese tertiary care center, patients underwent ECPR between
2008 and 2016 were included. All ECMO cannulations were
performed via femoral arteries and veins using an angiography.
Patients were either performed ECPR only or ECPR plus IABP support.
The primary outcome was the 30-day survival and the secondary out-
come was the successful removal of ECMO. Log rank test and Fisher
exact test were performed to compare these outcomes between two
groups.
RESULTS. A total 116 consecutive adult patients were included in
this study. The majority of study patients received bystander CPR
(69% vs. 76%, n.s). There was no significant difference between the
two groups in the median of circulatory collapse-to-ECMO time
(50min [42–72] vs. 50min [39–69], P = 0.41). The 30-day survival rate
was significantly higher in ECPR plus IABP support group than ECPR
only group (37% vs. 10%; P = 0.0052). Successful rate of weaning
from ECMO was also higher in ECPR plus IABP support group (50%
vs. 17%, P = 0.0013).
CONCLUSIONS. In the present study, the use of IABP was associated
with better survival and successful weaning from ECMO.
Combination of ECPR and IABP support may lead to better outcome
in patients with cardiac arrest.
REFERENCE(S)
Resuscitation. 2014 Jun;85(6):762–8.0146
Severe metabolic acidosis after out-of-hospital cardiac arrest
M. Jamme1, O. Ben Hadj Salem1, L. Guillemet1, P. Dupland1, W.
Bougouin1,2, J. Charpentier1, J.P. Mira1, F. Pène1, F. Dumas2,3, A. Cariou1,2,
G. Geri1,2
1Cochin University Hospital, Réanimation Médicale, Paris, France;
2INSERM U 970, Sudden Death Expertise Centre, Paris Cardiovascular
Research Centre, Paris, France; 3Cochin University Hospital, Services des
Urgences, Paris, France
Correspondence: M. Jamme
Intensive Care Medicine Experimental 2017, 5(Suppl 2):0146
INTRODUCTION. Metabolic acidosis is frequently observed as a
consequence of global ischemia-reperfusion after out-of-hospital car-
diac arrest (OHCA). However, the relationship between the level of
this metabolic disturbance at hospital admission and the outcome of
OHCA patients is still misunderstood and incompletely explored.
OBJECTIVES. We aimed to identify risk factors and assessing the
impact of metabolic acidosis on outcome after OHCA.
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 78 of 542METHODS. We included all consecutive OHCA patients admitted in
our cardiac arrest center between 2007 and 2012. Metabolic acidosis
was defined by a positive base deficit and was categorized by
quartiles. Main outcome was survival at ICU discharge. Neurological
recovery was assessed using the Cerebral Performance Categories
(CPC) scale. Factors associated with acidosis severity were evaluated
by linear regression. Factors associated with main outcome were
assessed by logistic regression.
RESULTS. 826 patients (68.3% male, median age 61 years) were
included in the analysis. Median base deficit was 8.8 [5.3,13.2] mEq/l.
Male gender (p = 0.002), resuscitation duration (p < 0.001), initial
shockable rhythm (p < 0.001) and post-resuscitation shock
(p < 0.001) were associated with a deeper acidosis. Brain damage
was the leading cause of death (n = 367, 67.6%) while multiple organ
failure resulting from refractory shock was responsible for 173
(31.9%) deaths. ICU mortality rate increased across base deficit quar-
tiles (39.1, 59.2, 76.3 and 88.3%, p for trend < 0.001) and base deficit
was independently associated with ICU survival (p < 0.001). The pro-
portion of CPC 1 patients among those discharged alive from ICU
was similar across base deficit quartiles (72.8, 67.1, 70.5 and 62.5%,
p = 0.21).
CONCLUSIONS. Severe metabolic acidosis is frequent in OHCA
patients and is associated with poorer outcome, in particular due to
refractory shock. However, we observed that about 10% of patients
with a very severe metabolic acidosis survived to ICU discharge with
a good neurological recovery.
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INTRODUCTION. Accurate prediction of clinical outcomes is
extremely important in cardiac arrest survivors and multimodal
approach is recommeded for neuroprognostication by current
international guidelines.
OBJECTIVES. The aim of our study was to evaluate prognostic
importance of combining clinical and laboratory methods for short-
and long-term outcomes using data from a prospective registry of
out-of-hospital cardiac arrest survivors
METHODS. We analysed data from a single-center prospective regis-
try of out-of-hospital cardiac arrest survivors admitted between 2010
and 2014 to the tertiary cardiovascular center. Study population was
comprised from cardiac arrest survivors alive at least 24 hours after
collapse. All subjects were treated with targeted temperature man-
agement using endovascular device (33°C for 24 hours). We evalu-
ated the prognostic significance of age, gender, initial rhythm, time
to return of spontaneous circulation (ROSC), initial levels of serum
lactate, potassium, D-dimer and pH, serial measurements of neuron-
specific enolase (NSE), C-reactive protein (CRP), procalcitonin, alanine
aminotransferase (ALT), serum creatinine, somatosensory evoked po-
tentials and electroencephalography (EEG) in this group. We investi-
gated the association of these variables with neurological outcomes
at 30 days and with one-year mortality. Good neurological outcomewas defined according to the Cerebral Performance Category (CPC)
as CPC 1–2.
RESULTS. One-hundred-and-fifty-three cardiac arrest survivors com-
posed the study group (mean age 64.1 years; male 74.7%). Univariate
analyses revealed that the initial rhythm, time to ROSC, the levels of
NSE measured during the first four days after cardiac arrest, levels of
ALT and serum creatinine 24 hours after arrest and the initial levels
of serum lactate and pH are significantly associated with 30-days out-
comes. Similar analyses showed that the same factors together with
age were significantly associated also with-one year mortality. Multi-
variate analysis indicated that only the levels of NSE measured at day
3 or 4 and “burst-suppression” or “status epilepticus” pattern on EEG
were independent predictors of 30-days outcomes; the same EEG
patterns and age independently predicted one-year-mortality.
CONCLUSIONS. Our results indicate that among numerous available
prognostic factors only NSE levels, EEG patterns and age were
independently associated with short- and long-term outcomes in car-
diac arrest survivors.
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INTRODUCTION. The management of cardiac arrest survivors has
improved during the past decades. The prognostication has become
an integral part of post-resuscitation care and it is based on multi-
modal paradigm combining clinical examination and additional tools.
OBJECTIVES. The aim of our study was to compare the day-specific
predictive values of neuron-specific enolase (NSE) collected during
the first four days after cardiac arrest and to determine an optimal al-
gorithm for neuroprognostication based on NSE
METHODS. Eligible patients were out-of-hospital cardiac arrest survi-
vors treated with endovascular hypothermia (33°C for 24 h). Blood
samples for NSE levels measurement were drawn on days 1, 2, 3 and
4 after hospital admission. Thirty-day neurological outcomes accord-
ing to the Cerebral Performance Category (CPC) scale and 12-month
mortality were evaluated as clinical end points.
RESULTS. A total of 153 cardiac arrest survivors (mean age
64.2 years) were enrolled in the present study. The NSE levels were
significantly lower in the CPC 1–2 group in comparison with the CPC
3–5 group at each time point (P < 0.05). Using ROC analysis, optimal
cut-off values of NSE for prediction of CPC 3–5 score on specific days
were determined as: day 1 ≥ 20.4 mcg/L (sensitivity 63.3%; specificity
82.1%; P = 0.002); day 2 ≥ 29.0 mcg/L (72.5%; 94.4%; P < 0.001); and
day 3 ≥ 20.7 mcg/L (94.4%; 86.7%; P < 0.001). The highest predictive
value, however, was observed on day 4 ≥ 19.4 mcg/L (93.50%; 91%;
P < 0.001); NSE value >50.2 mcg/L at day 4 was associated with poor
outcome with 100% specificity and 42% sensitivity. Moreover, NSE
levels measured on all individual days also predicted 12-month mor-
tality (P < 0.001); the highest predictive value for death was observed
on day 3 > 18.1 mcg/L (85.3%; 72.0%; P < 0.001). Significant associ-
ation with prognosis was found also for changes in NSE at different
time points. An NSE level on day 4 > 20.0 mcg/L, together with a
Table 48 (Abstract 0149). Results
PRE (52) POST (215) p
Male/Female (n/%) 41(78.8%)/
11(21.2%)
158(73.5%)/
57(26.5%)
0.0426
Age(mean ± standard desviation) 66.58 ± 14.77 69.77 ± 12.54 0.154
Shockable rhythms/Non-Shockable
rhythms (n/%)
6(11.5%)/
44(84.6%)
40(18.6%)/
167(77.7%)
0.479
Cardiac etiology/non cardiac etiology
(n/%)
25(48.1%)/
27(51.9%)
112(52.1)/
103(48%)
0.065
Response time of ALS (mean ±
standard desviation)
4.96 ± 4.77 3.41 ± 5.38 0.062
Initial outcome(Dead/Intensive care
unit)(n/%)
21(41.2%)/
28(55%)
78(40.2%)/
112(57.7%)
0.276
In- hospital mortality (n/%) 41(78.8%) 136(63.3%) 0.045
Table 49 (Abstract 0149). Treatment post PCR
Treatment post PCR (n/%) PRE (23) POST (105) p
Hypothermia 6(26.1%) 10(9.5%) 0.03
PCI 6(26.1%) 32(30.5%) 0.679
Fibrinolysis 1(4.3%) 6(5%) 0.794
Table 50 (Abstract 0149). Neurologic outcome
CPC Scale (n/%) (p= 0.497) PRE POST
1. Good cerebral performance 9(30%) 49(42.2%)
2. Moderate cerebral performance 0(0%) 2(1.7%)
3. Severe cerebral performance 0(0%) 1(0.9%)
4. Coma or vegetative state 1(3.3%) 1(0.9%)
5. Brain death 20(66.7%) 63(54.3%)
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(CPC 3–5) with 100% specificity and 73% sensitivity.
CONCLUSIONS. Results of the present study suggest that NSE
estimation is a useful additional tool for prediction of neurological
outcome(s) and long-term mortality in out-of-hospital cardiac arrest
survivors treated with targeted temperature management using
endovascular device. The highest predictive values for NSE were ob-
served on day 4 and day 3 after cardiac arrest. Using the NSE values
from these days, poor prognosis can be predicted with 100% specifi-
city and reasonable sensitivity.
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OBJECTIVES. To analyze the effect of a new Cardiac Arrest Code
(CAC) for in-hospital Cardiac Arrest (CA): before and after overall mor-
tality and neurological outcome, and describe the CA characteristics.
METHODS. Retrospective cohort study comparing mortality and
neurological outcome for in-hospital CA before and after a new CAC
(started on May 22, 2012).
Based on a national registry, we selected a cohort denominated
“PRE” that included the CA's between January 1, 2009 and May 22,
2012 and another cohort called “POST” that included the CA's
between May 23, 2012 and March 8, 2017.
Variables analyzed included: gender, age, characteristics of the CA,
time of response, treatment, success resuscitation, admission to the
ICU, neurological outcome and mortality.
A descriptive analysis was performed afterwards, expressing the
qualitative variables in percentages and the quantitative variables in
means ± standard deviation. A subsequent comparative study was
made between the groups with T-student and Chi-squared tests.
RESULTS. A total of 267 patients were included, 52 in the period
from January 1, 2009 to May 22, 2012, PRE implantation of the new
CAC, and 215 patients in the POST CAC period, from May 23, 2012 to
March 8, 2017.
Both groups were homogeneous, with no statistically significant
differences in the variables of age, gender, site of CA, etiology and
initial heart rhythm.
The time elapsed from the CPR to the warning to the Advence Life
Support (ALS) team is 3.71 ± 4.09 min in the PRE period and
3.54 ± 4.64 min in the POST group (p = ns). A reduction in the
response time of the ALS team of 4.96 ± 4.77 min in the PRE period
to 3.41 ± 5.38 min was observed, although these differences did not
reach statistical significance (p = 0.06). The duration of CPR in the
PRE and POST groups was similar, being 20.74 ± 21.13 min vs
18.53 ± 15.03 min (p = ns) respectively.
Among patients with recovered CA, a statistically significant
reduction in the use of therapeutic hypothermia from 26.1% in the
PRE group to 9.5% in the POST group was observed (p = 0.030). The
percentage of patients undergoing PCI increased from 26.1 in the
PRE group to 30.5% in the POST group, although this difference is
not statistically significant.
Neurologycal outcome was similar in both groups, but overall in-
hospital mortality was significantly lower in the POST group, 78.8%
compared to 63.3% with p = 0.045.CONCLUSIONS. After the implementation of the CAC, there has been
an improvement in the response time of the ALS team, and above
all, a reduction in in-hospital mortality. Such reduction in mortality
could be due to the improvement in post-resuscitation care with an
increase in post-PCI.
We believe that periodically developing and reviewing a CAC is
imperative to know what happens with the in-hospital CA and im-
prove its outcome.
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Fig. 71 (abstract 0150). See text for description
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 80 of 542INTRODUCTION. It has been known that bradycardia during targeted
temperature management in out of hospital cardiac arrest patient
have related to good neurological outcome in several studies
recently(1,2).
OBJECTIVES. Purpose of this study is to evaluate the relationship
between heart rate at 24-hour post-resuscitation and neurological
outcome in cardiac arrest patients.
METHODS. Out of hospital cardiac arrest patients who visited 3
tertiary urban hospitals from March 2013 to April 2016 were enrolled.
Patients were categorized therapeutic hypothermia (TH) group and
non-HT group. Heart rate, body temperature at 0, 8, 24, and 72 hours
were abstracted. Heart rate at 8-hour was divided into 4 quartiles
and 28-days good cerebral performance criteria (CPC) rate was com-
pared among those 4 quartiles.
RESULTS. Total 163 patients were enrolled and TH group was 90
(55.2%). Baseline characteristics were not different between two
groups. 8-hr and 24-hr body temperature was significantly low in TH
group (Fig. 70). 8-hr and 24-hr heart rate were significantly low in
good CPC (Fig. 71). The good CPC ratio for the 8 hour HR quartile is
higher at lower heart rates (Fig. 72).
CONCLUSIONS. Lower heart rate was associated with good
neurological outcome in out of cardiac arrest patient during post
cardiac arrest care. This result was found in both TH group and non-
TH group.
REFERENCE(S)
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during therapeutic hypothermia is associated with good neurologic
outcome in comatose survivors of out-of- hospital cardiac arrest. Crit
Care Med 2014; 42:2401–2408Fig. 70 (abstract 0150). See text for description
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INTRODUCTION. The cardiac arrest (CA) is defined as abrupt,
unexpected and potentially reversible disruption of breathing and
spontaneous circulation. It is essential to initiate manoeuvres to
restore breathing and circulation, whose primary objective is to
recover brain functions. The chance of successful recovery of a CA,
depend directly on the precocity and correct performance of the
resuscitation manoeuvres. Mild therapeutic hypothermia is
recommended to improve neurological prognosis and survival in
out-of-hospital cardiac arrest (OHCA) recovered with a shockable
rhythm. In International CPR guidelines, this recommendation has
been extended to other rhythms and in-hospital CA (IHCA) extrapo-
lating information from OHCA to IHCA.
Table 53 (Abstract 0151). Shows the bivariate analysis of factors re
N=310 Alive Dead p
Age. Years (SD) 65,4 (SD
16,3)
70,7 (SD
12,6)
0,009
IHRCA at night or holidays. N (%) 40 (47,1) 126 (61,8) 0,015
First rhythm shockable. N (%) 44 (51,8) 35 (17,2) <0,001
Defibrillation before arrive rapid response
team. N (%)
14 (35) 7 (8,5) 0,001
Cardiac etiology. N (%) 52 (61,2) 78 (38,2) <0,001
CPR manoeuvers < 20 min. N (%) 66 (77,6) 134 (65,7) 0,03
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 81 of 542OBJECTIVE. To analyse the epidemiology, characteristics, survival and
neuro-functional prognosis of the in-hospital recovered cardiac arrest
(IHRCA) admitted to ICUs in Spain.
METHODS. We analysed “The national registry of attention to
recovered cardiac arrest and use of hypothermia in the ICUs of
Spain”. An observational, prospective and multicenter study
conducted between January 2014 and June 2016. We have selected
only the IHRCA. Epidemiological, demographic, functional capacity
(Barthel Index scale) and neurological prognosis (CPC scale) were
analysed at hospital discharge and one-year survival. We make a de-
scriptive analysis for factors associated with survival.
RESULTS. 46 ICUs, we included 310 patients, the most frequent place
of the IHRCA was in general ward (32.8%). Table 51 shows the main
features related to IHRCA.
Only in 44 patients were performed mild hypothermia. The use of
controlled temperature techniques to perform mild hypothermia was
applied in 20 (45.5%) of cases, in 18 (40.9%) of patients, the central
temperature was higher 36°C before start hypothermia. The duration
of hypothermia was lower of 24 hours in 23 (52.3%) of cases, and the
rewarming was faster than 0.25°C/hour in 22 (50%) of cases.
CONCLUSIONS. The IHRCA is more frequent in general ward, at night
and holidays. Although the percentage of witnesses IHRCA is high, it
is not the performance of CPR manoeuvres or early defibrillation
before arrive rapid response team. A high number of mild
hypothermia techniques are performed by uncontrolled temperature
systems. The cases of patients with a central temperature above 36°C
prior the onset of mild hypothermia, the duration of the technique
less than 24 hours as well as a rapid rewarming were high. The
IHRCA is associated with a high mortality, but the neurological and
functional prognosis of survivors is good. Survival is associated to
shockable first rhythm, receive early defibrillation and cardiac
etiology.Table 51 (Abstract 0151). Describes the main features related to IHR
N=310
Male. N (%) 209 (67,4%)
Age. Years 69 (SD 3,7)
Means hospital stay. Days 27,6 (SD 29,4)
IHRCA at night or holidays. N (%) 175 (56,5%)
Defibrillation before arrive rapid response team. N (%) 21 (6,7%)
CPR manoeuvers > 20 min. N (%) 96 (31%)
Start CPR manoeuvers before arrive rapid response team. N (%) 127 (41%)
First rhythm shockable. N (%) 89 (28,8%)
Cardiac etiologic. N (%) 142 (45,8%)
Table 52 (Abstract 0151). Shows the results of survivals, functional
N=310 Hospital discharge One-year
Survivals. N (%) 119 (38,4%) 85 (27,4%)
CPC score 1-2. N
(%)
110 (35,5% of all IHRCA and
92,4% of all survivals)
83 (26,7% of all IHRCA and
75,4% of all survivals)
Barthel Index
score > 80. N (%)
92 (29,7% of all IHRCA and
77,3% of all survivals)
74 (23,8% of all IHRCA and
67,2% of all survivals)0152
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INTRODUCTION. The use of extra-corporeal life support (ECLS) in
refractory cardiac arrest (RCA) is now well-known (1), and rules
by French guidelines concerning indication on precise criterias,
except for toxic causes (2). Indeed, datas about RCA in severe
poisoning treated with ECLS are rare (3). Our study aims to de-
scribe survival in severe poisoning with ECLS.
MATERIAL AND METHODS. 20 patients treated with ECLS for severe
poisoning were retrospectively included in an universitary hospital
from 2007 to 2016. ECLS was indicated for RCA or for hemodynamic
instability. Pregnant women and RCA from other cause were
excluded.
RESULTS. Mean age was 49 ± 16 years. 60% of patients were
women. 17 patients presented cardiac arrest (CA), 11 of them
were RCA needing ECLS. 11 ECLS were started during cardio-
pulmonary resuscitation (CPR), and among these, 9 were out-of-
hospital RCA(OH-RCA). Overall mortality was 14 patients, with 9
deaths among the 11 RCA and 8 among the 9 OH-RCA, and
only 1 among the 2 patient presenting CA after hospital admis-
sion. Serum lactate and bicarbonate levels at admission were
significantly associated to with mortality (respectively p = 0.013
and 0.017). Median low-flow was 70 min (4–250 min) for all pa-
tients, but 104 min (60–250 min) in OH-RCA. Medications and
dosages were very heterogenous. All patients with CA had no
No-Flow.
CONCLUSION. Overall mortality was high in severe poisoning treated
with ECLS, particularly in OH-RCA. Other studies are needed to know
if the use of ECLS in severe poisoning is justified regardless of the
low-flow duration.
REFERENCE(S)
1. Intensive Care Med (2007) 33:758–764;
2. Annales Françaises d'Anesthésie et de Réanimation 28 (2009)
182–186;
3. Crit Care 2009, 13:R138 (doi:10.1186/cc8017)
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OBJECTIVE. To evaluate the factors associated with mortality and
disability after discharge in patients with decompressive craniectomy
(DC) in the ICU.
METHODS. Prospective study of patients admitted from January 1,
2013 to march 2017 who required DC. DC was performed by
intracranial hypertension (ICH) refractory to medical treatment. They
were collected and analyzed: main diagnosis at admission;
demographic data; neurological data (clinical examination and
Glasgow Coma Score: (GCS)); hypotension: at the site, at hospital
admission and at ICU and at hospital discharge; type of craniectomy
and DC complications; Rankin scale, and Glasgow outcome scale
(GOS) at 30 days after UCI admission, at ICU discharge and 6 months
after ICU discharge; preoperative serum lactate levels and number of
hours with intracranial pressure (ICP) > 20, 25 or 30 mmHg before
DC; hypo and hyperglycemia; application of mannitol or hypertonic
saline solution before and after DC; dose of catecholamines needed;
leukocytes and platelets before and after DC and other factors
related to prognosis. Categorical variables were summarized as
frequencies and percentages and the continuous variables as
medians and interquartile ranges (IQR) or means and standard
deviations. Univariate analysis of mortality and disability at ICU
discharge and 6 months after ICU discharge were performed.
Statistical significance was set at p ≤ 0.05.
RESULTS. Twenty patients with DC were collected. Demographic
data and types of admission are shown in Table 54.
Most were subarachnoid haemorrhages (SAH) (60%) and 70% of DC
were hemicranial. The most frequent complications were reoperation
due to complications (55%), hydrocephalus (50%) and extraaxial
hematoma (40%). Five patients died at the ICU discharge (25%), 4
(80%) of them were SAH. Rankin mean at ICU discharge was 4.1 and
GOS was 2.5. Rankin mean 6 months after ICU discharge was 3,16
and GOS was 3 (Table 55).
Mortality 6 months after discharge was significantly associated with
the presence of focal contusion with edema and expansivity, bilateral
pupillary reactivity prior DC (lower mortality), mean midline
displacement (millimeters) on admission Computed Tomography (CT)
as well as higher GCS at ICU discharge (lower motality) (Table 56).
We found no factors associated with mortality or disability at ICU
discharge or disability 6 months of ICU discharge.We found no
significant factors associated with mortality or disability at ICU
discharge and disability six months after discharge in our study.
CONCLUSIONS. Preliminary data show low mortality (25%) of DC
patients. Rankin and GOS reflect moderately severe disability in our
DC patients on discharge and six months after discharge from the
ICU. The presence of focal contusion with edema and expansivity,
bilateral pupillary rectivity prior DC, mean midline displacement on
admission CT and higher GCS at ICU discharge were significantly
associated with mortality six months after discharge from the ICU.
Table 56 (Abstract 0153). See text for description
Fig. 73 (abstract 0154) See text for description
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INTRODUCTION. Traumatic brain injury (TBI) can lead to severe brain
injury, major disability, and death. Current randomized literature
presents contrasting results on the effect of neurosurgical
decompression in this condition.
OBJECTIVES. The aim of this systematic review and meta-analysis of
randomized trials was to study the effect of decompressive surgery
on morbidity and mortality of TBI patients.
METHODS. PubMed, EMBASE, and the Cochrane Central Register of
clinical trials were searched up to April 1st, 2017 for randomized
controlled trials on the use of decompressive neurosurgery versus
any control in patients with TBI. The primary outcomes were
mortality, severe disability, and functional independence at longest
follow-up available. Severe disability was defined as GOS-E (Extended
Glasgow Outcome Scale) 2 to 4 and functional independence was
defined as GOS-E 5 to 8. To analyse the outcomes we calculated risk
ratios (RRs) and 95% confidence intervals (CIs).
RESULTS. Three studies for a total of 548 patients were included
in the analysis [1–3]. Decompressive surgery was associated with
significantly lower mortality compared to medical care (RR 0.64
[95% CI, 0.50, 0.81], p = 0.0002) (Fig. 73). After surgical
decompression, no difference in functional independency was
found (RR 0.96 [95% CI, 0.75, 1.22], p = 0.72), but severe
disability was more frequent with surgery (RR 1.68 [95% Ci, 1.31,
2.16], p < 0.0001) (Fig. 73).
CONCLUSIONS. Decompressive craniectomy in patients with TBI
resulted in lower mortality but higher rates of severe disability than
medical care. The rate of functional independence was similar in thetwo groups. Future randomized trials should define the impact of
this surgical strategy on patients´ outcomes and quality of life.
REFERENCE(S)
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P, et al. Decompressive Craniectomy in Diffuse Traumatic Brain Injury.
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INTRODUCTION. Intracerebral hemorrhage (ICH), a non-traumatic
bleeding in the brain parenchyma, is the second most common form
of stroke and an important source of death and disability world-
wide1. Treatment aims to support vital function and reverse possible
causal factors, as arterial hypertension or antithrombotic therapy2.
Surgical evacuation is still controversial, as indications for monitoring
and treatment of intracranial pressure (ICP)1,2.
OBJECTIVES. describe ICP and its treatment in a single-center con-
secutive case series of ICH
METHODS. Retrospective analysis of a prospectively collected
database. Demographic characteristics, imaging of all ICH patients
admitted to our intensive care unit (ICU) from January 2010 to
December 2016 were collected. Mean (for every 12-hour period) and
maximum (defined as higher value lasting more than 5 minutes in
the same period) ICP were recorded. Intracranial hypertension (HICP)
was defined as ICP maximum value higher than 20 mmHg Functional
outcome (obey command) and mortality were evaluated at hospital
discharge. Statistical analysis was performed using Prism. Significance
was set at a p value ≤ 0.05.
RESULTS. During the 7-year period, we recruited 157 ICH patients
(5% of all admissions), of which 53 had ICP monitoring. Baseline char-
acteristics are shown in Table 57. ICP patients were younger (55
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 84 of 542versus 63 years, p < 0.05) and had lower mortality (19% versus 61%,
p < 0.001) than non-ICP. In the ICP group, hypertension was most
likely cause in 60%, while ICH was secondary to coagulopathy (15%),
vascular malformation (18%). ICP was monitored for 4 days (median,
IQR 2–5.5), its median value was 15 mmHg (median, IQR 11–19). Brief
episodes of HICP (9% of all monitored period) were found in 79% of
patients. ICP was actively treated in 28% of patients, and 8 of them
received extreme therapy (7 decompressive craniectomy and 1 barbi-
turates). There was no difference in mean ICP between evacuated
versus non-evacuated patients. Mortality in the ICP group was low,
with good short term outcome (62% of patients obeyed command
at hospital discharge). Median hospital length of stay was 21 days
(median, IQR 15–28.5).
CONCLUSION. In our institution, ICH surgical evacuation and ICP
monitoring are preferred for patients with baseline predictors of
good outcome. A relevant proportion of patients (79%) suffered
episodes of HICP of rather short duration. Extreme therapy was
necessary in 15% of population. Outcome was good compared to
literature1,2, supporting the idea that aggressive treatment in
selected population can improve prognosis.
REFERENCES
1. Critical Care 2016; 20: 272.
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Age (median, IQR) 55 (45-67)
Female (%) 42%
Most likely cause (%)
Arterial hypertension 60%
Coagulopathy 15%
Vascular anomaly 18%
Other 7%
Admission Glasgow Coma Scale score (median, IQR) 8 (5-12)
Hematoma volume (median, IQR) 58 (32-85) mL
Surgical evacuation 72%0156
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INTRODUCTION. Brain injury is one of the major leading causes of
disability and death following trauma. Previous studies suggested
that among mild traumatic brain injuries (mTBI, as defined by a
Glasgow Coma Scale score of 13 or greater on arrival), around 80%
of patients had a favourable neurological recovery; however, some
patients had residual severe neurological deficit. Although previous
studies reported that patients with mTBI who required neurosurgery
may have higher mortality rates and worse neurological outcomes,
there were few studies that investigated an association between
intensive care and mortality for patients with mTBI.
OBJECTIVES. We aimed to determine whether critical care
management styles are connected with the neurological outcome in
patients with mTBI who required neurosurgical intervention, using
the Japan Neurotrauma Data Bank (JNTDB).
METHODS. We used the JNTDB, which is a national registry that
includes patients with traumatic brain injury. Within the 2009–2011
records of JNTDB (n = 1092), we retrospectively identified patients
with mTBI who needed neurosurgery. We used the Glasgow
Outcome Scale as the main outcome measurement. We groupedthese records into two groups: good outcome (good recovery and
moderate disability) and poor outcome (severe disability, vegetative
state, and death). We analysed neurological outcomes using a
logistic regression analysis adjusted for within-hospital clustering and
other factors that independently associated with neurological
prognosis.
RESULTS. In total, 195 patients with mTBI under operative
management were included in this study. Of these, the number of
patients with a poor outcome was 70 (35.9%). Logistic regression
analysis revealed that the use of osmotic agents resulted in poor
outcomes (odds ratio: 5.32, 95% confidence interval: 1.76-16.11).
However, following intensive treatments, these treatments had no
significant association with a worse outcome: anticonvulsants,
sedatives, and temperature management (odds ratio: 1.28, 95%
confidence interval: 0.52-3.18; odds ratio: 1.59, 95% confidence
interval: 0.28-9.05; and odds ratio: 0.71, 95% confidence interval:
0.23-2.19, respectively).
CONCLUSIONS. Our study using a Japanese nationwide brain trauma
registry suggested that the requirement of osmotic agents was possibly
associated with poor neurological outcome for patients with mTBI who
required neurosurgical intervention, although anticonvulsants, sedatives,
and temperature management was not significantly associated with
outcome.
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INTRODUCTION. Contention of the primary damage and prevention
of secondary damage is crucial in neurocritical care but the benefits
of very early surgical treatment have not been clearly demonstrated.
This leads to a lack of human and material resources specifically
available for these patients in the emergency department and a
dedicated track to the operating room.
PURPOSE. To understand the prognostic relevance of the hospital
delay to the induction of anaesthesia in order to define priorities in
patients admittance to the operating room.
METHODS. We collected data retrospectively about patients
admitted after an emergency neurosurgery during one year in one
neurocritical ICU (UCINC) of a central, tertiary hospital. 636 patients
were admitted from 1st April 2016 to 31st March 2017. We selected
the patients admitted after an emergency neurosurgical procedure
(N = 93).
RESULTS. Our sample has 54% of men and an average age of
67,2 years (SD 15,9). Average SAPS II is 38,6, (SD 16,5), SAPS3 61,3
(SD 12,7), APACHE II 20,1 (SD 7,0).
Among those coming from the emergency department (77,4%), the
median time between admission and induction of anaesthesia was
2,8 h. The median time from triage to neurosurgical observation was
0,5 h. The median time from neurosurgical formal operative
indication to anaesthesia was 0,8 h. For patients already in the
hospital this period was significantly longer - 1,8 h (Mann Whitney
p = 0.001), without statistical significant difference in the
preoperative Glasgow score (GCS). The median time between the
end of anaesthesia and admittance to the ICU is 0,6 h.
There is a weak positive correlation between time to the operating
room and GCS before the surgery, suggesting that patients with a
lower GCS wait less for surgery (R = 0,30, R2 = 0,09%, p = 0,003).
No correlation was found between the waiting period for surgery or
ICU admittance and hospital mortality, even after correcting for the
preoperative GCS.
CONCLUSIONS. Neurocritical out-patients arriving to our emergency
room are already treated with priority and we tend to treat first
Table 58 (Abstract 0159). Principal methods for fever management
DRUG PHYSICAL
METHOD
DEVICE
FIRST-LINE Paracetamol
[135 (70%)]
Ice Packs [90
(47%)]
External Non-Automated System
[49 (25%)]
SECOND-
LINE
Diclofenac
[62 (32%)]
IV Cold Fluids
[68 (35%)]
External Computerized Automated
Systems [75 (39%)]
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 85 of 542patients with more severe disease. More studies are needed to
understand the prognostic relevance of a longer interval of time, in-
cluding the determinants of outcome from those transferred from a
secondary to a tertiary hospital. Also, patients already in the hospital
that suffer neurological deterioration should be treated faster.
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INTRODUCTION. Intracerebral hemorrhage is a stroke subtype with
high mortality and significant disability among survivors.
OBJECTIVES. To evaluate Intracerebral Hemorrhage (ICH) score and
APACHE II scale in patients admitted to ICU with non-traumatic brain
hemorrhage.
METHODS. Multicenter prospective observational study in three
hospitals in Andalusia (Spain). We studied all patients with brain
hemorrhage admitted to the Regional Hospital of Malaga (2006 to
2011), Neurotraumatology Hospital of Jaen (2010 to 2012) and
Virgen de las Nieves Hospital of Granada (2006 to 2011).
Data were expressed as the mean and standard deviation for
quantitative variables and percentages for qualitative variables. For
the comparison of two means we used the Student's t-test and the
chi- squared test was used to compare proportions. Area Under the
ROC curve for analizing discrimination, Standardized Mortality Ratio
(SMR) and Hosmer-Lemeshow Test for analizing calibration. Statisti-
cally significant differences p < 0.05.
RESULTS. N = 336 patients (263 supratentorial). Mean age
59.43 ± 14.75 years, Glasgow score (GCS) at admission 8 ± 4 points,
APACHE-II 21.03 ± 7.6 points, intraventricular hemorrhage (IVH) was
58.6% of patients. 105 patients were treated by surgery. The hospital
mortality was 54.17%.
Bilateral mydriasiswas observed in 37 cases (11.1%), with mortality at
30 days of 100% and predicted by the ICH score of 78.11%.
Patients who died in hospital were older 63.76 ± 12.21 vs
59,43 ± 14.75 (p < 0.001), lower GCS 6 ± 3. vs 10 4 (p < 0.001) and
higher APACHE II 24.31 ± 6.37 vs 17.09 ± 7.08 (p < 0.001).
Mortality predicted by APACHE II scale (49.58%) compared with that
observed (54.17%). The Hosmer-Lemeshow test was 12,28, so there
not were statistically significant differences between the observed
and predicted mortality by APACHE-II. Discrimination by the area
under the ROC curve was 0.81 (0.76-0.85).
Mortality at 30 days predicted by ICH score (50,25%) compared with
that observed (52,38%). Standardized Mortality Ratio (SMR): 1.04
(0.89-1.19)(not statistically significant). Mortality predicted by ICH
score and observed: 0 point (N = 10) 0% vs. 10%, 1 point (N =52)
13% vs 21.15%, 2 points (N = 108) 26% vs 38.89%, 3 points (N = 109)
72% vs 66.97%, 4 points (N = 49) 97% vs 85.71%, 5 points (N = 7)
100% vs 85.71%, 6 points (N = 1) 100% vs 100%. Relation between
mortality observed and predicted by ICH score, Hosmer-Lemeshow
test (H) 45.01 (p < 0.001). Area under the ROC curve by ICH score
0.74 (0.69-0.79).
CONCLUSIONS. APACHE II scale has a correct discrimination and
calibration. The ICH score has an acceptable discrimination, but
not calibration. The differences between mortality observed and
predicted by ICH score are low, although higher to themethodologically allowed. In spite of this we believe that ICH
score is a useful instrument in ICU.
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INTRODUCTION. Fever occurs frequently in patients with acute brain
injury (ABI) and may play a role in the development of secondary
brain injury (1). The definition of fever and its clinical management
across countries are different and heterogeneous.
OBJECTIVES. To survey practices in the management of fever in
adult patients with ABI in Intensive Care Units (ICU). The main
endpoints of the survey were the evaluation of: a) the definitions of
fever, b) the thresholds and triggers to start intervention, c) and the
methods to control temperature.
METHODS. A questionnaire including 26 items was available on the
European Society of Intensive Care Medicine (ESICM) website
(www.surveymonkey.com/r/SUMMAfever) between July 2016 and
December 2016. The survey was endorsed and promoted by ESICM.
RESULTS. Respondents (RSP) were 231 [138 (60%) from Europe];
mainly intensivists [124 (54%)] and anesthesiologists [67 (29%)]. Body
temperature (BT) was measured mostly with a bladder probe [93
(43%)]. Few RSP measured directly brain temperature [47 (22%)].
Fever was most often defined as a BT: > 38.3°C [71 (33%)], > 38 °C
[56 (26%)] and > 37.5°C [38 (18%)]. The main thresholds for
antipyretic therapy were 37.5°C [74 (34%)] and 38°C [86 (40%)].
However, the thresholds were lower in case of intracranial
hypertension and cerebral ischemia. Principal methods for fever
management are reported in Table 58. Fever was generally treated
during the entire ICU stay [64 (33%)] or until intracranial
hypertension and/or cerebral ischemia were resolved [61 (32%)].
Written protocols for fever and shivering were available respectively
for 83 (43%) and 54 (28%) of RSP. Shivering was mainly managed
with opiates [115 (60%)]. Rewarming was controlled (0.1-0.4 °C/h) to
predefined temperature target for 75 (39%) of RSP and titrated to
intracranial pressure for 55 (29%) of RSP.
CONCLUSIONS. A wide variability in practices on fever definition and
management are identified in this survey. These findings may be
helpful to define future investigations in this topic.
REFERENCES
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2) Greer DM et Al. Impact of fever on outcome in patients with
stroke and neurologic injury: a comprehensive metaanalysis. Stroke
2008; 39: 3029–3035.
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INTRODUCTION. Elevated intracranial pressure (ICP) is a well-known
cause of secondary brain injury. The gold standard method of meas-
uring ICP is using an intra-cerebral catheter. Several non-invasive
techniques can be used to estimate ICP values, but they have never
been compared.
OBJECTIVE. To compare three non-invasive methods of ICP
assessment.
METHODS. Prospective observational study including ICU patients in
whom invasive ICP monitoring was initiated. The following non-
invasive methods were simultaneously used to estimate ICP: ocular
ultrasound to measure the optic nerve sheath diameter (ONSD);
transcranial Doppler to measure the pulsatility index (PI); and auto-
mated pupillometry (NeurOptics, Irvine, USA) to measure the neuro-
logical pupil index (NPi). The mean value from both eyes was
calculated for all measurements and correlations assessed using a
Pearson's or Spearman's test, as appropriate.
RESULTS. We studied 46 patients (traumatic brain injury = 12,
subarachnoid hemorrhage = 22; others =12) with a median age of 51
years. Median Glasgow Coma Scale score on admission was 9 [5–12].
ICP assessment was performed 2 [1–3] days after ICU admission and
median ICP values were 15 [11–25] mmHg. Median values from the
different non-invasive techniques were: ONSD 5.2 [4.8-6.1] mm, PI 1.2
[0.9-1.7] and NPi 4.2 [3.6-4.7]. There was a significant, although weak,
correlation between ONSD and PI (r2 = 0.11; p = 0.01) and between
PI and NPi (r2 = 0.37; p < 0.001), but not between ONSD and NPi
(r2 = 0.008; p = 0.53).
CONCLUSIONS. Non-invasive techniques to estimate ICP values cor-
relate poorly and cannot be considered as interchangeable.
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INTRODUCTION. There are common techniques to different medical
specialties and we have to look for the best practice for patients.
OBJECTIVES. Evaluate the complications after placement of
intraparenchymal pressure sensors in two different hospitals and
compare the results.
METHODS. Descriptive retrospective observational study. We
analyzed catheters placed consecutively by Intensivists at bedside at
Hospital Virgen de la Salud in Toledo (Spain) during 2008 (GROUP I),
and placed by neurosurgeons in the operating room at the Hospital
Fundación Jiménez Díaz at Madrid (Spain) between the years 2012–
2017 (GROUP II).
Data collected: sex, reason, location and implantation date time,
complications (hemorrhage, malposition and infection) and
functional evolution at ICU discharge according to Glasgow Coma
Scale (GOS).
RESULTS.
* GROUP I: number 58; Sex (M/F) 22 (37.93%)/35 (60.34%); Reason:
trauma brain injury (TBI) 46 (79.31%), spontaneous hemorrhage (SH)
11 (18.97%), Ischemia 1 (1.72%); Place (ipsilateral / contralateral: 39
(67.24%) / 19 (32.76%); Moment: at admission 36 (62.07%), < 24h 13
(22.41%), 2–3 day 8.62%), > 4 days 4 (6.90%); complications:
hemorrhage 11 (18.96%), malposition 7 (12.07%).No infection, GOS atICU discharge: GOS1 16 (27.59%), GOS2 6 (10.34%), GOS3 23
(39.66%), GOS4 6 (10.34%), GOS5 7 (12.07%).
* GROUP II: number 46; Sex (H/F) 12 (26.09%)/ 34 (73.90%); Reason:
TBI 22 (47.82%), SH 18 (39.13%), Ischemia 1 (2.17%), Infection 4
(8.70%), cerebral hypoxia 1 (2.17%). Place (ipsilateral / contralateral:
39 (84.78%) / 7 (15.22%); Moment: at admission 37 (80.40%), < 24h 5
(10.87%), 2–3 day (24.39%), >4 days 2 (4.35%); complications:
hemorrhage 10 (24.39%), malposition 10 (24.39%). No infection, GOS
at ICU discharge: GOS1 17(36,96%), GOS2 4(8,70%), GOS3 12
(26.09%), GOS4 10 (21.74%), GOS5 2 (4.35%).
CONCLUSIONS. There were no differences between the moment of
implantation and GOS to ICU discharge. In GROUP I there were more
patients with TBI. In group II, more ipsilateral catheters were placed
and more complications were observed. There are great differences
in patients at each center and the time analyzed. Intensivists
techniques are stricter compared to neurosurgeons, which in most
cases end in craniotomy.
Intensivists are able to place intraparenchymal pressure catheters in
cases that patient doesn´t need craniotomy, optimizing the initial
management and the final result.
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INTRODUCTION. Optimal cerebral perfusion pressure(CPP) thresholds
for use in the management of paediatric traumatic brain injury (TBI)
are not well known. Brain Trauma Foundation guidelines do not
recommend age-specific CPP targets other than a minimum of
40mmHg due to lack of robust evidence, despite widespread use of
age-specific CPP targets(1). There has been recent interest in cerebro-
vascular autoregulation monitoring and individualised optimum CPP
target derivation in children(2) after reports of the same in adult neu-
rocritical care(3).
OBJECTIVES.
1. To assess feasibility of pressure-reactivity index (PRx) monitoring in
paediatric TBI.
2. To analyse how often PRx monitoring results in an optimum CPP
recommendation
3. To report differences between commonly used age-specific CPP
thresholds (CPPopt_age) and optimum CPP (CPPopt_prx) generated
by PRx monitoring.
METHODS. Prospective observational study of patients admitted to a
paediatric intensive care unit (PICU) with severe TBI. Preliminary
analysis of patients admitted between November 2016 and April
2017 is presented here. PRx monitoring was done using ICM+
(Cambridge Enterprises, UK). Clinicians were blinded to the data and
retrospective analysis of prospectively collected data was performed.
Intracranial pressure was monitored using an intraparenchymal
pressure bolt (Camino). Details of PRx monitoring and the curve
fitting procedure to generate optimum CPP has been described
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 87 of 542previously(4). Optimum CPP curves were plotted 4 hourly based on
the distribution of PRx values in a series of 5 mmHg CPP bins.
RESULTS. Six patients (3 boys and 3 girls) had CPP monitored for
716 hours. As optimum CPP calculation was analysed in four
hour windows, there were 179 four hour windows. The plot of
PRx averaged within 5 mm Hg CPP bins showed a U-shape curve
on 71% of the windows (127/179). An optimum CPP (CPPopt_prx)
recommendation was available 65% (117) of the 179 windows.
Among individual patients this varied from 40 to 75%. Where
CPPopt_prx recommendation was available, it was higher than
CPPopt_age on 75% of occasions (88/117). CPPopt_prx was equal
to CPPopt_age on 3 (2%) occasions and was lower than CPPop-
t_age on 26 (22%) occasions. Mean (CPPopt_prx) MINUS (CPPop-
t_age) was +8 (range: −18 to +33). CPPopt_prx varied
considerably with time even within individual patients
CONCLUSIONS. PRx monitoring and optimum CPP derivation are
feasible in paediatric TBI patients. Optimum CPP
recommendation was successfully obtained on 65% of
occasions. Considerable differences exist between commonly
reported age-specific CPP thresholds and optimum CPP recom-
mended based on PRx.
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INTRODUCTION. Brain death (BD) is a catastrophic event
associated with significant disturbances in the function of other
organs. Even with maximum support, deterioration in
cardiorespiratory function leading to asystole usually occurs. A
continuous monitoring of brain and extra-cerebral organ function
is needed in this setting.
OBJECTIVES. The goal of this study is to evaluate SEDLine™ System
(Masimo Europe Limited, UK) values in traumatic brain injury (TBI) BD
patients.
METHODS. Prospective observational study in a surgical and
trauma tertiary intensive care of a universitary hospital including
18 consecutive TBI patients (2012–2016) diagnosed of BD during
their ICU stay. The SEDLine™ System (Masimo Europe Limited, UK)
was continuously recorded during the ICU stay but did not
interfere with clinical decisions. Data from the 4-channel proc-
essed electroencephalograph (EEG) monitor, including EEG wave-
forms, Density Spectral Array (DSA) and the Patient State lndex
(PSI) numeric and trend plot, were collected.
RESULTS. In all patients (median age 47 [23–78] years), PSI values
were < 5 at the moment BD was confirmed (clinical and
electrophysiological tests, according to the Spanish legislation).
PSI < 5 occurred 4.8 (±2.2) hours before BD could be confirmed by
required testing.
CONCLUSIONS. Low PSI values on the SEDLine™ System could be a
very useful method for early detection of brain death in acute brain
injured patients. The impact of such early recognition on organ
donors management and transplantion success need to be further
evaluated.0164
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INTRODUCTION. The Brain Trauma Foundation recommends that
cerebral perfusion pressure (CPP) is measured in all patients with
severe traumatic brain injury. There is evidence that doing so decreases
2 week mortality from 22% to 13%.1 The Brain Trauma Foundation
recommends a target CPP of 60-70mmHg. Aggressive attempts to
maintain CPP above 70mmHg poses a risk of adult respiratory failure
and should be avoided.2 To calculate CPP, the mean arterial pressure
(MAP) used must be transduced at the level of the middle cranial
fossa.3 This means that the arterial line transducer should be positioned
at the level of the tragus, an approximation for the middle cranial fossa.
OBJECTIVES. To assess compliance with the Brain Trauma
Foundation guidelines for monitoring and targeting CPP.
METHODS. There were 48 data collection episodes from brain
injured patients at Queens Medical Centre Intensive Care Unit
between September and December 2016.
RESULTS. In 23% of cases the arterial line transducer was not correctly
placed and therefore the CPP was measured incorrectly. 15% of
measured CPPs were below the target of 60mmHg. This increased to
21% when the transducer was moved to the correct position (tragus).
27% of those patients whose transducers were incorrectly placed
had CPPs measured that were within range, but their actual CPP was
below target when correctly measured.
Also of note, 22% of patients had a CPP of above 80mmHg, well
above the upper target of 70mmHg. Over 80% of these patients
were on noradrenaline indicating that in some cases CPP is being
over aggressively treated.
CONCLUSIONS. Greater awareness is needed that transducers should be
placed at the level of the tragus when measuring CPP. Transducer
position should be rechecked regularly, especially after patient
repositioning. The cost effectiveness of a dual transducer system should
also be investigated; this would allow simultaneous monitoring of the
'true' MAP (at heart level) and the CPP MAP (at tragus level). Finally care
should be taken not to over titrate noradrenaline to avoid the risk of
respiratory problems.
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Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 88 of 542INTRODUCTION. Prompt detection of raised intracranial pressure
(ICP) in traumatic brain injury (TBI) is mandatory. Measurement of
optic nerve sheath diameter (ONSD) by ultrasound (US) is emerging
tool to predict high ICP and it is found to be comparable to
computed tomography (CT) and invasive technique.
OBJECTIVES. To assess the accuracy of ONSD measurement by US to
predict increased ICP in TBI compared to CT and invasive
Ventriculostomy catheter technique as a gold standard, and to find
cutoff value of ONSD to identify patients with high ICP.
METHODS. This a prospective study on 49 adult unconscious
patients with TBI admitted to ICU at KFMMC in Dhahran,Saudi
Arabia.ONSD was measured by portable US machine with high
frequency probe by intensivist with previous training and experience
in ocular US. Simultaneous CT measurement of both ONSD and signs
of high ICP were determined by 2 different neuroradiologists. We
compared these 2 techniques to invasive ventriculostomy catheter
technique which was performed in 22 patients.
RESULTS. The study was done on 49 patients, invasive ICP monitor
catheteres were inserted in 22 patients. ONSD by US mean value was
0.6 ± 0.08 mm versus 0.62 ± 0.08 by CT with no significant difference
between the 2 modalities.17 patients with ICP > 20 mmHg have a
mean ONSD by US of 0.7 ± 0.1 mm which was significantly higher
than in 5 patients with ICP < 20 mmHg as the mean value was
0.5 ± 0.1 mm (p < 0.001). A cut off value of ONSD by US of 0.57 mm
has been found to differentiate patients with high ICP from those
with normal ICP with a sensitivity of 100% and specificity of
100%.There was no statistical significant difference in mortality and
in neurologic outcome between those with ONSD above or below
0.57 mm.
CONCLUSIONS. ONSD by US is as accurate as CT measurements, it
can be a good tool to predict the presence of increase in ICP with
good sensitivity and specificity. However, further studies with higher
number of patients are needed to validate these results.
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INTRODUCTION. Intracraneal hypertension is a common problem in
the neurocritical care patients. Fast treatment of raised ICP prevent
brain ischemia and brainstem herniation.
To measure ICP, invasive devices are the gold standard. In the last
years, noninvasive ICP monitoring are been studied. Ultrasonography
of optic nerve sheath diameter (ONSD) has been developed as a
possible ICP Indicator.
OBJECTIVES.
To analise relationship between ICP and ONSD.
To study the ability of ultrasonography ONSD as a diagnostic tool for
raised ICP.
METHODS. Prospective observational study. We included patients
admitted in the ICU of Burgos Hospital from January to December
2015 with invasive ICP monitoring.Ultrasound examination was made by trained investigators..
Measurements were performed every day and every ICP raised
above 20 mmHg.
RESULTS.
We included 15 patients. The mean age was 61 years. Diagnoses
were: traumatic brain injury 46,7%, subarachnoid hemorrhage 20%,
intracerebral hemorrhage 33,3%. Mean GSC was 6,5 and mean ICP
value was 13,83.
We made 113 ultrasound for each eye (total of 226 measurements).
Only 34 ultrasound was performed with raised ICP above 20 mmHg.
The median ONSD was 0,549 cm ±0,057.
There is a statistically significant relationship between ICP values and
ONSD with Rho Spearman coefficient of 0,183 (p = 0,006).
We had 20 mmHg like raised ICP level, and made ROC curve. The
area under the curve was 0,61 (95% IC 0,51-0,71) p = 0,043.
Optimal ONSD cutoff for the detection of raised ICP (>20 mmHg)
was 0,58. Sensitivity 0,53, specificity 0,72.
CONCLUSIONS. Ultrasound ONSD measurement could guide
intracraneal hypertension diagnosis but in our study this test didn´t
have enough statistic power.
Ultrasound ONSD needs validation with another studies and more
population.
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INTRODUCTION. Magnesium is amongst the most frequently used
drug on critical care units for reasons including eclampsia1,
aneurysmal SAH2 and correction of electrolyte imbalance.
OBJECTIVES. To assess the safety of the infusion protocol in
Neurosciences Intensive Care Unit, John Radcliffe Hospital. As
overshoots of plasma concentrations frequently occur, this trial was
conducted to ascertain if patients suffer any complications.
The local protocol instructs users to infuse 20mmol of magnesium
over 6 hours, diluted into 50ml of 0.9% Sodium Chloride.
METHODS. Retrospective analysis of 405 patients admitted to the Unit
excluding aneurysmal SAH (alternative protocol). All data was collected
using the electronic patient record system. The complications assessed
were prolonged duration of ventilation, reduced consciousness and
renal impairment (defined as reduction in eGFR).
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 89 of 542RESULTS. Of the 405 patients 370 were excluded due to not having
received magnesium or having received the aSAH protocol. Thirty
five (8.6%) received magnesium infusions, of which 21 (60%)
overshot plasma levels (Group A) and 14 (Group B) did not
overshoot (40%). The highest plasma levels were 3.03 mmol/L with a
mean rise of 1.27 mmol/L.
Regarding effects on ventilation in group A compared to B the total
ventilator days were 173 (mean 8.2) compared to 130 (9.2). 7/21
(33.3%) were extubated compared to 4/14 (28.5%) and 2/21 (9.5%)
did not require ventilation compared to 5/14 (35.7%).
Regarding the level of consciousness in Group A, 12/21 (57.1%) had
reduced levels out of which 6 deceased, 3 were due to the primary
brain injury and 3 were repatriated while under sedation. In Group B,
5/14 (35%) had a reduced consciousness out of which 1 patient
deceased; 3 were due to the brain injury and 1 was repatriated.
The renal functions worsened in 6/21 (28%) patients in group A out
of which 3 had pre-existing impairment and 1 demonstrated a fall in
eGFR prior to magnesium administration. In group B, 1/14 (7%) dem-
onstrated a reduction in eGFR.
CONCLUSIONS. Although the study size is small it demonstrates no
significant differences in ventilator days between groups. Effects on
level of consciousness cannot be accurately concluded as patients
either had significant brain injury, deceased or were repatriated.
Reduction in eGFR occurred more frequently in Group A however 4/6
had a reduced eGFR on admission. This may imply that magnesium
can worsen already impaired renal functions however the study
numbers are too small to conclude this.
We recommend larger trials to obtain sufficient data for statistical
analysis.
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INTRODUCTION. Self-harm and attempted suicide patients present a
large proportion of emergency admissions and intensive care plays a
significant role in managing patients with severe self-harm requiring
organ support or invasive monitoring.
OBJECTIVES. The primary objective was to determine the outcome
of patients who self-discharge from ICU and the rate of returns to
hospital with another episode of self-harm.
METHODS. We looked at all ICU admissions of self-harm patients for
the period between August 2014 and August 2016. We collected
data from ICNARC database, electronic notes and case notes where
needed. Data collected included patient demographics, type of self-
harm, presence of mental conditions, ICU stay, outcome, destination
at discharge and review by Mental Health Liaison Team.
RESULTS. There have been 142 admissions of self-harm patients
for the period studied (5.2% of all admissions). One hundred and
thirty-five patients presented after self-poisoning, alcohol and
benzodiazepines being the most common agents used, the rest
were mechanical self-harm. overall mortality was found to be
3.5%. Patients who self-discharge after being assessed by Mental
Health Liaison Team were less likely to return to hospital with an-
other self-harm episode.
CONCLUSIONS. The needs of mental health patients on ICU are not
familiar to intensivists and managing challenging patients is an areathat can be improved on by education of staff and interdisciplinary
work. Creating joint pathways for assessment and referral at local
and national levels could improve management of self-harm patients
and prevent re-admissions.
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INTRODUCTION. In-hospital trauma care must be provided in differ-
ent levels, according to patient's needs. Although classification of
some patients with extremely serious or mild injuries may be simple,
triage of others may be challenging. In several cases, in-hospital par-
tial trauma team activation (HPTTA) is necessary because of the possi-
bility of hidden life threatening injuries. Undertriage has been
associated with an increase in mortality (OR 1.24). [1] Nevertheless,
universal criteria for HPTTA are lacking.
In our institution, a classification tool based on Field Triage Decision
Scheme of the Centers for Disease Control and Prevention (CDC) [1] is
used in order to detect patients who may benefit from HPTTA.
OBJECTIVES. To evaluate the validity of our HPTTA criteria to detect
patients in whom ICU admission is needed. To determine the
frequency of undertriage and overtriage of each step of the triage
process.
METHODS. This was a prospective cohort study including all patients
requiring HPTTA at the moment of hospital arrival during a 56
month-period (May 1, 2012 through December 31, 2016). Patients ar-
riving more than 30 minutes before activation were excluded. HPTTA
criteria, data from physical examination, complementary tests and
the need of ICU admission were recorded. There are four steps in tri-
age process: step one: physiologic criteria, second: anatomic criteria,
third: mechanism-of-injury criteria, and fourth: special considerations.
For each criteria, sensitivity, specificity and under/overtriage rates
(proportion of patients admitted to ICU who do not fulfill criteria and
proportion of patients who fulfill criteria but ICU admission is not
needed respectively) were calculated. The average number of pa-
tients who need to be evaluated to indicate and ICU admission
(NND) was also determined. Analysis was performed using SPSS 16.0.
A total of 1548 patients were enrolled, 174 of which (11.24%) were
admitted to ICU. 1170 patients were male (75.6%). The median age
was 36 years old (IQR 27–47). HPTTA was indicated according to the
first step in 97 patients, 164 to the second, 1101 to the third and 34
to the fourth. The proportion of patients admitted to ICU and the
NND were respectively for each criteria 51.54% and 1.94 for the first;
21.34% and 4.68 for the second; 6.6% and 14.08 for the third and
8.82% and 11.69 for the fourth. Over/undertriage rates for each step
of our triage process are summarized in Fig. 74.
CONCLUSIONS. Field Triage Decision Scheme implemented by CDC is
a suitable tool to indicate HPTTA. First and second steps are
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 90 of 542associated with a high specificity while third and fourth ones present
a high sensitivity, which is needed to decrease undertriage rate to
acceptable values.
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INTRODUCTION. Diffuse axonal injury (DAI) is a severe traumatic brain
injury (TBI), associated with poor outcome whose mortality exceeds
40% (1).However, diagnostics of DAI has not yet been established,
especially in the early phase after injury. We hypothesized that serum
level of tau protein, which was localized in neuronal axons, would be a
useful biomarker to diagnose DAI.
OBJECTIVES. To determine the usefulness of serum tau protein
measurement in early diagnosis of DAI in clinical setting and to
elucidate relationship between severity of DAI and serum tau protein
concentration, using an animal model.
METHODS AND RESULTS. We measured serum level of tau protein
in patients suspected of DAI to evaluate its accuracy in the
diagnosis of DAI and its prediction ability of neurological
outcome at hospital discharge. DAI was diagnosed by clinical
findings, CT scan and magnetic resonance imaging. Neurological
outcome was evaluated using Glasgow Outcome Scale (GOS).
Twenty-six patients were enrolled to the study. The serum tau
levels were measured within 6 hours after TBI. The levels of
serum tau in DAI group (n = 7) were significantly higher than
those in non-DAI group (n = 19) (120.9 ± 207.9, 17.5 ± 57.2, re-
spectively, P = 0.0007). A receiver-operating characteristic curve
evaluating the diagnostic ability of serum tau level for DAI
demonstrated an area under the curve of 0.853 with 89.5% for
sensitivity and 85.7% for specificity. Concentration of serum tau
was higher in unfavorable outcome group (GOS score = 1-3,n = 11) than in favorable outcome group (GOS score = 4-5,
n = 15), but the difference was not statistically significant
(P = 0.057). Next, using a rat model of DAI, we evaluated associ-
ation between serum concentration of tau and severity of DAI.
DAI was induced by dropping a weight in the head from a pre-
determined height (mild DAI group; 1 meter, severe DAI group; 2
meters), according to Marmarou's protocol(2). Eighteen rats were
divided into three groups, sham-operated (n = 4), mild DAI
(n = 7) and severe DAI (n = 7). The serum levels of tau at 60 mi-
nutes after injury were statistically different among three groups
(sham < mild < severe, sham vs. mild, p = 0.024; mild vs. severe,
p = 0.018) .
CONCLUSIONS. Serum level of tau within 6 hours after TBI can be a
useful biomarker for diagnosis of DAI. It may also be useful in
predicting neurological outcome after TBI.
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INTRODUCTION. Previous studies reported that increased patient
volume in intensive care unit was associated to better patient
survivability.
OBJECTIVES. To assess association of trauma patient volume in
intensive care unit and hospital mortality.
METHODS. From the Japan Trauma Databank (JTDB, 244 hospitals) in
Japan from the year of 2004 to 2014, this retrospective cohort study
selected adult (≥16 y) hospitalized trauma patients in intensive care
unit whose the injury severity score (ISS) ≥ 9. A logistic regression
analysis after adjustment for age, mechanism of trauma, ISS assessed
adjusted odds ratio of the quartile of patient volume in each
intensive care unit (volume effect) for hospital mortality. Similarly, a
generalized additive model after adjustment for the same baseline
variables assessed adjusted odds ratio of patient volume in each
intensive care unit as a continuous variable (Fig. 75).
RESULTS. Of a total of 183457 trauma subjects registered in JTDB,
74942 severely injured trauma patients hospitalized to the intensive
care units and 9416 (12.6%) patients died during the hospitalizaton.
Each the quartile of patient volume included 18356 (0-25th), 18489
(25-50th), 18583 (50-75th) and 19154 (75-100th) patients,
respectively, and those hospital mortality were 30.4%, 25.2%, 21.0%
and 23.4%, respectively. Adjusted odds ratio [95% confident interval]
for hospital mortality in reference to the 25-50th quartile were 1.18
[1.11, 1.26] (0-25th quartile), 0.92 [0.86, 0.99] (50-75th quartile) and
0.96 [0.89, 1.03] (75-100th quartile), respectively.
CONCLUSIONS. Increased number of severe trauma patients volume
negatively associated to risk of hospital mortality.
Fig. 75 (abstract 0171) Association of ICU trauma patients volume
and mortality in generalized additive model
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INTRODUCTION. The introduction of major trauma networks (MTN) into
UK practice has led to a significant reduction in mortality (1). MTNs
should have all surgical specialities on site and surgeons available to
operate whenever required (2). In practice, some specialities aren´t
always on the site of MTCs due to the development of specialist services
in a region having many historical, political and geographical influences
other than trauma care. The surgical demand from major trauma is
poorly described and the lack of data makes it difficult to infer how often
and how urgently surgeons are required. Therefore, it is difficult to fully
assess whether the demand is met by the current supply of surgeons.
OBJECTIVES. This study aimed to quantify the major trauma load
placed on different surgical specialities, focussing on urgent and
non-urgent aspect of the interventions. It also discussed the implica-
tions of not having certain surgical specialities on site at the MTC.
METHODS. Anonymised datasets were retrieved from the Trauma Audit
and Research Network spanning from 01/09/14 to 31/08/2016. Analysis of
the registry provided a group of 1285 major trauma patients. Of these, 713
required at least one operation. To ensure quality of data, a random selection
of 5% of the ISS > 15 who didn t´ require an operation were analysed using
patient records to certify that there were no misclassified cases.
RESULTS. The proportion of major trauma patients requiring surgery
was lower than expected (55.49%). Neurosurgeons and orthopaedic
surgeons were involved in most of the major trauma interventions
(59.89% and 55.12% respectively). Due to the frequency and urgency
of both specialities they must be on site. Cardiothoracic, general andmaxillofacial surgeons were all required infrequently. However,
general surgeons were needed urgently as 45.13% of their
interventions were performed within 4 hours of arrival to the MTC.
Two-thirds of the cardiothoracic interventions weren't urgent, but
31.43% of cardiothoracic-injured major trauma patients required
thoracotomies- an urgent procedure. In this instance trained trauma
team leaders performed the thoracotomies, negating the effect of
not having cardiothoracics on site.
CONCLUSIONS. Having identified the urgency and frequency of the
surgical requirement, some issues with training and exposure can be
seen. By better understanding the surgical requirements of different
health regions for major trauma, the organisation and delivery of
major trauma care can be improved.
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INTRODUCTION. Patients suffering from traumatic haemorrhagic shock
use substantial haematological resources. Features at presentation may be
useful in helping influence clinicians' decision to continue resuscitation
once certain transfusion thresholds have been reached.
OBJECTIVES. To identify factors associated with both a favourable
and a poor outcome in trauma patients treated with a supra-massive
blood transfusion.
METHODS. A retrospective analysis over 4.5 years (2012–2016) of
patients receiving a supra-massive blood transfusion, defined as
15 units or more of red blood cells (RBC) in a 24 hour period, at
the Royal London Hospital (largest trauma centre in UK). Elec-
tronic and paper patient notes were compared to data obtained
from the transfusion laboratory.
RESULTS. We identified 49 trauma patients receiving a supra-massive
transfusion; the median age was 29 (range 15–78) and 92% were
male. 78% of patients died. Of the 11 who survived the median
length of stay was 57 days (range 32–509). Survivors received a me-
dian 22 units RBC (range 15–30), non-survivors significantly more
with a median 33 units RBC (range 15–74), p = 0.009. There were no
survivors above 30 units RBC, as shown in graph.
10 patients had a co-existing traumatic brain injury; none of them
survived. Survival of patients who had a thoracotomy was 11%,
whilst those suffering a cardiac arrest had a survival of 8%. Isolated
limb or pelvic injury was associated with a more favourable outcome
with 70% of these patients surviving (See Table 59).
CONCLUSIONS. Traumatic brain injury, cardiac arrest and need for a
thoracotomy are poor prognostic features when in combination with
a supra-massive transfusion requirement. An isolated limb or pelvic
injury has a much better chance of survival.
We propose that clinicians stop to review a patient's favourable
and unfavourable features when resuscitation has reached
15units of RBC; ie at the point of a supra-massive transfusion.
This could help decide whether or not to continue. Palliation
should be considered once 30 units of RBC have been transfused
in this group of patients.
Table 59 (Abstract 0173). Comparison of survivors and non-survivors
Survivors Non-
survivors
Survival chance
With Without
No. (%) 11 (22) 38 (78)
Age - median (range) 32 (19-68) 27 (15-78)
Intubated on arrival - No. (%) 3 (27) 30 (66) 9% 50%
Thoracotomy No. (%) 11% 30%
- pre-hospital 0 (0) 15 (40)
- in theatre 2 (18) 2 (5)
Cardiac Arrest No. (%) 8% 28%
- pre-hospital 0 (0) 10 (26)
- in theatre 1 (9) 2 (5)
Traumatic Brain Injury 0% 28%
- No. (%) 0 (0) 10 (26)
Isolated Limb/Pelvic Injury 70% 10%
- No. (%) 7 (64) 3 (8)
Received >30 units RBC 0% 38%
- No. (%) 0 (0) 20 (53)
Fig. 76 (abstract 0173) Units Red Blood Cells; Survivors
vs Non-survivors
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INTRODUCTION. Burn injury is associated with oxidative stress which
can lead to production of abnormal amino acids (meta- and ortho-
tyrosine).
OBJECTIVES. We aimed to assess the time course of tyrosine
isoforms in blood and urine samples of burned patients and
investigate their renal handling.
METHODS. Fifteen patients were involved in our study. Fifteen
healthy individuals served as controls. Blood samples were taken on
admission and on the next 4 consecutive days. Urine samples were
collected for 24 hours. Tyrosine isoforms were determined using
liquid chromatography with fluorescence detection.RESULTS. Decreased serum para-tyrosine (normal isoform) levels
were found in burned patients on days 2–5 (p < 0.01). Serum meta-
tyrosine levels showed a significant elevation on days 2–4 (p < 0.05)
similarly to ortho-tyrosine. Urinary para-tyrosine excretion tendency
was increasing (p < 0.01), as well as its fractional excretion
(p = 0.001). No significant tendency was found on fractional excre-
tion of meta- and ortho-tyrosine. Urinary para-tyrosine excretion and
fractional excretion were higher on days 2–5 (p < 0.05), urinary
ortho-tyrosine fractional excretion was higher on days 1, 2 and 5
(p < 0.05) compared to controls. Significant positive correlations were
found between serum meta-tyrosine and procalcitonin levels
(p < 0.05) and between para-tyrosine and injury severity indexes
(p < 0.05). Burned surface and fractional excretion of meta-, and
ortho-tyrosine showed positive correlation (p < 0.01).
CONCLUSIONS. Increased serum meta- and ortho-tyrosine levels
might be consequence of the oxidative stress similarly to the de-
creased serum para-tyrosine levels. Increased fractional excretion of
ortho-tyrosine suggests synthesis of it in kidneys, whereas, increased
fractional excretion of para-tyrosine might be sign of disturbed
reabsorption.
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INTRODUCTION. Disseminated intravascular coagulation (DIC) during
the early phase of isolated traumatic brain injury falls under the
fibrinolytic phenotype.
OBJECTIVE. The aim of this study was to investigate the role of
tissue hypoperfusion and brain damages on hyperfibrinolysis in DIC
associated with isolated traumatic brain injury (iTBI), leading to poor
outcome.
METHODS. iTBI was defined as an abbreviated injury scale of the
head ≥3 and other body parts ≤ 2. Ninety-two patients with iTBI
were retrospectively included in the present study. These patients
were divided into DIC (n = 45) and non-DIC (n = 47) groups based
on the Japanese Society for Acute Medicine DIC criteria on admission
(day 0). The DIC patients were further subdivided into those with
and without hyperfibrinolysis based on fibrin/fibrinogen degradation
products (FDP) levels > 100 μg/mL. The FDP/D-dimer ratio was used
as surrogate marker of fibrin(ogen)olysis. Systemic hypoperfusion
was defined as a blood lactate level of ≥ 4 mmol/L and the severity
of injury was assessed by the injury severity score. The sequential
organ failure assessment (SOFA) and systemic inflammatory response
syndrome (SIRS) scores were also evaluated. The main outcome
measure was the all-cause hospital mortality.
RESULTS. All DIC patients developed SIRS. The SOFA scores of the
DIC patients were significantly higher than those of the patients
without DIC, leading to worse outcome. These changes were more
prominent in DIC patients with hyperfibrinolysis. FDP/D-dimer ratios
in DIC with hyperfibrinolysis were significantly higher than those of
non-DIC patients. The mean blood pressures were identical between
DIC and non-DIC patients and DIC with and without hyperfibrinolysis.
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 93 of 542However, a significant difference was observed in the lactate levels
between the DIC and non-DIC groups (5.3 [2.5] vs. 3.2 [1.6]), which
was increased to a greater degree in DIC with hyperfibrinolysis. A
logistic regression analysis revealed that hyperfibrinolysis is an inde-
pendent predictor of death in iTBI patients, and a Kaplan-Meyer
curve showed a significantly lower survival rate in DIC patients with
hyperfibrinolysis than in those without hyperfibrinolysis. However,
neither hypoperfusion nor brain damage was identified as an inde-
pendent predictor of hyperfibrinolysis.
CONCLUSION. DIC with hyperfibrinolysis contributes to organ
dysfunction and a poor outcome in patients with iTBI. DIC-induced
low-flow-related hypoperfusion but not low-blood pressure-related
hypoperfusion may be the cause of the increased lactate levels ob-
served in this type of DIC.
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INTRODUCTION. The Parkland Formula has been used as gold
standard for calculation of initial fluid resuscitation in severe burn
patients (4 ml x TBSA burned x kg weight for 24 hours, half of that
amount being given during the first 8 hours) adjusting the following
requirements by urine output.
We studied the initial fluid administration needed when we used a
resuscitation protocol guided by transpulmonary thermodilution and
lactate levels and compared it with estimated fluid replacement with
Parkland formula.
METHODS. We studied 84 severe burn patients resuscitated with
Ringer lactate and after 12–18 hours we added colloids guided by a
protocol based on transpulmonary thermodilution and lactate levels.
We then measured fluid administration, hourly urinary output, and
transpulmonary thermodilution parameters. Laboratory analyses
were performed every 8 h.
RESULTS. The study included 84 patients with burns in 20% to 90%
of the TBSA, aged between 18 and 85 years. The mean age was
45 ± 15 years, the mean percentage of TBSA was 36 ± 15% and the
mean ABSI was of 8.2 ± 1.8. The mortality was 13%.
Fluid administration: The mean infusion rate per hour in the initial 8
hours after burn was 0,167 ± 0,117 ml /kg/hour per % of burned
TBSA, lower than the Parkland formula estimation to be given in
these first 8 hours (0,25 ml /kg/hour x % burn). During the period
between 8 to 16 hours, and 16 to 24 hours after burn the mean
infusion rate per hour was 0,165 ± 0,089 and 0,156 ± 0,095
respectively (Parkland formula estimates 0,125 ml /kg/hour per % of
burned TBSA between 8 and 24 hours after the burn). During the
24–32 hours after burn the mean infusion rate per hour was
0.144 ± 0.076.
ITBV Index: in the initial 8 hours after burn; 8 to 16 h; 16–24 h and
24–32 h after burn, the results were 715 ± 256; 705 ± 225; 740 ± 262
and 754 ± 269 respectively.
EVLW Index: in the initial 8 hours after burn; 8–16 h; 16–24 h and
24–32 h after burn the results were 7.05 ± 2.6; 7.2 ± 2.7; 7.6 ± 3.6
and 8.5 ± 4.7 respectively
Cardiac Index: in the initial 8 hours after burn; 8–16 h; 16–24 h and
24–32 h after burn the results were: 2,74 ± 1; 2.72 ± 0.9, 2.9 ± 1.0
and 3,3 ± 1.1 respectively
Lactate levels: in the initial 8 hours after burn; 8–16 h; 16–24 h and
24–32 h after burn the results were: 2.8 ± 2; 2.5 ± 1.7; 2.5 ± 1.9 and
2.3 ± 1.7 respectivelyOur patients required a relatively constant infusion of volume over the
first 24 hours. There was no need for fluid addition during the first 8
hours as advised in the Parkland formula. This lower fluid intake did
not deteriorate the preload (ITV 715 vs 705), maintaining an acceptable
cardiac index as well as an adequate lactate clearance.
CONCLUSIONS. Starting with a higher fluid administration in the
initial phase of resuscitation in severe burn patients can lead to an
unnecessary supply of liquid when the phase of altered permeability
has not yet occurred.
Resuscitation is a dynamic process and fluid administration should
be guided according to the haemodynamic needs of each moment.0177
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INTRODUCTION. Little is known about long term survival risk factors
in critically ill burn patients who survive hospitalization. Utilizing
biomarkers elevated with chronic inflammation such as the red cell
distribution width may inform risk prediction related to pre-existing
disease states.
OBJECTIVES. We hypothesized that elevated red cell distribution
width (RDW) at Burn ICU admission would be predictive of long term
outcomes in hospital survivors.
METHODS. We performed a two center observational cohort study
between 1998–2007 in 340 critically ill adult burn patients who
survived to hospital discharge. The exposure of interest was RDW at
Burn ICU admission and categorized a priori as ≤13.3% (normal), 13.3-
14.0%, 14.0-14.7% and >14.7%. The primary outcome was all-cause 5
year mortality based on the US Social Security Administration Death
Master File. Adjusted associations were estimated through fitting of
multivariable logistic regression models. Time-to-event analysis was
performed using Cox proportional hazard regression.
RESULTS. Of the cohort patients studied, 76% were male, 29% were
non white, 14% were over 65, 41% had TBSA > 20%, and 44% had
inhalational injury. The mean age was 45, 93% had partial thickness
burns, 62% had full thickness burns, 28% received vasopressors, and
26% had sepsis. The mean TBSA was 20.5%. The mean Baux score
was 65.1. Post hospital discharge 5 year mortality rate was 9.4%. The
30 day hospital readmission rate was 4%. Patients with RDW >14.7%
had a significantly higher Baux score (74 vs 64), and higher
development of inhalational injury and sepsis (all P < 0.05). In a
logistic regression model adjusted for Charlson comorbidity index,
gender, presence of full thickness burn, inhalational injury and the
Baux score, patients with a RDW of 14.0-14.7% or RDW >14.7% at
Burn ICU admission have an adjusted OR of 5-year post discharge
mortality of 6.0 (95%CI, 1.4-25.5; P = 0.017) or 11.4 (95%CI, 3.2-40.7;
P < 0.001) respectively, relative to patients with an RDW ≤13.3%. The
adjusted model showed good discrimination (AUC 0.89) and calibra-
tion (Hosmer-Lemeshow χ2 P = 0.67). Cox proportional hazard multi-
variable regression modeling showed that Burn ICU admission RDW
was predictive of mortality following hospital admission [RDW of
14.0-14.7% HR = 8.9 (95% CI 2.6-30.7; P = 0.001); RDW >14.7%
HR = 11.1 (95% CI 3.6-34.4; P < 0.001)].
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 94 of 542CONCLUSIONS. Burn patients with elevated RDW at ICU admission
have increased 5 year mortality compared to those with normal RDW.
The elevated RDW at the time of burn injury likely reflects a preexisting
proinflammatory or oxidative stress state, or a combination thereof
which may be reflective in long term recovery and outcomes.
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INTRODUCTION. In patients with pelvic fracture (PF), emergency
angiography (AG) is a first process to treat intra-pelvic major arterial
bleeding (IPMB). The typical indication of AG for these patients is un-
stable vital signs, but no clear consensus has been reached. We
aimed to clarify the association between initial clinical profile and
IPMB in patients with PF.
METHODS. A single-center retrospective study was conducted from
January 2012 to December 2015. Among the 3,354 trauma patients
admitted to a Japanese civilian trauma center, 390 had PF caused by
a blunt mechanism during the study period. One hundred seven
adult patients who underwent AG were included in this study. Pa-
tients who had no computed tomography (CT) scan or surgical inter-
vention available before AG for PF were excluded. We classified
patients into two groups according to the presence (E group, n = 70)
or absence (NE group, n = 37) of contrast extravasation on AG as a
diagnosis of IPMB and compared clinical profiles.
RESULTS. The median age of the patients was 66 years (interquartile
range: 56–76 years), and their median injury severity score (ISS) was
34 (22–50). The percentage of the patients who had embolization
was 76.6%. Univariate analysis indicated that age, the size of contrast
leakage on enhanced CT scan and D-dimer on admission were
higher in group E than in group NE. Admission vital signs were simi-
lar in both groups. The median vertical size of the contrast leakage
(VSCL) was lager in the E group than in the NE group (E: 20 mm, NE:
0 mm, P = 0.021). Multivariate regression analysis revealed that the
associated factors of IPMB were size of the VSCL (odds ratio [OR]:
0.316, 95% confidence interval [CI]: 0.119-0.838; P = 0.021) and D-
dimer level (OR: 1.013, 95% CI: 1.003-1.023; P = 0.012). The area
under the curve of the receiver-operating characteristics curve for ar-
terial bleeding in VSCL was 0.68 (95% CI: 0.57-0.78). The cutoff value
for VSCL from the sensitivity-specificity curve for IPMB was 10 mm
(Sensitivity: 50%, specificity 75.4%).
CONCLUSIONS. VSCL on enhanced CT scans and D-dimer level on ad-
mission were associated with IPMB in patients with PF. These factors
may be reasonable as additional information in selecting AG for PF.
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INTRODUCTION. In the physician-staffed helicopter setting, on-the-
scene prediction of patient mortality is important for the selection of
an appropriate hospital. Recently, quick sequential organ failure as-
sessment score (qSOFA) has been proposed for use as a simple pre-
diction tool for mortality among patients with sepsis [1].OBJECTIVES. This study evaluated the predictive ability of qSOFA for
in-hospital mortality among patients who were transported by
physician-staffed helicopters.
METHODS. We conducted a single center retrospective observational
study using the physician-staffed helicopter registry data between
2003 and 2016. Out of 2453 adult patients transported to our hos-
pital by helicopter, we excluded 604 patients because of missing in-
formation on patient outcomes and vital signs; hence, we included
1849 patients in our study. qSOFA score was evaluated for predicting
in-hospital mortality in various diagnostic categories by the receiver
operating characteristics curve analysis.
RESULTS. Median age of the patients was 66 (interquartile range 52–
78) years; 1285 (69.5%) patients were men. Diagnostic categories
included trauma (1038 patients, 56.1%), stroke (456 patients, 24.7%),
cardiovascular disease (134 patients, 7.2%), and sepsis (50 patients,
2.7%). In-hospital mortality occurred in 169 patients (9.1%). In-
hospital mortality rate among patients with qSOFA score 0, 1, 2 and
3 were 5 / 411 (1.2%), 69 / 797 (8.7%), 71 / 541 (13.1%), and 24 / 100
(24.0%), respectively. Area under the curve (AUC) was 0.67 (95% con-
fidential interval [CI] [0.63, 0.71]) in all patients. AUC in patients with
sepsis, trauma, stroke and cardiovascular disease were 0.66 (95% CI
[0.43, 0.83]), 0.75 (95% CI [0.70, 0.80]), 0.58 (95% CI [0.52, 0.64]) and
0.66 (95% CI [0.38, 0.86]), respectively.
CONCLUSION. As the qSOFA score increased, the mortality rate
gradually increased. In particular, patients with 0 score of qSOFA
exhibited very low mortality rate. In-hospital mortality was well pre-
dicted in patients with trauma.
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INTRODUCTION. Glial fibrillary acidic protein (GFAP) is promised
biomarker of traumatic brain injury (TBI) with positive head
computed tomography (CT) findings (J Neurotrauma 2015;32:527–33,
J Neurotrauma 2013;30:1490–7). On the other hand, traditional
indication of head CT is decided by Glasgow coma scale (GCS).
OBJECTIVES. In the present study, in order to help avoid
unnecessary head CT, serum GFAP and GCS were compared to judge
which indication would predict positive CT findings in mild to
moderate TBI patients of emergency department.
METHODS. All TBI cases were measured serum GFAP on admission,
and all cases were performed head CT. Serum GFAP and GCS on
admission were compared by receiver operating curve (ROC)
analysis, univariate and multivariate analysis.
RESULTS. 57 cases of TBI cases were analyzed. Median age was 70
y.o. and 39% males. Median serum GFAP and GCS were 0.11 ng/mL
and 15, respectively. 12 cases (21%) had positive head CT findings.
ROC analysis showed that area under the curve (AUC) of GFAP v.s.
GCS were 0.851 v.s. 0.756, respectively.
Table 60 (Abstract 0181). See text for description
All Group 1
(low DP)
Group 2
(low PP)
Group 3
(mixed)
n 90 22 45 14
Age (year) 66 ± 16 70 ± 15 64 ± 16 67 ± 14
APACHE II
score/SOFA score
21 ± 7/9 ± 4 23 ± 7/10 ± 3 20 ± 6/9 ± 3 21 ± 6/10 ± 3
Lactate (mml/L) 4.0 [2.9,5.8] 3.5 [2.7,6.4] 4.1 [3.0,4.9] 3.9 [3.0,6.7]
NE dose
(ug/kg/min)
0.10
[0.02,0.29]
0.16
[0.09,0.32]*
0.13
[0.05,0.30]
0.24
[0.12,0,44]**
MAP (mmHg) 76 ± 19 58 ± 9 68 ± 17* 55 ± 9**
ICU LOS
(days)/MV (days)
8 [6,14]/5
[3,9]
8 [5,11]/4 [1,7] 9 [7,12]/6
[3,9]
8 [5,11]/4 [3,8]
RRT, (%) 17 (19) 4 (18) 10 (22) 4 (28)
Mortality, (%) 12 (13) 3 (14) 4 (8) 2 (14)
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 95 of 542CONCLUSIONS. Serum GFAP showed the potential predictability of
positive CT findings in TBI cases, which might be superior to GCS
based on AUC data by ROC analysis.
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INTRODUCTION. S-3 consensus defined septic shock as NE require-
ments to maintain mean arterial pressure (MAP) > 65 mmHg and a
serum lactate level >2 mmol/L despite fluid resuscitation, and
claimed that these criteria will identify patients with a homogeneous
high risk of death, allegedly in excess of 40% [1]. However, a recent
study challenged this assumption demonstrating that the presence
of a hypoperfusion context determined huge differences in mortality
and morbidity among septic shock patients with similar lactate levels
[2]. The purpose of this study was to explore if some hemodynamic
parameters such as admission BP profile and NE requirements were
independently associated to morbidity or mortality in S-3 septic
shock patients.
METHODS. Retrospective analysis of a prospectively filled database
of ninety S-3 septic shock patients treated at an academic ICU. Local
IRB approved the study and waived the requirement of informed
consent.
Patients were classified as follows according to admission BP profile:
1) Vasoplegic patients, diastolic blood pressure (DP) < 50 mmHg; 2)
Patients with low pulse pressure (PP) < 50 mmHg and 3) mixed.
These subgroups were compared according to demographic,
hemodynamic, perfusion parameters, NE requirements. and outcome
data. Statistical analysis, the distribution of continuous variables was
explored using the Kolmogorov-Smirnov test. Student´s t test and
Mann Whitney test were used to analyzing parametric and non-
parametric continuous variables, respectively. Exact Fisher test was
used for qualitative variables. Multivariate analysis was performed to
determine the independent associations between NE requirements
and comorbid variables. Statistical analyses were performed using
IBM SPSS Statistics 20.
RESULTS. The main results are expressed in the Table 60
The BP profile at admission was not associated to prognosis.
Multivariate analysis demonstrated that only NE doses > 0.1 ug/kg/
min were associated to longer ICU stay and MV days after adjusting
to lactate levels, p = 0.023 and p = 0.012, respectively.
Values are expressed as mean ± SD or median (interquartile range)
or N (%); ICU, intensive care unit; LOS, length of stay; MV, mechanical
ventilation; RRT, renal replacement therapy; * (p < 0.05) comparing
group 1 and 2; **(p < 0.01).CONCLUSIONS. S-3 septic shock patients with a vasoplegic profile re-
quire higher NE doses but do not present a worse prognosis as com-
pared to patients with low pulse pressure at admission. NE
requirements >0.1 ug/kg/min are associated with outcome, again
challenging the homogeneity proclaimed by sepsis-3 consensus.
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INTRODUCTION. Dexmedetomidine was reported to improve immune
system interactions such as cytokine and organ systems such as brain
dysfunction, cardiovascular, lung injury, liver dysfunction and kidney
injury in animal model of sepsis. There were limited data on the effects
of dexmedetomidine on CRP or PCT as inflammation and Sequential
Organ failure Assessment (SOFA) score as organ failure.
OBJECTIVES. To evaluate whether administration of dexmedetomidine
could improve inflammation and organ failure in patients with sepsis
requiring mechanical ventilation.
METHODS. DExmedetomidine for Sepsis in Intensive care unit
Randomized Evaluation (DESIRE) Trial was randomized controlled trial
to examine whether a sedation strategy with dexmedetomidine (DEX
group) relative to without dexmedetomidine (non-DEX group) could
improve clinical outcomes in patients with sepsis requiring mechanical
ventilation. We compared CRP (days 1, 2, 4, 6, 8, 10, 12, 14); PCT (days
1, 4, 8, 14); and SOFA score (days 1, 2, 4, 6, 8, 10, 12, 14) during ICUs
between groups in this sub-analysis. We assessed time to improvement
of inflammation (CRP < 5 mg/dL and PCT < 0.5 ng/mL) with competing
risk of death and censoring of discharge from ICUs. We used the Cox
proportional hazards model to estimate the hazard ratio (HR) and 95%
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 96 of 542confidence interval (CI) of DEX group against non-DEX group with the
competing risk of death. We also used generalized linear models to es-
timate the overall differences in CRP and PCT between groups. We also
used Wilcoxon rank sum test for SOFA scores at each day.
RESULTS. We includes 201 patients; the DEX group was 100 patients
and the non-DEX group was the 101 patients. Mean age was 69 (stand-
ard deviation, 14) years and 63% were male. The number of abdominal
infection was 74 (37%), thorax infection including pneumonia was 72
(36%), and other site infection was 55 (27%). Improvement of inflam-
mation at 14 days was not significantly different (CRP < 5 mg/dL: 66%
vs 54%, p = 0.15; PCT < 0.5 ng/mL: 51% vs 44%, p = 0.35). The HRs of
DEX group were 1.23 (95% CI: 0.91-1.77) for CRP < 5 mg/dL and 1.16
(95% CI: 0.80-1.70) for PCT < 0.5 ng/mL. However, overall CRP and PCT
during ICU stay were significantly lower in DEX group than non-DEX
group (p = 0.03 and 0.04, respectively). Total SOFA score was not signifi-
cantly different between DEX group and non-DEX group (day 1; 8 vs. 9,
day 2; 9 vs. 9, day 4; 8 vs. 8, day 6; 8 vs. 7, day 8; 7 vs. 5, day 10; 6 vs. 6,
day 12; 5 vs. 5.5, day 14; 4.5 vs. 4). The SOFA score for each organ system
was not also significant different.
CONCLUSIONS. The sedation strategy with dexmedetomidine was
associated with lower inflammation status during ICU stay than that
without dexmedetomidine in patients with sepsis requiring mechanical
ventilation. However, the time to improvement of inflammation and
organ failure were not different between groups.
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INTRODUCTION. Lactate clearance is useful in resuscitating septic
shock patients (1). Dexmedetomidine increased the lactate clearance
in an experimental sheep model (2).
OBJECTIVES. To evaluate if dexmedetomidine increased lactate
clearance in septic shock patients.
METHODS. DESIRE was a randomized controlled trial enrolling 201
mechanically ventilated adult patients with sepsis to test sedation
strategy with and without dexmedetomidine in 8 ICUs in Japan (3).
We included 111 septic shock patients (60 in the dexmedetomidine
group and 51 in non-dexmedetomidine group) to evaluate the effect
of dexmedetomidine on lactate clearance. A linear regression model,
adjusted for baseline lactate value, was used to assess the effect of
dexmedetomidine on lactate clearance at 6 h after randomization.
RESULTS. Mean age was 71.0 ± 13.4 years. Median Acute Physiology
and Chronic Health Evaluation II score was 25 (interquartile range 19–
31). The use group had a lower median serum lactate value at
randomization than the non-use group (4.0 vs. 4.8 mmol/L). Lactate
clearance at 6 h was higher in the use group, but was not significantly
different (23.3 ± 29.8 vs. 11.1 ± 54.4; mean difference, 12.2; 95% confi-
dence interval [CI], 4.4-28.8; P = 0.15). The multivariable model indi-
cated lactate clearance at 6 h was significantly higher in the use group
(adjusted mean difference, 18.5; 95% CI, 2.2-34.9; P = 0.03). There was
no significant difference in 28-day mortality (13 [22%] in the use group
and 18 [35%] in the non-use group, P = 0.11).CONCLUSIONS. Compared with a sedation strategy without
dexmedetomidine, a sedation strategy with dexmedetomidine increased
lactate clearance in mechanically ventilated patients with septic shock.
The increased lactate clearance effect of dexmedetomidine might be
associated with the improved survival in sepsis patients.
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INTRODUCTION. Prediction of resting energy expenditure (REE) in
septic shock patients is crucial to determine the optimal caloric
requirement for patients on vasopressor therapy(1),(2). Many factors
may affect the resting energy expenditure (REE) through
manipulation of oxygen consumption (VO2) (3).
OBJECTIVES. To determine the effect of noradrenaline on REE and to
compare the REE measured via indirect calorimetry and REE
calculated by the Harris-Benedict equation.
METHODS. This prospective, observational study was conducted in
the 24- bed trauma-surgical ICU at Cairo University Hospital. REE was
measured and the corresponding vasopressor level was recorded on
admission (or upon starting vasopressors in the ICU department),
then after 24 hours and 48 hours thereafter. Measurements were
taken with the patient lying supine and ventilator settings left un-
changed for at least 60 minutes ahead of indirect calorimetry. The
Harris Benedict equation for prediction of energy expenditure was
also calculated(1).
RESULTS. A total of 40 patients fulfilling inclusion criteria were
enrolled in our study, There was a negative correlation between
noradrenaline dose and measured REE such that REE increased with
decreasing dose of noradrenaline and vice versa at 24 and 48 hours
{p value 0.002, 0.013(r = −0.469, −0.388)}. thirty one of the patients
have REE measured by indirect calorimetriy greater than REE
calculated by the equation.
CONCLUSION. There was negative association between resting
energy expenditure and noradrenaline dose that may be used as a
prognostic factor in septic shock
patients. We found no agreement between REE measured by indirect
calorimetry and REE calculated by Harris Benedict equation.
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INTRODUCTION. Sepsis is still one of the most important problems
of modern pediatric intensive care. As a component of the gram-
negative cell wall, endotoxin plays a primary role in the pathogenesis
of many cases of sepsis.
OBJECTIVES. To evaluate the effectiveness of selective LPS-sorbents:
LPS-adsorber Toraymyxin - PMX-0.5R (Toray, Japan) in critically ill chil-
dren with sepsis (S) secondary to gram-negative infection following
cardiac surgery.
METHODS. During 2016 the study included 10 children aged 9–14
months and weighing 6.2 - 12.5 kg. The inclusion criteria were:
clinical signs of sepsis with microbiologically confirmed focus of
gram-negative infection or/and gram-negative BAL and blood cul-
ture, elevated blood procalcitonin (PCT) >2 ng/ml, LPS concentration
according to the endotoxin activity assay (EAA) ≥0.6 and elevated
levels of CRP. All children had thrombocytopenia, DIC-syndrome
markers (D-dimers) and leukocytosis / leukopenia. Refractory hyper-
thermia (>38°С) was seen in all patients. Intensive therapy included
inotropic and vasopressor support, mechanical ventilation and
broad-spectrum antibiotics.
RESULTS. Each patient underwent 2 sessions of hemoperfusion with
Polymyxin B-immobilized cartridge lasting a maximum of 180 mi-
nutes. Extracorporeal therapy was initiated within 24 hours after the
diagnosis of sepsis was made. During the treatment the improve-
ment of hemodynamic indices, oxygenation index, the normalization
of leukocytosis and body temperature, positive dynamics on chest X-
ray and the negative results of bacteriological tests were noted. After
the procedures of LPS-adsorption we found the decrease of LPS con-
centrations according to the ЕАА, PCT, presepsin and levels of CRP. It
was noticed that five out of six patients have survived. One child
died from a surgical problem.
CONCLUSIONS. Our experience with clinical use of selective LPS-
adsorption suggests that it is reasonable to include this method of
extracorporeal therapy in complex intensive care treatment of sepsis
in children after heart surgery.
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INTRODUCTION. Severe sepsis and multiorgan failure (MOF) are the
commonest causes of ICU mortality. The extracorporeal cytokine
adsorption column (ECAC; Cytosorb®, CytoSorbents Corporation,
USA), a critical care therapeutic device, results in rapid reduction of
cytokines and prevents organ failure. Use of ECAC in patients with
sepsis is a new area of research. However, insufficient data are
published till now. Studies published till dates have shown promising
results. We report our clinical experience with ECAC in severe sepsis/
septic shock/MOF patients.
OBJECTIVES. Objective of the study was to analyze survival benefit,
selection of the eligible subgroup of patients, appropriate timing for
initiation; number of device filters required per patient, and selective
sepsis severity scores to identify rationales of ECAC therapy.
METHODS. A retrospective evaluation of ECAC in patients admitted
to a tertiary care ICU in Apollo hospital, Hyderabad, from November2015 to December 2016 was carried out. Patients were managed
with standard of care therapy as per international sepsis guideline
along with ECAC as adjuvant therapy. Vitals, APACHE II and SOFA
scores were evaluated before and after ECAC therapy.
RESULTS. Twelve ICU patients (10 male, 2 female; mean
age = 64.83 ± 12.1 [mean ± SD]; with baseline APACHE II 26.25 ± 0.84
[mean ± SD], SOFA score = 14.25 ± 0.41 [mean ± SD] and the majority
having infection largely in the lung (n = 7; alone or with blood
infection) followed by the abdomen (n = 4), and others (n = 1) were
given ECAC (total ECAC = 23). Predicted mortality (PM) was >60% and
100% survived; all of them had were ECAC early (24 hours). APACHE II
and SOFA scores after ECAC therapy were 11.66 ± 1.31 and 8.66 ± 1.39
respectively. Both SOFA and APACHE II score decreased >5 points in all
patients after single application of ECAC.
CONCLUSION. All our patients had multiple organ failures and septic
shock. Use of ECAC can be recommended as an adjuvant therapy in
the treatment of severe sepsis/septic shock/MOF. Our patients had
high predicted mortality and all could be saved with the use of ECAC
when introduced early (≤24 hours).
If ECAC is introduced early (≤24 hr.) in septic shock/MOF patients'
treatment, a better outcome in terms of mortality benefit can be
expected. However, large prospective studies are required to
understand the role of ECAC in patients with MOF/septic shock.
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INTRODUCTION. The removal of toxic cytokine in patients with
septic multiple organ failure may be aided by the extracorporal
cytokine adsorption filter(CytoSorb) as demonstrated in case studies
and in-vitro experiments. The effect of Cytosorb on the circulation of
the septic/septic shock patient however remains unknown.
OBJECTIVES. To examine the circulatory system in patients in the
first twenty-four hours of CytoSorb therapy by means of PiCCO. In
addition, to assess for possible decrease in norepinephrine-demand
in respect of the thereby achieved Mean Arterial Pressure (MAP in
mmHg) mentioned as Nor/MAP.
METHODS. Patients diagnosed with sepsis or septic shock were
prospectively included in the period from January to August 2016
(Intervention group, N = 5) and retrospectively from January to
December 2014 (Control group, N = 5)(Table 61). Patients in the
intervention group received standard care and CRRT in combination
with CytoSorb and hemodynamic monitoring with PiCCO. The
control group was retrospectively assembled from Patiënt Data
Management System, therapy included standard care and CRRT. The
intervention group was assessed by measuring; Cardiac Index (CI),
extravascular lung water index (EVLWI), systemic vascular resistance
index (SVRI), Nor/MAP and fluid balance. Measurements were taken
at 4 hour intervals in the initial 24-hour period. The demand for Nor-
epinephrine and fluid balance was assessed in both groups.
RESULTS. Data (Table 61, 62) show a clear reduction in demand of
Norepinephrine and the thereby achieved MAP (Nor/MAP) in the
intervention group compared to the control group, at start
0.65 ± 0.50, after 24h 0.26 ± 0.13. The control group also shows a
reduction, only less sharp 0.82 ± 0.41, after 24h 0.62 ± 0.42. At the
conclusion of the study, the results showed a normal CI for 4
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 98 of 542patients (3-5l/min/m2, N = 5). The initial values were 98 ± 1.53 and
after 24h 3.6 ± 0.73. The patients with high CI at start of therapy
showed a decline within 12h whilst values normalized for patients
with a low CI within 12h. The 4 patients who showed a low SVRI at
the beginning showed a sharp increase within the first 12h, however
normal values (1700-2400dyn°sec°cm-5°m2) were not achieved after
24h, 1336.60 ± 486.90 and 1543 ± 333.84 at the end of the study.
CONCLUSIONS. In the cytosorb group, we demonstrated a trend
towards stabilization of the CI, SVRI and Nor/MAP, especially in the
first 12 hours. In addition, there was a reduction in norepinephrine
requirement in this group. Our study was limited by small sample
size, there was no significant statistical difference.Table 61 (Abstract 0187). Baseline characteristics
Unit Min Max Mean SD
Age 1 Years 32 81 62 19
Age 2 Years 68 85 76,6 7
Weight 1 Kg 82 135 97,4 21
Weight 2 Kg 75 100 86,8 10
SOFA 1 Score 12 17 15 2
SOFA 2 Score 13 20 15 3
APACHE 1 Score 31 48 41 7
APACHE 2 Score 34 47 41 5
1. Intervention 2. Control
Table 62 (Abstract 0187). Baseline versus end study
Baseline End study 24H
Unit Min Max Mean SD Min Max Mean SD
Nor/MAP
1
mcg/kg/hr
mmHg
0,15 1,4 0,65 0,50 0,11 0,45 0,26 0,13
Nor/MAP
2
mcg/kg/hr
mmHg
0,50 1,27 0,82 0,41 0,13 1,06 0,62 0,42
CI 1 l/min/m2 2,8 6,3 4 1,50 2,7 4,3 3,6 0,73
SVRI 1 dyn°sec°cm-
5°m2
779 2074 1337 487 1282 2109 1543 334
EVLWI 1 ml/kg 4 12 9 3,46 5 18 11 5,11
Fluid
Balance 1
ml −4546 9751 4783 5589
Fluid
Balance 2
ml 2358 10774 7120 3601
1. Intervention 2. Control
Fig. 77 (abstract 0187) See text for description
Fig. 78 (abstract 0187) See text for description
Fig. 79 (abstract 0187) See text for description0188
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INTRODUCTION. Colloid solution was recommended for septic shock
resuscitation, in the patient who didn't respond to crystalloid fluid1.
Albumin is considered as the most suitable colloid1, however; its use
was limited by its price. Gelatin solution is an alternative colloid with
lower price, but the efficacy had not been identified.
OBJECTIVES. This study aims to compare the outcome of gelatin
versus albumin solution in septic shock resuscitation.
METHODS. A matched cohort study enrolled refractory septic shock
patients, not respond to 30 ml/kg of crystalloid resuscitation and
required either albumin or gelatin solution for fluid therapy. The
primary outcome was 28-day mortality.
RESULTS. Overall 127 patients were recorded. After adjusted for
patients' age, baseline mean arterial blood pressure, severity score
and lactate level, 97 patients were included. 47 patients received
albumin and 50 patients received gelatin for fluid therapy. There was
Fig. 80 (abstract 0189) Volume gain and mortality]
Fig. 81 (abstract 0189) Volume gain and 28th-day survival
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 99 of 542no significant difference in patients' baseline characters. The 28-day
mortality was 34% in albumin group, versus 42% in gelatin group,
p = 0.28. The ICU and hospital mortality were not difference. Acute
kidney injury, requiring renal replacement therapy occurred in 24%
of patients in both groups. Among the low baseline serum albumin
patients (<2.5g/dL), the 28-day mortality [4/21(19%) VS 13/25(52%),
p = 0.03] and hospital mortality [4/21(19%) VS 13/25(52%), p = 0.03]
were lower among albumin than gelatin group. The survival days in
28-day without organ support was significant longer in albumin
group (16.9 ± 9.9 VS 7.7 ± 9.7, p = 0.002).
CONCLUSIONS. The outcome of septic shock resuscitated with
albumin and gelatin solution was not different in overall population.
Albumin resuscitation associated with more favorable outcome
among the low baseline serum albumin septic shock patients.
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OBJECTIVES. To evaluate the fluid accumulation during the first
week of septic shock and its impact on mortality.
METHODS. Prospective, observational study, conducted in a
polyvalent ICU. 64 patients with diagnosis of septic shock were
included in a period of 18 months. Demographic characteristics,
comorbidities, APACHEII, SOFA, SAPSII, hemodynamic parameters,
daily fluid balance (DFB), daily cumulative balance (DCB), percentage
of fluid accumulation and the appearance of fluid overload were
analysed during the first week of hospitalization. The impact in 28-
day mortality was evaluated.
DEFINITIONS.
- DFB: Differences between volume income and daily diuresis.
- DCB: Addition of the DFB.
- Percentage of fluid accumulation: DCB divided by weight on
admission x 100.
- Fluid overload: Percentage of fluid accumulation more than 10%.
RESULTS. We included 64 patients with mean age 65 years, 53% male,
APACHE 28 ± 7, SAPS II 56 ± 20, SOFA on admission 8 ± 3, mechanical
ventilation 76%, continuous renal replacement techniques 38%. The
mean total volume administered during the first 7 days was 26 ± 8L
with a mean DCB of 16 ± 8L and a mean fluid accumulation of
21% ± 13. Regarding Fluid accumulation: 17% have < 10%, 35%
between 10-20% and 47,5% > 20%. 28th-day mortality and ICU mortal-
ity were 17% and 28% respectively. During the first week, the percent-
age of fluid accumulation was significantly higher in non-survivors than
in survivors (28,5 ± 10,7 L vs. 18,7 ± 13,1 L, p 0.046) (Fig. 80). Cumulative
survival was significantly lower (logRank = 6,05, p = 0,01) in patients
with >20% of volume gain since the 6th day (Fig. 81). >20% volume
gain in the 6th day is a independently associated variable to mortality
after adjusting by age, APACHE and hemodialysis (OR = 7,3; CI 95% 1,2-
43,9; p = 0,02).
CONCLUSIONS. In septic shock patients, fluid overload more than
20% since the 6th day of evolution is associated with a higher 28-
day mortality. Its early detection may influence the prognosis and
survival.
REFERENCE(S)
1. Soroko SB, Chertow GM, Himmelfarb J, Ikizler TA. Fluid accumulation,
survival and recovery of kidney function in critically ill patients with
acute kidney injury. 2009:422–427. doi:10.1038/ki.2009.159.2. Cordemans C, De I, Regenmortel N Van, Schoonheydt K, Dits H,
Huber W. Fluid management in critically ill patients : the role of
extravascular lung water, abdominal hypertension, capillary leak, and
fluid balance. Ann Intensive Care. 2012;2(Suppl 1):S1. doi:10.1186/
2110-5820-2-S1-S1.
3. Malbrain MLNG, Marik PE, Witters I, et al. 3, 4,. 2014;46(5):361–380.
doi:10.5603/AIT.2014.0060.
4. Boyd JH, Frcp C, Forbes J, et al. Fluid resuscitation in septic shock: A
positive fluid balance and elevated central venous pressure are
associated with increased mortality*. 2011;39(2):259–265. doi:10.1097/
CCM.0b013e3181feeb15.
GRANT ACKNOWLEDGMENT
None0190
Polyclonal intravenous immune globuline treatment as additional
strategy in sepsis
L. Mirabella1, L. Tullo1, A. Cotoia1, L. Montrano1, K. Mariano1, A. Carretta2,
G. Cinnella1
1University of Foggia, Anaesthesia and Intensive Care, Foggia, Italy;
2University of Foggia, Infectious Desease, Foggia, Italy
Correspondence: L. Mirabella
Intensive Care Medicine Experimental 2017, 5(Suppl 2):0190
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 100 of 542INTRODUCTION. Sepsis is defined as a life-threatening organ dys-
function caused by a dysregulated host response to infection associ-
ated with high mortality rate. The implementation of bundles for the
treatment of sepsis has improved the outcome but it is not clear
whether the success is tied to individual factors or to the synergy of
therapies. Recently, several Meta-analyzes have evoked a potential
role of (IG) as a treatment able to improve the outcome and reduce
mortality after septic shock.
OBJECTIVES. Aim of the study was to evaluate efficacy of
intravenous polyvalent immunoglobulin (IG) as additional therapy in
sepsis treatment in reducing mortality and improve outcome.
METHODS. Patients with diagnosis of shock septic according with
third International Consensus Definitions, received, as part of the
standard treatment protocol and based on the discretion of the
attending physician, IG at a dose of 5 mg /kg/day with slow infusion
of 10 hours for 3 consecutive days. In the treated patients were
assessed admission APACHE III score, Lactate, Procalcitonine and
Proteine C Reactive (PCR) before and after treatment with IG, ICU
length of stay, 28- day mortality and the occurrence of adverse
events to the administration of IG.
RESULTS. Between March and December 2016, 9 patients (4F: 5M)
were treated with IG, mean age 46 ± 10 years. The main diagnosis
was pulmonary infection in 44% of cases, 2 patients with ARDS, 1
with thoraco-polmonary fistula, and 1 with diagnosis of VAP. In 33%
of cases, the patients had Central Nervous System infection, 2
patients with bacterial meningoencephalitis and 1with autoimmune
encephalitis complicated by sepsis. The remaining cases (23%), 1 pa-
tient with renal abscess and 1 with dental abscess complicated by
mediastinitis. Two patients were concomitantly treated with
polymyxin-B and 3 with renal replacement therapy. APACHE III score
at admission was 65.5 ± 46, Lactate levels were 3.4 ± 0.9 mmol/L and
1.14 ± 0.2 respectively before and after treatment with IG, Procalcito-
nine was 46.1 ± 9 ng/mL and 2.18 ± 2.25 ng/mL, PCR was
425 ± 110 mg/L and 112.2 ± 90 mg/L. The duration of hospitalization
in the ICU was 21 ± 15 days, no difference was observed with non-
treated patients and the 28-day mortality was 33%, but 2 died
patients; the death is due to the underlying disease and not to the
sepsis. During treatment with IG no adverse events attributable to
the administration of the drug was detected.
CONCLUSIONS. Currently the lack of randomized clinical trials and
the small size of the sample treated do not supported sufficiently
evident conclusions but treatment with IG polyclonal as adjunctive
therapy in patients with septic shock diagnosis appears to improve
survival when early administered.
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INTRODUCTION. International guidelines for management of sepsis
and septic shock suggest against the use of IV immunoglobulins in
patients with sepsis or septic shock. There are studies which show
that the use of intravenous immunoglobulin therapy in adult septic
patients may may be beneficial and seems to be associated with a
reduce mortality. Immunoglobulins were used in our ICU during last
year,but there were no protocol of administration or control the
result of their use.
OBJECTIVES. The aim of the study was to assess agroup of patients
with sepsis and septic shock which may improve after implementation
of immunoglobulin.METHODS. The retrospective chart review (April 2016–2017) of
patients with septic shock treating with immunoglobulins.
RESULTS. 22 patients with septic shock received polyclonal IgG, IgM
and IgA (IgGAM); Pentaglobin, 5ml/kg, 12 hours infusion repeated for
the following 3 days. All of the patients were treated with abroad-
spectrum antibiotic, in 20 cases adequate to the results of microbio-
logical cultures. All of the patients needed renal replacement therapy,
in most cases (20/22) the Oxiris (adsorb endotoxin and cytokines) filter
was used. In all cases,hydrocortisone (4x50mg for 5–7 days) was admin-
istered. Patient with septic shock and without renal replacement thera-
pywas not treated with Pentaglobin. 9 of 22 patients were surgical and
died because of unsolved surgical condition (bowel ischemia, abdom-
inal abscess, delayed surgical intervention). In blood, cultures form 5 of
22 patients was Acinetobacetbaumanii MDR, only Collistin sensitive, all
of this patients died. After implementing immunoglobulin, start CRRT
with Oxiris filter, in all cases was observed temporary improvement in
patients condition- defined as adecrease of adose of catecholamines,
FiO2 reduction. Survived 6 of 22 (26%) patients, in all cases, the origin
of the infection was arespiratory system, in 2 cases Pentaglobin was a
part ofsecondary infectionstreatment, all of them had lower SOFA score
(less than 16) than so survivals in the moment of immunomodulatory
treatment implementation.
CONCLUSIONS. Immunoglobulin was used as a part of
animmunomodulatory bundle in patients with septic shock and renal
replacement therapy and this group of patients may beneficial of
such treatment. Based on this results we plan to prepare a protocol
forimmunoglobulins implementation in our ICU.
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INTRODUCTION. Minimous invasive drainage of abscess is a tool that
can decrease morbimortality in some ICU patients. The ecosonography
is indispensable to carry out these procedures.
OBJECTIVES. To describe the characteristics of patients subjected
to percutaneous drainage (PCD) during their stay in ICU and to
analize if that implies fewer surgical interventions in certain high-
risk patients.
METHODS. Retrospective study including patients undergoing
percutaneous drainage in a tertiary hospital ICU during 2016. They
are gathered by ICU admission reasons, clinical severity measured by
APACHE II and SOFA scales, PCD date, duration and complications.
We analyze PCD utility as a tool for preventable surgical intervention.
Variables expressed as a mean or percentage (RIQ) as appropriate,
and chi-squared when required.
RESULTS. A total of 52 patients undergoing PCD in our ICU in 2016
were included, with 62 years old mean (48–71), mean APACHE II 15
(10–19), SOFA 8 (6–12.75) and mean organ failure of 2 (1.25-3).
Sepsis was the main admission, 33 cases (63.5%), in which 18
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 101 of 542episodes (34,6%) was digestive septic focus, following 13 cases of
post-surgical abdominal intervention (25%). Main reason of PCD was
11 cases of pulmonary empiema (21.%), following 9 cases of infected
intraabdominal collections (17.35%) and pionefrosis in 8 cases
(15.4%). In 46 cases (88%) the PCD was performed under ultrasound
guidance. PCD was performed 1 day mean after ICU admission (0–
5.75), it was maintained 4 days mean (2–13.75).
No complications related to PCD were observed in most episodes (44
cases, 85%). The most frequent complications were drainage
obstruction in 5 cases (9.4%), and local bleeding in 2 episodes (3.4%),
none of them related with decease.
Subsequent surgical intervention after PCD was required only in 8
cases (15.4% of patients). ICU mortality was 13.5% (7 cases) and in-
hospital 19.2% (10 cases).
CONCLUSIONS. PCD can be a useful and safe tool for evacuation of
collections in ICU patients. Prospective studies are needed to
quantify surgical intervention reduction in these high-risk patients.
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INTRODUCTION. Co-stimulatory pathways provide crucial check-
points for the host response to infection. Among them, CD28 re-
ceptor delivers signals essential for T cell proliferation, survival,
cytokine production, and T-helper type-II development. Relteci-
mod, a CD28 antagonist short peptide, currently in phase 3 clin-
ical study in NSTI, improves the host's ability to effectively fight
the infection.
A single dose of Reltecimod confer higher survival rate compared to
multiple doses.
OBJECTIVES. Compare the effect of a single dose vs. two doses on
survival, circulating white blood cells profile and cytokine/
chemokines levels, in animals undergoing sepsis induced by Cecal
Ligation and Puncture (CLP).
METHODS. Sepsis was induced by CLP in BALB/c mice. PBS or
Reltecimod (5 mg/kg) were administered intravenously, once or
twice, at 2 hours or 2 and 24 hours post-CLP to randomized animal
groups. Animals were euthanized at either 24 or 48 hours (h) after
CLP. Blood was collected for measurements of various cytokines/che-
mokines (IL-6, IL-3, IFN-γ, IL-1a, IL-12, IL-17, IL-10, IL-5, MCP-1, MIP-1α,
RANTES) and lymphocytes profile (T cells [CD4+; CD8+], B cells, neu-
trophils, macrophages/monocytes) determined using flow cytometry.
Effect of a single dose was compared to control (PBS) or to two
doses. Separate groups, treated similarly, were used for survival
assessments.
RESULTS. Mice treated with a single dose of Reltecimod at 2h
showed significant improvement in survival (90%) on day 6,
compared to a control group (5%; p < 0.002) or to a group treated
with two doses (at 2 and 24h) of Reltecimod (40%; p < 0.002).
Average survival time was 2.9, 6.9 and 5.0 days, for control, a single
dose or two doses of Reltecimod, respectively. In the control groupat 24h post-CLP, levels of multiple pro-inflammatory cytokines/che-
mokines were elevated, increase in T cells subpopulation (CD4+; CD8
+) and decrease in neutrophils were observed. Without treatment,
these early changes normalized by 48h. Single dose of Reltecimod
significantly reduced various cytokines/chemokines levels (mean and
AUC) at 24h, which were positively correlated with (i) one another (ii)
reduction in T cells subpopulations (number, %, AUC) and negatively
correlated with neutrophils count (number, %), all compared to con-
trol. However, no further reduction at 48h post-CLP was detected in
cytokine/chemokines or lymphocytes sub-populations when add-
itional dose of Reltecimod was administered at 24h. These animals
experienced longer exposure (>24 hours) to high cytokines/chemo-
kines, without complete resolution of lymphocyte profile.
CONCLUSIONS. Improved mortality of mice following CLP and
treatment with Reltecimod is associated with reduced exposure to
cytokines during the early time period after infection and early and
sustained normalization of lymphocytes profile. Both processes are
enhanced when animals are treated with a single dose of
Reltecimod, whereas a second dose has less favorable outcome.0194
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INTRODUCTION. A metabolic shift towards lipid use occurs during
critical illness. This may represent an evolutionary conserved
response to utilize body fat stores as a energy substrate. Ketone
bodies, often regarded as a by-product of fatty acid beta-oxidation,
are emerging as important metabolic regulators. Ketogenic diets are
being used therapeutically in various diseases.
OBJECTIVES. To assess the impact of exogenous administration of
the ketone, beta-hydroxybutyrate (BHB), on metabolism and cardio-
respiratory function in a long-term rat model of fluid-resuscitated
faecal peritonitis.
METHODS. Instrumented male Wistar rats had sepsis induced by
intraperitoneal injection of faecal slurry. Sham-operated animals re-
ceived no injection. Animals were then placed in metabolic cages for
indirect calorimetric measurement of O2 consumption and CO2 pro-
duction. They had free access to food and water. Fluid resuscitation
with a balanced solution was started at 2h. At 6h animals were ran-
domized to receive iv BHB infusion (180mg/kg/h) or an equivalent
isocaloric volume of glucose solution. At 24h, blood and tissue sam-
ples were collected and animals euthanized.
RESULTS. At 24h BHB-treated animals had a metabolic alkalosis
(7.53 ± 0.04 vs 7.49 ± 0.03 untreated; p = 0.001) with increased bicar-
bonate (33.4 ± 2.5 vs 28.2 ± 3.2 mEq/L; p < 0.001) and base excess
(10.8 ± 3.2 vs 4.5 ± 3.9 mmol/L; p < 0.001), yet PaCO2 levels were un-
changed. BHB had no effect on respiratory exchange ratio (RER = CO2
production/O2 consumption) in sham-operated animals (0.85 ± 0.05
vs 0.89 ± 0.03 in placebo; p = 0.169). However, the septic animals,
regardless of BHB treatment, had similarly reduced RER values at 24h
(0.80 ± 0.03 vs 0.78 ± 0.01 untreated, p = ns; p < 0.001 compared to
sham). O2 consumption was unchanged at 24h, whereas CO2 produc-
tion was reduced in the septic groups (1245 ± 146 mL/kg/h vs
1441 ± 171 mL/kg/h sham; p = 0.003). Compared to placebo, BHB in-
fusion in septic animals produced no significant changes in clinical
severity score, temperature, blood pressure or cardiac function.
CONCLUSIONS. Sepsis produced a shift towards fat oxidation
signified by a fall in RER. BHB infused over 18 hours resulted in a
metabolic alkalosis but no effect on illness severity, haemodynamics
or RER. No positive impact was seen with a ketogenic diet in this
animal model of sepsis.
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INTRODUCTION. Hemodynamic resuscitation by means of fluid
boluses and norepinephrine is currently considered as a cornerstone
of the initial treatment of septic shock. However, there is growing
concern about the undesirable effects of this treatment. Thus,
previous studies have established a certain relationship between
fluid administration and the appearance of ARDS, and there is
increasing evidence of the detrimental effect that acute adrenergic
overload seems to exert with direct organ damage and multiple “off-
target” biological effects. Given the increased propensity of lung
damage in the context of septic shock, it is possible to assume that
resuscitation with fluids bolus and norepinephrine may increase
odds of subsequent development of ARDS.
OBJECTIVES. To investigate, in an experimental septic shock model, if
the hemodynamic resuscitation with fluids bolus and norepinephrine
lead to lung injury development.
METHODS. Experimental study carried out on 18 randomly selected
"New Zealand White" rabbits: 6 of them assigned to the control
group (SHAM) and 12 of them assigned to the endotoxin shock
group. These last ones received a Lipopolysaccharide (LPS strain
O55:B5 of E. Coli) bolus of 1 mg/kg. After 3 hours, 6 of them received
a 10 minutes infusion of 20 ml/kg of Ringer lactate. Afterwards, they
received a norepinephrine infusion titrated up to achieve theirs initial
arterial pressure (LPS-R). The other 6 animals did not receive
additional treatment (LPS-NR). Minimally invasive monitoring with
esophageal doppler probe and arterial catheter was performed, as
well as airway pressure and flow monitoring. After 4 hours of
experiment, animals were sacrificed. We analyzed the right lung
pulmonary edema by the relation between lung wet and lung dry
weight, and the left lung histopathological findings.
RESULTS. The animals of the SHAM group did not show any
hemodynamic or respiratory changes. The administration of the
LPS aimed at increasing cardiac output and arterial hypotension.
In the LPS-NR group, animals remained hypotensive until the end
of experiment. Conversely in animals from LPS-R group, the infu-
sion of fluids increased cardiac output without changing arterial
blood pressure, while the infusion of norepinephrine reversed ar-
terial hypotension. Compared to the animals in the LPS-NR group,
the animals in group LPS-R had more alveolar neutrophils and
pneumocytes with atypical nuclei, thicker alveolar wall, more
non-aerated pulmonary areas and less lymphocytes infiltrating
the interstitial tissue. In addition, the airway pressure increased
more in the group LPS-R, and the relationship between wet and
dry lung weight, although slightly higher in the LPS-R, did not
show significant differences.CONCLUSIONS. In this model of experimental septic shock
resuscitation with fluid bolus and norepinephrine increased cardiac
output and normalized blood pressure but worsened lung damage.Prognostication 1
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INTRODUCTION. Composite outcomes are often used as clinical
endpoints in clinical trials. A composite outcome focuses only on the
event that occurs first. Although there is some interest for the use of
a composite outcome, it can lead to statistical biases mainly because
each event defines the outcome, regardless clinical relevance and
timing to occurrence. The win ratio (WR) is a new tool, based on risk-
matched pairs of patients, which optimizes statistical power by con-
sidering hierarchical outcomes.
OBJECTIVES. Pot-hoc analysis of the EMPIRICUS trial using a modified
WR that includes adverse events and antifungal therapy duration.
METHODS. The EMPIRICUS trial compared an empirical systemic
antifungal treatment (micafungin) to a placebo for their impact on
invasive fungal infection (IFI)-free survival at day 28 of mechanically
ventilated patients with sepsis and fungal colonization. In this
analysis, a patient died at day 7 is similar to a patient who presented
an IFI at day 7 and ultimately survived. Micafugin and placebo
patients were matched according to a propensity score of IFI-free
survival computed by using a logistic regression with SOFA score
and Candida score as adjustment variables. In each pair, patients of
the micafugin arm were classified as winner or loser according to a
hierarchical outcome (day-28 survival or death) (Fig. 82). Finally a win
ratio (WR) was computed as the ratio of winners in the micafungin
arm to winners in the placebo arm. A sub-group analysis was per-
formed for patient with a baseline SOFA greater than 8.
RESULTS. Among the 251 patients included in the original analysis,
246 were successfully matched (123 from micafungin arm and 123
from placebo arm). For example, if a pair is constituted by two
patients who died in each arm, at day 3 for placebo arm and day 25
for micafungin arm, the pair is considered as winner for micafungin.
The original results using a multivariable Cox model with a
composite outcome and results obtained using WR are presented in
the following table. A WR > 1 is in favor of micafungin arm.
CONCLUSION. The win ratio is a simple tool to obtain a better
estimation of a treatment effect by hierarchizing the outcomes in a
RCT. This analysis showed great variation of the final effect of
micafungin whether or not SAE and SAT duration are taken into
account. Here, two improvements were made to the proposition of
Pocock et al. by using a propensity score for matching and by
considering more hierarchical levels for the outcome, by adapting the
method proposed by Evans et al. This new approach should be
extensively considered to replace composite outcomes in randomized
clinical trials or observational studies.
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Fig. 82 (abstract 0196) Schema of the hierarchical outcome criteria
Table 63 (Abstract 0196). Results
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INTRODUCTION. Emergency Severity Index (ESI) is both reliable and
valid tool for triage. And qSOFA score, which was recently proposed,
has good predictive validity for hospital outcome in patients outside
of the ICU (1, 2).
OBJECTIVES. We conducted this study to investigate whether qSOFA
score combined with Emergency Severity Index (ESI) predicts
hospital outcome better than ESI does alone.
METHODS. We retrospectively reviewed data of adult patients
(age ≥ 15 years) who visited an adult ED of a tertiary referral hospital
from January 1st, 2015 to December 31st, 2015. We calculated and
compared odds ratios, Akaike information criteria (AIC), and area
under receiver-operating curve (AUROC) of ESI alone and qSOFAscore combined with ESI for prespecified outcomes. The primary out-
come was hospital mortality, and the secondary outcome was com-
posite outcome of hospital mortality and ICU admission. Patients
were divided into 4 subgroups according to ESI levels; we also calcu-
lated hospital mortality rates by positivity of qSOFA score in each
subgroup.
RESULTS. 44367 patients visited the adult ED during study period;
43748 among them were included for analysis. The AICs of the logistic
regression models with qSOFA combined with ESI and the model with
ESI alone for hospital mortality were 4358 and 4417.2, respectively, and
the AICs of the logistic regression models for composite outcome were
12295 and 12342, respectively. The AUROCs were as follows: 0.786 vs
0.777 (p < 0.001) for hospital mortality; 0.778 vs 0.774 (p < 0.001) for
composite outcome. Hospital mortalities were higher for groups with
positive qSOFA score compared with those for groups with negative
qSOFA score in every prespecified subgroup with any hospital
mortality (20.4% vs 14.7% in ESI level 1 subgroup; 11.3% vs 2.7% in ESI
level 2 subgroup; 2.3% vs 0.4% in ESI level 3 subgroup; 0.0% vs 0.0% in
ESI level 4 & 5 subgroup).
CONCLUSIONS. The prognostic performance of qSOFA score
combined with ESI for mortality did not show significant difference
from that of ESI alone. But within every ESI groups, positivity of
qSOFA score were related with higher hospital mortalities.
REFERENCES
1. Seymour CW, Liu VX, Iwashyna TJ, Brunkhorst FM, Rea TD, Scherag
A, et al. Assessment of Clinical Criteria for Sepsis: For the Third
International Consensus Definitions for Sepsis and Septic Shock
(Sepsis-3). JAMA. 2016;315(8):762–74.
2. Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane
D, Bauer M, et al. The Third International Consensus Definitions for
Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315(8):801–10.
GRANT ACKNOWLEDGMENT
None.
0199
scores are superior to biomarkers to predict mortality in septic
patients
I. Granja Gomez1, E. Rodriguez-Ruiz1, R. Hernandez-Vaquero1, A. Lopez
Lago1, J.L. Garcia Allut1, A. Estany-Gestal2, M.A. Garcia Gonzalez3
1Hospital Clínico Universitario, Intensive Care Unit, Santiago de
Compostela, Spain; 2Fundación Ramón Dominguez, Unidad de
Epidemiología e Investigación Clínica, Santiago de Compostela, Spain;
3Instituto de Investigaciones Sanitarias (IDIS), Grupo de Genética y
Biología del Desarrollo de las Enfermedades Renales, Santiago de
Compostela, Spain
Correspondence: I. Granja Gomez
Intensive Care Medicine Experimental 2017, 5(Suppl 2):0199
INTRODUCTION. In sepsis, due to the lack of diagnostic and
prognostic precision of different scoring systems, multiple biomarkers
have been evaluated to date. After initial enthusiasm for some of these
biomarkers, well reviewed in the literature and reported as useful for
predicting sepsis survival, they can become frustrating in the daily
practice, and only a few have a realistic application in sepsis.
A more recent biomarker, advanced glycation end products (AGEs), is
increasingly described as playing a role in many diseases. AGEs
accumulation in different tissues including skin, and elevated
circulating levels of AGEs in plasma have been reported under
inflammatory conditions.
OBJECTIVES. Our aim was to study different biomarkers (TNF-α, IL-
1β, IL-6, IL-8, C-reactive protein, Procalcitonin), including AGEs in skin
and plasma, and well known ICU scores (APACHE II and SOFA), and
to analyze their ability to predict mortality.
METHODS. We assessed 89 consecutive septic patients admitted to
our medical-surgical ICU. TNF-α, IL-1β, IL-6, IL-8, C-reactive protein,
Procalcitonin, and AGEs in skin and plasma were determined on day
1. AGEs in skin were measured detecting skin auto-fluorescence with
the AGE Reader mu (DiagnOptics, Groningen, The Netherlands).
Plasma AGEs were measured by quantitative fluorescence spectros-
copy. APACHE II was calculated on day 1, and daily SOFA score was
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 104 of 542calculated for 5 consecutive days from admission. Chi-squared and
Mann–Whitney tests were performed to study the association of
these variables with 28-day mortality, and ROC curves were carried
out to verify their predictive power.
RESULTS. There were 72 survivors and 17 non-survivors. We did not
find association between the values of any biomarker on day 1: TNF-
α, IL-1β, IL-6, IL-8, C-reactive protein, Procalcitonin, AGEs in skin and
plasma, and the mortality on day 28. However, when analyzing scor-
ing systems, APACHE II showed association with 28-day mortality
(p = 0.009), and SOFA scores on days 1 to 5, were also associated
with 28-day mortality: SOFA 1 (p < 0.033), SOFA 2 (p = 0.005), SOFA
3 (p = 0.002), SOFA 4 (p < 0.001), and SOFA 5 (p < 0.001). The ROC
curve analysis showed the best prediction ability for the values of
SOFA 4 (AUC 0.798, p < 0.001), and SOFA 5 (AUC 0.819, p < 0.001).
CONCLUSION. In our cohort of septic patients, we found correlation
between APACHE II (day 1) and SOFA scores (day 1 to 5), and the
28d-mortality, being values for SOFA at days 4 and 5, good predic-
tors of mortality. Meanwhile, none of the studied biomarkers showed
this correlation. Our results support that, if we want accurate predic-
tion models, an approach of simultaneous evaluation of multiple
targets and their serial measurements should be favored over the
single target and single time-point approach.
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INTRODUCTION. N terminal probrain natriuretic peptide (Nt-proBNP)
is secreted by the heart in response to ventricular wall stress.
Increased Nt-proBNP plasma levels are also found in noncardiac dis-
eases, such as sepsis, renal failure, pulmonary embolism and chronic
obstructive pulmonary disease, which are common in intensive care
unit patients. We suggested that Nt-proBNP could predict intensive
care unit outcome in this setting.
OBJECTIVES.
1. To evaluate the relationship between Nt-proBNP and hospital
mortality.
2. To investigate the relationship between Nt-proBNP and severity of
disease (SAPS 3).
METHODS. This was a prospective study performed in the
emergency and intensive care department in the regional hospital of
Zaghouan. The patients were recruited between June 2015 and
December 2015. All adult patients admitted to the intensive care unit
(ICU) were included. Nt-proBNP plasma levels were measured at ad-
mission. Illness severity was assessed using the SAPS 3 score. Hospital
length of stay, and mortality rate were recorded in all patients.
RESULTS. During the study period, 108 patients were included.
Patients discharged alive from ICU (n = 83) had significantly lower
Nt-Pro-BNP levels (860 pg/ml [range, 25–4120 pg/ml]) than ICU non
survivors (n = 25) (2485 pg/ml [range, 80–5180 pg/ml]); p = 0.004.
Likewise, hospital survivors (n = 76) were characterized by signifi-
cantly lower Nt-Pro-BNP levels than hospital non survivors (n = 32)(862.5 pg/ml [range, 25–4120 pg/ml] vs. 1950 pg/ml [range, 60–
5180 pg/ml], respectively; p = 0.004). The area under the ROC curve
was 0.76 (95% confidence interval [CI], 0.66-0.86; p < 0.001) for Nt-
Pro-BNP and 0.83 for SAPS 3 (95% confidence interval [CI], 0.75-0.92;
p < 0.001). The difference between the curves did not reach statis-
tical significance (p = 0.125). The difference in mortality rates be-
comes evident after 6 days from admission. Survival distribution was
significantly different in the two groups (P < 0.001). Median survival
was 12 days (95% [CI], 3–20 days) in the group Nt-Pro-BNP ≥ 1300
pg/ml vs. 32 days (95% [CI], 22–41 days) in the group Nt-Pro-
BNP < 1300 pg/ml, p < 0.001. Multi logistic regression analysis re-
vealed that SAPS 3 score (odds ratio [OR], 9.6; 95% [CI], 3.7 - 25.22;
p < 0.001) and an Nt-Pro-BNP level more than 1300 pg/ml (OR, 4.38;
95% [CI], 1.78 - 10.78; p < 0.001) and sepsis
(OR, 9.42; 95% [CI], 2.7 - 32.69; p = 0.018) were significant and
independent outcome predictor.
CONCLUSIONS. In this study, elevated admission Nt-proBNP levels is
an independent predictor of mortality in critically ill patients.
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INTRODUCTION. Survivors from ICU admissions are more likely to
develop anxiety, posttraumatic stress disorder, and depression,
culminating in a poorer quality of life both physically and mentally.
The objective of this study was to evaluate the incidence of
psychological disorders of adult patients, 2 months after discharge
from the ICU.
METHODS. Retrospective cohort study, with all adult patients post-
ICU survivors (at General ICU in a teaching hospital) attended in the
post-ICU Outpatient Office in the same institution. Patients with pre-
viously diagnosed mental illness, terminal illness, admitted for
attempted suicide, unable to talk, and with neurological damage
after ICU discharge were excluded. It was made psychological evalu-
ation by specific instruments:
(1) Intensive Care Unit Memory/ICUM (for evaluate recollections),
(2) Hospital Anxiety and Depression Scale/HADS, and
(3) Impact of Event Scale-Revised (IES-R), for evaluating Post-
Traumattic Stress Disorder (PTSD) symptoms.
RESULTS. During the study period (2008–2014), XXX patients were
discharged alive from the ICU, of which 629 were attended by the
psychology team at the post-ICU clinic (62% male, age 42.7 y; the
most common causes of admission to the ICU were trauma [42%]
and medical [23%]). The incidence of psychological disorders was
45.0%, with 30.4% with anxiety, 13.8% depression and 19.4% with
PTSD symptoms. The distribution of incidences is shown in Fig. 83.
The main factors related to the presence of psychological disorders
were age, type / cause of ICU admission (with elective surgery
patients having a lower incidence of psychological disturbances, and
neurological (trauma or not) patients with a trend to more
psychological disorders), and use/time of MV during the ICU.
CONCLUSION. The incidence of psychological disturbances 2 months
after discharge from the ICU is high, especially in elderly patients,
those with acute neurological diseases and with longer MV use.
Fig. 83 (abstract 201) Distribution of psychological disorders in
post-ICU patients. n = 629.
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BACKGROUND AND AIMS. Admission of patients with cirrhosis with
organ failures to the intensive care unit (ICU) is associated with high
mortality despite aggressive management and involves a complex
resource usage, and considerations for withdrawing or withholding
life sustaining treatments. We aimed to develop and validate a
dynamic model, the Model for Early Recovery for Critically Ill
Cirrhotics (MERCIC)to predict intensive care futility in a prospective
cohort of critically ill cirrhotics.
METHODS. Consequtive[A1] 349 patients with cirrhosis admitted to
dedicated Liver ICU, were included, 145 in the derivation and 204 in
validation cohort.Binary logistic regression models were used to
identify score parameters and the derived estimated coefficients
were used as relative weights to compute the score which was also
tested for sequential use with repeated measures Generalised
Estimating Equations (GEE). The predictive ability of the score was
compared to MELD, CTP and SOFA scores.
RESULTS. The mean age of the cohort was 48(±11) years, 87%
males, with mean MELD of 30 (±8.3) and SOFA score of 11.6
(±4.5). Of these only 53% were alive at 1-month. At day 7, 45%
patients recovered and were shifted out from the ICU. Of all
patients with non-recovery at day 7 only 3% were alive at 28
days.Presence of circulatory shock (none versus one versus two
vasopressors), serum bilirubin (gm/L) (<5 versus 5–15 versus >15),
PaO2/FiO2 ratio(<200, versus 200–350 versus ≥ 350) and urine
output (<0.5ml/kg/hr versus ≥0.5ml/kg/hr) at day 0 were identi-
fied as significant predictors of non-recovery at day 7 and as
components of the MERCIC. Further, each unit change in score
was significantly associated with recovery at day 7 (p < 0.001,OR
0.74, 95% CI 0.68-0.81) on sequential evaluation from day 0 to
day7. Patients who recovered at day 7 showed decline (p < 0.05)
in bilirubin (OR,95% CI) [(0.91, 0.87-0.95), (0.95,0.91-0.99)] and
improvement in mean arterial pressure [(1.04,1.02-1.06; (1.03,1.01-
1.05)], PaO2/Fio2 ratio [(1.27,1.02-1.59);1.17, 1.01-1.4) and urine
output [(1.02,1.003-1.03); 1.02,1.005-1.04)] in both the derivation
and validation cohorts respectively.The AUROC of model was 0.85 and 0.74 in the derivation and the
validation cohorts which was better than the MELD (0.57, 0.50), CTP
(0.50,0.52) and SOFA scores (0. 66,0.61) respectively (p < 0.05).
The model also predicted 28-day mortality with fair accuracy
(p < 0.001, HR 1.18, 95% CI 1.11-1.25).
CONCLUSIONS. The MERCIC model can be used as an accurate tool
to guide intensive care futility in the first week in critically ill
cirrhotics.
[A1] Check if correct
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INTRODUCTION. Coronary artery bypass graft is indicated for
revascularization therapy in severe and unstable coronary artery
disease and risk assessment has been a major concern in cardiac
surgery.
OBJECTIVES. To determine whether patient demographics,
EuroSCORE II factors, creatinine and ALT are predictive in the
morbidity and mortality of post-coronary artery bypass graft patients.
METHODS. Patient dermographics, EuroSCORE II factors, ALT, serum
creatinine, postoperative outcomes, length of ICU and hospital stay
from in-hospital charts were collected using retrospective cohort ana-
lysis of 169 patients who underwent coronary artery bypass graft
(CABG) surgery from January 2011 to March 2016.
RESULTS. Presence of extra-cardiac arteriopathy (OR 4.37, 1.29-14.79
CI) is predictive in determining outcomes of patients after CABG sur-
gery.Inotrope use (75.1%) and blood transfusion (100%) were com-
mon complications after CABG surgery.
CONCLUSIONS. It is important to determine presence of extracardiac
arteriopathy in predicting outcomes of post-CABG patients.
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Table 64 (Abstract 0203). Multivariate regression analysis
Significant Variables in the equation OR (95% CI) p-value
Extracardiac Arteriopathy (n=20) 4.37(1.29-14.79) 0.018
Pulmonary Hypertension
Normal 0 0.003
Moderate (n=49) 0.88(0.07-11.57) 0.921
Severe (n=3) 3.60(0.27-47.64) 0.331
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INTRODUCTION. Hyperglycaemia stress is common during critical
illness and become one of important targets in intensive care. In severe
hyperglycemia, there are changes in metabolism and cytokine
response as well as anti-regulatory hormones release that cause cell
damage due to accumulation of reactive oxygen species. Blood sugar
level regulation within a narrow range (80–110 mg/dl) is recommended
as an effort to reduce mortality in critically ill patients in the ICU.
Previous studies show an association between a wide variations of
blood sugar levels with increasing mortality rate. APACHE II is an
assessment system generally used to estimate mortality in ICU
patients that involves a few examinations such as, body temperature,
MAP, heart rate, respiratory rate, Oxygen fraction, pH, Natrium serum,
kalium serum, creatinine, haematocrit, lecocyte and Glasgow coma
score.
OBJECTIVES. This study aims to determine the usefulness of
variations in blood sugar levels as a simplier predictor of mortality of
critically ill patients in the ICU of Dr. Hasan Sadikin Hospital.
METHODS. Analytic Observational Retrospective Study. The patients
blood sugar level were recorded as the object of this study and were
divided into 2 groups based on the high standard deviation values
reprensenting variations in blood sugar levels with a high range
(SD > 20.61) and a lower standard deviation (SD < 20.61) representing
variations in blood sugar levels with narrow range. Reassessment
survival rate performed on day 28 for each group to assess whether
any of these patients died.
RESULTS. The results showed that variations in blood sugar levels
had a sensitivity of 71.43, specificity of 86.36, positive predictive
value of 86.96, negative predictive value of 70.37, positive likelyhood
ratio variations in blood sugar levels of 5.23, and likelyhood ratio of
negative variations in blood sugar levels of 0.33.
CONCLUSIONS. Conclusion of this study is that variations in blood
sugar levels can be used to predict mortality critically ill patients
admitted to the ICU RSHS Bandung.
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INTRODUCTION. Existing intensive care unit (ICU) mortality
prediction scores suffer from complexity and limited accuracy of
predictions. An updated, simple score could prove a valuable tool in
both research and clinical practice.
OBJECTIVES. To develop and internally validate a new and simple
score that predicts 90-day mortality upon acute admission to the
ICU.
METHODS. We developed a simple score as recently recommended
[1] and according to a predefined, published protocol and statistical
analysis plan [2]. We used binary logistic regression and
multinational datasets including 2139 acutely admitted general ICU
patients and 1947 with severe sepsis/septic shock (the AID-ICU and
SUP-ICU inception cohorts and the 6S, TRISS and CLASSIC trials). We
selected variables through backward elimination, multiply imputed
missing data and assessed discrimination, overall performance, cali-
bration, and internal validity.
RESULTS. The Simplified Mortality Score for the ICU (SMS-ICU)
comprises seven variables readily available following ICU admission
(Fig. 84): age, hematologic malignancy or metastatic cancer, acute
surgical admission, lowest systolic blood pressure, and use of
vasopressors/inotropes, respiratory support and renal replacement
therapy.
Discrimination (area under the receiver operating characteristic
curve) was 0.72 (95% CI: 0.71-0.74), overall performance (Nagelkerke´
s R2) was 0.19, and calibration (intercept and slope) was 0.00 and
0.99, respectively. Optimism-corrected performance (internal validity
using bootstrapping) was similar to apparent performance.
CONCLUSIONS. The SMS-ICU predicted 90-day mortality upon ICU
admission with reasonable and very stable performance. The score
will be externally validated and compared to existing scores. If per-
formance remains adequate, it could prove a valuable tool for ICU cli-
nicians and researchers because of its simplicity and expected low
number of missing values.
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Table 66 (Abstract 0206). Unadjusted laboratory deviation (ICU-baseline)
Normal weight Obese P-value
WBC x109/L, mean ± SD 5 ± 5.9 6.4 ± 5.9 <0.001
Sodium, mmol/L, mean ± SD −2.6 ± 4.3 −3.2 ± 3.6 0.003
Potassium, mmol/L, mean ± SD 0.8 ± 1.1 1 ± 0.9 0.001
BUN, mg/dl, mean ± SD 3.1 ± 15.2 1.9 ± 14.2 0.10
BIC, mg/dL, mean ± SD −4 ± 4.1 −4 ± 3.6 0.8
Creatinine, mg/dL, mean ± SD 0.1 ± 0.8 0.2 ±0.8 0.05
Platelets x109/L, mean ± SD −75 ± 118.8 −70.6 ± 79 0.37
Table 65 (Abstract 0206). Demographic Characteristics
Normal weight (BMI =
18.5 - 24.9) N = 769
Obese (BMI >30)
N = 1,258
p-value
Age (years), (median, IQR) 66.9 (53 -78.5) 64.3 (55.5 - 72.7) 0.01
Male, n (%) 431 (56%) 741 (59%) 0.22
Ethnicity (white), n (%): 583 (76%) 583 (76%) <0.001
Comorbidity index
(median,IQR)
5 (0 - 10) 2 (0- 7) <0.001
Smoker (yes), n(%): 379 (49%) 649 (52%) 0.20
Primary ICD-9 diagnosis
(cardiovascular disease),n (%)
357 (46%) 528 (42%) 0.01
mechanical ventilation
(1st 24h), n(%)
453 (59%) 937 (74%) <0.001
SAPS-II score (median, IQR) 35 (27 - 45) 32 (25.2 - 40) <0.001
SOFA score (median, IQR) 4 (2 - 6) 4 (2 - 6) 0.02
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INTRODUCTION. Obesity is currently a global pandemic, responsible
for 3–4 million deaths per year [1].Obesity is over-represented in the
intensive care unit (ICU), comprising approximately one third of pa-
tients, compared to the 20% prevalence of being overweight or
obese worldwide. ICUs commonly use severity of illness scores, such
as APACHE, SAPS-II or SOFA to predict mortality, but none of these
scoring systems incorporates obesity into their risk adjustment
parameters.
Although obese and normal weight patients may present to the ICU
with a similar physiological “snapshot or phenotype” as reflected by
the same severity of illness scores, these identical scores may
actually represent inherently different levels of deviation from the
prior baseline state. This may inadvertently result in misclassification,
leading to potential errors in mortality prediction and severity
adjustment.
OBJECTIVES. We analyzed a large ICU database (which included
baseline laboratory results prior to hospital admission) to
compare the deviation of laboratory tests utilized in scoring
systems from baseline to ICU admission in both obese and
normal weight patients.
METHODS. Retrospective cohort study performed in an intensive
care unit (ICU) database.We included obese and normal weightpatients with age greater ≥ 16 years old who were admitted to the
ICU between 2001 to 2012, and had laboratory results documented
between 3 days to 1 year prior to hospital admission. Deviation on
ICU admission from baseline in the laboratory tests used in
calculating SAPS-II and SOFA score was compared between obese
and normal weight patients.
RESULTS. 769 normal weight patients were compared to 1,258
obese patients. Adjusting for SAPS-II score, age, comorbidity
index, baseline result and ICU type, the deviation in white blood
cell count (WBC) was 0.80 (95%CI 0.27-1.33) x109/L higher in
obese patients than normal weight patients (p = 0.003); and the
deviation in blood urea nitrogen (BUN) was 1.50 (95%CI 0.28-
2.71) mg/dl higher in obese patients than normal weight patients
(p = 0.016). Adjusting for SOFA score, age, comorbidity index,
baseline result and ICU type, the deviation in log(creatinine) was
0.03 (95%CI 0.02-0.05) higher in obese patients than normal
weight patients (p < 0.001).
CONCLUSION. Among patients with the same severity of illness
score, deviations in WBC, creatinine and BUN from baseline were
significantly higher in obese compared to normal weight patients.
Accounting for the extent to which critically ill patients deviate
from their own baseline may improve the objectivity, precision,
and generalizability of ICU mortality prediction and severity
adjustment models.
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Table 67 (Abstract 0206). Adjusted laboratory deviation (ICU -baseline)
Adjusted difference in deviation
(Δ (ICU - baseline) between obese
and normal weight individuals (95%CI)
P-value
Δ WBC, x109/L 0.80 (0.27 -1.33) 0.003
Δ Sodium, mmol/L −0.06 (-0.40 - 0.28) 0.712
Δ Potassium, mmol/L 0.01 (-0.07 - 0.09) 0.857
Δ BUN, mg/dL 1.50 (0.28 - 2.71) 0.016
Δ BIC, mg/dL −0.19 (-0.50 - 0.13) 0.254
Δ log (Creatinine, mg/dL) 0.03 (0.02-0.05) <0.001
Δ Platelets, x109/L 4.94 (-2.48 - 12.36) 0.192
Table 68 (Abstract 0207). Analysis of APACHE II model calibration by
the Hos
Probability
of death
N.° patients Observed
deaths
Predicted
deaths
Observed
survivors
Predicted
survivors
<0.10 9 0 0.80 9 8.20
0.10-0.20 29 3 4.37 26 24.63
0.20-0.30 52 12 12.77 40 39.23
0.30-0.40 44 17 15.36 27 28.64
0.40-0.50 41 24 18.83 17 22.17
0.50-0.60 32 21 17.73 11 14.27
0.60-0.70 44 34 28.26 10 15.74
0.70-0.80 42 33 31.39 9 10.61
0.80-0.90/>0.90 32/11 29/9 26.89/10.21 3/2 5.11/0.79
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INTRODUCTION. Intracerebral hemorrhage is a stroke subtype with
high mortality and significant disability among survivors.
OBJECTIVES. To evaluate the APACHE II scale in patients admitted to
ICU with non-traumatic brain hemorrhage.
METHODS. Multicenter prospective observational study in three
hospitals in Andalusia (Spain). We studied all patients with brain
hemorrhage admitted to the Regional Hospital of Malaga (between
2006 to 2011), Neurotraumatology Hospital of Jaen (between 2010 to
2012) and Virgen de las Nieves Hospital of Granada (between 2006
to 2011).
Data were expressed as the mean and standard deviation for
quantitative variables and percentages for qualitative variables. For
the comparison of two means we used the Student's t-test and the
Chi-squared test was used to compare proportions. Area under the
ROC curve for analizing discrimination, Standardized Mortality Ratio
(SMR) and Hosmer-Lemeshow Test for analizing calibration. Statisti-
cally significant differences: p < 0.05.
RESULTS. N = 336 patients (263 supratentorial). Mean age
59.43 ± 14.75 years, Glasgow score (GCS) at admission 8 ± 4 points,
APACHE-II 21.03 ± 7.6 points, intraventricular hemorrhage (IVH) was
58.6% of patients. 105 patients were treated by surgery. The hospital
mortality was 54.17%. Patients who died in hospital were older
63.76 ± 12.21 vs 59,43 ± 14.75 (p < 0.001), lower GCS 6 ± 3. vs
10 ± 4 (p < 0.001) and higher APACHE II 24.31 ± 6.37 vs 17.09 ± 7.08
(p < 0.001).
Hospital mortality predicted by APACHE II scale was 49.58% and
observed hospital mortality (54.17%), SMR: 1.09 (0.94-1.24) (not
statistically significant differences). The Hosmer-Lemeshow test was
12,28, so there not were statistically significant differences between
the observed and predicted mortality by APACHE-II. Discrimination
by the area under the ROC curve was 0.81 (0.76-0.85).
CONCLUSIONS. Patients admitted to the ICU with non-traumatic
brain hemorrhage have a high mortality. APACHE II scale has a good
discrimination and calibration.0208
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INTRODUCTION. The scores have been widely used in the Intensive
Care and Cardiac Units. The prognosis system SAPS 3 (Simplified
Acute Physiology Score 3) aims to establish a predictive mortality
rate for patients admitted to Intensive Care Units (ICU). The Charlson
Comorbidity Index (CCI) is a method of predicting mortality by
classifying or weighting comorbid conditions. Acute coronary
syndromes (ACS) are a common cause ICU admission. Specific
prognostic scores have been developed and validated for ACS
patients, like Thrombolysis in Myocardial Infarction (TIMI) and Global
Registry of Acute Coronary Events (GRACE) scores.
OBJECTIVES. To evaluate the accuracy of the SAPS 3 and CCI scores
in the prognosis of cardiac patients admitted to the ICU of a general
hospital in northeast region of Brazil.
METHODS. Prospective cohort study placed in a general ICU. In the
study were included 234 patients with cardiac disease of 1138
admitted patients to general ICU, from August 2015 and March 2017.
All the patients were assessed using the SAPS 3 (Global Equation and
Central & South American Equation) and CCI scoring systems.
Logistic regressions analysis was used to calculate the sensitivity,
specificity and accuracy as well as the OR probability of mortality.
The ability to predict mortality was performed with ROC curves. The
differences between observed-to- predicted mortality were analyzed
with the Hosmer-Lemeshow test.
RESULTS. The study population had the following general
characteristics: age 67 ± 16.15 years, men 59.8%, with a median time
of 4 days of hospitalization (IQR = 2.0-7.0). In the subgroup of
patients with ASC, the mean age was 65.89 ± 14.75 years, 48.6%
female, length stay of 4 days (IQR = 1.0-5.0), with diagnosis at
admission, ST-elevation myocardial infarction - STEMI (20.3%), non-
Table 69 (Abstract 0209). ICU admission rate within 48 hours from
EMS encounter classified according to either dispatch priorities or NEWS
Dispatch priorities NEWS class
A B C D High Medium Low
N total 616 3192 5637 3283 736 1871 10121
ICU admission
rate % (n)
7.5 (46) 2.4 (78) 1.0 (58) 0.7
(22)
10.6 (78) 3.5 (65) 0.6
(61)
RR (95%CI) 11.1
(6.8-17.7)
3.6
(2.3-5.7)
1.5
(0.94-2.5)
1.0
(ref)
17.6
(12.9-23.8)
5.8 (4.1-
8.1)
1.0
(ref)
p <0.001 <0.001 0.085 <0.001 <0.001
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gina - UA (14.9%) and there were only three deaths. The median TIMI
and Grace score were 3 (IQR = 2.00-4.00) and 112 (IQR = 86.8-142.8),
respectively. The median (in points) in SAPS 3 score was 44 (CI = 38.0-
50.0) and CCI was 1 (IQR = 0–2.0) and the area under the ROC curve
was 0.74 (CI 95% = 0.85-1.00) and 0.52 (CI 95% = 0.89-1.00), respect-
ively. Calibration was confirmed by the Hosmer-Lemeshow test for
SAPS 3-X2 = 6.029 df: 8 (p > 0.644) and CCI was X2 = 3.08 df:8
(p > 0.214).
CONCLUSIONS. The results showed that SAPS 3 score can be
effective in the prognostic assessment of cardiac patients admitted
to a general ICU, with good calibration and adequate discrimination
value. However, the CCI score doesn't have good discrimination in
this population.
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INTRODUCTION. Critical components of an efficient emergency
medical service (EMS) include correct risk assessment and emergency
patient identification (1). Under-triage may delay patients' appropri-
ate medical care and negatively impact patient survival (2). Know-
ledge about prehospital risk assessments´ predictability to ICU
admissions is scarce (3).
OBJECTIVES. To compare risk assessments made by dispatchers and
on the scene by EMS providers with ICU admission within 48 hours.
METHODS. All EMS patients over 15 years of age in two hospital
districts (Kainuu and Länsi-Pohja) in Northern Finland during
1.1.2014-30.6.2014 were prospectively studied. The risk assessments
according to the national criteria based dispatch protocol and
prehospital National Early Warning Score (NEWS) were coupled with
the ICU database to calculate admission and risk rates.
RESULTS. 204 out of 12.728 (1.6%) EMS patients were admitted to
the ICU. The highest priority A and high-risk NEWS groups were asso-
ciated with the highest risk ratio for ICU admission (RR 11.1; RR 17.6)
(Table 69). There were 92 (45.1%) cases where either of the risk as-
sessment tools classified the patient as a high-risk. In 36 (17.6%) pa-
tients admitted to the ICU both risk assessment tools classified the
patients as low-risk in the prehospital phase.
CONCLUSIONS. Both the criteria based dispatch protocol and the
prehospital NEWS indicated applicability to predict ICU admission in
an undifferentiated EMS population. However, approximately one-
sixth of ICU patients were classified as low-risk during the prehospital
phase. Better tools are needed to identify critically ill patients in the
early phase of the chain of medical care.
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INTRODUCTION. The prognostic value of nT-proBNP levels in COPD
patients due to acute exacerbations in the intensive care unit (ICU) is
unknown.
OBJECTIVES. In this study, we aimed to evaluate the relationship
between nT-proBNP level, NIV success, weaning and mortality in pa-
tients who underwent invasive or noninvasive mechanical ventilation
(IMV / NIV) support.
METHODS. In this prospective cohort study, demographics,
comorbidity, APACHE II score, NIV success, arterial blood gases,
intensive care unit and hospital stay, weaning and mortality rates
of patients with acute exacerbation of COPD followed in the ICU
between December 2015 and December 2016 were recorded. The
relationship between these dataand nT-proBNP levels and trends
were evaluated.
RESULTS. 110 patients (75 males) were included in the study. Median
age was 69 (61–76) years and APACHE II was 19 (15–23) years. The
highest median nT-proBNP level was found to be lower in cases with
NIV success than in those with failure (p: 0.053). In addition, the highest
median nT-proBNP level was significantly higher (4740 pg / ml vs. 3004
pg / ml, p: 0.001) in patients who underwent IMV than the ones who
did not. During hospitalization, mortality was significantly higher in pa-
tients with a trend of elevated nT-proBNP levels (59% vs. 23%, p: 0.015).
CONCLUSION. In patients with acute exacerbations of COPD
requiring mechanical ventilation, nT-proBNP measurement and trend
monitoring may be valuable in predicting prognosis.
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Fig. 85 (abstract 0210) nT-proBNP mortality
Fig. 86 (abstract 0211) Pmsf-arm values and 28 day mortality
Fig. 87 (abstract 0211) Pmsf-arm values and 60 day mortality
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INTRODUCTION. Optimisation of cardiac function and fluid
management are well recognised as key components in the care of
the critically ill patient. A cumulative positive fluid balance is
associated with both increased mortality and morbidity.[1,2] Mean
systemic filling pressure (Pmsf) is the pressure in the vascular system
when the heart is stopped and there is no blood flow. It depends on
the intravascular volume and mean vascular capacitance and it is a
quantitative measurement of intravascular filling.[3]
OBJECTIVES. To determine if higher values of Pmsf are associated
with increased 28, 60 and 90-day mortality in critically ill patients.
METHODS. Retrospective analysis of data collected in two different
clinical trials at the ICU in a tertiary centre. 160 patients admitted to
ICU were included for the analysis. 80 patients were admitted
following cardiac surgery, and 80 because of septic shock. Pmsf-arm
was measured at time of randomisation (recently admitted to ICU),
using a stop-flow transient occlusion method. Linear regression ana-
lysis was performed to find the differences in Pmsf-arm between sur-
vivors and non-survivors at 28, 60 and 90 days post randomisation,
adjusted by sepsis status (septics, non-septics) severity (APACHE II
score) and diabetes mellitus status. Area under the receiver-operator
curve (ROC) was calculated. Statistical analysis was performed with
SPSS v24.
RESULTS. Mortality at 28, 60 and 90 days were 16.3%, 18.1% and
18.1% respectively. The mean Pmsf-arm for the whole sample is
21.12 mmHg (95% CI 20.09, 22.15). The estimated difference in Pmsf-
arm between survivors and non-survivors at 28, 60 and 90 days ad-
justed by sepsis status and APACHE score is 0.38 mmHg (95% CI
−2.71, 3.47, p = .81), 1.01 mmHg (95%CI −1.91, 3.94, p = .49) and
0.95 mmHg (95%CI −1.93, 3.83, p = .52). Area under the ROC for mor-
tality at 28, 60 and 90 days against Pmsf-arm values were 0.62
(95%CI .50, .74), 0.59 (95%CI .47, .70) and 0.59 (95%CI .47, .71)
respectively.CONCLUSIONS. High values of Pmsf-arm are not related to increased
mortality in critically ill patients.
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Fig. 88 (abstract 0211) Pmsf-arm values and 90 day mortality
Table 70 (Abstract 0213). Patient demographics
Age, years, mean (SD) 65 (13)
Weight, kg, mean (SD) 81 (16)
Height, cm, mean (SD) 173 (9)
Gender, n 34 (10 F, 24 M)
Table 71 (Abstract 0213). Performance of HPI and ΔMAP in predicting
Variable AUC Sensitivity Specificity
HPI 0.914 83.7% 82.6%
ΔMAP 20sec 0.644 56.5% 65.2%
ΔMAP 1min 0.625 51.9% 52.2%
ΔMAP 3min 0.564 47.4% 47.8%
ΔMAP 5min 0.615 57.0% 56.5%
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INTRODUCTION. Cardiac Index CI is a key target of haemodynamic
monitoring. Initial clinical assessment of shock patients is based on
body surface temperature BST. Accurate measurement of BST with
an infrared thermometer (Thermofocus, Tecnimed) combined with
biometric data might provide a complete non-invasive estimate of
CI (CI_CNI) with a precision and accuracy comparable to a non-
invasive pulse-contour-analysis-estimate of CI (CI_CS; ClearSight,
Edwards; USA).
OBJECTIVES. We compared BSTs alone and combined with biometrics
("CI_CNI") to CI_CS and to a gold-standard CI derived from transpul-
monary thermodilution (TPTD; CI_TD; PiCCO; Pulsion; Germany).
METHODS. In 30 pats. (17m; 13f; APACHE-II 20 ± 9) 240 datasets
were recorded (8 datasets per patient within 24h). Immediately be-
fore TPTD we measured BST on the forehead, forearm, finger and
great toe and recorded un-calibrated CI_CS. These data were com-
pared to TPTD-derived CI-TD (PiCCO). Statistics: SPSS 23.
RESULTS. CI-TD was univariately (p < 0.001 except as indicated) associ-
ated to the BSTs of forearm (r = 0.507; p = 0.001), forehead (r = 0.433),
finger (r = 0.250) and great toe (r = 0.228) as well as to age (r = −0.192)
and male gender (r = 0.236; p = 0.012) and to CI_CS (r = 0.578).
Multiple regression analysis including the BSTs demonstrated that
BST_forehead (p < 0.001), BST_forearm (p < 0.001) and BST_finger
(p = 0.005) were independently associated to CI_TD. This regression
resulted in an CI-estimate based on BSTs (CI_BST; R2 = 0.333).
A combined regression (CI_CNI; R2 = 0.428) demonstrated
independent association of BSTs on forehead, forearm and finger as
well as male gender, age and height to CI_TD.
In a next step, we analysed, if these data could improve the
estimation of CI by CI_CS. Several regression analyses regarding
CI_TD demonstrated independent association of CI_CS in addition to
CI_BST (R2 = 0.504) or CI_CNI (R2 = 0.541).
The final model (CI_BST_CS_biometry; R2 = 0.541) included CI_BST,
CI_CS, age, gender and height. The bias (L/min/m2) and percentage
error values for CI_BST (0.023; 40%), CI_CNI (−0.108; 38%), CI_CS(−0.347; 51%), CI_BST_CS (0.001; 35%) and CI_BST_CS_Biometry (0.057;
33%) demonstrated at least comparable accuracy and precision for
CI_BST and CI_CNI compared to CI_CS. The combination of CI_CS with
CI_BST or CI_CNI substantially improved its predictive capabilities.
This is supported by the ROC-AUCs regarding CI ≥ 5L/min/m2 (all
p < 0.001) for CI_BST (AUC = 0.779), CI_CS (0.835), CI_CNI (0.856),
CI_BST_CS (0.869) and CI_BST_PA_Biometry (0.853) as well as regard-
ing CI ≤ 3.25L/min/m2 for CI_BST (AUC = 0.731; p < 0.001), CI_CS
(0.717; p = 0.001), CI_CNI (0.652; p = 0.016), CI_BST_CS (0.773;
p < 0.001) and CI_BST_A_Biometry (0.791; p < 0.001).
CONCLUSIONS. BSTs alone or combined with biometrics provide an
estimate of CI with predictive capabilities at least comparable with
those of CI_CS. Combination of CI_CS with CI_BST and biometrics
substantially improves its prediction of CI_TD.
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INTRODUCTION. Patients in the perioperative setting are often at risk
of developing arterial hypotension, which can lead to poor outcomes
such as acute kidney and myocardial injury [1]. The objective of this
observational study is to assess if the hypotension probability
indicator (HPI) recently developed by Edwards Lifesciences (Irvine,
USA) can predict hypotensive events before they occur more reliably
than changes of mean arterial pressure (MAP) can.
METHODS. We studied 34 patients that were mainly undergoing off-
pump Coronary Artery Bypass Grafting (OPCABG) surgery. The pa-
tient demographics are listed in Table 70. Radial arterial pressure
waveforms were monitored with FloTrac IQ™ sensors (Edwards Life-
sciences, Irvine, USA) and saved for offline analysis. A hypotensive
event was defined as MAP < 65 mmHg for at least one minute. The
ROC analysis was performed to assess AUC of HPI and ΔMAP to iden-
tify and predict a hypotensive event: four different ΔMAP were ana-
lyzed: they are calculated from two MAPs that are 20 seconds, 1
minute, 3 and 5 minutes apart, respectively.
RESULTS. A total of 389 hypotensive events were registered, 11
events on average per patient, and the cumulative time (mean (SD))
a patient spent in hypotension was 63 (±81) minutes. The area under
the curve, sensitivity and specificity of HPI and ΔMAP in predicting
hypotension 5 minutes prior to the actual occurrence of hypotension
are listed in Table 71.
CONSLUSION. This study shows that the change of MAP cannot be used
to predict hypotension, while HPI predicts the occurrence of hypotension
with an acceptable accuracy (sensitivity and specificity >80%).
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Fig. 89 (abstract 0214) See text for description
Fig. 90 (abstract 0214) See text for description
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INTRODUCTION. Persistent and profound vasoplegia is a common
phenomenon associated with septic shock. The use of vasopressors
for increasing arterial pressure is necessary to restore an adequate
perfusion pressure. However, the impact of vasopressor therapy
could potentially be detrimental if cardiac afterload is increased,
especially if systolic function is already impaired.
OBJECTIVES. We aimed to test whether vasopressors alter the
arterial pressure propagation and reflection phenomena in septic
shock patients, and how this could affect left ventricular (LV)
efficiency.
METHODS. 17 septic shock patients were monitored with an
oesophageal Doppler and a radial arterial line. Pulse wave
velocity (PWV) was calculated using the carotid-to-femoral PWV
(Sphygmocor). Aortic pressure waveform was estimated from
the carotid arterial pressure obtained by applanation tonometry.
Arterial waveform analysis was performed separating the aortic
pressure waveform in its forward (Pfw) and backward (Pbw)
components. The ratio between the systolic area of Pbw and
Pfw (Pbwarea/Pfwarea%), and Pbw and measured pressure
(Pbwarea/Pmeasuredarea%), augmentation index (the ratio of aug-
mentation pressure to aortic pulse pressure), and reflection
index (Pbw/Pbw + Pfw), were used as measures of LV load be-
cause of arterial reflections. Total, steady and oscillatory LV
power, subendocardial viability ratio (SEVR, an index of myocar-
dial perfusion relative to LV workload), and energy transmission
ratio (the ratio between the hydraulic power in measured pres-
sure and Pfw, expressing the effects of wave reflections on re-
ducing LV hydraulic power) were calculated from the analysis of
the central pressure and flow waveforms. Measurements were
obtained before (Fig. 89) and after introduction or increasing
norepinephrine dosage (Fig. 90).
RESULTS. Changing norepinephrine dosage from 0.05 (0 to 0.10) to
0.15 (0.08 to 0.27) μg−1Kg−1min−1 increased mean arterial pressure
(from 83 ± 13 to 98 ± 10 mmHg; p < 0.001); PWV (from 8.3 ± 2.2 to
10.3 ± 3 m/s; p < 0.001); Pbwarea/Pfwarea (from 16.9 ± 9 to
20.7 ± 10.5%; p < 0.001); Pbwarea/Pmeasuredarea (from 13.9 ± 6.6 to
16.5 ± 7.2; p < 0.001); augmentation index (from −3 ± 25 to
11 ± 23%; p < 0.001), and reflection index (from 0.26 ± 0.05 to
0.28 ± 0.06; p < 0.001). Cardiac output and stroke volume did not
change (5.86 ± 2.15 to 5.83 ± 2.3 L/min; p = 0.885; 66 ± 18 to
68 ± 18 mL; p = 0.201, respectively). Total, steady and oscillatory LV
power increased (from 0.97 ± 0.48 to 1.14 ± 0.51 W; from 0.76 ± 0.36
to 0.87 ± 0.39 W; and from 0.21 ± 0.14 to 0.26 ± 0.15 W; p < 0.001,
respectively), without increasing LV efficiency (ETR from 88 ± 7.5 to
85.1 ± 8.8%; p < 0.001, and SEVR from 154 ± 61 to 153 ± 62%;
p = 0.871).
CONCLUSIONS. Vasopressor support modifies the arterial pressure
propagation and reflection phenomena, increasing LV afterload and
impairing LV efficiency.0215
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INTRODUCTION. Shock is a state of acute circulatory failure.
Understating the hemodynamic alterations in shocked patient is
important for therapeutic planning.
OBJECTIVES. Assessment of change in ventricuo-arterial (V-A) coup-
ling in patients with shock and its effect on short-term outcome.
METHODS. 40 patients with shock were included. At the time of
preparing initial fluid resuscitation, the following transthorasic
echocardiographic views were obtained (parasternal long axis, apical
4 & 5 chambers) for offline analysis and calculation of Venticulo-
arterial coupling (VA coupling). VA coupling was measured using the
following equation:
Ea/Ees = (ESP/SV)/(ESP/ESV)
Where Ea is arterial elastance, Ees is ventricular elastance, ESP is end
systolic pressure (0.9 x systolic blood pressure (SBP)), SV is stroke
volume and ESV is end-systolic volume.
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APACHE II score & its predicted mortality were calculated on
admission and were compared with the in-hospital mortality.
RESULTS. 40 patients with mean age 60.25 ± 15.62 years and 60%
males. They included 24 patients with cardiogenic shock, 15 with
septic shock and one patient with hypovolemic shock. VA
decoupling was detected in 36 patients (90%), 100% of septic shock,
83.3% of cardiogenic shock, and the patient with hypovolemic shock.
In septic shock, decoupling was due to decreased Ea in 80% &
decreased Ees in 40%.
In cardiogenic shock, decoupling was mainly due to decreased Ees
(95.8%), increased Ea (62.5%), and decreased Ea (12.5%). The patient
with hypovolemic shock had increased Ea and normal Ees.
The mean APACHE II scoring was 43.3 ± 11.5 with mean predicted
mortality 68.4% ± 8. In-hospital mortality was 85%.
Predicted mortality by APACHE II showed good -ve correlation with
Ea /Ees (r = −0.7) and poor correlation with SBP on admission
(r = 0.16). Significant association was found between Ea/Ees and DM,
predicted and in-hospital mortality, all with p < 0.001. No association
was found between mortality and SBP on admission (p 0.5).
CONCLUSIONS. The incidence of VA decoupling was very high in
patients with shock and appeared to be correlated with worse
outcome. SBP on admission was not a good predictor of prognosis in
shocked patients.
0216
Comparison of cardiac function index CFI derived from jugular and
femoral indicator injection using the PiCCO-2 device: a prospective
observational study
A. Herner, R. Schmid, W. Huber
Klinikum rechts der Isar der TUM, Munich, Germany
Correspondence: W. Huber
Intensive Care Medicine Experimental 2017, 5(Suppl 2):0216
INTRODUCTION. Cardiac function index (CFI) is a transpulmonary
thermodilution (TPTD)-derived index of systolic function. CFI is
defined as the ratio of cardiac output CO divided by global
enddiastolic volume GEDV: CFI = CO/GEDV. The validity of CFI relies
on an accurate measurement of global end-diastolic volume GEDV.
Several studies demonstrated that the use of femoral venous access
results in a marked overestimation of GEDV. This also falsely reduces
CFI. One of these studies suggested a correction formula for femoral
venous access that markedly reduced the bias for GEDVI. Conse-
quently, the last PiCCO-algorithm requires information about the
CVC-position, and correction of GEDVI for femoral access has been
shown. However, a recent study suggests inconsistencies of the last
PiCCO algorithm using uncorrected GEDV to calculate CFI despite an
obvious correction of GEDVI. Nevertheless, the study was based on
mathematical analyses of the data displayed in a total of 15 patients
equipped with only a femoral, but not with a jugular CVC.
OBJECTIVES. Therefore, this study compared CFI_fem derived from
femoral TPTD to values derived from jugular indicator injection in 29
patients with both jugular and femoral CVCs.
METHODS. 29 ICU-patients with PiCCO-monitoring were included.
Each dataset consisted of three triplicate TPTDs using the jugular
venous access as the gold standard CFI_jug, and the femoral access
with (CFI_fem_cor) and without (CFI_fem_uncor) information about
the femoral indicator injection to evaluate, if correction for femoral
GEDV pertains to CFI_fem.
RESULTS. 29 patients (14f; 15m; 26/29 mechanically ventilated; 20/29
under vasopressors). CFI_fem_uncor was significantly lower than
CFI_jug (4.34 ± 1.70 vs. 5.29 ± 1.90 min−1; p < 0.001). Similarly,
CFI_fem_cor was significantly lower than CFI_jug (4.31 ± 1.6 vs.
5.29 ± 1.90 min−1; p < 0.001). This is explained by the finding that
CFI_fem_uncor was not different to CFI_fem_cor (4.34 ± 1.70 vs.
4.31 ± 1.6 min−1; p = 0.884). This clearly suggests that correction for
femoral CVC does not pertain to CFI. Calculatory correction of
CFI_fem_uncor was performed by multiplying CFI_fem_uncor by the
ratio GEDVI_fem_uncor/GEDVI_jug. This resulted in CFI_fem_formula
which was not significantly different from CFI_jug (5.56 ± 1.94 vs.5.29 ± 1.90 min−1; p = 0.136). The agreement of measurements
classified in the same category of CFI (decreased (<4.5), normal (4.5-6.5)
and increased (>6.5 min−1)) as CFI_jug was high for CFI_fem_formula
(identical categories in 25 of 27 comparisons), whereas the agreement
with CFI_jug was significantly lower for CFI_fem_cor (13 out of 27;
p < 0.001) and CFI_fem_uncor (14 out of 27; p = 0.001).
CONCLUSIONS. Femoral indicator injection for TPTD results in
significantly lower values for CFI. While the last PiCCO algorithm
obviously corrects GEDV(I), this correction is not applied to CFI.
Therefore, CFI-values are substantially underestimated in case of fem-
oral CVC.
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INTRODUCTION. The cardiovascular reserve hypothesis focuses on
the remaining momentary cardiovascular reserve (the potential to
gain cardiac output to meet increasing metabolic needs) rather than
momentary cardiovascular performance per-se. It proposes a compre-
hensive explanation to aerobic exhaustion (the reserve decreased
below exhaustion threshold), heart failure (low reserve which reaches
exhaustion threshold even in daily activity) and shock (cardiovascular
reserve decline to the sustainability limit regardless if the cardiac out-
put is low or high) [1].The cardiovascular reserve index (CVRI) was
proposed as an estimate of the assumed cardiovascular reserve
based on the principles of control theory [CVRI = f(BP,CVP,HR,RR,BSA)
where BP = blood pressure, CVP = central vein pressure, HR = heart
rate, RR = respiratory rate, BSA = body surface area]. We review the
entire results as for today.
OBJECTIVES. Empirical validity of CVRI was conducted by three
researches: 1) Validity of CVRI in diverse hemodynamic morbidities
and conditions. 2) Validity of CVRI during hemorrhage related
hemodynamic deteriorations and 3) Validity of CVRI during exercise
METHODS. Validity of CVRI in diverse hemodynamic morbidities was
conducted in ptients of 3 existing databases were evaluated (1.
patients with diverse exercise capacity, 2. heart failure and 3.
pending shock). Each database was stratified by severity to 3–4
subgroups. CVRI was computed for each patient. Validity of CVRI
during hemorrhage was evaluated in 17 swine experiment in the
surgeon general headquarter IDF. Validity of CVRI during exercise in
patients who underwent cardio-pulmonary exercise testing (CPX) in
Sheba Medical Center.
RESULTS. In diverse conditions highest mean CVRI was in the normal
exercise capacity group (around 1.0) and the lower at shock (0.2)
with intuitive ordinal order in-between [2]. During hemorrhage CVRI
demonstrated nearly linear decrease slop from pre-hemorrhage
(around 1.0) through increase in cumulative blood loss toward shock
(0.2). Interestingly, CO exhibits considerable detectability delay [3].
During exercise CVRI demonstrated highest CVRI at rest and decrease
with exercise intensity reaching a nadir at peak exercise (0.35) and
regain with recovery [4].
CONCLUSIONS. all three researches comply with the assumed
cardiovascular reserve. The results show that CVRI may indicate a
rough hemodynamic state in single measurement. CVRI may
indicate hemodynamic deterioration through monitoring or repeated
measurements of an individual patient. Prospective studies are planned
to validate CVRI predictive in diverse clinical settings.
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SBT success SBT failure P value
MAP (mmHg) 76.1±16.2 99.7±14.3 0.01
HR (bpm) 94.7±14.9 120.83±21.5 0.009
SVV (%) 9.9±4.1 12.2±5.8 0.36
SVI (ml/beat/m2) 47±14.4 40±17.4 0.44
CO (L/min) 6.8±2.4 8±2 0.33
CI (L/min/m2) 4±1.7 4.7±1.2 0.38
Haemodynamic parameters during 30 minutes of SBT with CPAP 5 cmH2O. Data are
expressed as mean±SD of the three time points (5-15-30 minutes). P value from
paired T-test.
HR heart rate, MAP mean arterial blood pressure, CI cardiac index, SVV stroke volume
variation, CO cardiac output, SVI stroke volume index0218
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INTRODUCTION. Cardiac Index CI is a major target of haemodynamic
monitoring. Initial clinical assessment is based on body surface
temperature BST (“cold shock vs. warm shock”). We hypothesized
that accurate measurement of BST with an infrared thermometer
(Thermofocus, Tecnimed) combined with biometric data might
provide a complete non-invasive estimate of CI (CI_CNI) with preci-
sion and accuracy comparable to a pulse contour analysis estimate
of CI (CI_PA; ProAqt, Pulsion, Germany).
OBJECTIVES. We compared BSTs alone and in combination with
biometric data (CI_CNI) to CI_PA and to a gold-standard CI
derived from transpulmonary thermodilution (TPTD; CI_TD; PiCCO;
Pulsion).
METHODS. In 29 patients (20m; 9f; APACHE-II 16 ± 5) 232 datasets
were recorded (8 datasets per patient within 24h). Immediately be-
fore TPTD we measured BST on the forehead, forearm, finger and
great toe and recorded CI_PA. Statistics: SPSS 23.
RESULTS. CI-TD was univariately (p < 0.001) associated to BST on
the forehead (r = 0.601), forearm (r = 0.473), finger (r = 0.392)
and great toe (r = 0.391) as well as to age (r = −0.408) and
CI_PA (r = 0.365).
In multiple regression analysis BST_forehead (p < 0.001) and
BST_forearm (p < 0.001) were independently associated to CI_TD.
This regression resulted in an CI-estimate based on BSTs (CI_BST;
R2 = 0.358). Furthermore, age (p = 0.001), gender (p = 0.047) and
height (p = 0.053) were independently associated to CI_TD. A com-
bined regression (CI_CNI; R2 = 0.465) demonstrated independent as-
sociation of BSTs on forehead, forearm and toe as well as male
gender, young age and height to CI_TD.
In a next step, we analysed, if these data could improve the
estimation of CI by CI_PA. CI_TD was independently associated with
CI_BST(R2 = 0.434) and/or CI_CNI in addition to CI_PA. The final
model (CI_BST_PA_biometry; R2 = 0.485) included CI_BST, CI_PA, age,
gender and height as independent predictors of CI_TD. The bias (L/
min/m2) and percentage error values for CI_BST (0.010; 47%), CI_CNI
(−0.077; 44%), CI_PA (0.117; 56%), CI_BST_PA (0.001; 43%) and
CI_BST_PA_Biometry (−0.001; 41%) demonstrated at least
comparable accuracy and precision for CI_BST and CI_CNI compared
to CI_PA. The combination of CI_PA with CI_BST or CI_CNI
substantially improved the predictive capabilities of CI_PA.
This is supported by the ROC-AUCs regarding CI ≥ 5L/min/m2 (all
p < 0.001) for _BST (AUC = 0.794), CI_PA (0.724), CI_CNI (0.819),
CI_BST_PA (0.842) and CI_BST_PA_Biometry (0.847) as well as regard-
ing CI ≤ 2.5L/min/m2 for CI_BST (AUC = 0.853), CI_PA (0.684), CI_CNI
(0.878), CI_BST_PA (0.858) and CI_BST_A_Biometry (0.888).
CONCLUSIONS.
1.) BSTs alone or combined with biometrics provided an estimate of
CI with predictive capabilities at least comparable to those of CI_PA.
2.) Combination of CI_PA with CI_BST and biometrics substantially
improved the predictive capabilities of CI_PA.
3.) CI_BST and CI_CNI could be used alone or as an external
calibration to improve accuracy and precision of CI_PA0219
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INTRODUCTION. Failure to wean from controlled mechanical ventilation
is associated with significant morbidity and mortality in the intensive care
unit1and this commonly occurs in patients with limited cardiac reserve.
The process of weaning leads to changes in the hemodynamic and
autonomic nervous systems. Spontaneous breathing trial (SBT) assesses
the patient´s ability to breathe while receiving minimal or no ventilator
support.2 It has been showed that reduced heart rate variability during
SBTs was significantly associated with extubation failure.3 Based on
strong evidence, the duration of SBT should be at least 30 minutes. The
initial few minutes of the SBT should be monitored closely before
judgment is made to continue the SBT.
OBJECTIVES. The aim of this study is to evaluate whether hemodynamic
parameters measured during a 30-minute SBT using a CPAP level of 5
cmH2O are able to detect weaning failure from weaning success.
METHODS. This was a prospective observational study, which included
intubated ICU patients with an expected duration of mechanical
ventilation of >24hrs.
Recordings of hemodynamic parameters were obtained using the
VigileoTM monitor (Edwards Life Sciences LLC, Irwine, CA, USA,
software version 01.10) at three time points (at 5, 15 and 30 minutes,
respectively), during the weaning trial.
RESULTS. Fifteen patients were enrolled, M/F: 10/5, with a mean age
of 69 (SD 14). The main causes of ICU admission were shock (30%),
pneumonia and cardiac arrest (20%).
Data collected showed a significant difference in mean arterial pressure
(MAP), 76.1 ± 16.2 mmHg vs 99.7 ± 14.3 mmHg (p < 0.01) and in heart
rate (HR), 94.7 ± 14.9 bpm vs 120.83 ± 21.5 bpm (p < 0.009), between
the success and failure SBT groups, respectively, with no difference of
the other hemodynamic parameters (Table 72.)
CONCLUSIONS. We observed a significantly difference of MAP and HR
between groups of patients who succeeded or failed a SBT. Preload
optimization may have influenced other hemodynamic parameters in
both groups.
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Table 73 (Abstract 0220). Patient's characteristics
Variable (n = 15) Mean
Age 44 years
Body mass index (BMI) 32.35
PBW Tidal Volume 6.55 ml/kg
PaO2/FiO2 75.73
PEEP 11.84 cmH2O
Driving Pressure 14 cmH2O
Compliance (Cstat) 28.39 ml/cmH2O
APACHE II 17 points
SOFA 9.5 points
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INTRODUCTION. The goal of fluid resuscitation is an increase in
cardiac output as result of increase in venous return carrying an
improvement of regional and global microcirculatory perfusion
(1). Hemodynamic optimization can be achieved by using
vasopressors, preload optimization or inotropic in an individual
way of each patient. Bedside ultrasound (US) has proven to be
useful for determinate volume response; superior or inferior cava
vein (collapsibility and distensibillity index) are used to decide if a
fluid bolus is beneficial, with controversial results. Internal jugular
vein collapsibility index (IJV-CI) ≥18% has proven to be an
equivalent of inferior cava vein measurements with a good
predictive value of volume responsiveness (2–4).
OBJECTIVES. Determine if IJV-CI is a good predictor for hemodynamic
optimization in prone position (PP) ARDS patients
METHODS. A retrospective analysis was made during the first 3
months of 2017 in a tertiary hospital ICU at Mexico City,
including ARDS patients who were in PP and requiring
vasopressor; a bedside US was used to measure IJV-CI and
analyze the behavior of vasopressor dose after an infusion of
250 ml of crystalloid.
RESULTS. Fifteen patients were analyzed, 28 measures were done.
A bedside US was performed to measure IJV-CI with a linear probe,
in B and M-mode, calculating the IJV-CI with this formula:.When
IJV-CI ≥18% and a 250 ml of crystalloid fluid challenge was infused
we observed vasopressor withdraw in 26 of 28 measures (92.8%).
Normal distribution was proven by Shapiro Wilks, hence a Student
t-test for related samples was made, resulting in a significant differ-
ence (p = 0.0008, CI 95%) for vasopressor withdraw in patients
who received a fluid challenge. Fisher's test was calculated
(F = 0.0421, p < 0.05, CI 95%) when the IJV-CI was ≥18%, with sens-
ibility 92%, specificity 67%, positive predictive value 96% and
negative predictive value 50% for vasopressor withdraw. The cor-
relation between IJV-CI value and amount vasopressor withdraw by
the Pearson r = 0.41.
CONCLUSIONS. IJV-CI ≥18% appears to be a good predictor for vaso-
pressor withdraw after fluid challenge in prone position ARDS pa-
tients, a prospective comparative study is needed to elucidate the
validity of this index as an hemodynamic optimization predictor in
this population.
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cardio-surgical spontaneous breathing patients
P. Bertini1,2, G. Brizzi1, G. Mancino1, L. Doroni1, R. Baldassarri1, F.
Guarracino1
1Azienda Ospedaliero Universitaria Pisana, Anaesthesia and Intensive
Care Medicine - Cardiothoracic and Vascular Anaesthesia and Critical
Care, Pisa, Italy; 2Royal Brompton & Harefield NHS Foundation Trust,
Critical Care, London, United Kingdom
Intensive Care Medicine Experimental 2017, 5(Suppl 2):0221
Correspondence: P. Bertini
Intensive Care Medicine Experimental 2017, 5(Suppl 2):0221
INTRODUCTION. In the ICU the assessment of haemodynamic
variables is critical in unstable patients. We usually focus on cardiac
output and on fluid responsiveness, which is assessed using dynamic
indices such as systolic pressure variation and pulse pressure
variation induced by positive pressure ventilation. Although we can
easily predict fluid responsiveness at the bedside using these
approaches, none of these parameters can explain why a patient is
or is not volume “requiring”, and they also require mechanical
ventilation and a sinus rhythm. For this reason we have studied the
venous side of the circulation as a determinant of cardiac output,
and in particular the mean systemic filling pressure.
OBJECTIVES. To evaluate the mean systemic filling pressure and its
analogous value derived by a mathematical model (Pmsa), the
venous return gradient and the heart efficiency as predictors of fluid
responsiveness in post-surgical cardiac patients.
METHODS. We performed our study in a post-surgical cardiac ICU. In
spontaneously ventilating patients, monitored with a central venous
catheter and invasive arterial blood pressure, we evaluated the Pmsa
and the venous return as previously described1, using the formula2:
Pmsa = aRAP + bMAP + cCO
Knowing the heart rate, CO was measured with echocardiography
measuring the LVOT diameter and LVOT VTI. We performed a passive
leg raising maneuver as described in literature3 and we considered
an increase of stroke volume or cardiac output greater than 10% as a
positive response.
We then measured the venous return gradient (the difference
between mean systemic filling and central venous pressure) and the
heart efficiency (Eh = (Pmsa - CVP)/Pmsa) and its change after fluid
challenge (ΔEh).
RESULTS. A total of 8 patients were studied. In 6 patients SV and CO
increased more than 10% after PLR. Pmsa increased in the 8 patients
(Pmsa 15 ± 4 mmHg before PLR, and 18 ± 4 mmHg after PLR). The
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 116 of 542venous return gradient (dVR) increased in the “responder group”, but
not in the “non-responder group”. Heart performance did not change
significantly in either group.
CONCLUSIONS. In this small preliminary study we have calculated
bedside the changes in Pmsa, dVR and Eh, and tried to correlate
them with fluid responsiveness. It seems that an increase of dVR
correlates with fluid responsiveness. Further studies are needed
to confirm this correlation and to assess its usefulness in clinical
practice.
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INTRODUCTION. The prognostic value of extravascular lung water
index (EVLWI) has been investigated in various settings by studies
that were often of small size.
OBJECTIVES. With this systematic review and meta-analysis, we
wanted to assess the ability of EVLWI to predict mortality in the
specific population of adult patients with septic shock and/or
acute respiratory distress syndrome (ARDS).
METHODS. We searched for all relevant observational studies
evaluating the ability of EVLWI to predict mortality in adult patients
with sepsis or septic shock and/or ARDS, from 1966 to March 2017
on MEDLINE database and the Cochrane Database of Systematic
Reviews.
RESULTS. We included 14 studies (1338 patients). EVLWI was
significantly higher in non-survivors than in survivors (mean differ-
ence: 5.1 mL/kg). The analysis of the receiver operating characteristic
(ROC) curve was available in 10 studies (1017 patients). EVLWI pre-
dicted mortality with a pooled sensitivity of 0.68 (confidence interval:
0.64-0.72) and a pooled specificity of 0.72 (0.67-0.76). The positive
likelihood ratio was 3.04 (2–4.6) and the negative likelihood ratio was
0.40 (0.31-0.54). The thresholds reported to discriminate between sur-
vivors and non-survivors ranged from 9 to 21 mL/kg. None of the co-
variates were found to be a significant source of heterogeneity. In
particular, the fact that EVLWI was indexed to predicted or actual
body weight and the fact that studies included ARDS patients or not
did not influence the predictive accuracy of EVLWI. The pooled area
under the receiver ROC curve was 0.76 ± 0.45 (p < 0.05 vs. 0.50).
CONCLUSIONS. EVLWI seems to be a good predictor of mortality in
patients with ARDS and/or septic shock. This suggests that EVLWI has
its own pathophysiological meaning and that the estimation of
EVLWI by thermodilution is reliable.
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Intensive Care Medicine Experimental 2017, 5(Suppl 2):0223INTRODUCTION. The assessment of cardiac output (CO) is a
cornerstone in haemodynamic management of shock patients. Many
minimally invasive systems have been introduced to provide CO
changes beat-to-beat and to allow a more widespread use of CO
monitoring bedside, replacing more invasive methods (i.e. pulmonary
artery catheter).
OBJECTIVES. The aim of this study was to evaluate if the estimation
of CO with two mini-invasive monitoring systems, MostCare (Vygon©TM)
and CardioQ (Deltex MedicalTM) was reliable and able to follow CO
changes in shock patients with profound hemodynamic instability.
METHODS. In this prospective, observational, monocentric study, we
enrolled patients with diagnosis of shock, in particular septic and
hemorrhagic shock, as suggested by common clinical parameters
(HR > 120 bpm, MAP < 70 mmHg, urinary output < 0,5 ml/Kg/h and
blood lactates >4 mmol/l, bleeding >1000 ml). Exclusion criteria
were: age < 18, pregnancy, survival expectancy < 24h and need for
urgent surgery. All patients might receive different intervention
according to clinical needs: volume expansion with 500 ml of
Ringer's lactate in 10 minutes, increase or decrease of
norepinephrine or increase or decrease of dobutamine. CardioQ and
Mostcare measurements were compared with transpulmonary
thermodilution (TPTD-EV1000) as reference method. A patient was
characterized as fluid responder (FR) if CO increase was > 12% after
fluid bolus. For each stage, we detected haemodynamic, respiratory
and metabolic parameters as SAP, DAP, MAP, HR, CVP, SVi, Ci, SVRi,
Ea, Cla, blood gas analysis and urinary output.
RESULTS. We obtained 23 measures on six patients, with an average
age of 65 ± 18 (30% male). At baseline a significant difference
between CO measured by CardioQ and TPTD emerged by Bland-
Altman analysis (mean −1.1, CI −7.2-5 L/min/m2) as well as between
MostCare and TPTD (0.5 CI −1.9-3 L/min/m2) but with lower differ-
ences. Mountain Plot showed that MostCare overestimates CI but
with a smaller error compared to CardioQ (50 percentile 0.5 vs 0 L/
min/m2). When we compared trending ability of the two systems, by
plotting the difference in CO before and after intervention, MostCare
had a smaller error compared to CardioQ (mean 0.21 CI −0.89-1.31 vs
mean 0.5 CI −2.3-3.2 L/min/m2, respectively).
CONCLUSIONS. Despite the major accuracy of MostCare to detect
CO values and acute changes than CardioQ, these mini-invasive
monitoring systems tend to be less accurate than TPTD also in fol-
lowing changes in cardiac output more than their absolute value.
The small number of patients enrolled hampers to draw definitive
conclusion on such devices and further studies are therefore needed.
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INTRODUCTION. Cardiac Index CI is a key target of haemodynamic
monitoring. Initial clinical assessment of shock patients is based on
the assessment of body surface temperature BST. We hypothesized
that accurate measurement of BST with an infrared thermometer
(Thermofocus, Tecnimed) combined with biometric data provides a
completely non-invasive estimate of CI (CI_CNI) with a precision and
accuracy comparable to a pulse-contour-analysis estimate of CI
(CI_FT; FloTrac, Edwards Lifesciences; USA).
OBJECTIVES. We compared BSTs alone and in a model (CI_CNI)
combined with biometric data and pulse pressure PP to CI_FT and to
a gold-standard CI derived from transpulmonary thermodilution
(TPTD; CI_TD; PiCCO; Pulsion).
METHODS. 240 datasets (eight per patient) in 30 patients (24m; 6f;
APACHE-II 20 ± 6) were recorded within 24h. Each dataset included
pre-TPTD BSTs of great toe, finger, forearm and forehead, CI_FT and
thermodilution-derived CI_TD.
Fig. 91 (abstract 0225) See text for description
Fig. 92 (abstract 0225) See text for description
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combined models to predict CI_TD were presented at the SCCM-
meeting 2013.
RESULTS. CI-TD was univariately (p < 0.001 except as indicated) as-
sociated to surface temperatures of forehead (r = 0.441), great toe
(r = 0.423) and distal forearm (r = 0.209; p = 0.001) as well as to
age (r = −0.756), height (r = 0.256), gender (r = 0.162; p = 0.012),
PP (r = 0.322) and CI-FT (r = 0.830). Multiple regression including
BSTs and biometrics demonstrated that BST_forehead (p = 0.001),
BST_toe (p = 0.012), age and male gender were independently as-
sociated to CI_TD. This regression formula resulted in CI_BB ("Biom-
etry and BST"; R2 = 0.541). Inclusion of PP resulted in a further
improved model CI_CNI (R2 = 0.646). In this model BST_forehead
(p = 0.001), BST_toe (p = 0.004), age (p < 0.001), height (p = 0.002),
weight (p = 0.033) and PP (p < 0.001) were independently associ-
ated to CI_TD.
In a next step, we analysed, if these models could improve the
estimation of CI by CI_FT. CI_BB and CI_FT were independently
(p < 0.001) associated with CI_TD. This model was termed CI_BB_FT
(R2 = 0.683). Similarly, CI_CNI and CI_FT were independently associated
with CI_TD. The resulting formula CI_CNI_FT provided the largest R2-
value (0.706). In Bland-Altman-analyses the bias (L/min/m2) and per-
centage error values (%) compared to CI_TD were −0.123 and 44% for
CI_FT, −0.001 and 37% for CI_CNI_FT, −0.049 and 47% for CI_BB, 0.031
and 41% for CI_CNI, and −0.003 and 39% for CI_BB_FT.
The ROC-AUCs regarding CI ≤ 2.5 and CI ≥ 5L/min/m2 were compar-
able for CI_FT (0.936; 0.883), CI_BB (0.930; 0.856) and CI_CNI (0.953;
0.888). They could be further improved by combination of the non-
invasive techniques with CI_FT for CI_BB_FT (0.957; 0.897) and for
CI_CNI_FT(0.962; 909; p < 0.001 for all ROCs).
CONCLUSIONS.
1.) BSTs combined with PP and biometrics provide an estimate of CI
with similar predictive capabilities as for the CI-FT.
2.) CI_CNI could be used alone or as an external calibration of CI_FT.
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INTRODUCTION. Determination of a patient´s volume status in
intensive care units (ICU) is still a challenging issue. Point of care
USG (POCUS) to measure inferior vena cava diameter (IVCD) and
variability with respiration have been shown to correlate with central
venous pressure, stroke volume and pulse pressure variation as a fluid
status determination method in critically ill adults. On the other hand,
during a routine ICU day, intensivist has to do ultrasonographic
evaluation of heart, lung and IVC several times for planning fluid
therapy. For this reason, a practical, reliable, faster and affordable
ultrasound device may be more convenient. Previous studies reported
pocket-sized (PS) devices can be used for POCUS in Cardiology,
Emergency Departments and ICU's effectively.
OBJECTIVES. We aimed to determine the diagnostic accuracy of (PS)
ultrasound in comparison with a high end(HE) device for
measurement of IVCD and variability with respiration.
METHODS. Patients were examined as a randomized order with the
PS (GE V-scan) and HE(GE Vivid Q) devices. Examinations were carried
out according to a standardized protocol by two intensivists with
sector probes of the devices. All images were saved as cineloop re-
cords and measurements were performed on this records according
to recent guideline recommendations. Paired t test, and Bland-
Altman analyses were used for statistical analysis.
RESULTS. 27 patients were included in this study. There was no
statistically significant difference in inspiratory (PS;1,34 ± 0,61cm, HE;1,38 ± 0,64cm) and expiratory (PS;1,95 ± 0,45cm, HE;2,04 ± 0,49cm)
diameter of IVC among PSand HE devices(p > 0,05). There was also
no significant difference between the calculated respirational
variability rates with PS (35 ± 20%) and HE (34,6 ± 20%) devices
(p > 0,05). The Bland-Altman analysis revealed that the width of
the 95% limits of agreement were similar for both devices(Figs.
91, 92 and 93).
CONCLUSIONS. There was good inter-device agreement among PS
and HE ultrasound devices for measurements of IVC in both respir-
ation phases and there was no significant difference in the respira-
tional IVC variability between the measurements with both devices.
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INTRODUCTION. The acute respiratory distress syndrome (ARDS) is a
common clinical disorder characterised by injury to the alveolar
epithelial and endothelial barriers of the lung and acute respiratory
failure [1]. Serum biomarkers released from inflammatory cells are of
a great value in the diagnosis and follow up of such condition
[2].HBP is one of these biomarkers that is released from azurophilic
granules of activated neutrophils and carries a great value in the
diagnosis and follow up of ARDS [3].
OBJECTIVE. To validate the diagnostic and prognostic role of HBP in
patients with ARDS and to correlate it with other prognostic markers
and scoring systems.
METHODS. Forty patients presented to the critical care department
at Beni-Suef & Cairo University and diagnosed as having ARDS ac-
cording to the New Berlin Definition [4] during the period from
March to November 2015 in addition to 10 non ARDS patients who
served as controls. Plasma HBP level was measured within 24 hours
from admission [HBP 1] & on day 5 [HBP 5] and only once for con-
trols by ELISA technique & correlated it with CRP & APACHE II, SOFA
& Lung Injury scores [LIS].
RESULTS. HBP1 was significantly higher in patients than in
controls with a p- value 0.001. HBP 5 was significantly higher in
non survivors than survivors with a p-value 0.006. HBP showed
an insignificant correlation with APACHE II score with a p-value
0.65 & 0.35 while it showed a moderate correlation with SOFA
score with a p-value 0.04 & 0.05. Also a negative insignificant
correlation was found between HBP and LIS with a p-value
0.107 & 0.742. HBP showed moderate significant correlation
with CRP with a p-value 0.026 & 0.025. HBP was significantly
higher in septic than in non-septic patients with a p-value 0.025
& 0.026. The cut-off point of HBP for diagnosis of ARDS was
16.2 ng/ml with a sensitivity of 97.5% & specificity of 100% with
a p-value of 0.001 while 52 ng/ml was the cut-off point to pre-
dict mortality with a sensitivity of 89.7% and a specificity of
72.7% with a P value of 0.001.CONCLUSION. Heparin Binding Protein can be used as an early
diagnostic and prognostic biomarker for ARDS with a high sensitivity
and specificity.
REFERENCES
1. Ashbaugh D, Bigelow D, Petty T, Levine B: Acute respiratory
distress in adults. The Lancet 1967, 290(7511):319–323.
2. Rubenfeld G, Caldwell E, Granton J, Hudson L, Matthay M:
Interobserver variability in applying a radiographic definition for
ARDS. CHEST Journal 1999, 116(5):1347–1353.
3. Borregaard N, Cowland J: Granules of the human neutrophilic
polymorphonuclear leukocyte. Blood 1997, 89(10):3503–3521.
4. Thompson B, Matthay M: The Berlin definition of ARDS versus
pathological evidence of diffuse alveolar damage. Am J Respir Crit
Care Med. 2013, 187: 675–677.
0227
Timing of ICU admission and clinical outcome in patients with
sepsis requiring invasive mechanical ventilation
Y. Shen, Y. Dong, O. Gajic, P. R. Bauer
Mayo Clinic, Rochester, United States
Correspondence: Y. Shen
Intensive Care Medicine Experimental 2017, 5(Suppl 2):0227
INTRODUCTION. Sepsis has initial hyper-inflammatory and subse-
quent immune-suppressive phase with different clinical outcomes.
Thus, the timing of sepsis and critical care support may influence
outcome in septic patients.
OBJECTIVES. To determine the impact of the timing of intensive care
unit (ICU) admission on the outcomes of patients with sepsis and
respiratory failure who originated from the emergency department (ED).
METHODS. Retrospective study of prospectively collected electronic
data from ICU patients with sepsis 2.0, identified by a sepsis alert system
and who required invasive mechanical ventilation between January 2006
to December 2014 in 3 ICUs from a tertiary medical center. Variables
identified by univariate analysis were included in multivariate logistic
regression analysis to analyze independent risk factors associated with
hospital mortality, using SPSS 18.0 for Windows.The study was approved
by the local Institutional Review Board (#14-008754).
RESULTS. From a total of 637 patients initially evaluated in the ED, 313
patients were directly admitted to the ICU and 324 patients were first
admitted to the floor and subsequently transferred to ICU. Median time
from ED to ICU admission was 3 hours [2–4] for direct admits and 48
hours [16–138] for transfers from the floor (p < 0.001). All patients
developed sepsis and were intubated after ICU admission. Patients
transferred from the floor to ICU had longer ICU (5.3 [2.8-9.4] vs. 4.6 [2.7-
8.4] days, p = 0.017) and hospital (14.6 [8.4-25] vs. 9.8 [4.9-15.7], p 0.002)
length of stay, higher ICU (33 vs. 21%, p < 0.001) and hospital (44 vs.
31%, p < 0.001) mortality than those admitted directly. Indications for
intubation varied according to the admission route: patients coming
from the floor were less often intubated for airway protection
(30 vs. 41%, p 0.003) and more often for respiratory failure (74 vs.
66%, p = 0.029). When compared with survivors, the non-survivors
were older (69 [59–79] vs. 63 [52–74] year-old, p < 0.001), more pre-
dominantly males (63 vs. 54%, p = 0.024), with higher APACHE III (96
[79–119] vs. 83 [70–100], p < 0.001), SOFA
(9 [7–13] vs. 8 [6–11], p < 0.001) and Charlson (3 [1–5] vs. 2 [1–5],
p = 0.002) scores, lower PaO2/FiO2 ratio (153 [97–206] vs. 185 [119–
246], p < 0.001), and delayed intubation time (12.1 [3.1-290] vs. 6
[2.2-20.3] hours, p = 0.014). By multivariate analysis independent
predictors of hospital mortality included initial floor status (OR 1.746,
95% CI 1.227-2.486, p = 0.002), APACHE III score (OR 1.017, 95% CI
1.006-1.028, p = 0.002), lower PaO2/FiO2 ratio (OR 0.997, 95% CI
0.995-0.999, p = 0.004) and timing of intubation
(OR 1.011, 95%CI 1.004-1.017, p = 0.001).
CONCLUSIONS. Patients originated from the ED, who were admitted
to ICU with sepsis requiring invasive mechanical ventilation, had a poorer
outcome if they were transferred from the floor, with hypoxemic
respiratory failure and delayed intubation in ICU, even after adjustment
for APACHE III score.
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INTRODUCTION. Few data are available on determinants of long-
term outcomes among lung transplant (LTx) patients who require re-
admission to the ICU.
OBJECTIVES. Our aim was to describe the variables associated with
one-year mortality in LTx recipients who require readmission to the
ICU beyond the postoperative period.
METHODS. Single-center, observational, retrospective analysis of a
prospectively assessed cohort of LTx patients who were readmitted
to the ICU over a 6-year period (2011–2016). LTx patients who
required readmission beyond 30 days after transplantation were
included. Patients were followed up until one year after ICU re-
admission. Demographic data, transplantation-related aspects, and
ICU-related variables were collected. Data were expressed as means
(standard deviation), medians (interquartile range) or frequencies
(percentage). Differences between categorical variables were
assessed by the chi-square or Fisher exact test when necessary.
Continuous variables were compared using the Student t test or
Mann–Whitney test, as appropriate. To determine which variables
were independently associated with one-year mortality, a backward
stepwise logistic regression analysis was performed. Variables with
p < 0.1 in the univariate analysis were introduced into the multi-
variate model. Continuous variables were categorized for this ana-
lysis using the observed mean in the overall cohort. A two-sided p
value of 0.05 or less was considered statistically significant.
RESULTS. During the study period, 342 LTx were performed and 84
LTx recipients required ICU readmission, with a total of 100 episodes.
Mean age was 53 (12) years and the mean APACHE II score was 16
(6). The main reason for ICU readmission was respiratory failure
(70%) and the main aetiology was lower respiratory tract infection
(LRTI) (59.6% of respiratory failure episodes). Fifty-four (64.3%) pa-
tients died during the follow-up period. APACHE II, SOFA at ICU re-
admission, need for MV during ICU stay, previous LRTI, presence of
chronic lung allograft dysfunction (CLAD) and reported FEV1(%)
value prior to ICU readmission were included in the multivariate lo-
gistic regression analysis. The model showed an association between
previous LRTI (OR 17.71 [95%CI 3.52 - 89.15]; p < 0.001), presence of
CLAD (OR 5.46 [95%CI 1.34 - 22.25]; p = 0.018), and need for MV dur-
ing ICU stay (OR 17.97 [95%CI 4.85 - 66.64]; p < 0.001). Thus, patients
diagnosed with LTRI and CLAD prior to ICU readmission and who
needed MV during their ICU stay had a predicted probability of one-
year mortality of 97%.
CONCLUSIONS. LTx patients who require ICU readmission present a
high risk of death during the following year. Previous LTRI and CLAD
as well as the need for MV during ICU stay are independent
predictors of one-year mortality.
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INTRODUCTION. Mannose-Binding Lectin (MBL) plays an important
role in the innate immune response. It can also contribute to a dele-
terious inflammatory response in mice infected with influenza A
(H1N1) virus (pdmH1N1) infection.
OBJECTIVES. Our aim was to determine whether baseline serum
levels of MBL at admission to ICU could predict mortality in ICU
patients with pdmH1N1 infection.
METHODS. Prospective observational study performed in ICU patients
with ARDS due to pdmH1N1 virus. Demographic characteristics and
severity indices were recorded at ICU admission. MBL was assayed from
blood drawn at H1N1 diagnosis. Outcomes were compared according
to MBL levels. Results are expressed as median and interquartile range.
RESULTS. MBL levels were studied in 27 patients (median age: 56
[29] years) with severe pdmH1N1 infection. Median admission SAPS II
and SOFA scores were 49 [26] and 12 [5], respectively. Thirty-day
mortality rate was 37% (n = 10/27). MBL was significantly higher in
non-survivors (3741ng/ml [2336]) vs survivors (215 ng/ml [1307]),
p = 0.005. MBL cut-off >1870ng/ml had a sensitivity of 80% and a
specificity of 88.2% for mortality (AUC = 0.82 (95%CI = 0.63-0.94)).
Kaplan-Meier analysis demonstrated a strong association between
MBL levels and mortality (logrank 7.8, p = 0.005). MBL > 1870ng/ml
was the only factor independently associated with mortality (ad-
justed HR = 8.7, 95%CI = 1.2-29.1, p = 0.007).
CONCLUSIONS. This study shows that baseline MBL > 1870ng/ml is
associated with higher mortality in ICU patients with severe pdmH1N1
infection.
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INTRODUCTION. In hemodynamically stable patients with acute
respiratory distress syndrome (ARDS), a conservative fluid
management strategy has been shown to improve lung function
and shorten the duration of mechanical ventilation (1). However
premature initiation of diuresis can increase non-pulmonary organ
failure such as acute kidney injury and there is no proven param-
eter or test to determine when or who to start diuresis. We hy-
pothesized that a patient who is "ready for diuresis" has a good
response in urine output to a small dose of furosemide.
OBJECTIVES. We investigated whether the urine output after a small
dose of furosemide predicts organ tolerability to negative fluid
balance (NFB) in acute respiratory failure.
METHODS. This study was a prospective observational study. All
mechanically ventilated and hemodynamically stable patients with
evaluations of hypervolemia for whom diuresis were planned were
included. A small amount of furosemide was administered (10mg for
eGFR > 50, 20mg for eGFR 30–50), and the urine output was examined
for 4 hours (a furosemide stress test; FST), which is a part of the
traditional practice in our hospital to predict tolerability to NFB although
no study has validated the practice. After a FST, the patients were
diuresed to achieve an NFB of more than 1000ml in 24 hours with
additional doses of furosemide as needed. The primary outcome of this
study was the tolerance to NFB. Tolerance to NFB was defined as
absence of hypotension, acute kidney injury, or need for fluid expansion.
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included in the intensive care unit at Tokyo Bay Urayasu/Ichikawa
medical center. 9 patients (75%) had a tolerance of NFB and
3(25%) patients did not have. The urine output following FST in
patients who did not have tolerance of NFB showed significantly
lower urine output than that of patients with tolerance to NFB in
the first 1 hour (p = 0.018). The area under the receiver operator
characteristic curves for the urine output in the first 1 hour
following FST to predict tolerance to NFB was 0.96 (p = 0.021). The
cutoff point of 120ml has the sensitivity of 0.89, and the specificity
of 1.00.
CONCLUSIONS. The furosemide stress test is a potential predictor of
tolerance to negative balance. Larger sample size is needed to
further determine the usefulness of the test.
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INTRODUCTION. Selenium is an important micronutrient implicated
in anti-oxidants enzymes modulation, incorporated in selenoproteins
and essential in oxidative defense. Glutathione peroxidases is a cru-
cial agent against oxidative stress associated with critical care condi-
tion. Inadequate Selenium intakes give rise to o wide spectrum of
disease and abnormal anti-oxidant activity.
OBJECTIVES. The hypothesis tested if abnormal nutritional status and
poor anti-oxidant capacity are implicated in bronchopneumonia
clinical evolution (considering acute respiratory distress syndrome
(ARDS) according to Berlin criteria).
METHODS. We enrolled 32 patients aged over 65 years old, with
bronchopneumonia and acute respiratory failure evaluated in
terms of body mass index (BMI), Selenium and glutathione
peroxidase levels.
RESULTS. Mean Selenium levels were different according to BMI
(patients having BMI under 20 had 48.50 ± 4.94 μg/L compared to
65.25 ± 15.46 μg/L Selenium level for normal BMI subjects).
Glutathione peroxidase level depends on BMI in a model adjusted
for Selenium level (p < 0.005). Subjects having low Selenium and
glutathione peroxidase levels had 2.5 higher risk for developing
ARDS (95% confidence interval [CI], 1.09 to 3.59; p < 0.001).
CONCLUSIONS. Selenium level might be a protective microelement
in critical care patients with bronchopneumonia. Abnormal
nutritional status is correlated with low anti-oxidant glutathione
peroxidase activity.
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Intensive Care Medicine Experimental 2017, 5(Suppl 2):0233BACKGROUND. COPD patients can develop respiratory acidosis
and metabolic alkalosis, the latter causing impaired ventilation.
Acetazolamide, a carbonic anhydrase inhibitor, can theoretically
stimulate breathing by inducing mild metabolic acidosis. This study
aims to determine safety and effectiveness of acetazolamide in
reducing the duration of mechanical ventilation, length of ICU stay and
mortality among COPD patients with hypercapnic respiratory failure.
METHODS. Various research databases were searched using predefined
MeSH terms. Unpublished data were obtained by correspondence with
authors. Studies selected are randomized clinical trials of COPD
patients with hypercapnic respiratory failure comparing acetazolamide
versus placebo measuring duration of mechanical ventilation, length of
intensive care unit stay and mortality, and arterial blood gas
parameters including change in pH, PaCO2, PaO2, and bicarbonate.
DATA ANALYSIS. Data were extracted and analyzed by two
independent reviewers. Continuous outcomes reported as mean
differences ± standard deviation and dichotomous outcomes as
relative risks using 95% confidence intervals.
RESULTS. Three randomized placebo-controlled trials were included in
the analysis, with a total of 499 patients (246 - acetazolamide; 251 - pla-
cebo). All trials have low risk of bias. A trend towards benefit with acet-
azolamide was seen in the duration of mechanical ventilation, length of
ICU stay, and all-cause mortality, but was not statistical significant.
There was no significant changes in pH and PaCO2, but produced a
mild improvement in PaO2 (MD = 0.48kPa; 95%CI 0.15,0.82; P = 0.004).
There was no statistically significant serious adverse effects.
CONCLUSIONS. A decrease in duration on mechanical ventilation,
days in the ICU, and all-cause mortality is seen with acetazolamide
use in COPD patients with ventilatory failure, but the small sample
sizes limited its statistical significance. Acetazolamide is not shown to
improve blood gas parameters apart from a small improvement in
oxygenation. Its use in such patients cannot be recommended yet
based on currently available data.
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INTRODUCTION. Severe asthma episodes leading to need for
mechanical ventilation are rarely seen in Slovenia due to efficient
national prevention strategies. Typically asthma worsening is seen
during winter months usually due to viral infections, especially
Respiratory Syncytial Virus (RSV). Muscular fatigue, hypercapnia and
severe hyperinflation are hallmarks of severe asthma. Mainstream
therapy consists of sedation, inhalation bronchodilator, steroids, fluid
management and bronchial lavage. Ventilator settings should include
moderately low respiratory rate (12–14 / min), low PEEP (3 cm H2O),
high inspiratory flow (!00 L/min) in order to relieve hyperinflation.
OBJECTIVES. We compared bronchodilatatory add on effects of
sevoflurane and propofll to fenoterol/ipratropium (F/I) in patients
ventilated because of severe asthma.
METHODS. We retrospectively analyzed 20 consecutive patients
admitted to our ICU with respiratory failure due to severe asthma, 10
sedated with propofol or sevoflurane (Anaconda, Sedana Medical).
Inspiratory and expiratory hold was performed while on volume
control ventilation with square flow pattern (90 L/min) and values for
Resistance (R), compliance (C) and intrinsic PEEP (PEEPi) obtained. All
patients received inhaled bronchodilator, steroids and antihistamines
in emergency department.
RESULTS. Admission values for C, R and PEEPi in sevoflurane group
were 35 ± 9, 25 ± 7 and 11 ± 4 respectively and in propofol group
42 ± 9, 27 ± 3 and 11 ± 4 respectively (p > 0.1). With F/I only R and
PEEPi decreased in both groups (20 ± 4 vs 21 ± 3, p = 0.04 and 6 ± 2
vs 8 ± 2, p = 0.02 respectively). In sevoflurane group C increased
(46 ± 8, p = 0.01), R and PEEPi decreased (13 ± 3, p = 0.003 and
6 ± 2, p = 0.02). Deep sedation (RAAS −5) was achieved with 3.3 ± 1
mg/kg/h propofol drip and 1.2 ± 0.3 vol% sevoflurane.
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 121 of 542CONCLUSIONS. When used in combination with fenoterol/
ipratorpium, sevoflurane ensures sufficient sedation level while
decreasing PEEPi and R in severe asthma. Propofol as a sedation
agent does not add to bronchodilation beyond fenoterol/ipratorpium
effect. Increase in C was seen in sevoflurane group only, probably
due to reduced lung hyperinflation.Fig. 94 (abstract 0234) Measurements0235
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INTRODUCTION. Cardiosurgical interventions are associated with
variable complications, affecting the main organs, including the
respiratory system [1]. Different pathophysiological changes lead to
variable clinical forms of acute respiratory failure (ARF) [2]. The main
reasons of ARF after open-heart cardiac surgery, are: acute respiratory
distress-syndrome (ARDS), cardiogenic pulmonary edema (CPE), ex-
acerbation of chronic obstructive pulmonary disease (COPD), pneu-
monia, pneumothorax and atelectasis [3].
OBJECTIVES. To evaluate ARF prevalence in cardiac surgery and
observe its main causes.
MATERIALS AND METHODS. A retrospective study included 8859
patients, who underwent open-heart cardiosurgical interventions in
Almazov North-West Federal Medical Research Centre from 2008 to
2012. The main inclusion criteria were the hypoxemia with PaO2/
FiO2 < 300 mmHg and prolonged mechanical ventilation after sur-
gery (>24 hours).
RESULTS. ARF developed in 377 cases (4.2%). The most common
clinical variant was ARDS - 159 patients (1.8% of all and 42.2% of
ARF). CPE occurred in 95 cases (1.1% of all patients and 25.2% of
ARF). Severe COPD exacerbations were registered in 43 patients
(0.49% of all population and 11.4% of ARF). 26 patients developed
pneumonia (0.3% of all and 6.9% of ARF). Atelectasis and
pneumothorax appeared both in 22 cases (0.25% of all and 5.8% of
ARF). 9 patients with ARF died (2.4%) and ARDS was the sole cause
of mortality.
We studied the severity of ARDS after cardiac surgery in accordance
with the Berlin definition (2012). The majority of ARDS cases were
mild - 107 (67.2% of ARDS population), moderate ARDS occured in
35 cases (22.0%) and severe ARDS developed in 17 patients (10.8%).
All-cases mortality in ARDS was 5.7%. Mortality rate was associatedwith the severity of ARDS. In mild ARDS population mortality was
2%, in moderate cases - 13%, and it was maximal in severe forms -
27.3%. There were no lethal cases, caused by uncontrolled hypox-
emia. All mortality cases were associated with multi-organ failure.
CONCLUSIONS. This study confirmed that ARDS is the main cause of
ARF in cardiosurgery. Severe ARDS continues to be associated with
high mortality.
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INTRODUCTION. Malposition of percutaneously inserted chest drains
(CD) is underestimated with a reported prevalence of 30% (1). As the
lung cross-section tapers in the cranial direction, a CD inserted for
pneumothorax drainage may turn cranially, laterally and ultimately
fall dorsally. As thus, an occult ventral pneumothorax may persist
particularly on mechanical ventilation.
OBJECTIVES. Retrospective study to assess several simple X-ray (CR)
parameters in diagnosing chest tube (CD) malposition inserted for
pneumothorax in non-trauma mechanically ventilated patients.
METHODS. Patients with a CD inserted to the pleural space from the
safe triangle with a subsequent CR and computerized tomography
(CT) scan performed for various reasons up to 24 hours apart were
assessed for CD foreshortening, angle of inclination of the CD and
CD tortuosity.
RESULTS. 28 patients were included in the study. The median time
between the CR and CT examinations was 5.4 hours (IQR3.8-6.9). The
angle of inclination above the horizontal line at pleural space entry
was the best marker of a misplaced CD with AUC 0.97(95%CI 0.83-
1.0, p < 0.0001), 100% sensitivity and 96% specificity for a cut-off
value of 50 degrees. CD tortuosity on single plane CR imaging was
higher in misplaced drains. Three patients with drains misplaced lat-
erally beyond axillary line had an occult ventral pneumothorax.
CONCLUSIONS. The steep angle of inclination of the CD above the
horizontal at chest entry measured on a CR should raise suspicion of
CD misplacement. Foreshortening of the CD requires additional
information like how much of the CD is actually inserted in the chest.
These CR signs herald further investigation by chest ultrasound to
rule out an occult pneumothorax not detected on a CR.
Reference
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OBJECTIVES. To evaluate clinical features, lab values, and outcome in
patients with scrub typhus and comparison in patients with or
without ARDS.
METHODS. Prospective observational study of 210 adult patients
with acute febrile illness admitted in MICU of tertiary hospital in
South India. Total of 198 patients suspected to have scrub typhus
were tested positive with Immune-chromatography test and higher
titres of weil felix test.Group A :110 out of 198 were patients having
either Immune-chromatography test/ Weil felix test positive. whereas
group B (88 out of 198) were negative for both Immune-
chromatography and Weil felix test were excluded. Clinical manifes-
tations, laboratory parameters, and outcome were evaluated in all
group A patients with scrub typhus. Statistical analysis done using
SPSSS version 10.0.
RESULTS. Among 110 group A patients who were included 65
patients had no ARDS and 45 patients had ARDS as per the Berlin
definition. Clinical presentations like shortness of breath, cough,
hypotension (MAP < 65 mmHg), and laboratory parameters like
Hemoglobin, Hematocrit(HCT),, worsening serum creatinine, serum
total bilirubin, serum Albumin(admission value), AST, ALT, LDH, CPK,
and serum lactate were statistically significant (P < 0.0001) in group
A patients. Group B patients recovered completely. Amongst group A
patients, 36 out of 45 recovered, 6 patients died and 3 were
discharged against medical advice.
CONCLUSIONS. Scrub typhus associated with ARDS has high
morbidity and mortality. Early diagnosis and treatment with
doxycycline is recommended.
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INTRODUCTION. COPD represents an important public health
challenge that is both preventable and treatable. Its treatment
success may be largely influenced by the proper implementation of
recommendations, such as Global Strategy for Diagnosis,
Management, and Prevention of COPD (GOLD 2011).
OBJECTIVES. To assess the frequency and the severity of
discrepancies, in reference to the 2011 GOLD recommendations, in
pharmacological treatment of stable COPD patients recruited upon
ICU admission for an acute exacerbation.
METHODS. A retrospective observational study conducted in an 8-
bed Tunisian medical ICU over a 6-years´ period (January 2011 to De-
cember 2016). Were included all consecutive patients admitted for
AE/COPD. Were described, patients´ past history characteristics and
at ICU admission and instrumental and pharmacological treatments.
GOLD 2011 stage, frequency and severity of discrepancies were
assessed using consensual two experts´ (JA, RB) definitions and
opinions.RESULTS. 314 patients were admitted for AE/COPD over the 6-years´
study period. They were 68.59 ± 10.8years aged, mainly men
281(89.5%). They presented severe clinical status attested by an
mMRC ≥ 2 in 268(85.4%) ; GOLD D 270(86%), frequent exacerbations
(≥3) in the last year 101(32.2%) with mean exacerbations episodes at
3.6 ± 3.6. Long term oxygen therapy and home mechanical ventila-
tion were respectively used in 56(18.5%) and 18(5.7%).
138(43.9%) patients were admitted in the ICU with a severe
hypercapnic encephalopathy. Mean pH, PaCO2 and bicarbonates
were respectively 7.31 ± 0.1 ; 59.8 ± 18.5mmHg and 31.4 ± 8.4mmol/
L. Mean SAPSII score was 32.5 ± 12. Firstline invasive mechanical
ventilation (IMV) was registered in 165(52.5%) patients. Mean length
of stay (LOS) was 10.9 ± 10.7days with mortality rate at 132(42%).
Pharmacological treatment including : Short acting beta agonists
(SABA), long acting beta agonists (LABA), inhaled corticosteroids
(ICS), long acting muscarinic agonists (LAMA), Theophyllin and LABA/
ICS combination were prescribed respectively in : 117(37.3%)
patients ; 16(5.1%) ; 68(21.7%) ; 15(4.8%) ; 33(10.5%) and 42(13.4%).
Only one patient benefited from rehabilitation. Discrepancies was
objectified in 261(83.1%) and were classified as severe in 165(52.5%)
patients.
CONCLUSIONS. In developing countries with low income, the
present study highlights the poor access of severe COPD patients to
health care system demonstrated by the huge discrepancies either in
frequency and in severity of recommended medication and over-
utilization of ICU´s facilities.
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INTRODUCTION. Elevation of NTproBNP in pathologies other than
heart disease, such as COPD, is related to prognosis. The elevation of
NTproBNP in these cases is due to the production of NTproBNP in
the right ventricle by the vasocontriction produced by hypoxia
OBJECTIVES. The aim of our study is to evaluate the relationship
between NTproBNP and the inhalation injury of burn patients.
METHODS. We conducted a three-year prospective cohort study of
84 consecutive critically burned patients with inhalation injury admit-
ted to a critical burn unit considered as a national burn reference
center.We used in all patients admitted to our unit with inhalation in-
jury, a resuscitation protocol guided by the parameters obtained with
transpulmonary thermodilution and tissue perfusion dataDemo-
graphic data, TBSA, severity scores, mechanical ventilation, length of
stay and mortality were collected, in addition to the data provided
by thermodilution and lactate value, troponin and NTproBNP.
RESULTS. During this period, 84 consecutive patients were admitted
with inhalation injuries, and the majority were men (75.6) with a
mean age (52.5.2 ± 17.5). The severity scores obtained were: ABSI
8.2 ± 2.8, Baux 80.5 ± 27.8, APACHE II 13.3 ± 6.8. 89.3% required VM.
The avarage stay was 25.5 ± 25.1 days and the mortality was 28.6%
With thermodilution we observed that patients who died had higher
cardiac dysfunction (with higher troponin and NTproBNP), higher
tissue hypoperfusion (elevated lactic) and a greater inflammatory
response with more altered permeability (elevations of ELWI).
Having a logistic regression with these values, the only factor that
was correlated with mortality was NTproBNP. Using as cutoff
point > 400 pg/ml, we found significant differences between both
groups (p 0.046). 71.4% of patients with inhalation injury who died
had a mean NTproBNP above this value.
CONCLUSIONS. In our study, NTproBNP is related to the mortality of
patients inhalation injury, with the optimum cutoff found at 400 pg /
dl. Possibly this is due to the cardiac dysfunction that is produced by
the initial aggression and hypoxia secondary to inhalation.
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INTRODUCTION. Respiratory Compromise is a state in which there is
a high likelihood of decompensation into respiratory insufficiency,
respiratory failure, unplanned admission to intensive care or death,
but in which early intervention might prevent decompensation.
OBJECTIVES. Our goal was to estimate the incidence and in-hospital
mortality of acute respiratory events for elective patients admitted
onto general wards in England.
METHODS. This is a retrospective analysis of the HES (Hospital
Episode Statistics) records of 1,162,807 elective admissions between
April 2015 and May 2016 to NHS hospitals in England. Descriptive
statistics were used to characterize incidence and distribution of
acute respiratory events. Acute events were pre-defined using
existing ICD-10 and OPCS codes for respiratory events. Statistical
techniques used were Welch t-test, Mann–Whitney test, ANOVA,
Chi-Squared test.
RESULTS. There were 25852 acute events and 3791 deaths reported,
representing 2.22% and 0.33% of the entire cohort. Adverse events
were significantly more common in those over 71 years of age;
(Welch t-test; p < 0.05). Opioid related events were reported in 1% of
all acute events.
Medicine and thoracic medicine had the highest number of acute
events at 4191 which accounted for 25% of the events in that
therapy area.
On surgical wards, 1656 events were reported for general surgery,
1482 for trauma and orthopedics accounting for over 60% of the
events in that therapy area.
OPCS Chapter K (Heart) had a significant higher number of events
per 100,000 procedures than all other OPCS Chapters (Mann–
Whitney; p < 0.05).
Comorbidities relating to codes used for resistant infection and
severe acute respiratory syndrome have the highest number of acute
events per 100,000 (n = 934) followed by diseases for respiratory
system (n = 676).Patient characteristics most strongly associated with adverse
respiratory events were age, primary hypertension, respiratory failure,
other diseases and ischemic heart failure.
CONCLUSIONS. Acute respiratory events on general wards in
England are relatively common and the incidence is similar to that
reported for US retrospective database analyses[1]. These events are
related to age, with those in their senior years more likely to suffer
an event. Multiple factors are associated with in-hospital events and
mortality and may suggest a need for better patient monitoring solu-
tions to detect respiratory compromise earlier.
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INTRODUCTION. Chest ultrasonography is a noninvasive and useful
tool for rapid diagnosis of lung abnormalities at bedside, especially
in emergency situations. For this reason, our institute set a 3-hour
lung ultrasound session for second and third year medical residents,
which was composed of 1-hour lecture and 2-hour hands on work-
shop. However, this learning program might not improve their com-
petency in using ultrasound in real clinical practice.
OBJECTIVES. We aimed to evaluate the competency of medicine
residents in using ultrasound to detect lung abnormalities at 6
months after they attended the lung ultrasound session and
surveyed the number of their experience cases.
METHODS. Four cadaveric models, including pneumothorax,
atelectasis, consolidation and pleural effusion were created. All
cadavers were assisted with mechanical ventilation. The medicine
residents had 10 minutes per the model to perform ultrasound,
describe lung abnormalities and make final diagnoses. Additionally,
the numbers of residents' experience cases were surveyed.
RESULTS. Fifty-six residents were enrolled to our study. The median
number of lung ultrasound examination was 2[1,4] cases per month.
The majority (66-82%) of them had never performed ultrasound to
detect pneumothorax, atelectasis or consolidation while 60% of them
had experience in using ultrasound to detect pleural effusion for at
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 124 of 542least 5 cases. Approximately, 84% of the residents correctly detected
pneumothorax, however 45% of them used nonspecific signs to
make diagnosis. Around 27% and 34% of the residents accurately di-
agnosed atelectasis and consolidation, nevertheless only 7% and
21% described correct signs of atelectasis and consolidation, respect-
ively. Most of the residents made diagnosis of pneumothorax, atelec-
tasis and consolidation based on inadequate information. Besides,
only 50% of the residents detected small and loculated pleural effu-
sion. Due to variable and small numbers of experience cases, compe-
tency in using lung ultrasound to detect the abnormalities was not
associated with the residents' experience.
CONCLUSIONS. The medicine residents had the highest skill to
detect pneumothorax by ultrasound, compared with the diagnosis of
atelectasis, consolidation and pleural effusion. However, due to the
fact that a large number of them made the diagnosis by non-
pathognomonic signs and inadequate information, competency in
using ultrasound to detect lung abnormalities might be lower than
these findings. Thus, we need to provide more effective strategies to
improve this competency.
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INTRODUCTION. The most efficient learning process consists of
supporting traditional teaching with e-learning methods. Classes con-
ducted in traditional educational institutions are complemented with
virtual labs. Teachers provide a variety of materials, guidelines and in-
structions using distance learning techniques. This method works
well for those who do not fully understand a particular part of the
material. By learning in blended mode, a learner is able to revise and
consolidate individual issues.
OBJECTIVES. Show a blended learning enviroment as an innovative
medical education technique for critical ultrasound point of care
teaching.
METHODS. Observative, prospective, transversal study of three
months in a blended learning environment.
RESULTS. 120 students; 96% from Mexico, 1.01% from Peru, 1.01%
from Ecuador and 1.01% from Guatemala. There were 13 modules on
line with different formative evaluation skills. Forums (40% of final
evaluation), integrated activities (30% of final evaluation),
questionnaires (20% of final evaluation) and a final test (10% of the
final grade) The sumative evaluation was made of these percentages
plus the assistance of the students to the six presencial modules at
the Hospital. There were a 10% of students who gave up the course,
the final grades for forums were 39.52%, these also included a space
where students could put their scanning ultrasound images and the
professor could grade them and give their own opinion. The final
grades for integrated activities were 28.4%, the final grade for
questionnaires was 19.09% and the total final grades of the entire
course was of 99.52%. Satisfaction of the students was measured
with a grading score showing that 93% of the students were
satisfied with the course and the results in ther education. We also
measured if students continued to use ultrasound after ending the
course. 37% continued to use ultrasound in ther units and 20%
bought and ultrasound equipment.
CONCLUSIONS. The blended environment permited evaluation of
the students in different areas as forums, integrative activities and
skill evaluations. Basing on the satisfaction of the students we
conclude that the use of this environment allows students to learnproperly ultrasound point of care techniques. However only a small
percentage continue to use ultrasound perhaps of the lack of
interest of hospital directions; other students bought ultrasounds so
they could continue performing.
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INTRODUCTION. Electrical impedance tomography (EIT) can trace
ventilation and perfusion related changes in electrical properties of
lung tissue. So far, the ability of EIT to assess lung perfusion has
been examined experimentally by electron-beam and single-photon-
emission computerized tomography (CT) in healthy or globally in-
jured lungs [1,2].
OBJECTIVES. To validate EIT measurements of regional perfusion by
dynamic CT in two animal models of regional sublobar ARDS.
METHODS. The study was approved by the University of Iowa
Committee for Animal Care. Regional lung injury was induced in two
adjacent sublobar segments of the right lung by repetitive saline
lavage (N = 3) or endotoxin injury (N = 5) in anesthetized
mechanically ventilated pigs (33 ± 2 kg). EIT measurements (Goe-MF
II, CareFusion, Höchberg, Germany) were performed at 25 scans/s
during a breath-hold and subsequent bolus injection of 0.45 ml/kg
5.8% saline via a right ventricle catheter. EIT scans were generated
using a FEM based linearized Newton–Raphson reconstruction algo-
rithm. To determine pulmonary blood flow (PBF) via CT, axial (4 cm
z-axis) ECG-gated dynamic CT (80 kV, 150 mAs, 0.75 mm section
thickness, 0.5 mm increments, 0.28s rotation time, 25 time points,
~4.2 mSv) was performed during breath-hold after right ventricular
injection of iodinated contrast agent (0.5 mL/kg over 2 s). PBF was
estimated both in CT and EIT data based on the indicator dilution
theory [3] and compared by Spearman correlation and Bland-Altman
analysis. For CT calculations, the necessary arterial input function
(AIF) was determined within the automatically segmented left and
right pulmonary artery. AIF for EIT perfusion estimation was chosen
within the right ventricle. The influence of the right cardiac region
on regional PBF was removed by image post-processing.
RESULTS. PBF estimated by dynamic CT was compared to PBF
obtained by EIT. For CT, PBF within the lung volume was projected
onto a cross-section to enable comparison with the 2D EIT image.
Further, regional distribution of PBF was compared within four quad-
rants respecting the centroid of the segmented lungs. In each of the
quadrants relative perfusion with respect to overall PBF was used for
comparison. The estimated regional perfusion distributions from CT
Fig. 97 (abstract 0244) Custom-made system
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jured lung regions (r2 = 0.88). EIT slightly overestimated PBF within
the ventral quadrants likely caused by incomplete heart region re-
moval during calculation.
CONCLUSIONS. EIT is able to monitor regional pulmonary perfusion
using a saline bolus. The perfusion estimation algorithm will be
extended in future research to better account for the right cardiac
phase of the bolus.
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INTRODUCTION. Muscular atrophy is frequent in ICU patients and is
associated with increased mortality and long term muscle weakness.
Bedside ultrasound has been proposed to assess muscle atrophy.
This tool has not been validated in ICU patients yet.
OBJECTIVES. The objective of this prospective observational study
was to compare the agreement between 2D ultrasound and 2D CT-
scan for the measurement of thigh quadriceps muscle thickness.
METHODS. Consecutive patients admitted in our neuro ICU were
included if they presented a Glasgow score ≤ 8 at admission,
required mechanical ventilation and were scheduled for repeated
follow-up CT scans of the brain. A written informed consent was ob-
tained from patient next-of-kin before study enrollment.
Muscle thickness was measured 15cm above the upper edge of the
patella perpendicular to the patella- anterior superior iliac spine axis.
A landmark was drawn on the skin with a permanent marker.
Iterative brain CT scans were associated with a quadriceps-centered
acquisition sequence. Concomitantly, an ultrasound of the quadri-
ceps was performed. The position of the leg was standardized for
both technics. A custom-made system was developed to enable a
precise and ergonomic positioning of the US transducer. (Fig. 97).
A maximum of three cerebral-CTs coupled with quadriceps imaging
were performed between ICU admission and the tenth day of
hospitalization. The thickness of the quadriceps was measured by an
independent operator on the CT and ultrasound sections. We calcu-
lated that 38 patients were necessary to show a different between
both technics.
RESULTS. Patients were included from August 2015 to December
2016, and 86 measurements of US and CT quadriceps thickness were
compared. The agreement between these two techniques was very
good as shown by the correlation coefficient (R2 = 0.86) and the
Intra-Class Correlation index of 0.96 (95% CI: 0.93-0.97). We also ob-
served a very good intra-operator reproducibility and inter-operator
variability.
CONCLUSIONS. We show for the first time in an ICU population that
the US set up used here for quadriceps thickness measurement is
reliable and reproducible.
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INTRODUCTION. The cardiogenic pulmonary edema (CPE) and the
acute respiratory distress syndrome (ARDS) are both characterized by
an increase in extravascular lung water. Computed tomography (CT)
provides not only a morphological but also a quantitative description
of the lung [1].
OBJECTIVES. Aim of this study was to evaluate the quantitative CT
findings in CPE and ARDS patients during the early phase.
METHODS. 60 ARDS (mild, moderate and severe) and 20 CPE
patients were enrolled. The amount of not inflated tissue, well
inflated tissue and edema were computed with a dedicated software
along the sterno-vertebral axis [2]. The edema was estimated as the
difference of lung weight measured with CT scan and the one pre-
dicted from the patient height [3].
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 126 of 542RESULTS. Considering both CPE and ARDS groups moving from the
non-dependent to the dependent lung regions, the not inflated lung
tissue significantly increased while the well inflated lung tissue
decreased. Significant differences were found between CPE and
ARDS mostly in dependent regions. In CPE, the estimated edema
was significantly lower than in severe ARDS (532 ± 637 vs
757 ± 740g) but higher compared to moderate and mild ARDS
(385 ± 673 and 447 ± 525g).
CONCLUSIONS. Although CPE has a lower and higher amount of not
inflated and well inflated tissue compared to severe ARDS, the
overall regional distribution of these tissues is similar within the lung.
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[1] M. Zompatori, F. Ciccarese, e L. Fasano, «Overview of current lung
imaging in acute respiratory distress syndrome», Eur. Respir. Rev. Off.
J. Eur. Respir. Soc., vol. 23, n. 134, pagg. 519–530, dic. 2014.
[2] L. Gattinoni, A. Pesenti, L. Avalli, F. Rossi, e M. Bombino, «Pressure-
volume curve of total respiratory system in acute respiratory failure.
Computed tomographic scan study», Am. Rev. Respir. Dis., vol. 136, n.
3, pagg. 730–736, set. 1987.
[3] M. Cressoni et al., «Limits of normality of quantitative thoracic CT
analysis», Crit. Care Lond. Engl., vol. 17, n. 3, pag. R93, mag. 2013.
GRANT ACKNOWLEDGMENT
NoneTable 74 (Abstract 0245). Lung aeration computed by CT in ARDS and
CPE
ARDS Mild
(n=20)
ARDS
Moderate
(n=20)
ARDS
Severe
(n=20)
CPE
(n=20)
p
Not inflated lung
tissue (%)
37±13 41±17c 53±14b,c 33
±20a,b,c
<0.0001
• Non- dependent
regions
7±11 8±10 13±13b,c 10±14 <0.001
• Intermediate
regions
16±21 24±22c 40±25b,c 22±21a <0.0001
• Dependent
regions
63±31 63±31 78±22b,c 49
±34a,b,c
<0.0001
Well inflated lung
tissue (%)
32±12 23±12c 14±8b,c 37
±21a,b,c
<0.0001
• Non- dependent 64±19 49±22c 42±21b,c 58
±24a,b
<0.0001
• Intermediate
regions
47±25 34±25c 17±16b,c 45
±25a,b
<0.0001
• Dependent
regions
13±18 8±12 4±6c 24
±28a,b,c
<0.0001
Table 75 (Abstract 0245). Estimated edema computed by CT in CPE
and ARDS
ARDS Mild
(n=20)
ARDS
Moderate
(n=20)
ARDS Severe
(n=20)
CPE
(n=20)
p
Estimated edema
(g)
447±525 385±673 757±740b,c 532
±637a,b
<0.0001
• Non-dependent
regions
8±6 18±19c 25±20b,c 13±15a <0.0001
• Intermediate
regions
17±12 36±33c 55±45b,c 31±35a,c <0.0001
• Dependent regions 23±15 45±41c 65±47b,c 40±52a,c <0.0001
Fig. 98 (abstract 0245) Regional distribution of aeration and edema0246
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Fig. 99 (abstract 0247). See text for description
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infection. It is characterized by a systemic inflammatory reaction with
varying degrees of organ dysfunction. Myocardial dysfunction
has a cumulative effect on sepsis-related mortality[1]. Hence,
echocardiography-Doppler remains essential for the assessment
of myocardial function in severe sepsis and septic shock. More
recently, a new imaging modality is coming into clinical focus
called speckle tracking imaging (STE)[2].
OBJECTIVES. The aim of our study is to investigate left ventricular
dysfunction in patients with severe sepsis or septic shock by
comparing standard echocardiography-based indices and STE as well
as their prognostic implications.
METHODS. we prospectively included 30 consecutive adult patients
(age > =18 years old) admitted to the intensive care unit of military
hospital of Tunis within 48 hours of diagnosis of severe sepsis or
septic shock. Standard trans-thoracic echocardiography and left ven-
tricular STE imaging were performed within 48 hours of sepsis
onset(D1). They were reassessed after 48 hours (D3) and 7 days
(D7)in survival patients. Troponion T high sensitive (ThT-hs) measure-
ment was performed on D1 of sepsis onset and reassessed on D3
and D7 in survival patients. All hypertensive patients, those with
known cardiovascular disease and post operative cardiac surgery pa-
tients were not included in the study.
RESULTS. There was no difference in age, heart rate, systolic and
diastolic blood pressure, vasoactive medication, ThT-hs levels and left
ventricular ejection fraction between survival group and non survival
group. However, survivor patients dilated their left ventricule in the
early phase of sepsis (survival group vs non survival group respect-
ively on D3 and D7 of sepsis onset: D3: 47.63 ± 4.17vs 44 ± 3.84,
p = 0.031/ D7: 49.6 ± 4.4 vs44.15 ± 4.56, p = 0.009). Left ventricular
filling pressure assessed by E/e' ratio were high in the two groups of
patients in D1 of sepsis onset. However, E/e' ratio decline in survival
group and remains high in non survival group with a statistically sig-
nificant result on D7 of sepsis onset (survival group vs non survival
group: D1: E/e': 10.42 ± 5.48 vs 9.97 ± 3.71 p = 0.8/ D7 E/e':
8.27 ± 3.84 vs12.06 ± 2.55 p = 0.018). The global longitudinal peak
systolic strain GLPSS in survival group was higher in D3 and D7 of
sepsis onset (survival group vs non survival group GLPSS D3:
−18.44% ± 3.37 vs −14.68% ±4.03, p = 0,013/ GLPSS D7:
−17.74% ± 4.53 vs −11.75% ± 4.34,p = 0,005).
CONCLUSIONS. Speckle tracking echocardiography could be an
important parameter for evaluating LV function that would detect
cardiac dysfunction at an early stage of the disease in septic patients.
REFERENCE(S)
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INTRODUCTION. Bedside ultrasound measurement has previously
been used to quantify muscle layer thickness at the quadriceps
muscle. Tillquist et al.1 showed that the technique had excellent intra
and inter-reliability when used to assess healthy volunteers.
OBJECTIVES. To evaluate the intra and inter-reliability of measuring
QMLT using bedside ultrasound.METHODS. The study was approved by the ethics committee of
Hospital Israelita Albert Einstein. We conducted a prospective
observational study of measuring quadriceps muscle layer thickness
(QMLT) in healthy volunteers. The thickness of the quadriceps
musculature was quantified with a portable B-mode ultrasound de-
vice with volunteer in the lying supine position with knees extended
and relaxed, 2 landmarks on each quadriceps were identified and
marked. QMLT was calculated by measuring at the border between
the lower third and upper two-thirds between the anterior superior
iliac spine (ASIS) and the upper pole of the patella, as well as the
measurement of the midpoint between the ASIS and the upper pole
of the patella (Fig. 99). The muscle thickness was quantified as the
distance between the upper margin of the femoral bone and the
lower boundary of the deep fascia of the femoral rectus muscle (Fig.
100). To standardize measurements, a procedural manual and an ac-
companying training with practical lessons were held with load time
of 6 hours for the team's training. Trainer were 1 physician with ad-
vanced training in bedside ultrasound. Trainees were comprised of 3
dietitians, 2 physician, 1 physiotherapists the majority with no prior
ultrasound experience. To validate the image collection by the quad-
riceps muscle ultrasound measurements were performed in two
healthy volunteers of different gender comparing between trainer
and trainees and between trainees.
RESULTS. Total 16 samples were examinations by trainer in the
procedure and compared the same exams for trainees. The Person's
correlation was found relation between trainer and trainees with
r2 > 0.90 (Fig. 101). The better association was between trainer and
dietitians with r2 of 0.99 P < 0.001 and the relation between trainer and
physicians was r2 to 0.92 P < 0.001. In comparison to Bland Altman,
evaluating the tests made by the trainer and the trainees, the highest
percentage of error was 5.12% (IC 95% 3.64 -12.37) and the lowest was
1.01% (CI 95% 0.72 -2.58), on the other hand the highest bias of the
values described was −0,12 ± 0,19 and smallest was −0,01 ± 0,04.
CONCLUSION. The data analyzed showed an excellent correlation of
measures between trainer and trainees. Therefore, this analysis
shows that the exam is feasible and easy application for all
professionals involved in the treatment of patients may present
nutritional deficits and loss of muscle mass.
Reference
1. Tillquist et al. Bedside Ultrasound Is a Practical and Reliable Measurement
Tool for Assessing Quadriceps Muscle Layer Thickness. JPEN J Parenter
Enteral Nutr.2014; 38:886–890).
Fig. 100 (abstract 0247) See text for description
Fig. 101 (abstract 0247) See text for description
Table 76 (Abstract 0248). Comparison between X-ray & USI exam of GIT
Barium-contrast X-ray USI
Intestinal lumen diameter - +++
Intestinal wall thickness — +++
Nature of peristalsis
(Active, decelerated, absent)
0 +++
Contents in GIT - +++
Presence of free fluid
in abdomen
0 +++
Intestinal microcirculation 0 +++
Used to just state
presence/absence
of IF
Used to evaluate stage
of IF,condition of GIT for
further Intensive Therapy &
Enteral Feeding correction
Well observed: +++, Poorly observed: -, Very poorly observed: —, Cannot be
observed: 0
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INTRODUCTION. Gastrointestinal Failure (GIF) is frequent early
postoperative(PO) period complication after abdominal surgery,
characterized by impaired motor, secretory, absorptive, barrier
function of gastrointestinal tract (GIT), usually develops as result of
sudden disturbance in abdomen leading to severe water-electrolyte
imbalance, if untreated leads to Abdominal Compartment Syndrome,
ultimately multi-organ failure. Common diagnostic method is
barium-contrast X-ray but unfortunately is less informative & doesn´t
allow monitoring of intestinal condition to observe changes in real
time. We tried to adopt Ultrasound Imaging (USI) as diagnostics
method allowing better evaluation of gut condition.OBJECTIVES. Observing intestinal wall structural changes, nature of
intestinal peristalsis after abdominal surgery using X-ray & USI.
METHODS. 70 PO patients after major abdominal surgeries. All
patients were examined with X-ray & USI to observe intestinal lumen
diameter, wall thickness, nature of peristalsis, amount of contents in
GIT, free fluid in abdomen, intestinal microcirculation.
RESULTS. Comparison of both diagnostic methods, we observed:
(1) 26 patients couldn't undergo x-ray examination due to unstable
condition, unfit for transportation to X-ray room,
(2) All 70 patients underwent USI,
(3) 44 patients underwent x-ray exam & USI. It was observed that
USI was more informative,
(4) 24 patients had pneumatised intestines in x-ray films, 20
patients had air-fluid levels showing insufficient information
for deciding further treatment tactics.
(5) Using X-ray exam except for air-fluid levels, any other details
weren't possible to detect. Whereas USI 38(54%) patients lumen
diameter < 3cm with unchanged peristalsis proving 1st stage GIF,
22(31%) patients lumen diameter < 4cm, slightly edematous in-
testinal wall, decelerated peristalsis shows 2ndstage GIF, 10(14%)
patients with lumen diameter > 4 cm, intestinal wall > 4 mm with
large amount of gastric-stasis shows 3rdstage GIF
CONCLUSIONS. Detailed USI information helps recognize GIF stage &
treatment options which is difficult using x-ray exam due to lack of
information. X-ray is difficult in early PO since patients need to as-
sume vertical position, consume oral contrast unlike in USI, special
positioning isn't required & is bed-side technique which doesn´t re-
quire transportation of unstable patients allowing evaluation of intes-
tinal wall condition, motor activity in real-time & thus, it's advisable
to be used as first-line diagnostic method of IF
REFERENCE(S)
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Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 129 of 542INTRODUCTION. So far, no study has specifically investigated the
precision of transthoracic echocardiography (TTE) in the intensive
care unit, i.e. how close repeated measurements are to each other.
We had two objectives: (1) to determine the least significant change
(LSC) of various measurements when the TTE probe is kept in the
same position. This allowed us to determine how many
measurements should be averaged within a TTE examination, (2) to
determine the LSC of these measurements between two
examinations. This allowed us to determine the least change that
can be considered as significant between two TTE examinations
performed at different times by the same operator.
METHODS. Two successive TTE examinations were performed by a
board certified operator in 100 hemodynamically stable patients (age
67 ± 16 y.o., 54% under invasive mechanical ventilation, 16% with
atrial fibrillation). Within each TTE examination, all measurements
were performed at end-expiration, the probe being kept in the same
position. We investigated the velocity time-integral of the subaortic
flow (VTI), the ratio of the early peak velocity of transmitral flow over
the early diastolic peak velocity of the lateral mitral annulus (E/e' ra-
tio), the left ventricular ejection fraction (LVEF), the ratio of the end-
diastolic right over left ventricular areas (RVEDA/LVEDA) and the tri-
cuspid annular plane systolic excursion (TAPSE).
RESULTS. When the probe was kept in the same position, i.e. within
one TTE examination, the LSC of VTI was 9[25-75% interquartile: 5–
15]% when only one single measurement was performed. It dropped
to 5[3–9]% if three measurements were averaged. In these
conditions, the LSC was close to 10% for all others measurements.
The LSC of VTI was higher in patients with atrial fibrillation (12[4–
17]%) than in the other ones (5[3–8]%, p = 0.007). There was no
significant difference in the LSC of VTI between patients with and
without invasive mechanical ventilation. Similar results were found
for TAPSE. No difference was observed for the other measurements
between subgroups of patients. Between the two TTE examinations,
the LSC of VTI was 11[5–18]%, 8[4–15]% for LVEF and close to 20%
for the other studied variables. Whatever the measurements, the LSC
was similar between subgroups of patients with and without atrial
fibrillation and between subgroups of patients with and without
invasive mechanical ventilation.
CONCLUSIONS. Averaging three measurements within one TTE
examination is enough for obtaining an acceptable LSC for TTE
measurements. Between two examinations, one can rely on changes
larger for 11% for VTI, 8% for LVEF and 20% for other usual variables.
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INTRODUCTION. Tachypnea is single most indicator of critical illness.
The causes of tachypnea vary from lung parenchyma disorders,
airway disorders, pulmonary vascular disorders, cardiac disorders and
metabolic disorders. Each and every tachypnoeic patient doesn't
need intubation. Furthermore an ABG analysis is immediately done
in ICU, by which we assess respiratory & metabolic parameters of the
patient. But ABG doesn't localize the cause of tachypnea, hence
doesn't define definite treatment. We combined this parameter with
LUS which is readily available as bedside tool in ICU, to localize the
cause of tachypnea. Once the cause of tachypnea is localized,
definite treatment could be initiated early.
OBJECTIVES. The objective of this study was to classify tachypnoeic
patient and to evaluate outcome variables on the basis of LUS and
arterial blood gas (ABG) findings.
METHODS. It was a retrospective chart based review in which all
tachypnoeic patients admitted in ICU were enrolled. On the basis of
LUS (presence of A- lines/ B-Lines) and ABG (Hypoxia/Hypercarbia)
patients were classified into six groups:a) Airway disorder
b) Perfusion disorder
c) Metabolic disorder
d) Airway and Alveolar disorder
e) Pulmonary edema
f) Pneumonia.
The patient's demographic data, SOFA score, need for intubation,
vasopressor and central venous catheter, form of mechanical
ventilation, ICU outcome and length of stay were noted.
RESULTS. There were 8 patients with airway disorder, 4 with
perfusion, 83 with metabolic, 16 with airway & alveolar disorder, 46
with pulmonary edema and 87 with pneumonia. The median age
was 55 (6–93) years in our study. The median SOFA score was 7(1–
18). 12.5% patients with airway disorder, 50% with perfusion, 14.5%
with metabolic, 56.3% with airway and alveolar, 21.7% with
pulmonary edema and 60.9% patients with pneumonia were
intubated (p < 0.0001). Non-invasive ventilation (NIV) was required in
87.5% of patients with airway disorder, 3.6% with metabolic, 37.5%
with ventilation & alveolar, 43.5% with cardiac, 9.2% with pneumo-
nia(p < 0.0001). We had maximum mortality in patients with pneu-
monias (21.7%) followed by metabolic (10.8%), pulmonary edema
(8.7%) and in patients with airway disorder it was nil (p < 0.0001).
CONCLUSIONS. This classification gives an organized approach in
managing patients with tachypnea. It predicts the need for
intubation/ mechanical ventilation early on. It also predicts that
patients with pneumonia are most sick of all the six groups and
needs immediate intervention.
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BACKGROUND. Despite Chest radiography (CXR) is the preferred tool
for lung imaging and a cornerstone for the diagnosis of pneumonia,
the diagnostic accuracy is 65% when compared with CT scan (1). CT
scan is the diagnostic gold standard. Because of high radiation dose
and high cost, it is not used routinely as diagnostic procedure of
patients with suspected pneumonia in ICU (2).
AIM. To assess the role of bedside lung ultrasound examination by
the critical care physician in the diagnosis of acute pneumonia in
ICU, in comparison with CXR and CT chest.
MATERIAL AND METHODS. This is an observational, prospective and
single-center study conducted between October 2015 and October
2016 in the intensive care unit of Ahamdi general hospital. The Lung
ultrasound examination (LUS) was performed by trained critical care
physicians, and a chest radiograph was interpreted by another critical
care physician blinded to LUS result. CT scans were obtained when
considered clinically indicated by the senior physician in charge of
the patient. The final diagnosis of pneumonia was made by physi-
cians in charge of the patients, on the basis of the clinical presenta-
tions, radiological examinations, clinical evolution, markers of
inflammation and microbiology (3).
RESULTS. We studied 92 patients and 73 confirmed pneumonia
(79.3%): 34 (36.6%) males with a mean age of 68.3 years (SD, 13.56).
Eleven (15%) patients were community acquired pneumonia 64
(85%) were hospital acquired pneumonia. In the group of confirmed
pneumonia, we had 72 (98.6%) positive LUS and 40 (54.8%) positive
Table 77 (Abstract 0252). Results
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the specificity and sensitivity of CXR were 63% and 54.7%, while in LUS
84% and 9806% respectively (Table 2). A chest CT scan was performed
in 38 of the 93 enrolled patients and was diagnostic for pneumonia in
32 cases. LUS was positive in 31 of 32 patients with CT confirmed
pneumonia and CXR was positive in 5 of 32 patients with CT confirmed
pneumonia. Sensitivity and specificity of LUS were 96.9% and 83%,
while in CXR were 15.6 and 16.6% in relation to CT chest (Table 3).
We could perform a complete LUS examination (scanning anterior,
lateral and posterior chest wall) in all the patients.
CONCLUSION. Bedside lung ultrasound is a reliable and accurate tool
for diagnosing pneumonia in the ICU setting, and superior to CXR. It
allows a faster, non-invasive and without radiation tool for the diag-
nosis of pneumonia in the ICU.
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INTRODUCTION. Current literature suggests that diaphragm
ultrasound (DUS) could be a useful and accurate tool to detect
diaphragmatic dysfunction in critically ill patients to predict
extubation success, monitoring, respiratory workload and assessing
atrophy in mechanically ventilated patients. On the other hand, there
is an increasing body of evidence comparing the diagnostic accuracy
of the pocket-sized ultrasonography devices (PSUD) with standard,
high quality ones suggesting that they may be safely used to en-
hance the diagnostic accuracy of cardiovascular examination and
proposed their use in various clinical settings such as emergency de-
partment, intensive care units and outpatient clinics.
OBJECTIVES. Aim of this study is to compare measurement accuracy
of (PSUD) with high end ultrasound device (HEUD) in the
measurement of diaphragm thickness(DT) and excurtion(DE) in ICU
patients.
METHODS. Ultrasonographic evaluation was performed using Vivid-Q
and V-Scan (GE, Fairfield, CT) devices with linear and sector probes.
Diaphragmatic thickness was measured in B mode in two devices
and excurtion was measured in M-Mode(MM) in HEUD. Because
PSUD does not have MM DE's were measured using the scale on the
right side of the screen on cineloop records. Blant - Altman statistical
method was used for bias and agrement determination.
RESULTS. Twenty-six patients were included in the study and all of
them had respiratory failure. Seven (27%) of them were intubated
and 12(46%) of them were receiving nononinvasive mechanical ven-
tilation therapy. In all patients diaphragm images were acquired with
both devices and there was a paradox movement in 2 patients. The
Bland-Altman analysis revealed that the width of the 95% limits of
agreement were similar in both devices.
CONCLUSIONS. Pocket sized ultrasound devices may be very reliable
in the evaluation of diaphragm thickness and excurtion in the ICU.
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INTRODUCTION. After insertion of a central venous catheter, its correct
placement has to be confirmed and complications ruled out. The proper
placement in the vena cava is usually assumed with correct projection in
the chest radiograph. To reduce unnecessary radiation exposure, an
alternative ECG-based approach has been suggested. Since this method
is only reliable with sinus rhythm, it cannot be applied in patients with
atrial fibrillation. We present here a novel approach for confirmation of
proper catheter placement using ultrasound offering a safe alternative
method even in this specific group of patients.
OBJECTIVES. The aim of this study was to visualize the j-wire in the
vena cava using ultrasound with two acoustic windows. Additionally,
an estimation of the correct length of insertion was examined.
METHODS. 100 critically ill patients (29 women, 65 men; mean age
66 ± 14yr) requiring a central venous catheter were examined. The
vena cava was visualized from the right body side through the liver
or the subcostal window displaying the heart with the connection of
the vena cava to the right atrium. In the last 48 patients of our study
population, the disappearance of the j-wire from the acoustic win-
dow was used to estimate the appropriate inserted length of the
catheter. The patients´ examinations were performed using the vivid
S6 with a sector scanner (M4S-RS, 1.5 to 3.6 MHz; GE Healthcare,
Munich, Germany). They were carried out during the insertion of the
j-wire before dilatation and insertion of the catheter.
RESULTS. After excluding duplicate examinations, 94 patients could
be analysed. The j-wire was correctly identified in the vena cava or
the right atrium in 91 patients. In one patient, where no wire was
seen, the catheter was inserted in the wrong way. In two patients,
the j-wire could not be identified although the catheter was later
shown to be placed correctly according to the X-ray. The examin-
ation of the inserted length of the catheter in 48 patients revealed
the following: in 42 patients, the catheter was correctly placed in the
vena cava superior, in 4 patients, in the vena anonyma and in 2 pa-
tients, the disappearance of the j-wire could not be identified. No
catheter was advanced into the right ventricle in our study patients.
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 131 of 542CONCLUSIONS. Identification of the j-wire in the vena cava or the
right atrium with ultrasound verifies the proper intravascular place-
ment and direction of catheter insertion as confirmed in nearly all
our patients. The appropriate length of the inserted catheter was also
correctly estimated. Since complications like pneumothorax and hae-
mothorax can also be ruled out with ultrasound [1], radiological X-
ray examinations would only be needed in the very few cases where
the ultrasound approach fails.
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INTRODUCTION. The use of ultrasounds in the intensive care units
has increased in the last decades due to an easy learn & use, great
accessibility, low cost and especially non invasive technique.
Nowadays, has become relevant the use of diaphragmatic ultrasound
to evaluate the patients response under invasive mechanical
ventilation and to guide the weaning process and safe artificial
airway removal avoiding re-intubation and thus, morbimortality.
OBJECTIVES. To describe the intraclass correlation index of
diaphragmatic movement in healthy volunteers measured by
ultrasound and between two intensive care physicians randomly
selected in a university intensive care unit hospital.
METHODS. Prospective study in which we registered 19 volunteers
from in 2 months (August and September 2016). An ultrasound
video of the right diaphragm was made in everyone of them by a
third professional not involved in the final measures. Afterwards, two
ICU professionals were randomly selected to measure diaphragmatic
movement as described in the literature. At the end, an intraclass
correlation index of the results was analyzed.
RESULTS. From the 19 volunteers none was withdrown. None of the
ICU physicians were prior trained in diaphragmatic ultrasound and
the measures were made blind and independently in two different
days. From all measures, the intraclass correlation index was 0.923
with a 95% CI (0,83 - 0.96).
CONCLUSIONS. Measurement of the diaphragmatic kinetics in the
critical care units is a feasible and reproducible technique that might
be part of the dairy practice in intensive care units.
Perioperative intensive care: General
0255
Early detection of lung congestion in pre-eclampsia using lung
ultrasound and electrical cardiometry
Y. Hammad, A. Omran, A. Refaie, A. El-Sakka, A. Lotfy, A. Hasanin, A.
Kamal, H. Mostafa
Kasralainy Faculty of Medicine, Cairo University, Cairo, Egypt
Correspondence: Y. Hammad
Intensive Care Medicine Experimental 2017, 5(Suppl 2):0255
INTRODUCTION. Pre-eclampsia is a common pregnancy syndrome
associated with poor maternal outcomes. Acute pulmonary edema is
a common complication of pre-eclampsia associated with serious
sequelae. Evaluation of lung water would be a helpful tool for early
detection of patients with pending acute pulmonary edema.
OBJECTIVES. To evaluate the ability of extra-vascular lung water
(EVLW) measured by lung ultrasound and total thoracic fluid content
(TFC) measured by electrical cardiometry in early detection of pul-
monary edema. We also correlated between EVLW and TFC using
spearman correlation coefficient.
METHODS. A prospective observational study including pre-eclamptic
parturients scheduled for delivery in Cairo university Hospitals. Lungultrasound was performed on patient admission, and lung score (LUS)
was calculated. Electrical cardiometry was used for measurement of
TFC. Patients were divided into two groups: Congested group (defined
as patients with clinical congestion requiring diuretics) and non-
congested group. Area under receiver operating characteristic (AUROC)
curve was calculated for both LUS and TFC for early detection of lung
congestion. Spearman correlation coefficient was calculated for correl-
ation between LUS and TFC.
RESULTS. Sixty parturients were available for final analysis. Eleven
patients (18.3%) developed clinically manifested congestion. Clinically
congested patients had a higher median lung ultrasound score 17(15–
19) and thoracic fluid content 46(40–48) compared to non-congested
patients 2(2–3) and 28(26–30) respectively (P value < 0.001). LUS
showed excellent predictive properties for clinical congestion
[AUROC = 0.964(0.881-0.995), sensitivity = 100%, and specificity = 93.8%
at cutoff value of >4]. TFC also showed excellent predictive value
[AUROC = 0.968(0.886-0.996), sensitivity = 100%, specificity = 89% at
cutoff value of >37]. There was a good correlation between LUS and
TFC with a spearman correlation coefficient (r) of 0.77.
CONCLUSIONS. Both LUS and TFC have excellent predictive
properties for early detection of clinical congestion in parturients
with severe pre-eclampsia. The presence of good correlation be-
tween TFC and LUS makes electrical cardiometry a promising alterna-
tive to ultrasound for assessment of EVLW.
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INTRODUCTION. General anaesthesia and surgery can be complicated by
postoperative cognitive dysfunction. Among different factors, the
impairment of mental functions and cerebral blood flow can be
associated with disturbances of gas exchange. However, it is still unsettled
whether the deterioration of cognitive function and gas exchange is
related with depth of anaesthesia. One of the novel parameters for
assessment of anaesthesia depth is a patient state index (PSI).
OBJECTIVES. Thus, the aim of this study was to explore the
relationship of cognitive function with gas exchange and PSI in
laparoscopic cholecystectomy.
METHODS. Totally 170 patients scheduled for laparoscopic
cholecystectomy were enrolled into a prospective study and
randomized into four groups:
1) normoxia-normocapnia (nO2-nCO2),
2) hyperoxia-normocapnia (hO2-nCO2),
3) normoxia-hypocapnia (nO2-lCO2),
4) hyperoxia-hypocapnia (hO2-lCO2).
Normoxia was defined as PaO2 within 70–150 mm Hg, hyperoxia —
within 150–300 mm Hg. Normocapnia was referred to PaCO2 of 35–
48 mm Hg, and hypocapnia — to 25–35 mm Hg. The intervention
was conducted under total intravenous anaesthesia (propofol/
fentanyl). All patients were tested for cognitive function using
Montreal Cognitive Assessment Score (MoCA), monitoring the depth
of anaesthesia was assessed by PSI (Masimo Root, USA).
RESULTS. Totally 109 patients strictly met the inclusion criteria and
targeted gas exchange. We observed the decrease in MoCA at 6
hours after surgery in the hO2-nCO2 and the hO2-lCO2 groups
(p < 0.03). Compared with the nO2-nCO2 group, arterial lactate and
pH increased significantly at the end of surgery in the hO2-lCO2 and
the nO2- lCO2 groups (p < 0.001). The PSI before induction of
anesthesia correlated with age (rho = −0.41, p = 0.01) and baseline
MoCA value (rho = 0.80, p < 0.001). In addition, we observed a posi-
tive correlation between PaCO2 and PSI at the end of intervention
(rho = 0.32, p = 0.046).
Fig. 102 (abstract 0258). See text for description
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capnia during laparoscopic cholecystectomy leads to transient post-
operative decline in cognitive function. The PSI correlates with age,
baseline cognitive function and PaCO2 at the end of the operation,
thus the monitoring of anaesthesia depth can be used for prediction
of postoperative cognitive dysfunction.
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INTRODUCTION. Sedation is often required during MRI for adult
uncommunicative patients or those with different psychiatric
disorders (phobia, anxiety etc.). Although it can be challenging to
obtain the deep sedation level required to prevent the patient's
movement while maintaining respiratory and hemodynamic stability.
Limited access to the patient may pose a safety risk during MRI.
Dexmedetomidine can be assosiated with better sedation quality
and lower risk of breathing complications during MRI (1).
OBJECTIVES. To compare efficacy and safety of dexmedetomidine
sedation versus propofol during MRI in adults.
METHODS. Prospective randomised study was conducted in the
private clinic “Boris” at department of anesthesiology and intensive
care of Bogomolets medical university (Kyiv, Ukraine) during 2015–
2016. Uncommunicative conscious patients with acute ischemic
stroke were included in the study and randomly allocated to 2
groups - dexmedetomidine (D) and propofol (P). The sedation goal
was the same in the both group (RASS 0 to −2). Patients in group D
receive dexmedetomidine infusion in dose 0,2-1.4 mcg/kg/h, in
group P - propofol 1–4 mg/kg/h. Data are presented as median and
25–75 quartiles. Nonparametric criteria were used for data analysis
(Fisher test, Mann–Whitney test).
RESULTS. 84 patients (42 in each group) with median age 64 [56–75]
years were included in the study. There were no statistical differences
between groups by demographics, severity of stroke, comorbidity. The
goal level of sedation was achieved during 81 [75–90]% of total sedation
time in group D, and in 65 [50–75]% of time in group P (p < 0.05). The
incidence of complications varied between groups: arterial hypotension
occurred in 6/42 (14%) patients in group D and in 2/42 (5%) patients in
group P (p > 0.05), bradycardia in 5/42 (12%) and 3/42 (7%) (p > 0.05),
desaturation in 2/42 (5%) and 10/42 (24%) (p = 0.26, OR 6 95%CI 1.2 to
61), bradypnoe in 0/42 and 2/42 (5%) (p > 0.05).
CONCLUSIONS. In this prospective randomized study dexmedetomidine
comparing to propofol was associated with higher sedation quality and
lower incidence of complication (desaturation) during acute ischemic
stroke patients sedation for MRI. Dexmedetomidine could be an effective
and safe alternative to propofol for procedure sedation during MRI.
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Intensive Care Medicine Experimental 2017, 5(Suppl 2):0258INTRODUCTION. Nursing care is a frequent procedure in the critically
ill, repeated several times a day, but it is often painful. The Analgesia
Nociception Index (ANI) evaluates analgesia/nociception balance, by
studying the heart rate variability. It has been validated in anesthesia
(1), but not in the critical care.
OBJECTIVES. The objective of this study was to assess whether an
ANI based analgesia protocol may reduce the incidence of pain
during nursing care.
METHODS. We performed a prospective, monocentric (surgical ICU),
before/after study, assessing the incidence of pain during nursing
care without and then with an ANI-based analgesia protocol. Pain
during nursing was assessed using a as a Numerical Scale (NS ≥ 4) in
patient able to communicate (communicating patient (CP)) or using
the Behavior Pain Scale (BPS ≥5) if not (non-communicating patient
(NCP)). During the first phase (5 months), we measured the resting
ANI, before nursing. We used Receiver-operating characteristic (ROC)
curves to defined the best resting ANI thresholds able to predict a
painful nursing. During the second phase (4 months), nurses gave an
analgesia bolus according to the resting ANI before the nursing. We
compared the incidence of painful nursing during the two periods, in
both CP and NCP.
RESULTS. We evaluated 137 nursing in 30 patients (age 57 ± 15 YO,
12(40%) women, IGSII 47 ± 15) and 146 in 32 patients (age 52 ± 18
YO, 11(34%) women, IGSII 46 ± 17) during the two successive
phases. An ANI ≤71 predicts the occurrence of pain during the
nursing procedures in CP (AUC = 0.85, Sensitivity 71%, Specificity
100%), and an ANI ≤ 63 in NCP (AUC = 0.63, Sensitivity 63%,
Specificity 66[Sl1] %). Administration of a bolus before nursing was
more frequent during the second phase: 51(35%) vs 25(18%),
p = 0.002. The incidence of resting pain was not different between
the 2 phases (p = 0.118), but the incidence of pain during the
nursing was lower with the use of ANI (27% with vs 43%, p = 0.004)
(Fig. 102). Regarding the nursing procedures without bolus, 47 (42%)
were painful without ANI, vs 15 (16%) with ANI (p < 0,001).
CONCLUSIONS. Pain during nursing care is common in critically ill
patients. The use of an ANI-based analgesia protocol allows a signifi-
cant reduction of this incidence, by almost 40%.
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INTRODUCTION. Abnormal sleep in critically ill patients may be
associated with delirium, prolonged stay in intensive care unit and
increased mortality. Polysomnography, the standard criterion method
of sleep assessment, is complicated in ICU. Standard sleep scoring
classification (American Academy of Sleep Medicine, AASM) is not
suitable in critically ill patients due to abnormal electrophysiological
patterns. Modified classification for critically ill patients has been
suggested by Watson et al. This classification has not been tested in
the homogeneous groups of critically ill patients and has not yet
been validated.
OBJECTIVES.
1. To describe sleep patterns in 2 homogeneous groups of
unsedated critically ill patients on mechanical ventilation: a severe
sepsis group, and a Chronic Obstructive Pulmonary Disease
(COPD) group;
2. To determine the association of sleep patterns with the severity of
critical illness scores, Systemic Inflammatory Response Syndrome
criteria and delirium; 3.to compare PSG findings to subjective sleep
evaluation performed by nurses in the ICU.
METHODS. PSG was performed in 2 homogeneous groups of
nonsedated conscious critically ill patients on mechanical ventilation:
a severe sepsis group (n = 16) and a group with COPD (n = 17).
AASM classification was used for sleep scoring in presence of wake-
sleep characteristics. Watson's classification was used if the character-
istics of normal sleep were absent. Subjective sleep assessment by
nurses was done with 15 min intervals.
RESULTS. We found significantly different distribution of sleep stages
in the severe sepsis and the COPD groups. COPD, higher APACHE II
and SOFA scores, and delirium were significantly associated with the
higher risk of atypical sleep. The correlation between the nurse sleep
assessment and PSG was only observed in the presence of normal
sleep characteristics.
CONCLUSIONS. COPD diagnosis, critical illness scores and presence
of delirium were associated with risk of atypical sleep. There was no
correlation between subjective sleep assessment by nurses and
objective PSG sleep recording in case of atypical sleep.
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INTRODUCTION. Sleep for patients in Intensive Care Units (ICU) is
known to be poor and is difficult to measure. There does not seem
to be a simple, robust alternative to full EEG monitoring which is
expensive and inappropriate for most patients in the ICU.
OBJECTIVES. To assess quality and quantity of sleep in patients
admitted to the intensive care unit using a small portable EEG
monitor designed for home use.
METHODS. An observational study was performed in a general adult
intensive care unit in a large teaching hospital in the UK. Patients
aged ≥16 years were recruited to wear a portable EEG monitor
(Sleep Profiler, Advanced Brain Monitoring Inc, Carlsbad, CA, USA) for
up to 48 hours. Sleep stage was determined using the validated
auto-staging algorithm supplied with the EEG monitor. Total sleep
time, percentage spent in sleep stages, and duration of unbroken
sleep periods were measured. Times are reported as hh:mm:ss.
RESULTS. (Recruitment is ongoing, data will be updated prior to
ESICM) 44 patients recruited (26 male), between August 2014 - April
2017; mean age 60.4 (SD16.4), median APACHE II 24 (range 10–31),
median length of stay in ICU 4.5 days (range 1–36 days). Total
recording time 610:54:00 (per patient median 14:42:30). During their
recording time, each patient slept for a median duration of 02:05:45
(range 00:00:30–12:38:30). Of this, 00:07:00 (5.6%) was spent in REM;
00:12:45 (10.2%) in slow wave sleep, and 01:26:30 (69.2%) in NREM1
and 2. 17% of sleep was unable to be characterised and 142mins
(16%) per patient recording was classified 'invalid'. Patients
experienced a median of 3.5 sleep periods per hour (maximum 13.6),
each period being a median of 00:01:00 in duration (maximum single
sleep period duration 05:26:00).
CONCLUSIONS. The total amount of sleep experienced by patients
admitted to ICU is considerably lower than the eight hours
recommended by the WHO1. Sleep was also highly fragmented
with up to 13.6 awakenings every hour. Patients also had reduced
REM sleep and increased non-REM sleep relative to normal sleep
patterns1.
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Sedation strategies using volatiles via classical Anaconda (Anaconda-C)
is gaining popularity over intravenous sedation with propofol and
midazolam. It's been demonstrated that sevoflurane exerts
organoprotective properties and shortens time to extubation. In
our ICU volatila sedation is mostly used mode of sedation and
sevoflurane only is used.
Fig. 104 (abstract 0261). Anaconda S (upper) and Anaconda
C (lower)
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death space in breathing circuit which can be challenging during
ultraprotective ventialtion under ECMO. In such circumstances, Ana-
conda C can be inserted into inspiratory limb in which case conserv-
ing effect of the device is abolished. Newly developed AnacondaS
being half the size and volume (50 mL) should address these issues,
while ensuring adequate sedation level. There is no published data
on volatile anesthetic consumption with Anaconda S.
METHODS. Different infusion rates of sevoflurane using AnacondaS
(Sedana, Sweden) were used in 20 consecutive patients were
ventilated with controled mechanical ventilation with constant
minute volumes (Elisa 800 EIT, Heinen + Löwenstein, Germany)
aiming to achieve sevoflurane concentration of 0.5 and 1.0 volume%
respectively. Data was obtained, analyzed, nomograms constructed
using statistical program Numbers (Apple, USA) and compared to
nomogram for currently marketed Anaconda-C.
RESULTS. To achieve 0.5 vol% of sevoflurane, almost twice the infusion
rate of sevoflurane is needed at MV up to 10 L/min when using
AnacondaS compared to Anaconda-C. In order to achieve 1 vol% of sevo-
flurane, difference in infusion rate is less pronounced. Infusion rate nomo-
gram curves converge as the MV increases, but never intersecting.
CONCLUSIONS. In order to achieve 0.5 vol% sevoflurane concentration
higher infusion rates of sevofluran are needed compared to Anaconda-C.
At 1 vol% and MV ≥ 9 L sevoflurane consumption is comparablewith
Anaconda C and Anaconda S.
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OBJECTIVES. Many critically ill patients treated in the intensive care
unit (ICU) experience sleep disruption. This study was undertaken to
identify the sleep status of non-sedated critically ill patients in Korea
medical ICU.
METHODS. This is a prospective study. Polysomnography recording
was performed over 24 hour to assess the quantity and quality
of sleep.
RESULTS. Total 20 patients were enrolled. Median total sleep time
was 03:43 (hh:mm, IQR: 00:49–06:10). The majority of sleep was stage
1 (median 03:02 [00:47–04:34]) with scant stage 2 (median 00:00
[00:00–00:46]), REM (median 00:00 [00:00–00:15]) and absent stage 3.
The number of waking episodes in 1 hour was a median of 14.0 (7.7 -
29.1). The APACHE II score showed a significantly negative
correlation with total sleep time (r = −0.49, P = 0.028). Patients
who stayed more than 5 days in the ICU showed similar total
sleep times. However, they showed significant reduction in night
sleep time compared to patients who stayed less than 5 days
(00:42 ± 0:46 vs 2:04 ± 1:25, P = 0.012).
CONCLUSIONS. The quantity and quality of sleep in critically ill
patients were poor. More severe disease influenced negative effects
on sleep. Long duration of ICU stay disrupted circadian rhythm in
critically ill patients.
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Table 78 (Abstract 0264). VAS of 3 conditions with 3 pain
management methods
Pethidine/NSAIDs
(n =135)
PCA (n = 71) PCEA (n = 73) p-value
VAS—Rest 23.41±14.26ξ 22.11±8.44ξ 11.92±10.23 <0.001
VAS—Movement 40.60±18.96ξ 42.96±12.58ξ 32.96±12.65 <0.001
VAS—Coughing 47.24±23.02 59.72±14.73ξ 50.27±14.34 <0.001
Patient satisfaction 4.01±0.24ξ 4.03±0.29ξ 4.21±0.52 <0.001
ξSignificant difference (p< 0.05) compared to PCEA
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 135 of 542INTRODUCTION. Delirium is highly prevalent in critically ill patients
and is related to poor outcomes. Identifying at admission those
patients at higher risk for developing delirium would allow apply
early preventive interventions.
OBJECTIVE. To assess the EARLY-PRE-DELIRIC model as a predictor of
delirium in a mixed medical- surgical ICU in a tertiary hospital in Bar-
celona Spain.
METHODS. A prospective observational cohort study of all patients
consecutively admitted to a mixed ICU, in a tertiary Hospital in
Barcelona Spain, between April and June 2016. Demographic data,
prognostic scores, and the E-PRE-DELIRIC score were collected at ICU
admission.
The presence of delirium was determined using the CAM-ICU scale
or by the clinical criterion of the physician in charge.
We performed a descriptive analysis of the demographic data and
prognostic scores. With a multivariate analysis we determined the
factors associated with the presence of delirium.
The sensitivity, specificity, and positive and negative likelihood ratios
were assessed by ROC curves. The statistical analysis was performed
with SPSS 18.0.
RESULTS. During the study period, 110 patients were admitted.
Fifteen patients were excluded because they were unable to be
assessed for delirium at any time for persistent coma or death during
their ICU stay. Of the 95 patients evaluated 66.3% were men; mean
age 63.3 ± 13.2, APACHE II 14.3 ± 5.1, SOFA at admission 5.8 ± 2.6,
SAPS II 27 ± 9.4, SAPS III 47.6 ± 12. The overall incidence of delirium
was 23,15%. The E-PREDELIRIC stratify the risk for developing delir-
ium during ICU stay in 4 subgroups:
a) Very low risk (0 - 10%),
b) Low risk (10-20%),
c) Moderate risk (20-35%) and
d) High risk (>35%).
In our study we had 5,1% in the group 1, 25% in the group 2, 41,2%
in the group 3 and 42,1% in the group 4. In our study the power of
the E-PRE-DELIRIC was moderate with a sensitivity of 72% and a spe-
cificity of 69,5% with a cut-off of 20%, and was correlated with the
published in the literature.
CONCLUSIONS. The E-PRE-DELIRIC score is simple to obtain and was
a predictor of delirium in our ICU. The identification of patients at
greater risk for developing delirium at admission would allow the im-
plementation of intensive early preventive strategies mainly in mod-
erate and high-risk patients.
REFERENCE
Wassenaar A, van den Boogaard M, van Achterberg T, Slooter AJ,
Kuiper MA, Hoogendoorn ME, Simons KS, Maseda E, Pinto N, Jones C,
Luetz A,Schandl A, Verbrugghe W, Aitken LM, van Haren FM, Donders
AR, Schoonhoven L, Pickkers P. Multinational development and
validation of an early prediction model for delirium in ICU patients
Intensive Care Med 2015; 41: 1048–56
0264
Comparative analysis of different methods of pain management
for critical cancer patients in the surgical intensive care unit
B. W.-Y. Huang1,2, C.-K. Fang2, Y.-L. Lai2,3,4
1Mackey Memorial Hospital, Critical Care Medicine, Taipei, Taiwan,
Province of China; 2Mackey Memorial Hospital, Hospice and Palliative
Care Center, Taipei, Taiwan, Province of China; 3MacKay Memorial
Hospital, Department of Radiation Oncology, Taipei, Taiwan, Province of
China; 4MacKay Medical College, Taipei, Taiwan, Province of China
Correspondence: B. W.-Y. Huang
Intensive Care Medicine Experimental 2017, 5(Suppl 2):0264
INTRODUCTION. With technological advancements, more critical
cancer patients are undergoing surgery and need surgical intensive
care unit (SICU) care1. Post -operation optimal pain management can
not only release cancer and surgical pain but also provide a more
stable hemodynamic status which shorten length of hospital stay as
well as reduced medical cost2.OBJECTIVES. We aimed to determine the pain management method
that provides better acute pain control in critical SICU cancer patients.
METHODS. This retrospective cohort study included a chart review of
patients treated in a 26-bed surgical intensive care unit from April
2011 through September 2012. Cancer patients who were uncon-
scious, uncooperative, post-brain surgery, or had an American Society
of Anesthesiologists classification < III, were excluded. The primary
aim was to compare visual analogue scale (0–100) scores between
three different methods of pain management. pethidine/NSAIDs,
intravenous patient-controlled analgesia (PCA), and patient-
controlled epidural analgesia (PCEA), under different conditions (rest,
movement, and coughing). The secondary endpoints were patient
satisfaction.
RESULTS. We chart reviewed 1872 patients and 1593were
excluded.VAS results presented as mean ± SD. Data analysis using
ANOVA with Scheffe post hoc test. The average age was 67 years,
and 64% were male. At rest, the PCEA group exhibited significantly
lower pain scores (11.92 ± 10.23) compared with the other two
groups. During movement, the PCEA group also has significantly
lower pain scores (32.96 ± 12.65) than PCA and pethidine/NSAIDs
groups. While coughing, the PCEA and pethidine/NSAIDs showed no
difference; both exhibited lower pain scores than the PCA group
(59.72 ± 14.73) The PCEA group showed highest patient satisfaction
(4.27 ± 0.51).
CONCLUSIONS. PCEA appears to be a better choice for pain
management for critical SICU cancer patients.
REFERENCE(S)
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INTRODUCTION. Volatile anaesthetics (VA) are increasingly finding a
place in intensive care sedation, and their benefits on patient
outcome are beginning to gather (1). The AnaConDa™ (ACD)
incorporates a reflector between the breathing circuit and the
patient which captures exhaled VA and resupplies it during the next
inspiration, obviating the need for a circle system to administer VA.
Concerns have been voiced that this device increases dead space
ventilation and arterial PaCO2 values, limiting its use in low tidal
volume ventilation strategies like ARDS (2) or in children. The
AnaConDa S™ (ACD S) features a smaller reflector which decreases
dead space from 100 to 50 ml.
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 136 of 542OBJECTIVES. We aimed to test the reflection ability of the ACD S by
comparing its VA consumption to that of the original ACD system in
an artificial lung model.
METHODS. We assembled an artificial lung model of 2x2L volume
with an additional reservoir of 3.9 L simulating the functional
residual capacity. This was connected to the ACD S or to the ACD
system, a Puritan Bennett™ 840 (Covidien, Mansfield, MA, USA)
ventilator and a Vamos monitor (Dräger, Lübeck, Germany) to
measure end tidal CO2 and expired VA concentration. Measurements
were each made continuously for 30 min after achieving steady state
at end tidal concentrations of 0.5, 1.0, 1.5, 2.0 and 2.5 Vol% for
Isoflurane (ISO) and Sevoflurane (SEVO) respectively. Every
measurement was repeated 3 times. The breathing parameters were
held constant (MV 5L/min, RR 10/min, TV 0.5 L). The groups were
compared using the Mann Whitney U test (SPSS® v. 24.0).
RESULTS. ACD S utilises an equivalent amount of ISO as ACD to
maintain end tidal concentrations in the range between 0,5% (0,73
ml/h vs 0,62 ml/h) and 1,5% (3,7 ml/h vs 2,6 ml/h). Beginning at
1.5%, the consumption of ISO rises steadily for the ACD S, surpassing
that of the ACD (3,7 ml/h vs 2,6 ml/h). In the case of SEVO, the
consumption of the ACD S remains equivalent with ACD only in the
end tidal concentration domain between 0.5% (0,73 ml/h vs 1,1 ml/
h) and 1% (1,63 ml/h vs 1,7 ml/h). Beginning at 1%, the efficiency of
the ACD S falls rather unexpectedly until 1.5%, surpassing the ACD
(4,3 ml/h vs 2,8 ml/h). At 2,5% the consumption is one and a half
times that of the classic ACD (10,7 ml/h vs 6,9 ml/h). For end-tidal
concentrations of 2.0 and 2.5 Vol% SEVO and 1.5, 2.0 and 2.5 Vol%
ISO ACD S utilizes significantly more VA than ACD (p < 0.01).
CONCLUSION. The new ACD S has a similar efficiency to the original
ACD in the concentration domain between end tidal VA 0.5-1.0 Vol%,
corresponding to ICU sedation targets (MAC 0.5), with the additional
benefit of reducing dead-space.
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INTRODUCTION. Inhalation sedation with the anesthetic conserving
device (ACD, AnaConDa®, Sedana Medical, Uppsala, Sweden) is
increasingly used to sedate critically ill patients in the ICU. Because
of the high volumetric dead space of 100 ml and the partial
reflection of carbon dioxide (CO2), concerns about CO2 retention
have been raised when using the AnaConDa®-100ml (ACD-100).
Since recently, a smaller reflector, AnaConDa®-50ml (ACD-50), with
volumetric dead space reduced to the half is available.
OBJECTIVES. We wanted to compare CO2 elimination and isoflurane
reflection efficiency of both reflectors on the bench.
METHODS. A test lung was ventilated with 500 mL, 10 breaths per
minute while constantly insufflating CO2. At the beginning of each
experiment a heat moisture exchanger (HME, 35ml) was connected
while adjusting CO2 flow to reach an end-tidal CO2 (et-CO2) of
5.3 ± 0.1 kPa. Successively connecting ACD-100 and ACD-50, et-CO2
was measured under different conditions: under ambient
temperature pressure (ATP), body temperature pressure saturated
conditions (BTPS), and BTPS with 0.4 or 1.2 Vol% isoflurane (ISO-0.4/
ISO-1.2). In a second experiment ACD-100 and ACD-50 were again
successively connected. For each reflector tidal volume was stepwise
adjusted to maintain normocapnia.To determine reflection efficiency of both ACDs isoflurane was
administered into the test lung via a syringe pump. Isoflurane
concentrations were measured in steady state at varying isoflurane
infusion rates (0.5-20 ml/hour) under ATP and BTPS + CO2. Reflection
efficiency was defined as:
Efficieny[%] = 100 × (Isofluranereflected ÷ Isofluraneexhaled)
RESULTS. Under all conditions ACD-100 caused higher et-CO2 than
ACD-50. CO2 reflection was highest under ATP, less under BTPS, smal-
lest with ISO-0.4 and ISO-1.2. Beside the enlarged volumetric dead
space compared to a normal HME there is an additional reflective
dead space of ACD-100 and ACD-50 which could be quantified as
40ml or 25ml under BTPS with isoflurane, respectively. Regarding the
reflection efficiency of both ACDs Isoflurane reflection was highest
under ATP. Under BTPS + CO2 reflection efficiency was above 80%
up to 4.2 Vol% with ACD-100 and up to 0.4 Vol% when using the
ACD-50.
CONCLUSIONS. While isoflurane reflection is still sufficient with ACD-
50 at lower concentrations, CO2 elimination is much less impaired
compared to ACD-100. Thus, it should be possible to use ACD-50
with tidal volumes as low as 200ml for lung protective ventilation
even of small patients.
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OBJECTIVES. To describe the general characteristics of kidney donors
after controlled circulatory death (CCD) and to evaluate the
incidence of delayed graft function (DGF) after normothermic
regional perfusion with extracorporeal membrane oxygenation (NRP)
versus in situ preservation (ISP).
METHODS. Descriptive and retrospective study (January 2012-
October 2016) performed at Hospital Universitario Puerta de Hierro
Majadahonda (Madrid, Spain). Variables analyzed included donors
age, sex, ICU length of stay, cause of death, body mass index (BMI)
and previous history of hypertension (HT) or diabetes mellitus (DM).
Age and sex of the recipients, development of DGF, preservation
methods and warm and cold ischemia times (WIT, CIT) were also reg-
istered. We considerer WIT as the period between systolic arterial
pressure below 60 mmHg to initiation of NRP or preservation solu-
tions (ISP), and CIT to the period between preservation solution infu-
sion and implant.
RESULTS. In the period studied, 30 patients were CCD donors, which
accounted for 60 transplanted kidneys. Forty-seven of them were im-
planted in our center and are the subject of this study. Sixteen do-
nors were men (46%). Mean age was 53.4 ± 13.4 years and mean ICU
days of stay were 9.7 ± 8.4. The main causes of death were: anoxic
encephalopathy [14 patients (47%)] and intracranial hemorrhage or
thrombosis [9 patients (29.9%)]. ISP was the technique of choice in
38 patients (80.8%) vs. NRP in 9 of the cases (19%). Median WIT was
20 minutes (8–41) and CIT was 6 hours (4–11).
In the recipient group (47), there were 34 (72.3%) men and
mean age was 54.5 ± 12.4 years. Twenty-two of them (40%) suf-
fered a DGF.
There was no statistical association between DGF and age, sex, BMI,
HT, DM or cause of death of the donors. There were 20 patients who
developed DGF after ISP vs. 2 patients after NRP (90.9% vs. 9%;
p = 0.1). Median time of CIT in the group of patients who developed
DGF after ISP vs. NRP was 6.75 hours (4–12.5) vs. 5.5 hours (4–8)
respectively; p 0.43.
Table 80 (Abstract 0268). Recipients' characteristics
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 137 of 542CONCLUSIONS. CCD has contributed to increase the number of
kidney donors in our centre in the recent years.
The incidence DGF after CCD is high, but NRP seems to reduce the
risk of this complication.
Larger series are needed in order to further asses the roll of NRP as a
preservation technique for CCD donors.
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INTRODUCTION. Kidney grafts' hypoperfusion due to longer warm
ischemia time is thought for a donor after circulatory death (DCD), a
suboptimal type of organ donor.1
OBJECTIVES. To compare the primary kidney transplantation results
in brain-death donors (DBD) vs DCD.
METHODS. Observational prospective study in one year period of
kidney grafts transplantation from DBD and controlled-DCD patients
in a tertiary care hospital (551 total beds which 88 belongs to critical
area). Analysis of data was performed with X2 and T Student.
RESULTS. 14 controlled-DCD and 13 DBD donors were included in
this period, in which a total number of 50 kidneys were obtained (a
non valid donor in each group of patients). Among DCD, 4 kidneys
were excluded from transplantation because of tissue biopsy score
or vascular anomalies. 35 kidney transplantation were performed in
our hospital; 4 kidneys were transferred to other hospitals and 7 (all
from DBD) were included in the Hyperimmunized Spanish Program.
Mean age was 61,46 years old in DCD and 60,53 years old in DBD.
Urea and Creatinine values in the day of organ removal were 54,02
mg/dL and 0,70 mg/dL respectively for DCD group and 31,33 mg/dL
and 0,77 mg/dL for the DBD group. Delayed Graft Function (DGF) was
established in 8 recipients from the DCD group (40%), whereas in the
DBD group were only 4 (26,6%). Mean cold ischemic time for DCD and
DBD group were 4,3 hours and 20,65 hours respectively. Mortality
among the recipient group was 1 patient for each type of donation.
CONCLUSIONS. Controlled-DCD's recipients tend to have a higher
amount of DGF, although there is a lower cold ischemia time compar-
ing to DBD donors. However, there is no significance in the results ob-
tained. Comparing both DCD and DBD groups there is an homogeneity
of patients' characteristics included in each group (age, renal function).
REFERENCE
1. Donación en Asistolia en España: situación actual y
recomendaciones. Consenso Nacional de Donación, año 2012.
Organización Nacional de Transplantes.Table 79 (Abstract 0268). Donors’ characteristics0269
Postoperative in the ICU of the renal transplantation of living
donor success; guarantees?
N. Palomo-Lopez, A. Roldan-Reina, D. Cuenca-Apolo, M. Adriaensens, M.
Porras-López, L. Martin-Villen, Z. Ruiz de Azua-López, J. J. Egea-Guerrero
Hospital Universitario Virgen del Rocío, Sevilla, Spain
Correspondence: N. Palomo-Lopez
Intensive Care Medicine Experimental 2017, 5(Suppl 2):0269
INTRODUCTION. Living donation process has an important risk for
the donor. For that reason, an optimal postoperative care must be
achieved.
OBJECTIVES. To analyze the differences between living and
cadaveric donors after renal transplantation, at the ICU admission.
METHODS. Observational retrospective study peformed from
January 2013 to December 2016. We collected demographic
data,comorbidity, type of donation, analytical values at ICU
admission, results of radioisotope tests, complications (both in ICU
and during follow-up during hospitalization) days of ICU stay, hos-
pital and mortality. Descriptive statistical analysis was performed.
The Xi square test was used for qualitative variables and the
Student´s T or Mann Whitney U test for the quantitative variables
depending on their distribution. We considered significance statis-
tical results p < 0.005.
RESULTS. We studied a total of 387 kidney transplants. The general
characteristics of the patients; the analytical values and the rest of
the variables, are shown in Table 81. 13% of patients received an
organ from a living donor, with a significant decrease in the
development of complications during admission (it is defined as
the need of dialysis an blood transfusion) compared to other
donors. They also had a shorter hospital stay and there was no
exitus in the live group.
CONCLUSIONS. That patients who receive an organ from living
donor have a more optimal postoperative outcome than those from
a cadaver donation. Our results suggest that transplanting a living
donor provides guarantees of success, thanks also to the careful
selection process and donor compatibility.
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Table 81 (Abstract 0269). General characteristics of the 387 transplants
acc
DONOR LIVING CADAVER P
n (%) 50 (13) 337 (87) -
Age, media (DE) 44,0 (13,3) 52,2 (12,6) 0,000
Male Sex, n (%) 31 (62,0) 213 (63,2) 0,869
creatinine median ICU admission (IR) 5,49 (4,23 - 6,66) 5,98 (4,55 - 7,59) 0,052
Pathological MAG-3, n (%) 5 (10,0) 49 (14,5) 0,387
Hospital, complications n (%) 22 (44,0) 217 (64,4) 0,060
ICU complications, n (%) 4 (8,0) 87 (22,8) 0,060
Length of stay, Hospital, median (IR) 13 (9,75 - 17,00) 15 (12,00 - 20,00) 0,010
Exitus, n (%) 0 (0,0) 2 (0,5) 0,585
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INTRODUCTION. Stress cardiomyopathy has been extensively
described after aneurysmal subarachnoid haemorrhage, but there is
little evidence after traumatic brain injury (TBI). Speckle-tracking
echocardiography (STE) analyses longitudinal left ventricular systolic
function, and is more sensitive than left ventricular ejection fraction
(LVEF) to detect early systolic dysfunctions.
OBJECTIVES. Incidence of infra-clinical stress cardiomyopathy after
TBI by using STE.
METHODS. Mono-centric longitudinal study in one university hos-
pital, in patients undergoing TBI with a Coma Glasgow Score ≤ 13
before ICU admission. STE was performed in the first 24 hours after
admission, at day 3 and day 7 after admission. Patients were ex-
cluded in the setting of thoracic trauma, out-of-hospital rescuscitated
cardiac arrest, history of major heart surgery or ischemic cardiomyop-
athy, clinical signs of brain death at admission, withdrawal of life-
sustaining therapies in the first 24 hours. Hyper-sensitive Troponin
was dosed in the first 24 hours after admission. The primary outcome
was the incidence Global Longitudinal Strain (GLS) > −16% which de-
fines significant longitudinal systolic function impairment.
RESULTS. We included 102 patients with TBI from March 2014 to
March 2017, 78(75%) male and 26(25%) female. Mean age was
43(±20). Glasgow Coma Score at admission was 7(±3). 77(75%)
patients received norepinephrine at day 1. 85 patients were kept in
final STE analysis because of appropriate echogenicity. At day 1, LVEF
was preserved 66(±21)% as well as GLS −20.3(±3.6)%. Troponin hs at
admission was 61(±156) pg/mL, but there was no correlation with GLS.
Only 4(4.7%) patients displayed a severe GLS impairment (> − 16%) at
day 1. There was a significant improvement in GLS at day 3
(−22.4(±3)% (p < 0.05), which did not sustain at day 7 (−20.7(±4)%).
There was no link between GLS and in-ICU mortality and day-90 neuro-
logical outcome evaluated with Glasgow Outcome Scale.
CONCLUSIONS. STE could detect up to 36% of stress cardiomyopathies
in patients with aneurysmal subarachnoid haemorrhage (1). In patients
undergoing TBI, stress cardiomyopathy evaluated assessed with STE is
very infrequent. Although it has been witnessed through case reports,
our data suggest that stress cardiomyopathy will not be a relevant
clinical issue in TBI patients.
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INTRODUCTION. Despite a large body of evidence testifying to the
development of myocardial injury in subarachnoid hemorrhage the
true incidence in this population remains unknown. Troponin (cTn)
release is accepted as the most specific marker of myocardial
necrosis. There is evidence on the use of cTnT as a predictive factor
in patients with ischemic stroke and subarachnoid hemorrhage.
However, there are few reviews that have studied the relationship
between elevated levels of cTnT and mortality of patients with
intracerebral hemorrhage (ICH).
OBJECTIVES. The aim of this study was to define the incidence of
cardiac injury in patients with ICH as determined by cTnT release. To
evaluate the relationship between elevated cardiac troponin T
(cTnT > 14 ng/L) and the outcome from ICH.
METHODS. We made a retrospective and observational study of patients
admitted to the ICU during one year and who have identified an ICH. On
admission, we recorded medical examinations, including CT and cardiac
troponin T (cTnT) measurements. Cerebral hemorrhages secondary to
TBI, vascular malformation, cerebral aneurysm, or ischemic hemorrhagic
transformation were excluded. CT scans were reviewed to determine the
hematoma size, location, presence of intraventricular or subarachnoid
hemorrhage, hydrocephalus, and midline shift.
RESULTS. 44 patients were identified. The mean age was 63.98 ± 9.47
years and 54.5% were women. On admission the mean value of
APACHE II and Glasgow Coma Score were 17.04 ± 6.3 and 10.2 ± 4.15,
respectively. The most common site of hemorrhage were basal ganglia
(54.6%) and the cortical region (22.7%). 31.8% had previous heart
disease, 18 patients (40.9%) were received some type of antiplatelet or
anticoagulant treatment. 17 patients (38.6%) had elevated cTnT values
(>14 ng / L) with a mean of 37.52 ± 78.78 ng/L. Factors related to
increase cTnT values were a previous history of cardiac disease (71.4%)
and need of vasopressors after admission (72.7%). The average stay in
ICU was 19.95 ± 22.19 days. Significantly higher in patients with
elevated TnT (28 vs 15 days p = 0.018). The most frecuent cause of
death was neurological complications (40%). Mortality was higher in
the group of patients with enzymatic mobilization, 52.9% compared to
22.2%. Troponin T values > 14 ng/L was an independent predictor of
ICU mortality (OR 3.94, 95% CI 1.06-14.67, p 0.041).
CONCLUSIONS. Elevated cardiac troponin T (cTnT) values occur
frequently in ICH and are independently associated with higher in-
hospital mortality.
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INTRODUCTION. Aneurysmatic subarachnoid haemorrhage (aSAH)
patients exhibit hypercoagulability state from six hours after the initial
bleed1 predisposing these patients to thromboembolic complications.
Rotational thromboelastometry (ROTEM) is a point-of-care test providing
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 139 of 542a targeted and dynamic analysis of coagulation cascade2 and it can
identify hypercoagulability by increased level of maximum clot
firmness (MCF)3.
OBJECTIVES. To evaluate the on-going coagulation process after
aSAH by ROTEM analyses and compare the results to ROTEM ana-
lyses of elective neurosurgery patients undergoing craniotomy.
METHODS. This prospective, observational study was conducted in
the Tampere University Hospital, Finland between September 2015
and June 2016. The ROTEM analyses were done at 12, 24, 48 and 72
hours from the onset of aSAH symptoms. In the control group the
ROTEM analyses were done prior the surgery (i.e. baseline) and at 24
and 48 hours. To screen an asymptomatic deep venous thrombosis
(DVT), a bilateral compression ultrasound was performed to all
patients on day 3–5. The primary endpoint was MCF of EXTEM test. It
was calculated that 16 patients were needed to achieve 80% power
to detect a clinically meaningful increase (from 65mm to 70 mm, SD
5 mm) in MCF with p-level of 0.05.
RESULTS. 17 aSAH (age 49, IQR 40–60 years, male 35.5%) and 16
control patients (age 62, IQR 56–67 years, male 43.8%) were enrolled.
At 72 hours, the MCF of EXTEM was significantly higher in aSAH
patients compared to the baseline value of the control group: 68
(IQR 66–71) vs. 65 (IQR 60–67), p = 0.024 (Fig. 1). The same comparison
done in MCF of FIBTEM analysis resulted in similar results: 23 (IQR 19–
25) vs. 15 (IQR 13–18), p = 0.001. No difference was detected when
compared EXTEM MCF results at 24 h 68 (IQR 63–70) vs. 65 (IQR 61–67),
p = 0.37 or at 48 h 66 (IQR 66–69) vs 67 (IQR 64–70), p = 0.79. Two
DVTs was detected in the study group and both patients developed
also a pulmonary embolism. In two patients with DVT + PE after aSAH
MCF values were not higher compared with other aSAH patients at 72
hours (62 vs. 69, p = 0.076). No thromboembolic complications were
observed in the control group.
CONCLUSIONS. It seems that after 72 hours from the aneurysmatic
subarachnoid haemorrhage, the patients develop a hypercoagulability
state, that may be detected by ROTEM EXTEM-analysis.
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BACKGROUND - OBJECTIVES. Polyuria and disturbances in electrolytes
are common complications after subarachnoid haemorrhage (SAH) and
can be potentially harmful. Previous studies have demonstrated that
patients with polyuria have an increased risk of symptomatic cerebral
vasospasm or delayed cerebral ischemia.1 The exact cause of this
polyuria is not always very obvious.2 In this study the prevalence and
possible causes of polyuria and the association of polyuria with length
of stay (LOS) and long term outcome in critically ill patients with
spontaneous SAH were examined.
METHODS. In this retrospective study data about demographics,
diuresis, LOS and outcome of patients with spontaneous SAH were
collected during a period of 7 years (January 2010 - December 2016).
Exclusion criteria were: traumatic SAH, secondary transport ≥24
hours after first admission and elective coiling. Polyuria was defined
as a diuresis of >80 ml/kg/day. Statistical analysis was performed
using Mann–Whitney U and Chi-Square tests with SPSS.RESULTS. 317 patients were identified with SAH of which 95
experienced polyuria (30.0%). The median duration of polyuria was 2.0
(1.0-5.0) days. There was no significant difference in demographics or
Hunt and Hess scale at admission between both groups. In 184
patients (58.0%), SAH was caused by a ruptured aneurysm; of these, 67
(36.4%) had polyuria. Diabetes insipidus was diagnosed in 90 patients
(28.4%) and cerebral salt wasting in 134 (42,3%). Hyponatremia
(sodium < 135mEq/L) was more frequent in polyuria versus no-polyuria
patients (82.1% vs 65.9%, p < 0.001). High urinary sodium concentra-
tion (>150mEq/L) occurred in 89 (93.7%) patients in the polyuria group
vs 140 (63.1%) patients in the no-polyuria group (p < 0.001). Patients
with polyuria experienced significantly more vasospasm compared to
those without (39.4% vs 12.9%, p < 0.001). Polyuria patients in compari-
son to no-polyuria patients had a longer LOS at both ICU (8.7 (6.0-16.0)
vs 3.0 (2.0-9.3), p < 0.001) and the hospital (26 (14.5-49.5) vs 14.5 (9.0-
30.0), p < 0.001). ICU mortality in polyuria patients was similar com-
pared to those without polyuria (7.4% vs 14.4%, p = 0.080); hospital
mortality was significantly lower in patients with polyuria (7.4% vs
17.6%, p = 0.018). No significant difference could be demonstrated in
Glasgow Outcome Scale after circa six months in the polyuria versus
no-polyuria group (GOS 1–3: 36.6% vs 32.8%, GOS 4–5: 63.4% vs 67.2%,
p = 0.546).
CONCLUSION. Polyuria is a frequent complication in patients with
SAH during ICU stay. Cerebral salt wasting and diabetes insipidus
were common causes of polyuria, but other causes have to be taken
into account. Patients with polyuria were more likely to have
vasospasms and had a longer ICU and hospital LOS. There was no
significant difference in long term outcome, except hospital mortality
was lower in polyuria patients.
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INTRODUCTION. Cerebral microdialysis (MD) monitoring enables
assessment of regional metabolic physiology and provides
biomarkers for clinical correlation in critical conditions, such as
subarachnoid hemorrhage (SAH).
OBJECTIVES. The aim of our current study was to investigate the
correlation between regional cerebral blood flow (CBF) and (MD)
parameters (Glucose (Glu), Lactate (Lac), Glycerol (Gly), Pyruvate (Pyr)
concentrations and Lactate/Pyruvate metabolic ratio- L/P) in patients
with SAH.
METHODS. 21 patients with SAH were enrolled in this prospective
study. A minimally invasive, multimodal, neuromonitoring system
was placed in the first 8 hours after admission to the ICU. A frontal
burr hole was placed at Kocher's point under aseptic conditions and
a bolt kit was used for insertion of:
(a) an intracranial pressure (ICP) measurement catheter (Codman
microsensor kit, Codman, Johnson & Johnson, Raynham. MA USA),
(b) a brain tissue-oxygen monitoring catheter (PbrO2 measuring
catheter, Licox, Integra NeuroSciences. Plainsboro. NJ. USA) and
(c) an MD catheter (CMA 70 Brain Microdialysis Catheter, 10 mm
membrane length, 20 kDa cut off, CMA. Stockholm, Sweden).
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Hemedex, Bowman, Boston, MA, USA) was drilled adjacently to the
first one. CBF based on thermal diffusion methodology, the thermal
coefficient K, and MD biochemical markers were recorded. All
patients were treated using a cerebral perfusion pressure (CPP)
guided protocol. The duration of the brain monitoring was 10 days.
RESULTS. Regarding the correlations of the MD parameters and CBF
of the sample, Glu correlated positively with CBF, cerebral
Temperature (T), Lac, Pyr, and negatively to the L/P, Gly and K
coefficient of thermal conductivity of the brain (K). Pyr was positively
correlated, while Gly and Lac correlated negatively with CBF. K
correlated positively with the CBF and T. When the CBF was bisected
in the median flow rate (25ml/100gr/min), Glu was correlated
inversely with T, the L/P ratio and the CBF, when the CBF exceeded
the limit value. However, when, CBF was below the limit value, K
correlated negatively with CBF and T and positively with all other
variables. Glu was positively correlated with the L/P and negatively
with the T. At even lower CBF (corresponding to ischemia), very
strong negative correlations between the L/P and CBF emerge. Glu
continues to positively correlate with the L/P ratio as was previously
described for CBF less than 25ml/100gr/min. However at this state
there is a positive Glu and CBF correlation. Gly shows a negative
correlation to the CBF.
CONCLUSIONS. Regarding the correlations of MD parameters, with
CBF, K, and T, and also between them, the correlations vary
depending on the level of CBF. In summary, as the CBF drops, the
statistically significant relationships, are strengthened
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Bauernfeind A.L. et al.2014. Rostami E. et al.2014. Bouzat P. et al.2015
0275
The role of sepsis in the outcome of subarachnoid hemorrhage
patients: an exploratory analysis
B. Gonçalves, R. Turon, D. de Barros, N. Melo, P. Lacerda, M. A. dos
Prazeres, F. Miranda, P. Kurtz, F. Bozza, C. Righy
Paulo Niemeyer State Brain Institute, Rio de Janeiro, Brazil
Correspondence: B. Gonçalves
Intensive Care Medicine Experimental 2017, 5(Suppl 2):0275
INTRODUCTION. Subarachnoid hemorrhage (SAH) following aneurysmal
rupture is a catastrophic cerebrovascular event with high mortality and
morbidity. Intense systemic inflammatory response (SIRS) is one of the
main characteristics of the disease occurring in up to 83% of patients. In
this study, we evaluated the prevalence of SIRS and sepsis and its
association with outcomes in this population.
OBJECTIVES. Our goal was to describe the incidence of SIRS and
sepsis and its relation to the outcomes in patients with SAH, as part
of a large ongoing prospective study.
METHODS. From April 2016 to March 2017, all consecutive patients
admitted with aneurysmal SAH to the Neuro-ICU of a reference cen-
ter in Rio de Janeiro were enrolled in our cohort. Demographic,
clinical characteristics and laboratory variables related to sepsis
were collected during the first 14 days of hospital stay. The primary
endpoint was mortality and dichotomized functional outcome
(poor outcome defined as Modified Rankin Scale 4–6) at hospital
discharge. Numeric variables were expressed as median and inter-
quartile interval, and categorical variables were summarized as fre-
quency and percentage. We used the Chi-square test to analyze
categorical variables.
RESULTS. A total of 55 patients were enrolled in the study. Median
age was 51 years (22–79), and 41 patients were female (75%). 10
patients (18%) had poor-grade SAH (World Federation of Neurologic
Surgeons score of 4 and 5).
From our cohort, 73% patients developed SIRS criteria during
hospital stay. Using the current definitions (Sepsis-3, defined as an
acute change in total SOFA score ≥2 points consequent to the
infection), 12 patients (22%) had the diagnosis of sepsis during the
first 14 days of hospital stay.The most common site of infection was pulmonary (6 patients - 50%),
followed by urinary tract (2 patients), upper airway (2), pressure ulcer
(1) and central nervous system (1). Median time to infection (from
bleeding) was ten days (4–24 days). When stratified by severity, on the
septic group, four patients (33%) had poor-grade SAH (WFNS 4 or 5),
against six patients in the non-septic group (14%).
On the studied outcomes, among septic patients, 6 had vasospasm
(50%), 2 had DCI (17%), two died (17%), and 9 had poor outcome (75%).
In the non-septic group, 16 (37%) had vasospasm (p = 0.42), 10
(23%) had DCI (p = 0.62), 4 (9%) died (p = 0.47) and 11 (25%) pa-
tients had poor outcome (p = 0.001).
CONCLUSIONS. Our data is in tandem with the hypothesis that SIRS
is highly prevalent in SAH patients. However, about a quarter of them
develop sepsis, and, in this cohort of patients with SAH, sepsis was
associated with poor outcome, but not with either mortality or DCI.
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INTRODUCTION. Subarachnoid hemorrhage (SAH) following
aneurysmal rupture is a catastrophic cerebrovascular event with high
mortality and morbidity. The intense systemic inflammatory response
is one of the main characteristics of the disease occurring in up to
83% of patients. Differential diagnostic between infection, sepsis and
systemic inflammatory response (SIRS) associated with acute brain
injury is a challenge in this particular group.
OBJECTIVES. Our goal was to describe the role of biomarkers for the
diagnosis of infection and sepsis in this particular cohort, as part of a
large ongoing prospective study.
METHODS. From April 2016 to March 2017, all consecutive patients
admitted with aneurysmal SAH to the Neuro- ICU of a reference
center in Rio de Janeiro were enrolled in our cohort. Demographic
and clinical characteristics were collected during the first 14 days of
hospital stay. Procalcitonin and C-reactive protein levels were mea-
sured in the first and third days of hospital stay. The primary end-
point was sepsis (using the current definitions - Sepsis-3 - defined as
an acute change in total SOFA score ≥2 points consequent to the in-
fection). Numeric variables were expressed as median and interquar-
tile interval and were analyzed using Mann–Whitney U-test.
RESULTS. A total of 55 patients were enrolled in the study. Median
age was 51 years (22–79), and 41 were female (75%). 10 patients
(18%) had poor-grade SAH (World Federation of Neurologic Surgeons
score of 4 and 5).
Twelve patients (22%) had the diagnosis of sepsis during the first 14
days of hospital stay.
Median Procalcitonin levels on the first day on septic patients was
0.085 ng/ml (interquartile range 0.28, 0.05 - 0.33), and 0.05 ng/ml
(IQR 0.04, 0.04 - 0.08) on non-septic (p = 0.14). On the third day, me-
dian procalcitonin concentration was 0.11 ng/ml (IQR 0.21, 0.05 -
0.26) in septic patients, and 0.05 ng/ml (IQR 0.06, 0.03 - 0.09), in non-
septic patients (p = 0.2).
On the first day, median C-reactive protein level was 93 mg/L (IQR
165.6, 45.5 - 211) on septic patients, and 29.3 mg/L (IQR 55.3, 9.8 -
65.1) on non-septic patients (p = 0.0008). On the third day, median
C-reactive protein concentration was 137.5 mg/L (IQR 99.7, 80.3 -
180) on septic patients and 37.8 mg/L (IQR 58.7, 13.7 - 72.4) on non-
septic patients (p = 0.0001).
Table 82 (Abstract 0278). Shows clinical characteristics and outcome
according development of pneumonia
Stroke without
pneumonia
(n = 46)
Stroke with
pneumonia
(n = 16)
Age (years) mean±sd 60,4±14 61±11
Gender %(Male/Female) 60,9/39,1 56,3/43,7
NIHSS at admission (mean±sd) 15,2±7 17,1±8
ICU lenght of stay (days) mean±sd* 3,35±2,5 9,8±5,1
Vascular risk factors Hypertension/
Diabetes/Dyslipidemia/Atrial fibrillation
67,4%/54,3%/
19,6%/28,3%/15,2%
87,5%/81,3%/
37,5%/25%/37,5%
Mechanical ventilation requirements (%)* 45,7 93,8
Vasoactive drugs (%)* 34,8 75
Stroke: Ischemic/hemorrhagic (%) 54,3/45,7 43,8/56,2
Mortality (%)* 26,1% 81,3%
* P < 0.05
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 141 of 542CONCLUSIONS. In this small cohort, procalcitonin did not differ
between the septic and non-septic groups, but CRP was higher in pa-
tients with sepsis, which could aid the differential diagnosis and
prompt early treatment of patients at high risk of sepsis.
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INTRODUCTION. Hyperglycemia has been associated with poor
outcome in patients with subarachnoid hemorrhage, and increased
systemic glucose variability was associated with cerebral metabolic
distress and increased hospital mortality in these patients in a
retrospective cohort. The impact of glycemic control in neurocritical
patients remains controversial.
OBJECTIVE. The objective of this study was to assess whether
glucose variability is associated with functional outcome after
subarachnoid hemorrhage.
METHODS. From July 2015 to December 2016, all consecutive
patients admitted with aneurysmal SAH to the Neuro-ICU of a refer-
ence center in Rio de Janeiro were enrolled in our cohort. Demo-
graphic, clinical characteristics and serum glycemic values were
collected on the first 7 days after admission. The primary endpoint
was mortality and dichotomized functional outcome (poor outcome
defined as Modified Rankin Scale 4–6) at hospital discharge.
RESULTS. A total of 72 patients and 2865 measurements of serum
glucose were analyzed, along with arterial pressure, temperature and
Glagow coma scale. Glucose variability was expressed as the standard
deviation (SD) of all serum glucose measurements. Fifty six patients
(78%) were female, 18 (25%) were poor-grade SAH with WFNS 3 to 5
and 40 (56%) had modified Fisher III or IV. Seven patients (10%) rebled,
21 (29%) developed cerebral infarcts and only 1 patient died during
hospital admission. At hospital discharge, 34 (47%) patients had poor
outcome and systemic glucose SD was higher in this group as com-
pared to those with good outcome (median [IQR] 30.6 [23.6 - 37.6] vs
26.4 [20.4 - 32.4] P = 0.09). Multivariate analysis will be undertaken to
adjust to other clinically relevant variables.
CONCLUSIONS. In this retrospective analysis of a prospective cohort
of SAH patients, increased systemic glucose variability during ICU
admission was associated with poor outcome at hospital discharge.
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INTRODUCTION. Infections occurs frequently after stroke, pneumonia
is a dreaded complication in stroke patients.
OBJECTIVES. The aim of the present study is to describe the
incidence of pneumonia in patients admitted in ICU with a stroke.To analyze the prognosis of stroke patients who develop pneumonia
as complication during the acute phase of stroke.
METHODS. Prospective observational study performed in a
community hospital. Inclusion criteria were patients admitted in
ICU with an acute stroke. Time of study recruitment was 12
months. Variables analyzed were: age, gender, type of stroke:
ischemic or hemorrhagic, NIHSS at admission, vascular risk
factors, mechanical ventilation requirements, vasoactive drugs
use, ICU lenght of stay and mortality. Two groups of patients
were classified according development of pneumonia. Statistic
analysis was performed by SPSS v18 program, chi square test
was applied to compare qualitative variables and t Student for
the quantitative variables.
RESULTS. During the study period, 62 stroke patients were admitted
to the ICU. Pneumonia occurred in 25.8%.
CONCLUSIONS. In our serie of patients development of pneumonia
was related with the presence of vascular risk factors.
Pneumonia in stroke patients increases ICU lenght of stay, support
therapies requirements and mortality.0279
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INTRODUCTION. Unexplained cerebral hemorrhage could appear
after brain tumor surgery because of some hemostatic abnormalities
not routinely studied. Perioperative D-Dimer levels could predict the
appearance of that cerebral hemorrhage.
OBJECTIVES. The aim of this study was to analyse the association
between perioperative levels of DDimer and cerebral hemorrhage
after brain tumor neurosurgery.
METHODS. We prospectively performed, during 18 months at Miguel
Servet University Hospital in Spain, 3 DDimer testings (A presurgery,
B postsurgery, C 24 hours after surgery) in patients with brain tumor.
Ethical approval from a Committee and Informed Consent were
required. We accepted 0-200ng/ml as normal values. A Head CT scan
done the day after surgery to evaluate surgical complications. Cere-
bral hemorrhage was defined by intracranial hypertension due to
blood volumen or mass effect.
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 142 of 542RESULTS. We included 109 patients, 69 male and 40 female. A total
of 67 patients in A (61,4%), 82 in B (75,22%) and 91 in C (83,4%) had
DDimer elevated. A total of 67 patients in A, 82 in B and 91 in C had
DDimer elevated. The average was abnormally elevated in 3 testings
(A 930,04ng/ml, B 728,51ng/ml, C 1105,55ng/ml, 95% confidence
interval 599.536 to 1260.464, 590.504 to 865.496, 915.825 to 1294.175
respectively). 39 of 109 patients included in the study (35,78%) suffered
from cerebral hemorrhage. The Wilcoxon-Mann–Whitney test stadistic
showed significance between cerebral hemorrhage and DDimer levels
in A and C testings (p 0,039 and 0,042 respectively).
CONCLUSIONS. The average of perioperative DDimer was elevated
in patients with brain tumor. DDimer abnormalities in, presurgery
and the day after neurosurgery, testings were associated with
cerebral hemorrhage. So, we can conclude that high levels of
DDimer could be considered as risk marker for cerebral hemorrhage
after brain tumor surgery.
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INTRODUCTION. Primary brain injury leads to a cerebral and
systemic inflammatory reactions, a massive release of catecholamines,
which can effects of the respiratory system state.
OBJECTIVES. To assess the lung mechanics during mechanical ventilation
(MV) in patients in acute period of intracranial hemorrhages (ICH).
METHODS. 58 patients with ICH requiring ventilation for more than 24
hours enrolled in the study (age - 48,9 ± 10,5 years, male/female - 37/21).
18 patients had severe traumatic brain injury, 40 - cerebral aneurism
rupture. We used lung protective ventilation in all pts. In first day after
the beginning MV we analyzed every hour the heart rate (n = 1068),
mean blood pressure (BPmean) (n = 1062), saturation (SpO2) (n = 985),
end-tidal CO2 (EtCO2) (n = 985), peak airway pressures (Ppeak) (n = 1076)
and mean airway pressures (Pmean) (n = 1048), dynamic respiratory
compliance (n = 1010), expiratory resistance (n = 914), minute ventilation
(MV) (n = 1022) and respiratory quotient (RQ) (n = 914).
RESULTS. Parameters of hemodynamics and gas exchange were stable:
heart rate - 90 ± 21 beats per minute, BPM - 107 ± 19 mmHg, SpO2 -
99 ± 1%. We identified a tendency to hyperventilation in pts in acute
period of ICH: EtCO2 - 32 ± 12 mm Hg, MV - 10.6 ± 3.5 l/min, RQ -
0.78 ± 0.15. The airway pressures: Ppeak - 23.7 ± 9.6 mmHg, Pmean -
12.7 ± 4.5 mmHg. The dynamic compliance of the respiratory system
was 62 ± 26.5 ml/ cmH20, expiratory resistance - 9.2 ± 2.8 cmH20/l/s.CONCLUSIONS. Already in the first day after start of MV in patients
in acute period of ICH lung mechanics there are changes, due to a
decrease in the respiratory compliance and an increase expiratory
resistance.
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INTRODUCTION. Low levels of near-infrared spectroscopy derived
brain tissue oxygenation (BtO2) are associated with poor neurological
outcomes, such as delirium, in critically ill patients.1
OBJECTIVE. To characterize the physiological determinants of BtO2
in critically ill patients.
METHODS. This cohort was part of the CONFOCAL study
(NCT02344043 clinicaltrials.gov). Participants (n = 103) with
respiratory failure and/or shock were enrolled within 24h of
admission. BtO2 was measured with the FORESIGHT cerebral
oximeter (Casmed, Caster Medical). Simultaneous multiple linear
regression analyzed which hemodynamic/physiological parameters
predict BtO2. A multivariable model was then selected using
stepwise backwards selection. Spearman's correlation coefficients
were calculated for each individual patients' hemodynamics and
BtO2. Hierarchical cluster was applied to these correlations in
order to identify unique physiological phenotypes.
RESULTS. The full regression model included: mean arterial
pressure (MAP), heart rate (HR), peripheral oxygen saturation
(SpO2), temperature, pH, central venous pO2 (CV-pO2), venous pCO2
(vPCO2), and hemoglobin (Hb). This model accounted for a
significant proportion of the variance in BtO2, R
2 = 0.405, p = 0.012.
Backwards model selection indicated that the best fitting model
included: HR, SpO2, CV-pO2, vPCO2, and Hb. This final model also
accounted for a significant proportion of the variance in BtO2,
R2 = 0.379, p = 0.002. The percentage of BtO2 increased signifi-
cantly as HR and CV-pO2 increased. However, SpO2, vPCO2, and Hb
were not significant predictors of BtO2. Correlational analysis indi-
cated that the per patient BtO2 correlations with hemodynamic
parameters were highly variable. For example, some clusters of pa-
tients had significant positive correlations between BtO2 and MAP,
whereas others had inverse correlations.
CONCLUSIONS. HR and central venous pO2 contribute significantly
to BtO2. The significant inter-individual variability may limit the pros-
pects of a universal algorithm to optimize BtO2, and suggest the need
for precision approaches based on individual patient physiology.
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Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 143 of 542INTRODUCTION. Neurologic injury remains a significant complication
and one of the most frequent causes of death in patients
undergoing extracorporeal membrane oxygenation (ECMO). As
ECMO patients usually require sedation, their neurological examination
is not reliable, but neuromonitoring can help. However, the use of
electroencephalogram (EEG) in adult ECMO patients has not yet been
analyzed.
OBJECTIVES. To assess the occurrence of EEG abnormalities and their
relationship to outcome in patients treated by ECMO.
METHODS. We reviewed data all patients undergoing venous-venous
(VV) or venous-arterial (VA) ECMO with a contemporary (either intermit-
tently or continuous) EEG monitoring (April 2009 - June 2016). EEG find-
ings of interest were: a) “mild-moderate encephalopathy” (i.e. diffuse
slowing with reactivity/variability) vs. “severe encephalopathy” (i.e. dif-
fuse slowing without reactivity/variability); b) “burst suppression” or flat;
c) epileptiform activity (i.e. ictal EEG pattern, sporadic epileptiform dis-
charges or periodic discharges); d) EEG reactivity. EEG findings were an-
alyzed according to the primary diagnosis (presence of cardiac arrest
(CA) or not), the use of VA vs. VV ECMO and ICU mortality.
RESULTS. We studied 94 sedated patients (50 [16–83] years; 30 (32%)
male gender) out of 434 treated with ECMO). ICU mortality was 60%.
There were more unreactive EEGs among VA-ECMO (n = 72) patients
than in VV-ECMO (n = 22; 57% vs. 23%; p = 0.006). As expected pa-
tients after cardiac arrest (n = 64) more frequently had a burst sup-
pression or flat EEG than the others (n = 30; 27% vs. 0%; p = 0.001).
Also the non-survivors (n = 57) more frequently had a severe en-
cephalopathy (56% vs. 27%; p = 0.006), burst suppression or flat EEG
(28% vs. 3%; p = 0.002) and unreactive EEG (60% vs. 32%; p = 0.01)
than the survivors. The presence of these three EEG findings was sig-
nificantly associated with ICU mortality (OR 14.05 [1.77-111.25];
p = 0.01), even after adjustment for confounders.
CONCLUSIONS. EEG monitoring can be very helpful in sedated
patients during ECMO.
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INTRODUCTION. From 1989 in RNSI of Prof. A.L.Polenov we have
been successfully using the method of anesthesia that includs a
combined effect on opioid (fentanyl) and adrenergic (clonidine)
antinociceptive system. The use of more selective ALPHA2-
adrenoagonists (dexmedetomidine) can be considered as an option
for application in the structure of anesthesia during removal of sub-
tentorial brain tumors.
The aim of the study was to compare clonidine and dexmedetomidine´s
effect on the major hemodynamic parameters during the removal of
posterior fossa tumors.
MATERIALS AND METHODS. The study included 89 patients
(average age of 52,3 ± 13), underwent the elective surgery in RNSI
for subtentorial brain tumors. In all patients induction of anesthesia
included: muscle relaxants (nondepolarizing muscle relaxant), hypnotic
(propofol 2mg/kg), an opioid analgetic (fentanyl 4,8 ± 0,6μg/
kg) + ALPHA2-adrenoagonists (clonidine or dexmedetomidine).
Maintenance of anesthesia: hypnotics (propofol and 5,2 ± 1,6mg/kg/h),
opioid analgetic (fentanyl and 1,2μg /kg/h) + ALPHA2-adrenoagonists
(clonidine or dexmedetomidine). All patients were divided into three
groups: in group I (21 patients) induction of anesthesia: Clonidine
1,5 ± 0,4μg/kg; maintenance of anesthesia: Clonidine 0,4 ± 0,2μg/kg/h.
In group II (25 patients) induction of anesthesia: Dexmedetomidine
0,7 ± 0,1μg/kg; maintenance of anesthesia: Dexmedetomidine
0,18 ± 0,07μg/kg/h. In group III (43 patients) induction of anesthesia:
Dexmedetomidine and 1,4 ± 0,3μg/kg; maintenance of anesthesia:
Dexmedetomidine 0,4 ± 0,2μg/kg/h.RESULTS. In group I, the initial value of the mean BP was
(mean ± standard deviation) 108 ± 14 mm Hg., HR 77 ± 14 beats per
min. After induction of anesthesia mean BP 76 ± 19mm Hg, HR
53 ± 8 per min. 20 minutes after induction of anesthesia mean BP
71 ± 14mm Hg, HR 55 ± 7per min. By the time of full closure of the
wound mean BP 83 ± 11mm Hg, HR 59 ± 13 per min.
In group II the initial value of the mean BP 110 ± 18mm Hg, HR
76 ± 15 per min. After induction of anesthesia mean BP 110 ± 21mm
Hg, HR 42 ± 7 per min. 20 min. after induction of anesthesia mean
BP 83 ± 17mmHg, HR 52 ± 6 per min. By the time of full closure of
the wound mean BP 84 ± 10mm Hg, HR 51 ± 7 per min.
In group III, the initial value of mean BP 101 ± 13mm Hg, HR 72 ± 11
per min. After induction of anesthesia mean BP 110 ± 17mmHg, HR
43 ± 8 per min. 20 min. after induction of anesthesia mean BP
93 ± 16mmHg, HR 51 ± 10 per min. By the time of full closure of the
wound mean BP 90 ± 13mm Hg, HR 55 ± 9 per min.
CONCLUSION. Thus, in the I and II groups after induction of
anesthesia central simpatolytic effect dominated. Such changes of
the hemodynamic parameters were preserved during the entire
operation.
And in group III after induction of anesthesia dominated the
peripheral vasoconstrictor effect.Such changes of hemodynamic
parameters were observed for a short period of time and later
during operations also dominated central simpatolytic effect.
Sedation, analgesia and delirium
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INTRODUCTION. Delirium occurs frequently in Intensive Care Unit
(ICU) patients and is associated with poor outcome. In spite of this,
there is limited evidence to support any specific pharmacological
interventions, and recent Clinical Practice Guidelines make no strong
recommendations.1 However, widespread use of haloperidol for ICU-
delirium is likely.
OBJECTIVES. To describe current use of haloperidol and other
pharmacological interventions for delirium in critically ill patients
admitted to the ICU and to explore associations to outcomes.
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 144 of 542METHODS. We conducted the international AID-ICU cohort study
with a 14-day inception period (March - August 2016) in Denmark,
Norway, Sweden, Finland, the Netherlands, Switzerland, Germany,
Belgium, Spain, Italy, Canada, Brazil and France. We included all pa-
tients aged 18 years or older who were acutely admitted to a par-
ticipating ICU not meeting an exclusion criterion (e.g. mental
illness, dementia). Follow-up was until 90 days after ICU admission.
We estimated that at least 1000 patients was needed to obtain
95% CI's of 11% - 15% around an estimated rate of the primary
outcome (the number of patients with delirium intervened with
haloperidol) of 13%. Patient consent was obtained according re-
quirements in each country.
RESULTS. (analysis in progress)
A total of 99 ICUs screened 1922 patients and excluded 648; 8
patients withdrew consent and 6 patients had incomplete data
leaving 1260 patients for the analyses. We will report the number of
ICU patients with delirium intervened with haloperidol (the primary
outcome) including dosages and types of administration, and the
number of ICU patients with delirium intervened with other
agents for delirium (other antipsychotics than haloperidol,
dexmedetomidine and benzodiazepines); the number of patients
with delirium; mortality at 90 days; days alive in ICU without
coma or delirium; days alive without mechanical ventilation, and
days alive out of hospital within the 90-day period. In the explora-
tive analyses we will assess any associations between baseline risk
factors and use of haloperidol and mortality.
CONCLUSIONS. With the results of the AID-ICU cohort study, we will
provide important data on the use of haloperidol for delirium in a
large number of ICUs Europe, Brazil and Canada. This will inform the
design of a large-scale, international, randomized, placebo-controlled
trial of ICU patients with delirium.
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INTRODUCTION. Immediate postoperative patients are under the
influence of anesthetics, which might affect the results of CAM-ICU.
And the consequence of immediate postoperative brief delirium
might be different from that of persistent delirium.
OBJECTIVES. The aims of our study were to compare early brief
delirium, late brief delirium and persistent delirium in patients
with an ICU LOS of more than 24 hours after surgery and to
evaluate the risk factors of persistent delirium in postoperative
surgical ICU patients.
METHODS. We performed a retrospective study of development of
delirium from November 1, 2012, to September 30, 2014. A total of
581 patients admitted to SICU for more than 24 h were enrolled.
Patients were evaluated for development of delirium using the
Confusion Assessment Method for ICU Patients (CAM-ICU).
Patients were categorized into 4 groups according to the onset
and duration of delirium: no delirium, delirium for less than 1 day
on postoperative day 0 and abated within first 24 hours
postoperatively (early brief delirium), delirium for less than 1 day
after postoperative day 0 (late brief delirium), delirium for more
than 1 day (persistent delirium).RESULTS. The overall incidence of postoperative delirium was 23.1%
(134/581). ICU and hospital length of stay and hospital and 1-year
mortality were not different between early brief delirium and no de-
lirium groups. Patients with persistent delirium showed longer length
of stay (ICU and hospital) and higher mortality rate (ICU, hospital, 1-
year) compared to patients with no delirium. After adjusting APACHE
II score, persistent delirium group was associated with hospital mor-
tality (hazard ratio (HR) 3.26, 95% CI [1.30-8.1], p = 0.012) and 1-year
mortality (HR 2.82, 95% CI [1.43-5.58], p = 0.003) in time varying mul-
tivariable cox regression analyses. Multivariable analysis revealed age
(OR 1.05, 95%CI [1.03-1.08], p < 0.001), higher APACHE II score (OR
1.08, 95%CI [1.03-1.12], p < 0.001), emergency operation (OR 2.29,
95%CI [1.31-4.02], p = 0.004), and alcoholism (OR 6.38, 95%CI [1.24-
32.99], p = 0.03) as significant predictors of persistent delirium.
CONCLUSIONS. In conclusion, we found that early brief delirium
group had similar outcome to no delirium group and significant
difference with persistent delirium group in ICU stay and mechanical
ventilation duration. And persistent postoperative delirium was
associated with increased ICU and hospital stay and increased
hospital and 1-year mortality.
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INTRODUCTION. Sedoanalgesia is a key component in the treatment
of many critical patients and providing the optimal level of sedation
in each patient is crucial. It is essential to use adequate doses of
sedatives and analgesics, as well as targeting and monitoring
constantly the level of sedation.
OBJECTIVE. Analyze the sedoanalgesia and delirium management in
the ICU of a referral hospital.
METHODS. Prospective observational study, masked for non-
participating professionals. Studied variables included type of admis-
sion (scheduled surgery, urgent surgery, medical and trauma), age,
gender, APACHE II, underlying disease, median length of stay and
ICU mortality. Therapeutic management related to sedation, anal-
gesia and delirium data were collected daily for 15 consecutive days
in all patients. Sedoanalgesic management in the ICU was analyzed
during the first, fifth and ninth days of admission. Values were
expressed as mean ± SD and frequency.
RESULTS. 46 patients were included, mean age was 63.6 years (SD
16.3). 68.1% were male. 45.7% were admitted after scheduled
surgery. Hypertension (45.7%), heart disease (41.3%), and smoking
(28.3%) were the three most common underlying conditions.
APACHE II of 13.2 (SD 6.9). 73.9% required mechanical ventilation
and 54.3% vasopressors. Median length of stay was 4.3 days (SD 5.0)
with a mortality of 16.3%. Delirium was not monitored in 97.5%, pain
in 91.3% and sedation in 81.1% of patients respectively. The
management of sedatives and analgesics with average doses (D) and
average hours (H) with minimum and maximum values in both D
and H are shown in Table 83. Results of sedation and agitation scales
obtained by the researches are shown in Table 84.
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 145 of 542CONCLUSIONS. The results revealed a lack of monitoring of pain,
sedation and delirium in our ICU as well as the use of medium-high
doses of sedatives but lower doses of analgesics reaching degrees of
moderate-deep sedation.
REFERENCE
1. Estébanez Montiel M.B, Alonso Fernández M.A, et al. Sedación
prolongada en Unidades de Cuidados Intensivos. Med Intensiva.
2008;32 Supl 1:19–30.
2. Chamorro C, Martínez Melgar J.L, et al. Monitorización de la
sedación. Med Intensiva. 2008;32 Supl 1:45–52.Table 83 (Abstract 0286). Characteristics of sedatives and analgesics
Variables Day 1 Day 5 Day 9
Propofol (mg/kg/h) D:2,5(0,01-4,59)
H:8,9(1-23)
D:2,7(0,95-4,18)
H:23,6(23-24)
D:2,5(1,46-3,51)
H:19,8(4-24)
Remifentanyl (mcg/kg/min) D:0,07(0,03-0,11)
H:8,9(3-23)
D:0,07(0,03-0,11)
H:23,6(23-24)
D:0,07(0,05-0,08)
H:19(4-24)
Midazolam (mg/kg/h) D:0,21 H:17 D:0,17(0,06-0,29)
H:17,5(12-23)
D:0,08(0,05-0,12)
H:24
Fentanyl (mcg/kg/h) D:3,2 H:17 D:1,59(1-2,19)
H:17,5(12-23)
D:1,37(0,09-1,76)
H:24
Morphine (mg/kg/h) D:0,03(0,02-0,04)
H:5,25(4-6,5)
- -
Dexmedetomidine
(mcg/kg/h)
- - D:0,81(0,66-0,99)
H:24
Table 84 (Abstract 0286). Sedation and agitation scales’ results
Variables Day 1 Day 5 Day 9
ESCID 0 82,4% 92,3% 80,5%
EVN < o = 4 76,9% 100% 92,6%
RASS < o = -3 38,6% 67,6% 45,5%
CAM-ICU (+) 3,8% 15,4% 16,7%0287
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INTRODUCTION. ICU-acquired encephalopathy is frequent and is as-
sociated with increased morbidity and length of stay (LOS), yet there
are no recognized monitoring tools for early prediction of delirium in
this setting.
OBJECTIVES. To examine the value of automated infrared pupillometry
(Neurolight-Algiscan®, ID-Med, France) to predict delirium.
METHODS. Cohort analysis of consecutive patients admitted to a
mixed medical/surgical ICU (December 2016-March 2017), who
underwent sedation and mechanical ventilation for > 48 hours and
had no acute/previous history of neurological dysfunction. Standard
neurological examination (GCS-motor response [GCS-M] and the
FOUR score) and quantitative pupillary light reflex (qPLR, expressed
as % pupillary response to a calibrated light stimulus) were per-
formed in parallel (5 [4–7] days following ICU admission). Delirium
was defined as a Richmond Agitation Sedation Score (RASS) > 1 re-
quiring antipsychotic medication.
RESULTS. 24 patients were included (median age 65 [IQR 54–72] yrs;
APACHE II score 24 [19–29]; SOFA score 12 [9–13]). All subjects had
sepsis, and 12 (50%) of them developed delirium. Delirium was
associated with longer ICU LOS (22 ± 18 vs. 8 ± 4 days in non-
delirium patients, p = 0.01). Quantitative pupillometry - performed a
median of 4 [1–8] days previous to delirium diagnosis - revealedsignificantly lower qPLR in patients with delirium than in those with-
out delirium (20 [16–29] vs. 30 [25–39] %, p = 0.03). All - except one
- subjects with impaired qPLR < 20% developed delirium (92% speci-
ficity; 86% positive predictive value). In contrast, simultaneous GCS-M
and FOUR score did not differ significantly between delirium and
non-delirium patients (p > 0.2). Similarly, no significant differences
were found between the two subgroups for age, APACHE II score,
SOFA score, and the cumulative dose of sedatives/analgesics/
vasopressors.
CONCLUSIONS. These preliminary data suggest that impaired
quantitative PLR may be used for early prediction of ICU-acquired en-
cephalopathy in critically ill non-neurological mechanically ventilated
patients.
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INTRODUCTION. Delirium is a common manifestation of acute brain
dysfunction in critically ill patients with a prevalence of 80% in
intensive care unit (ICU) patients1. It is associated with multiple
complications1. A revised version of the ICU pain, agitation, and
delirium (PAD) guidelines was published in 20132. Yet, its
dissemination in a community ICU is unclear.
OBJECTIVES. As the initial phase of a single center multifaceted and
multidisciplinary intervention with an overall aim to improve PAD
management in a community ICU, this study aimed to:
1. Review PAD management practice.
2. Examine nurses' comfort in, perception and satisfaction of PAD
management.
3. Explore potential barriers and improvement strategies of PAD
management.
METHODS. Daily collection of process and outcome measures was
conducted on all patients admitted to the ICU for >24 hours over a
20-week period (from April to August 2016). An anonymous 23-
question paper-based survey was administered to ICU nurses to
understand their comfort in, perception and satisfaction of PAD
management.
RESULTS. Pain using Numeric Report System, agitation using
Richmond Agitation Sedation Scale (RASS) and delirium using
Confusion Assessment Method for the ICU were assessed on a
median of 53, 73 and 24% of patients per day, respectively.
Benzodiazepines were administered to a median of 24% of patients
per day. A median of 20 and 36% of patients per day were found to
be in pain and over-sedated (RASS < −1), respectively.
For the survey, there were 81 responses (98% response rate) with a
median ICU experience of 6 years. >85% of nurses were comfortable
with pain and agitation assessment. Only 41% of nurses were
comfortable with delirium screening. 94, 70 and 57% of nurses were
comfortable with pain, agitation and delirium treatment, respectively.
70% of nurses would calm down an agitated patient first. 54% of
nurses performed sedation vacation or used non-pharmacological
therapy. 47 and 43% of nurses were satisfied with PAD management
by nurses & physicians, respectively. Multiple barriers to optimal PAD
management included inconsistencies in PAD management among
physicians and nurses, inadequate education and staff shortage.
Nurses also identified education, PAD protocol, consistency of patient
care among physicians and tailored non-pharmacological therapy as
potential improvement strategies.
Table 86 (Abstract 0289). Adverse Events
Timeframe
[hours since
clonidine
initiation]
Hypotension/
[total available
for estimate]
MAP<65/[total
available for
estimate]
HR<60/[total
available for
estimate]
Total daily dose
of clonidine (mg)
Total daily dose
of clonidine (mg)
Total daily dose
of clonidine (mg)
All ≤0.4 >0.4 All ≤0.4 >0.4 All ≤0.4 >0.4
24 20/95
(21%)
12/53
(23%)
8/42
(19%)
50/95
(53%)
30/53
(57%)
20/42
(48%)
7/95
(7%)
2/53
(4%)
5/42
(12%)
48 16/76
(21%)
9/36
(25%)
7/40
(18%)
29/76
(38%)
16/36
(44%)
13/40
(33%)
8/76
(11%)
1/36
(3%)
7/40
(18%)
72 11/58
(19%)
4/25
(16%)
7/33
(21%)
31/58
(53%)
12/25
(48%)
19/33
(58%)
12/58
(21%)
4/25
(16%)
8/33
(24%)
Table 85 (Abstract 0289). Clonidine Prescription Information
Total daily dose of clonidine (mg)
All
(n = 95)
≤ 0.4
(n = 53)
> 0.4
(n = 42)
P-value
(≤ 0.4 vs > 0.4)
Duration of use,
days
median
(IQR)
5 (2,8) 3.5 (2,7) 6 (4,12) 0.002
Transferred out of
the ICU on clonidine
n (%) 26 (27) 16 (30) 10 (24) 0.57
Tapered
(while in ICU)
n (%) 5 (5.3) NA (cannot
taper low
dose)
5 (12) 0.015
Table 87 (Abstract 0289). Utilization of opioids, sedatives and anti
Mean daily difference
(72h before - 72h after clonidine start)
Total dose of clonidine (mg)
All ≤0.4 >0.4 p value
Opioids (fentanyl
equivalents, mcg)
median
(IQR)
98.3
(-318.8, 881.7)
83.3
(-225, 608.3)
124.2
(-325, 1016.7)
0.716
Benzodiazepines
(midazolam
equivalents, mg)
median
(IQR)
0 (-0.7, 16.2) 0 (-0.33, 9.33) 0.58
(-4.67, 21.0)
0.848
Antipsychotics
(olanzapine
equivalents, mg)
median
(IQR)
−0.25
(-20.38, 0)
0 (-9.2, 0.76) −4.8
(-32.6, 0)
0.039
Propofol (mcg) median
(IQR)
0
(-43.4, 113.3)
0 (0, 20.0) 0
(-580, 318.3)
0.945
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 146 of 542CONCLUSION. Our audit data suggests a gap in PAD management.
Information elicited from our survey helps to explain this gap and
will guide subsequent nurse focused interventions as part of our
multifaceted interventional study.
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INTRODUCTION. Intensive care unit (ICU) patients often require
analgesia and sedation, especially to ensure safety and comfort in
the context of mechanical ventilation (MV). To this end, intravenous
sedatives (e.g. midazolam) and opioids (e.g., morphine) are routinely
administered. These drugs however, do have adverse effects (e.g.
respiratory depression, delirium), do not permit rapid neurological
assessment, and are associated with prolonged MV and ICU length
of stay (LOS). Using the lowest effective sedative and analgesic doses
while maintaining desirable pain control and sedation has been
shown to improve clinical outcomes. Clonidine is an alpha-2 agonist
traditionally used for hypertension, but is also gaining popularity in
the ICU setting, where it is used for its sedating and analgesic prop-
erties. To date, however, little research has been published on cloni-
dine for sedation in adult ICU patients.
OBJECTIVES.
1) describe clonidine dosing regimens,
2) report incidence of adverse events (hypotension, bradycardia), and
3) investigate possible sparing effects on traditional drugs used for
pain, sedation and agitation (e.g., opioids, sedatives, antipsychotics).
METHODS. Single-centre retrospective chart review. Inclusion: adults
(≥18 years) admitted to the ICU during a 5-year period and receiving
≥1 dose of enteral clonidine. Exclusion: patients on clonidine prior to
ICU admission. Data were extracted from pharmacy records and
medical charts. Demographic and outcome data: age, sex, MODS, ad-
mission type, adverse events (e.g., hypotension), duration of MV, ICU
and hospital LOS, and ICU mortality. Drug data: duration of clonidine
use, dosing regimen, and method of discontinuation. Subjects were
divided into those ever receiving 0.4 mg/day or more (high dose)
versus those never receiving 0.4 mg/day (low dose). Adverse drug
events were collected for the three days before and after clonidine
initiation.
RESULTS. Preliminary results are available for 95/195 patients
meeting inclusion criteria. Median age 56 years (36% female) and
median MODS 6.7. Fifty-six percent (53/95) of patients had clonidine
titrated beyond an initial dose (high dose) (Table 85). Median dur-
ation of clonidine use was 5 days. High dose patients had a longer
duration of clonidine use (6 vs. 2.5 days, p = 0.002) and MV (14 vs. 9
days, p = 0.037). Within 24 hours of starting clonidine, 21% of all pa-
tients experienced SBP < 90 mmHg, 53% experienced MAP < 65, and
7.4% had ≥1 episode of HR < 60 (Table 86). There was no difference
in adverse events between groups. No differences were found in
terms of reduction of overall opioid and sedative exposure (Table
87); however, the high dose group had greater antipsychotic usage.
CONCLUSIONS. Preliminary review shows only ~50% of patients
have their clonidine dose titrated beyond an initial dose. No
differences were found between groups in the incidence of
hypotension or bradycardia, nor in opioid and sedative exposure
after clonidine initiation.0290
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Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 147 of 542INTRODUCTION. Critically ill patients frequently need analgesics and
sedatives namely to improve patient ventilator synchrony, to relieve
anxiety and improve comfort. Eventually, some of those will develop
delirium known to increase morbidity and mortality.
OBJECTIVES. The aim of this study was to characterize the practices
of Portuguese Intensive Care Units (ICU) physicians towards
analgesia, sedation and delirium management (ASD).
METHODS. Between September 2016 and April 2017, an on-line sur-
vey was distributed to ICU physicians in Portugal. The database was
built from the Portuguese Intensive Care Society database.
RESULTS. A total of 117 physicians answered the survey (28% response
rate) and the majority of respondents (88%) work mainly in ICU. The
existence of protocols for ASD is considered useful by 94% of
physicians, but less than 50% refer having such protocol in their ICU.
Pain is considered a frequent problem in ICU (95%), but only 86%
monitor pain daily and only 67% use standardized scales. Opioids are
the most frequently used analgesic in ICU (94%), followed by
acetaminophen (77%).
Concerning sedation, the most frequently used medication is
propofol (91%), followed by opioids, both natural and synthetic
(79%), midazolam (68%) and dexmedetomidine (50%). Richmond
Agitated Sedation Scale is the most commonly used scale for
sedation assessment. Forty-four physicians consider that patients are
over sedated most of the time. Physicians are aware of delirium as
an important cause of mortality and morbidity but only 65% assess it
daily. Confusion Assessment Method for Intensive Care Unit (CAM-
ICU) is the most frequently applied delirium scale (55 physicians).
Some physicians report diagnosing delirium on clinical grounds,
without the use of scales (42 physicians). Almost half of the respon-
dents consider delirium diagnostic scales difficult to apply (49%).
Quetiapine (72%) and haloperidol (92%) are the most commonly
used drugs in hyperactive delirium.
CONCLUSION. Despite the recent advances in knowledge regarding
ASD, some recommendations are still not translated into clinical
practice. Concerning sedation, the regular use of sedation scales and
sedation assessment lacks effect as clinicians consider there is still
over-sedation. Even thought the recommendations towards the use
of sedation strategies with non-benzodiazepine sedatives, it is still
largely used in ICU. Pain is routinely monitored in almost every pa-
tient, and preemptive analgesia over baseline analgesia is becoming
a frequent approach. Delirium is considered a serious problem in
ICU, but only a small percentage of physicians use specifics screening
tool. The authors consider that there is still a long path to walk
concerning ASD in Portuguese ICU. Recently a group of physi-
cians created a national task force to address issues related with
ASD practices and education, hoping for better practices in the
near future.
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INTRODUCTION. Critically ill patients who are admitted to the
intensive care unit (ICU) are often sedated as agitation may lead to
ventilator dysynchrony and the inadvertent dislodgement of vital
equipment and medications. Despite the rampant use of sedation, to
date there is no consensus on the best sedation practices. In a
landmark trial by Shehabi [1], he found that patients who were
lightly sedated in the early admission period were more likely to be
extubated earlier and to have increase survival rates.OBJECTIVES. We attempt to investigate our sedation practices, and
to determine if there are any association between depth of sedation
and outcomes.
METHODS. This was a prospective, observation cohort study in
patients admitted to SGH MICU/SICU who were ventilated and
sedated for >24 hours. Baseline demographics were obtained, and
patients followed up for 28 days or up to ICU discharge. Details on
type and dose of sedative agents, ventilation duration, hospital/ICU
length of stay/mortality, delirium (by CAM-ICU), and sedation depth
(by RASS) were collected.
RESULTS. 58 patients were recruited from April-July 2012 (mean age
63.1+/−14.3 years; mean APACHE II, 20.2+/−8.5). Hospital mortality
rates were 32.8%.
Patients were followed up for 387 ICU patient-days. In the early (first
48h) period, the most popular sedative used was propofol(74.1%
patient-days), followed by morphine(29.3%), midazolam(13.8%), dexme-
detomidine(7.8%), no sedation(6%) and fentanyl(2.6%). In the subse-
quent period, most patients were not sedated(47.6%), morphine
became the most popular sedative(32.5%) followed by propofol(31%),
midazolam(3.7%), dexmedetomidine(3%) and fentanyl(0.4%).
1994 RASS assessments were performed with a prescribed target in
11.1%. Amongst them, 86% met their targets.
3 patients were excluded from outcome analysis as they were
ventilated for less than 48 hours. Lightly sedated(−2 > =RASS > = 1)
patients were less likely to be delirious (0.9% vs 7.7%, p = 0.0095),
with a reduction in ICU mortality (0% vs 21.1%, p = 0.048). There was
a trend towards a reduction in vasopressor use (41.2% vs 76.3%,
p = 0.057). There was no difference in rates of renal replacement
therapy, hospital/ICU length of stay and hospital mortality.
CONCLUSIONS. Propofol and morphine are the most common ICU
sedatives. Routine sedation goals should be prescribed as lighter
sedation leads to improved survival and delirium rates.
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INTRODUCTION. Sedation and pain control are crucial in the
management of ICU patients. Deep sedation, defined as a Richmond
Agitation-Sedation Scale (RASS) of −4 or −5 is indicated in intracra-
nial hypertension, epileptic status, therapeutic hypothermia, complex
respiratory situations, superficial sedation failure and terminal sed-
ation. Precise control of the depth of sedation is often not well man-
aged; patients are frequently oversedated with an accompanying
increase in morbidity and mortality.
OBJECTIVES. Analysis of the repercussion of inadequate sedation on
the length of stay and mortality in ICU patients.
METHODS. Observational and prospective study, masked for non-
participating professionals. The study was conducted in the 24-bed
capacity ICU of a referral hospital and was carried out over a period
of 15 days. All patients admitted to the ICU were included. Demo-
graphic data, severity scales and characteristic of sedoanalgesia were
collected daily for the whole period of the study. Inadequate sed-
ation was defined as a RASS < −3 (deep sedation) without indication
(without ARDS, intracranial hypertension, epileptic status, terminal
sedation or superficial sedation failure). Univariable analysis was per-
formed to explore association with days of inadequate sedation and
ICU lenght of stay and mortality. Those variables associated with
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 148 of 542mortality (p-value ≤0.10) and those associated with length of stay (p-
value ≤0.05) were included in a multivariate model to quantify the ad-
justed weight of days of inadequate sedation with mortality and length
of stay. The quantitative variables were analyzed by Student´s t or
Mann–Whitney U. The qualitative ones were analyzed by Chi-square or
Fisher´s test and correlation coefficients of Pearson or Spearman as ap-
propriate. The multivariate model was performed by logistic regression
for mortality and multiple linear regression for the length of stay.
RESULTS. 46 patients were included with a total of 207 days
analyzed with a median of 4.7 days analyzed by patient (range 1–15).
68.1% were male, mean age 63.6 years (SD 16.3 years). 16.3%
mortality. Inadequate sedation in 19 patients, with an average of 3.6
days (SD 2.6, range 1–9). In the multivariate analysis, (B) value for
days of inadequate sedation was 2.20 (95%CI 0.04 - 4.25) and p-value
0.047. For mortality 1.22 (95%CI 0.75 - 2.00) for each day of inad-
equate sedation, with p-value 0.419.
CONCLUSIONS. There was a high prevalence of inadequate sedation
in our study. Each day of inadequate sedation was associated with
an increase in the length of stay of 2.20 days and an increase in
mortality by 1.22 for each day of inadequate sedation - although this
last value does not reach statistical significance - probably due to the
shortness of the study.
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INTRODUCTION. To describe our experience (in terms of safety and
efficacy) of a sedoanalgesia protocol using dexmedetomidine (Dx) in
critically ill patients, under mechanical ventilation (MV) and
spontaneous breathing (SB), admitted to our Unit (medical ICU).
METHODS. Descriptive and prospective study carried out during a
18-month period, according to dexmedetomidine indications for
mechanical ventilation: sequential sedation, failure- tolerance to sed-
ation, agitation- withdrawal syndrome or hyperactive delirium; and in
SB: agitation-withdrawal syndrome, hyperactive delirium or adapta-
tion to non-invasive mechanical ventilation. The following parame-
ters were analyzed in both groups: age, gender, APACHE II score,
reason for admission, length of ICU stay, past psychiatric history and
toxic habits, time to achieve RASS goal (between −2 and 0): before
12 hours, between 12–24 hours or more than 24 hours, mean dosage
and maximum dosage, adverse effects, non controllable patients (fail-
ure of Dx strategy), time spent under sedoanalgesia and time of de-
escalation with Dx (hours). Statistical analysis: quantitative variables
are expressed as the mean and standard deviation (SD), and qualita-
tive variables as a percentage. The difference between qualitative
variables are expressed using chi-square test and quantitative using
an ANOVA analysis.
Results: 57 patients were included (35 male), mean age: 60 ± 22
years old, APACHE II score: 17,4 ± 9, reason for ICU admission:
trauma 9, respiratory 18, neuro 8, cardio 3, infectious 10,
intoxications 8, other 1. Past psychiatric history 12 and toxic habits 9.
Indication for Dx according to protocol (patients under MV/SB: 37/
20): sequential sedation 8/0, failure-tolerance 15/0, agitation-
withdrawal syndrome 10/7, hyperactive delirium 4/5 and adaptation
to non-invasive MV 0/8 (post-extubation 5). Time to achieve RASS
goal (between −2 and 0), in the MV group: < 12 hours:7, between
12–24 hours:21 and >24 hours:9 patients; in the SB group: < 12 hours: 4, between 12–24 hours: 10
and >24 hours: 6 patients. Mean dosage (Dx): 0,83 ± 0,25μgr/kg/h
(MV) and 0,4 ± 0,24μgr/kg/h (SB) and maximum dosage:
1,2 ± 0,16μgr/kg/h (MV) and 0,7 ± 0,12μgr/kg/h (SB). Failure of Dx: 7
patients. Adverse effects: bradycardia 4, hypotension 8. Time spent
under Dx: 39 ± 18 hours(MV) and 28 ± 14 hours (SB)
CONCLUSIONS. According to our protocol of sedoanalgesia with
dexmedetomidine, the RASS goal was achieved in 70% and 75% of
the patients under MV or SB in less than 24 hours respectively.
Failure of the strategy of sedation with Dx: 12% in our series. The
most common adverse effect was hypotension (14%).
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INTRODUCTION. The incidence of ICU delirium remains high1
particularly in mechanically ventilated patients2 and is associated
with substantial morbidity, mortality and ICU length of stay (ICU-
LOS)3. Dexmedetomidine was introduced on our Cardiothoracic
ICU (CT ICU) in April 2015 primarily for patients with ICU delirium
and this case series provides a report on our experience of using
the drug.
OBJECTIVES.
- To analyse our use of dexmedetomidine in a clinical setting
- To report the mean duration of mechanical ventilation (MV) and
ICU-LOS in all patients admitted to the ICU before and after the intro-
duction of dexmedetomidine, as secondary outcome measures.
METHODS. Data were retrieved retrospectively from an electronic
prescribing system over an 18 month period for all patients treated
with dexmedetomidine on the CT ICU. The mean MV and ICU-LOS
for all patients admitted pre (2014) and post-introduction of dexme-
detomidine (2016) was also calculated using a database retrieval
system.
RESULTS. A total of 72 patients were included in the case series
during April 2015 to October 2016. The mean age was 58 years old.
The mean initial and maintenance doses were 0.54 and
0.95micrograms/kg/hour respectively. The mean duration of
treatment was 2.43 days and the mean MV and ICU-LOS were 5.66
days and 9.07 days respectively. Adverse effects were found in 72%
of patients, the most common were hypotension (61%) and brady-
cardia (10%).
For all patients admitted to the CT ICU in 2016 the mean MV (days)
was 4.7 (n = 634) compared to 5.12 (n = 598) in 2014 (P-value
0.4056, unpaired t-test). The mean ICU-LOS (days) for all patient ad-
mitted to the unit in 2016 was 7.07 (n = 770) compared to 7.97
(n = 702) in 2014 (P-value 0.1424, unpaired t-test).
CONCLUSIONS. Dexmedetomidine has become a useful adjunct to
our sedation armamentarium in a specialist Cardiothoracic and
Transplant Centre. Our secondary outcome measure demonstrated a
reduction in mean MV and LOS-ICU when comparing 2016 to 2014
for all patients admitted to the unit, but this did not reach statistical
significance. This case series also illustrated that patients treated with
dexmedetomidine for delirium receive mechanical ventilation for lon-
ger and spend more time in the ICU.
REFERENCES
1. Thomason JW, Shintani A, Peterson JF, Pun BT, Jackson JC, Ely EW:
Intensive care unit delirium is an independent predictor of longer
hospital stay: a prospective analysis of 261 non-ventilated patients.
Crit Care 2005,9(4):R375–R381.
2. Ely EW, Shintani A, Truman B, Speroff T, Gordon SM, Harrell FE Jr,
Inouye SK, Bernard GR, Dittus RS: Delirium as a predictor of mortality
in mechanically ventilated patients in the intensive care unit.
JAMA2004,291(14):1753–1762.
3. Salluh et al.Outcome of delirium in critically ill patients: systematic
review and meta-analysis. BMJ 2015; 350.
Table 90 (Abstract 0295). Results of first and second DOPS
Assessment (1 point to 6 points) First DOPS (n=28) Second DOPS (n=25)
Explains indication of assessment 3.5 4.7
Demonstrates appropriate preparation 3.9 4.8
Explains assessment to patient 4.0 4.8
Performs assessment 3.7 4.2
Provides consideration for patient 4.0 5.5
Communication skills 4.0 5.3
Overall clinical competence 3.9 4.9
Table 88 (Abstract 0294). MV_ICU_LOS Table 89 (Abstract 0295). Results of pre- and post-lecture tests of
Question Number of
participants
answered
correctly (n=32)
Pre-
lecture
Post-
lecture
Delirium is a chronic onset of consciousness disturbance. 9 31
There are three subtypes of delirium in ICU: hyperactive,
hypoactive and mixed. Hyperactive delirium tends to
occur more in elderly patients and has a worse outcome.
7 31
Haldol is the drug of choice to manage delirium. 8 31
CAM-ICU is to assess the severity of delirium 5 30
Opiates and benzodiazepines are an independent risk
factor for delirium.
31 27
The four features of CAM-ICU are: (I) Acute change or
fluctuating course of mental status, (II) Inattention, (III)
Altered level of consciousness, and (IV) Disorganized thinking
13 30
Delirium is presence when any 2 features of CAM-ICU
are positive.
19 31
Feature III was absent if RASS is -2. 17 30
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INTRODUCTION. Despite the occurrence of delirium is common in
intensive care unit (ICU) and there is growing evidence demonstrates
that delirium is harbinger of worse patient outcome, many doctors
and nurses show little awareness towards delirium. This highlights
routine screening of all ICU patients for the presence of delirium is
important to its successful and early management. Nurses are on the
frontline to look after patients they can detect, manage and even
prevent delirium. Therefore we decided to launch a two-stage teach-
ing program to make sure nurses were competent to implement the
Confusion Assessment Method of the Intensive Care Unit (CAM-ICU)
correctly in our SICU.
OBJECTIVES. The present study is to use the Direct Observation of
Procedural Skills (DOPS) to assess the effectiveness of the two-stage
teaching program of implementing CAM-ICU to screen delirium in a
surgical ICU.
METHODS. 32 SICU nurses were included in this study. Stage 1
consisted of self-study and a lecture of CAM-ICU. References and
websites of delirium and CAM-ICU were provided to the nurses be-
fore the lecture. All participants took a test before and after the lec-
ture. Stage 2 was hands-on clinical practice of CAM-ICU on SICU
patients. First DOPS took place one month after the clinical screening
of delirium, another DOPS were repeated six months later.
RESULTS. The effect of self-studying of acquiring the knowledge of
delirium and learning of how to perform CAM-ICU was inadequate
(Table 89).
After the lecture as shown by the results of first DOPS, the nurses
performed CAM-ICU with awkwardness. Second DOPS showed that
nurses were more adept at performing CAM-ICU (Table 90).
CONCLUSIONS. Mere self-studying and lecture related to screening
delirium with CAM-ICU were inadequate. ICU culture and clinical
hands-on practicing CAM-ICU were keys to implement delirium
screening in the ICU.
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INTRODUCTION. Incidence of postoperative delirium ranges from 9
to 73% with high incidence found in critically ill surgical patients.
Delirium is associated with increase mortality and cost of treatment.
Factors associated with delirium vary between the study population.
The intraoperative and postoperative factors which can be modified
or prevented are less studied and the results are inconclusive.
OBJECTIVE. To identify risk factors associated with postoperative
delirium in patients admitted to surgical ICUs and to compare
outcomes of patients who did and did not develop delirium.
METHOD. This was a prospective cohort study in patients admitted to
general surgical ICUs at Siriraj hospital, Mahidol University, Thailand.
Adults patients (>18 years) who expected to stay in SICUs for more
than 24 hours and who were undergone the operations within 7 days
were included. Demographic data, intraoperative and postoperative
data were recorded. CAM-ICU was used as an assessment for delirium.
RESULTS. A total of 251 patients were enrolled. Delirium occurred in
61 patients (24.6%). Hypoactive type was found in 44 patients (72%)
and delirium frequently occurred on day 1 after SICU admission
(72%). Age, diabetes mellitus, severity of disease (SOFA score),
perioperative used of benzodiazepine and the use of mechanical
ventilation were independent risk factors for delirium in multivariate
analysis. The predictive score (Age + 4*SOFA + 19*DM + 14*BZP +
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 150 of 54218*Vent) was created. The cut point of 110 demonstrated a sensitivity of
74% and a specificity of 72%, respectively. Delirious patients showed
significantly higher hospital mortality than non-delirious patients (25% vs.
6%, p < 0.01, respectively).
The incidence of physical restraint, sleep deprivation and propofol
used were significantly higher in delirious patients.(p < 0.01, all).
CONCLUSION. The incidence of delirium was approximately one-
fourth of surgical patients admitted to SICUs and the mortality was
much higher than non-delirious patients. The identification of high
risk patients together with the prevention strategy will be the most
important role in clinical practice.
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INTRODUCTION. Long-term sedation with commonly used agents,
e.g. midazolam or propofol in intensive care units (ICUs) has serious
adverse effects. The intravenous benzodiazepine lormetazepam is ap-
proved for anxiolysis and sedation in critically ill patients in Germany
and might offer some advantages over other sedatives. However, the
literature lacks reports about the safety and efficacy of lormetazepam
as well as its effect on delirium in critically ill patients.
OBJECTIVE. It was the aim of the present study to evaluate the effect
of intravenous lormetazepam administration for prolonged sedation
after cardiac surgery on incidence and severity of delirium.
METHODS. 50 adult patients on the cardiothoracic ICU with the need for
sedation for more than 24 hours were included in this prospective
observational study. Intravenous lormetazepam was administered with
an initial bolus followed by a continuous infusion as clinically indicated
for a maximum of five days. Sedation level and delirium were assessed
using the Richmond Agitation-Sedation Scale (RASS) and Intensive Care
Delirium Screening Checklist (ICDSC) every 8 hours. Primary endpoint
was the ICDSC score 72 h after initiation of lormetazepam sedation.
RESULTS. 50 patients with a mean age of 60.8 ± 18.0 years (18
female) were included in this study. Mean duration of lormetazepam
administration was 77.7 ± 43.8 h with a mean dosage of 14.6 ± 11.9 mg
per day. Total ICDSC scores significantly improved after lormetazepam
administration (2.68 ± 2.32 vs. 3.8 ± 2.23, p = 0.045) as well as several
subscores e.g. inappropriate speech or mood (0.05 ± 0.19 vs. 0.34 ± 0.43,
p = 0.01) or altered level of consciousness (0.38 ± 0.47 vs. 0.69 ± 0.50 vs.
p = 0.03) accompanied by a significant reduction of other sedatives. A
mild bradypnoe was observed in one patient possibly related to the
administration of lormetazepam in combination with opioids without
need for further intervention.
CONCLUSION. Our data suggest that lormetazepam represents a safe
and efficient agent for prolonged sedation in cardiothoracic patients
with beneficial effects on incidence and severity of delirium.
However, randomized controlled trials are needed to investigate
whether administration of lormetazepam compared to other
sedatives might be favorable for the ICU patient.
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Intensive Care Medicine Experimental 2017, 5(Suppl 2):0298INTRODUCTION. Dexmedetomidine (Dex) is a sedative agent with
analgesic activity and a unique mechanism of action than the
traditional sedation by benzodiazepine and propofol. This traditional
sedative agent acts on Gamma aminobutyric acid (GABA) receptors1.
Dex causes sedation and anaxiolysis by acting on Locus ceruleus in
midbrain whereas analgesic effect is by acting on presynaptic
receptor in the spinal card. Its analgesic effect is through its effect on
alpha 2-adrenargeic receptors in the dorsal horn of spinal cord and
modulating the release of substance P2.
OBJECTIVES. Our study was to know the efficacy, safety and
analgesic sparing effect of dexemedetomidine (Dex) in critically ill
surgical patients.
METHODS. All patients receiving dexemedetomidine (Dex) in the
surgical intensive unit of a tertiary health care facility were included
in the study. Patients´ demographic data, diagnosis, surgical
interventions, traditional sedation, Dex dosage and days, post
extubation Dex use, adverse effects, adverse effects in lower and
higher Dex dose, analgesic requirement, and rescue sedation
requirement were prospectively recorded. Data entered in SPSS
program, required test were used for comparison and P < 0.05 was
considered as statistically significant.
RESULTS. A total of 428 patients were enrolled in the study. Majority
of patients were males (73.3%). Most common diagnosis was acute
abdomen and frequently performed surgery was laparotomy (28.9%).
Duration of Dexemedetomidine was ranging from 2 to 28 days;
common dose was 0.5 to 1.4 μg/kg/hours. 78% patients required Dex
in the post-extubation period in a dose of 0.2 μg/kg/hours. There
was significant reduction in the analgesia requirement in the post
Dex period (P < 0.001). Adverse effects were bradycardia 6.1%,
hypotension 1.6% and hypertension (4%) and there was no signifi-
cant difference in adverse effects between lower and higher dose of
Dex (P < 0.82). Patients in higher dose of Dex required significantly
higher rescue traditional sedation (P < 0.01).
CONCLUSIONS. Dexmedetomidine is a safe sedative agent in
variable dosage in surgical critically ill patients. It has a significant
analgesic sparing effect. Increasing dosage of Dex will not increase
the sedation efficacy but requires more rescue traditional sedation.
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INTRODUCTION. Pathogenicity of Enterococcus in intra-abdominal in-
fections in the ICU is debated (1–3). The treatment of intra-
abdominal infections is first surgical and the antibiotic therapy is an
adjunctive treatment. An inadequate antibiotic therapy is often asso-
ciated with a poor prognosis.
OBJECTIVE. To determine if an empiric antibiotic therapy active
against Enterococcus spp. in ICU patients who underwent surgery for
an intra-abdominal infection helps to reduce 30-day mortality.
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 151 of 542METHODS. Retrospective study of the OUTCOMEREA database which
includes 22 French ICU from 1997 to 2016. All patients hospitalized
in an ICU with intra-abdominal infection growing with Enterococcus
spp. who had undergone surgery were selected. The patient inclusion
was confirmed after reading the hospitalization records. Demograph-
ics, severity scores, microbiology, surgical complications and 30-day
outcome after surgery were collected. Chi2 and Mann Whitney tests
were used. Results are shown in median (interquartile) or numbers
(%). Stepwise multivariate logistic regression was used to identify in-
dependent factors associated with mortality.
RESULTS. Ninety-three patients were included but 66 were analyzed.
The empiric antibiotic therapy was active against Enterococcus spp. in
40 (70%) patients and inactive in 26 (30%) patients.
Inactive empiric antibiotic therapies included one penicillin inactive
against E. faecium in 21 cases (81%) and one cephalosporin inactive
against Enterococcus spp. in 5 cases (19%). Thirty-day mortality was
lower in patients with E. faecalis than with other types of Entero-
coccus: 4 (14.8) vs 16 (41) p = 0.023. In the multivariate analysis, SAPS
score (HR = 1.038 per point 95% CI (1.006 - 1.070) p = 0.0185) and
an empiric antibiotic therapy inactive against Enterococcus spp.
(HR = 3.391 95% CI (1.337 - 8.599) p = 0.0101) were independently
associated with 30-day mortality.
CONCLUSION. In our small cohort of ICU patients surgically treated
for an intra-abdominal infection, an empiric antibiotic therapy active
against Enterococcus spp. is associated with a reduced 30-day mortal-
ity when an Enterococcus is isolated in the peritoneal fluid.
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Number of patients/total number in
group
Percentage (95%
CI)
30-day
mortality
178/917 19% (17%-22%)
90-day
mortality
232/916 25% (23%-28%)
1-year mortality 274/915 30% (27%-33%)
Table 91 (Abstract 0299). Comparison active vs inactive antibiotic
therapy
Variables Empiric antibiotic
therapy active against
Enterococcus (n = 40)
Empiric antibiotic
therapy inactive against
Enterococcus (n = 26)
p
SOFA 7.5 (4.6) 9.2 (3.4) 0.046
Number of E. faecium
isolated in peritoneal fluid
13 (35.1) 16 (66.7) 0.016
30-day mortality 7 (17.5) 13 (50) 0.005
Fig. 105 (abstract 0300). The incidence of NSTI in Denmark
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INTRODUCTION. Necrotising soft tissue infection (NSTI) is a fast
progressing bacterial infection involving any layers of the soft tissue
and is associated with high rates of morbidity and mortality [1]. The
incidence and mortality rates vary widely between cohorts.
OBJECTIVES. The objective of the study was to determine the incidence
and mortality rate of NSTI in Denmark in the period 2005–2013.
METHODS. Data were obtained from the Danish National Patient
Register (DNPR), which collects data from all Danish hospitals, and
the Civil Registration System, which includes data on date of birth
and death [2]. Data can be linked at an individual level by the social
security number, a unique number assigned to every person living in
Denmark. The National Registry of Death collects data on causes of
death from death certificates. Data on population levels are available
on-line at Statistics Denmark [3].Data from 2005 to 2013 were obtained. The following codes from
the Danish diagnosis system were used: DA480, gasgangrene;
DM425A, necrotising fasciitis (before 2012); DM726, necrotising
fasciitis (from 2012) and DN498C, Fournier's gangrene. The DNPR was
searched for all patients with any contact to a hospital with one of
the above codes registered. Contacts registered as outpatient visits
were excluded.
Incidence rates were calculated from the yearly number of patients
with NSTI divided by the population registered midyear.
The study was approved by the Danish Health and Medicines
Authority and the National Data Protection Agency.
RESULTS. A total of 2668 contacts by 945 unique patients were
registered, leaving 918 when patients with only outpatient visits
were removed. The median age was 62 (IQR 49–71), 65% were male.
The average incidence of NSTI was 1.84 per 100,000 inhabitants/year
(Fig. 105). Of the 918 patients 737 (80%) were registered by the
diagnosis necrotising fasciitis, 86 (9%) by the diagnosis gas gangrene
and 283 (31%) by the diagnosis Fournier's gangrene. 17% were
registered with more than one of the diagnoses. Mortality rates are
seen in Table 92. NSTI was reported as the underlying cause in 60
(22%) of the deaths. One-year follow-up was achieved for 99.7% of
the patients.
CONCLUSIONS. The average incidence of NSTI in Denmark during
the study period was 1.84 per 100,000 inhabitants/year, and 90-day
mortality was 25% (95% CI: 23%-28%).
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INTRODUCTION. Mortality remains high in the ICU patients (pts)
with invasive pulmonary aspergillosis (IPA), but early diagnosis
could improve survival. However, definitive diagnosis is still difficult
even with extensive diagnostic procedure.
OBJECTIVES. To analyze the interest of thorough inspection of the
tracheobronchial tree associated with biopsies of the mucosal lesions
to confirm IPA diagnosis.
METHODS. Between 01/1997 and 03/2017,174pts presented positive
Aspergillus cultures in the airways during their ICU stay. Among them
169 underwent flexible bronchoscopy to exclude IPA. Suspicion of
IPA was also based on positive Aspergillus culture from the airways
with consistent clinical and radiological findings.
RESULTS. During bronchoscopy, tracheal and/or bronchial lesions
were observed in 57/169pts(34%).These consisted of areas of
erythema of the mucosa, associated with either patchy necrosis or
non-removable false membranes. In each case, biopsy of the lesions
revealed the presence of Aspergillus hyphae. In addition to these 57
patients, IPA was also proven in 16pts after autopsy, and finally, it
was probable in 21 others. Consequently, IPA was finally diagnosed
in 94 patients, thus bronchoscopy confirmed IPA in 61%(57/94pts).
In the remaining 75pts, Aspergillus was considered as a contamin-
ant; in these, although some mucosal lesions were encountered
during endoscopy, patchy necrosis or non-removable false mem-
branes were never found and none developed IPA.
CONCLUSIONS. Thorough endoscopic inspection of the
tracheobronchial tree associated with guided biopsies appears to
be minimally invasive and useful to diagnose invasive pulmonary
aspergillosis in ICU pts.
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INTRODUCTION. Chikungunya fever(CHIK V) is considered a self-
limiting disease with relapsing arthralgias. In the outbreak of Chikun-
gunya in the Reunion Island epidemic, there were 237 deaths with
case fatality rate of 1/1000 cases. However, it was not sure whether
the mortality was directly associated with Chikungunya or coexisting
morbidities worsened with Chikungunya infections.
OBJECTIVES. This study was conducted to assess the clinical
manifestations and to find out the prognostic factors of critical ill
patients with severe chikungunya.
METHODS. A single center retrospective observational study
conducted at the intensive care unit of a tertiary care teaching
hospital in North India.
Study period : 31st September 2016 to 31st December 2016.
Adult patients (>18 years) admitted to the intensive care unit with
history of an acute febrile illness and found to have lab confirmed
CHIKV infection by a positive RT-PCR test or detection of anti-CHIKV
IgM by ELISA, were enrolled.
Severe CHIKV infection was defined by the presence of a new organ
dysfunction or worsening of pre-existing organ dysfunction.The medical records of all the recruited patients were retrospectively
reviewed and the following information was collected: age, gender,
clinical manifestations, disease severity scores, underlying conditions,
laboratory examinations, and outcome.
The primary endpoint was to find the predictors of in-hospital mortality.
RESULTS. During study period, a total of 410 patients with
chikungunya infections were admitted to hospital. 76(18.5%) patients
with severe chikungunya infection required ICU admission.
Among these 76 critically ill patients, mean age was 69.7 years.
(Male: Female = 55:21)
Respiratory failure was the most common organ dysfunction on
presentation (n = 16, 21.0%) followed by acute kidney injury
(n = 11,14.4%).
Overall, a total of 40 patients died, and 28 day mortality was 39.4%
(n = 30).
For these 30,Mean SOFA on day 1 was 11.6 while only 9 had
Cardiovascular SOFA 2+ or above.
In multivariate analysis, we found that in-hospital mortality was signifi-
cantly high in age above 60 years(n = 22/50 44%) and in those with co
existence of diabetes mellitus & hypertension (n = 8/11 72.7%).
Requirement of positive pressure ventilation(n = 23/54, 42.6%) and
renal replacement therapy (n = 19/32, 59.4%) were also associated
with high mortality.
CONCLUSIONS. Severe chikungunya requiring ICU admission is
associated with high mortality. Mortality is likely to be more in those
aged 60 years and above, with co morbid conditions particularly
hypertension and diabetes mellitus if present together.
Worsening of respiratory failure and acute kidney injury was
associated with highest mortality in our study. These organ failures
were present despite not so poor hemodynamic status.
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INTRODUCTION. Nosocomial infection (NI) is a public health problem due
to its frequency, severity and costs, especially in intensive care unit (ICU).
OBJECTIVES. We aimed to investigate mortality's rate and potential
death risk factors related to NI.
METHODS. This was a retrospective study, from January 1, 2016 to
December 31, 2016; carried out within a 22-bed medical ICU of
Abderrahmane Mami's pneumology hospital in Tunis. Demographic,
microbiological and outcome data were recorded and multivariate
regression analysis was conducted to identify potential death's risk
factors. The endpoint of this study is to identify independent predict-
ive mortality's factors in ICU patients having nosocomial infections.
RESULTS. During the study period (12 months), 590 patients were
hospitalized; 59 patients (10%) presented at least one nosocomial
infection. We recorded 91 episodes of nosocomial infections (59 patients)
divided into pneumonia (n = 45, 49.5%), bacteremia (n = 26, 28.6%),
catheter related infections (n = 13, 14.3%) and urinary infections (n = 7,
7.6%). Acinetobacter Baumanii Resistant to Imipenem (ABRI) was the
most frequent pathogen responsible of pneumonia (n = 27, 60%)
and bacteremia (n = 9, 34%).
Mortality in patients with nosocomial infections (n = 59) was of
55.9% while mortality in all patients (n = 590) was of 32.88%.
Multivariate regression analysis identified 5 independent mortality
risk factors which are detailed in Table 93.
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 153 of 542CONCLUSIONS. In ICU patients with nosocomial infections, mortality
is high. Pulmonary location of nosocomial infections is a major factor
leading to pejorative outcome, especially when it is an ABRI. More
efforts in hygiene precautions should be deployed to limit this
fatal scourge.Table 93 (Abstract 0303). Mortality multivariate regression analysis
Surviving
(n=26)
Dead
(n=33)
OR CI 95% p
SAPS II 21.5 ± 17.3 73 ± 13.5 1.199 1.043 - 1.377 0.011
APACHE II 16.7 ± 7.4 28.5 ± 6.3 1.457 1.009 - 2.105 0.045
Nosocomial
pneumonia
N=15 N=30 6.206 1.351 - 28.510 0.019
Days with
vasopressive drugs
4.4 ± 7.18 13 ± 8 1.151 1.055 - 1.256 0.001
Pneumonia
caused by ABRI
N=5 N=22 5.500 1.434 - 21.096 0.0130304
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INTRODUCTION. Severe acute respiratory viral infections are among
the main causes of morbimortality around the world.
OBJECTIVES. To evaluate the epidemiology and outcomes of
patients admitted to the emergency department with signs of
Severe Acute Respiratory Syndrome (SARS) due to viral infections
METHODS. Clinical, epidemiological and laboratory data were
collected from patients older than 12 years old admitted to the
emergency department from January to May 2016. Multiplex qPCR
was used for viral detection
RESULTS. From January to November 2016, 159 patients were
admitted in the emergency department with cough, fever, throat
sore and respiratory symptoms (tachypnea or hypoxemia). A total of
78 patients were positive for Influenza, being 75 influenza A (all
H1N1pmd2009) and 3 Influenza B, with mean age of 47 ± 16 years.
Another 10 adult patients (Media age: 62 years) were negative for
Influenza A H1N1, and positive for Human Respiratory Syncytial Virus
(HRSV), of whom one patient aged 25 years old died (20%). A total of
28 Influenza A H1N1 and 3 Influenza B patients were admitted in the
ICU with ARDS and mortality rate of 57%. Non survivors had a longer
period between first symptom and first dose of oseltamivir (6,5 vs. 4
dias) or hospital admission (7 vs. 3,5 dias) in comparison to survivors.
In H1N1 patients, C-reactive protein on admission was higher in non
survivors (NS) than in Survivors (S) (31,3 vs. 18,3 mg/dL, p = 0,035 e
11,8 vs. 4,0 mg/dL, p = 0,035). NS had also higher serum lactate
levels, leucocytes and SOFA scores in the first days of admission.
Coinfection with bacterial pneumonia was suspected in 14 patients
of whom, 9 (Early: 3, late:6) microbiologically confirmed: pseudo-
monas aeruginosa (n = 3), staphylococcus aureus (n = 3), acinetobac-
ter baumannii (n = 2), klebsiella pneumoniae (n = 1). Patients with
bacterial coinfection had more severe hypoxemia (PaO2 / FiO2 at
ICU admission; 56 vs 184, p = 0.043), more organ dysfunction (SOFA
day 3: 10 vs 3.5, p = 0.023), as well as longer period of time in the
ventilator and on hospital.CONCLUSIONS. Acute Respiratory Syndrome due to viral infections
are associated with significant morbimortality even among adult
immunocompetent patients.
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INTRODUCTION. Fungal infections continue to be a major cause of
mortality in Intensive Care Units (ICUs), commonly associated with
immunocompromised patients. Lately, there has been an increase in
immunocompetent patients, being Candida spp the most prevalent
fungal infection. With the introduction of new antifungals, it has
been observed an increase resistance to them.
OBJECTIVES. To describe the incidence of candida infections, related
risk factors, comorbidities, resistance to antifungals, use of
vasopressors (VP), mechanical ventilation (MV) and mortality rate in
patients admitted into the ICUs at Fundación Santa Fe de Bógota,
Colombia in a five-year period.
METHODS. We conducted a retrospective observational study
between Jan 2012 and Dec 2016. Adult patients from FUINC
database with evidence of fungal isolation were reviewed. We
describe the frequency of candida infections, resistance patterns, risk
factors, use of VP, MV; outcomes as mortality and length of stay
(LOS) in general wards ICUs. The analysis was performed with SPSS
Statistic 23.0.
RESULTS. 159 patients were included in the study (male 63.52%).
The mean age was 59 years old. The most frequent diagnoses were
sepsis (n = 63, 39.62%) and respiratory pathologies (n = 29, 18.24%).
C. Albicans was the main isolated fungus (n = 72, 45.28%), followed
by C.Tropicalis (n = 29, 18.24%) and C.Parapsilosis (n = 26, 16.35%).
Bronchoalveolar lavage (n = 65,40.88%) and hemorrhage
(n = 35,22.01%) were the most frequent sites of isolation. 99.37% of
the patients presented at least one of the risk factors (sepsis 37.74%,
antibiotic management prior to infection 15.72%, and prolonged
hospitalization 13.27%). The use of VP and MV were required in 135
patients (84.28%). The overall mortality was higher in our population
(n = 83, 52%), compared with literature; the average of LOS at the
ICU was 27 days and 42 days for general wards. Clinical resistance to
antifungal treatment azoles (AZ), fluconazole (FZ), voriconazole (VZ)
echinocandins (EC) and polyenes (PY) were measured per years. In
2012 (n = 29), the percentage of resistance to medical treatment was
3% for AZ, FZ, and VZ; reported mortality was 41%. In 2013 (n = 36),
resistance to AZ and FZ was 3%, and mortality was 56%. In 2014
(n = 35), the resistance for AZ and FZ was (9%), EC (3%); and
mortality was 49%. In 2015 (n = 31), no patients with resistance and
mortality were 58%. Finally, by 2016 (n = 28), resistance to AZ, FZ
and PY was 3.5% and mortality was 57%.
CONCLUSIONS. The incidence of candida infection in our population
is relatively low. The mortality rate is slightly higher compared to the
literature. The diagnosis of sepsis is present in the great majority of
our patients. Other risk factors were antibiotic management prior to
infection and prolonged hospitalization. In general, resistance rates
to antifungals were very low.
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Table 94 (Abstract 0307). Neurological Deficit in the ICU
No or Mild
Neurological
Deficit
Moderate
Neurological
Deficit
Hemiparesis Paraplegia Epilepsy GCS < 4 Death
20 8 5 1 1 1 6
Table 95 (Abstract 0307). Long term outcome (Glasgow Outcome Scale)
GOS 5 GOS 4 GOS 3 GOS 2 GOS 1
22 Patients 9 Patients 4 Patients 2 Patients 6 Patients
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INTRODUCTION. Antibiotic therapy (AB) of acute pancreatitis (AP) at
the time of ICU admission has been poorly investigated. It is usually
recommended to delay AB to decrease selection pressure and to
avoid the emergence of multidrug resistant (MDR) bacteria.
OBJECTIVES. The frequency of early AB and their consequence on
the emergence of MDR bacteria and outcome were assessed in a
retrospective multicentre analysis.
METHODS. From 06/2009 to 03/2014, all patients (pts) admitted
with a diagnosis of AP in 17 ICUs were included in a database.
Demographic characteristics, underlying diseases, severity criteria
on ICU admission (Day0), AB and their reasons, emergence of MDR
bacteria in clinical samples during ICU stay and outcome at Day 30
were collected. Results are presented in medians (IQR) or
proportions. The pts receiving an early AB (AB+ started at Day0)
were compared to the AB-free pts using Fisher's exact test and
Wilcoxon test (p < 0.05 significant).
RESULTS. Among 860 collected cases, 355 (41.3%) pts received AB
from the admission in the ICU. Compared with AB-free pts, AB+
pts were older (60 [49–73] versus 56 [43–71], p = 0.004), with a
higher SAPS II score (42 [32–63] vs 36 [25–50], p < 0.001). They
had more frequent mechanical ventilation (37% vs 19%,
p < 0.001), renal replacement therapy (12% vs 7%, p = 0.02) and
vasoactive agents (46% vs 16%, p < 0.001). The two groups did
not differ in terms of underlying disease or frequency of morbid
obesity (BMI >30: 28%). In the AB+ group, a septic shock was ob-
served in 108 (30%) pts or sepsis in 200 (57%) pts. Empiric AB was
administered in 284 pts and targeted AB in 54 pts. The most fre-
quently used AB were betalactams (n = 271 (85% of AB), including
carbapenems n = 81 (23%)), aminoglycosides (n = 120 (35%)), anti-
Gram-positive AB (n = 50 (14%)). Antifungal therapy was pre-
scribed in 53 (15%) pts, mainly azoles (n = 46) and empiric
(n = 40)). The main reasons for AB prescription were: intra-
abdominal infection (n = 209 (60%)), pneumonia (n = 46 (13%)),
bacteremia (n = 45 (13%)), catheter related infection (n = 9 (3%))
or urinary tract infection (n = 9 (3%)). During their ICU stay, 34/132
(26%) pts in the AB+ group had a clinical isolate yielding MDR bac-
teria compared to 25/122 (20%) in the AB-free pts (NS). The most
frequent MDR strains were ESBL-producing Enterobacteriaceae
(n = 37 including 19 (56% of MDR strains) in AB+ pts), methicillin-
resistant Staphylococcus aureus (n = 13, 6 (18%) in AB+ pts) and
Pseudomonas aeruginosa (n = 16, 9 (26%) in AB+ pts). No link was
evidenced between MDR bacteria during the ICU stay and AB at
Day0. Overall, 197/860 (23%) pts died. The two groups did not dif-
fer for the delay of death in ICU (5 [1–27] days) or death rate at
Day30 99/505 (20%) vs 78/355 (22%).
CONCLUSIONS. Initial AB is frequently reported in ICU pts admitted
for AP. Compared to AB-free pts, early AB has no significant impact
neither in terms of emergence of MDR bacteria nor mortality.0307
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INTRODUCTION. The role of decompressive craniectomy in infectious
diseases has been sporadically documented in the literature in
patients with increased intracranial pressure and risk of brain
herniation. Evidence is lacking regarding the benefits or detriments
of neurosurgical intervention.
OBJECTIVES. The aim of this study is to systematically review the
literature regarding the role of decompressive craniectomy in cases
of infectious diseases.
METHODS. Data from the available medical literature were systematically
reviewed regarding decompressive craniectomy in cases of central
nervous system infection. Relevant studies published in any language
using the key terms “encephalitis”, “meningitis”, “meningoencephalitis”,
“decompression,” “decompressive craniectomy” in the PubMed and
Scopus databases. Bibliographies of the potentially relevant articles were
also hand searched. Our systematic review included case reports and
small case series reporting decompressive craniectomy in acute course
viral or bacterial meningitis, meningoencephalitis or encephalitis
including adults and children. Data was extracted regarding the
characteristics of the included studies such as author and date of
publication, study design, the number of patients reported in the study.
RESULTS. 43 studies were included in the systematic review
reporting on a total of 57 patients, with a mean age of 27 years
(range 1 to 66 years), including 27 females, 29 males and 4 cases
where sex was not reported. Six studies did not report the pathogen
involved. Viral pathogens were reported in 29 of 51 patients,
whereas bacterial pathogens in 22 of the 51 patients.
The initial Glasgow Coma Scale on admission to the hospital was
reported in 33 patients with a mean of 12 (range 3 to 15), pre-ICU admis-
sion GCS was reported in 32 patients with a mean of 6 (range 3 to 14).
In 11 patients, decision for decompressive craniectomy was taken by
direct measurement of intracranial pressure after conservative measures
failed. In 34 patients CT scan findings, compatible with herniation in
combination with clinical signs of herniation led to decision for
decompressive craniectomy, whereas in 12 patients, decision for
decompressive craniectomy was guided by clinical signs of herniation
alone. Time from symptom onset to the first CT brain scan was reported
in 35 patients with a mean of 4.7 days (range of 0 to 17 days). Time after
symptom onset until initiation of antibiotic treatment was reported in 29
of the cases with a mean of 6.7 days (range of 0 to 24 days).
In the ICU, neurological deficit was reported in 42 patients (Table 94).
Long term outcome was reported according to the Glasgow
outcome score more than 6 months after craniectomy in 43 of the
57 patients (Table 95).
CONCLUSIONS. Decompressive craniectomy may play a role in
infectious diseases in cases of impending herniation or in increased
intracranial pressure resistant to medication but further, higher
quality research is necessary.
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INTRODUCTION. Influenza is one of the most common vaccine-
preventable viral diseases, with the highest morbidity reported for
children and elderly patients. Data on complications in children with
seasonal influenza virus infection are limited.
OBJECTIVES. We initiated a 2-year surveillance of children who were
admitted to our pediatric intensive care unit (PICU) with severe sea-
sonal influenza.
METHODS. Active surveillance from October 2015 through April 2017
was performed among all children admitted to our PICU. Cases to be
reported were all hospitalized children < 16 years of age with PCR-
confirmed influenza treated in our PICU due to severe complications.
RESULTS. Eight severe influenza-associated cases were reported from
our PICU during two influenza seasons (2015–2017), all of them
treated with oral oseltamivir. Among these children there were 4
males and 4 females and their age ranged from 45 days to 14 years.
None had received vaccination against influenza. In 6 (75%) patients,
the infection had been caused by influenza A and in 2 (25%) by influ-
enza B. Patients spent a median of 10,5 days (IQR 1–20) in the PICU;
5 (62,5%) needed mechanical ventilation and one of them required
HFOV. Most frequent diagnoses were influenza-associated encephal-
itis/encephalopathy (50%), myocarditis/syncope (25%), secondary
bacteremia (12,5%) and ARDS (12,5%). Three (37,5%) children had
chronic underlying medical conditions; one of our patients who had
history of muscle weakness and ataxia was diagnosed with NARP
(Neuropathy, Ataxia, and Renitis Pigmentosa) after severe neuro-
logical sequelae caused by influenza B infection. All three patients
with encephalitis/encephalopathy had possible permanent sequelae.
One influenza-associated death was reported due to ARDS.
CONCLUSIONS. Influenza viruses may be associated with significant
childhood morbidity and PICU admissions. Many of the severe cases
might have been prevented by following the recommendations for
vaccination of risk groups.
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OBJECTIVES. To compare laboratory parameters, clinical manifestations
and outcome in dengue infection patients presenting with or without
encephalitis.
METHODS. Prospective observational study of 166 adult patients
with acute febrile illness and IgM-anti-DENV ELISA proven Dengue
fever admitted to MICU were included in the study. Baseline labora-
tory parameters, clinical spectrum and outcome were compared in
patients with or without encephalitis.
RESULTS. Out of 200 patients admitted during the 9 months period,
only 166 were positive for IgM-anti-DENV ELISA. Total of 78.3% pa-
tients had features of Dengue fever with no encephalitis (groupA)
while 21.6% patients presented with encephalitis (groupB). Altered
sensorium with fever dominated the second group (P-value < 0.05).
No significant baseline parameters differences between the two
groups. Notably Serum Ig-M, Ig-G antibodies, APTT, SGOT and SGPT
were statistically significant in encephalitis group (P-value < 0.05).
Group A patients recovered completely without any complications.Among group-B patients with encephalitis, 30 patients recovered
completely, 4 patients died of multi-organ failure and 2 patients
went discharged against medical advice.
CONCLUSIONS. Combination of laboratory parameters along with
high index of clinical suspicion may help in identification of Dengue
fever patients with possible encephalitis.
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INTRODUCTION. Clostridium Difficile is the most frequent etiology
for nosocomial diarrhea. The organism may asymptomatically
colonize the gut or cause illness extending from watery diarrhea
through pseudomembranous colitis, toxic megacolon, and even
death.
OBJECTIVES. The aim of this research was to study the epidemiology
of Clostridium difficile infections in Intensive Care Unit of our
Hospital.
METHODS. All patients admitted to general intensive care unit
with a planned hospital stay > 3 days were investigated (baseline
measurement, carriers control) and then, they were checked again
per week or during symptoms, such as intense or prolonged
diarrhea episodes. Trinity Biotech Uni Gold was used which
requires small amount of feces with results in 20 minutes. It is a
rapid immunochromatography membrane test for immediate
determination of glutamate dehydrogenase antigen and toxins A
and B in fecal samples.
RESULTS. In 10 months 31 middle-aged patients (66,4 ± 1,9 years
old) with a planned hospital stay > 3 days and ability to check fecal
samples within 24 hours after hospital admittion for carriers control,
were investigated.
APACHE II was 20,6 ± 1,0, SOFA was 9,4 ± 0,7 and mean duration of
hospitalization was 26,3 ± 4,3 days.
43 measurements were performed (baseline και recheck).
5 patients (16,1%) were positive for antigen by entering ICU but only
one (3,2%) patient was positive for toxins A and B. Between these
5 patients, 2 were rechecked because they developed diarroic
syndrome and both they were positive for antigen and negative
for toxins A and B.
Of the remaining 23 patients, 9 were rechecked because they
developed diarroic syndrome and all of them were negative for
antigen and negative for toxins A and B.
CONCLUSIONS. Clostridium difficile carriers in ICU of general hospital
are frequent enough (≈16%), although the disease appears to be not
so frequent.
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INTRODUCTION. Infective endocarditis is a serious disease with high
morbidity and mortality.
OBJECTIVES. The Purpose of our study was to analyze the
characteristics and outcomes of patients requiring valve surgery
during active infective endocarditis.
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 156 of 542METHODS. Retrospective review of data related to surgically treated
patients in our cardiovascular surgery department from January 2010
to December 2016 with a diagnosis of infective endocarditis
requiring surgical management.
RESULTS. Forty one patients data were analyzed. Mean age was 45
(17) years, with majority of males (72.2%). Native valves were
involved in 29 patients (70.73%). Infective endocarditis mainly
involved the aortic (24), mitral (17), and tricuspid valve (2). The most
common causative pathogens were streptococci (9), staphylococci
(7), and enterococci (3) (Table 96). The antibiotic treatment was
adapted to bacteriological results in 8 cases (22.22%). Perioperative
mortality was 41.7%. Timing for surgical procedure decision was 6.86
(9) days. Reasons for indicating surgery in 36 patients included heart
failure (36.2%), vegetation (27.8%), no control of infection (11.1%)
and unstable prosthesis (8.4%).
In our study, the biological profile of infectious endocarditis is marked
by the preponderance of streptococcus and staphylococcus according
to the international cohort [1] taken here as a reference with a larger
percentage of negative cultures. This would have affected the low
percentage of treatment adaptation (22,22%) and subsequently the high
rate of perioperative mortality (41,7%) vs 18% in the reference study.
CONCLUSIONS. Endocarditis remains a serious problem both in
terms of diagnosis and management. Current trends are for earlier
surgery favoring valve repair (AHA and ESC guidelines). A better
knowledge of microbiological characteristics would improve the
quality of management.
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Table 96 (Abstract 0311). Common pathogens in active infective
endocarditis
n= 41 (%)
Streptococci 9 (22)
Staphylococci 7 (17)
Enterococci 3 (7)
Other pathogens 9 (22)
Negative Culture 13 (32)
Fig. 106 (abstract 0311). Common pathogens in active
infective endocarditis0312
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OBJECTIVE. To describe the epidemiology, clinical characteristics,
evolution and mortality related factors of ICU acquired Gram-
negative bacteremia (ICU-GNB) in a tertiary hospital ICU.
METHODS. Descriptive study (2009–2016) of critically ill patients with
infection by ICU acquired Gram negative bacteria, defined by at least
one positive blood culture obtained ≥ 48 h after ICU admission.
Demographic data, comorbidities, invasive devices, source and severity
of infection, causative microorganism, antimicrobial susceptibility and
therapy were recorded. APACHE II, SOFA and Pitt bacteremia scores,
and the outcome were analyzed.
RESULTS. During the study period 42 ICU-GNB were diagnosed.
Twenty six were men and the mean age was 59 years (44–73). Most
patients came from emergency department (54%) and 23.8% pa-
tients were severely immunodepressed. The main reasons for ICU ad-
mission were sepsis (29%), neurocritical (19.6%) and trauma (16.6%).
Time from admission to ICU-GNB was 13.5 days (9–43). Median days
of central venous line exposure were 16 (10.5-45); arterial line 11 (7–
24) and of mechanical ventilation 17 (12–33).
Almost all patients (95%) had received antibiotics prior ICU-GNB. Fif-
teen patients (35%) were on septic shock. Sources of bacteremia
were the catheter-related (45.4%), respiratory (16.7%) and urinary
(11%). Microorganisms isolated are shown in Fig. 107.
After receiving the antibiogram, 56% of patients received monotherapy
with carbapenems (45%), the remaining 44% received a combination
and the association between meropenem and tigecycline was the most
frequent (33%). Resistance to carbapenems was documented in
58% of nonfermenting-GNB and 28% in Enterobacteriaceae. Twenty-
two percent of patients were colonized by Gram negative bacteria,
7% of infections were caused by the colonizing pathogen.
The median ICU and hospital lengths of stay were 36 (26–39) and 73
(44–141) days. In-hospital mortality was 38% and mortality attribut-
able to bacteremia was 9 (21.6%). APACHE II at ICU admission was
16.5 (11–23). Median SOFA and Pitt's scores on the day of bacteremia
in survivors and non-survivors were 7 (5–10) versus 10 (8–12) and 3
(2–6) versus 6 (5–8) (p < 0.05), respectively. The incidence of ICU-
GNB decreased significantly along the study period (p < 0.04).
CONCLUSIONS. ICU-GNB occur in critically ill patients with common
risk factors for nosocomial infections such as antibiotic exposure and
invasive procedures. Patients with ICU-GNB have a high in-hospital
mortality. Higher SOFA a Pitt's scores are associated with a poor out-
come. In our study, ICU-GNB experienced a steady decrease over the
last years.
Table 97 (Abstract 0314). See text for description
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AIMS. Analysis of demographics characteristics, clinics and outcomes of
patients with influenza A (H1N1) admitted to our intensive care units.
METHODS. All patients with Influenza Virus A (H1N1) confirmed with
PCR were included in this study between January 2016- March 2016.
Ventilatory strategy, demographics, hemodynamic data and
outcomes were recorded.
RESULTS. Six patients included in this study with H1N1, two of those
was man, four of those was women. H1N1 was diagnosed when two
of the patients was arrived. Test results of other patients have been
concluded in our clinic. Two patients admitted from emergency
clinics, the other from wards in our hospital. The average age was
61.6 years. Four patient have comorbidities. The most common
symptoms were respiratory failure (100%), fever (66.6%; mean
temperature, 38.9°C) and cough (66.6%). The other symptoms were
sputum extraction (50%) and sore throat (33.3%). Five patients have
type 1 hypoxemic respiratory failure, one patient has combined
respiratory failure (type 1 and 2). Two patients have high leucocyte
count whereas three patients have high leucocyte count. All patients
have high plasma C reactive protein. Two of patients admitted with
hyponatremia, one of those has thrombocytopenia. Patients were
present with lung infiltrates on chest X-ray. Patients were given two
times a day 75 mg Oseltamivir. Five patients admitted to the ICU
with acute respiratory distress syndrome whereas four of those were
died during hospital stay.
CONCLUSION. Mortality is very high with pneumonia and ARDS in
patients with H1N1 influenza virus infection. Survival is possible with
early and effective treatment.
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Acute respiratory failure monitoring
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INTRODUCTION. The use of esophageal pressure (Pes) to set PEEP in
ARDS patients has been shown to result in a trend towards lower
mortality as compared to a PEEP/FIO2 table [1]. Prone positioning
(PP) for long sessions in association with use of low tidal volume and
cisatracurium infusion has been shown survival benefit in ARDS
patients. PP, due to the removal of the weight of the mediastinum
might allow a more reliable measurement of Pes.
We hypothesized that Pes values are lower in PP than in supine
position (SP) and, hence, PEEP level required to reach a 3 ± 2 cmH2O
PEEPtot,L target should be lower in PP.OBJECTIVES. The main objective of the study was to assess the
amount of external PEEP set to reach positive PEEPtot,L in SP and in
early and late PP.
METHODS. A prospective interventional physiologic study was
performed in patients with moderate to severe ARDS (PaO2/
FIO2 < 150 mmHg), intubated, sedated and paralyzed, requiring PP.
Patients were assessed in SP at 30° and in PP at 0°or 15° from the
horizontal plane. The baseline PEEP was set according to PEEP/FIO2
table [2] in SP 30° and applied for 60 minutes. Respiratory mechanics
and blood gases were assessed. Then, PEEP was titrated to reach
3 ± 2 cmH2O PEEPtot,L and applied for one hour and measurements
were done again. The baseline PEEP was resumed and patient was
turned to PP with 0° or 15° inclinaison. Measurements were done
after one hour and PEEP titration performed as above. For the rest of
the PP session PEEP was randomly allocated between baseline PEEP
or Pes-guided PEEP and measurements done at the end of it (16h).
RESULTS. We enrolled 32 consecutive ARDS patients (31 with
complete data) during 15 months.
Pes-guided PEEP did not lead to significant variation of the amount
of PEEP, except for a trend to higher PEEP in PP 0° (+3 [0–5.8]
cmH2O, p = 0.1). Pes-guided PEEP strategy led to large (>5cmH20)
changes in 5/31 patients, in SP, and in 7/31 in PP.
Respiratory mechanics were not altered by the Pes-guided PEEP
strategy (Table).
PaO2/FiO2 ratio did not vary with Pes-guided PEEP in both SP (p = 0.31)
and PP (p = 0.12), but improved with PP itself : +19 [2.5-50]mmHg,
p < 0.003 at H + 1 and then +36 [16–66] mmHg (p < 0.001) at H + 16.
Respiratory mechanics did not change after 16 hours in PP.
CONCLUSIONS. PEEP required to reach a positive PEEPtot,L was
similar in PP and in SP. Pes-guided PEEP strategy did not significantly
alter respiratory mechanics in either SP or PP.
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INTRODUCTION. A previous research using electrical impedance
tomography (EIT) has demonstrated that in healthy volunteers, rising
flow rate of HFNC resulted in increase in pharyngeal pressure and
end-expiratory lung impedance (EELI), suggesting an increase in end-
expiratory lung volume (EELV) in a flow-dependent manner. How-
ever, it is still unknown whether this effect is promising in patients
with acute lung injury (ALI).
OBJECTIVES. In this study we investigated the effect of flow rate
during HFNC on EELV and regional ventilation in ALI patients.
METHODS. 5 different flow rates of 10, 20, 30, 40, 50 L/min of HFNC
were applied with random order in ALI patients. Each flow rate was
maintained for 10 min, and EIT measurements were performed and
recorded for 2 min at the end of each step. Respiratory rates and P/F
ratio were measured simultaneously and oropharyngeal pressures
were also monitored. EELI (impedance value at the end of expiration)
and TIV (tidal impedance variation of a respiratory cycle),
corresponding to EELV and tidal volume, respectively, were analyzed
by EIT software. Changes in EELI and TIV from at 10L/min of HFNC
were calculated and expressed as a percentage of TIV at 10 L/min.
The patients were not asked to breathe with their mouths closed
during the measurement period. Data was analyzed by one-way
ANOVA with repeated measures and Turkey test as post-hoc analysis.
RESULTS. We enrolled seven ALI patients with severe acute
pancreatitis, pneumonia, pregnancy induced hypertension. Mean P/F
ratio before HFNC was 244 mmHg. Mean changes in EELI between at
10 L/min and at 20, 30, 40, 50 L/min were 24, −6, −19, 11%,
respectively, indicating that flow rate was not associated with EELI. In
addition, neither respiratory rate nor P/F ratio changed significantly
with increased flow rate. On the other hand, mean oropharyngeal
pressure increased from 2.4 cmH2O at 10 L/min to 5.2 cmH2O at 50
L/min.
CONCLUSIONS. Increase in flow rate during HFNC does not
necessarily augment EELV in patients with ALI, despite low positive
airway pressure generated in the oral cavity.
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INTRODUCTION. The use of high flow nasal cannula (HFNC) is
increasing. Clinical studies show that HFNC reduce respiratory rate
(RR), but tidal volume and minute ventilation vary, and thus the
respiratory effect of HFNC is not fully understood. The majority of
these studies were performed on patients while awake and thus the
influence on respiratory patterns caused by conscious (comfort,
discomfort) rather than the respiratory physiological effect itself
cannot be excluded. We thus conducted a study using a HFNC in
sleeping patients and recorded respiratory parameters to determinerespiratory physiological effects that excluded the influence of
conscious effects.
OBJECTIVES. To evaluate respiratory physiological effects of HFNC
excluding the influence of conscious effects.
METHODS. The study was approved by our institutional ethical
committee. Eight patients who underwent cardiac surgery and
provided informed consent were included. A nasogastric tube
equipped with electrodes to measure electrical activity of the
diaphragm (EAdi) was inserted after extubated. Each patient received
dexmedetomidine to achieve RASS < −1. At midnight, after
recording the EAdi for 10 min with a venturi-mask (VM) to reach a
SpO2 of 95 ~ 98%, a HFNC was applied using a flow of 20 and 40 L/
min for 10 min each while recording EAdi. The FIO2 of the HFNC was
adjusted to reach the same SpO2 with the VM in each patient. The
RR and mean value of peak EAdi for each breath (p-EAdi) were deter-
mined from stable 1-min data from each phase. Blood gas analysis
was done at the end of each phase. Data of RR, p-EAdi, PaCO2, and
PaO2 for HFNC at 20 and 40 L/min were expressed as median (IQR)
and compared with the VM data using the Wilcoxon signed-rank test.
A p value < 0.05 was considered statistically significant.
RESULTS. RR (VM; 17/min (12–20) at HFNC 20 L/min; 16 (11–19) at
HFNC 40 L/min; 17(12–20)) PaCO2 (38 mmHg (37–40); 40 (37–41); 39
(34–40)) PaO2 (88 mmHg (78–96); 89 (86–92); 92 (87–103)) were not
affected by HFNC. With the HFNC at a flow of 20 L/min, p-EAdi was
reduced significantly, but showed no difference at a flow of 40 L/min
(8.4 uV (6.4-12.5), 6.7 (5.1-10.4), and 6.3 (4.9-15.4).
P-EAdi is correlated closely with inspiratory effort (1). As shown in
previous studies, a reduction in p-EAdi using a HFNC at a flow of 20
L/min reduced inspiratory effort without increasing PaCO2. Increasing
HFNC flow to 40 L/min may have caused increased inspiratory effort.
This change is not fully understood and more bench and clinical
studies are required.
Although many studies have reported a reduction in RR with HFNC
our study did not show this effect. This result indicated that a
reduction in RR using a HFNC while awake may be caused by the
conscious rather than respiratory physiological effect.
CONCLUSION. Using a HFNC during sleep reduces inspiratory effort
but does not reduce RR.
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INTRODUCTION. Acute respiratory distress syndrome (ARDS) is
characterized by acute diffuse inflammatory lung injury presents with
rapid onset of respiratory failure, dishomogeneity of the lung
parenchymal1, and significantly non-aeration region in the
dependent parts. It is largely accepted that the benefit of applying of
lung protective mechanical ventilation with low tidal volume and
high PEEP strategy to maintain the alveolar pressure above atmos-
phere pressure to prevent ventilator associated lung injury in
ARDS2,3.
OBJECTIVES. Clinical studies indicate that chest EIT is able to monitor
ventilation distribution at the bedside and may help to develop lung
protective ventilation strategies. EIT-guided PEEP titration for ECMO-
treated ARDS patients showed promising results, The aim of this
study was to test To compare the treatment outcome in moderate
Fig. 108 (abstract 0318). See text for description
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pressure-volume curve guided and electrical impedance tomography
guided positive end-expiratory pressure setting.
METHODS. Patients in both groups were ventilated with EVITA 4
(Dräger Medical, Lübeck, Germany) with low tidal volume (6 ml/kg
predicted body weight). In EIT group, the EIT data were recorded at
20 Hz and reconstructed with EIT Data Analysis Tool 6.3 (Dräger
Medical, Lübeck, Germany). Offline analysis of regional compliance
was achieved using a customized software compiled with MATLAB
(MathWorks, Natick, MA, USA).
RESULTS. A total of 68 ARDS patients were included,records of 34
patients titrated with pressure-volume curve were retrospectively
analyzed.survival rate, weaning successful rate, APACHEII24 hurs,
PaO2/FiO2 in EIT group were significantly higher than the control
group(p < 0.05).
CONCLUSIONS. The preliminary results show that our protocol is
feasible and the PEEP titration guided by EIT might lead to a better
clinical outcome in ARDS patients.
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INTRODUCTION. Esophageal pressure (Pes), as a reflect of pleural
pressure, has been proposed to help clinicians to set PEEP by
computing transpulmonary pressure (Ptp = airway pressure minus
Pes). In the supine position (SP), due to the compression of
esophagus by the mediastinum weight and by the displacement of
abdominal content toward the thorax due to inclination of the
thorax from the horizontal plane, the absolute value of Pes may be
misleading. PP should be less affected by both effects, and hence
Pes measurement more reliable.
OBJECTIVES. The objective of the study was to evaluate the variation
of end-expiratory esophageal pressure at zero flow (PEEPtotes) in PP
and in SP, each at two body inclinations.
METHODS. A prospective interventional physiologic study was
performed in patients with moderate to severe ARDS (PaO2/
FIO2 < 150 mmHg) requiring PP. Thorax angulation was 30 ° and 0 °
in SP and 0 ° and 15 ° in PP. Data are expressed as medians[interquartile range] and compared through Friedman test and
pairwise comparison with Holm correction.
RESULTS. Thirty-two consecutive ARDS patients were included. PEEP-
totes did not vary significantly between SP (30 °) and PP (0 ° or 15 °).
However, opposite variations were found according to thorax angula-
tion in PP: a rise of 2.1 [0.7—3.1] cmH2O in PP (0 °), p =0.01 and a
drop in PP (15 °) of 1.6 [0—2.6] cmH2O, p = 0.21. PP was associated
with lower ΔPL [−1 cmH20, P = < 0.001].
In a complementary analysis of 24 patients, PEEPtotes was studied in
four positions [SP (30 °), SP (0 °), PP (0 °) and PP (15 °)] and followed
an inverted U-shape pattern with median values of 9.7 [7.4—12.1],
12.8 [11.2—16], 11 [8.9—12.9] and 8.8 [6.7—11.1] cmH2O, respect-
ively (Fig. 108).
These differences were statistically significant (Holm adjusted p
value for multiple comparisons < 0.001) except between SP (30 °)
and PP (0 ° or 15 °).
As a consequence, PEEPtotL rose of 2.8 cmH2O between SP (0 °) and
PP (0 °), p < 0.001. With postural variations, EELV was significantly
altered. Hence, PEEPtotL at PP (0 °) was computed at the EELV in SP
(0 °), allowing to eliminate the impact of the change of EELV
between postures: 83% of PEEPtotL changes were due to change of
posture per se
[+3.5 cmH2O, p < 0.001]. Between SP (30 °) and PP (0 °), posture
effect on PEEPtotL variation was +2 cmH2O, p < 0.001. A linear
mixed model disclosed that rise of PEEPtotL was explained by PP for
an amount of 2.8 (SD 0.4) cmH2O and by thorax angulation for 0.10
(SD 0.02) cmH2O per degree (p < 10−7).
CONCLUSIONS. In PP (0 °) Pes increased as compared to SP (30 °)
and decreased as compared to SP (0 °). However, when analyzing
PEEPtotL variation due only to posture change (and not EELV
change), a rise close to 3 cmH2O of PEEPtotL was seen in PP (0 °)
compared to SP (0 °) or SP (30 °). Clinicians might therefore consider
lowering PEEP level in PP.
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INTRODUCTION. Electrical impedance tomography (EIT) is a non-
invasive and radiation-free imaging modality that is increasingly used
for monitoring of ventilation distribution within the lungs in patients
with or at risk for respiratory failure. Clinical observations in patients
with pleural effusion (PLE) and previous studies [1, 2] suggest that
areas of low impedance, like fluid accumulations, in close proximity
to areas of high impedance, like the ventilated lungs, cause out-of-
phase impedance changes that can easily be detected in EIT images.
OBJECTIVES. To investigate whether out-of-phase impedance
changes in the dorsal lung quadrants are a typical finding in patients
with PLE.
METHODS. We conducted a prospective observational study in 30
intensive care unit patients with and without PLE. EIT data were
recorded with PulmoVista 500 (Drägerwerk AG, Lübeck, Germany). In
patients with PLE, EIT data were recorded before, during and after
unilateral thoracocentesis. In patients without PLE, EIT data were
recorded without any intervention. EIT images were separated into
four quadrants of equal size. The sum of out-of-phase impedance
changes in the dorsal lung quadrants was compared between pa-
tients without and with PLE before drainage by the Mann–Whitney
test and receiver operating characteristics (ROC) curve. The compari-
son between patients with PLE before and after drainage was per-
formed by the Wilcoxon matched pairs test.
RESULTS. We included 20 patients with PLE (PLE group) and 10
patients without PLE (control group). There were no between-group
differences in age, height, weight, simplified acute physiology score
and gas exchange. The amount of drained fluid in the PLE group was
525 ± 214 (mean ± SD) ml. The sum of out-of-phase impedance
changes was 70, 49–119 (median, 25th-75th percentile) arbitrary units
(a.u.) in the PLE group before drainage, 25, 12–46 a.u. after drainage
(p < 0.0001) and 11, 6–17 a.u. in the control group (p < 0.0001 vs
PLE group before drainage). The area under the ROC curve was 0.96
(0.91-1.01) for comparison between PLE group before drainage and
control group.
CONCLUSIONS. In patients with PLE, out-of-phase impedance
changes in the dorsal lung quadrants are a typical EIT finding and
might be useful for detection and monitoring of PLE.
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INTRODUCTION. Positive end expiratory pressure (PEEP) is one of the
important factors to provide better global and regional ventilation
distribution that leads to better oxygenation and to preventventilator-induced lung injury. However, the method to set PEEP
safely and effectively is still not established. It is reported that elec-
trical impedance tomography (EIT) can provide valuable information
to determine PEEP level in an independent patient.
OBJECTIVES. In this study we assessed PEEP to obtain even
distribution of global and regional ventilation using two different
methods of EIT in patients after elective cardiac surgery, and
investigated the clinical efficacy of each EIT-evaluated PEEP.
METHODS. A decremental PEEP trial (from 20 to 4 cmH2O of PEEP, 8
steps of every 2 cmH2O) was performed in 22 consecutive post-
cardiac surgery patients in the intensive care unit. At each PEEP step,
EIT measurements were performed and recorded. Using EIT machine
at bedside (online PEEP) and software later (offline PEEP), the lowest
PEEP at which dorsal ventilation was preserved was determined in
each way. The surgeon who had no knowledge of the experiment
could change the PEEP one hour after determining PEEP. Time
course of oxygenation and ventilation distribution were investigated
and compared between the patients ventilated with EIT-evaluated
PEEP until weaning and the patients ventilated with reduced PEEP.
Wilcoxon rank sum test and chi-square test were used for statistical
analysis as appropriate.
RESULTS. Online and offline PEEP were 10 (6–15) and 10 (8–14)
cmH2O, respectively (median (interquartile range), p = 0.96). After 1
hour PEEP was decreased in 9 cases and in 6 of them dorsal ventilation
decreased later. In contrast, PEEP was maintained at EIT-evaluated level
in 13 cases and dorsal ventilation decreased in 3 of them (p = 0.04). In
8 cases EIT-evaluated PEEP was maintained until weaning process was
started and their oxygenation was preserved by standard oxygen ther-
apy, whereas in 6 of 14 cases PEEP was decreased from EIT-evaluated
level and the patients required non-invasive positive pressure ventila-
tion or high flow nasal cannula oxygen therapy (p = 0.03).
CONCLUSIONS. Offline EIT-evaluated PEEP provided better dorsal
ventilation distribution and might have an impact on oxygenation
and oxygen therapy after extubation.
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INTRODUCTION. Different methods of mechanics respiratory analysis
have been used, as Multiple linear regression (MLR1), Time constant
(TC2), Fourier analysis (fft3), and Occlusion techniques (Occ4). Some of
these methods are intrusive and complex to apply in clinical practice.
Futher, there are wide agreement limits between them.
OBJETIVES: To evaluate a new method for measurement of
mechanics respiratory in ventilated subjects. Our method is a variant
of isovolume technique5, simple and easy to apply by any ventilator.
METHODS. We studied a group of mechanically ventilated patients
during volume controlled mode with constant flow, due to acute
respiratory failure of different diseases. Airway, esophageal pressure,
and airway flow were recorded, sampling 561 Hz. The flow-resistance
was calculated by choosing the points in both the inspiratory and ex-
piratory phases of a respiratory cycle when the lung volume were
identical and flow rate were about maximal. The ratio of this pressure
change to the corresponding change in flow between these points
was calculated as the average flow-resistance for inspiration and ex-
piration (Rs). The elastance (Ers) and total PEEP was obtained from
linear regression between component elastic of pressure and vol-
ume, between 10%-90% of each respiratory phase. The results from
this method (iso*) were compared with those obtained from MLR,
TC, Occ and fft techniques. Data are expressed as mean (SD) in absolute
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 161 of 542values, and as a percentage. The comparison of the data was made
using one-way ANOVA, and Bonferroni post-hoc. The Bland-Altman
analysis and linear regression was applied to assess the agreement.
RESULTS. 30 patients were studied. For all data: Ers: Iso* 27.41 ± 1.43
cmH2O/L; MLR 27.49 ± 1.42 cmH2O/L; TC 24.5 ± 1.34 cmH2O/L; Occ
23.13 ± 1.15 cmH2O/L; fft 30.14 ± 1.52 cmH2O/L. Rrs: Iso*
17.19 ± 3.58cmH2O/L/sec; MLR 16.41 ± 3.36 cmH2O/L/sec; TC
19.15 ± 3.61 cmH2O/L/sec; Occ 18.53 ± 4.21cmH2O/L/sec; fft
16.67 ± 3.54 cmH2O/L/sec. The mean comparison of the Ers and Rrs
between Iso* and other techniques did not show statistical differences.
Solely for Ers, Occ vs fft p = 0.018. The Tables 98 and 99 show the
concordance analysis and correlation (R2) for Ers and Rrs, respectively.
CONCLUSIONS. The new method is equivalent to other techniques
established to compute the respiratory mechanics. The best fit is
shown with the most dynamic methods (MLR and fft), and less with
Occ and TC, perhaps because they are required to maintain a linear
relationship between flow and volume not always real in patients
with severe respiratory failure.
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5. Frank NR, Mead J, Ferris BG. J Clin Invest, 1957; 36:1680.Table 98 (Abstract 0321). The Bland-Altman analysis and correlation
for Ers
Ers Iso*
vs:
Means differences (SD),
(cmH2O/L)
95% Limits of
agreement
Percentage
Error
R2
MLR 0.09 (0.09) −0.09 to 0.027 0.33 0.99
TC −2.96 (4,30) −11.34 to 5.53 17.86 0.71
Occ −4.27 (3.94) −12.15 to 3.64 15.59 0.75
fft 2.74 (3.21) −3.68 to 9.16 11.16 0.85
Table 99 (Abstract 0321). The Bland-Altman analysis and correlation
for Rrs
Rrs Iso*
vs:
Means differences (SD),
(cmH2O/L/sec)
95% Limits of
agreement
Percentage
Error
R2
MLR −0.79 (0.76) −2.32 to 0.73 4.54 0.96
TC 1.95 (2.59) −3.23 to 7.13 14.25 0.55
Occ 1.33 (1.73) −2.12 to 4.78 9.68 0.84
fft −0.53 (0.7) −1.92 to 0.87 4.32 0.96
Table 100 (Abstract 0322). The Bland-Altman analysis and correlation
coeffici
Distending Pressure vs
Equation Motion
Means
differences (SD)
95% Limits of
agreement
%
Error
R2
PTP(cmH2O/s.min) 34.32 (129.32) −224.31 to 292.94 28.07 0,48
WOB(J/L) 0.13 (0.61) −1.07 to 1.35 26.26 0,43
Fig. 109 (abstract 0322). Distending Pressure vs Eq Motion0322
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INTRODUCTION. Instability of pleural pressure measured with
esophageal balloon by mobilizations, swallowing, changes with patient
movement, etc. make constant and reliable monitoring of muscle
pressure difficult with this technique. This has made its introduction
into the clinic scarce, and its use is usually relegated to research.OBJETIVES: We have designed a system that improves the ability to
monitor pleural pressure, respiratory effort (PTP), and work (WOB) by
replacing distending pressure (DP) by the equation of motion (EM)
with the parameters resulting from a multiple linear regression (MLR)
of 3–5 selected cycles between DP, Flow and volume.
METHODS. We studied a group of mechanically ventilated patients
under pressure-support ventilation. Airway, esophageal (Paw, Pes) and
airway flow signals were recorded, sampling 561Hz for more than 500 cy-
cles. The volume was obtained from the flow integration. Previously we
are measured on passive ventilation the chest wall elastance (Etw) as
function of pleural pressure change and volume. On a visual inspection
of each record, 3 to 10 successive cycles were selected, close to a Baydur
test in which the Pes signal was regular, there was no swallowing, signifi-
cant displacement of the baseline, or the maximum displacement of each
cycle. The Pes of these cycles was transformed into muscle pressure
(Pmusc) by subtracting of esophageal pressure, the product from the in-
stant volume by Etw. The Paw - Pmusc + PEEP of each cycle was used to
generate the DP. MLR of this pressure was performed with flow and vol-
ume to determine Ers, Rrs and total PEEP. The correlation (R2) between
EM and DP in the chosen cycles were > 0.96. PTP, WOB were obtained
simultaneously from DP and EM, and it´s was extended to 60 cycles
which included the previous selected records; of these were excluded
five with the lowest and the highest frequency. Data were expressed as
mean ± SD, the comparison was made with Student's t-test and agree-
ment with concordance analysis.
RESULTS. Comparison in the 1500 cycles. WOB: DP vs EM: 2.25 ± 0.77J/
L vs 2.39 ± 0.66 J/ L, p < 0.001. PTP: DP vs EM: 443.56 ± 175.02 cmH2O/
s · min vs 477.876 ± 152.99 cmH2O/s · min, p < 0.001. The Table 100
show concordance analysis. Figures 109 and 110 show two examples of
our approach. Figure 109a: The transformation contributes little to direct
measurement but serves to demonstrate that it can be substituted.
Figure 109b: In this other case the transformation contributes and much,
to the direct measurement, otherwise it becomes impossible. Figure 110:
Improvement of Pes by filtering effect and stabilization of signal.
CONCLUSIONS. Although equation of motion (EM) vs distending
pressure (DP) show wide dispersion, however EM can be used for the
monitoring of muscular effort and provides optimization of
esophageal pressure by filtered and calibration with respect to Paw.
Fig. 110 (abstract 0322). Signals
Fig. 111 (abstract 0323). See text for description
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INTRODUCTION. Lung recruitment decreases alveolar collapse (CL) but
may induce regional overdistension (OD). “Optimal PEEP” can be
defined as a PEEP level where CL and OD are balanced. However, the
effect of incremental or decremental PEEP steps on OD and CL
between patients post cardiac thoracic surgery (CTS) and with ARDS is
different. Electrical impedance tomography (EIT) enables visualization
of CL and OD1.
OBJECTIVES. To compare the effect of PEEP on CL and OD in ARDS
and post-CTS.
METHODS. Twenty-nine ARDS patients (mean PaO2/FiO2-ratio 141,
SD 55) and 17 CTS patients (mean PaO2/FiO2-ratio 339, SD 73) were
retrospectively analysed. Overdistension and CL were measured by
EIT during an incremental and decremental PEEP trial of 4 steps, each
with a delta pressure of 2 cmH2O. The balance between overdis-
tended and collapsed alveoli is calculated by adding CL to OD
(ODCL). An ODCL of 0% indicates an optimal balance between CL
and OD. Data are expressed as mean (SEM). Changes in ODCL be-
tween ARDS and CTC were tested using 2-way ANOVA.
RESULTS. At baseline ODCL in CTS patients was 22% (1,5) and 14%
(1,2) in patients with ARDS. During the increment in PEEP, ODCL
significantly increased to 30% (1,7) in CTS and 32% (1,3) in ARDS
(p < 0.001). The increase and decrease was significantly different in
both groups (p < 0.0001, Fig. 111). The changes in ODCL are more
gradual in the CTS group.
CONCLUSIONS. Alveolar OD and CL occur simultaneously and add
up to the ODCL. The ODCL can be influenced by increasing PEEP,
making the OD more pronounced than CL. During the incremental
PEEP trial the increase of OD is larger in ARDS patients than in post-
CTS patients, which is probably due to a lower respiratory system
compliance. At the beginning of the decremental PEEP trial the
ODCL is more optimal in the post-CTC patients, which could be ex-
plained by a better alveolar recruitability. When determining optimal
PEEP settings, variations in the balance between OD and CL should
be taken into account. To this end visualization of local ventilation
by EIT appears to be a useful tool.REFERENCE(S)
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INTRODUCTION. Pulmonary gas exchange results from the coupling
between alveolar ventilation (V) and perfusion (Q). In order to
individually optimize ventilator settings, combined measurement of
regional V and Q might be helpful (1). Electrical Impedance
Tomography (EIT) is a noninvasive imaging technique to monitor
regional V at bedside (2). We recently developed an EIT-based ap-
proach to measure regional Q (3).
OBJECTIVES. To validate an EIT-based approach to measure regional
lung perfusion against Single Photon Emission Computed Tomog-
raphy (SPECT) in a porcine animal trial.
METHODS. After admission of the local ethics committee (Uppsala
University Hospital, Uppsala, Sweden) experimental lung injury was
induced in 4 pigs by repeated recruitment and derecruitment.
Regional Q was measured using EIT and SPECT at PEEP levels of 0
and 15 cm H2O, respectively. Injections of a conductive contrast
agent (NaCl 10%, 10 ml) into a central venous catheter were
performed under temporary apnea. EIT measurements (EEK 2,
Draeger Medical GmbH, Luebeck, Germany) were acquired at a frame
rate of 40 Hz and images of conductivity change were reconstructed
from the measurements using individual finite element models
(FEM). Additionally, 99mTc-labeled albumin was injected and spatial
Q distribution was acquired using a dual-head gamma camera. EIT-
and SPECT-derived images of relative regional Q distributions (16x16
matrix) were compared in ventral-to-dorsal and right-to-left direction,
respectively, using linear correlations and Bland-Altman plots.
RESULTS.
CONCLUSIONS. EIT- and SPECT-based perfusion measurements
showed good to excellent correlation and agreement. Regional lung
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 163 of 542perfusion can reliably be measured by EIT using conductive contrast
agent injection during temporary apnea.
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INTRODUCTION. The use of esophageal balloon catheter to estimate
pleural pressure has gained renewed popularity in recent years.
Indeed, measurement of transpulmonary pressure (PL, computed
from the difference between airway pressure and esophageal
pressure) may allow a more pathophysiological-based approach to
ventilator strategy in ARDS patients. The occurrence of a negative PL
at end expiration (PL,ee) has been interpreted by some author has a
tendency of the lung to collapse. A recent study has shown that set-
ting of the PEEP level to reverse a negative PL,ee in acute respiratory
distress syndrome (ARDS). However, other authors refused the possi-
bility of a negative PL and interpreting it as measurement artefacts.OBJECTIVES. To assess the effect of PEEP, and calibration filling
volume (fv) and balloon size of the esophageal catheter on
measurement PL,ee.
METHODS. Prospective experimental study conduct on 16 (13 ARDS,
3 non ARDS) controlled mechanically ventilated. Esophageal pressure
was monitored with two different esophageal catheter: Cooper
Surgical (2 ml maximum fv) in 9 patients and Nutrivent (5 ml
maximum fv) in 7 patients.
Three PEEP levels were randomly applied: lowPEEP (8 and 4 cmH2O
respectively in ARDS and non ARDS patients), mediumPEEP (12 and 8
cmH2O) and highPEEP (16 and 12 cmH2O).
At each PEEP level we inflated the esophageal balloon with
increasing amount of air (from 0.2 to 2 ml and from 1 to 10 ml,
respectively in Cooper and in Nutrivent). For each fv, we performed
an end-inspiratory occlusion, an end-expiratory occlusion maneuver
during which we applied two manual chest compression to check
calibration (ΔPaw/ΔPes ratio between 0.8 and 1.2). At each fv we
computed the PL,ee. Effects of PEEP, fv (expressed as percentage of
the maximum volume), and catheter type on PL,ee were analyzed
with a three ways ANOVA.
RESULTS. Acceptable calibrations were obtained only in the range of
fv between 30 and 70% of maximum balloon volume and analysis
was restricted to fv in the range of 30 and 70%.
PL,ee decrease with increasing fv (Fig. 113). Occurrence of negative
PL,ee was higher at higher filling volume.
The effect of fv on PL,ee was significantly associated with the
catheter type: catheter with bigger balloon showed a faster decrease
in PL,ee; PL,ee was more negative with Cooper compared to
Nutrivent catheter at fv of 60 and 70%.
PL,ee increase with increasing PEEP independently of fv and catheter
type.
CONCLUSIONS. Even if well calibrated, the calibration filling volume
and catheter type have a great effect on transpulmonary pressure
measurement. Though effects of PEEP on PL,ee are not affected by
calibration filling volume or catheter type, lower filling volumes and
smaller balloon catheters would result in setting lower PEEP levels.
Fig. 115 (abstract 0326). See text for description
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INTRODUCTION. Electrical impedance tomography (EIT) is a
noninvasive imaging technique that can be used to monitor regional
lung ventilation (V) of mechanically ventilated patients in intensive
care units (ICU) at bedside (1, 2). In order to achieve an improved
adjustment of ventilation therapy, additional measures of regional
lung perfusion (Q) and regional lung ventilation to perfusion ratio (V/
Q) would be highly beneficial.
OBJECTIVES. To develop an approach to extract functional images of
V, Q and V/Q from EIT measurements and validate the method in a
porcine animal trial.
METHODS. After admission of the local ethics committee (Uppsala
University Hospital, Uppsala, Sweden) a healthy pig was anesthetized
and mechanically ventilated in supine position (3). Seven injections
of a conductive contrast agent (NaCl 10%, 10 ml) into a central
venous catheter were performed under temporary apnea at different
PEEP levels (0 to 20 cmH2O). During the injections, EIT
measurements (EEK 2, Draeger Medical GmbH, Luebeck, Germany)
were acquired at a frame rate of 40 Hz. EIT images of conductivity
change were reconstructed from the measurements based on a
cylindrical finite element model (FEM). Functional images of V were
obtained by Principal Component Analysis (PCA). A gamma-variate
model (4) was combined with a semi-negative matrix factorization to
extract functional images of Q from the EIT images.
RESULTS.
Functional images of V (see Fig. 115, line 1) and Q (line 2) at
different PEEP levels were obtained. A regional V/Q ratio (line 3) and
histograms of distribution (line 4) were calculated from the images.
At PEEP 0 cmH2O an inhomogeneous V/Q distribution is observed.
Modification of PEEP from 0 to 20 cmH2O yields a more
homogeneous V/Q which might indicate reduction in both dead
space ventilation and shunt perfusion. Gradually stepping down to
PEEP 0 cmH2O results in a more inhomogeneous V/Q as observed
before.
CONCLUSIONS. The presented approach allows for reliable
extraction of regional lung perfusion (Q) from EIT images.
It was possible to trace changes of regional V/Q after modification of
PEEP in a porcine animal trial. The described approach might thus be
a step into the direction of providing measures for improved
adjustment of ventilation therapy.
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INTRODUCTION. The measurement of Esophageal pressure (PES)
permits to estimate pleural pressure (PPL) and to compute
transpulmonary pressure (PL), which is the amount of pressure
actually dissipated across the lung independently from the effects of
the chest wall. PL is increasingly used in ARDS patients for
monitoring and, possibly, to tailor interventions regarding ventilator
settings. Nonetheless, it is still unclear how reliable is PES in
estimating PPL.
OBJECTIVES. We conducted a study on Thiel cadavers (an
embalming method that maintains the elastic and dynamic
properties of the corpse) to assess the relationship between PES and
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 165 of 542PPL directly measured in sternal (non-dependent) and vertebral
(dependent) regions (PPLs and PPLv). We previously showed that
Thiel cadavers' respiratory mechanics are similar to ARDS patients [1].
METHODS. Three cadavers from a donation program of the
Université du Quebec à Trois-Rivieres were studied in the supine pos-
ition. To standardize lung volume history, each cadaver was intu-
bated, recruited and mechanically ventilated for 30–60 minutes with
Vt 6 = ml/Kg PBW and PEEP = 20cmH2O.
An oesophageal balloon was inserted to monitor PES. PPLs and PPLv
were measured through dedicated sensors (wafer-type, flat balloon)
surgically implanted in the pleural space and inflated with 'non-
stress' volume.Chest x-ray and ultrasound excluded the presence of
pneumothorax. A 4-step decremental PEEP trial (20 to 5 cmH2O) was
then performed, with each step kept for 15 minutes.
Airway pressure (PAW), flow, PES, PPLs, and PPLv were recorded and
analysed during the last minutes of each step.
We evaluated the relationship between PES, PPLs, PPLv and the
corresponding PL at end-expiration and end-inspiration: end-
expiratory and end-expiratory PL were computed as the absolute dif-
ference between PAW and PES, PPL,and PPLv.in static conditions.
End-inspiratory PL was also calculated according the Elastance-
derived method.
RESULTS. At all PEEP levels, end-expiratory and end-inspiratory abso-
lute PES values were intermediate between PPLv and PPLs. Consist-
ently, end-inspiratory and end-expiratory PL computed as PAW-PES
were at a mid-value between PL measured using PPL in the sternal
and vertebral regions (Fig. 116a-b). Elastance-derived PL at end-
inspiration was close to the directly measured PL in non-dependent
regions (Fig. 116b).
CONCLUSIONS. The difference between the PAW and PES values
accurately reflects transpulmonary pressure at a mid-chest between
sternal and vertebral regions. In the supine position, end-inspiratory
PL derived from lung-elastance allows to estimate the distending
pressure in sternal, non-dependent lung regions. More data in spe-
cific groups of patients (obese etc.) are needed to fully validate this
concept.
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INTRODUCTION. The respiratory changes in esophageal pressure
(Pes) are representative of changes in pleural pressure. The
difference between plato airway pressure (Ppl) and Pes is a valid
estimate of transpulmonary pressure(TPP). Recently it has beenshown that setting respiratory parameters according to inspiratory
and expiratory TPP may allow more accurate tidal volume and PEEP
settings and improve oxygenation.
OBJECTIVES. In this study we wanted to evaluate the use of
esophageal pressure measurements in mechanically ventilated ICU
patients who has multiple respiratory system mechanical abnormalities
including chest wall problems.
METHODS. All measurements were performed (AVEA ventilator,
CareFusion) while patients sedated, paralyzed and ventilated with
volume control mode. Peak, plato, esophageal pressures were
measured and inspirtory, expiratory transpulmonary pressures(TPPi,
TPPe) driving pressure, transpulmonary driving pressure and total
respiratory system, lung and chest wall elastances were calculated.
Patients were classified according to mechanical abnormalities of the
respiratory system as airway, paranchimal and chest wall
abnormalities(CWA).
RESULTS. 28 patients were included in the study. Mean age was 67 and
mean APACHE II scores was 28.Sixty-one percent(17) of the patients had
airway, 50%(14) patients had chest wall abnormalities(obesity, massive
pleural effusion, pleural thickening, kyphoscoliosis) and all patients had
paranchimal problems(like edema, pneumonia, fibrosis). Mean Pplat was
24 ± 3 in CWA positive group(CWAPG)and 20 ± 5 cmH2Oin CWA
negative group)CWANG(p:0.001). Mean driving pressure was 21 ± 2.2 in
CWAPG and 14 ± 5 cmH2O in CWANG(0.0001). Mean transpulmonary
driving pressure was 15.5 ± 5.4 in the CWAPG and 11.6 ± 4.7 cmH2O in
the CWANG, p:0.51. Mean TPPi was 16 ± 10 in CWAPG and 13 ± 7 in
CWANG p:0.311. In 10 patients TPPe was negative(mean −8 cm H2O).
While mean Pplat and total resp system elastance were significantly
higher in CWAPG than the CWANG, TPPi and transpulmonary driving
pressures were similar across the groups.
CONCLUSIONS. Monitoring Pes might be more useful than Pplat in
ICU patients with CWAs to better understand underlying mechanical
problems and safer ventilatory settings.
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INTRODUCTION. Unplanned extubation (UE) is an unprecedented
happening in intensive care unit (ICU); which may lead to severe
complications in patients. It has been considered as an important
quality indicator of care and recognized as the most common airway
adverse event in the ICU.
OBJECTIVES. The objective of this study was to investigate that if
using indicators could improve the care quality by reducing the
incidence rate of unplanned extubation in the ICU.
METHODS. This study was conducted in a medical center with a
total capacity of 1276 beds with inclusive of 38 surgical ICU beds.
International quality indicator project was firstly introduced in the
year 1999, improvement initiatives were implemented since year
2001. The improvement initiatives, for examples, standardization of
procedures, improvement of communication skills, revision of
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 166 of 542sedation and weaning protocols, changing strategy for physical
restraints, establishment of task force for identification and
management of high-risk patients, implementation of quality im-
provement models including Breakthrough Series (BTS) and Team Re-
source Management(TRM) as well as new fixation method of
endotracheal tube, were launched during different periods to reduce
the incidence rate of unplanned extubation in mechanically venti-
lated patients.
RESULTS. The overall incidence rate of unplanned extubation
decreased from 6.4% in the year 2001 to 0.8% in the year 2016
without prolonged days of mechanical ventilation. In addition, rate of
failed UE was increasing over the years from 42.7% in the year 2001
to 88.9% in the year 2016 and it represented that the low possibility
of delayed extubation among these patient.
CONCLUSIONS. In conclusion, using indicators as the reference of
the implementation of serial improvement initiatives could reduce
the incidence of unplanned extubation in the ICU without prolonged
length of mechanical ventilation.
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INTRODUCTION. Mechanical ventilation is a lifesaving and integral
part of intensive care unit (ICU) medicine. It is, however, an
expensive intervention and is not problem free. Optimizing use and
outcomes of mechanical ventilation (MV) could result in substantial
cost savings and improved patient outcomes.
OBJECTIVES. Evaluate the cost-effectiveness of proportional assist
ventilation (PAV + TM ventilation [PAV + TMV]) compared with pres-
sure support ventilation (PSV).
METHODS. A cohort-level, in-silico, clinical model was built using
data from recent clinical studies and randomized, controlled trials
(RCTs). The model estimates the incidence of patient-ventilator asyn-
chrony >10%, tracheostomy, ventilator‑associated pneumonia (VAP),
other nosocomial infections, spontaneous breathing trial (SBT) suc-
cess, hypoxemia, and death. Patients, mean 55.4 years and 37.7% fe-
male,1 are on MV until a successful SBT or until they leave the ICU.
Time on MV is influenced by asynchrony >10% and VAP. MV is either
PSV or PAV + TMV, with differences between these interventions
taken from RCTs.2,3 PAV + TMV was associated with lower asynchrony,
shorter time on MV and in the ICU, but longer time in hospital. Mor-
tality was estimated from rates in peer-reviewed literature up to 3
years and with UK life tables thereafter. Quality-adjusted life expect-
ancy (QALE) used EQ5D utilities. All event costs are taken from peer-
reviewed literature and expressed in 2015 £. The time horizon ex-
tends from 1 to 40 years. Probabilistic sensitivity analysis provides es-
timates of outcome significance via the credible interval (CrI).
RESULTS. Over 40 years, the mean cost of care per patient was
£56,508 with PSV and £59,403 with PAV + TMV, difference GBP 2,895.
PAV + TMV increased life expectancy by 2.06 years (13.82 vs. 15.87)and QALE by 0.97 quality-adjusted life years (QALYs, 6.47 vs. 7.44).
The cost per life year and QALY gained with PAV + TMmode was
£1,407 and £2,987, respectively. PAV + TMV reduced mean days on
MV from 6.8 to 5.3 and days with VAP from 7.2% to 5.4%. In 2,000
simulations using sampled input parameters, PAV + TMV reduced
costs (95% CrI −7,743 to +19,078) in 29% of simulations and increase
QALE (95% CrI −0.5 to +2.5) in 91%. At a willingness to pay threshold
of GBP 30,000 per QALY gained, PAV + TMV was cost-effective in 89%
of simulations. If patients' NHS costs after discharge were excluded
then PAV + TMV would reduce costs in 62% of simulations. With a
time horizon of 1 and 5 years, PAV + TMV was more likely than PSV
to be cost saving and maintained its increase in QALE in 91% of
simulations.
CONCLUSIONS. PAV + TMV is likely to be considered a cost-effective
alternative to PSV in the UK. In the short term, PAV + TMV increased
patient life expectancy and decreased healthcare costs.
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INTRODUCTION. Arterial blood gas (ABG) ability to be performed at
the patient's bedside, and its rapid analysis make it an important tool
used by physicians to direct and redirect the treatment of their
patients, especially in patients who are critically ill.
OBJECTIVES. We aim to assess the value of the ABG is necessary and
appropriate in Intensive care unit (ICU) situation.
METHODS. This prospective observational study was conducted in
adult patients who admitted in ICU. Residents, fellows or staff who
were intimately involved in the care of the patient at the time of the
ABG test responded to the ABG survey such as for reason, interesting
parameters and change in management that response to ABG test
results.
RESULTS. There were 274 patients had been enrolled in this study
which 155 patients from MICU and 119 patients from SICU. We
collected 837 ABG tests performed in the laboratory. The most
common reasons for requesting an ABG test were changes in
ventilator settings 30.8% (258/837). Of the clinicians, 14.5% (121/837)
selected routine as their reason for ordering an ABG test in the
morning before round ward. The most interesting parameters in the
ABG test results was PaO2 that showed 34.5% (289/837) tests then
pH and PaCO2, respectively. A change in patient management
occurred in 438 times (52.3%). There was a change in ventilator
settings in 91.6% (401/438) of all management. The changes in
ventilator settings were 401 times (93.2%) of all management, 22.4%
(98/438) consisted of a change in FiO2.
CONCLUSIONS. Sometime though testing may not be indicated or
change management that maybe unnecessary testing eg. routine or
change in FiO2. If we reduce in unnecessary testing that help to
decrease risk from blood exposure, workload in healthcare providers,
blood loss and incremental cost saving.
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INTRODUCTION. Good communication is crucial when transferring
critically ill patients between hospitals as they are exposed to
potential physiological compromise. “The magnificent seven” are
evidence-based quality aspirations, agreed by all critical care units in
the East of England. One standard is all interhospital transfers are
conducted by adequately trained personnel with adequate equip-
ment and monitoring1. Our 14-bedded District General ICU employs
a regional transfer form in in order to ensure standardisation and
document this process.
OBJECTIVES. Assessing all interhospital transfers initiated from our
hospital over a 12-month period, we aimed to determine whether
those clinicians involved in critical care transfer had adequate trans-
fer training; and to evaluate adequacy of documentation and hand-
over.
METHODS. A retrospective audit was conducted of all interhospital
transfer forms completed in 2016. Seniority of clinician and reason
for transfer were analysed. The target standard was that all areas of
the transfer form should have been completed, especially relevant
times and observations during transfer including pupils for
neurosurgical cases.
RESULTS. We reviewed 23 interhospital transfer forms, yet were
aware of at least 6 transfers for which the forms were never
completed. The majority were for clinical reasons (96%) with 52% for
neurosurgical intervention. There was no documentation regarding
critical incidents in 57% of cases, though subjectively in all 23 cases
the observations recorded suggested that the patient had been
stable during transfer. Documentation of medications administered
was poor and observations recorded during transfer were
inadequate in 52% of cases missing at least 1 vital component for
the duration of the transfer for example a lack of pupillary responses
for neurosurgical cases. Level 3 transfers were all managed by
anaesthetists, 88% had at least 2 years experience. There was one
anaesthetist escort who had not attended a transfer course and 5
where it was unknown whether they had attended a course however
all other anaesthetists had been on a transfer course in the prior 4
years.
CONCLUSIONS. Transfer documents were not used for all cases and
when used, documentation was almost universally inadequate. We
have highlighted the availability and location of transfer forms. We
have raised awareness amongst nursing staff to help avoid cases
being missed where locum anaesthetists are involved. Attendance of
the local transfer course is now mandatory for novice anaesthetic
trainees prior to starting indirectly supervised on calls. The
department discussed that evaluation of available personnel would
occur on an individual case basis within the on call anaesthetic and
ICU teams. A re-audit will occur after changes have been
implemented.REFERENCE
1. East of England Critical Care Operational Delivery Network.
Magnificent 7 factsheet http://www.eoeccn.org.uk/documents/
documents [accessed April 2017]
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INTRODUCTIONS. Quality measurement in healthcare is based on a
construct devised over 50 years ago, but as healthcare has become
more complex, so too has the measurement of quality in healthcare.
The delivery of quality improvement might be improved by
knowledge of how well healthcare professionals understand quality
measurement.
OBJECTIVES. This study examines the perspectives of healthcare
professionals working in intensive care units on the methodology
and use of quality indicators, and the scientific basis on which they
are chosen. The study also aims to ascertain attitudes to quality
measurement amongst healthcare professionals, and the potential
benefits of improving their understanding of these quality indicators.
METHODS. A cross-sectional inquiry was performed amongst doctors,
nurses, allied health professionals and managers working in intensive
care units. A questionnaire was designed to elicit the level of under-
standing and views on quality measurement in intensive care units,
and this was conducted using an online survey platform.
RESULTS. 273 healthcare professionals responded. They demonstrated
a good understanding of the quality indicators in use at a national and
local level within intensive care medicine, but there were important
differences in how these indicators are perceived between doctors and
nurses. In particular, doctors appear to place less emphasis on patient
safety indicators than nursing staff do. There was good support for
adherence to care-bundle approaches to improving quality. Patient
safety was found to be more highly valued than other dimensions of
healthcare quality. Respondents indicated that quality of care may be
enhanced with improved education on quality measurement method-
ology, and improved feedback of performance against a range of qual-
ity indicators.
CONCLUSIONS. It is recommended that quality measurement and
quality improvement methodology be integrated at an early stage
into educational programmes for nursing and medical staff working
in intensive care medicine, and that feedback to staff should be
broadened to include clinical effectiveness measures as well as
patient safety measures.
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INTRODUCTION. Antimicrobial Stewardship Programs (ASPs) are
being employed to mitigate increasing antimicrobial resistance rates
and complications associated with inappropriate and unnecessary
prescriptions. Evidence exists on the benefits of ASPs however, less is
known about what program factors and conditions influence the
sustainability of ASPs in the intensive care unit (ICU) environment.
OBJECTIVES. To explore clinician's experiences associated with an
integrated Quality Improvement (QI) and Knowledge Translation (KT)
strategy aimed at improving ASPs in ICUs in four large academic
hospitals in Ontario, Canada.
METHODS. The QI-KT strategy focused on QI methods and sustain-
ability of change and involved five learning modules delivered in an
interactive Communities of Practice model with an assigned QI men-
tor. Each team implemented an AS project that focused on improv-
ing antimicrobial use in the ICU setting. Projects included the
reduction of
1) unnecessary use of antimicrobials in patients with possible
ventilator-associated pneumonia,
2) duration of empiric therapy, and
3) vancomycin prescription; and an
4) increase in appropriate use and days of therapy.
A qualitative research design was employed including focus groups
with clinicians followed by a constant comparative data analysis to
examine emergent themes.
RESULTS. A total of 25 individuals participated in the six focus
groups conducted in January 2016 (n = 15) and December 2016/
January 2017 (n = 10) with participating ICU clinicians. Key themes
regarding their experiences included:
1) the QI-KT Collaborative helped to keep projects on track and
aided in scoping projects to manageable change ideas;
2) having leadership and local level stakeholder engagement
enhanced the uptake of the QI activities;
3) embedding changes in daily work flow through their focused
project work aided in sustaining optimal antimicrobial use;
4) learning from other project teams aided in the development of
individual projects; and
5) their engagement in the collaborative provided confidence for
scaling the ASP activities to other areas.
CONCLUSIONS. Participants valued the QI-KT learning strategy and
its usefulness to sustain appropriate antimicrobial prescriptive prac-
tices in the ICUs and to spread to other units in their respective hos-
pitals. Findings from the larger study are informing the developmentof a toolkit that can be used by other ICUs in their efforts to improve
and sustain their ASPs.
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INTRODUCTION. Patients with mechanical ventilation (MV) in ICU is a
challenge for professionals because of the complexity of the care
and the multiple potential complications.
OBJECTIVES.
- Improve the quality of care that we provide to our patients.
- Describe the tools needed to detect the needs of those patients
- Describe the development of the individualized our care plan
METHODS.
- Descriptive study. Start 01-01-16.
- 8-bed ICU. Hospital district of sanitary area of about 160,000
people.
- We followed the model of Virginia Henderson.
- It included all staff of ICU, a total of 31 professionals.
- We used international taxonomy NANDA, NOC, NIC and clinimetric
tables of
valuation.
- The nurses´ interventions were put in common in the clinical
sessions.
- Started from the medical profile of our patients, we elaborated a
profile of the patient in MV. We detected the altered needs of these
patients admitted using the Virginia Henderson model.
RESULTS. Nurses´ diagnoses were associated with the indicators and
with a specific intervention for each patient, we organized the
activities to carry out.
The results of the assessments unit following the model of Virginia
Henderson, are
AUTONOMY PROBLEMS: food and hydratation, urinary and fecal
elimination, mobilization, cleanliness, body temperature
maintenance.
CARE PLAN: Nursing Diagnostics 00146 anxiety, 00148 fear, 00051
deterioration of verbal communication, 00034 dysfunctional response
to weaning, 00095 deterioration of the sleep pattern, 00128 acute
confusión.
COLLABORATION ISSUES: Ineffective ventilatory function: NIC 6680
Monitoring vital signs, NIC 3120 Intubation and stabilization of
airways, NIC 3300 Mechanical ventilation, NIC 3180 Management of
artificial airways, NIC 1910 Acid–base management, NIC 2300
Medication administration, NIC 7780 Management of technology.
DISCONNECTION OF MECHANICAL VENTILATION (MV): NIC 6880
Monitoring vital signs, NIC 3310 Disconnection from mechanical
ventilation, NIC 3270 Tracheal extubation
PROBLEMS ASSOCIATED WITH MV : pneumonia, atelectasia, retention
of secrections, barotrauma-neumotorax, renal, hemodynamic, gastro-
intestinal, neurological complications
CONCLUSIONS. The establishment of care plans allows the logical,
rational and systematic delivery of care through the scientific
method, supporting, supplying and helping the patient to cover their
needs individually.
It also allows the detection of deficiencies in plans already initiated,
being also an important tool in the orientation and help for the staff.
During the implementation of the care plan, we needed the family
help in order to fully and comprehensively evaluate our patients,
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 169 of 542since they are sometimes sedated or with serious communication
problems. In this way we have also detected in the main caregivers
problems of independence that can be treated by nursing, which has
given us the opportunity to develop a specific care plan for the
family.
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INTRODUCTION. The Case Mix Programme (CMP) of Intensive Care
National Audit and Research Centre (ICNARC), United Kingdom (UK)1
is an audit of patient outcomes and selected quality measures from
patient-level data submitted by 227 intensive care units (ICU). Stan-
dards for the provision of adult critical care services in the UK were
published in 2015 as the 'General Provision of Intensive Care Ser-
vices' (GPICS). ICNARC's annual quality report describes metrics per-
taining to patient outcomes, process and sepsis and provides a high-
level 'dashboard' of the hospital's performance against GPICS stan-
dards. Review of the ICNARC quality report - 2016 to our hospital
suggested that sepsis-related metrics are a cause for concern due to
high rates of “unit-acquired infection” in the blood defined as the
presence of an infection in any blood sample taken for microbio-
logical culture 48hrs or more after admission to the ICU. If more than
one organism is isolated, the primary organism isolated in two rather
than one blood culture bottle is given priority (except for MRSA,
which takes precedence). Potential contaminants such as Staphylo-
coccus epidermidis are excluded.
OBJECTIVES. Audit of the specific quality measure of “Unit acquired
infections in blood” flagged up as an area of concern as compared
to national benchmarks.
METHODS. Two investigators independently verified, the accuracy of
the database of patients coded as having unit acquired infection in
the blood, by checking corresponding electronic case records. True
positive results were analysed further by referring to the notes by
the Microbiologist and Infectious Diseases specialist. For confirmed
unit acquired infections in the blood, source of bacteraemia
ascertained by analysis of electronic patient records.
RESULTS. Out of twenty patients flagged positive, thirteen patients
did not meet the criteria for unit-acquired infections in blood and
five patients had ICU-acquired catheter-related blood stream infec-
tions. Reasons for false positive results included reporting non-blood
specimens such as bronchoalveolar lavage or ascites fluid, Staphylo-
coccus epidermidis flagging incorrectly as Staphylococcus aureus,
blood cultures with an organism that initially flagged within the first
48 hours and should, therefore, have been excluded and blood cul-
tures with an organism that initially flagged pre-ICU admission and
should therefore have been excluded. The risk-adjusted hospital mor-
tality and selected quality measures did not give rise to any signifi-
cant concerns when compared to 227 UK Critical Care Units.
CONCLUSIONS. A detailed audit of unit-acquired infection in blood
demonstrates systematic errors in reporting rather than a major clin-
ical concern in an adult ICU acting as a tertiary referral centre for crit-
ical care, regional vascular and major trauma services, and a large
transplant department in the UK.
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INTRODUCTION. The incidence of hospital acquired pressure
ulcers (HAPUs) in intensive care unit (ICU) is high and numerous
strategies have been implemented as a comprehensive
management of critical ill patients. Patients with pressure ulcers
(PUs) experience significantly increased morbidity, mortality and
financial burden; confirming that PUs prevention is an essential
component of patient care; immobility is a significant PUs risk
factor1, being prone position (PP) a major cause of it in severe
ARDS patients. In this study we compare the incidence of PUs
before and after an implementation of evidence based care
bundle2.
OBJECTIVES. Evaluate the impact in the incidence of PUs before and
after the implementation of a prevention care bundle.
METHODS. Retrospective-prospective observational study in a ter-
tiary level intensive care unit including patients < 65 years who
developed PUs during ICU stay. In a retrospective way we in-
cluded patients at ICU from January 2016 to September 2016,
evaluating the incidence and risk factors with a conventional
care; the prospective observational phase was from October 2016
to March 2017 after the implementation of a PUs prevention
bundle. PUs incidence was analyzed in both groups. The care
bundle is shown on Table 102.
RESULTS. In retrospective phase 212 patients were admitted in a 6
months period, 25 (12%) patients developed PUs including 11
patients in PP, 17 (68%) males and 8 (32%) females, the mean BMI
was 30.84 m2/kg, mean age was 40.32, mean APACHE II score at
admission was 20.16, mean ICU stay of 13.12 days, and average
albumin at admission of 2.7 g/dl and 19 (76%) patients has high
(<12) Brader score.In prospective phase of the study, 163 patients
were admitted in a second 6 month period, 31 (19%) patients
developed PUs, 24 were in PP, 24 males (77.42%) and 7 females
(22.58%), the mean BMI was 28.89 m2/kg, mean age 35.58 years,
mean APACHE II of 19.45, mean ICU stay 14 days, mean albumin at
admission 2.55 g/lL and 26 (83.8%) patients has high Brader score. In
a sub analysis of the data excluding the prone position patients the
incidence was of 7% before and 5% after care bundle
implementation.
CONCLUSIONS. PUs is a worrying condition in intensive care unit,
the implemented bundle care has promising results; PP is a high risk
factor for develop PUs and this can bias the results of this study. The
persistent application of the prevention care bundle and its benefit
will be evaluated again in prospective way, looking for more
homogeneous population.
REFERENCE(S)
1. Xiao-Lin Z, Fan-Jie M, A care bundle for pressure ulcer treatment in
intensive care units, International Journal of Nursing Sciencies, 2015,
340–347
2. Tayyib N, Coyer F, Lewis P, Implementing a pressure ulcer
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Care Nursing 2016, Elsevier
Table 102 (Abstract 0337). Pressure Ulcers (PUs) prevention care
bundle
ISSUE INTERVENTION
Risk
assesment
Brader score calculation
Skin care Bed bath once daily using clorhexidine, and application of mixture
of solid hydrocarbons and heavy mineral oils
Mobility Patients repositioned using a three hourly turning schedule using
a 'turn clock'. Foot of the bed elevated by 20 degrees if clinically
permitted Where clinically possibly patients are mobilized daily to
sit out of bed on chair
Support
surfaces
All ICU patients were managed on air mattresses
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INTRODUCTION. Routine blood tests have been shown to increase
anaemia in the critically ill patient leading to an increase number of
patients needing a blood transfusion1,3. They can also lead to
irrelevant clinical findings and do have a cost implication for the
department. Literature searches reveal a number of methods aimed
at reducing the number of blood tests. These included introduction
of specialist software (which resulted in a 12% reduction)2 another
introduced written guidelines in the critical care setting3.
Furthermore, literature suggests that changing the method for which
samples are obtained resulted in an 80% reduction in phlebotomy
associated blood loss4.
OBJECTIVES. To evaluate the number of patients in the Critical Care
Unit(CCU) at Colchester Hospital having routine regular blood tests
and assess if these were appropriate with a view to suggest potential
methods of reducing recurrence.
METHODS. A retrospective audit was carried out identifying the last
50 patients that were discharged from CCU (six were excluded due
to being transferred or had died). Our pathology database was then
used to see the number of tests that each patient had and
excessive/erroneous samples counted.
RESULTS. Of the 44 patients 75% were emergency admissions, 18%
elective admissions and 7% repatriations. Average number of
samples per patient was 33, with an approximate cost of £3,156.
Forty-one Group and Saves were sent with only 29% of patients re-
ceiving a transfusion. We identified that 33% of coagulation samples
were excessive, followed by Group and Saves(17%), Magne-
sium(17%), Full Blood Count(13%), Liver Function Tests(12%) and
Urea and electrolytes(12%).
CONCLUSIONS. Blood tests are being ordered excessively. Each time
a sample is taken from a patient there is always a risk of acquiring
an infection. In today's climate we should also be financially savvy.
Suggestions to improve this practice included disseminating the
already published evidence and the results from this audit to all staff
in the department. We also suggest that blood tests should be
performed on clinical basis and documenting the need for such tests
and frequency for each patient.
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INTRODUCTION. Continued monitoring of trends in the utility of the
ICU and the outcomes of ICU patients is important for estimating the
full future impact of ICU utilization.
OBJECTIVE. To investigate critical care medicine quality in Taiwan
between 1997 and 2013.
METHODS. Patients > 18 years and < 105 years old with first-time In-
tensive Care Unit (ICU) admission from January 1997 through Decem-
ber 2013 recorded in the Taiwan National Health Insurance Database
were enrolled. Age, gender, Charlson comorbidity index (CCI), age-
adjusted Charlson comorbidity index (ACCI), invasive mechanical ven-
tilator (IMV), noninvasive ventilation (NIV), continuous renal replace-
ment therapy (CRRT), extracorporeal membrane oxygenation (ECMO),
and intra-aortic balloon pump (IABP) data were collected. ICU mortal-
ity and ICU length of stay (LOS) were the main outcomes.
RESULTS. We identified 3,451,157 eligible patients (mean age: 65.4
years; mean ICU LOS: 5.9 ± 9.0 days; overall ICU-mortality rate:
19.8%). Annual ICU admissions increased from 115,754 in 1997 (inci-
dence: 734/100,000 population) to 244,820 in 2013 (incidence: 1266/
100,000 population) (P < 0.0001). The admission rate was highest for
patients > 75 years old. The uses of NIV, CRRT, and ECMO increased
from 4.3%, 1.1%, and 0.01% in 1997 to 11.5%, 2.0% and 0.4% in
2013,respectively. ICU LOS remained stable, but the annual mortality
rate significantly decreased from 23.0% in 1997 to 16.3% in 2013.
CONCLUSIONS. ICU admissions significantly increased between 1997
and 2013, especially for patients 375 years old, but the ICU mortality
rate for adult patients significantly declined.
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Table 103 (Abstract 0341). Assessment Audit
Admission
Assessment
Pre discharge
from ICU
Ward based
Assessment
Pre hospital
discharge
Total
Completed 365 170 117 49 701
Does not meet
criteria
4 101 126 130 361
Not completed 10 3 4 22 39
Clinical transfer 8 5 5 6 24
Died during
hospital stay
4 61 66 73 204
Non clinical
transfers
8 0 0 0 0
Continue on
other pathway
42 63 63 168
Repatriation to
own trust
17 18 49 84
No data 7 7
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INTRODUCTION. Multicenter prospective randomized controlled
trials (RCTs) are an important method of obtaining unbiased
estimates of treatment effect, but are difficult to conduct in the
heterogeneous intensive care unit (ICU) population.
OBJECTIVES. To determine which multicenter RCTs in critically ill
patients have reported that an intervention reduced mortality rates.
METHODS. A systematic review of the literature was performed using
the MEDLINE database to identify multicenter, randomized, placebo-
controlled trials evaluating any pharmacological, extracorporeal mem-
brane oxygenation or ventilatory strategy in critically ill patients and
which reported mortality as a primary or secondary outcome. We in-
cluded only trials written in English and no date limit was applied. The
trials were classified as reporting reduced, increased or no effect on
mortality. RCT methodology was assessed using the Jadad scale.
RESULTS. A total of 159 trials were identified. Eighteen of the trials
reported a significant reduction in mortality, including 5 trials that
evaluated interventions to limit ventilator-induced lung injury in patients
with acute respiratory distress syndrome (ARDS), such as prone position,
neuromuscular blockers, and low tidal volume mechanical ventilation.
The other 13 trials evaluated anti-inflammatory therapies in sepsis, ultrafil-
tration strategies in patients with cardiac arrest, invasive management of
ventilator-associated pneumonia and hemodynamic optimization using
gastric tonometry. Eleven trials reported an increase in mortality because
of iatrogenic effects of anti-inflammatory therapies in sepsis, colloids for
resuscitation in patients with hemodynamic shock, high frequency oscilla-
tory ventilation in patients with ARDS and non-invasive positive pressure
ventilation for respiratory failure after extubation. In 130 trials, there were
no significant differences in mortality between the two study arms. The
Jadad scores showed poor mean methodological quality.
CONCLUSIONS. Eighteen of the 159 RCTs identified in our literature
search reported a reduction in mortality with the intervention under
evaluation; 11 trials showed an increase in mortality and 130 reported no
effect. Reducing the risk of iatrogenic interventions was associated with
improved survival and may serve as a more attainable outcome than
mortality. This review raises questions about the standard approach of
targeting mortality as an endpoint in RCTs in critical care medicine.
0341
Maintaining compliance with the UK National ICU Rehabilitation
Guidelines (CG83)
L. M. Enoch1, J. Hyde1, J. Mcadam1, S. Rees-pedlar2, S. Law3
1Addenbrookes NHS Trusts Hospital, Critical Care, Cambridge, United
Kingdom; 2Addenbrookes NHS Trusts Hospital, Major Trauma,
Cambridge, United Kingdom; 3Addenbrookes Hospital, Critical Care,
Cambridge, United Kingdom
Correspondence: L. M. Enoch
Intensive Care Medicine Experimental 2017, 5(Suppl 2):0341
BACKGROUND. Survivors of Critical Care illness are faced with many
long term adverse sequelae both cognitive and physical which can
decrease their quality of life post hospital (Jones 2007). Recovery can
be prolonged and often incomplete.Prior studies have successfully demonstrated the benefits of early
rehabilitation in Critical Care. UK national ICU rehabilitation
guidelines (CG83) (NICE 2009) were introduced to improve patient
care and outcome by providing an integrated approach with a
continuum to recovery. Critics of CG83 have commented that it is
extremely time-consuming and a tick box exercise.
OBJECTIVES. We sought to demonstrate compliance and challenges
with CG83.
METHOD. Addenbrooke's Hospital is a 1200 bed tertiary referral centre
with two adult Critical Care Units (41 beds open at the time). Data was
prospectively collected and analysed using Excel for the 3 months from
October to December 2016. Approval obtained from the Trust audit
department. CG83 Assessments were performed by Critical Care
Specialist nurses (1.8 whole time equivalent). Qualitative data was also
obtained by interviewing patients and relatives in a focus group.
RESULTS. There were 399 admissions across the two Critical Care Units.
The results are summarised in Table 103. The majority (365; 91.5%) were
assessed on admission. 170 further assessments had to be performed prior
to ICU discharge, and a further 166 assessments were performed on the
wards, making a total of 701 assessments in total over the 3 month period.
Quotes from the focus groups:
Question: Do you think it was a valuable service?
 The advice about rehab and to re-establish a routine to help
regulate my days
 Very much so - I was referred for counselling to help with
PTSD
 very motivating
CONCLUSION. A large number (>700) of assessments were required
over the 3 months to comply with CG83; this volume of assessments
can be labour intensive. CG83 has not been fully implemented
outside of Critical Care and there is a need for cohesive working with
Multidisciplinary teams to facilitate ongoing rehabilitation.
Qualitative data suggested that the most valuable assessments were
prior to discharge from ICU and on the ward - preparing for a step
down in care. Assessments provide time for planning individualised
care, setting goals, referrals, and information giving opportunities. It
is an inclusive process accounting for relatives needs and addressing
their levels of life altering experiences.
Areas for future evaluation:
To collect data measuring the interventions and referrals made as a
result of the assessments completed.
To document and calculate the length of time for each assessment.
To implement a more robust method for collecting valuable
qualitative data.
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Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 172 of 5420342
Automatic quality improvement through intensive care unit data
management (ICU-DAMA) tool. Quality in information enhances
quality in critical patient care
M. Bodí1, J. Gómez2, G. Moreno2, F. Esteban2, M. Olona2, A. Rodríguez1,
J.J. Guardiola3, G. Sirgo2
1Hospital Universitario Joan XXIII/URV/IISPV/CIBERES, Intensive Care
Medicine, Tarragona, Spain; 2Hospital Universitario Joan XXIII/IISPV,
Tarragona, Spain; 3University of Louisville, Department of Pulmonary,
Critical Care and Sleep Medicine, Louisville, United States
Correspondence: M. Bodí
Intensive Care Medicine Experimental 2017, 5(Suppl 2):0342
INTRODUCTION. It is a priority in modern Intensive Care Medicine to
obtain quality indicators that are measurable, reliable and
reproducible from the data contained in the clinical information
systems (CIS).
OBJECTIVES.
1) To determine the feasibility of the automatic generation of health
care quality metrics from the data of the CIS, using the ICU-Dama ®
tool, and compare them with the gold standard (manual
measurement).
2) Describe and classify the differences between both methods.
METHODS. Descriptive study. University Hospital. Period of study:
two months. Selection of 25 variables to measure the quality of care.
Automatic method: using the ICU-DaMa ® tool based on Business Dis-
covery (designed to analyse data generated in the CIS (visualization,
generation of indicators, ad hoc studies of patient subgroups)
through a previous process of extraction, transformation and loading
of data from the CIS in a warehouse. Manual method: construction of
a database created from the CIS by two trained professionals. The
differences between the two methods were classified as plausibility,
completeness or conformance errors.
RESULTS. All variables could be captured automatically. There were no
significant differences between the automatic method and the manual
method. Errors of plausibility (sex), completeness (destination for ICU
discharge and days of use of continuous renal replacement techniques)
and conformance (reason for isolation and brain death) were detected.METRIC OVERALL (n = 149) Type of error AccuracySex 1 (0.7%) Plausibility 99.3%Reason for isolation 2 (1.3%) Conformance 98.7%Destination for ICU discharge 2 (1.3%) Completeness 98.7%Brain death 1 (0.7%) Conformance 99.3%days of CRRT 1 (0.7%) Completeness 99.3%[Data Quality Errors. ICU DaMa vs Gold Standard]
CONCLUSIONS. The automatic generation of quality metrics using
ICU-DaMa ® is feasible, and it allows optimizing the time of profes-
sionals. Discrepancies regarding the standard gold could be identi-
fied and potentially correctable. The training of professionals in the
culture of data quality is fundamental.
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Intensive Care Medicine Experimental 2017, 5(Suppl 2):0343INTRODUCTION. It has been suggested that patients admitted to the
ICU and discharged to the hospital ward during the weekend may
have a worse outcome because they are attended the ward staff on
call in the hospitals and not by the corresponding specialists.
OBJECTIVES. To analyze the clinical outcome of patients admitted in
the ICU and discharged to the ward during the weekend, comparing
them with discharged patients in working days.
METHODS. Retrospective study of all patients admitted in the ICU,
consecutively, discharged alive to conventional ward in a university
hospital during a period of 20 years. Patients were divided in two
groups, Group I: discharge day at the weekend (saturday or sunday)
and Group II: discharge, the rest of days. Sociodemographic, clinical
and evolutionary variables were analyzed. Quantitative variables
were expressed as mean ± standard deviation or median (first, third
quartile), and qualitative as absolute and relative frequency.
Comparisons between variables were performed using Pearson´s Ji2,
Student´s T or Mann Whitney tests.
RESULTS. During the study period, 18740 patients were discharged
alive to the ward, 3837 (20.5%), during the weekend. Neither age,
Group I: 63.6 ± 16.7 and Group II: 63.7 ± 17.3 (p = 0.779) or gender
(64.5% and 63.3% males, respectively; p = 0.157) differ in the two
groups. Charlson´s comorbidity index was similar in both groups,
median: 2 (1.3) [p = 0.896]. The severity at admission as measured by
the SAPS II index was higher in Group I: 34.1 ± 12.2 vs Group II:
35.1 ± 13.7 (p < 0.001), but the maximum SOFA index was lower,
2.6 ± 3.3 and 3.1 ± 3.5 respectively (p < 0.001). Patients with do not
intubate order were 216 (5.6%) in Group I and 933 (6.3%) in Group II
(p = 0.146), and 76 (2%) and 359 (2.4%) respectively presented no
readmission order (p = 0.116). Hospital stay was lower in patients in
Group I (16 ± 17 days) than group II (18 ± 20 days) [p < 0.001.] The
readmissions were slightly lower in Group I: 197 patients (6.3%)
compared to 859 (7.3%) in group II (p = 0.051), and hospital
mortality was 5.1% (202 patients) and 5.9% (890 patients)
respectively (p = 0.082).
CONCLUSIONS. In our cohort, the fact of being discharged during
the weekend does not result in an increased risk for patients, Since
there is no greater number of re-admissions nor a higher mortality
rate.
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INTRODUCTION. Intensive Care can be associated with unpleasant
and distressing experiences for patients and in the longer term may
result in significant physical and psychosocial morbidity, poor quality
of life and excess mortality1,2. Whilst published guidelines relating to
ICU discharge stipulate the need for clear plans for ongoing
treatment3, there is no specific reference to treatment escalation
planning (including ICU readmission status) at the time of ICU
discharge in the event of recurring critical illness.
OBJECTIVES.
1. To investigate the proportion of patients who have a documented
treatment escalation plan (TEP) on discharge from ICU (including “Do
Not Attempt Cardiopulmonary Resuscitation” - DNACPR orders).
2. For patients who do have TEPs, to determine the proportion that
were discussed with patients.
METHODS. Retrospective analysis at our institution of all patients
who survived an ICU admission over a 6-month period between 1st
September 2016 and 29th February 2017. Discharge summaries for all
patients were analysed to ascertain ceilings of care (including
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 173 of 542DNACPR orders), readmission status and whether these decisions
were discussed with the patient. Subgroup analysis was performed
on those who were intubated and had an ICU stay of 4 days or
more.
RESULTS. Of the 283 patients admitted to ICU during the data
collection period, 215 survived to ICU discharge. Five patients were
excluded due to a lack of available discharge summary. Of the 210
patients remaining, 134 (63.8%) were male, with a mean age of 60.1
years (SD 18.1). Median ICU stay was 3.8 days (IQR 1.71-7.13). On ICU
discharge, 133 (63.3%) patients had no TEP, 148 (70.5%) had no
documented DNACPR status and 181 (86.2%) patients were not
consulted about treatment re-escalation and potential future ICU
readmission.
For patients who had been intubated with a length of stay (LOS) of 4
days or more (n = 73), the median LOS was 7.8 days (IQR 5.7-14.29).
In this subgroup, 40 (54.8%) had no TEP, 50 (68.5%) did not have a
documented DNACPR status and 59 (80.8%) patients were not
consulted about treatment re-escalation and potential future ICU
readmission.
CONCLUSIONS. Our study shows that treatment escalation planning
on ICU discharge is inconsistent and patients are rarely consulted
about treatment re-escalation and ICU readmission at the point of
ICU discharge. It is recommended that treatment escalation plans
(that takes into account potential benefits, risks and patient's wishes)
should be routinely considered and documented on discharge from
the ICU.
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INTRODUCTION. The use of quality indicators (QIs) to improve care
in the intensive care unit (ICU) is increasing. In Norway, process-QIs
for Early Mobilization (EM) or Pain-Agitation/sedation-Delirium (PAD)
assessment are infrequently used.
OBJECTIVES. The aim of this pilot study was to evaluate the
frequency of these two processes measured by specific QIs in two
ICUs at the Oslo University Hospital Ullevål (OUHU).
METHODS. In this prospective observational study, all patients
admitted at two different ICUs at OUHU were included during a
predefined period in autumn 2015. Data for determining EM and
PAD-assessment were retrieved from the daily electronic patient rec-
ord (MetaVision). EM was defined as mobilization within 72 hours
from ICU admittance to either edge of bed, standing position, walk-
ing or sitting in a chair. PAD was defined as documentation of pain-
(P), agitation/sedation- (A/S) and delirium- (D) scores during each
nursing shift. Data analysis was performed using SPSS version 21. De-
scriptive statistics are presented as frequencies (percentages) for cat-
egorical variables, and as median with interquartile range (IQR) for
continuous variables.
RESULTS. We included 143 adult ICU patients (73% male, median
age 59 years (37, 71)), 92% being surgical patients. Among those,
69% were trauma patients and 20% surgical emergency patients.
Median SAPS II score was 28 (21, 41), median duration of mechanical
ventilation (MV) was 1 day (0, 6) and median ICU length of stay was4 days (2, 10). Altogether 97 patients (68%) were mobilized in the
ICU, and EM was performed in 60 patients (42%). In patients treated
with MV (n = 107), EM was performed in 36 patients (34%). The 143
patients were followed in 1192 ICU days corresponding to 3147
nursing shifts, and P, A/S and D were assessed in 22%, 52% and
0,004% of the shifts, respectively.
CONCLUSIONS. Guideline adherence for both EM and PAD-
assessments at OUHU is suboptimal, although we have to take into
account the large number of polytraumatic patients. Systematic mon-
itoring and focus on QIs like EM and PAD is important to improve
quality of care in an ICU.
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INTRODUCTION. Sedation in critical care is a balancing act. Whilst
patient comfort is paramount, depth of sedation also affects
haemodynamic stability, ventilatory requirement and neurological
assessment. Current guidelines advocate a light sedation technique
using tools such as the Richmond Agitation-Sedation scale (RASS) to
record and titrate depth1. Analgesia-first sedation and daily interrup-
tion are recommended strategies to manage pain, agitation and de-
lirium in critical care1. These recommendations form one of the
“Magnificent Seven” principles agreed by the East of England Critical
Care Operational Delivery Network for delivering evidence-based
quality care in the areas of diagnostic tests, red cell transfusion, par-
enteral nutrition, sedation, ceiling of care, antibiotic use and inter-
hospital transfers2. This audit focuses on current sedation practices in
Colchester General Hospital, a 560-bed district general hospital serv-
ing a population of 370,000 in North Essex.
OBJECTIVESl To audit current practice in Colchester General Hospital
Critical Care Unit against the recommendation from the East of
England Network and local guidelines. To highlight key areas for
improvement in sedation practice.
METHODS. Data were collected prospectively from all mechanically
ventilated critical care patients for one month. Patients were
excluded on day of intubation. Bedside notes were reviewed for
documentation of depth of sedation, use of analgesic, sedation hold
within previous 24 hours and reasons for deviation from above.
RESULTS. During the 45 ventilated patient days depth of sedation
was recorded daily in all patients using the RASS score. All patients
had multimodal sedation comprising opiate infusion with propofol,
dexmedetomidine or midazolam. Sedation holds were performed on
29 out of 45 ventilator days. Nine of the 16 reasons for omission
were consistent with local guidelines, including PEEP >12,
FiO2 > 60%, ongoing neuromuscular block and raised intracranial
pressure.
CONCLUSIONS. The audit revealed good nursing documentation of
depth of sedation but limited medical documentation of rationale for
sedation strategy. There was variable practice with sedation holds,
not always consistent with local guideline. Recommendations include
discussion of sedation on daily ward rounds involving assessment of,
and plan for weaning and withdrawal of sedation. When sedation
hold is not appropriate the reason should be documented. These
changes to practice will ensure judicious use of sedation in order to
optimise ventilatory wean and minimise side effects of over sedation.
REFERENCES
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Table 104 (Abstract 0347). See text for description
16-item IPREA, n = 994 18-item IPREA, n = 994
RMSEA (<0.05 good) 0.039 (0.03 - 0.05) 0. 042 (0.04 - 0.05)
CFI (>0.9 good) 0.932 0.918
TLI (>0.9 good) 0.916 0.901
SRMR (<0.08 good) 0.034 0.04
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INTRODUCTION. Critically ill patients in intensive care units (ICUs) are
exposed to stressful conditions and experience discomfort from
multiple sources. To assess the level of overall discomfort perceived
by the ICU patient, we developed the 16-item IPREA questionnaire1.
However, based on the high level of respiratory symptoms reported
by ICU patients as well as depressive symptoms that may persist
after ICU discharge, the content validity of IPREA can be increased by
introducing 2 items, shortness of breath and depression.
OBJECTIVES. The objective of this study was to assess the validity of
the overall discomfort score derived from the 18-item version in
comparison with that derived from the original 16-item version of
IPREA.
METHODS. We conducted the IPREA3 study, a multicenter, cluster-
randomized, two-period crossover trial, controlled study involving 34
French adult ICUs and 2130 ICU survivors to assess the efficacy of a
multicomponent tailored program to reduce discomfort in the ICU2.
On the day of ICU discharge, the bedside nurse asked patients to
rate the severity of each discomfort item from 0 to 10 (minimal to
maximal) using the 18-item version of IPREA. The primary outcome
of the IPREA3 study was the overall discomfort score derived from
the already validated 16-item version from 0 to 100 (minimal to max-
imal). The validation process of the 18-item version was based on a
confirmatory factor analysis (CFA) applied to patients not impacted
by the program. CFA consisted of calculating the root mean square
error of approximation (RMSEA), the comparative fit index (CFI), the
Tucker Lewis Index (TLI) and the standardized root mean square re-
sidual (SRMR).
RESULTS. Before implementation of the program, 994 ICU survivors
were included (age 62.4 ± 15.6, SAPS2 35.9 ± 16.5). The overall
discomfort scores were resp. 21.99 ± 13.88 and 21.92 ± 13.73 for the
16-item and 18-item versions. The scores for shortness of breath anddepression were resp. 2.84 ± 3.09 and 1.44 ± 2.57. CFA is presented
in Table 104.
CONCLUSIONS. The 18-item version of IPREA including the items
shortness of breath and depression presents the same satisfactory
psychometric properties as the 16-item version. Its use can be recom-
mended to monitor discomfort in unselected adult ICU patients.
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INTRODUCTION. The effect of pain experienced by post-cardiac sur-
gical patients on clinical outcomes has not been well studied.
OBJECTIVES. Determine the association between patient-reported
pain levels after coronary artery bypass graft (CABG) and hospital
length of stay, 30-day mortality, and 1-year mortality.
METHODS. Using the Medical Information Mart for Intensive Care
(MIMIC-III) database, a cohort of 844 post CABG patients, extubated
within 24 hours, was identified. Pain levels after extubation, reported
on a scale of 1 to 10, were represented as mean, median, and
maximum values during their intensive care unit (ICU) stay, and then
categorized into no (0/10), mild (1–3), moderate (4–6), and severe
pain (7–10). Regression analysis was used to study the relationship
between the pain scores, mortality, and hospital length of stay (LOS).
Falsification hypothesis testing using nausea, a symptom with no
known effect on the outcomes of interest, was performed on the
patient cohort.
RESULTS. Adjusting for age, sex, Oxford Acute Severity of Illness
Score (OASIS), the Elixhauser comorbidity index, and use of
extracorporeal circulation during surgery, increased levels of pain
were found to be significantly associated with reduced length of stay
and reduced mortality at 30 days and 1 year after among the patient
cohort. One point increase in mean pain level was found to be
associated with a 0.92 (95%CI 0.67-1.16, p < 0.001) day decrease in
hospital LOS, and a reduction in the odds of 30-day and 1-year mor-
tality by a factor of 0.44 (95%CI 0.28-0.65, p < 0.001) and 0.70 (95%CI
0.55-0.86, p < 0.01) respectively. Compared to patients who reported
no pain after extubation in the ICU, those with mild pain had hos-
pital LOS decreased by 3.8 (95%CI 2.56-5.34, p < 0.001), those with
moderate pain had a reduction of 5.19 (95%CI 3.60-6.79, p < 0.001)
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 175 of 542and those with severe pain had a reduction of 6.57 (95%CI 3.68-9.46,
p < 0.001). Falsification testing showed nausea was not related to
hospital length of stay or 30-day mortality in this patient cohort.
CONCLUSIONS. Some level of pain post-CABG may be related to im-
proved patient outcomes. This finding has not been reported and is coun-
terintuitive, and needs to be validated in other databases and settings.
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INTRODUCTION. Readmission to intensive care unit (ICU) is
associated with poor clinical outcomes and increased costs [1].
Moreover, it has been demonstrated that ICU readmission after 72
hrs from ICU discharge is associated with increased hospital mortality
in developed countries [1].
OBJECTIVES. To evaluate the effect of the time interval between ICU
discharge and readmission on resource use and outcomes in a
developing country.
METHODS. This retrospective single center cohort study was
conducted in a forty bed, medical-surgical, open model ICU of a private,
tertiary care hospital in São Paulo, Brazil. The Local Ethics Committee
approved the study protocol, and the need for informed consent was
waived. All consecutive adult (≥18 years) patients admitted to the ICU
between June 1, 2013 and July 1, 2015 were enrolled in this study.
Comparisons were made between patients readmitted within 72 hrs or
less (Early) and after 72 hrs (Late) after ICU discharge.
RESULTS. In total, 5,779 patients were included in this analysis. The
incidence of ICU readmission during the same hospitalization was 10%
(576/5,779 patients). Among the readmitted patients, 169 (29.3%) were
readmitted to the ICU within 72 hrs or less and 407 (70.7%) were
readmitted after 72 hrs. Patients readmitted after 72 hrs of ICU
discharge were slightly older [68 (56–81) vs. 65 (53–76) years,
respectively for Late and Early; p = 0.028)], more frequently male [258/
407 (63.4%) vs. 91/169 (53.8%); p = 0.039] and had a higher severity of
illness [Simplified Acute Physiology (SAPS) III score] on index ICU
admission [52 (42–63) vs. 47 (38–56); p = 0.001)] than those readmitted
within 72 hrs or less. The need for vasopressors, invasive mechanical
ventilation, and renal replacement therapy did not differ between Late
and Early ICU readmissions. Late ICU readmission was associated with
higher ICU [3 (2–8) vs. 2 (1–5) days, respectively for Late and Early;
p = 0.001)] and hospital [43 (26–70) vs. 20 (12–42) days; p < 0.001)]
length of stay and with a higher hospital mortality [149/407 (36.6%) vs.
47/169 (27.8%); p = 0.043] than Early ICU readmission. Nevertheless,
after adjusting for confounders in a multivariable logistic regression
analysis, time to ICU readmission was no longer associated with
increased hospital mortality.
CONCLUSIONS. Late ICU readmissions were frequent and associated
to higher ICU and hospital lengths of stay. The impact of late ICU
readmission on hospital mortality and the degree at which late ICU
readmissions are preventable in developing countries need to be
further determined.
REFERENCE. [1] Kramer AA, et. al. Intensive Care Unit Readmissions
in U.S. Hospitals: Patient Characteristics, Risk Factors, and Outcomes.
Crit Care Med 2012;40:3–10.
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INTRODUCTION. ICU readmission has been related to poor outcomes
and greater risk of death. By studying the specific group of deceased
patients and the death process, we believe that better characterizing
this subgroup would provide relevant information in order to
improve the quality of care and the use of ICU.
OBJECTIVES. To compare the characteristics of the deaths after the
first ICU stay with the characteristics of the deaths after readmission
to the ICU, and to identify behaviors associated with withholding/
withdrawing of life support therapies.
METHODS. A retrospective case-case study of all patients admitted
consecutive to the Intensive Care Unit of the Sírio-Libanês Hospital in
São Paulo, Brazil, with 370 total beds and 32 ICU beds, attending
highly complex clinical and surgical patients. A total of 2098 patients
were admitted, with analysis of 152 deaths in the single admission
group and 24 in the readmitted group. Readmission was defined as
follows: any patient transferred back to the ICU prior to death or hos-
pital discharge. Demographic, physiological variables, presence of sit-
uations or orders of withholding or withdrawing life support
therapies were collected. Life Support Therapies were considered de-
fibrillation for ventricular fibrillation, cardiopulmonary resuscitation,
treatment of acute cardiac arrhythmias, treatment with vasopressors
and / or inotropes, tracheal intubation and mechanical ventilation,
surgeries, transfusion of blood products, antimicrobial treatment and
renal replacement therapy. Statistical analysis has been performed
using the statistical program Stata® (version 11.2).
RESULTS. Readmission rate was 8.4%, mortality rate was 8.5% (95%
CI: 7.3% to 9.9%) among not readmitted patients and 14.1% (95% CI:
9.3% to 20, 1%) among those who were readmitted. The groups
were similar according to the physiological parameters studied,
gender, age range or marital status, except for length of stay. No
significant associations were found between an existence of cancer
diagnosis or causes of admission to ICUs with a number of passages
through the unit. Limitations of Therapeutic Efforts (LTE) were
adopted for 116 (65.9%) patients. The commonest LTE decisions
were: "Do not resuscitate" (DNR) and do not start renal replacement
therapy.
CONCLUSION. The similar rates of LTE in both groups may indicate
that they had the same intensity of care and died similarly,
regardless ICU readmission. There should be some perception that
the outcome will be adverse, regardless of the readmission event,
and this causes the high LTE rate.
REFERENCES. Al-Jaghbeer MJ, Tekwani SS et al. Incidence and Eti-
ology of Potentially Preventable ICU Readmissions. Critical Care Medi-
cine. 2016;44(9):1704–9. Phua J, Joynt GM, Nishimura M et al.
Withholding and withdrawal of life-sustaining treatments in low-
middle-income versus high-income Asian countries and regions. In-
tensive Care Med. 2016;42(7):1118–27.
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OBJECTIVE. To evaluate possible predicting variables related to
mortality after ICU discharge.
METHODS. Prospective observational cohorts study. All patients
(n = 1128) admitted to our unit for one year, excluding cardiac
patients and with < 24 hours stay, followed-up until hospital dis-
charge. We defined two groups: early [EM] (<48h) and late [LM] after
discharge mortality. A logistic regression analysis was performed.
With approval by the hospital Ethics Committee.
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 176 of 542RESULTS. Population: 35% women, 59.4(15.9) years, SOFA at
admission 4.1(3.1), APACHE II 16.6(7.9), expected mortality
29.2(21.5)%. From elective surgery 23.9%, urgent surgery 14.5%,
emergency area 34.5% and medical wards the rest. 18.4% developed
infection during the admission, 39.8% AKI and 7.2% required CRRT.
Overall mortality 21.8% (5.9% for elective surgery, 22.5% in the rest).
56 out of 939 patients (5.9%) died after ICU: 10 in EM group and 46
in the LM group. In EM group, 7 patients were readmitted and died
in the Unit and 3 died unexpectedly in the hospital (hidden
mortality). (Fig. 117)
Age, longer hospital stay before ICU, from medical ward, AKI and
Sabadell Score were related to after discharge mortality. The Sabadell
Score did not discriminate between the EM and LM groups (Fig. 118).
CONCLUSIONS. The distribution of mortality in our series is similar to
that published elsewhere. Even when the Sabadell Score detected
fairly well those patients with highest probability of death after ICU
discharge, regarding hidden mortality (an infrequent but serious
problem considering that are those patients not expected to die)
was not of aid for their detection.Fig. 117 (abstract 0351). See text for description
Fig. 118 (abstract 0351). See text for description0352
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INTRODUCTION. Surviving intensive care stay important, but
readmission after ICU discharge is associated with increased risk of
mortality and poor prognosis. The epidemiology of ICU readmission
remains unknown in Tunisia. To focus on patients at risk of readmission,
could help health caregivers to improve their ICU discharge.
OBJECTIVES. To identify the frequency and factors associated with
hospital readmission after ICU discharge.
METHODS. An observational prospective cohort study was
performed in a Tunisian medical ICU from January 2014 to December
2015 involving survivors after ICU stay. An analysis of collected data
from all patients readmitted to the hospital wards or ICU during 12-
month period after their ICU stay was conducted. A between group-
comparison of patients who were readmitted and not readmitted to
ICU was performed. Significant factors with a p value of < 0.2 were
entered into a backward conditional binary logistic regression to de-
termine independent factors leading to hospital readmission.
RESULTS. In this prospective study, 71(33%) patients were
readmitted. The first hospital readmission occurred within a median
of 89[1–365] days. 37(56%) were readmitted within the first month.
120(56%) were readmitted in the ICU and 23 (11%) in the
pulmonology department. The most common reason for readmission
was respiratory disorders for 47(66%) patients. 7(10%) persons were
readmitted for sepsis and a further 12(17%) were readmitted for a
cardiovascular event.
Multivariate analysis, identified significant independent factors for re-
admission were found to be coronary heart disease (OR, 2.7 ; 95%CI,
[0.96-8.02] ; p = 0.05) and physiological reserve (OR, 2.6 ; 95%CI, [1.5-4.6] ;
p = 0.001) as the two independent associated factors with post ICU
readmission.
CONCLUSIONS. The present study revealed a high risk of post ICU
readmission in a Tunisian medical ICU. Physiological reserve and
coronary heart disease were identified as independent associated
risk factors.
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INTRODUCTION. Delirium is an acute and fluctuative changes of
mental status and level of consciousness. Delirium will prolong
length of stay in ICU, higher cost during hospitalization, increase
morbidity and mortality and also will decrease the functional
recovery of ICU patients.
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 177 of 542OBJECTIVES. To measure the incidence and find out the risk factors
of delirium in patients who admitted to the ICU Dr. Hasan Sadikin
Hospital during 3 months from January to March, 2015.
METHODS. Descriptive observational cohort study using Confusing
Agitation Method-Intensive Care Unit (CAM-ICU) and Richmond Agi-
tation Sedation Score (RASS).
RESULTS. From 105 patients who admitted to the ICU, 22 patients
were excluded. Delirium was found in 37.3% (31/83) in ICU patients.
The risk factors in patients with delirium included: geriatric patient
48.4%, using mechanical ventilator 38.7%, morphine 29%, sepsis and
other infection 29%, cardiac disfunction 25.8%, High APACHE SCORE
II 25.8%, renal disfunction 22.6%, laboratory abnormality 22.6%,
sedation midazolam 19.4%, endocrine disfunction 16.1%, fentanyl
6.5% and stroke 3.2%
CONCLUSIONS.
We made a concussion that the incidence of delirium in ICU patients
of Dr. Hasan Sadikin Hospital was 37.3% and the most common risk
factor was geriatric patients
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INTRODUCTION. Unplanned readmission to intensive care is highly
undesirable in that it contributes to increased variance in care,
disruption, difficulty in resource allocation and may increase length
of stay and mortality particularly if subject to delays. Unlike the ICU
admission from the ward, readmission prediction has received
relatively little attention, perhaps in part because at the point of ICU
discharge, full physiological information is systematically available to
the clinician and so it is expected that readmission should be largely
due to unpredictable factors. However it may be that there are
multidimensional trends that are difficult for the clinician to perceive
that may nevertheless be predictive of readmission.
OBJECTIVES. We investigated whether machine learning (ML)
techniques could be used to improve on the simple published SWIFT
score [1] for the prediction of unplanned readmission to ICU within
48 hours.
METHODS. We extracted systolic BP, pulse pressure, heart and
respiration rate, temperature, SpO2, bilirubin, creatinine, INR, lactate,
white cell count, platelet count, pH, FiO2, and total Glasgow Coma
Score from ICU stays of over 2000 adult patients from our hospital
electronic patient record system. We trained our own custom
multidimensional / time-sensitive algorithmic ML system to predict
failed discharges defined as either readmission or unexpected death
within 48 hours of discharge. We used 10-fold cross validation toassess performance. We also assessed the effect of augmenting our
system by transfer learning (TL) with 44,000 additional cases from
the MIMIC III database.
RESULTS. The SWIFT score performed relatively poorly with an
AUROC of around 0.6 which our ML system trained on local data was
also able to match. However when augmented with an additional
dataset by TL, the AUROC for the ML system improved statistically
and clinically significantly to over 0.7.
CONCLUSIONS. Machine learning is able to improve on predictors
based on simple multiple logistic regression. Thus there is likely to
be information in the trends and in combinations of variables. A
disadvantage with this technique is that ML approaches require large
amounts of data for training. However, ML approaches can be
improved by TL. Basing prediction models on locally derived data
augmented by TL is a potentially novel approach to generating tools
that customised to the institution yet can exploit the potential power
of ML algorithms.
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INTRODUCTION. Epidural analgesia (EDA) for major abdominal
surgery is usually associated with a beneficial effect on postoperative
outcome. It is thought to reduce pulmonary complications, cardiac
dysrhythmias and to accelerate the return of gastrointestinal transit.It
is associated with a shorter length of ICU and hospital stay after
HIPEC and esophagectomy procedures.[1] Yet in our center we see a
longer ICU stay in patients with EDA because of hypotension and
vasopressor use.
OBJECTIVES. To investigate the association between epidural analgesia
and vasopressor use after elective major abdominal surgery.
METHODS. Medical records were reviewed from all consecutive
patients admitted to the ICU after elective major abdominal surgery
from June 2013 until November 2015. Prolonged duration of stay
was defined as more than two days. The association between EDA
and vasopressor use was quantified with a Mann–Whitney U test.
RESULTS. 195 patients were included, 46.2% after thoracoabdominal
esophagectomy (TAE), 25.6% after HIPEC, 15.4% after abdominal
aorta repair and 12.8% after liver surgery. 82% of patients received
EDA. Of all patients with EDA, 61 patients (38%) required additional
intravenous analgesia. TAE patients were most at risk for prolonged
ICU stay.
Of patients with a prolonged duration of stay (36 patients), 72% had
EDA and mean duration of vasopressors was twice compared to
patients who stayed 2 days or less. We found a significant
association between EDA and vasopressor use, especially in the TAE
patients (p = 0.009). A trend towards significance was observed for
HIPEC patients (p = 0.06).
CONCLUSIONS. These results confirm our perception that EDA is
associated with a longer stay in patients after major abdominal
surgery. This prolonged stay is mainly explained by hypotension and
need for vasopressors.
In patients receiving EDA, sympathic outflow is blocked resulting in
loss of vasomotor tone. Combined with a strong surgical trauma
induced systemic inflammatory response, this can result in significant
hypotension. This is detrimental for anastomotic healing and
interferes with mobilization due to orthostasis. Vasopressor use,
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 178 of 542prolonged hypotension and fluid overload are all associated with an
increase in gastro anastomotic leaks. [2]
We conclude that the possible benefits of EDA have to be
considered carefully in patients undergoing major abdominal surgery
when side effects lead to additional treatment and prolonged ICU
stay, especially when ICU capacity is scarce and costly.
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OBJECTIVE. To analyze the medium-term survival after a LT and to
determine which factors are related with survival.
METHODS. Prospective cohort. Patients after LT over the period
2009–2014, follow up until 2016. We analyzed variables related to
the long-term prognosis. Data: mean,median, Hazard-Ratio [H-R] Stat-
istic: non-parametric tests, Chi-square, Kaplan-Meier, Log-Rank, Cox
regression.
RESULTS. N = 253; 76.3% male; Mean age 54.7 ± 0.62 years Ethanol
etiology 45.8%, mean MELD 16.36 ± (0.43, SOFA on admission
6.53 ± 0.19. Median days in ICU: 3 and hospital 8. ICU Mortality 4.7%,
on ward 2.8% and overall 22.1%.
We performed a follow-up of 1174 days (632–1820). The complica-
tions were: no liver problems 78.7%, vascular problems 5.9%,
hemorrhagic 3.6%, rejection 3.2%, recurrence of basal 3.2% and bile
problems 3.2%. Mortality during follow-up was 14.6% and the cause
of mortality at discharge from the hospital was recurrence of the
underlying disease 21.6%, vascular problems 13.5%, bile 10.8%, rejec-
tion 5.4% and other causes 48.6%.
Univariate analysis: we found a relationship between survival and the
history of renal failure, viral etiology, previous LT, SOFA at admission,
plasma and noradrenaline supply after surgery, AKIN 3 in the
immediate postoperative period and graft dysfunction, Multivariate
analysis only found relationship between the survival and the viral
etiology [HR 2.72 (1.54-4.81) (p0.001), previous LT [HR 3.63 (1.75-7,
53) (p 0.001)], SOFA at admission [HR 1.15 (1.06-1.25) (p 0.001)] and
plasma transfusion [HR 2.14 (1.16-3.95) p 0.015].
CONCLUSION. Although the prognosis of LT patients is good, more
than a quarter will present graft-related problems and mortality in
the medium term remains high, close to 15%.
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Intensive Care Medicine Experimental 2017, 5(Suppl 2):0357INTRODUCTION. Elective admission to the Intensive Care Unit (ICU)
following major surgery comprises a significant proportion of all
admissions. Historically this was reserved for high-risk cases, however
there is increasing appreciation that lower risk patients may also
benefit by preventing excess morbidity. Recent evidence shows that
elective admission of patients post colorectal resection that are pre-
dicted to have a post-operative mortality of between 1 and 3% re-
duces complications, length of stay and costs1.
At our District General Hospital we see all elective major surgical
cases in a 'Shared Decision Making' pre-assessment clinic where we
categorise patients depending on their predicted 30 day post-
operative mortality (category (Cat) A if greater than 6%, Cat B if be-
tween 3 and 6%, Cat C if between 1 and 3% and Cat D if less than
1%). All patients with a predicted mortality of greater than 1% are
considered for High Dependency Unit (HDU) care. Elective surgery
currently accounts for 21% of all our ICU / HDU admissions, in com-
parison with emergency/urgent surgery that accounts for 23%. For
the year 2015–16, 128 out of 613 patients admitted were elective
surgical patients.
OBJECTIVES. To gain a better understanding of why patients with a
1-3% predicted post-operative risk benefit from HDU level care in the
immediate post-operative period.
METHODS. All elective surgical admissions that were admitted to
ICU/HDU between the months of August and November 2016 and
who had a length of stay greater than 8 hours were considered for
inclusion.
We collected baseline data on age, comorbidities, gender and pre-
operative risk status. Outcome data included mean arterial blood
pressure, vasopressor requirements, Sequential Organ Failure Assess-
ment (SOFA) scores, development of complications and other levels
of support.
RESULTS. Forty-six patients were included in data analysis.Categorisation (predicted mortality
A > 6%, B 3 to 6%, C 1 to 3%, D < 1%)Cat A n = 4 (95), Cat B n = 9 (20%), Cat C
n = 24 (52%) Cat D n = 1 (2%)
Uncategorised n = 8 (17%)Surgical case split General surgical n = 37 (80%) Urology
n = 11 (23%) Vascular n = 2 (4%)Mean age (years) 72 (range 28 to 88)Mean SOFA score 4 (range 2 to 9)Mean length of stay (days) 1 (range 0 to 4)Vasopressor use 19 patients (41%)Median vasopressor duration (hours) 27 (range 2 to 50)Vasopressor start time post-op (hours) Immediate n = 7 (37%) <5 hours n = 8
(42%) 5 to 10 hours n = 1 (5%) 10 to 15
hours n = 3 (16%)[Table of results]Incidence Acute Kidney Injury 8 (17%)Incidence other complications 2 (4%)Incidence readmission post discharge 2 (4%)Incidence return to theatre 1 (2%)[Incidence of complications]
Of the patients who were supported with vasopressors, 3 were Cat A,
4 were Cat B, 9 were Cat C (38% of all 24 cat C patients) and 1 was
Cat D. 2 patients were uncategorised. Of the patients who developed
acute kidney injury (AKI) 1 was Cat A, 2 were Cat B, 2 were Cat C and
3 were uncategorised.
CONCLUSIONS. Lower risk patients admitted to HDU / ICU after
elective surgery have a significant rate (38%) of vasopressor use to
maintain adequate mean arterial pressure. A service that provides
Fig. 119 (abstract 0358). See text for description
Fig. 120 (abstract 0358). See text for description
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treating relative hypotension otherwise underreported on the ward.
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INTRODUCTION. The key function of microcirculation is to deliver
nutrients and oxygen to tissues to maintain cellular and organ
function. The mirocirculatory dysfunction leads to regional hypoxia
and organ failure. Vascular occlusion test (VOT) using near infrared
spectroscopy (NIRS) is a method of observing the change in tissue
oxygen saturation (StO2) after applying a brief ischemic challenge.
The reduction rate of StO2 (occlusion slope) in the ischemic period
reflects oxygen extraction. The rate of StO2 increase (recovery slope)
in the reperfusion period is known to reflect microvascular reactivity.
The effects on microcirculation of general anesthetics have begun to
be studied recently, and the results are still inconsistent. We assume
that the inconsistent results may be due to the different states of
microvasculature in the subjects. In order to understand the effects
of general anesthesia on microcirculation, it is essential to study the
effects on healthy patients first.
OBJECTIVES. The main purpose of this study is to investigate how
general anesthesia affects microcirculation in healthy patients using
VOT derived parameters with NIRS. We also examined the effect of
age on microcirculation by analyzing young and elderly patients
without accompanying diseases.
METHODS. This prospective observational study was performed on
57 patients without comorbidities who had undergone elective
surgery under general anesthesia with inhalational agent. We
measured StO2 during VOT before (T0) and after general anesthesia
(T1). We divided the patients into two subgroups at the age of 50
and compared VOT derived parameters.
RESULTS. General anesthesia increased StO2 values and the recovery
slope (2.91 ± 1.06% sec−1 at T0 and 3.56 ± 1.70% sec−1 at T1,
p = 0.006) and reduced the occlusion slope (0.21 ± 0.08% sec−1 at T0
and 0.15 ± 0.05% sec−1 at T1, p < 0.001) (Fig. 119).
Similar changes were observed in young patients. On the contrary, in
elderly patients, the recovery slope did not increase after general
anesthesia (2.86 ± 0.98% sec−1 at T0 and 3.16 ± 1.47% sec−1 at T1,
p = 0.227) (Fig. 120).
CONCLUSIONS. General anesthesia increases microcirculatory flow
through vasodilation with improved microvascular reactivity, but
these beneficial effects were not seen in elderly patients.
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INTRODUCTION. Post-operative infection is a common complication
after liver resection. C-Reactive Protein (CRP) is an acute-phase pro-
tein that is frequently used as a marker of infection. As it is produced
by the liver, major resection of the liver can influence the postopera-
tive time course of CRP.
OBJECTIVE. In this retrospective study we determined the time
course of CRP after liver resection as a function of functional liver
remnant (FLR) in patients with and without infection.
METHODS. All consecutive patients (2008–2014) who were
postoperatively admitted to the intensive care unit (ICU) after liver
resection were included. Patients were classified based on a FLR of
≥60% (small resection), 35-60% (medium resection) and < 35% (large
resection). Postoperative infection was defined as any infection
Table 105 (Abstract 0360). Oxygenation values according to
operative stage
Operative stage
(number of
samples)
Median
FiO2
(IQR)
Median PaO2
in kPa (IQR)
Median P:F
ratio in kPa
(IQR)
Median
Haemoglobin
g/l (IQR)
Stage 1: dissection
(583)
0.48
(0.09)
24.82 (11.10) 54.96 (20.84) 92 (25)
Stage 2: anhepatic
(305)
0.49
(0.07)
26.60 (8.79) 56.50 (19.01) 90 (23)
Stage 3:
reperfusion (641)
0.47
(0.11)
24.60 (10.61) 54.69 (19.48) 85 (17)
Table 106 (Abstract 0360). Postop outcomes & relationship to
cumulative O2
Median (IQR) p value
Peak AST (U/l) 1493 (2085) 0.98
Day 3 AST (U/l) 154 (180) 0.58
24 hr creatinine (umol/l) 110 (93) 0.40
ICU LOS (nights) 4 (4) 0.14
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treatment. Numbers are expressed as mean ± standard deviation.
RESULTS. A total of 382 patients admitted to the ICU after liver
resections were included (33% after small resection, 48% after
medium resection and 19% after large resection). The main
indication was colorectal liver metastasis (63%). A total of 120
patients (31%) developed a postoperative infection. In patients with
a small liver resection there were significantly higher CRP levels
during the first postoperative week compared to the larger
resections (peak CRP 162 ± 61 mg/L versus 98 ± 47 mg/L, P < 0.001).
Also in patients with a small liver resection the time course of CRP is
markedly different in those who develop a postoperative infection
(P < 0.005), with a more gradual decline after the peak at day 2.
However in patients with a medium or large liver resection, there is
no difference in the time course of CRP in patients with and without
infection.
CONCLUSIONS. In patients after medium and major liver resection,
there is no difference in the time course of postoperative CRP in
patients with and without infection. Therefore CRP is not a useful
marker of inflammation in this patient group.
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INTRODUCTION. Supplemental oxygen is the most commonly
administered drug during general anaesthesia. Hyperoxaemia
(PaO2 > 13.3 kPa) is associated with adverse changes to the respiratory
and cardiovascular systems (1,2). This has particular relevance during
liver transplantation where ischaemia-reperfusion injury (IRI) post liver
reperfusion is potentiated by oxygen-induced production of reactive
oxygen species and immune cell activation (3). Avoidance of excessive
oxygen levels during general anaesthesia could therefore lead to im-
proved perioperative outcomes.
OBJECTIVES. This service evaluation characterised current anaesthetic
practice as regards intraoperative oxygenation during liver
transplantation in a single centre and looked at postoperative markers
of IRI and outcome.
METHODS. This retrospective service evaluation looked at
intraoperative data for sequential liver transplants performed over a
period of 26 months (November 2013 to January 2016) at the Royal
Free Hospital. Data were retrieved from anaesthetic charts, arterial
blood gases (ABGs), laboratory reports and hospital records.
We used ABG data to generate a graphical intraoperative oxygenation
profile for each patient and calculate the area under the curve (AUC) of
PaO2; allowing us to determine cumulative intraoperative PaO2.
RESULTS. 201 patients were included; 72.8% were male (n = 150).
The median age of all patients was 51.5 years. The median number
of intraoperative ABGs per patient was 9 (range 4 to 23). Table 105
demonstrates oxygenation and haemoglobin values according to
operative stage for all patients:
The mean cumulative oxygen dose during liver transplantation was
10,872 kPa with a mean duration of surgery of 433 minutes. The
relationship between cumulative oxygen dose and a number of post-
operative outcomes and markers of IRI was explored (Table 106):
CONCLUSIONS. We have demonstrated the consistent presence of
intraoperative hyperoxaemia throughout liver transplantation surgery
in our centre and there appears to be no adjustment of FiO2 in
response to this. No significant associations were found between
oxygen dose and markers of ischaemia-reperfusion injury. Debate
persists around the area of perioperative oxygenation however and
the question of 'how much is too much' remains unanswered in the
field of liver transplant surgery. Further research is required to ex-
plore this question in other transplant centres.REFERENCE(S)
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effects of 100% oxygen breathing in humans. Can J Physiol
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INTRODUCTION. With improved surgical techniques of liver
transplant (LT), perioperative major cardiac events (PMCE) have been
emerged as one of leading cause of death in the perioperative
period. The revised cardiac risk index (RCRI) is well-known risk stratifi-
cation index. We investigated the predictive value of preoperative
coronary CT angiography (CTA) in patients undergoing LT.
OBJECTIVES. Identify the value of coronary CTA in predicting
perioperative cardiac risk in liver transplant recipients.
METHODS. Of patients undergoing living-donor LT surgery from April
2010 to October 2015, we retrospectively analyzed 1512 patients
(mean age, 53 years; male sex, 77%; mean MELD score, 16) who
underwent coronary CTA for screening of coronary artery disease
(CAD) within a year before the surgery. PMCE were defined as non-
fatal myocardial infarction (MI), death, or combined events within 30
days after LT surgery. The severity of CAD was classified as normal
(no atherosclerosis), minimal (<25%), mild (25-50%), moderate (50-
70%), or severe (>75% narrowing) stenosis. Non-obstructive CAD was
defined as stenosis degree of no more than minimal or mild in all
coronary artery and obstructive CAD was defined as moderate or se-
vere stenosis. The RCRI score was calculated as the total number of
known independent predictors.1
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(512/1512 patients) and 7.7% (117/1512 patients), respectively. PMCE
developed in 2.9% (44/1512 patients). The incidence of PMCE was
significantly increased with increasing severity of CAD [2.4% (21/883)
vs 2.7% (14/512) vs 7.7% (9/117) for patients with normal coronary
vessel, non-obstructive, and obstructive CAD, respectively, P = 0.001].
The RCRI score 1 identified 1, 240 (82.0%) patients, score 2 identified
251 (16.6%) patients, and score 3 identified 21 (1.4%) patients, and
each score group showed event rate of 1.3% (16/1240 patients), 9.6%
(24/251 patients), and 19.0% (4/21 patients), respectively (P < 0.001).
In receiver operating characteristic (ROC) curve analysis, predictive
performance of RCRI alone (model 1) showed significant better C-
statistic compared with predictive model of RCRI plus MELD score
(model II) and RCRI plus MELD score plus severity of CAD (model III)
(C-statistic, 0.739; 0.800; 0.817; P < 0.01, respectively, Fig. 121).
CONCLUSIONS. Addition of abnormal coronary CTA to MELD score
and RCRI improved perioperative risk stratification, suggesting that
preoperative severe CAD deserves to be identified using coronary
CTA to predict the development of PMCE in patients undergoing LT
surgery.
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INTRODUCTION. Anastomotic leakage (AL) is one of the most serious
complications of gastrointestinal tract surgery. Several studies have
evaluated a variety of risk factors of AL; however there is no
universal agreement regarding the associated risk factors.
OBJECTIVES. To analyze postoperative patients admitted to an Intensive
Care Unit (ICU) and to determine predictive factors of AL in ICU.METHODS. Retrospective cohort study of all the adult patients
admitted to a 12-bed Intensive Care Unit after gastrointestinal tract
surgery between 1 January 2011 and 31 December 2015. Statistical
analysis: categorical variables (frequencies and percentages) and nu-
merical variables (mean and standard deviation or medians and
interquartile range). Comparisons: X2 test (percentages), Student´s
test (means) and Kruskal-Wallis test (medians). Statistical significance
p < 0.05. Multivariate logistic regression models were calculated. The
analysis was performed with the software SPSS v21.
RESULTS. We identified 376 patients; mean age 66.6 ± 14.6, 63%
were male. Mean APACHE II 11.3 ± 4.9, SOFA 5.2 ± 3.8.
Comorbidities: solid tumor (61.4%), DM (34.3%), liver disease (26.3%),
COPD (24.5%), chronic renal failure (12.5%), obesity (14.3%).
Emergency surgery 41.8%, elective 58.2%. Procedures: partial
colectomy (n = 74), hepatectomy (n = 49), small bowell resection
(n = 35), colostomy/ileostomy (n = 29), pancreaticoduodenectomy
(n = 17), total colectomy (n = 15). We found 64 (17%) anastomotic
leakage. ICU mortality 20.5%, hospital mortality 24.8%. Blood
transfusion during surgery 20.2%. Clinical situation at ICU admission:
sepsis (15.7%), severe sepsis/septic shock (37.2%). Vasoactive agents
(first 24 hours in ICU): noradrenaline (NAD) 43.1%, dobutamine 9.8%,
dopamine 2.1%. Patients with AL: higher APACHEII (12.7 ± 4.9 vs.
11.1 ± 4.9, p = .012), hospital lenght of stay (24.1 ± 22.2 vs. 18 ± 18.1
days, p = .033), COPD (39.1% vs. 21.5%, p = .003), elective surgery
(70.3% vs. 55.8%, p = .032), clinical situation severe sepsis/septic
shock (46.8% vs. 35.2%, p = .006), vasoactive drugs (NAD 53.1% vs.
41%) (p = .001), mechanical ventilation (64.1% vs. 47.1%, p = .014),
corticosteroids (14.1% vs. 3.8%, p = .004), haemoglobin at admission
(9.8 ± 1.6 vs. 10.5 ± 2.0 g/dL, p = .007). Multivariate logistic
regression model: elective surgery and use of corticosteroids were
independent predictors of AL in ICU.
CONCLUSIONS. Elective surgery and use of corticosteroids were
predictors of AL in adult patients admitted to ICU after
gastrointestinal surgery. There were no relation between AL and
mortality.
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INTRODUCTION. Associating liver partition and portal vein ligation
for staged hepatectomy (ALPPS) first performed in Germany in 2007
may minimize the risk of post-hepatectomy liver failure by producing
rapid marginal future liver remnant hypertrophy decreasing the time
between the first surgery and hepatectomy. Postoperative intensive
care course of patients undergoing ALPPS has not been previously
described as published series are still few.
OBJECTIVES. The aim of this study is to document the postoperative
intensive care course, hemodynamic and metabolic management
and ICU outcome of patients undergoing the ALPPS procedure.
METHODS. Inclusion criteria: All patients undergoing ALPPS in
Nicosia General Hospital since 2015.
Tertiary, referral, University affiliated Hospital, multidisciplinary ICU/
HDU reporting.
Prospective, observational study, data collection from Hospital EMR /
ICU CIS. Patients' demographics, type and staging of cancer,
comorbidities, and time elapsed between the 2 stages are reported
as well as intra-operative data. Postoperative Intensive Care course is
Fig. 123 (Abstract 0363). Lactate Kinetics
Table 108 (Abstract 0363). ICU morbidity, mortality, length of stay
Patient
Number
ICU Morbidity ICU length of
stay in days -
1st
procedure
ICU length of
stay in days -
2nd
procedure
ICU
Mortality -
Glasgow
outcome
scale
1 None 1 2 5
2 Renal replacement
therapy (5 of the 12 days
spent in ICU), Hepatic
insufficiency
11 1 1
3 Atrial Fibrillation 1 9 5
4 None 1 4 5
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fluids and vasopressors, acid–base balance, kinetics of lactate, blood
sugar, clotting profile, and liver function tests. ICU outcome is docu-
mented in terms of morbidity, length of ICU stay and ICU mortality.
RESULTS. Four patients had undergone the ALPPS procedure
between January 2015 and April 2017. Patient demographics are
presented in Table 107.
Three patients had metastatic cancer, 2 with metastatic colon cancer
and 1 patient with ovarian cancer, all of whom had undergone several
cycles of chemiotherapy. Only one patient presented a Klatskin tumour.
Cancer staging in all patients was Stage IV cancer. All four patients
underwent an extended right hepatectomy.
The mean time for stage 1 of the operation was 3.5 hours (3–4 hours).
For stage 2, the mean operation time was 5.25 hours (4.5-6 hours).
Depicted in Figs. 122 and 123 are fluid management and lactate
kinetics.
During the first part of the ICU stay the mean daily fluid infusions
were 4.5 litres, whilst during the second part of the ICU stay fluids
were infused with a daily average of 3.8 Litres.
ICU morbidity, mortality and length of stay are presented in
Table 108.
ICU length of stay for both parts of the procedures ranged between
3 and 12 days with a mean of 7.5 days. The mean length of stay for
the second procedure was 4 days with a range between 1 and 9
days. The patient with the longest stay in the ICU died less than 24
hours after the completion of the second part of the procedure and
required renal replacement therapy during his stay. No infections
were recorded during the ICU stay in any of the patients.
CONCLUSIONS. We present the post-operative course in the ICU of
four patients that underwent the ALPPS procedure. Further research
and evaluation in larger scale studies is necessary in order to opti-
mise the post-operative care of such patients.Table 107 (Abstract 0363). Patient Demographics
Patient
Number
Age,
Sex
Type of
Cancer
Cancer
Staging
Comoridities Time elapsed
between two
stages in days
1 67,
M
Metastatic
Colon
Cancer
Stage
IV
Moderate COPD 12
2 79,
M
Klatskin
Tumor
Stage
IV
None 12
3 78, F Metastatic
Ovarian
Cancer
Stage
IV
Hypertension, Atrial
Fibrillation
9
4 72,
M
Metastatic
Colon
Cancer
Stage
IV
Deep vein thrombosis,
pulmonary embolism,
pleural effusions
6
Fig. 122 (Abstract 0363). Fluid management in the ICU0364
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INTRODUCTION. Delirium after liver transplantation is one of the
major challenges in postoperative care because it is associated with
increased hospital length of stay and higher morbidity and mortality.
Dexmedetomidine has been reported to be effective in lowering the
incidence of delirium when used as a sedative agent in the intensive
care unit (ICU). A randomized controlled clinical trial was performed
to investigate whether perioperative low dose dexmedetomidine
infusion decreases the incidence of delirium after liver
transplantation.
METHODS. In this randomized controlled trial we enrolled patients
scheduled for living donor liver transplantation between August 11,
2014 and March 27, 2017, with informed consent. The liver recipients
were randomized to either the control group or the
dexmedetomidine group. Dexmedetomidine was continuously
infused during anesthesia and was continued until 72 hours
postoperatively in the ICU in the dexmedetomidine group while
0.9% normal saline was infused in the same manner in the control
group. The incidence of delirium after liver transplantation was
compared between the two groups. Factors that can affect the
occurrence of delirium such as patient age, Acute Physiology and
Chronic Health Evaluation score, preoperative and postoperative
ammonia level, the difference in pre and postoperative ammonia,
surgical time, and preoperative hepatoencephalopathy were also
Fig. 124 (Abstract 0365). graphs
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compared.
RESULTS. A total of 158 patients were enrolled and a total of 144
patients were used in the analysis. From the 67 patients in the
dexmedetomidine group and 77 patients in the control group,
delirium occurred in a total of 12 patients. There was no significant
difference in the incidence of delirium in both groups (7% [5/67] in
the dexmedetomidine group vs 9% [7/77] in the control group
p = 0.752, and the results showed no significance in multivariate
analysis (OR 1.448, 95% CI 0.268 - 7.818, p = 0.667) as well. Only the
Model for End-Stage Liver Disease (MELD) score showed to be signifi-
cant in its relation with delirium. MELD score greater than 17 showed
to have an OR 19.074 with 95% CI 2.599 - 139.988. However, sub-
group analysis of the MELD score did not show any significance.
There was no significant difference in the ICU LOS and hospital LOS
in the two groups as well.
CONCLUSION. Perioperative low dose dexmedetomidine infusion did
not reduce the incidence of delirium in living donor liver
transplantation recipients in the ICU. Because of the low incidence of
delirium, however, this study could have been underpowered, and
further studies are needed. MELD score greater than 17 was the only
significant variable in the incidence of delirium in the ICU in this
study.
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INTRODUCTION. ICU patients frequently develop gastrointestinal (GI)
motility disorders. Opioids, mandatory for pain management, play a
major role in the development of GI motility disorders. Their
influence on the GI tract is reduced by the administration of opioid
receptor antagonists (ORA) like Naloxon and Methylnaltrexon
(MNTX). Naloxon, a pan-ORA with a high antagonistic potency,
crosses the blood brain barrier and by this may alter analgesia while
the peripheral ORA MNTX has no effects on analgesia but restores or
improves bowel motility in only about 50% treated patients. This
may be explained by its low affinity to κ receptors.
OBJECTIVES. We used an experimental setting to evaluate if and to
which extent Remifentanil and Sufentanil inhibit colonic motility via
their interaction with κ receptors.
METHODS. Guinea pig's colonic segments were fixed on a polyacrylic
tray in a tissue bath. The speed of an intraluminally placed pellet
along these segments was measured before (V0) and after
administration (V1) of the test substances. The influence of the
substances on the transit speed was calculated as ratio V1/V0. A V1/V0
ratio of 1 means no influence on peristalsis, while V1/V0 > 1 means
stimulation and a V1/V0 < 1 demonstrates an inhibition of peristalsis.
In a first step Sufentanil 1nM and Remifentanil 30nM were tested
alone to quantify their inhibitory effect on colon transit. In a second
step we evaluated a combination of each opioid with the
antagonists Naloxon (0.03μM) or MNTX (1μM). Finally we tested a
combination of the highly selective κ ORA Norbinaltorphimine (nor-
BNI 0.03μM) and Remifentanil or Sufentanil to quantify the κ
receptor associated effect.
RESULTS. (mean ratio ± SEM): Sufentanil (0.2 ± 0.08) and
Remifentanil (0.02 ± 0.01) had a pronounced inhibitory effect on
colon motility. Naloxon (1.0 ± 0.1, p < 0.001) or MNTX (0.9 ± 0.14,
p < 0.001) plus Sufentanil had a high potency to restore colonic
motility. Although not significant, Naloxon's antagonistic effect
seemed more pronounced compared to MNTX. Nor-BNI (0.59 ± 0.14,
p = 0.026) also had a distinct antagonistic effect.In combination with Remifentanil Naloxon (0.85 ± 0.08, p < 0.001)
had a greater antagonistic effect by trend than MNTX (0.73 ± 0.2,
p < 0.001). Again nor-BNI (0.3 ± 0.1, p = 0.02) also markedly reduced
the inhibitory effect of Remifentanil.
CONCLUSIONS. Despite the 30 times higher concentration MNTX
had a lower potency to restore the inhibitory opioid effects
compared to Naloxon. This may be explained by the high affinity of
Naloxon to all opioid receptors in contrast to the peripheral
antagonist MNTX. Furthermore we were able to demonstrate a
distinct potency of nor-BNI to restore opioid induced colonic motility
disorders in this experimental setting which shows a notably effect
of opioids on colon peristalsis via κ receptors.0366
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INTRODUCTION. Intestinal ischemia is a life-threating abdominal
emergency encountered in a variety of clinical settings. Not only is-
chemia but reperfusion (I/R injury) triggers an intense inflammatory
injury locally and subsequently in remote organs1. Recently, extracel-
lular histones have been demonstrated as mediators of distant organ
damage in acute kidney injury and severe trauma2, 3. Recombinant
thrombomodulin (rTM) has been shown to possess anti-inflammatory
roles by inhibition of circulating histones4.
OBJECTIVES. We aimed to elucidate the effect of rTM on intestinal I/
R injury and the underlying mechanism of I/R injury-induced remote
organ damage.
METHODS. Intestinal ischemia was induced in male C57BL/6J mice
by clamping superior mesenteric artery for 30 minutes or 45
minutes. Intraperitoneal administration of 10 mg/kg rTM was
conducted at the initiation of reperfusion. For mice with intestinal I/R
injury (ischemia for 30 minutes and reperfusion for 180 minutes), the
levels of tissue damage, expression of inflammatory genes, and
extracellular histones were assessed in the jejunum, liver, lung, and
kidney. Neutrophil extracellular traps (NETs) formation were also
evaluated by immunostaining.
RESULTS. Treatment with rTM markedly improved survival of
intestinal I/R injured mice (hazard ratio 0.31; p = 0.014, n = 11 per
group). We detected significantly decreased expression of tumor
necrosis factor alpha, interleukin-6, and keratinocyte-derived chemo-
kine (n = 7 per group, p < 0.05), and degree of tissue damage in the
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 184 of 542liver, but not in the intestine compared with untreated I/R mice.
Moreover, intense accumulation of histones and NETs formation were
found in the liver among remote organs (liver 0.049 ± 0.011 AU/μg
wet tissue, lung 0.014 ± 0.008 AU/μg wet tissue, and kidney
0.006 ± 0.008 AU/μg wet tissue, n = 4–5 per group, p < 0.05 vs. lung
and kidney), and rTM significantly decreased the level of histones in
the liver (n = 8 per group, p < 0.05).
CONCLUSIONS. Our finding suggests that NETs and extracellular
histones cause liver injury through release of inflammatory cytokines
following intestinal I/R injury. Recombinant thrombomodulin may
have significant impact on blocking histones and decreasing
expression of inflammatory cytokines in the liver and contribute to
improvement of survival in mice with intestinal I/R injury.
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INTRODUCTION. Microcirculatory dysfunction are associated with
acute and chronic kidney diseases [1]. Only few studies tried to
compare microcirculation between healthy volunteers and patients
with chronic kidney disease. In addition, we found only one study
demonstrating that systemic microcirculatory dysfunction in type I
diabetes mellitus patients was improved in the first year after
simultaneous transplantation of the pancreas and kidney [2].
OBJECTIVES. The study aimed to compare the difference in
microcirculation among healthy volunteers, dialysis patients, and
kidney transplant recipients with a latest generation of hand-held
video microscope.
METHODS. This observational study was approved by the National
Taiwan University Hospital Research Ethics Committee, which is
registered on the ClinicalTrials.gov Protocol registration system (ID:
NCT02412839 and NCT02940275). Sublingual microcirculation was
examined using incident dark field imaging and was compared
among healthy volunteers, dialysis patients, and kidney transplant
recipients.
Age, height, and body weight were recorded. Heart rate and blood
pressure were measured. Data were analyzed using the statistical
software program SPSS 20 (IBM SPSS, Chicago, IL, USA). Numerical
data are expressed as mean (standard deviation) and were compared
using one-way analysis of variance, followed by Tukey multiple com-
parison tests.RESULTS. Heart rates, systolic blood pressure, diastolic blood
pressure, and mean arterial pressure were higher in the dialysis
patients and kidney transplant recipients than in the healthy
volunteers.Group Healthy
volunteersDialysis
patientsKindey transplant
recipientsP
valueFemale/Male (n/n) 40/30 2/8 7/8 0.084Age (years) 43.7 (13.5) 46.1 (11.6) 49.5 (13.2) 0.299Height (cm) 165 (8) 166 (5) 162 (9) 0.445Weight (kg) 61.8 (10.0) 65.6 (8.2) 62.4 (12.0) 0.546Heart rate (bpm) 71 (9) 86 (14)* 79 (14)* <0.001Systolic blood pressure
(mm Hg)119 (11) 141 (28)* 134 (19)* <0.001Diastolic blood
pressure (mm Hg)71 (9) 88 (13)* 79 (11)* <0.001Mean arterial pressure
(mm Hg)87 (9) 106 (18)* 97 (12)* <0.001[Basic characteristics]
Perfused vessel density and proportion of perfused vessels were
lower in the dialysis patients than in the healthy volunteers.Group Healthy
volunteersDialysis
patientsKidney transplant
recipientsP
valuen 70 10 15TVD (mm/mm2) 27.3 (2.1) 26.0 (1.8) 26.9 (2.2) 0.149PVD (mm/mm2) 26.8 (2.1) 25.0 (2.2)* 26.2 (2.4) 0.046PPV (%) 98 (2) 96 (4)* 98 (2) 0.042TSVD (mm/mm2) 25.7 (2.2) 24.9 (2.3) 26.1 (2.5) 0.372PSVD (mm/mm2) 25.2 (2.3) 23.9 (2.8) 25.5 (2.6) 0.218PPSV (%) 98 (2) 96 (4)* 98 (2) 0.048Microvascular flow
index2.9 (0.1) 2.8 (0.2) 2.9 (0.1) 0.094Heterogeneity
index0.08 (0.10) 0.13 (0.12) 0.11 (0.14) 0.212[Microcirculation parameters]
Perfused vessel density and proportion of perfused vessel did not
differ significantly between kidney transplant recipients and healthy
volunteers.
CONCLUSIONS. Perfused vessel density was lower in the dialysis
patients than in the healthy volunteers, and it did not differ
significantly between kidney transplant recipients and healthy
volunteers.
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809 Liver Transplants (LT) were made at Hospital Clínico Universitario
of Santiago de Compostela (Spain) in the period 1994–2014,
accounting 4.25% of all LT performed in Spain. Review of the impact
of the Donor´s Age on the Survival of Graft and Recipient in 20 years
of experience in our center.
MATERIALS AND METHODS. Retrospective and descriptive review of
809 cases of liver transplantation performed in the 1994–2014 period
at the Hospital Clínico Universitario of Santiago de Compostela
(Spain) acording to the Local Registry and the Spanish Registry of
Liver Transplantation (RETH).
RESULTS. 809 cases, 12 cases were Hepato-renal transplantation, 3
requiered Re- transplant. Media of Donors: 33 cases/year. 79.35%
Men and 20.64% Women with Recipeint Mean Age: 51 years old. Pre-
domintaly Blood group A (49%). Most frequent LT indication: Alco-
holic Cirrhosis (43,%), Idiopathic (43.01%) and Fulminant Liver Failure
(6.18%). Cumulative Survival at 20 years in our serie: 47% higher than
the comparison with the global data provided by RETH (37% apply-
ing Kaplan-Meier curve p <0.01) and in the last 5 years (2008–2013):
77% compared to RETH data for the same period (70% with p <0.05).
The Mean Age of the Donor in Brain Death: 53.5 years, increasing ex-
ponentially from the beginning of the program with a Median of 35
years (1994) to 68 years (2014).
Impact of Survival Rate of the Receiver based on the Donor's Age
divided into Age gropus (p 0.07): <50 years: 70%, 50–59 years: 59%,
60–69 years: 55% and >70 years: 53%. Impact on Cumulative Survival
Rate of the Graft (p 0.06): <50 years: 65%, 50–59 years: 58%, 60–69
years: 50%, >70 years: 50%. Segregated by Indication of LT (p <0.05):
Cirrhosis non HCV and non-Hepatocarcinoma: <50 years: 58%, 50–59
years: 50%, 60–69 years: 49%, >70 years: 49% and the group of Cir-
rhosis with Hepatocarcinoma: <50 years: 45%, 50–59 years: 40%, 60–
69 years: 32% > 70 years: 35%.
CONCLUSIONS. An exponential increase in Donor's Age in Brain
Death in our serie has non-statistically significant impact on Graft
and Recipient Cumulative Survival Rates, although it was statistically
significant in the Segregated group of Cirrhosis with Hepatocarci-
noma with low Cumulative Survival Rates in all Age groups and even
lower in those recipients with grafts coming from Elderly Donors. Cu-
mulative Survival Rate globally is similar to the ones found out in
other Transplantation Programs.
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INTRODUCTION. Eotaxin-1 (CCL11) is a chemokine involved in
eosinophil-dependent immunologic reactions, however, it has alsobeen implicated in further biological processes such as neurogenesis
and ageing [1]. Therefore, Eotaxin-1 is hypothesized as critical factor
which might influence a recipient`s cognitive functions and ageing
after transfusion of blood, a phenomenon which has recently been
described in mice [1]. However, until now it is unknown whether
Eotaxin-1 is detectable in transfusion blood products.
OBJECTIVES. The present study addresses the question if Eotaxin-1 is
detectable in different blood products processed for transfusions and
if yes, its level depends on demographic factors or storage time of
the blood product.
METHODS. Eotaxin-1 was measured in fresh frozen plasma (FFP;
n = 168), erythrocyte concentrates (EC; n = 160) and platelet concen-
trates (PC; n = 8) ready-to-use for transfusions using a Q-Plex immuno-
assay for detection of Eotaxin-1 and quantified using Q-view software.
For statistical analyses, Mann–Whitney as well as Kruskal-Wallis tests
were employed. Correlations have been assessed with Pearson correl-
ation analysis. Age groups of donors were defined as follows: Group 1:
18–25 years, group 2: 26–55 years, and group 3: >55 years.
RESULTS. Eotaxin-1 was consistently detected in FFP (median 69.4
pg/ml) and EC (median 42.6 pg/ml) but was only detectable in 3 of 8
PC (median 10.38 pg/ml). Eotaxin-1 levels did not differ between
male and female donors but increased with rising age in both, FFP
(median Eotaxin-1 group 1: 52.4 pg/ml; group 2: 72.4 pg/ml; group 3:
80.1 pg/ml) and EC (group 1: 36.1 pg/ml; group 2: 47.6 pg/ml; group
3: 48.7 pg/ml). A statistically significant increase in Eotaxin-1 was de-
tected between age groups 1 and 2 as well as groups 1 and 3 in FFP
and EC, respectively (p < 0.001 for all comparisons). Consequently,
Eotaxin-1 correlated with age in both blood products (Pearsons cor-
relation coefficient 0.35 [p = 3.8E−5] and 0.44 [p = 6.8E−9], respect-
ively. Importantly, no significant correlation of Eotaxin-1 and storage
time in neither blood product could be identified. Finally, we demon-
strated that Eotaxin-1 is subject to only minor fluctuations within one
donor over a longer period of time.
CONCLUSIONS. Eotaxin-1 is detectable and stable over time in FFP
and ECs and increases significantly with the donor`s age. Considering
the presumed involvement in ageing and cognitive impairment in
mice, differences in donor- and recipient Eotaxin-1 levels may affect
ageing and cognitive function after transfusion of blood products.
Further studies should decipher the exact role of Eotaxin-1 in cogni-
tive processes and assess the impact of high Eotaxin-1 levels in
blood products on recipient's cognitive function.
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INTRODUCTION. Although clinical research is vital for the
improvement of the quality of care there will always be a potential
disparity between the interests of the researcher and the patient.
Therefore medical ethical approval has to be obtained before
Fig. 125 (Abstract 0371). See text for description
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the process for ethical approval for high-risk studies, like interven-
tional trials in their clinical trials directive(s) (EU-CTD1/2). [1] However,
these directives do not focus on non-interventional observational
studies.
OBJECTIVES. To analyze the differences in ethical approval for an
anonymous, non-interventional, observational study between various
European countries using our experiences from a recent European
multicenter study in the very old ICU patients.
METHODS. European national coordinators (NCs) of that study
(www.vip1study.com) were asked to fill out an questionnaire on their
experience to get ethical approval.
RESULTS. 16 out of 17 NCs responded. N = 8/16 of the NCs could
apply at one central ethical committee (EC), while the others had to
apply to various ECs, individual hospital institutional research boards
(IRBs) or a combination thereof. The time between applying for
ethical approval and the final decision varied between 7 days and
300 days. In n = 9/16, informed consent from the patient was not
deemed necessary, and required from patients or relatives in the rest
(n = 7/16). One country accepted retrospective consent in survivors.
The upload of anonymous data to a central database required ethical
approval in n = 14/16. One country had to apply for this from a
separate EC. In n = 4/16 the NCs had to ask ethical approval to keep
a subject identification code list to de-anonymize the patients if
questions would occur. Only n = 2/16 of the NCs agreed that in-
formed consent was necessary for such an observational study. Over-
all, n = 6/16 of the NCs were satisfied with the entire process of
ethical approval, n = 8/16 were (very) unsatisfied and n = 2/16 were
neutral (time consuming but necessary). N = 11/16 would welcome a
European central EC that would judge observational studies for all
European countries, while n = 5/16 were “not sure” fearing “more
bureaucracy” in the ethical approval process.
CONCLUSIONS. There are huge variations between European
countries in the process and the time needed to get ethical approval
for low-risk, anonymized, observational studies (e.g. quality registries,
research studies or “big data” analyses). Such variations hamper in-
clusion of patients as well as countries and might have a negative in-
fluence the external validity of such observational studies. Further
harmonization of ethical approval across European countries is also
welcomed for low-risk observational studies.
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INTRODUCTION. Rapid response teams (RRTs) form the efferent limb
of rapid response systems (RRSs) intended to improve outcome of
deteriorating ward patients.1 As both the general and hospital
populations age, RRTs probably review geriatric patients with
comorbidities daily. This aspect sets new challenges to the 'ICU
without walls'2, but has not been studied.
OBJECTIVES. To investigate the prevalence and outcome of geriatric
RRT population and to evaluate, whether previously identified risk
factors for mortality among the general RRT population predict
tenuous outcome among the geriatric RRT patients.
METHODS. Data on patients reviewed by ICU's RRT in Tampere
university hospital, Finland, between 1 May 2012 and 30 April 2015,were prospectively collected. Independent risk factors for 30-day
mortality were identified from the whole study population using
multivariate logistic regression (MLR), and accumulation of these fac-
tors were investigated among the geriatric sub population without
treatment limitations (patients ≥ 75 years). The local Ethics Commit-
tee approved the study protocol (Approval no: R10111).
RESULTS. A total of 1372 patients were reviewed 1722 times.
Geriatric patients (n = 449, 33% of the study population) had more
comorbidities, received new limitations of medical treatment more
frequently and were more rarely admitted to the ICU as compared to
patients < 75 years old (n = 923, 67%). Geriatric patients had
substantially higher 30-day and one-year mortality as compared to
non-geriatric population (33% vs. 21%, p < 0.001 and 54% vs. 35%,
p < 0.001). In a MLR model, seven independent risk factors for 30-
day mortality among the whole RRT population were identified. Of
these, five factors (positive RRT criteria measured during the review,
Charlson comorbidity score ≥ 5, non-elective hospital admission,
medical reason for admission, afferent limb failure) were cumulatively
applied to the geriatric sub population without preceding treatment
limitations (n = 411) as data on these factors are feasibly obtainable
for both the ward staff and/or RRT. The risk for 30-day mortality in-
creased as these risk factors accumulated, p < 0.001 (Fig. 125).
CONCLUSIONS. One third of patients reviewed by RRT were over 75
years old. To no surprise, these patients have higher cumulative
comorbidity and poorer prognosis than younger RRT patients. ICU's
RRT staff are often faced with the dilemma of escalating or de-
escalating the care. Our results suggest, that the cumulative burden
of independent risk factors for 30-day mortality among the general
RRT population could provide some assistance in these situations,
and even trigger discussions on treatment goals rather than RRT acti-
vations. Our results, however, must be validated in future studies.
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INTRODUCTION. Deciding whether or not to admit to the Intensive
Care Unit (ICU) requires careful consideration as to whether the
likelihood of successful outcome (which includes not only survival
but also a quality of life that is acceptable to the patient) outweighs
risks of harm that may result in physical and psychosocial morbidity
and low quality adjusted life years1. Pre-existing frailty and comorbid-
ity may sway the balance against ICU admission. ICU admission
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 187 of 542should be regarded as a treatment and as such patient's wishes
should be ascertained where possible.
OBJECTIVES. To look at the quality of referrals for ICU admission in
relation to
- consideration of treatment escalation plans by referring teams prior
to or at the time of referral
- patient/family involvement in escalation plans (including ICU
admission).
METHODS. Prospective observational analysis at our institution
between July-October 2016 for all new ICU referrals and cardiac ar-
rest calls attended. Primary outcome included the % of patients who
had treatment escalation plans (TEPs) (+/− “Do Not Attempt Cardio-
pulmonary Resuscitation” - DNACPR orders) made before or at the
time of referral. The nature of these TEPs and DNACPR orders was
further analysed according to who made the TEP (referring or ICU
team) and whether or not this was discussed with the patient or fam-
ily. Subgroup analysis included patients with limited functional status
and severe comorbidity at baseline (as defined by ICNARCs CMP) and
in-hospital cardiac arrests during data collection period.
RESULTS. Out of 147 patients referred to ICU, only 24 patients (16%)
had a documented TEP. For the patients who did have a TEP, 12/24
(50%) were made by the ICU consultant and 11/24 (46%) were made
before ICU referral. Only 3/24 (13%) referrals/TEPs involved a
discussion with the patient (which represents 2% of all referrals
made) and 13/24 (54%) involved a discussion with the patient's
family. Similar trends were observed for the DNACPR orders. The
uptake of TEPs was poor and inconsistent even in those with limited
functional status and severe comorbidity at baseline (Table 109).
Eleven referrals were made following an in-hospital cardiac arrest.
Seven of these patients (64% of in-hospital cardiac arrests) either had
significant comorbidity and/or limited functional status but none of
them had a prior TEP considered.
CONCLUSIONS. The uptake of TEPs and decisions relating to CPR
was low, even for patients with limited functional status and severe
comorbidity at baseline. The nature as to how these are
implemented are inconsistent and patient/family involvement in the
decision making process is inadequate. There is an urgent need to
address these issues which should look into ways of increasing the
earlier uptake of earlier TEPs and involving patient and their
surrogates in these decisions.
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comorbidity
TEP
documented?
Independent/
No
comorbidity
Independent/
1 or more
comorbidity
Limited
functional
status/No
comorbidity
Limited
functional status/
1 or more
comorbidity
Yes 8 (11%) 5 (24%) 5 (18%) 6 (24%)
No 65 (89%) 16 (76%) 23 (82%) 19 (76%)
Fig. 126 (Abstract 0373). MODEL0373
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INTRODUCTION. The benefits of a complementary palliative care
(PC) approach in gravely ill patients in the Intensive Care Unit (ICU)
are well known. However, barriers limiting the interaction betweenthe specialties persist, more probably in contexts were PC is
developing. Factors influencing this interaction have been poorly
explored.
OBJECTIVES. To explore the perceptions, level of knowledge,
practices, and perceived barriers that intensive care physicians have
about the integration of a PC approach in ICUs.
METHODS. A descriptive-correlational design was used. An online
survey exploring the above-mentioned variables was developed ad
hoc. Members of the Colombian Association of Critical Care and In-
tensive Medicine were invited to participate. Descriptive and correl-
ational statistics were obtained and a Partial Least Squares Structural
Equation Modelling analysis to identify predictors of interaction
practices.
RESULTS. 101 physicians working in ICUs completed the
questionnaire (82,2% intensive care specialists). 31 participants
(30,7%) referred having some training in PC (average hours of
training was 61,24; SD: 177,08). Significant positive correlations were
found between perceptions and knowledge (r = 0.86, p < 0.01),
perceptions and practices (r = 0.33, p < 0.01), knowledge and
practices (r = 0.41, p < 0.01), and hours of training and practices
(r = 0.34, p < 0.01).
A negative and significant relation was found between
perceptions and barriers (r = −0,24, p < 0.5). The structural
model analyzed showed that hours of training had a positive
significant effect on perception about PC (b = .70, t = (95) 11.74,
p < .01), which in turn exerted a positive significant influence on
CP practices (b = .58, t = (95) 6.03, p < .01), and a negative
effect on barriers (b = −.31, t = (95) 5.12, p < .01). Finally,
perceived barriers exerted a negative and significant effect on
practices (b = −.14, t = (95) 2.03, p < .05). The model explained a
significant proportion of variance in perception about PC
(R2 = .49, p < 01), barriers to PC (R2 = .09, p < 05), and PC
practices (R2 = .39, p < 01).
CONCLUSIONS. Training in PC impacts on its positive perception,
while diminishing perceived barriers; in turn, all the above variables
favor interaction practices. A more formal training in PC in intensive
care educational programs will probably result in an increased use of
PC in ICUs.
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INTRODUCTION. ICU nurses are confronted frequently with patients
dying. This being a significant stressor due to the emotional
implications and irreversibility 1,2. Frequent exposure to patients
dying is related to an increased risk of stress and the potential
development of mental and physical symptoms, compassion fatigue
or burnout syndrome (BOS). This is increased when emotions
accumulate if not handled adequately or being ignored 3,4. With an
11% mortality rate and patients dying every other day, it was
decided to explore feelings of grief among our ICU nursing staff.
OBJECTIVES.
- Identify the emotional response.
- Inquire the prevalence.
- Investigate possible demographic deviations.
- Examine why emotions occur and what provoking factors are.
- Determine if peer support is effective.
METHODS. A quantitative study was performed using a peer validated
questionnaire that was distributed to the ICU nursing staff (N = 124).
The questionnaire was returned by 78% (N = 96). For qualitative and
explorative purposes peer group discussions were organized with
randomly selected ICU nurses (N = 50), divided into multiple groups.
RESULTS. Nurses’ emotions after patients dying were common and
usually ending after a 3 day period. Minimal differences based on gender,
age or experience were found.Yes NoDisbelief 66% (N = 63) 34% (N = 33)Sadness 66% (N = 63) 34% (N = 33)Anger 48% (N = 46) 52% (N = 50)Shame 20% (N = 19) 80% (N = 77)[Different emotions after a patient dying.]Yes NoUp to 3 days 65% (N = 62) 35% (N = 34)Up to 1 week 21% (N = 20) 79% (N = 76)Up to 1 month 3% (N = 3) 97% (N = 93)For more than 1 month 3% (N = 3) 97% (N = 93)[Duration of emotions after a patient dying.]Yes NoAre there differences in experiencing grief to how a
patient has died?67%
(N = 64)33%
(N = 32)Confrontation with a dying patient is an extra burden to
the job.35%
(N = 34)65%
(N = 62)I have a need for support/counseling after a patient's death. 86%
(N = 83)14%
(N = 13)ICU peer support/counseling is sufficient. 50%
(N = 48)50%
(N = 48)Informal and small scale peer support/counseling is more
effective.86%
(N = 83)14%
(N = 13)I have sufficient support in my private life/network. 92%
(N = 88)8%
(N = 8)(Continued)I am satisfied with the nursing role related to the process
of EOL decision making.55%
(N = 53)45%
(N = 43)I am satisfied with the nursing and intensivist
communication related to EOL Care.73%
(N = 70)27%
(N = 26)I am satisfied with the nursing role related to EOL Care
execution.70%
(N = 67)30%
(N = 29)[ICU nurses needs and experiences.]
Although peer support was considered ineffective by 50%, most
nurses did not experience long term emotions due to their own
coping mechanisms or supportive network. Frequently grief was
provoked or amplified by EOL care imperfections related to doctor-
nurse cooperation and communication. Nurses were dissatisfied by
lack of EOL care information and an unclear role in the EOL process,
however this was evaluated differently between younger and older
nurses.
Cross examining data we found a small group (8%) prone for
developing problems with peer support being ineffective (p = 0,003)
and having an insufficient supportive network (p = 0,014). These
nurses needed more time for effective coping (p = 0,000).
CONCLUSIONS. Confrontation and dealing with patients dying is
unavoidable and emotions with a short duration are normal for
almost all our ICU nurses. Peer support is not to be considered
effective for all team members. Combined with the absence of an
effective supportive network it makes a small group prone for
developing problems. Ward management should focus on
identifying these vulnerable team members besides offering
sufficient and continuous support to all ICU employees. Other
provocative factors were found related to an ineffective nursing role
in EOL process. These can be solved by (re)defining the nursing role
in the EOL care process.
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INTRODUCTION. The patient with a devastating brain injury (DBI)
may present to a wide range of specialities and the decision to refer
or admit these patients to the Intensive Care Unit (ICU) can be
difficult for both parties. Recent work has suggested that the ability
to predict outcomes of these patients at first presentation is
debatable and highlighted several potential benefits for admitting
these patients to the ICU, despite the high likelihood of non-
reversible pathology (1).
OBJECTIVES. To Identify:
1. Referring physician's & intensivist's attitudes towards the
management of the patient with DBI.
2. Perceived barriers to providing ICU care for patients with DBI.
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 189 of 542METHODS. An online survey was sent to all medical staff in ICU and
the specialities who refer patients with DBI to the ICU in a large,
Scottish teaching hospital. The survey presented two cases of DBI,
differentiated by the necessity for endotracheal intubation prior to
referral. Follow on questions examined whether the doctor would
refer the patient and enquired about the rationale surrounding their
decision.
RESULTS. A total of 83 respondents completed the survey with a
good representation of specialties (58% Anaesthesia, 14% Emergency
Medicine, 8% ICM, 16% Medicine and 4% Neurosurgery). The
majority of responses (54%) were from Consultants.
Doctors were less likely to refer the non-intubated patient (54% com-
pared to 83%). For both cases, the most frequent reason to refer the
patient was for potential organ donation. Looking at reasons against
referral, for both cases the most frequent reasons were perceived fu-
tility and the ability to provide end of life care outside of the ICU. A
number of respondents in each case would not refer to the ICU
based purely on the CT diagnosis of DBI.
Optimisation for organ donation and providing time for families
were the most commonly identified benefits of ICU referral; whereas
bed/capacity issues and the attitudes of the duty ICU Consultant
were identified as the leading barriers to referral.
CONCLUSIONS. In our survey, doctors were less likely to refer to the
ICU if there was no support to withdraw, or no requirement for ICU-
level interventions at the time of referral. Furthermore, several re-
spondents made their decision based on the CT imaging and neuro-
surgical diagnosis. Further work should be done to see if these
beliefs are similar to those of staff in other hospitals who care for
these patients.
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INTRODUCTION. Dignity and compassion should head the care for
patients dying in hospitals. Environment in the intensive care unit
(ICU) can be very impersonal and lead to additional suffering.
Recently, a report from the World Federation of Societies of Intensive
and Critical Care Medicine identified regional differences in the
processes of care for dying persons. A statement that will apply to all
regions and cultures of the world might be intangible, and so,
triggering local initiatives will be crucial to identify keystone
interventions to improve end-of-life care in the ICU.
OBJECTIVES. Characterization of the process of care for dying
patients in a 22-bed ICU in a university-affiliated hospital.
METHODS. Family integration in the care of patients admitted to our
ICU has been previously outlined and implemented. Relatives are
allowed to stay with the patient for long periods of time. Routine
care for patients include daily multidisciplinary rounds. In this study,
we did a protocol-driven retrospective review of prospectively regis-
tered data regarding the care for patients dying in our ICU (from
January 2016 till March 2017).
RESULTS. In the study period, a total of 696 patients were admitted
to our ICU. SAPS II was 40.7 (mean score). A total of 100 patients
died (ICU mortality rate: 14.3%). Only two patients died from
unexpected cause. Regarding this population of patients who died,main causes of death were sepsis and pure cardiogenic shock. SAPS
II score was 61.1 ± 16.4 and SOFA score at admission was 10.3 ± 3.9.
Eighty nine patients had respiratory failure and needed invasive
ventilation, 85 had shock and needed vasopressor therapy, 73 had
acute kidney injury and 38 needed CRRT. Regarding the dying
process, a collegial decision has been registered in 77% of the cases.
This consisted in withdrawal of therapy in 81% of patients and
definition of limits for intervention in 84% of patients. Vasopressors
were withdrawn in 26 and an upper dose limit defined for additional
36 patients, renal replacement therapy was stopped in 31 patients
and ventilation was withdrawn or withhold in 12 and 22 patients,
respectively. Time from decision to death averaged 9.1 hours
(minimum zero; maximum 144). Pharmacological intervention to
treat pain, anxiety, xerostomy and breathlessness included opioid (72
patients) and propofol (54 patients). Only one patient referred
persistent pain that required additional analgesia. Family has been
present at time of death in 27 patients.
CONCLUSIONS. Characterization of the dying process in the ICU is
important to encourage local initiatives and to develop
recommendations that boost excellence in end-of-life care. Decision
process registration need some improvement. Withdrawal and with-
hold respect ethical and legal precepts in our country, and are per-
ceived by relatives and professionals as adequate ways to dignify the
process of death in ICU.
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INTRODUCTION. Documentation in end of life (EOL) care in Intensive
Care Unit (ICU) is an effective means of communication and also a
prerequisite for audit and research in quality of care.
OBJECTIVES. This retrospective study is to investigate the
documentation of key components of EOL care in an university
hospital ICU in Hong Kong.
METHOD. Key components in clarifying the precondition before EOL
care decision, making the EOL care decision and implementing the
order were identified before reviewing the medical records. Clear
documentation was defined as explicitly written notes by the ICU
doctors in the medical record.
RESULTS. There were 65 adult cardiac deaths with full medical
record at ICU from 1st January to 31st December 2013 and 52 adult
patients with EOL care implemented were included in the study.
Clarifying the precondition of EOL care in ICU
The trigger of EOL discussion was documented in 43 patients'
medical records (82.7%) out of 52 recruited patients. The initiator of
the EOL care decision was documented in 46 records (89%). Only
two patients' medical records (4%) included documentation of
checking EOL decision making capacity. Consensus among ICU
physicians and consensus with primary care team clinicians were
documented in 29.6% and 17.3% of the records respectively.
Documentation of EOL care decision making process
Documentation of checking patients´ expressed value was found in
19% and clarification of consensus among patient's family in 15% of
the records. Documentation of explaining shared decision making
and substituted decision concept was found in 1 patient's record
(2%) and 2 patients' records (4%) respectively.
Documentation of life support therapy (LST) being withheld (WH)
or withdrawn (WD)
“Do-Not-Resuscitate” (DNR) order was implemented in all 52 patients,
48% of the records documented implementation of the order and
42% documented explanation to the family. All patients whose
ventilator support was WH/WD had the explanation in the family
meeting and implementation of the order clearly documented. In
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 190 of 542those 38 patients whose vasopressor support was WH/WD, 30
(78.9%) patients' record documented the implementation order
while 27 (71.1%) patients' record documented the explanation to
family. There are 12 patients whose renal replacement therapy was
WH/WD. All except one (91.7%) records documented the
implementation order and 9 records (75%) documented the
explanation to the family.
CONCLUSIONS. In this study, we found inadequate documentation
in key components in EOL care in ICU. In clarifying the precondition,
documentation of clarification of patient's decision making capacity
and consensus among health care workers are frequently lacking. In
the decision making process, documentation of reaching consensus
among family members, shared decision making and substituted
decision making concept are commonly missed out. The
documentation of implementing DNR order and explaining the order
to family is less common than limiting ventilator support.
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INTRODUCTION. The management of airway, oxygenation and
ventilatory support in patients who are dying on the critical care unit
remains a challenging area, particularly in relation to treatment
limitation (1). Specifically, the relative merits of reductions in
ventilatory support ('terminal weaning') versus removal of the
endotracheal tube ('terminal extubation') have not been explored
objectively. Further, concerns in relation to potential discomfort from
dyspnea or even airway obstruction may lead to overuse of analgesic
or hypnotic agents (2). Here we describe some preliminary data from
patients with pre-existing neural ventilatory drive monitoring where
these observations were extended to guide treatment withdrawal
and palliative care.
OBJECTIVES. To test the feasibility, acceptibility and utility of EADi
neural drive monitoring (NAVA, Getinge) in terminal weaning and
terminal extubation of patients receiving treatment limitation as part
of end-of-life care.
METHODS. Research and patient-public approvals were gained and
all data anonymised prior to publication. Retrospective data were
taken over a three-year period from 50 patients who underwent ei-
ther terminal weaning without extubation or terminal extubation. 25
patients had neural catheters already in place at the time of the deci-
sion to target palliative goals of care and 25 matched only by date
and decision. Staff were surveyed to record their perceptions and
use of EADi monitoring.
RESULTS. 15 patients underwent neural monitoring during terminal
extubation and 10 patients who had terminal ventilatory weaning
without extubation, Electrical activity of the diaphragm (EAdi) data
was obtained in all 25 patients throughout either palliative strategy.
Patients with neural monitoring received less hypnotic and analgesic
drugs and had fewer increases in these therapies. There were no
differences in time to death or time with nasogastric tubes or use of
enteral nutrition between groups. Critical care staff reported high
levels of satisfaction with neural monitoring during end-of-life care
and perceived it to be safe and useful.CONCLUSIONS. To our knowledge neural demand monitoring has
not been used previously in the context of terminal weaning or
extubation. Neural monitoring appeared to be feasible and
acceptable to staff; provide clinically useful information and did not
appear to lead to extended use of nasogastric tubes when compared
to standard care. We believe that further research is needed, and
that dying patients can benefit from new technologies.
REFERENCE(S)
1. Cottereau A et al. ICU physicians´ and nurses´ perceptions of
terminal extubation and terminal weaning: a self-questionnaire study.
Intensive Care Med. 2016 42: 1248–57
2 Billings JA. Humane terminal extubation reconsidered: the role for
preemptive analgesia and sedation.. Crit Care Med. 2012 40: 625–30.
GRANT ACKNOWLEDGMENT
NIHR Fellowship (DH) and the research program is supported by the
CRN critical care specialty.
0379
Treatment limitations before and during ICU admission affect
hospital mortality: a pilot study
N. Kusadasi1, K. Kaasjager2, M. van Dam1
1University Medical Center Utrecht, Intensive Care Center, Utrecht,
Netherlands; 2University Medical Center Utrecht, Internal Medicine,
Utrecht, Netherlands
Correspondence: M. van Dam
Intensive Care Medicine Experimental 2017, 5(Suppl 2):0379
INTRODUCTION. Most patients admitted to the Intensive Care Unit
(ICU) are offered treatment without any limitations. Withholding
resuscitation or mechanical ventilation could affect patients' survival.
This pilot study examines the effect of treatment limitations before
and during ICU admission on hospital mortality of ICU patiients.
OBJECTIVES. To examine the presence of treatment limitations set
before and during ICU admission and the hospital mortality of this
category of patients.
METHODS. In this single center, retrospective observational pilot
study in an academic 30-bed ICU all consecutive patients admitted
from February 1st until March 1st 2017 with a length of stay (LOS) of
more than 24 hours were included. Data collected were age, gender,
treatment limitations before and during admission to ICU, referring
specialty, vasoactive medication, invasive mechanical ventilation, ICU
LOS and hospital mortality. Follow-up was obtained through informa-
tion from the electronic patient file in the hospital. Statistic analyses:
P- values are determined by Chi-square and Fisher tests (OpenEpi,
version 3.01, www. openepi.com). A waiver was obtained from the
Medical Research and Ethics Committee.
RESULTS. Overall, 174 patients were admitted to the ICU in Februari
2017; 76 patients were included in this pilot study. Limitations of
treatment were determined for 13 patients (17%) before or during
ICU admittance. Patients characteristics are shown in Table 110.
Patients with treatment limitations were older (61 ± 18 yrs)
compared to patients without treatment limitations (56 ± 17 yrs).
Gender distribution was equal (male: female in the treatment
limitation group 62: 38% and 65:35% in the full treatment group. The
patients with treatment limitations were more often referred from
medical specialties, such as internal medicine, cardiology,
cardiovascular, respiratory, neurology. APACHE II and IV scores were
higher for patients with treatment limitations 21 ± 6 vs 17 ± 6 and
75 ± 24 vs 62 ± 22, respectively. Less patients with treatment
limitations were treated with mechanical ventilation 62% vs 81% and
vasopressors 62% vs 75%. Strikingly, the length of stay for both
patients groups was almost equal 6 ± 5 days for the treatment
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 191 of 542limitations group versus 6 ± 7 days for the full treatment group.
Hospital mortality was 69% in the cohort with treatment limitations
compared to 11% in patients full treatment. This is significantly
higher P = 0,00008 as determined by Fisher exact test using two by
two table.
CONCLUSIONS. Patients with treatment limitations before and
during ICU admittance have a significantly higher hospital mortality
in this study compared to patients with full treatment.Table 110 (Abstract 0379). See text for description
Characteristics Treatment
limitations N=13
Full
treatment
N=63
Age (years) 61 ± 18 56 ± 17
Gender Male (%) Female (%) 62/38 65/35
Referring specialisms Medical (%)/Surgical
(%)(Cardiothoracic/Gastroenterloogic/Vascular/
Urogenital/Trauma/Neuro/)
69/8/15/-/-/1/-/ 29/44/5/3/
6/8/5/
APACHE II* 21 ± 6 17 ± 6
APACHE IV** 75 ± 24 62 ± 22
Mechanical ventilation (%) 62 81
Vasopressors (%) 62 75
LOS (days) 6 ± 5 6 ± 7
Mortality (%)*** 69 11
Fig. 127 (Abstract 0380). Cause to consider LTE
Fig. 128 (Abstract 0380). Record in files0380
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INTRODUCTION. In clinical practice physicians, patients and their
families are involved in decision-making process (DMP). This process
is of paramount importance in patients with critical, chronic and/or
terminal illnesses, where bioethical dilemmas increase. DMP must re-
spect human rights of patient and physicians. Mexico City has a "Law
of advance directives" and recently legislated in favor of passive eu-
thanasia [1].
OBJECTIVES. To describe the DMP of medical staff regarding the
limitation of the therapeutic effort (LTE) in the ICU of Hospital Juárez
de México (HJM)
METHODS. Research was qualitative and descriptive. Authorization
was obtained from the Research Committee, Jenssen et al. survey [2]
was translated, adapted and applied to ICU´s medical staff (n = 11).
RESULTS. DMP included an item related if it is a difference between
withhold or withdraw treatment, 7/11 responded that there is a
difference. Cause to consid...
We also asked about who should participate in DMP:
a. Patient = 11/11
b. Family or surrogate = 7/11 (when patient is unable to decide)
c. Physician = 4/11 (when patient and family are unable to
decide)
Other item asked was if nurses should participate in DMP, 4
responded "always", 1 "frequently", 1 "sometimes", 1 "rarely" and 4
"never", but in practice only 2 of them consider consult nurses on a
regular basis.
*n=8; **n=46; ***P=0,00008 as determined by FisherAlthough all physicians agree to write down DMP´s including
functional prognosis and quality of life scales; in the medical record,
only 4 actually did it. Record in files
Tanatology, Algology and Palliative Care departments, are rarely
consulted by the ICU physicians.
CONCLUSIONS. This pilot study give us the opportunity to expand
our research to pediatric and obstetric patients.
Less than half of physicians write down in medical record DMP´s
about LTE.
Patients are not sufficiently involved because of their conditions
limits their capacity for DMP, that´s what we strongly support
advance directives; the opinion of family members and nurses seems
to be underestimated.
The paternalistic model of doctor - patient relationship prevails in
our ICU.
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OBJECTIVES. Nowadays there are several subtypes of intensive care
units in our hospital: cardiologic, neurotraumatologic, and general-
postsurgical. Our objective is to know if all the professionals have a
similar view about the limitation of the therapeutic effort (LTE) or it
varies according to the subunit in which they work.
MATERIAL: Surveys were carried out in an anonymous and voluntary
way to the intensive care workers (physicians, nurses, nursing
assistants, and caretakers). Our intensive care unit consists of the
following subunits: cardiological (C), neurotraumatology (NT), and
general-postsurgical (G-PS).
THE SURVEY:
A - Sex
B - Age
C - Professional category
D - Years of work activity: 0–3 / 3–6 / 6–9 / More than 9.1
E - Do you know what LTE means? Yes / No
F - Do you know what LTE is? Active Euthanasia / - Passive
Euthanasia / Non-establishment of treatment is an active measure
and a withdrawal is an active measure / None of the above.
G - Are you in favor of the LTE application? Yes / No
H - Do you think it is the same not to start a treatment as to
withdraw a treatment already in place? Yes / No
I - Do you consider that palliative or terminal sedation is similar to
euthanasia? Yes / No
J - Should we take into account the document of anticipated
willingness of the patient when implementing LTE?
K - Do you feel ready to make a decision about LTE? Yes / No
L - Do you think that sometimes you fall, even with the best
intentions, in the therapeutic cruelty, prolonging uselessly situations
of Suffering for both the patient and his / her family?
RESULTS. A total of 148 surveys were answered (92G-PQ, 36NT and
20C), 77.3% women, 61.5% > 45 years and 82.5% > 9 years of
experience. 18.5%, Nurses 54%, Nurses assistants 25.5% and 2%
caretakers. In favor of LTE: 99% G-PQ, 100% NT and 99% C. They
think it is the same to withdraw a treatment that not start it 20% G-
PQ, 17% NT and 20% C. Are LTE and passive euthanasia the same?
13% G-PQ, 11% NT and 20% C.No instauration is a passive measure
and withdrawal is an active one; 20% G-PQ, 11.1% NT and 10% C. Is
Terminal sedation equal to euthanasia: 5.4% G-PQ, 11.1% NT and
15% C. Do you feel capable of making a LTE decision? 46% G-PQ,
44% NT and 50% C. Almost 100% in all units believe that sometimes
we fall into therapeutic cruelty, even with the best intentions.
CONCLUSIONS. Despite working in different units, the feeling is
similar and most of the workers are in favor of LTE application.
However, many of them are not clear on what LTE is. A large part of
them believe that in too many cases, we fall into therapeutic cruelty.
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Intensive Care Medicine Experimental 2017, 5(Suppl 2):0382INTRODUCTION. Currently, there are 250 patients requiring kidney
transplantion and 300 patients suffering from liver failure in the
waiting list of the National Transplantation Agency of Republic of
Moldova. Due to the organs shortage individual waiting time and the
number of deaths is increasing. Because of the organs shortage all
over the world, the criteria of donation have been revised. As a
result, organ transplantation based on expanded criteria has been
accepted in case of the so called marginal donors. The donation
agreement in these cases plays an important role.
OBJECTIVES. To assess the frequency and causes of refusal to donate
organs (kidneys or liver) in case of marginal donors.
METHODS. During the years 2014–2016, a total number of 47 brain
dead donors (18 males and 29 females) were maintained in Intensive
Care Unit of Chisinau Municipal Hospital “Sfanta Treime”, of them 43
corresponded to the criteria of marginal donors. The study
represents a retrospective analysis based on the data from
informational system “SIA Transplant” and donors` files.
RESULTS. According to our data, the mean age of those 43 marginal
donors was 62.33 ± 11.36 years. The duration of treatment in
Intensive Care Unit untill the declaration of brain death was less than
48 hours in 55.8% (24/43) cases, 48–72 hours - in 39.5% (17/43) cases
and more than 72 hours - in 4.7% (2/43) cases. The cause of brain
death included intracerebral hemorrhage with eruption in ventricles
in 58.1% (25/43) cases and massive ischaemic stroke in 41.9% (18/43)
cases. The duration of maintenance of donors in brain death was less
than 12 hours in 25.6% (11/43) cases, 12–24 hours - in 20.9% (9/43)
cases and more than 24 hours - in 53.5% (23/43) cases.The refusals
from family members to donate organs were registered in 10 (23.3%)
marginal donors explained by the fear of negative opinions from
close family friends and in 2 (4.7%) cases the acceptance from
forensic medicine was not obtained due to the presence of
posttraumatic subcutaneous hematoma. The transplantologists` team
was present soon after the positive decision of the family, thus
minimizing the donor maintaining period. As a result, 31 organs (14
livers and 17 kidneys) were taken and no deaths of organs`
recipients were registered in posttransplantation period.
CONCLUSIONS. In our study the frequency of refusals of organ
donation in case of marginal donors during the years 2014–2016 was
27.9%, of which the majority of cases were due to donors` family
negative decision.
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INTRODUCTION. Transplantation is possible thanks to a life cycle,
enabling a society which donates to benefit from the process. In
order to keep this cycle working, it is essential to involve society,
which depend on cultural, religious, ethical, and educational factors,
among others.
OBJECTIVES. To analyze the differences of the process of organ and
tissue donation between Spanish population and foreigners.
METHODS. It is a descriptive, retrospective study performed in a
third level hospital accredited for organ and tissue extraction and
renal implant, between years 2010 and 2016 inclusive. Two
comparison groups were performed: patients with Spanish
nationality (group 1) versus patients with foreign nationality (group
2). We studied epidemiological variables, cause of death, nationality
and place of residence, judicial cases, organs donated and reasons
for non-donation. Our sample included all patients who arrived at a
diagnosis of brain death in our study period, who were assessed by
the transplant coordinator of our hospital. Different statistical tests
were used, including ANOVA and Chi square test.
Table 111 (Abstract 0384). General characteristics of the 87 transplant
DONOR TYPE II TYPE III P
n (%) 37 (42,5) 50 (57,5) -
Male sex, n (%) 30 (48,4) 32(51,6) 0.09
creatinine at ICU admission median (RI) 6,96 (5,26 -
8,87)
5,71 (4,47 - 7,67) 0,081
Creatinine at Hospital ward, median(RI) 7,84 (5,41 -
9,30)
5,60 (4,50 - 7,73) 0,004
Hospital discharge creatinine, median
(RI)
4,37 (2,07 -
6,18)
2,56 (1,93 - 3,98) 0,036
Exitus, n (%) 0 0 -
Lenght of stay at ICU, median (RI) 1 (1 - 2) 1 (1 - 1) 0,016
Lenght of stay at Hospital median (RI) 18 (15 - 22) 15 (12,72 -
20,25)
0,035
Age, media (DE) 47,97 (11,33) 51,98 (12,23) 0,123
Fig. 129 (Abstract 0384). Evolution of creatinine levels
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brain death in our hospital. The mean age of all patients was 55.78
years and 65.7% were men. The cause of the death in 68.5% of the
cases was cerebral stroke, in 18.2% of the cases was recovered
cardiorrespiratory arrest and finally in 13.3% the TBI. When analyzed
by study groups, we found differences in the cause of death, the
most frequent cause being TBI in the group of patients with foreign
nationality (p = 0.049, 95% CI: 0.14-1.01). Of the patients studied,
69.9% were effective donors, being the family negative the most
frequent reason to dismiss the donation process with 21% in the
total population studied. When analyzing by groups, although the
most frequent reason remained the family negative, there were
significant differences between both groups (p = 0.0025, 95% CI:
1.11-5.73).
CONCLUSIONS. Although our sample is small, there are some
differences in the process of organ and tissue donation between
Spanish and foreign patients. Probably attributable, among other
things, to cultural motives.
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INTRODUCTION. Insteed of the delay in creatinine evolution in those
who receive an organ afer CDC tipe II, survivial seems similar.
OBJECTIVES. To study the renal transplant evolution from controlled
and uncontrolled Donation after Circulatoy Death (DCD) (type II and
type III in Maastricht clasification) (super-rapid tecnique) in patients
who were admitted in ICU.
METHODS. Observational retrospective study conducted from
January 2013 to December 2016. We collected demographic data,
comorbidity, type of donation, analytical values at ICU admission,
creatinine values at admission in ICU, at the time of discharge from
ICU and from hospital, results of radioisotope tests, days in ICU stay,
hospital stay and mortality. Statistical descriptive analysis was
performed; Xi square test was used for qualitative variables and the
Student´s T or Mann Whitney U test for the quantitative variables
depending on their distribution. We consider significance statistical
results p < 0.005.
RESULTS. A total of 87 kidney transplants were studied. The general
characteristics of the patients, the analytical values and other
variables are shown in Table 111. The 42,5% of grafts came from
donation type II DCD, comparing his creatinine levels with donation
type III we can a see a significant delay in the decrease in creatinine
levels in the first group (Fig. 129). The average time of ICU stay was 1
day (IR 1–2). Survival rate during ICU stay was 100%.
CONCLUSIONS. Renal transplant patients admitted to the ICU after a
donation protocol in type II DCD have a slower recovery of kidney
function than those who receive an organ after DCD type III.
REFERENCE(S)
1. Steinbrook R. Organ donation after cardiac death. N Engl J Med.
2007; 357: 209–13
2. Summers DM, Watson CJ, Pettigrew GJ, et al. Kidney donation
after circulatory death (DCD): state of the art.Kidney International.
2015; 88: 241–9.
3. Salmeron-Rodriguez MD, Navarro-Cabello MD, Agüera_morles ML,
López-Andreu M, Rodriguez-Benot, A et al. Short-Term Evolution ofRenal Transplant With Grafts From Donation After Cardiac Death:
Type III Maastricht Category. Transplant Proc. 2015; 47, 23–26
4. Tomita Y, Tojimbara T, Iwadoh K, Nakajima I, Fuchinoue S.Long-
Term Outcomes in Kidney Transplantation From Expanded-Criteria
Donors After Circulatory Death.Transplant Proc. 2017 Jan -
Feb;49(1):45–48
GRANT ACKNOWLEDGMENT
We gratefully appreciate the invaluable of ICU staff.Outcome 1
0385
Clinical impact of a post-ICU follow-up program
I. Dot Jordana1, A. Vázquez Sánchez1,2, Y. Díaz Buendía1,3, M.P. Gracia
Arnillas1,3, A. Zapatero Ferrandiz1,2, P.-T. Purificación1,2, S. Vallés Angulo1,
J. Marín-Corral1, M. Gas Amat1, F. Alvarez-Lerma1,3, J.R. Masclans Enviz1,2,
J. Nolla Salas1,2
1Hospital del Mar, Critical Care Department, IMIM, Barcelona, Spain;
2Universitat Pompeu Fabra, Barcelona, Spain; 3Universitat Autónoma de
Barcelona, Barcelona, Spain
Correspondence: I. Dot Jordana
Intensive Care Medicine Experimental 2017, 5(Suppl 2):0385
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 194 of 542INTRODUCTION. After Intensive Care Unit (UCI) discharge some
patients have a high readmission risk, long-lasting impairments in
physical functioning, as well as, risk of complications and death.
OBJECTIVES. Post-discharge programs are supposed to reduce ad-
verse outcomes in high-risk patients. The objective of this study is to
investigate the clinical impact on readmission and mortality of ICU
patients after the application of a post discharge ICU follow-up
program.
METHODS. In a longitudinal prospective study performed at the ICU
of the Hospital del Mar de Barcelona, patients were included from
February 2013 to September 2015. Ethical Medical Committee of the
hospital approved the study. We studied all adult patients
discharged alive from the ICU who did not meet the exclusion
criteria were. Exclusion criteria were the transfer to other ICU/other
hospital/home and the admission for a scheduled neuroangiography.
All the included patients should had undergone at least one follow-
up visit, allowing the communication between ICU and general ward
professionals. The reasons for not performing follow-up were related
to physician criteria. Demographic collected data included age, sex,
ICU length of stay, admission type (medical, scheduled surgery) and
origin (emergency room, general ward). APACHEII, SOFA, clinical data,
type of discharge (emergent or planned) and evolution were also
analysed. Quantitative characteristics of patients were described
using their mean and median values. The qualitative characteristics
were compared using the Chi square test.
RESULTS. We included 1048 patients in the study. 63% (n = 661)
men, median age of 63 years (49–74), median APACHE II 15 (9–22),
median SOFA at admission 4 (1–6) and median SOFA at discharge 1
(0–3). ICU admission was due a medical diagnosis in 66.7%, and after
emergency room admission in 60.4%.
Followed-up patients were 768 (73%), who required a lower need for
readmission compared with those who were non-followed, 7%
(n = 54) vs 11.4% (n = 32) respectively (p < 0.05). ICU global readmis-
sion rate was 8.2% (2.5% < 48h), with a significant decrease in pa-
tient readmission from 2013 (11.8%) to 2015 (4.8%), p < 0.05. This
outcome translates into a decrease in the global mortality after ICU
discharge (IntraUCI mortality after readmission plus occult mortality)
over the years, from 11.4% (n = 40) in 2013 to 6.6% (n = 22) in 2015.
Intra ICU mortality of readmitted patients had a reduction from 3.7%
(n = 13) in 2013 to 0.3% (n = 1) in 2015.
CONCLUSIONS. The implementation of follow-up programs after ICU
discharge, in collaboration with general ward doctors, can lead to im-
prove communication and outcomes, with less readmissions and a
decrease in readmitted mortality.
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INTRODUCTION. The outcomes of critically ill patients who undergo
inter-hospital transfer (IHT) are not well understood. Physiciansassume that patients who undergo IHT will receive more advanced
care that may translate into decreased morbidity or mortality relative
to a similar patient who is not transferred [1]. However, there is little
empirical evidence to support this assumption.
OBJECTIVES. To understand whether, in mechanically ventilated (MV)
patients with sepsis, IHT is associated with a mortality benefit.
METHODS. This is a retrospective cohort study using the Nationwide
Readmissions Database (NRD), which contains information about
hospital admissions from 22 States, accounting for roughly half of
U.S. hospitalizations [2]. The database contains linkage numbers so
that admissions and transfers for the same patient can be linked.
From the 2013 NRD Sample, 14,325,172 hospital admissions were
analyzed. There were 61,493 patients with sepsis and on MV. Of
these, 1630 (2.7%) patients were transferred during their
hospitalization. A propensity-matched cohort of 1630 patients who
did not undergo IHT was identified. The propensity score included
age, gender, insurance coverage, do not resuscitate (DNR) status, use
of hemodialysis, presence of shock and Elixhauser co-morbidities
index. The exposure of interest was inter- hospital transfer to an
acute care facility. Primary outcome was hospital mortality. Second-
ary outcome was hospital length of stay (LOS).
RESULTS. After propensity matching, IHT was not associated with a
difference in in-hospital mortality (12.3% IHT vs 12.7% non-IHT,
p = 0.74). IHT was associated with a longer total hospital LOS (12.8
days IQR 7.7-21.6 for IHT vs 9.1 days IQR 5.1-17.0 for non-IHT,
p < 0.01).
CONCLUSIONS. Patients with sepsis requiring MV who underwent
IHT did not have improved outcomes compared to those who were
not transferred. The study raises questions about the risk-benefit pro-
file of IHT as an intervention.
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INTRODUCTION. High red-cell distribution width (RDW) has been as-
sociated with worse outcome in a variety of clinical conditions, in-
cluding critically ill patients. Ward survival after ICU discharge is a
challenge, but Sabadell score is one of the better predictors.
OBJECTIVES. To define the association of RDW with survival after ICU
discharge, and whether RDW can improve accuracy of Sabadell
score.
DESIGN: Observational cohort study.
SETTING: General ICU in a university-affiliated hospital.
PATIENTS: All patients discharged to the ward from the ICU from
January2010 to October 2016.
VARIABLES: Demographics on ICU admission (age, comorbidities,
severity score), during ICU stay (treatments, complications, and
length of stay), and at ICU discharge (Sabadell score and RDW).
Primary outcome was hospital mortality. Statistical analyses included
multiple logistic regression models and ROC analyses.
RESULTS. We studied 3.366 patients with a ward length of stay of 7
[4–13] days and ward mortality of 5.2%. Mean RDW at ICU discharge
was 15.4 ± 2.5%, and each quartile of RDW was associated with
higher mortality (0.7%, 2.9%, 7.5%, 10.3%) and AUROC of 0.81. The
most accurate logistic regression model for predicting ward mortality
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 195 of 542included age, SAPS3 and Sabadell score (SS) with AUROC of 0.90, but
the inclusion of RDW in the model did not improve accuracy. A
recursive partitioning analysis demonstrated higher mortality of
patients with high RDW at each level of Sabadell Score (1.6% vs.
0.3% in SS0, 9.7% vs. 1.1% in SS1, 21.9% vs. 9.7% in SS2, see Fig.
130).
CONCLUSIONS. After ICU discharge, high RDW is a marker of severity
and improves the accuracy of Sabadell score for predicting ward
mortality.
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INTRODUCTION. A majority of patients survive their episode of
critical illness but up to 30% of patients suffer from psychological
problems such as post-traumatic stress, anxiety and depression in
the year after intensive care unit (ICU) stay(1,2). A method to identify
discharged patients at risk for adverse psychological outcome would
be helpful in the triage for ICU follow up and enable early
intervention(3).
OBJECTIVES. The objective of this study was to evaluate if early
screening with validated questionnaires after ICU discharge can
identify patients at risk for symptoms of post-traumatic stress, anxiety
and depression three months after ICU stay.
METHODS. We performed a prospective observational cohort study
at the general ICU at the Karolinska University Hospital Solna,
Stockholm, Sweden. All adult patients surviving 324 hours in the ICU
in a 9-month period were eligible for inclusion. Patients with mental
disability, serious auditory and visual disorder, aphasia or who were
unable to understand Swedish were excluded. One hundred thirty-
two patients were included and visited by a follow-up nurse within a
week after ICU discharge. The Hospital Anxiety and Depression Scale
(HADS) and Post-Traumatic Stress Symptoms Checklist-10 (PTSS-10)were administered. Three months after ICU discharge patients re-
ceived the same questionnaires by postal mail.
RESULTS. Eighty-two patients [Office3] returned the follow-up ques-
tionnaires. We found correlation between early and late scores and
reasonable predictive precision regarding three-month outcomes,
with an area under the receiver operating characteristic curve
(AUROC) of 0.9 for PTSS-10 part B, 0.8 for HADS anxiety subscale and
0.75 for HADS depression subscale.
CONCLUSIONS. Symptoms of post-traumatic stress, anxiety and de-
pression assessed one week after ICU stay correlate with three-
month psychological outcome. HADS and PTSS-10 may be useful aids
to identify ICU survivors at high-risk for clinically significant symp-
toms of post-traumatic stress, anxiety and depression three months
post-ICU.
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INTRODUCTION. Patients' experiences during the Intensive Care Unit
(ICU) stay is associated with dissatisfaction (Hunziker et al. 2012).
OBJECTIVES. To describe the recall of ICU survivors' experiences,
stressors and their satisfaction with ICU services in a Low Middle
Income Country (LMIC).
METHODS. This follow-up study was carried out in 32 state ICUs in
Sri Lanka between July and December 2015. ICU experiences, stress
and satisfaction were gathered using an interviewer-administered
questionnaire adapted from two previous studies (Granja et al. 2005;
Wright et al. 2015).
RESULTS. There were 1665 eligible ICU survivors and 818 (49.1%)
patients were not contactable and 389 (23.3%) patients died after
discharge from the ICU. Twenty (4.4%) patients were excluded due
to being unable to communicate (12) or not consenting (8), 438
successfully contacted ICU survivors were included in this study.
Although 78.1% (n = 349) of patients remembered their admission to
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 196 of 542the hospital, only 42.3% (n = 189) could recall their admission into
the ICU. Only 3 patients (0.7%) of patients said they had no recall of
any of their ICU stay.Memory of ICU stayFig. 131 (Abstract 0389). Recollection
the ICUNumberof stressful experiencPrecentagePrefer not to remember 3 0.67%Don't remember anything 3 0.67%Don´t mind to remember 396 88.59%Want to remember everything 34 7.61%None of them 11 2.46%[Memory of your ICU stay]Experiences Number PrecentageDreams during ICU stay 59 13.20%Nightmares during ICU stay 54 12.08%Fig. 132 (Abstract 0389). Patients' perception on care received[Experiences during ICU stay]
The three commonest experiences patients were unable to recall
were dependence on ventilator, disconnection from the ventilator
and music being played in the ICU. The commonest stressful
experiences were being limited to bed, pain and general discomfort,
daily need punctures, family worries, fear of dying or uncertainty in
the future.
Overall, the patients found the level of health care received in the
ICU to be “very satisfactory” (91.5%, n = 409) with none stating they
were either “dissatisfied” or “very dissatisfied”.
CONCLUSIONS. In common with HIC, ICU survivors were very satisfied
with the critical care they received but in contrast, they are frequently do
not appear to recall specific ICU experiences. Stressful experiences, in
common with HIC, are commonly over the future, dependency, family,
and economic concerns. This follow up study highlights two concepts
which are central to the delivery and evaluation of critical care services in
LMIC settings; the feasibility and importance of determining outcomes
beyond ICU endpoints; the necessity of engaging with ICU survivors in
order to identify discriminators aiding quality improvement efforts.
The authors wish to acknowledge the support received from
participating ICUs and the Ministry of Health, Sri Lanka.
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INTRODUCTION. Post Intensive Care Syndrome includes physical,
psychological and cognitive deficits that arise and may persist after
critical disease. Patient's quality of life and long-term health percep-
tion are usually the most compromised items. The awareness of this
syndrome and of the possibility to prevent or at least to minimize it
should modify the primary goal of critical care, extending it beyond
patient survival.
OBJECTIVES. Evaluation of physical, psychological and cognitive
sequelae, including the quality of life (QoL) of patients and their
perception of health in ICU survivors up to 180 days after discharge.
METHODS. The study was performed in the general ICU of a large
University Hospital (San Raffaele of Milan, Italy), submitting two
questionnaires to all patients discharged over a 6-month period after
discharge for intensive treatment. The questionnaires were SF-36,
EQ-ED-5L, to be completed at ICU discharge, and then at 30, 90 and
180 days after discharge. The quality of life and the perception of
health were estimated by the synthetic physical index (ISF) and men-
tal index (ISM) from the SF-36 and by the subjective percentage
expressed by patients from 0 to 100 in the EQ-5D-5L questionnaire,
where 50 and 100 are respectively the best imaginable perception of
health from the ISF/ISM and from the EQ-5D-5L.
RESULTS. During the study period 173 patients were discharged, 90
(52%) being admitted for intensive treatment and 83 (48%) for
postoperative monitoring (questionnaires not submitted).
The average ICU length of stay was 6,7 ± 6,7 days. The mean ISF was
31,5 ± 9,5 at ICU discharge, 36,7 ± 10,7 at 30 days, 44,2 ± 11,6 at 90
days, 47,6 ± 11,5 at 180 days. The ISM was an average 43,2 ± 11,1 at
ICU discharge, 40,2 ± 11,6 at 30 days, 45,7 ± 11 at 90 days, 53,1 ± 11
at 180 days. The mean reported percentage about the perception of
health in the EQ-5D-5L was 50/100 (±23) at ICU discharge, 55/100
(±22) at 30 days, 65/100 (±23) at 90 days and 73/100 (±19) at 180
days; the positive trends reached a statistical significance for ISF at
90 days (p = 0.0006) and at 180 days (p = 0.0009) and for ISM at 180
days (p = 0.018).
CONCLUSIONS. We noticed a positive trend of the reported
perception of health, but six months after discharge from ICU the
values were almost 30 points below the best value, suggesting a
marked and persistent reduction in the quality of life. Moreover, ISF
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 197 of 542and ISM at 180 days are below the standard reference population
average score (50), confirming the impact of ICU stay on
patients'physical and mental abilities, when they return to their daily
lives. It is more important work on mental/cognitive problems. Our
findings confirm that patients discharged from an ICU report a
relevant worsening of the perceived quality of life. After ICU (and
hospital) discharge, patients should be followed long-term to identify
and possibly treat the post ICU sequelae.
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INTRODUCTION. In 2013 the ICU in Medical Center Leeuwarden,
initiated interventions aimed at reducing post intensive care
syndrome (PICS)1 related morbidity. In the following years, this lead
to increased functional independence, measured via the Barthelindex
(BI), at ICU discharge2.
OBJECTIVES. This paper attempts to determine whether the
observed improvements in functional independence are maintained
over the medium-term.
METHODS. The primary outcome of this research is the BI, measure
of functional independence. Over the period of 2012–2016, 289
patients were selected for having been admitted to the ICU for >48h
as well as having been seen at the outpatient department of the
ICU-MCL.
RESULTS. Patient group composition remained consistent, length of
stay and the duration of mechanical ventilation were significantly
reduced, post-intervention. The BI, at ICU discharge, rose from 8[5–
12] in 2012 to 13[9–18] in 2016.
At follow-up, performance on the 6 minute walking test (6mwt), and
MFI-20 score for fatigue improved significantly, whilst other scores
describing functional independence remained constant. At follow-up
we encountered a ceiling effect of the BI, all patient groups gained a
maximum 20[20–20] BI score. A BI of < 16 at ICU discharge is a sig-
nificant predictor for not reaching the ceiling effect thus scoring sub-
optimally on the BI.
When analyzing scores for physical abilities, a lower BI at discharge
predicts poor performance on both the 6mwt test and the physical
section of the Short Form 36. Poor performance on the ability to
climb stairs at ICU discharge, significantly predisposes to depression
with an AUC of 0,78.
CONCLUSIONS. The BI is not suitable for the follow-up of ICU pa-
tients post discharge. The BI is validated as adequate for the moni-
toring patient functional abilities during hospital admission. This
research shows however that the BI is not sensitive for determining
subtle but debilitating problems that ex-ICU patients face3.
Secondary parameters show that the implemented interventions
have subtle but positive effects on PICS related morbidity.
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INTRODUCTION. Survivors of critical illness suffer frequently from
loss of quality of life after discharge from the ICU. In recent years,
follow-up studies pointed at psychiatric morbidity as an important
contributing factor, especially symptoms of posttraumatic stress dis-
order (PTSD) were demonstrated in ICU survivors. Interventions like
ICU diaries, early in-ICU psychological assessment and ICU follow-up
clinics appear ineffective to improve psychological recovery.
Recently, Virtual Reality Exposure Therapy (VRET) was shown to be
effective in treating patients with combat-related posttraumatic
stress disorder, pain after burn injury and mental health disorders.
The need and possible effect of VRET in ICU survivors is not yet
known.
OBJECTIVES. To examine the prevalence of PTSD symptoms in a
representative sample of Dutch adult ICU survivors and assess their
preferred method of intervention, including VRET.
METHODS. A retrospective cohort of patients was recruited from 4
Dutch ICU's. Due to the retrospective nature of the study we set the
start of the study at October 1 2016. Patients, respectively 1 month
(4-8weeks), 6 months (26–30 weeks), 12 months (52–56 weeks), 2
years (104–108 weeks), and after 2,5 years (130–134 weeks) after ICU
discharge were eligible for inclusion. Eligible patient's had to be
mechanically ventilated for more than 2 days. Patients were sent a
postal survey containing a self-report questionnaire to assess: symp-
toms of anxiety, depression, and post-traumatic stress (Impact of
Event Scale (IES)) and quality of life (EuroQol health classification sys-
tem (EQ-5D)). They were also asked regarding different methods that
could improve their recovery and well-being the best, including an
information brochure and VRET.
RESULTS. A total of 67 patients received questionnaires of which 46
(69%) responded. Of these patients 22% were included in the 1
month cohort, 22% after 6 months, 19% after 12 months, 21% after
24 months, and 16% after 30 months. PTSD-related symptoms were
reported in 61% of the patients, with a maximum prevalence at 6
months. The presence of PTSD symptoms was associated with more
problems on all EQ-5D domains (mean 0.17 (SD 0.17) versus 0.49 (SD
0.36); P < 0.01)). Patients with PTSD reported significantly more anx-
iety/depression (60% versus 40%; P < 0.01) indicating decreased
Quality Of Life. Especially patients with PTSD more frequently ex-
pected a possible effect from VRET to cope with their problems, com-
pared to patients without PTSD ((62% versus 38%; P = 0.047)).
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 198 of 542Moreover, of the patients with PTSD, 65% favored VRET compared to
38% an information brochure; P < 0.01.
CONCLUSIONS. PTSD related symptoms persist up to 30 months
after recovery from critical illness and are associated with a
considerable decrease in Quality Of Life. Patients with PTSD appear
motivated to undergo Virtual Reality Exposure Therapy in the
aftermath of critical illness to finally improve quality of life.
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INTRODUCTION. Heart transplantation (HT) is considered the “gold
standard” therapy for patients with end stage heart failure. However,
only few patients can benefit from HT in the emergency setting,
essentially because of the lack of heart donors and/or associated
organ failure(s). LVAD implantation is a valid alternative in the
absence of multiorgan failure, but data on the potential interest of
this procedure in cardiogenic shock patients with MOF are scarce.
OBJECTIVES. We aimed to determine the prognosis and quality of
life of patients who underwent LVAD implantation with preoperative
cardiogenic shock and multiorgan failure.
METHODS. We performed a retrospective chart review of 37
cardiogenic shock patients with MOF who underwent LVAD (n = 36
Heart Mate II® and n = 1 Heartware® devices) implantation, between
October 2011 and September 2016. The primary end-point was all-
cause mortality one year following LVAD implantation. We also ana-
lyzed quality of life by phone interviews between February 2017 and
April 2017, using the EUROQOL and the Short-Form General Health
Survey (SF-36) scales (scores range from 0 to 100, with higher scores
indicating a better health care status). Results are presented as n (%)
or median [interquartile range].
RESULTS. Thirty-seven patients (male gender, n = 33 (89%); age, 60
[45; 66.5] years; SAPS II, 48 [34; 62]; SOFA 8 [6–13]) were analyzed.
The main cause of heart failure was ischemic cardiomyopathy
(n = 18 (49%) patients). All patients were mechanically ventilated, 34
(92%) patients received vasopressor/inotropic support, 21 (57%) pa-
tients received renal replacement therapy, and 22 patients (59%) re-
ceived venoarterial ECMO support before LVAD implantation. LVAD
implantation was performed after 10.5 [5.5; 16] days of ICU stay.
Overall, twenty-one (57%) patients were alive at ICU discharge. Dur-
ation of mechanical ventilation and duration of ICU stay were 9 [3.5;
21] and 32 [22; 58] days, respectively. Hospital survival and 1-year
survival were 57% (21/37) and 54% (20/37), respectively. Seventeen
(46%) patients underwent HT 264 [51; 342] days after LVAD implant-
ation, 2 (5%) patients were still waiting for HT at 1 year, and 2 (5%)
patients received LVAD implantation as a destination therapy. The
score on the EUROQOL scale was 67.5 [57.5; 76.3]. Among the SF-36
items, the lower score was observed on the role physical (RP) item
(12.5 [0; 50]), whereas higher scores were observed for other items
(i.e., Physical Functioning (PF) item: 80 [64; 95] and Social Functioning
(SF) item: 75 [60.1; 87.5]). The main qualitative complaint in survivors
was the incapacity to take showers or bathes.CONCLUSIONS. The implantation of a LVAD in cardiogenic shock
patients with MOF is associated with a 54% survival rate at 1 year,
with an acceptable quality of life in most of survivors.
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INTRODUCTION. Independence in activities of daily living was
absolutely decreased after the ICU stay and quality of life is altered.
The major challenge for medical staff is to decrease mortality and to
improve functional status for critically ill patients after discharge. The
effects of an ICU stay in patients with severe illness and comorbidity
on autonomy and functional capacity is certainly important.
OBJECTIVES. To evaluate functional autonomy and to quantify the
physical and mental activity in daily life in long term ICU survivors.
METHODS. A prospective cohort study was conducted with a follow-
up from hospital discharge to 12 months after for ICU survivors dur-
ing the period from January 2014 to December 2015. Functional sta-
tus was assessed by evaluation of autonomy for all survivors using
Activities of daily living (ADL)(1) and Instrumental activities of daily
living (IADL)(2) scales in telephone interviews with patient or their
proxies.
RESULTS. During the predetermined period of data collection, the
follow up concerned 280 patients. Only 215(77%) patients
responded. Among a total of 215 patients, 152(71%) patients
survived to 12 months. At the time of interview, 180(84%) patients
survived independently without specialized care. The median values
of ADL/IADL scales were respectively 4 and 6. The proportion of
those reporting combined difficulties in ADL (<3) or IADL (<5) were
respectively 16% and 8.6% with more patients reporting difficulty
with ADL than IADL. There were significant differences between
patients with or without difficulties; in age (45,5 ± 22,5 vs 54,3 ± 21,1
; p = 0.02) ; comorbidities of cancer (4(11,1%) vs 5 (2,9%) ; p = 0.02) ;
clinical diagnosis (neurological diagnosis at ICU admission for 13
patients (36,1%) vs 16 patients (9,1%) ; p = 0.000), invasive therapy
such as tracheostomy (6(16,7%) vs 8(4,6%) ; p = 0.0008) and
nosocomial infection for (13(36,1%) vs 31 (17,8%) ; p = 0.01).
CONCLUSIONS. Partial and moderate reduction in physical activity,
exercise capacity was detected in critically ill patients, but persisting
even 12 months after hospital discharge. Neurological critical illness
is the strongest factor associated with difficulties in daily living
activity.
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INTRODUCTION. Accidental hypothermia (AH) is defined as an
unintended decrease in core temperature < 35 °C. In addition to
acting as a risk factor in itself, AH occurs in different categories of
patients and thus worsen underlying diseases and their clinical
courses.
OBJECTIVES. The aim of our study was to estimate the incidence and
outcomes of AH in patients upon admission to the intensive care
unit (ICU).
METHODS. We performed a retrospective analysis of the ICU charts
of all patients admitted to the 52-bed adult ICU of the City hospital
#1 of Arkhangelsk in year 2016. The hospital has 1050 beds and
serves as a main emergency hospital in the region of North Russia.
We included for analysis all patients who had axillary
temperature < 35.0 °C upon admission to ICU and recorded demo-
graphic data, diagnosis, type of surgery, duration of ICU stay and
mortality.
After checking data distribution, we used the Student´s t-test and
the chi-square test to compare the data according to their type. The
results are presented as mean ± standard deviation.
RESULTS. Totally, 3299 ICU charts were examined. Upon admission
to ICU, AH was observed in 172 patients (5.2%). The mean age of
patients was 63.5 ± 13 years. The mean body temperature was
34.86 ± 0.42°C. AH was observed more frequently in cardiac ICU than
in general ICU [104 (60.5%) vs. 68 (39.5%), p = 0.008] patients. The
postoperative patients had higher incidence of AH [160 (93%) vs. 12
(7%), p = 0.0001]; the majority (65%) of postoperative patients were
after cardiac surgery. In general ICU, the main causes of AH included
abdominal surgery (50%), sepsis (17.6%), poisoning (10.3%), burns
(4.4%), freezing injury (2.9%). The axillary temperature was lower in
general ICU: 34.6 ± 0.6°C vs. 34.9 ± 0.1°C in cardiac patients
(p = 0.001). The mean values of plasma lactate and INR in patients
with AH on admission to ICU were 3.28 ± 3.7 mmol/L and
1.29 ± 0.56, respectively. The mean ICU stay of patients with AH was
3.6 days and overall mortality rate was 12.8%. Mortality rate was
higher in general ICU patients with AH: 22.6% vs. 6.8% in cardiac ICU
patients (p = 0.007).
CONCLUSIONS. The incidence of AH on admission to ICU is 5.2%
and occurs most frequently in postoperative patients, mostly after
cardiac and abdominal surgery. AH is accompanied by an overall
mortality rate of 12.8% and requires correction of metabolic and
coagulation abnormalities.
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INTRODUCTION. Haematology patients have historically had high
mortality rates in the Intensive Care Unit (ICU) (1). Despite an
improving trend in recent years, the perception remains amongmany intensivists that haematology patients have a poor prognosis
in ICU (2).
OBJECTIVES. To analyse characteristics of all haematology and
oncology patients admitted to ICU over a 3 year period, with the aim
of analysing mortality rates and identifying predictors of in ICU
mortality.
METHODS. Data from electronic patient records for a 3-year period
(2014–2016) was used to generate descriptive statistics for patients
admitted from haematology and oncology to ICU. The primary out-
come was survival to discharge from ICU vs death in ICU. Independ-
ent variables were: age, sex, referring service (haematology vs
oncology), APACHE II score, number of days requiring level 2 or 3
care, duration of stay, percentage of patients discharged within 1
day, primary diagnosis, and primary reason for ICU admission. Con-
tinuous variables were initially analysed using Student's t test and
categorical variables using Chi square test. A logistic regression
model was then applied.
RESULTS. 95 admissions to ICU from haematology and oncology
services were documented from 2014–2016 (66 from haematology,
29 from oncology). Survival to discharge from ICU, at 1 month post
discharge, and at 6 months post discharge was 69.5%, 51.6%, and
33.7% for the combined haematology and oncology patients, 65.7%,
48.4%, and 31.8% for haematology patients, and 78.6%, 55.2%, and
35.8% for the oncology patients. In univariate analysis, significant
differences between patients surviving to discharge and those that
died in ICU were observed for the following variables: Length of stay
in ICU (p < 0.05), number of days requiring level 2 support (p < 0.01)
or level 3 support (p < 0.01), maximum organ support required
(p < 0.01), and Apache II score (p < 0.01). The referring specialty was
not significantly associated with in ICU mortality. Logistic regression
confirmed that APACHE II score is a predictor of mortality in a
multivariate analysis.
CONCLUSIONS. Contrary to expectations, this study did not show a
significant excess of mortality for haematology patients over
oncology patients. However, the high mortality rates at 6 months
and the length of stay for patients who died in ICU (mean stay 8.9
days, but 24% died within 24 hours of ICU admission) raise two
questions. First, is patient selection for ICU adequately managed, and
second, have the patients and their families been sufficiently
counselled on their prognosis and the likely interventions while in
ICU. In line with previous studies, we find that a higher Apache II
score is associated with a higher mortality rate. Unfortunately, a
robust set of criteria for selecting haematology and oncology
patients for ICU treatment is still awaited.
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INTRODUCTION. Spontaneous Subarachnoid Hemorrhage (SAH) is a
neurological disease with high morbidity and mortality1. ICU
survivors of SAH often experience negative outcomes after ICU
discharge, including physical complaints, cognitive decline and
mental health problems. Recognition of ICU related risk factors and
early treatment of probable negative outcomes in these patients is
of great importance.
OBJECTIVES. The aim of the study was to examine the incidence of
somatic complaints, cognitive dysfunction, and negative emotional
Table 112 (Abstract 0398). Patient Demographics
Variable Data (n=22)
Age (years) 61 +/- 11
Male sex 21
Estimated downtime (mins) 26.6 +/- 16.5
Independent function pre admission 22
Table 113 (Abstract 0398). Relationship between CT, EEG and CPC of 5
CT : Mild CT : Moderate CT : Severe
EEG: Mild 0/2 (0%) 0/1(0%)
EEG: Moderate 1/3 (33.3%) 0/1 (0%)
EEG: Severe 1/2 (50%) 0/1 (0%) 9/9 (100%)
Number/total number (%)
Table 114 (Abstract 0398). Relationship between CT, EEG and CPC of 1
or 2
CT : Mild CT: Moderate CT: Severe
EEG: Mild 2/2 (100%) 1/1(100%)
EEG: Moderate 1/3 (33.3%) 1/1 (100%)
EEG: Severe 1/2 (50%) 1/1 (100%) 0/9 (0%)
Number/total number (%)
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disorder (PTSD), in patients with SAH treated in our ICU. Also, we
studied the association of ICU related factors with somatic com-
plaints, cognitive dysfunction, anxiety, depression and PTSD.
METHODS. Patients with SAH treated in our ICU between January 2012
and December 2016 for a minimum of 4 days were invited to the ICU
aftercare clinic. Six weeks after hospital discharge, patients received an
invitation letter along with three questionnaires: a health-related ques-
tionnaire for identifying somatic and cognitive complaints, the Hospital
Anxiety and Depression Scale (HADS) and the Impact of Event Scale -
Revised (IES-R). Patient characteristics and ICU admission characteristics
were obtained from electronic patient records.
RESULTS. A total of 110 SAH patients visited our aftercare program
(mean age = 58, SD = 10.40), of which 31.8% was male. Median
Apache II and Apache IV were 11 and 36, respectively. Median ICU
LOS and hospital LOS were 6 and 15 days, respectively. Of all
patients, 31.8% was mechanically ventilated with a median length of
4 days. Delirium during ICU treatment was observed in 24.5% of the
patients. Most frequently reported somatic complaints after
discharge were muscle weakness (41.8%), fatigue (73.6%), weight
loss (30.9%) and pain (36.4%). Reported cognitive complaints were
problems with concentration (63.6%), memory problems (45.8%) and
reduced thinking capacity (60.9%). The prevalence of clinically
significant anxiety and depression was 24.3% and 19.6%,
respectively. Additionally, 11.4% of the patients showed possible
PTSD. Length of mechanical ventilation was associated with PTSD
(p < 0.05) Clinical factors including ICU LOS, hospital LOS, APACHE
scores and drugs administered during ICU treatment were not
associated with somatic complaints, cognitive dysfunction or
negative emotional outcomes.
CONCLUSIONS. Incidence of PICS related symptoms, including
somatic complaints, cognitive dysfunction, anxiety, depression and
PTSD, was high in patients with SAH surviving the ICU. Patients with
longer duration of mechanical ventilation showed more PTSD
symptoms. No other ICU related risk factors could be identified.
REFERENCE(S)
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INTRODUCTION. Hypoxic brain injury (HBI) is a common
complication of out of hospital cardiac arrest (OOHCA). With
improved pre-hospital treatment and acute care interventions the
prevalence of patients with HBI is increasing. Research in this area is
limited and largely focused on prognostication with limited evidence
on long-term outcome and on-going rehabilitation needs (1).
OBJECTIVES. Physiotherapy plays a key role in rehabilitation of HBI
patients. The aim of this study was to evaluate clinical characteristics,
prognostic factors and outcomes following OOHCA.
METHODS. This study was a retrospective case note review of all HBI
patients admitted to our critical care unit over three months.
Targeted temperature management was used in all patients. The CT
and EEG findings were classified by a consultant neurologist and
neurophysiologist respectively as mild, moderate or severe. Outcome
measures were the Glasgow Outcome Scale (GOS) and the Cerebral
Performance Categories scale (CPC). The GOS and CPC were
recorded 1 month after admission and 1 month after discharge.
RESULTS. Twenty two patients were admitted during this time. 14%
of patients were discharged home with no or only minor deficits
within one month; 32% remained in either acute care or specialist
neurological rehabilitation and 54% of patients died. At one month
post discharge from acute care 18% of patients were at home withno or only minor deficits. Patient demographics are shown in
Table 112.
The average time to neurological investigation (CT and EEG) was 3
days; these investigations were performed in 91% of patients.
Neurological investigations and clinical examination were performed
after sedation hold when patients did not wake appropriately and/or
had adverse neurological signs e.g. seizure activity. Clinical seizure
activity was noted in 59% of patients. Of those who experienced
seizure activity the CT scan was classified as severe in 69% whilst in
77% the EEG was classified as severe. In 62% the CPC score was 4 or
5, indicating severe disability or vegetative state. All patients with both
severe EEG and CT findings had a poor CPC outcome (Tables 113 and
114). Of note some patients made a good functional recovery and
were discharged home despite adverse prognostic criteria.
CONCLUSIONS. Severe abnormalities seen on both EEG and CT are
strongly associated with a poor outcome or death in this patient
population. This small sample demonstrates that certain patients
with initially poor prognostic features can achieve a good functional
outcome at two months. Seizure activity does not always predict a
poor outcome. We will continue to prospectively enrol patients to
this study to achieve a larger sample size and a longer period of
follow-up.
REFERENCE
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future cardiorespiratory instability (CRI) has implications for patient
triage, allocation of surveillance resources and preemptive care.
OBJECTIVES. To determine if laboratory test values available within
the first 4 hr of unit admission improves forecasting of CRI compared
to models that include only patient demographics and vital sign (VS)
features.
METHODS. We collected continuous noninvasive VS monitoring data
(heart rate, respiratory rate, blood pressure, SpO2) from 1092
stepdown unit (SDU) patients and identified 584 patients with CRI
episodes (positive) defined as VS deviation beyond stability
thresholds, and 508 patients never displaying CRI (negative). This
dataset was augmented with demographics (age, gender, race,
Charlson Comorbidity Index) and 13 serum laboratory results (blood
chemistries, hematology, liver function). We extracted last lab test
values and changes of lab test values from the second-last test
within a 24-hour window up to 4 hours after SDU admission. For VS,
we computed mean and interquartile range during the first 4 hours
of SDU stay. After filtering out insignificant features using two-
sample t-tests, the final dataset included 9 lab test values features, 6
VS features and 4 demographic features. We fit three random forest
models: model 1 includes only demographics, model 2 adds VS fea-
tures, and model 3 further adds lab test value features. We report
model performance based on 10-fold cross validation.
RESULTS. The Area Under Receiver Operating Curve (ROC) scores are
0.52, 0.60 and 0.65 for models 1, 2 and 3 respectively. To better
illustrate the models' ability to identify true positives and negatives,
Fig. 133. shows a sub-part of the ROC diagram with true and false
positive and negative rates plotted on log scale. The left panel shows
that at a low level of false positive rate (<0.01) there is no significant
difference in true positive rate between the models. However, the
right panel shows that at a low level of false negative rate, model 3
exhibits a significantly higher true negative rate than models 1 and
2. For example, at a false negative rate of 1 in 1000, the true negative
rate is 0.08 for model 3 (95% CI [0.07, 0.09]), compared to 0.04 for
model 2 (95% CI [0.04, 0.03]) and 0.02 for model 1 (95% CI [0.02,
0.03]).
CONCLUSIONS. Adding laboratory test values to models forecasting
CRI carries extra predictive utility compared to models relying solely
on demographics and the initial 4 hours of VS after admission, and
in particular is advantageous in identifying those patients who will
never develop CRI at a very low miss rate. This insight may provide
guidance in developing a clinically relevant predictive triage model
to identify very early in their hospital unit admission patients who
need closer surveillance and those who do not using continuously
and automatically acquired clinical data.
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INTRODUCTION. Isotonic saline (0.9% sodium chloride) is the most
commonly used intravenous fluid for resuscitation. Conflicting data
regarding its association with greater incidence of AKI in comparison
to buffered crystalloids.
OBJECTIVES. To assess the association of 0.9% saline versus a
physiologically balanced crystalline (Sterofundin®) as a resuscitation
fluid with AKI incidence in shock patients.
METHODS. We randomly assigned shock patients diagnosed within 1
hour to receive either a balanced crystalloid or 0.9% saline (NSS) for
intravascular-fluid resuscitation during the first 72 hours. The primary
outcome was an incident of AKI according to KDIGO classification
during the 7-day period after randomization. Secondary outcomes in-
cluded the resolution from peak to baseline creatinine level in the
ICU, need for renal replacement therapy (RRT), length of stay in ICU
and hospital, mortality, and metabolic derangements.
RESULTS. Of 181 patients enrolled, 88 received a balanced crystalline
and 93 received saline. There were no significant differences in
baseline demographic and metabolic data between two groups at
enrollment. The median volume of fluid therapy in the first 3-day
were 11,158 ml and 11,189 ml in a balanced crystalloid, and saline
groups, respectively (p = 0.9). 64/88 (72%) patients in the balanced
crystalloid group and 69/93 (74%) patients in the saline group devel-
oped AKI during 7 day of admission (p = 0.82). At 7 days after
randomization, the number of cases who still had AKI decreased to
18/88 (20%) in the balanced crystalloid group, and 19/93 (20%) in
the saline group (p = 0.85). In the buffered crystalloid group, RRT was
used in 4 of 88 patients (4.6%) compared with 12 of 93 patients
(12.2%) in the saline group (p = 0.06). There were no difference in
28-d, ICU, or hospital mortality, hospital or ICU length of stay, or
ventilator-free and vasopressure-free days.
CONCLUSIONS. The use of a balanced crystalloid as the resuscitation
fluid in patients with shock did not reduce the incident of AKI
compared to saline.
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improve patient survival in moderate to severe ARDS patients, its
rate of use has been found as low as 16% in the Lung Safe study.
However, this latter did not specifically focus on PP.
OBJECTIVES. To determine prevalence of use of PP, physiologic
effects and reasons for not using PP in ARDS patients.
METHODS. The APRONET study was a prospective international one-
day prevalence study. Data collection was performed 4 times in April,
July, October 2016 and January 2017 in ICUs recruited through ESICM
website. Each ICU had to select one day per period among 4 pro-
posals. At each study day, investigators in each ICU had to screen
every patient staying in the ICU from 0 to 24 hours and to fill a spe-
cific electronic CRF. For patients with ARDS oxygenation, ventilator
settings and plateau pressure (Pplat) were recorded. For those receiv-
ing PP these variables were recorded before and at the end of PP
session. Reasons for not proning were also collected. ARDS was de-
fined according to the Berlin definition from the worst PaO2/FIO2.
Values are presented as median (1st-3rd quartiles). Prevalence rate of
ARDS was compared by using chi-square for trend and groups with
nonparametric tests.
RESULTS. Overall 6,614 patients were screened in 138 ICUs from 19
countries, and 743 had ARDS. ARDS prevalence was overall 11.2%,
and 13.7, 9.0, 10.2 and 11.6% in periods 1 to 4, respectively
(P = 0.113).
One hundred and one patients received at least one PP session
(13.6%). This rate was 13.9, 12.9, 15.0 and 14.1% in periods 1 to 4,
respectively (P = 0.826). It was 6.5, 11.3 and 37.0% in mild, moderate
and severe ARDS stages, respectively (P < 0.001), and 26.0% in those
with PaO2/FIO2 ratio < 150 mmHg.
First PP session lasted 18 [15–23] hours. Before and after first PP
session, PaO2/FIO2 was 101 [76–136] vs.171 [118–220]mmHg
(P = 0.0001), driving pressure 14 [11–17] vs.13 [10–16]cmH2O
(P = 0.001), FIO2 77 [60–100] vs. 60 [40–75]% (P = 0.0001), and PEEP
(12 cmH2O), tidal volume (6 ml/kg predicted body weight) and Pplat
were similar.
Main reason for not proning was not severe hypoxemia (60.7%).
PaO2/FIO2 at the time of inclusion was 164 [122–211] vs 102 [80–
142] mmHg in not proned vs proned, respectively (P = 0.0001). Other
reasons were: low mean arterial pressure (5.4%), tracheotomy (2.8%),
elevated intracranial pressure (1.6%), pneumothorax (1.2%), unstable
bone dislocation (1.1%), sternotomy (1.1%), excessive workload
(1.1%), facial trauma (0.7%), hemoptysis (0.4%), other (21.7%).
CONCLUSIONS. This study confirms a 11% prevalence rate of ARDS
with no significant seasonal variation. Rate of PP use is overall similar
as but higher in severe ARDS than in the Lung Safe study, which
could reflect change in practice or ICU selection bias. Significant
oxygenation improvement is confirmed together with decrease in
driving pressure. The main reason for not proning is lack of severe
hypoxemia.
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INTRODUCTION. Intensive Care Unit (ICU) patients consume
significant healthcare resources during their ICU admission and
studies have shown that factors present before ICU admission, such
as comorbidities, are strong predictors of hospital resource use [1].
However, little is known about the chronic conditions patients sufferbefore their ICU admission and the development of chronic
conditions over time. Moreover, it is unclear whether there is a
difference in developing chronic conditions between ICU patients
and the general population. Identifying groups of ICU patients with a
high risk of developing chronic conditions after ICU admission is
important for prevention and targeted care in order to reduce
healthcare expenditure.
OBJECTIVE. To describe the differences between an ICU population
and a population based control group with respect to existing
chronic conditions during the year before ICU admission and the risk
of developing chronic conditions during the year after ICU discharge.
METHODS. A retrospective cohort study combining data of the
Dutch National Intensive Care Evaluation (NICE) registry [2], with data
of the insurance claims database of Vektis [3]. A population based
control group was created by Vektis, based on the ICU population
and weighed on age, gender and socioeconomic status (SES).
RESULTS. The study population consisted of 56,760 ICU patients and
75,232 persons in the population based control group. The ICU
population had more chronic conditions during the year before ICU
admission compared to the control population (p < 0.05). The ICU
population showed an increase of 24.7% (CI 23.8%; 25.6%) in
number of chronic conditions in the year after ICU admission
compared to the year before admission. For the control population
the increase was 6.5% (CI 5.8%; 7.2%). After adjusting for gender, age
and SES, ICU patients had a higher odds on developing high
cholesterol, heart diseases, COPD, DM type II, DM type I and
depression, ranging from 2.0 (CI 1.8; 2.2) to 7.9 (CI 7.2; 8.6), compared
to the control group.
CONCLUSIONS. ICU patients have more chronic conditions during
the year before ICU admission and over time ICU patients develop
almost four times more chronic conditions compared to the control
group. After adjusting for gender, age and SES, differences in risk of
developing specified chronic conditions remained elevated for ICU
patients. We believe that the differences between the two
populations were not completely explained by demographics and
propose that factors related to the ICU admission may play an
important role in the development of chronic conditions in ICU
patients.
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INTRODUCTION. Intensive Care Unit acquired weakness (ICUAW) is
characterized by muscle weakness, wasting and a misbalance between
myosin synthesis and degradation. Recently we reported that protocol-
based physiotherapy (pPT) alone or with additional measures (adMeas),
such as electrical muscle stimulation, whole body vibration and the
Fig. 135 (Abstract 0403). Relative gene expression FBXO32/
TRIM63/TRIM
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when compared to standard physiotherapy (sPT) in muscle biopsies of
ICUAW patients1.
OBJECTIVE. To assess the effect of pPT and pPT + adMeas on
muscular protein synthesis and degradation.
METHODS. Within this prospective randomized controlled trial 37 patients
at high risk for ICUAW (SOFA ≥ 9) were randomized to receive either pPT
(n = 11) or pPT + adMeas (n = 26). Reference patients receiving sPT
(n = 22) were available from our previous trial2. Muscle biopsies obtained
on day 15 from the vastus lateralis muscle were assessed by qPCR for gene
expression and by Western Blot for protein abundance. Biopsy specimens
from six healthy patients undergoing elective orthopedic surgery were
included for baseline values (Charité EA 2/041/10).
RESULTS. Myosin expression increased significantly with pPT + adMeas
as opposed to sPT for MYH1/2/4 and for MYH1/4 in comparison to
controls. In sPT patients, no differences were observed for MYH1
expression while MYH2 showed a decreased and MYH4 an increased
expression (Fig. 134). FBXO32 and TRIM62 expression was increased in all
critically ill patients with no differences between the interventions. TRIM63
expression presented baseline values for sPT and an increase for pPT and
pPT + adMeas as opposed to controls or sPT (Fig. 135). The increase in
myosin expression was accompanied by a significantly increased myosin
total/fast/slow protein content for pPT + adMeas as opposed to sPT. In
line with the expression data pPT showed an increased and sPT a
decreased myosin protein abundance (Fig. 136). MuRF-1 protein was in-
creased with pPT and pPT + adMeas, which was coherent with its gene
expression. Atrogin-1 showed an increased protein content in
pPT + adMeas patients which was inconsistent with its gene expression.
CONCLUSION. In muscle of ICUAW patients, pPT + adMeas increases
myosin synthesis as well as muscular protein degrading systems. Our
data suggest that in pPT + adMeas treated patients protein synthesis
outbalances its degradation resulting in higher myosin protein
contents preventing muscle atrophy.
REFERENCES
1. Wollersheim T, et al.; ESICM LIVES 2016: part two; Intensive Care
Medicine Experimental 2016, 4(Suppl 1):A464
2. Wollersheim T, et al. (2014) Dynamics of myosin degradation in
intensive care unit-acquired weakness during severe critical illness.
Intensive Care Med.
GRANT ACKNOWLEDGMENT
Twinning research grant (TRG-3) was given to SWC, CB and JF by the BIH.
TW is a participant, in the clinical scientist program of Charité and BIH.Fig. 134 (Abstract 0403). Relative gene expression MY1/MYH2/MYH4 Fig. 136 (Abstract 0403). Protein content Myosin/Atrogin-1/MuRF-1
Table 115 (Abstract 0404). Patient characteristics
Variable Patients (N=2192)
Age in years, Mean (SD) 62.1 (15.2)
Male, N (%) 1330 (60.7)
Admission category, N (%) Surgery - Medical -
Trauma - Neurology/neurosurgery
1081 (49.3) - 859 (39.2) - 89
(4.1) - 163 (7.4)
Urgent admission, N (%) 1357 (61.9)
APACHE-II score, Mean (SD) 17.4 (7.1)
Delirium, N (%) 470 (21.4)
E-PRE-DELIRIC score, Median (Q1-Q3, min/max) 16.9 (9-32, 2/100)
PRE-DELIRIC score, Median (Q1-Q3, min/max) 18.6 (12-31, 3/100)
Fig. 137 (Abstract 0404). AUROC (E-)PRE-DELIRIC
Fig. 138 (Abstract 0404). Calibration plot (E-)PRE-DELIRIC
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INTRODUCTION. Delirium occurs frequently in Intensive Care Unit
(ICU) patients and is associated with poor outcome. Identification of
high risk patients is important in the facilitation of delirium
prevention. Currently, two ICU delirium prediction models are
available, that both predict delirium for the complete ICU length of
stay. The PRE-DELIRIC model reliably predicts ICU patients' risk for de-
lirium using ten predictors obtained within 24 hours after ICU admis-
sion and the E-PRE-DELIRIC model uses nine predictors obtained at
ICU admission. The use of a delirium prediction model is not yet im-
plemented in daily clinical practice, as it is unknown which of the
two available models can best be used to predict ICU delirium.
OBJECTIVES. To compare the predictive and clinical performance of
the PRE-DELIRIC model and the E-PRE-DELIRIC model.
METHODS. A multinational prospective cohort study in eleven ICUs
from seven countries. All ICU patients aged ≥18 years from the
participating centers were included within three consecutive months,
up to a maximum of 300 patients per participating ICU. Patients
were excluded if: they were already delirious at ICU admission; had
an expected ICU stay shorter than six hours; or were unable to be
reliably assessed for delirium. Delirium was assessed using the
Confusion Assessment Method-ICU or the Intensive Care Delirium
Screening Checklist. The predictive performance of both prediction
models was determined using the area under the receiver operating
characteristic curve (AUROC) and calibration was assessed graphic-
ally. The predictive performance of both models was compared using
the Hanley & McNeil method. Clinical performance was determined
by means of a questionnaire for physicians about the user conveni-
ence of both prediction models.
RESULTS. A total of 2192 patients were included. 620 patients were
excluded, of whom N = 162 were delirious at ICU admission; N = 76
had an expected ICU stay shorter than six hours; in N = 272 delirium
could not reliably be assessed and N = 110 were excluded for other
reasons. Patient characteristics are depicted in Table 115. The AUROC
of the E-PRE-DELIRIC model was 0.68 (95%CI 0.65-0.71) and the
AUROC of the PRE-DELIRIC model 0.73 (95%CI 0.71-0.76) (Fig. 137).
Both models were well calibrated (Fig. 138). The predictive perform-
ance of the PRE-DELIRIC model was significantly better compared to
the E-PRE-DELIRIC model with a Z-score of −2.64, p < 0.01. The evalu-
ation of the clinical performance is ongoing.
CONCLUSIONS. This study shows that both ICU delirium prediction
models statistically perform well. While the predictive accuracy of the
PRE-DELIRIC is somewhat better, the clinical relevance of this signifi-
cant difference is limited. Moreover, this model needs data obtained
during 24 hours, while the E-PRE-DELIRIC can be obtained at ICU ad-
mission, allowing direct preventive measures in high risk patients.
Which model warrants use as instrument of choice also depends on
the ongoing clinical evaluation.
Fig. 139 (Abstract 0405). a (upper image) and b (lower image)
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 205 of 542Acute respiratory failure clinical studies
0405
Circulating 1,25(OH)2-vitamin D concentration is associated with
increased mortality and predicts responsiveness to statins in
patients with the acute respiratory distress syndrome
M. Fitzgerald1, R. Verghis1, K. Amrein2, B. Obermayer-Pietsch2,
J. McNamee1,3, D. Thickett4, D. McAuley1,3, C. O'Kane1
1Queen's University Belfast, Centre for Experimental Medicine, Belfast,
United Kingdom; 2Medical University of Graz, Department of Internal
Medicine, Graz, Austria; 3Royal Victoria Hospital, Intensive Care Unit,
Belfast, United Kingdom; 4University of Birmingham, Centre for
Translational Inflammation Research, Birmingham, United Kingdom
Correspondence: M. Fitzgerald
Intensive Care Medicine Experimental 2017, 5(Suppl 2):0405
INTRODUCTION. The acute respiratory distress syndrome (ARDS) is
characterised by a dysregulated alveolar inflammatory response.
Vitamin D is a pleiotropic steroid hormone, increasingly implicated
in the regulation of the immune response of critically ill patients.
Vitamin D therapy may improve outcome in the critically ill (1).
HMG-CoA-reductase inhibitors (statins) may influence vitamin D
metabolism.
OBJECTIVES. To assess the relationship between vitamin D
deficiency, simvastatin and outcome in patients with ARDS.
METHODS. All participants in a multicentre randomised controlled
trial of simvastatin vs. placebo (2) were included in a post hoc
analysis. Patients received once-daily simvastatin at a dose of 80 mg
or placebo enterally for up to 28 days. Plasma concentrations of
25(OH)D, a biomarker of vitamin D status, and the active form of vita-
min D, 1,25(OH)2D, were analysed by automated enzyme immuno-
assay. 25(OH)D concentrations of < 12ng/ml and 1,25(OH)2D < 26pg/
ml were considered deficient. Outcomes were 28-day mortality and
ventilator free days (VFD) to 28 days. Data were analysed using Fish-
er's exact test.
A p < 0.05 was considered significant.
RESULTS. Of 506 patients, 246 had received the intervention drug
simvastatin, and 260 received placebo. The majority of patients,
330/506 (65%), were 25(OH)D deficient at baseline. No association
between 25(OH)D and mortality or VFD to 28 days was seen.
12% of patients were 1,25(OH)2D deficient at baseline. 28 day
mortality was significantly higher in those patients who were
1,25(OH)2D deficient vs. sufficient at baseline (38 vs. 23%,
p = 0.02, Fig. 139a). This mortality rate was reduced in those
patients who received simvastatin compared with control (25%
vs. 52%, p = 0.04, Fig. 139b). No association between 1,25(OH) 2D
and VFD to 28 days was seen.
CONCLUSIONS. Vitamin D deficiency was common in ARDS patients
in this RCT. The 28 day mortality was higher in those with
1,25(OH)2D deficiency, which was reduced by simvastatin. Further
investigation of how simvastatin mediates a protective effect in
1,25(OH)2 D deficient patients with ARDS is warranted.
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Do patients with unilateral opacities have a similar outcome than
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Table 116 (Abstract 0406). See text for description
u AHRF (n=769) ARDS (n=2377) p-value
Pneumonia 371 (48%) 1385 (58%) <0.01
Non pulmonary SOFA score 6.3±3.9 6.8±4.0 <0.01
PaO2/FiO2, mmHg 190±64 160±68 <0.01
Tidal Volume, mL/kg PBW 7.9±2.0 7.6±1.9 <0.01
PEEP, cmH2O 6 [5;8] 8 [5;10] <0.01
Ventilator-Free Days, days 18 [0;24] 10 [0;22] <0.01
ICU length of stay, days 9 [5;17] 10 [5;20] <0.01
Hospital length of stay, days 17 [9;31] 17 [8;33] 0.95
Hospital mortality 244 (32%) 952 (40%) <0.01
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INTRODUCTION. According to the BERLIN definition, chest
imaging must show bilateral opacities to fulfil ARDS criteria.
Chest X-ray interpretation is challenging in the ICU with poor
inter-rater reliability. There is no data in the literature comparing
patients with ARDS to hypoxemic patients having unilateral air-
space disease.
OBJECTIVES. We aimed to compare the outcome of patients with
ARDS to patients of similar severity having only unilateral opacity/
opacities on the chest X-ray.
METHODS. We enrolled all intubated patients included in the LUNG
SAFE study with hypoxemia (PF ratio < 300mmHg) and compared
patients fulfilling the ARDS definition to patients who fulfilled the
same other criteria but whose chest imaging only showed unilateral
opacities involving 1 or 2 quadrant(s) (Unilateral Acute Hypoxemic
Respiratory Failure « u AHRF »). The number of quadrants involved
was available for all patients. In order to determine in an adjusted
analysis the factors associated with outcome, severity variables
associated with hospital mortality with a p-value < 0.20 in a bivari-
able analysis were selected as candidate variables for multivariable
logistic regressions.
RESULTS. A total of 3146 patients were included in the present
analysis comprising 2377 patients with ARDS and 769 patients
with uAHRF. Patients with uAHRF were less severe than ARDS
and their main characteristics and outcome are presented in
Table 116.
Among patients with uAHRF, 451 (71%) had 1 quadrant involved,
188 (29%) had 2 as compared to 978 (42%), 535 (23%) and 830
(35%) patients with ARDS who had respectively 2, 3 or 4 quadrants
involved on the chest imaging.
In a multivariable analysis adjusting on baseline severity (age,
weight, pH, non-pulmonary SOFA score, PaO2/FiO2 ratio, respira-
tory rate, peak inspiratory pressure, medical cause of admission,
chronic liver failure, immunodeficiency, pancreatitis, the present
of concomitant cardiac failure), bilateral opacities were associated
with increased hospital mortality (OR = 1.35, 95%CI = 1.09-1.67,
p < 0.01). In the same model using number of quadrants instead
of bilateral status, having 3 quadrants (OR = 1.42, 95%CI =1.05-
1.93 p = 0.02) or 4 quadrants (OR = 1.54, 95%CI =1.16-2.06,
p < 0.01) involved were associated with higher mortality.
We then restricted the analysis to the 1166 patients with 2
quadrants involved. There was no difference of mortality between
the 188 uAHRF and 978 ARDS in bivariate (33% vs 36%,
p = 0.51) or multivariable analysis: OR = 1.17, 95%CI =0.82-1.68,
p = 0.39.
CONCLUSIONS. Patients with uAHRF have a high mortality
comparable to ARDS with 2 quadrants involved. The total number of
quadrants involved is as important as the bilateral characteristic of
the parenchymal injury. Although, the ability of physicians to reliably
count the number of involved quadrants was not tested, 3 or 4
quadrants of radiographic involvement are associated with
independent risk of death.0407
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INTRODUCTION. Either high-flow nasal cannula (HFNC)or noninvasive
mechanical ventilation (NIV) may reduce need for reintubation in pa-
tients at risk for post-extubation failure. The CPAP generated by
WhisperFlow system, a type of NIV, principally works like the HFNC.
However, there are no established data to compare the effectiveness
of HFNC and WhisperFlow CPAP system in patients ready to wean
from mechanical ventilation.
OBJECTIVES. We conducted a randomized controlled study to
compare the efficacy of HFNC and WhisperFlow CPAP System
regarding the rate of reintubation in high risk patients. The
secondary outcomes were post-extubation acute respiratory failure
requiring any type of assisted ventilation, mortality and effect on the
physiologic variables.
METHODS. The randomized controlled open-label trial was con-
ducted at the medical ICU of Ramathibodi hospital. The inclusion cri-
teria were age over 18 years with respiratory failure. All subjects
must be ready to wean from mechanical ventilation and had at least
one of the following high-risk criteria for post-extubation failure:
1) chronic heart failure;
2) an ineffective cough and excessive tracheobronchial secretions;
3) Acute Physiology and Chronic Health Evaluation (APACHE) II
score more than 12 points on day of extubation; and
4) upper airway obstruction without immediately required
intubation.
All subjects were randomly assigned to CPAP or HFNC. The duration
of intervention was 48 hours in both arms. The outcome was
determined during the intervention period.
RESULTS. A total of 116 subjects were recruited. 28 subjects were
excluded according to exclusion criteria. All 88 subjects were eligible
for intention to treat analysis. Forty-five subjects were randomly
assigned to CPAP group, and forty-three subjects were randomly
assigned to HFNC group. The baseline characteristics between
groups were not significantly different, except the APACHE II score
was higher in CPAP group than HFNC group. The reintubation rate
was similar [3(7%) in HFNC vs 5 (11.1%) in CPAP; P = 0.71]. Post-
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 207 of 542extubation respiratory failure was not significantly different between
groups [6 (14%) in HFNC vs 5 (11.1%) in CPAP; P = 0.27]. Effects on
the physiologic variables and mortality were also similar in both
groups.
CONCLUSIONS. HFNC provided the similar results to WhisperFlow
CPAP system for preventing reintubation and post-extubation re-
spiratory failure in high risk patients.
0408
Epidemiology and predictors of outcome in patients with acute
respiratory distress syndrome: the Calgary experience
K. ParharK. Parhar, K. Zjadewicz, A. Soo, A. Sutton, M. Zjadewicz, L. Doig,
A. Ferland, C. Lam, H.T. Stelfox, C.F. Doig
University of Calgary, Department of Critical Care Medicine, Calgary,
Canada
Correspondence: K. Parhar
Intensive Care Medicine Experimental 2017, 5(Suppl 2):0408
INTRODUCTION. Acute respiratory distress syndrome (ARDS) in an
inflammatory syndrome of the lungs resulting in increased vascular
permeability and a clinical syndrome of hypoxemia and reduced
lung compliance with associated lung infiltrates. ARDS is associated
with significant morbidity and mortality. Limited data on the
epidemiology of this condition within Canadian centers exists.
OBJECTIVES.
(1) To define the baseline incidence and prevalence of hypoxemic
respiratory failure and ARDS (Berlin Definition) within 4 Intensive
Care Units in Calgary, Alberta, Canada.
(2) To determine patient demographics for patients diagnosed with
ARDS
(3) To describe the practice patterns of patients treated for ARDS
(4) To determine predictors of patient mortality associated with
ARDS
METHODS. As a quality improvement measure a prospective
standardized screening program for ARDS was set up at 4 intensive
care units (ICUs) within Calgary Alberta from 2010 to 2012. All
patients ventilated for greater than 24 hours were screened with a
routine nightly ABG performed on a standard FiO2 of 1.0, and
patients with a PaO2:FiO2 (PF) ratio of less than 300 were considered
to have hypoxemic respiratory failure. A manual review of all chest
X-Ray images by two independent clinicians was performed to deter-
mine if criteria for ARDS (Berlin definition) were met. Patient demo-
graphics, details of ICU course, therapeutic interventions, as well as
ICU and hospital outcomes were analysed by univariate and multivar-
iable linear regression analysis.
RESULTS. During the study period 7944 patients were eligible for
screening. 986 patients (12.4%) upon screening were determined to
have hypoxemic respiratory failure (PF < 300), of which 731 patients
(9.2%) met criteria for ARDS. Overall ICU and hospital mortality for
the ARDS cohort were 31.6% and 37.9% respectively. Patients with
sustained ARDS had a hospital of mortality of 26.5% for mild, 31.8%
for moderate, and 60% for severe ARDS. Factors that were associated
with increased ICU mortality in patients with ARDS included older
age, higher admission SOFA score, higher cumulative fluid balance,
higher median peak and plateau pressure, as well as a higher driving
pressure. While on controlled ventilation, patients received tidal
volumes of less than 8ml/kg 56.5% of the time. Advanced
intervention use was variable with 35.9% receiving recruitment
manoeuvres, 36.2% requiring neuromuscular blockade, 2.7% of
patients required prone positioning, and 0.6% of patients requiring
extracorporeal life support.
CONCLUSIONS. Among 4 Calgary ICUs, ARDS was common and
associated with significant mortality, in a severity dependant fashion.
There was variability in the application of evidence based treatments
highlighting the potential for further study to determine barriers to
the use of evidence based therapy.
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INTRODUCTION. Extracorporeal membrane oxygenation (ECMO) is
expensive and demands high volume clinical experience and
proficiency to assure good clinical outcomes. Acknowledgement that
every hospital should have an ECMO program seems unrealistic in
terms of its financial and clinical implications, which obviously
imposes that ECMO centers develop and implement rescue
competence in their files.
OBJECTIVES. Primary objective was evaluation of an ECMO rescue
program in terms of clinical outcomes; secondary objectives were
evaluation of performance, efficacy, and complications. Additionally,
we would like to contribute to the development of benchmark
recommendations for interhospital transport of patients under
ECMO.
METHODS. Retrospective review of prospectively collected data from
our protocol-driven ECMO program. Characterization of the popula-
tion of patients referred from peripheral hospitals and transported to
our center under venovenous ECMO. Comparison of rescued (RP) ver-
sus non-rescued population (NRP) by case-match control and identifi-
cation of learning points to adequate triage of patients.
RESULTS. Sixty-six adult patients have been submitted to venove-
nous ECMO in our center, of which 36 have been rescued from hos-
pitals without ECMO programs. Rescue team consisted of two ECMO
physicians, two nurses and a perfusionist. Total distance was 5831
kilometres (min = 0.2; max = 1447km) and total time spent on trans-
port was 2405 minutes (min = 10; max = 220min). Most frequent
cause of respiratory failure was H1N1 infection (17 patients) and acute
bacterial pneumonia (13 patients). When comparing the rescued
population with patients primarily treated at our center, we found
significant differences in ECMO run duration (RP = 11.3 ± 8.2 vs
NRP = 16.5 ± 12.4 days; p < 0.05) and ventilation free days
(RP = 8.6 ± 7.6 vs NRP = 4.2 ± 6.1 days; p < 0.05). Six-month mortality
rate was also significantly inferior in rescued patients (RP = 22.2% vs
NRP = 46.6%; p < 0.05). There was no statistical difference in many
other parameters, including age (RP = 48.1 ± 13.0 vs NRP = 47.7 ± 11.6),
Murray score (RP = 3.3 ± 0.3 vs NRP = 3.2 ± 0.4), SAPS II
(RP = 42.2 ± 17.0 vs NRP = 38.9 ± 12.9), PaO2:FiO2 ratio
(RP = 67.4 ± 14.8 vs NRP = 76.7 ± 41.8) and PaCO2 (RP = 60.9 ± 22.1
vs NRP = 70.8 ± 23.4) before cannulation, and hospital mortality rate
(RP = 20% vs NRP = 29%; p = 0.393). Days of disease before ECMO
tend to be inferior in rescued patients (RP = 5.2 ± 3.5 vs
NRP = 10.8 ± 19.6; p = 0.103). Four transports were done by air. There
were no major complications during transport of patients to our
ECMO center.
CONCLUSIONS. Well prepared ECMO rescue programs, with early
referral and early implementation of ECMO, are safe and are
associated with good clinical outcomes. We favour the organizational
concept of ECMO centers and privilege an ECMO rescue team
including physicians, nurses and a perfusionist.
Mechanisms and prognosis of acute brain injury
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INTRODUCTION. The early identification of patients with poor
neurological outcome is becoming a major challenge for intensivists.
The absence of any ocular movement after caloric stimulation on
comatose patients has been proposed as a major factor for poor
prognosis. We also showed that the fast component of nystagmus
after caloric stimulation could predict consciousness recovery in
vegetative patients. Video oculography (VOG) could provide a more
objective measurement of ocular responses to caloric stimulation
than naked eye.
OBJECTIVES. The main objective was to evaluate the added
diagnostic value of VOG in the neurological assessment of ocular
response to caloric stimulation in ICU patients. The secondary
objective was to assess its prognostic value.
METHODS. We conducted a prospective study between 2013 and
2015 in two medical ICUs in La Pitié-Salpêtrière hospital. We included
all patients that presented disorders of consciousness, were intubated,
ventilated and free from sedation for more than 48 hours. Patients with
history of ORL or oculomotricity disease were excluded. Baseline
characteristics were noted. Bedside neurological examination was
performed by neurointensivists that scored Glasgow coma scale, Full
Outline of UnResponsiveness (FOUR) and Coma Recovery Scale-revised
(CRS-R). Caloric stimulation was elicited by the injection of 60cc of cold
water in the outer auditory canal. Clinical characteristics of ocular re-
sponses were noted. VOG was performed with the EBT mobile (Eye-
brain, Paris, France) that enables the quantitative evaluation of fre-
quency, number of jerks and latency of nystagmus. One-year survival
and sequelae were retrieved. Fifteen healthy controls were evaluated
as control group. Statistical analysis was performed with JMP 9.0 (SAS
Institute) using Khi2, Wilcoxon and Spearman correlation tests. Patients
or their relative and healthy controls give their written consent. This
study was approved by local IRB.
RESULTS. 35 patients and 15 healthy control subjects were included.
Patients were 53 years-old, 57% were men. Their median GCS was 8
[6–9], their FOUR 10 [7–12] and their CRS-R 8 [5–10]. VOG detected a
fast component of nystagmus in 82% of the subjects versus 70%
with the naked eye (p = 0,06). The fast component of the fast com-
ponent of nystagmus had a higher frequency in controls vs patients
(0,44 Hz vs 0,05 Hz, p < 0,0001) and more jerks were detected (63 vs
6, p < 0,0001). These parameters were correlated with the Glasgow
score, the FOUR score and the CRS-R (p < 0,05). Fast component of
nystagmus latency was longer (59,9 vs 24,9 seconds, p = 0,018) for
deceased patients than for survivors at one-year follow-up.
CONCLUSION. The VOG tend to detect higher number of fast
component of nystagmus than the naked eye. Higher frequency and
number of fast component of nystagmus jerks are correlated with
higher level of consciousness. Longer latency of the fast component
of nystagmus is correlated with poorer 1-year prognosis.
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BACKGROUND AND PURPOSE. Identifying a panel of blood
biomarkers that correlates with stroke severity and prognostic might
be useful for treatment of patients with acute stroke. The objective of
this study is to investigate the variability of common blood serum
biomarkers of neural injury according with stroke severity and evaluate
if these biomarkers could be used as prognostic tools in acute stroke
and if they could be predictors of hospital stay after stroke.
DESIGN AND METHODS. We investigated 60 consecutive patients
with acute stroke who were admitted within 24 h of event onset inour hospital. We evaluate blood levels of neuron-specific enolase
(NSE), S100ß protein (S100ß), interleukin-6 (IL-6), C-reactive protein
(CRP) and brain-derived neurotrophic factor (BDNF) within 24 h of
the acute event, on the third day and on the fifth day after the
stroke. Neurological stroke severity and global disability were deter-
mined with the National Institutes of Health Stroke Scale (NIHSS) and
modified Rankin Scale (mRS) at the same three times of blood collec-
tion and at the time of hospital discharge.
RESULTS. Levels of S100ß, IL-6 and CRP, but not NSE or BDNF,
showed significant positive correlations with stroke severity and
prognosis of patients. When patients were subdivided into two
groups according to the NIHSS and mRS scores, both neurologic
scores for worse outcome (NIHSS > 6 and mRS > 3) at hospital dis-
charge were significantly related to the S100ß protein and IL-6 levels
at all of the measured time points. Moreover, the length os hospital
stay was longer in patients with high levels of CRP within 24 h and
on the third day of stroke.
CONCLUSION. We conclude that S100ß protein, IL-6 and CRP may be
useful in acute stroke scenario associated with stroke scales to pre-
dict stroke severity, prognosis of patients and length of hospital stay
after acute stroke.
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INTRODUCTION. Patients with aneurysmal subarachnoid hemorrhage
(aSAH) frequently display elevated cardiac troponin I (cTnI) levels, but
the association between cTnI and aSAH associated myocardial injury
(SAHMI) as displayed by functional myocardial impairment on
echocardiography is not well established.
OBJECTIVES. We aimed to determine the ability of peak cTnI levels
to predict functional myocardial impairment as quantified by early
transthoracic echocardiography (echo; days 1–5) findings of
depressed cardiac index (CI), stroke volume index (SVI), and left
ventricular ejection fraction (LVEF).
METHODS. Longitudinal prospective analysis of 50 patients with aSAH.
Inclusion criteria: age 21–75 years, spontaneous aneurysm rupture,
Fisher grade ≥ 2 and/or Hunt and Hess grade ≥ 3, and with cTnI levels
and echocardiogram. Exclusion: traumatic SAH, and recent myocardial
infarction. cTnI was obtained daily, and the peak level from days 0–3
for each patient was used in the analyses, and dichotomized into
cTnI ≥ 0.3ng/ml and < 0.3ng/ml. Body surface area was derived by the
Mosteller calculation. From the echocardiogram, Doppler-derived SVI
Fig. 140 (Abstract 0413). FOUR ROC
Fig. 141 (Abstract 0413). FOUR distribution
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dichotomized as ≥ 35 ml/beat/m2 and < 35, CI was dichotomized
as ≥ 2.1 L/min/m2 and < 2.1, and LVEF was dichotomized as ≥ 60%
and < 60. Patients were then further dichotomized as a composite vari-
able for myocardial impairment positive by echo if they had any of
SVI < 35, or CI < 2.1, or LVEF < 60. Logistic regression was performed to
assess the ability of cTnI ≥0.3ng/ml to predict myocardial impairment
positive, with cTnI < 0.3ng/ml as the referent group in the model.
RESULTS. Of the 50 patients in the sample, only 46 had both cTnI
levels plus echo data available. Of these 46 patients, 83% were
female, with a mean age of 53.2 years ±11. The sample had a mean
cTnI of 0.96 ng/ml ± 2.3, a mean SVI of 58 ± 9, a mean CI of 3.0 ± 0.9
and a mean LVEF of 64 ± 7. For dichotomized variables, 35% had
cTnI >0.3 ng/ml, 39% had SVI < 35, 22% had CI < 2.1, and 17% had
LVEF < 60%. The composite variable of SAHMI positive by echo held
54% of the sample. In logistic regression, patients with a peak cTnI
≥0.3 ng/ml had 4 times the odds of being positive for myocardial
impairment by echo (OR = 3.98, 95% CI 1.025-15.01, p = 0.046).
CONCLUSIONS. Patients with even modest elevations of cTnI level
>0.3ng/ml after aSAH have 4 to 1 odds of experiencing functional
myocardial impairment by CI, SVI or LVEF when compared to
patients with cTnI < 0.03ng/ml. Clinicians should closely observe
patients with cTnI above this threshold for perfusion abnormalities
that may be a consequence of such impairment.
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INTRODUCTION. Full Outline of UnResponsiveness (FOUR) score was
developed by J Widjicks in 2005 (1), and includes additional
information not assessed by the Glasgow Coma Scale (GCS) such as
brainstem reflexes, visual tracking, breathing patterns, and
respiratory drive.
OBJECTIVES. The aim of the study was to determine whether the
Full Outline of UnResponsiveness (FOUR) score, which includes eyes
opening (E), motor function (M), brainstem reflex (B), and respiratory
pattern (R), can be used as an alternate method in predicting
intensive care unit (ICU) mortality in subarachnoid hemorrhage (SAH)
patients.
METHODS. We performed an observational prospective multicenter-
study in 5 spanish neurocritical ICUs in Castilla y León (Spain), cover-
ing a 2 years' period (from January 1th, 2015 to December 31, 2016).
The study was approved by the Ethics Committee of Burgos. All adult
patients admitted in ICU were recruited. The GCS, FOUR score, Hunt-
Hess, Fisher, modified-Fisher and WFNS was registered at ICU admit-
tance. APACHE-II was calculated 24 h after admission. GOS was regis-
tered at hospitalization discharge and after 6 months.
RESULTS. 169 patients were recruited. 53,85% female. 58,33 (SD
15,22) years old. APACHE-II 14,26 (SD 7,58). Cause of SAH: 66,27%
aneurysmatic, 4,14% arteriovenous malformation (AVM), 15,38% peri-
mesencephalic and 14,20% others.
The median with interquartile range in the FOUR score and GCS was
16 (9–16) and 14 (8–15), respectively.
Global mortality was 20,24%.Figure 140 shows the plot of the ROC curves to compare the
different scores used in SAH prognosis predicting mortality.
The area under the curve for the receiver operator characteristics
(AUC ROC) predicting ICU mortality was 78,28% for the FOUR score,
83,58% for the GCS, 81,26% for the Hunt-Hess scale, 81,03% for the
WFNS, 71,49% for the Fisher modified scale and 67,63% for the Fisher
scale. The difference between GCS and FOUR results statistically sig-
nificant (p = 0,039).
CONCLUSIONS. FOUR score at admission has a fair predictive power
of mortality at the ICU in our observational study. FOUR score was
higher than 14 in almost 2/3 of the sample. That suppose an
important bias. FOUR score should be tested as mortality predictor in
a larger population that includes more low score punctuation, to be
able to get a true understanding of this score as predicting tool.
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INTRODUCTION. In patients with traumatic brain injury (TBI) regional
ischemia is a common finding and normobaric hyperoxia is one
possible intervention used to alleviate secondary brain ischemia.
Moderate hyperoxemia increases cerebral aerobic metabolism and
has been suggested to improve outcome after TBI but thus far
clinical evidence is limited. Hyperoxemia introduced with high
fractions of inspired oxygen (FiO2) may cause formation of lung
atelectasis and some studies even suggest an increase in mortality in
general ICU patients.
OBJECTIVES. To compare daily blood concentrations of reactive
oxygen spieces (ROS), interleukin-6 (IL-6) and neuron spesific enolase
(NSE) over time and as well as the incidence of pulmonary complica-
tions between different oxygen groups.
METHODS. An open label randomized controlled study to compare
the hyperoxemia (FiO2 70%) to control (Fi02 40%) and its effect on
markers of oxidative stress, neurological injury, inflammation and
pulmonary complications after severe TBI.
RESULTS. We enrolled 27 patients in the control group and 38 in the
hyperoxemia group. The groups were well balanced on
randomisation, apart from a difference in hemoglobin consentration
(13.1 ± 2 g/dl in the 40% group and 12.4 g/dl in the 70% group,
p < 0.05) and a difference in TBI severity according to the The
International Mission for Prognosis and Analysis of Clinical Trials in
TBI 1 (IMPACT) risk of poor outcome (0,45 ± 0,21 in the 40% group
and 0.56 ± 0.20 in the 70% group, p < 0.05).
After randomisation there were no differences in ROS, IL-6 and NSE
over time:ROS concentrations in the control group and hyperoxemia
group were at admission 64.8 nM (22.6-102.1) and 64.9 nM (26.8-96.3),
p = 0.80., at day one 24.2 nM (20.6-33.5) and 29.2 nM (22.7-69.2),
p = 0.10, and at day two 25.4 nM (21.7-37.4) and 47.3 nM (34.4-126.1),
p = 0.95, respectively. IL-6 concentrations in the control group and
hyperoxemia group at admission were 92.4 pg/ml (52.9-171.6) and
94.3pg/ml (54.8-133.1), p = 0.52, at day one 112.7 pg/ml (65.9-168.9)
and 83.9 pg/ml (51.8-144.3), p = 0.41 and at day 3 55.0 pg/ml (34.2-
115.6) and 49.3 pg/ml (34.4-126.1), p = 0.95, respectively. NSE concen-
tration in control group and hyperoxemia group were at admission
21.04 ug/l (14.0-30.7) and 17.8 ug/l (14.1-23.9), p =0.35., at day one 15.9
ug/l (9.0-24.3) and 15.3 ug/l (12.2-26.3), p = 0.62, respectively. There
were no differences in the indidence of pulmonary complications.
CONCLUSIONS. In this pilot trial the use of a higher fraction of
inspired oxygen did not result in increased blood concentrations of
markers of oxidative stress, inflammation or neurological injury in
patients with severe TBI.
REFERENCE(S)
1. Marmarou A, Lu J, Butcher I, et al. IMPACT database of traumatic
brain injury: design and description. J Neurotrauma 2007;24:239–50.
GRANT ACKNOWLEDGMENT
None.Severe infections in the critically ill
0415
Prevention of nosocomial infections in critically ill patients with
Lactoferrin (PREVAIL Study)
J. Muscedere1, N. O'Callaghan2, D. Maslove2, J.G. Boyd2, X. Jiang2, S.
Reynolds3, M. Albert4, R. Hall5, A. Day2, G. Jones6, F. Lamontagne7
1Queen's University, Critical Care, Kingston, Canada; 2Queen's University,
Kingston, Canada; 3University of British Columbia, Vancouver, Canada;
4Universite de Montreal, Montreal, Canada; 5Dalhousie University, Halifax,
Canada; 6University of Ottawa, Ottawa, Canada; 7University of
Sherbrooke, Sherbrooke, Canada
Correspondence: J. Muscedere
Intensive Care Medicine Experimental 2017, 5(Suppl 2):0415
INTRODUCTION. Nosocomial infections (NIs) are a cause of
morbidity, mortality, and increased health care costs in critically ill
patients. Lactoferrin (LF), a protein component of the innate immune
system, has antibacterial, probiotic, and immunomodulatory
properties, making it of interest for the prevention of NIs in the
critically ill.
OBJECTIVES. To inform on the potential utility of LF for the
prevention of NIs and the conduct of a phase 3 study powered on
clinically important outcomes.
METHODS. A phase 2 randomized, multi-center, double-blind study
investigating LF for the prevention of NIs in mechanically ventilated
(MV) adult patients. Patients expected to be MV > 72 hours were ran-
domized to placebo or LF delivered both enterally and through an
oropharyngeal swab in a blinded fashion (using opaque syringes and
containers). The primary outcome was antibiotic free days, defined as
number of days alive and free of antibiotics 28 days post
randomization. The study was powered to detect a 25% increase in
antibiotic free days. Secondary outcomes included: occurrence of NIs,
hospital length of stay (LOS), hospital and 90-day mortality and im-
pact on biomarkers including cytokines. Data to inform the conduct
of a larger definitive trial, including recruitment rates and protocol
adherence was also collected.
RESULTS. Of the 214 patients randomized, 212 receiving the study
intervention were analyzed. See Table for baseline patient
characteristics. Patients in the LF group had a higher severity of illness
and need for vasopressors. Antibiotic free days and NIs per patient
between placebo and LF were (mean ± SD): 18.5 ± 7.1 vs. 17.3 ± 9.0,
p = 0.91 and 0.4 ± 0.6 vs. 0.3 ± 0.7, p = 0.48, respectively. Clinical
outcomes for placebo and LF were: ICU length of stay (15.0 ± 37.3 vs
14.5 ± 18.0 days, p = 0.82), hospital length of stay (28.1 ± 44.6 vs.
25.0 ± 25.9 days, p = 0.57), hospital mortality [32 (30.5%) vs. 44 (41.1%),
p =0.11], 90 day mortality [34 (32.4%) vs. 48 (44.9%), p =0.06],
respectively. There was no difference between the groups in the
biomarkers collected (data not shown). Protocol adherence was high
(87.5%) and no serious adverse events were reported.Placebo (n = 105) Lactoferrin (n = 107)Age: mean + SD 62.5 ± 16.2 66.3 ± 13.5Male: (%) 54 (51.4%) 59 (55.1%)APACHE II: mean (SD) 23.5 ± 7.9 26.8 ± 7.8Vasopressor Use: n(%) 74 (70.5%) 85 (79.4%)Baseline Infection: n(%) 63 ((60%) 75 (70%)Sepsis on Admission: n(%) 51 (48.6%) 62 (57.9%)Intervention duration (days): mean (SD) 8.8 ± 6.2 10.0 ± 8.6
Fig. 142 (Abstract 0416). Cumulative incidence if VAP
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 211 of 542CONCLUSIONS. We did not find an effect of LF on the primary
outcome of antibiotic free days or secondary clinical outcomes in
critically ill adult patients. Our data does not support the conduct of
a future, large-scale phase 3 randomized controlled trial powered on
clinically important outcomes.
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Controversies exist about the potential of bronchial colonization
(COL) with Candida (C) to promote bacterial VAP. This association has
been identified for P. aeruginosa (PA) VAP. In vitro, PA exploits
filamentous fungi resulting in fungal killing and limitation of C
growth in the host. C, PA and S. aureus (SA) are the most common
pathogens retrieved from endotracheal tube co-biofilms and secre-
tions in patients with VAP. Finally, it has been demonstrated that pre-
vious bronchial C. albicans COL enhanced the incidence of PA
pneumonia in a murine model and epidemiological studies reversed
by antifungals. This pathophysiologic scheme and clinical association
did not firmly demonstrate causal association since confounding fac-
tors such as mutipIe-organ failure (MOF) associated immunoparalysis
have not been taken into account.
OBJECTIVES. To study prospectively the relationship between
candidal COL and bacterial VAP on mechanically ventilated (MV)
patients with MOF.
INCLUSION: MV Patients with MOF ventilated for more than 4 days
were included. At inclusion (D0) and every 4 days until extubation
bronchial COL with C was determined. All the episodes of VAP using
quantitative proximal and bronchial cultures were recorded. HLA-DR
and PMN/lymphocytes ratio were used to monitor immunoparalysis
at D0 and D7. PA, SA and C recovered simultaneously from VAP epi-
sodes were stored for subsequent analysis of virulence pattern and
co-biofilm formation capability. Cause-specific models for repeated
events with adjustment on time-dependent confounders and im-
mune factors were used to model the relationship between C COL
and VAP.
RESULTS. Between Feb 2012 and Dec 2015, 213 patients (median
age 64, SAPS II 55, SOFA 10, medical 197(92%)), could be enrolled in
2 ICUs. The median ICU stay was 24 days and death occurred in 69
(32%) cases. HLA-DR was 5916 Ab bound per cell [3863 ; 8934], lower
than 8000 in 68% of the cases. Median lymphocyte count was 0.9
Giga/L [0.6 ; 1.3] and PMN/lymphocytes ratio was 10.9% [6.5 ;
19.7].bronchial colonization with C was observed in 146 cases (C albi-
cans n = 103). The first episode of VAP occurred in 62 (29.1%) cases
(13 SA, 15 PA), 5.5 days in median after D0 the second episode in 12
cases (1 SA, 2 PA), 15.5 days in median after DO.
After adjustment on risk factors of VAP, HLA-DR and PMN/lympho-
cytes ratio, bronchial colonization with C was not associated withVAP (adjusted Cause specific model CSHR = 0.98 [0.59 - 1.65] with
p = 0.950 significance level for the case specific adjusted model). In
subgroup analyses, similar results were observed for SA (CSHR = 0.54
[0.18 - 1.67], p = 0.286) and PA (CSHR = 0.90 [0.32 - 2.52], p = 0.841).
CONCLUSIONS. Bronchial colonization with Candida was not
associated with VAP even after adjustment on immune function in
MV patients for more than 4 days with MOF.
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INTRODUCTION. Healthcare-associated infections (HAI) affect 20 to
25% of patients admitted in the ICU, and are associated with consid-
erable morbidity, mortality and costs. Antimicrobial resistance (AMR)
is high in ICU, with the need of epidemiological studies assessing
trends.
OBJECTIVES. To assess the ICU-adjusted temporal trends of ICU-
acquired bloodstream infection (BSI) in France, with a particular em-
phasis to those due to AMR over 11 years.
METHODS. Data from the REARAISIN French national ICU surveillance
network, including ICUs participating for at least 5 successive years
from 2005 to 2015. Data at center unit level, patient level and
infection level were recorded. The annual incidence was computed
as the ratio of all BSI during one year to the number of patient-days
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 212 of 542during this year. The patients with a BSI were censored at the time
of the first bacteraemia. Univariate analyses of the temporal trends
of bacteraemia were performed using an autoregressive model.
RESULTS. During the period study, 150 ICUs participated for at least
5 years, corresponding to 241,510 patients, for a total of 2,589,678
ICU patient.days; 6,305 patients developed 7915 ICU-acquired bacter-
aemia. The yearly incidence of ICU-acquired BSI had a non significant
increase from 122 in 2005 to 183.9 BSIs per 100,000 patient.days in
2015 (p = 0.77) (Fig. 143). The incidence of ICU-acquired S. aureus
was stable, with a sharp decrease of MRSA over time, from 63% to
15% (p = 0.001). Regarding Enterobacteriacae, the incidence of BSI
due to E. coli remained stable with a resistance rate to third gener-
ation cephalosporin (3GC) at about 20% (Fig. 144). The incidence of
BSI due to Klebsiella spp. non-significantly increased, associated with
a significant increasing incidence of C3G-R isolates, from about 33%
to 51% (p = 0.004). The incidence of E. faecalis and E. faecium in-
creased over time, the former not significantly, whereas the increas-
ing incidence of E. faecium was significant (p = 0.008), mainly due to
E. faecium ampicillin R (p = 0.001). Finally the incidence of BSI due to
P. aeruginosa and A. baumannii remained stable over time, at 20–30
and 2–4 per 100,000 patient.days, without increasing proportion of
resistance of P. aeruginosa (~20%) or A. baumannii (~60%) to ceftazi-
dime. Nearly no VRE or CRE were identified.
CONCLUSIONS. Analysis of data from the REARAISIN network during
an 11-year period showed no significant trends of ICU-acquired BSI, ex-
cept for E. faecium. Major changes were observed: decrease in S. aureus
meticillin resistant and increase in Enterobacteriacae 3GC resistant.
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INTRODUCTION. Pneumonia remains a main cause of ICU admission.
The cost in the acute care setting with pneumonia has already been
reported but little is known about 1-year prognosis, resource use and
costs. We focused on pneumococal pneumonia, accessible to preven-
tion by vaccine therapy.
METHODS. We used the “Programme de médicalisation des
systèmes d'information” PMSI national administrative database. This
administrative database contains ICD-10 codes of all the
hospitalization in the acute care beds in France. It also includes many
individual demographic data, SAPS II, resource and procedure used
during the ICU stay. Individual patients can be tracked across mul-
tiple hospitalisations through a unique anonymous patient identifier.
It allows the follow-up of all the hospital admissions in acute care
bed after the index stay. We include all the patients with a diagnosis
of pneumococcal pneumonia (ICD-10 codes :J13 “Pneumonia due to
Streptococcus pneumoniae” and B953 “Streptococcus Pneumoniae
as the cause of diseases classified elsewhere”) who required ICU ad-
mission. Valuation of the stays was done through the French official
tariffs (T2A, Tarification À l'Activité) from the healthcare system per-
spective. All costs are presented in 2016 euros.
RESULTS. Of the 182858 patients hospitalized for pneumonia, 10587
were due to S pneumonia. The number of rehospitalization was 5816
during the first year. Comorbidities were as follows cardiac 74%,
respiratory 52%, liver 16%, renal 14%, cancer/hemopathy 30%, organ
transplant 16%, diabetes 25%. An history of smoking (35%) an
alcohol abuse (26%) was frequent. 1665 (aged 65 ± 15 years old;
58% men, SAPS II 48 ± 19) required ICU admission. ICU admission
was more frequent for male, patients with chronic liver, cardiac and
respiratory diseases, and for alcohol and tobacco users. The mean
duration of ICU and hospital stay (index hospitalization) were
respectively 13 and 23 days. KM estimated of 1-year survival was
68%.The index hospitalization and the 1-year median (25th-75th per-
centiles) costs were €4446 (2349–6698) and €7173 (3502–16011) for
all the cohort of P-PAC. It increased up to €14244 (9900–22752) and
€21004 (12623–32953) in case of ICU admission. Finally 1-year me-
dian costs for ICU survivors were €22042 (14148–35613).
Limitations: Out-of-hospital death and costs are not recorded.
CONCLUSIONS. Severe pneumococcal pneumonia is associated with
poor hospital and 1-year prognosis, important costs and resource
use. These results emphasized the need for preventive strategies.
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INTRODUCTION. It remains unclear whether a policy of systematic
screening for intestinal carriage of ESBLE may reduce the incidence
of healthcare-associated infections due to these pathogens in ICU
with otherwise optimized prevention measures.
OBJECTIVES. To investigate the impact of ceasing the screening for
ESBLE carriage on the incidence of ICU-acquired ESBLE infections, pa-
tient outcome and carbapenem consumption in a low-prevalence
ICU with single-patient rooms and universal contact precautions (CP).
METHODS. A single-center study based on prospectively collected
data and including all patients admitted for a first ICU stay ≥ 3 days
during two consecutive one-year periods : a first period with routine
screening for ESBLE carriage, and a second period without screening.
RESULTS. A total of 1,069 patients were enrolled [male, 61.5%, age,
64 [53–75] years, SAPS II at admission, 45 [33–59] points, recruitment
from the Emergency department, 84.1%], including 524 and 545
patients during the first period and the second periods, respectively.
Average consumptions of alcohol-based hand rub (149 mL per
patient-day), single-use gloves (51 pairs per patient-day) and single-
use gowns (22 gowns per patient-day) remained stable throughout
the study. During the first period, 28 EBLSE carriers (5.3%) were iden-
tified (imported carriage, 3.2%, acquisition rate, 2.4 events per 1,000
patient-days). Only 6 patients from the first period (1.1%) and 8 pa-
tients (1.5%) from the second period developed ≥ 1 ICU-acquired
ESBLE infection (P = 0.64), with crude incidence densities of 1.2 and
1.4 episodes per 1,000 patient-days, respectively (P = 0.80). The cu-
mulative incidence of ICU-acquired ESBLE infections did not differ
between inclusion periods after adjustment on the competing risk of
death or ICU discharge [standardized hazard ratio (SHR), 2.32, 95%
confidence interval (CI), 0.80-6.73, P = 0.12], while an admission dur-
ing the second period had no independent impact on the hazard of
ICU-acquired ESBLE infections after adjustment on potential con-
founders (stepwise logistic regression, odds ratio, 1.16, 95% CI, 0.38-
3.50, P = 0.79). Empirical antimicrobial regimens were adequate in all
cases. Crude ICU mortality rates (overall, 20.6%) and lengths of stay
(overall, 6 [4–11] days) did not vary between inclusion periods, with
no period-dependent effect on the competing hazards of death
(SHR, 1.22, 95% CI, 0.93-1.59, P = 0.15) and ICU discharge (SHR, 0.89,
95% CI, 0.79-1.01, P = 0.08). Carbapenem exposure in patients with-
out ESBLE infection decreased between the first and the second pe-
riods (75 versus 61 carbapenem-days per 1,000 patient-days,
P = 0.01).
CONCLUSIONS. In a low-prevalence ICU with universal CP, stopping
the screening for ESBLE carriage had no deleterious effect on the in-
cidence of ICU-acquired ESBLE infections and patient outcomes, and
was associated with a slight decrease in empirical carbapenem
consumption.
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INTRODUCTION. In 2013, The Centers for Disease Control and
Prevention (CDC) introduced a new surveillance paradigm for ventilated
patients. Ventilator-associated events (VAE), reflecting worsening oxygen-
ation, are defined as a persistent and significant increase in FiO2 or PEEP
level after a period of stability on the ventilator. VAE definition includes
ventilator-associated conditions (VAC), infection-related ventilator-
associated complications (IVAC) and probable ventilator-associated pneu-
monia (PVAP). The relevance of VAE for ventilator-associated pneumonia
(VAP) is low. However, the correlation between the three VAC, IVAC, and
PVAP, and the onset of ventilator-associated low respiratory tract infec-
tion (VALRTI), including ventilator-associated tracheobronchitis (VAT) and
pneumonia (VAP), has never been studied yet.
OBJECTIVES. To investigate the concordance between the onset of
three VAE tiers and VALRTI, and their impact on outcomes.
METHODS. We performed a retrospective analysis of prospectively
collected data from patients requiring mechanical ventilation for more
than 5 days in a 50-bed mixed ICU of a tertiary university teaching hos-
pital, between January 1 and December 31, 2016. VAT and VAP epi-
sodes were assessed by prospective surveillance of nosocomial
infections, according to the American Thoracic Society criteria. VAE
were identified retrospectively, according to current CDC definitions.
The agreement between VAC, IVAC, PVAP and VALRTI was assessed by
k statistic. The impact of VAE and VALRTI on duration of mechanical
ventilation, ICU and hospital length of stay and mortality was also
assessed for the first episode of VAT and VAP.
RESULTS. We included 545 patients (7927 ventilator days). 126 VAP (15.9
per 1000 ventilator-days), 80 VAT (10.1 per 1000 ventilator-days) and 115
VAE (14.5 per 1000 ventilator-days) were diagnosed. There was no agree-
ment between VAT and VAE and the agreement was poor between VAP
and VAC (k = 0.12, 95%CI 0.03-0.20), VAP and IVAC(k = 0.23, 95%CI 0.14-
0.32) or VAP and PVAP (k = 0.30, 95%CI 0.22-0.40). Patients who devel-
oped VAT, VAP or VAE had significantly longer duration of mechanical
ventilation, ICU and hospital length of stay, compared to patients who
did not, with similar mortality rates.
CONCLUSIONS. VAE are not relevant for VAT diagnosis and have low
agreement with VAP, despite their negative impact on ventilation
duration, ICU and hospital length of stay.
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INTRODUCTION. Prolonged mechanical ventilation (MV) can cause
muscle atrophy and adversely affect diaphragmatic force-generating
capacity, a condition referred to as ventilator-induced diaphragmatic
dysfunction (VIDD) [1]. Diaphragmatic ultrasound has been proposed
as a bedside daily monitoring of diaphragm function [2]; however, to
date there are no specific serum biomarkers for muscular damage
Fig. 146 (Abstract 0421). See text for description
Table 119 (Abstract 0421). See text for description
T0 T1 T2 p-value
slTnI, pg/ml 176.3 [119.8 -
685.9]
363.5 [121.2 -
623.1]
277.8 [99.7
-902.1]
0.957
sfTnI, pg/
mL
104.8 [38.0- 313.0 67.7 [18.3 - 431.4] 58.7 [9.0 -140.6] 0.003
DD, mm 18.5 [12.8 - 20.1] 14.0 [10.5 - 17.5] 11.0 [8.0 - 15.5] 0.004
TF, % 45 [39 - 49] 39 [29 - 43] 30 [26 - 39] <
0.0001
TEE, cm 0.30 [0.26 - 0.39] 0.34 [0.32 - 0.37] 0.36 [0.31 - 0.39] 1.000
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 214 of 542and dysfunction. Foster et al. [3] suggested that skeletal troponin I
(sTnI) could be a sensitive marker to detect early signs of muscle injury.
OBJECTIVES. Firstly, to study the trend of a novel biomarker (sTnI) in
mechanically ventilated ICU patients; secondly, to determine whether
this trend was associated with the development of VIDD as assessed
with diaphragmatic ultrasound.
METHODS. Serial serum samples were obtained from 24 mechanically
ventilated ICU patients at 24 (T0), 48 (T1) and 72 (T3) hours after
admission. Patients were not considered for inclusion if they had a history
of neuromuscular disease or a previously documented diaphragm
paralysis. Specimens were analysed and specific isoforms for sTnI (slow
(ssTnI) and fast (fsTnI)) were assayed by commercially available ELISA kits
(Human TNNI ELISA kit, Mybiosource). Simultaneously, in 16 patients
diaphragmatic displacement (DD), thickness at end expiration (TEE) and
thickening fraction (TF) were measured with ultrasound. Values were
compared using Friedman´s analysis for repeated measures and Wilcoxon
test for paired samples; p < 0.05 was considered statistically significant.
RESULTS. Patients' clinical charateristics are reported in Table 117.
Ventilatory variables did not change over time (Table 118).
The two sTnI isoforms had a different behaviour over time (Table 119).
ssTnI levels remained unchanged during the course of MV (p = 0.957),
while sfTnI significantly decreased over time (p < 0.003), with the lowest
level after 72 hours from admission (T0 vs T2, p = 0.004) (Fig. 146).
Both DD (p = 0.004) and TF (<0.0001) decreased over time (Fig. 147).
while TEE remained stable (Table 119).
We found a statistically significant correlation between the percent
change from baseline of sfTnI and TF at 72 hours from admission
(r = 0.661, p = 0.007).
CONCLUSIONS. Our results seem to demonstrate that both sTnI and
ultrasound describe adequately the decrease in diaphragmatic
function over time in mechanically ventilated ICU patients. Moreover,
fsTnI seems to be better correlated with echographical signs of
diaphragmatic dysfunction.
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mechanical ventilation” - P.I. Dr. Savino Spadaro).Table 117 (Abstract 0421). See text for description
Total population n = 24
Age, years 70 ± 11
Male, n (%) 15 (63)
BMI, kg/m2 27.4 ± 4.1
SAPS II score on admission 45 [36 - 58]
SOFA score on admission 7.50 [5.75 - 9.00]
ICU LOS, days 15 [7 - 23]
Hospital LOS, days 40 [19 - 53]
ICU mortality, n (%) 4 (17)
Table 118 (Abstract 0421). See text for description
T0 T1 T2 p-value
Vt, ml 508 [412 - 654] 548 [438 - 620] 554 [500 - 673] 0.496
RR, bpm 16 [13 - 19] 15 [14 - 18] 15 [12 - 20] 0.636
PS, cmH2O 8 [7 - 10] 8 [8 - 12] 8 [6 - 10] 0.217
PEEP, cmH2O 8 [6 - 10] 8 [5 - 10] 8 [6 - 10] 0.844
P0.1, cmH2O 1.5 [0.9 - 2.1] 0.95 [0.65 -1.60] 1.20 [0.58 - 2.18] 0.199
Fig. 147 (Abstract 0421). See text for description0422
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INTRODUCTION. Pulmonary dead-space fraction (VD/VT) has been as-
sociated to outcome in acute respiratory distress syndrome1. Even
though Bohr-Enghoff's dead-space (VDphys/VT) overestimates true
dead-space2, it is the best available index of overall ventilatory
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 215 of 542inefficiency (VI). Surrogate indices of VI available for critical ill pa-
tients are: Arterial to end-tidal CO2 pressure difference (PaCO2-EtCO2),
(PaCO2-EtCO2)/PaCO2, minute ventilation (VE) corrected for ideal
PaCO2(VECORR) and the ratio of the product of actual PaCO2 and VE
to the product of their ideal counterparts, termed the ventilatory ra-
tio (VR)3. In cardiopulmonary exercise testing VI is usually assessed
with the minute ventilation to carbon dioxide production ratio (VE/
VCO2), with prognostic value in chronic cardiac and pulmonary
diseases4.
OBJECTIVE. The aim of this study was to test the correlation of VE/
VCO2 to VDphys/VT as compared to other indices of VI in critically ill
patients.
METHODS. 43 mechanically ventilated patients monitored with
volumetric capnography (VCap) were included. Simultaneously
collected arterial blood gases and VCap parameters were recorded.
Surrogate VI indices were compared to VDphys/VT using Pearson
correlation. Significance was set at p < 0.01.
RESULTS. 162 measurements were recorded from 43 patients,
mean ± SEM PaO2/FiO2 ratio 253 ± 6, PaCO2 40 ± 4 mmHg, VE
9.0 ± 0.2 L/min. The following correlations to VDphys/VT were
obtained: PaCO2-EtCO2, r = 0.63; (PaCO2-EtCO2)/PaCO2, r = 0.60;
r = 0.18; VECORR, r = 0.62; VR, r = 0.45 and VE/VCO2,r = 0.88 (Fig. 148).
When only patients with PaO2/FiO2 < 200 (n = 17 patients, 47
measurements) or PaCO2 > 45 mmHg (n = 12 patients, 27
measurements) were considered all correlations improved, but VE/
VCO2 still performed best (r = 0.91 for PaO2/FiO2 < 200 and r = 0.96
for PaCO2 > 45 mmHg).
CONCLUSIONS. VE/VCO2 is an accurate, continuous and non-invasive
index of VI in mechanically ventilated patients. It correlates better to
VDphys/VT than other indices that use PaCO2. Its performance seems
to improve in severe respiratory failure.
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INTRODUCTION. Respiratory muscle dysfunction is an important
cause for difficult weaning from mechanical ventilation. Several
studies have evaluated inspiratory muscle function in weaning
patients. Although the expiratory muscles play an important role in
patients with inspiratory muscle weakness or high breathing effort,
the function of the expiratory muscles during weaning has not been
studied in detail.
OBJECTIVES. To compare the recruitment of the inspiratory muscles
and expiratory muscles during weaning.
METHODS. Twenty-one adult patients receiving pressure support
ventilation underwent a spontaneous breathing trial (T-tube with
supplemental oxygen) of maximal 1 hour. During the trial flow, gas-
tric pressure, esophageal pressure and diaphragm electrical activity
were recorded continuously. Transdiaphragmatic pressure, neurome-
chanical efficiency of the diaphragm, pressure–time product of the
inspiratory muscles and expiratory muscles were calculated.
RESULTS. Ten patients failed the spontaneous breathing trial. In the
failure group the contribution of the expiratory muscles to total
respiratory muscle effort increased up to 26 ± 4% during
spontaneous breathing compared to 10 ± 3% in the weaning
success group (p < 0.05). In the weaning failure group diaphragm
electrical activity was higher (71%; p < 0.05) and neuro-mechanical
efficiency of the diaphragm was lower (41%; p < 0.05).
CONCLUSIONS. The expiratory muscles significantly contribute to
respiratory muscle effort in patients who fail a trial of spontaneous
breathing. In addition, our findings confirm that impaired pressure-
generating capacity of the diaphragm, regardless of its origin, plays a
central role in failure to wean from mechanical ventilation.
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INTRODUCTION. According to the current Berlin definition,
mechanical ventilation is needed to identify patients with acute
respiratory distress syndrome (ARDS). Therefore the use of
noninvasive positive pressure ventilation in patients breathing
spontaneously allows categorizing them as ARDS. However it has
recently been suggested that NIV may be deleterious in ARDS,
especially in the most severe patients.
OBJECTIVES. We aimed to assess whether patients breathing
spontaneously under standard oxygen could be recognized early as
ARDS patients.
METHODS. In a post-hoc analysis from two prospective studies (1, 2),
all ICU patients admitted for acute hypoxemic respiratory failure and
treated with noninvasive ventilation (NIV) were analyzed. Patients
with cardiogenic pulmonary edema, acute exacerbation of chronic
obstructive pulmonary disease or hypercapnia were excluded. The
PaO2/FiO2 ratio was estimated at admission under standard oxygen
using the following formula: oxygen flow in liters per minute x
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 216 of 5420.04 + 0.21, then measured after 1 hour of NIV, and repeated within
the first 24 hours according to respiratory status. Severity of hypox-
emia was considered as mild when PaO2/FiO2 ranged from 201 to
300, moderate from 101 to 200 and severe when ≤ 100 mmHg.
RESULTS. Among the 219 patients admitted for acute hypoxemic
respiratory failure, 180 (82%) had bilateral infiltrates and 172 (79%)
fulfilled ARDS criteria under NIV within the first 24h following ICU
admission. Among all patients with bilateral infiltrates on chest
radiograph and a PaO2/FiO2 ≤ 300 mm Hg under standard oxygen,
96% (154 of 161 patients) had ARDS within the first 24 hours. Their
mortality (29%) was very similar to that of intubated patients in the
current Berlin definition of ARDS (30%).
CONCLUSIONS. Almost all patients with bilateral pulmonary
infiltrates and a PaO2/FiO2 ≤ 300 mm Hg under standard oxygen
fulfilled ARDS criteria under NIV within the first 24 hours after ICU
admission. Their mortality rate was not different from that reported
in the Berlin definition of ARDS. Therefore, patients with ARDS under
NIV could be diagnosed early while breathing spontaneously without
positive pressure ventilation.
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Sepsis therapy, any advances?
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INTRODUCTION. The polymyxin-B direct hemoperfusion therapy
(PMX-DHP) of 2 hours in patients with septic shock has been failed
to demonstrate the consistent effect on mortality.1) Prolonged dur-
ation of PMX-DHP has been suggested to be beneficial for shock re-
versal in those patients.
OBJECTIVES. To determine whether PMX-DHP longer than 2 hours
improve outcomes in patients with septic shock.
METHODS. We conducted DESIRE trial, a randomized controlled trial
with sedation strategy with or without dexmedetomidine in 201
adult patients with sepsis.2) Patients treated with polymyxin-B direct
hemoperfusion (PMX group) and patients treated without it (non-
PMX group) were compared. Then, we compared those with PMX-
DHP of 2 hours (conventional PMX group) and PMX-DHP longer than
2 hours (prolonged PMX group). A primary outcome was 28-day mor-
tality and compared by Kaplan-Meier estimate and log rank test. The
secondary outcome was vasopressor-free days within 7 days and
compared by Wilcoxon rank sum test. We developed Cox propor-
tional hazard model and linear model for these outcomes adjusting
for the sedation strategy with dexmedetomidine, age, the APACHE II
score, infectious sites was lung, emergency surgery.
RESULTS. The mean age was 70.6 (standard deviation (SD) 13.8) and
male was 61.6%. The median APACHE II score was 25.0 (interquartile
range (IQR) 19.3, 31.0). Among 112 patients with septic shock, PMX-DHP was introduced in 36 patients. The 28 day mortality was
19.4%% and 31.6% in PMX group and non-PMX group, respectively
(P = 0.18). The adjusted hazard ratio (HR) of PMX group was 0.85
(95% confidence interval: 0.32-2.10). Among the patients treated with
PMX-DHP, 22 patients received PMX-DHP for 2 hours and the rest 14
patients received it longer than 2 hours. The time of PMX-DHP was
5.5 (IQR 3.75, 12) hours in prolonged group at the first hemoperfu-
sion. Patients characteristics did not differ between the 2 groups. The
28 day mortality was 7 (31.8%) in conventional PMX group and 0
(0%) in prolonged PMX group (p = 0.029). The HR was < 0.001
(95%CI 0, 0.36) (P = 0.0036). The 7 day vasopressor-free days were
2.5 (SD 2.2) in conventional PMX group and 3.1 (SD 2.1) in prolonged
PMX group (p = 0.25).
CONCLUSIONS. PMX-DHP was not shown effective for patients with
septic shock when we compared those with PMX-DHP and without,
that was the same result as the previous study. However, PMX-DHP
longer than 2 hours was more effective than PMX-DHP of 2 hours.
Our result indicated that the prolonged duration-PMX-DHP therapy
may contribute better clinical outcome for the patient with septic
shock than conventional duration-PMX-DHP therapy.
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INTRODUCTION. Norepinephrine has been recommended as the first
choice vasopressor for septic shock resuscitation.1 However, the
appropriate timing for administration has not been clarified. Whether
the medication is given after adequate volume replacement or it
should be initiated along with fluid resuscitation is ongoing debated.
OBJECTIVES. To compare the efficacy of early norepinephrine
administration together with fluid resuscitation during septic shock
resuscitation with the use of this medication after adequate volume
replacement.
METHODS. In this double-blind, single-center (Siriraj Hospital, Mahi-
dol University, Bangkok, Thailand) randomized, placebo-controlled
trial, we enrolled adult septic shock patients within one hour after
the diagnosis. Patients were randomly assigned, in 1:1 ratio, to early
norepinephrine administration (intravenous norepinephrine 0.05
mcg/kg/min together with fluid resuscitation) or standard treatment
(placebo norepinephrine together with fluid resuscitation). Open-
label norepinephrine was added if the target mean arterial pressure
(MAP) of 65 mmHg was not reached after adequate volume. Other
managements were given according to Surviving Sepsis Campaign
2012.1 The primary outcome was the achievement of MAP goal and
the tissue perfusion target, as judged by urine output of more than
0.5 mL/kg/hour or the decrement of serum lactate more than 10%
from baseline, at 6 hours after resuscitation. This study was approved
by the Siriraj Hospital Ethics Committee and was registered in Clini-
calTrials.gov (NCT 01945983).
RESULTS. From September 2013 to March 2017, 320 patients were
included. Of these, 162 patients were assigned to “early group” and
158 patients to “standard group”. All were included in the intention-
to-treat analysis. Patients' mean age was 64.4 ± 15.9 years and mean
Fig. 149 (Abstract 0427). Plasma concentrations of Adrecizumab
(A,B), Adrenomedullin (C) and MR- proADM (D) after sinlge i.v.
administration of placabo oe Adrecizumab (0.5, 2 or 8 mg/kg) in
healty male volunteers (n = 6 per group). Data are expressed
as mean + SD.
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54.8 ± 7.5 mmHg and mean lactate level 4.5 ± 6.9 mmol/L. The “early
group” had higher rate of primary outcome achievement (76.2% vs
43.3%; odds ratio 1.96; 95% CI, 1.52 to 2.58; p < 0.001). The amount
of intravenous fluid given at 6 and 24 hours were similar
(2,718.2 ± 1,000.4 vs. 2,834.6 ± 1,097.3 mL; p = 0.39 and
5,125.1 ± 1,640.1 vs. 5,084.4 ± 1,686.2 mL; p = 0.85). Open label nore-
pineprine was given in 69.7% of early group and 80% in control
group (p = 0.08). Also, there were non-significant lower rate of ad-
verse events, namely cardiogenic pulmonary edema (25.6% vs 30.8%;
p = 0.39) and new onset arrhythmia (12.4% vs. 20.8%; p = 0.09).
CONCLUSIONS. Early norepinephrine administration during septic
shock resuscitation, when compared with standard therapy, resulted
in higher rate of shock reversal at 6 hours.
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INTRODUCTION. Adrenomedullin (ADM) is an important regulator of
endothelial barrier function and vascular tone during sepsis and
septic shock; it therefore may represent a potential novel treatment
target. Adrecizumab is a humanized IgG high-affinity antibody
against the N-terminus of ADM, which only partially inhibits ADM sig-
nalling. Administration of Adrecizumab in septic animals reduced cat-
echolamine requirements and vascular leakage, while improving
blood pressure, renal function, and survival.
OBJECTIVES. The aim of this study was to investigate the safety,
tolerability and pharmacokinetics/-dynamics of Adrecizumab in a
first-in-man study.
METHODS. 24 healthy male volunteers (18 to 35 years), were
recruited for this randomized, double-blind, placebo-controlled phase
I study. Subjects were randomized into four groups (n = 6 each): 0.5,
2, or 8 mg/kg Adrecizumab, or placebo. The study drug was adminis-
trated intravenously over 1 hour. Due to the expected long half-life
of Adrecizumab, subjects were followed for 90 days. Blood was sam-
pled at various points on the study drug administration day and dur-
ing the follow-up period. Several clinical safety parameters were
monitored, including local tolerability, vital signs and electrocardio-
graphic, biochemical, and haematological parameters. Additionally,
pharmacokinetic and -dynamic analyses were performed, including
plasma levels of Adrecizumab, ADM and MR-proADM (fragment of
the ADM precursor).
RESULTS. Adrecizumab was well tolerated and showed an excellent
safety profile. No severe adverse events occurred. Study drug
administration did not result in relevant changes in vital signs and
electrocardiographic evaluations. Apart from transient laboratory
abnormalities, which were deemed not clinically significant, 37
adverse events (AEs) (22 possibly related, 15 unrelated) were
reported of which the most common were headaches (n = 9) and
symptoms of common cold (n = 11). AEs were evenly distributed
across all groups (11 out of 37 AEs were reported in the placebo
group), implying no relation to the study drug. All AEs occurred
transiently and did not require intervention. PK of Adrecizumab
showed proportional increases of the maximum observed plasmaconcentration (Cmax; 9.7 ± 0.9, 44.1 ± 4.5 and 179 ± 21.1 μg/ml for
0.5, 2 and 8 mg/kg Adrecizumab, respectively), a small volume of
distribution (~100 ml/kg), a low clearance rate (~0.2 ml/h/kg) and a
terminal T1/2 of approx. 14 days. Adrecizumab administration elicited
a pronounced increase of plasma ADM levels, while levels of MR-
proADM remained unchanged (Fig. 149), indicating that de novo syn-
thesis of ADM is not influenced.
CONCLUSIONS. Administration of Adrecizumab is safe and well-
tolerated in humans. These findings pave the way for further investi-
gation of Adrecizumab during systemic inflammation using the hu-
man endotoxemia model, and in an upcoming phase II clinical trial
in sepsis patients.
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INTRODUCTION. Sepsis is a major health care burden with increasing
incidence and high mortality rates. A severely suppressed state of
the immune system called immunoparalysis is increasingly
recognized as the overriding immune dysfunction in septic patients.
Experimental studies have demonstrated that ASA exerts pro-
inflammatory effects and epidemiologic data show that prehospital
use of low dose acetylsalicylic acid (ASA) is associated with improved
outcome of patients with sepsis. However, it remains to be deter-
mined whether ASA can reverse immunoparalysis.
OBJECTIVE. We investigated whether ASA prophylaxis or treatment
prevents or reverses in vivo endotoxin tolerance induced by
experimental human endotoxemia (a model for sepsis-induced
immunoparalysis).
METHODS. We performed a double-blind placebo-controlled ran-
domized study in 30 healthy male volunteers (age 18–35 years) who
were intravenously challenged with bacterial endotoxin (LPS) twice
(each challenge consisting of a bolus of 1 ng/kg followed by continu-
ous administration of 1 ng/kg/hr during 3 hours). The two LPS
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three groups, a prophylaxis group (80mg ASA daily for a 14-day
period starting 7 days before the first LPS challenge), a treatment
group (80mg ASA daily for the 7-day period in-between both LPS
challenges), and a placebo group that was challenged with LPS twice
but received no ASA. We measured plasma cytokine levels (TNFα, IL-
6, IL-8, IL-10, MIP-1α, MIP-1β and MCP-1) and changes in vital param-
eters such as temperature and heart rate.
RESULTS. The first LPS challenge resulted in a profound increase of
plasma cytokine levels (p < 0.0001 for all cytokines), temperature
(+2.9°C, p < 0.001) and heart rate (+68%, p < 0.001) in all groups.
Prophylactic use of ASA enhanced plasma concentrations of TNFα by
50% compared with the placebo group (p < 0.001, Fig. 150a). The
development of endotoxin tolerance was illustrated by a severely
blunted plasma cytokine response upon the second LPS challenge in
the placebo group (reduction of TNFα: 58%, p < 0.001; IL-6: 73%,
p = 0.004; IL-8: 65%, p = 0.003; IL-10: 56%, p = 0.003; MIP-1α: 42%,
p = 0.002; MIP-1β: 55%, p = 0.01; MCP-1: 38%, p < 0.01). ASA prophy-
laxis did not result in different cytokine levels during the second LPS
challenge compared with the placebo group. ASA treatment resulted
in enhanced plasma levels of TNFα (+53%, p = 0.02, Fig. 150b), IL-6
(+91%, p = 0.03) and IL-8 (+42%, p = 0.02) upon the second LPS chal-
lenge compared with the placebo group, whereas the plasma level
of the key anti-inflammatory cytokine IL-10 was lower compared with
the placebo group (−40%, p = 0.003).
CONCLUSION. Low dose ASA partially reverses the development of
in vivo endotoxin tolerance in humans. These findings may partly
explain the beneficial effect of ASA in sepsis patients observed in
epidemiological studies and might provide rationale for use of ASA
in this group of patients.Fig. 150 (Abstract 0428). Plasma TNFα concentration during the
first LPS challenge (A) and the second LPS challenge (B)
Fig. 151 (abstract 0429). Survival after CLP-surgery in mice,
comparing sinlge (A) or repeated do ses (B) of either placebo or
Adrecizumab (n = 10 per group). Kaplan-Meier curves are depicted
and p-values were calculated using log-rank tests0429
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INTRODUCTION. Adrenomedullin (ADM) is an important regulator of
endothelial barrier function during sepsis and septic shock.
Previously, administration of a murine antibody targeted against the
N-terminus of ADM resulted in improved outcome in models of mur-
ine sepsis.
OBJECTIVES. To determine the effects of Adrecizumab on vascular
barrier dysfunction and survival in rodent models of systemic
inflammation and sepsis.METHODS. Male Wistar rats (n = 48) received Adrecizumab (0.02, 0.1,
0.5 or 2.5 mg/kg) or placebo, directly followed by lipopolysaccharide
(LPS; 5 mg/kg). Evans Blue dye was administered 24 hours later and
vascular leakage was assessed in kidney tissue. In subsequent
experiments, C57BL/6 mice (n = 24) received Adrecizumab or
placebo, immediately followed by CLP-surgery. Eighteen hours later,
kidneys were harvested for immunohistochemical analysis of albu-
min, vascular endothelial growth factor (VEGF) and angiopoietin-1
(Ang-1). Finally, survival was assessed in a CLP model using C57BL/6
mice (n = 60) that received single (2 mg/kg) or repeated dosages (4
mg/kg followed by 2 mg/kg after 24 and 48 hours) of Adrecizumab
or placebo.
RESULTS. In rats, LPS administration resulted in a 3.5-fold increase in
renal albumin leakage compared with saline-treated controls, which
was significantly attenuated by Adrecizumab at dosages of 0.1 and
2.5 mg/kg (71% and 40% attenuation, respectively), whereas a trend
towards decreased renal albumin leakage was observed for the 0.5
mg/kg dose (33% attenuation). Adrecizumab administration resulted
in significantly attenuated albumin (79%, 75% and 78% attenuation
for 0.1, 2.0 and 20 mg/kg Adrecizumab, respectively) and VEGF con-
centrations (55%, 45% and 59% attenuation) in the kidneys of septic
mice, whereas concentrations of the protective protein Ang-1 were
augmented (387%, 474% and 379% augmentation, respectively).
Both single and repeated administration of Adrecizumab resulted in
improved survival during murine sepsis (single dose: from 10% to
50%; repeated dose: from 0% to 40%; Fig. 151).
CONCLUSIONS. Pre-treatment with the humanized anti-ADM anti-
body Adrecizumab improves vascular barrier function and survival in
rodent models of systemic inflammation and sepsis. These results
pave the way for clinical development of this antibody. A phase I
study is in its final stages and a phase II study in septic patients is
planned.
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INTRODUCTION. Being discharged from an ICU is often just the
beginning of a long recovery process ahead that may be impacted
by anxiety and depressive symptoms or post traumatic stress
disorder (PTSD). This psychiatric morbidity is associated with
increased use of psychiatric medications or other mental health
services1. Available studies exploring this issue have numerous
limitations, including a low number of patients coming from single
sites, the focus on specific pathologies, and the multiplicity of the
methods used to recognise these symptoms.
OBJECTIVES. To evaluate the prevalence of psychiatric symptoms
one year after ICU discharge in a large cohort of unselected adult
ICU survivors.
METHODS. After carrying out the IPREA3 study (a multicenter,
cluster-randomized, controlled study involving 34 French adult ICUs
to assess the efficacy of a multicomponent tailored intervention to
reduce discomfort in the ICU2), we conducted a 1-year follow-up of
the patients included in IPREA3 in 30 of 34 ICUs. We assessed anxiety
and depressive symptoms and PTSD using resp. the Hospital and
Anxiety Depression Scale (HADS) and the Impact of Event Scale-
Revised (IESR). The HADS anxiety and depression subscales consist of
7 items, each rated on a 4-point scale from 0 to 4 leading to poten-
tial scores for each subscale from 0 to 21. Patients with score ≥ 8 are
considered symptomatic for anxiety or depression. The IESR consists
of 22 items, each rated on a 4-point scale leading to a mean total
score ranging from 0 to 4. We used the threshold of 1.6 for which
the sensitivity and the specificity for detecting full DSM-IV PTSD were
resp. 100% and 85%. HADS and IESR were administered either by
telephone or returned by patients after mailing.
RESULTS. Of the 1893 enrolled patients, 297 (16%) died before 1-
year follow-up and 590 could not be interviewed for the following
reasons: lost to follow-up (302), declined participation (93), no ques-
tionnaires return (117), and disability (78). Data exploring psychiatric
morbidity were available for 1006 patients (response rate: 63%). One
year after ICU discharge, resp. 31%, 26%, and 8% of survivors had
anxiety, depressive, and PTSD symptoms; 42% of them presented
symptoms in at least one domain.
CONCLUSIONS. Psychiatric comorbidity affects nearly one in two
survivors 1 year after ICU discharge. This high prevalence should
raise awareness of the need for a health policy applied to unselected
adult ICU survivors.
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Intensive Care Medicine Experimental 2017, 5(Suppl 2):0431INTRODUCTION. Frailty is a multiply determined at-risk state, typic-
ally accompanied by decreased mobility, weakness, poor muscle
mass, poor nutritional status, diminished cognitive function and char-
acterized by reduced functional reserve (1). This renders frail individ-
uals more susceptible to extrinsic stressors. Assessing baseline frailty
in critically ill patients may provide important prognostic and diag-
nostic information.
OBJECTIVE. To determine the impact of frailty on critical care
outcomes through the conduct of a systematic review and meta-
analysis.
METHODS. We searched the Cochrane Central Register of Controlled
Trials, MEDLINE, EMBASE, Pubmed, and Clinicaltrials.gov. All study
types except for narrative reviews, case reports and editorials were
included. Studies must have assessed frailty in critically ill
patients > 18 years of age and compared frail and non-frail patients.
Two reviewers independently applied eligibility criteria, assessed
quality, and extracted data. The primary outcome was hospital mor-
tality and long-term mortality (≥6 Months). Secondary outcomes in-
cluded the prevalence of frailty, health-related quality-of-life (HRQL)
among survivors and health service utilization. Quality was assessed
using the Newcastle-Ottawa Scale (NOS) for observational trials.
RESULTS. Ten observational studies enrolling a total of 3030 patients
(927 frail and 2103 non-frail patients) were included. The overall
methodologic quality on the NOS was moderate with 5 high, 5 mod-
erate, and no low quality studies. Frailty was assessed with the Clin-
ical Frailty Scale (7 studies), Frailty Index (4 studies) and Frailty
Phenotype (2 studies). The pooled prevalence of frailty was 30%
(95% CI 29 - 32%). Frailty was associated with higher hospital mortal-
ity [Relative Risk (RR), 1.71; 95% CI, 1.43, 2.05; p < 0.00001; I2 = 32%]
and long term mortality (RR, 1.53; 95% CI, 1.40, 1.68; p < 0.00001;
I2 = 0%). Frail patients remained in hospital for 3.39 days longer than
non-frail patients, although this was not statistically significant (mean
difference; 95% CI, −0.33, 7.10, p = 0.07, I2 = 77%). Frail patients were
also less likely to be discharged home than non-frail patients (RR,
0.59; 95% CI, 0.49, 0.71; p < 0.00001; I2 = 12%). Reduced HRQL was
found in the only two studies assessing this.
CONCLUSIONS. Frailty is common among ICU patients and is
associated with increased hospital and long-term mortality. Frail pa-
tient are less likely to be discharged to home than non-frail patients.
Routine screening for clinical frailty in critically ill patients may pro-
vide important diagnostic and prognostic information to clinicians,
patients and their families. Further studies to reduce mortality and
disability in frail patients should be conducted.
REFERENCES
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INTRODUCTION. It is well known that survivors after critical illness
perceive poorer health-related quality of life (HRQoL) compared with
an age and sex adjusted control group. In addition to the effects of
medical treatments, individual psychological factors may also influ-
ence HRQoL. These include psychological resources such as ability to
cope, sense of coherence and perceived control, together with
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 220 of 542psychological risk factors such as depression, exhaustion, and hope-
lessness. The ability to cope with life is central for health and shown
to be associated with better HRQoL in patients with chronic disease.
If the individual cannot cope, this can lead to feeling of
hopelessness.
OBJECTIVES. To assess the independent associations between the
psychological factors ability to cope and hopelessness with measures
of HRQoL and their effects on mortality up to 3 years after discharge
in patients who have been treated in an ICU.
METHODS. A prospective, cross-sectional, multicenter study of 980
adult patients (mean age 58 yrs.,42% women). Ability to cope, hope-
lessness, and HRQoL were evaluated using validated instruments: the
Mastery Scale questionnaire, Eversons's 2-item scale and Short Form-
36. Linear mixed models and multiple linear and logistic regressions
adjusted for confounding variables (i.e. age, sex, marital status, level
of education, APACHE II score, comorbidity, and duration of ICU and
hospital stay) were used.
Questionnaires were sent to patients 6, 12, 24, and 36 months after
discharge from ICU.
RESULTS. Low scores for ability to cope and high scores for
hopelessness were both related to poorer HRQoL for all SF-36 sub-
scales (except for coping with bodily pain). Effects were in the same
range as coexisting disease for physical subscales, and stronger for
social and mental subscales. High scores for hopelessness also pre-
dicted mortality up to 3 years after discharge from ICU (p < 0.001).
CONCLUSIONS. Ability to cope and hopelessness showed significant
and independent effects on HRQoL after ICU care, and this effect
was stronger than the effect of coexisting disease. Hopelessness also
predicted mortality after critical illness. Awareness of the
psychological state of patients after critical illness is important to
identify those with increased risk.
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INTRODUCTION. Towards RECOVER (Phase I: RECOVER Program)
stratified survivors of ≥1 week of mechanical ventilation (MV) into 4
disability groups (Grs) based on age and ICU length of stay (LOS)
that determine 1-year recovery trajectories and healthcare use inde-
pendent of admitting diagnosis or illness severity (1). Tracheostomy
(T) was performed in 49% of patients (pts). In this study we evaluatedthe impact of T on pt outcomes in the 'Older' ('Older Long LOS', age
46–66 years; ICU LOS ≥ 2 weeks) and 'Oldest' ('Oldest Long LOS',
age > 66 years; ICU LOS ≥ 2 weeks) risk Grs.
METHODS. There were 237 pts in the 'Older' (N = 144) and 'Oldest'
(N = 93) Grs. We compared baseline and outcome variables in T
versus non-tracheostomy (NT) pts within each Gr, assessed severity
of illness using Acute Physiology and Chronic Health Evaluation II
(APACHE II), Multiple Organ Dysfunction Score (MODS), Elixhauser
(Elixsum), Charlson score. At 1 week, 3-6-12 months post ICU dis-
charge we compared: survival, Functional Independence Measure
(FIM) total, motor and cognitive subscales, distance walked in 6 mi-
nutes, Short Form 36 (SF36), Medical Research Council Scale (MRC),
Impact of Event Scale (IES), Beck Depression Inventory-II (BDI-II); dis-
position at hospital discharge, ICU readmission, number of specialist
visits post ICU discharge.
RESULTS. Of the 237 pts, 144 (60.8%) had T performed on median ICU
day 13. Baseline severity of illness scores were not significantly different
between T and NT pts. Total FIM, FIM motor subscale were significantly
lower in T pts at day 90 (p = 0.02), FIM cognitive subscale was never
significantly different. Duration of MV, ICU-hospital LOS were signifi-
cantly longer in T pts. T was not associated with higher mortality in the
disability Grs at any time point. T pts had higher ICU readmission rates
(p = 0.09). No interactions between Gr and T in any other outcome vari-
ables, number of specialist visits, hospital readmission. Total lung cap-
acity, vital capacity, forced expiratory volume 1 second, and carbon
monoxide diffusion capacity, were significantly lower in the T Gr
(p = 0.04, 0.01, 0.01, 0.02 respectively). The effects of T on the dispos-
ition at hospital discharge were not the same for the 2 RECOVER Grs, a
single effect of T could not be estimated. Disposition at 1 year was not
significantly different between the 2 Grs.
CONCLUSIONS. In this population of pts older than 46 years, MV ≥ 1
week, ICU stay ≥ 2 weeks, T was not independently associated with
mortality. Pts who received a T had worse pulmonary outcomes,
longer duration of MV, ICU, hospital LOS. T after 2 weeks of MV was
not independently associated with functional or cognitive outcomes.
The daily burden of care required by the patient, expressed by FIM,
was not significantly influenced by T.
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Table 120 (Abstract 0435). See text for description
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 221 of 542BACKGROUND. Moderate to severe depressive symptoms occur in
20-33% of survivors at one year after Intensive Care Unit (ICU) dis-
charge and may have a negative impact on functional outcomes.
The extent to which patient and caregiver factors impact the devel-
opment of depressive symptoms remains unclear.
OBJECTIVES. We sought to evaluate patient and caregiver factors
associated with the development of post-ICU depressive symptoms.
METHODS. Using the RECOVER Program cohort of 391 medical/
surgical ICU patients, we investigated factors associated with
depressive symptoms captured by the Beck Depression Inventory-II
(BDI-II) score. We determined the association between BDI-II and
baseline characteristics (age, sex, socioeconomic status, Charlson Co-
morbidity Index (CCI) score and ICU length of stay (LOS)), Functional
Independence Measure (FIM) motor subscale score and caregiver
characteristics (Caregiver Assistance Scale, Center for Epidemiologic
Studies Depression Scale and caregiver BDI-II) using linear regression
and mixed models at the 3, 6 and 12-month time points. All analyses
were preplanned.
RESULTS. BDI-II data was available for 246 patients. Median age at
ICU admission was 54 years, 58% were male (n = 143) and median
LOS was 19 days. Mean BDI-II scores at 3, 6 and 12 months were
12.3, 11.4 and 10.7. Across all time points 17% of patients had a BDI-
II score ≥21, indicating moderate-severe depressive symptoms. At
each time point, a lower FIM motor subscale score was significantly
associated with more severe depressive symptoms. At 6 and 12
months, age had a curvilinear relationship to BDI-II, with the highest
depressive symptoms associated with ages 45–50. Over the 12
months, mixed models found more severe depressive symptoms in
patients with lower FIM motor subscale scores, those who had not
completed secondary education, and the same curvilinear relation-
ship to age. No statistically significant associations were found be-
tween patient BDI-II and patient CCI, sex, LOS, income or caregiver
variables.
CONCLUSIONS. Severity of post-ICU depressive symptoms is associ-
ated with less education, greater functional dependency, and has a
curvilinear relationship with age. No associations between caregiver
variables and patient outcome were identified. Knowledge of risk fac-
tors for clinically important depressive symptoms may inform surveil-
lance and targeted mental health follow-up. Rehabilitation programs
aiming to improve the FIM may serve to modify mood disorders.
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Sedation, analgesia and delirium
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OBJECTIVE. Whether patients undergoing thrombectomy (TRB) in
acute ischemic stroke (AIS) should be managed with conscious
sedation (CS) or general anesthesia (GA) remains controversial. Our
objective is to compare both strategies and study the differences in
mortality, neurological improvement and those related with TRB.METHODS. Retrospective study (October 2013 - July 2016). AIS
patients treated with TRB admitted to our ICU. Data collected are
shown in Tables 120 and 121. We considerer neurological
improvement as a difference ≥ 4 points between the initial and
before discharge NIHSS scores, and reperfusion as angiographic flow
recovery. ICU and hospital length of stays, in-hospital and 6-month
overall mortalities together with modified Rankin scores at 6-months
where also registered. Statistical analysis included X2 and Mann–
Whitney tests together with logistic regression.
RESULTS. During the period studied, 183 patients were admitted to
our ICU with a diagnosis of AIS. Of them, 108 (59%) underwent TRB.
Fifty-four were managed with CS and 54 with GA. Only APACHE II
and NIHSS scores were higher in the GA group (Table 120). Twenty-
one patients (38.8%) in the CS group and 32 (59.2%) in the GA had a
NIHSS ≥ 18. Reasons for GA were: elective (37), diminished level of
consciousness (8), agitation (7) and respiratory impairment (2). There
were no crossovers between the CS and GA groups.
GA was associated with longer arrival to puncture times and a more
frequent usage of vasoactive drugs, but onset to reperfusion times
were similar between groups and GA was associated with better
reperfusion rates. Although neurological improvement (NIHSS ≥ 4)
was higher in the GA group, modified Rankin scores at 6 months
were better for the CS group (Table 121). Median time until
extubation was 13h (5–31.2). Patients undergoing GA had longer ICU
stays [1 day (1–2) vs. 2 days (2–5);p < 0.005) but hospital length of
stay was similar between groups [14 days (9–23) vs. 11 days (8–
26.5);p = 0.5]. The GA group had higher in-hospital and 6-month
overall mortality rates [3 (5.6%) vs. 13 (24.5%);p = 0.07 and 6 (11.5%)
vs. 15 (29.5%);p = 0.02) but, after adjusting by APACHE II, initial
NIHSS, reperfusion rate, vasoactive drug usage and ICU length of stay
we found no differences in in-hospital [OR 3.47 (0.51-23.38)] or over-
all 6-month mortalities [OR 3,19 (1,12-9,05)]. Initial NIHSS for de-
ceased patients was 18 (15–20).
CONCLUSION. Even though GA was associated with better
reperfusion rates and larger NIHSS improvements, patients under CS
had a better neurological recovery, which could be related with
lower initial NIHSS scores.
In our series, GA was used in patients with higher APACHE II and
initial NIHSS scores without causing significant delays in treatment
times.
GA patients had higher in-hospital and overall six-month mortalities,
however, after adjusting by confounding factors we found no differ-
ences in mortality rates between groups.
Table 121 (Abstract 0435). See text for description
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INTRODUCTION. Delirium is a common manifestation of acute brain
dysfunction in critically ill patients with a prevalence of 80% in
intensive care unit (ICU) patients1. It is associated with multiple
complications1. In 2013, a revised version of the ICU pain, agitation,
and delirium (PAD) guidelines was published2. Yet, its dissemination
in a community hospital is unclear. More importantly, nurses play an
integral part in PAD management and their perspectives should
inform the development of a multifaceted and multidisciplinary
quality improvement (QI) program to improve PAD management.
OBJECTIVES. This qualitative study explored the views of ICU nurses
regarding PAD management in order to inform the subsequent
development of a multifaceted and multidisciplinary QI program
with the aim to improve PAD management in a community ICU.
METHODS. Focus groups (1-hour) with nurses were conducted using
a structured interview guide containing six questions designed to
explore themes related to nursing practice, professional preferences
and improvement strategies around PAD management. Transcripts
were analyzed using a constant comparative approach to identify
themes that emerged from the data. Responses for each question
were analyzed individually and then compared across sessions to
examine similarities or differences across the responses.
RESULTS. Forty-five out of sixty-eight nurses attended 1 of 5 focus
group sessions. Themes that developed from the analysis outlined
differences in nurse perceptions of optimal sedation and physical re-
straint use, but there was alignment in their perception regarding
the impact of environmental factors on delirium development. Differ-
ences were found related to physical restraint use as some nurses
felt that they contribute to delirium while some felt that they arenecessary for safety. Some nurses preferred deep sedation to avoid
awareness of traumatic experience, whereas others preferred wake-
fulness facilitating participation in their medical care. Most nurses
agreed that noise, lights, medications, disjointed care and physical
restraint use contribute to delirium development. They agreed that
consistencies among healthcare professionals in the form of an algo-
rithm, individual patient-tailored non-pharmacological therapy in-
volving input from family members and education for staff and
family members would aid in PAD management.
CONCLUSIONS. The results of this study will guide subsequent
interventions as part of our multifaceted and multidisciplinary QI
program. Core to this project is the nurse engagement in the
development of these interventions which in turn will impact
improvement for PAD in the ICU.
REFERENCE(S)
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INTRODUCTION. Delirium and agitation are common in mechanically
ventilated patients admitted to the intensive care unit (ICU).
Retrospective data have shown that smoking, or the acute
abstinence of smoking, is an additional risk factor for agitation. A
safe and effective method to treat nicotine withdrawal symptoms in
outpatient and hospitalized smoking adults is transdermal nicotine
replacement therapy (NRT). Previous studies on the use of
transdermal NRT in critically ill smokers admitted to the ICU have
produced conflicting results.The main goal of this pilot study was to
investigate the feasibility of a phase III trial, by conducting a test run
of a randomized controlled trial. We aimed to assess the safety and
efficacy of transdermal NRT in mechanically ventilated smokers
admitted to the ICU.
METHODS. In this two-centre, randomized, placebo-controlled pilot
study, mechanically ventilated smokers admitted to the ICU were in-
cluded. Subjects received either a nicotine patch (14 or 21 mg/day)
or a placebo patch daily until ICU discharge or for a maximum of 30
days. The primary outcome was 30-day mortality. Secondary out-
comes included 90-day mortality and number of (serious) adverse
events. In a post hoc analysis, we defined a composite outcome par-
ameter as time spent alive without sedation and delirium in the first
30 days.
RESULTS. The study was stopped after the inclusion of 47
patients. The two groups were comparable with respect to
baseline characteristics. No differences were found in 30-day mor-
tality and 90-day mortality between NRT and control group (2/21
vs. 2/26; p = 0.843 and 3/21 vs. 5/26; p = 0.665). There was no
difference in the number of adverse and serious adverse events,
between NRT and control patients (102 vs. 177; p = 0.096, and 5
vs. 11; p = 0.251). Patients in the NRT group had spent more
time alive without sedation and delirium during the first 10 days
(160 hours (96–216) vs. 88 hours (20–210); p = 0.043) and during
the first 20 days (400 hours (316–448) vs. 304 hours (110–432);
p = 0.033) of treatment.
Table 122 (Abstract 0438). See text for description
Fig. 152 (Abstract 0437) Comparison of guideline Domain Scores.
DAS = DAS Guideline, PAD = PAD Guideline, NICE = NICE Guideline,
FEPIMCTI Guideline, eCASH = eCASH statement, DSIT = DSIT
Guideline. The dotted line represents the cut-off for a high quality
score (60%)
Table 123 (Abstract 0438). See text for description
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had no effect on 30- and 90-day mortality, although our study was
underpowered to establish such differences.
Furthermore, the number of (serious) adverse events between the
two groups was comparable.
Finally, patients with NRT spent more time alive without sedation
and delirium during the first 10 and 20 days.
We suggest that future trials should focus on a possible effect of NRT
on predefined delirium endpoints, particularly in the second and
third weeks of ICU stay.
The results of this pilot study showed that, with some modifications
of the trial design, a randomized controlled phase III study to assess
the safety and efficacy of transdermal NRT in mechanically ventilated
smokers admitted to the ICU is feasible.
0438
Guidelines and consensus statements on delirium-, analgesia- and
sedation- management in the ICU - a systematic literature search
and critical quality appraisal with AGREE II
M. Rosenthal, B. Weiss, J. Grunow, R. Moergeli, F. Balzer, C. Spies
Charité Universitätsmedizin Berlin, Department of Anesthesiology and
Intensive Care Medicine CC7, Berlin, Germany
Correspondence: M. Rosenthal
Intensive Care Medicine Experimental 2017, 5(Suppl 2):0438
INTRODUCTION. The management of delirium, analgesia and sedation
(DAS) is an integral part of critical care. Various guidelines and
recommendations are available to assist clinicians in their everyday
decision-making. However, the benefit of these guidelines and their ac-
tual potential of bringing evidence into clinical practice is highly
dependent on their quality, which is largely unknown.
OBJECTIVES. The purpose of the study was a literature search and
quality assessment of DAS guidelines to identify
(1) high quality guidelines and
(2) possible domains to improve guideline-development in the future.
METHODS. We conducted a systematic literature search of DAS-
guidelines in the critical care context published between 2007 and
2017. Guidelines were systematically identified by searching six elec-
tronic bibliographic databases. Critical appraisal was performed by
three independent expert reviewers using the Appraisal of Guidelines
Research and Evaluation (AGREE II).
RESULTS. 2The search algorithm revealed 625 manuscripts that were
manually screened for inclusion and exclusion criteria. We identified five
guidelines and one consensus statement meeting the criteria. Three
guidelines (50%) were predominantly developed on a regional/national level,
the others were international/continental (other specifications s.f. Table 122).
AGREE II domain-scores varied considerably among the six guidelines (Fig. 152).
Two guidelines exceed the quality threshold of 60% in all domains, although
the full version of one of these guidelines is exclusively available in German lan-
guage, which limits applicability outside German-speaking countries.
From the methodological perspective, the highest AGREE II-scores were
achieved in the domains “scope&purpose” (median 80.6% [min 25.9%;
max 90.7%]) and “editorial independence” (median 70.8% [min 0%; max
94.4%]). In contrast, the domains “stakeholder involvement” (median
54.6% [min 9.3%; max 81.5%]) and “applicability” (median 44.4% [min
0%; max 84.7%]) scored lowest (Table 123). These quality gaps in particu-
lar evolved from a lack of consideration of patient's treatment prefer-
ences and the concrete development of implementation strategies.
CONCLUSION. In the field of DAS-management, there are three guide-
lines of highest quality available. However, our analyses revealed a
quality deficiency in stakeholder involvement and applicability of
current guidelines. These are vital domains for implementation and ac-
ceptance of guidelines and should be increasingly considered in future
guideline development.
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INTRODUCTION. Postoperative delirium in elderly patients with major
surgery including cardiac surgery is a relatively frequent complication.
Although dexmedetomidine has been known be effective to prevent
Fig. 154 (Abstract 0439) Cortisol concentration in three groups (A)
and in patients with delirium (B). *P vs Group S, †P vs other
two groups
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 224 of 542delirium, its use is still controversial. The present study was aimed to
investigate the effect of the timing and dose of dexmedetomidine on
postoperative delirium.
MATERIALS AND METHODS. Postoperative delirium was evaluated for
5days after surgery in 318 patients older than 65 years undergoing
non-cardiac surgery under general anesthesia. Patients received either
dexmedetomidine (1 μg/kg bolus followed by 0.2 to 0.7 μg/kg/ h infu-
sion from induction of anesthesia to the end of surgery (Group D1), or
1 μg/kg bolus at 15 minutes before the end of surgery (Group D2) or
saline (Group S).The primary endpoint was incidence of delirium. Sec-
ondary outcomes were duration of delirium, visual analog scale (VAS)
for pain, patient controlled analgesia (PCA) volume for 24 h after sur-
gery, and haloperidol use in delirium patients). As secondary analysis,
cytokines (TNF-a, IL-1beta, IL-2, IL-6, IL-8, and IL-10), C-reactive protein
(CRP), and cortisol were measured on 1st hour and 1st day after surgery.
RESULTS. Group D1 reduced incidence and duration of delirium.
However group D2 didn't decrease incidence of delirium but its
duration in patients with delirium. VAS and PCA volume consumed
for 24 h after surgery in group D1was significantly lower than that of
other two groups. Haloperidol dose used in patients with delirium
was lower in group D1 and D2 than in group S. IL-6 in group D1 was
significantly lower at 1 h and 24h after surgery than in group S and
lower at 24 h after surgery than in group D2. IL-6 in group D2 was
significantly lower at only 1 h after surgery than in group S. However,
Il-6 in group D2 with delirium was significantly lower at 1h and 24 h
after surgery than in group S. Cortisol at 1 h after surgery was signifi-
cantly lower in group D1 and D2 than group S.
CONCLUSIONS. In present study, dose and timing of dexmedetomidine
may be important in preventing delirium. The reduced incidence and
duration of delirium by dexmemdetomidine is associated with reduced
IL-6 level at 1st day after surgery.
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INTRODUCTION. Severe sepsis and septic shock are conditions with
high acute mortality [1]. It may also contribute to long-term mortality
[2], but the causes of long term mortality in severe sepsis patients
are poorly described.
OBJECTIVES. To describe the causes of death ≥ one year after being
treated in an ICU due to severe sepsis or septic shock.
METHODS. The study cohort consisted of 8760 patients with severe
sepsis or septic shock registered in the Swedish Intensive Care
Register (year 2008–2013, American College of Chest Physicians/
Society for Critical Care Medicine definition). These patients were
compared with a control group consisting of 8760 patients treated in
the intensive care unit (ICU), but not suffering from severe sepsis or
septic shock (matched by gender, age, SAPS3 score and ICU length
of stay). Death causes (primary and secondary diagnoses as
International Classification of Diseases codes) were obtained from
the Swedish Cause of Death Register (year 2008–2014).
RESULTS. A total of 903 patients with severe sepsis died > = 365
days after their initial intensive care unit stay, but within the study
period (year 2008–2014). In the control group, 884 patients
died > =365 days after the initial event. The most common causes of
death in patients surviving more than 1 year were heart diseases
(50,2% in the severe sepsis and septic shock patients, 48,6% in the
non-sepsis patients) and cancer (33,7% and 31,7%, respectively). In-
fectious diseases were more common as a cause of death in the sep-
tic cohort than in the control group, even in those patients surviving
more than 1 year after the initial ICU episode (24,3% and 19,6% re-
spectively, p < 0.05).
CONCLUSIONS. The most common cause of death after severe sepsis
and septic shock is heart disease, which is similar to a matched non-
septic ICU cohort. However, septic patients have a significantly
higher incidence of infectious diseases as a cause of death than non-
sepsis patients, even one year after the initial septic episode. The rea-
sons for this suggests an immune related difference but more studies
regarding this are needed.
Table 124 (Abstract 0441). Patient clinical and demographic features
n=69
Age 59(51-68.5)
Male sex 41 (59%)
Patient location: Intensive care: 23 (33.3%)
General ward: 46 (66.6%)
SOFA score day 0 (ICU cohort) 6.4 (2-13)
Gram -ve infection 37 (53.6%)
Gram +ve infection 31 (44.9%)
Fungal infection 1 (1.4%)
Fig. 155 (Abstract 0441) Cytokine production (pg/ml) of PBMCs
stimulated with LPS (a. IL-10, b. IFNγ) and PMA (c. IFNγ, d. TNFα,
e. IL-6)
Fig. 156 (Abstract 0441) Gene expression levels of a) EHMT2
and b)KDM6B
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BACKGROUND & OBJECTIVE. Patients surviving a septic illness
experience significant reductions in long term survival that
persists for up to 8 years after hospital discharge (1). Recurrent
infectious illnesses in previously healthy patients is a major
contributor to this increased long-term morbidity (2). Our hypoth-
esis was that epigenetic alterations induced by a septic episode
imparts a persistent, newly acquired immunological defect.
METHODS. Patients with positive blood cultures underwent blood
sampling within 24 hours of blood culture result, 4–7 days later
and 6–12 months following hospital discharge. Healthy volunteers
served as a comparator group. Gene expression was determined
using quantitative polymerase chain reaction. Peripheral blood
mononuclear cells (PBMCs) were cultured in 10% serum with and
without lipopolysaccharide (LPS) and PMA/ionomycin (Sigma) for
24 hours. Cytokine concentration in the supernatants were
quantified using Cytometric Bead Array (Biolegend).
RESULTS. Clinical and demographic features are outlined in Table
124. Median age of the volunteer group was 41 (IQR 36.6-49.5)
and 22 (60%) were male. Patients with acute infection produced
less IL-10, IL-6, IFNγ and TNFα than healthy volunteers following
stimulation. This persisted in the convalescent samples (Fig. 155).
In comparison to healthy volunteers, gene expression of histone
modification enzymes EHMT2 and KDM6B were downregulated
and upregulated, respectively. This persisted in the convalescent
samples (Fig. 156).
Table 124 Demographic and clinical features of the patient cohort.
Numbers refer to median with IQR in parenthesis or absolute count
and percentages.
CONCLUSIONS. Patients recovered from an infectious insult display
features of immune suppression which could be attributable to infection
induced histone modifications. Further Chromatin Immunoprecipitation
assays are required to inform causation.
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Fig. 157 (Abstract 0442)Kaplan-Meier analysis in Derivation cohort
Fig. 158 (Abstract 0442)Kaplan-Meier analysis in Validation cohort
Table 126 (Abstract 0442). COX regression analysis in Derivation
Cohort
HR 95% CI p-value
Age 1.029 [1.00-1.06] 0.046
APACHE II 1.045 [1.00-1.09] 0.043
Diabetes 0.536 [0.24-1.18] 0.121
Gram + 0.564 [0.32-0.99] 0.045
Basophils cut-off (> 110 cells/mm3) 2.288 [1.20-4.37] 0.012
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Basophils and mortality in septic shock
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INTRODUCTION. Septic shock is defined as a subset of sepsis in
which underlying circulatory, cellular, and metabolic abnormalities
are associated with a greater risk of mortality than sepsis alone1.
Septic syndromes deeply perturb immune homeostasis and impair
innate and adaptive immunity. In this sense, leukocytes and its
subpopulations are crucial components of the innate immune
response and the first line of defense against infection2.
OBJECTIVES. The aim of this study is to evaluate the role of basophil
in septic shock and its ability to predict mortality.
METHODS. We conducted a two-stage multicenter, retrospective study,
aimed at evaluating the prognostic value of leukocyte subpopulations
in patients with septic shock and no immunosuppression. Thus, we de-
veloped a Derivation cohort formed by 238 patients and a Validation
cohort of 186 patients. Statistical analyses were performed to evaluate
the impact of basophil count on mortality at 28 days.
RESULTS. When patients of the Derivation cohort were split based
on deciles for basophils count at 28-days mortality prediction, those
with basophils > 110 cells/mm3 died earlier (Fig. 157). Thus, multi-
variate COX regression analysis was performed based on statistically
significant variables and it demonstrated that 110 basophils cut-off
was statistically significant (p = 0.048 and HR = 2.32) (Table 125).
The cut-off identified in the Derivation cohort was tested in the Val-
idation Cohort. Kaplan-Meier survival analysis (Fig. 158) and COX re-
gression multivariate analysis based on statistically significant
variables confirmed the previous results obtained in the Derivation
cohort (p = 0.012 and HR = 2.288) (Table 126).
CONCLUSIONS. In conclusion, monitoring basophil count represents
a promising prognostic tool in septic shock patients.
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HR 95% CI p-value
Age 1.014 [0.99-1.04] 0.240
APACHE II 1.067 [1.03-1.10] 0.000
COPD 1.460 [0.74-2.89] 0.278
Mechanical Ventilation 2.768 [1.22-6.28] 0.015
Gram + 0.554 [0.27-1.15] 0.111
Fungi 2.553 [0.98-6.66] 0.055
Basophils cut-off (> 110 cells/mm3) 2.320 [0.98-6.66] 0.0480443
Hypothermia and fever in sepsis - different responses associated
with differences in mortality
D. Thomas-Rüddel1,2, K. Reinhart1,2, F. Bloos1,2, for the MEDUSA Study
Group
1Jena University Hospital, Anesthesiology and Intensive Care, Jena,
Germany; 2Jena University Hospital, Center for Sepsis Control and Care
(CSCC), Jena, Germany
Correspondence: D. Thomas-Rüddel
Intensive Care Medicine Experimental 2017, 5(Suppl 2):0443
INTRODUCTION. Fever has recently been reported to be associated
with lower mortality in septic patients in the emergency department
(1,2) and is still widely believed to be strongly associated with
bacteremia (3).
OBJECTIVES. To assess the association of fever and hypothermia
with bacteremia, different foci of infection and mortality in a large,
mixed population of hospital and community acquired sepsis.
Fig. 161 (Abstract 0443)Temperature boxplot and focus
of infection
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quality improvement study where ICU patients with sepsis (all with
organ dysfunction) were documented prospectively. The most
pathological central body temperature within 24 hours after sepsis
onset was recorded resulting in 7599 patients available for analysis.
RESULTS. Body temperature showed a bimodal distribution in
patients with and without bacteremia. Lower body temperatures
were associated with higher mortality (p < 0.001 in binary logistic
regression). Fever was more frequent in pulmonary and urogenital
sepsis (p < 0.001).
In a binary logistic regression analysis female sex, older age, negative
blood cultures, lower procalcitonin values and abdominal or soft
tissue and bones infections were independently associated with a
hypothermic response, but only a small portion of variance
(Nagelkerke R square 0.06) was explained by those factors.
CONCLUSIONS. While normothermia is rare, a hypothermic and a
hyperthermic response can be observed in a mixed population with
severe sepsis and septic shock. Fever is more frequent in bacteremic
patients but this association is not as absolute as commonly
believed. Further research should analyze which underlying factors
trigger the possibly maladaptive hypothermic response in sepsis.
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INTRODUCTION. The qSOFA score has been proposed to assist
identification of potentially septic patients at high risk of
mortality presenting outside the ICU, but in external validation
has been found to lack discrimination early on in the
presentation of sepsis [1]. UK guidance for the emergency
departments (EDs) recommends risk stratification of potentially
septic patients using the National Early Warning Score (NEWS)
and additional parameters [2] which can be time consuming in
the context of a busy ED.
OBJECTIVES. To derive a parsimonious, readily calculated clinical
prediction model (CPM) with practical utility in the ED to assist
with rapid identification of those potentially septic patients at
high risk of mortality.
METHODS. A dual centre ED study was performed using a
prospective cohort of 1,552 patients (2014–16) identified at triage as
potentially septic. Univariate analysis identified 15 variables
associated with 30-day mortality (p < 0.01). Multiple imputation was
used to adjust for missing values. Multivariate logistic regression in a
stepwise backwards elimination method in 11 steps was performed
until 6 variables remained. Area under receiver operator curves
(AUROC) were constructed for the new predictive model and were
compared to those for qSOFA and NEWS at the point of decision to
admit to hospital (leaving the ED).
RESULTS. Six factors independently associated with mortality were
weighted to generate a CPM: LUCA2. Odds ratios and 95%
confidence intervals were calculated (Fig. 162).
AUROC for LUCA2 (95% CI) was 0.79 (0.72-0.81). Hosmer-
Lemeshow demonstrated good fit (p = 0.291). This compared
with an AUROC of 0.67 (0.65-0.69) for NEWS and 0.63 (0.61-0.65)
for qSOFA (Fig. 163).
A cut-off of 4 points had the best sensitivity of 97% but poor specifi-
city of 23%. At a cut-off of 5 points, sensitivity was 80%, sensitivity
68%, Positive predictive value 30% and Negative Predictive Value
95%. This compared with NEWS and qSOFA as follows (Fig. 164).
Though not included in the model, absence of chills was
identified as a significant univariate predictor of mortality
(p < 0.001) but because of negative association was excluded
from the final score for simplicity of use.
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 228 of 542CONCLUSIONS. We describe a new CPM that could be made
automatable and assist the ED team in risk stratifying patients with
signs of infection early in their presentation. Further internal and
external studies are required to validate this score for clinical use.
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INTRODUCTION. Intensive care-unit acquired weakness (ICUAW) is
frequent (incidence as high as 80% [1]) in survivors of multi organ
failure. Bioenergetic failure has been discussed as one of the possible
mechanisms. Previous analyses indicate improved metabolic function
in critically ill patients after protocol based physiotherapy [2].
AIM. To investigate the impact of different types of physiotherapy on
glucose and lipid metabolism in skeletal muscle.
METHODS. We compare the effects between three groups of ICU
patients (SOFA-Score ≥9 within 72h of ICU admission): standard
physiotherapy (sPT), protocol based physiotherapy (pPT) and protocol
based physiotherapy with added measures (pPT+). In the context of a
randomized interventional trial the effects of pPT with and without
additional measures (whole body vibration and electrical muscle
stimulation) were compared to results of a previous trial with sPT alone
in ICU patients and 4 healthy controls. Hyperinsulinemic euglycemic
clamp (HE-clamp) was used to measure insulin sensitivity index (ISI).
Before and during the maximal insulin stimulus of the HE-clamp base-
line and flexibility of muscular metabolism was assessed as lactate,
pyruvate and glycerol concentrations in musculus vastus lateralis
Fig. 166 (Abstract 0445). lactate and pyruvate concentration,
lactate/pyruvate ratio in dialysate obtained by microdialysis of m.
vastus lateralis before (dark grey) and during (light grey) insulin
stimulus: there is no significant increase in muscle metabolism
measured by metabolites and no effect of interventions standard
physiotheraphy(sPT). protocol based physiotheraphy(pPT), protocol
based physotheraphy and added measures (pPT+) healthy controls
shown for compariosn. *indicates p<0.05
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day of being adequately awake. Data shown as Median (25th/75th per-
centile). Ethic vote (Charité EA 2/041/10).
RESULTS. HE-clamp was performed in 50 severely critically ill pa-
tients with ICUAW (SAPS-II: 51(39/63), SOFA at admission: 13(10/
14), MRC: 3.0(2.1/3.5)) in the groups sPT (n = 22), pPT (n = 8)
and pPT+ (n = 20) on median day 17 of critical illness. First, ICU
patients show a significant reduction in ISI compared to healthy
controls without effect of the type of intervention (Fig. 165). Sec-
ond, while healthy controls show a massive induction of the
glycolytic pathway during insulin stimulus and glucose supply,
ICU patients do not and remain metabolically inflexible (Fig. 166).
Third, healthy controls and ICU patients show a significant sup-
pression of lipolysis due to insulin stimulus measured by glycerol
concentration (Fig. 167).
CONCLUSIONS. In our severely critically ill patients the type of
physiotherapeutic intervention does not have any impact on
systemic insulin sensitivity which is strongly reduced in ICU
patients. This finding goes in line with a local metabolic
inflexibility of the glycolytic pathway despite maximal insulin
stimulus and glucose supply. Lipolytic energy delivery may play a
role in skeletal muscle of ICUAW-patients. Lipolysis seems to be
active and its regulation is sensitive to insulin in our cohort.
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Fig. 165 (Abstract 0445). insulin sensitivity index, intervention
groups: standard, physiotheraphy (sPT), protocol based physiotheraphy
(pPT), protocol based physiotheraphy and added measures (pPT+).
healthy controls shown fro comparison. *indicates p<0.05.
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INTRODUCTION. In patients with end-stage renal disease (ESRD) a
positive association of body mass index (BMI) and outcome, the
“obesity paradox” has been described. It remains unknown whether
this association extends also to ESRD patients treated at an ICU.
OBJECTIVES. In a large group of intensive care patients we assessed
whether a potential beneficial effect of a high body mass is seen in
ESRD patients with critical illness.Methods and Participants: In a
retrospective analysis of a prospectively collected data base of 82,323
patients from 98 Austrian intensive care units (ICUs) in whom BMI was
available, in 9,869 patients with ESRD the association of 6 groups of
BMI and outcome was assessed. Results were adjusted for severity of
disease, age, sex and other acute and chronic comorbidities.
MAIN RESULTS. The 9,869 patients with ESRD were older, sicker, had
a longer ICU stay and a higher ICU and hospital mortality. Within the
group of ESRD patients a high BMI (>25) was associated with an
improved survival in a multivariate analysis (BMI 25–30: OR 0.88, CI
0.77-0.99; 30–35: OR 0.8; CI 0.68-0.93; 35–40, OR 0.74, CI 0.6-0.92) but
this was not seen in morbidly obese patients with a BMI > 40. The
association was significant in patients with the highest disease
severity (SAPS-3 Score > 56) but remarkably, also in those patients
without systemic inflammatory response syndrome (SIRS) and those
not requiring mechanical ventilation.
CONCLUSIONS. Also in ESRD patients who have acquired an acute
intermittent disease and are admitted to an ICU an increased BMI is
associated with an improved outcome. This association however, is
not seen in morbidly obese patients with a BMI > 40. This improved
tolerance to acute disease processes may in part explain the “obesity
paradox” observed in ESRD patients.
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INTRODUCTION. Sarcopenia refers to the involuntary loss of skeletal
muscle and is a predictor of physical disability and mortality. Its
pathogenesis is poorly understood, although roles for altered hypoxic
signalling, oxidative stress, adipokines and inflammatory mediators
have been suggested. Sarcopenia also occurs upon exposure to the
hypoxia of high altitude.
OBJECTIVES. Using data from the Caudwell Xtreme Everest
expedition (1) we therefore sought to analyse the extent of hypoxia-
induced body composition changes and identify putative pathways
associated with fat-free mass (FFM) and fat mass (FM) loss.METHODS. After baseline testing in London (75m), 24 investigators
ascended from Kathmandu (1,300m) to Everest base camp (EBC
5,300m) over 13 days. Fourteen investigators climbed above EBC,
eight of whom reached the summit (8,848m). Assessments were
conducted at baseline, during ascent and after one, six and eight
week(s) of arrival at EBC. Changes in body composition (FM, FFM,
total body water, intra- and extra-cellular water) were measured by
bioelectrical impedance. Biomarkers of nitric oxide and oxidative
stress were measured together with adipokines, inflammatory, meta-
bolic and vascular markers.
RESULTS. Participants lost a substantial, but variable, amount of
body weight (7.3 ± 4.9 kg by expedition end; p < 0.001). A
progressive loss of both FM and FFM was observed, and after eight
weeks, the proportion of FFM loss was 48% greater than FM loss
(p < 0.008). Changes in protein carbonyls (p < 0.001) were associated
with a decline in FM whereas 4- hydroxynonenal (p < 0.001) and IL-6
(p < 0.001) correlated with FFM loss. GLP-1 (r = −0.45, p < 0.001) and
nitrite (r = −0.29, p < 0.001) concentration changes were associated
with FFM loss. In a multivariate model, GLP-1, insulin and nitrite were
significant predictors of FFM loss while protein carbonyls were pre-
dicted FM loss.
CONCLUSIONS. The putative role of GLP-1 and nitrite as mediators
of the effects of hypoxia on FFM is an intriguing finding. If confirmed,
nutritional and pharmacological interventions targeting these path-
ways may offer new avenues for prevention/treatment of loss of skel-
etal muscle at high altitude and in susceptible patient groups
including older patients, critically ill patients, or in those susceptible
to hypoxia as a result of cardiovascular or pulmonary disease.
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INTRODUCTION. Assessment of muscle mass in intensive care (IC)
patients remains a challenge. Bioelectrical impedance analysis (BIA) is a
validated method to assess muscle mass in people with fluid homeostasis.
However, IC patients often have an abnormal fluid balance.
OBJECTIVES. To determine the confounding effect of fluid balance
and body hydration on the change in BIA-derived muscle mass
(ΔMM) during IC admission.
METHODS. Prospective observational study in 46 adult IC patients,
with BMI ≤ 35 kg/m2. Cum fluid balance, total body water
(TBW = (height(cm)2/resistance)*0.713)1,2, and BIA-derived phase
angle and muscle mass (BIA 101 Anniversary, Akern®, Italy) were
measured at day 1, 3 and 7. Analysis of variance (ANOVA), univariate
regression analysis and multivariate regression analysis using the
stepwise backward method were performed.
RESULTS. Mean age 63 ± 16 years, APACHE II score 23 ± 8, SOFA
scoreadmission 9 ± 3. Median cum fluid balance (L) was significantly different
between day 1, 3 and 7. Mean phase angle (°), muscle mass (kg) and total
body water (L) were not different between day 1, 3 and 7 (Table).
ΔMM day 1–3 was positively associated with ΔTBW (R2 = 0.63;
p < 0.001) but not related to Δcum fluid balance (R2 = 0.03;
p = 0.28). ΔMM day 1–7 showed positive associations with both
ΔTBW (R2 = 0.43; p < 0.001) and Δcum fluid balance (R2 = 0.40;
p < 0.001). ΔMM day 1–3 and ΔMM day 1–7 were not significantly
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 231 of 542associated with SOFA (day 1–3 p = 0.51; day 1–7 p = 0.38) or
APACHE II score (day 1–3 p = 0.91; day 1–7 p = 0.19). ΔPhase angle
(odds ratio (OR) = 2.41-3.68; p < 0.001) and ΔTBW (OR = 0.31-0.51;
p < 0.001) appeared as independent explanatory variables of ΔMM
day 1–3 (R2 = 0.93), and day 1–7 (R2 = 0.87; Δphase angle OR = 2.17-
3.34; p < 0.001; ΔTBW OR = 0.18-0.33; p < 0.001) while Δcum fluid
balance did not contribute.
CONCLUSIONS. Although mean BIA-derived muscle mass did not sig-
nificantly change over the first week, individual changes were great.
The change in muscle mass was explained by changes in total body
water by more than two thirds, supporting the confounding effect of
changes in body hydration on BIA-derived muscle mass. Future stud-
ies should focus on the validation of a muscle mass equation taking
changes in body hydration into account.
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No grants received.Fig. 168 (Abstract 0449). VC (vital capacity), FEV1 (forced expiratory
volume in 1 second) and hand grip strength pre- and
postoperatively for n = 19 patients
Table (Abstract 0448). Results of BIA, hydration and fluid balance
Day 1 Day 3 Day 7 P-value
(ANOVA)
Phase angle (°) 4.7 ± 1.6 4.2 ± 1.5* 4.1 ± 1.8 0.10
ΔPhase angle -0.45 ± 1.33 -0.49 ± 1.48
MM (kg) 34.7 ± 8.7 34.7 ± 8.7 33.4 ± 9.2 0.46
ΔMM 0.10 ± 6.93 -0.23 ± 6.27
TBW (L) 51.8 ± 13.6 56.3 ± 14.5* 53.3 ± 17.7 0.09
ΔTBW 4.41 ± 10.15 2.93 ± 16.82
Cum fluid balance
(L)
2.03[0.63-4.18] 5.78[3.98-8.72]* 6.21[1.71-11.26]* <0.01
ΔCum fluid balance 3.65 ± 4.02 3.19 ± 6.04
Data as mean ± SD or median [IQR]. Δ = change day 1–3 or day 1–7
respectively, MM = muscle mass, TBW = total body water. *p < 0.05 vs. day 1.0449
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INTRODUCTION. Intensive Care Unit Acquired Weakness (ICUAW) is a
common complication in critically ill patients and develops early
during ICU stay (1). Even 2 h of mechanical ventilation in healthy
patients leads to weakness and muscle protein degradation in
respiratory muscle (2). Hyperglycemia is a major risk factor for ICUAW
and is frequently seen perioperatively.
OBJECTIVES. Our aim is to investigate whether perioperatively
acquired weakness occurs and the impact of glucose metabolism.
METHODS. We analyzed a subgroup of 19 patients enrolled in a
prospective, ethically approved (EA2/092/14), observational study
undergoing elective non-thoracic surgery of at least 60 min. Lung
function respectively hand grip strength (dominant hand) were
assessed preoperatively, as well as the day after surgery by Spirom-
etry (Pneumotrac, Vitalograph) respectively Dynamometer (SH5002,
SAEHAN). Data of vital capacity (VC), forced expiratory volume in 1
second (FEV1) and hand grip strength are shown as percentage of
patients individually expected standard values. Blood glucose was
measured every 20 min throughout the procedure via arterial blood
gas analyses (ABLflex 800, Radiometer). Maximum, minimum, mean
and variability by standard deviation (SD) were calculated forintraoperative blood glucose. Non-parametric Wilcoxon tests were
performed. Data shown as median [25th/75th perc].
RESULTS. VC (p = 0.003) and FEV1 (p < 0.001) decreased significantly
from preoperative to postoperative (median postoperative day 1 [1/3])
The FEV1/VC ratio remains unchanged (preoperative median 76%
[68/87], postoperative 76% [69/82]; p = 0.286). Hand grip strength
significantly decreased after surgery by 13.3% (Fig. 168). Surgical
time was significantly positively correlated with FEV1 decrease
(p = 0.012) and hand grip strength decrease (p = 0.028) whereas no
influence was seen on decrease of VC (p = 0.085). Furthermore,
perioperative glucose metabolism as characterized by maximum (144
mg/dL [128/195]), minimum (112 mg/dL [93/132]), and mean blood
glucose concentration (128 mg/dL [114 /156]), as well as blood
glucose variability (SD 11.9 mg/dL [7.4/20.4]) showed no impact on
lung function and hand grip strength by correlation in our data.
CONCLUSION. Decreased lung function test by about 13% for VC
and by about 18% for FEV1 may be explained in all probability by
perioperative acquired respiratory muscle weakness. Unchanged
FEV1/VC ratio makes obstructive reasons implausible. Furthermore,
hand strength decreased by about 13% in our cohort. We could not
find an impact of intraoperative blood glucose levels on the
development of perioperative acquired reduced lung function or
hand grip strength.
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Elderly: Triage and outcome
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INTRODUCTION. Healthcare resource allocation refers to the
distribution of healthcare resources among individuals and populations
and encompasses rationing and triage. With more complex medical
procedures, increasing patient age and expectations, and the increased
severity of diseases, there is a greater demand for all medical services.
Decisions on whether to admit a critically ill patient to ICU or not are
complex, since they need to balance the potential risks and benefits for
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 232 of 542the individual patient with the limited bed availability and thus the
implication for future patients. Unfortunately, the indications for
admission to ICU remain poorly defined, and the identification of
patients who can benefit from intensive care is extremely difficult.
OBJECTIVES. The objective of this study is to evaluate factors
influencing triage decisions among patients referred for ICU
admission and to assess its impact in outcome.
METHODS. A single-center, prospective, observational study of 252
consecutive triage evaluations was conducted in patients referred for
ICU admission that were either accepted, or refused and treated on
the medical or surgical wards.
RESULTS. One hundred ninety-eight patients (78.6%) were accepted
for ICU admission. The majority of referrals were of medical patients
(62.3%), followed by surgical (22.2%), trauma (10.7%) and obstetrics
and gynaecology (4.7%). The chief indications for referral were the
need for cardiovascular and respiratory support. Mean Acute Physi-
ology and Chronic Health Evaluation (APACHE)-II score was 19.5 (0–
52) and 19.8 (4–50) for accepted and refused patients, respectively.
Younger age, chronic heart failure, and higher APACHE-II score at the
time of evaluation were associated with acceptance of ICU admission
with OR of 6.59, 12.01 and 6.69 respectively. Thirty-six (18.2%) died in
ICU, while the in-hospital mortality for refused patients was 31.5%.
CONCLUSION. The majority of referred patient was admitted to ICU.
Refusal of ICU admission was associated with higher mortality.
Further efforts are needed to define which patients are most likely to
benefit from ICU admission. Triage protocols or guidelines to
promote efficient critical care beds use are warranted.
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INTRODUCTION. Historically, intensivists have took age as a
determinant factor in a patient´s admission to intensive care units.
However, the increase in life expectancy, the development in chronic
treatments and the parallel improvement of ventilation techniques,
renal replacement therapy, and drugs with lower adverse effects...
have made us think that elderly patients may not present greater
comorbidities only in relation to his age.
METHODS. Our goal is to perform a comparative retrospective
analysis of patients aged 75 years and above. We performed a
comparative study between patients with 75–80 years old and 80–90
years between April 2013 - August 2016. We describe the incidence
of mechanical ventilation(MV), renal replacement therapy (RRT),
vasopressors drugs (VD) and mortality in both groups and then, we
compare them to each other.
RESULTS. A total of 157 patients older than 75 years (75–90) were
included. 45.9% Women 54.1%Men. Age 79.87 ± 3.6 (75–90) SOFA
8.21 ± 8.12 (1–80) APACHE II20.84 ± 8.7 (4–47) SAPS II54.7 ± 18.47(2–
100). Tabulated diagnostic: cardiovascular (26/157) Gastrointestinal
(15/157) Infectious (23/157) Metabolic (6/157) Neurological (29/157)
Surgical (15/157) Respiratory (40/157) Traumatology (3/157).
7% of patients required RRT (11/157), 63%MV (99/157), and 62%VD
(98/157). The mortality rate was 33% (53/157) with limitation of the
therapeutic effort (LTE) in 12% of the cases (19/157).Performing non-parametric tests, higher mortality was observed in
elderly patients requiring MV (P < 0.001)and in those requiring VD
(P < 0.02)
In the75-79years group, a total of 81 patients were collected.43.2%-
Women. Age 76.98, SOFA 8.81 APACHE II 21.95 SAPS II 54.32.
9.8% of the patients in this group required RRT (8/81), 65.3%MV (53/
81) and 64.2%VD (52/81). The mortality was 33.3% (27/81) with LTE
in 12.3% (10/81).
Performing non-parametric tests, higher mortality was observed in
elderly patients whose age ranged from 75–79 years and required
MV. P < 0.0001.
In the group of 80–90 years. 76 patients have been studied. 48.7%
Women. Age 83; SOFA7.56; APACHE II19.65; SAPS II55;
1.3% of the patient's required RRT (1/76), 60.5% MV (46/76), and
60.5% VD (46/76). Mortality rate was 34% (26/76) with LTE in
11.8%(9/76)
Performing non-parametric tests, a higher mortality was observed in
elderly patients aged 80–90 years who require MV P < 0.0001 and in
those who require VD. P < 0.03.
Performing a comparative statistical analysis between both groups,
we found differences in mean age in both groups 76.98vs83.
(P < 0.0001). Performing chi-square analysis, we did not observe sta-
tistically significant differences in the use of MV, VD and RRT in both
groups. There were also no significant differences in mortality in any
of the groups.
CONCLUSIONS. The comparative analysis between patients aged 75–
79 years vs 80–90 years does not show significant differences in
mortality, use of MV, VD and RRT.
The entry of older patients 80–90 years does not equate to a worse
prognosis compared to the elderly 75–80 group.
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INTRODUCTION. The chronic critically ill (CCI) comprise a growing
population of patients who have survived acute critical illness. There
are few studies about their characteristics as well as their emotional,
social status and quality-of-life.
OBJECTIVES. To assess the characteristics of CCI patients and their
family members admitted to the ICU of two different social level
hospitals in São Paulo, Brazil and to identify their socio-economic sta-
tus, emotional disorders and quality-of-life.
METHODS. A prospective study was conducted in two hospitals of
different social levels. Patients were defined as CCI after a stay of at
least 8 days in the ICU plus one of the six eligible clinical conditions:
mechanical ventilation for at least 96 hrs; tracheotomy; sepsis; severe
wounds; stroke; traumatic brain injury [1]. Family members filled out
the Hospital Anxiety and Depression Scale (HADS) and the WHOQOL-
BREF. Regarding patients, family members also responded the EQ-5D
and KATZ index of patients at the ICU, 30-and 90-days after first
assessment.
RESULTS. Between May 2015 and March 2017, 100 patients from a
hospital in the central region and 86 from a hospital in the suburbs,
fulfilled the CCI criteria and participated in this study. Patients from
the suburban hospital were younger (59 vs 69 years old; p < 0.001),
had a similar median SAPS3 (55 vs 54; p = 0.689) and Charlson index
(1.0 vs 2.0; p = 0.059). The difference was found in the ICU mean
length of stay (21 vs 16; p = 0.006) and in the median days on
mechanical ventilation (13 vs 9; p = 0.026).Furthermore, patients
were more often submitted to tracheostomy in the suburban
hospital (42% vs 16%; p < 0.0001). The ICU mortality was higher in
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 233 of 542the suburban no hospital (32.6% vs 17.2%, p = 0.026) but with no
difference in hospital mortality (38.1% vs 35.1%, p = 0.837). No major
difference was found in EQ-5D (p = 0.651). Regarding family mem-
bers, in the suburban hospital there were more protestants than
catholic (p < 0.001), their monthly family income was less than
$1,000 compared to that of the central region (>$ 2,400; p < 0.001),
32.6% were unemployed vs 1.0%, p < 0.001. Presented worse scores
in all domains of WHOQOL-BREF [Psychological (70 vs 75, p = 0.032),
Social Relationships (75 vs 83, p < 0.001), Environment (62 vs 87,
p < 0.001) and Physical Health (71 vs 78, p = 0.011)] and had a
higher HADS score (p = 0.003). The difference in Physical Health re-
mains similar in 30-and 90-days after first assessment.
CONCLUSIONS. It was observed that the CCI patients' outcomes are
the same, regardless of socio-economic differences. Their characteris-
tics are similar, that is, they had similar comorbidities and severity.
However, family members with a lower socio- economic level had
high HADS scores and worse quality of life.
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INTRODUCTION. Long-held assumptions of poor prognoses for eld-
erly patients have meant that physicians have been reluctant to
admit them to the Intensive Care Unit (ICU). Heterogeneity of this
elderly population need a broader geriatric assessment and adequate
evaluation of the burden of comorbidities and critically ill disease on
prognosis.
OBJECTIVES. The objective of the present study was to analyze the
characteristics of old and very old patients admitted to an ICU,
identify predictors for ICU mortality and assess the relative effects of
age on ICU outcome.
METHODS. A single-center, retrospective cohort study was carried
out among geriatric patients, aged 75 years or older, admitted to an
ICU of a Tertiary Hospital between 1 January 2008 and 31 December
2016. Patients who underwent uncomplicated elective surgery were
excluded from the study. The study population was divided in two
groups: old patients (≥74 to 80) and very old patients (≥80 years
old). Data acquired included: patient characteristics, reason for ICU
admission, Hospital length of stay prior to admission (HLOS), comor-
bidities, SAPSII, modified SAPSII (without age) and APACHE II. Labora-
tory values, organ failures, and level of organ support were recorded
on ICU admission. Predictors for ICU mortality were evaluated using
uni- and multivariate analysis.
RESULTS. A total of 667 elderly patients (old patients: 294, very old:
373) were admitted to ICU during the study period. The mean
APACHE II (p = 0.023), SAPSII (p < 0001) and modified SAPSII
(p = 0.012) were significantly higher in the very old group. The mean
HLOS prior to admission was 14 ± 35 days, the mean ICU length of
stay was 13.6 ± 19.8 and there were no significant differences
between the two groups. ICU mortality was higher in the very old
group (33.9% vs 41.6%, p = 0.039). When comparing patients who
survived with those who didn't survive, there were significant
differences in APACHE, SAPSII and modified SAPSII (all p < 0.001),
age > 80 (p = 0.039), Chronic Liver disease (CLD) (p = 0.003), renal
replacement therapy (p = 0.002), Organ dysfunction and Malignancy
(both p < 0.001). By multivariate analysis, factors identified asassociated with ICU mortality were modified SAPS II (p < 0.001, OR
1,069, IC95%: 1.056-10.82), CLD (p < 0.007, OR 17,88, IC95%: 1.918-
166.5); Hematologic disease (p = 0.009, OR 0,363; IC95%: 0.170-
0.774), Malignancy (p = 0.03, OR: 2.330; IC95%: 1,338-4,057) and
organ dysfunction prior to admission (p = 0.015, OR: 1.676; IC95%:
1,106-2,542).
CONCLUSIONS. Our findings suggest that old age per se does not
markedly influence ICU mortality, while other factors, such as disease
severity and comorbidities (CLD, Hematologic disease and
Malignancy) appear to be responsible for the poorer prognosis. More
appropriate admissions decisions based on shared decision-making
and improved prediction models that include comorbidities and
functional status are needed for this particular patient population.
0454
4th age at ICU: a reality
D. Iglesias Posadilla, O. Badallo Arévalo, R. Vara Arlanzón, C. Carbajales
Pérez, E.M. Pérez Cabo, P. De La Torre Vélez, M.E. Perea Rodríguez, M.E.
Martinez Barrio, M. Del Valle Ortíz, S.A. Ossa Echeverri, M. Montero
Baladia, M. Gero Escapa, L. Fisac Cuadrado, M. Martínez Barrios, F. Callejo
Torre, M. Arroyo Díez, A. Zabalegui Pérez, J.A. Fernández Ratero
Hospital Universitario de Burgos, Intensive Care Department, Burgos,
Spain
Correspondence: D. Iglesias Posadilla
Intensive Care Medicine Experimental 2017, 5(Suppl 2):0454
INTRODUCTION. Very old patients´ admission at ICU are growing in
the last years due to the aging of the population.
OBJECTIVES. To study the clinical mortality and ICU supports of the
very old aged patients (>80 years old - 4th age-) in comparison to
middle old aged (65–80 years old -3rd age-) or youngers, admitted
to the Intensive Care Unit of the Burgos University Hospital during
2015 and 2016.
METHODS. We performed a descriptive observational study that was
approved by the Ethics Committee of Burgos. The main interesting
variables: demographic data and admission diagnoses, APACHE II,
procedures, ICU length of stay and ICU and hospital´s mortality. The
continuous variables are described as mean (SD), using T-Student
Test to compare them, or medians (IQR); the qualitative ones are
written as rates, and were compared using Chi-Square Test.
RESULTS. During the period 01/2015 to 12/2016, 2587 patients were
admitted to ICU. 961 (37,15%) of those belong to 3rd age group and
480 (18,55%) to the 4th age group, being male 68,54% and 57,50%
respectively. Within the 4th age, 167 (34,8%) were extremely old
(>85 years old).
The 4th age patients were admitted due to coronary heart disease
more than the 3rd age (34,17% vs 25,70% p =0,001).
The severity measured by APACHE II scale was 18,07 (SD 8,74) for the
3rd age and 19,15 (SD 9,21) for the 4th age, presenting no significant
difference when APACHE was corrected by age (p = 0,43).
The mean stay was 5,41 days (SD 8,75) in < 65 years old, 6,61 (SD
11,73) for the 3rd age and 4,96 (SD 9,28) for the 4th age, appearing
significant difference in this last two (p = 0,007). The extremely old
had less stay (3,87) tan the very old ones (5,54), nearly touching the
statistical significance (p = 0,06).
Invasive mechanical ventilation (IMV) was needed by 38,18% of the
4th age against to 47,37% in the 3rd age, difference that turned out
statistically significant (p < 0,001). About the IMV length there were
no statistically significant differences (2,94 vs 3,85) (p = 0,11), even
though < 65 years. The use of non-invasive ventilation (NIVM) was
similar in both groups 20,60% (3rd age) vs 25,18%(4th age)
(p = 0,07). Both groups had a highest use of NIMV (22,10%) com-
pared with the youngers (11,88%) (p < 0,001).
The ICU mortality was 14,46% for the 3rd age, meanwhile for the 4th
age was 17,71% (15,97% very old and 20,35% extremely old) without
statistical difference (p = 0,11). However, hospital mortality was
21,23% for the 3rd age and 30% for the 4th age. By causal disease,
in the 4th age patients were found greater mortality in those after
trauma (with or without TBI) (100% vs 16,67% p = 0,003; 50% vs
9,09% p = 0,048) and after surgery (17,72% vs 7,14% p = 0,006).
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 234 of 542CONCLUSIONS. According to our experience, the correct selection at
admission to ICU of very old age patients could involve acceptable
survival rates for that ages, without using more resources and longer
ICU´s stays.
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Young group
(N=133)
Elder group
(N=34)
P-value
Operation duration (mins, mean(SD)) 291(63) 284(46) 0.540
Blood loss (ml, mean(SD)) 488(337) 397(249) 0.145
Packed RBC transfusion (ml, mean(SD)) 103(197) 141(184) 0.305
FFP transfusion (ml, mean(SD)) 390(370) 498(321) 0.093
Platelet transfusion (ml, mean(SD)) 158(1043) 0(0) 0.380
Total fluid intake (ml, mean(SD)) 2701(948) 2462(726) 0.173
Fluid balance (ml, mean(SD)) 1511(783) 1507(703) 0.980
Urinary output (ml, mean(SD)) 703(658) 558(388) 0.221
Intraoperative lactate (mmol/L, mean(SD)) 1.4(1.1) 1.2(0.8) 0.642
Table (Abstract 0454). Results
3rd age 4th age p
Coronary heart disease 25,70% 34,17% 0,001
APACHE II 18,07 (SD 8,74) 19,15 (SD 9,21) 0,033
APACHE II corrected (− age) 12,75 (SD 8,70) 13,15 (SD 9,21) 0,432
LOS 6,61 (SD 11,73) 4,96 (SD 9,28) 0,007
IMV (%) 47,37% 38,18% <0,001
IMV length 3,85 (SD 9,04) 2,94 (SD 8,37) 0,11
NIMV (%) 20,60% 25,18% 0,001
ICU Mortality 14,2% 17,5% 0,11
Hospital Mortality 21,23% 30% <0,001
Table 129 (Abstract 0455). Post-operative outcomes in SICU
Young group
(N=133)
Elder group
(N=34)
P-value
ICU admission APACHE-II (mean(SD)) 6.9(3.7) 10.3(3.0) <0.001
Mechanical ventilation (hours, mean(SD)) 8.8(37.2) 30.8(92.4) 0.004
length of ICU stay (day, mean(SD)) 3.3(6.4) 6.2(10.2) 0.127
Length of hospital stay (day, mean(SD)) 26.8(16.4) 30.9(14.5) 0.178
Hospital mortality (n, %) 2(1.5) 1(3.0) 0.497
Delayed gastric (n, %)emptying 17(13) 13(38) 0.001
Pneumonia/ARDS (n, %) 9(7) 7(21) 0.029
Bacteremia (n, %) 9(7) 2(6) 1.000
Bowel ischemia (n, %) 1(1) 0(0) 1.000
Table 127 (Abstract 0455). Patient demographics and preoperative
data
Young group
(N=133)
Elder group
(N=34)
P-value
Age (years, mean(SD)) 57.7(12.3) 78.8(3.81) <0.001
Gender (male/female) 69/64 18/16 0.912
ASA (I and II/III and IV) 58/75 5/29 0.002
Underlying CAD (n,%) 8(6) 5(15) 0.142
Underlying COPD (n,%) 6(5) 2(6) 1.0000
Underlying renal insufficiency (n,%) 4(3) 0(0) 0.583
Underlying cirrhosis (n,%) 6(5) 2(6) 0.666
Baseline hemoglobin (g/dl, mean(SD)) 12.7(2.0) 12.0(1.9) 0.089
Baseline albumin(g/dL, mean(SD)) 4.2(0.5) 3.8(0.6) 0.0010455
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INTRODUCTION. The risk of developing pancreatic cancer increases
with age and the Whipple operation remains the most effective
treatment for patients with a localized periampullary neoplasm. With
the advance of medicine and aging population, more elderly
patients of pancreatic malignancy are undergoing the Whipple
operation, even it is still one of the most complex gastrointestinal
surgeries. Although several studies showed that Whipple operation
could be carried out safely in elderly patients with acceptable results,
elderly patients may still present challenges in their postoperative
period [1].
OBJECTIVES. The purpose of this study is to investigate intensive
care unit (ICU) resource utilization in elderly patients undergoing the
Whipple operation.
METHODS. This is a retrospective study reviewing 167 patients
undergoing Whipple operation consecutively between January 2011
and December 2013. Enrolled patients were categorized into two
groups: the “Young group” (<75 year-old) and the “Elderly group”
(≥80 year-old). Patients demographic, comorbidity, preoperative, in-
traoperative and postoperative data were collected from the medical
records of the patients. The main outcomes were postoperative com-
plications, ICU length of stay, hospital length of stay, and mechanical
ventilator hours.
RESULTS. There were 133 patients in the Young group (mean age
62.0 year-old) and 34 patients in the Elder group (mean age 78.8
years). Basic characteristics were similar in the two groups, despite
higher American Society of Anesthesiologists.classification in the
Elder group (p = 0.002).
Intra-operative outcomes were all similar in the two groups.
Although postoperative complications were more frequently
occurred in the elder group, especially the incidence of delayed
gastric emptying (p = 0.001) and the incidence of pneumonia/ARDS
(p = 0.029), only the mechanical ventilation hours (p = 0.004) was
higher in the elder group(p = 0.055). The rest of ICU resource
utilization were not statistically significant higher than the young
group (Table 129).
CONCLUSIONS. The present study demonstrated that patients aged
75 years or elder undergoing the Whipple operation requiredincreased medical resources in treating airway and pulmonary
complications even they have similar intra-operative outcomes com-
pared with the younger counterpart. Careful preoperative evaluation
and meticulous perioperative managements, especially focus on re-
spiratory system, are mandatory to decrease morbidity and ICU re-
source utilization.
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INTRODUCTION. There is an increase demand for intensive care unit
(ICU) admission of elderly oncological patients, but the outcome and
factors related to hospital mortality in this subgroup of critically ill
patients are still understudied. Our objective was to assess risk
factors for hospital death in a cohort of elderly patients with solid
cancer admitted to the ICU.
METHODS. This is a retrospective cohort study conducted at a
private tertiary oncological hospital (Hospital Sírio-Libanês) at São
Paulo, Brazil. We extracted relevant information from the adult ICU
database (sistema Epimed™). All consecutive patients ≥ 65 years old
with a diagnosis of active solid cancer were evaluated. We used
univariate and multivariate analysis to identify risk factors associated
with hospital mortality.
RESULTS. Between July 2012 to June 2016 we studied 1562
patients ≥ 65 years old who had cancer (hospital mortality of 17.1%).
Patients who died were more severely ill compared to patients those
who survived (SAPS 3 of 59 [52–68] versus 42 [36–53] respectively;
p < 0.001), were older, more frequently came from the ward with
longer hospital length of stay before ICU admission, had more
comorbidities and worse performance status, higher prevalence of
metastatic disease, more frequently required mechanical ventilation
and vasoactive drugs as well as dialysis, and had a different pattern
of primary tumor site. Independent risk factors for hospital mortality
in our multivariate logistic model were higher SOFA score, admission
source other than the operating room, longer length of stay before
ICU transfer, invasive life support procedures, metastatic disease,
primary tumor site and worse physiological parameters at ICU
admission.
CONCLUSION. Most of risk factor for hospital death in our cohort
were similar to non-oncological patients and reflect the severity of
critical illness.
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INTRODUCTION. As average life expectancy increases, the expectations
of care delivered to the elderly population also rise.However, very old
patients (≥80years) intensive care unite (ICU) admissions are often
questioned by the presence of multiple comorbidities and previous
impaired functional status.
OBJECTIVES. To describe the epidemiology and outcome of patients
≥80years admitted to an ICU.
METHODS. Retrospective analysis of very old patients consecutively
admitted to the ICU in a portuguese university hospital between 01/
01/2015 and 30/06/2016.
RESULTS. A total of 228 patients were admitted (~12% of total
admissions), mostly male(53%) with a mean age of 84(±3,4) years.
The majority of patients(92%) had ≥ 2 comorbidities, mainly
congestive heart failure (17%) and chronic renal disease (17%) and
were considered severe in 23% of them. ICU causes of admission
were: medical (41%), urgent (39%) and elective surgery (10%) and
trauma (10%). At admission, mean SAPS II score was 53,2(±16,5) with
an expected hospital mortality of 50%.Mean SOFA score was7,1(±3,6) and the most prevalent organ dysfunctions were
respiratory(70%) and neurologic(70%). ICU and hospital mortality
were 25% and 36% respectively.Mean ICU length of stay was
6,7(±6,7) days.After 30 days post-ICU discharge, 28% of patients re-
gain their previous functional status.At 6 months, mortality was 53%
and hospital readmission rate was 33%. In univariate analysis, ICU
mortality was associated with total SOFA score at admission (9,3 vs
6,7;p < 0,01), cardiovascular SOFA ≥ 3 (35,7% vs 17,3%;p = 0,003),
neurologic SOFA ≥ 3 (41,8% vs 16,4%;p < 0,001) and SAPS II (66 vs
51;p < 0,001) while 6 months mortality was associated with total
SOFA (8,0 vs 6,6;p = 0,003), neurologic SOFA ≥ 3 (66,7% vs
48,3%;p = 0,011), SAPSII scores (59,6 vs 48,9;p < 0,001) and presence
of severe comorbidities (71,4% vs 51,0%;p = 0,018). Multivariate ana-
lysis showed that SAPSII (OR 1,06; 95%CI 1,03-1,09) and SOFA (OR
1,13; 95%CI 1,01-1,27) scores and admission type (OR 1,74; 95%CI
1,00-3,04) were independently associated with ICU mortality. In
addition, age(OR 1,13; 95%CI 1,02-1,24), SAPSII (OR 1,05; 95%CI 1,02-
1,07), presence of severe comorbidities(OR 2,66; 95%CI 1,12-6,32) and
frailty index (OR 0,86; 95%CI 0,75-0,99) were independently associ-
ated with 6-months. mortality.
CONCLUSION. Although a small percentage (25%) of very old
patients died in ICU and hospital mortality was lower than predicted,
a significant number of patients succumb or are readmitted to a
hospital within a 6 months period.Nevertheless,28% regain their
previous functional status 30 days after ICU discharge. SAPS II, SOFA
score and admission type were associated with ICU mortality.
Variables associated with 6 months-mortality were age, SAPSII, the
presence of severe comorbidities and frailty index.
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INTRODUCTION. Sepsis in a prevalent medical condition in critically
ill patients with high mortality and significant consumption of
health-care resources (1).
OBJECTIVES. To compare outcomes between elderly (≥65 years old)
and non-elderly (<65 years old) patients with sepsis and septic shock
in our ICU and determine short and long term mortality in both
groups.
METHODS. Retrospective cohort study including 261 sepsis and
septic shock patients admitted to the ICU of the the University
Hospital of Río Hortega de Valladolid, for more than 48 hours
between January 2011 to January 2017. Our study consisted of 261
patients, of whom 55 belonged to the group of < 65 years and 206
over 65 years old. We determined the following variables: age,
divided into groups, sex, diagnosis of sepsis, severe sepsis or septic
shock, SOFA scale at 24 h of admission and during the first 7 days of
recovery, APACHE II scale at 24 h of admission, presence of
comorbidities (two groups: < 2 comorbidities and > 2), acute renal
failure, need for renal replacement therapy, need for mechanical
ventilation, stay in resuscitation unit, mortality in ICU unit, at 28 days,
90 days and 1 year before.
RESULTS. Non-elderly patients accounted for 21,1% (55/261) and eld-
erly patients for 78,9% (206/261). Elderly patients had a higher APA-
CHE II score [18 (13–22,25) versus 14 (10–17); p < 0.001], and SOFA
score at 24 H [7 (5–9), versus 6 (5–9) p < 0.05] compared to non-
elderly patients, although the number of organ dysfunctions was not
stadistically significant between both groups neither the number of
days with organ dysfunction. Significant differences were found in
28-day (14,5% versus 32,5%), in-hospital mortality (18,2% Vs 35,4%),
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 236 of 54290-day (20% Vs 37,9%) and 1 year mortality (27,3% Vs 47,6%) rates
between non-elderly and elderly patients respectively.
Predictors of death among elderly patients included the number of
organ dysfunctions, presence of acute kidney failure, heart disease,
non hematological cancer and liver dysfunction.
CONCLUSIONS. Studies published so far of elderly critically ill
patients show a death rate higher than 65%, reporting a mortality
"greater than 92% at 6 months and 97% at 12 months in patients
older than 85 years" according to P Biston (2). In our study, mortality
was increased according to age, but also with some comorbidities
wich may be an independent factor of mortality, and not only age as
reported in other studies until the date. Elderly population will
increase in the forthcoming years so new prospective studies for
long-term impact on functional status and quality of life are
necessary.
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INTRODUCTION. Up to 10% of critical ill patients may present a slow
recovery developing chronic critical illness (CCI)1. Although there's
no consensus in it's definition, it's known that CCI is a complex
syndrome that involves metabolic, neuroendocrine, neuropsychic
and immunological mechanisms2. This group of patients contribute
to an increase in personal, family, financial and institutional burden
and costs.
OBJECTIVES. To identify the main dysfunctions that are related to
the increase of ICU length of stay and mortality.
METHODS. Observational retrospective study, with clinical
information from and ongoing database. The study included patients
admitted to the ICU between 1/1/2015 31/12/2015 and with a n ICU
lenght of stay ≥ 14 days. Criteria for organ dysfunction was
according to clinical criteria SAPS II e APACHE scores.
RESULTS. Of the 474 patients admitted to the ICU during that
period, 72 patients (15.2%) were eligible for the study, 62.5% were
females, with a mean age of 62.5 years old, with mean APACHE
scores of 28 and SAPS II of 60. ICU mortality was 26%. Reason for
admission: 44% medical, 39% non-scheduled surgery, 14% trauma
and 3% elective surgery. The mean ICU length of stay was 24 days,
with a mean time of invasive mechanical ventilation (IMV) of 18 days;
22 patients were submitted to tracheostomy between the 12th and
49th days of ICU stay; 48 patients underwent exclusive enteral feed-
ing, 13 patients received exclusive parenteral nutrition and 10 pa-
tients underwent both. The identified dysfunctions that justified an
increase in the ICU length of stay were respiratory (cRd) - 93%,
neurological (cNd) - 44%, cardiovascular (cCd) - 29%, renal (cR'd)
18%, with patients presenting more than one dysfunction. Despite
the large number of patients with cRd, patients with cNd presented
a greater tendency to the need of tracheostomy (p < 0.007). The dys-
functions that best correlated with mortality, at ICU discharge or hos-
pital discharge, were cCd (p < 0.000 and p < 0.000, respectively) and
cR'd (p < 0.013 and p < 0.009, respectively).
CONCLUSIONS. The respiratory and neurological dysfunctions
significantly increased the mean ICU length of stay. The
cardiovascular and renal dysfunctions were significantly associated
with mortality.
The need for traqueostomy was related with neurological dysfunction.
Early identification of these organ dysfunctions might help us to
identify CCI patients.REFERENCES
1) Leung, D; in American Journal of Hospice and Palliative Medicine;
May 2016;
2) Marchioni, A; in European Journal of Clinical Investigation; 2015
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INTRODUCTION. The National Emergency Laparotomy Audit (NELA)
is a set of national clinical audit projects designed to provide trusts
with reports on their compliance and performance against evidence
based standards for patients undergoing emergency laparotomies1. It
was introduced in 2012 to improve patient care following a high
incidence of death following emergency laparotomy. This quality
improvement project interrogates data from the Heart of England
Foundation Trust (HEFT) and looks at mortality and the characteristics
of patients who have underwent emergency laparotomy requiring
intensive care in order to identify areas to improve patient care.
OBJECTIVES.
1) Number of emergency laparotomies requiring admission to the
Intensive Care Unit (ICU) at HEFT
2) Length of stay in ICU
3) Number of laparotomy admissions resulting in death
4) Age of patients who died following surgery and ICU admission.
METHODS. Data (n = 316) consisted of all patients admitted to ICU
following emergency laparotomy between the years 2015 and 2016
from two sites across HEFT. All information on patient age, type of
surgery, admission time, discharge time and mortality were collected
from patient notes and compiled onto a spreadsheet. Analyses were
conducted using descriptive statistics.
RESULTS. During 2015 and 2016 there were 316 emergency
laparotomies requiring ICU admission. Small bowel and large bowel
pathology accounted for 58% (n = 173) of cases. Average length of
stay was 88.6 hours but lower for large (72.7 hours) and small bowel
(85.4 hours) conditions compared to non-bowel pathology (100.4
hours). Overall ICU mortality was 11.0% (n = 33) but had increased from
8.2% in 2015 to 13.3% in 2016. Small bowel laparotomy resulted in the
greatest mortality (14.1%) followed by non-bowel (11.1%) and large
bowel procedures (6.8). 60% of those who died were admitted out of
hours. 63% of all patients who died were above 71 years of age.
CONCLUSIONS. Patients aged over 70 years have an increased risk of
mortality. This may be because elderly patients are more likely to
have significant comorbidity and required increased cardiovascular
and respiratory support. Other considerations for increased mortality
include the surgical procedure and admission time.
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INTRODUCTION. The number of elderly patients admitted to intensive
care unit (ICU) has been increased worldwide. Elderly patients are
subjected to various physiologic changes related to aging process and it
has been recognized that aging is an important predictor for mortality.
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 237 of 542OBJECTIVES. The aim of this present study is to determine the
hospital mortality in elderly patients admitted to general surgical
ICUs at a tertiary referral hospital in Thailand.
METHODS. This was a retrospective study of the prospective
observational cohort study conducted in two general surgical ICUs at
Siriraj Hospital between April 2011 and November 2012. Elderly
patients were defined as patients whose age of more than 70 years
old. Demographic data and clinical outcomes were collected. The
adjusted logistic regression analysis was performed to identify
independent risk factors for hospital mortality.
RESULTS. There were 377 elderly patients admitted to general
surgical ICU, which was accounted for 41.7% (95% CI, 38.5-45.0%) of
all admission and their mortality was 12.5% (95% CI, 9.4-16.3%). Age
of more than 70 years old was an independent risk factor for
hospital mortality in patients admitted to ICU (adjusted OR, 1.85;
95% CI, 1.07-3.21). Three independent risk factors for hospital
mortality in elderly patients admitted to ICU included APACHE II
score of more than 15 (adjusted OR, 7.06; 95% CI, 3.29-15.16) and
presence of coagulation and cardiovascular dysfunction at ICU
admission (adjusted OR, 3.39; 95% CI, 1.38-8.31 and adjusted OR,
2.66; 95% CI, 1.21-5.84; respectively).
CONCLUSIONS. Hospital mortality in elderly patients admitted to
general surgical ICU was 12.5%. Age of more than 70 years old was a
risk factor for mortality in patients admitted to general surgical ICU.
Among elderly patients, severity of acute illness was an important
risk factor for hospital mortality.
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INTRODUCTION. Early warning scores (EWS) are recommended as
part of tools in the early recognition and response to patient who
get worse breathing 65 years or more than older patients.
OBJECTIVES. The objective of this research is to evaluate the
predictability of Modified Early Warning Scores (MEWS) for the
elderly patients with respiratory difficulties in emergency
department.
METHODS. This retrospective study was conducted demographic
data, laboratory data, and Framingham criteria influencing MESW
using medical records older than 65 years who had visited tertiary
emergency department from January 2015 to December 2016. The
usefulness of MEWS as a predictor for the patient's need for ICU care
was analyzed using IBM SPSS Statistics for Windows.
RESULTS. Of the 213 patients, 142 patients (84 males) were enrolled
in the analysis. Pulmonary disease was diagnosed in 74 patients
(52.2%) and 49 patients (34.5%) in cardiogenic disease. We found the
following factors influencing MEWS; arterial carbon dioxide (β = .203,p < 0.001) and body temperature (β = .176, p < 0.006), heat beat
rate (β = .247, p < 0.001), systolic blood pressure (β = .329,
p < 0.001), and lactate (β = .282, p < 0.001). The receiver operator
characteristic (ROC) curve shows that MEWS has higher sensitivity
and specificity than lactate and temperature.
CONCLUSIONS. MEWS is good predictor for the patients aged 65 or
older with dyspnea in emergency department with higher sensitivity
and specificity. MEWS can be used to predict for ICU care need and
clinical deterioration.
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INTRODUCTION. Donor shortage together with the increase in organ
demands have led to the development of different strategies aimed
at raising organ retrieval rates. Amongst these strategies, the
evaluation of expanded criteria donors has aroused as an alternative.
OBJECTIVES. To assess the viability of livers harvested from
very elderly donors (≥80 years), and to study the evolution of
both the graft and the recipient during a minimum follow-up
period of six months.
METHODS. Retrospective study (January 2011 - December 2016),
including very elderly liver donors, which were offered by the
National Transplant Organization to the Transplant Coordination
Team of Puerta de Hierro Majadahonda University Hospital. We
compared livers discarded exclusively because of donor's age to
those who were implanted. The following variables were studied:
age, sex, body mass index, cardiovascular risk factors, toxic habits,
comorbidities, natraemia, use of vasoactive drugs, development of
diabetes insipidus, use of antibiotics (prophylactic or therapeutic)
and length of ICU stay. We also conducted a six-month minimum
follow-up of recipients, assessing graft and patient survival.
RESULTS. During the period studied a total of 66 livers were offered
(Fig. 169). Of the 49 (74.2%) livers rejected, in 26 (39.4%) the
reason stated for rejection was age exclusively. Seventeen (25.8%)
livers ≥ 80 years of age were implanted, of which two needed
retransplantation. There were no statistically significant
differences between livers rejected and implanted in the variables
detailed above, except for the number of comorbidities, which
were lower in the rejected group. During the follow-up period
four deaths were registered.
CONCLUSIONS. In our series, liver rejection due exclusively to age
was frequent. Recipients of livers that came from very elderly donors
had an evolution that is similar to what has been previously
described for younger livers.
Very elderly patients should be evaluated carefully as liver donors
before discarding them based exclusively on age criteria.
Fig. 169 (Abstract 0463) See text for description Table (Abstract 0464). Test charactertistic of high and low risk groups
Risk Sensitivity (95%
Confidence
Interval)
Specificity
(95% CI)
Positive
Predictive
Value (95% CI)
Negative
Predictive
Value (95% CI)
REDS
score- Low
15.00
(9.14-22.67)
48.54
(45.07-52.02)
4.08
(2.69- 6.15)
79.64
(77.92-81.26)
REDS
score-High
85.00
(77.33-90.86)
51.46
(47.98-90.86)
20.36
(18.74-22.08)
95.92
(93.85-97.31)
ΔSOFA-Low 24.17
(16.28-32.83)
44.16
(40.73-47.63)
5.94
(4.38-8.02)
79.96
(77.84-81.91)
ΔSOFA-High 75.83
(67.17-83.18)
55.84
(52.37-59.27)
20.04
(18.09-22.16)
94.06
(91.98-95.62)
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 238 of 542Sepsis epidemiology and early identification
0464
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INTRODUCTION. The objective criteria defining sepsis is a ≥2 point
increase in the Sequential Organ Failure Assessment (SOFA) score.
This is associated with a minimum 10% mortality rate, thus risk
stratifying patients for mortality. But accurate calculation of the SOFA
score in a busy emergency department (ED) is difficult and inaccurate
as some criteria are not met or measured in the ED.
The quick SOFA (qSOFA) is a rule-in score [1] and cannot be used
alone. The Mortality In Severe Sepsis in the Emergency Department
(MISSED) score together with refractory hypotension and hyperlac-
taemia would identify the majority but not all deaths [2]. Both the
qSOFA and MISSED (Age ≥65y, albumin ≤27g/l, INR ≥ 1.3) scores
have three variables each and range from 0–3 and a score ≥2 is
deemed high-risk.
OBJECTIVES. To create a scoring system combining the validated
MISSED and qSOFA scores with refractory hypotension and
hyperlactaemia, to risk-stratify ED patients admitted with an infection
for in-hospital mortality and compare its performance to that of the
change in SOFA (ΔSOFA) score to do the same.
METHODS. Patients aged ≥18y admitted from the ED who received
intravenous antibiotics for an infection and met at least one Red-Flag
or two SIRS criteria on presentation, were included. Each patient was
scored 0–3 for MISSED and qSOFA scores. Refractory hypotension
and lactate were allocated scores ranging from 0 to 3. Refractory
hypotension with lactate ≤2 and >2mmol/l were scored 2 and 3, re-
spectively, a score of 1 was not allocated. Lactates ≤2, 2.1-3.9 and
≥4mmol/l were scored 0, 1 and 3, respectively. The cumulative score
of all four scoring systems, the Risk-stratification of ED Sepsis (REDS)
score, ranged from 0–12. A score ≥2 in any one of the fours constitu-
ent scoring systems placed the patient in a high-risk category as did
a cumulative score of ≥3. Patients with a ΔSOFA score of ≥2 were
classed as high-risk. Missing values were assumed to be normal.
RESULTS. Population: 942 patients including 120 deaths. The area
under the receiver operator characteristic (AUROC) curve for the
REDS score 0.774 [95%CI 0.745-0.800) was greater than the AUROCcurve for the ΔSOFA score 0.707 [95%CI 0.677-0.736]; p = 0.0036.
Odds ratio for mortality, between high-risk and low-risk categories in
the REDS score was 6.01[95%CI 3.57-10.10]; p < 0.0001, and that for
the ΔSOFA score was 3.97[95%CI 2.56-6.16]; p < 0.0001.
CONCLUSIONS. The REDS score is equivalent to ΔSOFA to risk stratify
ED patients with an infection, for mortality.
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INTRODUCTION. In the presence of sepsis or septic shock, delay in
administration of appropriate antimicrobials is associated with an
increase in mortality [1]. Matrix-assisted laser desorption/ionization
time-of-flight (MALDI-TOF) has been found to decrease time to
microorganism identification by 1.2-1.5 days compared to conven-
tional methods [2]. However, there are limited data focusing the use
of MALDI-TOF on patients with sepsis.
OBJECTIVES. To evaluate the impact of MALDI-TOF on clinical and
antimicrobial therapy-related outcomes in patients with sepsis.
METHODS. A total of 98 adult patients with bacteremia who met ≥2
quick SOFA criteria and were admitted to the intensive care unit
(ICU) were reviewed. Patients for whom microorganisms were
identified via MALDI-TOF (between March 2014 and February 2016;
n = 58) were compared with patients for whom microorganisms
were identified using conventional methods (between March 2011
and February 2013; n = 40).
RESULTS. The mean time from blood culture drawn to
microorganism identification and the availability of antimicrobial
susceptibility results was significantly shorter in the MDLDI-TOF
group compared with the conventional group (90.2 ± 32.1 h vs.
108.7 ± 43.1 h; P = 0.02). In the MALDI-TOF group, the proportion of
patients with appropriate antimicrobial therapy before susceptibility
results were significantly higher than those in the conventional
group (77% vs. 47%; P = 0.005). The 28-day mortality after ICU admis-
sion was 40% in the MALDI-TOF group and 70% in the conventional
group (P = 0.003). In survivors, there were no differences between
the groups with regard to duration of mechanical ventilation and ICU
Table 130 (Abstract 0466). See text for description
Table 131 (Abstract 0466). See text for description
Fig. 170 (Abstract 0466). See text for description
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organism identification via MALDI-TOF associated significantly with
mortality (OR, 0.28; 95% CI, 0.12-0.66) along with malignancy (OR,
8.83; 95% CI, 2.76-28.27) and baseline SOFA score (OR, 1.31; 95% CI,
1.14-1.50).
CONCLUSIONS. Our results suggest that rapid identification of
microorganisms in blood via MALDI-TOF was associated with ap-
propriate antimicrobial therapy and decreased mortality in pa-
tients with sepsis.
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INTRODUCTION. The Sepsis-3 definition recently released claimed for
validation in low and middle income economies. Besides, there was
no data regarding sepsis characteristics and outcomes in Argentina.
Hence the SATI and the National Ministry of Health launched a pro-
spective cohort study to address these relevant issues.
OBJECTIVES. To analyze epidemiological features and validate the
Sepsis-3 definitions.
METHODS. Prospective national cohort study. SATI sent invitations,
and a website-based database was designed to collect data. Between
7/1-9/1/16,patients admitted to the ICU with suspected infection that
triggered blood cultures and antibiotic administration were included
as these categories: 1. Infection; 2.Sepsis (infection + SOFA ≥ 2);
3.Septic shock (inotropics + lactate ≥2 mmol/L); 4.Cardiovascular dys-
function (lactate ≥2 without inotropics); 5. Inotropics without lactate
measurement. Epidemiological, self-perceived health status (E-QoL
VAS),Sepsis-3, infectological and management data were recorded.
Hospital mortality was the main endpoint. Kaplan-Meier curves were
constructed for each category and compared (logrank). Variables dif-
fering from survivors and nonsurvivors were entered in a logistic re-
gression model. ROC curves were built to assess SIRS, qSOFA and
SOFA performance. A p value of 0.05 was considered significant.
Adjustement for multiple comparisons was made if necessary.
RESULTS. 809 patients from 47 UCIs were included; 44% had
respiratory infections, 19% UTI, 9% intrabdominal, 6%soft tissue and
3% catheter-related. 28% of cultures were negative. Different variablesand outcomes for the entire population, comparisons between categor-
ies, and Kaplan Meier curves are shown in Table 130 and Fig. 170.
General mortality was 38%, and by categories 13%, 20%, 38%, 51% and
39% respectively; independent predictors are displayed on Table 131.
Crude AUROC values for SIRS, qSOFA and SOFA were 0.51[0.47-0.55],
0.52[0.48-0.55] and 0.73[0.79-0.77] respectively (P = 0.000).
CONCLUSIONS.
1) Increasing severity of Sepsis-3 categories adequately tracks mortality.
2) Lactate measurement was not an impediment for diagnosis of
septic shock (available in 97%of patients).
3) As recently published, SOFA shows acceptable predictive validity
for ICU patients, whilst SIRS and qSOFA exhibited low discrimination.
4) The findings of this study, the first prospectively carried out
in a LMIC, support the usefulness of the Sepsis-3 definition re-
cently issued.
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INTRODUCTION. The early identification of the microorganism
causing infection in a patient with sepsis could have an influence in
the initial treatment and an impact on prognosis. Regular cultures
don't usually provide a rapid diagnosis. IRIDICA PCR / ESI-MS (Abbott)
is a blood qualitative diagnostic technique that identifies bacteria
and Candida sp nucleic acids in septic patients in 7 hours. It also
identifies genes that encode resistance to antibiotics (blaKPC, mecA,
vanA, vanB). DNA is amplified by PCR and analyzed by mass spec-
trometry ionization electrospy (PCR / ESI-MS).
OBJECTIVES. Evaluation of PCR / ESI-MS ability to detect bloodstream
microorganisms in septic patients.
METHODS. We included all septic patients with CS activation
admitted to the hospital between May and December 2016.We
analyzed 1 blood sample with PCR / ESI-MS and two blood cultures
taken at least 1 hour apart. We were on continuous communication
with the Department of Microbiology to perform the technique and
read the results. We compared the results of blood cultures and PCR
/ ESI-MS. The quantitative variables are expressed as average (SD)
and categorical variables as percentage. The Ethics Committee ap-
proved the study IRIDICA and CS: PR (AG) 162/2016, PR (AG) 88/2016
and PR (AG) 336/2016.
RESULTS. We obtained 252 samples, 4.3% were rejected for technical
error and 19.44% for polymicrobial detection and confusing
interpretation. Of the remaining 190 samples, 62.1% were septic
shock infection and 37.9% with sepsis. Age of the patients were 60.1
(SD 16.4), men 63.7%, SOFA score 6.6 (SD 3.4). The sources of
infection were: abdominal 32.1%, respiratory 26.8%, urinary 22.1%
and other 19%. Required drainage of the source of infection 22.1%
and Intensive Care Unit (ICU) admission 52.6%. Required
norepinephrine 46.3%, mechanical ventilation 21%, high flow nasal
cannules 19.4% and renal replacement therapy 12.1%. The hospital
mortality was 25.8% and the hospital mortality in ICU patients was
38.9%.Taking as gold standard all clinical and available cultures, the
obtained values for sensitivity, specificity, positive predictive and
negative predictive were 91.2%, 86.9%, 89.2% 90 2% for IRIDICA® and
61.6%, 89.9%, 85.5%, 70.8% for blood cultures. The results of PCR /
ESI-MS were obtained in the following 7 hours whereas positivity of
blood cultures ranged from 10 hours to several days.
CONCLUSIONS. PCR / ESI-MS provides a fast and reliable identifica-
tion of microorganisms responsible for a blood infection in patients
with sepsis. The high sensitivity and specificity make technical PCR /
ESI-MS a valuable tool for diagnosing septic patients and could im-
prove their optimal management and prognosis.
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INTRODUCTION. Chronic comorbid conditions are present in the
majority of sepsis patients and these patients have a significantly
worse outcome than patients without comorbidities. It is thought
that sepsis occurs as a terminal event in a proportion of sepsis
patients dying from a disease process other than sepsis.
OBJECTIVE. To determine the attributable mortality of sepsis in
critically ill adult patients in intensive care.
METHODS. We conducted an inception cohort study including all
patients admitted to the ICU at a tertiary hospital in Sydney,
Australia between October 1st 2016 and December 31st 2016. In all
patients diagnosed with sepsis using clinical criteria we used an
adjudication system where clinicians estimated the pre-sepsis life ex-
pectancy of patients who died in-hospital within 60 days. Patients
who had an estimated life expectancy of less than 90 days were ad-
judicated to have died with sepsis rather than from sepsis.
RESULTS. From 864 patients admitted, 146 (16.9%) patients were
prospectively diagnosed with sepsis and included. Comorbidities
were present in 117/146 (80.1%) of patients. 39/146 (26.7%) died in-
hospital within 60 days. 30/39 (76.9%) of deceased patients were ad-
judicated not to be in a terminal phase of an underlying disease
process before onset of sepsis. These deaths were therefore adjudi-
cated to be directly attributable to sepsis.
CONCLUSIONS. Despite the presence of comorbidities in the
majority of patients, most patients who died were not in a terminal
stage of an underlying disease process when sepsis occurred.
Therefore, sepsis did result in an appreciable loss of life years.
Further research in this area is warranted.
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INTRODUCTION. According to changes for definitions in sepsis and
septic shock during the last year and the latest recommendations
published by the Surviving Sepsis Campaign there is an important
request for improving our system of detection and management of
septic patients.
OBJECTIVES. Evaluate the usefulness of sepsis bundles accomplishment
at the emergency department and intensive care unit in septic patients
admitted in a tertiary hospital.
METHODS. A prospective observational study was performed in a
tertiary hospital in Spain. Data was collected from patients with
criteria for sepsis at all emergency levels, and from all the patients
admitted with septic shock at the intensive care unit between the
period from December 2015 to March 2017. We evaluated the
accomplishment of the initial measures of resuscitation, control of
infection source and adjuvant treatment in patients with sepsis and
septic shock.
RESULTS. 171 patients were enrolled. 60,8% of patients were men,
and mean age was 62,2 +/− 14 years. Sepsis was identified at
emergency department (72%), at other hospital (11%) and at ward
(10%). Sepsis protocol was electronically activated in only 20% of
these patients. 38% of these patients developed septic shock. The
most frequent etiologies of sepsis were pneumonia 32,7% and
urinary infection with 32,2%. 43% of the blood cultures were
positive. Mean Systolic blood pressure (SBP) was 96.4mmHg, mean
leucocytes were 16800 +/− 14000 mm3, mean creatinine was 137+/− 81
umol/l, mean central venous oxygen saturation was 76,5%. Mechanical
ventilation was required in 16,3% of patients, and non invasive
ventilation in 12,9%. Steroids were used in 23,7% of patients and 7,7%
required renal replacement therapy. Accomplishment of bundles in
patients with electronically protocol activation was better specially
concerning initial resuscitation measures. Global mortality was 20,7%.CONCLUSIONS. Electronically sepsis protocol activation can be a
useful tool in septic patients but our actual utilization is still low.
REFERENCE(S)
Rhodes A et al. Surviving Sepsis Campaign: International Guidelines
for Management of Sepsis and Septic Shock: 2016. Intensive Care
Med. 2017;43:304–377.0471
MALDI-TOF MS is not superior to standard blood-cultures in
patients with infection who require mechanical ventilation or
noradrenalin
J. Golub1, A. Markota1, S. Lorenčič-Robnik2, A. Sinkovič3
1University Medical Centre Maribor, Medical Intensive Care Unit, Maribor,
Slovenia; 2National Laboratory of Health, Environment and Food, Centre
for Microbiology and Imunology, Maribor, Slovenia; 3Faculty of Medicine
University of Maribor, Maribor, Slovenia
Correspondence: A. Sinkovič
Intensive Care Medicine Experimental 2017, 5(Suppl 2):0471
INTRODUCTION. Identifying microorganisms from blood in septic
patients is paramount in sepsis(1). Matrix assisted laser desorption
ionisation-time mass spectroscopy (MALDI-TOF MS) is one of new
methodes for rapid microbal idetification that has proven to have
many advantages in the past studies (2).
OBJECTIVES. The aim of this study was to compare blood culture
(BC) technique and MALDI-TOF MS.
METHODS. We performed a retrospective study on critically ill
patientes who were hospitalised between January and March 2015 in
a medical intensive care unit. We included patients with infection
who required mechanical ventilation or noradrenalin. Standard BC
were used as the gold standard. Multiple sets of BC (2 aerobic and 2
anaerobic bottles, 40 ml of blood in total) were allowed for each
patient. One pair of BC was considered as one study sample. MALDI-
TOF MS assay was performed from positive BC bottles in an auto-
mated system (BacT/ALERT®,Biomérieux, USA). Medical documenta-
tion for 81 patients was examined for basic demographic data, BC
results, MALDI-TOF MS results, time to results and time to change of
antimicrobial therapy.
RESULTS. We included 81 patients, 51 (63%) were men. The total
number of samples was 147. Mean age was 64 ± 14 years. Survival at
discharge from intensive care unit was 65,4%, and survival at
discharge from hospital was 53,0%. Concordance between BC and
MALDI-TOF MS was: +/+ 16 (10,8%), −/− 114 (77,5%), +/− 17 (11,6%)
and −/+ 0 (0%). Sensitivity was 48,5%, specificity was 100% and
negative predictive value was 87%. Positive BC bottles are the starting
point for MALDI-TOF MS assay, which needs to be considered when
interpreting concordance with BC. In cases where MALDI-TOF MS was
positive and BC negative other microbiological samples (e.g. urine,
tracheal aspirates, wound swabs…) were examined for concordance
with MALDI-TOF MS, and none were discovered. Time to results was
31,1 ± 15,2h for BC, and 31,4 ± 17,3h for MALDI-TOF MS, p = 0.6.
CONCLUSIONS. According to our study MALDI-TOF MS is not superior
to standard BC in identifying pathogens in patients with infection who
required mechanical ventilation or noradrenalin. Further studies are
required to evaluate the role of MALDI-TOF MS assay in critically ill.
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INTRODUCTION. The Third International Consensus Definition Task
Force released clinical criteria for sepsis and septic shock (Sepsis-3) in
20161). Although the Task Force encouraged clinicians to apply the
Sequential Organ Failure Assessment (SOFA) score in intensive care
units (ICUs) and the quickSOFA (qSOFA) score outside the ICU, there
is no evidence to suggest which scoring system should be used in
tertiary critical care emergency centers, which primarily treat referred
and/or complicated patients.
OBJECTIVES. To compare the prognostic value of the SOFA score,
qSOFA score, and systemic inflammatory response syndrome (SIRS)
criteria for patients with suspected infection admitted to a tertiary
critical care emergency center.
METHODS. In this retrospective observational study, we reviewed the
medical records of patients admitted to our emergency department
between September 2014 and August 2016 who underwent
bacteriological culture and treatment with antibiotics within 2 days of a
primary diagnosis of infection. The patients' clinical data were retrieved
from electronic medical records. The SOFA score, qSOFA score, and
number of SIRS components on admission were retrospectively
determined using these data. We evaluated the prognostic value of the
SOFA and qSOFA scores and the SIRS criteria for the following
outcomes: in-hospital mortality, ICU-free days, and length of stay.
RESULTS. Overall, 174 patients were included in this study. Their
mean age was 69 years (standard deviation: 16 years), 160 patients
(92%) were treated in the ICU, and 29 patients (17%) died in hospital.
The hospital mortality rates were significantly greater in patients with
SOFA scores ≥ 2 vs < 2 (22% vs 2%, P < 0.01) and qSOFA scores ≥ 2
vs < 2 (27% vs 8%, P < 0.01) but not between ≥ 2 vs < 2 SIRS
components (16% vs 19%, P = 0.73). A SOFA score of ≥ 2 on
admission was a better predictor of in-hospital mortality compared
with the qSOFA score and SIRS criteria (sensitivity: 0.97, 0.76, and 0.21,
respectively). Furthermore, in-hospital mortality was significantly asso-
ciated with SOFA (odds ratio [OR] 1.36, 95% confidence interval [CI]
1.20-1.54, P < 0.01) and qSOFA (OR 1.93, 95% CI 1.20-3.10, P = 0.01) but
not with SIRS criteria (OR 0.82, 95% CI 0.55-1.24, P = 0.35).
CONCLUSION. A SOFA score of ≥ 2 on admission showed greater
sensitivity and prognostic utility for detecting patients with severe
infection compared with a qSOFA score of ≥ 2 or the presence of ≥ 2
SIRS components among patients admitted to a tertiary critical care
emergency center.
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Intensive Care Medicine Experimental 2017, 5(Suppl 2):0473INTRODUCTION. An in-hospital sepsis code can help in the
standardization of management of sepsis/septic shock and improve
morbimortality.
OBJECTIVES. To analyze the activations of an in-hospital sepsis code
(SC) and to analyze the demographic and diagnostic characteristics
of sepsis/septic shock patients.
METHODS. Prospective observational study of SC patients during 1
year (15-oct-2015 - 15-oct-2016) in a third level hospital. Demo-
graphic data, APACHE II score, laboratory data, physiological vari-
ables, Intensive care unit (ICU) and intrahospital mortality were
recorded in patients with suspected sepsis or septic shock. SEPSIS III
definitions were used. This study was approved by Ethical Committee
(PR(AG)336/2016). Quantitative variables with normal distribution
have been expressed as mean ± standard deviation, non-normal dis-
tribution as median and interquartile range (25-75%) and categorical
variables as a percentage. Statistical analysis was done with SPSS
18.0 (SPSS Inc., Chicago, IL, USA).
RESULTS. 517 patients (55.3% men) were included with a mean age
63.7 (±16.6) years and APACHE II 23.5 (±8.9). 44.9% of the activations
were made by the Emergency Department, 18.6% by the Intensive
Care Unit and 5.8% by the General Surgery Department. Of all SC
activations, 28.8% were by sepsis; 51.93% septic shock; 11.6% for
infection without sepsis and 7.11% were not infection. The most
frequent sepsis focuses were abdominal (32.17%) followed by
respiratory (27.8) and urinary (23.8%). Blood cultures were performed
in 93.8% of the cases (42.9% positive). The most frequent
microorganisms were E. coli (30.9%), K. pneumoniae (7.9%) and P.
aeruginosa (7.9%). The control of the septic focus was performed in
39.5% of the cases. 64.8% of patients required vasoactive drugs and
31.8% mechanical ventilation, 11.7% HFNC and 11.7% renal support
techniques. 180 patients were admitted to the ICU (49.4%), 47 died
(26.1%). The in-hospital mortality of patients admitted to the ICU was
54 (29.4%) and those not admitted to the ICU 39 (21.1%) with an
overall mortality of 96 (26.5%).
CONCLUSIONS. Sepsis code is mainly activated in the emergency
room and the wards. Most activations are on septic shock patients.
The knowledge of the most frequents focus of infection and
associated pathogens can help with treatment.
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INTRODUCTION. As a major worldwide public health problem, sepsis
carries a high disability and mortality rate. Epidemiologic data about
sepsis are still scarce and are mainly from developed countries.
OBJECTIVES. To determine prevalence of sepsis and septic shock at
admission to an ICU and to determine factors affecting 28th-day
mortality.
METHODS. Patients admitted to a 9-bed medical-ICU of a university
hospital between 1.1.2007-31.12.2014 were analyzed retrospectively.
Patients were classified as no-sepsis, sepsis and septic shock groups
at admission according to new Sepsis-3 definitions. Comparisons
were done between 3 groups and between survivors and non-
survivors. Kaplan-Meier survival analysis was performed and logistic
regression analysis was done to determine independent predictors of
28th-day mortality.
RESULTS. Data of 1404 patients were analyzed. Sepsis was the
reason for admission in 536 (38.3%) patients, 164 (11.7% of all) of
whom had septic shock. When no-sepsis, sepsis and septic shock
groups were compared, APACHE-II, SOFA and Charlson co-morbidity
scores were highest in septic shock group (p < 0.001 for all). 28th-
day mortality was 16.5%, 31.2%, 49.4% and hospital mortality was
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 243 of 54226.3%, 50.3% and 70.1% in no-sepsis, sepsis and septic shock groups,
respectively (p < 0.001 for both). Kaplan-Meier survival analysis
showed similar results in terms of 28th-day and hospital mortality, re-
vealing that the survival was worst in septic shock group (log-rank
test, p < 0.001, for both). When 8 year period was divided into quar-
tiles, frequency of sepsis increased from 1st to 4th quartile (35.3%,
35.0%, 40.6% and 41.8%; respectively; p = 0.002). However, there was
no significant difference in 28th-day (24.7%, 24.5%, 25.5%, 22.4%; re-
spectively; p = 0.80) and hospital mortality (35.0%, 35.3%, 43.9%,
37.2%; respectively; p = 0.06) between quartiles. In logistic regression
analysis, presence of sepsis at admission was an independent risk
factor for 28th-day mortality as compared to no-sepsis group (OR
(95% CI): 1.51 (1.06-2.16); p = 0.02). Other factors affecting mortality
were a high admission APACHE-II, SOFA, Charlson co-morbidity
scores; admission lactate level >2mmol/L and administration of fresh
frozen plasma.
CONCLUSIONS. According to new sepsis definitions, sepsis is
responsible from 38.3% of admissions during an 8 year period in a
medical-ICU with high 28th-day and hospital mortality rates. Al-
though frequency of sepsis increased from 2007 to 2014, mortality
rates did not increase significantly. Presence of sepsis at admission
was an independent risk factor for 28th-day mortality.
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INTRODUCTION. Blood cultures are routinely taken at the time of
admission to the intensive care unit (ICU) for patients suspected to
have infection. We undertook this study to determine the incidence
of bacteremia in our area and to assess its impact on the outcome of
our patients.
OBJECTIVES. To analyze the characteristics of the bacteremias
admitted in the ICU of Punta de Europa Hospital: community-
acquired (CB) and nosocomial-acquired (NB).
METHODS. Descriptive retrospective analysis performed in a 12-bed
ICU between 2015 and 2016. BC was considered to be the one with
positive blood culture at < 48 hours of admission, and BN if blood
culture was positive after 48 hours of admission. Demographic vari-
ables, comorbidities, risk factors, clinical situation, severity scores, ICU
and hospital length of stay (LOS) were recorded.
Statistical analysis: categorical variables (frequencies and percentages)
and numerical variables (mean and standard deviation or medians
and interquartile range). Comparisons: X2 test (percentages),
Student´s test (means) and Kruskal-Wallis test (medians). Statistical
significance p < 0.05.
RESULTS. 72 bacteremias were included: 33 (45,8%) CB and 39
(54,1%) NB. Significant differences were found in patient type
(medical: CB 84.8% vs NB 38.5%, p < 0.01), diabetes (CB 42.4% vs
NB 69.2%, p = .022), previous hospitalization (CB 3% vs NB 30.8%,
p = .002), previous isolation of multiresistant bacteria (CB 3% vs NB
23.1%, p = .017), bladder catheter (CB 54.5% vs NB 89.7%, p = .001),
central catheter (CB 69.7% vs NB 92.3%, p = .013), postoperative
wound (CB 15.2% vs NB 64.1%, p < .001), SOFA (CB 2.8 [1.5] vs NB3.6 [1.5], p = .029), use of catecholamines (CB 57.6% vs NB 92.3%,
p = .001), LOS in ICU (CB 5 [3; 12] vs NB 14 [6; 27], p = .009),
hospitalization (10 [7; 17.5] vs 32 [16; 69], p < .001). Site of infection
(p = .025): CB (urinary 30.3%, respiratory 24.2%, abdominal 15.2%),
NB (abdominal 33.3%, CRB 25.6%, unknown 15.6%). Most frequent
microorganisms isolated: CB (E. coli 33.3%, S. epidermidis 18.2%), NB
(S. epidermidis 25.6%, E. coli 17.9%). Empiric antibiotic (ATB): CB
(without ATB 42.4%, ceftriaxone 21.2%), NB (without ATB 30.8%,
piperacillin/tazobactam 25.6%). Directed ATB: CB (ceftriaxone
18.2%, piperacillin/tazobactam 15.2%, meropenem 12.1%), NB
(piperacillin/tazobactam 23.1%, meropenem + vancomycin 23.1%,
imipenem 12.8%).
CONCLUSIONS. NB were related to increased use of central catheters,
bladder catheter, surgical procedures, days of hospitalization and
previous isolation of multiresistant bacteria. The mortality of
bacteremia is high, although there were no differences between CB
and NB. The most frequent site of infection were urinary (CB) and
abdominal (NB).0476
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INTRODUCTION. Septic patients frequently require ICU admission as
well as agressive treatments such as intravenous antibiotics,
mechanical ventilation and use of corticosteroids. Delay in time to
start the treatment may lead to severe complications or death.
OBJECTIVES. To analyze the factors related to the mortality of septic
patients admitted to the ICU of a regional hospital during 2016.
METHODS. Descriptive retrospective analysis performed in a 12-bed
ICU during the year 2016. Demographic variables, comorbidities, risk
factors, mortality predictors (APACHE II and SOFA), antibiotic therapy
(ATB), ICU and hospital length of stay (LOS) and mortality. Statistical
analysis: categorical variables (frequencies and percentages) and
numerical variables (mean and standard deviation or medians and
interquartile range). Comparisons: X2 test (percentages), Student
test (means) and Kruskal-Wallis test (medians). Statistical signifi-
cance with p < 0.05.
RESULTS. 94 patients were included: 58.5% male, medical patients
56.4%, surgical patients 40.4%, trauma patients 3.2%. Mean age
61.6 ± 14.3. APACHE II 17.6 ± 5.9. SOFA 7.4 ± 3.4. 48.9% came from
the Emergency area and 35.1% came from a surgical area. The most
common site of infection was abdominal (44.7%), followed by
respiratory (26.6%) and urinary (13.8%). Global mortality: 36.2%.
There were no statistically significant diferences between gender,
age, type of patient, comorbidities, site of infection, ICU and hospital
LOS. Patients who died had more days of mechanical ventilation
(76.5% vs 43.4%, p = .002), corticoids (20.6% vs 5.0%, p = .033),
higher APACHE II score (20.7 [5.2] vs 15.9 [5.6], p < .001), and SOFA
score (9.5 [3.2] vs 6.2 [2.9], p < .001) at ICU admission. Most used
antibiotics: piperacillin/tazobactam (17.6%), meropenem (17.6%)
and ceftriaxone + levofloxacion (17.6%). Appropriate antimicrobial
treatment: deceased 29.4% vs survivors 43.4%, p = .182. There was
no difference in the de-escalation percentage.
CONCLUSIONS. The use of mechanical ventilation and corticosteroids
were associated with higher mortality in septic patients admitted to
the ICU, as well as a higher APACHE II and SOFA score at admission.
The choice of the initial antimicrobial had no influence on mortality.
The inadequate antimicrobial treatment was not significantly
associated with higher mortality.
Fig. 172 (Abstract 0477). a Time to Antibiotics. b Time to Sepsis 6
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INTRODUCTION. UK national guidelines advocate completion of
Surviving Sepsis Campaign (SSC) resuscitation bundle within 1 hour
of a patient being identified septic.[1] Bundle implementation has
been associated with improved mortality outcomes.[2] Furthermore,
pre-hospital identification of sepsis has been associated with more
timely delivery of resuscitation measures [3].
OBJECTIVES. To compare the impact on measures of process and
outcome in potentially septic patients flagged pre-hospital or in the
emergency department (ED).
METHODS. A single-centre, prospective cohort (2014–16) of ED pa-
tients (n = 672), identified as potentially septic, was analysed for
measures of process (time to antibiotics, to completion of SSC resus-
citation bundle) and outcome (30 day mortality, admission to inten-
sive care, length of hospital stay, final coded diagnoses of sepsis
and/or infection). Those identified pre-hospital were compared with
those identified on ED arrival.
RESULTS. 307 of the cohort were identified by ambulance crew pre-
hospital and a further 365 were identified in the ED. Age, gender,
previous medical history, lactate level and acute kidney injury inci-
dence were not significantly different between the groups. Incidence
of final coded diagnosis of sepsis was not significantly different be-
tween groups. However, when infection was added as final diagnosis
code, significantly more pre-hospital patients had a final diagnosis of
´sepsis and/or infection´ (89% vs 82% p < 0.05).
There was a significant association with earlier delivery of processes
of care in patients identified pre-hospital including antibiotics < 1
hour (72% vs 53%, p < 0.0001) and completion of a resuscitation
bundle < 1 hr (32% vs 23%, p < 0.01) [Fig. 172a & b].
There was no significant difference in any outcome measures
between either group. Additionally, for the whole cohort analysis of
mortality against time to antibiotics and time to resuscitation bundle
completion showed no significant association between variables
(p = 0.183 and p = 0.491, respectively).
CONCLUSIONS. Pre-hospital use of a sepsis identification tool signifi-
cantly improved time to antibiotics and completion of the SSC resus-
citation bundle, but did not affect outcomes.
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Fig. 174 (Abstract 0478). Incidence of episodes with sepsis and
septic shock
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INTRODUCTION. Estimates of the incidence of sepsis are often based
on retrospective database or coding studies and the accuracy of
these estimates in comparison with prospective cohort studies is not
clear.
OBJECTIVES. To compare the incidence of sepsis derived from a
prospective inception cohort study (clinically diagnosed sepsis) and
that derived from retrospective database (ANZICS CORE) coding in
ICU patients.
METHODS. This study is an inception cohort study including all
patients admitted between the 1st of October and the 31st of
December 2016 at the ICU of The Royal North Shore Hospital, St
Leonards, Australia.
MAIN OUTCOME MEASURES: Incidence of sepsis and septic shock
using a clinical and a database definition.
RESULTS. A total of 864 patients were admitted during the study
period, of these 146 patients (16.9%) met the clinical definition of
sepsis, of which 49/146 (33.6%) met the clinical definition for septic
shock. A total of 98/864 patients (11.3%) met the database definition
of sepsis, with 83/98 (84.7%) diagnosed with septic shock. Hospital
mortality was higher in patients who met the clinical definition of
sepsis (39/146, 26.7%), compared to patients that met the database
definition of sepsis (17/98, 17.3%).
CONCLUSIONS. Our study showed that the incidence of sepsis using
the ANZICS CORE database definition is lower and the incidence of
septic shock higher when compared with a prospective clinical
definition. The database definition also provides a falsely low
estimate of sepsis mortality.
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INTRODUCTION. Previously we have shown divergent humoral
responses to 23-valent pneumococcal polysaccharide vaccine
(PPSV23) when administered to critically ill burn and neurosurgical
(NS) patients. Burn patients generated a robust response to PPSV23
compared to a blunted response in NS patients.
OBJECTIVES. Utilizing PPSV23 responsiveness as a marker of antigen
challenge, we assessed differences in biomarker concentrations at
time of vaccination (D0), 14 days after vaccination (D14) and changes
in concentration over 14 days; correlating values with successful
antigen challenge in two critically ill populations.
METHODS. Following consent, patients were administered PPSV23
within six days of injury. Blood samples were obtained at D0 and
D14. Samples from 32 (10 burn and 22 NS) patients were analyzed.
Of those, 16 were male with a mean age of 51 ± 16, APACHE II score of
16 ± 8, 22 required mechanical ventilation, 20 required vasopressors, 6
died prior to discharge, and 17 responded to PPSV23 antigen
challenge. An electrochemiluminescence immunoassay was used to
measure 30 cytokines (V-plex, MesoScaleDiscovery). Associations
between antigen responsiveness and cytokine differences at D0, D14
and the change over time was assessed by non-parametric methods
using a significance value of p < 0.05. Further, we compared cytokine
expression between burn and NS patients.
RESULTS. At D0, antigen responders had significantly higher levels of
G-CSF, IL-12p70, IL-15, IL-4, and IL-6; and significantly lower Eotaxin
and MCP-4. No significant associations were observed between cyto-
kine level and antigen responsiveness at D14. Increases in IL-16, MIP-
1α, and TNFα, and significant decreases in G-CSF and IL-12p70 over
14 days were significantly associated with antigen response. Burn pa-
tients had significantly higher levels of G-CSF, IL-10, IL-12p70, IL-1β,
IL-2, IL-4, IL-6 and IL-8, as well as lower levels Eotaxin compared to
NS patients at D0. At D14, burn patients had higher Eotaxin-3, G-CSF,
IL-1β, and VEGF levels compared to NS patients. Those with burn in-
juries had significant decreases in G-CSF, IL-10, IL-12p70, IL-1β, IL-2,
IL-6, and IL-8 levels; whereas, TARC and VEGF significantly increased
over 14 days compared to NS patients.Further cytokine analysis and
models of antigen responsiveness will be constructed.
CONCLUSIONS. Our findings suggest that immunologic responsiveness
by PPSV23 antigen challenge during critical illness is related to
measurable differences in cytokines at the time of challenge and
changes over time. Although exploratory, we've identified differences
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 246 of 542in biomarkers that relate to a T-cell independent immune response.
Burn patients have higher levels of many measured cytokines at D0
and a greater decrease by D14 which, coupled with our previous
observations of burn patients being more likely to respond to
PPSV23, supports an immune responsiveness phenotype. Further
research is needed to identify derangements in immune non-
responsive phenotypes.Table 132 (Abstract 0480). See text for description
Burn patients Critical burn patients Inhalation injury
Patients 362 96 84
Male (%) 76,2 72.9 75,6
Age 45.2 ±19.1 44.9±18.5 52.5.2 ±17.5
TBSA (%) 18.7 ± 16.8 34,8±17,5 28.1 ± 25.7
ABSI 5.9 ± 2.2 7,6±2,3 8.2 ± 2.8
Baux 64,1± 26,8 79,82±28.90 80,5± 27,8
APACHE II 7.4 ± 6.9 12.2±6.8 13.3 ± 6.8
SOFA 1.7 ± 2.2 2.3 ± 2.7 4.7 ± 2.80480
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INTRODUCTION. Total burned surface area, age and inhalation injury
are the main factors related with mortality of burn patients.
OBJECTIVES. The aim of our study is to evaluate the mortality in a
critical burn unit.
METHODS. A prospective, observational and descriptive study was
conducted over a period of two years in burn patients admitted to a
critical burn unit considered as a national burn reference center. We
considered critical burn patient when total burn surface area
(TBSA) > 20% or while having a minor TBSA the patient has
associated at least one of the following issues: trauma, deep
affectation of the face and / or neck, advanced age (greater than 75
years), previous illness, inhalation injury, electrical or chemical
mechanism. Demographic data, TBSA, ABSI, Baux score, APACHE II,
SOFA, mechanical ventilation, complications, length of stay, hospital
course and mortality data were collected. Data are presented as
number and percentage or as median and interquartile range and
they were analyzed with Fisher exact test and Mann–Whitney test.
RESULTS. During this period 362 burns patients were admitted in
our unit. Nearly 50% (180 patients) were considered as critical ill
patients. 84 patients had inhalation injury. Demographic characteristics
and severity scores are shown in the Table 132.
34.3% of burn patients required mechanical ventilation, 59.4% of
critical burn patients and 88.1% of those who had inhalation injury.
Critical burn patients had more respiratory, renal, infectious
complications and more need of vasoactive support than those who
were not considered critical, but there were no significant differences
with patients who also had inhalation injury. There was no statistically
significant difference in volume used during initial resuscitation in the
different groups, nor in the average stay.
Mortality was 9% for burn patients, 18.8% for critical burn patients
and 28.6% for inhalation injury. The multivariate analysis shows that
the age TBSA and inhalation injury are independent factors of mortality
in our population. However, when we analyzed mechanical ventilation
as a mortality factor, we observed that mechanical ventilation is also an
independent factor of mortality. Mechanical ventilation and TBSA are
the most influence mortality's factors.
CONCLUSIONS. In our study, patients with inhalation injury had the
highest severity scores, with a greater necessity for mechanical
ventilation and higher mortality.We found that TBSA, age, inhalation injury and mechanical ventilation
were independent risk factors for mortality in burn patients. However,
mechanical ventilation and TBSA are the most related factors to
mortality in our population.
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INTRODUCTION. Damage control laparotomy (DCL) is a technique
utilized to control the massively injured abdominal trauma patients.
This operation is well known as a life saving procedure, especially in
coagulopathy, nevertheless, prolonged open abdomen and pad
packing is likely associated with increased morbidity and mortality.
OBJECTIVES. We conducted microbiologic analysis of the pad used
for packing in DCL and studied its association with morbidity and
mortality.
METHODS. This is a retrospective review of all patients undergoing
immediate laparotomy at Chonnam National University Hospital
Trauma Center between 2011 and 2015. DCL was defined as
temporary abdominal closure at the initial surgery. 18 consecutive
patients undergoing DCL were analyzed. Microbiologic samples from
pad used in DCL were collected and analyzed.
RESULTS. 15 microorganisms were cultured. Samples from 12
(66.7%) patients were positive by microbiologic culture and six
(33.3%) patients were negative. Morbidity rate (91.7% vs. 66.7%) and
mortality rate (41.7% vs. 16.7%) were higher in patients with positive
culture than patients with negative culture. Infection rates such as
surgical site infection (75.0% vs. 33.3%) and sepsis (41.7% vs. 16.7%)
were higher in the culture-positive patients. Four patients underwent
two or three take back surgeries and all samples from these patients
were positive for microorganism.
Table (Abstract 0482). Trauma scores predicting 30 days mortality
Trauma
severity scores
ROC AUC (upper
95% CI, lower 95% CI)
Hosmer Lemeshow
C-statistic
HL
p-value
ASCOT 0.62 (0.51,0.73) 7.49 0.4853
TRISS 0.67 (0.56,0.78) 15.83 0.0449
RTS score 0.53 (0.41,0.65)
ISS score 0.46 (0.36,0.56)
Table (Abstract 0482). Functional outcome at 3 months after discharge
Moderate
injury (n = 38)
Severe injury
(n = 63)
Total
(n = 101)
RTA
(n = 68)
Fall
(n = 24)
Dead/Vegetative
(GOSE 1,2)
16(42) 33(52) 49(49) 36(53) 9(38)
Disability (GOSE
3,4,5,6)
10(26) 16(25) 26(26) 17(25) 7(29)
Good Recovery
(GOSE 7,8)
9(24) 10(16) 19(19) 10(15) 6(25)
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 247 of 542CONCLUSIONS. There was a high infectious complication rate in
patients with positive culture of the pad. And two or more frequent
take back surgery seems to increase risk of infection in DCL.
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INTRODUCTION. The burden of TBI is greatest in Low and Middle
Income Countries (LMIC), where 85% of the world´s population live
(De Silva et al., 2008).
OBJECTIVES. This study evaluates post-ICU outcomes of patients ad-
mitted with moderate and severe TBI to a tertiary neurocritical care
unit in an LMIC and the performance of RTS, ASCOT, ISS and TRISS in
this setting.
METHODS. Consecutive adult patients directly admitted to the Neuro
Trauma Intensive Care Unit (NTICU) I, II and Emergency Treatment
Unit (ETU) of the National Hospital of Sri Lanka (NHSL) between 21st
July 2014 and 1st October 2014 with moderate or severe TBI were
recruited for this study. Socio-demographic and injury related data
were gathered from the patient or the next of kin during their stay
in the setting. Medical data was extracted from case notes.
A telephone administered questionnaire based on the GOSE scale
was used to assess functional outcome of patients at 3 and 6
months after injury. The economic impact of the injury was assessed
before injury, and at 3 and 6 months after injury based on an
adapted tool from Griffiths et al.(Bouamra et al. 2015).
RESULTS. 101 patients with TBI were included in the study. Majority
of patients had severe TBI (n = 63) and others had moderate TBI
(n = 38). Survival at ICU discharge, 3 months and 6 months was
68.3%, 49.5% and 45.5% respectively.
Out of survivors at 3 months after ICU/ETU discharge, 43 (86%) were
living at home while others were in rehabilitation centres or in
hospital. Respectively, only 19 and 20 patients had a good recovery
(as defined by GOSE 7 and 8) at 3 and 6 months after ICU/ETU
discharge. Three months and six months after ICU/ETU discharge,
respectively 25 patients and 14 patents had become “economically
dependent”. Similarly, 17 families who were “economically
independent” prior to the event became dependent and 10 families
were still dependent 6 months after discharge.
ISS, RTS, ASCOT and TRISS had poor discriminatory ability in
predicting mortality.
CONCLUSIONS. This observational study of patients sustaining
moderate or severe TBI in Sri Lanka reveals only 46% of patientswere alive at 6 months after ICU discharge and only 20% overall
having a good recovery. The social and economic consequences of
TBI were long lasting in this setting. ISS, RTS, ASCOT and TRISS all
performed poorly in predicting mortality in this setting and illustrate
the need for setting adapted tools.
The authors acknowledge the support given by staff at NTICU I, II
and ETU of the NHSL, Sri Lanka.
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OBJECTIVES. Trauma is a major health problem in the world whose
complications are associated with increased morbidity, length of
Fig. 176 (Abstract 0483). Specific complications
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overhead costs. Identification of the epidemiology, clinical
parameters, and causes of complications following trauma may
provide useful information for improving treatment strategies. The
aims of our study were to evaluate the incidence and type of
complications after trauma among patients admitted to the ICU.
METHODS. We made a retrospective and observational study of
polytrauma patients admitted to the ICU from January 2015 to
December 2015. Information was collected on the severity of illness.
Demographic and clinical data, including age, sex, and mechanism of
injury, procedures, hospital length of stay, complications, and
inhospital mortality were obtained.
RESULTS. This study included 190 patients, 18 years of age or older,
presenting with trauma and admitted to ICU. The mean age was
57 + 18 years and 70% were men. On admission the mean value of
APACHE II and GCS was 19 and 12 points respectively. Most frequent
medical history was alcoholism (35%), smoking (29%) and psychiatric
history (29%). 55% came from other hospital, 41% from emergency
department and 3% from operating room. Overall falls (53%) were
the most frequent cause of trauma, followed by traffic accidents
(33%) and autolytic attempts (7%). Autolytic attemps were the most
frequent in < 50 years. The most common type of trauma was
cranioencephalic (45%) followed by thoracic (36%). The
complications developed in the hospitalization ward, from highest to
lowest frequency, were: 39.5% cardiovascular (AHT, arrhythmias,
pulmonary embolism and coronary artery disease), 30.5% infectious
(skin and soft tissue, urinary with/without bacteremia), 25.8%
hematological (anemia and coagulopathy), 24% metabolic
(hyponatremia), 19.5% abdominal (paralytic ileus and acute
cholecystitis) and 14% neurological (acute confusional syndrome and
epileptic seizures). Cardiocirculatory diseases (82%) were more
frequent in patients older than 50 years and neurological (40%) in
patients younger than 50 years. Overall, the acute confusional
syndrome was the most frequent complication in the hospital ward
(34.2%). Most frequent indications of returned to the ICU were
infections and decreased level of consciousness. The average stay in
ICU and in the hospital ward was of 9 and 18 days respectively.
Hospital ward mortality was 29.2%.
CONCLUSIONS. Critical polytrauma patients have been hospitalized
for a long time. In general, most frequent complications were
cardiocirculatory, followed by infectious, hematological and
metabolic, although the most common was acute confusional
syndrome. Inpatient mortality is low and usually occurs within the
first ten days.Fig. 175 (Abstract 0483). Global complications0484
The impact of cumulative fluid balance on mortality and late
multiple organ failure of trauma patients with prolonged ICU stay
K. Okada1, N. Saito1, M. Kujo1, T. Yagi1, H. Matsumoto1, H. Yokota2
1Nippon Medical School Chiba Hokusoh Hospital, Shock and Trauma
Center, Inzai, Japan; 2Nippon Medical School, Emergency and Critical
Care Medicine, Tokyo, Japan
Correspondence: K. Okada
Intensive Care Medicine Experimental 2017, 5(Suppl 2):0484
INTRODUCTION. The increased attention has been paid to detrimental
effects of excessive volume resuscitation in acute phase of trauma,
including ARDS, coagulopathy and abdominal compartment
syndrome1,2. However, the optimal long-term fluid management
remains unclear in trauma patients.
OBJECTIVES. To clarify the effects of cumulative fluid balance on the
outcome of trauma patients with prolonged stay in ICU.
METHODS. We retrospectively reviewed trauma patients who had
stayed in ICU for more than 10 days. Patients were classified into
high (≥12L) or low (<12L) fluid balance according to cumulative
balance for 10 days in ICU. Multivariate logistic regression was
conducted to assess the associated factors of 28-day mortality rate
and developing late multiple organ failure.
RESULTS. 81 patients were included in this analysis. 28 patients
(34.6%) had the high cumulative fluid balance (≥12L). The high fluid
balance group was associated with higher 28-day mortality rate com-
pared to low balance group (17.9% vs 1.9%, P = 0.017). The max-
imum SOFA score during the period of 10 days in ICU of both
groups were 12.6 ± 3.0 and 9.5 ± 3.0, respectively (P < 0.001). Multi-
variate analysis revealed that high cumulative fluid balance was inde-
pendently associated factors of 28-day mortality (odds ratio [OR]
15.0, 95% confidence interval [CI] 1.3 to 174.7, P < 0.03) and develop-
ing SOFA score greater than 10 during the period of ICU stay (odds
ratio [OR] 6.8, 95% confidence interval [CI] 2.0 to 23.3, P = 0.002).
CONCLUSIONS. High cumulative balance for 10 days in ICU is
significantly associated with risk of mortality and late multiple
organ failure.
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INTRODUCTION. Severe head trauma is a common reason for
patient's admission to the intensive care unit and it is the leading cause
of death in young adults. The outcome of these patients depends on
many factors such as cerebral hypoxia. Pulmonary contusion can cause
an acute respiratory failure that aggravates head trauma.
OBJECTIVES. To evaluate the impact on morbidity and mortality of
pulmonary contusion in patients admitted for severe head trauma.
METHODS. This was a retrospective study performed in the
emergency and intensive care department in the regional hospital of
Zaghouan. The patients were recruited during 3 years, from January
2013 to December 2015. All adult patients admitted for severe head
trauma (Glasgow coma score (GCS) ≤ 8) were included and
evaluated by quantified injury severity scores including APACHE2,
GCS, ISS, TISS. The diagnosis of pulmonary contusion was based on
the history of blunt chest trauma and the appearance of four types
of lesions on chest CT scans. Hospital length of stay, mortality rate,
incidence of adverse events including pneumonia, ARDS and shock
were recorder and compared into the tow groups (with or without
pulmonary contusion).
RESULTS. During the study period, 104 patients were included. The
diagnosis of pulmonary contusion was retained in 34 patients
(32.7%). The two groups were compared for age, genre, APACHE 2
and GCS. There was a significant difference in the ISS and TISS
(p < 0.001). Patients with pulmonary contusion had significantly
lower PaO2/FiO2 ratio (240 [range, 160–380]) vs. 430 [range, 210–
590]; p = 0.009); and significantly higher PaCO2 levels (43.5 mmHg
[range, 38–52 mmHg] vs. 38 mmHg [range, 32–40 mmHg],
p < 0.001). The number of cases of pneumothorax and hemothorax
were significantly higher in the group of pulmonary contusion
(p = 0.003, p = 0.021; respectively). Likewise, The occurrence of
pneumonia and ARDS was significantly higher in the group of
pulmonary contusion (p = 0.031, p = 0.023; respectively) with a
shorter length of time between ICU admission and the occurrence of
such complications; (6 days [range, 6–10 days]) vs. 13 days [range, 8–
16 days]; p = 0.024) and (6 days [range, 2–8 days]) vs. 10 days [range,
8–10 days]; p = 0.016), respectively. No significant difference was
observed with regard to the number of cases of shock (p = 0.174).
The length of hospital stay was significantly higher in the group ofpulmonary contusion (13.44 ± 6 days vs. 12.44 ± 4 days; p < 0.001).
The overall mortality rate was 11.5% in pulmonary contusion group
and 7.7% in the other group (Odds ratio, 4.22; 95% confidence
interval, 1.527 to 11.703; p = 0.004).
CONCLUSIONS. In this study, pulmonary contusion alters gas
exchange and appears to increase the morbidity and mortality in
patients with severe head trauma.
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INTRODUCTION. The occurrence of delirium is well known risk
factors associated with poor prognosis in ICU patients.
OBJECTIVES. The purpose of this study is to identify risk factors for
delirium after abdominal trauma and to predict the development of
delirium.
METHODS. Data was collected retrospectively from August 2015 to
December 2016 at a regional truma center on consecutive trauma
patients. Head trauma patients and patients under 18 years were
excluded. A multivariate logistic regression was performed to identify
risk factors for delirium.
RESULTS. Of the 264 patients who met criteria, 32 (12.1%) were
diagnosed with delirium. The mean age of the patients was 52 ± 19
years, 15.7 for Injury Severity Score(ISS), 14.4 for Glasgow Coma
Scale(GCS) and 3.6 days for Intensive Care Unite(ICU) stay. In
addition, chest Abbreviated Injury Score(AIS) was 1.2 ± 0.9, abdomen
AIS was 2.9 ± 0.1 and extremity AIS was 1.0 ± 0.9. Among these
factors, Age(odds ratio[OR], 1.05; 95% confidence interval [CI], 1.02-
1.08; p = 0.01), ICU day(odds ratio[OR], 1.14; 95% confidence interval
[CI], 1.04-1.24; p = 0.04), abdominal operation(odds ratio[OR], 2.54;
95% confidence interval [CI], 1.10-5.85; p = 0.03) were correlated
with delirium.
CONCLUSIONS. Abdominal operation is strongly asscociated with
delirium in patients with traumatic injury. Careful observation of
changes in consciousness after operation is necessary.
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INTRODUCTION. There is ample evidence demonstrating that
disseminated intravascular coagulation (DIC) occurs in patients with
traumatic brain injury.
OBJECTIVE. The aim of this study was to test the hypothesis that DIC
during the early stage of isolated traumatic brain injury (iTBI)
contributes to systemic hypoperfusion and organ dysfunction, which
affects the outcome of these patients.
METHODS. We conducted a retrospective cohort study of 335
trauma patients with brain injury. iTBI was defined as an abbreviated
injury scale of the head ≥3 and other body parts ≤ 2. Out of 335
patients, 92 patients with iTBI were included in the present study.
These patients were divided into DIC (n = 45) and non-DIC (n = 47)
groups based on the Japanese Society for Acute Medicine DIC criteria
Fig. 178 (Abstract 0488). Time-course of Creatinine
Fig. 179 (Abstract 0488). Time-course of Urea
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lactate level of ≥ 4 mmol/L and the severity of injury was assessed
by the injury severity score (ISS). The sequential organ failure assess-
ment (SOFA) and systemic inflammatory response syndrome (SIRS)
scores were also evaluated. The main outcome measure was the all-
cause hospital mortality.
RESULTS. There were no significant differences in the background
data, including the ISS of the two groups. The mean (SD) DIC scores
of the DIC and non-DIC patients were 5.1 (1.4) and 1.5 (0.8), respect-
ively. The prevalence of systemic hypoperfusion among the DIC pa-
tients (64.4%) was significantly higher than that among the non-DIC
patients (23.4%), and a significant difference was observed in the lac-
tate levels of the two groups (5.3 [2.5] vs. 3.2 [1.6]). All DIC patients
developed SIRS. The SOFA scores of the DIC patients were signifi-
cantly higher than those of the patients without DIC. DIC patients re-
quired a larger volume of transfusion than the non-DIC patients. The
mortality rate of the DIC patients (28.9%) was more than twice that
of the non-DIC patients (10.6%) (p = 0.025).
A stepwise logistic regression analysis and the area under receiver
operating characteristic curves confirmed that DIC is an independent
predictor of death. The Kaplan-Meier curves showed that DIC signifi-
cantly reduced the survival rate of patients with iTBI.
CONCLUSION. DIC accompanied by systemic hypoperfusion and
organ dysfunction contributes to a poor outcome in patients
with iTBI.
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INTRODUCTION. During critical illness assessment of renal function
using serum creatinine may be confounded by decrease in its
generation [1,2]. Major trauma patients are at particular risk of acute
muscle wasting resulting in reduced creatinine production while the
time course of changes in urea after major trauma has not been
well-described.
OBJECTIVES. To examine the time course of changes in creatinine,
urea and urea:creatinine ratio in major trauma cases admitted to ICU.
METHODS. Single centre retrospective analysis of major-trauma ICU
admissions hospitalised for ≥7 days, excluding those who received
renal replacement therapy and deaths before d7.
RESULTS. In 1021 patients, median age was 43 (IQR: 27–58), Injury
Severity Score 27 (17–33), Hospital length of stay 24d (17–33), ICU
length of stay 8d (4–15); 8.7% died in hospital and 15% experienced
non-RRT-requiring acute kidney injury. After admission median cre-
atinine fell rapidly over the first 7 days while median urea rose pro-
gressively after d4 (Figs. 178 and 179). In 647 patients with
measurements on d7, creatinine had fallen from median 81μmol/L
(66–102) at admission to 56μmol/L (47–71) by d7 (p < 0.0001), over
the same period urea rose from median 4.9 (3.9-6.4) to 6.6mmol/L
(5.0-8.9) (p < 0.0001) and median Urea:Creatinine ratio almost dou-
bled from 62 (45–77) to 116mmol/mmol (89–147) (p < 0.0001). Me-
dian Ure:Cre ratio at d7 was significantly higher in patients who had
either died or were still in hospital ten days later (at d17) compared
to those who were discharged in this interval: 122 (96–154) vs
85mmol/mmol (63–108) p < 0.0001, Fig. 180. However, in isolation
creatinine at d7 did not predict longer hospitalisation, falling similarly
to day 7 values of 56 vs. 57μmol/L respectively in those discharged
by d17 and those dying or remaining in hospital (p = 0.65).
CONCLUSIONS. After major trauma creatinine progressively fell while
urea rose, potentially reflecting differential changes in their
production or clearance in response to major injury, muscle wasting
and tissue catabolism. In support of this hypothesis, longer
hospitalisation or death was associated with an acute and sustainedrise in Ure:Cre ratio in the first seven days after injury. Higher Ure:Cre
ratios have been previously associated with adverse outcomes in
critical illness [3] however this study is novel in documenting
dynamic changes in Ure:Cre ratio and outcome. Studies examining
both production and clearance of creatinine and urea are required to
understand the changes in these markers of renal function after
major trauma and their association with patient outcomes.
REFERENCES
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Fig. 180 (Abstract 0488). Time course of Ure:Cre ratio by outcome
Table (Abstract 0489). Comparison according to infectious complication
No complication
(12)
Complication
(11)
P-value
Age 57.4 ± 15.3 64.6 ± 9.6 0.195
Injury severity score 40.4 ± 9.8 37.6 ± 5.7 0.405
Initial serum lactate 4.27 ± 2.37 5.44 ± 3.44 0.348
Pelvic fracture type (B & Y) 0.680*
Pelvic binder use 1 (8.3%) 6 (54.5%) 0.027*
Concurrent pelvic external fixation 0 6 (26.1%) 0.005*
Duration of surgical pad
maintenance (hours)
58.8 ± 27.4 51.3 ± 19.1 0.465
Total requirement of packed RBC 14.3 ± 5.1 16.3 ± 11.3 0.597
Mortality 4 (33.3%) 4 (36.4%) 1.000*
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INTRODUCTION. Despite using a multidisciplinary treatment approach,
the mortality with hemodynamic instability due to severe pelvic
fracture is still 40-60%. Recently, several studies have showed that
preperitoneal pelvic packing (PPP) was useful hemostatic technique
for these patients in the acute phase. However, there are few stud-
ies about complications after the procedure.
OBJECTIVES. The purpose of present study was to evaluate the
efficacy and complications of PPP in these patients.
METHODS. We retrospectively reviewed the medical charts of 53
patients with hemorrhagic shock due to pelvic fracture between
March 2011 and February 2017.
RESULTS. Twenty-eight patients in the PPP group had significantly
lower hemorrhagic mortality rate than 25 patients in the non-PPP
group (17.9% vs 48.0%, p = 0.019), although both groups had similar
patient characteristics(age, Injury severity score, and initial serum lac-
tate). In 28 patients of PPP group, the mean age and injury severity
score were 61.6 years and 39.3. Pelvic external fixation (EF) was per-
formed concurrently with PPP in 7 patients (25%). Complications oc-
curred in 11 of 23 patients except 5 patients who died of bleeding in
the PPP group. The most common complication was pneumonia
(72.7%), followed by surgical site infection (36.4%), and meningitis
(18.2%). Patients with complication underwent more frequently pel-
vic EF with PPP, compared with patients without complication
(26.1% vs 0%, p = 0.005).
CONCLUSIONS. Although PPP is an effective method of hemostasis,
complications after the procedure should be considered.
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INTRODUCTION. Previous studies have demonstrated numerous
factors which predict the mortality in blunt chest injuries but most
include patients who were not ventilated thereby increasing the case
mix and heterogeneity.Factors determining survival or mortality are
different in middle income(MIC) or low-income countries with limited
resources.The present study was conducted to know the clinical pro-
file of patients with chest injuries requiring mechanical ventilation
and to know the factors predicting mortality in the particular cohort
presenting to trauma centre of MIC.
OBJECTIVES.
1. To study the demographic, clinical and biochemical parameters of
patients with chest trauma requiring mechanical ventilation.
2. To compare demographic, clinical and biochemical parameters
between the survivors and non-survivors.
3. To assess the clinical and biochemical variables which are
independent predictors of mortality.
METHODS. Patients (n = 2058) presented over a period of four years
(Jan 2012 to Dec 2015)were selected.Out of these,746 (36.24%)
required mechanical ventilation. Patients were identified from the
Trauma registry after ethical clearance. These 746 patients were
further divided in to two groups -Group A (survivors) and Group B
(non-survivors). Demographic, clinical and biochemical parameters
were compared between these two groups. Independent predictors
of mortality were assessed using multivariate logistics regression
model.
RESULTS. 746 (36.24%) patients with thoracic trauma required
mechanical ventilation. Majority, 479 (64.2%) survived inhospital
while 267 (35.8%) died during the stay. Age was comparable in both
survivors and non-survivors. Tachycardia was a feature of non-
survivor group. Both Systolic (110 mmHg) as well as diastolic blood
pressures (69 mmHg) were significantly low in non-survivor arm. (p
value < .001) Glasgow coma scale (GCS) score was significantly lower
in the non-survivor group (median 4) as compared to the survivor
group. (median 10).
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 252 of 542Systolic blood pressure < 90mmHg, Random Blood Sugar (<60 and
>400mg/dl), HCO3 (<23 and >29 mmol/L), Serum Lactate (>6 mmol/L),
GCS score (<8), Injury by physical assault and no Intercostal drainage
were significant predictors of mortality in this group of patients.
CONCLUSIONS. Shock,hyper or hypoglycemia,associated severe
head injury, hyperlactatemia, and without intercostal drainage at
presentation are significantly associated with worse outcome in
patients put on mechanical ventilation following chest injures.
REFERENCE(S)
1. Battle C,Hutchings H,Lovett S,et al.Predicting outcomes after blunt
chest wall trauma: development and external validation of a new
prognostic model. Crit Care. BioMed Central; 2014 May 14;18(3):R98
2. Battle C,Hutchings,H,Evans P.Risk factors that predict mortality
in patients with blunt chest wall trauma: a systematic review and
meta-analysis. 2012 Jan;43(1):8–17
GRANT ACKNOWLEDGMENT
None
0491
Safety evatualion of passive verticalization for patients with
polytrauma in intensive care unit
V. Movsisyan, Z. Marutyan, S. Petrikov, I. Aliev, A. Evdokimov
N.V. Sklifosovsky Research Institute of Emergency Medicine, Healthcare
Department, Moscow, Russian Federation
Correspondence: Z. Marutyan
Intensive Care Medicine Experimental 2017, 5(Suppl 2):0491
INTRODUCTION. Passive verticalization is one of the most essential
part of early rehabilitation in Intensive care unit (ICU). However, there
is no information provided about verticalization in intensive care unit
for patients with polytrauma.
OBJECTIVES. Adaptation of the passive verticalization (PV) protocol
for patients with polytrauma in ICU.
METHODS. In the Intensive care unit of N.V. Sklifosovsky Research
Institute of Emergency Medicine were held 34 episodes of PV for 15
patients with polytrauma, of these, 5 women and 10 men.
Verticalization was provided by the medical tilt table. In 11 (32%)
cases we verticalizated patients on artificial lung ventilation (ALV), in
23 (68%) cases on spontaneous breathing. Verticalization was
provided according to Russian clinical recommendations for passive
verticalization of 2015 y. Before every episode of PV assessment of
patient's volume status was held. Also for every patient was defined
a comfortable orthostatic position.
Verticalization was provided up to 15° with the exposition on each
level during 15 minutes.
Maximum duration of the episode was 2 hours, maximum angle of
tilt able - 60°. In case of aggravation (arterial hypotension,
tachycardia, subjective complaints of the patient), the angle of the
tilt table was returned to the previous level, with the duration of the
exposure up to 15 minutes. The episode was stopped if aggravations
lasted for more than 15 minutes and continued if the regression of
aggravation has been completed during this time.
During an episode was held dynamic monitoring of the level of
consciousness, hemodynamic parameters, saturation of peripheral
blood and acid–base status of arterial blood.
RESULTS. Patients on ALV successfully reached the target value
during 9 (82%) episodes. Most of the episodes (n = 6 (67%)) were
performed without aggravation; in 3 cases (33%), were noted some
insignificant aggravation were noted. Two of the episodes (18%),
had to be stopped because of the orthostatic failure (arterial
hypotension, tachycardia).
Patients on spontaneous breathing reached a target angle in 10
episodes (43%), four of them (40%) had no aggravation, 6 (60%), had
insignificant aggravation. Thirteen episodes (57%) had to be
interrupted because of the aggravation.The most frequent aggravations during the verticalization are
tachycardia (n = 9 (37,5%)), arterial hypotension (n = 11 (46%)) and
complaints on subjective discomfort (n = 4 (16,5%)).
CONCLUSIONS. Passive verticalization in intensive care unit for
patients with polytrauma is safety to use for both groups of patients:
on ALV and on spontaneous breathing.
Most usual aggravation are arterial hypotension and tachycardia.
0492
Traumatic brain injury and quality indicators: how is our
compliance?
A. Clara, P. Cavaleiro, A. Coutinho, R. Bernardo, J. Moreno, C. Granja
Algarve Hospital Center, Faro, Portugal
Correspondence: A. Clara
Intensive Care Medicine Experimental 2017, 5(Suppl 2):0492
INTRODUCTION. Traumatic brain injury (TBI) is one of the main
causes of morbidity and mortality, especially among young
individuals1. According to the Glasgow Coma Scale (GCS) it can be
classified as mild if GCS 15–13, moderate if GCS 12–9 and severe if
GCS < 8, which has important implications in its approach1. The
approach to the patient has improved in the last two decades with
the implementation in our country of a protocol-based acute man-
agement of TBI patients and quality indicators for moderate and se-
vere injuries have been defined: GCS < 13 - head-computerized
tomography (CT) in the first 4 hours after injury; GCS < 9 - prompt
endotracheal intubation (ETI), surgery in the first 4 hours when indi-
cated and intracranial pressure (ICP) monitoring2.
OBJECTIVES. To verify the adherence to quality indicators in patients
with TBI admitted to the ICU and its morbidity by applying GOSE
(Extended Glasgow Outcome Score) after 3 months.
METHODS. Observational retrospective study, with data collected of
an ongoing database. The study included patients diagnosed with
moderate and severe TBI requiring admission to the ICU from 1/11/
2013 to 31/12/2016.
RESULTS. Seventy-five patients were included in the study with a
mean age of 51 [18–88] years, 72% were male. The sample was simi-
lar over the years: 29 patients in 2014, 21 patients in 2015 and 24 pa-
tients in 2016. The ICU mortality was 14.7% with a length of stay of
12,32 [1–68] days. Of the 85.3% survivors, 73.8% remained alive at 28
days. Clinical records of GCS in pre-hospital setting were found in
95.2% of the patients, either on the pre-hospital setting or in the
emergency department; 39% presented severe TBI with ETI in 100%
of patients and 71.7% had ICP monitoring. The median time for cra-
nial CT-scan was 0h40min[±3h20min47s]. When craniotomy was indi-
cated, it was performed in < 4 hours in 38.7% patients. Only 29.4%
met all the quality indicators. We were able to evaluate the GOSE at
3 months in 66,6% of the patients; 21 patients had a GOSE < 6 and
18 patients had a GOSE ≥ 6. The lower GOSE score was related with
longer ICU length of stay (95% CI 0,902 to 15,271;p = 0.028) and lon-
ger overall hospitalization (95% CI 3,562 to 66,528;p = 0.03), as well
as GCS at UCI discharge
(95% CI −3,491 to −0,728;p = 0.006).
CONCLUSION. Regarding the adherence to quality indicators ICP
monitoring and craniotomy performance are the areas that need
more improvement. Patients with a GOSE score < 6 were
significantly associated to lower GCS at ICU discharge, longer ICU
length of stay, and longer overall hospitalization. Due to the
small sample, we weren't able to establish a association between
the adherence to quality indicators and 3 months TBI outcome.
REFERENCE
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INTRODUCTION. Heparan sulfate (HS) represents an integral
component of the endothelial glycocalyx, a thin anticoagulant layer
on the surface of the undisrupted vasculature. Hypoperfusion and
sympathoadrenal activation following major trauma result in
endotheliopathy and the shedding of HS, which is suspected to
promote the allosteric activation of plasmatic antithrombin. This
endogenous mechanism of heparinization might represent a
contributor to trauma-induced coagulopathy.
OBJECTIVES. We investigated whether the trauma-induced shedding
of HS could exert heparin-like effects of anticoagulation.
METHODS. ROTEM was performed on whole blood of trauma
patients, using an intrinsically-activated assay (INTEM) in the pres-
ence or absence of Heparinase (HEPTEM) upon emergency room ad-
mission. To assess the course and magnitude of HS shedding
following injury, rats were subjected to a well-characterized model of
hemorrhage, trauma and resuscitation (HTR). INTEM/HEPTEM were
performed at time points with peaking HS levels. Clinically relevant
doses of two different HS preparations were added to whole blood
from healthy donors and measured in an INTEM assay with heparin
as a positive control.
RESULTS. Severe injury was not associated with a prolongation of
INTEM clotting time (CT) in trauma patients which was unaltered in
the presence of Heparinase (HEPTEM). In our rat model of HTR, shock
and resuscitation resulted in the shedding of endothelial HS without
a prolongation of INTEM CT or an effect of Heparinase. When
compared with Heparin, clinically relevant concentrations of HS did
not exert anticoagulant effects.
CONCLUSIONS. Our data suggest that severe injury results in the
shedding of HS from the endothelium. Although structurally similar,
the amount of shed HS does not appear to exert an anticoagulant
effect comparable to that of heparin. Our data do not substantiate
the concept of clinical autoheparinization.
Microcirculation and tissue oxygenation
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INTRODUCTION. Septic shock remains one of the most common
causes of mortality in intensive care unit (ICU). In order to ensure
an adequate cellular oxygen utilization, macro haemodynamic
optimization is a main issue. Validated markers of organ
hypoperfusion are serum lactates, ScvO2 and veno-arterial CO2
difference (CO2gap).
OBJECTIVES. This study aimed at exploring the relationship between
these markers mortality at 28 days.
METHODS. This prospective, observational, monocentric study
enrolled all consecutive patients (pts) with septic shock, diagnosed
according to SSC guidelines of 2012, within 8h from ICU admission.
Exclusion criteria were age < 18 years, a life expectancy < 28 days,
pregnancy and severe immunodeficiency.At admission SOFA, SAPSII, Charlson's comorbidity scores, haemodynamic
and metabolic parameter as SAP, DAP, MAP, HR, CVP, CI, organ perfusion
pressure (MAP-CVP), venous and arterial blood gas analysis, DO2, VO2,
O2ER, urinary output were recorded. All updatable parameters were then
detected at 6h, 12h, 24h, 36h, 48h, 60h and 72h after admission and daily
up to a week. Haemodynamic assessment was performed through
transpulmonary thermodilution EV1000 (Edwards Lifescience©TM).
RESULTS. This study included 25 pts, with an average age of 64 ± 15
(52% male). Overall mortality at 28 days was 56%. At admission,
haemodynamic parameters showed no significant differences
between the survivors (S) and non survivors (NS) at 28 days. Lactate
were higher in NS [5.2 vs 1.7 p < 0.01]; Charlson's, SOFA and SAPSII
showed significantly higher values in NS (p = 0.025, p = 0.005,
p = 0.01 respectively). MAP, CI and MAP-CVP were also significantly
higher in S [p < 0.001], with similar CVP.
The CO2gap over time was significantly higher in S (p = 0.045) as
well as blood lactate (p < 0.01). CO2 gap was also significantly
related with MAP-CVP (p < 0.001, r = 0.71), CI (p = 0.038, r = −0.42)
and DO2 (p < 0.001, r = 0.67). VO2 and DO2 were significantly higher
in S (p < 0.001 and p = 0.014, respectively); similarly, O2ER, particu-
larly in the first 48h (p = 0.003). Conversely, no significant differences
were detected in terms of ScvO2 and pCO2 gap/CaO2-CvO2 between
the two groups. Regarding to the positive predictive value of 28 days
mortality of the analyzed variables, lactates at admission showed the
highest AUC (0.76, p = 0.014) with a specificity of 91% and a sensitivity
of 64% for lactate >2.9 mmol/l. S had a longer ICU stay than NS (16 vs
6 days, p = 0.01), as well as more mechanical ventilators and less vaso-
pressors free days (8 vs 1, p = 0.01 and 9 vs 2, p = 0.01 respectively).
CONCLUSIONS. This work showed that parameters associated with
tissue hypoperfusion were closely related to septic shock patients'
outcome. In particular, lower values of CO2gap in the first hours of
hospitalization seemed to be associated to poor outcome because
mirrored tissue inability to employ oxygen supply.
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INTRODUCTION. Peripheral perfusion may be altered in patients with
ARDS and the degree of alteration may be associated with disease
severity.
OBJECTIVE. To compare skin microvascular perfusion in patients with
ARDS with and without shock and survivors and non-survivors.
METHODS. We studied 26 healthy volunteers and 27 patients within
24 hours after a diagnosis of ARDS (using the Berlin criteria). All
patients were receiving mechanical ventilation. Using skin laser
Doppler (Periflux, Perimed5000), we evaluated, at baseline (T0) and 6
(T6), 24 (T24) and 48 (T48) hours, skin blood flow before and after a
thermal challenge test (TCT) performed by increasing the skin probe
temperature to 37°C for 3 minutes. SOFA and APACHE II scores were
obtained at baseline. We compared healthy volunteers with ARDS
patients, ARDS patients with circulatory shock (defined as need for
vasopressors to maintain mean arterial pressure [MAP] ≥65 mmHg
with >1 sign of poor tissue perfusion [altered consciousness, oliguria,
skin hypoperfusion, lactate ≥2 mmol/L]) and those without shock,
and survivors with non-survivors. Results were analyzed using STATA
14.0 and p < 0.05 was considered statistically significant.
RESULTS. Baseline clinical characteristics are shown in Table 133. The
causes of ARDS were sepsis (19), pancreatitis (3), near drowning (2),
inhalation (2), chest contusion (1); overall mortality was 55%. Twenty
patients had circulatory shock. At baseline (T0) the SBF and the
relative change in SBF after TCT (ΔSBF) were lower in ARDS patients
than in volunteers; the ΔSBF was significantly lower in ARDS patients
with than in those without shock; and the SBF and ΔSBF were lower
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hours, the SBF was lower in ARDS patients with than in those with-
out shock. The SBF was lower in the non-survivors than in the survi-
vors at 48 hours and the ΔSBF was lower in the non-survivors than in
the survivors at 24 and 48 hours (Table 134). The SBF increased from
48(18–64) at T6 to 101(39–157) at T24 (p = 0.03) in the survivors but
did not change significantly in the non-survivors.
CONCLUSION. Cutaneous microvascular perfusion is altered in ARDS
and these changes are related to disease severity.Table 134 (Abstract 0495). See text for description
Volunteers
(N=26)
Total
(N=27)
p ARDS
without
shock(N=7)
ARDS with
shock
(N=20)
p Survivors
(N=12)
Non
Survivors
(N=15)
p
SBF at T0
(PU)
226(171-
254)
24(9-
74)
0.01 86(24-132) 16(6-35) 0.07 60(26-
120)
16(6-31) 0.03
Relative
change at
T0(%)
76(61-85) 34(13-
102)
0.01 56(18-125) 13(10-16) 0.03 112(28-
295)
15(11-78) 0.01
SBF at T6
(PU)
- 47(13-
75)
- 31(7-76) 47(15-75) 0.5 48(18-64) 47(9-97) 0.8
Relative
change at T6
(%)
- 62(18-
114)
- 42(18-111) 45(19-70) 0.7 66(21-
137)
42(14-96) 0.4
SBF at T24
(PU)
- 47(18-
146)
- 140(88-179) 21(10-41) 0.01 101(39-
157)
27(13-95) 0.05
Relative
change at
T24 (%)
- 57(24-
133)
- 42(14-73) 58(40-133) 0.2 120(55-
284)
40(18-79) 0.02
SBF at T48
(PU)
- 33(17-
157)
- 118(51-151) 29(21-83) 0.03 156(92-
180)
21(12-28) 0.01
Relative
change at
T48 (%)
- 26(17-
64)
- 65(40-96) 38(29-75) 0.3 48(25-99) 20(12-45) 0.02
Table 133 (Abstract 0495). See text for description
Volunteers
(N=26)
Total
Patients
(N=27)
p ARDS
without
shock
(N=7)
ARDS
with
shock
(N=20)
p Survivors
(N=12)
Non
survivors
(N=15)
p
Age 30(29-31) 62(42-
75)
<0.01 41(26-74) 63 (54-
72)
0.7 63(52-77) 59(26-75) 0.3
SOFA score - 15(13-
16)
- 15(11-16) 15(13-
16)
0.4 14(12-16) 15(13-16) 0.2
APACHE II score - 30(24-
33)
- 30(24-32) 31(27-
35)
0.6 28(22-32) 31(27-33) 0.3
Mean arterial
pressure (mmHg)
- 69(66-
79)
- 68(65-79) 75(70-
79)
0.2 73(68-81) 68(65-78) 0.1
Cardiac index (L/
min/m2)
- 2.1(1.5-
2.4)
- 2(2-2.1) 2(1.1-3) 0.6 3.1(1.5-
3.8)
1.8(1.5-
2.1)
0.1
Norepinephrine
dose(μg/kg/min)
(No. of patients)
- 0.3(0.1-
0.8) (20)
- - 0.3(0.1-
0.8)
<0.01 0.3(0.1-
0.5) (9)
0.5(0.2-
0.8) (11)
0.2
Lactate (mmol/L) - 3(2-7) - 2(2-4) 4(2-7) 0.1 3(2-7) 3(2-7) 0.3
PaO2/FiO2 - 92(70-
150)
- 132(74-
216)
112(66-
154)
0.6 122(73-
231)
85(67-
111)
0.1
Venovenous
extracorporeal
membrane
oxygenation (N%)
- 9 (33%) - 1 8 (40%) 0.2 3(25%) 6(40%) 0.4
Fig. 181 (Abstract 0496). See text for description0496
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Intensive Care Medicine Experimental 2017, 5(Suppl 2):0496INTRODUCTION. Administration of supplementary oxygen may lead
to hyperoxia, which can have acute cardiovascular effects, such as
vasoconstriction and a reduction in cardiac output, which may even
result in a paradoxical reduction in oxygen delivery. Most
hemodynamic effects have been studied in healthy volunteers
inhaling either air or oxygen. Due to the lack of blood gas analysis
in healthy volunteers, very few data exist on the effect of hyperoxia
on oxygen delivery. Because of this common strategy, the direct
relation between PaO2 and oxygen delivery remains ambiguous.
Here we describe, in a PaO2 guided fashion, the relation between
several levels of hyperoxia and hemodynamic effects and oxygen
delivery in healthy volunteers.
OBJECTIVES. To study the dose–response relationship between PaO2,
systemic hemodynamics and resulting oxygen delivery, as well as
sublingual microcirculatory perfusion.
METHODS. Ten healthy volunteers received five incremental FiO2s
for 10 minutes each via a non-invasive ventilation mask, without
mechanical ventilatory support, to reach PaO2s of baseline (air), 20,
40, 60 and max kPa (oxygen). An arterial line was placed for blood
gas sampling. During each period, hemodynamics (Heart Rate, Mean
Arterial Pressure, Cardiac Index, Stroke Volume and Systemic Vascular
Resistance Index) were measured continuously by the volume-clamp
method (Nexfin(r)). At the end of each period, the sublingual micro-
circulation was recorded by sidestream darkfield imaging.
RESULTS. Seven males and three females with a mean age of 28
years (SD ± 7), without cardiac or respiratory illness completed the
protocol. PaO2s during the five sequential periods were 14 (SD ± 1.5),
21(±1.5), 39(±3.0), 56(±5.6) and 74 (±2.4) kPa. Cardiac Index decreased
linearly (linear regression, P = 0.0003) with increasing PaO2, with a
maximum decrease of 0.33 L/min/m2 (SD ± 0.22) when breathing
oxygen (−8% vs baseline, P < 0.0001; paired t-test, Fig. 181a). The re-
duction in CI was explained by a decrease in Heart Rate (7 bpm, −10%
vs baseline, P < 0.0001) and not Stroke Volume. Systemic Vascular Re-
sistance Index rose slightly (linear regression, P = 0.043) with a max-
imum of 110 dynes · sec/cm5/m2 (SD ± 101, +5% vs baseline, P = 0.007,
Fig. 181b). MAP was not affected. Oxygen delivery remained stable at
an average of 77 ml O2/min/m
2 at each PaO2 (Fig. 181c). Sublingual
vessel density and perfused vessel density were decreased by 16%
(P = 0.06) and 17% (P = 0.04, Fig. 181d), respectively.
CONCLUSIONS. In healthy volunteers, oxygen has hemodynamic
effects over the entire range of 14–74 kPa, evident by a stepwise
decrease of cardiac index (through a reduction in heart rate), and a
small increase in systemic vascular resistance index. In these subjects,
the increased arterial oxygen content is sufficient to maintain oxygen
delivery despite a decrease in blood flow. However, whether the
reduction in (sublingual) perfusion affects oxygenation at the tissue
level in vital organs remains to be determined.
Table 136 (Abstract 0498). Results
Results Total Survivors Non-survivors Significance
Death 46.5% (20/43)
Admission APACHE II 18,1±2,5 14,8±2,8 22 ±4,1 p= 0,01
AKI 81.4% (35/43) 69,6% 95% p= 0,033
Peak creatinine 2,23±0,36 1,80 ±0,41 2,72±0,59 p= 0,035
RRT 23,3% (10/43) 35% 13% p= 0,089
Sepsis 30.2% (13/30) 30% 30,4% p= 0,975
Admission lactate
(mmol/L)
6,7±1,37 5,5 ±1,2 8,1 ±2,6 p= 0,38
24 h lactate 4,4±1,7 2,07 ±0,67 7,12 ±3,5 p= 0,003
Table 135 (Abstract 0498). Baseline characteristics
Age (years) 61,9 ± 10,4
Male 74,4% (32/43)
PCI 82,2% (37/43)
Time to PCI (min) 314 (150-460)
Time to IABP 325 (150-660)
Admission lactate (mmol/L) 6,7 ± 1,37
Admission NT-proBNP (pg/ml) 2862 (790-7671)
Admission LVEF 30% (20-35)
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INTRODUCTION. Severe acute heart failure (AHF) is associated with a
poor short-term outcome, while patients with chronic heart failure
(CHF) exhibit a poor long-term prognosis. Tissue hypoxia may lead to
cellular damage and the release of intracellular mitochondrial DNA
(mtDNA), which may activate the immune system due to its resem-
blance to bacterial DNA.
OBJECTIVES. The aim of this study was to analyze circulating levels of
mtDNA as a possible predictor of outcome in patients with AHF and CHF.
METHODS. Plasma levels of circulating mtDNA were measured in 90
consecutive patients with AHF admitted to our ICU and in 109
consecutive patients with CHF at our HF outpatient department by
real-time PCR.
RESULTS. Patients in the ICU group were 64.7 (49.4-74.3) years old
and median NT-proBNP levels were 4986 (1525–23842) pg/mL. 30-
day survival was 64.4%. In the CHF group, median age was 63 (IQR
52–72) years. 49.5% of patients had ischemic and 50.5% had a non-
ischemic etiology of CHF. 38.5% were in NYHA class III/IV, and pa-
tients had a median NT‐proBNP level of 1025 (IQR 450–3480) pg/mL.
Patients with AHF showed significantly higher circulating levels of
mtDNA as compared to patients with CHF (27.0 IQR 8.2 - 52.2 ng/mL
vs. 14.5 IQR 8.5 - 25.4 ng/mL, p < 0.005). In CHF patients, mtDNA
levels were associated with NYHA functional class but did not differ
according to HF etiology and outcome. On the contrary, in patients
with severe AHF, mtDNA levels were significantly higher in patients
that died within 30 days after ICU admission (30.6 IQR 13.0 - 90.1 ng/
mL vs. 22.8 IQR 6.4 - 41.6 ng/mL, p < 0.05); patients with plasma
levels of mtDNA in the highest quartile (mtDNA > 50.9 ng/mL) had a
3.1-fold risk (p = 0.002) of dying.
CONCLUSIONS. Circulating levels of mtDNA predict mortality in
patients with severe AHF but are not associated with outcome in
patients with CHF. Reduced tissue perfusion with release of mtDNA
may play a role within the pathophysiology of AHF and severe CHF.
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INTRODUCTION. Acute heart failure syndromes (AHFS) after acute
coronary syndromes (ACS) still pose a significant clinical challenge
for the intensivist. Despite recent progress in extracorporeal assist
device therapy, little evidence suggests outcome benefit. Intra-aortic
balloon pump (IABP) remains a viable option for improving coronary
perfusion and ventricular unloading in this population.
OBJECTIVES. To identify clinical predictors of mortality in patients
with CS requiring IABP support in the setting of ACS.
METHODS. We performed a cross-sectional study, retrospectively
analysing patients with AHFS after ACS, admitted to our ICU between
1 January 2014 and 31 December 2015. Patients presenting with CS
and requiring IABP support were further analysed. Independent predic-
tors of mortality were identified using a multivariate logistics model.RESULTS. 241 patients were identified. Of these, 43 (17%) presented
with CS and received IABP support.
Baseline characteristics (Table 135) show that they were predominantly
male (74,4%), with an average age of 61,9 (±10,4) years. 82,2% received
primary PCI, with a median time to PCI of 314 min (IQR 150–460). IABP
was placed after PCI in all patients. Median left ventricular ejection
fraction was 30% (IQR 20–35).
46,5% of patients died. We found significant differences between
survivors and non-survivors (Table 136) in admission APACHE II
scores (14,8 ± 2,8 vs 22 ± 4,1, p = 0,01), incidence of acute kidney in-
jury (AKI - 69,6% vs 95%, p = 0,033), peak creatinine (1,80 ± 0,41 vs
2,72 ± 0,59 mg/dl, p = 0,035) and serum lactate levels at 24 hours
after hospitalization (2,07 ± 0,67 vs 7,12 ± 3,5 mmol/L, p = 0,003). We
also noted a trend toward increased renal replacement therapy
usage in survivors (35% vs 13%, p = 0,089). There were no differences
in sepsis incidence and admission lactate between the groups.
Using multiple logistic regression analysis, we identified 2 independent
predictors for in-hospital mortality - lactate levels > 2,5 mmol/l at 24
hours (odds ratio [OR] 1,64, CI 95% 1,072-2,52) and worsening of renal
function defined as elevation of creatinine levels by >0,3 mg/dl (OR 2,6,
CI 95% 1,12-6,022).
CONCLUSIONS. Normalization of serum lactate at 24 hours after
admission in patients with CS requiring IABP after ACS, as well as
avoiding AKI could be clinical objectives worth following. Further
studies to prove outcome improvement are warranted.0499
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well as nonhypoxic causes such as drug therapy, cardioplegia,
hypothermia, and cardiopulmonary bypass (CPB), but, although
hyperlactatemia is common after cardiac surgery, its value as a
prognostic marker remains controversial.
OBJECTIVES. To identify the intraoperative factors causing early
high lactate levels (lactate >3mmol/L) at intensive care unit (ICU)
admission in patients undergoing cardiac surgery and to evaluate
the association between early high blood lactate levels and
postoperative outcomes.
METHODS. A retrospective observational study including 102
patients who underwent cardiac surgeries in a tertiary care center
from April to August 2016. The patients were divided into 2
groups based on serum lactate levels at ICU admission; those with
serum lactate levels greater than or equal to 3 mmol/L considered
as hyperlactatemia and those with serum lactate levels less than 3
mmol/L. Preoperative and intraoperative clinical data and
postoperative outcomes were evaluated in both groups.
RESULTS. Hyperlactatemia was present in 46 patients (45%) at ICU
admission. There was no significantly association between lactate
levels and preoperative clinical data. Age (P = 0.619), body index
mass (P = 0.154), EuroSCORE (P = 0.954) and left ventricular ejection
fraction (P = 0.132) were similar in both groups. Hyperlactatemia
group received significantly higher intraoperative blood transfusion
(50% vs 28,6%; P = 0.027). Other intraoperative factors such as type
of surgery, duration of cardiopulmonary bypass, cross clamp and
fluid balance were not associated with hyperlactatemia. There were
also no significant differences in the postoperative outcomes, except
for low cardiac output syndrome which occurred more frequently in
the hyperlactatemia group (37% vs 10.7%, P = 0.002). There were no
differences in the surgical complications: 30-day mortality (6.5% vs
1.8%, P = 0.325), cardiogenic shock (6.5% vs 3.6%, P = 0.656), bra-
dyarrhythmias (6.5% vs 1.8%, P = 0.325), tachyarrhythmias (34.8% vs
41.1%, P = 0.516), acute renal failure (54.3% vs 41.1%, P = 0.181),
stroke (0% vs 3.6%, P = 0.500) or infection (52.2% vs 50%, P = 0.827).
Patients from the hyperlactatemia group had more frequent low out-
put syndrome in the postoperative period (37% vs 10.7%,
P = 0.002).The length of ICU stay (5,57 days vs 5,38 days, P = 0,655),
duration of mechanical ventilation (2348 min vs 1349 min, P = 0,863)
and hospital stay (22,87 days vs 22,27 days, P = 0,828) were similar in
both groups.
CONCLUSIONS. Patients with hyperlactatemia at the ICU admission
received more blood transfusion at the surgery and had a higher
incidence of low cardiac output in the postoperative period. On the
other hand, the occurrence of hyperlactatemia had no significant
association with other postoperative complications.
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INTRODUCTION. Mortality associated to septic shock is related with initial
macrohemodynamic disturbances and ongoing hypoperfusion, ending in
irreversible mitocondrial disfunction. Early recognition of mortality
predictive variables in these patients encourage therapeutic strategies
directed to hemodynamic optimization in macro and microcirculatory
level. Cardiac Index (CI) is the prefered macrohemodynamic variable and
recently Dv-aCO2/Da-vO2 index appeared as the most integral noninva-
sive way to evaluate global tissue perfusion.OBJECTIVES. Estimate mortality risk in septic shock patients,
evaluated by CI and Dv-aCO2/Da-vO2 index behaviour.
METHODS. Retrospective, observational study, in a tertiary level
intensive care unit during march 2013 to july 2016 including patients
with diagnostic of septic shock, with hemodynamic monitorization
by continuos cardiac index by wave pulse contour analysis, in which
Dv-aCO2/Da-vO2 index was calculated. Mortality was evaluated in
this group of patients.
RESULTS. 77 patients were analyzed (46.8% males and 53.2%
females), with a mean age of 48.01 years, mean APACHE II score of
23.7 points and SOFA score of 11.4 points at entry. Abdominal
infection was the main cause of septic shock (48.1%). The
macrohemodynamic analysis was obtained of CI at entry, with a
median of 3 L/min/m2, becoming this the cut-off point. 44 patients
(57%) had an CI >3 and 33 patients (43%) had an CI < 3. Global tis-
sue perfusion was analized with Dv-aCO2/Da-vO2 index at entry,
with a cut-off point of 1.4; 54 patients (71%) had an index >1.4 and
23 patients (29%) < 1.4. Global mortality was of 31% (24 patients),
31.8% (14 patients) in the group of CI >3 (OR = 1.05, IC 95%(0.535 a
2.06), p = 0.02) and 30.3% (10 patients) in the group of CI < 3;
Mortality according to Dv-aCO2/Da-vO2 index was of 24.67% in the
group >1.4 (OR = 1.79, IC 95% 0.178 - 1.745 p = 0.557) and 6.49%
in the group < 1.4.
CONCLUSIONS. In this group of septic shock patients,
macrohemodynamic alteration characterized by an CI > 3 L/min/m2
was asociated with an increase in mortality risk of 1.05 folds, with
stadistic significance. Conversely, in the same group there was a trend
in increase mortality risk when Dv-aCO2/Da-vO2 index >1.4 was
present, but without stadistic significance. We suggest further prospect-
ive studies to elucidate the validity of this study.
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INTRODUCTION. During coronary artery by-pass graft (CABG) venous
to arterial (v-a) carbon dioxide content difference (CCO2gap) is a
useful marker of tissue hypoperfusion. Coronary sinus (CS) CCO2
can also be explored during cardiac surgery and its behavior may
be a possible marker of myocardium hypoperfusion. This work
aimed at comparing CS pCO2 and CCO2 gap with central venous
(CV) and mixed venous (MV) blood before and during cardio-
pulmonary bypass (CPB) and at exploring the behavior of myocar-
dial CO2 production.
METHODS. This prospective, observational, monocentric study
enrolled all consecutive patients undergoing CABG. Exclusion criteria
were age < 18 years, combined surgery, pregnancy. At baseline
clinical characteristics were registered, as well as SOFA, SAPSII,
Euroscore and Charlson's comorbidity scores. Haemodynamic and
metabolic parameters as SAP, DAP, MAP, systolic, diastolic and mean
coronary sinus pressure (SCSP, DCSP, MCSP respectively), SPAP,
DPAP, MPAP, CO, CI, coronary perfusion pressure [CPP] (MAP-mean
coronary sinus pressure [MCSP]), MV, CV, CS and arterial blood gas
analysis, DO2, VO2 and O2ER were recorded before and in later CPB.
All clinical and hemodynamic parameters, HS troponin, fluid balance
Fig. 182 (Abstract 0502). Receiver operating characteristic (ROC) for
stroke volume variation (SVV) and pulse pressure variation (PPV) for
prediction of a decline of 10% mean microcirculatory bloos flow
(mFlux) of the ileum due to volume administration. Areas under the
curves (AUC) are given beside the curves.
Table 137 (Abstract 0502). See text for description
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Haemodynamic assessment was performed with Swan-Ganz catheter
(Edwards Lifescience©TM).
RESULTS. We enrolled 5 male patients with a mean age of 69 ± 17
years, SAPS II at 24 h of 32 ± 3, Euroscore of 1 ± 0.3, NYHA of 3, BMI
of 26 ± 4; TnI at 6h and 24h was 7 ± 11 and 5 ± 12 mcg/l,
respectively. CCO2 gap was significantly higher in CS compared to
MV and CV before CPB (10 [7–11] vs. 4.4 [2.2-7.7] vs. 3 [1.9-4.2],
p = 0.04-Fig. 1). O2 consumption was also higher for CS before CBP
(31 [27–33] vs. 24 [22–27] vs. 22 [19–27] p = 0.015). pCO2 gap was
similar among groups, as well as the ratio between CCO2 gap and
arterial-venous (a-v) difference in O2 content (Respiratory quotient -
RQ). RQ was not different among groups, however a clear trend to-
wards higher RQ in CS was evident (1.9 [1.3-2] vs. 0.9 [0.5-1.5] vs. 0.8
[0.5-1.2] p = ns). During CPB O2ER from CS was not significantly lower
(14 [7–23] vs. 31[26–34], p = 0.06), as well as CCO2 gap (1.5 [0.9-18]
vs. 10 [4.7 - 11.6] p = ns). A decrease in CPP below 45 mmHg caused
an abrupt decrease in CCO2 gap (r = 0.84, p = 0.07) and, similarly, a
sudden decrease in RQ below 1.9 (r = 0.81, p = 0.09-Fig. 2).
CONCLUSIONS. We showed that myocardial CO2 production is not
negligible and contributes to differences observed in CO2 and O2
content observed between central venous and mixed venous blood
samples, meaning that in certain situation CV samples may not be
considered interchangeable with MV samples. Moreover, relationship
between myocardial perfusion pressure and CCO2 gap or RQ
suggests that myocardial CO2 production decreases linearly below a
critical value of blood flow. Other studies are warranted to confirm
such preliminary results.
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INTRODUCTION. Dynamic preload parameters such as stroke volume
variation (SVV) and pulse pressure variation(PPV) have been widely
recommended for evaluation of volume responsiveness. However,
when guiding volume therapy, either hypovolaemia as well as
volume-overload have to be avoided. Over-infusion results in im-
pairments of microcirculation, which are associated with decreased
outcome[1]. Endothelial dysfunction - that can be caused by ische-
mia/reperfusion - aggravates this problem and promotes interstitial
swelling leading to further deterioration of microcirculation[2]. To
date no effort has been made to evaluate whether SVV and PPV
potentially can help to avoid decreases of microcirculation due to
volume overload.
OBJECTIVES. The aim of this study was to evaluate, whether low
values of PPV and SVV do have the potential to predict an
impairment of intestinal microcirculation caused by volume-overload
in experimental ischemia/reperfusion.
METHODS. In 8 pigs ischemia/reperfusion was induced during
experimental aortic bypass surgery. Mean microcirculatory blood
flow (mFlux) of the ileum was measured using direct laser-speckle-
contrast-imaging. PPV and SVV were measured using aortic flow-
probes and femoral microtip-catheters. 6 hours after ischemia/reper-
fusion injury measurements were performed during 4 consecutive
volume-loading steps (VLS). We performed ROC Analysis to deter-
mine ability and potential thresholds of SVV and PPV to predict a
microcirculatory decrease due to volume loading. A reduction of
≥10% mFlux was considered a relevant decrease.RESULTS. I In total 28 VLS were analysed. Haemodynamic changes
throughout the protocol are shown in Table 137. In ROC-analysis SVV
presented with an AUC of 0,76 (CI 95% 0,57-0,96; p = 0,034) and PPV
with an AUC of 0,84 (CI 95% 0,68-0,99; p = 0,003). ROC curves are
presented in Fig. 182. Youden Index was calculated to determine
ideal cut-off values predicting microcirculatory decrease. The follow-
ing cut-off values can be proposed: SVV < 12,69% (Youden Index
0,57; sensitivity 77,78%, specificity 73,33%), PPV < 8,02 (Youden Index
0.64; sensitivity 72,73%; specificity 87,50%).
CONCLUSION. The results of our study show that low values of SVV
and PPV do have the potential to predict decreases of intestinal
microcirculatory blood flow caused by volume-overload in experi-
mental ischemia/reperfusion. Therefore, dynamic preload parameters
may not only be used to detect volume responsiveness but might
also help to prevent microcirculatory impairments.
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INTRODUCTION. SvO2 and pCO2 gap are indices of tissue perfusion
to detect early organ dysfunction. Many studies have validated them
as predictors of organ failure, prolonged ventilatory support and
hospital stay, and mortality. In the Philippines, the use of SvO2 and
pCO2 gap as tools for monitoring cardiac surgical patients is still
underutilized and there is a paucity of evidence regarding their use.
OBJECTIVES. To determine the accuracy of SvO2, pCO2 gap, and
their combination in predicting adverse outcomes in adult patients
undergoing cardiac and aortic aneurysm surgeries.
METHODS. A prospective cohort study approved by the Technical
Review Committee (TRC) and the Institutional Ethics Review Board
(IERB) which included 108 adult patients who underwent cardiac and
aortic aneurysm surgeries from October to December 2016 in the
Philippine Heart Center (PHC). PHC is the Center of Excellence in
Cardiovascular Care in the Philippines which operates a semi-open
cardiac surgical intensive care unit (SICU) where attending cardiolo-
gists can opt to refer or not to refer to intensivists. SvO2 and pCO2
gap of subjects were taken on admission to the SICU and were ana-
lyzed as to their accuracy in predicting adverse outcomes namely,
organ dysfunction, in-hospital, and 30-day mortality.
RESULTS. To predict organ dysfunction, SvO2 < 60% and in
combination with pCO2 gap ≥6 mmHg showed high specificity of
90% (SvO2 < 60% PPV = 82.35%; pCO2 gap ≥6mmHg PPV = 81.36%).
To predict in-hospital mortality, they showed good specificity of
82.93% and 85.37%, respectively (SvO2 < 60% NPV = 82.93%; pCO2
gap ≥6mmHg NPV = 82.98%; combined parameters NPV = 82.35%).
To predict 30-day mortality, they likewise showed good specificity of
84.44% and 86.67%, respectively (SvO2 < 60% NPV = 83.52%; pCO2
gap ≥6mmHg NPV = 83.67%; combined parameters NPV = 82.98%).
The receiver operating characteristic (ROC) curves of SvO2 and pCO2
gap to predict organ dysfunction, in-hospital, and 30-day mortality
were 0.43 and 0.64, 0.52 and 0.47, and 0.49 and 0.47, respectively.
This can be explained by factors like absence of standard protocol
for post-op care in our institution for hemodynamic optimization and
goal-directed therapy and varying hemoglobin levels as transfusion
trigger.
CONCLUSIONS. SvO2 < 60% and its combination with pCO2 gap
≥6mmHg revealed high specificity and good PPVs in predicting
organ dysfunction. They also revealed good specificity and good
NPVs in predicting in-hospital and 30-day mortality.
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INTRODUCTION. There is a growing interest in the state of the
microcirculation during critical illness [1]. Sidestream Dark Field
Imaging (SDFI) is widely used to study microcirculation in vivo. One
such SDFI device is the Glycocheck®, which estimates the thickness
of the endothelial glycocalyx by measuring the thickness of the
Perfused Boundary Region (PBR). Though single measurements are
current clinical practice, intra observer variability is unknown.
OBJECTIVES. This study aims to determine the intra observer
variability of the PBR as measured with the Glycocheck®.
METHODS. Microcirculation was assessed in a pilot study of 49
mechanically ventilated mixed ICU patients using SDFI (Glycocheck®).
Each patient was assessed three times consecutively within 30
minutes by the same experienced operator. The operator was
unaware of the results of the measurements until all three
measurements were completed. The Glycocheck® calculated the
PBR for each of the measurements. The intra-observer agreement was
calculated using an intra-class correlation coefficient (ICC) using SPSS.
RESULTS. The mean (SD) PBR was 2,02 (0,26) μm. The ICC for single
measures was 0,362, indicating a poor intraobserver agreement for
single measures. ICC for average measures was 0,630 indicating
reasonable reliability of the averaged value of 3 consecutive
measurements.
CONCLUSIONS. Intraobserver variability in this pilot study was
higher than expected. Averaging the results of three consecutive
measurements improved data quality. Whether intraobserver
agreement was limited by patient factors such as hemodynamic
instability or whether it is inherent to the method itself remains
unclear. Reliability of measurement of PBR by SDFI should be
increased by averaging (at least three) multiple consecutive
measurements. A single measurement is insufficient to yield
reliable data on PBR diameter assessed by glycocheck.
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INTRODUCTION. Microcirculatory dysfunction cannot be predicted
by systemic hemodynamic parameters.1 A serum lactate above 4
mmol/l was previously considered abnormal but this upper level has
been lowered to 2 mmol/l.2 This is considered to indicate inadequate
oxygen delivery.3
OBJECTIVES. To determine whether a lactate level above 2 mmol/L
is associated with microvascular dysfunction compared to normal
lactate.
METHODS. We conducted a cross-sectional observational pilot study.
In each intensive care patient sublingual microcirculation was
assessed with the Cytocam-IDF (incident dark field illumination) de-
vice simultaneously with the collection of an arterial blood gas for
lactate measurement. Microcirculatory images were analysed auto-
matically with Cytocam analysis software. We assessed the direct
bedside relationship between total vessel density (TVD), perfused
vessel density (PVD), proportion of perfused vessels (PPV) and the
lactate level of blood collected at the same time. Descriptive analyses
and Pearson's correlation coefficient were used. Mann–Whitney U
tests were used for comparison between the lactate groups ≤ 2
mmol/L and > 2 mmol/L.
Fig. 184 (Abstract 0506). ROC curves for predicting an
high P(v-a)CO2/C(a-v)
Fig. 183 (Abstract 0506). The percentages of high ratio in the
four groups
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8 with sepsis. Lactate level was below 2.0 mmol/L in 14 and in 17
the lactate level was above 2.0 mmol/L. Mean age was 65 years (SD
8.1), median APACHE IV predicted mortality 4.9% (IQR 23), mean
SOFA score 6.4 (SD 2.8). Lactate levels were median 2.4 mmol/L (IQR
1.7) and varied between 0,5 mmol/L and 6.7 mmol/L.
TVD, PVD and PPV were non-significantly different between groups
(all p > 0.3). All correlation coefficients between lactate and TVD, PVD
and PPV were below 0.2 and non-significantly different from zero.
CONCLUSIONS. No significant correlation was found between
sublingual IDF microcirculation parameters and lactate levels. Groups
with normal and slightly elevated lactate were comparable too.
Higher lactate ranges need further research.
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INTRODUCTION. Studies had shown that venous-to-arterial CO2 dif-
ference/arterial-central venous O2 difference(P(v-a)CO2/C(a-v)O2)ratio
is related to lactate levels, lactate clearance and the response of
VO2to an acuteincrease of DO2. The P(v-a)CO2/C(a-v)O2 is calculated
from a well-known formula[1], using the values of central venous
saturation(ScvO2) and thevenous-to-arterial CO2 difference (P(v-
a)CO2). To our knowledge, thedependency of the calculation of P(v-
a)CO2/C(a-v)O2 ratio to ScvO2 and P(v-a)CO2has not been explored
sufficiently in clinical practice.
OBJECTIVES. Determine the relationship between ScvO2, hemoglobin,
SaO2, venous-to-arterial CO2 difference and P(v-a)CO2/C(a-v)O2 ratio,
and define the corresponding factors which identify give a high P(v-
a)CO2/C(a-v)O2 ratio in critically ill patients.
METHODS. A total of 1294 pairs of simultaneous arterial and central
venous blood gas measurements were retrospectively studied in
354critically ill patients. A cutoff of P(v-a)CO2/C(a-v)O2 ratio > 1.68
was defined as an abnormally high ratio based on published
literature[1]. The measurements were divided into four categories
based on cutoff values of ScvO2 (70%) and P(v-a)CO2 (6mmHg):
group I (P(v-a)CO2 ≤ 6mmHg on ScvO2 < 70%), group II (P(v-
a)CO2 ≤ 6mmHg on ScvO2 ≥ 70%), group III (P(v-a)CO2 > 6mmHg on
ScvO2 < 70%), and group IV (P(v-a)CO2 > 6mmHg on ScvO2 ≥ 70%).
RESULTS. P(v-a)CO2 show a significantly stronger correlation with
P(v-a)CO2/C(a-v)O2(r =0.692, P < 0.05) than ScvO2 (r = 0.104, P < 0.05)
and hemoglobin(r = −0.159, P < 0.05). The group I measurements
had the lowest P(v-a)CO2/C(a-v)O2 ratio value (1 ± 0.46) and
percentage of high P(v-a)CO2/C(a-v)O2 ratio(5.8%(8/136)). Moreover,
the group IV measurements had the highest P(v-a)CO2/C(a-v)O2 ratio
value (2.32(1.9-3.4)) and percentage of high P(v-a)CO2/C(a-v)O2
ratio(84%(176/209)). (Figure 183) However, there was a significantly
lower SaO2, hemoglobin and higher lactate in the group I. The P(v-
a)CO2(ROC area 0.793) was with the best ability to predict the high
ratio and was significantly better than ScvO2 and hemoglobin.(Figure 184). For predicting the high P(v-a)CO2/C(a-v)O2 ratio, a
P(v-a)CO2 threshold of 7mmHg was associated with a sensitivity
of 41.77% and a specificity of 90.62%.
CONCLUSIONS. P(v-a)CO2 is predictive of high P(v-a)CO2/C(a-v)O2
ratio, and P(v-a)CO2 is more relevant to P(v-a)CO2/C(a-v)O2 ratio
than ScvO2. There might be a “pseudo-normalization” of P(v-a)CO2/
C(a-v)O2 ratio in the group I with low P(v-a)CO2(≤6mmHg) and low
ScvO2(<70%).
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Fig. 185 (Abstract 0508). Correlation between ΔPCO2 and
Lactate levels
Table (Abstract 0508). Correlation between lactate levels and ΔPCO2
H0 H1 H2 H3 H6 H10
Correlation between Lactate levels and
ΔPCO2 (%)
59 50 49 57 59 53
p 0.001 0.03 0.04 0.001 0.001 0.002
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INTRODUCTION. Renal function impairment is common after cardiac
surgery,. The early mortality rate in patients with AKI is around 5%
but raises up to 50% when renal replacement therapy (RRT) is
needed. Various factors related to CPB have been implicated as
possible determinants of AKI but few studies analyze the C02 and 02
metabolism. Venous-arterial CO2 derivatives (ΔpCO2, ΔpCO2/ΔO2c-
ontent, ΔCO2content/ΔCO2) are intensively studied in sepsis, but
there are lack of studies concerning cardiac surgery.
OBJECTIVES. To analyze the relationship between CO2-derived vari-
ables measured during the first 12 hs after an elective cardiac sur-
gery and renal failure in the following 28 days. The calculated
sample is 150 patients. These are preliminary results.
METHODS. prospective, observational study; following a cohort of
adults who underwent cardiac surgery and were admitted in a 16-
bed cardiac ICU. Informed consent was obtained from the next-of-
keen or reconsent was signed by the patient after extubation. The
study was approved by the Hospital Ethics Committee.
Previous history of renal and hepatic disease was recorded as well as
type of surgery and surgical times. Central venous and arterial gases
were analyzed at ICU admission, 6 hs and 12 hs later, as well as,
hemoglobin, creatinine, lactate, and hemodynamic variables. Fluid
balance was also collected. In the following 28 days, ICU mortality,
hospital and ICU stay and acute renal failure incidence, according
AKIN and RIFLE classification were analyzed. All normally distributed
data were expressed as the mean ± standard deviation (SD) unless
otherwise specified. Quantitative variables were compared using
non-parametric tests. Qualitative variables were compared with chi
square or Fisher's tests. p < 0,05 was considered significant.
RESULTS. 22 patients were analyzed. 13 were male (59,1%). Mean
age was 66,68 years (SD ± 12,77). Four patients had previous renal
disease (18,2%) but none of them had hepatic disease. Type of
surgery: valvular (11), CABG (5), CABG + valvular (4) and aortic root
(2). EuroScore II was 1,63 (IQR 0,92-2,44) and admission CASUS was 3
(1,75-5). CPB was used in 18 surgeries (81,8%): CPB time was 101 min
(SD ± 51,64) and cross clamp time 78 min (SD ± 36,31). Fluid balance
at 12 hs was 578 ml (IQR −55-928). Four patients (18,2%) were
ventilated and 8 (36,4%) treated with vasoactive drugs >12 hs. Peri-
operative ARF was diagnosed in 7 patients (31,8%) but none of them
received RRT. CPB was not associated with renal failure (p = 0,19) No
patients died. Hospital stay was 11 days (SD ± 6,63) and ICU 1,81
days (SD ± 1,25). delta-12hs Svc02, Lac, CO2 variables and fluid bal-
ance were not associated either with renal failure, mortality or
lengths of stays (p > 0,05).
CONCLUSION. These preliminary results show that in the first 12 hs,
CO2 derivates are not related either with postoperative renal failure
or mortality.
REFERENCES
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INTRODUCTION. The arteriovenous difference in CO2 (ΔPCO2) is an
indicator of macro and microcirculatory perfusion during shock
states. In septic shock, an arteriovenous pressure gradient of CO2 < 6
mmHg (in addition to venous saturation of oxygen [SvO2] > 70%)
demonstrates a restored central hemodynamics and constitutes a
therapeutic objective [1].
OBJECTIVES. The purpose of this study was to evaluate the clinical
relevance of high values of ΔPCO2 and to assess the association between
both ΔPCO2 and arterial lactate levels with cardiac surgery outcomes.
METHODS. Between January and March 2017, all patients scheduled to
undergo open heart surgery using cardiopulmonary bypass were
included in this prospective single-center observational study. A stand-
ard technique for anesthesia was followed. Demographic and biological
data, PCO2 gap, central venous oxygen saturation, lactate levels, vaso-
pressor/inotropic support and postoperative complications were re-
corded for all patients at ICU admission, then 1 hour (H1), 2 hours (H2),
3 hours (H3), 6 hours (H6) and 10 hours (H10) after admission.
RESULTS. Thirty-three consecutive patients were included. Mean age
was 48 (9) years. Nine patients (27%) required mitral valve replace-
ment. Eight (24%) required aortic valve replacement. Another eight
(24%) required coronary bypass surgery, and eight (24%) underwent
Bentall procedure. The mean left ventricular ejection fraction (LVEF)
was 50 (2)%. Correlation between ΔPCO2 and lactate levels was sig-
nificant at all time points. We found a significant correlation between
mortality rate and ΔPCO2 up to H2 (57%, p = 0.001) but no correl-
ation with length of ventilation, and hospital length of stay.
CONCLUSIONS. The arteriovenous difference in CO2 might be a
useful tool to detect global and microcirculatory hypoperfusion in
postoperative cardiac surgical patients.
REFERENCE(S)
[1] The role of central venous oxygen saturation, blood lactate, and
central venous-to-arterial carbon dioxide partial pressure difference
as a goal and prognosis of sepsis treatment, J Crit Care, 2016 Dec;
36:223–229
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INTRODUCTION. Pleural effusions are common in ICU patients,
making therapeutic thoracocentesis one of the most commonly
performed medical procedures. However, the effect of pleural
effusions drainage on lung mechanics and on the distribution of
tidal volume between the thoracic and abdominal compartments has
not been elucidated.
OBJECTIVES. To investigate the distribution of tidal volume among
the thoracic and abdominal compartments before and after drainage
of pleural effusions in mechanically ventilated patients and the effect
of positive end expiratory pressure (PEEP) on this distribution.
METHODS. Six sedated and mechanically ventilated ICU patients
with bilateral pleural effusions were enrolled in the study. A central
venous catheter was inserted in each pleural cavity for fluid drainage
and direct pleural pressure measurement. The following variables
were measured: Rib cage (RC) and abdominal (AB) compartment
contribution to tidal volume (Vt) using Respiratory Inductive
Plethysmography, Functional Residual Capacity (FRC) using the
dilutional nitrogen wash in and wash out method (Carescape R860
ventilator), static compliance (Cstat), diaphragmatic displacement
using ultrasonography, PaO2/FiO2 ratio and transpulmonary pressure.
Our measurements were recorded during four different steps: i:
before drainage of pleural fluid, ii: after drainage with zero peep
(ZEEP), iii: after drainage and application of 14 cmH2O of PEEP for 20
minutes and iv: after release of PEEP. ANOVA with post hoc analysis
was performed using IBM statistics SPSS 23.
RESULTS. The mean volume of pleural fluid drained was 1700ml. The
distribution of Vt in RC and AB did not change significantly after the
evacuation of pleural fluid. On the contrary the application of 14 cm
H2O of PEEP increased the distribution of Vt in the RC compartment
by 13% (p = 0,047). The application of PEEP also induced an increase
in FRC by 1lt (p = 0,01) and PaO2/FiO2 ratio by 120 mmHg
(p = 0,078). Additionally, transpulmonary pressure also increased by
123% (p = 0,046), whereas Cstat remained constant. All the effects of
PEEP on lung mechanics were abolished after the release of PEEP
except for the effect on oxygenation. Moreover, an increase in
diaphragmatic displacement was observed with ultrasonography in
all patients after the release of PEEP (p = 0,04) probably due to
reopening of basal atelectasis.
CONCLUSIONS. Pleural fluid drainage itself does not accomplish
sufficient lung recruitment. Only high levels of PEEP are associated
with a significant improvement in FRC; however, the improvement is
temporal and is abolished after the release of PEEP.
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INTRODUCTION. It is estimated that more than 140 million of people
lives in areas situated higher than 2500 mts above sea level. The
effect of low airway pressure induced by high altitude has never
been studied in invasive mechanically ventilated (IMV) patients.
OBJECTIVE. To define the effect of high-altitude over ARDS and mor-
tality rate in IMV patients.
METHODS. This international, prospective, cohort and observational
study of patients (> = 16 years-old) undergoing IMV was conducted
during 4 consecutive weeks (August 1st to 31st) of 2016 in a con-
venience sample of 27 ICUs from Bolivia, Brazil, Colombia, Ecuador,
México, Peru and Spain. Exclusion criteria: change the altitude over
sea level during the 40 days before ICU admission. Demographic
data, comorbid diseases, and clinical and laboratory data were col-
lected. Patients were followed up until death, hospital discharge or
for 28 days, Day 0: pa02/Fio02 < =300mmHh.ARDS was defined ac-
cording to Berlin. Results are shown as median (IQR). Categorical and
continuous variables were compared with χ2 and Mann–Whitney or
kruskal-wallis, respectively. Ethical committee approved this study.
RESULTS. From 178 patients that were recruited, n = 24 belong to
the sea level group (≤600mt); n = 75 to the mild altitude group
(>600mts & ≤2600mts); n = 69 to the high altitude group (>2600mts
& ≤ 3600mts) and n = 10 to the extreme high altitude group
(>3600mts). Apache II scores were 18 (12; 26); 16 (12; 21); 19 (11; 26)
and 17 (15; 18) respectively (p = 0.50). Age (years-old) were 65 (56;
71); 60 (44; 74); 58 (39; 71) and 40 (36; 56) respectively (p = 0.01).
Mortality rates were 33%, 23%, 26% and 30%, respectively (p = 0.76).
ARDS rates were 42%, 14%, 21% and 60%, respectively (p = 0.01).
CONCLUSIONS. In this pioneer study the increase in the altitude
above sea level seems to be influence the risk of ARDS but not the
mortality of patients undergoing IMV.
TRIAL REGISTRATION. Clinicaltrials.gov Identifier: NCT02871063 .
GRANT
Escuela de Medicina de la Universidad Internacional del Ecuador
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INTRODUCTION. Proportional Assist Ventilation (PAV) generates
pressure in proportion to instantaneous effort by amplifying inspiratory
effort without a preselected target in spontaneously breathing patients.
PAV plus measures compliance and resistance, calculates work of
breathing and elastance, and adjusts the level of support provided
according to a preset level of assistance. Although PAV and PAV+ are
expected to augment patient comfort and synchrony, whether they
confer clinical benefits remains unknown.
OBJECTIVES. To summarize randomized controlled trials (RCTs)
comparing invasive and noninvasive PAV and PAV+ in critically ill
adults and children reporting clinical outcomes.
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Sept 2015) and CENTRAL (August 2015) to identify potentially
eligible trials using database-specific search strategies. Five authors
hand-searched conference proceedings from 5 meetings (Society of
Critical Care Medicine, European Society of Intensive Care Medicine,
International Symposium of Intensive Care and Emergency Medicine,
American College of Chest Physicians, and the American Thoracic
Society) from 2005–2015. The search was not limited by language or
publication status.
We selected parallel group and crossover RCTs that enrolled critically
ill adults or children receiving invasive or noninvasive PAV or PAV+,
compared them to an alternate mode, and reported at least one
clinically important outcome.
RESULTS. We identified 13 RCTs (10 parallel-group, 3 crossover) in-
volving 881 patients. Eight trials evaluated PAV and 5 trials evaluated
PAV+. Of these, 4 parallel-group RCTs evaluated noninvasive PAV in
patients with acute respiratory failure (ARF). Two parallel-group trials
evaluated invasive PAV as a weaning strategy. Four trials evaluated
PAV+ as an initial support strategy (n = 1), weaning strategy (n = 2),
and as an SBT technique (n = 1). Three cross-over trials [2 invasive
PAV and 1 invasive PAV+] assessed sleep quality. Trials were of low
to moderate quality.
Compared to noninvasive Pressure Support (PS), noninvasive PAV
showed a nonsignificant reduction in intubation rate [RR 0.92
(0.59,1.43); 2 trials, n = 161; I2 = 0%] and no effect on ICU or hospital
mortality or length of stay. Compared to invasive PS, we found no
effect of invasive PAV on the proportion of rapid eye movement
sleep [MD −2.93 (−14.20, 8.34) (percentage); 2 trials, n = 50; I2 = 43%].
Compared to invasive PS, invasive PAV+ showed a nonsignificant
increase in weaning time [MD 0.46 (−0.71,1.63); (hours)2 trials,
n = 74; I2 = 0%].
CONCLUSIONS. Available RCT data do not support use of invasive or
noninvasive PAV or invasive PAV+ for various indications in critically
ill adults. No trial evaluated PAV or PAV+ in children. Promising
areas for future investigation include evaluation of (i) noninvasive
PAV as initial support for patients with ARF, (ii) invasive PAV on
sleep quality, and (iii) invasive PAV+ in weaning.
GRANT ACKNOWLEDGMENT
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INTRODUCTION. VAP is the most common healthcare-associated in-
fection in critical care units, occurring in up to 30% of patients re-
quiring mechanical ventilation. Attributable mortality is estimated at
9–13.5% and the additional financial cost of each VAP episode
ranges from £7000-£25,000. VAP rates are a quality indicator, and a
reduction in VAP rates has been demonstrated to result in reduced
length of stay, more efficient use of critical care beds, and financial
savings.1,2
OBJECTIVES. To demonstrate a reduction in VAP rates through two
separate interventions:
a) implementation of a standardised VAP prevention bundle for
every intubated patient and
b) introduction of subglottic suction port ETTs.
METHODS. Prospective study conducted in a large tertiary critical
care centre with two phases: Phase 1 over 20 working days (July-
August 2016) followed by phase 2 on working days over 8 weeks
(February-April 2017). All patients ventilated >48 hours across fourspecialist critical care units were audited (total 68 beds). Patients
were assessed using the HELICS criteria, and the impact of two
consecutive interventions on VAP rates:
a) implementation of a standardised VAP prevention bundle for
every intubated patient (between phases 1 and 2) and
b) introduction of subglottic suction port ETTs (during phase 2). VAP
prevention bundle compliance was audited simultaneously.
RESULTS. VAP rates during phase 1 were 38 per 1000 ventilator days.
VAP rates reduced to 29 per 1000 ventilator days following the
introduction of the VAP prevention bundle (phase 2a). Compliance
with the VAP bundle was considered sub-optimal at 84%. During
phase 2b VAP rates were further reduced in those patients with sub-
glottic suction port ETTs (14.7 per 1000 ventilator days) compared to
those with standard ETTs (26.6 per 1000 ventilator days). VAP preven-
tion bundle adherence was similar during both phases.
CONCLUSIONS. Overall compliance with the VAP prevention bundle
was considered sub-optimal, however despite this, a trend towards
improvement in VAP rates was seen with this intervention. Introduc-
tion of ETTs with subglottic suction ports in addition to the VAP pre-
vention bundle showed a marked improvement in VAP rates. Based
on our data, optimisation of VAP prevention bundle adherence and
routine use of subglottic suction port ETTs is recommended. There is
likely to be a significant cost saving associated with a reduction in
VAP rates following these interventions.
REFERENCE(S)
1. Ventilator associated pneumonia in the ICU. Kalanuria et al. Critical
Care 2014, 18:208
2. Number needed to treat and cost effectiveness in the prevention
of ventilator-associated pneumonia. Wyncoll and Camporota. Critical
Care 2012, 16:430
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INTRODUCTION. Calculated dynamic stress measured as mechanical
power in respiratory system (Powerrs) is a recently described tool
for assessment of lung injury1. However information related to
spontaneous ventilation (SV) is limited, moreover whether the
Powerrs is modified by conventional protective lung strategies
(CLPS) is unknown in SV.
OBJECTIVES. To measure and to compare Powerrs in patients with SV
and controls with controlled ventilation (CV) modality and to stratify
according to CLPS.
METHODS. We conducted a case–control study with critical patients
from a single center in an intensive care unit (ICU) in Mexico. Study
subjects included subsequent cases of patients with spontaneous
ventilation and 1:1 age-and sex-matched-controls with CV modality.
Demographic, and Clinical variables were collected from clinical files.
We included the following Ventilator parameters: tidal volume (TV),
predictive body weight (PBW), compliance (CRS), respiratory rate (RR),
total positive end expiration pressure (tPEEP), peak pressure (PeakP),
plateau pressure (PlatP) and Powerrs calculated according to an equa-
tion described according to the work published on intensive care
med in 2016 a cutoff > = 13 J/min was defined as high dynamic
stress. We tested the following CLPS:
1) TV < 6ml/Kg/PBW,
2) Platp < 30 mm H2O,
3) Driving pressure < 15 cm H2O.
Fig. 187 (Abstract 0514). Automatic weaning function of IV-ASV
Fig. 186 (Abstract 0514). Representative screenshot of a patient
on IV-ASV
Table (Abstract 0514). Characteristics of the patients at randomization
IV-ASV P-ACV p
Age, years 70 (62–77) 67 (59–73) 0.19
SAPS II 41 (37–45) 43 (35–48) 0.86
pH 7.20 (7.16-7.27) 7.20 (7.16-7.26) 0.54
PaCO2, mmHg 99 (82–116) 101 (87–115) 0.95
PaO2/FiO2 152 (115–195) 200 (155–260) 0.018
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and 63% males with 30 matched controls. Overall, 23% of patients
had full CPLS. PBW of 62 (SD ± 10.5 kg, mean RR of 18
(SD ± 5.5)min-1, mean TV of 0.46 (SD ± 0.1) liters, mean CRS of 55
(SD ± 22) mL/cm H2O, tPEEP of 7.6 (SD ± 3.3) cm H20, PeakP 20.4
(SD ± 6.9) cm H2O, PlatP of 17.05 (SD ± 5.8) cm H2O. Global mean
Powerrs 12.7 (SD 8.25) J/min. Powerrs in SV was similar for both
protected and unprotected patients 7.25 (SD ±1.59) vs. 6.09 (SD ±1.8)
J/min (p = 0.11), and lower in controls with 12.3 vs 20.35 J/min
(p = 0.02) when in CPLS. Case patients had lower overall risk for high
dynamic stress OR = 0.26 (95% CI 0.14 - 0.48, p < 0.01) and was not
modified by any of the CLPS.
CONCLUSIONS. Patients in SV modality showed lower estimated
Powerrs vs. control group. CPLS did not modify the risk for with high
dynamic stress since any of subjects in this group reached > = 13 J/min.
Lower cutoff points for dynamic stress might not be clinically relevant
because the risk for lung injury at lower cutoff values is improbable and
additional CPLS possibly should not be further required.
REFERENCE(S)
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INTRODUCTION. There are some studies suggesting that adaptive
support ventilation (ASV), a closed loop ventilation mode may
shorten the duration of intubation and weaning duration in some
patient groups (Kirakli et al. 2015; Domingo et al. 2010). IntelliVent-
ASV™ (IV-ASV) is a full closed-loop ventilation mode that automatic-
ally adjusts ventilation (according to end tidal CO2) and oxygenation
(according to pulse oximetry) parameters in both passive and active
patients with promising results (Arnal et al. 2013; Bialais et al. 2013).
OBJECTIVES. We aimed to investigate the effect of IV-ASV on the
duration of intubation and weaning, workload regarding the setting
of the ventilator and other ventilation parameters in COPD patients
when compared to conventional modes.
METHODS. COPD patients who were intubated longer than 24 h
were randomized into IV-ASV or pressure assisted controlled ventila-
tion (P-ACV). Weaning was performed with the “Quickwean” function
and automatic spontaneous breathing trial (SBT) in IV-ASV and pres-
sure support ventilation and SBT with a t-tube trial in P-ACV. In both
groups ventilation data were recorded with dedicated software con-
nected to the ventilator. Duration of intubation and weaning, num-
ber of manual and automatic settings of the ventilator and other
clinical endpoints were compared between the two groups.
RESULTS. Data are expressed as median (25th-75th percentiles).
Eighty one patients out of 188 (study sample size) until now were
enrolled. Median duration of intubation from randomization and
weaning duration seemed insignificantly shorter with IV-ASV. Number
of manual adjustments per hour for setting the ventilator was signifi-
cantly lower in the IV-ASV group. IV-ASV performed median 93 (76–136)
automatic adjustments per hour for setting the ventilator parameters.
CONCLUSIONS. IV-ASV may decrease the total duration of mechanical
ventilation and weaning and significantly staff's workload when
performed from intubation until extubation.
REFERENCES
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Table (Abstract 0514). Comparison of the two ventilation modes
IV-ASV P-ACV p
Weaning duration, h 35 (18–70) 41 (18–69) 0.91
Duration of intubation, h 63 (23–91) 71 (45–101) 0.34
Number of manual
adjustments per hour, n
0.05 (0.01-0.07) 0.28 (0.19-0.34) <0.001
Proportion of the ventilation
time patient is actively
triggering the ventilator, %
94 (72–100) 64 (59–88) 0.002
Tidal volume/IBW, ml/kg 8.6 (8.1-9.7) 8.1 (6.4-8.4) 0.07
ABG number/day, n 0.94 (0.56-1.44) 2.18 (1.75-3) <0.001
Weaning success, n (%) 37 (93) 33 (97) 0.37
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INTRODUCTION. Different factors may to modify the mechanics
properties of respiratory system following lung transplantation (LT).
Changes in the airway resistance, lung elasticity and chest wall, could
be provide detailed information allow some intervention in order to
improve the outcome (1,2).
OBJETIVES: To assess the mechanics of lung and chest wall after of
postoperative LT and its usefulness to discriminate the prognosis.
METHODS. Prospectively collected data from 27 patients undergoing
LT between 2016–2017. During volume controlled mechanical
ventilation with constant flow at the first day(d) after LT. Airway and
Esophageal pressure, Flow signals were recorded. Multiple linear
regression was used to compute elastance and resistance of
respiratory system (Ers, Rrs) and his components. Demographic data,
complications, prolonged mechanical ventilation ≥ 21d(PMV), stay
ICU, survival 90d, were evaluated. Data were analyzed by the Fisher
exact test, Mann–Whitney test or t-test as appropriate.
RESULTS. Males 21(77.8%); 51.18 ± 11.33y. Fibrosis 13(48,14%),
Emphysema 12(44.4%), fibro-emphysema 1(3.7%), Idiopathic Pul-
monary Hypertension 1(3.7%). Double LT 8(29.6%). Death 5(18,5%)
3 in double. Preservation 345,8 ± 68,4min. Respiratory system me-
chanics: All Data: Rrs 14.23 ± 5.94 cmH2O.s/L, Ers
33.48 ± 11.02cmH2O/L, EL 23.73 ± 10.94 cmH2O/L, Rcw 0.92 ± 0.93
cmH2O.s/L, Ecw 7.1 ± 2.9cmH2O/L, PEEP 5.8 ± 1.2cmH2O, V'
0.69 ± 0.14 L/s, Vt 0.5 ± 0.09L, RR 19.7 ± 2.6/min. Single vs double
LT: Rrs 15.78 ± 6.32 vs 10.56 ± 2.56cmH2O.s/L, p = 0.034; EL
24.58 ± 11.41 vs 21.7 ± 10.15cmH2O/L, p = 0.54. Ecw 7.05 ± 3.14 vs
7.28 ± 2.48cmH2O/L, p = 0.86. Emphysema vs fibrosis: Rrs
14.30 ± 6.36 vs 12.45 ± 2.91cmH2O.s/L, p = 0.38; EL 19.08 ± 6.14 vs
27.44 ± 13.10cmH2O/L, p = 0.048; Ecw 7.42 ± 3.04 vs
7.01 ± 2.98cmH2O.s/L, p = 0.74. Survival: Rrs 12.2 ± 3.1 vs
19.5 ± 9.9cmH2O.s/L, p = 0.007; EL 20.01 ± 6.8 vs 32.5 ± 9.3cmH2O/
L, p = < 0.002; Ecw 7.02 ± 2.9 vs 7.49 ± 2.9cmH2O/L, p = 0.76. Stay
ICU 9(7–25)d < />: Rrs 13.47 ± 5.8 vs 15.75 ± 6.3cmH2O.s/L,
p = 0.36; EL 19.25 ± 6.77 vs 26.55 ± 9.48cmH2O/L, p = 0.04; Ecw
6.99 ± 3.1 vs 7.36 ± 2.8cmH2O/L, p = 0.78. PMV < />: Rrs
13.48 ± 5.54 vs 18.54 ± 7.22cmH2O.s/L, p = 0.12; EL 18.81 ± 5.88 vs
31.54 ± 10.67cmH2O/L, p = 0.003; Ecw 5.9 ± 1.8 vs 7.2 ± 3.2cmH2O/
L, p = 0.34. Reperfusion injury: Rrs 10.44 vs 17.18 ± 8.23cmH2O.s/L,
p < 0.03; EL 19.32 ± 6.19 vs 27.02 ± 7.75cmH2O/L, p = 0.03; Ecw
7.2 ± 6.9 vs 6.9 ± 3.6cmH2O/L, p = 0.84. Rejection or pneumoniae:
Rrs 14.3 ± 6.5 vs 14.2 ± 5.4cmH2O.s/L, p = 0.97; EL 18.75 ± 6.8 vs
29.95 ± 12.2cmH2O/L,p = 0.006; Ecw 6.83 ± 3.2 vs
7.51 ± 2.6cmH2O/L,p = 0.58.CONCLUSIONS. The mechanics respiratory following LT tend to be
worse in the patients with worse results. Particularly, EL could
discriminate morbidity and mortality. The surgery modality can
influence in the respiratory mechanics. We could speculate that early
assessment of respiratory mechanics after LT can provide better
understanding of patient's conditions and therapeutic approach.
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INTRODUCTION. The clinical diagnosis of VAP is notoriously difficult
and there is often significant discordance between units and
individual clinicians. There is currently no gold standard for diagnosis
with significant variability between existing diagnostic criteria.1
OBJECTIVES. To assess VAP rates using three different diagnostic
criteria (HELICS, CPIS, CDC NHSN 2008) versus clinician diagnosis,
followed by an assessment of the criteria for concordance. The
objective was to choose a diagnostic tool for long term use based on
ease of use and concordance with clinician diagnosis.
METHODS. Prospective study conducted in a large tertiary critical
care centre on working days over 8 weeks (February-April 2017). All
patients ventilated >48 hours across four specialist critical care units
were audited (total 68 beds). Patients were assessed using HELICS,
CPIS and CDC NHSN 2008 criteria for identification of VAP. This was
compared to patients with a documented clinician diagnosis of VAP.
These data were analysed for concordance between clinician
diagnosis and the three VAP diagnostic criteria and additionally
between the VAP criteria themselves.
RESULTS. VAP rate according to clinician diagnosis was 31 per 1000
ventilator days. VAP rates were 24 per 1000 ventilator days, 36 per
1000 ventilator days and 15 per 1000 ventilator days according to
HELICS, CPIS and CDC NHSN 2008 diagnostic criteria, respectively.
Concordance with clinician diagnosis was highest for HELICS (28.2%)
followed by CPIS (23.9%) and CDC NHSN 2008 (18.2%). Concordance
between criteria was greatest for HELICS and CDC (88.2%).
CONCLUSIONS. CPIS and HELICS appear to have similar VAP
detection rates compared with clinician diagnosis. CDC NHSN 2008
appears to underestimate VAP rates compared to the other criteria.
However, all three criteria have poor concordance with clinician
diagnosis. Of the three, HELICS had the best concordance with
clinician diagnosis. Based on this data we have adopted HELICS as
our tool for VAP diagnosis.
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INTRODUCTION. Reverse triggering is a form of patient-ventilator
dyssynchrony referred to as patient's breathing effort induced by
mandatory ventilation. Reverse triggering is often seen in deeply
sedated critically ill patients. Reverse triggering causes double
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 265 of 542breathing accompanied by large tidal volume (VT) increased transpul-
monary pressure (PL = Airway pressure - pleural pressure) and can
exacerbate the lung injury. There has been little knowledge about
appropriate ventilation modes for reverse triggering phenomenon.
OBJECTIVES. Responses to induced spontaneous breathing effort in
reverse triggering are different between Pressure Controlled Assist-
Control ventilation (PC-AC) mode and biphasic positive airway pres-
sure ventilation (Bilevel) mode. We hypothesized that Bileve mode
would limit VT and reduce PL in comparison with PC-AC mode.
METHODS. We simulated reverse triggering phenomenon by using a
twin bellow-type lung model, which can produce spontaneous
breathing effort. The lung model consisted of two bellows implanted
into one closed box. One bellow represents lung and the other bel-
low make activity of inspiratory muscles, which can be controlled by
a personal computer. We can know pleural pressure by measuring
the pressure inside the box. Spontaneous breathing of the lung
model was set at 500 mL of tidal volume, 1.5 or 2.0 s of inspiratory
time, and sine-wave inspiratory flow pattern. The lung model was
connected to the Puritan-BennettTM 840 ventilator (Nellcor Puritan
Bennet, Carlsbad, CA). The mandatory ventilation was performed by
Bilevel mode or PC-AC mode with 20 cmH2O of inspiratory airway
pressure, 5 cmH2O of end-expiratory pressure, 1.0 s of inspiratory
time, and 10 /min of ventilatory rate. Reverse triggering
phenomenon was simulated by making spontaneous inspiratory ef-
forts following the mandatory ventilation with short, moderate, or
long delay (0.3, 0.6, and 1.0 s after the beginning of mandatory in-
spiration, respectively). Respiratory flow, airway pressure, and pleural
pressure were measured. VT and maximum PL were calculated as an
average of 10 breaths at each condition.
RESULTS. Airway pressure rose at all the entrained inspiratory efforts
in PC-AC mode. Airway pressure did not rise in response to the
entrained triggering efforts in Bilevel mode except the condition of
1.5 s of inspiratory time with short delay. VT and maxPL during BILE-
VEL mode were significantly smaller than those during PC-AC.
CONCLUSIONS. Biphasic positive airway pressure ventilation mode
might be advantageous to suppressing the excessive tidal volume
and transpulmonary pressure in reverse triggering phenomenon.Table (Abstract 0517). The VT and PL at each condition
VT (mL) maxPL (cmH2O)
inspiratory time delay A/C Bilevel A/C Bilevel
1.5 sec short 650 ± 7 650 ± 13 17.8 ± 0.2 18.4 ± 0.2
moderate 947 ± 5 629 ± 14 18.6 ± 0.2 16.9 ± 0.3
long 968 ± 8 641 ± 4 18.7 ± 0.1 13.5 ± 0.1
2.0 sec short 912 ± 14 614 ± 18 17.6 ± 0.1 12.4 ± 7.4
moderate 982 ± 12 619 ± 22 18.2 ± 0.4 15.9 ± 0.3
long 936 ± 10 596 ± 22 18.6 ± 0 13.6 ± 0.10518
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INTRODUCTION. Patients with chronic dependence on mechanical
ventilation should not stay all the time in intensive care unit. Ideally,
if their personal situation allows, it is follow at home, for this it is
necessary the support of a Home Mechanical Ventilation Program.
Currently, in Granada, Spain, there is a program, that started
more than 20 years ago and created with the objetive of
improving the quality of life of these patients and facilitating
their family reintegration. It has an infrastructure of eleven beds,
a office and an intensivist care physician who plans, coordinates
and evaluates all the process, providing integral care due to its
multidisciplinary training.OBJECTIVES. Show the sociohealth care utility of Home Mechanical
Ventilation Program in Granada led by intensive care physicians.
METHODS. Observational, descriptive retrospective study of patients
treated from 1/10/95 to 31/3/17, by management of an anonymous
database, regarding patients included in the program and referred
from intensive care unit, follow up visit at the medical office,
telephone attention, sex, age, pathologies and therapies.
RESULTS. Patients included in program: 405. Average of patients/
year: 90–130. Medical office/year:> 300, telephone support: 3–5 calls/
day. Beds availability for acute admission, respiratory therapies
training, family rest and palliative care.
Patients derived from ICU 110, Men 66 (60%), mean age at admission:
51.3 ± 17.9 years; Pathologies: amyotrophic lateral sclerosis 33 (30%);
Myopathies 24 (21.8%); Thoracogens 15 (13.6%); Multifactorial 18
(16.4%), others 20 (18.2%). Invasive ventilation 80 (72.7%), noninvasive
25 (22.7%), non-ventilated tracheotomy 5 (4.6%).
CONCLUSIONS. The program leads by intensive care physcians is
fully justified because:
– Achieves an integral approach to the patients
– Allows the transfer from the ICU to the home through a
structured care circuit
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OBJECTIVE. To describe the clinical characteristics and physiological
effects of APRV (Airway Pressure Release Ventilation) in patients with
ARDS (Acute Respiratory Distress Syndrome) at the Intensive Care
Unit (ICU).
METHODS. Retrospective descriptive observational study in a polyvalent
10 - bed adult intensive care unit in an University Hospital in Madrid,
Spain. Patients with ARDS (based on Berlin criteria) were included from
October 2013 to December 2016. Patients receiving APRV for less than
24 hours were excluded.
RESULTS. 17 patients fulfilled the eligibility criteria. A total of 21
episodes on APRV were included (because 4 of these patients had 2
APRV episodes each one). 86% were men; median age was 60 years
(interquartile range (IQR) 41–66). Initial APACHE II and SAPS 3
median were 25 (11–29) and 58 (53–79), respectively. SAPS 3
associated predicted mortality was 28% (18–71). The majority were
Table (Abstract 0519). Ventilatory, gasometric and hemodynamics
outcomes
Ventilatory parameter,
gasometric and hemodynamics
outcomes. Mean (SD)
On initiation
of APRV
12 h post
initiation of
APRV
24 h post
initiation of
APRV
High pressure (cmH2O); Low
pressure (cmH2O)
24,76 (3,83);
0,14 (0,47)
24,66 (3,81);
0,14 (0,47)
24,28 (4,05);
0,14 (0,47)
Peak airway pressure (cmH2O);
Mean airway pressure (cmH2O)
25,95 (3,85);
21,80 (3,57)
25,52 (3,86);
22,04 (3,77)
25,80 (3,41);
21,57 (3,21)
Minute volumen (ml);
spontaneous breathing frequency
10,92 (2,95);
15,19 (6,88)
10,54 (3,18);
12,36 (5,56)
10,00 (3,51);
10,71 (6,47)
High time (sec); Low time (sec) 4,13 (0,80);
0,47 (0,10)
4,13 (0,80);
0,47 (0,10)
4,06 (0,67);
0,52 (0,10)
pO2 (mmHg) 85,04 (22,12) 113,28 (34,54) 108,94 (54,19)
FiO2; pO2/FiO2 ratio (mmHg) 0,68 (0,16);
130,36 (48,48)
0,61 (0,15);
198,24 (81,72)
0,56 (0,16);
206,93
(110,48)
PH; pCO2 (mmHg) 7,35 (0,04);
54,05 (13,59)
7,38 (0,05);
54,57 (15,08)
7,38 (0,05);
52,08 (18,74)
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Injury Score was 2,5 (IQR 2,25 - 3,25) and median PaO2/FiO2 was
117 (80,5 - 145). At the beginning of APRV, most of patients had a
−4 in the RASS sedation scale. PaO2/FiO2 significantly improved
within 24 hours post - APRV initiation (ANOVA F (2) = 8, 07;
nP
2 = 0,288; p < 0,05).There were no significant differences related
to partial pressure of carbon dioxide on APRV. 4 of the 17
patients were place in prone position. Only one patient had a
pneumothorax associated to barotrauma and required intercostal
catheter insertion during APRV ventilation. The half of these
patients were changed of ventilation mode for improving, and
the other half were changed because of respiratory deterioration.
Only one patient was extubated in APRV. ICU mortality rate was
33.3%. (Tables showing median and interquartile range (IQR),
mean and standard deviation (SD).
CONCLUSIONS. In patients with ARDS and severe hypoxemic
respiratory failure, initiation of APRV was associated with an early
and sustained improvement in oxygenation and low incidence of
clinically significant complications. The safety and efficacy of APRV as
a rescue strategy for patients with ARDS and severe hypoxemic
respiratory failure requires further consideration.Heart rate (beats/min);
Mean arterial pressure (mmHg)
91,57 (15,41);
84,09 (12,30)
87,38 (13,80);
78,09 (12,54)
93,04 (16,88)
87,71 (15,25)
Table (Abstract 0519). Baseline characteristics of patients (n = 21)
Age 60 (41–66)
Gender, n (%) Male 18 (85,7); Female 3 (14,3)
Admission type, n (%) Medical 14 (66,7); Surgical 7 (33,3)
Lung injury mechanism, n (%) Pulmonary 17 (81); Extrapulmonary 4 (19)
APACHE II score 25 (11–29)
SAPS 3 score 58 (53–78,5)
Predicted mortality based on SAPS 3 score 28 (18–71)
ARDS severity (Berlin criteria), n (%) Mild 2 (9,5); Moderate 7 (33,3);
Severe 12 (57,1)
Murray criteria, n 2,5 (2,25 - 3,25)
Mode of ventilation prior to APRV (%) Pressure control 14 (66,7), volume
control 2 (9,5), pressure support 5 (23,8)
Table (Abstract 0519). Baseline characteristics of patients 2
Hours from intubation to APRV, mean (SD) 201,95 (1–1100)
Noradrenaline requirement on initiation of
APRV, n (%)
With noradrenaline: 11 (52,4%);
mean 0,26 (0,26 ug/kg/min); without
noradrenaline / vasopresors: 10 (47,6)
PaO2/FiO2 ratio prior to APRV (mmHg) 126,14 (68–250)
RASS scale at the beginning of APRV, n (%) −4: 11 (52,4), −3: 4 (19), −2: 3
(14,3), −1: 1 (4,8), 0: 1 (4,8)
Tracheostomy (%) 11 (52,4)
Duration on APRV (hours) 82 (IQR 11–228)
Mechanical ventilation duration (days) 21,5 (IQR 1–55)
Mode of ventilation after APRV, n (%) Pressure support 9 (42,9); pressure
control 11 (52,45); extubation 1 (4,8)
ICU LOS (days), mean (SD) 46,33
Mortality, n (%) ICU Mortality 7 (33,3%); Hospital
Mortality 7 (33,3%)0520
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INTRODUCTION. Pompe´s disease (Acid Maltase deficiency) is a rare
metabolic myopathy. Unlike other neuromuscular diseases in which
respiratory problems occur after loss of ambulation, respiratory
failure in pompe disease progress more rapidly than motor
impairment and hypoventilation during sleep may occur even if the
patient is still fully mobile.
OBJECTIVES. To study correlations between clinical features and
physiological respiratory parameters to better predict respiratory
disorders onset.
METHODS. It´s a retrospective observational study. All patients with
late onset Pompe´s disease followed at the Raymond Poincaré
teaching hospital (Garches, France) until November 2013 were
included. Data recorded were: demographic characteristics, clinical
features, ABG´s parameters, ventilatory functional tests assessed at
diagnosis and at the time of ventilation. Patients were divided in two
groups patients who needed mechanical ventilation (group 1) and
patients who didn't require home ventilation until November 2013
(group2). The two groups were compared using an unpaired t test.
Correlations between respiratory parameters and clinical features
were studied with Wilcoxon rank sum test with continuity correction.
RESULTS. A total of 33 patients (48,5% male; 51,5% female) were
included. The mean age at the first motor symptoms and at
diagnosis of pompe´s disease was respectively 38,3 ± 14,6 and
46,4 ± 14,5 years. 80,6% of patients could walk without aids, and
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 267 of 5429,7% were confined to wheelchair. The average score of Walton was
at 3,16 ± 1,5 while 54% of patients required home ventilation. 72,2%
of patients complained of dyspnea and 61,1% had clinical signs of
hypercapnia. The comparison of the two groups showed no
difference in age at diagnosis, age at onset of motor symptoms and
diagnostic delay.
However, Walton score was higher in group 1 (4,1 ± 1,9 vs 2,6 ± 1;
p = 0,04). Vital capacity (VC), Maximal inspiratory pressure (Pimax)
assessed at diagnosis was significantly lower in group 1: VC in sitting
position (1,1 ± 0,4 vs 1,8 ± 0,8; p = 0,01), VC in supine position
(1,8 ± 0,5 vs 2,4 ± 0,9; p = 0,03) and Pimax (24,3 ± 8,1 Vs 43,8 ± 29;
p = 0,03).
No significant correlations were found between clinical symptoms
and ventilator capacity. However, significant correlation was found
between excessive daytime sleepiness and VC in sitting position
(W = 63.5; p = 0.026).
CONCLUSIONS. An early onset of respiratory disorders preceding
muscular weakness distinguishes Acid maltase deficiency from
other neuromuscular diseases. These patients may warrant home
ventilation early in the natural course of motor disorders. A sharp
follow up using ABG's, ventilatory functional tests and Walton
Score may add a valuable discriminative properties to the clinical
monitoring.
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INTRODUCTION. Invasive positive-pressure home ventilation via
Tracheostomy (TPPV) and home non invasive ventilation (NIV) are
being increasingly used to treat chronic hypercapnic respiratory
failure after ICU discharge. However, there are little data evaluating
compliance with ventilation prescriptions and long term outcome
remains uncertain.
OBJECTIVES. To assess the compliance with home ventilation (TPPV
and NIV) and outcomes of patients ventilated at home for chronic
hypercapnic respiratory failure after ICU discharge.
METHODS. Prospective observational study conducted in an 8-bed
Tunisian medical ICU over a two year period (January 2015 to
December 2016). Were included all consecutive ICU survivors dis-
charged with home TPPV or home NIV. Were collected patients´
characteristics, clinical presentation on admission and at discharge,
SAPSII, type of home ventilation at ICU discharge. Compliance reports,
readmissions and outcomes were assessed.
RESULTS. A total of 23 patients were collected. The Median age was
65 years, 25-75CI [17–76]. Sixteen (70%) patients were male. Twelve
(54%) were admitted for acute exacerbation of COPD. Five (22%) and
6(24%) were respectively admitted for acute exacerbation of restrict-
ive and mixed chronic respiratory failure. Among all the admitted pa-
tients, 4(17%) were already under home NIV. Median SAPSII was 28,
25-75CI [22–36]. Overall, firstline NIV use was registered in 15(65%)
patients and 6(40%) failed. Thirteen(56%) patients required invasive
mechanical ventilation (IMV) during ICU stay. The median duration of
IMV was 5 days (range 4–14). At ICU discharge, median pH was 7.43,
25-75CI [7.36-7.46] and median PaCO2 was 49mmHg, 25–75 CI [41–
66]. Eleven(56%) were discharged with tracheostomy all performed
for weaning difficulties. Twelve (52%) patients were discharged with
home NIV. Respectively, median daily use of home NIV and TPPV was
4h 25-75CI [3.25-7.75] and 6.5 h 25-75CI [5–6.5]. The median NIV use(≥4h per day) was respectively 48% for NIV and 98% for TPPV.
Three(25%) of Home NIV and 1(9%) of TPPV patients were readmit-
ted. Survival rates at 6 months for the home NIV and home TPPV pa-
tients were respectively 90% and 70%.
CONCLUSION. This study shows a low adherence to home NIV as
well as TPPV ventilation for ICU survivors of acute exacrbation of
chronic hypercapnic failure. Otherwise, this therapy seems to provide
survival for long periods of time.
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INTRODUCTION. Maintenance of a normal level of carbon dioxide in
arterial blood (РаСО2) is an important goal of intensive care patients
with severe traumatic brain injury (TBI). However, methods of
providing stable РаСО2 in this category of patients are not
completely defined.
Goal of research is: To assess the safety and efficacy of implementing
the "Intellivent-ASV" in patients with dire TBI.
METHODS. We surveyed 15 patients with TBI and oppression of level
of the wakefulness to 8 and less points according to GCS. In 11
(73%) cases there was a concomitant injury with the prevalence of
TBI, and 4 (27%) patients had isolated TBI. The victim's mean age
was 27 ± 6 years, the proportion between male/female was 13/2. The
victims were carried out on ALV - adjustable volume (Volume Control
Synchronized Intermittent Mandatory Ventilation), and then shifted into
intellectual mode "Intellivent-ASV" ("HAMILTON-G5", SWITZERLAND).
Duration of respiratory support in each mode was 2 hours.
The mean airway pressure (Reap) was designated to all the patients,
the partial pressure of oxygen in arterial blood (РаО2), РаСО2,
РаО2 relation to the fraction of oxygen in the inspired air (FiO2)
in an hour and at 2 hours after the start of mechanical ventilation in
different modes.
RESULTS. Data analysis revealed no differences between the average
values РаО2 in patients ventilated by volume monitored modes, and
in intelligent way: РаО2 183,9 ± 18.8 mm.Hg.(n = 30) vs 180,3 ± 24.4
mm.Hg.(n = 30) relationship РаО2/ FiO2 368 ± 53 (n = 30) vs
360 ± 67 (n = 30), respectively. Noted a trend towards a more
sustainable retention level РаСО2 when using the "Intellivent-ASV"
34,5 ± 1,7 mm.Hg.(n = 30) against 35,3 ± 2,6 mm.Hg. (n = 30) in
volume monitored modes. The patients who underwent volume
monitored modes, the minimum value РаСО2 was 29.4 mm.Hg. vs
30.3 mm.Hg. in patients who underwent respiratory support in
intelligent mode, the maximum value РаСО2 - 41 mm.Hg. against
39,5 mm.Hg. respectively.
The fluctuation РаСО2 was 12.5 mm.Hg. in patients ventilated in
controlled-volume vs 9.5 mm.Hg. in patients who underwent respira-
tory support in an intelligent way. The average amplitude of fluctua-
tions of РаСО2 during the observation period were −0.2 (−1,5;1,1)
mm.Hg. at patients who underwent volume monitored modes, vs.
1.7 (0;3) mm.Hg. in patients ventilated in an intelligent way, the max-
imum change in level РаСО2 during the observation period was 8.2
mm.Hg. vs 5.9 mm.Hg., respectively.
The mean airway pressure was comparable during respiratory
support in both ventilation modes:11,7 ± 1.5 cm.wg. at volume
monitored modes, compared with the 8.5 ± 1.4 cm.wg. in patients
ventilated in an intelligent way.
CONCLUSIONS. The intelligent ventilation mode "Intellivent-ASV" is
effective and safety to use for patients with TBI, providing a high
level PaO2 and adequate level РаСО2.
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INTRODUCTION. Acute exacerbation of patients with chronic
obstructive pulmonary disease (COPD) has been a classical reason for
admission in ICU. The advances in mechanical ventilation (noninvasive
modality) and changes in patient decision-making (preferences for
treatment) have substantially modify the pattern of ICU utilization for
this type of patients.
OBJECTIVE. The objective was to study the epidemiology and
outcomes of patients admitted in ICU for acute exacerbation of COPD
patients requiring mechanical ventilation and to determine the impact
of patient characteristics on decisions to limit therapeutic effort.
METHODS. Retrospective cohort study from January 2014 to
December 2016 in the ICU of a University Hospital. We described the
epidemiology, treatment and outcome of COPD patients admitted
in ICU requiring mechanical ventilation. Variables related to
comorbidities, functional status (number of visits to the Emergency
department in previous year), acute physiology derangement
(APACHE II) of the episode and type of mechanical ventilation
(invasive vs noninvasive) were recorded. A multivariate analyses
(logistic regression) was made to relate this factors with the
decision to limit therapeutic efforts. Results are expressed as
adjusted OR and 95% confidence intervals.
RESULTS. 44 patients were included. The mean age was 68 ± 10
years and sex ratio (male/female): 4.1. APACHE II score was 19.9 ± 4.8
points. 22.7% of patients had chronic right heart failure. The use of
invasive mechanical ventilation was required in 40 patients (90%). Of
these, 7 of 40 patients requiring invasive mechanical ventilation due
to failure of non-invasive mechanical ventilation. ICU and overall hos-
pital mortality were 20.5% and 25%, respectively. Primary cause for
mortality was limitation of therapeutic effort for advanced respiratory
disease (9 of 11 patients, 82%).The APACHE II score (22 ± 6 points vs
19 ± 4, respectively) and emergency department visits (3.8 ± 4.9 vs
1.1 ± 1.6, p > 0.001) were significantly higher in non-survivors. Pa-
tients with diabetes mellitus (40% versus 10.3%, p = 0.02) and with
right heart failure had a higher mortality (57.1% versus 13.5%, p < <
0.009). In the adjusted multivariate model, emergency department
visits was a significant independent predictor of limitation of thera-
peutic effort (adjusted OR, 1.39; 95% confidence interval,
1.00-1.97; P = 0.05).
CONCLUSION. Limitation of therapeutic effort represents the most
common reason of mortality in exacerbation of COPD. Emergency
department visits is an independent risk factor for the decision to
limit therapies for life support in acute exacerbation of COPD.
Which nutritional practices in ICU ?
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INTRODUCTION. Large amounts of albumin are used during and
after liver transplantation, mainly to keep up plasma albumin
concentration (P-alb). However, the fate of albumin beyond the initial
volume effect is poorly understood. Likewise, the recovery rate of
synthesis capacity for albumin in the transplanted liver is unknown.OBJECTIVES. To study the cumulative perioperative loss of albumin
from plasma up to the end of surgery and until post-operative day 3
(POD 3) as well as albumin synthesis rate and transcapillary escape
rate (TER) on POD 3 after liver transplantation.
METHODS. Patients (n = 16) were studied during liver transplantation,
and 11 of these had complete data until POD 3. Albumin net loss
was assessed by mass balance of albumin and hemoglobin obtained
from measures of P-alb, blood hemoglobin and hematocrit, and
the sum of albumin given and lost. Synthesis rate of albumin
was estimated by the flooding technique using deuterium labeled
phenylalanine. TER was assessed by radio iodinated (125I) human
serum albumin.
RESULTS. P-alb was 31 ± 8 g/L at the start of surgery, 30 ± 4 g/L at
the end of surgery, and decreased marginally to 26 ± 4 g/L on POD
3 (p = 0.049). At the end of surgery, 91 ± 37 g of exogenous albumin
had been administered, and 33 ± 22 g (p = 0.0014) of albumin was
lost from the circulation. Until POD 3 another 47 ± 35 g of exogen-
ous albumin was administered, and at that time a total of 44 ± 38 g
(p = 0.0085 vs baseline, p = 0.458 vs end of surgery) had left plasma
since start of surgery. On POD 3 albumin absolute synthesis rate was
239 ± 84 mg/kg/day, TER was 5.9 ± 1.9% per hour, and the corre-
sponding plasma volume was 4.8 ± 1.0 L.
CONCLUSIONS. Albumin net leakage from plasma progressed until
the end of surgery, and was maintained until POD 3. This is in
contrast with the absence of albumin leakage found at day 3 after
major abdominal surgery, when P-alb was low and only small
amounts of exogenous albumin was administered.1 On POD 3 albu-
min synthesis rate was high compared to reference values.
REFERENCE(S)
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INTRODUCTION. Frailty is a multidimensional syndrome characterized
by loss of physiologic and cognitive reserves that confers vulnerability
to adverse outcomes during hospitalization, with higher morbidity and
mortality rates.
OBJECTIVES. To describe the prevalence and outcomes associated
with frailty among critically ill patients who required nutrition support
therapy in a Brazilian tertiary hospital.
METHODS. We conducted a prospective single-center cohort study
of patients admitted to the Intensive Care Unit (ICU) of Hospital Sírio-
Libanês (São Paulo, Brazil), between October 2015 and March 2017.
Frailty syndrome was classified using the Canadian Study on Health
and Aging Clinical Frailty Scale (CFS). Patients were considered to
be frail if they had a score > 41. Multivariable analyses were used
to evaluate the independent association between frailty and hos-
pital mortality.
RESULTS. We studied 548 patients during the study period (mean
age was 71.7 years, 66.6% were admitted for non-surgical reasons,
47.3% had cancer, 58.8% were frail and 27.6% died during
hospitalization). 436 (79.6%) patients undergone enteral nutrition
and 173 (31.6%) parenteral nutrition. Patients who died were more
severely ill compared to patients those who survived (SAPS 3 of 53
[40–63] versus 42 [34–53.5] respectively; p < 0.001), were older, more
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 269 of 542frequently came from the ward due to non-surgical reasons, had
more comorbidities, more frequently required mechanical ventilation
and vasoactive drugs, had longer ICU and hospital length of stay,
and more frequently were frail (75.5% vs 52.4% respectively,
p < 0.001). After controlling for baseline differences, adjusted odds
ratio for hospital death associated with frailty was 2.00 (95% CI 1.15 -
3.50; p = 0.014).
CONCLUSIONS. Frailty is very common among our population of
critically ill patients undergoing nutrition support therapy, and it was
associated with higher adjusted odds ratio for hospital mortality.
REFERENCE(S)
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frailty and short- and long-term outcomes among critically ill
patients: a multicentre prospective cohort study. CMAJ 2014;
186(2): E95-102.
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INTRODUCTION. Although guidelines recommend a protein intake
of 1.2-2.0 g/kg/day, no randomized trials have investigated the
relationship between protein intake and outcomes. Additionally,
the mean body mass index (BMI) in most nutritional studies has
generally been greater than 25 kg/m2. Therefore, the optimal
practice for populations with low BMI, such as the Japanese
remains unclear.
OBJECTIVES. We conducted a multicenter observational study to
assess the current status of nutritional practices in Japanese ICUs and
the relationship between amino acid and protein intake, and
outcomes in critically ill patients.
METHODS. The study population consisted of patients who were on
mechanical ventilation for at least 24 hours and in the ICU for longer
than 72 hours between April 2015 and March 2016. The reasons for
ICU admission, APACHE II and SOFA scores, type and amount of
nutrition received in the ICU on days 3 and 7 and at ICU discharge,
ICU-free and ventilator-free days during the first 28 days following
ICU discharge, 28-day mortality rate, and rehabilitation status (bed
rest, sitting, end sitting, sitting on wheelchair, or walking) at ICU dis-
charge were recorded. The primary outcomes were the protein and
amino acid intake in the ICU on days 3 and 7 and at ICU discharge;
the secondary outcome was the relationship between the intake of
protein and amino acids and patient rehabilitation status at ICU dis-
charge. We defined a good rehabilitation status as more than end sit-
ting and poor rehabilitation status as bed rest and sitting. Data are
expressed as the median (interquartile range).
Values of p < 0.05 were considered statistically significant.
RESULTS. The data collected from 403 patients (34% women) from
13 hospitals were analyzed. The age and BMI were 70 (60–78) years
and 22.3 (19.7-25.2) kg/m2, respectively. The APACHE II and SOFA
scores were 19 (14–26) and 11 (9–13), respectively. The protein and
amino acid intake on days 3 and 7 in the ICU and at ICU discharge
were 0.2 (0–0.5), 0.5 (0.3-0.9), and 0.6 (0.2-1.0) g/kg/day, respectively.
Although the caloric intake in the ICU on day 7 was significantly
lower in patients with a good rehabilitation status than in those with
a poor rehabilitation status (13 [9–22] vs. 18 [12–27] kcal/kg/day,
P = 0.01), the protein and amino acid intake in both groups did not
significantly differ. Oral intake in the ICU on day 7 and at ICU
discharge was achieved by a significantly higher proportion of
patients with a good rehabilitation status than by those with a poor
rehabilitation (12 vs. 2%, P < 0.01 on day 7 and 35 vs. 7%, P < 0.01at ICU discharge). The ICU-free and ventilator free days were 16 (0–
21) and 19 (0–24), respectively. The 28-day mortality rate was 15%.
CONCLUSIONS. Our study showed that the protein and amino acid
intake during the acute phase was 0.6 g/kg/day in Japanese ICU
patients. Our findings indicated that high early caloric intake might
be associated with poor ICU rehabilitation.
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INTRODUCTION. Hyperglycemia in critically ill patients is associated
with increased morbidity and mortality. Control of hyperglycemia
has concentrated on the use of insulin but there are significant
side effects.
OBJECTIVES. Determine whether blood glucose control can be
facilitated by using an enteral nutrition formula containing low
carbohydrates, very high level of hydrolyzed whey protein, and
medium chain triglycerides ensuring optimal protein delivery.
METHODS. Multi-center, randomized, open label clinical trial in
mechanically ventilated critically ill, overweight and obese subjects
requiring enteral nutrition assigned to an experimental - very high
protein (37%) low carbohydrate (29%) group (Peptamen® Intense
VHP) or control - high protein (25%), high carbohydrate (45%) group
(Replete®). Both groups were prescribed 1.5 g protein/kg ideal body
weight. Primary endpoint was glucose variability and was measured
as incidence of glycemic blood glucose levels outside the range of
6.1 - 8.3 mmol/L.
RESULTS. 105 patients were randomized (52 experimental, 53
control) and 102 were included in the intention to treat population.
Forty nine patients (mean ages 63 ± 12, 61 ± 15, ns) completed at
least 5 days on protocol. Data presented are n, mean (sd). Both
groups received similar amounts of protein
(47, 0.95 (0.32) g/kg/d vs. 49, 0.86 (0.38) g/kg/d, p = 0.25) with lower
total energy (47, 10.19 (3.47) vs. 49, 13.77 (6.04) kcals/kg/d kcals/kg/d
p < 0.0001) and lower carbohydrate load (47, 0.79 (0.27) g/kg/d vs.
49, 1.54 (0.68) g/kg/d p < 0.0001) in experimental vs. control,
respectively. There was no significant difference in the incidence of
glucose levels outside the range between 6.1 mmol/L and 8.3 mmol/
L (primary endpoint): 52, 0.59 (0.25) vs. 50, 0.62 (0.24) p = 0.54. In the
experimental group there was a lower incidence of glucose levels
above 8.3 mmol/L (delta = −13%, p = 0.015) and higher incidence of
levels between 4.4 and 6.1 mmol/L (delta = +14% p = 0.0007). Mean
glucose level was lower in the experimental group than the control:
7 mmol/L [5.5, 8.9] mg/dl vs. 7.7 [6, 9.8] p = 0.0039. Glycemic
excursion (standard deviation) was 10% lower in the experimental
group (p = 0.0015). There were no significant differences in adverse
events. Insulin use was lower in the experimental group (p = 0.048).
Twenty three patients experienced glucose below 4.4 mmol/L with
no differences between groups; use of rescue dextrose for
hypoglycemia did not differ between groups. One patient died in the
experimental group while 6 patients died in the control group
during the study.
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 270 of 542CONCLUSIONS. A very high hydrolyzed whey protein and low
carbohydrate formula facilitates blood glucose control in critically ill
overweight patients and is associated with a lower incidence of
hyperglycemia, lower glycemic excursion and a decrease in insulin
use without increased adverse events or mortality.
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INTRODUCTION. Burn patients are at risk of vitamin D (VD)
deficiency. It has been recommended stoss therapy of cholecalciferol
(VD3) benefit critically ill patients through its pleiotropic effects.
However, little is known specifically in adult burn setting with a large
VD3 bolus.
OBJECTIVES. Aim of this study was to assessed the effect as well as
safety of a single mega-dose VD3 supplementation in young major
burn patients.
METHODS. This is a retrospective data analysis. There was a major
explosion from flammable starch-based powder at a party at the
Coast Water Park, New Taipei, Taiwan, on June 27, 2015. Out of 499
young people injured, 34 patients were transferred to our hospital in-
cluding 28 major burns. 22 patients received a single mega dose of
576000 IU of liquid VD3 supplementation enterally at the 4th week of
intensive care unit (ICU) stay. The main outcome of interest was tra-
jectory of serum 25(OH)D level before and after supplementation.
Blood samples were collected before (D0), 7 days, 14 days and 21
days after VD3 bolus to measure 25(OH)D, intact-parathyroid hor-
mone (iPTH), TNF-α and CRP.
RESULTS. 25 major burns who remained in ICU at the 4th weeks after
injury were included. The mean age and BSA were, respectively,
21.8 ± 4.3 years and 49.4 ± 19.6%. At D0, the serum 25(OH)D
averaged 13.7 ± 3.9ng/ml with 8% of patients presenting a VD
insufficiency (20-30ng/ml) and 92.0% a deficiency (≤19.9 ng/ml).
Furthermore, severe deficiency (<13ng/ml) was disclosed in 48% of
patients. The baseline 25(OH)D deficiency was associated with BSA,
regardless of age, sex, inhalation injury, TNF-α, CRP, and number of
surgery. Hypocalcemia and elevated iPTH were noted. After VD3
supplementation in 22 of them, 25(OH)D levels increased quickly,
peaking on day 3 at 28.8 ± 12.6ng/ml. iPTH and TNF-α were in-
versely associated. 25(OH)D levels dropped below 30 ng/mL soon
during the follow-up.
CONCLUSIONS. This is the first study providing valuable data of stoss
therapy of VD3 on burn patients, particularly young adult burned
en masse during a large explosion event. High prevalence of
profound VD deficiency were shown. A single mega-dose VD3
(576000 IU) increased serum 25(OH) levels, however, even insuffi-
cient to ensure restoring body reserve above 30ng/ml. A followed
rapid drop implicates high consumption which mainly comes
from complex immuno-inflammatory disarrangement, a specific
problem of burn due to critical illness, multiple procedures and
frequent infection. No hypercalcemia or hypercalciuria was noted
after supplementation. Our findings suggested a single high load-
ing dose of cholecalciferol is safe and mandatory to correct the
potential severe VD deficiency in acute major burn and mainten-
ance therapy should start earlier to meet the greatly elevated
metabolic demand.REFERENCE(S)
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INTRODUCTION. Adequate energy supplement has been shown to
reduce mortality and the nosocomial infection. The 2016 ASPEN/
SCCM nutrition guideline also recommend rating nutrition risk with
NUTRIC score based on expert consensus. Rahman et al. removed IL-
6 level and reported a modified-NUTRIC score which is easier to be
applied in clinical practice. However, the optimal caloric target have
not yet been widely reported according to different levels of nutri-
tion risk. This study aims to provide evidence in optimal caloric tar-
get among critically ill patients.
OBJECTIVES. In the present study, we reviewed the information in
the hospital database from September 2015 to August 2016. To be
eligible for the study, patients were required to admitted to medical
and surgical intensive care unit (ICU) for more than 48 hours and
older than 20 years old.
METHODS. Clinical data for analysis included basic demographic data,
body mass index and total calories intake, including parenteral
nutrition and enteral nutrition. The nutrition supplement targets were
separated into three groups, less than 50%, 50-79% and more than
80% of calculated goal calories intake. Clinical outcomes included in-
hospital mortality, and ventilator dependent days. High nutrition risk
was defined by modified NUTRIC score≧5; low nutrition risk was de-
fined by modified NUTRIC score < 5. Adjusted hazard ratios (aHRs) and
the associated 95% confidence intervals (CIs) were estimated using the
Cox proportional hazards model with APACHEII score as covariate.
RESULTS. Of 1649 patients enrolled in the study, 1035 (62.8%)
patients were at high nutrition risk. In-hospital mortality rate among
patients at high nutrition risk was 33.6%, and compared to those tar-
get less than 50% of calculated goal calories (46.9%), that was lowest
in who targeted more than 80% (24.3%, aHR: 0.31 [95% CI, 0.24-0.41],
p < 0.001), and then who targeted 50-79% (29%, aHR: 0.34 [95% CI,
0.26-0.44], p < 0.001). On the other hand, the mortality rate in pa-
tients at low nutrition risk was 11.2%, compared to lowest nutrition
target (9.8%), that was best in who targeted 50-79% (8.8%, aHR: 0.32
[95% CI, 0.16-0.69], p = 0.003), and then who targeted more than
80% (14.8%, aHR: 0.49 [95% CI, 0.28-0.87], p = 0.015).
CONCLUSIONS. The optimal nutrition supplement goal could be more
than 80% of calculated target among patients at high nutrition risk,
and 50-79% of calculated target among patients at low nutrition risk.
REFERENCE(S)
1. Rahman A, et al. Identifying critically-ill patients who will benefit
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Table (Abstract 0530). Timeline
Day 0 1 2 3 4 5 6 7
AP D % 1 −8 −8.2 −15.8 −21.5 −27.2 −20.9 −28.7
AP p= ns 0.3 0.3 0.7 0.02 0.005 0.04 0.02
CO2 D % 1.1 −3.8 −7.5 −7.1 −10.1 −8.9 −10.5 −14.8
CO2 p= ns 0.3 0.05 0.06 0.01 0.04 0.02 0.004
Bicarb D mmol/L −0.9 0.112 0.0007 −0.055 −0.123 −0.169 −0.125 −0.191
Bicarb p= ns 0.06 0.9 0.4 0.09 0.03 0.1 0.03
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INTRODUCTION. The metabolic effects of an enteral formula containing
High protein in the form of hydrolyzed whey and low carbohydrates
needs are unknown.
OBJECTIVES. Describe the metabolic effects of the use of such a
formula in critically ill patients.
METHODS. Multi-center, randomized, open label, clinical trial, in sub-
jects requiring enteral nutrition for at least 5 days. Medical critically
ill ventilator dependent patients with a BMI of > 26 receiving a very
high protein (37%) low carbohydrate (29%) formula (Experimental
formula - Peptamen® Intense VHP) or control protocol with a high
protein (25%), high carbohydrate (45%) formula (Replete®) infused to
provide 1.5 g protein/Kg.
RESULTS. 105 patients were randomized (52 experimental (E), 53
control (C)) with 102 providing data according to the intention to
treat principle. Groups were comparable with respect to age, BMI
and sex. Most frequent diagnoses on admission were acute
respiratory failure, pneumonia and sepsis. Data presented are n,
mean (sd) for patients completing 7 days on protocol (n = 36). Both
groups received similar amounts of protein (19, 1.15 (0.43) g/Kg/d vs.
17, 1.41 (0.37) g/Kg, p = 0.11) with lower total energy (19, 18.36
(6.86) vs. 17, 15.11 (4.00) p < 0.03) in the experimental group.
Carbon dioxide (CO2) accumulation (as measured by blood levels)
was lower in the experimental group and was maintained across
time, along with lower bicarbonate levels (Table - data presented as
the difference between means (delta-D), significance per day (p=).
Alkaline phosphatase (AP) progressively increased in the controls
with no change in the experimental group. No differences were
observed in C- peptide, C-reactive protein or albumin levels. In the
experimental group at day 7 a modest decrease in total protein and
an increase in the number of patients with detectable ketones in
blood and urine were observed. There were no differences in renal
function (plasma creatinine & eGFR). White blood cell counts were
lower in the experimental group by day 7.
CONCLUSIONS. A very high protein, low carbohydrate whey based
formula is associated with metabolic changes that could potentially
be of clinical significance. Lower CO2 and bicarbonate may translate
to a potential clinical benefit in patients with acute respiratory failure
and renal dysfunction. Increasing AP (suggesting cholestasis) in the
control group was avoided with the experimental product. Higher
ketones observed with lower caloric loads may benefit obese
patients. The significance of lower circulating total protein with no
difference in albumin between groups needs to be defined.
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INTRODUCTION. Vitamin D deficiency is common in chronic liver
disease and it has been correlated with a worse outcome after
orthotopic liver transplantation (OLT).[1]
OBJECTIVES. We evaluated the change of the level of vitamin D,
Parathyroid hormone (PTH), calcium and phosphate in OLT recipients
28 days post-OLT as compared to the pre-OLT asset and we corre-
lated their possible association, with the rate of infections, surgical
complications and death after OLT.
METHODS. Single center prospective observational study. All
consecutive recipients of cadaveric OLT were included (Sep 2016 -
Jan 2017). As descriptive statistics mean ± SD, or median (IQR) were
used. Comparisons between biochemical assets pre- and 28 days
post-OLT were assessed using Wilcoxon Rank Sum Test.
RESULTS. Twenty-nine patients were enrolled. Clinical characteristics
of the patients were Age 57 ± 7, BMI 27 ± 5, Meld score 16.6 ± 8.3,
Child Pugh score 6.5 ± 1.3; overimposed hepatocarcinoma was found
in 20 patients (69%). Table 138
All the recipients but one, were deficient in vitamin D (<20 ng/dl)
pre-LT: median 8.1 (IQR 0.9 - 9.1), and all of them remained deficient
at day 28 after OLT: median 7.25 (IQR 4.6 - 8.6), with a slight reduc-
tion that was not statistically significant (p = 0.79). We found a trend
in reduction of PTH and Phosphate with a significant increase of total
calcium levels (p < 0.001).
The length of stay was 9 ± 12 days in ICU and 27 ± 24 days in
hospital; pts were mechanically ventilated for 4 ± 10 days and
received vasopressor for 2.9 ± 7.3 days. 14 pts (48%) experienced at
least one infection, 10 (34%) had surgical complication and 3
patients deceased. Table 140
The incidence of early post-OLT surgical complications were not cor-
relate with change in vitamin D, PTH, calcium and phosphate
whereas total calcium level increased more in the patients alive
(p < 0.01) than in those deceased (p = 0.18) arising the hypothesis
that an improvement in calcium metabolism may be a positive
marker after OLT. Infections were not correlated to changes in vita-
min D, PTH, calcium and phosphate. Moreover we found a lower pre-
OLT vitamin D level in those patients who developed an infection
during the first 28 days after OLT (mean value 7 vs 15).
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 272 of 542CONCLUSIONS. Liver transplantation, with its consequent metabolic
storm, might have a strong impact in further reducing vitamin D
blood levels, and this in turn could have a significant impact on
clinical outcomes.
Our preliminary results show a high prevalence of vitamin D
deficiency pre-OLT (97%), and that it was correlated with an in-
creased risk of infection in the early post-OLT period. Although a
larger study is mandatory to confirm such results, we believe that
a protocol with vitamin D supplementation should be used in all
patients both in the pre- and post- OLT period.
REFERENCES
1. Reese PP, et al. Changes in vitamin D binding protein and vitamin
D concentrations associated with liver transplantation. Liver Int
2012;32(2):287–296Table 140 (Abstract 0532). See text for description
Clinical Outcomes
ICU length of stay, days 9 ±12
Mechanical Ventilation, days 4 ± 10
Vasopressor, days 2.9 ± 7.3
Hospital length of stay, days 27 ± 24
Bilirubin Day28, mg/dl 1.24 (0.8 - 24.6)
INR Day28 1.06 (0.9 - 2.1)
Infection, N(%) 14 (48)
Surgical Complication, N(%) 10 (34%)
Death, N(%) 3 (10%)
Table 138 (Abstract 0532). See text for description
Age, years 57 ± 7
Body Mass Index 27 ± 5
MELD 16.6 ± 8.3
Charlson Comorbidity Index 6.5 ± 1.3
Child Pugh Score 8.6 ± 2.2
Hepatocarcinoma N (%) 20 (69)
Creatinine mg/dl 0.89 (0.4 - 2.96)
MDRD 86 (22 - 139)
Donor Age, years 58 ± 22
Cold ischemia Time, minutes 435 ± 102 min
Table 139 (Abstract 0532).See text for description
Variable Pre OLT 28 days post OLT p value
Vitamin D, ng/ml 8.1 (0.9-9.1) 7.3 (4.6-8.6) 0.79
Parathyroid Hormone, pg/ml 55.8 (15.7-160) 49.7 (21.4-142.7) 0.61
Total Calcium, mg/dl 8.3 (7.1-9.5) 9.2 (8.0-10.0) <0.001
Phosphate, mg/dl 3.6 (2.2-5.5) 3.5 (1.2-4.5) 0.52
Fig. 188 (Abstract 0532). Adherence to fasting guidelines0532
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INTRODUCTION. Intensive care unit (ICU) patients' nutritional
requirements are frequently unmet. On average patients receive 60%
of nutritional requirements (1, 2). Enteral nutrition (EN) delivery is
frequently interrupted for surgical and airway procedures to avoid
aspiration of stomach contents. Recurrent fasting leads to under
delivery of EN and is associated with worse outcomes (3, 4).
International fasting recommendations do not provide guidance for
intubated patients receiving EN. This may be due to a dearth of
research on fasting times for stopping EN in this patient population.
Consequently, clinical practice varies considerably and extended
fasting times is commonplace. Currently, no data are available on
practice in the United Kingdom.
OBJECTIVES. This study aimed to gain a detailed perspective of UK
critical care fasting practices.
METHODS. A web-based survey was sent to 232 UK ICUs via critical
care dietitians, consisting of questions relating to local ICU fasting
practices, presence of guidelines, average fasting times for common
procedures and dietitian time per ICU bed. Qualitative analysis
was undertaken to assess any common themes within the free
text comments.
RESULTS. 176 ICU responded (72% of all ICUs in the UK). Only 20%
of units had a fasting guideline and these were not consistently
adhered to (mean compliance was 66%). Units with greater dietetic
involvement were more likely to have guidelines. Fasting times were
shorter for abdominal surgery (p = 0.002), non-abdominal surgery
(p = 0.016) and radiology (p = 0.015) if a guideline was present. Fast-
ing for extubation and tracheostomy was predominately 4–6 hours
irrespective of the presence of a guideline. Considerable variation in
fasting times was reported, usually due to inconsistencies in clinical
decision-making.
CONCLUSIONS. This comprehensive survey of national practice,
demonstrates that fasting times are varied and inconsistent, leading
to long fasting times and under-delivery of EN. Where guidelines
were present, fasting was significantly shorter for surgery and radi-
ology. However, for procedures perceived to be at higher risk (such
as extubation and tracheostomy), fasting times were similar between
all units irrespective of the presence of a guideline. More dietetic in-
put was associated with increased likelihood of a fasting guideline.
REFERENCE(S)
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Fig. 189 (Abstract 0532). Decision makers without guideline
Table (Abstract 0533). Patient Demographics (Median[Range])
Age (y) 63
Sex 18 Male, 4 Female
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Length of stay (d) 22 [2–229]
Days of mechanical ventilation 17 [6–229]
Days of RRT 0 [0–56]
Days until diagnosis ACPO 5.5 [1–35]0533
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INTRODUCTION. Acute colonic pseudo-obstruction (“ACPO”) is charac-
terised by dilatation of the colon in the absence of an anatomical lesion
that obstructs the flow of intestinal contents and is also known as Ogil-
vie's syndrome. A clinical diagnosis of ileus is commonly made in critically
unwell patients but the prevalence of ACPO underlying this is unknown.
ACPO can result in colonic ischaemia, perforation and death (1).
OBJECTIVES. We aimed to retrospectively identify cases of ACPO
over the course of one year. We reviewed the diagnosis and
management of ACPO, including complications arising. We assessed
our practice against a recently developed institutional guideline to
examine if there were further needs of the critical care population.
METHODS. A search of our electronic patient records for the terms
“ileus”, “distension” and “obstruction” yielded 273 patients. Full
clinical notes and imaging were examined by two independent
clinicians to confirm the clinical features of ileus, associated
medication and nutritional parameters, and treatment. Abdominal
computed tomography scans were examined to find evidence of
colonic dilatation without a structural obstructing lesion.
RESULTS. Sixty-eight cases of clinical ileus representing 5.2% of crit-
ical care admissions were identified. Twenty-two of 68 patients (32%)
patients had abdominal imaging consistent with ACPO, but most did
not have the colonic diameter documented on the report. Only 63%
had cross-sectional imaging.
82% of cases were prescribed opioids, and alpha agonists were
prescribed in 32% of cases. The most common interventions were a
reduction in the opioid dose and the use of prokinetics.
Eight patients had enteral nutrition formally prescribed and a further
5 had parenteral nutrition in addition to this. Of these 13, only 3
attained >80% of their target energy intake.
Five patients were treated with neostigmine and 6 were re-imaged.
77% received surgical review but only 6 were treated with a decom-
pression tube and 5 had endoscopy. Three patients (14%) experi-
enced a bowel ischaemia and/or perforation, and two of theserequired laparotomy. There were 3 deaths amongst the 22 cases, 2
of which were related to ACPO.
CONCLUSIONS.
1. Clinical ileus is common; a subset of patients will develop ACPO
and there is a significant risk of complications.
2. Many of our patients were not imaged. Of those that were, plain
films are sub-optimal for diagnosing ACPO and CT reports did not
contain sufficient detail.
3. Opioid and alpha-agonist use was common in this cohort and may
be difficult to avoid.
4. Patients with ACPO did not attain their target nutritional intake.
5. Neostigmine and endoscopic decompression, recommended by
local protocols, were used in fewer than 25% of cases, probably on
an individual risk/benefit basis.
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INTRODUCTION. We created early goal-directed enteral nutrition
protocol (EGDN NAGOYA) in 2010.
OBJECTIVES. The purpose of this study is to evaluate the relation
between nutrition management methods and the outcome in
emergency and medical ICU.
METHODS. We investigated retrospectively the patients hospitalized
for 48 hours or more, in the ICU of in Nagoya University hospital in
Japan, from May 2011 to june 2015. According to the first nutrition
method, the patients were classified into the following three groups:
peroral intake group (PO), enteral nutrition group, and total parenteral
nutrition group (TPN). Enteral nutrition group was classified into the
following four groups, according to the time to initiate enteral feeding:
within 6 hours(EN6), 6 hours or more, and less than 24 hours(EN6-24),
24 hours or more, and less than 48 hours(EN24-48), and 48 hours or
more(EN48). We evaluated APACHEII score and mortality in ICU of each
group. A paired t-test was used for statistical analysis.
RESULTS. There were 745 cases in the criteria of this study. Enteral
nutrition according to EGDN NAGOYA were 377 cases (50.6%) were
classified into enteral group: EN6 63 (8.5%), EN6-24 166 (22.3%),
EN24-48 110 (14.8.4%) and EN48 38 (5.1%). The mean of the APACHE
II score was 29.4, 29.9, 29.2 and 29.3, and the ICU mortality was
1.6%,7.2%,8.2%, 10.5%, respectively. On the other side, in TPN, the
APACHE II score was 29.4 and its ICU mortality was 20.3%. EN accord-
ing to EGDN NAGOYA showed the significantly better outcome than
PN in spite of the similar severity.
CONCLUSIONS. This study showed that early beginning enteral
nutrition with a protocol could lead to good prognosis of critically
ill patients.
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INTRODUCTION. Mucosal erosions can occur on luminal surface of
stomach in approximately 75-100% patients during the first 24 hours
of intensive care unit admission. These erosions often cause bleeding
with penetrating superficial capillaries. Enteral nutrition (EN) may
have protective effects against stress ulcer bleeding by neutralizing
the acidic pH in the stomach lumen, providing a structural and
functional integrity of the mucosal surface and trophic effect on
the GI mucosa. There is no sufficient data showing the relation
between enteral nutrition and stress ulcer hemorrhage.
OBJECTIVES. To determine effect of enteral nutrition on stress ulcer
bleeding in critically ill patients.
METHODS. This study was performed as prospective randomized
controlled multicenter trial in critically ill patients. Patients
randomized into two groups; Group 1 received only oral/enteral
nutrition, group 2 received oral/enteral nutrition and pantoprazole.
RESULTS. We enrolled 158 (group 1: 78, group 2: 80) patients. The
mean age was 61.3 ± 17.6 years. The most common cause of
admission to ICU was respiratory failure in 48 patients (30%),
followed by renal failure 18 (11%) and sepsis/septic shock in 14
patients (9%). Mean APACHE II score was 19.8 ± 6.0, first day median
SOFA score was 4 (range: 0–12), first day mean GCS was 12.9 ± 3.2
and mean NUTRIC score was 4.0 ± 1.8. Time to starting nutrition was
8.1 ± 5.7 hours. Length of nutrition time was 3 (1–36) days and
length of ICU stay was 3 (1–130) days (Table 1). Overall, 119 (75%)
patients were fed by oral route, 37 (24%) patients fed by enteral
tube and 2 (1%) patients were fed by oral + entral tube. There was
no any overt GI bleeding in any patients in both groups. ICU
mortality rate was 16%.
CONCLUSIONS. This study showed that stress ulcer related GI
bleeding was not observed in critically ill patients who were fed via
oral/enteral route in both groups. Stress ulcer prophylaxis may not
be needed in critically ill patients receiving oral/enteral nutrition.
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INTRODUCTION. In intensive care unit (ICU) we have the
combination of several problems, thats the reason why sometimes
the cases in ICU are a puzzle to manage. We have patients in sepsis,
with glucose, psychotics abnormalities and shock. So to find the
clue or the perfect phamacology combination is complex, though
the evidence supports them. Psychosis is a mayor problem in
critical care patient in any stage, now the evidence points to
atypical antipsychotic use, the most studied in critical areas is
olanzapine with its accute use.
OBJECTIVES. The purpose of this study is to evaluate the hyperglycemia
in ICU patients receiving newly prescribed olanzapine.METHODS. From January 2015 to february 2017 we accepted in our
ICU 186 patiets charts reviewed, from this example 51 patients were
included in this study. We find that 46% of patients at least report 1
hyperglycemic episode (blood glucose >160 mg/dL) after the we
start dose olanzapine in the ICU in front of any kind of pshycotic
episode. But the patients at least with more than 5 hyperglycemic
episodes (64.3%) that experienced it was associeted to the septic
state with multiple organic faillures. 19 (38%) patients with severe
neumonias discharged from the ICU with olanzapine, 3 (6%) patients
died in the ICU and all the patients with glucose disturbance, 31
(62%) patients were treated with fast insulin scale. Logistic regression
analysis showed that patients in ICU with a higher APACHE II score
were significantly more likely to have multiple hyperglycemic
episodes.
CONCLUSIONS. Psychosis is a commom mayor problem in the ICU
as well as infections and hyperglycemia, so olanzapine as an
antipsychotic drug is a fast and extraordinary option, but base don
our results, we recommend to be careful with its use in ICU for the
risk to develop hyperglycemia of other glucose-disturbance. We
need to investigate the link between the use of atypical antipsy-
chotics and acute hyperglycemia and its clinical significance.
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INTRODUCTION. Trace elements (TE) repletion has been shown to be
beneficial in burn patients who suffer from large exudative losses of
Copper (Cu), Selenium (Se) and Zinc (Zn), in terms of infectious
complication reduction and improved wound healing.
OBJECTIVES. The study aimed at checking if our repletion protocols
were appropriate to normalize TE plasmatic levels of our burn
patients during the first 3 weeks after injury over a period of
16 years.
METHODS. Retrospective analysis of a prospective cohort of patients
admitted to the ICU between 1999 and 2015. Inclusion criteria: burn
injury requiring an ICU stay > 7 days. The cohort was divided into 4
groups according to the period defined by changes in our
management protocol. Period 1 (P1): 1999–2000, P2: 2001–2005, P3:
2006–2010, P4: 2011–2015. Changes were mainly increasing TE
repletion doses and better compliance with the repletion protocol.
Demographic data, daily TE intakes and weekly TE plasma levels
were retrieved for the first 21 days. Data is expressed as median and
(IQR). Study periods were compared using the χ2 test, Fisher´s exact
test or one-way-ANOVA when applicable.
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surface area were included (no difference between periods). Daily Cu,
Se and Zn intakes increased significantly between 1999 and 2015,
allowing normalization of plasma Cu (19mg/l) and Zn (12mg/l) levels
during P4. Median plasma Se levels were elevated during P4, flirting
with the maximal range (1404μg/l).
CONCLUSIONS. The study shows that our supplementation protocol
normalizes Cu and Zinc levels, but Se doses seem too high,
suggesting a reduction of the dose.
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Variable All
periods
Period 1
(99–01)
Period 2
(02–05)
Period 3
(06–10)
Period 4
(11–15)
P-value
Number of
patients
253 32 57 85 79
Daily Cu
intake (mg)
2.5 (3.4) 2.7 (3.4) 2.0∗ (3.0) 2.2 (3.0) 3.3∗ (4.2) <0.001
Cu level (mg/l)
(12.5-23.6)
14.2
(11.7)
8.3∗ (5.2) 11.7
(16.4)
17.6 (9.3) 19.3∗
(8.7)
<0.001
Daily Se
intake (μg)
334 (484) 300∗
(374)
323 (397) 392∗ (540) 292 (647) <0.001
Se level (μg/l)
(750–1500)
1233
(769)
530∗
(430)
1053
(540)
1461∗
(683)
1404
(538)
<0.001
Daily Zn
intake (mg)
33 (48) 27∗ (35) 30 (37) 45 (50) 40∗ (61) <0.001
Zn level (mg/l)
(10.1-17)
12.3 (5.8) 6.7∗ (3.9) 13 (7) 13.2∗ (5.6) 11.5 (4.2) <0.001
Fig. 191 (Abstract 0538). See text for description
Fig. 190 (Abstract 0538). See text for description0538
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INTRODUCTION. Survivors of critical illness experience significant
skeletal muscle wasting that may predict clinical outcome.
Ultrasound is a noninvasive method that can measure muscle
quadriceps muscle layer thickness (QMLT) at the bedside. 1,2
OBJECTIVE. To evaluate the measuring quadriceps muscle layer
thickness using bedside ultrasound in critically ill patient.
METHODS. This was a prospective, single-center study, conducted in
a tertiary care hospital. The study was approved by the ethics com-
mittee of Hospital Israelita Albert Einstein and written informed con-
sent obtained from each study participant. Demographic data,
anthropometric data, prognostic index (SAPS 3), nutrition risk screen-
ing (NRS) and image of US QMLT were collected for analysis. The
thickness of the quadriceps musculature was quantified with a port-
able B-mode ultrasound device. With the patient lying supine, knees
extended and relaxed, 2 landmarks on each quadriceps were identi-
fied. The underlying tissues were then maximally compressed by the
ultrasound probe, and the screen image was frozen. The muscle
thickness was quantified by the use of onscreen calipers and taken
as the distance between the upper margin of the femoral bone and
the lower boundary of the deep fascia of the rectus femoris. Each
landmark was imaged and averaged across each leg and then be-
tween legs. Measurements of the first (D1), third (D3) and seventh
(D7) days were performed and the percentage of QMLT was com-
pared by comparing the left and right legs.RESULTS. It was enrolled 20 patients underwent to 40 QMLT using
US in each leg. The mean age was 57.0 ± 20.2 years, 75% male, BMI
24.6 ± 3.0 kg/m2, SAPS 3 was 51.3 ± 17.4 and NRS 3.2 ± 1.0. Overall,
8.4% (22.0% to −8.9%) of muscle wasting in the right leg (Fig. 190)
and 5.2% (22.6% to −11.0%) in the left leg (Fig. 191) assessed by the
US occurred from the first to the seventh day. In the right leg the
median values evaluated by the US were 1.16 (0.92 to 1.75) D1, 1.13
(0.92 to 1.60) D3, 1.02 (0.81 to 1.41) D7; P = 0.005. In the left leg, the
median values evaluated by the US were 1.23 (0.93 to 1.43) D1, 1.16
(0.92 to 1.34) D3, 1.13 (0.89 to 1.31) D7; P = 0.017.
CONCLUSION. The measuring quadriceps muscle layer thickness
using ultrasound demonstrated that critical ill patients present
muscle wasting daily, and this procedure can be a great differential
to identify patients most likely to benefit from enhanced nutritional
and rehabilitation support.
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INTRODUCTION. Extracorporeal life support (ECLS) is a rescue
technique for refractory cardiac arrest (CA). However, eligibility
criteria and benefit on survival or neurological outcome are still
controversial. The goal of our study was to assess the effect of
extracorporeal cardiopulmonary resuscitation (e-CPR) on mortality
during refractory CA.
OBJECTIVES. The primary goal was to study the effect of e-CPR
on survival in refractory CA (low flow > 20 minutes). Secondary
goals were, i) to describe the characteristics of patients proposed
for e-CPR, ii) to identify the factors associated with survival after
refractory CA.
METHODS. Two observational monocentric prospective cohorts were
concatenated and studied: the first one (RéAC) included all out-of-
hospital refractory CA patients managed between March 2012 and
June 2016 by a local ambulance service. The second cohort included
all patients admitted for e-CPR at our center between May 2004 and
April 2016 for refractory cardiac arrest.
RESULTS. Six hundred and thirty-five patients were included, 240
(38%) were proposed for e-CPR whereas 395 (62%) were not. One
hundred fifty six patients (25%) actually underwent e-CPR. Patients
proposed for e-CPR were younger, had more witnessed CA and initial
shockable rhythm. 30-day survival rate was 2.5% for patients who
actually benefited of e-CPR.
Survival at 30 days was not different among patients proposed
or not for e-CPR (7 (3.0%) vs 6 (1.5%) respectively, p = 0.23). In a
multivariate analysis, the only factor associated with survival after
refractory CA was initial shockable rhythm (OR 0.26, 95%CI = 0.09-
0.81, p =0.02) whereas treatment with e-CPR was not.
CONCLUSIONS. e-CPR did not improve survival in patients treated
for refractory CA. Reducing the duration of low-flow might improve
the results of e-CPR for refractory CA.
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INTRODUCTION. Substantial proportion of patients who suffered
cardiac arrest do not respond to conventional cardiopulmonary
resuscitation. Recently, extracorporeal cardiopulmonary resuscitation
(ECPR) has been introduced as a potentially life-saving procedure in
refractory cardiac arrest.
METHODS. Eligible patients for this analysis had to undergo ECPR
after unsuccessful cardiopulmonary resuscitation with a minimum of
three defibrillation attempts. For extracorporeal life support (ECLS)
we used Cardiohelp system (Maquet-Cardiopulmonary-AG, Hirrlingen,
Germany) or Levitronix CentriMag blood pump (Levitronix LLC,
Waltham, MA, USA). LUCAS II (Physio-Control, Lund, Sweden) system
was used for chest compressions during ECPR insertion and cannulas
were placed with percutaneous puncture under fluoroscopy or
ultrasound control. The relations of blood lactate and pH levels,
measured before ECPR insertion and after 24 hours as well ascomorbities (diabetes, hypertension, BMI) to the clinical outcomes at
3, 6 and 12 months were evalueated.
RESULTS. We analyzed data from 29 patients treated with ECPR for
refractory cardiac arrest. The mean age of our patients was 58 years
(31–81). Out-of-hospital cardiac arrest (OHCA) occurred in 16 pa-
tients, 13 patients suffered from in-hospital arrest (IHCA). Baseline
value of lactate was 11.52 ± 3.97 mmol/l, initial pH 6.98 ± 0.21. In
comparison with survivors, patients who died had significantly higher
initial lactate levels (15.05 ± 1.56 vs. 10.01 ± 1.03; P < 0.05) and lower
baseline pH (6.87 ± 0.06 vs 7.04 ± 0.04; P < 0.05). Moreover, survivors
had significantly lower lactate levels after 24 hours and lower BMI
(26.7 vs 33.1; P < 0.05). Diabetes or hypertension in our group have
no influence on the mortality. The difference of mortality in the
group of OHCA or IHCA was also not significant. With good neuro-
logical outcome (CPC 1–2) survive 34% three months, 28% six
months and one year 24% of the patients.
CONCLUSIONS. ECPR represents virtually the last chance to survive
refractory cardiac arrest. The levels of blood lactate, pH are
significantly associated with clinical outcomes of ECPR.
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INTRODUCTION. Out-of hospital cardiac arrest (OHCA) associates
with high mortality. Current ERC guidelines recommend targeting
normal or decreasing lactate levels during post-resuscitation care.
Hyperlactatemia is a well-known marker of tissue hypoperfusion and
hypoxia in critically ill patients. Recent data have suggested that early
lactate reduction over the first six hours during ICU care is associated
with better survival but data on associations with long term outcome
are lacking.
OBJECTIVES.
To determine the associations between lactate values during the first
72 h after OHCA and one-year neurologic outcome. We hypothesized
that high early lactate values after out-of-hospital cardiac arrest are
associated with poor long- term neurologic outcome.
METHODS. We included 458 OHCA patients with data on lactate
values, treated in 19 ICUs from the FINNRESUSCI study between 2010
and 2011. Using separate multivariate backward regression models
along with factors at resuscitation, during ICU treatment and SAPS
scores, we tested associations with long-term neurologic outcome,
dichotomized to good (cerebral performance category (CPC 1–2) and
poor (CPC 3–5).
RESULTS. Of 458 OHCA patients, 185 (40%) patients had good and
273 (60%) patients had poor one-year outcome. We analyzed 10299
lactate values, a median of 16 (7–35) values per patient. Admission
lactate (p < 0.001), the lowest measured lactate (p < 0.001), the high-
est measured lactate (p < 0.001) and the last measured lactate
(p < 0.001) were all significantly higher in patients with poor one-
year neurological outcome. Areas under receiver operating character-
istic (AUCs) regarding poor one-year outcome were: admission lac-
tate (AUC 0.638, 95% CI 0.588-0.689), time-weighted lactate for ICU
stay (AUC 0.654, 95% CI 0.604-0.703), and last measured lactate (AUC
0.719, 95% CI 0.673-0.765). In multivariate backward regression ana-
lyses lactate at 72 h (OR 0.80, 95% CI 0.64-0.99, p < 0.01), time-
weighted total lactate (OR 0.68, 95% CI 0.52-0.90, p < 0.01) and last
measured lactate (OR 0.48, 95% CI 0.27-0.79, p < 0.01) were inde-
pendent predictors of good one-year outcome.
Table 141 (Abstract 0543). Patients characteristics
Age(year) 59.65±20.46
Gender (M/F) 69/36
Hospital discharge (day) 14.66±16.50
First documented rhythm(n:105) Asystole and PEA VF
and pulseless VT Unknown
74 (70%) 12 (12%)
19 (18%)
Survive in 3 days (n:105) 83 (79%)
Survive in 7 days (n:105) 70 (66%)
Outcome (n:105) Discharge with neurologically disability
Discharge without neurologically disability Death
7(7%) 17(16%) 81 (77%)
Location of arrest (n:105) In hospital Out of hospital 54 (53%) 49 (47%)
Duration of Resuscitation (min) 18.75±11.71
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 277 of 542CONCLUSIONS. In this prospective multicenter study, we found that
higher lactate at 72 h, higher time-weighted lactate during ICU stay,
and higher last measured lactate were independent predictors of
poor one-year outcome.
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INTRODUCTION. Current options for outcome prediction in cardiac
arrest survivors remain significantly limited. Prognosis assessment
is extremely important especially in patients remaining comatose
even after the end of temperature intervention and withdrawal
of sedation.
OBJECTIVES. The aim of our study was to evaluate the prognostic
value of individual clinical characteristics and recommended
examinations in specific subpopulation of cardiac arrest survivors
remaining comatose more than four days after collapse.
METHODS. We analyzed data from a single-center prospective regis-
try of out-of-hospital cardiac arrest survivors admitted between 2010
and 2014 to the tertiary cardiovascular center. All subjects were
treated with endovascular hypothermia (33°C for 24 hours). Studied
population comprises individuals remaining comatose on artificial
ventilation more than four days after arrest. We evaluated the prog-
nostic significance of age, gender, initial rhythm, time to return of
spontaneous circulation (ROSC), initial levels of serum lactate, po-
tassium, D-dimer and pH, serial measurements of neuron-specific
enolase (NSE), C-reactive protein (CRP), procalcitonin, alanine ami-
notransferase, serum creatinine, and electroencephalography (EEG)
in this group. Clinical outcomes were assessed according to the
Cerebral Performance Category (CPC) at 30 days (good neurologic
outcome was defined as CPC 1–2).
RESULTS. A total of 99 patients remaining comatose four days after
arrest were included in the study (mean age 65 years, males 64%).
Univariate analysis revealed that age, EEG, and values of NSE, initial
serum lactate and D-dimer were significantly associated with clinical
outcomes. On the other hand, several well-known prognostic factors
(e.g. initial rhythm, pH or time to ROSC) were not associated with
prognosis in this specific population. Multivariate analysis found that
only EEG (“burst-suppression” pattern, P = 0.0007), initial level of D-
dimer (P = 0.0009) and NSE value at 72 hours (P = 0.0008) were inde-
pendent predictors of prognosis in these patients. Receiver operating
characteristic analysis revealed that especially EEG pattern and NSE
levels had high value for accurate prediction of poor prognosis.
CONCLUSIONS. Prognosis prediction is extremely important especially
in those cardiac arrest survivors remaining comatose even after
withdrawal of sedation. Our results indicate that EEG pattern, levels ofD-dimer and NSE are independent predictors of prognosis in this sub-
population of cardiac arrest survivors.
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INTRODUCTION. Scoring systems have been used for evaluating
severity of disseases and predicting mortality. Some of scoring
systems also have been developed for predicting mortality and
good neurologic outcome after CPR. It has been estimated 192.000
in hospital and 395.000 out of hospital cardiac arrests in the US
annually1,2.
OBJECTIVES. We evaluated to success of predicting mortality of ICU
and CPR scoring systems after CPR.
METHODS. We calculated of 105 patient's GOFAR, PAM, MODS,
LODS, SOFA, APACHE II, SAPS II scores after succesful CPR
retrospectively after approval ethics committee. We used on the
day of resuscitation parameters when calculating scores. Student t
test was used to compare mean scores of patients in which survive
or death. Receiver operating characteristic curve (ROC) was used to
evaluate of scoring systems success on predicting mortality.
RESULTS. Characteristics of patients showed in Table 141.
Survived and died patient had statistically significant mean GCS,
GOFAR, PAM and SAPS II scores (Table 142) (p < 0.05).
Predicting in first 3 day mortality succes of GOFAR, PAM and SAPS
II were calculated statistically significant. (AUC values; GOFAR:0.629,
PAM:0.691, SAPSII:0.653 respectively, p < 0,05). There was no
difference in terms of success of predicting mortality in three
scoring systems (Fig. 192).
CONCLUSIONS. We found SAPS II could be an helpful instrument to
evaluate mortality after CPR near to GO-FAR and PAM. More studies
needed to evaluate scoring systems and mortality rate to prevent
poor neurologic outcome after resuscitation.
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Table 142 (Abstract 0543). Mean scores of survived and death patients
Survived Death
Age (year) 54.50±4.03 61.18±2.78
GCS 3.81±0.35α 3.08±0.04
GOFAR 1.41±2.38α 6.29±1.29
PAM 1.7±0.84α 4.83±0.58
APACHE II 28.79±1.23 30.59±0.84
LODS 7.83±0.41 8.71±0.31
SOFA 11.33±0.61 12.43±0.37
SAPS II 59.13±2.16α 68.72±1.88
MODS 7.08±0.57 7.66±0.22
Fig. 192 (Abstract 0543). ROC curve of GOFAR, PAM and SAPS II
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INTRODUCTION. Out-of-hospital cardiac arrest (OOHCA) remains as-
sociated with significant mortality. Guidelines suggest that all non-
traumatic OOHCA patients should be cared for at a centre with ICU
and primary percutaneous coronary intervention (PPCI) services. Air
ambulance transfer can facilitate this. We analysed data from all
OOHCA patients who were treated by advanced practitioners from
the air ambulance service before being transferred to a tertiary re-
gional specialist cardiac centre.
OBJECTIVES. Determine current rates of survival to discharge and
sought to identify novel prognostic indicators for survival to
discharge post cardiac arrest.
METHODS. A retrospective analysis of all consecutive hospital
records extracted from our regional Air Ambulance service and
tertiary regional angioplasty centre databases. Data presented as
mean ± SEM.
RESULTS. Out of all OOHCA patients studied, 15/27 (55.6%) had
ROSC before and 5/27 (18.5%) after arrival of the air ambulance and
1/27 (3.7%) achieved ROSC during PPCI. All patients achieved ROSC
for a period, although this was short in some cases, however thelocation of ROSC was not recorded in 6/27 (22.2%) cases. 25/27
(92.6%) underwent coronary angiography and 13/25 (52%) went on to
have stenting performed. Patients who were discharged alive spent an
average of 8.5 ± 1.7 days in hospital including an average of 5.9 ± 1.4
days in ICU. All patients who died did so in ICU following an average
length of stay of 2.7 ± 0.7 days. None of the patients died more than 6
days after admission. Overall, 18/27 (66.7%) of patients survived.
Multivariate analysis confirmed that suffering a witnessed arrest and
receiving bystander CPR are both independently associated with
higher likelihood of achieving pre-hospital ROSC.
CONCLUSIONS. Current survival figures are comparable to previously
published data in relation to out of hospital cardiac arrests attended
by air ambulance services (1). Only around half the patients had
stenting performed but we were unable to identify on-the-scene var-
iables predicting requirement for the need of coronary stenting or
for survival. This is in keeping with other previous studies that have
shown that ECG on ROSC is a poor predictor of STEMI (2). Pre-
hospital evaluation by echocardiography or use of advanced electro-
cardiographic techniques might be considered.
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INTRODUCTION. In recent years veno-arterial extracorporeal mem-
brane oxygenation (VA-ECMO) has been more frequently used for
treatment of refractory cardiac arrest (CA) as the last step of cardio-
pulmonary resuscitation (ECPR), with different results between stud-
ies regarding outcomes and prognostic factors (1).
OBJECTIVES. To evaluate possible predictors of mortality in ECPR
along the whole chain of survival, from the event to ECMO, in Table
143 a metropolitan Italian city.
METHODS. Among all VA-ECMO performed in a ECMO-tertary single-
center hospital from 2014 to April 2017, we have considered those
used for ECPR, in a setting of CA. VA-ECMO was performed in a stan-
dardized protocol, maintaining 36°C of internal body temperature,
positioning intra-aortic balloon pump and inotropic support with epi-
nephrine. An electronic-dedicated database was created to prospect-
ively collect clinical and pathophysiological variables.
RESULTS. We analyzed data from 30 ECPR, two of these were
excluded for impossibility to ECMO implantation. 26 patients had
Out-of-Hospital cardiac arrest (OHCA), 2 patients In-Hospital cardiac
arrest (IHCA). The overall hospital-survival and within 24-hours were
respectively 4% and 36%. When we have analysed the time of the
various steps of the survival chain up to ECPR, we have registered a
time-to first shock of 7 [5–12] minutes, a time-to ACLS of 16 [12–20]
minutes and a time-to hospital of 55 [45–59] minutes (median, 25th-
75th perc). The time-to-ECMO for OHCA is averagely the same of
literature reports (2–3), with an incannulation time of 30 [23–44]
minutes. At the end no-flow time was 5 [0–10] minutes, low-flow
time 80 [69–88] minutes. When performed a multivariate analysis,
the main factors predicted 24-hours survival was low-flow (Cox's
Regression-Table 143).
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 279 of 542CONCLUSIONS. As reported in this work the key variable to reduce
unfavourable 24-hour outcome was the reduction of pre-hospital
timing, in particular low-flow time, emphasizing, at the same time,
that witnessed-CA, with an immediate RCP leading to zero no-flow
time, and the presence of automatic devices are essential precondi-
tions to increase the survival rate. We consider that protocols with
targeted timing should be used in order to obtain better outcomes
including the possibility to position VA-ECMO circuit on the place of
the event.
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INTRODUCTION. Mild therapeutic hypothermia has been integrated
into management strategies for improving the neurological outcome
of out-of-hospital cardiac arrest. However, the shivering leads difficult
body control during therapeutic hypothermia (TH).
OBJECTIVES. We monitored peripheral and core temperature to
achieve adequate peripheral perfusion. This study aims to evaluate
the dissociation between peripheral and core temperature affects
temperature control during TH for post cardiac arrest syndrome
(PCAS) in ICU.
METHODS. From January 2014 to March 2017, 23 patients were
treated with mild hypothermia (34 degrees centigrade, for 24 hours).
Each patients were inducted with Arctic-sun®, Thermogard XP®, or
ECMO for unconscious out-of-hospital-cardiac arrest patients of PCAS.
All patient were measured both peripheral and bladder temperature
as core temperature. Analgo-sedation were administered during TH,
however, neuro-muscular blocking agent was not given routinely.
We divided 23 patients into Group C (well controlled peripheral
temperature) and Group U (uncontrolled peripheral temperature).
Ventilator associated pneumonia, shivering and neurological outcomeswere evaluated. Shivering was evaluated with bedside shivering ass-
cessment scale. A favorable outcome was defined as a Cerebral Per-
formance Category (CPC) of 1–2.
RESULTS. As compared with group C (N = 10), group U (N = 13) had
higher rates of shivering (20% vs. 62%, p < 0.05). Skin counter
warming was used higher rate in Group C (60% vs. 15%, p < 0.05).
There were no significant differences between the two groups about
pneumonia and favorable outcomes.
CONCLUSIONS. Though we cannot found the advantage of control
peripheral temperature, the dissociation between peripheral and
core temperature increases the rate of shivering as results. In
addition, skin counter warming is useful method to achieve good
peripheral perfusion.
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INTRODUCTION. Ischemic brain injury is one of the most important
postresuscitation syndrome in patients after out-of-hospital cardiac
arrest (OHCA) and associated with increased mortality.
OBJECTIVES. To evaluate independent predictors of ischemic
brain injury in successfully resuscitated OHCA patients, admitted
to medical ICU.
METHODS. We retrospectively included 119 successfully resuscitated
OHCA patients, admitted in 2011–2013 (73.1% men, mean age
64 ± 13,5 years). Therapeutic hypothermia within the first 24
hours, early treatment of acute coronary syndromes, prevention
of recurrent cardiac arrests, maintainance of adequate ventilation
and circulation were among measures in the ICU to improve the
outcome. Neurological outcome was classified by cerebral
performance category (CPC) scale 1–5. Significant ischemic brain
injury was defined by CPC scale 3–5 and included patients with
brain death, vegetative state or other severe impairment of
cerebral function. Good neurological recovery was defined by
CPC scale 1–2 and included minor to intermediate brain injury
with the ability for independent life. Predictors of brain injury
were tested by logistic regression.
RESULTS. Among successfully resuscitated OHCA patients, admitted
to ICU good neurological recovery was observed in 35.3% and
significant ischemic brain injury in 64.7%. Patients with significant
brain injury in comparison to those with good neurological outcome
were significantly older (66 ± 12.9 years vs 60.2 ± 13.9 years,
p < 0.05), resuscitated longer (8.3 ± 5 min vs 4.3 ± 4.8 min, p < 0.05),
less likely due to ventricular fibrillation or tachicardia (VF/VT) (45.5%
vs 71.4%, p < 0.05), but more likely due to asystole (53.2% vs 21.4%,
p < 0.05), with significantly increased mean admission lactate level
(7.5 ± 4.3 mmol/l vs 4.2 ± 2.9 mmol/l, p < 0.05), less likely performed
PCI (32.5% vs 54.8%, p < 0.05), more likely observed heart failure
(96,1% vs 83.3%, p < 0.05) and with increased in-hospital (75.3% vs
7.1%, p < 0.05) and 6-month mortality (77.9% vs 7.1%, p < 0.05).
There were nonsignificant differences in comorbidities, achieved
hypothermia < 34°C and hypothermia < 36°C. Independent predic-
tors of ischemic brain injury were age (OR 1.044, 95% CI 1.000 to
1.090, p = 0.048), admission lactate (OR 1.241, 95% CI 1.007 to
1.528, p = 0.042) and resuscitation time (OR 1,106; 95% CI 1.015 to
1,205, p = 0.022).
CONCLUSIONS. Among several predictors only older age, increased
admission serum lactate and resuscitation time independently
predicted ischemic brain injury in our OHCA patients.
Fig. 194 (Abstract 0548). See text for description
Fig. 193 (Abstract 0548). See text for description
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INTRODUCTION. Cardiac arrest is a disastrous event and is related
with high mortality. Some of the patients will survive and will be
admitted in ICU. The most important cause for a poor prognosis in
these patients, who will survive initially, remains the post-cardiac
arrest syndrome. This is a pathophysiological situation characterized
by cerebral damage, myocardial disfunction and systemic ischemia.
The cerebral damage remains the most common cause of death in
these patients.
OBJECTIVES. We designed this clinical research to study the
prognostic value of early brain CT scan in patients' outcome after
cardiac arrest.
METHODS. Our study included 19 patients. These patients developed
spontaneous circulation (SC) after successful CPR and received a
brain CT scan within 1 hour after the return of SC. Then, they were
admitted in ICU of our hospital. After that, we recorded if the CT was
positive or negative for brain damage, and the final outcome of
these patients. We hypothesized as positive CT the loss of gray-white
matter differentiation or/and basilar cistern or/and sulcal effacement
(Figs. 193 and 194), and negative without any recently findings.
RESULTS. 19 patients were included in our study with min age
69 ± 16 years old (min 20, max 87). The duration of their
hospitalization in ICU was 12 ± 10 days.
In 7 (37%) patients brain damage in cerebral CT was observed. In
the rest 12 (63%) patients the cerebral CT was negative for brain
damage. All the 7 patients with positive CT did not survive. From
the 12 patients with negative CT only 3 survived and left ICU in
good mental status.
CONCLUSIONS. From the above mentioned results, we can conclude
that all patients with positive CT did not survive. It is obvious that
there is a correlation between brain damage and mortality, so we
can say that in our study the cerebral CT has a positive prognostic
value of 100%. From the patients with negative CT survived only
25%. That means that the examination has poor negative prognostic
value (25%), due to the fact that most patients with negative CT for
brain damage had the worst outcome. To sum up, the cerebral CT
in the first hour after successful CPR in patients after cardiac arrest
may be a useful tool for the prognosis of these patients only when
findings of brain damage appear.
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cause of global cerebral ischemia. Due to a lack of effective therapies
to treat the subsequent brain damage, most patients are left with
incomplete neurological recovery. Several brain regions, including
the cornu ammonis field 1 (CA1) of the hippocampus are particularly
affected by a transient hypoxic-ischemic insult. This “selective vulner-
ability” is observed in rodent models as well as in humans.
OBJECTIVES. To develop an in vitro surrogate for the in vivo rat
model of cardiac arrest/resuscitation, using organotypic hippocampal
slices, and test it for regenerative therapy by neuronal progenitor
cells (NPCs) grafting.
METHODS. Hippocampi from rats pups are cut into slices, cultivated
for one week, and then subjected to oxygen-glucose deprivation
(OGD) to reproduce in vitro the hypoxic-ischemic injury observed
after CA. Duration of OGD is optimized to reproduce the extent and
pattern of damage observed in vivo. Neuronal damage is quantified
by Fluoro-Jade B (FJ) staining, specific for degenerating neurons. For
transplantation experiments, NPCs are isolated from hippocampi of
newborn rats, expanded as neurospheres for one week and grafted
into injured cultures. Their survival, differentiation and migration are
assessed by immunohistochemistry (IHC).
RESULTS. Organotypic cultures submitted to 33 minutes of OGD
developed hippocampal damage to a similar extent as observed in
the in vivo model. A significantly higher amount of FJ-positive cells
was found after OGD in the CA1 segment compared to the normoxic
control (582 ± 244 FJ+ cells/mm2, n = 9 versus 155 ± 84 FJ+ cells/
mm2, n =5; P = 0.0034). The cellular composition of the neuro-
spheres, as tested by IHC, showed the presence of numerous nestin-
and doublecortin-positive cells, indicating NPCs. After NPCs trans-
plantations into OGD-injured hippocampal cultures, viable cells were
found at different time points after grafting, confirming the overall
feasibility of the procedure.
CONCLUSIONS. We could successfully reproduce damage to CA1
neurons of the hippocampus in vitro after OGD, as observed
in vivo after CA. Neurospheres were mostly composed of neuronal
progenitors, as confirmed by IHC. The survival, migration and
differentiation of grafted cells are currently assessed using NPCs
isolated from Green Fluorescent Protein transgenic rats, therefore
facilitating the identification of the grafted cells. This project represents
a first step in the development of a cell-based regenerative therapy
after global cerebral ischemia consecutive to CA.
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INTRODUCTION. Cardiac arrest survival is determined by the 4 links
within the chain of survival: early access, early CPR, early
defibrillation and post-resuscitation care. Studies have shown that
early cardiopulmonary resuscitation (CPR) with minimal interruption
is crucial for improving cardiac arrest survival rates. One of the de-
terminants for successful resuscitation is effective CPR with ad-
equate depth (5-6cm) and rate (at least 100 per min) while allowing
complete chest recoil. Current AHA guidelines recommend that res-
cuers switch every 2 minutes, while allowing assessment of ECG
rhythm, despite the harmful effect of interrupting chest compres-
sions. This also allows recognition of fatigue and replacement of
the rescuer to maintain optimal chest compressions. A variety of
feedback devices have been designed to improve the quality of
chest compressions.METHODS. We evaluated the quality of chest compressions using an
electronic feedback device in a simulated resuscitation during a 1-
week period. The monitoring device was a ZOLL 'R' series defibrillator
with an accelerometer, providing real-time audio-visual feedback
prompts. 40 participants were grouped in pairs, resulting in 20 pairs.
Each pair performed two rounds of chest compressions and defibril-
lation according to ACLS protocol on a manikin in 10-minute resusci-
tation periods.
RESULTS. In the pairs with no feedback first (NFF), overall CPR
performance was poor. However, with the use of feedback, the
quality of chest compressions improved from 11.8% to 58.1%. In
the pairs with feedback first (FF), percentage of quality chest
compressions improved from from 24.7% to 47.1%. The results
emphasized the variability of CPR quality between clinicians and
the need for CPR coaching, which may translate to improved
patient outcomes in the clinical setting. Our results showing an
improvement in the quality of CCs induced by CPR feedback, were
consistent with those previously reported. To our knowledge, our
study is the first to date to evaluate the effect of chest compression
quality in a continuous 10-minutes x2 simulation (with a short 5-
minute interval), mirroring clinical scenarios where resuscitations
often last longer than 2–5 minutes in previously published studies.
CONCLUSIONS. Chest compressions are the cornerstone to
successful cardiopulmonary resuscitation. Good quality chest
compression is vital for patient survival and improved
neurological outcomes following cardiopulmonary arrest. Our
study showed significant variation in chest compression quality
among clinicians with room for improvement. The ability to
improve clinicians' performance of chest compressions with
technological advancements (CPR feedback device) and training
may translate to better survival outcomes in real patients in the
future. Good quality CPR continues to be a focus of quality
assurance and improvement programs.
0551
Factors associated with successful on-site return of spontaneous
circulation by automated external defibrillator
C.-C. Chao1,2, W.-F. Kao1,2, T.-H. Wang3,4
1Taipei Medical University, Taipei, Taiwan, Province of China; 2Taipei
Medical University Hospital, Taipei, Taiwan, Province of China; 3National
Taiwan University, Taipei, Taiwan, Province of China; 4Ministry of
Health and Welfare, Department of Medical Affairs, Taipei, Taiwan,
Province of China
Correspondence: C.-C. Chao
Intensive Care Medicine Experimental 2017, 5(Suppl 2):0551
INTRODUCTION. Many countries have legislation for encouraging
the use of automated external defibrillators (AEDs) to reduce the
mortality of out-of-hospital cardiac arrest (OHCA) patients. Taiwan
Legislature passed amendments to the Emergency Medical Services
Act, thereby requiring the installation of AEDs in mandatory areas
in 2013.
OBJECTIVES. Our study aims to analyze the efficacy of the policy
regarding AED installation.
METHODS. 215 cases received AED treatment was reviewed between
July 11, 2013 and July 31, 2015. The data was reported by lay
persons or supervisors of public facilities; however, only 124 of
all cases had complete data. The analysis of data was performed
using SPSS 14.0.
RESULTS. Trained responders rescued 139 (64.7%) cases.
Approximately 55% cases were male. In mandatory areas, schools,
mass gathering places, and special institutions are places with
most usage of AEDs, accounting 33 cases (15.3%). Long-term care
facilities had the most cases among the non-mandatory areas, 32
cases (14.9%). The odds for long distance transport were lower
than those for commuting stations, 0.481 (95% CI, 0.24 ~ 0.962).
The odds ratio for commuting stations and schools, large -scale
gathering places, and special institutions was 4.474 (95% CI,
2.497 ~ 8.015). Non-mandatory areas had a higher frequency of
AED use, 4.259 (95% CI, 2.223 ~ 8.159).
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 282 of 542District Value 95% CINon-mandatory area + V.S. Mandatory areas 2.302 1.407-3.768Mandatory areas: compared with commuting stationLong distance transport 0.481 0.24-0.962Sightseeing area 1.978 0.906-4.318School, mass gathering place, and special institution 4.474 2.497-8.015Large entertainment facility 1.546 0.648-3.688Large shopping mall 1.847 0.733-4.656Hotel 1.324 0.525-3.337Hot spring area 0.696 0.196-2.476[Odds ratio of AED usage]
CONCLUSIONS. The policy regarding AEDs improved the prevalence.
However, more AEDs are required in schools, mass gathering places,
and long-term care facilities. Furthermore, mandatory areas should
include long-term facilities.
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INTRODUCTION. On average 20 people per day die in traffic
accidents, and major trauma is the leading cause of death of young
adults in Argentina. New approaches in trauma care and advanced
treatments are needed to improve the actual therapeutic strategy
and treatment protocols. Extracorporeal life support (ECLS) has
proven to be effective in cases of shock (in venous-arterial modality,
VA-ECLS) and pulmonary failure (in Venous-Venous modality, VV-
ECLS or ECMO), when standard therapies have failed. However, the
need for anticoagulation has historically limited the use of ECLS in
polytrauma patients because of the increased risk of bleeding. We re-
port our initial experience with ECLS,which would be the first cases
reported in our country as a rescue therapy in severely polytrauma-
tized patients in a refractory clinical setting.
OBJECTIVES. To evaluate the feasibility of performing ECMO in
severe trauma patients with acute respiratory failure to whom the
optimal ventilator strategies and adjunctive measures had failed.
Also describe the outcome of patients and hemorrhagic
complications during the procedure.
METHODS. We performed a retrospective analysis of ECMO patients
who had severe polytrauma with acute respiratory failure at a
tertiary-level referral trauma center. Demographic, severity of illness
and outcome data were recorded, and we also described ECMO con-
figuration used and hemorrhagic complications.
RESULTS. We performed 10-VV ECMO during a 2-year period. The
mean age of the survivors was 21 years vs. 29 years for non-survivors
and the mean time of ECLS treatment was 9 days in survivors vs. 3
days in non-survivors.The ISS and APACHE II were 38, 17.25 in survi-
vors vs 42, 19.4 in non-survivors. Out of 10 patients, 5 patients (50%)
were discharged from the hospital. All patients were treated with
intravenous heparin with a mean onset of 12.5 h from the beginning
of ECMO, and the mean dose of heparin was 18.25 u/kg. Two pa-
tients required transient anticoagulation discontinuation due to epi-
sodes of major bleeding, which was subsequently restarted. Inpatients efficiently supported by ECLS, the cardiac index, mean arter-
ial pressure, blood lactate concentration, arterial oxygen tension, ar-
terial carbon dioxide tension, and pH all showed significant
improvement within the first 6 hours.
CONCLUSIONS. In our review, we conclude that the use of ECMO in
polytrauma patients who develop refractory respiratory distress or
high-debit pleural fistulas is a feasible therapy if it is performed by a
properly trained team and with close monitoring of anticoagulation.
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INTRODUCTION. Survival of cardiopulmonary resuscitation (CPR) for
traumatic cardiac arrest patients is very poor. Furthermore, some
consider laparotomy for abdominal trauma after CPR futile.
OBJECTIVES. This study aimed to describe the outcomes for victims
of trauma who is pulseless and received CPR with laparotomy.
METHODS. We conducted a retrospective review of medical records
of our hospital from January 2009 to March 2016. Patient's
demographics, injury severity score, CPR time, operative data and
mortality data were collected and analysis.
RESULTS. 385 patients underwent laparotomy due to trauma. Sixty
two (16.1%) patients died after laparotomy. Sixteen patients
underwent CPR at emergency room and after successful CPR, these
patients underwent laparotomy for treatment of abdominal injuries.
Among these patients, fifteen patients (93.7%) died after laparotomy,
and only one patient (6.2%) survived who suffered by iliac artery
injury. Five (5/15, 33.3%) patients had a length of stay of < 1 day,
Three patients (3/15, 20.0%) had a length of stay of >7 days. Mean
time from injury to admission was 172 minute. All patients were
victims of blunt injury.
CONCLUSIONS. Survival rate of laparotomy following CPR after
traumatic cardiac arrest was very poor. But this modality is not
always futile. And more improvement of emergency transport system
to trauma center seems to be needed.
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INTRODUCTION. Acute respiratory Distress (ARD) is a condition rarely
present before an elective surgical procedure and should be a
preventable postoperative complication. Extravascular lung water
Table 144 (Abstract 0554). Differences between NON-PARD and
PARD group
Non-PARD(N = 107) PARD (N = 32) p
Fluid Input mean ± SD 3665 ± 1857 3801 ± 2475 0.73
Transfusions n (%) 34(32) 19(59) 0.005
LUS score mean ± SD 9 ± 4 11 ± 4 0.001
ICU stay (hours) median (IQR) 24(24–72) 95(72–102) <0.0001
Mortality at day 8 n (%) 0(0) 0(0) n.s.
Mortality at day 28 n (%) 0(0) 1(3) n.s.
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 283 of 542(EVLW) is an early marker of lung edema and ARD[1,2]. Lung
ultrasound (LUS) has proven to be a reliable tool in assessing EVLW
and may help in early identification of postoperative ARD (PARD)[3]
OBJECTIVES. Evaluating the predictive value of EVLW assessed by
LUS as an early marker of PARD in patients admitted to ICU after
major surgery.
METHODS. In adult patients admitted to ICU after major surgery, LUS
was performed at admission: a LUS score ranging from 0 to 36 was
computed on the basis of percentage of occupied pleura [4] in the
12 standard thoracic areas. PARD was defined as length of
mechanical ventilation >6h or need for non-invasive ventilation
within 48 hours after extubation.
RESULTS. We prospectively enrolled 139 patients (age 65 ± 13; BMI
27 ± 6; male 59%, ASA score 3 [2–3]): 32 patients (23%) presented
PARD. LUS score was significantly higher in patients who developed
PARD compared to the non-PARD (11 ± 4 vs. 9 ± 4; p = 0.001). A LUS
score >6 was associated with a prolonged mechanical ventilation
and a longer ICU stay (Figs. 195 and 196). Fluid resuscitation during
surgery didn't differ between the 2 groups; on the contrary, transfu-
sions were significantly more frequent in the PARD group (59% of
patients vs. 32%, p = 0.005)(Table 144).
CONCLUSIONS. EVLW assessed by LUS seems to be an early marker
of PARD in patients admitted to ICU after major surgery
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INTRODUCTION. The Mechanical Power (MP) measures the energy
applied by the ventilator to the respiratory system of the patient
during mechanical ventilation[1]. An excessive energy load applied
could lead to ventilator-induced lung injury (VILI) development [2].
OBJECTIVES. We quantified MP and investigated MP's components
distribution in obese patients without pulmonary disease and in
ARDS patients at 2 PEEP levels.
METHODS. Flow and airway pressure (Paw) were recorded during
volume controlled ventilation in 19 obese and 50 ARDS patients at
different tidal volumes (6 to 12 ml/kg) at 2 levels of PEEP (5 and 15
cmH2O), and respiratory rate (RR) 13 ± 4 breaths/min. MP was
computed as the area between the inspiratory limb of Paw-Volume
curve and the Volume axis times RR. Elastic recoil-, gas motion- and
PEEP-related components were obtained [1]. MP and its 3 compo-
nents were then normalized by the functional residual capacity (FRC).
RESULTS. MP/FRC was significantly higher in obese than ARDS patients
at both PEEP levels (25 ± 12 vs 14 ± 8 and 31 ± 16 vs 21 ± 12 mJ/min/ml,
respectively at 5 and 15 cmH2O; p < 0.001 for both). As shown in Fig. 197,
MP's PEEP-related component/FRC was higher in obese than in ARDS pa-
tients at both PEEP levels (6 ± 2 vs 4 ± 2 and 18 ± 9 vs 12 ± 6 mJ/min/ml
at 5 and 15 cmH2O, respectively; p < 0.001 for both).
Interestingly, in obese patients the MP's elastic recoil-related compo-
nent/FRC was lower at higher PEEP (9 ± 5 vs 7 ± 4mJ/min/ml, p < 0.001).
CONCLUSIONS. Mechanical ventilation in obese patients was associated
with higher MP than in ARDS patients. The PEEP-related component
could play a central role in modulating the total MP applied.
REFERENCES
[1] Gattinoni L. Intensive Care Med 2016; 42:1567
[2] Cressoni M. Anesthesiology 2016; 124:1100Fig. 197 (Abstract 0555). MP’s components-FRC ration in obese
and ARDS patients at two PEEP levels. The meam values of PEEP-,
elastic recoil- and gas motion-related components are represented
in blue, green and red, respectively
Table 145 (Abstract 0557). Characteristics
OVERALL TIVA HALOG p
PATIENTS 63 25 38
AGE 65.67 +/- 9.18 66.72 +/- 8.02 64.97 +/- 9.93 0.22
SEX M 48 16 32 0.06
BMI 26.59 +/- 3.76 26.32 +/- 3.46 26.76 +/- 3.98 0.65
CPB time (min) 76.07 +/- 28.25 79.6 +/- 30.05 73.82 +/- 27.1 0.42
Clamping (min) 62.00 +/- 26.53 67.24 +/- 31.71 58.64 +/- 22.41 0.2
HCT (%) 29.13 +/- 4.30 28.66 +/- 4.83 29.46 +/- 3.94 0.52
LV mass 214.80 +/- 62.70 198.76 +/- 61.13 223,31 +/- 62.8 0.19
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INTRODUCTION. Mechanical ventilation is often a necessary
supportive intervention during general anaesthesia. Over the past 20
years, the pro-inflammatory potential of mechanical ventilation has
been recognised. Volutrauma, barotrauma, atelectrauma, biotrauma
and hyperoxia are all mechanisms implicated in ventilator induced
lung injury leading to potentially serious pulmonary and systemic
complications. Historically, high tidal volumes (10-15ml/kg) were
used to prevent atelectasis and ensure adequate oxygenation during
surgery. Since the ARDSnet trial in 2000, the role of protective lung
ventilation using tidal volumes 6-8ml/kg (predicted body weight), ap-
plication of Positive End Expiratory Pressure (PEEP), recruitment ma-
noeuvres and judicious titration of FiO2 has been established as a
gold standard of care for patients in the critical care setting. There is
recent evidence that the translation of this standard of care to those
with healthy lungs in the perioperative setting may be of benefit to
patients.
OBJECTIVES. The aim is to evaluate that current mechanical
ventilation settings in the operating theatre comply with current
proposed lung ventilation strategy.
METHODS. Intraoperative ventilation data were voluntary collected
by anaesthetists prospectively using a proforma data collection form
on patients undergoing elective or emergency surgery. Those on
mandatory, supported or combined modes of ventilation were
included. Missing variables were obtained by retrospective review of
hospital notes. Data was initially recorded in Microsoft® Excel® 2011
and analysed using IBM® SPSS® Statistics Version 22.
RESULTS. Compliance with protective low tidal volume ventilation
(≤8ml/kg PBW) was 66.4% (n = 79). Less than 10ml/kg PBW was
achieved in 101 cases (84.9%). Interestingly, those who were
ventilated with more than 10ml/kg (n = 18; 15.1%) were all female
with height < 167 cm and 47.6% had a BMI ≥ 30kg/m2. Overall,
females received larger Vt (9ml/kg PBW) compared to men (7ml/kg
PBW). PEEP 2–8 cmH2O was applied in 73.6% of cases (n = 92) with
neurosurgical patients receiving the least amount of PEEP (39.4%).
Peak pressure < 30 cmH2O was achieved in 94.4% of cases (n = 118).
FiO2 ≥ 0.5 was used intraoperatively 61.4% of the time (n = 62)
despite median SpO2 ≥ 95%.
CONCLUSIONS. Protective lung ventilation (PLV) is being employed
in theatre, however the delivery of higher tidal volumes to females is
a concern, as it is the used of low PEEP. A consistent use of high
concentration of administered O2 (FiO2 ≥ 0.5 despite SpO2 ≥ 95%)
was also identified. A default setting on the ventilator of 500 ml and
a PEEP of zero might have been partly responsible. To encourage
compliance with the PLV we have proposed to changed the default
setting to 400 ml VT and PEEP 4, as well as more sensible use of O2.
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Intensive Care Medicine Experimental 2017, 5(Suppl 2):0557INTRODUCTION. Strain Analysis by 2D TEE is a new technology
allowing a semiobjective and quantitative measure of regional
myocardial function (1) which is less preload dependant than left
ventricular ejection fraction (LVEF). Applications of Speckle-tracking
Strain imaging in the perioperative period of cardiac surgery are still
being evaluated (2). The only study available with a before/after CPB
design demonstrated a LV improvement and a RV impairment after
aortic valve replacement (3).
OBJECTIVES. We conducted a pilot observational study to assess LV
strain modification before/after CPB and investigate the role of
anesthesia technique.
METHODS. All scheduled cardiac surgery patients with a complete
perioperative TEE examination (10/01/2016 to 01/31/2017) were
included. TEE was performed with a GE Vivid S70 device, before
sternal incision and after sternal closure. Speckle-tracking Strain im-
aging calculations were made on site using the vendor software (AFI)
using 3 incidences (APLAX, 4C, 2C). Patients were divided in two
groups depending on the anesthesia technique with volatile anes-
thetics (HALOG) or with total intravenous anesthesia (TIVA). Normo-
thermic blood cardioplegia is used in all patients. Groups were
compared using Student t and Chi2 tests as indicated (p < 0.05
significant).
RESULTS. 63 patients were included : 25 AVR, 36 CABG, 1 MVR, 1
AVR + CABG. 25 patients are in group TIVA, 38 in group HALOG.
Some characteristics are shown in Table 145.
Overall, a significant decrease is observed for AvgGLS before and
after CPB (−13,60% +/− 4,44 (IC95% : [− 12,48%;-14,72%]) vs −10,60%
+/− 5,70 (IC95% : [−9,17%:-12,02%]), p < 0,05). There is no difference
between TIVA and HALOG groups for the characteristics studied
(Table 146).
This is the first study investigating the role of anesthesia technique
on LV strain modification in cardiac surgery. We observed an overall
impairment of LV strain in our study, and this result is not consistent
with the only study available to date (3). While mean decrease of
AvgGLS was larger in the HALOG group, there is no statistically
significant role of volatile anesthetics on LV strain variation. These
findings should be investigated through a randomized controlled
trial in order to assess the factors accounting for LV strain
impairment in the perioperative period of cardiac surgery. Further
studies are also needed to assess the role of GLS impairment on
patients outcome. Speckle-tracking Strain imaging could be used as
a unique clinical tool to investigate the pharmacologic effect on the
myocardium of anesthesia and cardioplegia techniques.
CONCLUSIONS. TEE measurement of the global longitudinal strain
didn't reveal any significant difference on the alteration of LV
function and patient's outcome according to the type of anesthesia
in cardiac surgery with CPB.
REFERENCE(S)
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Table 146 (Abstract 0557). Results
OVERALL TIVA HALOG p
LVEF (%) BEFORE 59.45 +/-
9.61
62.18 +/-
7.37
57.87 +/-
10.46
0.06
LVEF (%) AFTER 58.69 +/-
11.83
62.65 +/-
8.7
56.52 +/-
12.84
0.056
GLOBAL LONGITUDINAL
STRAIN BEFORE(%)
−13.60 +/-
4.44
−12.88 +/-
4.48
−14.07 +/-
4.41
0.3
GLOBAL LONGITUDINAL
STRAIN AFTER (%)
−10.60 +/-
5.70
−9.58 +/-
6.4
−11.25 +/-
5.18
0.25
DELTA STRAIN (%) 16.32 +/- 0.4 12.98 +/-
0.5
18.52 +/-
0.29
0.58
TROPO (ng/l) 428.46 +/-
642.11
458.36 +/-
570.23
409.31 +/-
690.81
0.76
VENTIL (h) 4.94 +/- 2.51 5.32 +/-
3.39
4.69 +/-
1.73
0.33
LOS ICU (d) 3.66 +/- 1.55 3.52 +/-
1.85
3.74 +/-
1.53
0.6
MAJOR EVENT (n) 16 6 10 0.55
Fig. 199 (Abstract 0557). box & whisker plot for deltastrain TIVA &
deltastrain HALOG. Y axis values from 0 to +1 feature an AvgGLS
impairment, values from 0 to −1 feature an AvgGLS improvement
Fig. 198 (Abstract 0557). Spread plot of the ration of variable of
AvgGLS between before and after CPB (Deltastrain) in patients in
group TIVA (n = 25) and group HALOG (n = 38). Y axis values from 0
to +1 feature an AvgGLS impairment. Y axis values from 0 to −1
feature an AvgGLS improvement. p = 0.58
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INTRODUCTION. Direct electrical cardioversion (DEC) may be needed
during weaning from cardiopulmonary bypass (CPB), which may lead
to a higher cardiac troponin I (cTnI) peak. Mild elevations in cTnI may
be associated with lower survival after cardiac surgery.
OBJECTIVES. Evaluate factors associated with the need of major
number of DEC, the influence of DEC over cTnI levels and if there is
any association between DEC needs and outcomes.
METHODS. Prospective, observational study in our Surgical ICU in a
tertiary-level university hospital. cTnI was measured at 0h, 6h, 12h,
24h and 48h following CS. We divided our population in 3
subgroups: those needing ≤1 DEC (64.6%;1731), 2 DECs (17.8%;478)
and ≥3 DECs (17.6%;472).
RESULTS. 2681 patients were included. Mean age was 64.4 ± 11.7
years; Mean APACHE II: 12.2 ± 4.5; Body Mass Index: 27.9 ± 4.2Kg · m−2;
64.3% (n = 1725) were male.
We showed that valvular (OR: 2.008; 95% IC:1.077-3.744; P = 0.028) or
combined procedures(valvular plus bypass graft) (OR: 2.400; 95%
IC:1.107-5.204; P = 0.027) were associated with the need of ≥3 DECs,
whereas hypertrophic myocardiopathy in the preoperative
echocardiography (OR: 0.632; 95% IC:0.469-0.851; P = 0.003) was
protector.
Despite pattern of levels of cTnI was similar between subgroups, the
area under the curve of different levels of cTnI was different
between those needing ≤1 DEC and ≥3 DECs when calculated
during 24h (186 ± 478 vs. 248 ± 388ng∙mL−1∙h−1; P = 0.021) and 48h
(379 ± 651 vs.510 ± 803ng∙mL−1∙h−1; P = 0.001). This was also
confirmed when we only analyzed patients who underwent valvular
surgery. As well, higher levels of cTnI 12h were showed in the
subgroup of patients with ≥3 DECs (OR: 1.009; 95% IC:1.003-1.015;
P = 0.004), which was also confirmed when we only analyzed
patients who underwent coronary artery bypass graft surgery. We
did not find any association between DEC needs and outcomes.
CONCLUSIONS. DEC may lead to a modest increase in cardiac
troponin levels in our population, which did not have any influence
over outcomes. Type of surgery and hypertrophic myocardiopathy
may be associated with the need of DEC during weaning from CPB.
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Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 286 of 542INTRODUCTION. Left Double-Lumen Tube (LDLT) incorrect choice is
frequent and may lead to tracheal damage, mainly if oversized [1].
Correlation between left bronchial diameter (LBD) and patients' char-
acteristics (height, gender) or tracheal diameter (TD) alone is poor
[2]. Thus patients' characteristics or TD alone are inaccurate for pre-
dicting LBD. Ultrasound (US) may help in improving LDLT choice
adding TD to standard parameters.
OBJECTIVES. Comparison of standard LDLT choice approach to a
new approach, integrating TD measured by US to standard
parameters.
METHODS. Patients requiring LDLT were prospectively enrolled. Step 1:
LDLT was chosen by anaesthesiologists based on patients'
characteristics. LDLT size was deemed appropriate if volume inflated
into bronchial-cuff to achieve isolation was 0,5 to 2,5ml. LDLT requiring
bronchial-cuff volume < 0.5ml or >2,5ml were considered oversized or
undersized respectively [3]. TD was measured above the sterno-
clavicular junction to identify cut-off values[2]. Step 2: LDLT was chosen
according to TD cut-off and height outlined in step 1. Men whose
height was 165-175cm had 37F if TD < 17mm or 39F if TD >17mm;
when taller than 175cm they had 39F if TD < 18mm or 41F if
TD >18mm. Women whose height was 150-165cm had 35F if
TD < 14mm or 37F if TD >14mm; when taller than 165cm they
had 35F if TD < 15mm or 37F if TD >15mm.
RESULTS. Step 1 and Step 2 enrolled 102 and 50 adult thoracic
surgery patients respectively. Step 1: conventional approach is
associated with high rate of incorrect tubes. Compared to step 1, in
step 2 we had statistically significant lower inappropriate tubes (61%
vs. 14%; p < 0.01)(Table 147). In particular, the US integrated
approach significantly reduced the number of oversized tube (38.2%
vs. 6.0%, p < 0.001).
CONCLUSIONS. Ultrasound measurement of TD matched with
patients' characteristics significantly increased the rate of adequate
LDLT and reduced oversized and potentially harmful tube. Further
studies are needed to confirm that US measurement of TD may
guide LDLT choice.
REFERENCE(S)
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Intensive Care Medicine Experimental 2017, 5(Suppl 2):0560INTRODUCTION. Cardiac surgery with cardiopulmonary bypass (CPB)
triggers a systemic inflammatory response syndrome (SIRS) that is
associated with postoperative morbidity and mortality. Steroids may
attenuate this response but there is currently controversy over
its use.
OBJECTIVES. We aimed to assess the effects of two dosage of
steroids in CPB in AKI development during ICU stay.
METHODS. Retrospective observational study of a cohort of patients
that underwent to cardiac surgery at our institution between 2006
and 2014. Two groups were compared, one group administers 1 gr
of methylprednisolone (MTPN) during cardiopulmonary bypass and
another group administers 2 gr. AKI development during ICU stay
was defined as impaired renal function with elevation to twice
baseline creatinine or need of renal replacement therapy.
Demographic data, clinical and surgical variables were collected from
de Hospital database. Values expressed as mean +/− SD or %.
Significant variables in the univariate analysis were entered into a
multivariate logistic regression model to calculate the odds ratio with
confidence interval 95%.
RESULTS. Out of 4573 patients; 64.8 males; 67.78+/− 11.13 years old;
BMI 28.36 +/− 6.81; Logistic EuroScore 6.36 +/− 4.85; ICU stay 6.58
+/− 15.41 days; postoperative bleeding at first 24 hours 560.74 +/−
447.95 cc; preoperative haemoglobin 13.58 +/− 5.72 gr/ dL;
preoperative urea and creatinine 51.39 +/− 23.76; 1.13 +/− 0.57 mg /
dl respectively. By pass time 104.31 +/− 231.75; cross clamp time
71.76 +/− 32.74 minutes. Two groups were compared: group 1 :
MPNL (1 gr) ;group 2 with 2 gr of MPNL during CPB and analyzed its
relation with the development of AKI during ICU stay. Patients who
received higher doses of steroids had a lower risk of developing AKI:
Relative Risk 0.891, 95% CI (0.817 to 0.972) p = 0.009. Multivariate
analysis showed that a dose of 2 grams of MTPN reduced the
incidence of AKI in the postoperative period of cardiac surgery OR
1.44 95% CI (1.09 to 1.91) p = 0.012.
CONCLUSIONS. While new circuits of extracorporeal circulation have
been shown to decrease the incidence of SIRS in the postoperative
period of cardiac surgery and there is controversy about its use, in
this study a higher dose of steroids was shown to reduce the
incidence of AKI after cardiac surgery.
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INTRODUCTION. In myasthenia gravis (MG),an autoimmune disease,
the number of postsynaptic acetylcholine receptors decrease,
resulting in weakness and fatigability. Therefore, performing
thymectomy is challenging because of the increased risk for
postoperative respiratory complications (PORCs).
OBJECTIVES. To determine the incidence and risk factors for PORCs
in MG patients.
METHODS. Patients who underwent thymectomy at Siriraj Hospital
between 2010 and 2014 were retrospectively analyzed. PORCs were
defined as delayed extubation or need for reintubation. Patients'
characteristics and perioperative data were recorded and analysed.
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 287 of 542RESULTS. Among 134 MG patients, 9.7% developed PORCs.
Univariate analysis identified preoperative pyridostigmine alone[odds
ratio (OR) = 3.82, 95% confidence interval (CI) = 1.12-13.07,
p = 0.033], preoperative plasmapheresis (OR = 10.82, 95% CI = 1.39-
84.46, p = 0.023),and prolonged operation
(OR = 1.02, 95% CI = 1.00-1.03, p = 0.033) as risk factors for PORCs.
Multivariate analysis identified preoperative pyridostigmine alone
(OR = 6.37, 95% CI = 1.32-30.88, p = 0.021) and Osserman stage 3
(OR = 5.44, 95% CI = 1.02-24.63, p = 0.028) as predictors of PORCs.
CONCLUSIONS. The incidence of PORCs in myasthenic patients who
underwent thymectomy in this study was 9.7%. Muscle function
monitoring by TOF before extubation did not warrant safety.
Preoperative use of pyridostigmine and Osserman stage 3 were the
significant risk factors for PORCs.
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INTRODUCTION. Cardiac surgery can be accompanied by cognitive
dysfunction and complicated postoperative period. Recently, a novel
brain protein "Cellex" has been introduced into clinical practice.
However, despite several promising pilot studies after stroke, its' role
for attenuation of postoperative cognitive dysfunction is still
unsettled.
OBJECTIVES. The aim of our study was to evaluate the efficacy of
brain protein "Cellex" for prevention of postoperative cognitive
dysfunction after cardiac surgery.
METHODS. Our study included 60 patients undergoing elective
cardiosurgical operations who were randomized into two groups. In the
“Cellex” group, the patients received 1,0 ml of "Cellex" subcutaneously
daily during 8 days, beginning from the preoperative day; the control
group received a saline treatment as a placebo. The cognitive function
was assessed using Montreal cognitive assessment (MoCA) test. The
plasma concentration of S 100b protein was measured before the
surgery, at Days 3 and 7. The patients received monitoring of gas
exchange, hemodynamics and cerebral oxygenation. In addition, the
efficacy of "Cellex" and the severity of cognitive dysfunction were
evaluated in operations with cardiopulmonary bypass (CPB).RESULTS. There was no difference between groups in age and
preoperative MoCA score. The duration of surgery and mechanical
ventilation, as well as hemodynamics and cerebral oxymetry data
also did not differ significantly. There was a transient decrease of
cognitive functions at Day 3 after surgery in both groups (p < 0.01).
At Day 7, the MoCA score was still decreased in the control group
(p < 0.003) but returned to baseline in the "Cellex" group; these
effects were more evident after surgery with CPB. The plasma
concentrations of S100b protein at Day 7 after surgery correlated
with baseline MoCA score and PaCO2 during early postoperative
period; intraoperative PaCO2 was also associated with cerebral
oxygenation.
CONCLUSIONS. The perioperative use of "Cellex" can attenuate
cognitive dysfunction after cardiac surgery, especially after
interventions with CPB.
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INTRODUCTION. Most GDT (goal directed therapy) protocols1 are
passive decision support systems where physicians apply a GDT
protocol as seen fit. In passive protocols, reasons for non-adherence
are frequently not immediately obvious. In an active decision-
support system (ADSS) where digital alerts or another person actively
give GDT-based advice to the treating physician, reasons for non-
adherence may be recognised more easily.
OBJECTIVE. The objective of this study was to evaluate the
adherence and feasibility of an active decision-support system that is
based on a GDT protocol.
METHODS. In this prospective trial, 31 patients were included who
underwent major elective vascular surgery except carotid artery
surgery. A study anaesthesiologist was solely dedicated to actively
give GDT-based advice to the anaesthesiologist in charge. The latter
could reject the advice by indicating a clinically justified reason. The
GDT protocol determined the need for fluid, vasoactive drugs and
inotropes in series based on individualized optimal stroke volume
variation (SVV), mean arterial pressure (MAP), and cardiac output
(CO). SVV and CO were measured with a LiDCO rapid® device.
RESULTS. Median (IQR) duration of use of the ADSS given as
percentage of length of surgery was 100% (94-100%). During ADSS
the anaesthesiologist in charge followed the ADSS advice in 634 out
of 743 (85%) interventions. Reasons for non-adherence were either
inadequate time to assess the action of given drugs or artificially in-
creased SVV (1%), foreseen or unexpected surgical conditions (2%),
orders of a senior physician (2%), dobutamine-induced ST-segment
changes (2%), or unstable haemodynamics (6%). Adaptation of either
too low or too high individualized goals for MAP and CO were neces-
sary in five patients prior to ADSS use.
CONCLUSIONS. The majority of interventions occurred according to
the ADSS. Surgical conditions, haemodynamic changes and inherent
limitations of SVV were reasons for non-conformity.
REFERENCE(S)
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INTRODUCTION. Nowadays, the proportion of patients with
underlying comorbidities who underwent cardiac surgery (CS) is
higher. Those suffer more frequently from prolonged ICU length of
stay after CS (PICULOS), which leads to more complications and
worst outcomes.
OBJECTIVES. To evaluate the risk factors associated with PICULOS
and outcomes of this group of patients who underwent CS.
METHODS. Prospective, observational study in our Surgical ICU in a
tertiary-level university hospital. PICULOS was defined the need of
>72h of ICU stay following CS. A complete follow-up during 4.6 ± 2.4
years was performed in 2840 patients.
RESULTS. 2939 patients were included. Mean age was 64.6 ± 11.6
years; 67% (n = 1880) were male; Body Mass Index: 28 ± 4.3Kg · m−2.
66.3% (n = 1950) experienced PICULOS.
In our population, we showed that a high chest drain loss during the
first 12h after procedure (OR: 1.002; 95% IC:1.001-1.003; P = 0.001), a
low preoperative hemoglobin (OR: 0.762; 95% IC:0.659-0.881;
P < 0.001), and a lower arterial partial pressure of O2 and fraction of
inspired oxygen ratio (PaO2/FiO2) 24h after CS (OR: 0.996; 95%
IC:0.992-0.999; P = 0.02) were variables associated with PICULOS.
Regarding outcomes, we showed higher mean hospital stay (OR:
1.025; 95% IC:1.010-1.039; P = 0.001), higher mechanical ventilation
needs (OR: 1.054; 95% IC:1.037-1.072; P < 0.001), higher pacemaker
needs (OR: 7.698; 95% IC:1.315-45.056; P < 0.001) and higher
mortality (OR: 16.846; 95% IC:4.593-61.787; P < 0.001).
Subgroups of patients with PICULOS showed worst survival during
hospital stay (93.4% vs. 95.2%; P = 0.035) and from the long-term
mortality scenario (80.3% vs. 87.7%; P < 0.001).
CONCLUSIONS. Patients who experienced PICULOS suffer from
higher mortality in our population, even in the long-term scenario.
Lower levels of preoperative hemoglobin and PaO2/FiO2 24h after
CS, and higher chest drain losses were variables associated with
PICULOS.
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Intensive Care Medicine Experimental 2017, 5(Suppl 2):0565INTRODUCTION. Classic disoxia markers, such as central venous
saturation (Svc02) and lactate (Lac) have been questioned
throughout in the last years because they might not be adequate to
predict tissue disoxia in certain situations. Venous-arterial CO2 deriva-
tives (ΔpCO2, ΔpCO2/ΔO2content) have been proposed as global
markers of the adequacy of perfusion and O2 utilization in shock. In
lastest studies, Haldane effect has been taken in account, so the ratio
between CO2 and O2 contents is proposed as more accurate. These
CO2 derivatives are intensively studied in sepsis, but there are lack of
studies concerning cardiac surgery.
OBJECTIVE. Compare the adequacy of CO2-derived variables with
Svc02 and Lac during the first 12 hs after an elective cardiac surgery
as markers of perfusion. The calculated sample is 150 patients. These
are preliminary results.
METHODS. Prospective, observational study; following a cohort of
adults who underwent cardiac surgery and were admitted in a 16-
bed cardiac ICU. Informed consent was obtained from the next-of-
keen or by the patient after extubation.
Previous history of renal and hepatic disease were recorded as well
as type or surgery and surgical times. Central venous and arterial
gases were analyzed at ICU admission, 6 hs and 12 hs later, as well
as, hemoglobin, creatinine, lactate, total bilirrubin and hemodynamic
variables. Fluid balance was also collected. Normally distributed data
were expressed as the mean ± standard deviation (SD) unless
otherwise specifed. Quantitative variables were compared using non-
parametric tests. Qualitative variables were compared with chi square
or Fisher's tests. p < 0,05 was considered significant.
RESULTS. 22 patients were analyzed. 13 were male (59,1%). Mean
age was 66,7 years (SD ± 12,77). Four patients had previous renal
disease (18,2%) but none of them had hepatic disease. Type of
surgery: valvular (11), CABG (5), CABG + valvular (4) and aortic root
(2). EuroScore II was 1,63 (IQR 0,92-2,44) and admission CASUS 3
(1,75-5). CPB was used in 18 surgeries (81,8%): CPB time was 101 min
(SD ± 51,64) and cross clamp time 78 min (SD ± 36,31). Fluid balance
at 12 hs was 578 ml (IQR −55-928).
4 patients (18,2%) were ventilated and 8 (36,4%) treated with
vasoactive drugs >12 hs. ΔSvc02 0–12 hs is not statistically correlated
with CO2 measured variables. Changes in Lac are not correlated with
changes in Scv (correlation −0,274, p 0,21) and ΔpCO2 (−0,36, p
0,093) ; they are inversely correlated when O2 content is analyzed:
ΔCCO2/ΔCO2 (−0,618, p 0,004) and ΔpCO2/ΔC02 (−0,55, p 0,007).
12hs-fluid balance was correlated with ΔCCO2/ΔCO2 (0,598, p 0,005)
and ΔpCO2/ΔC02 (0,482 p 0,023) but not to ΔpCO2 (0,318, p 0,15),
ΔLac (−0,514, p 0,14) and ΔSvc (0,162, p 0,47).
CONCLUSION. These preliminary results show that, after cardiac
surgery, CO2 derivatives that analyzed CO2 consumption are related
with more fluid requirements although they might not correlate with
disoxia (using lactate as a standard marker).
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INTRODUCTION. There are many institutions in which the pulmonary
artery catheter (PAC) is blindly inserted with reference to the
pressure waveform. However, occasionally, position abnormality or
aberration may be caused, possibly requiring an unexpectedly long
time for insertion and causing iatrogenic complications such as
severe arrhythmia or pulmonary artery injury. In our hospital, in
order to insert the PAC safely and surely, from June 28th, 2016, in
principle, insertions are all performed under X-ray fluoroscopy. The
fluoroscopic device is installed and operated by a radiological
technician.
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 289 of 542OBJECTIVES. We examined the influence and safety of PAC insertion
under X-ray fluoroscopy on the time of general anesthesia induction
(from the start of anesthesia to the start of surgery) retrospectively.
METHODS. Adult cardiovascular surgical cases in which PAC was
inserted at the time of induction of general anesthesia were
investigated at our hospital between January 1st and October 31st,
2016. We divided the cases into the former group and the latter
group before and after the principle of fluoroscopic use (June 28th,
2016). We analyzed electronic records and anesthesia records
retrospectively, and extracted the anesthesia induction time and
complications. As they influence anesthesia induction time, cases of
one-lung ventilation, multiple arterial pressure measurement, and
intra-aortic balloon pumping insertion during the induction of
anesthesia were excluded.
RESULTS. There were 98 cases in the former group and 56 cases in
the latter group. The number of cases used for comparing the
anesthesia induction time was 64 cases in the former group and 41
cases in the latter group. The anesthesia induction time [minutes]
[median (interquartile range)] was 80 (72–91) in the former group
and 86 (78–93) in the latter group (Mann–Whitney U test, p = 0.26).
Complications in the former group were observed in 2 cases (loop
formation 1 case and pulmonary artery injury 1 case), but none were
observed in the latter group.
DISCUSSION. Position confirmation of PAC by transesophageal
echocardiography and echo operation are difficult for an
anesthesiologist to perform alone. Although X-ray fluoroscopy takes
time to set up and cooperation with a radiological technician is ne-
cessary, it is possible to check the position of the endotracheal tube
and central venous catheter, as well as whether there is pneumo-
thorax or hemothorax at the same time. Furthermore cardiologists
generally insert PAC under fluoroscopy during percutaneous coron-
ary intervention. Hybrid operating rooms are more common and
fluoroscopy can be used easily by anesthesiologists and the use of
that can contribute to the safety.
CONCLUSIONS. We suggest that PAC insertion under fluoroscopy
can be performed safely without affecting the anesthesia
introduction time.
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INTRODUCTION. In pediatric cardiac patients, various setting of
congenital heart disease is well studied to show the relationship
between BNP and heart failure. However, we still need discuss the
utility of BNP in children during postoperative period because we do
not have strong evidence.
OBJECTIVE. We conducted a prospective multicenter observational
study to investigate the recent consideration of Japanese pediatric
cardiac intensivists how to use BNP for postoperative management
in pediatric cardiac intensive care unit.
METHODS. Study period: From August 21st 2015 to July 31st 2016.Study site: Six tertiary teaching hospitals in Japan.
Study population: Children under 15 years old who underwent
pediatric cardiac surgery.
BNP measurement: All BNP measurement for postoperative patients
was prospectively collected in PICU. We checked how often did we
measure BNP concentration postoperatively. Then we checked
whether each BNP measurement was used for the decision-making
of intervention or not. The intervention for patients on the strength
of BNP was defined as follows: 1 inotropic support, 2 ventilator set-
ting, 3 respiratory support device (NIPPV, HFNC), 4 others. To investi-
gate the frequency of postoperative BNP measurement and
intervention threshold of BNP we divided each BNP measurement
into 4 groups: A 0–299 pg/ml (reference), B 300–999 pg/ml, C 1000–
1999 pg/ml, D >2000 pg/ml.
Statistical analysis: Logistic regression analysis was performed to
compare the intervention ratio between A (reference) and B, C, D.
We also did multiple comparison analysis to compare intervention
ratio in each group.
RESULTS. 246 BNP measurements for 353 patients were included in
this study. Thirty six (15.9%) measurements were used as a criterion
to decide to intervene children. The number of BNP measurements
in each group is as follows: A 113 (45.9%), B 81 (32.9%), C 45 (18.3%),
D 7 (2.8%). The intervention ratio in each group was 4.4% (A, 5/113),
8.6% (B, 7/81), 44.4% (C, 20/45), and 71.4% (D, 5/7). The intervention
ratio of C and D were significantly higher than A (reference): (Odds
ratio (95%CI) 12.1(4.8-33.9),p < 0.0001, 25.2(5.2-146.2),p < 0.0001).
The relationship of the intervention ratio in each group from the
result of multiple comparison is similar to logistic regression analysis;
the intervention ratio of C and D compared to A (p < 0.0001).
CONCLUSIONS. BNP was not measured regularly for postoperative
pediatric cardiac patients. High BNP concentration measured in PICU
especially more than 1000pg/ml were frequently considered as a
good sign for intervening children compared to that of less than
1000pg/ml.Further study should be conducted to investigate
whether BNP guide therapy for postoperative pediatric cardiac
patients may improve patient's prognosis or not.
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INTRODUCTION. Central venous catheters (CVCs) are required in
much major thoracic operation. The use of ultrasound guidance
during CVC placement can use to improve patient safety. However,
serious complications may also occur due to catheter tip malposition.
Our study aims to assess CVC placement and the malposition ratios
in cases that underwent pulmonary resection.
METHOD. CVC placement was retrospectively examined in the
patients who underwent pulmonary resection between 2012 and
2016. The 2nd intercostal space-carina (C2-carina), carina-catheter tip
(carina-tip), clavicular notch-carina (notch-carina) and clavicular
notch-catheter tip (notch-tip) distances were measured in the post-
operative lung graphs. Zone A, upper right atrium and lower superior
vena cava (SVC) and Zone B, upper SVC and junction of the right in-
nominate vein(1). The tip of catheter positioned below the carina
was evaluated as Zone C (in the right atrium), whereas the position-
ing of a catheter outside the superior vena cava was considered a
malposition.
RESULTS. Of 234 patients, 103 had the catheter tip on Zone A, 85 on
Zone B, and 27 on Zone C, whereas the malposition number was 19
(8.11%). When the patients were divided into two groups as < 165
Fig. 200 (Abstract 0569). Trajectories of eGFR
Fig. 201 (Abstract 0569). Long-term renal function in AKI patients
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 290 of 542cm (short, n = 109) and >165 cm (tall, n = 125) by their height, the
carina-tip and notch-tip distances were greater, but the carina-notch
distance was smaller in short patients. The Zone 0 patients and mal-
position were also higher in short patients (15 vs 4). The most place-
ment of malposition was right subclavian vein.
CONCLUSION. The malposition ratio is 7% in the literature and may
be related to vascular structural deformity, obesity, malignity and
postural changes (2). Larger diameters at the brachiocephalic vein
due to malignancy, besides mediastinal displacement because of
lateral position, the short carina-notch distance may also cause the
misplacement of the right internal jugular CVC in patients with lung
resection.
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OBJECTIVE. Worsening of estimated glomerular filtration rate (eGFR)
is associated with a higher risk of end stage renal disease (ESRD) and
increased mortality. However, little is known about the long-term
patterns of change in eGFR, particularly in critically ill patients with
acute kidney injury (AKI). In a recent study, we elucidated the hetero-
geneity of these patients and identified four distinct trajectories of
eGFR. In this study, we extended our analysis to explore dialysis free
survival rates among these four groups.
METHODS. We studied 1,223 patients (60% males) who were
admitted to a multi-disciplinary ICU in a University Hospital between
2004–2008 and discharged from hospital alive, and collected follow-
up data up to June 2016. The eGFR was obtained at 6 months, then
annually up to 7 years after hospital discharge with 1223 patients re-
cording at least 2 eGFR measuremnts anda subgroup of 427 patients
with at least four. Trajectories of eGFR were identified using group
based trajectory modelling (GBTM).1 The rate of dialysis free survival
was examined using Kaplan-Meier estimates, and hazards ratios (HRs)
were calculated from multivariable Cox regression models, using
Stata (14.0).
RESULTS. Four patterns of eGFR were identified: Persistently low (PL)
11.3% of patients; Rapidly increasing (RI) 2.2%; Persistently moderate
(PM), 81.7% and Rapidly dropping (RD) 4.8%. (Fig. 200)
The 4 groups differed in clinical and demographic characteristics.
The risk of death or dialysis was significantly higher in the PL group,
used as a reference. The HRs within 7 years of hospital discharge,
adjusting for age, gender and pre-existing chronic conditions, were:
0.28 (95% CI: 0.12 to 0.65); 0.35 (95% CI: 0.27 to 0.46) and 0.61 (95%
CI: 0.40 to 0.95), and P values were: 0.003, < 0.001, and 0.029, for the
3 trajectories RI, PM and RD respectively, compared to the reference
(HR = 1.0). Results in the subgroup of 427 patients were consistent
with those in the full sample, with slight differences in magnitudes
but not in significance. The median eGFRs over 7 years of hospital
discharge were higher for patients with no AKI, and lowest for those
with maximum AKI stage III (Fig. 201)
CONCLUSIONS. Recognition of the heterogeneity of patterns of
eGFR, and the mortality risk associated with each, is useful for the
application of cost effective personalized long term management of
AKI survivors after ICU discharge.REFERENCE
1. Nagin DS, Odgers CL. Group-based trajectory modeling in clinical
research. Annual review of clinical psychology. 2010;6:109–138
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INTRODUCTION. Acute kidney injury (AKI) represents a public health
problem associated with high rates of morbidity and mortality
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 291 of 542among critically ill patients, along with considerable short- and long-
term clinical consequences. AKI survivors are at increased risk of de-
veloping acute kidney disease (AKD), chronic kidney disease (CKD)
and end-stage renal disease (ESRD).
OBJECTIVES. To describe the clinical characteristics, complications,
short- and long-term outcomes (up to 5 years of follow-up) of critic-
ally ill patients with AKI.
METHODS. A prospective observational cohort study from January
2011 to January 2016 was performed, which included 370 patients
with AKI at or during admission in the intensive care unit (ICU) of
Bellvitge University Hospital, in Barcelona, Spain. Clinical data,
comorbidities and long-term outcomes [incidence of CKD, as stated
by Kidney Disease Improving Global Outcomes (KDIGO) guideline cri-
teria, requirement of renal replacement therapy (RRT) and mortality]
were assessed at 6 months, 2 years and 5 years after a single AKI epi-
sode. We performed a binary logistic regression model with an ad-
justed analysis of risk factors for long-term RRT dependence. 11
patients were lost during the follow-up period.
RESULTS. Mean age was 58 ± 16 years; 65% of patients were men.
One-hundred and twenty-three patients (34.6%) did not require RRT
during ICU stay. Among survivors (174 patients), 39.1% (68 patients)
presented CKD stage 3 or more according to KDIGO criteria and 22
patients (12.6%) required RRT at 5 years of follow-up. Independent
risk factors associated with long-term RRT requirement were a de-
creased renal function (measured in terms of serum creatinine) at
baseline and at hospital discharge. Overall 5-year mortality was
34.8% after hospital discharge.
CONCLUSIONS. Long-term morbidity and mortality of patients pre-
senting with AKI are high. Risk factors associated with long-term RRT
dependence were an elevated baseline serum creatinine and ele-
vated creatinine at hospital discharge.
REFERENCE(S)
Chawla LS, Bellomo R, Bihorac A, Goldstein SL, Siew ED, Bagshaw SM,
et al. Acute Disease Quality Initiative Workgroup 16. Acute kidney
disease and renal recovery: consensus report of the Acute Disease
Quality Initiative (ADQI) 16 Workgroup. Nat Rev Nephrol 2017
Apr;13(4):241–257.
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INTRODUCTION. Perioperative AKI is associated with significant
morbidity and mortality1. Albuminuria has recently been recognized
as a significant risk factor for AKI, even when estimated Glomerular
Filtration Rate (eGFR) is >90 mL/min/1.73 m2 2. Moreover, only one
clinical AKI prediction model, the AKI Risk Index, has been developed
for the general surgery population3. While several predictive markers
for AKI have been proposed in the non-cardiac surgery population4,
preoperative albuminuria has not been studied in this context.
OBJECTIVES. The aim of this observational study was the evaluation
of the AKI Risk Index, as well as preoperative albuminuria as AKI
predictors in a cohort of non-cardiac surgery patients.
METHODS. 61 major surgery patients without CKD stage IV or V
were studied. AKI was defined according to AKIN criteria within 48
hrs after surgery5. The AKI Risk Index (which includes nine risk
factors: age ≥ 56yrs, male sex, congestive heart failure, hypertension,
diabetes, ascites, serum creatinine > 1.2mg/dl, emergency and
intraperitoneal surgery) was calculated for each patient, with one
point being assigned to each risk factor. At pre-defined time points(preoperatively, recovery room and on postoperative days 1 to 7) the
following markers were measured: Serum creatinine, cystatine C,
urine albumin and creatinine, whereas eGFR (using the CKD-EPI Cre-
atinine Equation)6 and urine albumin to creatinine ratio (UACR) were
calculated. An eGFR < 90ml/min/m2 and a UACR value ≥ 30mg/g
were considered abnormal.
RESULTS. 11 patients (18%) developed AKI. While there was no
difference in preoperative eGFR between AKI and non-AKI patients
(75.3 ± 16 vs 83.9 ± 15.2 ml/min/m2, p = 0.09), recovery room eGFR
was already lower in AKI patients (mean: 69.5 ± 18.7 vs 85.7 ± 15.6
ml/min/m2, p = 0.001) and remained significantly lower until day 7. A
significantly higher mean AKI Risk Index score was observed in AKI
versus non-AKI patients (4.36 vs 3.48, p = 0.02). On multivariate re-
gression analysis each point in AKI Risk Index score increase was as-
sociated with a higher OR (2.01, 95% CI: 1.07-3.77, p = 0.03) for AKI,
while an abnormal pre-op UACR was also strongly associated with
AKI development (OR = 5.47, 95% CI:1.36-21.92, p = 0.019).
CONCLUSIONS. In a general surgery population the AKI Risk Index
proved to be a simple yet powerful predictive tool for perioperative
renal dysfunction. Furthermore, an abnormal preoperative UACR was
strongly associated with postoperative AKI development, regardless
of baseline eGFR and other comorbidities. Being based on readily
available data, the AKI Risk Index and the UACR should be
considered part of a routine preoperative patient evaluation.
REFERENCE(S)
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4. Schley G et al.: PLoS One 2015;10(12): e0145042
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INTRODUCTION AND OBJECTIVES. Acute kidney injury (AKI) is a
known detrimental complication in patients with cirrhosis. Currently,
there are no studies evaluating AKI and the impact of extra-renal
organ failures (E-OF) on the course of AKI and outcome in critically ill
cirrhotics.We addressed this question in a large prospective cohort of
cirrhotics admitted to Liver intensive-care.
METHODS. Patients were prospectively followed from admission until
death, recovery or liver transplant for prevalence, development and
progression of AKI and it's association with extra-renal organ failures (E-
OF) (i.e. cerebral failure, circulatory failure and respiratory failure). Binary
logistic regression models using multivariate repeated measures Gener-
alised Estimating Equations (GEE) were used to identify significant vari-
ables associated with AKI progression at day 7. Cox-regression analysis
was done to identify predictors of 28-day mortality.
RESULTS. A total of 291 patients with cirrhosis, aged 48. ± 11years,
87% males, with mean MELD of 30.1 ± 8.4; SOFA score of 11.6 ± 4.5
were included of which only 145(49.8%) were alive at 1 month. AKI
at admission was present in 194(67%), (Stage I:II:III in 21%:29%:50%
respectively); 244 patients (84%) had at least one E-OF. At day 7, 49%
had AKI progression with peak AKIN stage III:II:I in 66%: 25%:9%
respectively. Presence of any E-OF was strongly associated with pro-
gression of AKI (p = 0.002, OR 3.99, 95%CI 1.6-9.8). This risk further in-
creased with increase in the number of E-OFs (p < 0.001,OR 1.8, 95%CI
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 292 of 5421.4-2.4). Further, AKI at admission alone was not associated with mortal-
ity, but predicted mortality together with any E-OF (p = 0.02, OR 1.9,
95%CI 1.12-3.4). On multivariate analysis using GEE model, number of
extrarenal organ failures (OR 1.67, 95% CI 1.32-2.14), increasing serum
bilirubin (OR 1.05, 95% CI 1.02-1.08), declining urine output (OR 0.98,
95% CI 0.97-0.99) and increase in the components of SIRS (OR 2.5, 95%
CI 1.2-4.8) predicted AKI progression at day 7.
CONCLUSION. Extra-renal organ failures are commonly associated
with AKI in critically ill patients with cirrhosis which determine pro-
gression of AKI as well as mortality. Presence of AKI alone is not asso-
ciated with worse outcome in critically ill cirrhotics.Table 148 (Abstract 0574). Baseline characteristics
Development Validation
All
Patients
No AKI AKI 1-3 p AKI
vs No
AKI
All
Patients
No AKI AKI 1-3 p AKI
vs No
AKI
Number 830
(100%)
667
(80.4%)
163
(19.6%)
- 564
(100%)
466
(82.6%)
98
(17.4%)
-
Age (y) 42 (24-
50)
40 (27-
54)
50 (32-
66)
0.4 41 (27-
58)
40 (25-
56)
52 (33-
71)
<0.001
Male
Sex
676
(81.4%)
539
(80.8%)
137
(84.0%)
<0.001 437
(77.5%)
361
(77.5%)
76
(77.6%)
1.00573
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INTRODUCTION. Solid cancer in many instances has become a
chronic disease process. When cancer patients are admitted to the
ICU because of reversible complications the prognosis is not
necessarily worse than in other patients groups.
OBJECTIVE. In a large group of ICU patients we assessed how a
complicating acute kidney injury (AKI) requiring renal replacement
therapy (RRT) affects outcome in this especially vulnerable patient
group.
METHODS. In a retrospective analysis of a prospectively collected
data base of 165,848 patients from 151 Austrian intensive care units
(ICUs) 20,689 patients with solid cancer were identified of whom 996
patients had AKI requiring RRT (AKI-3). Impact of AKI on prognosis
was assessed and results were adjusted for severity of disease, age,
sex and other acute and chronic comorbidities.
MAIN RESULTS. ICU patients with solid cancer were older but had a
comparable severity of disease, need of mechanical ventilation,
length of ICU stay and ICU/ hospital mortality (10.28/ 16.81 vs. 9.99/
14.53%). Cancer patients with AKI versus patients without AKI had a
much higher severity of disease, requirement of mechanical
ventilation and an increased ICU/ hospital mortality (49.05/ 59.24%
vs. 8.32/ 14.67%, p < 0.001). Moreover, mortality was much higher in
cancer than in non-cancer ICU patients with AKI (49.05/ 59.24% vs.
36.60/ 45.52%, p < 0.001).
CONCLUSIONS. Cancer patients in the ICU have a comparable
survival as other patients groups but have much worse prognosis
when developing AKI requiring RRT during their ICU stay. Survival of
these patients is much lower than in other ICU patients with AKI.
Nevertheless, diagnosis of cancer per se does not justify withholding
RRT in these patients, a decision which must be based on a
thorough individual assessment.New
Injury
Severity
Score
34 (24-
50)
34 (22-
50)
34 (25-
50)
0.66 34 (22-
50)
34 (21-
50)
43 (29-
57)
<0.001
Hospital
LOS (d)
19 (8-
39)
18 (8-
38)
21 (8-
45)
0.32 15 (7-
32)
15 (7-
31)
19 (7-
37)
0.44
Mortality 156
(18.8%)
103
(15.4%)
53
(32.5%)
<0.001 103
(18.3%)
63
(13.5%)
40
(40.8%)
<0.001
RRT 42
(5.1%)
- 42
(25.8%)
- 25
(4.4%)
- 25
(25.5%)
-
Median (IQR) or Number (%). Wilcoxon or Fisher’s Tests0574
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Intensive Care Medicine Experimental 2017, 5(Suppl 2):0574BACKGROUND. Acute Kidney Injury (AKI) complicating major trauma is
associated with mortality and prolonged hospitalization. Trauma-
associated AKI has specific risk factors and predictable timing of injury
making diagnostic prediction of AKI for targeted intervention attractive.
OBJECTIVES. To develop and test risk prediction models for AKI after
major trauma based on data close to ICU admission.
METHODS. In a single centre, retrospective observational study we
studied major trauma ICU admissions who survived for at least 24h
after ICU admission excluding patients with advanced renal
impairment at hospital admission (creatinine > 356μmol/L). We
defined a development cohort admitted from February 2012 to Oct
2014 and a validation cohort admitted Nov 2014 to May 2016. AKI
was defined by KDIGO creatinine criteria in the first 7 days or need
for Renal replacement therapy (RRT). For predictive modelling, we
considered demographics, injury severity, observations, blood
transfusion, first blood results and ICD-10 comorbidities. Missing
values were handled by simultaneous transformation and single im-
putation. To avoid over-fitting we use hierarchical clustering and
principal component analysis for data-reduction. We then used back-
ward variable selection to develop final logistic regression models.
Model performance was assessed by the c-statistic in the develop-
ment and validation datasets.
RESULTS. We identified 830 patients for development and 564 for
validation, AKI occurred in 19.6% and 17.4% respectively, with ~5%
receiving RRT (Table 148). Models predicting need for RRT and all AKI
were developed and validated (Table 149). First serum creatinine,
first serum phosphate, units of packed reds cells transfused in the
first 24h after injury, age and Charlson comorbidity score were found
to be predictive of AKI. A model predicting need for RRT had a c-
statistic of 0.92 (95%CI 0.88-0.96) in the development cohort and
0.91 in the validation group (Fig. 202). However even with apparently
excellent discrimination, positive predictive value for RRT at the opti-
mal cutoff was only 22% in both groups, as need for RRT was rare
overall. A model predicting all AKI performed less well, c-statistic 0.77
(0.72-0.81), and was worse in validation (c-stat: 0.70, 0.64-0.77).
CONCLUSIONS. Risk prediction modelling has demonstrated that
age, first values of serum creatinine and phosphate, and need for
major blood transfusion are associated with development of AKI and
need for RRT after trauma. Interestingly, variables such as injury
severity and serum creatine kinase did not appear in our final
models, potentially because other variables such as transfusion and
serum phosphate were better measures of underlying severity of
injury and muscle damage. However, even with apparently excellent
model performance, ability to predict need for a rare intervention
such as RRT was limited.
Table 149 (Abstract 0574). Predictive Models for AKI and RRT
Model for RRT Model for all AKI
Odds Ratio p Odds Ratio p
Age (y) 1.031 0.0007 1.020 0.0001
First Phosphate (mmol/L) 4.56 <0.0001 2.19 0.0002
First Creatinine (μmol/L) 1.009 0.027 1.008 0.0017
Packed cells in first 24h
(Units)
1.121 0.0007 1.085 <0.0001
Charleston Index 1-2 (Ref 0) Not retained in model 2.36 0.0002
Charleston Index ≥3 (Ref 0) Not retained in model 2.92 0.0066
Development c-statistic 0.92 (0.88-
0.96)
<0.0001 0.77 (0.72-
0.81)
<0.0001
Validation c-statistic 0.91 (0.86-
0.97)
<0.0001 0.70 (0.64-
0.77)
<0.0001
Fig. 202 (Abstract 0574). ROC curve analysis for RRT prediction model
Table 150 (Abstract 0575). Demographic characteristics
Male gender, n (%) 34/55 (61,8%)
Median age (years) 73 [39-93]
Median BMI (kg/m^2) 26,1 [17,3-52,2]
ICU/IMCU stay (days) 12 [1-112]
Total duration of hospitalization (days) 16 [1-112]
Median SAPS 2 score at admission 45 [13-97]
Median SOFA score at admission 7 [2-15]
Table 151 (Abstract 0575). Comorbidities
Cardiovascular, n (%) 39/55 (70,9%)
Diabetes, n (%) 14/55 (25,5%)
COPD-Asthma, n (%) 28/55 (50,9%)
Tumors, n (%) 8/55 (14,55%)
CKD, n (%) 12/55 (21,8%)
Tobacco, n (%) 20/55 (36,4%)
Cirrhosis, n (%) 11/55 (20%)
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INTRODUCTION. Acute kidney injury (AKI) is a recurring finding in
critically ill patients and is linked to some short and long-term ad-
verse outcomes.Contextually, Streptococcus pneumoniae (SP) infec-
tions can be associated with an increased risk of AKI1even if, as far as
we know, this relationship has been not extensively analysed in crit-
ically ill patients yet.
OBJECTIVES. We hypothesized that SP infections could be
significantly associated with an high incidence of AKI in critically ill
patients. We analysed mortality rates, Intensive Care Unit (ICU)/Intermediate Care Unit (IMCU) stays and the different factors that
could have facilitated AKI onset during SP infections.
METHODS. We reviewed all patients admitted in our ICU and/or
IMCU from June 2014 to December 2016 (21 months). The inclusion
criteria were age ≥ 18 y.o; positive microbiological samples (urinary
antigen; endotracheal aspirate with a bacterial count ≥ 106 CFU/mL;
broncho-alveolar lavage with a bacterial count ≥ 104 CFU/mL; blood
culture; pleural culture or cerebro-spinal fluid culture).The exclusion
criteria were: patients with bronchitis, aspiration pneumonia or with
non-pneumococcal infections. KDIGO criteria were used to classify
AKI. We also analysed two subgroups: patients with AKI and patients
without AKI.
RESULTS. 55 patients respected inclusion criteria. Demographic
characteristics and comorbidities are shown in Tables 150 and 151.
The main causes of admission were : acute respiratory failure in 53/
55 patients (96,4%) and circulatory failure in 19/55 patients
(34,6%).We collected different kinds of positive microbiological
samples: 27 urinary antigen, 24 endotracheal aspirates, 4 broncho-
alveolar lavage, 1 pleural fluid culture, and 1 cerebro-spinal fluid cul-
ture. 11/55 patients (20.0%) had SP bacteraemia. AKI occurred in 22/
55 patients (40%): stage 1 in 10/22 patients (45,5%) ; stage 2 in 8/22
patients (36,4%); stage 3 in 4 patients (18,2%). No patient needed
any renal replacement therapy. A compromised renal function per-
sisted at discharge in 2 patients (3,6%). All of AKI patients showed
mortality rates (see Fig. 203) and ICU/IMCU stays (17 days [1–112] vs
7.7 [1–37], p value: 0.02) significantly higher compared to no AKI
patients. Chronic kidney disease (CKD) and circulatory failure at
admission were significantly related to AKI onset (see Table 152). No
difference was found in two groups about SAPS 2, the use of
iodinated contrast media, aminoglycosides, glycopeptides, ACEi/
sartans, colistin.
CONCLUSIONS. AKI is a recurring complication in critically ill patients
with SP infection. Patients with AKI show higher mortality rates and
more prolonged ICU/IMCU stay compared to no AKI patients. CKD
and circulatory failure are significantly related to AKI onset during SP
infections.
REFERENCE(S)
1) Mongardon N et al. Epidemiology and outcome of severe
pneumococcal pneumonia admitted to intensive care unit: a
multicenter study. Critical Care 2012;16(4):R155.
Fig. 203 (Abstract 0575). Mortality rate
Table 152 (Abstract 0575). Factors associated to AKI onset
Patients with AKI Patients without AKI p value
CKD, n. of patients 8/22 4/33 0,03*
Circulatory failure, n. of patients 12/22 7/33 0,01*
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INTRODUCTION. Mortality and morbidity from cardiac arrest are
high. Subsequent shock and tissue ischemia effects are associated
with worse outcome. Acute kidney injury (AKI) has been identified
like predictor of increased mortality.
OBJECTIVES. Our aim was to evaluate the prevalence of acute kidney
injury (AKI) and identifying risk factors and clinical course in out-of-
hospital cardiac arrest.
METHODS. We conducted a retrospective, observational and
descriptive study analyzing all out-of-hospital cardiac arrest patients
admitted our unit, from Jan 2012 to March 2016. AKI was defined as
KDIGO criteria. Demographics, comorbidities, cardiac arrest condi-
tions and ICU interventions were collected. The results are expressed
as mean, median or percentage.
RESULTS. 95 patients were included, 64,2% were male, mean age
65,3 years old, average admission APACHE II score was 32. An initial
shockable rhythm was in 55,8% of patients and hypothermia is
achieved in 57 (60%). 25 patients (26,3%) developed AKI. 8 of whom
(32%) presented AKI stage 3, requiring renal replacement therapy 3
cases. 6 patients suffered chronic renal disease previously. Between
AKI group and non-AKI group there are not significant differences in
comorbidities as COPD, cardiopathy, oncologic diseases or drugs
abuse. Longer duration of cardiac arrest, initial higher lactate, initial
decreased Ph, lower bicarbonate and increased transaminases were
independent predictors of AKI development as well as norepineph-
rine and dobutamine postarrest administration. History of pre-arrest
renal insufficiency was significantly more common in AKI vs. non-AKI
patients (1,5% vs 25%; p < 0,05). However, no independent associ-
ation was between AKI and diagnostic or therapeutic coronary
catheterization and hypothermia. ICU stay (9,4 vs 5,9 days), and hos-
pital mortality were significantly higher in AKI group (p < 0,05).
CONCLUSIONS. Post-cardiac arrest AKI occurs in more than 25% of
patients. AKI is not influenced by the initial rhythm. These patients
have higher severity of shock and more serious hypoperfusion
markers and therefore are associated with increased acute renal fail-
ure and ICU and hospital mortality.0577
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INTRODUCTION. Many factors are involved in the prognosis of
trauma patients. Acute kidney injury (AKI) is one of the most
threatening complications because of its high association with bad
outcomes, increasing morbid mortality, length of stay in ICU (LOS)
and higher treatment costs.These patients are exposed to multiple
injuries such as shock, rhabdomyolysis, abdominal hypertension and
administration of IV contrast, which make them vulnerable to
developing AKI. In this study we describe the incidence and
outcomes of patients with trauma related AKI who were managed in
the Trauma Intensive Care Unit.
OBJECTIVES. To identify the incidence and outcomes of patients
with trauma related acute kidney injury (AKI), as defined by KDIGO
criteria, at a single level I trauma center in Santa Fe, Argentina.
METHODS. We performed a retrospective study of 611 trauma
patients admitted to the Hospital Cullen intensive care unit from
January 2014 to January 2016. The trauma unit database (Hardinero
Q) was used to retrieve patient data for this analysis. We collected
patient demographics: age, sex and injury severity score (ISS).
We conducted multivariable logistic regression to identity
independent predictors for AKI and mortality. In the mortality
prediction model we evaluated the following risk factors: age,
mechanism of injury (blunt vs. penetrating) or traumatic brain injury
(TBI), BMI, hematocrit on admission and AKI.
RESULTS. The overall incidence of AKI was 19.5% (n = 119), ICU LOS
in non AKI 14 days vs 21 days in AKI. Mean ISS was 23 and mean
age was 37 (SD 15.2) in the AKI group. Overall mortality in the AKI
group was 71% (n = 85) but was significantly lower in the non AKI
group (71% versus 27% P < 0.00001). AKI was an independent
predictor of mortality (OR 11,6 95% CI 4.51-29.82). Hematocrit on
admission was an independent risk factor for AKI. Forty-one patients
(36%) required renal replacement therapy.
CONCLUSIONS. Our findings are similar to other studies where AKI in
trauma patients was an independent risk factor for mortality and LOS
ICU. Renal replacement therapy treatment is high in this group and
represents a significant health care cost burden.
REFERENCE(S)
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259–264
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INTRODUCTION. The dynamic prediction score (DPS) for renal
replacement therapy (RRT) model is a recently validated tool to
predict RRT in acute kidney injury (AKI), however its possible utility
for sepsis, mortality, and need for CRRT are unknown.
OBJECTIVES. To assess the capability of a new model to predict
mortality, CRRT-free days and the need for CRRT in septic patients in
an intensive care unit (UCI).
Fig. 204 (Abstract 0579). See text for description
Fig. 205 (Abstract 0579). See text for description
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patients admitted with diagnosis of sepsis and AKI from august 2014
through august 2016 in a single center in Mexico. Demographic,
clinical, and laboratory data was collected for all patients. We used
the model described by Erdfelder1 et al. for all patients. Primary
outcomes included mortality, median free - CRRT days, and higher
levosimendan-vasoactive-inotropic score (L-VIS)2,3. Statistical ana-
lyses were done in STATA SE 11.0.
RESULTS. Preliminary data from 26 patients were included, mean
age of 68 (SD ± 13) years, 61.54% male. Overall mortality of 42.31%
and need for CRRT in 50% with a global median of CRRT-free days of
10 (IQR 3–14) days. The DPS model was found to be accurate (= > 4
points) for discriminate mortality [AUC = 0.65 (0.43 - 0.86)], fewer
CRRT-free days with a median of 3(IQR2-9) vs.12 (IQR 8–18) days, p
=0.013, the need for CRRT [AUC = 0.70 (0.49 - 0.91)] and risk for CRRT
with HR = 6.46 (95% CI 1.23 -33.9, p = 0.027). Additionally L-VIS
(> = 33 points) was found to be able to discriminate the need for
CRRT [AUC = 0.72 (0.54 - 0.91)] and HR = 8.8 [(95% CI = 1.7 - 46,
(p = 0.009)].
CONCLUSIONS. DPS may be accurate to predict renal outcomes
related to CRRT including need to initiate, survival free days and
mortality in septic patients with AKI, additionally a higher L-VIS pre-
dicted the need for CRRT in this clinical setting.
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INTRODUCTION. Acute Kidney Injury (AKI) is estimated to occur in 7-
18% patients in hospital and approximately in 50% patients admitted
to Intensive Care1. AKI is associated with worse clinical outcomes, in-
creased length of stay (LOS), increased morbidity and mortality that
extend beyond ICU stay1.
OBJECTIVES. In this retrospective analysis we quantify the effect of
developing AKI in ICU on clinically relevant outcomes such as
mortality and ICU and hospital LOS.
METHODS. Using routinely collected data from integrated electronic
health records (EHR - Phillips IntelliVue Clinical Information Portfolio -
ICIP) incorporating laboratory results and hourly observations, we
developed a novel method of interrogating time series of serial
(hourly) weight adjusted urine output measurements and daily
serum creatinine levels to describe the incidence and progression of
acute kidney injury (according to AKIN stage definition2) in our
cohort. Electronic Health Records data from 4000 encounters was
selected. This equates to 3781 patients admitted to ICU for more
than 24 hours during 18 month period in 2015/16. Outcomes
including mortality, length of stay, ICU outcome were collected as
part of routine national audit and the odds risk of outcomes from
AKI were calculated.RESULTS. Developing AKI in ICU increases the risk of mortality by 5
times (Fig. 204: Mortality by AKI Stage). Moreover, patients who do
not develop AKI in ICU are 5 times more likely to have an improved
ICU outcome (Fig. 205: ICU Outcome by AKI Stage). Median ICU
length of stay is 3 days for patients with no AKI vs 8 days for
patients with AKI stage 3.
(Figure 206: Median LOS by AKI Stage).
CONCLUSIONS. To our knowledge this is the first study utilizing the
evaluation of time series of hourly weight adjusted urine output
measurements and daily serum creatinine levels to define AKI score
and progression during ICU stay. Developing AKI in ICU correlates
with adverse ICU outcomes, including a longer ICU and hospital
length of stay, higher risk of mortality and lower chance of improved
outcome upon ICU discharge.
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INTRODUCTION. Acute kidney injury (AKI) is a common and
potentially fatal complication of sepsis. The aim of this study was to
describe the incidence of and its prognostic value within the first 24
hours after the diagnosis of severe sepsis (SS) or septic shock (SSh),
Surviving Sepsis Campaign 2008.
METHODS. Prospective study in a cohort of consecutive septic
adults, hospitalized, from August 2008 to July 2015, in a polyvalent
Intensive Care Unit (ICU). Demographic variables, severity score,
mortality, and renal dysfunction parameters were recorded within
the first 24 hours. Statistical analysis was performed using SPSS 18.0
for Windows (SPSS Inc. Chicago, IL, USA).
RESULTS. We analyzed 741 consecutive septic patients episodes
admitted in the ICU. The median age of the study sample was 64
(inter-quartile range, 51–73) years old; 61.4% were male and 85.5%
had SSh. Chronic renal failure was presented in 7.3% of our serie and
23.1% had diabetes. The main sources of infection were: respiratory
tract 36.2% and intra-abdomen 33.2%. The median length of stay
was 6 [3–14] days, with APACHE II severity score of 24 [20–29] and
SOFA score of 9 [7–11] and mortality was 27.9% (n = 207).
Of our serie, 88.3% presented oliguria and 58.4% creatinine
increased. In the group of patients with SS, 80.3% had oliguria and
52.3% presented pathologic creatinine values vs. 89.7% and 60.1%,
respectively in SSh group, p < 0.05.
The difference in oliguria among those who survived was not
significant 87.4% vs. 90.3%; however, it was in the case of organic
dysfunction according to creatinine values 52.1% vs. 68.3%, p < 0.05.
Non-survivors had significantly higher creatinine values 68.3% vs.
52.1%, however they had no significant higher oliguria 90.3% vs.87.4%. The following table shows the creatinine values and mortality,
chi square = 18.91 p < 0.05.Values Creatinine* Survivors (%)
n = 534Non-survivors (%)
n = 207TOTAL
(%)<0.6 mg/dl 4.3 0.5 3.20.6-1.1 mg/dl 22.3 14.1 19.61.1-1.4 mg/dl 14.6 15.1 13.51.5-1.9 mg/dl 20.2 20 202-3.4 mg/dl 27.5 32.2 28.83.5-4.9 mg/dl 8.1 11.7 9.1>4.9 mg/dl 2.8 6 5.4*Chi square = 18.91 p
<0.05[AKI and Mortality in Sepsis]
CONCLUSIONS. The incidence of AKI is very high in septic patients,
being significantly higher in patients with SSh. Higher values of
creatinine show significantly worse prognosis.
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INTRODUCTION. Acute kidney injury (AKI) is a common condition
occurring in more than half of Intensive Care Unit (ICU) patients
worldwide and is associated with increased mortality and morbidity
that extends beyond ICU stay1. It is a condition clinicians may fail to
diagnose early.
OBJECTIVES. In this study, we use Electronic Health Records (EHR -
Phillips IntelliVue Clinical Information Portfolio -ICIP) to
retrospectively evaluate the incidence and progression of AKI in a
general and cardiac ICU at a large teaching hospital in UK.
METHODS. Using routinely collected data from an integrated EHR
incorporating laboratory results and hourly observations we
developed a novel method of interrogating time series of serial
(hourly) weight adjusted urine output measurements and daily
serum creatinine levels to describe the incidence and progression of
acute kidney injury according to AKI stage using AKIN criteria 2 in
our cohort. EHR data from 4000 encounters was selected. This
equates to 3781 patients admitted to ICU for more than 24 hours
during 18 month period in 2015/16. The prevalence of AKI at ICU
admission, improvement or deterioration in AKI stage during ICU
stay and on ICU discharge were evaluated.
RESULTS. 10% of the population had AKI at ICU admission and 14% had
AKI at discharge. 32.6% developed AKI in ICU. Of these patients, 25%
were discharged with AKI. AKI risk progression is shown in Fig. 207a.
The largest increase in AKI risk occurs between Day 1 and Day 2 of ICU
admission. The proportion of patients with AKI Stage 3 increases from
Day 1 through Day 5. Analysis of AKI stage improvement and
deterioration (Fig. 207b) reveals that most deteriorations occur
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 297 of 542between Day 1 and Day 2. From Day 3 to Day 5 the proportion of
patients improving is more than deteriorating.
CONCLUSIONS. To our knowledge this is the first study utilizing the
evaluation of time series of hourly weight adjusted urine output
measurements and daily serum creatinine levels to define AKI stage
and progression during ICU stay. A significant proportion of ICU
patients develop AKI, although most are discharged with no risk of
AKI. AKI typically manifests on Day 2 of ICU admission and the
largest proportion of patients develop low risk of AKI (Stage 1 AKIN
criteria). This risk is typ ically reduced over the course of ICU stay.
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INTRODUCTION. The Royal College of Physicians developed the use
of NEWS across the UK to help to provide enhanced clinical review
of patients at risk of acute deterioration (1). The six parameters used
in scoring system do not incorporate urine output or other measure
of renal function.
The Acute Kidney Injury Network developed a score designed to observe
changes in creatinine and urine output over a 48 hour period to aid the
identification of acute kidney injury.(3) It is known that even patients with
a mild creatinine elevation have an increased mortality. (2) The AKIN score
is sensitive to smaller changes in creatinine and therefore able to pick up
those early changes which are still associated with a poorer outcome.
OBJECTIVES. The aim of this retrospective study was to assess whether
adding the AKIN score to the NEWS in patients subsequently admittedto ICU could have helped to predict the need for renal replacement
therapy (RRT), organ support and 28 day mortality.
METHODS. Data was collected from ICU admissions at the Royal
Sussex County Hospital, UK. The last NEWS score and creatinine for
each patient prior to ICU admission were obtained. Due to limited
documentation of urine output a decision was made not to include
this. Need for renal replacement therapy, other organ support, and
28 day mortality were recorded. Outcomes of NEWS versus
NEWS + AKIN score were then compared to see whether the
combined score was a better prediction tool for outcomes.
RESULTS. Interestingly 20% of patients with a NEWS score of 0–5
went onto require RRT suggesting NEWS alone is a poor indicator for
need for renal replacement therapy. However, the NEWS + AKIN
score showed a difference of 5% between the lower score group
(score 0–6) compared to the higher score group (score >6). With
regards to 28-day mortality the NEWS score versus the NEWS + AKIN
score showed similar increase between the lower and higher score
groups (increase of 13% in the NEWS group versus 8% in
NEWS + AKIN).
CONCLUSIONS. This study has shown that NEWS + AKIN score may
be a better predictor for need for RRT compared to NEWS alone.
With increasing national focus on identifying and managing AKI as
early as possible, this study highlights the need to regularly review
renal parameters combined with clinical assessment and
haemodynamic markers in the assessment of all acutely unwell
patients. We aim to repeat this study prospectively adding urine
output and creatinine to the NEWS to assess if this is a more
accurate predictor of outcome.
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INTRODUCTION. Critically ill patients with acute kidney injury that
require continuous renal replacement therapy present a high
mortality rate. The recovery of renal function is unknown in the long
term in the survivors, as well as its relation with the mortality.
OBJECTIVES. To determine the differences in terms of renal function
recovery, depending on the cause, in patients with acute kidney
injury (AKI) that required continuous renal replacement therapy
(CRRT) and evaluate mortality according to renal function recovery.
METHODS. Prospective observational study including AKI patients
that required CRRT, of a tertiary care hospital between january 2013
and december 2014 with at least 2 year follow-up. Chi-Square,
Fisher´s Test, T-Student, U of Mann Whitney and Kaplan Meier curves
were used. Data expressed as frequency (%) and median (interquar-
tile range).
RESULTS. One hundred sixty seven patients were included, median
age 66 (55–74) years, men 103 (61.7%), Charlson comorbidity index 3
(1–6) and APACHE II 23 (16–28).
AKI etiology was multifactorial in 61 (37.2%) patients, septic in 60
(36.6%), hemodynamic in 32 (19.5%), toxic in 4 (2.4%) and miscellany
in 7 (4.3%). There were no differences between groups and the CRRT
protocol was similar.
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mg/dL and at CRRT initiation 2.57 (1.82-3.58) mg/dL. Length of CRRT
was 4 (2–8) days, initiated mostly before the 4th day of admission.
Twenty-eight patients (23.9%) required one or more subsequent
intermittent hemodialysis (IHD) sessions. Overall ICU mortality was
60.5% and mortality rate at 2 years 71.9%.
Nineteen patients (30.2%) died during follow-up period, only 4
(21.1%) patients had presented data compatible with recovery of
baseline renal function (BRF). Patients who recovered BRF during
follow-up had a greater survival (87.1% vs. 60.9%, p = 0.03).
Forty-four (60.8%) patients survived at least 2 years. BRF was
recovered by 27 (65.9%) patients, only 3 (6.8%) needed chronic IHD.
According to AKI etiology, BRF was recovered by 11 (77.8%) patients
of multifactorial group, 11(73.3%) septic group and 6 (54.5%)
hemodynamic group; (p = 0.56).
CONCLUSIONS. The etiology of AKI in critically ill patients submitted
to CRRT could guide us through the recovery of basal renal function,
which influences long-term survival.
Sepsis therapeutics 2
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INTRODUCTION. Empirical antifungal treatment (EAT) is frequently
prescribed to septic critically ill patients with risk factors for invasive
Candida infections (ICI). However, antifungal discontinuation is rarely
performed in patients with no proven ICI, resulting in unnecessary
overuse of antifungals.
OBJECTIVES. The primary objective of this study was to determine
the impact of a biomarker-based strategy on early discontinuation of
EAT.
METHODS. Prospective randomized controlled unblinded study
performed in a single mixed ICU. 110 patients receiving EAT for the
first time, with an expected length of stay of at least 6 days, were
randomly assigned to one of the two following decision-making
strategies regarding EAT duration:
(1) a strategy in which EAT duration was determined by β-D-1,3-
glucan, mannan, and anti-mannan serum assays, performed at
day 0 (day of EAT initiation) and day 4 (biomarker strategy); or
(2) a routine care strategy, based on international guidelines,
which recommend 14 days of treatment (routine strategy).
Primary outcome was the percentage of patients receiving early
discontinuation of EAT, defined as a discontinuation strictly before
day 7. Secondary endpoints included duration of EAT, renewal of
any antifungal therapy after EAT discontinuation, proven ICI after
EAT discontinuation, intensity of Candida colonisation during ICU
stay, antifungal-free days at day 28, ventilator-free days at day 28,
ICU-free days at day 28, ICU mortality and day 28-mortality. This
trial was registered at ClinicalTrials.gov, number NCT02154178.
RESULTS. 109 patients were analyzed (one patient withdraw
consent), including 54, and 55 in intervention and routine strategy,
respectively. Patient characteristics were similar in the two study
groups. EAT was early discontinued in 29 patients in biomarker
strategy, compared with 1 patient in routine strategy (54% vs 2%,
p < 0.001, OR (95% CI) 62.6 (8.1-486)). Duration of EAT was
significantly shorter in biomarker strategy compared with routine
strategy (median (IQR): 6 (4–13) vs 13 (12–14) days, p < 0.001). After
EAT discontinuation, antifungal treatment was restarted in 6 patients(5 in the biomarker-strategy group, and 1 in the routine-strategy
group, p = 0.113). The percentage of patients with proven recurrent
ICI was similar in the two groups (4% versus 2% in intervention and
control group, respectively, p = 0.54). Biomarker strategy significantly
increased antifungal-free days, compared with routine strategy (3.5
(0–17) vs 0 (0–7) days, p = 0.004). Ventilator-free days, ICU-free days,
ICU mortality and day 28-mortality were similar in the two study
groups.
CONCLUSIONS. The use of a biomarker-based strategy increased the
percentage of early discontinuation of EAT among critically ill pa-
tients with suspected ICI, without negative impact on outcomes.
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INTRODUCTION. Clinical, guidelines advocate recommend empirical
therapy with an echinocandin in critically ill patients with candidaemia.1
However, recent observational studies have questioned the superiority
of echinocandins over fluconazole for empirical treatment of
candidaemia in critically ill patients.2
OBJECTIVES. To determine if, compared with fluconazole and after
adjustment for confounders, the empirical therapy with an
echinocandin is associated with a lower mortality rate (at 30 and 90-
day) in patients with proven candidaemia admitted to intensive care
units (ICUs) at disease onset. The microbiological isolations of these
proven candidaemias were described.
METHODS. It is a Retrospective multicenter study carried in nine
Spanish medical-surgical ICU. Adult patients (≥18 yr) with an episode
of Candida bloodstream infection during admission to the ICU from
January 2011 to April 2016 were included. All patients were followed
up for 90 days after the episode of candidaemia. There were
reviewed patients characteristics, severity of illness, infection-related
variables, severity of illness the day of candidaemia, microbiological
data, therapeutic interventions and metastatic complications. Univar-
iante statistical analysis (SPSS v18) was performed using chi-square o
exact Fisher test for qualitative variables and t-Student or U Mann–
Whitney test for quantitative variables when appropriate. After that a
propensity score (PS) adjusted -multivariable analysis was performed
to identify the risk factors significantly associated with 30-day and
90-day mortality.
RESULTS. 294 patients were included. Candida albicans was the most
common species isolated (46.6%) followed by C. parapsilosis (21.8%),
C. glabrata (17.3%), C. tropicalis (9.9%) and others (2.0%). 60 were
excluded (other antifungals in the primary therapy or died without
empirical antifungal therapy). The study group is comprised by 115
patients that received fluconazole (30-day mortality 37.4%) and 119
patients treated empirically with an echinocandin (30-day mortality
31.9%). The use of an echinocandin in the empirical therapy was a
protective factor of 30-day (OR 0.32; 95%CI 0.16-0.66; p = 0.002) and
Table 153 (Abstract 0586). Demographic and comorbidities
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sity score adjusted-multivariable analysis.
CONCLUSIONS. In critically ill patients with documented
candidaemia, empirical use of an echinocandin significantly reduces
mortality at 30 and 90 days.
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INTRODUCTION. Combination therapy refers to the use of two
different classes of antibiotics for the treatment of a single pathogen
that is sensitive to both. Nowadays no firm evidence exists regarding
the benefit or harm of combination therapy1 and current guidelines
only recommend it for the treatment of septic shock2.
OBJECTIVES. To assess the benefits of empirical monotherapy versus
combination therapy in bacteriemia developed in adult patients
admitted the Intensive Care Unit (ICU) of a Spanish tertiary hospital
(Hospital Clínic of Barcelona). The primary outcome was all cause
mortality.
METHODS. Retrospective study (2010–2016). We selected all mono-
pathogen positive blood cultures of patients admitted to the ICU for
more than 24 hours. We collected demographic, clinical, microbio-
logical data (including antibiogram) and antibiotic treatment. Empiric
antibiotics were evaluated separately in order to quantify the num-
ber of correct antibiotics and three group categories were created:
incorrect empirical therapy (not analyzed in this study), monotherapy
and combination therapy. Statistical analysis with Chi square, Stu-
dent´s t-test and forward logistic regression using SPSS IBM software.
RESULTS. During the period studied, 443 mono-pathogen positive
blood cultures were identified. A total of 269 patients received a cor-
rect antibiotic therapy and of those 204 (76%) were treated with
monotherapy and 65 (24%) with combination therapy.
In the monotherpy group, the most frequent isolated microorganisms
were Gram-positive cocci (42.9 vs 20.3%;p = 0.001) while in the combin-
ation therapy group there was a higher rate of Gram negative bacilli
(45.8 vs 76.6%; p < 0.001). In the statistical analysis we found that the
monotherapy group had shorter hospital lengths of stay (mean of 22
vs 33 days; p = 0.001) and less solid organ transplant recipients (10.3 vs
20.3%; p = 0.04).
Crude analysis of all-cause mortality between monotherapy and com-
bination therapy showed no differences (29.9% vs 30.8%;p = 0.89)
and this result was sustained (p = 0.79) after logistic regression ana-
lysis adjusted by shock (HR 6.43;p < 0.001) and prognosis (using
McCabe classification;p < 0.001). We didn´t find differences in related
mortality (21.6% vs 16.9%;p = 0.42) nor in the subgroup of patients
with shock.
CONCLUSIONS. In our study we found no differences between
mortality in patients treated with a correct monotherapy vs.
combination therapy.
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INTRODUCTION. The presence of a hypoperfusion context
determines huge differences in mortality and morbidity among
septic shock patients. The purpose of this study was to explore if the
normalization of capillary refill time (CRT) after 6 hours of
resuscitation is associated to decrease in morbidity (HVHF,
Mechanical Ventilation, ICU and Hospital length of stay) or mortality
in S-3 septic shock patients.
METHODS. Retrospective analysis of a prospectively filled database
of ninety S-3 septic shock patients treated at an academic ICU. Pa-
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 300 of 542tients were classified according to the presence of persistent abnor-
mal CRT (>3 sec) vs. normal CRT after 6 hours of intense treatment.
These subgroups were compared according to demographic,
hemodynamic, perfusion parameters, NE requirements.
RESULTS. 90 patients with septic shock were enrolled; the main
demographic and clinical variables are shown in the table. Persistent
abnormal CRT after 6 hours of resuscitation is a predictor of HVHF
requirement (OR: 3.37 95%CI 1.14-10.24, p = 0.032).
CONCLUSIONS. Persistent abnormal peripheral perfusion predicts
requirement of HVHF as a rescue therapy in septic shock patients.Table 155 (Abstract 0587). See text for description
Table 156 (Abstract 0588). See text for description0588
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OBJECTIVES. To assess the appropriate use of antibiotics and their
de-escalation (DE) to treat nosocomial infections along 5 years in an
ICU with Selective Digestive Decontamination (SDD).
METHODS. In a 30 bed mixed ICU from October 1, 2011 to
September 30, 2016 nosocomial infections (pneumonia, urinary tract
infections, catheter-related bacteremia (CRB) and bacteremia of un-
known origin and secondary nosocomial bacteremia) were prospect-
ively collected. ENVIN-HELICS diagnostic criteria were applied.
Etiology, inflammatory response to infection, antibiotic treatment
(ATB T) and treatment modifications according to culture results,
were analyzed. SDD was applied to all admitted patients requiring
endotracheal intubation over 48 hours. For each groups categorical
variables were summarized as frequencies and percentages and
number in means and standard deviations (SD) or median with inter-
quartile ranges (IQR). Percentages were compared, as appropriate,
with the Fisher´s exact test.or X2 test and medians with the Wilcoxon
test for independent samples. For those variables that were associ-
ated with DE in the univariate analysis were entered into a logistic
multidimensional analysis. The model obtained was expressed by p-values and odd-ratios, which were estimated by confidence intervals
at 95%. A hypothesis test was considered statistically significant
when p-value was less than .05.
RESULTS. DE was done in 105 out of 339 patients. There were no
significant differences in demographics or type of admission (Table 156).
Mortality was lower in patients receiving DE antibiotic (ATB) (27.6% vs.
43.2%, p: 0.006). In the multivariate study, ICU mortality, CRB, severe
sepsis and septic shock were statistically significant (Table 157).
Fifty-four patients with CRB (51.4%) and 44 with nosocomial
pneumonia (41.9%) had DE. The ATB T was inadequate in 58
infections (15%).Targeted therapy was performed in 101 infections
(21%). In 85 patients DE was applied once, 17 twice and 3 three
times and 76 had septic shock. The number of antibiotics used was
845 and in 128 ATB DE were performed. The most DE ATB were
levofloxacin, meropenem and cefepime. Frequency of use and DE
are shown in Table 158.
CONCLUSIONS. ICU patients who received, compared to those that
did not received DE, had a significantly lower mortality. Factors
independently associated to DE were in addition to ICU mortality,
severe sepsis, septic shock and CRB infection. Inadequate ATB T was
applied to 15% of nosocomial infections. Finally, the most commonly
DE ATB were levofloxacin, meropenem and cefepime.
Table 157 (Abstract 0588). See text for description
Table 158 (Abstract 0588). See text for description
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INTRODUCTION. Therapeutic normothermia was previously found to
decrease early mortality in patients with septic shock. However, the
pathophysiologic effect of therapeutic normothermia in sepsis is still
unclear. Recently, immunomodulation effect has been proposed as
one of the key mechanism on sepsis outcome.
OBJECTIVES. To study immunomodulation of the febrile septic shock
patients undergoing therapeutic normothermia when compared with
standard fever control using CD11b, neutrophil chemotaxis, IL-6, IL-
10, CRP and mHLA-DR levels.METHODS. In a single-center, randomized, open-label trial, febrile pa-
tients with septic shock who presented to the emergency department
were enrolled. The patients were randomly assigned to either standard
fever control or therapeutic normothermia, which was aggressive fever
control to maintain body temperature around 36–37 degree Celsius for
the first 24 hours. Primary outcome was immunomodulation as mea-
sured by CD11b, neutrophil chemotaxis, IL-6, IL-10, CRP and mHLA-DR.
Secondary outcomes were various clinical outcomes.
RESULTS. Fifteen patients, consisting of 7 patients in the therapeutic
normothermia group, were enrolled and analyzed. The changes on
day 0, 1 and 7 of CD11b, neutrophil chemotaxis, IL-6, IL-10, CRP and
mHLA-DR were not statistically significantly different between groups
(p > 0.05). Both groups demonstrated the increase in neutrophil
chemotaxis and mHLA-DR, and the decrease in CD11b, CRP, IL-6 and
IL-10 over time. The standard fever control group showed statistically
significant changes from day 0 to day 7 of CD11b (−10.9 ± 7.5%,
p = 0.016), neutrophil chemotaxis (+9.5 ± 3.2%, p = 0.001), and
mHLA-DR (+16.7 ± 8.7%, p = 0.005). The therapeutic normothermia
group showed statistically significant changes from day 0 to day 7 of
IL-6 (−1135.7 ± 908.9pg/ml, p = 0.049). There were no statistically sig-
nificant differences between groups regarding to secondary out-
comes. There was more shivering in the therapeutic normothermia
group (p = 0.007), which led to protocol violation in two patients.
CONCLUSIONS. In this study, therapeutic normothermia when
compared to standard fever control did not result in change in
immunomodulation, though more significant shivering ensued.
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INTRODUCTION. With an increasing incidence and high mortality
rates, sepsis is a public health issue. There is growing evidence that
sepsis induces long lasting alterations of transcriptional programs
through epigenetic mechanisms that may lead to protracted
inflammation, organ failure, sepsis-induced immune suppression
(SIIS), secondary infections and death. We hypothesized that epigen-
etic changes contribute to the pathophysiology of SIIS. To test this
hypothesis, we studied the effects of histone deacetylases (HDAC) in-
hibition with trichostatin A (TSA) in a murine model of SIIS and sec-
ondary pneumonia.
METHODS. C57BL/6 mice were treated with TSA (2 mg/kg ip) or
saline serum (CTL) 30 min before induction of sepsis by cecal ligation
puncture (CLP). Surviving mice underwent intratracheal instillation of
1.5x106 CFU of P. aeruginosa 8 days after CLP. We evaluated the
effect of TSA on survival and cellular responses to the primary and
secondary infections. Cellular responses in the blood, spleen and BAL
were assessed by flow cytometry at different time points after CLP
(Days 1,3&8) and after pneumonia (4 & 12h). We also studied
lymphocyte apoptosis and dendritic cells (DC) expression of CD40,
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 302 of 542CD86, and CMHII. Bacterial clearance was assessed in the BAL and in
the blood 4 and 12 h after pneumonia. Continuous variables
represented as means ± SD were compared using Student t test.
Kaplan-Meier curves were compared by the log rank test. P < 0.05 in-
dicated statistically significant differences.
RESULTS. Whereas treatment with TSA did not change survival after
CLP, TSA significantly improved survival after tracheal instillation of P.
aeruginosa (P = 0.009, Fig. 208).
Treatment with TSA partially reversed features of SIIS. TSA-treated
mice had significantly higher absolute dendritic cells, T-lymphocytes
counts with reduced lymphocyte apoptosis after CLP and reduced
dendritic cells deactivation. Four hours after secondary pneumonia,
TSA-treated mice improved bacterial clearance in the BAL, with re-
duced systemic dissemination of P. aeruginosa
CONCLUSIONS. In murine model of secondary pneumonia, HDAC
inhibition with TSA improves survival, improve bacterial clearance
and attenuate cellular features of SIIS. These results suggest that
sepsis-induced epigenetic changes contribute to the advent of SIIS.Fig. 208 (Abstract 0590). See text for description0591
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INTRODUCTION. Hemodynamic resuscitation in septic shock requires
aggressive fluid replacements and appropriate use of vasopressors to
optimize mean arterial pressure (AP) and peripheral perfusion, i.e.
cardiac output (CO). Because responses to these drugs vary between
patients and within patient over time, strict monitoring of patient
condition and repetitive adjustment of drug dose are required. This
is time and labor consuming task, which has been associated with
poor adherence to resuscitation guidelines of Surviving Sepsis
Campaign. One potential way to ease these tasks is to automate
them via the use of closed-loop control schemes.
OBJECTIVES. The aim of this study was to develop a closed-loop
drug infusion system for automated hemodynamic resuscitation in
septic shock by extending our previous system [1], and to validate
performance of the system in a canine model of endotoxin shock.
METHODS. Our system continuously monitors AP, CO and central
venous pressure (CVP), and computes arterial resistance (R), stressed
blood volume (V) and Frank-Starling slope of left ventricle (S). Oursystem controls R with noradrenaline (NA), and V with Ringer's acet-
ate solution (RiA), thereby controlling AP and CO. In 4 dogs, CO was
measured invasively with aortic flow probe. In 4 dogs, CO was mea-
sured less-invasively using transthoracic Doppler aortic velocimetry
and peripheral AP contour to further develop the system for clinical
application. In all the 8 dogs, we created endotoxin shock by injec-
tions of bacterial lipopolysaccharide, which significantly decreased
AP from 101 ± 20 to 42 ± 5mmHg, CO from 123 ± 27 to 60 ± 17 ml/
min/kg, and increased blood lactate level from 1.7 ± 0.4 to 3.0 ± 0.8
mmol/L. The system was then connected to the dogs and activated.
RESULTS. Our system immediately started NA and RiA. Within 40
min, RiA increased V to its target, and NA maintained R to its target
while S was concomitantly increased. These resulted in restoration of
AP to 70 ± 2 mmHg and CO to 130 ± 10 ml/min/kg. Steady state
deviations from target values were small for AP (−1 ± 4 mmHg) and
CO (−3 ± 10 ml/min/kg). AP and CO were controlled stably over a
period of 4 h even when CO was measured less invasively. Blood
lactate level at 4 h of hemodynamic resuscitation (3.3 ± 1.5 mmol/L)
was not significantly different from that observed before
resuscitation.
CONCLUSIONS. In a canine model of endotoxin shock, our system
automatically improved and stably maintained the hemodynamics
over the period of 4 h. In clinical settings, the period may be
extended without difficulty until the infection causing septic shock
can be eradicated. Our system could be an attractive clinical tool for
rescuing patients with septic shock.
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INTRODUCTION. APL-13, the dominant isoform of APLs in human
heart with strong inotropic effect, is a promising non-
catecholaminergic drug to improve cardiac performance during sep-
sis. APL-13 binds to the apelin receptor (APJ), a GPCR highly
expressed in the cardiovascular system. APJ activation by APL-13 en-
gages either G-protein or β-arrestin stimulating downstream intracel-
lular pathways and triggers physiological responses. Although
efficient and cardioprotective, the myocardial APJ signaling is still
poorly understood during sepsis. Engineered C-terminal modifica-
tions of APL-13 by unnatural amino acids can change ligand-receptor
interactions and downstream signaling. These biased ligands (BLs)
are new pharmacological tools to investigate the apelinergic system
modulation and protection of cardiac functions.
OBJECTIVES. To develop and trial BLs triggering the Gai pathway
and better understand how the apelinergic system influences
cardiomyocyte's function and signals in healthy and septic
conditions.
METHODS. Signal transduction was first screened in HEK293 cells
and cardio-specific pathways were assessed by Western blots in rat
neonatal ventricular cardiomyocytes (RNVC) with or without human
APJ over-expression. Sepsis-related myocardial dysfunction was
induced by Cecal Ligature and Puncture (CLP) in rats. Myocardial
function was assessed by Langendorff assay ex-vivo and by echocar-
diography in vivo.
Table 159 (Abstract 0593). See text for description
Mean
blood
pressure
(mm Hg)
Cardiac
index
(mL/
min/kg)
Systemic
DO2
(mL/min/
kg)
Systemic
VO2 (mL/
min/kg)
Systemic
O2
extraction
ratio
Left renal
blood flow
(mL/min/
100 g)
Renal
DO2
(mL/
min/100
g)
Renal
VO2
(mL/
min/kg)
Renal O2
extraction
ratio
Sham 0
min
80 (74-94) 131
(112-
149)
15.9
(14.4-
18.1)
6.1 (5.2-
7.8)
0.40 (0.36-
0.45)
198 (150-
443)
24.5
(17.1-
62.2)
5.1 (3.4-
9.1)
0.18 (0.16-
0.23)
Endotoxic
shock 0
min
83 (71-98) 112 (92-
128)
14.1
(12.2-
16.6)
5.3 (5.0-
6.0)
0.40 (0.29-
0.48)
205 (157-
293)
28.4
(19.0-
38.2)
5.3 (4.0-
8.8)
0.21 (0.15-
0.24)
Sham 60
min
87 (78-99) 121
(106-
145)
15.2
(13.0-
17.7)
5.8 (4.9-
6.9)
0.40 (0.33-
047)
199 (157-
394)
25.4
(18.9-
51.8)
5.4 (4.6-
9.4)
0.22 (0.18-
0.26)
Endotoxic
shock 60
min
34 (31-
40)*†
71 (53-
82)*†
8.4 (7.4-
10.2)*†
4.4 (3.8-
5.4)*†
0.54 (0.46-
0.66)*†
131 (99-
185)*†
15.8
(13.5-
23.2)*†
3.7 (3.3-
4.5)*†
0.26 (0.18-
0.36)
Sham 180
min
93 (74-
107)
130
(114-
170)
17.2
(14.9-
19.2)
6.6 (4.7-
7.2)
0.39 (0.32-
0.45)
221 (170-
279)
25.8
(19.2-
35.7)
5.1 (4.5-
7.1)
0.21 (0.18-
0.26)
Endotoxic
shock 180
min
72 (70-
73)†
123 (97-
147)
14.3 (9.6-
16.0)
5.1 (4.3-
5.9)
0.36 0.30-
0.51)
174 (92-
186)†
20.5
(10.8-
22.7)*
3.8 (1.9-
4.8)*†
0.21 (0.16-
32)
Fig. 209 (Abstract 0593). See text for description
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correlated with their potency to decrease cAMP content in forskolin-
stimulated HEK293 (Spearman r = 0.61; p = 0.023). BLs inducing high
cAMP inhibition (cAMP EC50: APL-13 1.4 ± 0.1 nM; BL1 0.04 ± 0.1
p < 0.05 vs. APL-13; BL2 0.07 ± 0.1 p < 0.05 vs. APL-13) were more ef-
ficient than APL-13 to inhibit the inotropic response induced by for-
skolin (Fsk) in isolated-perfused hearts (increased contractility from
baseline; Fsk (1μM) 340 ± 81%; Fsk + APL-13 (0.1nM) 266 ± 33;
Fsk + BL1 142 ± 40.34 p < 0.05 vs. Fsk) as well as to reduce phospho-
lamban Ser-16 and Threo-17-phosphorylations in Fsk stimulated
RNVC. After CLP induction, these later responses were ineffective (Fsk
279 ± 70%; Fsk + APL-13 304 ± 44%; BL1 269 ± 68%) and BLs be-
came highly cardiotonic ex vivo as well as in vivo (Cardiac index in
continuously infused rats; CLP (6h) 11.2 ± 0.8 mL/min/100g,
CLP + APL-13 15.9 ± 1.4 vs. CLP; CLP + BL1 15.8 ± 1.2 and CLP + BL2
15.7 ± 1.1, p < 0.05 vs. CLP) comparatively to their effects in healthy
rats (CI; Sham 20.8 ± 0.9 mL/min/100g, APL-13 23.7 ± 0.7; BL1
20.7 ± 1.3; BL2 20.5 ± 0.5).
CONCLUSIONS. Sepsis uncouples APJ from the Gαi/Adenylyl Cyclase/
cAMP pathwayand acts as a negative feedback for the inotropic
response of APJ agonists. This standpoint of knowledge is important
for the future pharmacological development of the apelinergic
pathway in the context of sepsis-related myocardial dysfunction.
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INTRODUCTION. The pathophysiology of renal failure in sepsis is
complex. In addition, the role of hypoperfusion is controversial.
OBJECTIVES. To characterize kidney perfusion, oxygenation, and
function in shock and resuscitation. Our hypothesis was that the
normalization of systemic oxygen transport fails to correct renal
dysfunction occurring in endotoxic shock.
METHODS. We studied 24 anesthetized and mechanically ventilated
sheep. We measured systemic hemodynamics, and oxygen transport
and consumption (DO2 and VO2), renal blood flow, DO2, and VO2,
cortical microcirculation, and creatinine clearance. Endotoxic shock
(n = 12) was induced by intravenous injection of E. Coli endotoxin (5
mg/kg endotoxin, followed by 2.5 mg/kg/hr for 180'). After 60' of
shock, resuscitation was performed by fluid infusion (30 mL/kg of
saline solution) and norepinephrine, which was titrated to reach a
mean arterial pressure (MAP) of 70 mm Hg. We also included a sham
group (n = 12). Data are shown as median (25–75 IQR).
RESULTS. As shown in Table 159, endotoxic shock decreased MAP,
cardiac index, and systemic DO2 and VO2, which returned to basal
values after resuscitation. Renal blood flow, DO2 and VO2, cortical
perfused vascular density, and creatinine clearance (Fig. 209) were
reduced in endotoxic shock. Resuscitation only partially improved
some of them. All these variables were unchanged in sham group.
CONCLUSIONS. Endotoxic renal failure was characterized by reductions
in renal blood flow, DO2 and VO2, and cortical microvascular perfusion.
The administration of fluids and norepinephrine improved systemic
hemodynamics but was unable to normalize kidney perfusion and
oxygenation. Nevertheless, the magnitude of these alterations might not
be enough to explain the persistent and severe reduction in creatinine
clearance. Consequently, other mechanisms might be also involved.0594
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INTRODUCTION. Endothelial dysfunction plays a key role in sepsis
physiopathology, leading to multiorgan failure and death.
Defibrotide (DF) is a product effective in the treatment of veno-
occlusive disease (VOD), a complication of hematopoietic stem cell
transplanted patients where endothelial activation is also corner-
stone. Although the mechanism of action of DF is uncertain, it seems
to modulate endothelial cells activation. Therefore, DF may have a
role as potential treatment for sepsis complications.
OBJECTIVES. Characterize in an in-vitro model of sepsis the activa-
tion and damage of endothelial cells in different sepsis syndrome
and determine the influence of DF in these alterations.
METHODS. Human umbilical vein endothelial cells (HUVEC) were
grown in the presence of 20% pooled sera collected from patients
with septic syndrome (sepsis, severe sepsis and septic shock) or
systemic inflammatory response syndrome (SIRS) within the first 24
hours of symptoms onset. Sera from healthy volunteers was used as
control. We assessed changes in the expression of endothelial cell
receptors at the surface (intercellular adhesion molecule-1 (ICAM-1)
and vascular cell adhesion molecule-1 (VCAM-1)), the presence of
extracellular adhesive proteins such a Von Willebrand factor (VWF)
and the thrombogenicity of the extracellular matrix (ECM) generated
by these cells. To explore the effect of DF, cells were incubated with
DF (100 μg /mL) for 24 hours before being exposed to the sera and
every 24 hours after the exposition.
RESULTS. Endothelial cell activation, determined by an increase in
expression of ICAM-1 and VCAM-1 and an increase in expression of
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 304 of 542VWF and platelet adhesion on the ECM, was higher in septic syn-
drome compared with SIRS and control group (p < 0.001) with a pro-
gressive increase correlated with sepsis severity (sepsis < severe
sepsis ≤ septic shock) (p < 0.05 for VCAM-1, ICAM-1 and VWF;
p < 0.001 for platelet adhesion). Previous exposure and continuous
incubation of endothelial cells with DF modified the endothelial re-
sponse by significantly reducing VWF, ICAM-1, VCAM-1 and platelet
adhesion induced by sera from patients with septic syndrome in all
gropus (p < 0.001).
CONCLUSIONS. DF prevents activation and endothelial damage
induced in septic syndrome in an ex-vivo model of sepsis.
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INTRODUCTION. Sepsis is responsible of both an immune hyperactivity
damage from inflammation and an immune suppression and paralysis
causing vulnerability to infection. Literature provides few retrospective
studies supporting the role of IgM enriched immunoglobulins (IgM-e-IG)
as adjunctive of antimicrobial treatment (1).
OBJECTIVES. To evaluate the likely roleof IgM enriched
immunoglobulins (IgM-e-IG) as adjunctive of antimicrobial treatment.
METHODS. Since December 2016 to the end of March 2017, patients
experiencing a septic shock and admitted with a first 24h SAPS
II > 25, associated with a SOFA-score > 4 - were considered for the
treatment with IgM-e-IG, given for three days at the total dosage of
500 mg/kg. Response to the therapy was based on clinical, microbio-
logical and rheological data.
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 305 of 542RESULTS. A total of 9 patients (3 pneumococcal meningitis, 2
pneumococcal pneumonia, 2 E. coli peritonitis, 1 MRSA thigh
necrotising fasciitis and bacteraemia), median (IQR): age: 48 (28–60),
1st 24 hrs. SAPS II: 55 (43–68), SOFA-score: 12 (7–14) were treated
with IgM-e-IG in association with median (IQR) adequate antimicro-
bial treatment of 7 (8–14) days. Clinical response to therapy occurred
by 72 hrs, whereas median (IQR) duration of mechanical ventilation
and vasopressor infusion were respectively 3 (2–7) and 3 (2–3). We
recorded a median (IQR) 80% decreasing procalcitonin [47(7–209)ng/
ml vs.7.1 (0.3-9.1)] and CRP [333(225–407)mg/ml vs. 27 (10–70)] re-
spectively on day 3 and 5, whereas of SOFA-score on day 6. All pa-
tient were alive on 30th day, even if one of them (pneumococcal
pneumonia) died after 2 months for a KP-cp bacteraemia.
CONCLUSIONS. Despite the exiguous sample size it seems that early
adjunctive treatment with IgM may be associated with a survival
benefit. A larger patient sample and a control group will be
warranted to corroborate this preliminary results.
REFERENCE(S)
Cavazzuti I, Serafini G, Busani S, Rinaldi L, Biagioni E, Buoncristiano
M,Girardis M. Early therapy with IgM-enriched polyclonal immuno-
globulin in patients with septic shock. Intensive Care Med. 2014
Dec;40(12):1888–96.
GRANT ACKNOWLEDGMENT
NONE.
0596
Stem cells mobilization in surgical patients with septic shock
A. Cotoia1, S. Altamura1, R. Villani1, G. Palumbo2, F. Cutillo2, L. Tullo1, L.
Mirabella1, S. Capalbo2, G. Cinnella1
1University Hospital of Foggia, Critical Care Medicine, Foggia, Italy;
2University Hospital of Foggia, Hematology, Foggia, Italy
Correspondence: A. Cotoia
Intensive Care Medicine Experimental 2017, 5(Suppl 2):0596
INTRODUCTION. Complicated intra-abdominal infection is a frequent
cause of sepsis and septic shock in surgical patients. Several efforts
have been made to study the stem cells role in septic patients, but
we currently lack of informations regarding septic surgical patients.
OBJECTIVES. The aim of the study is to evaluate the time course
level circulating endothelial stem cells in septic shock patients
undergoing major abdominal surgery.
METHODS. In the prospective observational study were enrolled
consecutive patients undergoing major abdominal surgery at
University Hospital, Foggia. After written informed consent, blood
samples were collected on admission of the post surgical patients in
intensive care unit (ICU) or in surgery ward at 24 hours (T1), and 3
(T3), and 7 (T7) days postoperatively. Quantitative analysis of
endothelial progenitor stem cells (CD34) was performed. At any time
were also collected the clinical parameters, the laboratory values of
interleukins, procalcitonin, C-reactive protein and endotoxin, white
blood cells, red blood cells, hemoglobin and platelets. The outcome
was also recorded. The data are presented as median ± SE.
RESULTS. 33 patients undergoing major abdominal surgery were
analysed. 20 patients with septic shock required ICU admission
following surgery and 13 patients (controls) were admitted in post-
surgical ward. 13 of 20 patients with septic shock deceased within 15
days postoperatively. At T1, CD34 cells were 0.23 ± 1.5/mcl in control
group, 0.06 ± 0.09/mcl in septic shock survivors and 0.32 ± 2.2/mcl in
septic shock non survivors (NS). At T3, the circulating stem cells
slightly increased in septic shock survivors and control while they re-
duced, whereas non significantly, in non survivors patients (0.2 ± 0.9/
mcl, 0.27 ± 1.1/mcl, 0.16 ± 2.5 respectively). At T7 the CD34 stem
cells were slightly higher in septic shock survivors as compared to
control and non survivors (0.36 ± 0.1/mcl, 0.21 ± 0.06/mcl and
0.25 ± 0.4/mcl, respectively).CONCLUSIONS. The presented preliminary findings indicate a
increased level of the circulating CD34 stem cells in the blood of
surgical patients likely due to an adaptive response to surgical stress.
Moreover it appears that patients capable of increasing the
production of CD34 stem cells exhibit a better outcome following
major abdominal surgery. This pilot study encourages the
continuation of the research project on a larger sample size of
patients to better understand if and how CD34 stem cells are
involved in the surgical patients with septic shock.
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INTRODUCTION. The Surviving Sepsis Campaign 2016 recommends
that serial assessments of hemodynamic status be performed after
initial fluid loading. Front-line hemodynamic parameters include
blood pressure, heart rate, central venous pressure, which are inter-
preted in light of ScvO2 and lactate levels.
OBJECTIVES. To describe the hemodynamic profile of a cohort of
ventilated patients assessed within twelve hours of ICU admission for
septic shock using transesophageal echocardiography (TEE) and
evaluate the diagnostic value of front-line hemodynamic parameters.
METHODS. This is an ancillary study of two prospective,
observational, multicenter, French cohorts of ventilated patients who
were hemodynamically assessed for a septic shock using TEE
(HEMOSEPSIS and HEMOPRED studies). In each patient, cardiac index
(CI), left ventricular ejection fraction (LVEF), respiratory variations of
the superior vena cava (ΔSVC) and of the subaortic Doppler
velocities (ΔVmaxAo), and the ratio of end-diastolic areas of both the
right and left ventricle in the long axis view of the heart (RVEDA/
LVEDA) were measured. A LVEF < 40% defined LV systolic dysfunc-
tion, a CI < 3 l/min/m2 defined low cardiac output, and a RVEDA/
LVEDA ratio > 0.6 (± associated with a paradoxical septal motion in
the short axis of the heart) defined RV dysfunction (± acute cor pul-
monale). The preload-dependence was evaluated using ΔSVC or
ΔVmaxAo. Front-line hemodynamic parameters were noted at the
time of TEE assessment.
RESULTS. LVEF and CI could be simultaneously measured in 388 of
410 patients who were hemodynamically assessed (95%). 74 patients
(19%) had a low CI related to LV systolic dysfunction (lactate:
4.36 ± 3.49 mmol/l), 141 patients (36%) had a low CI and a preserved
LVEF related to a RV dysfunction or to a sustained preload-
dependence (lactate: 3.58 ± 3.28 mmol/l), 146 patients (38%) had
preserved CI and LVEF (lactate: 3.38 ± 3.32 mmol/l) including only 23
patients (6%) with a hyperkinetic profile (high CI and LVEF > 70%),
and 27 patients (7%) has preserved CI but altered LVEF (lactate:
3.49 ± 2.95 mmol/l) due to a marked tachycardia. None of the front-
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 306 of 542line hemodynamic parameters was discriminatory to identify the cir-
culatory profile identified by TEE assessment (Table 160).
CONCLUSIONS. Front-line hemodynamic parameters fail to discrimin-
ate between the distinct hemodynamic profiles identified during TEE
assessment of ventilated patients with septic shock.Table 160 (Abstract 0597). See text for description
EF < 40% EF ≥ 40%
CI ≥ 3 l/min/m2 n (%) 27 (7%) 146 (38%)
mBP (mmHg)/HR (bpm) 82 ± 15/119 ± 26 76 ± 16/114 ± 20
CVP (mmHg)/ScvO2 (%) 10 ± 4/76 ± 13 10 ± 4/80 ± 10
CI < 3 l/min/m2 n (%) 74 (19%) 141 (36%)
mBP (mmHg)/HR (bpm) 78 ± 16/108 ± 26 77 ± 17/96 ± 23
CVP (mmHg)/ScvO2 (%) 11 ± 5/76 ± 11 10 ± 5/76 ± 110598
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INTRODUCTION. Antimicrobial resistance threatens the prevention
and treatment of an ever-increasing range of infections and leads to
increased morbidity and costs of care. 30-40% of antibiotics pre-
scribed in ICU´s are unnecessary, inappropriate or suboptimal.
OBJECTIVES. We aimed to examine whether the ICU was meeting
recommendations for antibiotic prescribing, according to the
Magnificent Seven standards. In doing so, we aimed to look for ways
of improving practice and patient outcomes, and to find practical
ways of avoiding unnecessary antibiotic usage.
METHODS. A retrospective audit was performed on notes of all
patients commenced on antibiotics on ITU within a 3 week period.
Interrogation looked for documented evidence of infection, an
indication for antibiotics, evidence that blood cultures were taken
prior to antibiotic doses, a planned duration for treatment, and a
review of antibiotics at 48 hours.
RESULTS. 21 patients were included, among which 20 errors were
made. 18 errors (90%) occurred in 8 particular patients. All patients
had documented evidence of infection but this was felt to be
subjective in some cases. Only 1 patient did not have antibiotics
reviewed, 4 (19%) had no cultures taken and 8 (38%) had no
planned duration for treatment. 7 (33%) had no documented
indication for the antibiotics.
CONCLUSIONS. Amongst staff, there was a lack of awareness of the
Magnificent Seven standards. Ambiguity around which member of
the team carries the ultimate responsibility for antibiotic stewardship
creates the potential for gaps in care. In some instances, a lack of
regular review meant antibiotics were continued for longer than
necessary, or despite negative microbiology results. Recommendations
to the department included assigning a junior doctor to microbiology
rounds to ensure adequate documentation, and training on the
Magnificent Seven at staff inductions. The electronic medical records
system, CareVue, is due to be expanded on ITU. The authors
recommended a specific microbiology section be created, containing
prompts for each of the standards. We also recommended using serum
procalcitonin tests to provide evidence of infection and to guide
treatment. Once these changes are implemented, we hope to perform
a PDSA re-audit to assess their impact on the standards.REFERENCE(S)
1. Jong et al. Efficacy and Safety of Procacitonin Guidance in
Reducing the Duration of Antibiotic Treatment in Critically Ill
Patients: A Randomised, Controlled, Open-Label Trial. Lancet Infect.
Dis. 2016 Jul;16(7):819–27.
2. WHO Antimicrobial Resistance Factsheet, updated 2016.
3. Harbarth et al. Diagnostic Value of Procalcitonin, Interleukin-6 and
Interleukin-8 in Critically Ill patients Admitted with Suspected Sepsis.
American Journal of Respiratory and Critical Care Medicine 2001,
Aug;164(3).
4. Public Health England. Start Smart Then Focus. Antimicrobial
Stewardship Toolbox Kit for English Hospitals. Updated March 2015.
Transfusion and blood management
0599
D-Dimer testing in patiens with concomitant renal insufficiency in
critical ilness: usefuleness and new perspectives
C. A. Pfortmueller1, G. Lindner2, G.-C. Funk3, A. B. Leichtle4, G. M. Fiedler4,
C. Schwarz5, A. K. Exadaktylos6
1Inselspital, Bern University Hospital, Department of Intensive Care, Bern,
Switzerland; 2Hirslanden Klinik Im Park, Department of General Internal
Medicine & Emergency Medicine, Zurich, Switzerland; 3Otto Wagner
Hospital and Ludwig-Boltzmann Institute for COPD and Respiratory
Epidemiology, Department of Respiratory and Critical Care Medicine,
Vienna, Austria; 4Inselspital, University Hospital Bern, Center for
Laboratory Medicine, Bern, Switzerland; 5Landeskrankenhaus Steyr,
Department of Internal Medicine and Nephrology, Steyr, Austria;
6Inselspital, Bern University Hospital, Department of Emergency
Medicine, Bern, Switzerland
Correspondence: C. A. Pfortmueller
Intensive Care Medicine Experimental 2017, 5(Suppl 2):0599
BACKGROUND. D-Dimer was found to be elevated in renal insuffi-
ciency. We tried to A.) evaluate whether D-Dimer shows a relation to
renal function in critically ill patients with suspected VTE; B.) identify
renal function adjusted D-Dimer cut-offs.
METHODS. In this retrospective analysis, all patients presenting to an
emergency department between 01 January 2009 and 01 November
2013 with suspected VTE were included. Linear regression analysis
was used to identify factors related to D-Dimer.
RESULTS. 9,716 patients (55% male) were included. D-Dimer was 583
μg/L (297 to 1,274) and it was >500 μg/L in 5,372 (55%) patients.
7,439 (77%) had an eGFR > 60 ml/min, 1,759 (18%) an eGFR of 30–60
ml/min and 518 (5%) an eGFR < 30 ml/min. Prevalence of negative
D-Dimer decreased with declining eGFR. There was a significant in-
verse correlation between eGFR and D-Dimer. While sensitivity of D-
Dimer was unchanged by declining eGFR, its specificity for VTE de-
creased substantially. After adjustment for renal function D-Dimer
cut-off values yielded a post-test probability for VTE of 1%.
CONCLUSIONS. Our findings confirm the relationship between renal
function and D-Dimer. Use of renal function adjusted D-Dimer cut-
offs in combination with clinical prediction rules could result in less
need for further investigations to rule out VTE.0600
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Fig. 213 (Abstract 0600). Three zones error grid plot before
adjustment
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 307 of 542INTRODUCTION. Point-of-care (POC) arterial blood gas analysis
(ABGA) is widely used for checking hemoglobin (Hb) level. However,
there is the tendency of downward bias of conductivity-based POC
ABGA Hb measurement compared with optical methods.
OBJECTIVES. Authors tried to correct that bias by linear regression
equation.
METHODS. We retrospectively collected a total of 86 Hb result pairs
during surgeries. Hb measured by the Sysmex XE-2100 in the labora-
tory was set as the gold standard and was compared with that mea-
sured by the GEM Premier 3500. Data were compared using the
Bland-Altman analysis, the reliability of trasfusion decision was
assessed using three-zone error gird. The linear regression analysis
was performed to find out the relation between the Hb results of
POC ABGA and those of laboratory based test.
RESULTS. The bias of the Hb measured between Sysmex XE-2100
and GEM Premier 3500 was - 0.85 g/dl (p < 0.0001).
The percentage error was 16.4%. According to error grid
methodology, zone A, B and C encompassed 89.5%, 10.5% and 0%
of data pairs.
After adjusting the POC ABGA Hb values, the bias of the Hb
measured by two methods was 0 g/dl (p = 0.99). The percentage
error was 18.2%. The zone A, B and C encompassed 91.9%, 8.1% and
0% of data pairs.
CONCLUSIONS. Hb measurements obtained with reference to
conductivity via a POC ABGA were significantly lower than those
obtained via optical methods. Correcting the bias by linear
regression formula reduced data pairs in zone B and C, but increased
percentage error. This bias may deserve attention of
anesthesiologists when POC ABGA Hb level is used as a transfusion
guideline.
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INTRODUCTION. Recombinant Factor VIIa (rFVIIa) is an expensive but
effective therapy for promoting haemostasis in certain
haematological conditions. Although its efficacy is questionable for
use in haemorrhage secondary to major trauma1 it is often used as a
'last ditch attempt'. Local policy allows for rFVIIa use in certain
haematology patients, those with post partum haemorrhage but not
recommended in major haemorrhage due to trauma.
OBJECTIVES. To review guideline compliance for the use of rFVIIa
and compare patient outcomes and amount of blood transfused.
METHODS. Audit of adult patients prescribed rFVIIa over a 3 year
period at the Royal London Hospital (largest trauma centre in UK).
Electronic pharmacy records of rFVIIa prescription were reviewed
along with patient paper and electronic notes. Data on red blood cell
transfusion was obtained from the transfusion laboratory.
RESULTS. rFVIIa use is rare; 16 patients were prescribed rFVIIa of
whom 13 went on to receive it; 7 according to the guidelines and 6
off label.
Of the 7 cases compliant with the guidelines 3 received rFVIIa due to
a clotting abnormality or extreme intolerance to blood transfusion
(Glanzmann's thrombasthenia, Bernald-Soulier syndrome, sickle cell
anaemia with numerous red cell antibodies); the remaining 4 as part
of an obstetric major haemorrhage. 6 patients were given rFVIIa off
label after a supra-massive blood transfusion due to a traumatic rea-
son (2 stabbings, 2 road traffic collisions, 1 pancreatic surgery, 1 for
hepatic drain).
All the patients with a haematological condition were treated for
minor bleeding that was halted with the use of rFVIIa and platelet
transfusion; none received any red blood cells (RBC). The obstetric
haemorrhage patients received median 15 units RBC (range 7–29)
whilst the trauma patients received significantly more blood
products, median 41 units RBC (range 24–55), p = 0.03, see Table
161. All patients given rFVIIa for a traumatic reason received it after
at least 15 units RBC and numerous other blood products.
All of the patients with a haematological abnormality and obstetric
related haemorrhage survived whereas all of the trauma patients
died.
CONCLUSIONS. Almost half the cases of rFVIIa use are not compliant
with current hospital guidelines. Our findings do not support its use
in patients who have suffered major haemorrhage secondary to
trauma.
This audit should serve as further evidence that rFVIIa has limited
value in the treatment of patients who have already received a
supra-massive blood transfusion.
REFERENCES
1. Simpson E et al. Recombinant factor VIIa for the prevention and
treatment of bleeding in patients without haemophilia. Cochrane
Database Syst Rev. 2012 Mar 14;(3):CD005011Table 161 (Abstract 0601). Comparison of groups treated with rFVIIa
Haematological Obstetric Traumatic
Number 3 4 6
Packed red cells - median, (range) 0 15 (7-29) 41 (21-
55)
Length of Hospital Stay Post Bleed -
median (range)
6 (3-31) 17 (9-26) 1 (0-7)
Survived to Hospital Discharge - No. (%) 3 (100) 4 (100) 0 (0)
Cost of rFVIIa Per Patient - median £4963 £3309 £52390602
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INTRODUCTION. Standard dose of 40 mg of enoxaparin
subcutaneously once a day is so far recommended for prophylactic
anticoagulation in all patients regardless their weight and physical
status although it has been shown in ICU patients in numerous
studies to be unreliable and not effective enough according to
antiXa activity. Evidence suggests decreased bioavailability of
enoxaparin in ICU population.We have started testing antiXa activity
routinely in our ICU patients after every enoxaparin given for
prophylactic anticoagulation in 2013. The dosing of enoxaparin is
adjusted according to antiXa activity in each patient. The initial dose
used in our ICU is 40 mg in most patients, higher initial dose is used
mostly in obese patients, but the initial dosage is left to the ICU
physician, we do not have a set protocol.
OBJECTIVES. Evaluation of the efficacy of prophylactic
anticoagulation with dosing of enoxaparin guided by routine testing
of antiXa activity.
METHODS. Data was retrospectively collected from patients
admitted to our 9 bed mixed ICU over 3 months period (1.4.-
30.6.2016). Included were all patients on prophylactic anticoagulation
by subcutaneously administered enoxaparin in whom antiXa activity
was measured. AntiXa activity is measured 3 hours after the
subcutaneous application of enoxaparin in our institution, the
recommended prophylactic range of antiXa activity is 0,2-0,5 U/ml.
RESULTS. 49 patients who met the set criteria were admitted during
the 3 month study period to our ICU. 284 antiXa measurements were
taken, 190 (66,9%) were within the prophylactic range (0,2-0,5 U/ml),
80 (28,2%) were under the prophylactic range and 14 were over the
prophylactic range.
40 mg of enoxaparin was used 118 times (41,5%), 60 mg 106x
(37,3%), 80 mg 45x (15,8%),100 mg 5x (1,8%) and 20 mg 10x (3,5%).
The initial dose of enoxaparin was 40 mg in 40 patients, in 19 antiXa
was within prophylactic range, in 19 was antiXa activity too low and
in 2 patients was antiXa activity too high. The initial dose was 60 mg
in 8 patients, in 5 patients antiXa activity was within the
recommended range and in 3 patients it was too low. The initial
dose was 80 mg in one patient with antiXa activity within
prophylactic range. In summary the initial dose was correct in 25
patients, it was too low in 22 patients and too high in 2 patients.initial dose
of
enoxaparinNo. of
patientsadequate antiXa
range (0,2-0,5 U/
ml)low antiXa
activity (<0,2 U/
ml)high antiXa
activity (>0,5 U/
ml)40 mg 40
patients
(81,6%)19 patients (47,5%) 19 patients
(47,5%)2 patients (5%)60 mg 8 patients
(16,3%)5 patients (62,5%) 3 patients
(37,5%)080 mg 1 patient
(2%)1 patient 0 0all initial
doses49
patients
(100%)25 patients (51%) 22 patients
(44,9%)2 patients
(4,1%)[Initial dose of enoxaparin]
CONCLUSIONS. Prophylactic anticoagulation in critically ill patients is
essential but poses many problems. The standard recommended
dosage is often not sufficient, in our study standard dosing was used
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 309 of 542only in 41,5%. Even though we used higher dosage than
recommended in 54,9%, the antiXa activity was adequate only in
66,9%. The bioavailability of enoxaparin changes in a patient during
his critical illness. The initial dose of enoxaparin should also be
individualized. Monitoring of antiXa activity seems to be essential
but even routine monitoring is not the only answer. More studies
need to be done.
REFERENCE(S)
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INTRODUCTION. Intensive care unit (ICU) patients may develop deep
vein thrombosis (DVT) or pulmonary embolism (PE).
OBJECTIVES. The aim of the study was to explore occurrence, risk
factors and outcome of venous thromboembolism (VTE) in ICU
patients.
METHODS. Prospective observational study of adult medical and
surgical patients at Oslo University Hospital in Norway from 2012 to
2016. Patients with ICU length of stay above 48 hours were included
according to predefined inclusion and exclusion criteria. Doppler
Ultrasound (DUS) was used for screening of the neck and the upper
and lower extremity veins to elbow and knee level. The DUS
examination was performed at inclusion, and thereafter twice a weekuntil discharge from the ICU or up to 30 days. Computed
tomography angiography was used when clinically indicated for any
medical reason.
RESULTS. Seventy patients were included (mean age 62 years, 79%
males), half with normal kidney function and half with acute kidney
injury undergoing renal replacement therapy. All included patients
received thromboprophylaxis with dalteparin, 44 (63%) additionally
used graduated compression stockings. VTE was found in 19 (27%)
patients, DVT in 15 (21%) and PE in four (6%). Among those with
VTE, 11 (58%) events were present within the first 48 hours after
admission, and nine (47%) were related to central vein catheters. The
VTE was clinically suspected in five (26%) patients, three with PE and
two with DVT. Treatment was therapeutic anticoagulation in 15
(79%) patients, and removal of the central vein catheter related to
the DVT in seven. Risk factors for VTE were abdominal surgery (53%
vs. 28%, p = 0.05), malignant disease (32% vs.10%, p = 0.03) and
central vein catheter in the internal jugular vein (100 vs. 67%,
p = 0.04), but not acute kidney injury treated with renal replacement
therapy (47% vs. 51%, p = 0.79). Patients with and without VTE had
comparable ICU LOS (13 days vs. 11 days, p = 0.79) and mortality
(16% vs. 20%, p = 0.72).
CONCLUSIONS. In adult ICU patients, DVT was observed in 21% and
PE in 6% of the patients. Most of the VTE events were present within
the first 48 hours after admission, but not clinically suspected.
Abdominal surgery, malignant disease and central vein catheters in
the internal jugular vein were risk factors for VTE. Presence of VTE
did not impact on ICU length of stay or mortality.
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INTRODUCTION. EXTEM clotting time (CT) is considered representative
of the activation of the coagulation cascade and therefore of the
thrombin generation potential. However CT is defined as the time
needed to reach 2 mm amplitude on the viscoelastic tracing and it is
thus also dependent on fibrinogen concentration.
OBJECTIVES. To test the correlation between EXTEM CT and
parameters of thrombin generation in the setting of reconstituted
whole blood (RWB) with increasing plasmatic dilution and fibrinogen
supplementation.
METHODS. Whole blood (WB) was collected from six healthy donors
and divided into red blood cells, platelet-rich and platelet-poor
plasma (PPP) by consecutive centrifugation steps. These components
were then re-mixed to produce aliquots of reconstituted whole blood
(RWB) with increasing plasma dilutions (20, 40, 60, 80% by addition
of saline) but constant hematocrit and platelet count. WB and RWB
aliquots were tested with EXTEM after the addition of either 10 μL of
saline (EXTEM) or 10 μL (600 μg) of fibrinogen concentrate
(EXTEM + Fib) to the cup. PPP of these aliquots was then tested with
CAT assay (thrombin generation).
RESULTS. Blood cell count and plasma dilution are displayed in
Table 162.
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 310 of 542Dilution of the plasmatic component was associated with an increase
(not significant) of thrombin generation area under the curve (TG
AUC) that was maintained from 20 to 80%. EXTEM CT was shortest at
20% dilution and then significantly increased with increasing
dilution. Addition of fibrinogen to the test (EXTEM + Fib) significantly
reduced CT (Fig. 217). Linear regression of EXTEM CT and AUC and
Lag Time parameters of TG are displayed in Fig. 218.
CONCLUSIONS. No correlation between EXTEM CT and thrombin
generation parameters was found. Our experiments also showed that
EXTEM CT is significantly dependent on fibrinogen, a substrate of the
activated thrombin enzyme.
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WB 20% diluted
RWB
40% diluted
RWB
60% diluted
RWB
80% diluted
RWB
Hematocrit (%) 41 ±
6
24 ± 1 25 ± 1 24 ± 2 25 ± 1
Platelet count
(*1000/μL)
227 ±
47
90 ± 8 89 ± 10 92 ± 7 89 ± 7
Plasma dilution
(%)
0 ± 0 20 ± 0 40 ± 0 60 ± 0 74 ± 6
Fig. 217 (Abstract 0604). See text for description
Fig. 218 (Abstract 0604). See text for description0605
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INTRODUCTION. Central venous catheter (CVC) thrombosis is a
common problem in the ICU. Tissue plasminogen activator (tPA) may
be required to restore lumen patency, but carries a risk of bleeding.
Studies supporting this practice have not evaluated for the possible
complication of systemic hyperfibrinolysis.1
OBJECTIVES. We sought to determine if tPA given for CVC declotting
is associated with hyperfibrinolysis, as directly measured using
rotational thromboelastometry (ROTEM), the clinical gold standard
for hyperfibrinolysis detection.2
METHODS. We conducted an observational study of patients who
required tPA administration for CVC thrombosis. At our center, 2 mg
of tPA is dissolved into 2 mL of sterile water, administered into the
occluded CVC lumen for 90 minutes, and then removed. We tested
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 311 of 542for evidence of hyperfibrinolysis before (pre-tPA), 5–10 min after tPA
was inserted (mid-dwell), and after tPA (post-tPA) using EXTEM and
INTEM ROTEM assays. The primary outcome was the difference in
mean maximum lysis index (ML) between each time point above.
RESULTS. 20 patients were enrolled. Of these, 8 patients were
excluded from analysis due to technical errors. In the remaining 12
patients, the mean EXTEM ML pre-tPA, at mid-dwell, and post-tPA
were as follows (standard deviations in parentheses): 2.5% (2.5%),
10.9% (28.2%), and 3.3% (2.5%), respectively. The mean INTEM ML
pre-tPA, at mid-dwell, and post-tPA were as follows: 1.5% (1.6%),
10.1% (28.4%), and 2.8% (1.7%), respectively. In one patient, INTEM
ML pre-tPA was 0%, was 100% at mid-dwell, and was 1% post-tPA.
This patient's EXTEM ML post-tPA assay was inadvertently not per-
formed, but EXTEM ML pre-tPA ML was 0% and mid-dwell ML was
100%. When analyzing the other 11 patients, the mean EXTEM ML at
pre-tPA, mid-dwell, and post-tPA were as follows: 2.5% (2.4%), 2.8%
(3.4%), and 3.3% (2.5%), respectively. Similarly, in these same 11 pa-
tients, the mean INTEM ML at pre-tPA, mid-dwell, and post-tPA were
as follows: 1.6% (1.6%), 1.9% (2.0%), and 2.9% (1.7%).
When analyzing all 12 patients ML values at each time point via
matched pairs analysis, there was a significant difference between
INTEM ML at pre-tPA and post-tPA (p = 0.045). When including only
those 11 patients that did not have ML elevations at any time point,
the INTEM ML between pre-tPA and post-tPA was not significant
(p = 0.062). There were no significant differences between ML's at
any other time points.
CONCLUSIONS. Low dose tPA for CVC declotting can be associated
with systemic hyperfibrinolysis. However, our results were likely
influenced by one outlier who did become hyperfibrinolytic.
Importantly, post hoc review determined that this was the only
patient that had blood samples drawn from a CVC lumen directly
adjacent to the lumen in which tPA was administered, thus the
clinical implications of this are unclear.
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INTRODUCTION. In obstetrics, the massive blood loss (MBL) occupies
a leading position in the structure of maternal mortality. The
application of VII factor at massive bleeding in obstetrics is debatable
and requires further investigations.
OBJECTIVES. The aim of the study was to evaluate the efficiency of
the recombinant activated VII factor (FVIIa) for coagulopathy
correction at massive bleeding against the background of invasive
placenta.
METHODS. A prospective study included 60 patients with MBL with
the invasive placenta. In 30 patients, the correction of acute
coagulopathy in the background of MC with a volume of
2939.7 ± 248.2 ml was performed with freshly frozen plasma (FFP)
and in 30 patients, with the MBL volume of 3146.1 ± 640.2 ml - fVIIa
(90 μg / kg) + FFP. The state of haemostasis was assessed by
thromboelastography (TEG) with the TEG 5000 apparatus
(Haemonetics); the indices of platelets, fibrinogen, MNO and APTV
have been analyzed. The time of elimination of coagulopathy from
the moment of registration (min) and the volume of injected FFP
(ml) have been recorded.
RESULTS. At the peak of blood loss, in all patients, the structural and
chronometric hypocagulation was recorded by the TEG method,which was eliminated in the SLE group after 43.4 ± 2.1 min after
registration of coagulopathy, and in the fVIIa + FFP group - after
5.4 ± 1.8 min (p < 0.0001). The first group required 1297 ± 67.5 ml
FFP, while the group with fVIIa - 766.0 ± 242.0 ml (p < 0.05).
Complications of fVIIa have not been registered.
CONCLUSIONS. The application of fVIIa at the MBL with invasive
placenta reliably reduces the correction time of coagulopathy
compared to the isolated use of FFP and is accompanied by a
significant decrease in the required volume of FFP to achieve the
desired effect. In case of the MBL in obstetrics it is necessary to
apply FVIIa immediately after the registration of coagulopathy.
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INTRODUCTION. Anticoagulation with unfractionated heparin (UFH)
is a mainstay in critical care. Monitoring of this therapy is based
either on aPTT or antiXa. There is no clear recommendation on
which method should be used in critical care: studies addressing this
issue are a few and include small cohorts of patients. In clinical
setting this often leads to the simultaneous determination of both
parameters, increasing costs with no obvious advantage. Indeed the
two measures may disagree with regard to their therapeutic range
leading to confusion.
OBJECTIVES. This study aimed at analysing the agreement between
aPTT and antiXa in a large population of therapeutically
anticoagulated critically ill patients. Patients treated with
extracorporeal devices such as continous renal replacement therapy
(CRRT) and circulatory assist devices (CAD) were predefined
subgroups.
METHODS. Retrospective study of prospectively collected data of a
35 beds mixed-ICU population between years 2006 and 2016 in a
University teaching hospital. Inclusion criteria were the delivery of a
UFH dose superior to 15'000U/24h during at least 1 day with a con-
comitant antiXa determination. Analysed data: demographic vari-
ables, aPTT, antiXa, extracorporeal devices (CAD, CRRT). Couples of
simultaneously dosed antiXa and aPTT were analysed on the basis of
their agreement to the subtherapeutic, therapeutic (aPTT 50-80”,
antiXa 0.3-0.7 U/ml) or supratherapeutic range. Data as mean and
percentage.
RESULTS. Out of 23'334 admissions, 2'254 were analysed: 2'123
patients, age 63.7 yrs, SAPSII 46.9 pts, median ICU stay 8.2, ICU
mortality 13%. In 2006, antiXa was used in 9% of the patients
increasing to >96% after 2012. Altogether 40'795 antiXa and 80'696
aPTT were analysed, resulting in 40'578 couples of values. Only 217
antiXa (0.53%) were determined without simultaneous aPTT. The
overall agreement between antiXa and aPTT was 59.8%
(disagreement 40.2% with aPTT > antiXa 30.5% and aPTT < antiXa
9.7%). Agreement was lower in patients with extracorporeal devices
(CAD 57.9% / CRRT 57.3%), being lowest with both devices
(agreement 54.1%, disagreement 45.9% with aPTT > antiXa 39% and
aPTT < antiXa 6.9%).
CONCLUSIONS. The agreement between antiXa and aPTT is < 60%
and lower in patients with CAD and/or CRRT. The analysis of the
proportions in the disagreement group suggests a factitious
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 312 of 542prolongation of aPTT in presence of extracorporeal devices. The very
large proportion of simultaneous aPTT/antiXa determination
probably reflects a lack of confidence in usual UFH monitoring
methods and causes unnecessary costs. Establishing the factors
influencing the antiXa/aPTT agreement may assist the clinician
choosing the optimal monitoring for UFH in ICU patients.
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INTRODUCTION. Recently, thromboelastography (TEG) has been
used in liver transplantation (LT) as well as conventional coagulation
tests (CCTs) such as prothrombin time (PT), activated partial
thromboplastin time (aPTT), antithorombin III (ATIII), platelet count
and fibrinogen concentration.
OBJECTIVES. The purpose of this study was to investigate the
correlation between the TEG and CCT values during each phase of LT
and to evaluate the clinical utility of TEG in LT.
METHODS. Patients who underwent deceased donor liver
transplantation (DDLT) at Pusan National University Yangsan
Hospital, Yangsan, Korea, between October 2010 and July 2015, were
retrospectively evaluated. Samples were obtained from all patients at
1 hour after initiation of the operation (pre-anhepatic phase), 30
minutes after total hepatectomy of the recipient (anhepatic phase),
and 1 hour after reperfusion (neo-hepatic phase). A portion of the
sample was used for TEG and the rest was subjected to CCTs.
RESULTS. The Spearman correlation coefficient between TEG and
CCT was obtained. At the pre-anhepatic phase (Table 1), the reaction
time (R), PT, and aPTT did not show a high correlation with each
other, but rather showed a negative correlation with the number of
platelets. Clot formation time (K) showed a similar correlation with R,
but a negative correlation with fibrinogen. The maximal amplitude
(MA) and α-angle (α) were positively correlated with the number of
platelets and fibrinogen, and inversely correlated with aPTT. During
the anhepatic phase (Table 2), MA was significantly correlated with
PLT, and inversely correlated with aPTT; other parameters had no sig-
nificant correlation. During the neo-hepatic phase (Table 3), R and K
were significantly correlated with aPTT, and inversely correlated with
the number of platelets and fibrinogen, similar to the pre-anhepatic
phase. A correlation of MA and α with PLT, aPTT, and fibrinogen was
also reported. It was revealed in this study that clot lysis at 30 mi-
nutes (LY30; percentage) and estimated percent lysis (EPL) were in-
versely correlated with levels of ATIII and fibrinogen. PT was not
correlated with TEG during all of these phases.
CONCLUSIONS. This study demonstrated that conventional
coagulation tests and TEG tests show particularly poor agreement
during the anhepatic period of liver transplantation. TEG can be
more reliable in the anhepatic phase, which is more complicated and
during which dynamic hemostatic changes occur.REFERENCE(S)
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INTRODUCTION. Venous thromboembolism is a common
complication in intensive care units, which increases mortality
morbidity. According to different risk assesment methods, without
use of thromboprophylaxis, the risk of deep venous thrombosis may
reach up to 81% and in case of its usage,can be reduced to 44% or
even lower based on predisposing factors.
OBJECTIVES. We were to assess the appropriate use and extent of
adherence to venous thromboprophylaxis in different intensive care
units (ICUs) according to Caprini scoring system.
METHODS. In this study, 296 patients admitted in five different types
of ICUs in two referral, university affiliated hospitals were studied
during a 6 month period in year, 2016 . Data were collected in a
predefined questionnaire based on caprini risk assesment tool and
appropriatness of thromboprophylaxis consumption was assessed.
RESULTS. Among the studied population, 87 (29.4%) cases were
female and 209 (70.6%) were male. Distribution of patients among
different ICUs was, medical 27%, trauma 32.4%, neurosurgical 25%,
surgical 11.5% and neurological 4.1%. Distribution of patients
according to risk level was as follows ; very low 2.7%, low 507%,
moderate 17.2% and severe 74.3%. Overall, most of the patients who
required prophylaxis received it but appropriateness and
sufficiencies, varied.From 296 studied cases, only 62 patients (20.9%)
received appropriate and sufficient prophylaxis while 64 patients
(21.6%) did not received it at all. 78 patients (26.4%) had
contraindication to administeration of drug prophylaxis, among
them, 67 cases need compression device but it was applied in only
19 cases (28.3%). Although according to Caprini score, all patients
admitted in neurological ICU were at severe risk, but none of them
received sufficient prophylaxis.
CONCLUSIONS. There is a gap between real life VTE prophylaxis and
what is suggested by the Caprini scoring recommendations in our
ICUs.Improved prescription of extended thromboprophylaxis is
warranted to ensure adherence to standard guidelines.
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INTRODUCTION. Blood transfusions are an usually practice at the
ICU. There is an increasing evidence of potential harm and
sometimes worsen patient outcomes so, nowadays, we suggest that
blood and component transfusions carry significant though poorly
quantified risks. It has been estimated that greater than 40% of
patients receive one or more red blood cell transfusions (RBC) while
in the ICU.
OBJECTIVES. The aim of our study was to determinate short term
survival and associated predictors obtained on admission and during
staying at ICU.
METHODS. We made a retrospective and observational study of
patients admitted to the ICU during six months and who have
received at least one blood component. Patients admitted with
cardiac diseases were excluded. On admission, we recorded clinical
and laboratory parameters. Survival of patients at the end of the
study was investigated. Kaplan-Meier survival curves were calculated
and compared by Long Rank test. Factors associated with survival
were obtained using multivariate Cox regression analysis.
RESULTS. 137 patients were identified. The mean age was 61.6 ± 15
years and 65% were men. On admission the mean value of APACHE II
was 22 ± 7. 43% came from the emergency department, 37% from the
hospital ward and 20% from another hospital. 61% required invasive
ventilation, 48% received vassopresors and 19% CVVHDF. Among of
1144 units were transfused, 602 (53%) were red blood cells, 305 (27%)
platelets, 234 (20%) fresh frozen plasma (FFP) and 3 (<1%)
cryoprecipitates. Most patients received RBC (79%). The average
pretransfusion hemoglobin concentration was 7.9 ± 2 g/dl and the
ratio RBC/patient was 5.6 ± 6.2. The common indication for transfusion
was low hemoglobin (39% had Hb < 7 g/dl, 42% between 7–9 g/dl).
Overall, 67 (49%) and 31 (23%) of the patients were transfused platelets
and FFP, respectively. The indications for transfusion were hemorrhage,
low platelet counts, prolonged prothrombin time or to provide cover
for invasive interventions. Most platelet transfusions were given at
values in the order of > 50.000/ mcl (53.7%). Total survival achieved
63.5%. The accumulated survival decreased below 50% at the month.
Immunosuppression, APACHE II, ventilation, CVVHDF, vasopressors,
number of RBC transfused, hemoglobin and platelet pretransfusion
values were statistically significant variables related to survival analysis
(p < 0.05). The number of transfused RBCs was the only independent
predictor of survival (p = 0.035). The average stay in ICU and in the
hospital ward was of 14 ± 15 and 21 ± 28 days respectively. ICU
mortality was 29.2%. Most patients died within the first week.
CONCLUSIONS. Transfusion practice in ICU is consistent with the
clinical practice guidelines. The most frequent indication is the
hemorrhage. We have a restrictive therapy. ICU mortality of
transfused patients is high. Up to 1/3 dies during the first week. The
number of transfused RBCs was the only predictor of survival at the ICU.0611
EXTEM ROTEM profile in a cohort of patients with non recovered
cardiac arrest
J. A. Barea-Mendoza, L. Terceros-Almanza, C. García-Fuentes,
C. Mudarra-Reche, S. Bermejo-Aznárez, I. Prieto-Portillo,
J. A. Cantalapiedra, J. C. Montejo-González, M. Chico-Fernández, Trauma
and Emergency Research Group (GINTEM_12O)
112 de Octubre Hospital, Trauma and Emergency ICU (UCITE), Critical
Care Department, Madrid, Spain
Correspondence: J. A. Barea-Mendoza
Intensive Care Medicine Experimental 2017, 5(Suppl 2):0611
INTRODUCTION. Traditionally, coagulopathy has been diagnosed
with the usual laboratory tests. However, these determinations are
not sensitive and do not allow us to detect the mechanisms
responsible. ROTEM has been developed to enable early point of
care in ICU. Hypoperfusion has been described as a coagulopathy
trigger. Several studies have assessed the incidence of coagulopathy
during and after cardiac arrest. Cardiac arrest (CA) is the most
extreme hypoperfusion example in the human specie. The study of
those process during CA could offer a better understanding about
the role of hypoperfusion in the coagulation during critical illness.1
OBJECTIVES. To describe the ROTEM (Rotational Thromboelastometry)
pattern in patients with non shockable cardiac arrest.
METHODS. Prospective, unicentric study was developed according
with prespecified protocol. We include all patients admitted in our
center with out-of-hospital cardiac arrest in non-shockable rhythm
from February to December 2015. No exclusion criteria were estab-
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 314 of 542lished. We collected initial heart rhythm, time between arrest and ad-
mission, and characteristics of cardiopulmonary resuscitation (CPR).
Blood sampling was performed at admission. Coagulation tests were
performed within 30 min after blood collection. The routine coagula-
tion tests performed: prothrombin activity (PT), partial thromboplas-
tin time (aPTT) and fibrinogen determination. We analyzed the
ROTEM EXTEM assay in all samples. The included parameters were:
clot time (CT), clot formation time (CFT), maximum clot firmness
(MCF), maximum lysis (ML). Quantitative data are reported as median
(Interquantile Range; 25–75). Categorical ones are shown in N (%). All
analyses are performed with STATA 12.
RESULTS. The study included 14 patients. The median age was 48
years (42.7-54.31), 12 were men (82.2%). The time from arrest until
hospital admission was 83 min (62.3-105.4). All patients stayed in
cardiac arrest during blood sampling. Initial rhythm was ventricular
fibrillation in four patients, asystole in seven patients and unknown
for three patients. At admission the hemoglobin levels were 13.6 g/dl
(12–15.3) and the platelet count was 137.6 × 109/L (115.2-160). The
results of the routine coagulation tests were: AP 75% (66.4-83.7);
TTPA 64 (52–75.5) and fibrinogen levels 235 mg/dl (114–355). For the
ROTEM EXTEM assay the results expressed as median (IQR) were: CT
125 (96–153), CFT 287 (179–396), MCF 34 (25–43), ML 80 (63–96).
ML > 15% for 13 patients.
CONCLUSIONS. In our sample, patients after non reversed cardiac
arrest presented prolonged TTPA. The EXTEM assays presented a
pattern suggestive of alterations in the extrinsic pathway and
fibrinolysis. The study of the coagulation disturbances after CA could
be an interesting model of hipoxia-couagulation relationships.
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INTRODUCTION. Hypofibrinogenemia is defined as fibrinogen
levels < 150 mg/dL, and is distinguished in acquired and congenital,
the latter being very rare. The acquired disorder is usually attributed
to reduced hepatic production, as it happens in hepatic failure or
when consumption is increased in cases of DIC. Rarer causes include
medicines that inhibit synthesis in the liver, and primary fibrinolysis.
OBJECTIVES. To evaluate the incidence, causes and significance of
hypofibrinogenemia in the ICU.
METHODS. All pts admitted to an 8-bed general ICU during 2015
were retrospectively assessed. Demographics, cause of admission,
APACHE II and SOFA scores, ICU LOS and outcome were recorded in
all pts that developed hypofibrinogenemia during their ICU stay.
Data are presented as means ± SD or as median (min, max), for nor-
mal and skewed distributions, respectively. Graph Pad Prism 5.0 was
used for the descriptive statistics.
RESULTS. A total of 173 pts were admitted during 2015. The number
of pts who developed hypofibrinogenemia was 12 (6.94%, 8 females)
with a mean age of 66 ± 19 years, APACHE II 26 ± 7.20 and SOFA
10 ± 2.90. One pt presented 2 episodes of hypofibrinogenemia
during ICU stay, and 8 pts were septic (66.67%). ICU LOS and
mortality rate was 39 ± 42 days and 75%, respectively.
Hypofibrinogenemia occurred in the 11th day of stay (1st to 63th)
and lasted 5.40 ± 3.70 days. Median levels of fibrinogen were 110
mg/dL (unspecified-150). Seven pts had DIC and 2 hepatic failure, 8had received tigecycline (for ≥1 reasons in 6 cases) and 2 had an
unknown cause.
Hemorrhagic complications occurred in 2 cases (15.38%), while FFP
transfusion or dry fibrinogen substitution was undertaken in 3 cases
(23.08%).
CONCLUSIONS. Hypofibrinogenemia was observed in only a small
percentage of critically ill pts who usually were septic, more seriously
ill and had a worse outcome. Hypofibrinogenemia was more
frequently associated with the use of tigecycline, a finding that has
been referred in small case reports up to now. Physicians should be
aware of this complication and monitor fibrinogen levels during
tigecycline administration.
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INTRODUCTION. Percutaneuos dilational tracheostomy (PDT) is a
common and increasingly used procedure in the intensive care unit
(ICU), usually performed with bronchoscopy guidance. Ultrasound
has emerged as a useful tool to assist PDT, potentially improving its
success rate and reducing procedure-related complications.
OBJECTIVE. To investigate whether ultrasound-guided PDT is equiva-
lent or even superior to bronchoscopy-guided and anatomical
landmark-guided PDT with regards to the procedure-related and clin-
ical complications.
METHODS. We conducted a systematic review of randomized clinical
trials comparing ultrasound-guided PDT to control groups (either
bronchoscopy- or landmark-guided PDT) in patients undergoing PDT
in the Intensive Care Unit (ICU). Our primary outcome was major
complications rate and our secondary outcome was minor complica-
tions rate. A random-effects meta-analysis was used to pool the
results.
RESULTS. Four studies fulfilled inclusion criteria and were analyzed,
comprising 588 subjects. There was no difference in the major
complications rate between patients assigned to ultrasound-guided
PDT compared to control groups (pooled RR 0.48; 95% confidence
interval [CI] 0.13-1.71, I2 = 0%). Minor complications rate were not
different between groups, with high heterogeneity (pooled RR 0.49;
95% confidence interval [CI] 0.16-1.50, I2 = 85%). Sensitivity analysis
including only RCTs using landmarks-guided PDT as the control
group showed lower rates of minor complications in the ultrasound-
guided PDT group (pooled RR 0.55; 95% CI 0.31-0.98, I2 = 0%).
CONCLUSION. Ultrasound-guided PDT seems feasible and compar-
able to bronchoscopy-guided PDT regarding major and minor com-
plications, while it seems to reduce minor complications when
compared to landmark-guided PDT.
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INTRODUCTION. Endotracheal intubation (ETI) is one of the most
commonly performed procedures in the intensive care unit
(ICU)[1]. ETI can be life-saving for patients presenting with acute
respiratory failure. However, if the clinician is not vigilant during
the procedure, complications can arise that may impact the
overall outcome of patients. In addition, ETI carried out in the
ICU, as compared to other environments, can be associated
with increased complications, likely resulting from the lack of
time for optimization before ETI as well as patient-related fac-
tors [1].
OBJECTIVES. Our primary aim was to identify predictors of an
immediate airway complication during the peri-intubation period
and to assess outcomes of those who developed an airway com-
plication. Secondary aims were to report short-term outcomes of
those who developed an airway complication compared to those
who did not.
METHODS. We conducted a nested case control study of adult
critically ill patients admitted to a medical and/or surgical ICU
requiring emergent and non-emergent ETI during two year
study period. For the primary aim, data on airway management
was collected during the peri-intubation period (60 minutes
pre- and post- intubation). We defined an immediate airway
complication as hypoxemia (pulse oximetry reading < 90%) oc-
curring at any time 30 minutes following ETI. Once identified
within the cohort, patients were then classified as cases (those
who experienced hypoxia) and controls (those who did not ex-
perience hypoxia).
RESULTS. 74 out of 420 patients experienced an airway
complication (incidence of 18%). Patients who experienced an
immediate airway complication were of lower age, male gender,
and higher weight. These patients also had significantly higher
illness severity APACHE 3 score at 24 hours of ICU admission. A
history of obstructive lung disease did not lead to increased
odds of experiencing an airway complication. However,
intubating patients with acute respiratory failure was associated
with experiencing an airway complication. On the contrary,intubating for airway protection and/or for a procedure resulted
in decreased odds of experiencing an airway complication.AIRWAY
complication
(N = 74)No AIRWAY
Complication
(N = 346)p-
valueAge (years), mean ± SD 62.1 ± 17.2 63.0 ± 16.1 .655Male, n (%) 45 (60.8) 199 (57.5) .602Weight (kg), mean ± SD 86.2 ± 33.1 84.5 ± 28.6 .639APACHE III 24hr score,
mean ± SD89.6 ± 33.8 82.6 ± 25.0 .041Reasons for intubation, n (%)Airway protection 20 (27.0) 153 (44.2) .006Acute respiratory failure
(dyspnea and/or Sa02 < 90%)61 (82.4) 221 (63.9) .002Neurologic (stroke/altered
mental status)18 (24.3) 115 (33.2) .135Procedure-related (endoscopy/
bronchoscopy)9 (12.2) 94 (27.2) .007[Patient characteristics]AIRWAY complication
(N = 74)No AIRWAY Complication
(N = 346)p-
valueSa02(30 mins pre-),
mean ± SD89.1 ± 8.1 94.6 ± 6.2 <.001Sa02(30 mins post-),
mean ± SD88.6 ± 6.3 96.9 ± 2.7 <.001MAP (mmHg),
mean ± SD84.5 ± 22.0 83.7 ± 18.5 .740Emergency, n (%) 61 (82.4) 252 (72.8) .085Operator level, n (%) .050ICU attending 9 (12.2) 22 (6.4)ICU Fellow 60 (81.1) 314 (90.8)Resident 5 (6.8) 10 (2.9)[Variables obtained]AIRWAY
complication
(N = 74)No AIRWAY
Complication
(N = 346)p-
valueInvasive ventilation (days),
median [25th, 75th]1.8 [0.6, 6.5] 1.9 [0.6, 4.6] .524Non-invasive ventilation (days),
median [25th, 75th]0.0 [0.0, 0.9] 0.0 [0.0, 0.5] .300Tracheostomy during ICU, n
(%)10 (13.5) 25 (7.2) .076Tracheostomy during hospital,
n (%)13 (17.6) 36 (10.4) .082ICU LOS (days), median [25th,
75th]4.6 [1.8, 9.1] 4.0 [1.9, 7.2] .480Hospital LOS (days), median
[25th, 75th]9.5 [4.4, 21.4] 11.9 [6.2, 21.0] .139ICU death, n (%) 22 (29.7) 58 (16.8) .010Hospital death, n (%) 35 (47.3) 85 (24.6) <.001[Outcomes]
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 316 of 542CONCLUSIONS. Known risk factors associated with a difficult airway
and hence hypoxia did not result in increased risk of experiencing an
airway complication. Rather, patients not identified earlier in their
clinical deterioration are more likely to decompensate (intubation for
acute respiratory distress and pre-existing hypoxia). Furthermore, in-
experienced intubating providers are more likely to have an airway
complication as compared to experienced intubating providers. This
study sheds light on the fact that early recognition is paramount to
preventing an immediate airway complications,
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OBJECTIVES. Analyzing the impact of early tracheostomyon the
impact of ventilator-associated pneumonia (VAP), as well as analyzing
whether early tracheostomy reduces VM, sedation, ICU and hospital
stay duration, and whether it has any impact on death rate.
MATERIAL AND METHODS. Observational, prospective and
comparative study between patients who had been performed
elective early tracheostomy (within the first 7 days of MV) and
patients who were performed tracheostomy after 7 days of MV while
they were admitted in ICU from March 2012 to June 2015. Alpha
error was 5%. Multivariate logistic regression was applied to identify
factors which may predict interesting variables, thus controlling
confusion factors and potentially-related interactions.
RESULTS. A total number of 250 tracheostomies were performed in
that period. The profile of the tracheostomized patient is a middle
aged (58 years old) man who is admitted upon ICU usually after a
mainly neurological problem, followed by non-surgical reasons with
average APACHE II and SAPS 3 upon admission. Tracheostomy was
performed to 3.4% of the patients admitted upon this ICU in this
period, most of them being percutaneous (86.8%).
A total number of 104 early and 146 late tracheostomies were
performed. No significant differences are observed between both
groups regarding age, gender, comorbidities or severity on
admission scales. Early tracheostomized patients generally presented
VAP upon 18.4 ± 6.2days, while late tracheostomized patients
showed VAP upon 20 ± 6.6. However, VAP impact was significantly
lower in the group of early tracheostomized patients (14.4 vs. 30.1%;
p < 0.05). VAP was diagnosed according to SEMICYUC and ATS/IDSA
criteria. Multivariate analysis shows that early tracheostomy is a
protective factor (OR 0.359, IC 95% 0.184-0.699) against VAP when
stratified according to severity on admission (valued by means of the
APACHE II and SAPS 3 scales) and patient type (neurological
subgroup). Early tracheostomized patients presented fewer days of
MV (13.63 ± 11.69 days) relative to their late tracheostomized
counterparts (20.72 ± 11.84 days); p = 0.0001. Likewise, the first
group showed fewer days of sedation (p = 0.0001) and shorter ICU
stays (p = 0.0001) but not shorter hospital stays (p = 0,08). Early
tracheostomy shows no protective effects against mortality (OR 1.44,
IC 95% 0.75-2.75).
CONCLUSIONS. Early tracheostomized patients show significantly
lower VAP incidence, shorter VM and sedation (which involves
numerous related problems) duration, and shorter hospital stay
relative to late tracheostomized patients. Early tracheostomy shows
no impact on either ICU death rates or hospital stay.0616
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INTRODUCTION. Rapid sequence induction of critically unwell
patients outside of the operating theatre is high risk and associated
with significant morbidity (1). It is often performed by inexperienced
trainees with lack of expert assistance or advanced equipment, in an
unwell cohort of patients. The Fourth National Audit Project (NAP4)
highlighted this, and also the higher frequency of adverse airway
events (2). Following a local audit, which revealed a high
complication rate (39%), an Intubation Bundle was introduced to
standardise airway management in Critical Care. This consisted of a
standardised checklist and equipment preparation sheet, difficult
airway algorithms with regular in situ MDT training & an Airway
Rescue in Critical Care Course (ARCC).
OBJECTIVES. To undertake a snapshot audit of Airway Management
in the ICU. To evaluate the efficacy of an "Intubation Bundle".
METHODS. Performed in a 67-bedded intensive care department in a
central London teaching hospital. Data was collected from August to
October 2016. Proforma completed by staff performing the RSI.
RESULTS. Data was collected for 24 intubations. Majority performed
for respiratory failure (n = 8, 33.3%). First pass intubation performed
in 92% (n = 22) of RSIs and waveform capnography and an
intubation checklist were used in 96% (n = 23). All intubations
performed by doctors with more than 2 years of airway experience,
with 2 doctors present in 33% and a consultant present in 29% of
cases. 8 patients (33%) suffered one or more adverse events &
included significant hypoxaemia (21%), significant hypotension
(17%), bradycardia and 2 multiple intubation attempts (3 attempts in
both cases). In total, there were 12 adverse events affecting 8
patients compared with 15 adverse events affecting 7 (39%) patients
prior to the introduction of the intubation bundle. This was not
statistically significant (p = 0.7).
CONCLUSIONS. We have demonstrated a snapshot of RSI practice in
a busy, tertiary ICU. A high first-pass success rate was shown with
good use of the Intubation Bundle. A non-significant reduction in
complications is reported, which may be related to the Intubation
Bundle and its safety features. This bundle of care has heightened
airway awareness across critical care and is now being introduced
throughout the the hospital. Airway documentation in the ICU has
been updated, with electronic proforma which will enable ongoing
analysis. Education with MDT training, including simulation, com-
bined with audit will hopefully improve airway management in this
challenging environment.
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Fig. 221 (Abstract 0618). Comparison of Pre and post
course confide
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standard device to facilitate endotracheal intubation (ETI), however,
it is very difficult to be skilled in the technique.
OBJECTIVES. The goal of this study was to determine the utility of
the C-MAC (Karl Storz, Tuttlingen, Germany) as a training tool for DL
in the emergent ETI.
METHODS. This was a single-center, retrospective propensity-
matched study of continuous quality-improvement data from April 1,
2014 to October 30, 2016. All ETI for adult patients (18 years of age
or older) performed by emergency medicine residents with conven-
tional Macintosh DL or C-MAC as DL were included for the analysis.
When C-MAC was used as DL, operator was not allowed to see the
monitor and identified anatomy through the mouth of the patient.
Supervising physician saw the monitor and gave instructions in real
time to find glottis. The primary outcome was the first pass success
rate (FPS). The secondary outcome was multiple attempts and
intubation-related complications. Patients were matched based on
propensity scores determined by variables including indication of in-
tubation, presence of difficult airway characteristics, level of resi-
dency (junior vs senior) and intubation experiences.
RESULTS. A total of 939 intubations took place over the study period,
and 744 were included for the analysis. Of the eligible patients, 163
were performed using C-MAC as DL, and 581 using conventional DL.
From these, 163 propensity score matched pairs were generated (1-to-
n matching: C-MAC as DL group, 163 vs. conventional DL group, 428).
Before matching, the overall FPS rate of eligible patients was 72% (539/
744). For the propensity-matched groups, overall FPS rate was 69%
(409/591), 79% (129/163) for the C-MAC as DL group and 65% (129/
428) for the conventional DL group. Overall multiple attempts were 8%
(44/591), 4% (6/163) for the C-MAC as DL group and 9% (38/428) for
the conventional DL group. Overall intubation related complication rate
was 11% (65/591), 4% (7/163) for the C-MAC as DL group and 14% (58/
428) for the conventional DL group.
CONCLUSIONS. The C-MAC (Karl Storz, Tuttlingen, Germany) is useful
as a training tool for DL indicated by increased FPS and decreased
multiple attempts and intubation-related complications compared to
conventional DL.
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INTRODUCTION. Tracheostomies are performed within Intensive
Care. With increased throughput, patients are discharged to wards
prior to decannulation. NCEPOD in 2014 stated members of staff on
wards should be 'competent in recognising and managing common
airway complications including tube obstruction or displacements'
[1]. In a review of NPSA reports it was shown that 453 tracheostomy
incidents over 2 years were largely due to blocked or displaced
tubes and were associated with patient harm [2]. Newly qualified
(foundation) doctors haven't got experience with managing
tracheostomies but they may be called to manage emergencies
when on call, without seniors immediately accessible. Therefore a
session involving lectures and scenario training was held for
foundation doctors at a District General Hospital (DGH).
OBJECTIVES.
1. Assess Foundation Doctors' knowledge of tracheostomies and
management of a blocked tracheostomy emergency scenario
2. Teach the above3. Assess success of teaching sessions
a. Knowledge
b. Feedback
METHODS. A pre-course survey was sent to all foundation doctors at
a DGH to assess knowledge and experience. Each cohort received 1
teaching session of:
1 Lecture- tracheostomies, laryngectomies, types of tracheostomy
tubes and management of blocked tracheostomies.
2 Practical session- different tubes and associated equipment.
3 Scenario teaching session running through a blocked tracheostomy
scenario.
Post-course questionnaires were circulated.
RESULTS. There were 43 pre and 39 post course responses. 72%
hadn't received tracheostomy teaching previously; 88% had come
into contact with tracheostomy patients.
Confidence improved managing blocked tracheostomies, the
majority of trainees said they would score their confidence as 3-4/5
post course. (1- not confident, 5- very confident)
There was improvement in knowledge comparing pre and post
course questionnaires of managing blocked tracheostomies;
application of oxygen via mouth and tracheostomy, passing a
suction catheter and removal of the inner tube.
CONCLUSION. We identified requirement for tracheostomy training
for Foundation Doctors. Using multimodal sessions we saw an
improvement in knowledge and confidence managing blocked
tracheotomies. This is a short, cheap, repeatable intervention which
could be adapted for multi disciplinary use. Increasing tracheostomy
knowledge and familiarity should translate to improved patient
safety post discharge [3].
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Fig. 222 (Abstract 0618). Steps involved in emergency
blocked trach
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INTRODUCTION. Critically ill elderly patients requiring prolonged
intubations often develop ICU-acquired swallowing disorders (ICU-
ASD), which related to the worse outcomes. However, few research
has examined the incidence of ICU-ASD using fiberoptic endoscopy.
OBJECTIVES. The aim of our study is to describe the incidence and
clinical characteristics of ICU-ASD in the elderly patients using fiber-
optic endoscopy.METHODS. A cross-sectional study was conducted in our medical-
surgical ICU from May 2016 to March 2017. The inclusion criteria
were all consecutive patients aged ≥65 years old who required pro-
longed intubation (endotracheal intubation ≥48 hours). Exclusion cri-
teria were patients who had preexisting dysphasia, tracheostomy,
and altered mental status (GCS < 13). All included patients were ex-
amined for ICU-ASD using fiberoptic endoscopy within 48 hours after
extubations. The severity of ICU-ASD was evaluated using the Hyodo-
Komagane score which consists of four categories (0: normal, 1: mild,
2: moderate, 3: severe) and assessed four findings (salivary pooling in
the vallecular and piriform sinuses, response of the glottal closure re-
flex, swallowing reflex initiation, pharyngeal clearance after swallow-
ing of test water). The primary outcome was incidence of ICU-ASD.
The secondary outcomes were incidence and characteristics of vocal
code injury (edema, ulceration, granulation, and immobility), and the
length of ICU stay.
RESULTS. 59 patients were included in our study. Median age was
79.0 (73.5-83.0) years old and 59% were male. The median intubated
days were 6.0 (5.0-9.0) days. Indications of intubations were sepsis
(42.3%), respiratory failure (22.0%), trauma (16.9%), and others
(18.8%). The median APACHE II score was 21 (17–13). The incidence
of ICU-ASD was 16 patients (27.1%). The severity of ICU-ASD was nor-
mal 22 patients (37.3%), mild 12 patients (20.3%). And observed ab-
normal findings were as follows: 16 patients had aspiration, 3
patients had moderate to severe salivary pooling degree, 6 patients
had that reduction of the glottal closure reflex, 11 patients had de-
layed time of the swallowing reflex, and 6 patients had reduction of
pharyngeal clearance. The vocal cord injuries were seen in 14 pa-
tients (edema 5 patients, ulceration 3 patients, granulation 6 patients,
and immobility 6 patients, respectively). The length of ICU stay was
8.0(6.0-10.0) days.
CONCLUSIONS. The incidence of ICU-ASD was 27.1% in the elderly
patients. Further studies are warranted to investigate the risk factors
of ICU-ADS in elderly patients.
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INTRODUCTION. Surgical tracheostomy (SgT) is a time-established
procedure. Percutaneous tracheostomy (PcT) has been said to have
many advantages over SgT: a smaller skin incision and less dissection
and tissue trauma, and therefore fewer wound complications such as
hemorrhage, infection, tracheal stenosis or scar problems, and less
cost of the intervention. Studies comparing PcT and SgT show that
advantages of PcT are less obvious. However, there are not many
large studies comparing outcomes.
OBJECTIVES. To analyse quality indicators and compare the outcome
in patients that underwent for a SgT or PcT.
METHODS. A retrospective study was undertaken to compare
outcome, in critical care patients admitted in Barts Health Trust (Barts
Hospital, Royal London Hospital, Newham University Hospital and
Whipps Cross Hospital) during 2016, PcT technique performed at the
bedside vs SgT technique performed in the operating room. Criteria
for elective SgT remained on the decision of the intensivist, based
on: anatomy, morbid obesity or possible major complications (i.e.
bleeding). Indicators used were: time to insertion, time to
decannulation, decannulation success, complications and mortality.
Statistical analysis for description of the sample and averages
comparison were performed by Excel and SPSS.
RESULTS. Our population consisted on 274 patients (n = 274): 190
males (69%) and 84 females (31%) with an average age of 52 ± 17
years. SgT was performed in 56% (n = 154) of our patients while PcT
Table 163 (Abstract 0621). Baseline and follow-up parameters
Baseline 5´ 60´ p
Heart rate 97.7 ± 14.4 97.1 ± 15.1 97.3 ± 14.2 0.82
Mean blood pressure 87 ± 11.9 87.6 ± 14.7 83.6 ± 14.7 0.57
PaO2 105.5 ± 23.9 124 ± 55.5 143 ± 42.3 0.031
PaCO2 37.5 ± 12.6 40.5 ± 13.3 35.2 ± 8.2 0.058
PaO2/FiO2 239.8 ± 96.8 285.5 ± 140 328.7 ± 104.7 0.14
Minute Volume 10.6 ± 3.6 11.0 ± 3.2 9.6 ± 2.6 0.13
Static Compliance 18.7 ± 8.8 17.2 ± 9.1 19.1 ± 9.3 0.33
Dynamic compliance 17.7 ± 9.5 16.3 ± 9.4 17.6 ± 9.6 0.4
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 319 of 542was inserted in 44% (n = 120). We found statistical differences
(p < 0.005) for the time to insertion of Tracheostomy: 12.77 days for
SgT and 10.60 days for PcT; as well as in relation to SgT and PcT
mortality: 9% (n = 26) and 4% (n = 11) respectively. Successful
decannulation occurred in 97% of our patients but all the patients
that failed (n = 4) had a SgT and was related to secretion load. Our
results show no significant differences between the two techniques
of tracheostomy, in terms of time to decannulation: 23.15 days for
SgT and 23.82 days for PcT or complications (5% SgT; 2% PcT). No
major complications were observed with any of the techniques.
CONCLUSIONS. SgT and PcT techniques were both safe when
conducted by experienced, skilled practitioners, with no difference in
major complications or time to decannulation, but SgT showed
higher rate of failure at the time of decannulation and carried, in our
population, double rate of mortality.
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INTRODUCTION. Catheter suctioning of respiratory secretions in
intubated patients is limited to the proximal airway and associated
with complications like traumatic lesions to the mucosa and poor
tolerance. “Mechanical insufflation-exsufflation” (MIE) with “airway
clearance devices” exerts positive pressure, followed by an abrupt
drop to negative pressure. Potential advantages of MIE are aspiration
of distal airway secretions, avoiding trauma and improving tolerance.
OBJECTIVES. We evaluated the safety of MIE (50 cmH2O, 3 seconds;
−45 cmH2O, 4 seconds), with high frequency oscillation on both
pressure plateaus.
METHODS. Clinical, laboratory, respiratory and ventilator parameters
were recorded at baseline and compared to values collected at 5
and 60 minutes after MIE. Patients were reconnected to baseline
ventilator parameters immediately after MIE. Quantitative variables
were compared by Student's t test, analysis of variance for repeated
measurements, or non-parametric tests, as appropriate. Qualitative
variables were compared with chi square or Fisher's tests. Patients
were followed during their ICU stay until discharge or death.
RESULTS. We studied 7 male and 6 female patients requiring
suctioning who were connected to the MIE device a total of 26 times
on median day 12 (IQR 6.25; 28.25) after ICU admission and 11.5 (IQR
6.25; 25.75) after endotracheal intubation. Per session, a median of 2
(IQR 1; 2) cycles were performed. Mean tidal volume during
mechanical insufflation was 1043.6 ± 649.9 ml. The device was
connected 16 times to a tracheostomy tube and 10 times to an
endotracheal tube. All, except 1, MIE cycles were productive and well
tolerated. No statistically significant differences were identified
between baseline and post-MIE time points, except for an increase in
PaO2 (Table 163). Barotrauma, desaturation, atelectasis, hemoptysis
or hemodynamic complications were not detected after MIE.
CONCLUSIONS. Mechanical insufflation-exsufflation seems safe and
effective in this pilot study. Safety and efficacy need to be confirmed
in larger studies with different patient populations.0622
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INTRODUCTION. A multidisciplinary tracheostomy team (MDT) was
set up in Cork University Hospital (CUH) in Ireland in 2005. This team
comprised physiotherapists, speech and language therapists, nurses
and intensivists. The purpose of this quality improvement initiative
was to enhance the care provided to adult patients with
tracheostomies. Developments included various forms of education,
weekly ward rounds (including review of clinical practices of
tracheostomy care), support for staff caring for tracheostomy
patients and an annual database report is sent to all hospital
consultants. Data were collected prospectively over 10 years to
monitor changing trends after introducing the MDT.
Objectives:
• Examine numbers and outcome of patients with tracheostomies
• Identify changing trends
• Explore differences across subspecialties
Methods: Analysis of prospective data collected over 10 years during
weekly hospital wide MDT tracheostomy ward rounds. Data were
analysed using Microsoft excel descriptive statistics.
Results: There were 368 new patients (258 (70%) male) with
tracheostomies in CUH between Jan 2007 and December 2016. The
decannulation rate improved from 48% in 2007 to 63.5% in 2016
(Fig. 223).
Hospital mortality rate fell from 36% in 2007 to 12% in 2016 (Fig.
224) with an average of 23% for the 10 years. The mortality rate by
subspecialty can be seen in Table 164.
Overall 1 year mortality rates are currently being collated via national
register. There was no tracheostomy-related mortality during the 10
years.
Average time to decannulation dropped from 48 days in 2007 to 30
days in 2016 showing a slight downward trend over the 10 years.
Conclusions: Cumulative results over 10 years of MDT input in
tracheostomy care show improving outcomes in terms of
decannulation rate and mortality with a trend towards shorter times
to decannulation. Subgroup analysis shows that cardiothoracic,
respiratory and renal patients have higher than average mortality
rates, while neurosurgery patients have a much lower mortality rate.
These results are now being used as one aspect of informing
decision making on tracheotomy insertion in CUH. The database
facilitates local review and audit of the service provided to this
patient group. Overall the development of a tracheostomy multi-
disciplinary team has been a very welcome development whose suc-
cess is supported by these encouraging data.
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Fig. 223 (Abstract 0622). Decannulation rate (%)
Fig. 224 (Abstract 0622). In-hospital mortality rates (%)
Table 164 (Abstract 0622). Average mortality rate of subspecialties
over 10 years
Discipline Number of patients Average mortality rate
Neurosurgery 95 9%
Cardiothoracics 76 33%
Respiratory 43 33%
Vascular/General surgery 37 27%
Neurology 32 25%
Renal 22 36%
Others 63 21%
Average mortality of subspecialties over 10 years
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INTRODUCTION. Standardised care provided by a specialised
multidisciplinary tracheostomy team is associated with decreased
time to decannulation and fewer tracheostomy related complications
(Yu 2014 & de Mestral 2011) Patients with tracheostomies can
therefore benefit from a co-ordinated, multidisciplinary approach to
care. Speech and Language Therapy (SLT) specific expertise in asses-
sing and managing communication and swallowing needs is a vital
part of this process. (McGrath 2014) This SLT role includes assess-
ment and management of swallowing, voice and communication
function (Freeman - Sanderson 2011) Standardized care provided by
a specialised MDT tracheostomy team was associated with fewer
tracheostomy-related complications and an increase in the use of a
speaking valve.OBJECTIVES. To audit (SLT) intervention with patients with a
Tracheostomy in a Cardio-Respiratory ICU in London as compared to
a clinical audit carried out in an Australian Tertiary hospital ICU in
2011.
METHODS. Data was retrospectively analysed of all patients referred
to SLT, with a tracheostomy in situ in ICU, for 5 month period,
evaluating average time taken to commence verbal communication,
average time taken to commence oral intake from date of
tracheostomy insertion and length of tracheostomy cannulation.
Patient demographic data and reason for intensive care admission
were also collected. These results were compared to the audit data
presented in the Australian study.
RESULTS. A total of 25 patients were tracheostomised over the 5
month period. There were 9 males and the median age was 60.2.
The average time taken to commence phonation was 7 days post
tracheostomy insertion and the average time to commence oral
intake was 12 days post insertion (as compared to 16 days for
phonation and 15 days for oral intake in the Australian audit)
17/25 patients were initially assessed for speaking valve usage, to
allow phonation, whilst still on mechanical ventilation (Pressure
support).
CONCLUSIONS. Significantly improved length of time in
commencing phonation in patients with a tracheostomy in situ and
comparable times in facilitating oral intake, were demonstrated as
compared to the Australian audit. It is surmised that speaking valve
trials to facilitate verbal communication are commenced earlier in
our cardiothoracic intensive care unit, whilst most patients are still
on mechanical ventilation.
REFERENCES
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INTRODUCTION. When unplanned extubation (UE) occurs in
intensive care patients, mechanical ventilation therapy is affected
negatively(Epstein SK 2000, Kapadia F 2001).
OBJECTIVES. In this study, we aimed to investigate the
characteristics of UE patients, the duration of extubation and the risk
factors for re-intubation.
METHODS. In this retrospective cohort study of patients with UE
between May 1, 2010 and December 31, 2012; re-intubated patients
were defined as Group 1 (n = 12) and patients who did not need re-
intubation were defined as Group 2 (n = 12). Demographic features,
mechanical ventilation mode, UE source (patient - staff), APACHE II
score, presence of ventilator associated pneumonia, extubation time,
sedation, noninvasive mechanical ventilation (NIV) requirement after
extubation and reintubation requirement were recorded.. Group 1
and 2 were compared in terms of risk factors for reentubation.
RESULTS. Twenty-four patients (23 male) were included in the study.
Median age was 75 years (56–81). In group 1, APACHE II score was
significantly higher than group 2 (27 vs 23, p = 0.03); The pH was sig-
nificantly lower (7.26 vs 7.35, p = 0.008). Weaning was significantly
lower and mortality was significantly higher in group 1 (1/12 vs 8/12,
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 321 of 542p = 0.003) and (11/12 vs 1/12, p = 0.0001) respectively. In group 1,
the number of patients with ventilator-associated pneumonia was
higher (7/12 vs 2/12, p = 0.035). NIV support was applied to all cases
except 1 case.
CONCLUSIONS. Unplanned extubation is an undesirable condition in
intensive care. Patients with advanced age and high APACHE II
scores may be at higher risk of re-entubation and mortality.
REFERENCE(S)
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OBJECTIVE. Analyzing complications both during and up to 1 year
after the procedure of electively tracheostomized patients upon ICU
admission. Elaborating a checklist which shall allow us to prevent
some of the aforementioned procedure-related complications, thus
improving patient safety.
MATERIAL AND METHODS. Observational, prospective and
comparative study with patients who had been tracheostomized
during their ICU stay. Tracheostomies performed in UCI-admitted pa-
tients from March 2012 to June 2015 were analyzed, as well as
complications.
RESULTS. 250 tracheostomies were performed in that period.
Tracheostomy was performed to 3.4% of the patients admitted upon
this ICU in this period, most of them being percutaneous, with no
procedure-related lethal complications. Tracheostomies were per-
formed by widely experienced personnel.
Complications registered during the procedure represent 12%
(no = 23) of the analyzed population. The most frequent
complication, by far, was bleeding demanding cauterization, bonding
or surgical revision; followed by cannula misplacement (2.8%,
no = 7), pneumothorax (1.9%, no = 3) and, finally, tracheal rupture
(0.8%, no = 2). Late complications represent 7.6% (no = 19), the most
frequent one being tracheal stenosis (3.2%, no = 8) diagnosed after
ENT revision, followed by stoma bleeding and infection (both 2.8%,
no = 7). Of all tracheostomies performed in this period, 86.8% were
performed percutaneously by intesivists. The remaining
tracheostomies were performed in the operating theater by ENT
specialist. No significant differences are observed regarding
immediate complications between both techniques. More late
complications are generally observed with the surgical technique
(p = 0.001) (24.2 vs. 5.1%) in each of the three considered
complications. Ward monitoring was performed by ENT personnel by
means of interconsultation forms. We design our check list in order
to reduce procedure complications.
CONCLUSIONS. Tracheostomy is not exempt from risks and
complications, although they are not usually lethal. Even though,
comparing complications between the different existing studies is a
complex process due to the different definitions followed for each
complication. On the other hand, most complications depend on the
patient´s anatomy or basal features and personnel´s experience.0626
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INTRODUCTION. The common denominator of the reanimation
wards is to avoid their overcrowding with patients who need long-
term mechanical ventilation (LTMV) support.
OBJECTIVES. The necessity to be applied an advanced respiratory
management in children with tracheostomy airway prosthesis.
METHODS. The study is formed from 81 of patients from pediatric
reanimation ward of the IM&C and who have been under LTMV
during the last 9 years. Children were divided in 2 groups - the Ist
contained 46 children who were under LTMV without the application
of tracheostomy and the IInd which contained 35 children whose
ventilation management was with tracheostomy airway prosthesis.
RESULTS. This retrospective trial has identified the following facts:
children who were under artificial prolonged ventilation spent on
average 12 ± 2,9 days in bed. The causes for which the children
were under APV were the following diseases: Multiple developmental
abnormalities 28; Cerebral diseases and muscle diseases 25 children;
Congenital diseases of the bronchopulmonary apparatus and
cardiovascular system 14; Genetic diseases 14 children, inclusively 4
children with Down syndrome. The age of children was 1 month - 17
years. All the children have benefited from a special care for a critic
child who is under APV and an approach of the respiratory
Fig. 226 (Abstract 0627). See text for description
Table 165 (Abstract 0627). See text for description
circuit/
respiratory
rate
HA intercept of the
reference GE ventilator
(mg/L)
effect of VT
on HA per ml
VT
effect of
Servo U on
HA
effect of V
500 on HA
adult/15 29.44 +0.02* −2.57* +0.65*
neonate/
15
23.63 +0.02* +1.42* +2.22*
adult/30 33.18 +0.02* −2.61* −2.62
neonate/
30
28.13 +0.02* −0.32* +0.21
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respiration support by the artificial respiration through the cannula
tracheostomy in Volume SIMV or Pressure SIMV needed Vt 5 ml/kg
and smaller pressure in comparison with IET children under APV.
Simultaneously with the amelioration of general condition,
resumption of spontaneous breathing it was possible to re-initiate
oral feeding in 9 children of the second group beginning with the
second day after the installation of the tracheostomy. It should be
mentioned the significant decrease of the duration of being under
artificial respiration which was identified in the second group of chil-
dren 18 ± 1,9 days, and in the first group it constituted 37 ± 1,7 days.
Because of the severity of the main disease in the first group died 14
children and in the second group died 8 children, thus we have
founded high mortality in both groups, but it was succeeded to
transfer the children from the second group to palliative care.
CONCLUSIONS.
1. If comparing with IET children the advanced respiratory
management in children with tracheostomy airway prosthesis need
ventilator support with small volumes and pressure.
2. besides the increase of the survival rate in the second group, we
have founded a decrease of the duration of stay in intensive care,
improving the transfer of these children, thus decreasing the prime
cost of medical care.
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INTRODUCTION. In ARDS patients under ECMO common ventilator
strategy aims at resting the lung by lowering tidal volume (VT). We
were wondering whether such low VT can impact the efficacy of
heated humidifiers (HH) in ICU ventilators to achieve the
recommended target of 30 mg/L or more absolute humidity (HA).
OBJECTIVES. To assess on the bench HA over a range of low VT in
ICU ventilators.
METHODS. A pneumatic test lung (TTL, Michigan inc. Grand Rapids,
USA) was set at 20 ml/cmH2O compliance and 20 cmH2O/L/s
resistance and attached to either 3 ICU ventilators (V 500 (Drager),
Carescape R 860 (GE Healthcare), Servo U (Maquet)) equipped with
Fisher-Paykel MR 850 HH and double wired limb ventilator circuit.
PEEP was set to 12 cmH2O and FIO2 0.21. HA (mg/L) was assessed
by using the psychrometric method. Two probes measured the in-
spiratory gas temperature into a double circuit inserted between Y
piece and lung model. HH was set in manual mode and targeted 37°
C into the chamber and 40°C at the Y piece. HH was run during 45
minutes at VT 500 ml then 100 ml, each at respiratory rate 30
breaths/min. Temperature in both probes was continuously moni-
tored (Biopac M150) during the whole experiment. Once both tem-
peratures leveled off (change of 1% or less) at VT 100 ml, 10 cycles
were counted then 120 ml VT was delivered til next plateau
temperature and so on by 20 ml-increment in VT up to 280 ml. Then
VT was lowered to 100 ml and respiratory rate to 15 breaths/min. At
the time of plateau temperature same VT increment as above was
performed. The experiment was performed by using adult (RT 380
EVAQUA Fisher Paykel) and repeated with neonate (RT 266 EVAQUA
Fisher-Paykel) ventilator circuit. The primary end-point was the im-
pact of VT on HA. Data were analyzed by using linear mixed model.
RESULTS. Figure shows the box and whisker plots of HA across VT
for each ventilator, at 15 (upper panels) and 30 (lower panels)breaths/min with adult (left panels) and neonate (right panels)
circuits.
Over all the ventilators (taken as the factor with random effect in the
model), there was a significant effect of VT on HA: the mean value of
HA intercept of the reference (adult circuit and respiratory rate 15/
min) (25.75 mg/L) increased significantly by 0.02 mg/L per 1 ml VT
increase (P = 0.0001). It was significantly reduced by 4.17 mg/L with
the neonate circuit (P = 0.0011) and significantly increased by 0.19
mg/L with the 30 breaths/min respiratory rate (P = 0.0001). There
was no significant interaction between circuit and respiratory rate.
The table summarizes the effect of VT on HA in each panel of the
figure
CONCLUSIONS. A safe HA can be achieved at any low VT by using
adult circuit and respiratory rate 30 breaths/min with any ICU
ventilator presently investigated.Organisation issues
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INTRODUCTION. Intensive care medicine (ICM) is a relatively young
discipline that has rapidly grown into a full-fledged specialty. Intensi-
vists are responsible for managing an ever-increasing number of pa-
tients with complex, life-threatening diseases. Several factors may
influence their performance, including age, training, experience,
workload, and their socioeconomic contexts.
OBJECTIVES. To gain insight on individual and behavioral aspects of
the intensivist workforce in Latin America (LA).
METHODS. Cross-sectional study through a web-based electronic sur-
vey, in public and private ICUs from LA countries, academic and non-
academic. Study population were intensivists from Argentina, Bolivia,
Brazil, Chile, Colombia, Ecuador, Guatemala, Mexico, Paraguay, Peru,
and Uruguay, currently working in the ICU.
The survey included questions about training, workload,
competencies, continuous education, research activities, and
experiential aspects. Additionally, considering septic shock as a key
ICU condition that integrates diverse facets of clinical functioning, we
incorporated specific question regarding its treatment. Intercountry
comparisons were performed using the Gross National Income
indicator from the World Bank. The survey was submitted by email
to a list of LA intensivists obtained by national scientific societies and
personal contacts, with weekly reminders from June through
September 2016 to non-respondents.
RESULTS. 735 surveys (45% return) were responded from Brazil
(29%), Argentina (19%), Chile (17%), Uruguay (12%), Ecuador (9%),
Mexico (7%), Colombia (5%); Bolivia, Peru, Guatemala and Paraguay
(2%). LA intensivists' workforce is predominantly male (68%) and
young (42.0 ± 9.2 yr-old). ICU formal training among countries is be-
tween 2–4 years. ICU workload runs from 39–60 hours/week. Aca-
demic rounds are more frequent in academic units, mainly from
high-income countries (55 vs 46%, p = .014). Satisfaction with condi-
tions for appropriate septic shock management were reported as ad-
equate by most participants (85%). Unsatisfactory conditions were
attributed to insufficient technology (11%), laboratory support (5%),
imaging resources (5%), and limited drug availability (5%). Satisfac-
tion with septic shock management was significantly associated with
country income (p =0.0148). A 70% of intensivists participate in re-
search, and a 54% read scientific papers regularly (1–3 times a week).
On the other hand, 32% of them reads no more than one scientific
paper a month. Intensivists are mostly unsatisfied with their income
(81%). However, a minority of them (27%) report having considered
quitting their job as intensivists.
CONCLUSIONS. LA intensivist workforce faces resources and time
constraints. New challenges arise in terms of learning new
competencies, while balancing clinical, academic and personal areas.
National income seems to be an important determinant for the
quality of care in LA ICUs.
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INTRODUCTION. Adverse clinical events occur to all clinicians at
some point in their careers. These events can lead to a variety of
strong negative emotional consequences, e.g. isolation, self-doubt,
depression, rumination, and anxiety, that may result in reduced pro-
fessional performance and prolonged psychological stress. It isimportant that clinicians don't feel left alone and are supported
under these circumstances. Recently, a Peer Support (PS) program
was implemented in the hospital to address this need. Physicians,
nurses and paramedics from a wide variety of departments and
levels of experience were trained to provide PS during this difficult
time for their colleagues (peers).
OBJECTIVES. To evaluate the training program for physicians, nurses
and paramedics to offer PS with enough self confidence to
professional victims of an adverse event.
METHODS. The PS training program is developed after models used
in the Harvard teaching hospitals[i] and the OLVG, Amsterdam. The
one-day course covers an introduction to urgency of PS, the
organization in the hospital, an inventory of personal communicative
styles and a half day of interactive training of true PS conversations
and interactions of all participants with training actors. The training
is completed with a anonymous written evaluation.To become a Peer
supporter we asked all clinical co-workers in the hospital, over 8400
people, through e-mail to propose a colleague suitable for PS. This
lead to 195 suggestions from all kind of backgrounds: nurses, med-
ical doctors, physicians assistants, OR nurses, both experienced and
in training, young and old, covering almost all specialties in the hos-
pital. Colleagues introducing themselves or who were not clinically
involved were excluded. Few colleagues declined.
RESULTS. 68 participants (15 nurses, 25 medical specialists, 11
residents, 14 paramedics e.g. OR nurses,physician assistants and
midwives) were trained to perform PS. 66 completed the evaluation.
The training program was considered a positive educational
experience (n = 65) with a mean score of 4.3/scale 1–5 (SD 0.5)The
training met their expectations (n = 63) mean 4.2/5 (SD 0.7). 64
participants appraised the training offering guidance for performing
PS themselves in clinical practice, mean score 4.3/5 (SD 0.6).During
verbal feedback the trainees mentioned repeatedly that for many
clinicians the first impulse is to act when suffering is observed while
true PS is essentially listening and supporting the colleague with the
attention they need. The practical training made them more aware
of this mechanism. Overall satisfaction was scored 8.2 on a10 point
scale (mean, SD 0.8).
CONCLUSIONS. These results suggest that a practical training
program to strengthen clinicians´ confidence to offer PS may help to
actually to give that support, and so enhance professional
performance and learning of adverse events.
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INTRODUCTION. Sepsis is a clinical condition of disseminated and
uncontrolled inflammation associated with an infectious outbreak.
The organization of patient flow through the health system, ensuring
ICU beds is critical.
OBJECTIVES. Evaluate the association of the prioritization of
Vacancies in ICU with the mortality, morbidity and hospital stay time
of the patients;the strategy of prioritizing vacancies in the access of
patients in severe sepsis or septic shock to ICU beds; the strategy of
prioritization of vacancies in the delay to access of patients in severe
sepsis or septic shock to ICU beds and the strategy of prioritization
of vacancies in the mortality of patients in severe sepsis or septic
shock to ICU beds. The Quick SOFA prognostic index in patients with
severe sepsis or septic shock admitted to U.E.-HCFMRP-USP.
METHODOLOGY. This is a retrospective cohort based on
administrative data obtained from January 01,2010 to December 31,
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 324 of 5422016. We used Student t tests, Analysis of Variance or non-
parametric equivalents, chi-square or Fisher´s exact test and Receiver
Operating Curves for univariate analysis.Multivariate logistic regres-
sion with binary or categorical outcome and multivariate Poisson re-
gression as appropriate for the multivariate analysis. A p < 0.05 or
the exclusion of the unit from the confidence interval signaled statis-
tical significance.
RESULTS. Patients who received higher priority for ICU
access(priority 1–5826; 62,5%) were younger (55;12-100-p < 0,01),
had less comorbidities(Charlson 0,3583; 61,5%, p < 0,01) and less
severity (Quick SOFA 0,2170; 37,2%-p < 0,01;SOFA < 10%-1782; 0,5%-
p < 0,01). They were admitted in greater proportion (2097; 35,9%-
p < 0,01) and had faster access to ICU (1081;52,5%-
p < 0,01),presenting lower mortality (1853;31,8%- p < 0,01).The odds
ratio to receive priority 1, higher value of the Charlson class OR 0,53;
0,49-0,57, the Quick SOFA (Severity)-OR 0,45;0,43-0,48 and the
presence of Sepsis condition-OR 0,20-0,17;0,23 were independently
associated with a lower chance of being classified as priority 1.Sepsis
was more associated to lower chance of receiving priority 1(0,2; IC
95%-0,17;0,23). It persisted as an independent factor for total in-
hospital mortality(2,7; IC 95%- 2,32;3,17) and for the mortality of pa-
tients admitted to the ICU (2,38;IC 95%-1,82;3,11). The prioritization
of vacancies facilitated the access of the septic patients to the ICU.
There was no delay in ICU admission for septic patients who received
priority 1 (0,43; IC 95%-0,35;0,53). The Quick SOFA prognostic index
had low accuracy in patients with severe sepsis or septic shock ad-
mitted to U.E.-HCFMRP-USP (AUROC = 0,5646, IC95%-0,52991;
0,59930-p < 0,001).
CONCLUSIONS. Sepsis presented a high mortality even when
admission to the ICU was guaranteed. Flow management strategies
were effective in securing access in ICU.
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INTRODUCTION. Intensive Care services are under increasing
pressure, with higher than recommended bed occupancy (1), an
ageing population and burden of chronic disease. This results in an
increased workload for ICU teams. It is recommended that senior
clinicians should be involved in unplanned admissions to ICU, both
in the referring and reviewing teams. Prompt admission to critical
care is associated with reduced morbidity and mortality (2).
There is no international standard for the referral process. In our unit,
there are no formal data for referral numbers and details, and no
formal system for documentation of telephone advice or follow-up
of patients who do not need immediate admission but are at risk of
deterioration.
OBJECTIVES. This project aimed to quantify the workload generated
by referrals to a tertiary centre ICU, understand who is making them
and look at the outcomes of these referrals to assess whether an
electronic system is required.
METHODS. A purpose designed referral proforma booklet was
provided to doctors receiving referrals. Details for referrals were
collected continuously over a 3 week period. Various matrix of the
referral process was recorded including time of referral, patient
demographics, prior ceilings of treatment, seniority of referrer and
whether the Consultant was involved was noted.
RESULTS. 117 referrals were recorded over 3 weeks. 18/117 (15.4%)
were from a Consultant and 25/117 (21.4%) were from a doctor
below registrar level. In 47/117 (40.2%) the patient's Consultant wasunaware of the referral. 7/117 (6.0%) had a DNACPR order in place.
26/117 (22.2%) referrals were given telephone advice only with no
documentation being made by the ICU team. 93/117 (79.5%) of
referrals were not discussed with the ICU Consultant at the time of
referral. 23/117 (19.7%) were admitted to ICU or another specialist
critical care unit on site. 50/117 (42.7%) were felt to not require ICU
and 22/117 (18.8%) were felt to be inappropriate to admit to ICU. Of
referrals from doctors below registrar grade, 22/25 (88%) did not
require ICU admission. Documentation of timing of referral, review
and admission was poor, with all 3 only recorded in 8 cases.
CONCLUSIONS. Recording data for referrals to ICU yields useful
information, which impacts on teams throughout the hospital. An
electronic system for referrals is needed. This will allow effects of
interventions to be measured. It will also allow the ICU team to
document advice given over the phone and discussions with
consultants about referrals.
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INTRODUCTION. Prompt admission to critical care is associated with
reduced morbidity and mortality, and it is recommended that senior
clinicians should be involved in unplanned admissions.
Recommendations for target timescales of under 4 hours (UK ICS)
and under 6 hours (SCCM) to admission have been made but there
is no gold standard referral process (1) (2).
In our unit, there are no data for referral numbers and details, and
no formal system for documentation of telephone advice or follow-
up of patients referred but not admitted. Times from referral to ad-
mission are not recorded. This project aimed to quantify the work-
load generated by referrals to a tertiary centre adult intensive care
unit (AICU). It also looked at who is making them and at the out-
comes, to see whether an electronic referrals system is needed.
OBJECTIVES. To record prospective data for referrals to the AICU at a
university teaching hospital made over a 3 week period.
METHODS. A purpose designed paper referral proforma booklet was
carried by registrar doctors receiving referrals to AICU at a university
teaching hospital. Details of the patient, condition, referring team,
actions taken and outcomes were collected continuously over a 3
week period.
RESULTS. 117 referrals were recorded. 18/117 (15.4%) were from a
consultant and 25/117 (21.4%) were from a doctor below registrar
level. In 47/117 (40.2%) the patient's consultant was unaware of the
referral. 7/117 (6.0%) had a not-for-CPR order in place. 26/117
(22.2%) referrals were given telephone advice only with no docu-
mentation being made by the ICU team. 93/117 (79.5%) of referrals
were not discussed with the ICU consultant at the time of referral.
23/117 (19.7%) were admitted to ICU or another specialist critical
care unit on site. 50/117 (42.7%) were felt to not require ICU and 22/
117 (18.8%) were felt to be inappropriate to admit to ICU. Of referrals
from doctors below registrar grade, 22/25 (88%) did not require ICU
admission. Documentation of timing of referral, review and admis-
sion was poor, with all 3 only recorded in 8 cases.
CONCLUSIONS. Recording data for referrals to ICU yields surprising
and useful information, which impacts on teams throughout the
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 325 of 542hospital as well as in ICU. An electronic system for ICU referrals is
required, to allow measurement of interventions to increase referring
doctor seniority and home consultant involvement. It will also allow
documentation of telephone advice given and ICU consultant
opinion. Finally it will allow measurement of the timescale of
admissions to ICU.
REFERENCES
(1) Guidelines for the prevision of Intensive Care Services. (2017)
[online] Available at: http://www.ics.ac.uk/ICS/guidelines-and-
standards.aspx
(2) Nates, J.L., et al. ICU Admission, Discharge, and Triage Guidelines:
A Framework to Enhance Clinical Operations, Development of
Institutional Policies, and Further Research. (2016) Critical Care
Medicine: 44:8, pp 1553–1602
0633
Blood glucose control in critically ill adult patients: results of a
practice survey in French intensive care units
G. Besch1,2, L. Carteron1,2, C. Schneider1, J. Paillot1, E. Samain1,2,
S. Pili-Floury1,2
1Centre Hospitalier Universitaire de Besancon, Anesthesiology and
Intensive Care Medicine, Besancon, France; 2Université de Bourgogne -
Franche-Comté, EA 3920 Marqueurs Pronostiques et Facteurs de
Régulation des Pathologies Cardiaques et Vasculaires, Besancon, France
Correspondence: L. Carteron
Intensive Care Medicine Experimental 2017, 5(Suppl 2):0633
INTRODUCTION. Stress hyperglycemia is associated to an increase in
morbidity and in mortality in intensive care unit (ICU) patients.
Intravenous (iv) insulin infusion is the gold standard treatment of
stress hyperglycemia in the ICU. The modalities of blood glucose
(BG) control remain a matter of debate as contradictory results have
been reported with the various iv insulin therapy protocols that have
been published. If everyone agrees that hyperglycemia has to be
corrected to improve the outcome of ICU patients, no consensual
protocol has emerged. To date, the daily practice in BG control in
French ICU patients has never been studied.
OBJECTIVES. To assess how BG control is managed in French ICUs.
METHODS. An on-line questionnaire (SurveyMonkey®) was sent by
email to all heads-of-department of French ICUs that were accredited
for post graduate teaching of French residents from January to De-
cember 2016. The questionnaire has been build, tested and validated
by 4 attending physicians from our surgical intensive care unit prior
to on-line submission. The 14 first questions were used to describe
the characteristics of the ICU and to ask if a standardized BG man-
agement was protocolized. If the answer was “yes”, 29 more ques-
tions were added to precise the modalities of BG control and of the
iv insulin therapy protocol. Data presented are median [interquartile
range] and number of ICUs (percentage).
RESULTS. Among the 385 ICUs interviewed, 187 (49%) answers have
been analyzed. An iv insulin therapy protocol was used in 154 (82%)
ICUs. 116 (75%) ICUs have declared iv versus subcutaneous infusion
of insulin in BG control at the acute phase. The insulin infusion rate
was adjusted in 110 (71%) ICUs on the current BG value, in 50 (32%)
ICUs on the previous BG value, in 66 (39%) ICUs on the current
insulin infusion rate, and in 47 (31%) ICUs on the caloric intake. The
median values of the upper and of the lower limits of the BG target
range were respectively 150 [140–180] and 90 [80–110] mg.dl−1. The
safety and the efficacy of the iv insulin therapy protocol have never
been assessed in respectively 121 (78%) and 125 (81%) ICUs.
CONCLUSIONS. A practice survey conducted in French ICUs suggests
a great heterogeneity in the modalities of BG control managementat the acute phase of care in critically ill adult patients. A global
strategy based on actualized guidelines appears desirable to improve
the quality of these practices.0634
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INTRODUCTION. Despite lung-protective ventilation and other mea-
sures inpatient mortality for acute respiratory distress syndrome
(ARDS) remains high at over 40%1. Proning has long been suggested
to improve oxygenation in mechanically ventilated patients with
ARDS.
Recent research demonstrated that proning longer than 16 hours
within 36 hours of starting mechanical ventilation significantly
reduces 28-day mortality in patients with severe ARDS2. There are
further meta-analyses which also recommend proning1,3.
However, the United Kingdom currently has no national guidelines
on proning. The European Society for Intensive Care Medicine has
not published any either so the management of ARDS patients is
currently entirely dictated by local practice and individual
preferences.
OBJECTIVES. The primary aim of our project was to establish how
many hospitals in London had a pre-set formal local or regional
proning guideline for patients with ARDS. We also sought to evaluate
their specific triggers for proning and the duration. Our hypothesis
was that there was likely to be wide variations in practice.
METHODS. A total of 23 intensive care units in London were
contacted via telephone and/or email. Senior staff members were
asked to complete eight questions about their local proning practice.
22 intensive care units were very forthcoming and provided insight
into their local practice.
RESULTS. Of the 22 hospitals, only 18% (n = 4) had set guidelines on
proning.
64% (n = 14)of the ITUs routinely considered it as a way of treating
patients with ARDS whereas 36% (n = 8) did not.
67% (n = 14) favoured proning only in severe ARDS compared to
33% (n = 7) which used proning in moderate ARDS. The mean
maximum duration of proning was 18.3 hours over a 24 hour period,
ranging from 4–24 hours. The triggers for proning varied greatly
between the different units.
CONCLUSIONS. We found considerable variations in practice in the
22 units evaluated. Given that current evidence supports proning as
a beneficial measure in managing ARDS patients, there is an urgent
need for national guidelines to streamline the management of this
particular patient group.
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INTRODUCTION. Data registry in critical care is a valuable tool to
understand patients' demographics, disease characteristics, resource
utilization, quality measures, and service performance. Yet, only
limited objective information is available to describe the specific
epidemiological characteristics of critically ill patients in Qatar, where
the critical care services are overwhelmed by the substantial growth
of the population over the last few years.
OBJECTIVE. To study the demographic and clinical characteristics of
patients admitted to Medical Intensive Care Unit (MICU) in Hamad
General Hospital (HGH), the main tertiary hospital in the State of
Qatar.
METHOD. A retrospective descriptive study of the data registry for
adult patients above the age of 14 years, who were admitted toMICU in year 2015. Descriptive statistics were given as numbers and
percentages for categorical variables, or as the mean ± standard
deviation for continuous variables. Calendar days were used to
calculate patients' days.
RESULTS. in 2015, a total of 1472 out of 1679 referrals were
accepted for admission to MICU. From all accepted referrals, 682
(46.3%) patients were admitted to MICU, and 790 (53.7%) patients
were managed by the outreach team outside the ICU. Of those
managed outside the ICU, 657 (83.2%) patients did not get access to
MICU, while 61 (7.7%) patients died, and 72 (9.1%) patients were
transferred to other hospitals. Planned extubation occurred in 32
patients, and a total of 1879 patients-days in the whole year were
managed outside the ICU. Of the 682 patients physically admitted to
MICU, 62% came from the emergency department, 25.8% were from
inpatient wards, and 12.3% were from other sources. Males formed
65.5%, while females were 34.5%. Mean age was 55.8 ± 19 years.
Qatari patients formed 39.1% of all admissions. The most common
reasons for admission were respiratory failure in 28.7%, septic shock
in 27.8%, and central nervous system pathology in 24.2%. The Crude
Mortality was 26.1%. The mean disease adjusted APACHEII score of
20.8 ± 9.4 predicated a mean mortality of 38.5 ± 27.0%. The mean
length of stay observed was 10.1 ± 11.5 days, including 429 wait
days to get floor beds after ICU discharge decision. Out of the 70.8%
intubated; planned extubation was performed in 47.3%, re-intubation
occurred in 9.2%, and tracheostomy was performed in 22.2%.
CONCLUSION. This Epidemiological registry demonstrates the
variation in critical care practice, when the service is overwhelmed to
a breaking-point. More than half of the patients who did not get ac-
cess to critical beds were assessed, triaged, and managed by ICU
physicians outside the ICU. The difference in their outcome requires
further research that links it to a validated severity scoring system.
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INTRODUCTION. International survey demonstrated variable practice
and responsibilities in mechanical ventilation and weaning in
different countries. In addition, a number of mechanically-ventilated
patients are managed outside the intensive care unit in limited-
resource countries that may affect clinical outcomes.
OBJECTIVES. This study aimed to evaluate current practice in starting
and stopping of mechanical ventilation among Thai physicians, and
professional responsibilities of mechanical ventilation in Thailand.
METHODS. A survey questionnaire was sent to new first-year medical
residents in 3 university hospitals before medical residency training
was started. The questionnaire was composed of 4 parts including
1) personal demographics,
2) professional responsibilities of ventilator,
3) mechanical ventilation practice and
4) weaning practice.
We analyzed data as numbers, percentages and proportions.
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questionnaire. Almost all (99%) worked in public hospitals before the
training. Approximately, 65% of them had experience in taking care
of mechanically-ventilated patients in general wards. The median
number of ventilated patients was 5[3, 8.5] cases per day in 1 ward.
Interestingly, nurses had authorities to set and adjust mechanical
ventilation in 26% of the hospitals. Moreover, in the physicians' view,
nurses had the important role in adjustment of ventilator with the
median score of 7/10 (0 = no role and 10 = the most important role).
Nurses also played role in evaluation of the readiness for weaning in
18.7% of the hospitals, while in determination of weaning failure and
termination of weaning in 35% of the hospitals. Besides, nurses de-
cided to extubate the patients in 12% of the hospitals. For the wean-
ing practice, 56% of the responders used weaning protocols, and T-
piece was the most common method used for weaning. Rapid shal-
low breathing index was the most frequently used parameter for pre-
diction of weaning outcomes. Additionally, 67% of the responders
evaluated cuff leak test before extubation but only 37% of them rou-
tinely assessed the test. Furthermore, 43% of the responders pro-
vided noninvasive ventilation after extubation, however only 22.4%
of them applied it early as the prophylaxis for extubation failure.
CONCLUSIONS. Due to limited ICU resources, Thai physicians had to
provide ventilatory care in general wards. Additionally, Thai nurses
had the important role in ventilator management and weaning.
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INTRODUCTION. Muscle weakness is a common complication in
critically ill (CI) patients. Objective quantification of muscle strength
is now considered essential when assessing functional status of CI
survivors. To date, published data are very heterogeneous in terms
of device, patient positioning and measurement standardization.
OBJECTIVES. To assess feasibility and intra-observer reliability of a
standardized bedside protocol of quadriceps strength measurement
performed in supine position in collaborative CI patients.
METHODS. Maximal isometric quadriceps strength was assessed
using a handheld dynamometer (MicroFet2). Standardized patient
positioning was ensured through an adjustable system of vertical
and horizontal traction plain bars and clamp bars, aiming to get a
45° hip flexion and 40° knee flexion. The operator was positioned in
front of the patient, at foot of the bed, withstanding the subject's
movement (raising the leg). The MicroFet2 was localized at the
anterior face of the ankle, two fingers above external malleolus level.
The same trained operator performed measurements at 3 different
sessions (T0, after 1h and after 24h). He provided strictly
standardized instructions and encouragements during testing. RASS
score was used to identify collaborative patients. Vital parameters
were recorded during T0 session. Interclass correlation coefficients
(ICC) and minimal detectable changes (MDC%) were computed to
assess respectively relative reliability and absolute reliability of the
tests. Paired data were analyzed using Friedman test (p < 0.05:
significant).RESULTS. Thirty consecutive CI adults were enrolled (68 [54–76]
years, 77% men). Quadriceps strength was highly variable among
patients. Median strength was 192.5 [113.4 - 266.1] N at H0, 206.5
[111.8 - 273.5] N at H1 and 181.5 [122.7 - 281] at H24. Peak forces
measured during the three sessions were not statistically different
(p = 0.69), showing a good stability over time in the absence of
intercurrent acute event. The relative intra-observer reliability was
very high: ICC of the tests were > 0.9. MDC% ranged from 17.13 to
27.33, which are acceptable values when considering the potential of
muscle strength improvement in CI patients. Procedures were highly
feasible without any clinically significant changes in vital parameters.
CONCLUSIONS. Very high relative and absolute intra-observer reli-
abilities were observed for quadriceps strength measurement using
the MicroFet2 device. The present extremely standardized protocol
was well tolerated. Reproduced with strict observance, such assess-
ment, feasible at bedside, could be used in clinical practice and fu-
ture studies. Handheld dynamometry may be viewed as a key step in
weakness assessment, from diagnosis and identification of patients
most likely to benefit from rehabilitation, to follow-up and assess-
ment of post-rehabilitation progresses.
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INTRODUCTION. Health service use following ICU discharge is
generally increased. Studies showed that doctors´ visits are very
important for the follow up. The study was performed to determine
the frequency of medical visits over one year follow up after an ICU
stay and to identify factors associated with a higher frequency of
medical visits.
METHODS. A prospective cohort study was conducted in a tertiary
Tunisian medical ICU. Adult survivors after an ICU stay between
January 2014 and December 2015 were included. ICU survivors were
interviewed through regular phone calls from 3 months after
discharge until 1 year. Data recorded were medical visits frequency,
causes of visits concluded by the investigating physician on the basis
of non-standardized questions. 2 groups of patients were compared
regarding frequency of visits (≤3 and >3 visits per year). Significant
factors with a p value of < 0.2 were entered into a backward condi-
tional binary logistic regression to determine independent factors for
frequent visits.
RESULTS. 325 patients were included. 215 among them were able to
follow up with phone interviews over 1 year. ICU survivors were
mainly transferred to the hospital ward 174(62%) and only 106(38%)
were discharged home. 157(73%) patients consulted at least once
during the year following the hospital discharge, however 58(27%)
patients had no medical visit after their discharge. 141(90%) patients
saw general practitioner or specialist physician in the first three
months. The mean frequency of visits during the year was 3.
Pulmonologist, cardiologist and ED practitioner were the frequent
physicians visited respectively by 42, 23, and 17 patients. Reasons for
doctor visits were classified into 3 categories: systematic control for
(108 patients), exacerbation of a chronic disease for (43patients) and
a new disease for (6 patients). Multivariate analysis showed that
chronic respiratory failure (OR, 1.77 ; 95%CI, [1–3.1] ; P = 0.04), and
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 328 of 542the patients with ventilatory device at discharge (OR, 3.22 ; 95%CI,
[1.4-7] ; P = 0.002) were the independent factors for frequent visits
after ICU discharge.
CONCLUSION. After ICU discharge, the doctors´ visits seem to be
rather frequent in survivors. Chronic respiratory failure and a home
ventilatory device at discharge are the independent factors for these
frequent visits.
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INTRODUCTION. A positive correlation is evident between intensive
care unit (ICU) (beds) occupancy rate and mortality. reduce in
likelihood of ICU admissions following high ICU congestion can be a
main reason.
OBJECTIVES. The aim of this study was to assess the effect of
increasing ICU capacity in a trauma center with unchanged
admission protocol, on ICU admission rate and mortality.
METHODS. We conducted an observational retrospective cohort
study on patients admitted in referral trauma ICU, affiliated with
Shiraz university of medical sciences.
This study observed in two periods, at first period our hospital had 4
general ICUs.
And in second period had 6 general ICUs.Each ICU comprises of nine
beds.
ICU Triage decision makers were emergency medicine, surgery and
neurosurgery attending physicians, all were faculty of Shiraz
university of medical sciences and they did not change between
these two periods.
These data were extracted from patients' documents. We compared
rate of admission, number of patients with less than 48 hours ICU
stay, patients mortality rate, age and ICU length of stay, between
First and second period.
RESULTS. During the study period a total of 731 patients admitted in
ICUs that comprise of 149 women (20%) and 582 men(80%). Age
range was between 14 and 95 years (mean 41.6 years). Admission
rate in second period (n = 456) comparing to first period (n = 275)
was significantly increased, (p < 0.001).In whole study population.
The proportion of mortality in second group,54 out of 456 cases,
comparing to first group, 84 out of 275, showed significant drop in
mortality rate from first period, 84 deaths (30.54%), to second
period,54 deaths (11.84%). (p < 0.001)Patients admitted in ICU for
less than 48 hours were 52 out of 275 cases (18.9%) in first period
and 143 out of 456 case (31.4%) in second period. Which
demonstrates a significant increase in less than 48hours admission
rate after expanding ICU capacity. (p < 0.001)Considering patients
admitted for < 48 hours, we saw no significant improvement in
mortality rate in second group (p = 0.07) A logistic regression
analysis was conducted to ascertain the effects of age (being >40
or = < 40 years of age), year of admission (admitted in first or
second period) and duration of ICU stay on mortality rate.CONCLUSIONS. Increase ICU bed availability leads to growth in ICU
turn over probably due to effect on triage decision making. Near half
of this increase belongs to patients admitted in ICU for less than 48
hours. Increase ICU turn over reduced mortality. Decrease in
mortality following ICU expansion seems to be unrelated to age and
has same proportion in different age groups.
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INTRODUCTION. The Japanese Association for Acute Medicine
Committee recently proposed a new classification system for the
severity of heat illness that is now used by healthcare professionals
and non-medical personnel to avoid underestimating the severity of
heat stroke, the most serious heat illness. It is classified simply into
three stages based on symptoms and management/treatment:
Stage I is a condition that may be managed on site;
Stage II is a condition requiring immediate examination at a medical
institute; and
Stage III is a condition requiring admission to hospital for at least
one of the following: neurologic disorder, hepatic failure, renal
dysfunction, or coagulation disorder.
Stages I, II, and III broadly correspond to heat cramp and heat
syncope, heat exhaustion, and heat stroke, respectively. However, the
use of the new classification for assessing the severity of heat illness
has not been validated.
OBJECTIVES. Our objective was to examine whether this new
severity classification shows similar validity to an internationally
accepted classification for heat illness, such as heat stroke and heat
exhaustion.
METHODS. A nationwide surveillance study of heat illness was
conducted between June and September, 2012, at emergency
hospitals in Japan. We used these data to compare the distribution
of severity on admission and patient outcomes between the new
classification and the existing international classification.
RESULTS. Of 2130 patients surveyed at 103 emergency hospitals, the
severity of heat illness and the outcome were recorded for 1799
patients who were included in this study. The distribution of the
severity of heat illness determined using the new classification was
significantly correlated with that determined using the international
classification (ρ = 0.448, P < 0.001). However, of 879 patients
classified as stage I, 564 (64.2%) had heat exhaustion. Meanwhile,
564 (49.5%) of 1139 patients with heat exhaustion were classified as
stage I. We found that Stage II and heat exhaustion, and Stage I and
other heat illness (e.g. heat cramp and heat syncope) did not match
on a one-to-one basis. In addition, Stage III may include other forms
of mild to severe heat illness associated with organ dysfunction. Al-
though the mortality rate was not significantly different between the
new classification and the international classification, there were no
deaths among patients classified as Stage I using the new
classification.
CONCLUSIONS. The new classification classified the severity of heat
illness consistently with the international classification. There were
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 329 of 542no deaths among patients classified as Stage I, indicating that it may
avoid underestimating the patient's severity. However, Stage III
included many patients with mild to moderate disorders, except for
heat stroke. Future studies should evaluate sensitive indicators of
organ failure associated with the outcome of heat illness.
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INTRODUCTION. Technology is widely used in nursing field in the
intensive care units (ICU); thus, nurses must be prepared to accept
and work in a high technology environment. However, in many cases
nursing staff have been reported to avoid technology and
computing. Little is known about the acceptance of technology and
computing among nursing staff in ICUs, especially in hospitals in
Israel.
OBJECTIVES. The aim of this study was to examine factors associated
with the acceptance of a new electronic medical records system
among the nursing staff in ICUs in Israel based on the Technology
Acceptance model (TAM) and Theory of Planned Behavior (TPB).
METHODS. It´s was a prospective, descriptive-correlational study. Eth-
ical approval was received from all participating institutions. Study
population included 152 nurses in five ICUs of four Israelis tertiary-
care academic medical centers. A Davis TAM2 questionnaire was
used to examine the perceived usefulness and ease of use, attitudes
and acceptance of ICU electronic medical records system. Factors in-
fluencing attitides and acceptance of the system were compared
using stepwise regression.
RESULTS. 123 nurses responded to the questionnaire (80.9%
response rate). Subjective norms to use technology explained 60%
(R2) of technology acceptance. Output quality and perceived ease of
use explained other 59% of the variance in perceived usefulness.
Perceived ease of use had the greatest influence on perceived
usefulness (correlation 0.72, p < .001). Perceived usefulness had the
greatest influence on acceptance (correlation 0.67, p < .001).
CONCLUSIONS. The TAM2 was found to be a good predictor of
acceptance of new electronic medical records system by ICU nurses.
Therefore, this model can be used as a basis for designing
interventions aimed at improving ICU nurse acceptance of new
technologies.
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INTRODUCTION. High quality patient records are an integral part of
clinical practice, as a means to document and communicate essential
information regarding a patient's condition and the care they receive.
In the ICU, the sheer volume of data is overwhelming and arguably
beyond the processing power of the average human. It is therefore
important that this information is recorded in an accessible,
complete, and organised format.
Electronic Clinical Information Systems (CIS) have been advocated as
a way forward in medical record-keeping in order to appropriately
manage but also analyse the large quantities of information
available.
However even in high-technology environments such as ICU, the im-
plementation of CIS alongside electronic patient records (EPR) is not
universal and is subject to local variation.
OBJECTIVES. The aim of this study was to compare the quality of
medical documentation in paper versus digital (CIS) patient records
in the context of intensive care as part of a quality improvement
project.
METHODS. A retrospective analysis of medical records was
undertaken in 3 critical care areas within the same trust which utilise
different ways of recording patient records (1 paper based vs. 2
different CIS platforms).
For all patients on each unit at the point of survey, records up to the
first 5 days of their admission were analysed. A variety of parameters
were used to assess the quality of records and a neutral party was
used to adjudicate legibility.
RESULTS. Our findings showed that EPR was superior to traditional
paper records in a number of areas e.g. legibility, dated, timed. In
areas where EPR was found lacking, this was due to intrinsic software
limitations which could be improved with better templating of data
entry (Table 166).
CONCLUSIONS. By the standards set by the Royal College of
Physicians on quality of medical record-keeping, our findings show
that electronic CIS records were superior to traditional paper records.
These parameters may have implications for the fulfilment of
treatment plans, patient safety, continuity of care and potential
litigation issues.
Those areas where digital records were not superior were on account
of intrinsic software limitations which could be improved with better
templating of data entry. Other advantages of EPR/CIS such as built-
in clinical decision support modules, improved auditing ability and
notification prompts should also be considered.
The decision to move towards electronic patient records/ CIS needs
to be individualised to the particular ICU taking into account work
flow and logistics.
Table 167 (Abstract 0644). See text for description
Day 1 Day 2 Day 3 Day 4 Day 5 Day 6 Day 7 Day 8 Day 9
Pain 2.00 2.00 2.00 2.00 2.00 2.00 2.00 1.50 2.00
Thirst 5.00 5.00 5.00 5.00 5.00 5.00 5.50 6.00 6.50
Anxety 3.50 3.00 3.00 5.00 5.00 5.00 5.00 4.00 3.50
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Health Affairs Blog 2014Table 166 (Abstract 0642). Comparisons between healthcare records
Paper CIS 1 CIS 2
Number of notes reviewed 19 9 6
Clearly identified home consultant 17 9 6
Pt identifiers on each entry 11 9 6
Entries filed in chronological order 15 9 6
All entries legible, timed, dated and signed 1 9 6
Dyspnea 2.00 2.00 2.00 2.00 3.00 3.00 4.00 2.00 3.00
Sleep 4.00 5.00 4.00 5.00 5.00 5.00 2.00 3.00 4.50Caring for the ICU patient: Challenges and
opportunities
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INTRODUCTION. Ideally, patients in the intensive care unit (ICU)
should be comfortable at all times and assessment is required for
relief of the patients' self-reported symptoms. Pain, Thirst, Anxiety,
Dyspnea and Poor sleep are known as the most stressful symptoms
for ICU patients. However, it is not known the time dependent
change of them.
OBJECTIVES. In this article, we focused on five patient symptoms
and assessed how they changed by lapse of time.
METHODS. All consecutive patient admitted to our hospital were
enrolled from February 2016 to Januraly 2017. We included patients
who were intubated over 24 hours, and the mental status with
Richmond Agitation-Sedation Scale (RASS) of −1 or 0. Patients sus-
tained traumatic brain injury or living with dementia were excluded.
Primary outcome was patient symptoms (thirst, anxiety and dyspnea)
during intubation. We evaluate these symptoms every day using 0–
10 numeric rating scale (NRS). We descrived patient's data as median
(interquartile range).
RESULTS. Of 401 patients, 160 patients were excluded. Median age
was 65(IQR 42 to 74). Table 167 presents the results of the median
NRS of five symptoms. A score on thirst were positively associated
with the ICU length of stay until day 10 and a score on dyspnea
were positively associated until day 7, while a score on pain were
not changed. The degree of satisfaction of sleep was once decreased
at day 7 but it substantial increase at day 10. A score on anxiety
were inreased at day4 after an initial fall but it continued to fall after
day6.
CONCLUSIONS. It must be allowing the clinicians to the better
consideration and management for the tracheal intubated patient to
recognize the change of the most stressful symptoms.
REFERENCE(S)
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INTRODUCTION. Dysphagia in cervical spinal cord injury (CSCI) is
associated with respiratory complications, increased length of stay
and mortality risks [1]. The cause is multi-factorial with subtle clinical
presentation [2]. Early dysphagia identification helps to prevent com-
plications (including silent aspiration) however a lack of national
guidance and effective screening methods has led to varied clinical
practices in non-specialised units resulting in poor outcomes [3].
OBJECTIVES. To use a Delphi technique, gathering expert consensus
on risk factors for dysphagia, to develop a screening tool and clinical
recommendations for critical care healthcare professionals.
METHODS. Following a literature review, 85 statements were
generated across seven domains: co-morbid factors, definition,
screening, assessment, identification, management, to form the first
round of a Delphi. A multi-disciplinary international expert panel of
27 clinicians ranked the statements using a 5 point Likert scale. State-
ments not achieving consensus of >70% of the panel were modified
and recirculated for a subsequent round until levels of agreement
were static. Participants received individual feedback at the end of
each round detailing their response compared to the group's
response.
RESULTS. Following two rounds of the Delphi, 62 statements
achieved consensus (round 1, 59%; round 2, 48%) with statements
for dysphagia screening and assessment achieving the least
consensus. Based on the results, a screening tool was developed to
identify dysphagia risks with 3 domains: injury risk (brain injury,
cervical surgery, spinal injury level and severity); clinical risk
(intubation, tracheostomy, ventilation, and nutrition) and urgency
(chest infection, pyrexia, oral care and suction). A set of clinical
recommendations provided additional guidance on optimal
respiratory and nutritional management.
CONCLUSIONS. This Delphi study achieved multi-professional con-
sensus on factors contributing to dysphagia risk in CSCI allowing de-
velopment of a screening tool. This will aid referral to Speech and
Language Therapy for prompt and consistent diagnostic assessment
and intervention in non-specialised units. A future multi-site pilot
study of the tool is necessary to validate its utility and impact on pa-
tient outcomes.
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INTRODUCTION. Between 10-20% of ICU patients die in the ICU or
soon thereafter 1; many after a decision to curtail curative treatment
2. Palliative care is considered an optimal treatment paradigm when
such decisions have been made 3. However, studies have shown that
there is a reluctance among critical care practitioners to embrace pal-
liative care 4. Efforts are being made around the world to inform phy-
sicians and nurses about the advantages of palliative care in the ICU
5. Few studies have described the process of how such programs
have changed caregivers' attitudes.
OBJECTIVE. To describe nurses' experiences of the process of
transforming from a belief in only curative care to an integration of
curative and palliative care in the ICU.
METHODS. Three cohorts of participants (n = 73) of a 112-hour, 6
month, Palliative Care in the ICU course were asked two questions,
“What does palliative care mean to you?” and “How has palliative
care been implemented on your unit?”. Six Knowledge Cafes were
conducted, at the start and end of each course. A Knowledge Cafe
consisted of participants responding to each question in small
groups and then each group sharing their responses with the entire
cohort. Responses were recorded on paper for each small group and
for the entire cohort, for all three cohorts. Responses were then
reviewed independently by two reviewers and themes were
identified.
RESULTS. At the beginning of the course, respondents reported
what they were observing at their patients´ bedsides. They identified
the need for palliative care (relief of pain, decreased suffering and
dying with dignity) but were unable to deliver it. Six months later,
three themes emerged related to the meaning of palliative care:
a. holistic care
b. effective and open communication within the staff and with
families;
c. empowerment of participants to take an active role related to
palliative care at the unit level.
At the beginning of the course, participants reported little or no
palliative care delivery on their unit. Nurses recognized the need for
palliative care but were unable to provide, consult or initiate such care.
At the conclusion of the course, participants reported a slight change
in the care environment, where nurses and physicians were more
aware of palliative care; and communication with families and within
the staff was greater. However, a third theme emerged, frustration,
where nurses felt empowered to initiate palliative care measures but
were unable due to the current healthcare environment.
CONCLUSIONS. Nurses can be empowered to become more active
palliative care practitioners. However, constraints in the healthcare
system can limit their ability to practice to the full scope of their
training.
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INTRODUCTION. Although sleep is essential for physical and mental
well-being, a Dutch study showed 48% of ICU patients having signifi-
cant sleep problems1. Interrupted sleep is, in addition to pain, anx-
iety, and thirst, one of the most important stress factors for ICU
patients2. For ICU patients, all stages of sleep are reduced and REM
sleep is often absent. Because sleep is frequently interrupted, the pa-
tients´ sleep is superficial which can interfere with the recovery and
enhance delirium onset3.
Nightly noise contributes significantly to sleep disturbance4.
Community Noise Guidelines5 prescribe an average noise level of no
more than 30 dB in hospitals where patients are treated. The
maximum noise level may not be higher than 40 dB.
OBJECTIVE. How can we improve patients sleep using non-drug
nursing interventions?
METHODS. The Pain-Agitation-Delirium (PAD) team created a nurse-
nightly checklist for achieving noise reduction and improving patient
comfort that can contribute to improve sleep quality. The implemen-
tation program contained increasing nurses´ awareness regarding
sleep quality and potential risks, introducing the Nightly checklist
and the RCSQ score.Patient
relatedRoom related Alarm/ machine
relatedCare relatedPatient sleep
habitsIV med/bags laid
downPerfusors/infusions
changed earlier to
reduce alarmsQuiet behind nurse
station/corridorComfortable
positionSleeping signs in
corridorTurn down the
volumeStrive maintain night/
day rhythmSleeping
aidsScreen between
patients closedTurn alarm wide After midnight staff
only allowed in room
when necessaryVAS score
<5Door of room closed
if savety permits,
turn intercom onDo rounds every
other hour by stable
patientsSleep
medicationLow light, dark room Enter the delirium
score through CAM-
ICU/DOSS/RASSMove patient if
necessaryEnter the sleep score
through RCSQ[Nurse-Nightly checklist]
After implementation, PAD team members did daily rounds to
ensure the checklist has been done and answer questions.
RESULTS. For measuring noise levels the Digital Noise Meter Db
Logger Noise Monitor were used. During 20 nights noise
measurements were performed on fixed moments. RCSQ reporting
was done by the shift nurses and doctors. The RCSQ score was
evaluated daily besides regular items like PAD scores.Before Nightly checklist After Nightly
checklistPerfusor alarm 76 Db (max. noise level) 52 Db (max. noise
level)Ventilator alarm 85 Db (max. noise level) 67 Db (max. noise
level)Corridor noise level (23.00-
06.00)65 Db (average) 100 Db
(peak)48 Db (average)Sleep score RCSQ (20
patients)4.8 (average) 6.4 (average)[Noise monitor data]
CONCLUSIONS. After implementing the nightly checklist, patients
reported better sleep quality, probably due to reduced noises during
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 332 of 542the night shift. Patients are less frequently disturbed by changing
alarms and syringes or IV bags as anticipated on with the checklist.
Nursing and other disciplines became more aware of noises during
the night shift.
More investigation with concerns to improved sleep quality is
needed. We want more focus on the relation between improved
sleep and the effects on delirium onset and prevalence. We also
need to investigate the effects of reducing ICU alarm levels on
patient safety when noise level guidelines are abided.
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INTRODUCTION. Whilst impairments in strength and physical
functioning are common for survivors of critical illness [1], no studies
have examined whether these individuals have a heightened falls
risk.
OBJECTIVES. In survivors of critical illness to explore:
1) falls risk and fear of falling over the first six months post
discharge; and
2) the prevalence, time to first fall and severity of falls; and
3) the relationship between fear of falls and reported falls.
METHODS. Nested pilot study within a prior NIH-prospective study
examining early rehabilitation [2]. Fear of falling was assessed using
the Falls Efficacy Scale-International tool [3] and falls risk was
assessed using the Falls Risk for Older People in the Community Set-
ting [4]. Both measures were assessed at 2, 4, and 6-months post
hospital discharge. The number of falls were monitored using a falls
calendar, which were returned on a monthly basis for six months
post discharge [5]. A fall was defined as an ´unexpected event in
which the participant comes to rest on the ground, floor or lower
level.´ [5] Further details about the nature of the fall, falls severity
and medical care required were reported.
RESULTS. 11 participants were recruited. At 2-months post discharge,
55% (n = 6/11) had a high fear of falling and 27% (n = 3/11) had a
high falls risk. At 6-months; 36% (n = 4/11) had both a high fear of
falling and falls risk. In the first six months post hospital discharge,
55% (n = 6/11) of participants had a fall, with 36% (n = 4/11) falling
more than twice in the six-month period. The number of falls over
six months were moderately related to fear of falling at 2-months
(r = 0.68, p = 0.03). Five out of six participants who fell had their first
fall in the first 3 months post discharge and three had moderate se-
verity injuries which required medical attention.CONCLUSIONS. This pilot study suggests falls may be a common
complication for survivors of critical illness with associated higher
falls risk and fear of falling. Further research is required to
understand the incidence of falls and the associated risk factors to
minimise the morbidity associated with survivorship.
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INTRODUCTION. In intensive care units, restraints are usually used
either as an independent tool or in combination with sedatives to
facilitate optimal environment for mandatory therapeutic procedures
and diagnostic evaluations in patient care, to prevent adverse events
leading to deleterious consequences such as patient removal of
catheters, surgical drains and devices necessary for life support [1–3].
OBJECTIVES. To study the perspective of the healthcare professionals
on the utilization of restraints in the intensive care unit.
METHODS. To implement the research objectives 116 respondents
were surveyed. Respondents were divided into critical care providers
(group A, n = 98) and other healthcare professionals (group B,
n = 18).
RESULTS. Respondents considered restraints as the only way to
"pacify" patients and to establish a safe environment for them(group
A - 47.8% positive responses, in group B - 72.2%).When a patient is
agitated or develops a delirious behaviour and interfere with the
performance of procedures, 66.3% of the critical care providers
prefer restraining interventions.Methods alternative to restraining
therapies, are often used by 41.8% of critical care providers and
22.2% of other healthcare providers. Among the alternative methods,
respondents consider the use of sedatives, analgesics, neuroleptic
agents, neuromuscular blocking agents and several of other methods
as beneficial..The healthcare providers surveyed are convinced that
for the implementation of restraining interventions, obtaining formal
informed consent of patient's legal guardian of surrogate is not
required (group A- 83.7% affirmative responses, in group B - 83.3%).
The healthcare professionals who considered consultation of a
psychiatrist as a mandatory condition for utilization of restraining
therapy (group A - 26.5%, in group B - 22.2%).Healthcare providers
rarely encounter with complaints of patients or their guardians about
the use of restraints (group A - 5.1%, in group B - 0%).Very few
respondents believed that fixation had any adverse effects on the
health of the patient (group A-9.2% of positive responses, in
group B - 11.1%).
CONCLUSIONS. Thus, the perspective of the healthcare providers
surveyed on the question about the utilization of restraining
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 333 of 542therapies was contradictory as most respondents recognize the need
for restraints on ICU patients and consider it to be the only possible
method.
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INTRODUCTION. Intravenous (IV) therapy is a widely used method
for the administration of medication in hospitals worldwide. ICU and
surgical patients in particular often require multiple IV catheters due
to incompatibility of certain drugs and the high complexity of
medical therapy. This increases discomfort by painful invasive
procedures, the risk of infections and costs of medication and
disposable considerably. When different drugs are administered
through the same lumen, it is common ICU practice to flush with a
neutral fluid between the administration of two incompatible drugs
in order to optimally use infusion lumens. An important constraint
for delivering multiple incompatible drugs is the volume of separator
fluid that is sufficient to safely separate them.
OBJECTIVES. In this pilot study we investigated whether the choice
of separator fluid, solvent, or administration rate affects the separator
volume required in a typical ICU infusion setting.
METHODS. A standard ICU IV line (2m, 2ml, 1mm internal diameter)
was filled with methylene blue (40 mg/l) solution and flushed using
an infusion pump with separator fluid. Independent variables were
solvent for methylene blue (NaCl 0.9% vs. glucose 5%), separator
fluid (NaCl 0.9% vs. glucose 5%), and administration rate (50, 100, or
200 ml/h). Samples were collected using a fraction collector
until < 2% of the original drug concentration remained and were
analyzed using spectrophotometry.
RESULTS. We did not find a significant effect of administration rate
on separator fluid volume. However, NaCl/G5% (solvent/separator
fluid) required significantly less separator fluid than NaCl/NaCl
(3.6 ± 0.1 ml vs. 3.9 ± 0.1 ml, p < 0.05). Also, G5%/G5% required
significantly less separator fluid than NaCl/NaCl (3.6 ± 0.1 ml vs.
3.9 ± 0.1 ml, p < 0.05). The significant decrease in required flushing
volume might be due to differences in the viscosity of the solutions.
However, mean differences were small and were most likely caused
by human interactions with the fluid collection setup. The average
required flushing volume is 3.7 ml.
CONCLUSIONS. The choice of separator fluid, solvent or
administration rate had no impact on the required flushing volume
in the experiment. Future research should take IV line length,
diameter, volume and also drug solution volumes into account in
order to provide a full account of variables affecting the required
separator fluid volume.
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INTRODUCTION. Central peripheral insertion catheters (PICC) can
remain from days to months allowing the administration of fluids,
medications, and/or parenteral nutrition in critically ill patients.
However, the best technique for PICC placement is still controversial.
OBJECTIVE. To describe the experience of nurse driven PICC
placement in a cohort of adult ICU patients using dynamic
ultrasound (D-US) guided compared to the anatomical landmark (LM)
technique on the outcomes of number of attempts before successful
cannulation, misplaced catheters and complication rates.
MATERIALS AND METHODS. 84 surgical ICU patients with PICCs
inserted by ICU nurses were included from 2015 to 2017 (45 women
and 39 men). Median age was 55 years [IQR 38.2 - 72]. The main
indications for PICC placement was the initiation of vasoactive drugs
and electrolyte replacement. The median number of days with a
PICC catheter was 8 days [IQR 4–10.7]. Categorical data was reported
as percentages and continuous data as median [IQR]. Comparisons
between the two groups were done using generalize linear models.
We used R language version 1.0.136 for all statistical analysis
RESULTS. The number of attempted punctures were lower using the
D-US guided technique (estimate −0.8, 95% CI −1.1 to −0.5,
p < 0.001). Fewer misplaced PICCs were found using the D-US tech-
nique (estimate −0.2, 95% CI −0.4 to −0.1; p = 0.001). Catheter-
associated infections and peripheral vein thrombosis were signifi-
cantly lower using the D-US technique (estimate −1.7, 95% CI −3.2 to
−0.6, p < 0.01) as compared to the LM technique.
CONCLUSION. Dynamic US-guided PICC placement was associated
with fewer attempts before successful central venous cannulation
and complication rates. It may also be associated with less misplaced
catheters. This study highlights the importance of maintaining a
highly-trained nursing team to achieve optimal results.
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INTRODUCTION. To monitor patients on an ICU, we extensively use
various medical devices. These devices have the ability to generate
alarms when abnormal values appear or when there is a malfunction.
The majority of alarms in the ICU are false alarms[1] and are often
induced by nurses during daily routine activities like arterial blood
sampling or physical care. Therefore many alarms are nurse-driven
and potentialy preventable. The risk of too many alarms is alarm-
fatigue, which can lead to longer response times or missing import-
ant alarms[2][3][4].
OBJECTIVES. Can the number of alarms be reduced by promoting
nurse awareness, a modified protocol and by training?
METHODS. Improving began with a baseline-measurement in which
the average number of alarms per bed and day were measured over
a 4 week period. Alarms were divided into high- or medium priority
and technical alarms. The data was obtained from the Philips Central
monitor database.
Introduced improvement measures consisted a modified alarm
protocol with the primary goal to reduce self-induced alarms during
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 334 of 542nursing care by using the alarm-pause button more effective. The
modified protocol also included redefined alarm limitations, in wich
the nursing staff can ajust the alarms and when it´s necessary to con-
sult a physician. The modified protocol was implemented by means
of an educational and communication program. One month after im-
plementation the 4 week follow-up measurement was repeated.
RESULTS. During the two measurement periods the occupancy rate
on the 18 bed ICU department was 90 - 95% with no significant
changes in the ICU casemix.High priority Medium priority technicalBefore inroduction 20,4 217,9 5,8After introduction 14,5 178,8 4,8[Average monitor alarms, per bed, per day]High priority Medium priority Technical29 18 18[Alarm reduction in %]
CONCLUSIONS. Introducing a modified alarm protocol and
increasing the awareness regarding alarm-fatique, we achieved a
substantial reduction in (false) alarms.
However we believe that there are still many false alarms and that
there is room for further improvement. With these results, the ICU
nursing staff can be motivated for a further reduction of alarms.
Besides altering nursing workflow, exploring technical solutions[5] for
preventing alarm-fatigue should be initiated by using alarm software
and other technical solutions to improve ICU alarm management.
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INTRODUCTION. Delirium occurs frequently in ICU patients and is
associated with numerous deleterious outcome. Early recognition of
delirium is essential for treatment and improvement of ICU
outcomes. Several studies on ICU delirium incidence have been
published which reported a large variety on delirium incidence.
Unknown is to what extend this variety exist and also it is unknown
for what reason, other than patient characteristics, this wide variety
can be explained.
OBJECTIVES. To systematically review the variety of reported ICU
delirium incidences, and the role of organizational factors to delirium
incidence in adult ICU's.
METHODS. A systematic review was undertaken following the
Cochrane methodology searching for 'Critical Care', 'Delirium' and
'Incidence' and synonyms. Medline, Embase, Cinahl and CochraneLibrary databases were searched till January 27th, 2017. Studies were
independently assessed for eligibility by two researchers (PR, MB),
differences were settled by a third researcher (HV). Solely prospective
cohort studies which primary observed delirium incidence were
included. There was no language restriction. Methodological quality
was assessed using the STROBE checklist. All available organisational
factors were extracted from the included studies and analyzed using
meta-regression analysis.
RESULTS. A total of 9,357 studies were found, of which nineteen
studies met the inclusion criteria. All included studies reported at
least ICU delirium incidence. The overall good quality (median 32/38
points [IQR 30–35]) prospective cohort studies published between
2005 and 2016, and originated from 17 countries. A total of 11,965
ICU patients were included, which originated from medical, surgical
and mixed populations. In total five different delirium assessment
methods were used. Incidence rates varied from 4-55%. The median
ICU delirium incidence is 26% [IQR 21–41]. Location, hospital type
and admission type, screening frequency and executive screener did
not significantly influence the variance found. Variations in research
methodology might have influenced the incidence found.
CONCLUSIONS. The reported ICU delirium incidence varies largely.
This variety cannot be explained by the organisational factors which
we could extract. It may be more plausible that differences in
patients characteristics and treatment differences are responsible for
this variety in reported ICU delirium incidences.0653
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INTRODUCTION. Recent short term mortality in children admitted to
an intensive care unit (ICU) has varied from 1.3 to 3.9%. (1, 2) Studies
of long-term outcome after an admission to ICU are scarce. An earlier
study comparing outcomes following ICU discharge with non-ICU ad-
mitted age matched control population found a 20-fold increase in
mortality after five years follow-up. (3) Studies of long-term outcome
following ICU discharge are needed to understand the effectiveness
of intensive care and long-term sequelae of critical illness.
OBJECTIVES. To compare long-term mortality after ICU discharge
and causes of deaths in children with normal population.
METHODS. The mortality and causes of deaths following ICU
discharge in all Finnish children admitted to ICU during years 2009
and 2010 were analyzed retrospectively. The study population was
followed-up to the end of year 2014. The causes of death in patients
alive following 30 days after ICU discharge were compared to a co-
hort of one million Finnish children of the same age.
RESULTS. Totally 2792 children were admitted to the ICU during the
study period. Of those, 53 children died during ICU stay, and 2739
were discharged alive. Thirteen children died within 30 days of
discharge and 68 children between 30 days and the end of the
follow-up. In the control population, there were totally 1037 deaths
(0.10%) between years 2009 and 2014. Standardized mortality rate
(SMR) for the ICU admitted children for five years was 53.4 (95% CI
44.7 to 63.2). One year after the discharge the SMR was 16.7 (12.1-
22.6). The most common causes of death in post ICU 30 day survi-
vors were neoplasms (35.3%), neurological (17.6%) and metabolic
diseases (11.7%) when in the control group they were traumas
(45.3%), neoplasms (12.7%) and neurological diseases (9.5%).
CONCLUSIONS. There was more than 50-fold mortality in a cohort of
ICU-admitted children compared to Finnish children at the same age
and the difference was nearly 20-fold one year of ICU discharge.
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 335 of 542Medical causes of death dominated in post 30 day ICU survivors´
group and trauma deaths in control group.
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INTRODUCTION. Extracorporeal Membrane Oxygenation (ECMO) is
commonly used to support critically ill children with life threatening
respiratory or cardiac failure. Adequate nutrition support for children
on ECMO should be based on their metabolism, metabolic reserves,
and nutritional needs.
OBJECTIVES. The study aim was to assess nutritional support before
and after implementation of nutrition support guidelines (NSG) in
critically ill children receiving ECMO.
METHODS. Records of children on ECMO (2/11-6/16) were reviewed.
Data collected: type of ECMO: venous-arterial (VA), venous-venous
(VV), oxygenation index (OI) and vasoactive-inotropic score (VIS). Nu-
tritional status was assessed by weight for age (WFA: underweight),
weight for height (WFH: acute malnutrition), height for age (HFA:
chronic malnutrition) z-scores and caloric (CI) and protein (PRO) in-
takes recorded after initiation of ECMO. Energy and protein needs es-
timated by Schofield and ASPEN, respectively. Nutrition support was
compared before and after implementation of NSG. Values are
mean ± SE.
RESULTS. Fifty-six patients (30 males) included; median (IQR 25th-
75th) age was 8.1 (2–15) yrs, weight, 27 (11–45) kg, and height, 124.5
(84–155) cm. Forty-four and 12 patients received VV and VA ECMO,
respectively; OI and VIS scores at time of initiation of ECMO were
37 ± 3 and 18 ± 3, respectively; ICU length of stay (LOS): 21 (7–43)
days; Hospital LOS: 33 (18–71) days; ECMO duration: 9 (4–20) days;
WFA, HFA, and WFH/BMI z scores of, −0.88 ± 0.36, −0.97 ± 0.38, and
−0.13 ± 0.22, respectively. The prevalence of undernutrition, acute
and chronic malnutrition was 45%, 29%, and 45%, respectively; albu-
min was 2.89 ± 0.14 mg/dl at time of initiation of ECLS. Patients with
acute malnutrition (n = 16) vs. no malnutrition (n = 40) had a ICU
LOS, 43 (21–54) vs. 15 (6–30) days, (p < 0.01); Hospital LOS, 59 (33–
82) vs. 28 (9–59) days, (p < 0.05); and duration of ECMO; 19 (9–31)
vs. 7 (3–14) days, (p < 0.01); average CI and PRO intake on days 1–4
of 34 ± 4 kcal/kg/d vs. 19 ± 2 kcal/kg/d (p < 0.005) and 2.01 ± 0.3 g/
kg/d vs. 1.21 ± 0.2 g/kg/d, (p < 0.05), respectively. The proportion of
patients receiving enteral feeds on days 1,3, 5, and 7 of ECMO were:
14.2%, 44.6%, 57.5%, and 62.5%, respectively; (Day 1 vs. all,
p < 0.005).Day 1 Day 3 Day 5 Day 7Before
n = 28After
n = 28Before
n = 28After
n = 28Before
n = 28After
n = 28Before
n = 17After
n = 23CI kcal/kg/
day14 ± 3 18 ± 3 23 ± 4 34 ± 4a 16 ± 3 31 ± 4a 26 ± 4 38 ± 4Needs met
(%)34 ± 6b 38 ± 5b 56 ± 7b 72 ± 7b 64 ± 7b 81 ± 5a,b 62 ± 8b 80 ± 5a,bPRO g/kg/
day0.72 ± 0.2 0.98 ± 0.2a 1.4 ± 0.2 2.4 ± 0.3a 1.1 ± 0.2 2.1 ± 0.2a 1.9 ± 0.3 2.6 ± 0.2aNeeds met
(%)31 ± 8c 37 ± 8c 63 ± 9c 95 ± 10a 81 ± 8c 106 ± 7a 85 ± 9 107 ± 7a p < 0.05 vs. before implementation of NSG, by Mann–Whitney test; b p < 0.005 vs. estimated caloric needs; c
p < 0.05 vs. estimated protein needs, by paired t-test.[Nutrition Support]
CONCLUSIONS. Almost half of the children were malnourished at time
of ECMO initiation. Patients with acute malnutrition had longer PICU
and hospital length of stay and duration of ECMO. Malnourished
patients received better nutrition early after initiation of ECMO support
and two-thirds of the patients were receiving enteral feeds by day
seven. Implementation of NSG improved nutrition intake in this popula-
tion of critically ill children.
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INTRODUCTION. Bordetella pertussis infection is a common, under
recognized, and vaccine-preventable cause of critical illness with a
high mortality in infants worldwide. The syndrome of hyperviscosity
and arteriolar thrombosis is responsible for the development of com-
plications including refractory hypoxemia, pulmonary hypertension
and cardiocirculatory collapse. Hyperleukocytosis is a severe form of
the disease with up to 80% mortality rate.
OBJECTIVES. This study aimed to determine clinical outcomes of
exchange transfusion in infants with severe pertussis.
METHODS. Medical charts of patients of patients < 1 year admitted to
the Pediatric Intensive Care Unit (PICU) of HRMIAE with clinical diagnosis
of severe pertussis over a 5-year (01/2010-07/2015) period were reviewed.
RESULTS. Sixty-seven infants (M/F:31/36), age 2 (1–2) months (me-
dian, IQR), and PICU length of stay (LOS) and mechanical ventilation
(MV) days of 6 (3–13) and 3 (0–7) days, respectively. White blood
count (WBC) on admission was 35,890/mm3 (20,940-52,870). Forty-
eight patients received supportive treatment (ST) and 19 patients
had exchange transfusion (ET). Patients in ET group had higher WBC.
Overall mortality was 19.4%. Admission WBC >35,000/mm3 was asso-
ciated with mortality (unadjusted OR 7.4, 95%CI 1.5-36.7), and was an
independent predictor of mortality (OR 8.6, 95%CI 1.4-51.4) adjusted
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 336 of 542for age, prematurity, MV and inotrope requirement. No mortality dif-
ference between ET and ST.Age
monthsBordetella
CX (+) n(%)WBC
Count/
mm3Inotropic
use n(%)PICU
LOS
daysMV
daysMortality
n (%)ST
n = 481 (1–
2.0)24 (50) 29,875 22 (45) 5 (3–
10.5)3 (0–
6)8 (16)ET n
=191 (1–
2.8)11 (57) 55,200* 14 (73) 10 (6–
19.8)*6
(2.3-
9.8)*5 (26)Values are median (25th-75th IQR); * p < 0.05 by Mann–Whitney[Clinical Outcomes]
CONCLUSIONS. Critically ill infants with severe pertussis had
significant mortality and exchange transfusion had no effects on
survival. Patients who received exchange transfusion had increased
PICU length of stay and duration of mechanical ventilation.
Admission white blood count was a strong predictor of mortality.
Additional studies are required to identify exchange transfusion
candidates according to admission white blood count.
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INTRODUCTION. Early mobilisation within the adult critical care
setting has been found to be beneficial. Benefits reported include;
reduced length of stay, improving quality of life, decreased days on
ventilator and prevention of intensive care acquired weakness1. In
paediatric critical care, early mobilisation is in its infancy2.
AIMS. The aim of this project was to ascertain current mobilisation
practices within a paediatric intensive care unit (PICU) and identify
potential barriers to mobilisation.
METHODS. An eight week prospective service evaluation was carried
out. The Manchester Mobility Scale3 was utilised following
adaptation to suit our paediatric population. Data was collected by a
physiotherapist, Monday - Friday at 4pm. Data collected included;
ventilation status and maximum mobilisation achieved during that
day. In addition, if the child did not take part in any activity, the
reason was discussed with nursing staff.
RESULTS. 92 patient admissions (age range 1 month - 17 years
mean, 3.96 years) were observed during the data collection period
accounting for 529 PICU bed days.
At least one mode of mobilising (passive movements to independent
mobility) was recorded during 58 (63%) of the admissions however
34 (37%) patients did not mobilise at all during their PICU stay. The
three most common modes of mobilising were; Lift/hoist in to chair
(33.5%), 'up for cuddles' (21.8%) and 'mat play'(16%).
Early mobilisation (during first 5 days of admission) occurred for
patients intubated on 5 out of 83 days (6%) and for patients non-
intubated on 44 out of 69 days (64%). Patients who were intubated
mobilised on 93 of the 253 days (36.8%) and patients who were non-
intubated mobilised 216 of the 276 days (79.7%).
The most common reason for not mobilising was the patient was
perceived to be 'too unwell'.CONCLUSIONS. Patients were mobilised during their PICU admission
with some evidence of early mobility. However, intubated patients
were less likely to mobilise than non-intubated patients particularly
in the earlier stage of their admission. Guidelines and education for
staff may help to increase opportunities for all children within PICU
to experience the benefits of early mobilisation.
Further research is required within the paediatric population to
develop greater knowledge in this field.
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INTRODUCTION. In 1985, criteria for brain arrest excluded children
under 6 years of age was indicated but transplantation from the brain
arrest donor was not permitted. The Japanese Organ Transplantation
Law was established in 1997 and transplantation under brain arrest
could be done only in adult. Although in 2010, organ transplantation
has been permitted from under 15 years of age after Japanese Organ
Transplantation Law was revised. Unfortunately, only 12 cases have
been transplanted from brain arrest children until 2016.
OBJECTIVES. To identify the unresolved problems about determination
of brain arrest from the survey of brain arrest at Tokyo Metropolitan
Children´s Center is objective.
METHODS. Pediatric patients who admitted PICU of Tokyo Metropolitan
Children's Center and were suspected of brain arrest due to deep coma,
dilatation of pupil, loss of brain stem reflex and loss of spontaneous
breathing during 2010.3 to 2016.12 were included this study. Clinical
records were studied retrospectively.
RESULTS. During study period, 4,973 patients admitted to PICU and
the number of patients who were thought to be brain arrest were
thirty-one. Twenty-six cases were excluded due to various reasons.
Eleven patients were dead due to collapse of circulation before deter-
mining the brain arrest. Six cases couldn't be denied for child abuse,
due to no witness of out-of-hospital cardiac arrest. Three cases couldn't
be assessed due to luck of system for estimation about brain arrest.
Two cases were excluded because of the age, they were under 12
weeks after birth. There were another reasons such as social problem,
findings of electroencephalogram, family's wish of continue for treating
and severe infection. Five cases were thought to be a brain arrest if
they were estimated following the law. There was no one who was di-
agnosed as a brain arrest by law, it was because that their families
wished the palliative care or rejected transplantation from their child.
CONCLUSIONS. In our country, number of brain arrest pediatric patients
estimated by law is very law. According to that, there are few reports
about the epidemiology of brain arrest in children. It accounts for only
3% of all the transplantations from brain arrest. In our country,
transplantation from the victim of child abuse is not permitted, and
difficulty of denying the child abuse makes it difficult to proceed to
estimation for brain arrest in children. Insufficient grief care to family
about end-of-life is also the main reason for difficulty of proceeding the
evaluation of brain arrest by law.
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INTRODUCTION. Levosimendan is an inodilator indicated for the
short-term treatment of acutely decompensated severe chronic heart
failure, and in situations where conventional therapy is not consid-
ered adequate. Levosimendan improves cardiac function by a novel
mechanism of action compared to currently available drugs. We hy-
pothesized that, in patients with severely compromised ventricular
function, the use of levosimendan would be associated with better
postoperative cardiac function than with inotropic drugs that in-
crease myocardial oxygen consumption.
OBJECTIVES. To evaluate the efficacy and safety of levosimendan,
given intravenously to cardiomyopathic patients during and after
cardiopulmonary bypass surgery
METHODS. 250 patients with a preoperative ejection fraction ≤30%
scheduled for elective cardiac surgery with cardiopulmonary bypass
were subjected to two different inotropic protocols: group A
(levosemindan goup) levosimendan started immediately after the
release of the aortic cross clamp by loading dose 6 μg / kg
administered in 10 minutes then 0.1 mg /kg/ min continuous
intravenous infusion in addition to our standard protocol started
immediately after finishing the loading dose and maintained for 48
hours infusion. And group B (usual protocol group) received our
standard protocol for these cases milrinone ± dobutamine and
noradrenalin, adrenalin and dopamine according to blood pressure.
The treatment was masked to the observers.
We assessed Haemodynamics of patients using Flotrac, Invasive
arterial pressure monitoring, blood lactate level in ABG samples.
RESULTS. Cardiac Index was similar between groups initially after
surgery, but it declined 12 h after surgery in the usual inotropic
group but not in the levosemindan group (P < 0.05 between groups)
despite similar filling pressures. Total dose, duration of inotropic drug
administration and norepinephrine dose were lower in the
levosimendan group than in the usual inotropic group (P < 0.05).
The duration of tracheal intubation and Intensive care length of stay
were shorter in the Levosemindan group compared with the group B
(P < 005). Three patients in the group B died within 30 days of
surgery but only one in levosemindan group.
CONCLUSIONS. In cardiac surgery patients with a low preoperative
ejection fraction, Cardiac index and stroke volume was better
maintained when adding levosimendan to our inotropic protocol.
Also, ICU LOS was decreased with no increased risk of adverse
Cardiovascular events.
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INTRODUCTION. Growth differentiation factor (GDF)-15 levels are
associated with all-cause mortality in patients with acute coronary
syndromes, however data in patients with acute heart failure are
conflicting.[1]
OBJECTIVES. The aim of this study was to investigate the predictive
value of GDF-15 in patients with severe acute heart failure (AHF) or
cardiogenic shock requiring the admission to an intensive care unit.
METHODS. We included 90 consecutive patients with AHF or
cardiogenic shock admitted to a cardiac ICU. GDF-15 was measured
at admission using ELISA and patients were followed for 30 days.
RESULTS. Mean age of the patients was 62.1 ± 16.0 with a male to
female ratio of 76.7% to 23.3%. Median NT-proBNP levels were mark-
edly increased (median: 4986, IQR 1525–23842 pg/mL). 30-day mor-
tality was 35.6%. In the group of non-survivors, GDF-15 was
significantly increased (median: 7119.5, IQR = 3816.2 - 10168.2 ng/
mL) as compared to the group of survivors (median: 2719.7, IQR
1472.9 - 7099.9 ng/mL), with a p-value < 0.001. Patients within the
third tertile of GDF-15 had a 5.1-fold increased risk of mortality
(p < 0.005), independently of demographics, NT-proBNP and vaso-
pressor usage. Interestingly, GDF-15 and NT-proBNP showed additive
prognostic value. When patients were stratified according to the me-
dian of NT-proBNP and GDF-15, those with both GDF-15 and NT-
proBNP levels above the median had the highest risk of dying (HR
5.8, p < 0.005).
CONCLUSIONS. GDF-15 is a strong predictor of mortality in patients
with severe acute heart failure or cardiogenic shock requiring the ad-
mission to an intensive care unit. Furthermore, it adds additional
prognostic value to NT-proBNP levels.
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INTRODUCTION. Extracorporeal membrane oxygenation (ECMO) is
an important rescue method for patients with cardiac or respiratory
failure regardless of underlying diseases. With the development of
instruments and skills, we can apply ECMO with lower complications
and a higher survival rate. However, several patients detoriate after
weaning from ECMO.
OBJECTIVES. This study aims to evaluate the survival after weaning
from ECMO.
METHODS. We retrospectively reviewed clinical records of patients
who underwent ECMO from 2014 to 2016 in a tertiary university
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 338 of 542hospital. According to the indications, ECMO support was classified as
respiratory, cardiac, and ECMO cardiopulmonary resuscitation (ECPR).
RESULTS. ECMO was applied to 172 adult patients. Respiratory
support was 46 (26.7%), cardiac support was 70 (40.7%), and ECPR
was 56 (32.6%). The mean duration of ECMO support was 7.9 ± 12.0
days. Successful weaning from ECMO occurred in 88 (51.2%)
(respiratory 23 (50.0%), cardiac 43 (61.4%), and ECPR 22 (39.3%),
respectively). Survived to discharge were 65 (37.8%) (respiratory 19
(41.3%), cardiac 31 (44.3%), and ECPR 15 (26.8%)). After weaning from
ECMO, 23 patients (26.1%) died in hospital and 4 patients (4.5%) died
after discharge from hospital. The cause of death in hospital after
weaning were heart failure (n = 5), infection (n = 16, 14 patients with
pneumonia, 6 with blood stream infection, and 5 from gastrointestinal
origin), and neurological dysfunction (n = 2). In the multivariable
logistic regression, higher age and longer duration of mechanical
ventilator support were associated with mortality after ECMO weaning.
CONCLUSIONS. Mortality after weaning from ECMO was 30.7%. Most of
patients deteriorated with infectious complications after ECMO removal
rather than with primary causes of respiratory or cardiac failure.
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INTRODUCTION. Mini-invasive mechanical circulatory support (MCS)
systems are increasingly used in patients suffering from severe or
rapidly progressing cardiogenic shock and from refractory cardiac ar-
rest. However, current evidence on long-term outcomes of this thera-
peutic approach is still insufficient.
OBJECTIVES. The aim of our study was to assess one-year mortality
in patients treated with MCS for severe circulatory collapse.
METHODS. We analyzed data from a group of patients treated with
mini-invasive MCS in our center from March 2008 until March 2016.
One-year survival data were obtained from all subjects. Mortality of
patients with severe or rapidly progressing cardiogenic shock (CS
group), subjects with refractory cardiac arrest treated by extracorpor-
eal cardiopulmonary resuscitation (ECPR group) and patients with
non-urgent MCS insertions for support of high-risk interventions (NU
group) was compared using log-rank test.
RESULTS. One-hundred-and-twenty-nine individuals were enrolled
into the study. TandemHeart system was used in 16 patients, Pulse-
Cath in 14 subjects, Impella 2.5 in 2 individuals and extracorporeal
membrane oxygenation in veno-arterial configuration (VA-ECMO) in
111 patients. One-year mortality in the CS group (N = 87) was 40.2%, in
the ECPR group (N = 33) 75.8% and in the NU group (N = 23) 8.7%,
P < 0.001. In a subgroup of VA-ECMO treated patients, on-year mortal-
ity in CS individuals (N = 71) reached 43.7%, mortality of ECPR (N = 33)
was 75.8% and mortality in NU subjects (N = 7) was 14.3%, P < 0.001.
CONCLUSIONS. Mini-invasive MCS represents often last chance to
survive severe circulatory collapse. The highest survival rate wasfound in patients with non-urgent MCS use, followed by CS patients
and the worst survival was observed in the ECPR group. Neverthe-
less, our data indicate that this therapeutic option offers considerable
long-term survival in these patients with extremely high predicted
mortality.
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INTRODUCTION. Cardiogenic shock (CS) is a life-threatening compli-
cation of several different conditions, as acute myocardial infarction,
fulminant myocarditis, incessant arrhythmia, leading to cardiocircula-
tory shock with a insufficient peripheral perfusion and multi-organ
dysfunction syndrome. In those cases veno-arterial extracorporeal
membrane oxygenation (VA-ECMO) is used in order to maintain an
adequate peripheral perfusion putting myocardial at rest and as a
bridge-to-diagnosis/bridge-to-treatment. Several studies have exam-
ined possible factors predicting survival in patients under VA-ECMO
support, and several score have been created. Until now there are
not precocious prognostic determinant for non post-cardiotomy car-
diogenic shock (1).
OBJECTIVES. To assess the presence and the trend of possible
biochemical markers that correlate with survival.
METHODS. Among all VA-ECMO performed in an Italian ECMO-
tertary single-center hospital from 2014 to April 2017, we have con-
sidered those used for support to CS, caused by different pathologies
(Table 168).
VA-ECMO was performed in a standardized protocol, maintaining 36°
C of internal body temperature, positioning intra-aortic balloon
pump and inotropic support with epinephrine. An electronic-
dedicated database was created to prospectively collect clinical and
pathophysiological variables.
RESULTS. We have analyzed data from 17 VA-ECMO. The overall ICU-
survival was 59% while 6-months survival was 50% (Table 168), with
a CPC score 1–2 at 3 months of 100%. The mean VA-ECMO duration
was 154 [79–336] vs 43 [16–165] hours (median, 25th-75th perc.) re-
spectively in survivors and deceased patients. We observed that in
survivors arterial lactate had a very fast clearance, with a significant
decrease already at twelfth hour, while in non-survivors lactate had
not a variation (Fig. 229). This observation was also applied in rela-
tion to weaning from VA-ECMO (lactate values: 6,6 ± 4,4 vs 2,9 ± 2,3
p < 0.05, at start and at twelfth hour respectively).
CONCLUSIONS. This preliminary study for the first time suggests
that lactate clearance already 12 hours after VA-ECMO implant-
ation could be a prognostic factor in patients with cardiogenic
shock from different etiologies, highlighting the importance of
early recovery of vital organs perfusion in a framework of effect-
ive systemic disfunction.
REFERENCE(S)
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Fig. 229 (Abstract 0662) See text for description
Table 168 (Abstract 0662). See text for description
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INTRODUCTION. Is well known the importance of correct and rapid
diagnosis of ST-segment elevation myocardial infarction (STEMI) for
the appropriate management of patients, particularly since primary
percutaneous coronary intervention (pPCI) programs have been
established. This is why it becomes remarkably important to
minimize false positive events. In our city, Granada, a coaching and
training course directed to emergency department physicians and
extra-hospitalary emergency units was given before starting the pro-
gram and in the first 3 months of it, to improve the electrocardio-
graphic reading, fast diagnosis and STEMI activation code for a
primary revascularization.
OBJECTIVES. First, to analyze the prevalence, epidemiology and
etiologies of false-positive diagnosis of STEMI who underwent pPCI. Sec-
ondly, to compare extra and intra-hospital false positive activation rates
in the first and second semester, after finishing the coaching program.
METHODS. Observational study based on spanish ARIAM (Acute
Myocardial Infarct Delay Analysis) database of STEMI who underwent
pPCI in our ICU (18 beds) from the beginning of the program in
February 2015 until February 2016.
From the total of STEMI with pPCI as reperfusion treatment (150),
70% were male, a false-positive diagnosis of STEMI was made 18 pa-
tients (12%). 12 (66.66%) occur during the first 6 months ofimplementing the pPCI program (8 activated by extra-hospital units,
4 intra-hospital). And 6 (33.33%) in the second semester (50%-50%
activation percentage extra and intra-hospital units). Common causes
for the false-positive diagnosis were X syndrome (including coronary
spasm) in 8 patients (44.44%), in these female were more frequent
(65%), thoracic pain with new diagnosis of LBBB in 4 patients
(22.22%), myocarditis in 3 patients (16.66%) and altered repolariza-
tion in 3 patients (16.66%).
CONCLUSIONS. Non ischemic causes of ST elevation are frequent.
Our false positive results are in the line of other studies. As we
analyzed, rates obtained during the first semester were higher than
last period, probably due to the implementation of a training course
to extra-hospital units as we see the same results in extra and intra-
hospital units after finishing the coaching program. Causes of non is-
chemic ST elevation are similar to other trials.
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INTRODUCTION. Is well known that the recent implementation of
primary PCI programs around the world for acute STEMI patients has
changed the type of primary revascularization, hospital time stay and
outcomes of these patients.
OBJECTIVES. To analyze the causes of non-revascularized STEMI pa-
tients (with PCI or fibrinolysis) after the implementation of a primary
PCI program (24 hours/365 days) in Granada.
METHODS. Observational study, before and after the implementation
of a primary PCI program in January 2014 of all patients with STEMI
admitted in our ICU unit of 18 beds from January 2013 to January 2015.
Main variables studied: demographic (age, sex), KILLIP, type of
revascularization (fibrinolysis, primary PCI, rescue PCI), causes of non-
revascularization (absolute/relative contraindication, lack of electro-
cardiographic criteria, delayed, presentation of limitation of thera-
peutic effort and others).
RESULTS. In the first period (Jan 2013 - Jan 2014), 150 STEMI were
admitted in our ICU. 67.3% were revascularized, 22.7% with primary
PCI and 44.7% with fibrinolysis. Causes of non-revascularization were:
51% non EKG criteria and 18.3% delayed STEMI.
In the second period (Jan 2014 - Jan 2015), from 170 STEMI
admitted, 80.9% were revascularized, all of them underwent primary
PCI. The most important reason of non-revascularized STEMI was
non-EKG criteria, in the 73.9% of them.
In both periods the proportion of contraindications were similar
(18.4% vs 17.4%) as well as the limitation of therapeutic effort (18,4%
vs 17,4%).
CONCLUSIONS. The introduction of a primary PCI program (24h/365
days) has increased the global revascularization rate and modified
the non-revascularized STEMI causes, mostly due to the time window
widening of this treatment.
0665
A single-centre retrospective observational study to evaluate Tako-
Tsubo syndrome
C. Collado Moreno, I. Valiente Aleman, I. Diaz Torres, S. Blasco Turrion, I.
Lobo Torres, I. Dominguez Fernandez, I. Perez Lopez, F.J. Morales Ponce
Hospital Universitario Puerto Real, Cadiz, Spain
Correspondence: C. Collado Moreno
Intensive Care Medicine Experimental 2017, 5(Suppl 2):0665
INTRODUCTION. Takotsubo syndrome (TTS) was first described in
Japan in 1990 by Sato (1) and Mayo Clinic criteria were proposed in
2004 and modified in 2008 (4) facilitating the diagnosis of TTS.
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 340 of 542OBJECTIVES. The aim of this study is to describe prevalence, clinical
features, treatment and short-term prognosis of patients diagnosed
with TTS.
METHODS. A restrospective observational study of patients admitted
to Intensive Care Unit (ICU) of our hospital meeting the criteria for
TTS was performed between March 1st 2007 and February 28 th
2017.
RESULTS. A total of 1602 patients with diagnosis of acute MI were
registered but only 30 patients fulfilled inclussion criteria for TTS.The
prevalence of TTS was 1.87% with a mean age of 59.73 ± 10.9 years.
TTS was more frequent in women (83.3%). Cardiovascular risk factors
were hypertension (56.6%), dyslipidemia (30%), diabetes (20%) and
smoking (13.3%). Anxiety or depressive disorders were only found in
2 patients (6.6%). Preferred treatments at discharge were aspirin
(96%), beta blockers (90%), ACEI/ARBs (83.3%), statins (70%) and
DAPT (53.3%). One month follow-up of these patients revealed one
death (3.3%) due to cardiovascular disease. This patient suffered a
second episode of TTS after an elective major surgical intervention.
CONCLUSIONS. We found a limited number of patients, nevertheless
TTS showed an important short-term mortality and prevalence be-
tween Acute Coronary Syndromes admitted to our ICU. Clinical fea-
tures were similar to the International Registry (2) except anxiety or
depressive disorders. Beta blockers were preferred to ACEI/ARBs.
REFERENCE(S)
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INTRODUCTION. Up to date octuagenarians and over-octuagenarians
represents 6-10% of patients undergoing heart surgery (HS) (1). The 30th
day mortality seems to be higher (3,1-21%, vs. 1,6-2,2 p < 0.001) if com-
pared with younger patients, even if not associated with longer ICU stay.
OBJECTIVES. Retrospective observational cohort study to asses
predictors of 30th day mortality.
METHODS. We considered all the patients undergoing any type of
HS since January 1994 through 2015 at Luigi Sacco Hospital, Milano.
Patients were divided into two group in relation if their age was ≥85
or < 85 yrs. End point variable is 30th day mortality. On all the
patients we collected the following variables:
(i) demographics, chronic diseases and type of cardiac diseases;
(ii) risk score (i.e. NYHA, Euro-Score) and left ventricular ejection
fraction;
(iii)intra- and post-operative variables (i.e. organ failure, vaso-active
drugs, IABP, duration of mechanical ventilation).
Stata 12.1 was used for statistical analysis.
RESULTS. A total of respectively 889 (6.9%) over 85 yrs. and
11966 < 85 yrs patients were found.
The 30th day overall mortality was 4.3% higher in the over 85 yrs.
Same difference was confirmed after stratifying patients according
type of HS, particularly in case of combined and aorta surgery. ACox´s proportional model found the following variables (out the 32
considered) as predictors of 30th day death:
(i) pre-operative chronic renal failure [HR: 1.826, (95% CI: 1.141-
2.933) p = 0.012];
(ii) vasculopaty [HR: 2.088, (95%CI: 1.396 - 3.125) p < 0.0001];
(iii)aorta disease [HR: 2.512, (95% CI: 1.489 - 4.238) p = 0.001)];
(iv)pre-operative cardiogenic shock [HR: 7.654, (95% CI: 2.327 -
25.17) p = 0.001];
(v) post-operative septic shock [HR: 5.410 (95% CI: 2.459 - 11.90)
p < 0.0001];
(vi)post-operative acute hepatic failure: [HR: 3.969 (95% CI: 2.194 -
7.180) p < 0.0001]. Surprisingly age ≥85 [HR 1.576, (95% CI: 0.843
- 2.915) p = 0.156] was not confirmed as a variable significantly
affecting the mortality. The age interaction with the predictors
was tested without finding any statistical significance or model
modifications.
CONCLUSIONS. Despite its limitations, our study suggests that HS
might be an option for octuagenarian and over since an age ≥ 85
yrs. does not seem to impact on post-operative mortality.
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INTRODUCTION. The control of cardiovascular risk factors (CRF) is
important to decrease the incidence of ischemic heart disease and
mortality of acute coronary syndrome (ACS).
OBJECTIVES. To analyze over a period of 10 years the evolution of
CRF in patients with ST-segment elevation myocardial infarction
(STEMI), admitted in a 18 beds medical-surgical Intensive Care Unit
(ICU), compared to other hospitals in the region (Andalusia) and its
relationship to mortality.
METHODS. It is a prospective cohort study of patients with a diagnosis
of STEMI admitted to a second level Universitary Hospital Virgen de la
Victoria (UHVV) ICU, n = 2188 or, in other ICUs of Andalusia, n = 23167.
The data were extracted from the Spanish record of Acute Myocardial
Infarction Delay (ARIAM) between 01/01/2005 to 31/12/2014.
Comparing the evolution of variables studied in three intervals of time:
2005–2007, 2008–2010 and 2011–14 and the results obtained in
Andalusia. Descriptive and comparative statistical analysis was
developed using SPSS version 18.0 (SPSS Inc., Chicago, IL, USA).
RESULTS. The percentage of each of the cardiovascular risk factors is
similar in HUVV and Andalusia although, the percentage of smokers
is greater in HUVV. There is no difference between the periods of
time; except the obesity that increases significantly in the third
period (2011–14), 8% in HUVV and 5% in Andalusia, Table 169. STEMI
mortality is related significantly with women, hypertension, Mellitus
Diabetes, dyslipidemia and inversely related to smoking cessation.
CONCLUSIONS. CRF remain stable over the decade analyzed. Control
of the CRF is important to prevent ischemic heart disease and the
data suggest that we should have an impact on health education to
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 341 of 542reduce the number of smokers and increase mediterranean diet and
exercise habits to control body weight.able 169 (Abstract 0667). Cardiovascular Risk Factors in HUVV and
ndalusia
riables UHVV
2005-07
N=534
UHVV
2008-10
N=679
UHVV
2011-14
N=975
UHVV
2005-14
N=2188
Andalusia
2005-07
N=6322
Andalusia
2008-14
N=6727
Andalusia
2011-14
N=10118
Andalusia
2005-14
N=23167
moker 48% 50% 48% 49% 40% 41% 42% 41%
. Diabetes 29% 27% 25% 27% 29% 30% 29% 28%
ypertension 50% 49% 49,3% 49% 50% 48% 49% 49%
yslipidemia 37% 34% 37% 36% 38% 39% 38% 39%
besity 5,5% 5,6% 13,3% 8% 8% 12% 13% 12%
amily H. 11% 10% 10% 10% 10,5% 12% 12% 12%
VV Hospital Universitary Virgen de la Victoria, M. Diabetes Mellitus Diabetes, Family H. Family HistoryT
A
Va
*S
*M
*H
* D
**O
*F
HUTable 170 (Abstract 0667). Mortality and cardiovascular risk factor
Variables UHVV, STEMI
Survivors N=2068
UHVV, STEMI No
survivors, N=120 (5,4%)
UHVV 2005-14
N=2188
*Smoker cessation 17% 10% 17%
*M. Diabetes 26% 42% 27%
*Hypertension 49% 60% 49,3%
**Dyslipidemia 36% 37% 36%
**Obesity 8% 11% 8%
**Family H. 11% 10% 10%
*Women 21% 41% 22%
UHVV Universitary Hospital Virgen de la Victoria, STEMI ST-segment elevation
myocardial infarction, M. Diabetes Mellitus Diabetes, Family H. Family History
(*) Chi Square p=<0,05; (**) p=ns
(*) Chi Square p=ns; (**) Chi Square p=<0,050668
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INTRODUCTION. Acute Heart failure (AHF) is a prevalent and
increasing disease and represents a frequent cause of critical care
admission. It is associated with an important morbi-mortality. The
outcome for such patients is poor with low survival rates. AHF is also
an increasing burden on health care systems. The correct risk stratifi-
cation of patients could improve clinical outcome and resources
allocation.
OBJECTIVES. To describe the characteristics of ICU admitted patients
with AHF and identify independently associated factors.
METHODS. It is a retrospective study of admitted AHF patients in the
medical ICU of Farhat Hached teaching hospital between January
2011 and December 2016. Variables found to be statistically
significant in univariate analysis were included into a multivariate
regression model to identify factors independently associated to
poor prognosis. For all tests, a P value of less than 0.05 was
considered statistically significant.RESULTS. 138 patients were included with an average age of
66.33 ± 15.6 years. 41.3% were women. Hypertension 74(53.6%),
Diabetes mellitus 64(45.7%), and chronic obstructive pulmonary
disease 23(16.7%) were the most outstanding associated
pathologies. SAPSII was 38.24 ± 37. 91(65.9%) patients received
vasopressors. Acute coronary syndrome 56(48.6%) was the most
common cause of AHF. Mean duration of ICU stay was
4.27 ± 4.99 days. Mortality rate was 53.6%. Univariate analysis
identified several factors associated to fatal outcome:
physiological reserve [McCabe score ≥2 (p = 0.000), Knaus C or D
(p = 0.01), OMS ≥3 (p = 0.04), NYHA ≥ 3 (p = 0.029)], severity on
admission [severe acute respiratory failure (p = 0.02),
vasopressors use (p = 0.00), shock (p = 0.02), SAPSII (p = 0.00),
and Glasgow coma scale ≤12 (p = 0.028)] and reference from
cardiology Ward (p = 0.03). A multivariate regression model
identified the following factors as independently associated to
mortality: OMS ≥ 3 (OR, 4.44 ; 95%CI, [1.64 -12.01] ; p < 0.003),
vasopressor use (OR, 6.76 ; 95%CI, [2.23 - 20.43]; p < 0.001),
SAPSII (OR, 1,05 ; 95%CI, [1.01-1.09] ; p < 0.005) and admission
from cardiology ward (OR, 7.98 ; 95%CI, [1.77-35.99] ; p < 0.007).
CONCLUSIONS. The present study revealed a relatively poor
prognosis of AHF patients admitted to the ICU. Physiological reserve
(OMS), severity on admission (SAPSII and vasopressors use) and the
reference from the cardiology ward were identified as independent
predictors of fatal outcome.
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INTRODUCTION. Clinical differences in relation the gender would
permit to adapt the messages in acute coronary syndrome (ACS) to
decrease the mortality in women group.
OBJECTIVES. To analyze over a period of 10 years in men vs. women
with ST-segment elevation myocardial infarction (STEMI) and admit-
ted in a 18 beds medical-surgical Intensive Care Unit (ICU), the differ-
ences in clinical variables N-US; mso-fareast-language:ES;mso-bidi-
language:AR-SA´ > acute coronary syndrome (ACS) to decrease the
mortality in women group.
METHODS. It is a prospective cohort study of patients with a
diagnosis of STEMI admitted to a second level University Hospital
Virgen de la Victoria (UHVV) ICU, n = 2188. The data were extracted
from the Spanish Record of Acute Myocardial Infarction Delay
(ARIAM) between 01/01/2005 to 31/12/2014. Comparing clinical
variables studied in both groups. Descriptive and comparative
statistical analysis was developed using SPSS version 18.0 (SPSS Inc.,
Chicago, IL, USA).
RESULTS. STEMI mortality is significantly high in women, with more
cardiovascular risk factors and delay from first symptoms to
diagnosis and treatment strategies. Women are oldest, have more
cardiovascular risk factors than men and significant differences in
mortality. Creatinine mg/dl and hematocrite at 48 hours show
significant differences in both groups: 2.7 ± 12.5 vs. 1.8 ± 12.5 and
38 ± .4.6 vs. 42.4 ± 5.6. Grace and Crusade scores in women are
significant highest than men: 142 ± 36 vs. 132 ± 34 and 43 ± 13 vs.
25 ± 14. The Table 171 shows more results.
Table 172 (Abstract 0670). Delays in STEMI in UHVV and Andalusia
Variables UHVV
2005-07
N=534
UHVV
2008-10
N=679
UHVV
2011-14
N=975
UHVV
2005-14
N=2188
Andalusia
2005-07
N=6322
Andalusia
2008-14
N=6727
Andalusia
2011-14
N=10118
Andalusia
2005-14
N=23167
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 342 of 542CONCLUSIONS. Women with STEMI arrive later to Health System and
the delay continues in diagnosis and treatments, this group is oldest
and have more cardiovascular risk factors than men.**FS-CSS,
P50
59 60 58 60 60 60 50 54
**FS-HE,
P50
120 135 129 126 120 130 120 130
**FS-Ext.
Fx., P50
87 92 91.5 90 90 95 90 90
**FS-Fx,
P50
140 126 120 130 140 135 120 130
***FS-
PPCI,
P50
290 220 210 220 255 245 210 215
UHVV Hospital Universitary Hospital Virgen de la Victoria, FS First Syntoms, CSS Contact Sanitary System, HE
Hospital Emergency, Ext. Fx Extrahospital Fibrinolysis, PICP Primary Percutaneous Coronary Intervention
*Values expressed as minutes and median (P50), **Kruskal-Wallis p=>0,05, ***Kruskal-Wallis p=<0,05
Table 171 (Abstract 0669). Gender and ST Segment Myocardial
Infarction
Variables Women, n=493 Men, n=1716 Total, n=2209
*Age (years), p=<0.05 66,55±12.5 60,46±12 62±12.4
***M. Diabetes %, p=<0.05 32 25 26
***Hypertension %, p=<0.05 65 45 50
**FS-CSS, p=<0.05 76 [41-196] 60 [30-160] 65[30-162]
**FS->3h Fx, %, p=<0.05 38.2 27.7 30.1
**Time FS-PPCI, P50
minutes, p=>0.05
290[180-572] 225[145-553] 230[150-476]
***Killip ≥ II%, p=<0.05 14 10 11
***Non-survivors%, p=<0.05 11 4.6 6
FS First Symptoms, CSS Call Sanitary System, EH Emergency Hospital, >3h Fx
>3 hours Fibrinolysis, PPCI Primary Percoutaneous Coronary Intervention
* ** ***0670
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INTRODUCTION. In ST-segment elevation myocardial infarction
(STEMI)) is essential to reduce delays between the symptoms, the call
to health care system and the coronary reperfusion to improve the
prognosis.
OBJECTIVES. To analyze in 10 years, the evolution of period of times
between the first symptoms and reperfusion coronary interventions
in patients with ST-segment elevation myocardial infarction (STEMI),
admitted in a 18 beds medical-surgical Intensive Care Unit (ICU),
compared to other hospitals in the region (Andalusia) and its rela-
tionship to mortality.
METHODS. It is a prospective cohort study of patients with a
diagnosis of STEMI admitted to a second level Universitary Hospital
Virgen de la Victoria (UHVV) ICU, n = 2188 or, in other ICUs of
Andalusia, n = 23167. The data were extracted from the Spanish
record of Acute Myocardial Infarction Delay (ARIAM) between 01/01/
2005 to 31/12/2014. Comparing the evolution of the variables
studied in three intervals of time: 2005–2007, 2008–2010 and 2011–
14 and the results obtained in Andalusia. Descriptive and
comparative statistical analysis was developed using SPSS version
18.0.
RESULTS. We studied 2188 STEMI patients in UHVV group with a
mean age of 61.8 ± 12.2 years old (61.3 ± 12.3 vs. 61.9 ± 12.5 vs.
62.2 ± 11.69, p= > 0.05) and 23% were female (23% vs. 22% vs. 22%;
p= > 0.05). In Andalusia group (n = 23167) mean age was
62.3 ± 11.7 years old (62.5 ± 11.7 vs. 62.1 ± 11.8 vs. 61.9 ± 11.9;
p= > 0.05) and 23% were female (24% vs. 23% vs. 22%; p= > 0.05).
We found no significant diferences in mortality in three periods,
6.8%, 5.7% and 5% in UHVV vs. 5.9%, 5.9% and 4.7% in Andalusia.
We can see the results in Table 172.
CONCLUSIONS. There is a reduction in the delay in relation to
coronary reperfusion times, fibrinolysis and primary percutaneous
coronary intervention (PPCI), but there is no change in the depedent
patient time how is the call to health care system after the first
syntoms, that would permit to reduce the mortality.
( ) T Student, ( ) Kruskal-Wallis, ( ) Chi Square0671
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INTRODUCTION. Myocardial infarction (MI) with angiographically no
obstructive coronary arthery (MINOCA) is an important subtype of MI
where the underlying cause is not immediately apparent and its
management is often suboptimal.
OBJECTIVES. The objectives of this study are to describe the clinical
characteristics of patients with MINOCA, its prevalence, risk factors,
treatment at discharge and outcome.
METHODS. We performed a restrospective observational study of
patients admitted to a single center Intensive Care Unit with
diagnosis of acute MI from the ARIAM Andalucia registry between
January 1st 2007 and December 31 st 2016. All patients underwent
coronary angyography.Those patients with normal result or coronary
stenosis less than 50% were diagnosed as MINOCA.Follow-up data
were available by merging data from the DIRAYA. Statistics:
categorical variables are presented as frecuency values and
compared by chi-square test and continuous variables are presented
as mean ± standar deviation (SD).
RESULTS. We identified 54 (3.2%) patients with MINOCA among 1676
patients screened.Clinical investigations on most of these patients were
suboptimal. MINOCA was more frequent in women (8.66%) than in
men (2.1%) and in NSTEMI (4.2%) than in STEMI (2.7%) p < 0.001 and
p < 0.05 respectively.Mean age was 60.59 ± 13.93 y. Most frequent
cardiovascular risk factors among MINOCA patients were hypertension
(55.6%), smoking (51.9%) and hyperlipemia(35.2%). Median risk score
GRACE was 123 ± 32.68 and CRUSADE 27.4 ± 16.07. LVFE
were > 50%(59.39%); 50-40% (24.1%); 40- 30% (11.1%) and < 30%
(5.5%). Preferred treatments at discharge were aspirin (96%), statins
(86%), ACEI/ARBs (80%), beta-bloquers (70%) and DAPT (64%). One pa-
tient had died at 3 month follow-up (1.85%).
CONCLUSIONS. Diagnostic workup of patients with MINOCA is often
suboptimal, and can be a cause of short-term mortality, despite an
adequate medical treatment. More studies on aetiology and out-
comes of MINOCA are needed to improve care on these patients.
REFERENCE(S)
1 Medical Therapy for Secondary Prevention and Long-Term Out-
come in Patients with Myocardial Infarction with Non-Obstructive
Coronary Artery (MINOCA) Disease.Lindahl B, Baron T, Erlinge D,
Fig. 230 (Abstract 0672) Mean CI (L/min/m2) during 120 minutes,
Blue line = Cold group, Red line = Warm group, Green bar = 1
Standard Error
Fig. 231 (Abstract 0672) Mean MAP (mmHg) during 120 minutes,
Blue line = Cold group, Red line = Warm group, Green bar = 1
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INTRODUCTION. Fluid boluses are often administered with the aim
of improving tissue perfusion in critically ill patients. The
hemodynamic persistence of these boluses is poorly understood (1)
and also whether the temperature of fluid has an impact on the
hemodynamic response (2). This study´s aims were to look at the
effects on circulation of different temperatures of infused fluids.
Particularly, we aimed to assess whether the temperature of the fluid
influences heart rate (HR), mean arterial pressure (MAP), systolic blood
pressure (SBP), diastolic blood pressure (DBP) and cardiac index (CI)
OBJECTIVES. Primary endpoint: Difference in CI at 15 minutes after
bolus start. The hypothesis was that CI would increase more with
cold fluids.
Secondary endpoints: Change in HR, MAP, SBP, DBP, CI and
temperature during 120 minutes.
METHODS. We performed a randomized, controlled study with a
cross-over design. 21 healthy volunteers aged 18 or over were in-
cluded. Exclusion criteria: ASA class of 2 or above or known preg-
nancy. Monitoring with pulse oximetry, ECG, non-invasive cardiac
output and non-invasive blood pressure (Clearsight®) was performed.
Body temperature was measured by a heat flux sensor (3M SpotOn®).
The subjects were randomized to receive either 500ml of Ringer´s
acetate at room temperature 22°C or heated to body temperature
38°C. Fluid was infused over 15 minutes. For two hours after infusion
start HR, SpO2, MAP, SBT and DBT, temperature and CI were
measured continuously and registered every 5 minutes during
infusion and then every 15 minutes. The subjects would then return
another day to receive the other temperature infusion.
RESULTS. Preliminary results showed no statistically significant
difference in CI at 15 minutes or at any of the time points. There was a
difference in MAP between groups, with a statistically significant increase
in the cold group during infusion and at 15 minutes after bolus start.
CONCLUSIONS. Our preliminary analysis showed no statistically
significant difference in CI between cold or warm fluid boluses in
healthy volunteers.
However, we found a statistically significant increase in MAP and
DBP which could be of clinical significance and merits further study
in the clinical setting.
REFERENCES
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INTRODUCTION. High-flow nasal cannula (HFNC) oxygen therapy cre-
ates positive oropharyngeal pressure, washes out the nasopharyngeal
dead space, and improves oxygenation [1]. We reported the effects
of HFNC oxygen therapy on thoraco-abdominal synchrony in adults
[2], however the effect has not been evaluated in pediatric patients.
OBJECTIVES. The objectives of this study were to:
1) clarify the effect of HFNC oxygen therapy on thoraco-abdominal
synchrony in pediatric patients with mild-to-moderate respiratory
failure;
2) investigate optimal flow of HFNC oxygen therapy in this
population.
Standard Error
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 344 of 542METHODS. We surveyed pediatric patients with body weight of 2 to
10 kg. Thoraco-abdominal synchrony was evaluated with respiratory
inductive plethysmography (RIP). Before extubation, transducer
bands were circumferentially placed around the rib cage and the ab-
domen. RIP was calibrated by using isovolume maneuver. After extu-
bation, we applied oxygen via face mask for 30 minutes (CTL1) and
observed respiratory status. We enrolled the patients when they
showed one or more of the followings: SpO2 < 95%; breathing fre-
quency > 50 breath/min; dyspnea, or asynchronous or paradoxical
breathing pattern. Each patient received 1 or 2 L/kg/min via HFNC
for 30 minutes, then another flow via HFNC for 30 minutes. After
HFNC oxygen therapy, they were returned to face mask (CTL2). Rib
cage and abdominal movement were converted into volumes, and
two quantitative indexes: maximum compartmental amplitude/tidal
volume ratio (MCA/VT) and phase angle were calculated. Data were
analyzed by repeated measures analysis of variance with multiple
comparisons for an effect over time. P < 0.05 was considered statisti-
cally significant.
RESULTS. Ten patients were enrolled (mean age; 10 ± 8 months,
mean body weight; 6.7 ± 2.4 kg). Table 173 shows measured
variables during face mask and HFNC oxygen therapy. Compared
with CTL1, breathing frequency, MCA/VT, phase angle and minute
volume significantly decreased at a flow 2 L/kg/min (p < 0.05 for all)
but not at a flow 1 L/kg/min. PaCO2 did not differ among oxygen
therapies. Any measured variables did not differ between CTL1 and
CTL2.
CONCLUSIONS. HFNC oxygen therapy at a flow 2 L/kg/min improved
thoraco-abdominal synchrony and decreased breathing frequency in
pediatric patients after cardiac surgery.
REFERENCES
[1] Nishimura M. High-flow nasal cannula oxygen therapy in adults:
physiological benefits, indication, clinical benefits, and adverse ef-
fects. Respir Care 2016;61:529–41.
[2] Itagaki T et al. Effect of high-flow nasal cannula on thoraco-
abdominal synchrony in adult critically ill patients. Respir Care
2014;59:70–4.
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CTL 1 HFNC 1
L/kg/min
HFNC 2
L/kg/min
CTL 2
Breathing frequency,
bpm
37 ± 7 35 ± 7 33 ± 8* 36 ± 10**
Phase angle, degrees 32 ± 20 21 ± 12 19 ± 15* 22 ± 13
MCA/VT 1.07 ± 0.08 1.03 ± 0.04 1.01 ± 0.02
* 1.02 ± 0.02
Minute volume, mL/kg 303 ± 130 245 ± 98 242 ± 83* 261 ± 76
PaCO2, mmHg 36 ± 5 35 ± 5 34 ± 5 35 ± 4
CTL control. Data are expressed as mean ± SD. * = p < 0.05 vs CTL1; ** = p <
0.05 vs 2 L/kg/min
able 174 (Abstract 0674). See text for description
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INTRODUCTION. Non-invasive ventilation (NIV) is the first option for
the treatment of patients with exacerbations of cystic fibrosis (CF).
High flow nasal oxygen cannula (HFNC) has demonstrated benefits in
terms of survival in patients with acute hypoxemic respiratory failure
and in preventing postextubation failure. This technique may also
have benefits in patients with hypercapneic respiratory failure includ-
ing CF patients. We hypothesize that HFNC would not be inferior to
NIV in terms of reducing work of breathing and improving breathing
pattern in CF patients requiring ventilator support.
OBJECTIVES. To compare HFNC vs. NIV induced changes in
inspiratory work of breathing assessed non-invasively by the thicken-
ing fraction of the diaphragm (TFdi), and breathing pattern, CO2
level, hemodynamics, dyspnea and comfort.
METHODS. CF patients with exacerbation requiring ventilator
support were stabilized and ventilated with HFNC and NIV for 30
minutes in random order. TFdi was measured using ultrasound at
baseline and at 25 minutes with each device. Pulse oximetry (SpO2),
transcutaneous CO2 (PtcCO2) were continuously recorded; respiratory
rate, tidal volume (VT) and minute ventilation (MV) were measured
by bio-impedance; hemodynamics, dyspnea (high scores associated
with more shortness of breath) and comfort (high scores associated
with better comfort) were assessed by visual analog scales.
RESULTS. 15 patients were enrolled (mean age 31.3 years, mean
FEV1/FVC 49.0%, mean FEV1 28.0% predicted). TFdi was similar with
the two techniques. Compared to baseline, HFNC significantly
reduced the respiratory rate by 19% vs 2.8% for NIV (p < 0.01) and
NIV significantly increased mean arterial pressure by 6% vs 0.6% for
HFNC (p < 0.01). HFNC compared to NIV resulted in a significantly
higher VT by 10.8% (p = 0.03). No differences were found for heart
rate, MV, SpO2, PtcCO2, dyspnea or comfort (Table 174).
CONCLUSIONS. There was no difference between HFNC and NIV
with respect to diaphragmatic work in stabilized CF patients who
had an indication for ventilator support. These preliminary data
suggest that HFNC may confer physiological benefits by decreasing
respiratory rate, and constitute an interesting alternative or
complement to NIV.
REFERENCES
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2012;38(5):796–803.
GRANT ACKNOWLEDGMENT
This study was supported by Cystic Fibrosis Canada and by a grant
from Siriraj Hospital in Bangkok. LB's laboratory received a grant and
equipment from Fisher Paykel for the study. LB is the Keenan Chair
in Critical Care and Acute Respiratory Failure.T
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 345 of 5420675
High flow nasal cannula vs standard oxygen face mask during
physiotherapy in brain injury patients: a feasible study
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INTRODUCTION. In severely brain injured (BI) patients many
cardiorespiratory complications may be observed due to
hypoventilation and inability to maintain airway clearance after
extubation. Physiotherapists play an important role inside the
intensive care unit (ICU) as members of multidisciplinary team in
preventing cardiorespiratory complications. In the last years
increasing interest about the use of High Flow Nasal Oxygen (HFNO)
has been noted in patients affected by acute respiratory failure.
OBJECTIVES. We tested if HFNO is more effective than standard
oxygen (O2) therapy administered via facial mask (FM) to keep an
appropriate oxygen saturation and respiratory rate in patients
affected by BI during chest physiotherapy.
METHODS. From July 2016 to February 2017 we treated in our
multidisciplinary ICU 20 patients affected by BI due to ischemic (13)
and hemorrhagic (7) stroke. Inclusion criteria were as follow: Glasgow
Coma Scale (GCS) ≥ 8 at study entry, weaned from mechanical
ventilation (MV) at least from 48 hours with spontaneous breathing
and no need of Non Invasive Ventilation, respiratory rate (RR) ≤ 30,
hearth rate (RR) ≤ 90. Patients were uniform for age (mean age 66
years old), sex (12 female), BMI (mean 26) and duration of MV.
Supplementary O2 was administered with HFNO and FM at FiO2 = 0.5
and flow = 50 L/min for the former and with FiO2 = 0.5 and flow 8 L/
min for the latter. We recorded for every patient oxygen saturation
(SaO2), HR, RR and systolic arterial pressure (SAP) 5 minutes before
start, 15 minutes after the start and 5 minutes after the finish of
physiotherapy. Every physiotherapy treatment took 30 minutes.
RESULTS. All patients were treated twice daily until discharge from
ICU. The average of ICU length of stay after MV discontinuation was 6
days (4–8). A total number of 130 treatments were given by 2 physical
therapist. The first treatment was performed alternately with FM or
HFNO and each patient received the same number of treatment with
both methods. The average values of vital signs recorded were similar
at baseline in all patients. The results are summarized in Table 175. We
found that RR showed a great reduction during physiotherapy when
supplementary O2 was administered with HFNO whilst it increased
when oxygen was administered with FM. It is possible that positive end
expiratory pressure (PEEP) related to HFNO could play a role.
Substantial letup were observed also in HR while short change in SAP
were seen and none in SaO2.
CONCLUSIONS. HFNO is feasible to use at bedside, well tolerated by
patients and shows during physiotherapy great reduction in RR probably
related to increased availability of O2 and a variable level of PEEP.
More studies in this setting are needed to better assess these results.Table 175 (Abstract 0675). See text for description
HFNO BASELINE TREATMENT AFTER FM BASELINE TREATMENT AFTER
SAO2 100% 100% 100% SAO2 100% 100% 100%
HR 74 64 70 HR 72 81 70
RR 18 12 14 RR 18 29 20
SAP 149 154 147 SAP 152 170 155
Fig. 232 (Abstract 0676) See text for description0676
Optiflow can be safely used by the outreach team to prevent
unplanned ICU admissions
M. Noureldin, F. Rubulotta1
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Intensive Care Medicine Experimental 2017, 5(Suppl 2):0676INTRODUCTION. Acute respiratory failure (ARF) is worldwide the
most common cause of in-hospital emergency. Optiflow is a new
medical device, which allows the comfortable delivery of high flows
humidified warm (37 °C, 44 mg/L) oxygen directly into the nares.
Optioflow supplies also positive end-expiratory pressure (PEEP) 3 ± 1
mmHg. Our hypothesis is that early use of Optioflow by nurses work-
ing for the outreach team in hospital wards can be safe, effective
and cost-effective method to prevent aggravation of ARF and un-
planned transfer to the Intensive Care unit (ICU).
OBJECTIVES. To investigate the use of Otpiflow ventilation by our
outreach nursing team in the ward in relation to the management of
ARF (ref 1).
METHODS. Authors did include all consecutive adult patients treated
between January 2014 and January 2015 with optiflow within 4 hours
from outreach nurse alert due to hypoxia (PaO2/FiO2 < 100 mmHg or
PiO2/FiO2 < 200mmHg and PEEP > 5 mmH2O) in the general medical,
general surgical, neurosurgical and neurology wards of a large teaching
hospital in London, UK. We collected demographics, reasons for
admission to the hospital, time and needs to start optiflow (including
differentiation between type one and type two ARF), and hospital
outcome. All patients did receive the best available standard treatment
(including chest physiotherapy and nebulisers) in the wards.
RESULTS. 223 adult (age >18y old) patients were randomized and
43 patients were included. Patients' median age was 60 year old, 62%
were male, SAPS II 45 +/− 17, type one ARF in 82% of cases.
(graphic 1 shows the referring teams). Main reasons why patients
were not included in this study were consent, treating physician
choice, transfer to the ICU, lack of available optiflow machine.
Graphic 2 shows the reason why treatment was started in the ward.
Graphic 3 shows optiflow use by the outreach nurse in the ward.No
complications were recorded using optiflow in surgical or medical
hospital wards even with limited monitoring and staff. Optiflow was
always initiated by the outreach nurse with no medical input.
CONCLUSIONS. Optiflow was used successfully to follow up patients
in the surgical ward post extubation in the operating theater. Optiflow
alone reversed ARF in 26% of patients in the general medical, general
surgical, neurosurgical and neurology wards. This device can be safely
used by experienced nurses (outreach team) in the ward.
Reference
1. The ARDS Definition Task Force (2012) Acute respiratory distress
syndrome: the berlin definition JAMA 307:2526–2533.
2. Frat JP, Thille AW, Mercat A, et al. High Flow Oxygen through Nasal
Cannula in acute hypoxemic respiratory failure. NEJM 2015; 372: 2185–96.
3. Stephan F, Barrucand B, et al. High flow nasal oxygen VS non invasive
positive airway pressure in hypoxemic patients after cardiothoracic surgery.
Fig. 233 (Abstract 0676) See text for description
Fig. 234 (Abstract 0676) See text for description
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INTRODUCTION. High flow oxygen therapy (HFOT) has shown to be
a good technique for patients with Type 1 respiratory failure (T1RF).
In Type 2 respiratory failure (T2RF) is more controversial and it is
noted that there is a gap in the literature in identifying clinical
parameters that highlight the high risk patients likely to fail HFOT or
identify failing HFOT therapy in T2RF.
OBJECTIVES. To describe the outcomes with HFOT in the critical
patient with respiratory failure and to establish clinical parameters
that identify high risk patients likely to fail HFOT or deteriorating
patients on HFOT.
METHODS. We conducted a retrospective observational study on the
use of HFOT use (Optiflow; Fisher & Paykel Healthcare, Auckland,
New Zealand) in an ICU setting at Newham University Hospital in
London. We included 97 consecutive patients which were identified
as having either T1RF or T2RF. We collated their vital signs, arterial
blood gases before initiation of HFOT and one hour after and their
outcomes (improvement, non-invasive ventilation, intubation or pal-
liative). Statistical analysis for description of the sample and averages
comparison was performed by Excel and SPSS.RESULTS. Our population consisted of 97 patients (n = 97): 55
males (56.70%) and 42 females (43.30%) with an average age of
63 ± 17 years. T1RF was the reason for admission in 46 patients
while 51 patients had T2RF. Patients were stratified into high risk
for use of HFOT according to their co-morbidities and we found
62% of our patients were high risk. We observed an improve-
ment in vital signs with statistical significance (p < 0.005) in both
T1RF and T2RF. HFOT was used successfully with patient dis-
charge from ICU in 62 patients (63.92%). Failure of HFOT was
considered when intubation or NIV was required, which occurred
in n = 9 (9.28%) and n = 18 (18.56%) respectively. Palliative care
was applied in 8 patients (8,25%). In both types of respiratory
failure it was observed that poorer outcomes were associated in
patients with an acidosis prior to HFOT pH (≤7.30) and tachyp-
noea (RR ≥ 30). Particularly in T2RF with these clinical parameters,
it was observed that 55% required NIV and 18% intubation.
CONCLUSIONS. In our population of critical patients, HFOT showed
to be a good strategy for management of T1RF and T2RF failure.
However it was observed that poorer outcomes were associated
with pH ≤ 7.30 or/and RR ≥ 30. Failure of improvement in these
clinical parameters suggest a high probability of therapy failure and
need for treatment escalation.
REFERENCE(S)
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INTRODUCTION. Dyspnea is frequent and intense in intubated
patients. It is a threatening sensation, is reported by patients as one
of the worse experiences of the intensive care unit (ICU) stay and is
associated with adverse outcomes. Non invasive ventilation (NIV) is
increasingly used and has become the cornerstone therapy of acute
respiratory failure (ARF). However, little attention has been given to
dyspnea in patients receiving NIV.
OBJECTIVES.
1) To quantify the prevalence and intensity of dyspnea in patients
receiving NIV for ARF at admission and in response to NIV,
2) To examine the factors associated with dyspnea,
3) To investigate the impact of dyspnea on NIV success or failure and
on post-ICU quality of life and burden.
METHODS. Second analysis of a prospective observational cohort
study in patients who received NIV for ARF in 54 ICUs in France and
Belgium, in 2010/2011. Dyspnea measurement was assessed with a
modified Borg scale at admission and in response to the first NIV
session. Patients with a dyspnea intensity < 4 (defined as light to
moderate) were compared to those with dyspnea intensity ≥4
defined (moderate to severe).
RESULTS. Among the 426 patientswho received NIV for ARF, the
median dyspnea on admission was 4 [3–5] and decreased to 3 [2–4]
in response to the first NIV session (p = 0.001). Moderate to severe
dyspnea in response to NIV was independently associated with
severity as assessed by the SOFA (OR 1.09, p = 0.023), anxiety (OR
1.84, p = 0.009), leaks (OR 2.15, p = 0.002) and poor NIV tolerance
(OR 2.01, p = 0.012). NIV failure rate was 31% (n = 133). Four factors
independently predicted NIV failure: moderate to severe dyspnea in
Fig. 235 (Abstract 0679) Esophageal pressure swing during NIV
and HFNC
Table 176 (Abstract 0679). Respiratory and hemodynamic variables
NIV HFNC-10 HFNC-20 HFNC-30 HFNC-40 HFNC-50 P-value
Pes swing
(cmH2O)
10.4±6.1 11.8±6.0 11.7±5.3 11.4±5.5 11.5±6.7 12.2±6.9 0.056
SpO2 (%) 95.2±2.3 95.0±2.5 96.2±2.6 96.8±2.3 97.3±2.0* 97.6±2.1* 0.001
PtcCO2 (mmHg) 42.2±6.8 41.6±7.6 41.4±7.6 41.3±7.2 41.1±7.0 40.4±6.5 0.671
Respiratory rate
(/min)
23±6 24±4 22±5# 22±4# 22±4# 22±4# 0.042
Mean arterial
pressure (mmHg)
104±21 96±14 93±9 93±11 91±12 94±15 0.051
Heart rate (/min) 94±19 95±18 91±15 91±17 92±18 96±19 0.155
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p < 0.001), SOFA score (OR 1.35, p < 0.001) and poor tolerance to
NIV (OR 1.81, p = 0.046). Finally, dyspnea was associated with higher
hospital length of stay (8 [4–21] vs. 6 [3–11] days, p = 0.014), hospital
mortality (29% vs. 14%, p = 0.001) and day-90 mortality (54% vs.
35%, p < 0.001) but was not associated with higher post ICU burden
and altered quality of life as assessed by the HADS (hospital anxiety
and depression scale), SF-36 (physical and mental health) and IES-R
(impact of event scale).
CONCLUSION. In patients receiving NIV for ARF,
1) dyspnea is frequent, intense and linked to anxiety,
2) dyspnea exposes patients to a higher risk of NIV failure,
3) dyspnea is associated with an increased mortality and length of
stay.
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INTRODUCTION. Non-invasive ventilation (NIV) is the first line man-
agement in patients with chronic obstructive pulmonary disease
(COPD) who develop acute hypercapneic respiratory failure. High
flow nasal oxygen cannula (HFNC) is a heated humidified, high-flow
oxygen delivery system that has demonstrated benefits in patients
with acute hypoxemic respiratory failure and prevention of extuba-
tion failure. Current evidence of using HFNC in hypercapneic respira-
tory failure is still limited. However, the mechanisms of HFNC in
particular reducing deadspace potentially decreases respriatory effort
and it would also has a beneficial effect in COPD patients. Our study
evaluated the effect of HFNC at different flow rate and NIV on pa-
tient inspiratory effort assessed by esophageal pressure (Pes) swing,
respiratory and hemodynamic variables.
OBJECTIVES. To evaluate Pes swing, gas exchange, breathing pattern
and hemodynamic variables of NIV and HFNC with different flow
rate.
METHODS. A prospective physiological study was conducted in
COPD patients who had an indication for non-invasive ventilator sup-
port. Patients were ventilated with NIV and HFNC at flow rate of 10,
20, 30, 40 and 50 LPM for 15 minutes in each step. Pes was recorded
and Pes swing was calculated using AcqKnowledge data acquisition
system. Respiratory rate, blood pressure, heart rate, pulse oximetry
(SpO2) and transcutaneous CO2 (PtcCO2) were also continuously re-
corded throughout the study.
RESULTS. A preliminary results from 10 patients (mean age 75 ± 9
years, mean post-bronchodilator FEV1/FVC 45.9 ± 7.7% and FEV1
51.6 ± 18.0% predicted) demonstrated that patient inspiratory effort
assessed by Pes swing was lowest during NIV in comparison to HFNC
but not statistical significant different (P = 0.056) (Fig. 235). Higher
flow rate of HFNC significantly decreased respiratory rate in compari-
son to HFNC at flow rate of 10 LPM (22 ± 4 vs 24 ± 4 breaths/min)
but there was no significant difference when compared with NIV
(22 ± 4 vs 23 ± 6 breaths/min). HFNC at optimal flow rate signifi-
cantly improved oxygenation (P = 0.001). HFNC also demonstrated a
trend towards decrease in PtcCO2 when compared to NIV but no
statistical significant difference was found (P = 0.671). There were no
differences in respiratory rate, mean arterial pressure and heart rate
between the two devices (Table 176).
CONCLUSIONS. NIV seems better than HFNC in terms of reducing
patient inspiratory effort. HFNC improves oxygenation and may
improve ventilation in comparison to NIV. HFNC may be an alternative
method for hypercapneic COPD patients requiring ventilator support.
REFERENCES
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INTRODUCTION. Patients with hypoxemic respiratory failure (ARF)
may be treated with noninvasive ventilation (NIV) but assuming a
high percentage of failures. The prediction of NIV failure by a
prediction rule would facilitate a better selection of patients with
greater possibility of success through non-invasive support.
OBJECTIVES. To analyze the predictive capacity of NIV failure using
the HACOR scale in patients with hypoxemic ARF.
METHODS. Retrospective study on a prospective database. All
patients with hypoxemic ARF admitted consecutively to the ICU for a
period of 20 years and receiving NIV were analyzed. The HACOR
scale is based on easily observed variables measured at the onset of
NIV: heart rate, pH value, state of consciousness using the Glasgow
coma scale, oxygenation using the PaO2 / FiO2 ratio and respiratory
rate. With a score greater than 5, patients with a high risk of NIV
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used, are identified. Quantitative variables are expressed as
mean ± standard deviation, median (first and third quartile), and
qualitative variables as absolute and relative frequencies. The
comparison between quantitative and qualitative variables is done
by Student´s T test. ROC curves are constructed and the area under
the curve (AUC) is calculated with its 95% confidence intervals.
RESULTS. During the study period, 2529 patients with hypoxemic
ARF received NIV, mean age 67.3 ± 16.8 years, 1290 men (51%) and
509 (20.1%) with do not intubation order. The main reasons to start
NIV were heart failure (944 patients, 37.3%) post-extubation ARF (459
patients, 18.1%) and pneumonia (412 patients, 16.3%). HARCOR scale
value was a mean of 4 (2,6). Successful NIV was achieved in 1629 pa-
tients (64%) with an HACOR score of 3.5 ± 2.3 compared to the NIV
failure group with a score of 7.21 ± 3.9 (p < 0.001). The AUC of the
HACOR scale for predicting NIV failure was 0.805 (IC-95% = 0.789-
0.821), whereas for failure in the first hour of NIV was 0.950 (IC-
95% = 0.941-0.958) and 0.851 (IC-95% = 0.836-0.864) for the first 6
hours of NIV.
CONCLUSIONS. In our cohort of patients diagnosed with hypoxemic
ARF and treated with NIV, the HACOR scale shows the best ability to
predict the failure of the technique in the first hour of treatment and
with good performance up to the first 6 hours, being slightly less
effective to predict failure during the treatment.
REFERENCE
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INTRODUCTION. Although Severe Hypercapnic Encephalopathy (SHE)
is a critical situation, where intubation delays can have disastrous
outcomes, a first short trial of NIV could identify a spectrum of
responsive patients thus avoiding IMV and its complications, when
performed by an experienced team.
OBJECTIVES. To assess NIV use, efficiency and outcomes in Severe
Hypercapnic Encephalopathy (SHE) compared to Mild to Moderate
Hypercapnic Encephalopathy (MMHE).
METHODS. Retrospective, observational, monocentric study
conducted in an 8-bed medical Tunisian ICU from January, 2000 to
December, 2015. Were included all consecutive patients admitted for
acute on chronic respiratory failure (AE/CRF). Two groups were indi-
vidualized according to the severity of hypercapnic encephalopathy
(SHE and MMHE). Were compared patients characteristics, initial clin-
ical presentation, SAPSII, ABG's on admission, NIV use and outcomes.
RESULTS. Within the study period were admitted 1245 patients for
AE/CRF, 727(58%) patients presented with SHE on admission, among
them only 31(4,3%) patients received a first trial of NIV. 518 patients
were admitted with MMHE with 343 (68,5%) patients receiving
firstline NIV (p = 0.0001). SHE patients had less Home Mechanical
Ventilation and Long Term Oxygen therapy compared to patients
who presented with MMHE, respectively, 21(2,9%) vs 33(6,6%),
p = 0.002 ; and 127 (17,5%) vs 117(23,4%), p = 0.011. On admission,
they had higher SAPSII score, 35,63 ± 13,44 vs 28,45 ± 10,37,
p = 0.0001, with lower pH levels, 7,30 ± 0,11 vs 7,33 ± 0.08,
p = 0.0001. First line NIV success rate of 8(25,8%) was achieved in
the SHE group, vs 218(63,3%) in the MMHE group, p = 0.0001.
Intubation delay was lower in SHE patients, 1,38 ± 1,15 days vs
2,4 ± 3,07 days, p = 0.0004. Intubation rate was higher in SHE group,23(74,2%) vs 125(36,4%), p = 0.0001. There was no significant
difference in term of overall mechanical ventilation duration,
Ventilator Associated Pneumonia density incidence and length of
stay between the two groups. Mortality rate for SHE patients was
higher, especially those who were intubated after first line NIV,
378(52%) vs 78(26,4%) for MMHE patients, p = 0.0001.
CONCLUSIONS. Initial NIV is rarely performed for Severe Hypercapnic
Encephalopathy, but when implemented, 25% rate of NIV success
has been achieved. However, intubation delay is lower for these
patients compared to non SHE patients, showing an adapted
behavior of the attending physician in SHE.
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INTRODUCTION. Non-invasive ventilation (NIV) and high flow nasal
cannula (HFNC) are used in acute respiratory failure (ARF).
OBJECTIVE. We conducted this systematic review to examine their
use.
METHODS. We searched several databases; including randomized
trials comparing at least NIV with HFNC or NIV + HFNC with NIV.
Primary outcome was mainly intubation rates. Secondary outcomes
included ICU mortality and morbidities. We reported medians (IQRs),
p values, odds ratios (ORs)
[95% CIs].
RESULTS. Five trials were included; three compared HFNC to NIV.
One compared HFNC, NIV and oxygen therapy (OT) while one
compared HFNC + NIV with NIV. They recruited patients with acute
hypoxaemic RF largely defined as PaO2/FiO2 ≤ 300 mmHg.
Heterogeneity occurred in patient populations, primary outcomes
and study design; preventing result pooling. Patient populations
ranged from post cardiothoracic surgery to pneumonia. Two trials
were done post extubation, two pre-intubation and one during in-
tubation. Three trials reported patient-centred primary outcomes
(PCPOs) [re-intubation and Day 28 intubation rates]. The other two
trials reported lowest SpO2 during flexible bronchoscopy (FB) and in-
tubation. Three and two studies had superior and non-inferior design
respectively. Of the trials with PCPOs, the ORs for intubation or re-
intubation for the NIV vs HFNC group ranged from 0.80 (95% CIs:
0.54 - 1.19) to 1.65 (95% CIs: 0.96 - 2.84). For the trials with surrogate
primary outcome, only one reported higher lowest SpO2 during in-
tubation in the NIV + HFNC vs NIV group [100 (IQR: 95–100)% vs 96
(IQR: 92–99)%; p = 0.029]. Important secondary outcomes were lower
ICU mortality rate in HFNC vs NIV or OT group and better patient tol-
erability favouring HFNC over NIV.
CONCLUSIONS. Results were conflicting but highlighted important
future research directions. These include selection of patients with
acute hypercapnic RF, more severe hypoxaemia (PaO2/FiO2 ≤ 200
mmHg); inclusion of an OT arm, superior trial design and PCPOs.
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INTRODUCTION. NIV has become a cornerstone for the supportive
therapy to manage critically ill patients with AE/CRF. It reduces the
need of mechanical ventilation, complication rates and mortality.
These benefits deserve more evaluation, especially in developing
countries where organization difficulties may impede NIV efficiency.
OBJECTIVE. To assess trends in use of NIV in AE/CRF in a Tunisian
medical ICU.
METHODS. Retrospective, observational, monocentric study
conducted in an 8-bed Tunisian medical ICU from January, 2000 to
December, 2015. Were included all consecutive patients admitted for
AE/CRF. Were assessed : patient's characteristics, trends in use of NIV,
success and failure rate of NIV use, length of ICU stay, ventilatory free
days and mortality.
RESULTS. Among the 4650 patients admitted within the 16 years'
study period, 1245(26,7%) presented with AE/CRF. They were
66,72 ± 12,99years aged, 913 (73,3%) were COPD, 145(11,7%)
restrictive disease, and 109 (8,8%) OHS. 648 (52,1%) had mMRC ≥ 4.
Mean SAPSII was 32,93 ± 13,03. 727(58,4%) patients were presented
with a severe hypercapnic encephalopathy. Mean pH and PaCO2
were respectively 7,31 ± 0,11 ; 63,17 ± 22,37. Overall firstline NIV use
was registered in 374(30%), 226(60,4%) patients succeeded.Length of
stay (LOS), ventilator free days (VFD) and mortality were respectively
10,3 ± 9,59 ; 3,37 ± 4,7 ; 26,2%. Compared results between three
predefined periods (P1, P2, P3) are displayed on the Fig. 236.
CONCLUSIONS. Despite a progressive increasing rate of NIV use over
the course of sixteen years, this did not result in a similar
progression neither of its success rate with no significant impact nor
on mortality rate, probably due to ICU organizational problems, that
may have interfered with NIV management and resulting in a steady
gain in the learning curve.Fig. 236 (Abstract 0683) See text for description0684
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BACKGROUND. The use of NIV has increased over the span of two
decades considering its various benefits. On the other hand, NIV
failure is regarded to be associated with worse prognosis, which
makes the identification of factors related to NIV failure necessary.
OBJECTIVES. To identify risk factors of NIV failure in AE/CRF in a
Tunisian medical ICU.
METHODS. Retrospective observational study conducted in an 8-bed
Tunisian medical ICU over a 16 years period (January 2000 to Decem-
ber 2015). Were included all consecutive patients admitted for acute
on chronic respiratory failure for whom NIV was initiated within the
ICU as first line ventilatory support. Were collected patients' charac-
teristics, clinical presentation on admission, SAPSII, NIV success rate
and outcomes. Univariate and Multivariate analyses were conducted
to identify factors independently associated to NIV failure.
RESULTS. 1245 patients were admitted to the ICU for AE/CRF. They
were 66,72 ± 12,99years aged, 913 (73,3%) were COPD, 145(11,7%)
restrictive disease, and 109(8,8%) OHS. 648 (52,1%) had mMRC ≥ 3.
Mean SAPSII was 32,93 ± 13,03. 727(58,4%) patients presented with a
severe hypercapnic encephalopthy. Mean pH and PaCO2 were
respectively 7,31 ± 0,11 ; 63,17 ± 22,37. Overall firstline NIV use was
registered in 374(30%), 226(60,4%) patients succeeded. Length of
stay (LOS), ventilator free days (VFD) and mortality were respectively
10,3 ± 9,59days ; 3,37 ± 4,7days and 26,2%. Univariate analysis
identified that patients who failed NIV had less Home Mechanical
Ventilation 24(10,6%) vs 6(4,1%), p = 0.022 ; with severe initial clinical
presentation SAPSII 31,5 ± 12,3 vs 26,5 ± 8,6, p = 0.0001, severe
hypercapnic encephalopathy on admission 23(15,5%) vs 8(3,5%),
p = 0.0001 ; circulatory failure on admission 20(13,5%) vs 15(6,6%),
p = 0.026 ; pH, 7,31 ± 0,08 vs 7,34 ± 0,08 (p = 0.0001) ; PaCO2,
67,7 ± 21,1 vs 62,7 ± 21,1 mmHg, p = 0.026. Multivariate analysis
identified SAPSII (OR, 1.036 ; 95%CI [1.012-1.060] ; p = 0.003),
hypercapnic encephalopathy score on admission (OR, 2.41 ; 95%CI
[1.65-3.52] ; p = 0.0001) and pH ≤ 7,30 on admission (OR,1,95 ; 95%CI
[1,22-3,13]; p = 0.005) as independent risk factors of NIV failure.
CONCLUSION. The present study showed that independent factors
of NIV failure were Hypercapnic Encephalopathy score, SAPSII and
pH level on admission.0685
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Acute Exacerbation of Chronic Obstructive Pulmonary Disease
(AECOPD) is considered the main indication to Non Invasive
Ventilation (NIV). However, this seeming, better response of NIV in
AE/COPD compared to other causes of AHRF, needs further
investigations.
OBJECTIVES. To assess the differences of NIV use and outcomes
when in AECOPD compared to other causes of AHRF.
METHODS. Retrospective observational study conducted in an 8-bed
Tunisian medical ICU during 16 years from January 2000 to Decem-
ber 2015. Were included all consecutive patients admitted for AHRF.
Two groups were formed, patients admitted for AECOPD and
patients admitted for AHRF other than AECOPD. Were compared pa-
tients characteristics, SAPSII, ABG´s on admission, NIV use and its suc-
cess rate, NIV and invasive mechanical ventilation (IMV) duration,
Ventilator Associated Pneumonia (VAP) density incidence and mortal-
ity rate.
RESULTS. Among 1245 admitted for AHRF, 913(73,3%) were
admitted for AECOPD. Other causes of AHRF were mainly acute on
restrictive chronic respiratory failure (11,7%) and Obesity
Hypoventilation Syndrome (8,6%). Sex Ratio was 8,13:1, in the
AECOPD group, and 0,45:1 in the non AECOPD group (p = 0.0001).
Patients in the AECOPD had a lower rate of Home Mechanical
Ventilation 3,7% vs 6,3% (p = 0.048), and had less associated
comorbidities such Hypertension 21,6% vs 38% (p = 0.0001),
Diabetes Mellitus 13,4% vs 24,4% (p = 0.0001), and chronic heart
failure 16,3% vs 8,2% (p = 0.0001). They presented more severe
clinical status attested by a higher SAPSII score 33,7 ± 13,4 vs
30,8 ± 11,9 (p = 0.001). There was no significant difference between
the two groups regarding firstline NIV use 28,6% vs 34% (p = 0.64)
and its success rate 59,4% vs 62,8% (p = 0,5). For patients who failed
NIV mean intubation delay was estimated at 2,32 ± 2,8 for COPD
patients vs 2,31 ± 3,2days in non COPD patients with no significant
difference. Total intubation rate combining firstline IMV and NIV
failure was estimated at 758(83,1%) in COPD patients vs 261(78,6%)
in non COPD patients. They presented overall higher VAP density
incidence 22,75/1000VD vs 18,18/1000VD (p = 0.041) but when
considering patients who had first line NIV there was no significant
differences in terms of VAP density incidence, mechanical ventilation
duration, length of stay or mortality rate between the two groups.
CONCLUSIONS. The present study did not show a better response of
AECOPD to NIV compared to other causes of AHRF, this may be due
to the initial severity of the COPD patients.
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BACKGROUND/AIM. ICU mortality of chronic respiratory patients was
decreasing by the use of NIV. There are only few reports on long-
term survival for chronic respiratory failure. The purpose of this study
is to determine long-term outcomes of ICU survivors admitted for an
acute exacerbation of chronic respiratory disease (AE/CRD).
METHODS. A prospective cohort study was performed in a Tunisian
medical ICU between 2014 and 2016. A follow-up was performed on
ICU survivors admitted for AE/CRD during 1-year using phone inter-
views. The study collected: clinical features at admission, acute man-
agement procedures, functional characteristics and vital parameters
(BP, HR, ABG's) at ICU discharge. Outcomes during 1 year after ICUdischarge (mortality, readmissions) were assessed. Survivors and died
patients after discharge were compared.
RESULTS. We identified 325 ICU survivors with 97(30%) admitted
for AE/CRD. Among these patients, 61(62%) had COPD, 26(26.8%)
had chronic restrictive respiratory disease and 10(10.3%) had
overlapping syndromes. Mean age was 66 ± 13 years. 68% were
male. Mean SAPSII at ICU admission was 30 ± 9. Mean length of
stay was 10 ± 9 days. 51(52%) patients were treated with NIV
and 46 (48%) patients required first line invasive mechanical
ventilation or after NIV failure initiated. Clinical features at
discharge evaluated by mean value of BP, HR, pH, PCO2 and PO2
were respectively (11,7 ± 1.7mmHg; 87 ± 13 b/mn; 7.42 ± 0.05;
49 ± 12mmHg; 92 ± 45mmHg). Mean value of functional status
was 3.3 ± 0.7. After ICU discharge only 79(81.4%) patients were
respondent. Among them 30(38%) patients died during 1 year.
Median survival was 110 days. 90-day mortality rate was 46.7%.
Hospital readmission rate was 48% during 1-year of follow up
and 22(27.8%) patients were ICU readmitted. Univariate analysis
identified two factors associated with post ICU mortality: SAPSII
was higher in died patients (33.48 ± 11.3 versus 28.9 ± 7;
p = 0.03) and functional status measured at ICU discharge was
also reduced among this group (4 ± 0.5 versus 3 ± 0.7;
p = 0.000).
CONCLUSION. Like post ICU survivors, patients admitted for AE/CRD
have decreased long term survival rates. Patients at risk of dying
after ICU discharge were those with severe acute disease at ICU
admission and poorer functional status at discharge.
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INTRODUCTION. Reintubation is associated with poor outcome. Non
invasive Positive Airway Pressure Ventilation (NPPV) after extubation
for high risk patients could be used to prevent reintubation.
However, patients are often intolerant of NPPV. High Flow Nasal
Cannula (HFNC) might increase comfort level. Tolerance of NPPV is
different among interfaces. Nasal masks are better tolerated than the
full-face masks.
OBJECTIVES. We compared nasal mask NPPV with HFNC after
extubation.
METHODS. This retrospective cohort study was conducted in a
medical and surgical ICU between April 2014 and December 2016.
The patients who were underwent nasal mask continuous positive
airway pressure (N-CPAP) or HFNC after extubation were included.
We investigated comfort level of interface (NRS: numeric rating
scale), modified borg scale, critical-care pain observation tool (CPOT),
the Ratio of Partial Pressure Arterial Oxygen and Fraction of Inspired
Oxygen (P/F) and rentubation.
RESULTS. N-CPAP group patients (n = 23) were younger and more
obese than HFNC group patients (n = 30). NRS (N-CPAP: 2, 2–3 vs.
HFNC: 2, 1–3), modified borg scale (2, 1.5-3 vs. 2.5, 2–5) and CPOT
(1, 0–2 vs. 2, 1–3) were not significant different between two groups.
Although P/F didn't change after etubation in N-CPAP group (mean
P/F at SBT 252 vs. mean P/F after extubation 246), P/F decreased
after extubation in HFNC group (277 vs. 217, p = 0.005). Three pa-
tients were reintubated in HFNC group, but there is no reintubation
in NPPV group.
CONCLUSIONS. N-CPAP might be used to avoid impairment of oxy-
genation and as tolerated as HFNC after extubation.
REFERENCE(S)
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Fig. 237 (Abstract 0689) ROC curves
Fig. 238 (Abstract 0689) Survival estimates
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INTRODUCTION. Patients admitted to a medical intensive care unit (ICU)
are characterized by an activated immune system and exhibit a high
mortality rate irrespective of the underlying cause of admission. Interleukin
(IL)-33 has been shown to be protective in experimental sepsis models and
it has been demonstrated that circulating levels of its “decoy” receptor
soluble ST2 (sST2) are associated with outcome in critically ill patients.
OBJECTIVES. The aim of the present study was to investigate
whether circulating IL-33 is associated with 30-day mortality in pa-
tients admitted to a medical ICU.
METHODS. In this prospective, observational study, both IL-33 and
sST2 levels were assessed in 223 consecutive patients at ICU admis-
sion using specific enzyme-linked immunosorbent assays (ELISAs).
RESULTS. During the 30-day follow-up, 58 patients (26%) died. Circu-
lating IL-33 was detectable in 166 patients and in 57 patients serum
IL-33 was below the detection limit. Both detectable IL-33 and sST2
below the median were strong predictors of survival in critically ill
patients independent of acute physiology and chronic health evalu-
ation II (APACHE II) score. IL-33 and sST2 predicted risk independent
from each other. Patients with both, non-detectable levels of IL-33
and sST2 levels above the median, showed a dramatically increased
mortality risk (HR 6.9 95% CI 3.0-16.2; p < 0.001).
CONCLUSIONS. Low levels of IL-33 and increased levels of sST2 predict
mortality risk in critically ill patients independent from each other and
APACHE II score. Both together showed additive predictive value suggest-
ing a pathogenic role of the IL-33/ST2 system in critically ill patients.
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INTRODUCTION. Sepsis is one of the main causes of admit ion to the
intensive care unit (ICU), its early diagnostic and management
significantly reduce mortality. Hematological anomalies are common
amongst patients with inflammatory process in the ICU, sepsis
physiopathology has been related with coagulation alterations, platelet
activation, and a decreased platelet count. Platelet count is used for
diverse severity indexes. Currently, there has been a growing interest
towards the platelet function, especially regarding the mean platelet
count, which when increased suggests platelet activation and
production. It has been associated with thrombotic process such as
ischemic cardiomyopathy and cerebrovascular events, as well as its
increase has been related to inflammation and sepsis.
OBJECTIVE. To assess clinical prediction for mortality of the mean
platelet volume (MPV) and other inflammation markers in critical
patients on admission.
METHODS. We conducted an observational cohort with critical
patients from two intensive care units in Mexico City, Mexico.
Demographic, Clinical, laboratory data was collected for all patients. We
estimated the following severity indexes on admission: sequential
organ failure assessment (SOFA) score with acute physiology and
chronic health evaluation (APACHE) II, Predisposition, Insult/Infection,
Response and Organ Dysfunction (PIRO). Inflammation markersincluded were serum procalcitonin (PCT), ultrasensitive reactive protein
(CRP) and MPV for all patients. Cutoff points were obtained for the
inflammation markers and survival analysis was performed for the most
accurate cutoff values for each one. Statistical analyses were done in
STATA SE 11.0.
RESULTS. We included 202 patients with a mean age of 61(SD ± 18)
years, 50% females, median and interquartile range (RIQ) for length
hospital stay of 17 (11–30) days. Overall mortality of 16.83%. The
median and RIQ for severity scores were for SOFA, PIRO and APACHE
II of 7 (5–10), 7(4–9) and 9 (7–12), respectively. Inflammation markers
with a Median serum level of CRP 6 (RIQ 2–13)mg/dL, Median PCT
value of 0.07(RIQ 0.05-5)ng/dL, Median for MPV of 7.3(RIQ 6.8-8.9)fL/
μm3. Areas under the curve (AUC) and 95% confidence interval (CI)
for PCT, CRP and MPV of 0.77(0.68-0.85), 0.52 (0.42-0.63) 0.74 (0.65-
0.83). ROC analysis obtained the following cutoff values for PCT
(> = 2ng/dL), CRP (> = 9mg/dL) and MPV (> = 8 fL/μm3). Cox
regression analysis showed that for selected cutoff points mortality
risk was as follows: PCT > =2ng/dL, HR = 5.2 (IC 95% = 2.02-13.8);
CRP > = 9 mg/dL, HR = 1.08 (95% CI = 0.54-2.1), p 0.8; MPV of > =8
HR 2.32 (95% CI = 1.07-5.03).
CONCLUSION. High MVP and PCT on admission were associated with
mortality in ICU critical patients. PCT was an independent factor for
mortality.
REFERENCES
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Table 177 (Abstract 0690).Piperacillin population PK parameter
estimates
PK parameter Mean Median SD
Vd (L) 25.54 23.53 9.91
CL (L/h) 8.38 7.68 3.65
Fig. 239 (Abstract 0690): PTA ~ CLcr (100% fT > 4xMIC) and
MIC = 16 mg/L
Table 178 (Abstract 0690). Cumulative Fraction of Response (CFR) ~ CLcr
CLcr (Cockroft-
Gault) ml/min
CFR, 100% fT>4xMIC) All
P. aeruginosa isolates
CFR, 100% fT>4xMIC susceptible P.
aeruginosa isolates (MIC ≤16 mg/L)
30 0.88 0.99
60 0.84 0.97
90 0.78 0.91
120 0.70 0.82
150 0.64 0.75
180 0.56 0.65
210 0.48 0.56
240 0.44 0.51
270 0.39 0.45
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INTRODUCTION. Most population pharmacokinetic (PK) models for
piperacillin have been designed based on intermittent and/or
extended infusion data. To our knowledge, there are very few PK
models for piperacillin that have been constructed based on
continuous infusion (CI) data[1].
OBJECTIVES. To evaluate the population pharmacokinetics of CI
piperacillin in critically ill patients.
METHODS. Patients admitted to the Ghent University Hospital ICU
receiving piperacillin/tazobactam by CI were eligible for inclusion.
Patients younger than 18 years or patients receiving extracorporeal
membrane oxygenation or renal replacement therapy were excluded.
Daily blood samples for piperacillin assay were analysed in the Ghent
University Hospital laboratory using ultra-high performance liquid
chromatography coupled to tandem mass spectrometry. Population
PK modelling was undertaken using Pmetrics[2]. Probability of target
attainment (PTA's) for 100% fT > 4 xMIC were compared for different
CI regimens (8g, 12g, 16g, 20g and 24g per day), for varying renal
clearances (30 ml/min to 300 ml/min) at the MIC breakpoint of 16
mg/L (representing a worst-case scenario). The cumulative fraction of
response (CFR) was calculated using EUCAST data on the wild-type
MIC distribution of P. aeruginosa.
RESULTS. 110 patients with a total of 270 samples were described
using a one-compartment model. Drug clearance was best described
using Cockroft-Gault creatinine clearance estimation (CLcr) as a
model covariate. The estimated population PK parameters for clear-
ance (CL) and volume of distribution (Vd) are described in Table 177.
The PTA for a standard CI piperacillin dosing regimen (4g loading
dose + 16g/24h) has a probability of ≥ 90% to achieve target
concentrations in patients with a CLcr ≤ 47 ml/min (Fig. 239). CI of
16g/24h piperacillin achieves target concentrations against 80% of
the wild-type P. aeruginosa isolates in patients with a CLcr ≤75 ml/
min and target concentrations against 80% of the susceptible P. aer-
uginosa isolates (MIC ≤ 16 mg/L) in patients with a Clcr ≤ 120 ml/
min(Table 178).
CONCLUSIONS. Based on CI piperacillin data, we constructed a one-
compartment model with renal clearance as a covariate. In ICU pa-
tients, the risk of target non-attainment increases with increasing
renal clearance.
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INTRODUCTION. Inadequate antimicrobial treatment is known to be
associated to worst outcome in bacteremia.
OBJECTIVES. To analyze the adequacy of antimicrobial use (ATB) in
patients admitted to the ICU with sepsis.
METHODS. Descriptive retrospective analysis performed in an ICU
with 12 beds during the year 2016. Adequate ATB was defined as
Fig. 240 (Abstract 0692) See text for description
Fig. 241 (Abstract 0692) See text for description
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desescalate when indicated was considered unsuitable. Demographic
variables, comorbilities, risk factors, severity scores, ICU and hospital
length of stay (LOS), ATB and mortality were recorded. Statistical
analysis: categorical variables (frequencies and percentages) and
numerical variables (mean and standard deviation or medians and
interquartile range). Comparisons: X2 test (percentages), student test
(medias) and Kruskal- Wallis test (medians). Statistical significance
with p < 0.05.
RESULTS. 94 patients were included: 58.8% men, 61.6 ± 14.3 years.
APACHE II 17.6 ± 5.9. SOFA 7.4 ± 3.4. Not adequate ATB (61.7%),
adequate (38.3%). 48.9% were medical and 35.1% surgical. The most
frequent infectious focus was abdominal (44.7%) followed by
respiratory (26.6%) and urinary (13.8%). ATB monotherapy (51.1%),
combined treatment (28.7%) or sequential (20.2%). Reason for ATB
change (p < 0.001): ATB not adequate (not change 58.6%, de-
escalation 5.2%, escalation 34.5%), adequate ATB (not change 63.9%,
de-escalation 30.6%, escalation 2.8%). There were no significant dif-
ferences between groups (not adequate vs. adequate) in terms of pa-
tient type, comorbidities, risk factors, site of infection, severity scores
at ICU admission, ICU and hospital LOS. The most frequent inappro-
priate ATBs were piperacillin-tazobactam (25.9%), ceftriaxone (13.8%)
and imipenem (12.7%). The differences found in mortality were not
statistically significant (not adequate 41.4% vs. adequate 27.8%,
p = 0.182).
CONCLUSIONS. In our Unit, the percentage of inadequate ATB was
high. Patients with adequate ATB had a higher proportion of de-
escalation.
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INTRODUCTION. Multidrug-resistant (MDR) pathogens have in-
creased worldwide causing a public health crisis.Here the importance
of control strategies to avoid the spread of MDR bacteria.“Zero Re-
sistance” Project consists of 10 recommendations that deal with all
the factors that stimulate the apparition of MDR bacteria in critical
patients.
OBJECTIVES. To discuss the impact and steps taken in an
Acinetobacter Baumanni (AB) outbreak within an ICU.
METHODS. Observational prospective study of an AB outbreak in our
ICU from April to September 2016 during the “Zero Resistance
Project(RZ)”
Epidemological, clinical and environmental samples were collected.
Classification of the strain was performed.Reinforcement of the RZ
protocol was implemented, increasing patients insulation in a cohort
way, maintaining in this area just exclusive staff with restricted
entrance. Cleaning trolleys were replaced and a strict protocol was
developed so as to perform portable X-Rays with specific staff, wash-
ing matress covers in addition to this.
Mean and typical deviation were presented for quantitative variables
and rates for qualitative variables.
RESULTS. 34 patients were detected, 88.2% were male with an
average age of 59.85(SD 14.8). Mean APACHE II 23.12(SD 12.77).
Mean stay of 26.55 days(SD 19.13) and colonization period of
patients in ICU with AB were 13.57 days(SD 8.31).
From those, 79,4% of them were colonized patients with AB and
20.6% developed infection. 11.8% were infected outside the ICU,
including the primary case.These outside infections were 2
bacteriemia associated to catheter, however the ones got in ICUwere 2 urinary infections, a pneumonia with bacteriemia, a
bacteriemia secondary to surgical wound infection and a peritonitis.
655 environmental samples were collected (the epidemiological ones
according to RZ protocol):infusion pumps, medication dispensing
machine, cleaning trolleys, monitors, X-Ray devices, lead shields,
ultrasound machines, mattresses.76 samples proved positive
(11.6%).As posible reservoirs:X-Ray devices and claning trolleys.
During the outbreak, the consumption of hydroalcoholic liquid rose
from 24L to 168L /1000 stays from July to September. The fulfillment
of hand hygiene reached 80%.
The strain of AB found was carbapenemasa OXA-23 like producer.
Global mortality within ICU was 20.6%. Mortality directly related to
AB was 5.8%.
CONCLUSIONS. RZ Project allowed to detect AB outbreak early with
the colonized cases for most of them.Enviromental samples
identified the posible reservoirs.The use of hydroalcoholic liquid was
increased, an excelent adherence to hand hygiene.With all these
strategies the outbreak was controlled in 3 months and the amount
of infected patients was low, being also low the mortality
attributable.
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INTRODUCTION. Influenza is often under-diagnosed in acute-care
hospitals. It is also the greatest current pandemic disease threat to
humankind and places a large burden on healthcare providers and
society. In February 2016, there was a large outbreak of influenza in
Taiwan, and a high percentage of patients required ICU admission
for intensive care.
OBJECTIVES. We wanted to assess clinical manifestations and
prognostic factors of critically ill patients with severe influenza
admitted to the intensive care unit (ICU) in Taiwan's recent outbreak.
METHODS. This retrospective study was done in a tertiary referral
hospital with 96 adult ICU beds. Patients admitted between January
1, 2015, and March 31, 2016, were identified and their medical
records were reviewed. The primary endpoints were outcomes and
predictors of in-hospital mortality.
RESULTS. There were 125 patients with an average Acute Physiology
and Chronic Health Evaluation II (APACHE II) score (20.8), Therapeutic
Intervention Scoring System (TISS) score (20.8), and Glasgow coma
scale score (9.8). Hypertension (62.4%) and diabetes mellitus (40.8%)
were the two most common underlying diseases. Ninety-eight
(78.4%) patients had at least one organ failure: the lungs were the
most common (71.2%), followed by the heart (53.6%), and metabolic
acidosis (32.8%). Two of the most common symptoms of patients at
ICU admission were fever (68.0%) and cough (78.4%). Ninety-two pa-
tients had comorbid cultures of gram-negative bacteria (62.4%),
gram-positive bacteria (22.4%), and fungus (17.6%). Thirty-three pa-
tients (26.4%) died; most (40.9%) were middle-aged (50–65 years
old). Cox regression analysis showed that multiple organ failure
(MOF) (hazard ratio [HR] = 3.618; 95% confidence interval [CI] = 1.058-
13.662) and negative fluid balance (HR = 0.362; 95% CI = 0.140-
0.934) were significantly associated with mortality.
CONCLUSIONS. The mortality rate of severe influenza patients
admitted to the ICU was high, especially in middle-aged adults. Mor-
tality predictors were MOF and negative fluid balance. Additionally,
comorbid bacterial and fungal cultures were common in this cohort.
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appropriate and effective empirical antimicrobial treatment as a key
point. However, some broad spectrum antibiotics like carbapenems
should probably be reserved for targeted therapy, given the increasing
occurrence of multidrug resistant bacteria (MDR).
OBJECTIVES. To study if a carbapenem regimen for empirical
treatment of community-acquired infections provides some benefit
over narrower spectrum antibiotics.
METHODS. We retrospectively compared patients admitted to our
ICU with community-acquired infections treated with empirical car-
bapenem with those who received other antibiotics. We studied
demographic, clinical and outcomes data in both groups.
Groups data were compared using t-Sudent, U-Mann–Whitney, Chi-
Square o Fisher test as appropriate.
RESULTS. A total of 335 patient with community-acquired infection
were admitted and analyzed; 57 patients (17%) received carbapenem
and 278 other different antibiotics. No differences in age were ob-
served. APACHE II was 21.1 (95% IC 18.9-23.2) in carbapenem group
and 19.1 (18.3-20) in non-carbapenem group (p 0.09).
Patients in carbapenem group were inmucompromised in higher
proportion (19.3 vs 8.3%, p 0.016), had more bacteremia (56.1% vs 29.1%,
p < 0.001) and presented septic shock at admission in higher rate (66.7%
vs 46.8%, p 0.005) No differences were found in terms of incidence of
inadequacy of the empirical treatment (antibiogram based)
Length of ICU and hospital stay (LOS) did not differ between groups
(4 vs 5 and 14 vs 13 days respectively) and no differences in ICU or
hospital mortality were found.
When we analyzed only patients with septic shock, carbapenem was
prescribed more often in medical patients (94.7 vs 78.5, p 0.014),
inmunocompromised (21.1 vs 10%, p 0.07) and bacteremic (60.5 vs
33, p 0.002) When we analyzed only patients with highest APACHE II
(>25), similar results were observed. In both subgroups, no
differences in LOS or mortality were found. In inmunocompromised
patients, despite higher APACHE II in carbapenem group (28.6 (22.8-
34.3) vs 20.2 (17.2-23.1), p 0.01), we observed no differences in
outcomes.
CONCLUSIONS. A carbapenem regimen in community-acquired in-
fections were used more often in inmunocompromised, septic shock
and patients with bacteremia. Neither globally nor analyzing these
subgroups, differences in outcomes were found when a carbapenem
was used. This data should make us consider with caution to pre-
scribe a carbapenem in community-acquired infections when the risk
of MDR is low.
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INTRODUCTION. Turkey is one of the countries in which
Carbapenem-resistant Acinetobacter baumannii (CRAB) is most com-
monly seen (1). Polymyxin E (colistimethate) is one of the several ef-
fective antibiotics against CRAB (2). The effect of AB infection on
mortality has been found to be indefinite, and mortality has rather
been attributed to the underlying disease (3). The early antibiotic ad-
ministration is one of the mainstays of treatment in sepsis (4). Clini-
cians suspect AB to be the infectious agent in patients with sepsis in
locations where CRAB is endemic; however, clinicians have question
marks in their minds while initiating empiric colistin treatment.
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 355 of 542PURPOSE. In our study, we aimed to investigate whether CRAB
affects mortality in cases with severe sepsis/septic shock treated with
colistin initiated based on culture results or initiated empirically.
METHODS. Our study was conducted retrospectively in the Erciyes
University Faculty of Medicine Tertiary Care Medical and Surgical
Intensive Care Units between January 2015 and January 2016. The
patient data were obtained from the electronic recording system of
the hospital and the patients' files. Patients who were administered
colistin for severe sepsis/septic shock were included in the study.
RESULTS. A total of sixty-nine patients were included in the study.
The empiric group (Group 1) consisted of 33 (47%) patients while
Group 2, in whom the treatment was initiated based on antibiotic
sensitivity test results, consisted of 36 (53%) patients. The median
ages in the empiric and sensitivity test groups were 63.5 and 58.6
years respectively (p = 0.76). There were no differences between the
groups regarding the demographics. The mean APACHE II score was
higher in the empiric treatment group. There were differences be-
tween the two groups in terms of days on which antibiotics were
started (p = 0.02), and the cultural breeding ground (p = 0.01).
CONCLUSION. We could not find any effect of empiric initiation of
MDRAB treatment in patients with severe sepsis/septic shock in whom
the information about the pharmacology and tissue penetration of
colistin used in the treatment of AB, which has increased virulence and
that the treatment has become difficult, is limited.
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INTRODUCTION. Antibiotics are the most commonly prescribed drugs
in ICU. In the era of antibiotic resistance it is a common and difficult
problem while choosing empiric antibiotics during septic episode.The
choice of antibiotics mainly depends on clinical diagnosis, culture
sensitivity, and local flora. Whether severity of illness really matters is
not well known. Antibiotic stewardship is the mainstay to prevent
resistance.
OBJECTIVES. To study the antibiotic prescription pattern and
whether the choice of empiric antibiotic varies according to
hemodynamic stability in patients admitted in ICU.
To study the microbiological isolates and their variability according
to hemodynamic stability in patients admitted in ICU.
METHODS. All adult patients more than age of 18 years admitted in
ICU, who have received antibiotics and whose cultures have been sent
were included.Patients discharged against medical advise and patients
with treatment withdrawn were excluded from study.Prospective
observational cohort study, carried out in ICU, AMRI Group of Hospitals,
Kolkata,India. Data were collected from the patients file and nursing
chart from July 2016 to March 2017. Microbiologic isolates and
antibiotics advised were noted.Patients were divided into stable and
unstable group according to hemodynamic parameter and usage of
type of antibiotic and microbiological isolates were correlated.
RESULTS. 786 sepsis episodes were analysed. Mean age was 64years,
male predominant and average APACHE IV score is 58(sd25). We had444 patients in unstable group of whom 71% got discharged and
86% got discharged in stable group.More combination therapy has
been used in hemodynamically unstable patients(P < 0.05).There was
no difference in usage of BLBLI, carbapenem in stable or unstable
group. Pattern of drug resistance in the isolates did not reveal any
signficant difference.
CONCLUSIONS. There is a tendency to administer combination
antibiotics in more sick patient who are in shock.However,in less sick
and hemodynamically stable patient there is a tendency to use
higher antibiotics as empiric one though p value is not in significant
range.
REFERENCE(S)
1. Drupad HS, Nagabushan H and Prakash GM. Prospective and
observational study of antimicrobial drug utilization in medical
intensive care unit in a tertiary care teaching hospital. International
Journal of Pharmacological Research.2016; Volume 6 Issue 01;
DOI:10.7439/ijpr; ISSN: 2277–3312.
2. Julian Mettler, Mathew Simcock, Pedram Sendi, Andreas F Widmer,
Roland Bingisser, Manuel Battegay, Ursula Fluckiger and Stefano
Bassetti. Empirical use of antibiotics and adjustment of empirical
antibiotic therapies in a university hospital: a prospective observational
study. BMC Infectious Diseases,7:21; DOI: 10.1186/1471-2334-7-21;26
March 2007.
3. Kollef MH, Fraser VJ:Antibiotic resistance in the intensive care unit.
Ann Intern Med. 2001 Feb 20;134(4):298–314
GRANT ACKNOWLEDGMENT
None
0697
Frequency of identification and results of treatment of patients
with Pseudomonas aeruginosa (P.aeruginosa) in a Russian cancer
research center in 2011–2014
O. Obukhova, I. Kurmukov, S. Kashiya
N.N. Blokhin Russian Cancer Research Center, Moscow, Russian
Federation
Correspondence: O. Obukhova
Intensive Care Medicine Experimental 2017, 5(Suppl 2):0697
INTRODUCTION. The prevalence and relatively high incidence of
infection, and a significant effect incidence of infection, and a
significant effect on prognosis of P.aeruginosa bacteremia led to
the need to include antibiotics with antipseudomonal activity in
the program of antibiotic prophylaxis and empiric antibiotic
therapy in cancer patients (pts). However, consecutive use of
such programs and some other factors over time significantly
change the spectrum of pathogens of hospital infection,
including bloodstream infection (BSI).
OBJECTIVES. We determined the frequence of BSI caused by
P.aeruginosa, the causes of its occurrence and the immediate results
of treatment of this BSI in pts in a large specialized oncological clinic
(950 beds, more than 22000 hospitalizations per year).
METHODS. In our retrospective cohort study, included pts with
microbiologically documented BSI treated in our clinic from 01/01/
2011 to 31/12/2014. The endpoint of clinical efficacy (primary
endpoint) was 30-day mortality. The secondary endpoints were hos-
pital length of stay (HLOS) after diagnosed BSI (for surviving pts) and
the possibility of chemotherapy treatment (for pts who planned this
treatment before detection of BSI).
RESULTS. During the study, 88217 hospitalizations of pts older than
18 years with malignancy were recorded. In 432 pts, 654 episodes of
BSI were microbiologically confirmed. In 17 pts (3.9% of all pts with
BSI), P.aeruginosa (2.8% of all episodes of septicemia) caused 18
episodes of BSI. One patient had 2 episodes of BSI with an interval of
more than 10 months, during which he received chemotherapy for
multiple myeloma. The median age was 57.5 years (from 22 to 74
years); male were 12 (71%). 13 pts had solid tumors, 4 had
hemoblastoses. In 3 pts with solid tumors, the prevalence of
malignancy was stage II, in 10 pts - stage III-IV. In 6 pts the BSI of
P.aeruginosa was one of the complications after surgical intervention
on the abdominal organs. In 14 cases, BSI was secondary, and
Table 179 (Abstract 0698). Comparison
CHARACTERISTIC INFRATARGET(N=21) TARGET(N=12) p
AGE(SD) 62(15) 62(10) 0.996
BACTEREMIA 4(19%) 8(81%) 0.018
APACHE-II(SD) 20(8) 25(9) 0.122
NO VASOACTIVE DRUGS(%) 15(78.9) 4(21.1) 0.033
CREATININ(SD) 1(0.7) 2(1) 0.003
UREA(SD) 57(28) 108(74) 0.008
GLOMERULAR FILTRATION(SD) 86(31) 49(26) 0.001
BILIRRUBIN(SD) 1.3(2) 3.8(3.7) 0.039
INR(SD) 1.3(0.1) 1.9(1) 0.009
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 356 of 542developed in pts with multiple organ dysfunction (MOD) and was as-
sociated with generalization of infection due to pneumonia (n = 5),
cholangitis (n = 4), severe enterocolitis (n = 2), peritonitis (n = 2),
wound infection (n = 1). In 4 cases, BSI was a catheter-related. The
30-days mortality after detection of BSI of P.aeruginosa was 61%; all
episodes of catheter-related BSI (n = 4), 2 of BSI due to cholangitis
and 1 of secondary BSI in peritonitis were cured. The median HLOS
of 7 cured pts was 9 days (4 to 15 days), with 4 pts continuing to re-
ceive outpatient antibiotics. In the study cohort, the BSI of P.aerugi-
nosa in cured pts was not the reason of failure or delay of
chemotherapy more than 30 days.
CONCLUSIONS. Gram-negative bacteria P.aeruginosa caused only
2.8% of microbiologically confirmed BSI in our clinic in 2011–2014.
The overall mortality in BSI of P.aeruginosa remains high; however, it
is mainly due to already severe MOD.
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INTRODUCTION. Meropenem (MER) is an extended-spectrum beta-
lactam antibiotic (ATB) broadly used in intensive care units. It has
been suggested that standard doses of MER might not be sufficient
for critically ill patients.
OBJECTIVES. Evaluate the effectiveness of continuous infusion (CI)
administration of MER in critically ill patients in order to maintain
serum concentrations 4–6 times above the minimum inhibitory
concentration (MIC) for 100% of the interval time of infusion.
METHODS. Open, prospective, single-center study. All consecutive
patients in whom treatment with MER was indicated from October
2014 to March 2017 were included. A 1g MER loading dose was
given followed by a 6g MER CI over 24 hours. Serum concentrations
were determined by high-performance liquid chromatography
(HLPC) 24 hours after the start of the infusion, determining free
steady state concentrations (ƒCss). The objective was maintaining
ƒCss 4–6 times above the MIC corresponding to the clinical break-
point for Pseudomonas aeruginosa from our hospital database: 8 μg/
ml for MER. When the target was not achieved, the dose was ad-
justed. Univariant, multivariant and logistic regression analysis were
performed. A p value < 0.05 was considered statistically significant.
RESULTS. We enrolled 49 patients, 37 male (75.5%) with mean age
62 years. A total of 33 patients (67.3%) presented with septic shock
and 13 (26.5%) severe sepis. Mean APACHE-II score was 21 ± 8. In 19
patients (38.8%) bacteremia was present. In 21 (43.8%) patients,
levels were below target. Those patients were hemodynamically
stable, had better renal function, were not cirrhotic, did not have
bacteremia and did not have hyperbilirubinemia nor coagulopathy
(Table 179). In multivariate analysis we identified as risk factors for
infradosification: plasmatic creatinine [OR 6.1 (14–27.2)] and not bac-
teriemic patients [OR 0.08 (0.1-0.6)].
15 patients (31.2%) surpass our target. Those patients received
higher doses calculated by mg/Kg/day (p 0.039).
CONCLUSIONS. 43.8% of our patient did not achieve the goal even
optimizing ATB administration. We identified as risk factors for
infradosification: hemodynamic stability and renal function. We identified
the dose administration as risk factor for MER supradosification.0699
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INTRODUCTION. Piperacilin-tazobactam (TZP) is a broad-spectrum
-lactam antibiotic broadly used in ICUs. Recent studies show that nor-
mal doses may not be sufficient in critically ill patients.
OBJECTIVES. Identify factors to predict Piperacilin free steady state
concentrations (ƒCss) in critically ill patients.
METHODS. Open, prospective, single-center study from October
2014 to March 2017. All consecutive patients in whom treatment
with TZP was indicated were included. A 4g (TZP) loading dose
was given followed by a continuous infusion (CI) of 16-24g over
24 hours. Serum concentrations were determined by high-
performance liquid chromatography (HLPC) 24 hours after the
start of the infusion, determining free steady state concentrations
(ƒCss). The objective was maintaining ƒCss 4–6 times above the
MIC corresponding to the clinical breakpoint for Pseudomonas
aeruginosa from our hospital database: 16/4 μg/ml for TZP. When
the target was not achieved, the dose was adjusted. Univariant
and linear regression analysis were performed. A p value < 0.05
was considered statistically significant.
RESULTS. We enrolled 145 patients (mean age 64 years, 73.1%
male). A total of 104 patients (71.7%) presented with septic
shock at ICU admission. Mean APACHE-II was 20 ± 7.7. 29 pa-
tients (20%) presented positive blood cultures. 36 patients
needed CRRT (24.8%). We classified ƒCss ranges into three
groups: ƒCssT< 4xMIC (35 patients, 24.1%), ƒCssT4-6xMIC (36, 24.8%)
and ƒCssT>6xMIC (74, 51%). Linear regression analysis was per-
formed in order to identify factors to predict TZP Css. Results are
shown in Table 180 (R-squared = 0.559).
Creatinine concentration was de most important determinant of
elevated TZP Css, followed by being female and APACHE-II score.
CONCLUSIONS. We identified factors to predict TZP Css: age, sex,
APACHE-II Score, creatinine levels, TZP dose and the need of
CRRT. A high interindividual variability of Css in patients studied
was shown that is important to determine Css.
Table 180 (Abstract 0699).Model with linear terms and no interaction
CHARACTERISTIC COEFFICIEN STANDARD
ERROR
LOWER LIMIT
OF 95% CI
UPPER LIMIT
OF 95% CI
p
CONSTANT −45.20 18.48
AGE 0.53 0.24 0.06 1.004 0.029
FEMALE 30.30 7.19 16.08 44.53 <0.001
APACHE-II 1.66 0.47 0.73 2.59 0.001
CREATININE 33.86 3.70 26.54 41.17 <0.001
24g/day TZP 35.85 7.55 20.92 50.78 <0.001
CRRT 19.48 8.1 3.46 35.49 <0.001
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INTRODUCTION. Carbapenems are the most potent class of β-
lactams and are typically used for the treatment of the most severely
ill patients. Adequate procalcitonin clearance after the start of antibi-
otics has been associated to better prognosis in septic patients.
OBJECTIVES. We hypothesized that use of carbapenem as empirical
treatment in patients with sepsis may lead to a higher decrease in
procalcitonin levels, assuming a correlation of this clearance with
outcomes and the theoretical higher potency of carbapenem.
METHODS. We made a retrospective analysis of a prospective
database for procalcitonin kinetics. We studied procalcitonin at
admission and on subsequent days and its relationship with the kind
of antibiotic used as empiric therapy.
Comparison of variables was made using t-Sudent, U-Mann–Whitney,
Chi-Square o Fisher test as appropriate.
RESULTS. We studied 190 patients. Of those, 52 (27.4%) received
imipenem or meropenem as empirical antibiotic. No differences were
observed in terms of age and lactate or SOFA at admission. APACHE
II was higher in carbapenem group (22 (16.25-17.75) vs 19 (15–25); p
.024) and CRP at admission higher in non-carbapenem group (19.7
(12.30.5) vs 26 (16.3-34.2); p .045) More patients in carbapenem
group had any kind of inmunodepression (28.8 vs 13%; p .01).
Procalcitonin at admission, 48, 72 and 96 hours was similar between
groups. When we analysed procalcitonin clearance (delta-PCT), we
found a trend to a higher one at 96 hours in carbapenem group
(86.6% vs 82.9%; p .065), without differences at earlier days. By other
side, the proportion of patients reaching 80% of procalcitonin
clearance at 96 hours was higher in carbapenem group (70.6% vs
51.8%), without reaching statistical significance (p .061).
No differences in mortality at 28 days was observed among patients
who received carbapenem versus another antibiotic. As expected,
age, severity scores and lactate were higher in non-survivors, and
procalcitonin at 48, 72 and 96 hours and delta of procalcitonin at
those times were lower in non-survivors.
CONCLUSIONS. In our patients, the use of a carbapenem as
empirical antimicrobial therapy in septic patients did lead to a trend
to greater decrease in procalcitonin levels. However, we could not
demonstrate a relationship with patients outcomes. The small
sample size may have limited these results.
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INTRODUCTION. Early diagnosis of fungal peritonitis is a challenge.
Yeast-positive peritoneal fluid culture remains the gold standard but
suffers from a delayed time response. Decision to start an empiric an-
tifungal treatment is based on direct examination (DE) and/or the
use of predictive scores such as the Peritonitis Score (PS), with sensi-
tivity (Se) and specificity (Sp) of 84% and 50% respectively. New
diagnostic tools such as fungal PCR or serum 1.3 Beta-D-Glucan (1.3
BDG) emerged.
OBJECTIVES. To evaluate the usefulness of the 1.3 BDG assay in the
peritoneal fluid for the early diagnosis of fungal peritonitis and to
compare it with the conventional methods and with universal fungal
PCR.
METHODS. This retrospective study was conducted at the
University Hospital of Nancy between April 1st and December
31th 2016 after ethics committee approval. All peritonitis
admitted in the intensive care unit were included. On the
peritoneal fluid were performed: DE, yeast culture, universal
fungal PCR and 1.3 BDG. Demographic data and microbiological
data were collected. Yeast culture of the peritoneal fluid was
used as a reference to determine the Se and Sp of the other
techniques. An ROC curve was performed for 1,3BDG. Statistical
analysis was performed with SPSS V22 (IBM).
RESULTS. This study included 33 patients with an average age of 65
years (±13.1), 54% of whom were women. Severity scores (APACHE 2
and SOFA) averaged 45 (±18.6) and 9 (±3), respectively. Sixty percent
of patients were in septic shock and 27% were mechanically
ventilated for more than 48 hours. Most were secondary peritonitis
(97%), mainly postoperative (42%) and supra meso-colic (63%). Yeast
culture was positive for seven patients (21%) with 57% of Candida
albicans. Initial anti-fungal treatment was adequate in 85% of cases.
The mortality at Day 28 was 15% and the average length of stay was
10 days (1–31). PS was ≥3 and DE was positive for 5 patients (15%).
PCR was positive for 3 patients (9%). The ROC curve for the 1.3BDG
identified a cut off at 320 pg/ml with an area under the curve at 0.76
(95% CI [0.6-0.92]). Considering cut-off value of 320 pg/ml for a
1.3BDG, it provided a Se/Sp of 100% and 57%, respectively, with a
negative predictive value (NPV) of 100%. Se/Sp of the other diagnos-
tic methods were 57/96% (ED), 14/84% (PS) and 42/100% (PCR),
respectively.
CONCLUSIONS. This is the first study assessing the level of 1.3 BDG
specifically in the peritoneal fluid. In our sample size, an assay of less
than 320 pg/ml could eliminate a fungal peritonitis with a NPV of
100%.
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Table 182 (Abstract 0702). Patient-day P-SEP-Outcome
Survivor (pg/mL) Non-survivor (pg/mL) p-value
Day 1 825 (437 - 1395) 1632 (453- 3870) p<0.001
Day 2 881 (428 - 1337) 1825 (599- 3760)
Day 3 765 (450 - 1320) 1885 (826- 3654)
Day 4 784 (451 - 1621) 2570 (958- 4154)
Day 5 794 (401- 1643) 3231 (131- 5752)
Table 183 (Abstract 0702). Patient-day P-SEP levels-Clinical Course
Favourable Clinica Course Unfavorable Clinica Course p value
Day 1 849 (456-1455) 772 (127-2360) p<0.001
Day 2 887 (479-1591) 1333 (458-2543)
Day 3 807 (479-1419) 1138 (490-2361)
Day 4 810 (472-1539) 1812 (826-4085)
Day 5 837 (444-1668) 1624 (660-3231)
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sepsis. Various sepsis biomarkers have been studied in the past years
and commonly used ones include C-Reactive Protein (CRP) and Pro-
calcitonin (PCT). A new biomarker is sCD-14-st, known as Presepsin
(P-SEP), derived from mCD14, co-receptor of the Toll-like Receptor 4
for LPS. Its utility in critical ill patients has yet to be defined.
OBJECTIVES. To prospectively assess the potential role of presepsin
in the diagnosis of sepsis and its prognostic value in a critical care
setting.
METHODS. All adult patients admitted to one of the ICUs of the
University Hospital Integrated Trust of Verona were prospectively
screened from June 2016 to January 2017. Patients < 18 yrs, those
admitted for < 48-hr observation, and those who refused to
participate were excluded. Sepsis and septic shock were defined
daily (patient-day) according to new standard criteria1.
We recorded demographic characteristics, daily clinical and
laboratory data, procalcitonin (PCT) and presepsin (P-SEP) plasmatic
levels. Serum P-SEP levels were measured on ICU admission and then
daily until ICU discharge using luminescent monoclonal antibodies
(“pathfast method”). At the fifth day we used SOFA score variation
(delta-SOFA score) to divide patients in favourable (delta-SOFA < 2)
and unfavourable (delta-SOFA > 2) clinical course.
RESULTS. 97 patients (57 men) were included. Median age was 73
(62–80) yrs, APACHE II and SOFA score at admission were 14 (10–21)
and 7 (5–10), respectively. Admissions were due to medical
conditions (n = 66), elective surgery (n = 24) and emergency surgery
(n = 7). Sepsis was diagnosed at admission in 69 patients (71.1%),
whose 29 had septic shock (29.8%). Overall ICU mortality was 17.5%.
P-SEP levels in septic shock patients were significantly higher than in
those classified as septic and non-septic (1966 (909–4845) vs 1226
(730–2223) vs 504 (373–856) pg/ml, respectively. PCT showed the
same trend and thus similar accuracy, as showed by ROC AUC of
0.82 for both biomarkers (P-SEP best cut-off = 1036 pg/ml).
No correlation was found between P-SEP and the APACHE II score
(r = 0,29). However, differently from PCT, P-SEP trend was signifi-
cantly different between survivors/non-survivors and, during the first
five days, between favourable/unfavourable course (p < 0.001, two
way ANOVA.
CONCLUSIONS. In ICU patients P-SEP concentrations are increased in
septic patients and show similar prognostic power than PCT. P-SEP
trends may represent a promising early prognostic marker of both
recovery and mortality.
REFERENCE(S)
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Class n° (%) P-SEP pg/ml
Median
(Q1-Q3)
p-value Class n° (%) P-SEP pg/ml
Median
(Q1-Q3)
p-value
Sepstic
shock
189 (18.8) 1966
(909-4845)
p<0.001 “Sepsis” 681 (67,9) 1330
(779 -3051)
p<0.001
Sepsis 492 (49) 1226
(730-2323)
p<0.001
Local
infection
92 (9.1) 448 (354-727) p>0.05 “No
sepsis”
323 (32,1) 504 (373- 856)
No
infection
230 (22.9) 597 (387-874)
Total 1003 10030703
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INTRODUCTION. Shock affects 1/3 of the patients in the intensive
care unit with survival time often measured in hours.1,2 Vasodilatory
shock (VS) is the most frequent sub-type of shock and patients with
VS requiring high dose vasopressors have a high mortality.1,3 Previ-
ous reports suggest low angiotensin II (Ang II) levels and decreased
angiotensin-converting enzyme (ACE) activity predict worse out-
comes in sepsis.4 ATHOS-3, a randomized, double-blinded, phase 3
clinical trial demonstrated that administration of human Ang II sig-
nificantly increased blood pressure in VS with a trend toward im-
proved mortality.
OBJECTIVES. To assess if Ang I/II ratio predicts outcomes in
distributive shock.
METHODS. Ang I and Ang II were measured at baseline prior to
study treatment as part of a pre-specified analysis. Ang I, Ang II, and
Fig. 243 (Abstract 0703) Survival Day 28 by Baseline Ang I/II
Ratio >/=1.63
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 359 of 542Ang I/Ang II ratio were dichotomized by median value. Mortality at
day 28 was summarized by Kaplan-Meier estimates and differences
in survival compared by log-rank test. Proportional hazards models
were conducted for multivariate analyses with covariates of age, gen-
der, race, body mass index, baseline mean arterial pressure, baseline
serum albumin, baseline APACHE II score, geographic region, recent
exposure to ACE inhibitors, recent exposure to angiotensin receptor
blockers, history of acute respiratory distress syndrome (history or x-
ray finding), history of sepsis, baseline norepinephrine-equivalent
dose, and baseline endogenous Ang I and Ang II levels.
RESULTS. A relatively low Ang II state, as assessed by higher Ang I/II
ratios (≥1.63, median across the study population), was associated
with higher mortality across the full population in multivariate
analysis (HR = 1.78; 95% CI: 1.25 - 2.53, p = 0.002). The risk of death
within the placebo arm was significantly associated with an elevated
Ang I/II ratio, as assessed by multivariate analysis (HR = 1.77; 95% CI:
1.10-2.85, p = 0.019).
In the Ang II treated arm, the high ratio effect was attenuated in
multivariate model (HR = 1.64, 95% CI:0.97-2.79, p = 0.066). This
attenuation was associated with a significant treatment effect of Ang
II compared to placebo on mortality for patients with high Ang I/II
ratio (HR = 0.64; 95% CI: 0.41-1.00, p = 0.047).
CONCLUSIONS. A relatively low Ang II state, as assessed by higher
Ang I/II ratios, predicted increased mortality in patients with VS,
suggesting the vital importance of ACE effects. In addition, the
predictive capacity of a high Ang I/II ratio was attenuated by the
administration of Ang II.
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INTRODUCTION. Elevated cardiac troponin values are commonly
observed in sepsis and septic shock and reflect cardiac ischemia. The
impact of these elevations on patient outcomes remains
controversial.
OBJECTIVES. The study purpose was to determine the association of
serum troponin values within 24 hours of intensive care unit (ICU)
admission with mortality in sepsis and septic shock.
METHODS. This was an IRB-approved, single-center, retrospective,
observational study of patients admitted to an ICU between Septem-
ber 2012 and May 2015. The primary endpoint was in-hospital mor-
tality. Patients were at least 18 years of age and possessed a
diagnosis of sepsis or septic shock. Categorical data were analyzed
using Chi-squared or Fisher Exact tests. Student t test was used for
continuous data with equal variances, and a student t test with the
Satterthwaite method was used for continuous data with unequal
variances. Multivariate logistic regression analysis was performed
using forward selection (p < 0.05 used for variable entry into the
model) to evaluate variables associated with in-hospital mortality.
RESULTS. In total, 360 patients formed 2 groups: low (≤0.2 ng/mL,
n = 236) and high troponin (>0.2 ng/mL, n = 124). The only
differences in baseline characteristics were a greater percentage of
patients with chronic kidney disease (21 vs. 10.6%) and a lower
percentage with liver disease (7.3 vs. 15.7%) in the high troponin
group. Average troponin values were 0.07 and 2.72 ng/mL,
respectively. There was no association between troponin and in-
hospital mortality (odds ratio 1.155, 95% confidence interval 0.690-
1.933, p = 0.584).
CONCLUSIONS. This study did not find a significant increase in
mortality with elevated troponin values in patients with sepsis or
septic shock.
Fig. 244 (Abstract 0705) See text for description
Fig. 245 (Abstract 0705) a CRP values (mg/dl): post ON-CPB CABG
(UK). b CRP values (mg/dl): post ON-CPB CABG (BE)
Table 184 (Abstract 0705). Baseline patients' characteristics
Sex Male/Female 96/333 22,4%/77,6%
Age (mean±SD) 67,9±11
Admission type Elective/Emergency 299/130 69,7%/30,3%
Type of surgery CABG/Valve replacement/Valve
repair/Valve+CABG
255/90/21/63 59,2%/21% 4,9% 14,7%
CPB NO/YES 86/343 20%/80%
LV function preop. Normal/Abnormal 348/81 81,1%/18,9%
RV function preop. Normal/Abnormal 428/1 99,8%/0,2%
PMH:diabetes NO/YES 317/112 73,9%/26,1%
PMH:smoker No/Yes/Unknown 117/97/215 27,3%/22,6%/50,1%
Infection NO/YES 384/45 89,5%/10,5%
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INTRODUCTION. Sepsis is a leading cause of morbidity and mortality
in acutely ill patients, and after major surgery the early diagnosis of
sepsis is challenging [1].
OBJECTIVES. To analyze CRP and WBC kinetics during the first
postoperative (PO) week after cardiac surgery and between groups
of patients with and without postoperative infection (POI).
METHODS. This is a multicenter retrospective observational study
conducted from Nov 2013 to Aug 2014. We screened all post cardiac
surgery patients admitted to the Cardithoracic Critical Care Unit at JR
Hospital in Oxford and to the Intensive Care Unit at Erasme
University Hospital in Bruxelles. We included all adult (>18 yrs)
patients post cardiac surgery (elective/emergency), ON/OFF CPB. We
excluded: ongoing preoperative infections (including endocarditis),
thoracic interventions, trauma, pregnancy, immunocompromised,
cirrhotic patients. Four groups were identified: CABG (ON/OFF CPB),
valve replacement (R), valve repair (r), CABG + valve r/R. For all
subgroups, we separated patients who developed a PO infection
from the others. EUROSCORE, SOFA score, clinical, microbiological
data, CRP, WBC values, antibiotic therapies were daily recorded up to
7 POD in ICU and in the ward. Intraoperatively, as routine practice, at
Erasme Hospital, a bolus of steroid was administered before starting
on CPB.
RESULTS. A total of 511 patients were screened, and 429 included.
Baseline patients characteristics are presented in
(Table 184). When compared ON-CPB vs OFF-CPB CABG, considering
patients without POI, no difference was found on CRP kinetics at
JRH, while data from Erasme showed CRP significant rising during
POD1, 2 and 3 in the group OFF-CPB CABG (Fig. 244). No difference
was observed for WBC count. In the ON-CPB CABG group, infected
patients had higher CRP values than patients with no infection from
POD3 to POD7 (Fig. 245), with cut off values ranging from 131 to 153
mg/dl (Table 184); and from 8 to 18.5 mg/dl when steroids were ad-
ministered preCPB (Table 186). Moreover, when no steroids were
given, we got higher WBC values in the patients group with POI from
POD0 to POD3. In the OFF-CPB CABG and post valve surgery groups,
no difference was found for CRP and WBC kinetics between patients
with and without POI.
CONCLUSIONS. Interestingly, the ON-CPB group did not show higher
CRP and WBC values than the OFF-CPB group despite the use of
CPB, probably due to the high biocompatibility of the new pump cir-
cuits. After ON-CPB CABG, higher CRP values after POD3 could help
in detecting PO infections. CRP got higher sensitivity and specificity
from POD3 to POD7, while WBC count from POD0 to POD3. Post
valve and valve + CABG surgery no WBC count difference was found
between infected and not infected.
REFERENCE
1. Angus DC, van der Poll T. Severe sepsis and septic shock. N Engl. J
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Table 186 (Abstract 0705). Cut off values for CRP (mg/dl) (Erasme
Hospital-BE
Postoperative day (POD) Cut off (mg/dl) Specificity Sensitivity
3 13.5 0.44 1
4 18.5 0.76 0.66
5 15 0.72 0.66
6 9 0.73 0.83
7 8 0.68 1
Table 185 (Abstract 0705). Cut off values for CRP (mg/dl) (JRH-UK
data)
Postoperative day (POD) Cut off (mg/dl) Specificity Sensitivity
3 142 0.19 1
4 153 0.69 0.71
5 139 0.74 0.85
6 151 0.80 1
7 131 0.8 0.73
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BACKGROUND. Increases in the plasma concentration of
neutrophil gelatinase-associated lipocalin (NGAL) due to increased
production by renal proximal tubular cells occur relatively soon
after acute kidney injury. However, plasma NGAL concentrations
are also elevated in inflammatory conditions as a result of en-
hanced production by non-renal cells. In this study, we aim to in-
vestigate the predictive value of plasma NGAL in patients with
severe sepsis.
METHODS. A total of 124 patients were enrolled in this prospective
observational study. Peripheral blood samples were obtained at
admission, on day 2, and day 7, and measurements of plasma
NGAL (immunofluorescence assay) along with blood cell counts,
CRP, plasma lactate, procalcitonin (PCT), and creatinine were made.
Receiver operating characteristic (ROC) curves were generated to
assess the utility of plasma NGAL in prediction of 28-day mortality
and need for CRRT. Based on clinical variables, Cox proportional
hazard regression curves were built with and without plasma NGAL
for 28-day mortality prediction to determine NGAL's contributive
predictive value. A possible association between plasma NGAL and
PCT levels (acting as surrogate for infection) was also investigated.
RESULTS. Relative to surviving patients (at 28 days), plasma NGAL
was significantly increased in non-survivors group on day 2 and 7.Survivors (n = 82) Non-survivors (n = 42)Day 1 241.5 (126.8-523.5) 352.0 (181.0-801.0)Day 2 233.0 (106.5-469.3)* 413.0 (224.5-1050.0)§Day 7 161 (98.8-262.3)*, † 458.5 (212.0-862.0)*, §Plasma NGAL concentration presented as median (IQR), ng/mL
*P < 0.05 compared with day 1 within group, †P < 0.05 compared
with day 2 within group, § P < 0.05 compared between groups
[Change of NGAL in survivors and non-survivors]
At cut-off values of 240.5 and 261 ng/mL, respectively, plasma NGAL
on day 2 and 7 (but not at admission) predicted 28-day mortality
with AuROC values of 0.675 (95% CI 0.570-0.780) and 0.752 (95% CI
0.619-0.885), respectively.AuROC (95% CI) Cut-off value (ng/
mL)Sensitivity Specificity PPV NPVDay
10.584 (0.476-
0.691)282 57.1% 59.8% 42.1% 73.1%Day
20.675 (0.570-
0.780)240.5 75% 52% 43.3% 80.9%Day
70.752 (0.619-
0.885)261 73.1% 75.6% 49.3% 89.6%AuROC area under receiver operating characteristic, PPV positive
predictive value, NPV negative predictive value
[Plasma NGAL in prediction of 28-day mortality]
Moreover, patients categorized according to the NGAL cut-off
values on day 2 and 7 showed significant differences in 28-day
mortality. Addition of day 2 NGAL to the clinical model resulted
in a net reclassification index (NSI) increment (SE) of 0.17(0.08)
for prediction of 28-day mortality. Moreover, NGAL levels at ad-
mission and day 2 (cutoff values, 294 and 107.5 ng/mL, respect-
ively) outperformed creatinine in prediction of the need for CRRT,
with AuROC of 0.726 (95% CI 0.612-0.841) and 0.692 (95% CI
0.564-0.820), respectively.AuROC (95% CI) Cut-off
valueSensitivity Specificity PPV NPVPlasma NGALDay
10.726 (0.612-
0.841)294ng/ml 75% 63.0% 32.8% 91.28%Day
20.754 (0.640-
0.868)444.5ng/mL 66.7% 74.5% 39.1% 90.1%Day
70.908 (0.832-
0.983)363.5ng/mL 81.3% 88.6% 56.5% 96.3%Plasma CrDay
10.692 (0.564-
0.820)107.5μmol/
L66.7% 67% 32.7% 89.3%Day
20.738 (0.609-
0.866)113.5μg/mL 73.9% 72.4% 39.7% 91.9%Day
70.815 (0.686-
0.944)120.5μg/mL 75% 80.3% 40.9% 94.6%AuROC area under receiver operating characteristic, PPV positive
predictive value, NPV negative predictive value, Cr creatinine
[Plasma NGAL and Cr in prediction of CRRT]
A direct association between plasma NGAL and PCT quintiles (ng/
mL) ranging from < 0.05 (normal) to >10 (septic shock) was also
observed (P < 0.05).
CONCLUSIONS. Plasma NGAL discriminated 28-day survivors from
non-survivors on day 2 and 7. Based on ROC values, Day 2 (but
not admission) plasma NGAL was a relatively robust predictor of
28-day mortality prediction - this predictive value increased on
day 7. Furthermore, plasma NGAL outperformed creatinine in the
prediction of need for CRRT. Finally, the direct relationship be-
tween plasma NGAL and PCT requires further evaluation.
Fig. 246 (Abstract 0706) NGAL change in survivor and non-survivor
Fig. 247 (Abstract 0706) NGAL in 28-day mortality prediction
Fig. 248 (Abstract 0706) NGAL and Cr in CRRT prediction
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INTRODUCTION. The risk of developing long term cognitive impairment
and dementia is increased after systemic infections. The greatest risk is in
those patients that develop an encephalopathy (delirium) during the
infection. Therefore a common pathophysiology in systemic inflammation
and neurodegenerative diseases is assumed. Recently, neuroinflammation
has been shown to play a role in both disease entities, however little
evidence is available on which biochemical pathways are dysregulated in
the brain during infections and delirium.
OBJECTIVES. In this observational retrospective pilot study we
studied whether there are differences in protein expression in CSF
between infectious patients with or without delirium. Furthermore
we assessed if protein expression in CSF in infectious delirium shows
similarities to patients with mild Alzheimer's disease (AD).
METHODS. Stored CSF samples from adult patients with a systemic
non-neurological infection (with or without delirium) at the time of
lumbar puncture were eligible. Samples were compared to healthy
controls and to patients with mild AD which served as 'positive' neu-
roinflammatory controls. CSF samples were analyzed using a proxim-
ity extension assay (PEA). We compared expression levels of 133
inflammatory and brain-specific proteins between groups with un-
paired t-tests and corrected for multiple comparisons with the False
Discovery Rate adjustment. In order to better understand the bio-
logical significance of the differentially expressed proteins we per-
formed an Overrepresentation Test using PANTHER Classification
System with Bonferroni correction for multiple testing.
RESULTS. Fifteen samples from infectious patients with delirium and
30 samples from infectious patients without delirium were included
and compared to 15 healthy controls and 29 patients with AD. IL-6,
CXCL1, IL-8 and CXCL6 were significantly upregulated in CSF from in-
fectious delirium patients compared to healthy controls (FDR ad-
justed p-value < 0.05 and fold change >2). 54 proteins were
significantly upregulated in patients with delirium relative to patients
without a delirium. Although pro-inflammatory protein expression
was increased in infectious delirium relative to AD, protein expres-
sion in patients with AD and infectious delirium showed the largest
overlap (Chi-square test p < 0.0001).
CONCLUSIONS. Infectious delirium was associated with increased pro-
inflammatory protein expression in CSF relative to infectious patients
without delirium, to healthy controls and to patients with mild AD. The
largest overlap in CSF composition was between infectious patients with
delirium and patients with AD. This suggests an overlapping pathophysi-
ology and could attribute to understanding why some patients go on to
develop cognitive failure after suffering from an infection.
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evated in patients with heart failure, as well as in some patients with
a variety of conditions including renal failure and sepsis. Numerous
studies suggest that high Pro-BNP levels represent a reliable marker
of sepsis-induced myocardial dysfunction, and are associated with
increased mortality. However other findings indicate that the rela-
tionship between Pro-BNP and myocardial dysfunction is weak, and
data on the prognostic impact of high Pro-BNP levels in septic pa-
tients are conflicting. The primary conditions predisposing patients
to Pro-BNP elevation in sepsis are largely undetermined, and clinical
studies did not find correlation between cytokine concentration and
septic myocardial dysfunction.
OBJECTIVES. The purpose of our study was to determine the
relationship between the plasma levels of Pro-BNP and different bio-
markers of the septic inflammatory cascade (TNF-α, IL-1β, IL-6, IL-8,
C-reactive protein). Also, our aim was to analyze the correlation be-
tween Pro-BNP and diagnosis (severe sepsis vs. septic shock), APA-
CHE II and SOFA score, and to check its ability to predict mortality.
METHODS. We assessed 58 consecutive septic patients admitted to
our medical-surgical ICU. Plasma levels of Pro-BNP and inflammatory
mediators (TNF-α, IL-1β, IL-6, IL-8, C-reactive protein) were deter-
mined on day 1. APACHE II and SOFA score were also calculated on
day 1. Spearman, Kruskal-Wallis or Mann–Whitney tests were done to
study the association of Pro-BNP with the different inflammatory me-
diators, APACHE II, SOFA and mortality at day 28.
RESULTS. It was found significant association between the levels of
Pro-BNP and the plasma concentrations of TNF-α (p < 0.001), IL-6
(p = 0.005) and IL-8 (p = 0.025). There were 18 patients with severe
sepsis and 40 patients with septic shock. Pro-BNP levels were signifi-
cantly elevated in septic shock patients compared with those with
severe sepsis (p = 0.006). Also, we found significant correlation be-
tween Pro-BNP and SOFA (p = 0.01), dependent on its renal
(p = 0.003) and cardiovascular (p = 0.036) components. Mortality at
day 28 was 24.1% (44 survivors and 14 non-survivors), but Pro-BNP
did not show correlation with it.
CONCLUSION. We found that Pro-BNP was associated to certain
acute phase mediators (TNF-α, IL-6 and IL-8), linking Pro-BNP levels
to the inflammatory cascade. Also, Pro-BNP was significantly higher
in septic shock patients, and its levels were correlated to organ dys-
function, due to the renal and cardiovascular components of the
SOFA score. However, Pro-BNP has bad prognostic performance, not
showing correlation with mortality. The role of Pro-BNP in sepsis re-
mains not fully established, and larger studies including assessment
of myocardial dysfunction should be done.
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INTRODUCTION. Sepsis-associated encephalopathy (SAE) is relevant
for short- and long-term outcome in patients with septic shock (1).
Diagnosis and monitoring of SAE are sophisticated due to a high pro-
portion of sedation among these patients. Body fluid biomarkers
might therefore be valuable, but the majority of available studies on
NSE and S100B in SAE provided contrary results (2). The potentialrole of neurofilament (Nf) heavy (NfH) and light chains (NfL) as neu-
roaxonal injury markers (3) in SAE has not been investigated.
OBJECTIVES. To evaluate the relevance of NfH and NfL in
cerebrospinal fluid (CSF) and plasma to diagnose, monitor and
predict outcome in patients with SAE.
METHODS. 25 intensive care unit (ICU) patients with septic shock
(n = 20) and without sepsis (n = 5) were prospectively included in a
single-center observational study between 2012 and 2016 (ethics
board identifier: A 2012–0058, ClinicalTrials.gov: NCT02442986). Main
exclusion criterion was a previously known patient history of cerebro-
vascular disease as ischemia, hemorrhage, tumor or dementia. All pa-
tients were clinically assessed for signs of SAE in sepsis or delirium in
patients without sepsis by an interdisciplinary team consisting of
intensivist and neurologists. Electroencephalography (EEG) and delir-
ium screening methods (CAM-ICU) were used to detect and to assess
the severity of SAE or delirium. CSF analysis (n = 12) after sepsis on-
set and longitudinal plasma biomarker measurements for NSE,
S100B, NfH and NfL on study days 1, 3 and 7 were performed in all
patients.
RESULTS. 18 patients with SAE showed a significant increase of NfH
(p = 0.043) and NfL (p < 0.001) between study day 1 and 7 in
comparison to a slight, but non-significant increase of both markers
in patients without SAE or delirium (n = 7). NSE and S100B values
did not change significantly in both groups. Non-survivors until day
100 after study inclusion had significantly higher NfL values in CSF
(p = 0.01) as survivors, all other markers did not change significantly
between the groups. Plasma levels of NfH at day 1 (p = 0.017) and
day 7 (p = 0.029) and S100B values at day 3 (p = 0.005) were signifi-
cantly higher in non-survivors until day 100. In total 6 patients with
sepsis and 1 patient without sepsis died until follow-up at day 100.
CONCLUSIONS. In comparison to NSE and S100B both NfH and NfL
might represent promising biomarkers to monitor SAE and to predict
outcome in sepsis. Larger longitudinal body fluid biomarker studies
are indicated.
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INTRODUCTION. Clinically significant infections (CSIs) are life-
threatening but difficult to diagnose after liver transplantation
(LTx) [1].
OBJECTIVES. This study investigates the value of presepsin (PSEP)
and procalcitonin (PCT) as a prognostic marker for CSIs in LTx
recipients.
METHODS. The clinical course of 33 LTx recipients was
retrospectively studied. Study group included patients who
developed CSI postoperatively. CSIs were defined as pulmonary,
bloodstream, or intra-abdominal infections with criteria proposed by
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 364 of 542the Centers for Disease Control and Prevention [2]. Control group in-
cluded patients with uncomplicated course of LTx.
RESULTS. Groups were comparable in demographic and
anthropometric parameters, as well as the level of inflammatory
markers (procalcitonin, presepsin, CRP), and white blood cells count
before surgery. The presepsin concentration in study group was
significantly higher in POD 1 (4275 ± 3878 ng / ml vs 1916 ± 1413
ng / ml, p = 0.027), POD2 (4978.5 ± 2473.3 ng / ml vs. 2029,
5 ± 1260 ng / ml, p = 0.002) and POD 5 (5397.06 ± 3916.09 vs.
2473 ± 1140.7 ng / ml, p = 0.002) than in control group. There was
no significant difference in procalcitonin concentration in POD1
(24.73 ± 17.87 ng / ml vs. 16.54 ± 21.74 ng / ml, p = 0.126), however,
significant difference in the concentration of procalcitonin was
observed in POD2 60.07 ± 49.26 ng / ml versus 16.38 ± 15.44 ng /
ml, p = 0.0003) and POD5 (13.22 ± 8.73 ng / ml vs. 4.09 ± 7, 03 ng /
ml, p = 0.003). There was no significant difference in concentration
of CRP and the level of white blood cells count during the first five
days after TP. According to the ROC analysis, the area under the
curve (AUC) for presepsin in POD1 was 0.75, which was much, but
not significantly, higher than for procalcitonin (AUC 0.51, p = 0.124).
The diagnostic cut-off of presepsin in POD1 is 1693 ng / ml, sensitiv-
ity is 81.2% and specificity is 66.7%. In the POD 2 the AUC for presep-
sin was 0.883, for procalcitonin - 0.922 (p = 0.679).
CONCLUSIONS. Presepsin is the earliest laboratory marker for
postoperative infectious complications and sepsis in liver transplant
recipients. In our study we found the diagnostic cut-off of presepsin
which was defined as 1693 ng/ml in POD1.
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INTRODUCTION. Clinical assessment of central nervous system
dysfunction to detect encephalopathy in septic shock with multiple
organ failure is challenging. IL6 and TNFα are known to activate
brain responses during inflammatory processes, which clinical
significance is unknown. (1, 2).
OBJECTIVES. The aim of the present study is to evaluate the NSE and
S100 levels in septic shock with multiple organ failure.
METHODS. Neuron specific marker NSE and glial cell specific marker
S100beta of 31 adult patients admitted to ICU due to sepsis were
analyzed. The inflammatory response was evaluated by analyzing
inflammatory markers including TNFα, IL6, PCT and CRP and the
need of noradrenaline. Multiple organ failure (MOF) was determined
as SOFA score of 3 or 4 in two organ systems during the blood
sampling.
RESULTS. A total of 20 (64%) patients had NSE and 23 (74.2%) had
S100beta above normal values (17ug/L and 0.11 ug/L, respectively).
The median APACHE II, SOFA, PCT and CRP levels as well as the
cumulative noradrenaline dose were similar between those with NSE
or S100beta above or lower than normal values. TNFα was higher in
those with S100beta above normal value (42.1 pg/mL [29.8-65.1] vs
20.1pg/mL [19.4-22.8], P = 0.013). There was a positive correlationbetween S100beta and TNFalpha as well as S100beta and IL6
(R = 0.452, P = 0.012 and R = 0.453, P = 0.012, respectively). There
were no differences in the levels of either S100beta or NSE between
patients with or without MOF.
CONCLUSION. Majority of patients with septic shock had increased
levels of neurobiomarkers. Proinflammatory markers (TNFalpha, IL6)
correlated with glial cell marker S100beta.
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INTRODUCTION. Sepsis is life threatening organ dysfunction caused
by dysregulated host response to infection[1] Despite SOC mortality
remains 40-60% [2].Regulating the disproportionate cytokines could
reduce the end organ damage.ECAD removes key cytokines in vitro
&i n vivo from cytokine storm seen in sepsis[3,4]
OBJECTIVES. To assess pre & post ECAD safety,
efficacy,hemodynamics & outcome among septic patients.
METHODS. Observational,prospective,pilot study done in tertiary ICU
in Pune,India during Aug 2016 to Mar 2017 after ERB
approval.Inclusion criteria: confirmed diagnosis of sepsis or septic
shock and hospitalized in ICU,age 18–80 yrs,evidence of at least 1
organ dysfunction during sepsis,at least 6 hours of antibiotic therapy
& SOC as per Sepsis-3.Exclusion criteria: pregnant/ nursing mother,
established septic shock for >48 hrs,more than 3 failed organs at
entry, platelet count < 20,000/mm3,uncontrolled hemorrhage within
last 24 hrs, active malignancy on chemo or radiation therapy within
last 60 days,CPR during current episode of sepsis,patients with im-
mune deficiencies or on immunosuppresant therapy. Blood samples
collected for cytokines IL-1,IL-6,IL-10,TNF α,CRP before and after each
ECAD. APACHE II & SOFA calculated.All patients recieved SOC. Avera-
geg duration of ECAD 12 hrs each.
RESULTS. Case series of 10 patients, 6 men &4 women with
septic shock and or MultiOgan Failure(MOF) from the ICU treated
with SOC along with ECAD as an adjuvant therapy.Total 18 ECAD
used, minimum 1 and maximum 3 per patient. Average APACHE
II score reduced by 18.95%. All surviving patients showed
decrease in IL-6 levels except for two.[Table 187]. 6 out of 10 pa-
tients survived despite of average predicted mortality rate of
27.21% prior to ECAD therapy. Limitations of study: small sample
size & no control group.
CONCLUSIONS. ECAD substantial reduced IL6, IL10, CRP, APACHE II &
predicted mortality scores and improved MAP values along with
SOC.ECAD can be a beneficial adjuvant therapy in sepsis and /or septic
shock and / or MOF. It is a safe and well tolerated therapy in critically ill
septic patients. Bigger, prospective, multicentric randomized control
study would help to reconfirm findings of this pilot study.Sepsis is a life
threatening condition that arises when the body´s respouse to
infection injures it´s own tissues, hence the ways to modify such
damaging immune dysregulation could be the future of Sepsis
management to improve outcomes
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Table 187 (Abstract 0712). Demography and Efficacy parameters of
patients
SERIAL
NO
AGE SEX PRE
ECAD
APACHE II
POST
ECAD
APACHE II
PRE
ECAD
IL6
LEVELS
POST
ECAD
IL6
LEVELS
PRE
ECAD
MAP
(mm Hg)
POST
ECAD
MAP
(mm Hg)
OUTCOME
1 73 F 20 13 1013 80.64 67 94 SURVIVED
2 60 M 25 25 2517.56 50.8 59 76 DEATH
3 25 M 13 5 31.24 15.36 78 84 SURVIVED
4 65 M 29 30 7.84 3.24 60 81 SURVIVED
5 34 F 18 9 51.4 33.27 57 82 SURVIVED
6 64 F 27 16 147.16 5.12 65 90 DEATH
7 22 F 5 4 4.4 4.4 92 87 SURVIVED
8 60 M 13 19 14.08 1269.2 108 120 DEATH
9 64 M 17 16 131.2 147.16 100 106 DEATH
10 66 MALE 23 17 15.36 21.12 112 72 SURVIVED
Fig. 250 (Abstract 0713) See text for description
Fig. 251 (Abstract 0713) See text for description0713
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INTRODUCTION. Procalcitonin (PCT) is a more than promising marker
to be used to guide antibacterial therapy and reduce its duration in
terms of reduce risk of development of antimicrobial resistance.
OBJECTIVES. We study the correlation betwen PCT, CRP and WBC in
septic shock.
METHODS. Since January 2012 to December 2016, patients
experiencing a septic shock and admitted with a first 24h SAPS
II > 25, associated with a SOFA-score > 4 and likely ICU length ofstay ≥ 72 hrs. were enrolled for the study. We studied the correlation
between PCR, CRP and WBC in septic shock by linear regression and
Bland Altman analyses.
RESULTS. During the study period, 768 (38.5%) out of 1990 patients
admitted to ICU - median (IQR) age 61 (58–77), 1st 24 hrs. SAPS II 58
(47–78), SOFA-score 12 (10–14) were enrolled for the analysis. Correl-
ation between PCR, CRP and WBC in the 142 (18.5%)/768 recorded
septic shock are shown in Figs. 250 and 251, respectively linear re-
gression and Bland Altman analyses. PCT is not correlated neither
CRP nor WBC, whereas the latter two showed a similar trend and
closer correlation.
CONCLUSIONS. PCT is not correlated neither CRP nor WBC, whereas
the latter two showed a similar trend and closer correlation.
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INTRODUCTION. Despite improvement in care of burned patients
sepsis remained the leading cause of death. The diagnosis of sepsis
is difficult due to the existing systemic inflammatory response
syndrome (SIRS) which can mimic the signs of sepsis in the absence
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 366 of 542of real infection too. Early detection of infections can be lifesaving in
burn victims because an earlier diagnosis can lead to earlier initiation
of antibiotic treatment which is associated with better outcome. On
the other hand unnecessary antibiotic treatment can be avoided.
OBJECTIVES. Our aim was to evaluate the predictive power of
leukocyte antisedimentation rate (LAR), serum C-reactive protein
(CRP) and procalcitonin (PCT) levels regarding mortality risk and de-
velopment of septic complications.
METHODS. In our prospective observational study 21 patients
admitted to our intensive care unit immediately after severe burn
injury were included. Blood samples were taken at admission and on
the following mornings till discharge from ICU. The initial kinetics of
the parameters were analysed for 5 days (T1-T5). The patients were
divided into survivors and non-survivors. Sepsis was diagnosed by
clinical signs according to the guideline of the American Burn Associ-
ation. The kinetic of the measured parameters were analysed 3 days
before (D-3-1) and 3 days after (D + 3-1) when sepsis was declared.
16 healthy volunteers with similar age and sex to the observed
population served as control group.
RESULTS. The patients' age median was 66 (IQR: 49–80) years.
Median abbreviated burn severity index was 7 (IQR: 5–8) and total
burned surface area (TBSA) 30 (IQR: 25–40). Ten patients became
septic,
7 patients died due to infectious complications. LAR levels in survivors
were significantly higher compared to controls on T3-5 (p < 0.001)
whereas LAR levels of non-survivors were significantly lower on T2
(p < 0.05) and became higher on T5. Non-survivors and survivors
showed significant difference on T2, T4 and T5 (p < 0.05) with higher
levels in survivors. CRP levels were above the upper normal limit in
survivors and non-survivors from T2 without significant difference
between groups. PCT level were slightly elevated in non-survivors
without significant difference between groups. In septic patients LAR
showed a significant drop on D-1 (p < 0.05). CRP levels showed this
decreasing tendency too, but this was not statistically significant. PCT
levels failed to predict this. It became significantly elevated only
since the onset of sepsis.
CONCLUSIONS. Patients who showed a drop in LAR levels on T2
were more likely to die. A sudden decrease in LAR levels may predict
the onset of sepsis in contrast to the other studied parameters
among our patients.
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INTRODUCTION. Procalcitonin (PCT) is a more than promising marker
to be used to guide antibacterial therapy and reduce its duration in
terms of reduce risk of development of antimicrobial resistance. We
evaluated its efficacy both in predicting septic shock and in likely
antibiotic duration saving.
OBJECTIVES. To asses the role of PCT and its trend in guiding
antibiotic therapy in ICU.
METHODS. Since January 2012 to December 2016, patients
experiencing a septic shock and admitted with a first 24h SAPS
II > 25, associated with a SOFA-score > 4 and likely ICU length of
stay ≥ 72 hrs. were enrolled for the study. On all the patients the fol-
lowing was collected: demographics, comorbidities and admission
diagnosis together with severity of illness, duration of ICU supportive
therapies; moreover PCR, CRP and WBC were daily collected in asso-
ciation with type and duration of antibiotic therapy.RESULTS. During the study period, 768 (38.5%) out of 1990 patients
admitted to ICU - median (IQR) age 61 (58–77), 1st 24 hrs. SAPS II 58
(47–78), SOFA-score 12 (10–14) were enrolled for the analysis. A total
of 142 (18.5%) out of the enrolled patients experienced a septic
shock and were associated with significant higher median (IQR) level
of PCT if compared to those with only sepsis findings [respectively:
25 (4–37) and 1 (0.2-2), p = 0.0005]; moreover early PCT values were
lower in survived patients [respectively: 4 (2–21) and 27 (5–39),
p = 0.0005]; conversely we do not find a PCT cut off value consider-
able as a good predictor of septic shock, even though a PCT ≥ 1.85
has been found related to a specificity of 65.7% and sensitivity of
62% to predict septic shock. PCT was an helping tool in stopping
antibiotic therapy and saving its costs only in survived patients and
not in dead ones. Actually it decreased of ≥ 80% in day 5th of ther-
apy in over 90% of patients that were discharged to the ward.
CONCLUSIONS. PCT may be a good performing biomarker to inform
practice in antibiotic therapy stopping and stewardship.
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INTRODUCTION. Rapid response system (RRS) screens high risk
patients earlier in the general ward and performs interventions to
prevent an unexpected intensive care unit (ICU) admission and
cardiac arrest. Recently, scoring systems such as modified early
warning score (MEWS) or national early warning score (NEWS) were
used in mandatory in several hospitals.
OBJECTIVES. This study was done to evaluate whether new scoring
system (Quick alert score, QA score) composed of vital sign and
laboratory data could effectively screen high risk patients by the
ward care team.
METHODS. All patients with which was screening by Medical Alert
System (MAS) and randomly selected controls with sampling ratio of
5% were selected among adult admission during October 2013 were
extracted for development of the QA score, and vital sign and
laboratory data considering SBP, PR, RR, lactate, total CO2 were
collected. Same process was conducted among admission during
December 2013 for validation. Multivariable logistic regression was
used to create the QA score using bootstrapping methodology with
external validation.
RESULTS. Of the 12,523 measures check-up, 5,700 measures were
screened by MAS (45.5%), and 387 were activated by medical
alert team (MET) (3.1%). As MAS screening were conducted each
time of repeated measures, analysis was conducted spell-based.
The QA score was developed using combination of the vital sign
and laboratory test, and variables independently associated with
ICU admission on logistic regression. The receiver operating
characteristics curve analysis of the QA score was c = 0.82 (95%
confidence interval, 0.79-0.84). External validation, performed on
13,166 measures, exhibited excellent discrimination (c = 0.76;
95% confidence interval, 0.73-0.79).
CONCLUSIONS. The QA score using the vital sign and lactate score
could be a good scoring system for screening high risk patients in
general ward.
Table 188 (Abstract 0817). See text for description
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INTRODUCTION. Rapid response teams (RRTs) are one of the core
elements when intensive care is expanded to general wards (the
critical care without walls concept).1 The objective RRT activation
criteria define vital dysfunctions, and are applied by the ward staff
with the subjective 'worried criterion' to trigger RRT. Most patients
are triaged to stay on ward, although some of them fulfill the
activation criteria during the actual RRT review also. Outcome of
these patients has not been studied, despite they likely are high risk
patients that deteriorate further on.
OBJECTIVES. To compare those RRT patients triaged to stay on ward
despite they fulfill RRT activation criteria during the actual review to
those that don't. If the patients with positive activation criteria are at
higher risk for adverse events, follow-up by the ICU liaison nurses
could be targeted to these patients.2
METHODS. We collected prospectively data on RRT activations in
Tampere University Hospital, Finland, between 1 May 2012 and 30
April 2015. Hospital's RRT activation criteria were: heart rate < 40/min
or > 140/min, systolic blood pressure < 90 mmHg, peripheral
arteriolar oxygen saturation < 90%, respiratory rate < 5/min or > 24/
min and AVPU ≤ 3. The local Ethics Committee approved the study
protocol (Approval no: R10111).
RESULTS. During the study period, 860 patients had their first review
and were triaged to stay on ward with active treatment plan, and
564 (66%) of these patients had objective vital dysfunctions noted by
the RRT during the review while 296 (34%) did not. Patients with
objective vital dysfunctions during the review were of comparable
age and comorbidity index as compared to the stabile patients and
had as often had a preceding ICU admission or surgery. Despite the
patients with altered vital signs received more often RRT
interventions such as fluids and medications as compared to the
stabile patients, they required a new RRT review more often and had
higher in-hospital mortality rate and higher fixed mortality for up to
one year (37% vs. 29%, p = 0.014). Table 188 presents the multivari-
ate regression model of the factors that were independently associ-
ated with 30-day mortality among the 860 patients triaged to stay
on ward; having altered vital signs according to the RRT was one of
them (OR 1.74; 95% CI 1.12 - 2.70).
CONCLUSIONS. Patients triaged to stay on ward despite
acknowledged vital dysfunctions by the RRT are high risk patients
that could potentially benefit from routine follow-up by the ICU's li-
aison nurses. The 'ICU without walls' concept could be easily ex-
panded to include these high risk patients before they deteriorate
beyond salvation.
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INTRODUCTION. General ward staff trigger ICUs' rapid response
teams (RRTs) to attend patients with altered vital signs.1 RRTs may
conduct further diagnostics, including point-of-care (POC) arterial
blood gas (ABG) analysis, interventions and escalate the level of care
if deemed appropriate. However, there is no robust evidence, that
advanced bed-side diagnostics per se improve patient outcome in
comparison to, for example, simple ICU liaison nurse assessment
based on patient's status during an RRT review.1
OBJECTIVES. We aimed to investigate, whether altered vital signs,
defined as simple RRT activation criteria (heart rate < 40/min
or > 140/min OR systolic blood pressure < 90 mmHg OR SpO2 < 90%
OR respiratory rate < 5/min or > 24/min OR AVPU assessment ≤ 3,
detect the patients whose POC-ABG analysis reveal hypoxemia/acid-
osis/hyperlactatemia/decreased base excess. RRT criteria were tested
both with and without the AVPU assessment.
METHODS. Prospectively collected data on ICU's RRT activations
between 1 January 2011–30 April 2015 in Tampere University
Hospital, Finland. POC-ABG analysis was conducted if deemed appro-
priate by the RRT physician, and vital signs measured by the RRT staff
during these reviews were compared to the results of the ABG ana-
lysis. The i-STAT® handheld device (Abbott Point of Care Inc., NJ, USA)
was used for the ABG analysis. The local Ethics Committee approved
the study protocol (Approval no: R10111).
RESULTS. During the study period, 2652 RRT reviews were
conducted. After the exclusion of no POC-ABG reviews (2203) and
POC-ABG reviews with complete but unreliably data (6), 443 RRT re-
views with full data on both vital signs and POC-ABG results were in-
cluded. Median (Q1, Q3) age of the patients was 69 (58, 77), 68%
(301) were male and 18% (80) had been electively admitted to the
hospital. Vital signs were defined as abnormal in 76% (337) of the pa-
tients according to the RRT criteria (AVPU not included) and in 86%
(381) of the patients according to the RRT criteria including the
AVPU. Sensitivity of the RRT criteria including the AVPU was 89%
(80% without the AVPU) for any mild deviation and 96% (91%) for
any severe deviation in ABG (Fig. 252).
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 368 of 542CONCLUSIONS. RRT criteria including the assessment of the level of
consciousness detected patients with decompensated acidosis/
deoxygenation/hyperlactatemia/decreased base excess in POC-ABG
with good sensitivity. Sensitivity was excellent when RRT criteria were
compared with severe disturbances in POC-ABG (and thus to rule out
patients with severe ABG disturbances). We conclude, that simple
vital sign measurements are sufficient to rule out patients with se-
vere ABG disturbances during ICU's RRT reviews.
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INTRODUCTION. Adequate monitoring, early recognition of
physiological abnormalities and response trigger are fundamental
cornerstones to achieve Medical Emergency Team (MET) positive
outcomes1–3.
In our hospital, a MET was implemented in Oct 2015. During the first
year, 629 MET activations occurred (activation rate 30,2/1000
inpatients). Data analysis revealed a constant decrease in the total
activation number and an increased percentage number of
activations due to unexpected cardiac arrests. Concerns related with
the contribution of the afferent component of the system to these
results have been raised, justifying the present study.
OBJECTIVES. To compare the outcomes of patients who fulfilled
activation criteria and for whom the MET was activated against
those for whom there were no interventions by the MET; to
determine the vital signs (VS) assessment standards in the wards
and to determine if the presence of MET criteria was associated
with unplanned admissions to Intensive Care Unit (ICU)/
Intermediate Care Unit (IntCU), unexpected cardiac arrests (UCA),
increased hospital length of stay (LOS) and death at hospital
discharge.
METHODS. Retrospective observational single-center study. Patient
clinical records during a ten day-period following admission date
were reviewed against MET activation criteria. Two groups were
established: fulfill MET´criteria patients (FMC) and do not fulfill MET´
criteria (NFMC) patients.
RESULTS. 211 patients were included, 53 of those (25,1%) fulfilled
MET criteria during the study period. The MET was activated for 6 of
those patients (11,3%). FMC and NFMC had similar distribution of
age, sex, age-adjusted Charlson Comorbidity Index and parental unit.
FMC group patients were more likely to die in the hospital (OR =28;
95% CI; 1,81-4,855). In FMC group the intervention of MET was not
associated with different LOS, unplanned ICU/IntCU transfer, UCA
and in-hospital mortality.
Overall, VS were more frequently assessed at least 3 times per day
(n = 126/73,9%). In 75 cases (35,3%) the assessment was not directly
related to medical prescription. Respiratory rate (RR) was only
included in VS assessment of 2 patients (0,9%).
CONCLUSIONS. The number of patients evaluated by the MET
was low when compared with the number of ward patients that
fulfilled the MET activation criteria. We were unable to find
statistical significant effects on outcomes, probably related with
the low number of MET activations, although we found a clinical
significant positive association between the presence of MET
criteria and mortality during in-hospital stay. We found discrepan-
cies between vital sign assessment pattern and medical prescrip-
tion, more significant in surgical patients. The RR, a vital sign
included in several severity scores, was seldom recorded.
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Intensive Care Medicine Experimental 2017, 5(Suppl 2):0720Control group Intervention group P valueRate of ICU transfer No. (%) Total 22(3.9%) 33(5.7%) 0.159Low risk 9(1.8%) 10(2.1%) 0.684Moderate risk 7(26.9%) 6(8.7%) 0.021High risk 6(20.7%) 17(40.5%) 0.080In-hospital mortality No. (%) Total 11(2%) 15(2.6%) 0.473Fig. 253 (Abstract 0720) See text for descriptionLow risk 4(0.8%) 7(1.5%) 0.297Moderate risk 4(15.4%) 2(2.9%) 0.026High risk 3(10.3%) 6(14.3%) 0.624INTRODUCTION. National Early warning scores (NEWS) are widely
used in general wards to identify the patient at risk of deterioration.
The specific interventions responding to the different values of
NEWS should be determined to improve the patients' outcomes.
OBJECTIVES. This study aimed to assess the impact of a hospital
protocol responding to the deterioration of the patients stratified by
NEWS on patients' outcomes regarding in-hospital mortality and the
percentage of intensive care unit (ICU) transfer.
METHODS. We conducted a prospective observational cohort study
in adult medical patients admitted to a university hospital in
Bangkok. A 4-month period of pre-protocol (November 2015-Febuary
2016) was assigned as a control group and a protocol period (March
2016-June 2016) was assigned as an intervention group. On admis-
sion, the vital signs (respiratory rate, pulse rate, systolic blood pres-
sure), oxygen saturation, the presence of oxygen supplement and
neurological status were used to calculate the NEWS. Patients were
categorized to low, moderate and high risk based on their NEWS. Ei-
ther essential managements and/or ICU transfer were provided to
patients based on the hospital protocol. The primary outcomes were
compared between the control group and intervention group.
RESULTS. A total of 1145 patients were enrolled for analysis, 564
patients were in the control group and 581 patients were in the
intervention group. The mean age was 65 ± 16.12 years and 53.3%
of patients were male. The EWS of patients at admission in the
control group was lower than the intervention group (1.77 ± 2.158
vs. 2.4 ± 2.4; P = 0.000).
The percentage of patients with moderate and high risk were higher
in the intervention group than the control group (11.9% vs. 4.6% in
moderate risk group, 7.2% vs. 5.1% in high risk group; P = 0.000).
There were no significant differences in in-hospital mortality and the
percentage of ICU transfer between these two groups. Among 95 pa-
tients (8.3%) with moderate risk, the in-hospital mortality and the
percentage of ICU transfer in intervention group were lower than
control group [2.9% vs. 15.4%; P = 0.026; relative risk(RR) of 0.188,
95% confidence interval(CI) 0.037-0.968 and 8.7% v.s. 26.9%
P = 0.021; RR of 0.322, 95%CI 0.12- 0.87, respectively].
CONCLUSIONS. The implementation of a hospital protocol
responding to the deterioration of the patients stratified by NEWS isassociated with a reduction of in-hospital mortality and the percent-
age of ICU transfer in patients with moderate risk.
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INTRODUCTION. To ensure patient safety and improvements in the
quality of hospital care, rapid response teams (RRTs) have been
implemented in many countries, including Korea. The goal of an RRT
is early identification and response to clinical deterioration in
patients. However, there are differences in RRT systems among
hospitals and limited data are available.
OBJECTIVES. In this study, we retrospectively reviewed the RRT
activation records of our institution to determine the clinical
characteristics and predictors of survival of Korean patients who
required an RRT activation.
METHODS. In Seoul St. Mary's Hospital, the St. Mary's Advanced Life
Support Team was implemented in June 2013. We retrospectively
reviewed the RRT activation records of 287 cases from June 2013 to
December 2016. The RRT was activated by phone calls (74.9%) and a
screening system (25.1%).
RESULTS : The median response time and median modified early
warning score were 8.6 (5.6-11.6) minutes and 5.0 (4.0-7.0) points,
respectively. Eighty percent of RRT activations occurred on weekdays,
not including holidays. Residents (35.8%) and nurses (59.1%) were
the main activators of the RRT. Of the RRT activation cases, presence
of malignancy and a postoperative status were 34.8%, and 69.3%,
respectively. The survival rate was 83.6% and survival was mainly
associated with malignancy, Acute Physiology and Chronic Health
Evaluation-II (APACHE-II) score, and the time from admission to RRT
activation. RRT activation with screening showed a better outcome
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 370 of 542compared to activation via a phone call in terms of the intensive care
unit admission rate and length of hospital stay after RRT activation.
CONCLUSIONS. Malignancy was the most important factor related to
survival. In addition, RRT activation with patient screening showed a
better outcome compared to activation via a phone call. Further
studies are needed to determine the effective screening criteria, and
improve the quality, of the RRT system.
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INTRODUCTION. Critically ill patients could have various risks
including life threatening events during intra-hospital transportation.
The incidence of global adverse events was reported from 20% to
68% and cardiac arrest was 0.34 ~ 1.6% [1,2]. The level of compe-
tence of accompanying members during transportation is also con-
sidered as one of the risk factors.
OBJECTIVE. To elucidate whether intra-hospital transportation by the
rapid response team (RRT) influenced on patient´s safety and out-
come compared with transportation by general members.
METHODS. A single-center retrospective cohort study was done from
January 2016 to February 2017. This study included a total of 135
transports in 111 adult patients admitted to the medical intensive
care unit due to respiratory failure under mechanical ventilation.
Forty-five transports required a portable ventilator received escort by
the RRT. Other 90 transports as control group were selected by age
and sex matching. Major adverse event was defined as any situation
needed cardiopulmonary resuscitation. Minor adverse event was de-
saturation and hypotension whether requiring intervention or not.
RESULTS. Of all subjects, the mean age was 68.8 ± 9.6 years and
male 55 (59.3%). Although there was no significant difference in
APACHE II score between both groups, mean score was 35.2 ± 6.5 in
the RRT group and pre-transport demand of oxygen supply and
sedative agents were higher in the RRT group than control group
(P < 0.01). There was no significant different frequency of cardiopul-
monary resuscitation in both groups. However, transportation by the
RRT had more minor adverse events than general transportation
(22.2% vs. 6.7%, P < 0.01).
CONCLUSION. Under intra-hospital transportation supported by the
RRT, no significant major clinical deterioration occurred in critically ill
patients who were highly vulnerable to adverse events.
KEYWORD. Transportation, Critically ill, Intensive care unit
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INTRODUCTION. There are few studies that describe the level of
activity and risk factors for cardiopulmonary arrest(CPA) during the
process of intra-hospital transport(IHT) of critically ill patients with
the monitoring of rapid response team(RRT).
OBJECTIVES. The aim of this study was to describe the activity of
RRT's IHT and identify risk factors associated with CPA during IHT.
METHODS. In this retrospective cohort study, we reviewed and
extracted data from electronic medical records of consecutive adult
critically ill patients who were transported under the monitoring of
RRT from September 2012 to May 2016. We analyzed the detailed
activity of RRT's transport monitoring and the outcomes of interest
were CPA during IHT.
RESULTS. A total of 540 patients were included. The mean age
was 65 years, and male patients constituted 65.4% of the cohort.
The mean frequency of IHT with RRT was 12 times per month.
Mean Charlson comorbidity index was 5.7 point and in-hospital
mortality rate was 43.1%. The portable mechanical ventilator was
used in 253(46.9%) patients and 18(3.3%) were transferred with
ECMO. Continuous inotropes and sedatives were used in
241(45.6%) and 172(31.9%) patients, respectively. Although all
cases were accompanied and monitored by RRT members,
12(2.2%) CPA occurred during IHT. Prior ischemic heart disease
and peripheral vascular disease were more prevalent in the
CPA(+) group than in the CPA (−) group (25.0 vs. 5.3, p = 0.004
and 8.3 vs. 0.9%, p = 0.016, respectively). Patients with CPA
showed higher in-ICU mortality (66.7% vs. 33.0%, p = 0.015). The
proportions of patients who were transported with ambu bagging
and with 3 or more inotropes were greater in the CPA (+) group
than in the CPA (−) group (58.3 vs. 22.9, p = 0.004, 25.0 vs. 5.1%,
p = 0.003, respectively). Also, a significant difference in the FiO2
was observed (91.6 vs. 70.2%, p = 0.040). Using multivariate ana-
lysis (logistic-regression), gender, age-adjusted Charlson comorbid-
ity index, department of patient admitted, FiO2 level, ambu
bagging, and use of 3 or more inotropes were assessed as pre-
dictors of CPA in critically ill patients during IHT under RRT moni-
toring. The transport with ambu bagging (OR 3.829, 95% CI
1.106-13.256, p = 0.034) and use of 3 or more inotropes (OR
5.730, 95% CI 1.331-24.666, p = 0.019) were found to be inde-
pendent predictors of CPA during IHT with RRT.
CONCLUSIONS. Transport with ambu bagging and use of 3 or more
inotropes were significant risk factors associated with CPA during IHT
of critically ill patients under RRT monitoring. When IHT is needed,
very cautious measures should be taken before and during IHT and
further prospective study is needed to develop in-hospital protocols
to reduce CPA during transport of critically ill patients.
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INTRODUCTION. The implementation of the Rapid response team
(RRT) at our hospital started in May 2011.
The performance of the RRT improves the quality and safety of the
care provided and this result in a reduction of the number of
adverse events and unexpected cardiac arrests1.
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 371 of 542OBJECTIVES. After 5 years of activity of our RRT, the main objective
of this study is to evaluate its effectiveness, based on selected
indicators.
METHODS. The RRT performance data was consulted and specific
indicators were selected for analysis: incidence of activation,
response time, transfer rate to intensive care unit (ICU) of another
hospital, unexpected cardiorespiratory arrest (CRA), hospital survival
rate after Advanced Life Support (ALS), rate of inappropriate CRA
alarms, average ICU delay, rate of readmissions at ICU, number of
inappropriate admissions in ICU, ICU mortality rate and mortality rate
after ICU. A benchmarking analysis methodology was used.
RESULTS. In our hospital, the incidence of RRT activation has
increased progressively, in line with what was already reported in
several studies2. The response time remained below 5 minutes. In
the first year, RRT transferred to another hospital 29.8% of the total
number of patients admitted at ICU. This percentage has decreased
(between 5.8 and 9.6%) in the following years. The unexpected CRA
rate varied between 2.4 and 4.3% hospital admissions, being under
the maximum threshold. In some years, the hospital survival rate
after ALS is lower than the target. This is the result of a late or
inappropriate activation of the RRT. Some inappropriate CRA
activations are maintained (between 3 and 15 cases, per year). The
average waiting time and rate of readmissions at the ICU suffered
only little variation within the period of study. Between 42 and 56
admissions to the ICU were avoided annually (patients too well or
too bad). The ICU mortality rate remained constant, whereas a
reduction in the mortality rate after ICU discharge was noticed over
the last 2 years, agreeing with what authors had also observed3.
CONCLUSIONS. The RRT performance had a remarkable impact on
the reduction of inappropriate admissions at the ICU, optimizing the
management of hospital beds. The ICU mortality rate seemed to be
not affected by the RRT performance, but a progressive reduction of
the mortality rate after ICU discharge was observed.
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INTRODUCTION. The Rapid Response Team (RRT) is an integrated
system that assesses patients with signs of acute clinical
deterioration or cardiorespiratory arrest in all sectors of the hospital
through the activation of the blue and yellow code, aiming to reduce
mortality in non-critical sectors. At Hospital Municipal Pimentas Bon-
sucesso in Guarulhos, a city in the metropolitan region of São Paulo,
the RRT was implemented in 2014, with medical care provided by
the Emergency Room (ER) team. As from March 2016, the Intensive
Care Unit (ICU) team became responsible for the RRT.
OBJECTIVES. To compare the outcome of the patients cared by both
teams.METHODS. Retrospective study of RRT care from March 2015 to
August 2015 provided by the ER physician, and from March 2016 to
August 2016 provided by the ICU physician. All the RRT calls were
recorded in a specific form and the outcomes evaluated were: Time
lapse between the RRT call and the medical care, how many patients
per calls were directed to the critical sectors (emergency and ICU)
and hospital discharges per call.
RESULTS. A total of 112 RRT calls were recorded during the study
period. Of the 112, twenty-five yellow-code calls happened from
March to August 2015, totaling 22% of the calls and eighty-seven
yellow-code calls from March to August 2016, totaling 78% of the
calls. This difference between the groups was significant, as there
was an underreporting of the codes by the nursing team in the ER
care. It took 5.28 seconds on average to call the ER team and an av-
eraged 4.04 seconds to call the ICU team. This demonstrates an im-
provement in the ICU medical team care, meeting the 5-minute
target for the calls. Regarding transfers, 15 critical-care patients were
referred to the critical sectors by the ER team totaling 60% of the
pacients and 53 critical-care patients by the ICU team, totaling 60,9%
of the pacients. Regarding hospital discharge, 20 were by the ER
team, totaling 80% of the calls, and 71 by the ICU team, totaling
81.6% of the calls.
CONCLUSIONS. Both study teams have not produced different
outcomes.The RRT calls have gradually increased after the training of
the teams and this demonstrates a positive outcome in the patients´
survival.
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INTRODUCTION. Medical Emergency Teams (EMT) are a cornerstone
of quality medical care. They are formed by doctors and nurses with
advanced life support skills who respond to intra-hospital calls on
patient's clinical deterioration and cardiopulmonary arrest. Initially
created to respond to Cardiopulmonary Arrest (CPA) situations, their
action has expanded to rapid clinical deterioration, allowing for bet-
ter patient outcome, using the New Early Warning Scale (NEWS) as
activation method.
OBJECTIVES. The study aims at characterizing the activation of the
Medical Emergency Team of the researchers Hospital, evaluating the
activation criteria and reasons, location of activation and the
destination of patients after the EMT intervention.
METHODS. Observational Retrospective Study based on information
retrieved from the EMT database between the 1st of January 2013
and the 31st of March 2017, based in the Intensive Care Unit.
RESULTS. During the period evaluated, there were a total of 272
activations of the EMT. Being a Hospital with a predominance of
Medical Specialties, the vast majority from the activations came from
the Medical Ward (68%), followed by the Emergency Room (18%)
and the Orthopedic Surgery Ward (6%). The activation was made by
fellow doctors on 50% of the cases, the rest being made by nurses.
In regard to the cause of activation, CPA corresponded to 39%,
followed by Respiratory Distress with 36%, Glasgow Coma Scale
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 372 of 542inferior to 8 (7%), Requirement for Definitive Airway (5%), Severe
Hypotension (4%), Severe Arrhythmia (3%), Status Epilepticcus (2%)
and Severe Metabolic Acidosis (3%). By the end of EMT intervention,
35% of the patients,the majority with acknowledged Limitation of
Treatment Status, died; 31% remained in their respective
Department, 24% were admitted to the Intensive Care Unit and 4%
were transferred to another Hospital for requiring differentiated
treatment not available at the institution.
CONCLUSIONS. The study reveals that the most frequent motive of
EMT activations at the researchers' Hospital remains to be CPA.
However, there are an increasing awareness to the role of EMT as
the activations came equally from Doctors and Nurses and 61% of
the calls did not require Advance Life Support. It is crucial to raise
further awareness to all Hospital personnel in order to recognize
potentially life threatening conditions and call for the EMT earlier.
This is the only way to better the outcomes, as the initial recognition
and measures taken before the arrival of the EMT comprises the
most fragile link in the chain of survival.
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INTRODUCTION. Patients admitted to the hospital ward who evolve
into clinical deterioration, culminating with cardiac arrest and death,
often present changes in physiological parameters many hours
before these events. These changes are often not adequately
recognized or conducted and, when those patients are transferred to
the intensive care unit (ICU), such changes increase their mortality.
Early identification of clinical deterioration can be performed by
simple protocols based on records of vital signs. Such immediate
actions as calling an experienced doctor or even the transfer to an
ICU may enable an improvement in prognosis.
OBJECTIVES. In this study, we evaluated whether the changes in
physiological parameters and a higher score in MEWS of patients
admitted to the hospital ward correlated with greater severity and
mortality in the ICU and, secondly, whether there was a correlation
between the MEWS and the length of stay and the intensity of
provided care.
METHODS. This one-center historical cohort was conducted in the
ICU of the Hospital Guilherme Alvaro of Santos, Brazil. Patients admit-
ted to the ICU from the hospital ward were evaluated. The calcula-
tion of MEWS was performed with the physiological parameters,
measured upon the request for a place in the ICU.
RESULTS. Eighty one patients presented the average age of 58.3 + 16
years, predominance of females (62%) and the most common
comorbidities were high blood pressure (44%), diabetes mellitus (32%),
cardiopathies (24%), cancer (18%) and chronic obstructive pulmonary
disease (9%). The average MEWS was 4.7 + 2.4 and the average
simplified acute physiology score (SAPS 3) was 66 + 15 points, and
these two parameters showed good linear relationship (r = 0.55;
p < 0.01). Endotracheal intubation was performed in 52% of patients
who remained an average of 7.9 (1–138) days using invasive
mechanical ventilation (IMV). The use of central venous catheter was
frequent (86%), besides that 55% required vasoactive drugs (VAD), 28%
required transfusion of erythrocytes and 20% required hemodialysis.
There was nosocomial infections by multidrug-resistant bacteria in 20%
of patients. It was observed that the use of VAD was twice as likely tobe risky when used in patients with high score (p = 0.002). Patients
with high score (≥5) were 1.5 times more likely to acquire nosocomial
infections by multidrug-resistant bacteria (p = 0.08). The chance for the
need of endotracheal intubation was increased by 2.65 times in individ-
uals at the top level of the score (p < 0.01). Time of IMV and ICU lenght
of stay did not correlate with MEWS (p = 0.23 and 0.5, respectively). Pa-
tients who evolved into death in the ICU and hospital, showed to be
2.12 times (p = 0.001) and 2.47 (p < 0.01) more likely to belong to the
score high level, respectively.
CONCLUSIONS. The MEWS correlated positively with SAPS 3 and
patients with high scores showed a greater need for the use of
intensive support and a higher chance of mortality.0728
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INTRODUCTION. Rapid response teams (RRT) have been established
to manage unstable patients in general wards, with the aim of
preventing further deterioration leading to cardiac arrest1.
Our team consists of a doctor and a nurse on call for all critical
events happening inside the hospital, excluding the emergency
department. Our RRT may be activated for events on admitted
patients, visitors or staff.
OBJECTIVES. The main objectives of this study were to audit our RRT
performance in in-hospital cardiac arrest, to compare it to the bench-
mark, to identify potential pitfalls and to seek opportunities for
improvement.
METHODS. We have retrospectively analyzed the RRT's performance
of CPR during a period of 5 years (May 2011–2016). We evaluated
response times, the 1st documented rhythm and the outcomes for
return of spontaneous circulation (ROSC) and survival to discharge.
Additionally, we examined the cases in which RRT decided not to
attempt resuscitation (DNAR).
RESULTS. Among 1856 events occurred during the period of study
(May 2011–2016), CPR was performed in 228 cases. The mean time to
arrival on code was under 3 minutes. Most frequent first rhythm
documented was asystole (62.7%), second being PEA (23.2%) and lastly
VF/ pulseless VT (14.0%). ROSC was obtained in more than 40% of all
cases, improving in the last 3 years. The rhythm with more ROSC was
VF/ pulseless VT (nearly 1/3 of the cases). Survival to discharge on all
rhythms was 16%. RRT decided DNAR in 11% of total calls.
CONCLUSIONS. Our data indicates a higher number of asystole cases
in comparison to international data2, which may reflect delayed
recognition of arrest, although this percentage is decreasing in our
hospital during the last 3 years. More than half of all cardiopulmonary
arrests are preceded by deterioration in vital signs, which are often not
appropriately evaluated, suggesting that many of these adverse events
could be prevented by early identification and treatment1. Despite this,
survival to discharge is comparable to literature (16% vs 18%).
DNAR implementation indicators remain below the target (5%) in
relation to the DNAR rate established by the RRT. This result could be
improved if the physician responsible for the patient start to ask RRT´
s opinion regarding DNAR of certain patients prior to the occurrence
of a potential critical event.
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Table 189 (Abstract 0730). Characteristics of the study population
Sex male, n (%) 97 (50.5)
Age. Median (IQR) 74 (66-85)
Aggregate_NEWS:0-4, n (%) 83 (45.6)
Aggregate_NEWS:5-6, n (%) 46 (25.3)
Aggregate_NEWS ≥7, n (%) 53 (29.1)
NEWS Individual parameter scoring 3, n (%) 78 (42.9)
Any serious event, n (%) 19 (10)
Hospital LOS. Median (IQR) 8 (5-10)
Hospital Mortality, n (%) 13 (6.8)
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INTRODUCTION. Rapid response teams (RRT) have been established to
manage unstable patients in general wards, with the aim of preventing
further deterioration leading to cardiac arrest1. Our team consists of a
doctor and a nurse on call for all critical events happening inside the
hospital, excluding the emergency department. Our RRT may be
activated for events on admitted patients, visitors or staff.
OBJECTIVES. The main goal of this study was to understand, since
the implementation of the RRT, the standard of its performance and
effectiveness.
METHODS. We have retrospectively analyzed the RRT's performance
during 5 years (May 2011–2016). We analyzed the available data
regarding: who activates the team, in which time of the day, from
where are the calls made, as well as the gender and age of our
patients, which organ system triggers the activations, and finally, the
effectiveness of RRT for the operation of our hospital.
RESULTS. Among 1856 events that occurred during the period of
study, most of the activations are triggered by physicians (62%) and
cardiovascular problems are the main cause (782) followed by
respiratory problems (646), with little variation in the different years.
Half of the activations take place between 8 am and 4 pm. The age
range of patients is very extensive, from infants up to 102 years, with
a predominance above 65 years. Calls for help mostly come from
Intermediate Care Units, consistently each year.
Annually, 20-30% of the patients assisted by the team are treated/stabi-
lized using the satellite beds of the Intensive Care Unit (ICU). The num-
ber of readmissions to the ICU has not decreased (4.4%), but the
number of admissions avoided has increased (40 in 2016), as well as
the inappropriate admissions to the ICU has decreased (4 in 2106).
CONCLUSIONS. From all the patients assisted by the RRT, the use of
the satellite beds allows anticipate the need for higher level of care
and is a very effective way to expand the intensive care beyond the
beds limit of the ICU.
The benefit obtained from the RRT´s performance is mainly due to
the improvement of care to the patient outside the ICU, and this
effect can be translated not only into a reduction in the number of
readmissions to the ICU, but also in early readmission when clinically
indicated. These results are due to the effectiveness of the team that
improves ICU treatment capacity and allows to optimize the use of
ICU beds.
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Intensive Care Medicine Experimental 2017, 5(Suppl 2):0730INTRODUCTION. There are no widely used scores specifically
designed to detect deteriorating patients, who may be at risk to
develop serious adverse events (SAEs) 1 in emergency department
(ED).Among different early warning score (EWS), the National Early
Warning Score (NEWS) has been well established. Its purpose was to
introduce a standardised trigger system to identify acutely ill patients
throughout hospitalisation 2.
OBJECTIVES. NEWS score calculated in ED before to be transferred to
medical ward would show an association with short- and long-term
adverse outcomes.
METHODS. Prospective, observational feasibility pilot study was
performed at a University Hospital. All patients ≥ 18 years old presenting
to the ED during 3 weeks with criteria of admission in any medical ward
were included.2 trained researchers collected data (demographic,
treatment, past medical history and vital signs). Data used to calculate
NEWS were collected at the moment to transfer. Outcomes registered:
Serious events (urgent medical attention, ICU admission and hospital
mortality) and length of stay. NEWS score classified the patients into
3categories: low risk (0–4 points), medium (5–6 points or any NEWS
Individual parameter scoring = 3) and high (≥7 points).
STATISTICS. Qualitative variables are expressed as percentages
and compared using the Χ2-test; Descriptive statistics were used
to determine patient characteristics (presented as mean and SD
or median and inter-quartile range (IQR) or mean ± SD. Student's
t test was used for independent. Level of significance was placed
at p < 0.05. The statistical analysis was performed using specific
software (IBM SPSS Statistics for Windows, Version 19.0. Armonk,
NY: IBM Corp).
RESULTS. 192 patients were included. The most frequent department
of admission was internal medicine (59.4%). Aetiologies of admission
were: infectious (30%), respiratory (24%) and cardiac (14.6%).
CONCLUSIONS. In our pilot study the NEWS measured at transfer
time to a medical ward can be of additional value to detect
patients at risk of presenting serious events once they are
transferred from the ED department. It may be useful for
clinicians receiving these patients at medical wards and so
enhance the quality and safety of care. We expect to complete
the study to achieve stronger conclusions.
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Table 190 (Abstract 0730). Factors associated with any serious event
Any serious
event
No serious
event
p
NEWS Individual parameter scoring
3. n (%)
14 (73.7) 64 (39.3) 0.004
Age. Mean (SD) 78.8 (13.9) 72 (16.6) 0.06
Hospital LOS. Mean (SD) 8.8 (5.4) 8 (3.9) 0.6
Aggregate_NEWS: 0-4. n (%) 4 (21.1) 79 (48.5) 0.06
Aggregate_NEWS: 5-6. n (%) 7 (36.8) 39 (23.9) 0.06
Aggregate_NEWS ≥7. n (%) 8 (42.1) 45 (27.6) 0.06
Table 191 (Abstract 0730). Factors associated with the aggregate NEW
Aggregate_NEWS 0-4 5-6 ≥7 p
Hospital LOS. Mean (SD) 6.96 (3.9) 8.3 (4.2) 9.3 (3.6) 0.04
Age. Mean (SD) 70.1 (17.7) 75.2 (18.3) 74.7 (11.9) 0.15
Any serious event. n (%) 4 (21.1) 7 (36.8) 8 (42.1) 0.06
Hospital Mortality. n (%) 3 (23.1) 5 (38.5) 5 (38.5) 0.23
Fig. 254 (Abstract 0731) Barriers to earlier implementation of TEPs
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INTRODUCTION. The decision of whether or not to escalate organ
support and/or refer to ICU in the event of critical illness is complex
and should take into account the pros and cons of treatment
escalation and patient's wishes where possible1. Clinicians that do
not necessarily hold an Intensive Care background are often on the
frontline for making treatment escalation decisions.
OBJECTIVES.
1. To determine whether or not there is an existing knowledge gap
amongst non-ICU physicians surrounding the short term adverse ef-
fects and longer-term physical and psychosocial morbidity relating to
escalation of organ support and prolonged ICU admission
2. To determine whether or not an education session about ICU
changes outlook and positively influences confidence in making
treatment escalation plans (TEPs)
3. To investigate factors which might account for variation in practice
when making TEPs and potential barriers for earlier implementation.
METHODS. An education session about ICU was delivered to non-ICU
clinicians of varying grades and levels of seniority during a regional
registrar training day and a hospital grand round session. All dele-
gates were asked to complete a survey following the session.
RESULTS. Of the 103 clinicians who attended the sessions, the
majority (79%) were medical registrar level (ST3-ST8), 46 (45%) had
never had any previous intensive care training and 35 (34%) had
little or no prior knowledge of the potential negative impact ICU can
have on patients. Sixty nine delegates (67%) thought the session
altered their outlook in how to implement TEPs, DNACPR orders and
appropriate involvement of the ICU team and 92 (89%) felt they now
had more confidence in discussing such issues with patients and
families. Seventy four (72%) and 70 (68%) claimed that they would
welcome further training and guidance in this area respectively.
Although 95 delegates (92%) felt it was important for the ICU team
to be involved when making treatment escalation decisions, 47(46%) found it difficult in practice to get the ICU team to aid with
the decision making process. Ninety one (88%) felt the TEPs should
be made before the onset of critical illness in select patients but
time constraints and potential conflicts with patients and relatives
were seen to be the greatest barriers for earlier implementation.
CONCLUSIONS. There is an existing knowledge gap amongst non-
ICU clinicians about the negative impact ICU can have on patients
and further education and training in this area may positively influ-
ence the process of how TEPs are formulated. Involvement of the
ICU team may be important to aid the decision making process and
support parent teams in reaching a consensus. Whilst earlier TEPs
were thought to be important in certain patients, several barriers
were highlighted, which need to be tackled in order to facilitate earl-
ier formulation of TEPs in practice.
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INTRODUCTION. Most of the financial and human resources of a
hospital are needed in the ICU (intensive care unit). Despite the
enormous developments in intensive care over the past years, the
general public has unrealistic expectations and for example
overestimates the survival rate after cardiopulmonary resuscitation.
This is certainly influenced by the fact that most people obtain their
medical knowledge from nonprofessional information sources like
TV-series and ad-hoc internet searches.
OBJECTIVE. To uncover the population's level of knowledge about
critical care topics.
METHODS. 145 women and 93 men (adult medical laypersons), from
the German-speaking countries, predominantly from Austria, were
surveyed in the form of a short online or paper questionnaire. The
11, partly open-ended questions, focused on various intensive care
topics. At the end, the participants were asked to declare, from
which sources they get their information about these topics. Then
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 375 of 542there was a statistical evaluation of the data differentiated by gender,
age, level of education, and place of residence (urban or rural areas).
RESULTS. The most frequently mentioned diagnoses on an intensive
care unit were cardiovascular problems, especially heart attack, but
also fractures, serious injuries as well as strokes. A large proportion of
the participants (49%) thought that 85% of all patients, hospitalized
at an ICU, are still alive one year after their discharge. 45% of the
participants estimated the survival rate after cardiopulmonary
resuscitation at 50% and 31,5% at 85%. Sepsis was defined as blood
poisoning by 47% of the interviewed and 25% didn't know the word
Sepsis. Nearly all people (98%) recognized a defibrillator as an
electrical device, which is used for resuscitation. The three most
commonly used information sources were family and friends, the
internet as well as television.
CONCLUSIONS. In conclusion, several misconceptions of the
respondents can be detected. This lack of adequate knowledge can
lead to subjective dissatisfaction and disappointment in the event of
illness. Therefore, it is important to undertake further larger studies
to uncover the current population's level of knowledge. In addition,
it is necessary to improve the quality of the information available to
laypersons and to adjust the often too optimistic expectations to
reality.
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OBJECTIVE. To evaluate the relationship between mortality and
number of total lymphocytes and lymphocyte sub-populations at ICU
admission.
METHODS. Cohort study. We exclude coronary patients and
programmed surgery. Statistical analysis:
T Student, χ2 and multiple logistic regression.
RESULTS. N = 99 patients. Age 51.76 ± 15.89 years, APACHE II
17.91 ± 6.97, total lymphocytes at admission 1197 ± 1758. Hospital
mortality 24.5%.
Patients who died had a higher APACHE II (23.86 ± 6.49 vs
15.93 ± 5.94) (p < 0.001) and lower total lymphocytes (900 ± 629 vs
1304 ± 1998), but the differences were not e.s. (p = 0.334).
58% of patientes had less than 1000 lymphocytes at admission and
mortality was 28.6% vs 19.5% (p = 0.30). 28% of the patients had less
than 600 lymphocytes with a 40.7% mortality vs 18.6% (p = 0.025).
Regarding the different subpopulations, there were no differences
between dead and alives.
58.6% had low CD3 (less than 690 lymphocytes) and their mortality
was 26.3% vs 22% in patients with a normal number of CD3
(p = 0.62). 57.6% CD4 low (<410 lymphocytes) mortality 23.2% vs
26.2% (p = 0.73). 46.5% had low CD8 (<190 lymphocytes, mortality
was 31.1% vs 18.9% (p = 0.160). 45.5% had low CD16 (<90
lymphocytes) Mortality 28.9% vs 20.8% (p = 0.351). And 23.2% had
low CD19 (<90 lymphocytes) mortality was 36.4% vs 21.1%
(p = 0.141).
Logistic regression showed that hospital mortality was related with
total lymphocytes below 600 (OR: 3.1, CI: 1.73-8) but not with a low
number of lymphocytes from the different lymphocyte subpopulations.
CONCLUSIONS. A high percentage of patients presented a low total
lymphocytes and low lymphocytes in the various subpopulations at
admission. A number of total lymphocytes less than 600 is associated
with higher mortality and a low number of lymphocytes in different
subpopulations does not provide additional information regarding
mortality.0734
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INTRODUCTION. ICU patients requiring CRRT (ICU/CRRT) have a high
hospital mortality and reduced long term survival (1). Renal function
may be decreased in survivors. These consequences may be more
pronounced in patients with pre-existing CKD.
OBJECTIVES. To examine the impact of pre existing CKD on long
term outcome in ICU patients treated with CRRT and to assess renal
outcome in 2 year survivors.
METHODS. We conducted a retrospective cohort study of all patients
admitted to our ICU in 2013 and 2014 requiring CRRT. Data was
obtained from Clinical Information and laboratory systems and
entered into a database for analysis. Parameters recorded included age,
gender, APACHE 11 score, SOFA score and serum creatinine prior to
admission and on hospital discharge. Patients with CKD were defined
as those having an abnormal creatinine 3 months prior to ICU
admission. No known CKD (non CKD) was defined as no clinical history
of CKD and no abnormal creatinine in the 2 years before ICU admission.
Surviviors to hospital discharge were followed up to 2 yrs to
determine survival, dialysis dependency and renal function for those
who were dialysis independent. Categorical variables were compared
using chi-square test and continuous variables using Mann–Whitney
U test. The study received ethical committee waiver. Primary out-
come was 2 yr. mortality. Secondary outcomes included renal func-
tion at 2 years.
RESULTS. During the study period there were 686 admission to ICU.
201 patients (29.3%) were treated with CRRT. Following exclusion of
patients with ESRD and those dialysed for reasons other than kidney
injury 181 were included for further analysis. Of these 56 (31%) had
CKD prior to ICU admission. Overall 83 (46%) patients survived to
hospital discharge. There was no difference in hospital mortality
between CKD and non CKD patients (55% v.54%). At 2 year follow
up 48% of CKD patients discharged alive had died compared with
21% of non CKD patients (p < 0.01). Two patients were lost to follow
up. 53 non CKD patients were dialysis independent on discharge. Of
these 42 (79%) survived to 2 years. The eGFR in these at 2 yrs
was < 60 mL/min/1.73 m2 in 14% of patients, >60 mL/min/1.73 m2 in
43% and unavailable in 40%. 10 CKD patients dialysis independent at
discharge survived to 2 yrs. In 4 of these (40%) serum creatinine was
higher than their pre admission value (mean increase = 50.75 mmol/
L, range = 22–94). In the other 60% creatinine was either unchanged
or slightly less than pre admission value.
CONCLUSIONS. Pre-existing CKD was associated with a non signifi-
cant trend towards dialysis dependency on discharge (p = 0.58) and
a significantly lower 2 yr survival (p < 0.01). 14% of non CKD patients
who survived to 2 years had moderate renal impairment.
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INTRODUCTION. Health-related quality of life (HRQOL) considerably
decreases after trauma.
OBJECTIVES. This study aimed to assess and compare quality of life,
three years after injury and hospital stay in trauma patients admitted
to an intensive-care unit (ICU) for 24 hours at least with non-ICU
trauma patients to identify potential factors associated with
outcome.
METHODS. In this cross sectional retrospective study, data of 204
trauma patients(103 ICU and 101 non ICU patients)who admitted to
a referral center in IRAN were evaluated.HRQOL was measured using
the Medical Outcomes Study Short Form 36 (SF-36). Patients were
called and asked to answer SF-36 questioner according to current
condition.
RESULTS. The mean age of ICU and non-ICU patients were 34.34 and
37.68 years respectively. The majority of patients in both ICU and
non-ICU groups were male (83.5%, 88.1%) and lower than 60 years
old (91.3%, 92.1%). The injury severity score (ISS) was marked as crit-
ical in 66.99% of ICU patients. Except for social functioning, the mean
SF-36 scores in ICU patients were lower than the similar indices in
non-ICU patients in all other domains(in Physical Function-Bodily
Pain-Role Emotional -Mental Health p < 0.001).Insignificant differ-
ences between ICU and non-ICU patients were observed for only two
subscales.
CONCLUSIONS. Although a significant improvement was observed
in the HRQOL after three years period in our sample, for most
subscales of SF-36 ICU patients' scores were lower in comparison
to the non-ICU population. This study emphasizes on the role of
trauma specialist teams, including physical therapists, social
workers and psychologists, in sufficient pain management and
consideration during care. Finally, providing adequate information
and long term follow-up of trauma patients can oblige health
professionals by identifying patients that require additional help
and support after discharge from acute care medical centers.
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INTRODUCTION. The high rate of postoperative complications in free
flap surgery due to cancer of the head and neck is a known
phenomenon but previous studies have not analyzed the complications
in detail or the onset of complications (1–3).
OBJECTIVES. The aim of this study was to evaluate the complications
during and after the postoperative surgical ICU stay among the
patients operated due to cancer of the head and neck with free flap
repair.METHODS. Retrospective analysis of 136 patients, who underwent
head and neck cancer operation with free flap repair in Oulu
University Hospital during 2008–2015.
RESULTS. The median age of patients was 65 [59–74] years. The
median ICU stay was 0.9 [0.8-1.7] days and hospital stay 13 [9–17]
days. 51 patients (37.5%) had medical complications and 56 patients
(41.2%) had surgical complications. Both, medical and surgical
complications were recorded in 20.6% (N = 28) of the patients. Those
with complications had a higher rate of alcohol abuse (25.3% vs
10.5%, p = 0.030), were more often recorded as ASA 3–4 (63.3% vs
40.4%, p = 0.008), had a longer operation (566 [452–652]min vs 490
[425–556]min, p = 0.003) and higher intraoperative blood loss (750
[410–1150]mL vs 520 [300–950]mL, p = 0.037) compared to patients
without complications. The median onset of medical complications
was 5[3–7] days for pneumonia (N = 36), 7[5–9] days for pulmonary
odema (N = 13), 3[1–8] days for myocardial infarction (N = 7) and
8[7.5-11.5] days for sepsis (N = 9). The median onset of surgical
complications was 5[2–10] days for wound infection (N = 39), 6 [1–9]
days for wound hematoma (N = 22) and 10 [3–14] days for flap
failure (N = 15).
CONCLUSIONS. More than half of the patients had complications,
which were related to alcohol abuse, higher preoperative risk and
more complicated intraoperative course. Most of the complications
were recorded after ICU discharge and infectious complications seem
to occur after the fifth postoperative day.
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INTRODUCTION. About one third of hospital mortality in critically ill
patients occurs after Intensive Care Unit (ICU) discharge[1].
OBJECTIVES. To perform a predictive model of mortality after ICU
discharge.
METHODS. Multicentric prospective study in 7 hospitals in Spain. We are
collected periods of two or three months during 2011, 2012 and 2015.
Data were expressed as the mean and standard deviation for
quantitative variables and percentages for qualitative variables. For
the comparison of two means we used the Student's t-test and the
chi-squared test was used to compare proportions. Multiple logistic
regression was used for multivariable analysis and area Under the
ROC curve for analizing discrimination. Statistically significant differ-
ences: p < 0.05.
RESULTS. 1934 patients with a mean age of 61.22 ± 15.58 years,
SAPS-3 45.26 ± 13.68 points. Predicted mortality by SAPS 3 in ICU
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was 10% and mortality after ICU discharge (Ward mortality) was 5.%.
1731 patients were transferred to Ward hospitalization area, with
mortality of 5.6% (97 patients). Mean age of 60.66 ± 15.62 years,
SAPS 3 at ICU admission 43.06 ± 11.86 points and SOFA score at the
last day of 0.91 ± 1.61 points.
Ward mortality of patients with Medical pathology (754 cases) was
6.5%, elective surgery (801 cases) 5.5% and emergency surgery (173
cases) of 2.3%(p = 0.185).
Patients who died after ICU discharge were older (65.72 ± 14.61 vs.
60.36 ± 15.63 years) (p < 0.001), higher SAPS-3 score at ICU admis-
sion (54.06 ± 13.07 vs 42.4 ± 11.43) (p < 0.001) and higher SOFA
score at last day of ICU stay (2.8 ± 3.21 vs 0.9 ± 1.61) (p < 0.001).
Pre-admission functional status (by Glasgow Outcome Scale) is
related with mortality after ICU discharge. Mortality pf patients with
Normal status (72.6%) was 2.8%, mortality of patients limited and
self-sufficient status (21.3%) was 10.8%, and mortality of patients lim-
ited and non-autosufficient status (6.1%) was 21% (p < 0.001).
Multiple logistical regression: Mortality after ICU discharge was
related with SOFA score at last day of ICU stay (OR 1.39(1.19-1.46)),
SAPS-3 score at ICU admission (OR 1.06(1.04-1.08)), type of pathology
(medical OR 1, emergency surgery OR 1.56 (0.93-2.61) and Scheduled
surgery OR 0.3(0.009-0.97)) and pre-admission functional status
(normal status OR 1, limited and self-sufficient status OR 2.64(1.59-
4.39), limited and non-autosufficient status OR 4.89(2.54-9.24)).
Discrimination of this model evaluated by Area under the ROC curve:
0.84(0.8-0.88).
CONCLUSIONS. Mortality after ICU discharge is related to SOFA score
at last day of ICU stay, severity illness at admission by SAPS-3 score,
type of pathology and pre-admission functional status. These vari-
ables perform a predictive model with a high discrimination capacity.
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INTRODUCTION. Critical illness leading to prolonged length of stay
in an intensive care unit(ICU) is associated with significant mortality.
A prognosis of these patients is difficult to assess due to many inter-
related factors that influence outcomes.
OBJECTIVES. To evaluate factors associated with outcomes in
patients with prolonged ICU length of stay(PICULOS).
METHODS. Prospective, observational study in two tertiary-level uni-
versity hospital. PICULOS was defined the need of >7 days of ICU
stay. Clinical and laboratory data were recorded on admission and
weekly, as well as outcomes, emphasizing infections and mortality.
RESULTS. 115 patients were included. Mean age was
62.7 ± 14.5years; 64.3%(n = 74)were male; BMI:29.7 ± 2.1Kg∙m
−2;APACHE II:19 ± 7.60.8% (n = 70) were medical patients.Hospital
mortality was 21.7%(n = 25).77.4%(n = 89)were under Enteral
Nutrition and 15.7%(n = 18) under Parenteral Nutrition. Nutritional
support was initiated 26 ± 14h after ICU admission. Mean ICU stay
was 22 ± 15days and mean hospital stay was 43 ± 29days.We
showed the following differences between survivors and non-survivors:APACHE II(18 ± 7vs.23 ± 6;P < 0.001),bilirubin on admission
(0.85 ± 0.7vs.1.96 ± 4.1mg/dL;P = 0.017), prealbumin on 7thday
(17.8 ± 7.6vs.12.3 ± 6.5mg/dL;P < 0.001), platelets on 7thday(302 ± 158
vs.209 ± 111nL−1;P = 0.004)and bilirubin on 7thday
(0.73 ± 0.66vs.2.8 ± 7.7mg/dL;P = 0.001). Higher levels of prealbumin
on 7thday (HR:0.924;95% IC:0.858-0.995;P = 0.036)were associated
with lower mortality at the multivariate analysis.Patients with severe
lower levels of prealbumin on 7thday (<23mg/dL) showed worst hos-
pital survival(87.8%vs.61%;P = 0.002).
CONCLUSIONS. A higher prealbumin on 7thday was associated with
better survival during hospital stay in patients with PICULOS. Factors
associated with nutritional and inflammatory status may be
associated with the outcome of these patients.
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INTRODUCTION. Cardiovascular events frequently occur within 30
days after liver transplantation (LT) (1). It is not known whether these
events affect long-term outcome.
OBJECTIVES. We investigated the prevalence of in-hospital cardiovas-
cular events after liver transplantation, and the correlation with long-
term outcome.
METHODS. We performed a retrospective study in consecutive
patients who were subjected to LT in the time period 1986–2017 at the
Erasmus University Medical Centre, Rotterdam, NL. The primary
endpoint was all-cause mortality at 5 years, stratified according to the
presence of in-hospital cardiovascular events (CVEs; CVE+ vs. CVE-).
RESULTS. A total of 915 patients underwent LT. 113 out of 915
patients (12%) experienced a cardiovascular event during the in-
hospital period. CVE patients were divided in subgroups; ventricular
tachycardia, ventricular fibrillation or CPR (n = 30, 27%), atrial fibrilla-
tion or other supraventricular tachycardia (n = 30, 27%), bradycardia
(n = 8, 7%), myocardial infarction (n = 14, 12%), venous thrombosis
or thrombo-embolism (n = 13, 12%), cerebrovascular accident
(n = 10, 9%), heart failure or cardiomyopathy (n = 6, 5%), and vascu-
lar injury related to surgery (n = 2, 2%). In the CVE+ group, patients
were older (53 ± 11 vs. 48 ± 13, p < 0.001), had more hypertension
(32% vs. 20%, p = 0.01) and had more often a history of cardiovascu-
lar disease (15% vs. 9%, p = 0.04). 30-day mortality was 26% vs. 5%
(log rank p < 0.001). At 5 years, the overall survival of 30-day survi-
vors was 81%. There was no significant difference between both CVE
groups. (Figure 255).
CONCLUSIONS. This study demonstrates that the occurrence of in-
hospital cardiovascular events do not affect long-term outcome in
30-day survivors of liver transplantation. We should therefore 1) per-
form better preoperative risk stratification and 2) must make urgent
efforts to tide patients over the early postoperative phase so that
they can have good longer term outcome.
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BACKGROUND. ICU survivors, have a high and ongoing risk of death
after ICU discharge.
OBJECTIVES. To investigate the patients' profile after ICU discharge
during 1 year and to determine prognostic factors in longterm
mortality.
METHODS. An observational prospective cohort study including all
survivors, after an ICU stay in medical ICU between January 2014 and
December 2015. Patients were followed up via phone calls at 3, 6
and 12 months after discharge. A multivariate Cox model was used
to predict 1year survival. Factors associated with longterm mortality
were presented as a hazard ratio (HR). The overall survival was
analyzed on the basis of the KaplanMeier curves. A Pvalue lower
than 0.05 was accepted as significant.
RESULTS. Among 325 ICU survivors only 215 were followed. The
overall cumulative rate of death in hospital survivors was 63(29%)
patients after 1 year of ICU discharge. Median survival time was 30
days. Clinical features of deaths were: Mean age 58.6 ± 2.3years,
mean Charlson index 2.61 ± 1.8 mostly involving chronic respiratory
disease n = 108(50.6%) and chronic heart failure n = 99(46%).
Physiological reserve was altered in 129(60%) before ICU admission.
ICU admissions were more often for acute respiratory illness in 160
patients(74.6%) and mean SAPSII was 34.9 ± 13. 109 patients(51%)
received invasive mechanical ventilation. 28(44,4%) required
inotropic agents. The most common ICU adverse events were
respectively acute renal failure 26(41.3%), cardiac arrhythmia 21(33.3)
and nosocomial infection in 13 (20.6%). Autonomy was reduced in
86(40%) of patients. ICU length of stay was 9.3 ± 10.9 days.
Multivariate Cox regression analysis shows only two independent
variables associated with long term mortality: Physiological reserve
status before ICU (HR, 2.02 ; 95%CI, [1.153.51] ; p = 0.013), and
reduced autonomy at ICU discharge (HR, 2.01 ; 95% CI, [1.16 3.46],
p = 0,012).
CONCLUSION. Post ICU mortality rate proves to be high. Death delay
after ICU was significantly shortened by altered physiological reserve
prior to ICU admission and autonomy at ICU discharge.0741
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INTRODUCTION. Decompensated Obstructive Sleep Apnea-Hypopnea
Syndrome (OSAHS) is a condition that sometimes requires admission in
an ICU to treat hypercapnic respiratory failure.
OBJECTIVES. This study was undertaken to determine the
characteristics and outcome in patients with decompensated OSAHS
admitted to the ICU and to describe the pattern of utilization of
mechanical ventilation in these patients.
METHODS. A retrospective cohort study over a 3 year-period (2014–
2016) in an ICU of a University Hospital. We described the epidemi-
ology, treatment and outcome of OSAHS patients admitted in ICU re-
quiring mechanical ventilation. Variables related to comorbidities,
functional status (number of hospitalizations and visits to the Emer-
gency department in the previous year), acute physiology derange-
ment (APACHE II) of the episode and type of mechanical ventilation
(invasive vs noninvasive) were recorded. A bivariate analyses (chi-
square, student-t) was made to compare the results between the
two groups of patients related to the type of mechanical ventilation
used. Results are expressed as percentages and mean with standard
deviation. P < 0,05 was considered significant.
RESULTS. Twenty six patients were included.The mean age was
65 ± 12 years, 53.8% were female, 34.6% were diabetic, 23.1%
suffered chronic right heart failure. The APACHE II score was 19 ± 3
points. Three out of 26 patients (11.6%) had at least one hospital
admission in the previous year and 13 out of 26 (50%) had a visit to
the emergency department. All patients began with non invasive
ventilation (NIV). Six out of 26 (27%) patients required invasive
mechanical ventilation (IMV) due to progressive respiratory failure.
Duration of mechanical ventilation was 3.6 ± 2.6 days (0.8 ± 1.7 days
for the subgroup of invasive). Eleven out of 24 patients (45.8%) were
moved to the ward with noninvasive ventilation. Overall ICU and
hospital mortality was 7.7% (2 of 26) and 30.8% (8 of 26),
respectively. Those who died, 5 were subjected to limitation of
therapeutic effort, 2 from cardiac cause and 1 refusing treatment. Six
out of 19 patients (31.6%) with NIV died versus 2 out of 7 patients
(28.6%) with IMV (p = 0.88). Non-survivors were older (68 ± 15 vs
64 ± 11, p = 0.43), had higher APACHE II score (21 ± 3.5 vs
18.7 ± 2.8, p = 0.08) and greater number of hospitalizations
(0.7 ± 2.1 vs 0.1 ± 0.3, p = 0.21) and visits to emergency department
(2.5 ± 5.5 vs 0.8 ± 0.9, p = 0.17).
CONCLUSIONS. The use of non-invasive ventilation in decompen-
sated OSAHS has a similar failure rate than in COPD, but the duration
of invasive mechanical ventilation appears to be much shorter.
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INTRODUCTION. Intensive care mortality has been decreasing over
the last decade. However, mortality after ICU discharge and its risk
factors remain not well known. Studies showed that death occurs
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 379 of 542mostly at the first month after discharge. Data are lacking for the
post ICU mortality in Tunisian ICU´s patients.
OBJECTIVES. To analyze the short-term mortality after ICU discharge
and its predictor factors.
METHODS. An observational prospective cohort study performed in
a medical adult ICU with approximately 250 admissions per year. The
study included all survivors after ICU admission. Data were collected
between January 2014 and December 2015 and the mortality was
assessed by telephone interviews at thirty days after ICU discharge.
Factors associated with post hospital mortality are presented as odds
ratios. A P value lower than 0.05 was considered significant.
RESULTS. Among 573 patients admitted in ICU between January
2014 and December 2015. 215 were included. A total of 63(29%)
patients died after ICU discharge during the same year and 34(19%)
at the first month. Physiological reserve (OR, 2.73 ; 95%CI, [0.9-7.5] ;
p = 0.05), severity at ICU admission (SAPSII > 30 OR, 1.07 ; 95%CI,
[1.03-1.13] ; p = 0.002), the functional status (OR,10.9 ; 95%CI, [3.8-
31.1] ; p = 0.000) and tachycardia on ICU discharge (OR, 1.04 ; 95%CI,
[1–1.07] ; p = 0.01) were the only independent factors of 30 days
post ICU mortality.
CONCLUSION. 30 days´ post ICU mortality in the present study
proves to be rather important. Physiological reserve and severity on
ICU admission, then functional autonomy and tachycardia at ICU
discharge were the only independent risk factors of 30 days´ post
ICU mortality.
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INTRODUCTION. Tracheostomy in ICU patients has been a matter of
unsolved debate, yet.
OBJECTIVES. In this retrospective study, we objected to elucidate
pros and cons of tracheostomy in our mixed- type ICU-population,
and help to quantify literature data, for future evidence based
approaches.
METHODS. Retrospective data of mixed-type ICU, in 2016, were ana-
lyzed in tracheostomy patients, for 90-day mortality rates and deter-
minants of survival. Regression and survival analysis were executed
at significance of p < 0.001 (CI: 95%); all cases were weighted for
APACHE II scores.
RESULTS. 34 patients out of 347 (9.7%), 11 female and 23 male, at
mean age of 61.5 (19–91) years, mean APACHE II scores of 19.5 ± 6.5,
found mean length of stay (LOS) 50.8 (8–182) days, 17 were died
included 5 after discharged (mean 48.2 (3–130) days), 14 discharged
to wards, and 3 discharged to palliative-care-centers. Among 34
tracheostomy patients; 15 were from ED, 5 from outer-centers, 17
post-CPR and 10 were post-op or trauma patients. Analyses referred
to patients from ED were 5.1x, from outer-centers 6.5x, and post-CPR
6.96x less likely to survive. 24 of tracheostomy were performed by
intensivists in ICU and 10 by surgeons in op-theater. Tracheostomies
were performed on mean 15.9 ± 8.1 days (14–18), and ICU cases
were 1.1-2.0x more likely to survive. At the time of tracheostomy; se-
vere infection, assumed by multiple antibiotics, added about a 2x risk
to survive. In addition to these; tracheostomy performed before 10
and after 30 days (2x vs 6x) also significantly increased mortality risk.
However, no significant correlation was shown between tracheos-
tomy and ICU LOS, in not only between 347, but even within 34
tracheostomy patients.
CONCLUSIONS. Take home messages of this study are; (1) ICU-
tracheostomy was not uncommon (about 10%), (2) but even a half
were dead in 90-day, (3) ED admissions were more prone to die, (4)
more severe the infectious condition less chance to survive at the
time of tracheostomy, (5) tracheostomy performed by intensivists inICU, and between on 14-18th days had better survival, (6) no correl-
ation found between tracheostomy and ICU LOS.
0744
Correlation of gastric residual volume and illness severity based on
modified sequential organ failure assessment in critically ill
patients
D. Aditianingsih, M. Farina, L. Sutanto
Universitas Indonesia Ciptomangunkusumo Hospital, Anesthesiology and
Intensive Care, Jakarta, Indonesia
Correspondence: D. Aditianingsih
Intensive Care Medicine Experimental 2017, 5(Suppl 2):0744
INTRODUCTION. The Sequential Organ Failure Assessment (SOFA)
score has been recommended for predicting in-hospital mortality in
critically ill septic patients. [1] The modification sequential organ fail-
ure assessment (MSOFA) score is a simplified version of the SOFA
score, that eliminates the platelet count, uses arterial oxygen satur-
ation (SpO2), and replaces serum bilirubin with scleral icterus or jaun-
dice. [2] Sepsis may impair gastrointestinal motility, and causes
increasing gastric residual volume (GRV) that often occurs in the crit-
ically ill. Patients with increasing GRV had a higher ICU mortality
compared with patients with decreasing GRV. [3]
OBJECTIVES. This study determined the validation of MSOFA to
predict mortality in sepsis, the correlation of GRV with MSOFA, and
whether it could complement the parameters of MSOFA scoring
system.
METHODS. This study was a prospective cohort study of 148 septic
patients enrolled in the ICU Cipto Mangunkusumo Hospital
Indonesia. MSOFA score and total GRV were measured in the first
and second 24 hours of treatment.
RESULTS. Both MSOFA score day 1 and 2 was associated with 28-day
mortality (p < 0.001) with AUC 0.754 and 0.846. There is a correlation
between 24-hour gastric residual volume day 2 with the MSOFA day
2 (p < 0,001; r 0,52). The scoring category of 24-hour GRV day 2 was
made into 5 categories (score 0–5) based on the ROC curve percent-
ile. The addition of GRV score on the MSOFA scoring system on day
2 had a good ability to predict the mortality [AUC 0,851; CI 95%
(0,788- 0,914)].
CONCLUSIONS. There was a correlation between GRV with disease
severity scores MSOFA for septic shock patients on the second day
of ICU care. The addition of the second 24-hour GRV score to MSOFA
could be used to predict the critically ill patient mortality.VARIABLE AUC 95% CIMSOFA score day 1 0,754 0,667-0,842MSOFA score day 2 0,846 0,783-0,909GRV day 1 0,674 0,577-0,771GRV day 2 0,731 0,638-0,823MSOFA score day 1 with GRV day 1 0,797 0,719-0,874MSOFA score day 2 with GRV day 2 0,851 0,788-0,914[MSOFA score and GRV to predict 28-day mortality]
REFERENCE(S)
1. Raith EP et al. Prognostic Accuracy of the SOFA Score, SIRS Criteria,
and qSOFA Score for In-Hospital Mortality Among Adults With Sus-
pected Infection Admitted to the Intensive Care Unit. JAMA.
2017;317(3):290–300.
2. Halim DA et al. Comparison of Apache II, SOFA, and Modified
SOFA scores in predicting mortality of surgical patients in intensive
care unit at Dr. Hasan Sadikin General Hospital. Crit Care & Shock.
2009;12:157–169.
3. Elke G et al. Gastric Residual Volume in Critically Ill Patients: A
Dead Marker or Still Alive? Nutr Clin Pract. 2015;30:59–71.
Table 192 (Abstract 0745). Demographic and clinical characteristic
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 380 of 542Weaning from mechanical ventilation
0745
Low central venous oxygen saturation before a spontaneous
breathing trial predicts weaning failure
E.D. Valenzuela Espinoza1, S. Dubó2, A. Aquevedo3, M. Jibaja4, D.
Berrutti5, C. Labra6, R. Lagos6, M.F. García7, V. Ramírez7, M. Tobar7, F.
Picoita7, C. Peláez7, D. Carpio6, L. Alegría6, C. Hidalgo8, K. Godoy8, R.
Castro1, M. Silva6, J. Bakker1,9,10, G. Hernández1
1Pontificia Universidad Católica de Chile, Medicina Intensiva, Santiago,
Chile; 2Universidad de Concepción, Kinesiología, Concepción, Chile;
3Hospital Dr. Sótero del Río, Medicina Intensiva, Santiago, Chile; 4Hospital
Eugenio Espejo, Medicina Intensiva, Quito, Ecuador; 5Universidad de la
República, Medicina Intensiva, Montevideo, Uruguay; 6Pontificia
Universidad Católica de Chile, Santiago, Chile; 7Hospital Eugenio Espejo,
Quito, Ecuador; 8Hospital Guillermo Grant Benavente, Concepción, Chile;
9Columbia University Medical Center, Pulmonology and Critical Care,
New York, United States; 10New York University Medical Center,
Pulmonology and Critical Care, New York, United States
Correspondence: E.D. Valenzuela Espinoza
Intensive Care Medicine Experimental 2017, 5(Suppl 2):0745
BACKGROUND. Abnormal central venous oxygen saturation (ScvO2)
reflects an disbalance between oxygen demand and oxygen supply.
In addition, weaning from mechanical ventilation by a spontaneous
breathing trial (SBT) results in a significant increase in oxygen
demand. Therefore, we hypothesized that the presence of low
ScvO2 at the beginning of SBT would be a risk factor for weaning
failure.
METHODS. In a multicenter observational study, patients
mechanically ventilated for more than 24h and clinically ready for
a SBT were studied. Study variables were recorded at baseline,
2min, 30min, and at the end of the SBT. Decisions to extubate
where taken by the attending physician based on their usual
practice without knowledge of ScvO2 levels. Weaning failure was
defined as a decision not to extubate at the end of the SBT, or
reintubation within 48h after extubation. The baseline values of
ScvO2 were categorized in quartiles. One-way ANOVA test and
kruskal wallis test were used to analyze parametric and non-
parametric continuous variables. A Chi-square test was used for
qualitative variables. Multivariate regression analysis (corrected for
the presence of a history of cardiac dysfunction) was used to find
independent associations between ScvO2 and weaning failure.
RESULTS. 204 patients from 5 centers were included. Demographic
and clinical characteristic are show in the Table 192. 156 (76%)
patients were successfully weaned. Of the patients that failed
weaning (n = 48), 37 (77%) were not extubated at the end of the
SBT, and 11 (23%) were reintubated within 48h.
At baseline patients that failed to wean had lower central venous
pressure, higher respiratory rate, and lower ScvO2 (Table 192).
Sixty patients (29%) patients had a ScvO2 less than 70%.
Multivariate regression analysis revealed the 25th quartile
(ScvO2 = 63 ± 4%) to be an independent risk factor for weaning
failure OR 2.78 95% CI (1.09-7.08; P = 0.03). No other variables
recorded were related to weaning failure.
CONCLUSIONS. In a mixed group of critically ill patients ready for a
SBT after at least 24h of mechanical ventilation, a low ScvO2 at the
start of the SBT was an independent risk factor for a failure to wean.0746
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INTRODUCTION. Diaphragm ultrasound is a noninvasive and
realtime tool to evaluate diaphragm function and activity. Diaphragm
thickening fraction (TFdi) during tidal breathing has a good
correlation with patient effort determined by pressure–time product
and it would be used to estimate respiratory muscle workload during
spontaneous breathing trials (SBT) whereas rapid shallow breathing
index (RSBI) is the most accurate index used in daily practice for
predicting weaning outcome. Diaphragm dysfunction may also lead
to weaning failure.
OBJECTIVES. The primary objective was to evaluate diaphragm
activity determined by change in TFdi at tidal breathing during the
course of SBT. The secondary objectives were the difference in 1)
TFdi and RSBI between patients who pass and fail SBT 2) diaphragm
function determined by diaphragm excursion (DEmax) and TFdimax.
METHODS. A prospective cross-sectional study was done in 45 venti-
lated patients who were ready to be weaned. Patients who had dia-
phragm paralysis or neuromuscular disease were excluded. SBT was
performed using flow-by technique for 30 minutes. Diaphragm thick-
ness (Tdi) was measured at the right hemidiaphragm in the zone of
apposition using a 10 MHz linear ultrasound probe. TFdi was calcu-
lated from the percentage change between inspiratory and expira-
tory Tdi as the following formula: TFdi (%) = ((Tdiinsp - Tdiexp)/Tdiexp x
100). We recorded TFdi at tidal breathing and RSBI at 0, 5, 10, 15 and
30 min of SBT. We also evaluated diaphragm function by measuring
DEmax and TFdimax during maximum effort before starting SBT.
RESULTS. TFdi was significantly increased at the end of SBT
(TFdi0 = 29.8 ± 13.8% and TFdi30 = 37.4 ± 13.0%; P < 0.001). In
patients who failed SBT (13/45; 28.8%), TFdi at the onset of SBT was
a significant higher in comparison to patients who passed SBT
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 381 of 542(36.3 ± 16.4% vs 27.1 ± 11.9%; P = 0.043) representing higher
inspiratory effort in failure group. There was also a significant
difference in RSBI at the onset of SBT between success and failure of
SBTs (57 ± 20.1 vs 80.6 ± 32.7; P = 0.005). In the failure group, DEmax
and TFdimax were lower than the success group but there was no
statistical significant difference. In patients who were ventilated less
than 7 days (n = 25), we found that there was significant higher
DEmax than the failure group (26.8 ± 9.0 vs 19.2 ± 6.4 mm; P = 0.002).
CONCLUSIONS. Patient efforts determine by TFdi significantly
increased during the course of SBT. TFdi immediately increased and
significant difference at the onset of SBT in the failure SBT group.
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INTRODUCTION. In difficult-to-wean ICU patients, the influence of sleep
quality on weaning duration of mechanical ventilation has never been
studied. We aimed to compare sleep quality between patients with a
short weaning duration and those with a prolonged weaning duration.
PATIENTS AND METHODS. Prospective physiological study performed
in a French teaching hospital. All patients intubated at least 24h and
difficult-to-wean, i.e. those who experienced at least one weaning trial
failure, could be included. Patients with continuous sedation, central
nervous system or psychiatric disease, or underlying neuromuscular dis-
ease were excluded. A complete polysomnography was performed dur-
ing the night following the first weaning trial failure. Peripheral muscle
strength, maximal inspiratory pressure and delirium were measured at
time of polysomnography. Weaning duration was defined as the time
from polysomnography to extubation. Prolonged weaning was defined
as a weaning duration at least 3 days (failure of at least 3 weaning tri-
als) according to the international conference consensus of weaning.
Altered sleep quality was defined as atypical sleep or absence of REM
sleep (1).
PRELIMINARY RESULTS. Over a 24 month-period, 52 difficult-to-
wean patients were screened and 33 patients were analyzed. Among
them, 14 patients (42%) had prolonged weaning (>3 days) and
19 patients (58%) had short weaning.
Patients with prolonged weaning had shorter rapid eye movement
(REM) sleep duration than patients with short weaning (0 minute [0–5]
vs. 9 [0–52], p = 0.038). Atypical sleep was more likely to be found in
patients with prolonged weaning: 79% (11 of 14 patients) vs. 32% (6 of
19 patients), p = 0.01. The weaning duration was longer in patients
with altered sleep quality than the others (6.2 ± 5.7 days vs. 3.3 ± 2.7,
p = 0.03 log-rank test). Absent electroencephalographic reactivity at ini-
tiation of polysomnography was more frequently observed in patients
with prolonged weaning: 71% (10 of 14 patients) vs. 26%
(5 of 19 patients), p = 0.01. The score of delirium at time of
polysomnography as well the total dosis of sedation prior to
polysomnography did not differ between groups. Maximal inspiratory
pressure was similar in the 2 groups and the only difference was a lower
peripheral muscular strength in the prolonged weaning group as
indicated by a lower MRC score group (31 points [24–55] vs. 58 [46–60],
p = 0.01).
CONCLUSION. Our preliminary results show that ICU patients with
altered sleep quality at the beginning of weaning from mechanical
ventilation, i.e. atypical sleep or absence of REM sleep, had
prolonged weaning.
KEYWORDS. Weaning; Mechanical ventilation; Sleep; Polysomnography;
Intensive care unit.
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INTRODUCTION. Current recomendations (1) for respiratory failure
criteria of spontaneous breathing trials (SBT) report considering
failure in patients who fulfill the following criteria:
1) PaO2 ≤ 50-60 mmHg on FiO2 ≥ 0.5 or SaO2 ≤ 90%;
2) PaCO2 > 50 mmHg or an increase in PaCO2 > 8 mmHg;
3) pH < 7.32 or a decrease in pH ≥0.07 pH units.
However, more recent data (2), confirm that patients with
PaCO2 > 45 mmHg irrespective of pH value at the end of the SBT
benefit with noninvasive ventilation (NIV) in term of survival rate,
suggesting that the former criteria should be modified.
OBJECTIVES. As patients at risk for hypercapnia are mainly COPD
patients, we aimed to assess whether arterial blood sample could be
avoided in non-COPD patients.
METHODS. We performed a prospective single center study, in a ICU
with a weaning protocol including preventive therapy for high-risk
patients (those who present at least one high-risk factor for reintuba-
tion) with both high-flow conditioned oxygen therapy or NIV. The
high-risk factors include: age > 65 years, cardiac failure, moderate-to-
severe COPD, APACHE II > 12 points the extubation day, body mass
index (BMI) > 30, patients at high-risk for developing laringeal
edema, patients considered unable to deal with respiratory secre-
tions (inadequate cough reflex or >2 suctioning within 8h previous
to extubation), difficult or prolonged weaning, ≥2 comorbidities
(Charlson index), and prolonged MV defined as MV > 7 days. Under
those conditions, we performed two analysis:
1) the probability of developing hypercapnia at the end of the SBT in
a non-COPD patient;
2) we compared oxymetric values from an arterial blood sample to
oxymetry. Consecutive patients were enrolled since January 2016 to
January 2017. Statistical analysis included ROC curves and
multivariate analysis to adjust for covariates.
RESULTS. 200 patients were analyzed, including 35 COPD. The 12%
(24/200) of patients failed the SBT, 33% were COPD patients (8/24).
Respiratory related reintubation rate was 10% (21/200) and all cause
reintubation rate was 12% (25/200). The 54% (19/35) of COPD
patients presented with hypercapnia, while only 4 non-COPD pa-
tients presented a CO2 level at the end of the SBT above 45; all of
them were surgical patients, and the reason for the hypercapnia was
residual effect of sedatives. None of them required reintubation sec-
ondary to hypercapnic failure. According to the oximetric values, the
ROC curve for PaO2 and SaO2 were similar (0.73 vs 0.74, respectively;
p = 0.65).
CONCLUSIONS. Non-COPD patients do not seem to benefit with ar-
terial blood samples in terms of improvement in diagnostic quality of
SBT failure criteria.
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INTRODUCTION. Automated ventilators (INTELLiVENT-ASV:I-ASV),
with which physicians only need to set target PETCO2 and SpO2
levels, were developed to provide more appropriate ventilation to
patients and reduce medical staff workloads. However, I-ASV has notbeen thoroughly investigated for the patients after cardiac surgery.
Thus, we compared ventilator settings adjusted by I-ASV and manual
ASV (M-ASV) after cardiac surgery in our ICU.
OBJECTIVES. To assess feasibility of I-ASV for the patients after car-
diac surgery.
METHODS. We enrolled patients who underwent cardiac surgery
from July 2013 to April 2014. After ICU admission, patients were
randomized into two groups: I-ASV and M-ASV. With I-ASV, SpO2 tar-
get shift was fixed to +3 and PETCO2 target shift was adjusted for
PaCO2 of 35–45 mmHg. Ventilator settings were automatically ad-
justed until spontaneous breathing test. With M-ASV, PEEP, FIO2 and
%minute volume (%MV) were initially decided by ICU physicians.
PEEP and %MV were adjusted by physicians and FIO2 was adjusted
by nursing staff based on arterial blood gas analysis. Ventilator set-
tings (PEEP, FIO2, %MV), P/F ratio, PaO2, respiratory rate (RR) and
PaCO2 were recorded each hour after ICU admission for 24 hours.
Statistical analysis was made by Wilcoxon rank sum test, and p-
values of < 0.05 were considered significant.
RESULTS. Data from 48 patients were analysed (I-ASV: 28, M-ASV: 20).
No safety issues occurred. All of the parameters (PEEP, FIO2, %MV, P/
F ratio, PaO2,RR and PaCO2) were not detected significant difference
as a trend, except for FIO2 from one to six hours after the operation.
The FIO2 of I-ASV group is much lower than that of M-ASV group (I-
ASV versus M-ASV: FIO2-1h 0.3(0.3 to 0.34) versus 0.4 (0.35 to 0.49),
FIO2-2h 0.3 (0.3 to 0.33) versus 0.4 (0.3 to 0.4), FIO2-3h 0.3 (0.3 to
0.32) versus 0.4 (0.3 to 0.4), FIO2-4h 0.3 (0.3 to 0.33) versus 0.38 (0.3
to 0.4), and FIO2-6h 0.3 (0.3 to 0.32) versus 0.35 (0.3 to 0.4), respect-
ively; P < 0.05).
CONCLUSIONS. I-ASV ventilator adjustments were not much different
compared with M-ASV settings. FIO2 during early phase was set lower
by I-ASV, although oxygenation was not different. Thus, INTELLiVENT-
ASV use may be feasible for patients after cardiac surgery.
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INTRODUCTION. Prolonged mechanical ventilation (MV) is associated
with high morbidity, mortality, and health care costs.
OBJECTIVES. The aim of this study is to evaluate predictors for
failure of early weaning from MV in critically ill surgical patients.
METHODS. The medical records of 926 critically ill patients who
underwent emergency gastrointestinal surgery for diffuse peritonitis
between January 2007 and December 2015 were reviewed
retrospectively. All patients who underwent MV during operation and
required continuation of MV during postoperative period were
included. Early weaning failure from MV was defined as the failure of
extubation or the need for reintubation within the first 48 hours after
surgery. Clinical and laboratory parameters before surgery and within
1 day after surgery were investigated.
RESULTS. This study included 315 adult patients, of whom 207
(65.7%) were successfully weaned within the first 48 hours after
surgery. Patients who failed extubation within the first 48 hours after
surgery showed significantly higher 30-day mortality than those who
were successfully extubated (28.7% versus 6.3%, p < 0.001). Serum
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 383 of 542creatinine levels of > 1.2 mg/dL (odds ratio [OR] 2.984; 95% confi-
dence interval [CI] 1.130-7.882; p = 0.027), platelet counts
of < 140,000/μL (OR 3.866; 95% CI 1.418-10.540;
p = 0.008), delta neutrophil index of > 25% (OR 3.503; 95% CI 1.264-
9.705; p = 0.016) measured immediately after surgery, failed
spontaneous awakening trial (SAT; OR 3.993; 95% CI 1.052-15.157;
p = 0.042) and spontaneous breathing trial (SBT; OR 10.231; 95% CI
3.413-30.674; p < 0.001) within the first 48 hours after surgery were
independent predictors of early weaning failure from MV.
CONCLUSIONS. Elevated serum creatinine level, low platelet counts,
high delta neutrophil index immediately after surgery, failed SAT and
failed SBT within the first 48 hours after surgery were independent
predictors of early weaning failure from MV in critically ill surgical
patients.
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INTRODUCTION. Diaphragmatic dysfunction in controlled mechanical
ventilation (MV) is generated in at least 24 hours and has been
associated with the development of diaphragmatic atrophy. Direct
diaphragm measurement has a role as a predictor of success or
failure in weaning of mechanical ventilation.
OBJECTIVE. The goal of this study was to determine the efficacy in
weaning of mechanical ventilation from a protocol of ultrasound
diaphragm measurements in association with clinical-ventilatory
variables.
MATERIAL AND METHODS. This prospective, observational study was
conducted at the Intensive Care Unit, Centro Médico Nacional del Bajío
UMAE 1, in León Guanajuato, between February 2016 to January 2017.
Patients were admitted over 18 years and mechanical ventilation over
24 hrs. A prospective clinical data sheet was used to collect clinical
variables (GCS 13–15 points, hemodynamic stability, presence of tusigo
reflex and swallowing), ventilatory variables (CROP index, SpO2 > 90%
FiO2 < 60 mmHg PaO2/FiO2 > 150 PEEP < 8 cmH2O respiratory rate
(RR) < 35, RR/tidal volume < 105) and diaphragmatic ultrasound
measurements (diaphragmatic excursion, diaphragmatic contraction
velocity).
RESULTS. We included 90 patients, mean age of 49.18 years, female
gender 54%, male 46%; the following significant results were
obtained: respect to clinical variables, the presence of tusigo reflex
and swallowing with a p = 0.001, CROP index >13 with a p = 0.03,
PEEP < 8 cm H2O with a p = 0.001, RR/tidal volume with a
p = 0.0001; respect to diaphragmatic ultrasound measurements,
diaphragmatic excursion with a p < 0.05.
CONCLUSIONS. There is a positive correlation between the
diaphragmatic excursion and a success weaning of mechanical
ventilation, as well as other clinical variables (presence of tusigo
reflex and swallowing, CROP index, PEEP and RR/tidal volume).REFERENCES
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INTRODUCTION. Surgical patients receiving opioids for pain control
are at greater risk of respiratory depression following extubation. To
decrease postoperative pulmonary complications, incentive spirometry
has gained widespread use in the postoperative period by encouraging
patients to achieve maximal inspiration by providing visual feedback.
However, there is a limit to the use of incentive spirometry in patients
who have undergone tracheotomy. Recently, impedance-based nonin-
vasive respiratory volume monitor (RVM, ExSpiron, Respiratory Motion,
Inc, Waltham, MA) became available to continuously measure minute
ventilation (MV), tidal volume (TV), and respiratory rate(RR).
OBJECTIVES. This study was designed to determine if RVM can be
used to determine respiratory depression after SBT.We also
investigated whether RVM can measure respiratory changes before
and after deep breathing training (DBT) after SBT.
METHODS. Fifty two postoperative patients completed the study. Of
the 51 patients, 31% were tracheotomy patients who were unable to
use inspirometry. During the spontaneous breathing trials,
continuous respiratory data were recorded from an impedance-
based RVM (ExSpiron, Respiratory Motion, Inc, Waltham, MA) simul-
taneously with ventilator data Hamilton G5 (Hamilton Medical AG;
Bonaduz, Switzerland). The TV measured by the ventilator during this
period was then entered into the RVM to calibrate the TV estimated
by the RVM during this same period. After mechanical ventilator
weaning, we have continued respiratory monitoring by RVM without
any intervention. During immediately post-extubation periods, pa-
tients are continuously injected with remifentanil for pain control.
After 1 hour, patients underwent DBT for 15 minutes using RVM
monitoring. We did arterial blood gas analysis before and after the
deep breathing exercise.
RESULTS. 51 subjects (28 females/23 males; age: 59.9 ± 12.8 years;
BMI: 22.8 ± 3.3 kg/m2, mean ± SD) completed the study. 21 patient
data were used to study the accuracy of RVM compared to ventilator
in TV measurements. TVs as measured by RVM and ventilaotr during
SBT were strongly correlated (R = 0.95 ± 0.1). As expected, almost all
patients after extubation showed respiratory depression on RVM. On
the ABGA, mean PaO2 decreased (−46.2 ± 38.1, p < 0.001) after
extubation.
After DBT using RVM, PaO2 showed an average increase of 8.8
mmHg.(−8.8 ± 25.4, p = 0.017).
CONCLUSIONS. After mechanical ventilator weaning, most patients
underwent respiratory depression. RVM can be used successfully for
postoperative respiratory physiotherapy as well as accurate measurement
of respiratory volume.
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INTRODUCTION. Patients undergoing cardiac surgery are generally
able to wean from mechanical ventilation within the first
postoperative hours. Some patients however, require mechanical
ventilation for a longer period and this is associated with morbidity
and costs.
OBJECTIVES. The aim of this study was to identify factors associated
with delayed weaning from mechanical ventilation, following cardiac
surgery.
METHODS. A prospective study was performed including consecutive,
adult patients who had undergone an elective cardiac surgery and
were admitted to ICU. Demographic and clinical characteristics, pre-
and intraoperative parameters and type of surgical procedure were
recorded. The patients underwent a weaning trial under low-level pres-
sure support. They were divided into 2 groups: Group A included pa-
tients who weaned from mechanical ventilation within 12 hours after
surgery and Group B those who were mechanically ventilated for more
than 12 hours following ICU admission.
RESULTS. Ninety patients (mean age 67 ± 10 years, 62 males) who
have undergone a cardiac surgical procedure (coronary artery bypass
grafting, valve replacement, ascending aortic aneurysm repair or
combined surgery) were studied. Group A included 70 patients
(mean duration of mechanical ventilation 8.5 ± 1.6 hours) and Group
B the remaining 20 patients (mean duration of mechanical
ventilation 55.6 ± 35 hours).
Compared to patients in Group A, the Group B patients were older
(mean age of 72 ± 9 vs. 65 ± 11 years, p = 0.004); they had increased
duration of cardiopulmonary bypass and aortic cross-clamping
(171 ± 28 vs. 93 ± 30 min and 123.8 ± 21.3 vs. 70.6 ± 27.6 min, re-
spectively, p < 0.001) and more red blood cells (RBCs) transfusion
(4.5 vs. 1.6, p = 0.027). On ICU admission, central venous oxygen con-
tent (ScvO2) was significantly lower in Group B patients compared to
Group A (64 ± 7 vs. 67 ± 5, p < 0.001), and serum troponin I was
significantly higher (13.7 ± 2.7 ng/ml vs. 4.2 ± 2.8 ng/ml, p < 0.05).
During the weaning trials the respiratory frequency / tidal volume
was lower in Group A patients compared to Group B (32.6 ± 7.8 vs.
42.3 ± 17.9 respectively, p = 0.038). Also, combined surgery as
compared to a single surgical procedure was associated with delayed
discontinuation from the ventilator (p = 0.043).
CONCLUSIONS. Increased age, increased duration of extracorporeal
circulation and aortic clamping, RBCs transfusion number, low ScvO2
and high troponin I values following surgery, and combined surgery
should be considered as factors that delay the weaning from
mechanical ventilation in patients after cardiac surgery.
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INTRODUCTION. Endotracheal intubation with mechanical ventilation
(MV) support is an important intervention for managing patients
with respiratory failure in the intensive care unit (ICU). However, 2-16% of patients on MV undergo potentially life-threatening un-
planned extubation (UE), which is defined as an accidental or a
patient-induced removal of an endotracheal tube.
OBJECTIVES. We reviewed the outcomes of unplanned extubation
(UE) in patients in a medical center's 6 intensive care units (ICUs) and
calculated their mortality risk.
METHODS. We retrospectively reviewed the medical records of all
adult patients in Chi Mei Medical Center who underwent UE
between 2009 and 2015. The following data were collected:
demographic and clinical variables, severity of the patient's
condition, and outcomes.
RESULTS. During the study period, there were 305 episodes of UE in
295 ICU patients (men: 199 [67.5%]; mean age: 65.7 years; age range:
18–94 years). The mean Acute Physiology and Chronic Health
Evaluation (APACHE) II score was 16.4, mean therapeutic intervention
scoring system (TISS) score was 26.5, and mean Glasgow coma scale
score was 10.4. One hundred thirty-six patients (46.1%) were re-
intubated within 48 h. Forty-five died (mortality rate: 15.3%). Multi-
variate analyses showed 5 risk factors—respiratory rate, APACHE II
score, uremia, liver cirrhosis, and weaning status—were independ-
ently associated with mortality.
CONCLUSIONS. Five risk factors including a high respiratory rate
before UE, high APACHE II score, uremia, liver cirrhosis, and not
being weaned from intubation—were associated with high mortality
in patients who underwent UE.
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INTRODUCTION. The weaning is a key element of mechanical
ventilation (MV), occupying up to 50% of its duration. It's crucial to
identify the right time to extubate, since re-intubation is associated
with an increased risk infections, prolonged ICU-LOS, death and sub-
stantially increased costs. Innovative modes of MV, mainly based on
complex closed loop, have been developed and are available for clin-
ical use, therefore, it is necessary to compare them with conventional
modes for weaning.
OBJECTIVES. Determine the relationship between success in
weaning and the ventilatory modes used at the ICU of a thertiary
hospital Mexico City.
METHODS. A retrospective analysis, during last 5 months of 2016,
collected patients who received MV and were ready for weaning,
randomly assigned to one MV mode for weaning: Pressure Support
(PSV), Mandatory Minute Volume (MMV), Proportional Assist Ventilation
(PAV) and Adaptive Support Ventilation (ASV). Standardized protocols
were followed for each MV mode.
RESULTS. We collected 51 patients (28 males). The causes of MV
were: acute respiratory failure (ARF) 27%, neurocritical care 24%,
abdominal surgery 16%, thoracic surgery 10%, acute heart failure
10%, and other 14%. The distribution by mode of MV was PSV = 28,
ASV = 10, PAV = 7 and MMV = 6. The average time of MV was 4.72,
3.1, 5.77 and 2.73 days respectively, with an overall average time of
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 385 of 5424,05 days. Total patients per group, successful weaning, mean and
variance in Table 193.
The analysis of variance show the sum of the squares = 4.5098, 3
degrees of freedom intergroups and 47 intragroups, through F-test
we obtain F = 0.2616 and a ciritical value for F = 2.8023, and
p = 0.8526, so there is no variation in the 4 ventilatory modes used
in for weaning.
CONCLUSIONS. The PSV mode was the most used, similar to
international literature. There is no significant difference between the
4 modes used. Nevertheless, the study regarding modes to facilitate
weaning remains of interest, large sample are needed to elucidate
the role of ventilatory modes, as well as to analyze other variables
that may contribute to the success or failure of the weaning
protocol.
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Ventilation mode Total patients Succesful weaning Mean Variance
ASV 10 9 0.9000 0.1000
PAV 7 6 0.8571 0.1429
PSV 28 25 0.8929 0.0992
MMV 6 6 1.0000 0.00000756
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INTRODUCTION. Anxiety is a commonly reported and distressing
symptom recalled by ICU survivors in association with mechanical
ventilation. Repeated weaning failure may contribute to worsening
of anxiety. No studies have measured anxiety and dyspnea in
patients experiencing progressive tracheostomy mask (TM) trials
following repeated weaning failure.
OBJECTIVES. To quantify anxiety and dyspnea before, during, and
after daily progressive TM weaning. Secondary objectives were to
examine correlations between anxiety, dyspnea, and respiratory rate
and to explore anxiety over time.
METHODS. We included patients admitted to a specialized weaning
centre in Toronto, Canada. We excluded patients unable to rate
anxiety due to impaired neurological status or inability to understand
English. We measured anxiety (1–10 scale; 1 = no anxiety and
10 = extreme anxiety) at 3 time-points, (T1) immediately prior to TM
trial commencement; (T2) 30 mins prior to anticipated completion;
and (T3) 30 mins after completion on successive weaning days. At
the same time-points we measured dyspnea using the modified Borg
Scale and documented respiratory rate. Measures were repeated
across the number of days to wean. Due to the large range in the
number of weaning days, anxiety scores were averaged across daysfor each time point and analyzed using a two-way repeated ANOVA,
with time as the within factor and days to wean (tertiles < 7 days, 7–
16 days, >16 days) as the between factor. At each time point, we cal-
culated Pearson's correlations between mean anxiety, dyspnea, and
respiratory rate.
RESULTS. We recruited 21 participants (mean (SD) age 63 (12.6)
years; 62% male) with a mean (SD) duration of mechanical
ventilation of 84 (68.8) days prior to weaning centre admission.
Participants received 2 to 58 days of TM trial weaning. Anxiety
decreased over time from a mean (SD) score of 4.77 (1.59) (T1), to
4.55 (1.74) (T2) and 3.92 (1.71) (T3) (f = 9.25; p = 0.001); however, the
pattern of change varied according to number of days to wean
(f = 3.39; p = 0.01). Those weaned in < 7 days or 7–16 days had a
large (4.40 to 3.33) or small (5.62 to 5.58) decline in anxiety from T1
to T2, respectively. Those who took >16 days had increased anxiety
at T2 (4.22 to 4.76). Anxiety was highest at all three time points
among those who took 7–16 days to wean. Anxiety at T2 was
correlated with dyspnea measured at all three time-points (r = 0.46
to 0.58; each p < 0.05); respiratory rate at T2 only (r = 0.51; p = 0.02).
Anxiety at T1 was not correlated with dyspnea or respiratory rate,
while anxiety at T3 only related to dyspnea at T3 (r = 0.47; p = 0.04).
CONCLUSIONS. Overall, anxiety was moderate before, during, and
after TM trial weaning. Anxiety decreased substantially during TM
trials for those experiencing the shortest weaning duration and
conversely increased during the trial for those experiencing the
longest durations. Anxiety during a TM trial correlates with dyspnea.
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INTRODUCTION. The Magnificent Seven bundle is designed to
ensure consistent, optimal and evidence-based care throughout the
region. One of it's branches is on TPN and states: 'Parenteral nutrition
should not be given to adequately nourished, critically ill patients in
the first seven days of an ICU stay.' This is based on evidence (1,2,3)
that showed that 'In patients who are adequately nourished prior to
ICU admission, parental nutrition initiated within the first seven days
has been associated with harm, or at best, no benefit, in terms of sur-
vival and length of stay in ICU. These findings are true even among
patients who cannot tolerate enteral nutrition'.
OBJECTIVES. To assess our adherence to the TPN branch of the
Magnificent Seven, to investigate any failings and to look at some
basic outcomes to see they are seemingly resulting in harm to
patients or excess cost.
METHODS. Retrospective audit of the year of 2016 for ICU patients
who received TPN. This included
19 patients. Case notes were used to find: how long after admission
to ICU TPN was started, duration of TPN, no. of bags of TPN, duration
of hospital stay and ICU stay, in hospital mortality and 90 day
mortality and reason for ICU admission.
RESULTS. There were a total of 19 patients, 6 of these patients were
started on TPN after 7 days following admission (group A), 13
patients were started on TPN before 7 days (group B), 1 of which
was clearly documented as being underweight prior to admission so
was in line with guidelines.10/13 patients started against guidelines
were post-operative from bowel surgery. Group B had a mean 37
total hospital days/person and median 30 days. Group A had a 72.3
mean total hospital days/person and a median 45.5. Group B had a
mean 8.7 ICU days/person and median value of 7. Group A, 60.6
mean ICU days/person and a median of 35.5. In group B 2/13 died in
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 386 of 542hospital and 1/11 remaining died before 90 days after discharge. In
group A 4/6 died during their stay, 0/2 remaining died before 90
days following discharge. In group B there was a mean of 13.5 TPN
bags/person and a mean of 21.2 TPN bags/person in group A.
CONCLUSIONS. We are not adhering to our guidelines, the majority
of these failings are in post-operative patients, and therefore we
need to work with the surgical team to make an agreement on pol-
icy. Hospital/ITU stays, mortality, number of TPN bags used and dur-
ation of TPN was longer in group A, which may indicate the severity
of illness of these patients, which I would argue would suggest a
more genuine need for TPN rather than poor outcomes due to TPN. I
noted that documentation of nutritional status in ICU was poor and I
am planning on creating a brief nutritional assessment tool. I will re-
audit in 9 months.
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INTRODUCTION. Acinetobacter baumannii (AB) has become one of
the most important nosocomial pathogens. AB was previously
considered to have low virulence and colonization was considered to
be more common than infection. However, recent increases in the
incidences of multi-drug-resistant (MDR) and carbapenem resistant
(CR) AB infections and in difficulties associated with their treatments
pose serious medical problems. Studies on the correlation between
the DNI with severity and infectious mortality in sepsis patients due
to pneumonia are limited.
OBJECTIVES. The aim of this study was to evaluate the usefulness of
the DNI as a predictor of infectious mortality in surgical patients with
AB pneumonia.
METHODS. The medical records of 104 surgical patients with AB
pneumonia treated from March 2011 to October 2014 were analyzed
retrospectively.
RESULTS. The mean patient age was 60.8 ± 18.8 years, and the
mean APACHE II score was 15 ± 5.3.At the time of culture, 18
patients (15.4%) had renal failure, and the median DNI was 2.7 (0–
39.4) %. Twenty-four patients (23.1%) died from infection. Univariate
analysis indicated that several factors were associated with infectious
mortality, namely age, occurrence of shock, renal failure, low platelet
count and elevated DNI at the time of culture. Logistic regression
analysis revealed that elevated DNI (OR 1.136, 95% CI 1.001-1.288),
acute renal failure (OR 3.811, 95% CI 1.025-14.176) and decreased
platelet count (OR 0.994, 95% CI 0.989-1.000) at the time of culture
are independent risk factors for infectious mortality. When a receiver-
operating characteristics curve was constructed to determine the op-
timal cut-off value to predict infectious mortality within 7 days of the
bacterial culture, the area under the curve was 0.839 (95% CI 0.694-
0.985) and the cut-off DNI value was 6.85%.
CONCLUSIONS. DNI may be an effective predictor of infectious
mortality in critically ill surgical patients with AB pneumonia.
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INTRODUCTION. Admission of cancer patients with poor prgnosis
like relapsed acute myeloid leukemia (AML) continue to be
controversial. The ICU trial may be an alternative in this case to ICU
refusal.
OBJECTIVES. The objective of this study was to find variables to
predict prognosis in ICU: invasive mechanical ventilation (IMV),
vasopressor (VAS), dialysis (RRT).
METHODS. Retrospective monocentric study of consecutive patients
with a relapsed AML admitted to the 30 beds medical ICU of an
academic hospital between 2002 and 2014.
RESULTS. Between 2002 and 2014, 24 patients with relapsed AML
were admitted in the ICU. At admission, patients were 54 years old,
IGS 2: 64 ± 24, Lactates: 4.9 mmol/L (±4.7). Eight patients underwent
bone marrow transplant (BMT). Five patients had graft-versus-host
disease (GVHD). BMT was signicantly associated with higher mortality
[Odds ratio (0R) 13.0 (95% confidence interval (95% CI) 1.7-99,
43)—p: 0.02]. 7 BMT patients died in ICU. Neutropenia [OR 0.33 (95%
CI 0.05-1.87)—p: 0.4] and GVHD (OR 2.0 [95% CI 0.07- 51.6)—p: 1.0]
were not able to predict mortality in ICU. Mortality in ICU was 37%. 4
patients died from acute illness before day 3. Among the 24 patients
admitted in ICU, none of the life-sustaining interventions at admis-
sion were associated with higher mortality: invasive mechanical ven-
tilation [OR 9.14 (95% CI 0.9-92.4) - p: 0.08], vasopressor perfusion
[OR 6.2 (95% CI 0.6-62.2)—p: 0.18] and renal replacement therapy
[OR 4.8 (95% CI 0.3-65.8)—p: 0.27]. On day 3, life supports were not
associated with higher mortality: invasive mechanical ventilation [OR
3.7 (95% CI 0.32-41.1)—p: 0.35], vasopressor perfusion [OR 2.0 (95%
CI 0.27-14.7)—p: 0.64] and renal replacement therapy [OR 1.2 (95%
CI 0.08-16.45)—p: 1.0].
CONCLUSIONS. Mortality in ICU was 37% in patients with relapsed
AML. In fact, temporary full-code ICU management in patients with
relapsed AML seems to be appropriate. None of the life-sustaining in-
terventions at admission and on day 3 were able to predict survival.
An ICU trial of 3 days might not be enough to appraise precisely the
outcome. In case of relapsed AML with BMT, ICU management is still
challenging.
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INTRODUCTION. Although the role of central venous pressure (CVP)
in fluid management is declining, CVP measurement is still essential
in evaluation of hemodynamic state and cardiac efficiency. Higher
CVP was previously reported to be associated with poor outcomes in
septic patients.
OBJECTIVES. The aim of this work is to evaluate the baseline CVP as
mortality predictor in critically ill septic patients with high severity
scores.
METHODS. A pilot study was conducted including a cohort of severely
ill septic patients with Acute Physiology and Chronic Health Evaluation
(APACHE) II score above 20. All patients were mechanically ventilated
and on norepinephrine infusion. Severity scores (APACHE II and SAPS
II), demographic data, vital signs (heart rate and arterial blood
pressure), CVP, serum albumin, and in-hospital mortality were reported.
Area under receiver operating characteristic (AUROC) curve was calcu-
lated for all parameters for prediction of mortality. Sensitivity, specifi-
city, and cutoff values were also determined for variables with
AUROC > 0.6.
RESULTS. Among 23 patients aged 48 ± 12 years, median APACHE II
score was 28 with interquartile range of (22–30). There were 15(65%)
male patients and 6(26%) survivors. APACHE II showed good
predictive properties for in-hospital mortality with AUROC of
0.73(0.47-0.991). Baseline CVP also showed good predictive proper-
ties for in-hospital mortality with AUROC of 0.721(0.503-0.938). A CVP
value of 8 cmH2o could predict mortality by sensitivity of 94% and
specificity of 33%. A CVP value above 12.5 cmH2o predicted mortality
by sensitivity of 41% and specificity of 100%.
CONCLUSIONS. High CVP on ICU admission could predict in-hospital
mortality in septic patients with high severity scores. Larger studies
are recommended to confirm our findings with inclusion of more
survivors.
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INTRODUCTION. Early Warning Systems (EWS) to identify hospital
patients at risk for deterioration common in high-income countries
(1, 2) have not been widely evaluated in resource-poor settings.
OBJECTIVES. This study aimed to assess the feasibility and
performance of selected aggregate weighted track and trigger
systems (AWTTS) and single parameter track and trigger systems
(SPTTS) to discriminate patients at risk of adverse outcomes in a low-
middle income setting; Sri Lanka.
METHODS. Available physiological variables, adverse outcomes
and survival status at hospital discharge were extracted from
existing records for all patients (age >17 years) admitted to
District General Hospital (DGH), Monaragala over an 8 month
period, where no EWS exists. Discrimination for selected AWTTS
was assessed by the AUROC. The prognostic value of admission
SPTTS, using available single and paired parameters, to predict
death was evaluated.RESULTS. Of the 16,386 patients included, 502 (3.06%) had 1 or
more had adverse outcomes; 100 (0.64%) cardiac arrests; 83 (0.51%)
unplanned admission to ICU; 253 (1.54%) transfers to tertiary
facilities; and 149 (0.91%) deaths. Availability of physiological
parameters on admission was systolic blood pressure 86.80% (CI
86.27, 87.31), heart rate 90.97% (CI 90.52, 91.40); oxygen saturation
23.94% (23.29, 24.60) and assessment of mentation (32.89 (32.17,
33.61). Best performing AWTTS and SPTTS had equally adequate
ability to predict death when applied at admission. Discrimination of
AWTTS was poor (AUROC < 0.60) in predicting other adverse
outcomes.
AWTTS AUROC (CI)
admission:
Death patientsAUROC (CI) 24
hours: Death
patientsAUROC (CI)
admission:
Patients with
eventsAUROC (CI) 24
hours: Patients
with eventsMEWS score with
missing values
imputed0.667 (0.615,
0.720)0.490 (0.423,
0.557)0.617 (0.591,
0.642)0.386 (0.355,0.416)NEWS score with
missing values
imputed0.677
(0.624,0.731)0.583 (0.525,
0.641)0.602 (0.574,0.629) 0.475 (0.450,0.501)SEWS score
missing values
imputed0.702 (0.656,
0.748)0.599
(0.547,0.651)0.609 (0.585,0.633) 0.510 (0.489,0.532)CART score
missing values
imputed0.781 (0.744,
0.818)0.744
(0.699,0.740)0.636 (0.611,0.630) 0.569 (0.541,0.596)ViEWS score
missing values
imputed.0.677 (0.624,
0.730)0.585
(0.526,0.643)0.601 (0.574,0.629) 0.476 (0.450,0.502)[AWTTS and outcomes]
CONCLUSIONS. There was poor availability of physiological variables
used by EWS to detect patient deterioration. AWTTS and SPTTS have
similar ability to predict mortality when applied on admission.
Awareness of the importance of bedside observations as a way of
alerting clinicians to patients at risk of avoidable adverse outcomes is
needed. SPTTS may have a place in this setting as a trigger system
to help identify patients on admission who may benefit from
increased monitoring.
The authors wish to acknowledge the support received from
consultants in charge of wards, DGH Monargala: Dr AC Weerarathne,
Dr K Jayasuriya, Dr KCC Gamage, Dr HKSI Premaratne, Dr SSM
Kariyawasam and the team of facilitators: N Dullewe, L Pieris, CS
Suraweera, ET Jagoda and Dr MF Miskin.
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INTRODUCTION. About one third of hospital mortality in critically ill
patients occurs after Intensive Care Unit (ICU) discharge.
OBJECTIVES. To evaluate the utility of SOFA score at last day of ICU
stay to predict ward mortality after ICU discharge.
METHODS. Multicentric prospective study in 7 hospitals in Spain. We
collected periods of two or three months during 2011, 2012 and 2015.
Data were expressed as mean and standard deviation for quantitative
variables and percentages for qualitative variables. For the comparison
of two means we used the Student's t-test and the chi- squared test
was used to compare proportions. Multiple logistic regression and area
under the ROC curve for analizing discrimination were used.
RESULTS. 1934 patients with a mean age of 61.22 ± 15.58 years,
SAPS-3 45.26 ± 13.68 points. Predicted hospital mortality by SAPS 3
was 17% and observed hospital mortality was 15%.ICU mortality was
10% and mortality after ICU discharge (Ward mortality) was 5.6%.
1731 patients were transferred to Ward hospitalization area, with
mortality of 5.6% (97 patients). Mean age of 60.66 ± 15.62 years,
SAPS 3 at ICU admission 43.06 ± 11.86 points and SOFA score at the
last day of 0.91 ± 1.61 points.
Ward mortality of patients with Medical pathology (754 cases) was
6.5%, elective surgery (801 cases) 5.5% and emergency surgery (173
cases) of 2.3%(p = 0.185).
Patients who died after ICU discharge were older (65.72 ± 14.61 vs.
60.36 ± 15.63 years) (p < 0.001), higher SAPS-3 score at ICU admis-
sion (54.06 ± 13.07 vs 42.4 ± 11.43) (p < 0.001) and higher SOFA
score at last day of ICU stay (2.8 ± 3.21 vs 0.9 ± 1.61) (p < 0.001).
SOFA score at the last ICU day: 1050 patients (60.8%) with 0 points and
Ward mortality of 2.4%, 297 patients (17.2%) with 1 point and mortality
rate of 4.4%, with 2 points (N = 159, 9.2%) and mortality of 8.2%, 96
patients (5.6%) with 3 points and mortality of 17.7%, and 124 patients
(7.2%) with 4 or more points and mortality of 22.6% (p < 0.001).
Discrimination capacity evaluated by SOFA score at the last day of
ICU stay was 0.74 (0.68-0.8) and by SAPS-3 at ICU admission was
0.75(0.68-0.80).
There is complementarity between both. Multivariate analysis
indicates that conventional hospitalization area mortality after ICU
discharge is related by SAPS-3 at admission (OR 1.06(1.04-1.08)) and
SOFA score at the last day of ICU stay (OR 1.36 (1.23-1.50)). Discrimin-
ation of this model by Area under the ROC curve:0.79(0.74-0.84).
CONCLUSIONS. Mortality of ICU patients after ICU discharge is
related by SOFA score at last day of ICU stay, severity illness at
admission by SAPS-3 score. Both variables are complementary to pre-
dict conventional hospitalization area mortality after ICU discharge.
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INTRODUCTION. Critically ill cirrhotic patients have high mortality
rates, particularly when they present with acute kidney injury (AKI)
on admission. Careful and evidence-informed identification, manage-
ment and prognostication of cirrhotic patients at risk of developing
multiple organ dysfunction are a high priority. However, there isn't
still a consensus regarding which are the best and reproducible
prognostic models in critically ill cirrhotic on admission to the ICU.
OBJECTIVES. The aim of the present study is to assess the accuracy
of specific prognostic models [Acute Physiology and Chronic Health
Evaluation (APACHE) II, Simplified Acute Physiology Score (SAPS) II,
Acute Kidney Injury Network (AKIN), Model for End-stage Liver Dis-
ease (MELD) and Child-Pugh-Turcotte (CPT) in predicting mortality in
cirrhotic patients admitted to a medical Intensive Care Unit (ICU).
METHODS. We retrospectively reviewed medical records of 72
cirrhotic patients admitted to an ICU in a Tertiary Care University
Hospital from January 2001 to December 2016. Demographic, clinical
and laboratory data recorded on the first day of ICU admission and
scoring systems applied (SAPSII, MELD, APACHEII and CPT) were
collected. Some of the scores not recorded at admission (AKIN) were
calculated based on the medical records. The discriminatory capacity
of the different scores were evaluated using areas under the receiver
operating characteristic curve (AUROC), posteriorly the areas were
compared using DeLong et al. (1988) method.
RESULTS. In our study population, 72% were male patients, average:
60 ± 13 years. The ICU mortality was 52.8%. The main causes of
cirrhosis were alcoholism (70.8%), followed by Hepatitis C (20.8%).
The major cause of ICU admission was septic shock (38.9%), followed
by hypovolemic shock (36.1%). In this study, 87.5% patients needed
organ support at admission (renal replacement therapy: 47.2%,
mechanical ventilation: 70.8% and vasoactive therapy: 73.6%).
By using AUROC, the SAPSII score had a good discriminative power
(AUROC: 0.92, IC 95%: 0.83-0.97), followed by AKIN (AUROC: 0.85, IC
95%: 0,745 to 0,923), MELD (AUROC: 0.83, IC 95%: 0,72 to 0,91), all
p < 0.05.
In Pairwise comparison of ROC curves, SAPSII presented the best
discriminatory power when compared with CPT (p < 0.001) and
APACHE (p < 0.020).
CONCLUSIONS. The SAPSII, AKIN, MELD and APACHE scores showed
well discriminative power in predicting ICU mortality in this group of
patients. The SAPSII scoring system proved to be a reproducible
evaluation tool with excellent prognostic abilities for these patients.
The AKIN classification is also a simple and easily applied evaluative
tool. Since it is difficult to predict outcome in cirrhotic ICU patients, a
combination of prognostic scores such as SAPS and AKIN could be
used as complementary tools during the difficult decision-making
process on whether to withdraw or pursue care for cirrhotic patients
in an ICU.
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INTRODUCTION. Cardiac surgery is the field where risk assessment
has developed the most, designing increasingly complex models
with different statistical techniques.
OBJECTIVES. This study is aimed to design a simplified cardiac
surgery risk score based in the number of risk factors of each patient
to evaluate operative mortality in our patients. This is defined as in-
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 389 of 542hospital mortality or mortality by 30 days after the operation for pa-
tients discharged from the hospital.
METHODS. Data of all patients undergone heart surgery at the
University Hospital of Salamanca, Spain, between 2001 and 2016
were collected. The data set was divided into two subsets: a
developmental one for modeling and the other, validation subset, for
model testing. Results were compared with EuroSCORE II. Accuracy
was defined with a receiver-operating characteristics operator and
calibration with a Hosmer-Lemeshow test. Data was analyzed with
SPSS v.22 and MedCalc v.13.
RESULTS. In the developmental subset we included 3950 patients
who had undergone cardiac surgery between 2001 and 2012, with
6.7% mortality. We identified predictors of mortality with x2 and t-
Student tests (p < 0.05) and recode the variables in “presence” or
“absence” of each risk factor. We used the Youden index to deter-
mine the age and creatinine cut point. Logistic regression was used
to establish the independent variables associated with mortality.
These variables were female sex, age greater than 71 years, extracar-
diac arteriopathy, active endocarditis, NYHA class IV, left ventricle
ejection fraction lower than 30%, pulmonary artery pressure greater
than 55 mmHg, critical preoperative state, emergency operation,
serum creatinine greater than 1.32 mg/dl, isolated CABG and three
or more procedures. Only 591 patients (15%) didn't present any risk
factor and none of themhad more than nine. We do not include
isolated CABG since it appears as a “protector” factor in the logistic
regression analysis. x2 test was used to evaluate if the number of risk
factor was related with mortality. Observed mortality increased with
more risk factors.The validation series included 1263 patients be-
tween 2013 and 2016. Discrimination, assessed with the ROC curve,
was good with our model (AUC 0.81, CI 0.76-0.86) and also with
EuroSCORE II (AUC 0.80, CI 0.76-0.85), but EuroSCORE II was poor cali-
brated in the validation data with a significant Hosmer-Lemeshow
test (x2 17.90, p: 0.02).
CONCLUSIONS. Using a model that only considers the number of
risk factors without taking into account the weigh of each variable, is
statistically consistent. Complex models don't assure good calibration
and discrimination and are less user friendly.
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INTRODUCTION. There are limited data on the performances of
pneumonia severity scores and intensive care unit (ICU) scores to
predict mortality in community-acquired pneumonia (CAP) and
Healthcare-associated pneumonia (HCAP) patients hospitalized to ICU.
OBJECTIVES. The purpose of this study is to evaluate the
performance of the pneumonia severity index (PSI), CURB-65 (confu-
sion, urea, respiratory rate, blood pressure, age ≥ 65) score, and
Acute Physiology and Chronic Health Evaluation (APACH) II score for
the prediction of mortality in non-nosocomial pneumonia patients
admitted to ICU.
METHODS. We retrospectively evaluated 162 patients admitted to
ICU with non-nosocomial pneumonia between 1 January 2008 and
31 December 2011. The performances of PSI and CURB 65, APACHE II
score were evaluated for mortality prediction.
RESULTS. Of total 162 patients, 76 (46.9%) patients died in hospital.
Mean age of patients is 68.1 years and 112(69.1%) are men. 128
(79%) patients had ventilator care. PSI and APACHE II were
significantly lower in survivors than in non-survivors (145.2 vs. 166.1,P < 0.001; 20.6 vs. 29.8, P < 0.001), but CURB-65 was not (2.4 vs. 2.7,
P = 0.075). Receiver operating characteristic curves showed that APA-
CHE II (area under the curve [AUC] = 0.79) performed better than PSI
(AUC = 0.67, P < 0.016) and CURB-65 (AUC = 0.58, P < 0.001) to pre-
dict in-hospital mortality.
CONCLUSIONS. APACH II predicted mortality of non-nosocomial
pneumonia patients requiring ICU admission better than PSI and
CURB-65 do.
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OBJECTIVES. This research studied the importance as an indicator of
hypocalcaemia in model of extensive burn patients which the
capillary leakage occurred then calcium banded with albumin can
leak to interstitial space. Then we try to find an pritical tool to
evaluation the severity of leakage of capillary in critical ill.
METHODS. This is a retrospective study to study the influence factor
resulted in hypocalcaemia in extensive patients in initial phase post-
burn when the capillary bed emerged a typical leakage situation. The
patients enrolled in this study should have a Burn Surface area was
larger than 50%TBSA, time of admission < 24 hrs post-burn injury
and the age of the patients were older than eighteen years old. We
applied Chinese fluid resuscitation formula continuous infused fluid
contained colloidal solution in initial phase post-extensive burn.
RESULTS. A total 142 cases treated in our burn center from January
2010 to July 2015 enrolled.
The average initial calcium of all studying case was 1.87 ± 0.20mmol/
l (normal value ranged from 2.25 to 2.75). 97.2%extensive burn
patients in our center suffered from hypocalcaemia and 36.6% of
them were severe hypocalcaemia (lower than 1.8 or 1.75). From
dynamic tendency of calcium of this study we could find: average
calcium decreased in first three days then rebounded steady. The
calcium change in survival group was similar to the overall
performance. But the calcium in no-survival group decreased sharply.
The lowest level in this group could be found in second day post-
burn with respect to lowest level was three in survival group. In
rebounding phase in no-survival group, we could find a twisted
curve, up and down. Firstly we found the calcium between survival
and no-survival group are significant different. But we did not found
the difference in kaplan-meier survival curves between two groups.
The factors influence the mortality is not calcium, but the age of the
patients, the area of full-thickness burn wound and inhalation injury.
Then we found: total burn area, full-thickness burn area and length
of time from injury to admission are the risk factors result in severe
hypocalcaemia. Then we compared pH value in different group of
total burn area, full-thickness burn area and length of time from in-
jury to admission. We found: in groups of larger total burn area, lar-
ger full-thickness burn area and longer length of admission groups,
the initial pHs are lower than the control groups. In this study, we
found that serum albumin level in larger total burn area, larger full-
thickness burn area and longer length of admission groups are lower
than in control groups.
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 390 of 542As a result, the group of patients in severe hypocalcaemia had high
incidence of morbidity of longer mechanical ventilation and stay in
ICU.
CONCLUSIONS. Calcium level could be applied as a tool to evaluate
the severity of leakage of capillary in critical patients.
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INTRODUCTION. Severity scoring systems are increasingly used for
benchmarking in intensive care unit (ICU). Acute physiology and
chronic health evaluation (APAHCE) scoring system and simplified
acute physiology score (SAPS) are two famous systems used for
benchmarking. Both APACHE and SAPS scores are calculated from
first admission day data; thus, we hypothesized that the accuracy of
these scores for mortality prediction would be lower in patients with
longer length of stay (LOS).
OBJECTIVES. To evaluate the accuracy of APACHE II, APACHE IV, and
SAPS scoring systems in patients with different categories of LOS.
METHODS. A retrospective study was conducted in surgical and
trauma ICU at Cairo university hospitals including patients admitted
from June 2013 till December 2016. Patients were divided into three
groups: Two-day-stay group (LOS ≤ 2 days), Five-day-stay group
(LOS ≤ 5 days), and Long-stay-group (LOS > 5 days). Receiver operat-
ing characteristic (ROC) curves were constructed for APACHE II, APA-
CHE IV, and SAPS II scores as mortality predictors in the three
groups.
RESULTS. The data of 1812 patients was available for analysis.
Median length of stay was 5 days with interquartile range of (2–10)
days. The incidence of mortality was 47% (860 patients). Five-day-
stay group included 1028(57%) patients; whereas Two-day-stay
group included 308 (17%) patients and long-stay-group included
476(26%) patients. Area under ROC (AUROC) curve for APACHE IV,
APACHE II, and SAPS II scores as mortality predictors was highest in
Two-day-stay group {0.883(0.854-0.911), 0.877(0.848-0.906), and
0.870(0.839-0.900)} followed by Five-day-stay group {0.745(0.702-
0.787), 0.747(0.704-0.790), and 0.716(0.670-0.761)}, then Long-stay-
group {0.637(0.598-0.676), 0.614(0.575-0.653), and 0.603(0.563-0.642)}
(P value < 0.001).
CONCLUSIONS. Validity of Scoring systems decreases with longer
LOS. We recommend further adjustment for these scoring systems
according to LOS.
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OBJECTIVE. There are different diagnostic scores for assessing graft
dysfunction (GD) after liver transplantation. We want to determine if
there are differences between scores to assess liver GD and their
ability to predict prognosis and mortality.
METHODS. Prospective cohort of patients who received liver
transplant (LT) performed over the period 2009–2014, follow up until
the end of 2016. We compared classic criteria (CC) of GD against
Makowska (MK), Ardite (Ar) Nanashima (Nn), Dhillon (Gh) and MEAF.We analyzed hospital stay and mortality. Data: mean (mean error)
and median (quartiles). Non-parametric tests: Chi-square, Kappa and
Log-Rank for p < 0.05. Approved by Ethical committee.
RESULTS. N = 253. 76.3% male. Mean age 54.7 years. Ethanol
etiology 45.8%, Mean MELD 16.36 (0.43), SOFA on admission 6.53
(0.19). Median days in ICU 3 (3–5) and in hospital 8 (6–13). ICU
mortality 4.7%, in Ward 2.8% and at discharge 22.1%.
Severe GD was detected in 13.8% with CC, Dh 30.8%, Nn 20.6%
MEAF 13.4%, MK 6.3% and Ar 0.7% and concordance with CC was
low; Kappa for Ar 0.49 (0.47-0.50), Nn 0.55 (0.39-0.68), Mk 0.46 (0.29-
0.64), GDh 0.44 (0, 32–0.56) and MEAF 0.41 (0.250-0.58).
Logistic regression showed that ICU stay and mortality was
related with CC (OR 5.85 (4.47-56.18), MEAF (OR 11.09 (3.29-
37.41), AR (OR 7.11 (2, 08–24.29), Nn (OR 8.96 (2.58-31.07), Mk
(OR 9.54 (2.51-36.19) and Gh (OR 4.88 (1.43-16, 75), but after ICU
discharge only MEAF was related to hospital mortality. Regarding
survival, only CC (p 0.034) and MEAF (p 0.006) showed significant
relationship.
CONCLUSIONS. Although all dysfunction scores had a goog relation
with hospital mortality and therefore apparently assessed well GD,
the MEAF showed the closest relationship and was related to the
long-term prognosis, so its use may have an advantage over the
others diagnostic scores.0769
Usefulness of quick sepsis-related organ failure assesment to
predict severity in influenza A H1N1v pneumonia patients
A. Estella1, F. Valenzuela1, M. Recuerda1, J.F. Rodriguez Gutierrez2, L. Perez
Fontaiña1
1Hospital SAS Jerez, Unidad de Gestión Clínica de Medicina Intensiva
Hospital del SAS de Jerez, Jerez, Spain; 2Hospital SAS Jerez, Unidad de
Gestión Clínica de Hematología Hospital del SAS de Jerez, Jerez, Spain
Correspondence: A. Estella
Intensive Care Medicine Experimental 2017, 5(Suppl 2):0769
INTRODUCTION. In 2016 has been published quick Sepsis-related
Organ Failure (qSOFA) like a new screening system for detection of
septic patients with suspected infection outside ICU. Usefulness of
this score may be to identify bedside patients and rapidly life-
threatening patients.
OBJECTIVES. The aim of the present study is to analyze the
usefulness of the application of qSOFA outside the ICU in the
estimation of the risk of patients with Influenza A H1 N1 v
pneumonia.
METHODS. Retrospective study performed in a 17-bed ICU. Inclu-
sion criteria were patients admitted in emergency department with
a microbiological confirmed pneumonia caused by Influenza A H1
N1 v. The qSOFA scale was by a retrospective analyses of clinical
data at admission in the emergency room department. We ana-
lyzed clinical features, destination: ICU versus hospitalization wards
and mortality. Statistical analysis was performed using SPSS, v.18
program.
RESULTS. 24 patients were included, five patients were admitted
in medical wards and 19 in ICU requiring mechanical ventilation
most of them (78.9%). Mortality was 21.1%. Only 10.5% of
patients admitted to the ICU had a qSOFA with a score of 2.
57.9% had qSOFA scores of 1 and 31.6% of 0. Tachypnea of
more than 22 breaths per minute was the most common clinical
sign in the group of patients admitted in ICU, 68.42%. Majority of
patients admitted in medical wards (80%) obtained a qSOFA
score of 0, 20% had a qSOFA of 1. Only a 50% of died patients
had a qSOFA score of 2 points, the remaining deceased patients
obtained a qSOFA score of 0 points.
CONCLUSIONS. Use of qSOFA score in the emergency department
may underestimate the risk of patients with influenza A H1N1 v
pneumonia.
Tachypnea was the most altered qSOFA score parameter in severe
patients with Influenza A pneumonia H1 N1 v.
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INTRODUCTION. A persistently high veno-arterial carbon dioxide
(ΔPCO2) difference is related to dysoxia and increased multiple organ
dysfunction in patients with septic shock, variations in ΔPCO2 have
shown an independent behavior from macrocirculation variables or
from products of oxygen metabolism, turning ΔPCO2 into a marker
that identifies patients at high risk of death in septic shock. Although
there are predictors of mortality such as SOFA, SAPS II, APACHE II
and MPM II, which provide important information on severity but re-
quire multiple data (demographic, clinical and biochemical) to be
calculated.
OBJECTIVES. To demonstrate that ΔPCO2 is a better predictor of
mortality in patients with septic shock compared to APACHE II, SOFA,
SAPS II, MPM II.
METHODS. We performed an observational, retrospective study of
patients who were hospitalized in the Emergency Department of a
tertiary level hospitalin México City during the first 10 months of
2014, with diagnosis of septic shock.
RESULTS. We reviewed 47 files, the highest mortality occurred in
males (53.2%) from 49 to 58 years. The most frequent diagnosis was
pulmonary sepsis (23.4%). The positive predictive value (PPV) for
ΔPCO2 was 87%, with a specificity of 80%, only overcome by
APACHE II and MPMII, however, there was no statistically significant
difference between the use of both scales to predict mortality with
respect to ΔPCO2 p = 0.052 and p = 0.56 respectively. A p = 0.006
was observed in the medians test for the ΔPCO2 and MPM II scales.
Sensitivity, sp...
Kruskal-Wallis test for analysis of several scales comparing ΔPCO2
with APACHE II, shows no statistically significant (p = 0.052), with
SAPS II (p = 0.70), as did SOFA (p = 0.030), and MPMII (p = 0.56).
When performing the concordance analysis between each scale and
mortality, we found that by means of Kendall´s Tau-b for ΔPCO2
there is a significant association (p = 0.009), APACHE II (p = 0.001),
SAPSII (p = 0.02) and SOFA (p = 0.019).Scale Sensitivity Specificity Positive predictive
valueNegative predictive
valueΔPCO2 62 80 87 50APACHE
II50 86 88 44SOFA 53 80 85 44SAPS II 50 80 84 42MPM II 71 86 92 59[Sensitivity, specificity and predictive values]
CONCLUSIONS. The venous ΔPCO2 only obtained a better PPV
compared to SOFA and SAPS II, while it behaved similarly with
APACHEII and MPMII; Exceeded all scales with 92% of PPV for
mortality
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INTRODUCTION. Acute myocardial infarction is one of the leading
causes of death worldwide despite advances in revascularization and
medications. Therefore, assessing the risk factors of outcomes after
AMI remains an important research topic. HCV infection was
hypothesized as a contributing risk factor of endothelial dysfunction,
atherosclerosis,1
and CAD,2 with the association in between remains controversial.3
OBJECTIVES. The present study aimed to analyze the impact of HCV
infection on 12-year mortality after AMI using Taiwan National Health
Insurance Research Database (NHIRD).
METHODS. Approximately 23,000,000 cases diagnosed with AMI
between January 2000 and December 2012 were identified from the
NHIRD and finally leaves 186,112 cases by exclusion criteria.
Then 4,659 with HCV infection without interferon therapy were
enrolled and further divided into those with liver cirrhosis (n = 107)
and those without (n = 4,552). Propensity score-matching technique
was applied by one-to-one matching using the background variables.
The data from 4,552 AMI patients with HCV infection but without
liver cirrhosis and 4,552 matched controls were included in our final
analysis. For the outcome analysis, survival was defined as the time
interval from the hospital admission date to the NHI coverage end
date.4. RESULTSThe 12-year mortality rate was significantly higher in
AMI patients with HCV and cirrhosis than HCV without cirrhosis or
controls (P < .0001). The patients with HCV without cirrhosis had sig-
nificantly higher long-term mortality rates than the matched controls
(P < .0001).
The hazard ratio (HR) for mortality was higher in patients with HCV
without cirrhosis (HR: 1.09; 95% CI: 1.04-1.15) and those with HCV
and cirrhosis (HR: 2.23; 95% CI: 1.82-2.73). HCV influenced outcomes
among the subgroups of whom were male (HR: 1.06), were younger
(HR: 1.27), had hypertension (HR: 1.10), had dyslipidemia (HR: 1.19),
or received percutaneous coronary intervention (HR: 1.20)
CONCLUSIONS. HCV infection was demonstrated to influence the 12-
year mortality of patients after AMI in this study. Additionally, the
mortality rate was higher among the patients with HCV and liver cir-
rhosis, and also long-term outcomes in patients after AMI among the
subgroups of male patients; younger patients; those with hyperten-
sion; those with dyslipidemia; and those who underwent PCI.
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INTRODUCTION. Traumatic brain injury (TBI) is a leading cause of
death and disability in the developing world. Guidelines-based
management is limited in low-middle income countries by resource
availability, utilization and cost1. Computed tomography (CT) is par-
ticularly expensive, not consistently available, yet forms the core of
surgical management of severe TBI patients. There is a lack of data
on the pattern of utilization of CT in TBI patients in resource-limited
settings in East Africa,2 while in other developing countries it is sig-
nificantly inderutilized3. Therefore, an impact assessment of CT use in
the management of severe TBI patients is necessary to develop cul-
turally competent evidence-based protocols.
OBJECTIVES. We evaluated the utilization of CT scan in the
management of severe TBI and its impact on surgical treatment and
2-week patient mortality at a tertiary care referral hospital in Dar-es-
Salaam, Tanzania.
METHODS. This is a retrospective analysis of prospectively collected
data of all severe TBI patients admitted to Muhimbili Orthopaedic
Institute, Dar-es-Salaam, Tanzania, 2014–2017. The Brain Trauma
Foundation TBI-trac® database was implemented locally and utilized
for this project. Epidemiological and treatment data was exported in
an anonymized manner and analyzed.
RESULTS. 253 patients with severe TBI were enrolled. Average age
was 33.65years, 87% were male, median initial GCS was 7, and
overall mortality was 56.1%. From the 44.7% patients who had at
least one brain CT scan: 92% had post-traumatic abnormalities,
Fig. 262 (Abstract 0773). Global cortical CBF at day 4–7 and 8–12
after SAH
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patients who had a post-traumatic abnormality on CT, 36.6% were
operated and 51.4% died. From the group of patients who did not
undergo a CT scan on admission, only 12.2% underwent surgery and
66% died.
CONCLUSIONS. The majority of patients did not undergo brain CT
after severe TBI at our tertiary care hospital with a high overall 2-
week mortality. Patients who underwent a cranial CT had a higher
surgical rate and lower mortality than patients that did not have a
CT on admission. The surgical mortality of severe TBI patients, with
or without an admission CT is still high.. We are currently exploring
obstacles in routinely obtaining CT, and factors determining CT-
based surgical intervention in these patients in order to help develop
an evidence-based approach to lowering mortality after severe TBI.
REFERENCE(S)
1. Ohaegbulam et al. Surg Neurol Int 2011; 2:182
2. Ogbaide E, et al. Sahl Med J 2015;18:27–30
3. Harris OA et al. J Neurosurg 2008; 109:433–38.
0773
Cerebral blood flow dynamics during the acute course after severe
subarachnoid hemorrhage studied by bedside Xenon-enhanced CT
H. Engquist1,2, E. Rostami1, P. Enblad1
1Uppsala University, Neuroscience, Neurosurgery, Uppsala, Sweden;
2Uppsala University, Surgical Sciences, Anesthesia and Intensive Care,
Uppsala, Sweden
Correspondence: H. Engquist
Intensive Care Medicine Experimental 2017, 5(Suppl 2):0773
INTRODUCTION. The dynamics of cerebral blood flow (CBF) disturbances
after subarachnoid hemorrhage (SAH) and the relation to delayed
cerebral ischemia (DCI) remains poorly elucidated.
OBJECTIVES. The aim of the present study was to assess global and
regional CBF in different phases of the acute course after severe SAH,
hypothesizing that CBF disturbances are more pronounced at day 4–
7 compared to day 0–3 and that there is a gradual restitution of CBF
at day 8–12. The influence of HHH-therapy on CBF in patients with
DCI was also addressed.
METHODS. Patients diagnosed with SAH and requiring mechanical
ventilation due to their neurological state were prospectively
enrolled in the study. Bedside measurements of regional CBF were
scheduled for day 0–3, 4–7 and 8–12, using Xenon-enhanced CT
(XeCT). Patients with clinical suspicion of DCI receiving HHH-therapy
during their course after SAH were grouped accordingly to allow
analysis of the influence of DCI and HHH on CBF. Regional CBF was
characterized by the proportion of area with local blood flow below
specified thresholds and by blood flow in the worst vascular territory
in each patient.
RESULTS. During 2013–2016, a total of 216 valid XeCT-measurements
were performed in 119 SAH-patients. Fifty patients had measurements
at both baseline (day 0–3) and day 4–7; in non-DCI patients (n = 36)
global cortical CBF decreased from 33.7 (IQR 27.5-45.4) to 31.7 (IQR
25.3-38.3) ml/100g/min (*P = 0.028), whereas DCI-patients receiving
HHH-therapy (n = 14) showed an increase from 31.9 (IQR 23.0-35.0) to
38.8 (IQR 28.4-42.6) ml/100g/min (*P = 0.009). Regional CBF in the worst
vascular territory followed a similar pattern for the respective groups.
Thirty-three patients had measurements at baseline and day 8–12;
no statistically significant differences in CBF-parameters compared
to baseline could be observed in neither non-DCI patients nor DCI
patients receiving HHH in this late phase.
CONCLUSIONS. Our study revealed different patterns in CBF-
dynamics of poor grade SAH patients depending on the occur-
rence of DCI and subsequent HHH-therapy. In non-DCI patients
there was a decrease in CBF at day 4–7 compared to baseline,
whereas CBF increased significantly from a lower baseline level in
DCI patients receiving HHH-therapy. At day 8–12 no significant
differences in CBF parameters compared to baseline were found
in either of the groups.0774
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INTRODUCTION. Ischemic Stroke is the leading cause of death
amongst Portuguese Population. The existent pre Hospital triage and
quick reference to a Stroke Unit, allied to the early recognition of
acute neurological signs has contributed to the increasing numbers
of effective fibrinolysis in Acute Ischemic Stroke Patients, decreasing
morbidity and mortality. However, there are no studies evaluating
late outcomes of this population after treatment.
OBJECTIVES. The objective of the study is to evaluate mortality and
its cause of patients at 3 months, 6 months and 12 months after
treatment with Intravenous Fibrinolysis with Alteplase at the
researchers' Intensive Care Unit and characterize this population.
METHODS. Observational retrospective study based on information
retrieved from the Clinical Records of patients admitted in the
Intensive Care Unit for Intravenous Fibrinolysis between the 1st of
January 2010 and 31st of December 2015, and its statistical analysis.
RESULTS. Among the total of patients included (n = 102), 63% were
male with an average of 70 years old. The average admission
National Institutes of Health Stroke Scale (NIHSS) score was 14 and
the average Symptoms-to-Needle time was 156 minutes. There were
a total of 23 deaths occurring in the first 3 months after treatment.
Of these, 4 were due to Intraparenchymal Hemorrhage after Fibrin-
olysis, 7 to ineffectiveness of Thrombolythic treatment, 10 to Aspir-
ation Pneumonia, 1 to Septic Shock, and 1 patient died at home,
with no reference to cause of death on Clinical Records. Between 3
months and 6 months occured two deaths, caused by Septic Shock
in patients with established Limitation of Treatment. Between 6 and
12 months there were no registered deaths.
CONCLUSIONS. With the State of The Art Organization and
Protocols, Mortality due to to Ischemic Stroke has reduced. The vast
majority of deaths occurred in the first 3 months after treatment.
Patients who died within 3 months had an average NIHSS stroke of
20 at 12 hours after Fibrinolysis, similar to those who died between 3
and 6 months. Patients who survived the first 12 months, had a
lower NIHSS score at 12 hours (7). Although Intraparenchymal
Hemorrhage and unresponsiveness to treatment are unavoidable,
causes such as Aspiration Pneumonia, which occurred after hospital
Table 195 (Abstract 0775). See text for description
Table 194 (Abstract 0775). See text for description
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of post-Hospital care in order to help patients recover after stroke
and minimize complications which may worsen their condition and
lead to death, especially in the first trimester. This would preferably
be done by multidisciplinary teams involving Neurology, Internal
Medicine and Physiotherapy support and adequate infrastructures
and response time.
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INTRODUCTION. Although intravenous thrombolysis (IVT) remains
the standard of care in acute ischemic stroke (AIS), in selected
patients, endovascular therapies (ET) can improve recanalization
and functional outcomes. Because both treatments are limited by
a narrow window of time, stroke systems of care (SSC) are
necessary. In 2013 a SSC was implemented in Madrid and
Hospital Universitario Puerta de Hierro de Majadahonda (HUPH)
became a primary stroke center of care, patients were admitted
to the ICU for initial management.
OBJECTIVE. To analyze patients admitted in our ICU with the
diagnosis of AIS and their evolution since the implementation of
the SSC.
METHODS. Descriptive and retrospective study (October 2013-
September 2016). Patients admitted to ICU with an AIS diagnosis
who received treatment with IVT and/or ET were studied. Demo-
graphic data, severity scores [APACHE II and baseline and at ICU dis-
charge NIHHS (National Institute of Health Stroke Scale)], vascular
territory involved, arrival from other hospitals, timelines, ICU compli-
cations, ICU and hospital stays and mortalities, destination upon dis-
charge, and overall three months mortality were recorded. Statistical
analysis: STATA (v. 14.2).
RESULTS. 171 patients were treated for IAS in the period studied: 54
(31.6%) received treatment with IVT and 117 (68.4%) with ET. Table
194 describes the main characteristics of AIS patients. 74 (43.3%)
patients came from other hospitals (5 in the ITV group and 69 in the
ET group). AIS location, treatment received and timelines are on
Table 195.
ICU complications involved 39 patients (23%), being the most
common: infections and neurological. Median ICU length of stay was
1 day (1–2) and 9 days (4–13) in-hospital, with a mortality of 13
(7.6%) and 20 (11.7%), respectively. The patients were discharged:
home 67 (39.2%), referal hospital 63 (36.8%) and chronic facilities 21
(12.3%). Overall three months mortality was 25 (14.6%).
CONCLUSIONS. Acute ischemic stroke was a common disease that
concerned slightly more to males, usually with more than one
comorbidity. Patients had a short ICU stay with low mortality and
complications. In general, patients experienced a neurological
improvement upon discharge from the ICU and most of them were
discharged to home or referal hospital but some needed longer
stays in chronic facilities.
In our experience, implementation of a stroke system of care is
feasible. Nevertheless, coordination between different hospitals and
healthcare networks and also primary stroke centers with
endovascular experience are required to achieve good outcomes. It
would be desireable to find new strategies to shorten times.0776
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associated with increased morbidity and mortality.
OBJECTIVES. The aim of this study was to describe the clinical
characteristics of patients requiring placement of an external
ventricular drain admitted to a third-level hospital, and to identificate
risk factors for acquiring EVDI.
METHODS. A retrospective cohort study was performed from
January 2015 to December 2016, which included 100 patients
admitted to a third-level hospital in Barcelona, Spain. Patients in-
cluded were those who required insertion of an external ventricular
drain catheter (EVDC). EVDI was defined as a positive culture of cere-
brospinal fluid with biochemical and cytology abnormalities. Clinical
and laboratory data were registered. Follow-up was conducted until
hospital discharge. We assessed short-term outcomes as well.
RESULTS. A total of 100 patients required EVDC placement during
study period. Mean age of the sample was 53 years ± 14; 58% of
patients were women. Admission diagnosis was subarachnoid
hemorrhage in 43% of patients. The main EVDC placement
indications were obstructive hydrocephaly (58%) and intraventricular
hemorrhage (29%). Median duration of EVDC placement was 8.5 (4–
14) days. Median of Glasgow Coma Scale (GCS) was 14 (9–15) and 10
(7–14) days at hospital and critical care unit (CCU) admission,
respectively. Overall in-hospital mortality was 24%, being the admis-
sion diagnosis the most frequent cause of death. A total of 17 pa-
tients (17%) presented EVDI. The most frequent microbiological
isolations were: Enterobacter spp., Staphyloccoccus epidermidis and
Pseudomonas aeruginosa (23.52%, 17% and 17%, respectively). Pa-
tients who acquired an EVDI had a higher CCU and hospital length-
of-stay (LOS) than non-infected EVDC patients [25 (10–44) vs 6 (1–21)
days, p = 0.001; and [55 (38–98) vs 31 (16–58), p = 0.006, respect-
ively]. A bivariate analysis was performed to analyze risk factors asso-
ciated with EVDI. Previous craniotomy and EDVC-related
complications (EVDC misplacement and the presence of intracranial
hematoma located in EVDC path) were factors significantly associ-
ated with EVDI.
CONCLUSIONS. EVDI are a frequent entity in neurocritical care
patients. Main factors associated with acquisition of an EVDI are
previous craniotomy, EVDC misplacement and the presence of
intracranial hematoma located in EVDC path. CCU and hospital LOS
of EVDI patients were significantly higher than patients without EVDI.
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INTRODUCTION. Postoperative delirium (PD) is one of the most
common complications following surgery with a reported incidence
ranging from 10-70% depending on the type of surgery. One pos-
sible area of intervention to prevent postoperative delirium (PD) is
postoperative blood pressure management. However, the relation-
ship between postoperative blood pressure and PD is unclear.
OBJECTIVES. The goal of this study was to test the hypothesis that
postoperative fluctuations in blood pressure increased the occurrence
of postoperative delirium in patients undergoing neurosurgery.METHODS. Study subjects were undergoing neurosurgery, who were
enrolled in an ongoing prospective observational study of the
pathophysiology of postoperative delirium. Postoperative blood
pressure was measured and predefined criteria were used to define
hypotension. Delirium was measured by the Confusion Assessment
Method on the first two postoperative days.
Fluctuation in a patient's blood pressure was quantified by
calculating the variance of the patient's blood pressure record during
ICU. Variance is a measure of the data spread. Blood pressure
fluctuation was calculated according to the formula: variance = (åni=1
(xi - xm)
2/n - 1, where xi is a patient's blood pressure at a particular
time point, xm is the mean of the patient's blood pressure, and n is
the number of blood pressure measurements.
Patients were categorized based on whether they developed PD. We
analysed continuous data that were normally distributed by
Student's t-test and continuous data that were not normally distrib-
uted by Mann–Whitney analysis. The analysis of normal distribution
was performed by the Kolmogorov-Smirnov test. Dichotomous data
were compared with the Fisher exact test. We used backwards step-
wise multivariate logistic regression by including those univariate
variables that differed between patients with and without PD, with a
P-value of < 0.1.
RESULTS. PD was observed in 45 (9.2%) patients. Mechanical
ventilation for < 48 h [odds ratio (OR), 3.94; 95% confidence interval
(CI), 1.72-9.03], postoperative blood pressure variance (OR, 3.0; 95%
CI, 1.29-6.96), prior stroke (OR, 2.79; 95% CI, 1.12-6.96), and age (per
year of age; OR, 1.01; 95% CI,1.01-1.07) were independently
associated with PD.
It´s the first study that found that increased fluctuations in blood
pressure in neurosurgical patients to be predictive of PD.
CONCLUSIONS. Postoperative fluctuations in blood pressure
increased the occurrence of PD in patients undergoing neurosurgery.
Maintaining blood pressure at a stable level, based on preoperative
values, appears to help preventing PD.
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INTRODUCTION. Diffuse axonal injury (DAI) constitutes a pathology
with a low incidence, but with catastrophic results for the patient
and society. There are very few studies in the literature that review
its epidemiology and the prognosis of these patients.
OBJECTIVES. To analyze the clinical characteristics of patients with
TBI and DAI confirmed in MRI, as well as their prognosis and
functional assessment in the short and medium term.
METHODS. Retrospective, descriptive study of patients suffering from
TBI, admitted in ICU, over a four-year period (November 2011-
November 2015).
RESULTS. A total of 257 patients were included, 176 men (68.5%)
and 81 women (31.5%). Of these, 108 were mild TBIs (42%), 56
moderate (21.8%) and 93 severe (36.2%). The most frequent
mechanism was accidental falls (36.6%) followed by motorcycle
traffic injury (16%).
DAI was suspected with the initial CT in 21 cases, rising to 26 in
patients admitted with poor neurological evolution, although it could
be only confirmed by MRI in 13 of them (5.1%). The majority were
severe, grade III (61.5%). As in the global TBI, it was more frequent in
men (69.2%), although the mean age was lower (42.3 +/− 21.8 years)
and secondary to high energy injuries, mainly car crashes (30.8%).
Length of stay in ICU (28.3 +/− 22.2 days) and total hospital
admission (52.7 +/− 43.5 days) were also longer.
In 76.9% of the cases were severe TBI (10 patients), and were
classified radiologically on a Marshal Scale of 2 (53.8%). The overall
mortality with TBI was 28.1%, according to the APACHE II score at
admission (mean 15.6 +/− 8.5). However, mortality in the subgroup
Table 196 (Abstract 0779). See text for description
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radiological confirmation of the lesion, probably due to a selection
bias, failing to consider those patients in whom If there was an initial
suspicion and no MRI was performed (12 patients), which had a
mortality rate of 66.7%.
DAI was associated with a poor functional prognosis (assessed
according to the GOS scale) at medium (6 months) and long term
(more than 1 year), GOS ≤ 3 in 53.8% and 50% of cases respectively,
with significant statistic association regarding the global of traumatic
brain injuries, which is also corroborated in a longer stay in ICU and
hospitalization.
CONCLUSIONS. DAI is still a challenge from a diagnostic and
therapeutic point of view within patients suffering from TBI, with a
significant functional repercussion for the patient, severe deficits and
major dependence in many cases, as well as important costs for the
health system, due to prolonged stays in intensive care and hospital
units, as we demonstrated in our series.
Although the mortality observed in these patients is low, we believe
that it may be explained by the underdiagnosis of LAD, either
because of a low suspicion in the context of TBI, or because of the
initial severity of the lesion and the short-term poor prognosis that
prevents radiological confirmation in many cases.
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INTRODUCTION. The absence of clinical manifestations of non-
convulsive status epilepticus (NCSE) makes it a challenging diagnosis
amongst ICU comatose patients. For this reason NCSE is frequently
poorly recognised and subsequently an under treated cause of per-
sistent altered mental status in the ICU, which can lead to long-term
impairment.
OBJECTIVES. To describe our experience in the recognition of NCSE
together with risk factors associated to its appearance, treatment
strategies used and evolution of this group of patients.
METHODS. Retrospective and observational study (Jan 2012 - Dec
2016) carried out in the medical ICU of a Spanish tertiary university
hospital. We reviewed every EEG performed in our ICU in the period
studied. Patients with anoxic encephalopathy following cardiac arrest
were excluded.
RESULTS. During the period studied 310 patients underwent EEG
monitoring, and 10 NCSE were identified, six of them during the last
twelve months. Demographic data are described in Table 196.
All of our patients had at least one risk factor for developing NCSE.
In six of them reason for ICU admission was a central nervous system
insult and other two had suffered a previous brain injury. Upon the
time of NCSE diagnosis five were being treated with beta-lactam an-
tibiotics and three had metabolic disturbances.
Regarding NCSE treatment, the initial antiepileptic drug (AED) of
choice for all patients was levetiracetam. Seven of them required the
addition of a second AED for seizure control: lacosamide (5) and
continuous intravenous (CIV) valproate (2). Three patients had
refractory status epilepticus in spite of the use of two AED so they
also received treatment with phenytoin (1), IV clonazepam (1) or CIV
valproate (1). Until control with AED of NCSE was assured all patients
were treated with concomitant intravenous anesthetic drugs [IAVD:
propofol + remifentanil (9) or propofol + remifentanil + midazolam
(1)] between EEGs.
Mean time from diagnose to complete seizure control without IVAD
was 4 ± 2 days. The fact that EEG registration is only available during
working hours (8 am to 3 pm; Monday to Friday) should be takeninto account. Two of our patients had a relapse during AED tapering.
In two cases, limitation of life sustaining treatment was decided
before resolution of NCSE.
In terms of prognosis, four patients died in the ICU and two more
within the next sixty days after ICU discharge.
CONCLUSIONS. Physicians in our ICU are starting to think more about
the possibility of underlying NCSE as a cause of unexplained coma.
The appearance of NCSE in our series was related with the presence
of at least one risk factor.
In our study treatment of NCSE was challenging and most patients
required at least two AED.
EEG follow-up is crucial to determine treatment success.
NCSE patients had a high ICU and short-term mortality.0780
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INTRODUCTION. To analyze our experience in the management of
patients admitted to our Unit (medical ICU- tertiary university
hospital) with the diagnosis of epileptic seizures and/or epilepsy in a
six-year period (2010–2015).
METHODS. Descriptive and retrospective study, carried out during a
six-year period, of patients admitted to our Unit with the diagnosis
of epileptic seizures and/or epilepsy, according to criteria for inclu-
sion in Minimum Basic Data Set (MBDS). The following parameters
were recorded: age, gender, source of admission to the ICU, past
medical history, reason for admission, classification, diagnostic
methods, monitoring, antiepileptic drugs (AEDs) and control of sta-
tus, Patients with epileptic seizures after anoxic enchepalopathy were
excluded. Statistical analysis: quantitative variables are expressed as
the mean and standard deviation (SD), and qualitative variables as a
percentage. The difference between qualitative variables are expressed
using chi-square test and quantitative using an ANOVA analysis.
Table 197 (Abstract 0781). Patient characteristics
Variable Hospital 1 N= 914 Hospital 2 N=1020
Age in years, mean (SD) 63 (14) 58 (16)
Male, N (%) 608 (67) 628 (62)
Admission type, N (%) Surgical - Medical
- Trauma - Neurological/-surgical
665 (73) - 131 (14)
- 41 (5) - 77 (8)
503 (49) - 339 (33)
- 0 (0) - 178 (18)
Acute admission, N (%) 388 (43) 689 (68)
APACHE II score, mean (SD) 14 (5) 18 (7)
APACHE IV score, mean (SD) 52 (20) 62 (26)
CAM-ICU positive, N (%) 171 (19) 428 (49)
ICU Length of stay in days, median [IQR] 1 [1-2] 5 [3-9]
Complete 25-item CFQ, N (%) 819 (90) 918 (90)
Fig. 263 (Abstract 0781). Bland Altman plot of the 25-item
CFQ and
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years old, source of ICU admission: emergency 16 patients,
neurology 18, other departments 4 and another hospital 13. Past
medical history: epilepsy 17, CTE 7, alcoholism 8, psychiatric
pathology 6. Diagnosis: structural pathology 10, epilepsy 16 (de novo
2, recurrence 14), CTE 5, toxic-alcoholism 6, infection 5, limbic en-
cephalitis 4, metabolic 3 and prion disease 2. Diagnostic methods:
EEG 100%, bispectral index (BIS) unilateral 72,5% y bilateral 27,5%,
head CT scan 100% (with contrast 66,7%, without 33,3%), brain MRI
35%, others 9%. EEG recorded. < 4 : 35%, 4–6: 12% and >6: 12%. EEG
pattern: spike-and-wave:59%, polispikes:42%, mixed: 35%, others: 9%.
AEDs (second line) used: phenytoin 82%, valproic 64%, levetiracetam
34%, lacosamide 18%, combination (<2 AEDs):48%, and combination
(>3 AEDs:) 35%; AEDs (third line): midazolam (MDZ) 82%, propofol
(PF) 18%, MDZ + PF 64%, phenobarbital 19%; AEDs (fourth line): cor-
ticosteroids 6%, immunoglobulins 9%, plasmapheresis 6%. control of
status epilepticus: established (>24hours):16%, refractory(24-
72hours):23%, super refractory (>72hours):12%.
CONCLUSIONS. In our series (data collected according to MBDS) 47%
of the patients admitted to our Unit with the diagnosis of epileptic
seizures and/or epilepsy needed treatment for status, being the most
common causes: relapse of known epilepsy and cerebrovascular
disease respectively. The most frequent EEG pattern was spike-and-
wave (59%) with a mean number of EEG recorded of 4–6 in 53% of
the cases. In terms of AEDs (second line) used, pheniytoin and val-
proic were administered in 88 and 69% of the cases compared with
AEDs (third line) used MDZ and PF in 84% and 49% of the cases
respectively.
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INTRODUCTION. Intensive Care Unit (ICU) survivors often develop
physical, mental, and cognitive impairments following ICU discharge
described as Post Intensive Care Syndrome (PICS). In particular long-
term cognitive impairment is a growing public health problem, as it
occurs in up to 62% of the ICU survivors. Despite its frequent occur-
rence, post-ICU cognitive impairment remains inadequately charac-
terized. Post-ICU cognitive impairment leads to everyday cognitive
failures that negatively influence daily routine and HRQOL. The Cog-
nitive Failures Questionnaire (CFQ) is the most widely used and
broadest measure in terms of covered domains of failures. Although
the CFQ is used in previous research to measure cognitive function-
ing in ICU survivors, this questionnaire has never been validated for
that purpose. Given the multifaceted nature of PICS and the de-
creased capacity of ICU patients, developing and validating an opti-
mal short form of the CFQ for ICU patients is desirable.
OBJECTIVES. To develop and validate a shortened version of the self
evaluating CFQ to measure cognitive failure in ICU patients.
METHODS. A multicenter cohort study in two Dutch academic
hospitals. Exclusion criteria were: admitted to the ICU for < 1 day; no
delirium assessment during ICU stay; and an incomplete CFQ.
Between 12 and 24 months after ICU discharge, patients' cognitivefunctioning was evaluated using the CFQ. Forward selection in a
linear regression model was used in the first hospital to assess which
of the 25 CFQ items could be omitted without loss of correlation.
Selection criteria: a minimal number of CFQ items with a maximum R
Square and a proportional coverage of the items on the dimension
structure memory, distractibility, social blunders, and names. The
performance of the shortened CFQ was determined in the second
hospital using Pearson's correlation. A Bland Altman plot was used to
examine whether the reduced-item outcome scores, the predicted
scores, of the CFQ were replaceable for the 25-item CFQ outcome
scores.
RESULTS. In total 1759 patients were included, 914 in hospital one
and 1020 in hospital two (Table 197). The selection criteria were most
optimal for the model with 14 CFQ items. The R Square of this model
was 0.973, with a correlation of 0.987. This 14-item CFQ score predicted
cognitive failure with a Pearson's correlation of 0.986 (p < 0.0001). The
mean (SD) of the difference scores was −0.26 (2.675) and 95% of the
difference scores were falling within +5 and −5.5 on a 100-point max-
imum score (Fig. 263). Meaning the 25-item CFQ outcome scores are
replaceable by the 14-item CFQ outcome scores.
CONCLUSIONS. In this study we developed and validated a shortened
CFQ version to examine cognitive failure in ICU patients. This
abbreviated CFQ provides us with insight in the ICU patients'
cognitive functioning, to ultimately better recognize the Post
Intensive Care Syndrome.
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INTRODUCTION. Nonconvulsive seizures (NCSzs) and nonconvulsive
status epilepticus (NCSE) are relatively frequent in comatose patients
with acute brain injury (ABI). The use of conventional surface
electroencephalography (EEG) for continuous monitoring has
significant limitations in the intensive care unit (ICU) setting
including poor signal-to-noise ratio, insensitivity to capture localized
seizures and movement artifacts. Early experience with the use of
mini-depth electrodes suggest that many of the limitations of scalp
EEG recordings can be overcome
OBJECTIVES. We describe our experience in patients with severe ABI
in whom intracortical EEG (iEEG) and multimodal neuromonitoring
was carried out.
METHODS. Commercially available eight-contact Spencer minidepth
electrodes (AD-Tech, Racine, WI) designed for clinical iEEG recording
were choosen for use. Intracortical electrode location when possible,
was placed next to the damage tissue. In addition, 21 needle elec-
trodes attached with collodion placed according the International
10–20 System were included. EEG was recorded using a digital
video-EEG monitoring system (XLTEK). Moreover, insertion of other
monitoring devices including intracranial pressure monitor (ICP),
brain tissue oxygen monitor and brain temperature sensor was per-
formed. This protocol was approved by the local Ethics Committee.
RESULTS. There were 12 patients (8 men and 4 women). The mean
age was 53 (range 22–73) years. The study included: 2 patients with
traumatic brain injury (TBI), 6 spontaneous intracerebral hemorrhage
(SIH) and 4 aneurysmal subarachnoid hemorraghe (SAH). Glasgow
coma scale (GCS) mean at ICU admission was 6 ± 2. iEEG monitoring
was started within 48 h after admission and the mean duration was
4.5 (range 2–8) days. No complications related with Spencer
electrode insertion were observed. One patient had NCSzs and two
patients had lateralized periodic discharges (LPDs), only visible on
iEEG recording. One patient had LPDs 48 hours prior to developed
cerebral vasospasm. Asymmetry of the background activity, rhythmic
delta waves and occasional focal epileptiform discharges were some
of the most important neurophysiological findings. Good outcome at
hospital discharge (modified Rankin scale scores ≤ 2) was 16.6% and
one patient died.
CONCLUSIONS. iEEG monitoring is a feasible technique that can be
performed without complications in patients with severe ABI, and its
use can shed light on the intrinsic pathophysiological mechanisms of
NCSzs and LPDs in comatose subjects.
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Intensive Care Medicine Experimental 2017, 5(Suppl 2):0783INTRODUCTION. Survivors from cardiac arrest (CA) often experience
poor outcome. Targeted temperature management (TTM) is regarded
as an effective neuroprotective strategy, but ensuring adequate brain
perfusion remains of paramount importance. Little is known about
cerebral autoregulation during TTM.
OBJECTIVES. The aim of this study was to investigate the association
between cerebral autoregulation and outcome in CA patients.
METHODS. We prospectively studied 22 adult (>18 yo) patients
treated by TTM following CA (January 2015 - March 2017).Exclusion
criteria were: CA due to trauma, sepsis or intoxication; irregular heart
rhythm; severe hemodynamic instability or hypercapnia; cardiac
mechanical support. Transcranial Doppler (TCD) was performed
insonating the left middle cerebral artery (LMCA) with a 2 MHz probe
(DWL, Germany) once successively during the hypothermic (HT) and
normothermic (NT) phase. LMCA flow velocity and arterial pressure
from peripheral arterial catheter were recorded simultaneously
(Doppler Box, DWL). Patients were in steady state condition, with no
concurrent stimulus or change in therapy. CAR analysis was
performed using MATLAB (MathWorks, US). Mean arterial pressure
and FV were first averaged on a 10 sec moving window with 50%
overlap and then Pearson´s correlation coefficient was calculated.
CAR was considered as altered if Mxa >0.3.
RESULTS. Fourteen (44%) patients survived at ICU discharge. TCDs was
performed 13 [8–17] and 39 [36–47] hours after CA during HT (core
temperature 33.6 [33.1-33.9]°C) and NT (37.0 [36.6-37.4]°C) phases,
respectively. During HT all patients were sedated and 25 (78%) were
paralysed. During NT 13 (41%) patients were sedated and 4 (12%) were
paralysed. Arterial pCO2 were 38 [35–42] mmHg and 37 [34–39] mmHg
at time of TCD examination during HT and NT respectively. Overall,
Mxa was 0.21 [−0.05 to 0.54] and 0.43 [0.12 - 0.84] during HT and NT,
respectively (p = 0.09); CAR was altered in 12/32 (37%) and 19/32 (59%)
patients during HT and NT, respectively (p = 0.47). There was no
significant difference in Mxa in survivors (p = 0.6), but in non-survivors
Mxa increased from 0.21 [0.002 - 0.58] during HT to 0.61 [0.32 - 0.85]
during NT (p = 0.04). CAR during NT was more commonly altered in
non-survivors than in survivors (14/18, 78% vs 5/14, 36% p = 0.03).Age (yrs) 65 [53–73]Male 26 (81)APACHE II 27 [24–31]Time to ROSC (min) 20 [11–36]CA: witnessed 10 (31)CA: cardiac 17 (53)CA: anoxic 7 (22)Arterial hypertension 15 (47)Diabetes Mellitus 3 (9)Median [IQR] and n (%)
[Characteristics of population and CA]
CONCLUSIONS. Cerebral autoregulation is altered in a significant
proportion of CA patients. During normothermia, non-survivors are
more likely to have altered cerebral autoregulation than survivors.
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INTRODUCTION. Apnea testing is the cornerstone of clinical
diagnosis for Brain Death (BD) deternination in suspected BD
children. However, data on determinants of apnea test completion
failure in children are limited.
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 399 of 542OBJECTIVE. To study the feasibility and safety of apnea testing in
children, and examine the factors associated with apnea test
completion failure.
METHODS. Retrospective 17 years study of all BD patients in a 8bed
multidisciplinary PICU of Northern Greece. Data collected:
Demographics, Pediatric Risk of Severity Score at admission (PRISM
III-24), baseline and apnea ventilation and oxygenation parameters,
inotropic support, and the way of conducting and the outcome of
apnea testing. Two apnea tests (A, B) per patient were aimed if pos-
sible, by a panel of three senior physicians, according to tailored by
the Greek law guidelines for children. Statistical analysis: Mann–Whit-
ney U test, χ2 Fisher's exact test; data expressed as percentages or
median (IQR), as appropriate.
RESULTS. During the study period 48 suspected BD pts were
recorded, male (52%), aged 66 (25.50-100.50) months, PRISM III-24 21
(14–26), co morbidity (52.10%), ischemic-anoxic brain injury (56.30%),
severe head trauma (37.50%), inotropic support (78.50%). Apnea test
were not performed in 5 patients (10.41%, 1 hypoxia, 1 shock, 3 time
not permitted), 1 patient had only A and 1 only B test recorded (lack
of data), given a total of 84 apnea tests for evaluation. A-apnea test
was aborted 6 times
(4 hypoxia-2 shock) and B-apnea 8 times (6 hypoxia-2 shock), given a
total abortion rate of 16.66%. Apnea was conducting through tracheal
insufflation of oxygen (2–6 lit/min, max 12 in case of developing hyp-
oxia) in 29/84 cases (34.52%), CPAP 5–10 cm H20 in 20/84 (23.80%), lack
of data in 35/84 (41.66%). No death and only 1 complication was re-
corded (1 pneumothorax during tracheal insufflation that led to test
abortion but 2 successful tests followed). Age (p = 0.82), PRISM III-24
(p = 0.320), and baseline PA-aO2 (p = 0.708), PaO2/FiO2 (p = 0.274), and
PEEP (p = 0.069) were not related with apnea completion. Patients that
did not manage to complete apnea test had significantly higher base-
line Peak pressures (26.14 vs. 22.24 cmH20, p = 0.017), higher PCO2
levels (36.51 vs. 32.36 mmHg, p = 0.002), and lower ph (7.40 vs. 7.45,
p = 0.04). Sex (p = 0.230), head trauma (p = 0.236) and inotropic sup-
port (p = 0.283) were not associated with the success of apnea testing.
4 pts became organ donors (8.33%).
CONCLUSIONS. In one out of ten suspected BD pts apnea testing
could not be conducted at all, and in the remaining the abortion
rate was 16.66%. The main reason for abortion was hypoxia (10/84,
11.90%) followed by shock (4/84, 4.76%). Higher baseline Peak and
PCO2 pressures, probably reflecting more severe lung injury, and lower
ph were associated with apnea test completion failure in our cohort.
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INTRODUCTION. Over the last years in Portugal, solid organ donation
and transplantation had a significant increase. The Centro Hospitalar e
Universitario de Coimbra (CHUC) has played a major role at national
level, as it is the main donation center in Portugal. The diagnosis of
brain death is mainly clinical with very strict and well defined rules.
However, in some special cases, such as the usage of some drugs
(central nervous system depressants), metabolic disturbances and
severe facial trauma (that impairs the clinical diagnosis), imaging
techniques that evaluate brain perfusion are required to support its
diagnosis. The most common exams used in this setting are
angiography and brain perfusion scintigraphy, the later performed in
the last 25 years in our hospital. These exams have allowed the
diagnosis of brain death in some cases, otherwise not possible.METHODS. Retrospective analysis of the brain perfusion scintigrams
performed with the objective of brain death diagnosis over the last
10 years in CHUC. The absence of radionuclide activity of Tc-99 m-
HMPAO intracranially on static SPECT images, creating a so-called
“Hollow skull” appearance, is indicative of brain death.
RESULTS. Between 2006 and 2016 were performed 86 brain
perfusion scintigrams for brain death diagnosis in 78 patients (20
female, 58 male, mean age 48 years). Most patients had severe
traumatic brain injury (39,7%), but in some cases other causes were
present, like stroke and aneurysms (38,5%). The main reason for
usage of this imaging technique was the presence of barbiturates or
benzodiazepines. 71 exams were positive for brain death (15
negative, some were repeated afterwards according to clinical
suspicion). Most patients came from the Intensive Care Unit. 58
patients (74,35%) were solid organ donors.
CONCLUSIONS. The brain perfusion scintigraphy is a key element for
diagnosis of brain death in selected cases, allowing faster diagnosis
and therefore increasing solid organ donation. However, its usage is
impaired by the time required for its execution and the unavailability
at bedside.
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INTRODUCTION. In developing countries, there are few data on
predictive factors related to the outcome of organ donation in
patients with brain death (BD) in the ICU. The objective of this study
was to evaluate the clinical-demographic profile of adult patients
with brain death in a general ICU, and to identify and analyze clinical
and demographic predictors for organ donation.
METHODS. Retrospective cohort study, analyzing medical records of
all patients hospitalized in the adult ICU of a Brazilian teaching
hospital for a period of 1 year, with clinical diagnosis of BD (non-
reactive coma, fixed/dilated pupils, absence of cough reflexes and no
respiratory movements, several hours without sedatives and without
other causes of diagnostic confusion). According to Brazilian Ministry of
Health, in addition to the clinical diagnosis, laboratory confirmation
(arteriography, EEG, transcranial doppler) is needed for the diagnosis of
BD. Descriptive statistical analysis was performed. All donations were
with heart-beating donors. It was made logistic regression analysis, aim-
ing at finding predictors of success for donation.
RESULTS. During the study period, 625 patients were admitted to
the ICU with acute neurological diseases. Of these, 85 had clinical
diagnosis of BD and were included for analysis. Among donors
(n = 9), all had kidney removal, 7 donated liver, and 1 donated heart;
77.7% males, age 39.6 years, and APACHE II 25.5 (compared to
69.7%, 41.2 and 26.9 among non-donors). Two thirds of the patients
were victims of trauma, with a high incidence of smoking but not of
alcoholism or use of illicit drugs. Almost half (47%) of BD patients
were already in coma (with Glasgow score = 3) on admission at
Emergency Department. Among donors, the mean time between
acute neurological event (stroke / trauma) and the first confirmatory
test (after clinical trials) was 237 hours, and between the event and
organ withdrawal was 269 hours. In turn, the time between the first
diagnosis of non-reactive coma (Glasgow score = 3) and the first con-
firmatory test for BD was 162 hours, and the time between Glasgow
score = 3 and organ withdrawal was 208 hours. The main predictive
factors (of success for donation) found by logistic regression were:
lower incidence of renal insufficiency (lower maximum creatinine
value), higher sodium value, lower arterial lactate, shorter time be-
tween hospital arrival and Glasgow score = 3.
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10.6% became effective donors of vital organs (heart, liver, kidneys).
Among the predictive factors of success for donation, it is noted that
persistently elevated arterial lactate was a marker of not being able
to reach the donation. On the other hand, patients that developed
coma and evolved to BD long after hospital admission had lower
chance to become an organ donor.
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INTRODUCTION. Catheter Associated Blood Stream Infections (CABSI)
remain a significant cause of Device Related Hospital Acquired
Bacteraemia (DRHAB) and lead to increased hospital length of stay,
increased cost as well as morbidity and mortality. Over the last
decade, several initiatives have proven effective in reducing the
incidence of CABSI including insertion and care bundles and
specialised insertion teams1,2. Nurse led insertion teams have been
effective within defined clinical areas including Neuro- Intensive Care
Units and in Paediatrics3,4. However, no previous study has assessed
the impact of a nurse led Intravenous Therapy Team on CABSI rates
across an entire hospital organisation.
OBJECTIVES. We hypothesized that the introduction of a dedicated
Nurse Led Intravenous Therapy Team across a hospital organisation
would reduce the incidence of CABSI throughout the institution.
METHODS. An Intravenous Therapy Team consisting of trained
nurses was introduced in August 2012. The purpose of the team was
to establish intravenous access in any patient throughout the
hospital including all wards and the intensive care unit. A doctor or
nurse could refer any patient in whom intravenous access was
required. The Intravenous Therapy Team would liaise with the clinical
team and aim to establish either an ultrasound guided peripheral
venous line or a peripherally inserted central catheter (PICC) line
depending upon the clinical need. As well as establishing venous
access the Intravenous Therapy Team would also take responsibility
for the ongoing care of the line, including daily line inspection,
dressing changes and line removal.
RESULTS. A database of all DRHABs has been maintained since Jan
2009. This revealed a baseline median incidence of 6 CABSI per 1000
line days across the hospital organisation. Within six months of
introducing the Intravenous Therapy Team the median incidence of
CABSIs had reduced to 3 CABSI per 1000 line days across the
organisation. To ensure that this result was not due to the
Hawthorne effect, data has been prospectively collected throughout
the study. The median incidence of CABSI has remained at 3 CABSIs
per 1000 line days since the inception of the team to the present
with more than 3000 devices inserted.
CONCLUSIONS. A dedicated Nurse led Intravenous Therapy Team to
establish ultrasound guided peripheral venous lines and PICC lines
across an entire hospital organisation resulted in a significant
reduction in the incidence of CABSI in our institution. This model is
both feasible and highly effective in reducing the incidence of CABSI
across a hospital organisation.
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INTRODUCTION. The literature consistently states that critical care
patients and their families want clear and honest information
regarding prognosis and treatment1. However the evidence also
shows that families are more dissatisfied with communication than
with any other aspect of care delivered on critical care units2.
Health-care professionals(HCPs) in our institution reported that
previous communication skills training(CST) had not prepared them
for dealing with real-world clinical situations such as discussing escal-
ation of care. 'Parallel Communications' is an innovative, goal orien-
tated, simulation workshop developed to address this unmet need.
OBJECTIVES. The aim of this study was to investigate the workshop's
impact on Critical Care nurses(CCNs) confidence to approach difficult
conversations.
METHODS. The 2-hour workshop was delivered to by 2 facilitators to
groups of 6–10 CCNs.
Anonymised data was collected regarding the CCNs' confidence on a
scale of 1 (not confident) to 10 (as confident as possible) regarding
different aspects of communication.
Paired statistical tests were used to assess the impact of training on
the CCNs' pre/post-training scores.
RESULTS. Full data sets were available for 50 CCNs.
Analysis showed statistically significant improvement in CCNs
confidence regarding:
 Explaining complex information to relatives(mean 1.6,
p < 0.001)
 Managing uncertainty(mean = 2.2, p < 0.0001)
 Recognising distress(mean = 1.4, p < 0.0005)
 Responding helpfully to distress(mean = 2.1, p < 0.005)
 Anticipating concerns at end of life(mean = 1.8, p < 0.005)
 Talking about withdrawal of treatment(mean = 2.8, p < 0.0005)
 Discussing escalation of treatment and resuscitation
status(mean = 2.8, p < 0.0005)
 Talking to bereaved relatives(mean = 1.98, p < 0.0005)
 Talking to families with children about end of life(mean = 2.1,
p < 0.0005)
Of the CCNs that answered 39/40(97.5%) rated this workshop as very
useful or useful. 28/50(56%) reported that they would alter their
behaviour as a result of teaching.
CONCLUSIONS. This study shows that Parallel Communications a
2-hour CST workshop, improved CCNs' confidence in multiple as-
pects of communication. 54% reported that they would alter their
behaviour.
Whilst confidence does not equate to competence, increasing CCNs'
self-confidence and providing a safe environment to rehearse diffi-
cult scenarios may increase their willingness to engage in difficult
conversations rather than avoiding or blocking these topics3.
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INTRODUCTION. The ICU is a dynamic, rapidly changing environment
where clinical decisions are often made under stress. The quality of
these decisions and their outcomes is affected by the level of
collaboration, communication and shared decision making (SDM)
between physicians and nurses. A model was developed that describes
ICU shared decision making and the factors that affect it.
OBJECTIVES. Explore ICU inter-professional shared clinical decision
regarding fluid resuscitation in a national study.
METHODS. Prospective, multi-center survey investigating the deci-
sion making process regarding delivery of fluid resuscitation to
hemodynamically compromised patients in the ICU. Inclusion criteria-
all nurses and physicians working in ICUs in Israel The questionnaire,
based on actual ICU scenarios, with additional demographic data.
RESULTS. The frequencies of the levels of shared decision making
used to decide whether to administer a fluid bolus were similar in
this study. Most nurses reported that they exchanged or relayed
information (Level 2 of the model) (n = 73, 67%), deliberated (Level 3
of the model) (n = 69, 63%), or shared decision making (Level 4 of
the model) (n = 74, 68%), either often or always. Other methods of
decision making, such as administering the bolus and then calling
the physician (n = 78, 72%) and only providing information that
supports the nurse´s decision (n = 41, 38%) were also used.
Most nurses in the sample delivered boluses of 500 ml (n = 73, 67%).
The type of fluid administered was predominantly either Full Normal
Saline (n = 25, 23%), Hartmann Solution (n = 44, 40%), or Glucose/
Saline (n = 25, 23%).
Changes in arterial pressure according to the arterial line was the
most common sign used to determine a clinical response to the
bolus (n = 98, 90%), followed by urine output (n = 82, 75%), and
Central Venous Pressure (n = 60, 55%).
The level of shared decision making was not related to any of the
work or personal characteristics measured.
CONCLUSIONS. ICU nurses, regardless of their role or other
characteristics, use different strategies to obtain medical orders for
fluid bolus administration. This is in contrast to a body of literature
stating that physicians often dominate clinical decision making in the
ICU. These results imply that at least in situations related to fluid
bolus administration, high levels of collaboration are found. It has
long been shown that higher levels of physician-nurse collaboration
are associated with improved patient and staff outcomes. Therefore,
it would seem that outcomes related to fluid bolus administration
are potentially optimized.
Nurses should be encouraged to share clinical decisions at the
highest level, when clinically appropriate.
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INTRODUCTION. Lung volume reduction surgery (LVRS) aims to
relieve symptoms and improve function in advanced emphysema.
The NETT trial (2003) validated outcomes of LVRS and a subsequent
study shows durable long term effects (Ginsberg et al., 2016).
Complications include admission to the Intensive Care Unit (ICU),
potential intubation, increased length of stay (LOS) and persistent airleaks. Post-operative physiotherapy (PT) aims to ensure lung re-
expansion, effective sputum clearance and increase exercise toler-
ance, with ICU patients potentially requiring more intensive PT for
weaning/ rehabilitation for ICU acquired weakness (Stiller, 2013). A
survey of PT provision for patients undergoing thoracic surgery at UK
tertiary centres shows mobilisation and the active cycle of breathing
technique were the most prevalent techniques (Agostini et al., 2013).
OBJECTIVES. This study aims to review outcomes of patients
requiring an ICU admission post LVRS compared to ward based care
and review if there are any predisposing factors that may be linked
with an ICU admission. This study also aims to ascertain whether PT
requirements differ in these cohorts.
METHODS. Data was collected retrospectively on all LVRS patients
over a 6 month period (Oct '16- April '17). Data was collected
pre and post-operatively and included FEV1, pre-operative mobil-
ity and oxygen (02) requirements, lobe resected, LOS, number of
PT interventions and type, post-operative mobility, on-going 02
requirements and any complications on discharge. Data was sta-
tistically analysed to determine trends in patients being admitted
to ICU and outcomes.
RESULTS. 22 data sets (n = 17 male) were gathered and analysed
(Stata Version 14). All patients were reviewed by PT day 1 post LVRS
as per local thoracic protocol. There was a weak correlation between
pre-operative FEV1 (mean 26%) and resulting post- operative mobility
(p = 0.75). Of these, 5 patients were admitted to ICU. There was no
link between those on pre-operative 02 therapy or lobe removed and
an ICU admission. Patients of increased age were more likely to have
an ICU admission (not statistically significant). There was a statistically
significant link using Mann–Whitney analysis between low pre-
operative mobility and an ICU admission (p = 0.03). The ICU group
had greater improvement in their mobility (median 6m to 60m),
compared to the ward group (median 90m to 200m). Patients on ICU
required more PT intervention (median n = 36, IQR 28–38) than the
ward group (median n = 7, IQR 4–10), with a greater LOS (median
n = 45, IQR 39–66 compared to n = 12, IQR 10–18).
CONCLUSIONS. Correlation was found between low pre-operative
mobility levels and admission to ICU which may further the need
for research into the effectiveness of pre-operative rehabilitation.
PT techniques remain the same among both groups with ICU pa-
tients requiring greater input due to LOS which has financial im-
plications. Conclusions must be interpreted with caution due to
the small sample size.
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INTRODUCTION. Ambient light is important in the regulation of
circadian rhythms working via retinal photoreceptors. Critical care
supplies specialised intervention constantly over 24 hours. Disrupted
circadian rhythms have been shown to worsen outcome from critical
illness. Within critical care mechanical ventilation, sedation, illness
severity and ambient light and noise may disturb circadian rhythm.
OBJECTIVES. Light intensity was measured within the intensive care
unit over during daytime and overnight.
METHODS. We measured light intensity in three different bed
locations over 24–48 hours. A battery operated light meter was
placed close to the patient at eye level. It measured light intensity
every 15 seconds. The light sensor was optimised for human vision
(infrared filtered). Three bed spaces were used, a typical space on
the open ward, a side room with a window and a side room without
a window. Bedside lights were of three kinds - ceiling lights (150–
200 lux), pendant lights for invasive procedures (160,000 lux) and
low level lights at the bedside for overnight activity. No change in
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 402 of 542clinical practice was implemented. Normal practice was to switch the
overhead lights on at 08:00 and off at 23:00. Light intensity was
measured as mean and SEM against time. Paired t-tests were used to
compare means.
RESULTS. Overall mean illuminance during the daytime was 159 lux
and at night was 10.5 lux. Light intensity was analysed by location.
During daytime light intensity was significantly greater in the side
room with the window compared to the other locations. During
night time there was significantly lower light levels in the side room
without a window compared to the other locations.
We identified patterns in the change of light intensity. On the open
ward gradual changes in light intensity occurred consistent with
dawn and dusk. The side room without a window demonstrated a
pattern of lighting consistent with artificial light. This 'block' of light
abruptly reduces when the light is switched off. In addition,
overnight, bright pulses of light are observed as procedures or
checks are carried out on patients.
CONCLUSIONS. Light intensity varies within intensive care units and
is dependent on access to natural light and clinical activity. Normal
sunlight can have intensity as high a 100,000 lux and an overcast
day can record levels of 1000 lux. Levels of light less than 200 lux
have been demonstrated to be insufficient to maintain circadian
rhythms. We measured a mean levels of 159 lux during daytime. In
addition we demonstrated interruptions overnight. The authors
suggest that this pattern of lighting may be implicated in the
disturbance of circadian rhythms. This may affect the incidence of
delirium and clinical outcomes in critical care.
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INTRODUCTION. Intensive care nurses often are confronted by death
in their work. They may experience challenges to self, such as
aroused emotions and queries about life´s meaningfulness. Assessing
their level of ''self-competence´´ in coping with these challenges is
crucial in understanding their needs in death work.
OBJECTIVES. To translate and to adapt the Self-Competence in Death
Work Scale (SC-DWS) for the context of the Spanish nursing profes-
sionals, and to determine his preliminary psychometric properties.
METHODS. An observational and transversal design was used.
Analysis data was done with SPSS, v.22.0, calculating the descriptive
indexes, exploratory factorial analysis and Pearson's correlation.
RESULTS. A total of 106 participants were recruited. A Cronbach's
alpha coefficient of 0,72 was obtained for the 16 items of the
Spanish SC-DWS form. A factorial structure of five factors were found in
his set explaining 59,9% of the total variance. Confrontation of the un-
certainties, acceptance of the death, emotions before the death, emotions
of the work and impotence and limitations were identified as subscales
in the five-factor structure. Correlations of the whole scale and sub-
scales with measures of Perceived Life Significance (p < 0,01), Hospital
Anxiety, and Depression (p < 0,01), Death Anxiety Inventory Revised
(p < 0,05) and General Self-Efficacy (p < 0,01) provided evidence for the
construct validity. Reliability analyses showed that the entire scale and
subscales were internally consistent.CONCLUSIONS. The results suggest that the Spanish form of SC-DWS
has adequate construct validity and acceptable metric properties.
This scale may facilitate helping professionals´ understanding of their
self-competence in death work, so appropriate professional support
and training may be obtained.
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INTRODUCTION. Trauma admissions to Intensive Care Units often
develop a dysregulated host response to injury leading to multiple
organ dysfunction syndrome (MODS) (1), and consequently an
extended length of stay.
OBJECTIVES. To evaluate the severity and duration of MODS in ICU
trauma admissions and the associations with patient outcomes.
METHODS. This retrospective, observational study from April 2016-
December 2016 reviewed 200 consecutive trauma admissions to an
adult general ICU of an urban Major Trauma Centre. Patients aged
under 16 years, burns, for palliation or organ donation were ex-
cluded. Further exclusions were made in cases of poor data quality,
leaving a total sample size of 164 patients. Data collected included
demographics, mechanism of injury, admission Glasgow Coma Score
(GCS), lactate, APACHE II score, injury severity and sequential organ
failure assessment (SOFA) up to day 28 in ICU. MODS was identified
by calculating daily SOFA scores as a measure of organ dysfunction
with a score of ≥5 defining a patient as being in MODS (2). Signifi-
cance was measured between patients who developed MODS and
those that did not (nMODS group). Significance was determined
using a Mann Whitney U test (indicated by ~) or a Chi squared (indi-
cated by⊞) and set at p = 0.05. The primary outcome was mortality
during the in hospital phase of care, and secondary outcome was
length of stay for survivors.
RESULTS. 164 patients were reviewed of which 104 (63%) developed
MODS Table 198. Admis.... Patients who developed MODS did so
within 48 hours of admission, were more severely injured and
admitted with a significantly lower GCS, higher admission lactate,
and SOFA and APACHE II scores (Table 198-Results shown as median
values with interquartile ranges). Median SOFA scores for patients
that developed MODS remained ≥5 until day 12, with the
neurological and respiratory components taking until days 25 and
22, respectively, to recover. Patients without MODS required
significantly less organ support, had shorter ICU and hospital length
of stays, and significantly lower mortality (Table 199).
CONCLUSIONS. In this study, the presence of MODS after trauma
significantly increased ICU length of stay due to prolonged
neurological and respiratory dysfunction. The presence of ICU delirium
perpetuating neurological dysfunction should be investigated.
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Table 199 (Abstract 0793). Outcomes
% and Median Values
(Interquartile Range)
All Patients MODS nMODS P Value
ICU Length of Stay Days 2 (2-5) 4 (2-8) 2 (2-2) p=<0.01~
Hospital Length of Stay
Survivors Days
14 (9-27) 19 (10-33) 13 (8-22) p=<0.01~
Mortality 14% 21% 2% p=<0.01⊞
Table 198 (Abstract (0793). Admission Demographics
% and Median Values
(Interquartile Range)
All Patients MODS nMODS P value
Size n=164 n=104 n=60
Age Years 51 (33-76) 52 (37-77) 44 (28-76) 0.13⊞
Male (%) 69% 67% 72% 0.43⊞
Blunt Trauma (%) 92% 91% 87% 0.34⊞
Admission GCS 13 (6-15) 8 (3-14) 15 (14-15) <0.01~
Admission Lactate 2.0 (1.3-3.1) 2.4 (1.6-3.6) 1.4 (1.0-2.1) <0.01~
Admission SOFA Score 5 (3-8) 7 (5-9) 2 (1-3) <0.01~
Admission APACHE II Score 12 (7-17) 14 (9-19) 8 (5-13) <0.01~
Injury Severity Score 16 (6-27) 20 (9-29) 9 (4-17) <0.01~
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INTRODUCTION. Nursing round is an innovative learning method and
has been shown to have a potential in keeping nurses abreast on
current evidence and improving intra- and inter-professional relation-
ships. Implementation of nursing rounds in intensive care unit is feasible,
and it has been used in many settings as an education and practice im-
provement strategy. However, to date, there are no published papers on
the impact of nursing rounds in intensive care in the Asian context.
OBJECTIVES. To determine the impact of nursing round on nurses'
perception on the practice environment and their work satisfaction
in the neuroscience intensive care unit (NICU).
METHODS. In this study, we used a pre-test and post-test quasi-
experimental study design. The Practice Environment Scale of the
Nursing Work Index (PES-NWI) and the Index of Work Satisfaction
(IWS) scale were used to measure study outcome. An informed con-
sent was taken and a convenient sample of 65 participants was en-
rolled. Nursing rounds was held once fortnightly from July to
December 2016. Each session lasted forty-five minutes to an hour,
during which one case study was discussed. After implementing
nursing rounds for six months, the same post-intervention question-
naires were distributed to and collected from the same 65 partici-
pants. All the data were analysed using STATA Version 13.1.
RESULTS. The PES-NWI sub-scale of staffing and resource adequacy
improved after the intervention period (pre - 11.09; post - 11.74,
p = 0.0144). While there was no significant difference in the PES-NWI
sub-scale of nursing foundations for quality of care, scores improved
after the intervention period (pre - 29.09; post - 30.15, p = 0.0712).
Upon further breakdown analysis, use of nursing diagnoses, which is
under the PES-NWI sub-scale of nursing foundation for quality of
care, showed a statistical difference between the pre- and post-
intervention period (pre - 2.48; post - 2.74, p = 0.0296).
CONCLUSIONS. With reference to the results as whole, by increasing
the use of appropriate nursing diagnoses, nursing rounds could havehelped build nurses' confidence and equipped them in making
sound clinical decisions. This may have in turn improved staff
capability and efficiency in the settings of an intensive care unit,
resulting in a positive impact on staffing and resource adequacy.
The limitation of this study includes the time constraint being
and a relatively small sample size. Hence, a longer study with a
larger sample size, with the use of a control group, may give
more insight into how and to what extent nursing rounds can
affect nurses' perceptions of the work environment and nurses'
work satisfaction.
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INTRODUCTION. Patient safety is a key point in patient care and is
considered as a critical issue in national and International policies
and guidelines.
Nowadays, in the college environment, the knowledge that students
acquire is based on the competences acquisition instead of just
theoretical knowledge.
The learning outcomes chosen which are related to different
competences are included in the Strategic plan of patient safety
from the Spanish Ministry of Health, social services and equity.
OBJECTIVES. To investigate the acquisition level of the learning
outcomes of the students related to critically ill patient safety.
METHODS. Observational study carried out in a Spanish University
during the courses 2014–2016. Students were in their 3rd year of of
Nursing Degree. In the subject evaluated nursing students have 4
ECTS where they learn different aspects related to critical care
(surgery, general care in the ICU, applied pharmacology, advanced
cardiopulmonary resuscitation and electrocardiography). The learning
methods used are: theoretical lectures, case studies and simulation lab.
The evaluation of the subject is mainly performed by an objective
structured clinical examination (OSCE) and simulation lab cases.
The OSCE had 15 stations due to the amount of students. Of all the
stations, 6 had an evaluator inside and in the others the students
had to do a written theoretic-practical assessment. In the OSCE, stu-
dents were evaluated of 7 “critical items” across the stations which
were defined as those which in case they are not accomplished the
patient safety could be put in danger.
The punctuation of the critical items was dichotomous (yes/no).
Students had to perform correctly half of them to be able to pass
the exam independently of the rest of the OSCE results.
Results are presented descriptively with absolute and relative
frequencies and median and percentiles as appropriate.
RESULTS. One hundred forty-four students were evaluated. One hun-
dred fourteen were female and 83.9% were younger than 26 years
old. In the OSCE the critical items evaluated and their results are: dif-
ferentiation of arterial and venous catheter was performed correctly
by 48.9% of the students, identification of the patient's allergies
(66.7%), correct practical calculation of the drug to administer
(42.2%), recognition that the enteral nutrition is being administered
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 404 of 542through the central venous catheter (47.5%) and correct calculation
of a theoretical drug calculation problem (63.8%).
Of the total critical items that were evaluated, students failed from
none till all of them. The median of correct critical items was 3 (p25 2
- p75 5). 68 students (48.2%) performed correctly ≥4 critical items.
CONCLUSIONS. Our results point out several points where
improvement measures have to be implemented. The simulated
environment facilitates the student's training in patient safety.
Training in patient safety is aligned with the national and
international strategies in quality of care.
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INTRODUCTION. Critically ill patients admitted to Intensive Care
Units (ICU) spend long periods of time in bed, with well known
physical and psychological consequences1. Early and progressive
mobilization was introduced as a component dell´ABCDEF bundle2,
but turns out to be one of the most complex phases to implement,
especially in the Italian ICUs, often characterized by the absence of
physical therapists and the nurse/patient ratio different from 1: 1,
seen in the other countries.
OBJECTIVES. To describe the implementation of the Early and
Progressive Mobilization program in the general ICU of a big
University Hospital in Italy, without physiotherapists.
METHODS. In november 2014 a plan to guide the Mobility was
developed and education sessions were performed. Episodes of
advanced mobilization are monitored: dangling, out of bed and
walking. Patients in ICU for more than 24 hours were included.
RESULTS. In the first year post implementation 321 episodes of
active mobilization were performed: 155 dangling, 166 out of bed
and 4 walking (29,6% of patients). In the second year there were 462
episodes (35,8% of patients) :139 dangling, 277 out of bed episodes
and 36 of walking.
The number of patients mobilized out of bed in VAM increased
progressively, from 8 in 2015 to 21 in 2016. Adverse events were
rare and never serious (hypotension, desaturation, panic, Atrial
Fibrillation).
The number of personnel involved in the mobilization sessions has
remained constant over time (2.1 DS 1–4).
CONCLUSIONS. From the obtained data it is clear the feasibility and
safety of the early and progressive mobilization managed and
performed exclusively by the ICU nurses.
However, it is not enough to reach the systematic and regular
approach obtained in centers with dedicated staff.
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after their ICU stay. Critically ill patients may be unable to self-report
their pain due to the use of mechanical ventilation and sedative
agents that alter their level of consciousness. In addition, agitation in
critically ill patients may be a result of inadequately treated pain,
anxiety or delirium all associated with increased mortality, prolonged
ICU stay and cognitive impairment. As such, assessment of Pain, Agi-
tation, and Delirium (PAD) has been recognized as a pivotal part of
patient care (1).
OBJECTIVES. This study took the format of an audit undertaken in
November 2016 and February 2017 investigating the compliance of
PAD assessment in terms of frequency and choice of tool applied
with the intention to compare the findings with current best practice
guidelines.
METHODS. Data collection took place during the two time periods
within an 18 bedded adult general ICU. All patients were included
who required either level 2 or level 3 care.
The following data points were collected by the authors:
1. Is there any documentation related to PAD assessment? What is
the frequency of the assessment?
2. Was the patient sedated and did he have a sedation hold /
SAT? (Sedation awake trial).
3. Which analgesic / sedative agent was administered?
4. Which pain tool was used? Was this documented?
5. Has the patient a prn analgesia prescription (yes/no)? What was
the frequency in the last 24 hours?
6. Did the patient have acute/ chronic pain issues?
RESULTS. The results indicate that nurses collected the Richmond
Agitation Sedation Score (RASS) more often than the pain score
(Critical-Care Pain Observation Tool). The reason behind this may be
explained by the fact that a box to document the RASS is included
on the observation chart. Interestingly delirium status, assessed by
CAM-ICU was documented more often than pain score.
CONCLUSIONS. The results indicate that there exists a lack of
knowledge regarding PAD assessment in view of the assessment
tools applied and their frequency of documentation.
Consequently, assessment practices during the study periods did not
conform with what is regarded current best practice. We recommend
the implementation of training package
to improve compliance with this important aspect of patient care
followed by another audit to ascertain if any change has been
achieved. In addition, the routine use of stickers.
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INTRODUCTION. Patients and family members recovering from critical
illness may experience physical and psychological disorders which
impair healthy recovery. Intensive care diaries have been developed as
a tool to improve factual memory of time spent in intensive care, with
an aim to improve recovery from critical illness. (Ullman A.J. 2015).
Diaries have been introduced as a tool for helping patients to remember
or rebuild their Intensive Care Unit (ICU) stay (Petersson 2015). The use
of ICU Diaries in the Italian contest hasn't yet been described.
OBJECTIVES. The aim of this study was to implement the use of the ICU-
diaries in the IRCCS San Raffaele Hospitals's General ICU, in Milan, Italy.
METHODS. The diary consisted in a small notebook that it was given
to the patients and their families. An educational program was
conducted for the ICU team.
RESULTS. The sample included 19 diaries of patients hospitalized
between 2 to 43 days of Intensive Care. The authors of the diaries
are the patients´ family members, friends and the ICU nurses.
Through the qualitative analysis of the 19 diaries were identified and
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 405 of 542classified 12 recurring themes (narrative units) according to the
topics discussed. Looking at the results it appears that the diaries
represented a much more complex care intervention and not only a
vehicle to complete the gaps in the period in the ICU memory. The
writers shared their feelings, their time and offered moral support to
the patients during hospitalization.
CONCLUSIONS. The implementation of ICU diaries in Italy resulted
feasible, an important families' participation to the project has been
achieved. The diaries reppresented an activity of care for the patient,
and a helpful therapeutic activity for the family to face its relative's
critical ill. There is need for more research to be performed about
diaries, expecially in the Italian contest.
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INTRODUCTION. Venous thromboembolism has increased in
pediatrics and the most frequently associated risk factor is the
presence of a central venous catheter. This pathology can determine
morbidity, however, there are currently no pediatric protocols
validated for its prevention. The aim of this study was to determine
the incidence of venous thrombosis and to identify risk factors in
pediatric patients with central venous catheters, as an initial
approach to the creation of thromboprophylaxis protocols.
PATIENTS AND METHODS. Prospective cohort study. Patients
younger than 15 years who required the installation of a transient
central venous catheter in the pediatric intensive care unit of the
Pontificia Universidad Católica de Chile between May and November
2016 were included. Data were extracted from their clinical file,
antithrombin III activity was measured and during the first 48 hours
after catheter removal a Doppler ultrasonography was performed to
detect thrombosis.
Results: 31 patients were included. The incidence of VT was 45.1%,
all were asymptomatic. The factors that were significantly associated
with VT were: need for vasoactive drugs, patients undergoing cardiac
surgery, presence of a 3-lumen catheter and jugular location com-
pared to subclavian. There were no significant differences in the level
of antithrombin III.
CONCLUSIONS. In this group of patients, the incidence of central
venous catheter-related venous thrombosis was 45%, however, all
patients were asymptomatic. Studies with a greater number of pa-
tients are required to establish risk factors and the need for
thromboprophylaxis.
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INTRODUCTION. National and international studies show that
critically ill patients suffer from Post Intensive Care Syndrome (PICS).
PICS is defined as new or worsening problems in physical, cognitive
or mental health status arising after critical illness and persisting
beyond acute care hospitalization(1)
In an intensive care unit in a University Hospital in Denmark patients
are offered a nurse-led consultation 3 months post intensive care
unit (ICU) admission, to help them cope with PICS and identify op-
portunities for further intervention.
OBJECTIVES. 1) To describe former intensive care patients'
experiences of the consultation, specifically regarding content and
setting. 2) To explore the benefits of the consultation with regards to
the individual patient's symptoms of PICS.
METHODS. A two-part qualitative study: 1) an observational study of
the current follow-up consultation; 2) a semi-structured interview
with 10 patients, conducted approximately two weeks later, where
the interview guide was based upon observations and statements
arising during the initial consultation.
RESULTS. The study is ongoing, however, the preliminary findings
suggest that the content and setting are of upmost importance.
Revisiting the unit and experiencing the setting in person plays a huge
role in coping after surviving critical illness. Involving relatives also
proves to be of great importance. During analysis of the data regarding
the benefits of the consultation in relation to the patient's symptoms of
PICS, four major themes arose:1) Confronting the demons.2) Coming to
terms with the reality of having been critically ill.3) Making sense of the
symptoms.4) Regaining a sense of normality.The themes are closely
linked, as all are related to the patient's ability to cope with the
traumatic event. An important benefit for many patients turned out to
be a sense of relief knowing that other patients experience the same
symptoms. Many patients did not know how their symptoms were
related to having been critically ill, and described themselves in
condescending terms and this caused a great deal of anxiety.
CONCLUSIONS. The patients who participated in the study were
generally pleased with the consultation. The most important part of
the consultation proved to be viewing the unit, as seeing the setting
and hearing the sounds initiated coping. The consultation helped the
patients understand the symptoms they were suffering from, and to
make sense of what had happened during their stay in ICU. The findings
are of importance when developing the follow-up service in the future.
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INTRODUCTION. The American Heart Association (AHA) published
guidelines outlining a universal standard of care for patients who
experience in-hospital resuscitation or receive post cardiac arrest care
following an in-hospital or out-of-hospital event (1). While some
Fig. 265 (Abstract 0802). Acute Care Mortality Rates
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ity from unexpected cardiac arrest and reduce the number of unex-
pected ICU admissions (2), there remains a paucity of data on the
impact of simulation based MERT training using HFMs on achieving
the recommended AHA guidelines.
OBJECTIVES. HFM use in simulation training has demonstrated a
benefit in clinical outcomes by providing a more realistic setting to
improve clinical skills and facilitate communication amongst emergency
team members (3). This study aims to explore if HFM simulation use
during MERT training will result in better adherence to the AHA
guidelines and improve patient outcomes and decrease mortality.
METHODS. We performed a retrospective blinded cohort study of
cardiopulmonary/cardiac arrest codes called at ORMC before and
after the implementation of the HFM-MERT program.
Analysis included Student´s T test and Chi-Square of AHA metric ad-
herence both during the code and post-resuscitation. Additionally,
we compared hospital staff confidence in the MERT between groups
via anonymous survey and the impact HFM-MERT training had on
hospital acute care mortality rates.
RESULTS. Statistically significant differences were found in time to
delivery of first shock for ventricular fibrillation (VF) or pulseless
ventricular tachycardia (pVT). No other comparison reached statistical
significance. There was a downward trend in acute care mortality rates.
There was an upward trend of hospital staff confidence in the MERT,
as well as willingness to call the team.
CONCLUSIONS. We hypothesized that HFM incorporation would
significantly improve current MERT training for acute cardiopulmonary
events. Though HFM-MERT training showed little improvement with re-
spect to AHA metrics, it demonstrated the strong impact of MERT train-
ing on team dynamics. MERT training improved communication
amongst team members and strengthened the confidence of hospital
personnel in the MERT. When correlated with a downward trend in
mortality, HFM use in MERT training demonstrates great utility.
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INTRODUCTION. Adverse events are defined as an injury caused by
medical treatment and not by the underlying disease. There are two
methods of quantification and search for adverse events: passive and
active. Of the latter, the Trigger Tool looks for signs of potential
unpleasant events in a sample of medical records.
OBJECTIVE. It intends to establish the incidence of disadvantageous
events by using the Global Trigger Tool in a high complexity
Intensive Care Unit.
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 407 of 542METHODS. Analytical cross - sectional study between January 1 to
December 31, 2016, in a uci of university character of 12 beds in
the city of Medellín, Colombia. Trained reviewers conducted a
retrospective examination of medical charts searching for clue
events that elicit the investigation, in order to detect an
unfavorable event. Information was processed through SPSS
software version 21; for numerical variables, the mean was reported
with standard deviation. Percentages were calculated for qualitative
variables.
RESULTS. 244 triggers occurred; 82.4% of subjects presented with at
least one, and the average was 3.37 (SD 3.47). A total of 178 adverse
events took place in 48 individuals, with an incidence of 52.1%.
On average, four events per patient were recorded, and for each
unfortunate event, 1.98 triggers were presented. The most frequent
displeasing issues were: pressure ulcers (17.6%), followed by
complications or reactions to medical devices (4.3%), lacerations or
skin defects (3.7%), the least presented was delayed diagnosis or
treatment (0.56%). 38.4% of mishap events caused temporary
damage that required intervention; 48.9% of adverse events were
preventable.TRIGGER n %Skin defects or lacerations 36 14,7Excitation or drowsiness of the patient 34 13,9Unscheduled withdrawal of surgical catheter, probes, drains or other
devices34 13,9Hypotension 33 13,5Initiation of antibiotics after 48 hours of admission 28 11,4[Triggers.]ADVERSE EVENT n %Pressure ulcers 62 17,6Complications or reactions to medical devices 15 4,3Lacerations 13 3,7Drug-induced hypotension 10 2,8Nosocomial pneumonia 9 2,6[Adverse events]
CONCLUSIONS. Almost half of the unfavorable issues were classified
as avoidable, which leaves a very wide field of work in terms of
preventative activities for the occurrence of such events.
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INTRODUCTION. Aminoglycoside antibiotics are commonly used for
the treatment of severe bacterial infections in the intensive care unit
[1]. However these drugs require close monitoring to prevent adverseeffects such as nephrotoxicity and ototoxicity [2]. This is of particular
concern in critically unwell patients, in whom pharmacokinetics are less
predictable [3]. Incorrect dosing can contribute to this risk, with studies
of surgical patients suggesting that only 30% of patients receive the
appropriate dose of gentamicin [4].
OBJECTIVES. To determine the burden of high trough serum
aminoglycoside concentrations, and the impact of a quality improvement
project on these.
METHODS. A quality improvement project was conducted at a large UK
University adult cardiothoracic ICU from January to March 2017. During
an initial 15 day audit period, the following were recorded: the incidence
of high trough levels of aminoglycosides, the response to a high level
(in terms of drug administration and change in prescription), as well
as overall adherence with local guidelines. Preliminary interventions
involved raising awareness among staff via clinical governance
meetings and daily safety briefings, as well as specific departmental
pharmaceutical teaching for all ICU medical and nursing staff. A second
analysis of practice was conducted following these interventions.
RESULTS. During the first audit period there were 8 patients on
intravenous aminoglycosides and 16 instances of a high trough
level - subsequent doses were correctly omitted in all cases in
response to these high trough levels. These omitted doses
accounted for 57% of all prescribed doses (16/28), and an
amendment in prescription to prevent further high levels was only
made in 25% of cases (4/16). Inappropriate prescribing was
identified as the chief cause for high trough levels: prescriptions
were not appropriately adjusted for renal function and ideal body
weight. During the second audit period (following systematic
multidisciplinary departmental teaching), there were 7 patients on
aminoglycoside antibiotics and only 7 incidences of a high trough
level - again all doses were correctly omitted. This time only 21% of
all prescribed doses were omitted (7/33) and correct adjustments
to prescriptions were made in 40% of cases (2/5).
CONCLUSIONS. At a University cardiothoracic ICU, inappropriate
aminoglycoside prescribing may have contributed to over half of all
prescribed doses needing to be omitted, increasing the risk of
inadvertent toxic dosing. Department-wide teaching in aminoglyco-
side prescribing and monitoring appeared to be effective in reducing
the incidence of high trough levels and subsequent risk of toxicity.
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INTRODUCTION. Patient´s safety in Intensive Care Units has become
a real concern among care givers. Different tools have been
proposed to reduce errors during everyday care. Real time random
safety audits (AASTRE) is a validated checklist that has 37 safety
measures which are randomly checked in ICU patients in order to
detect and solve errors in many aspects of their health care.
OBJECTIVES. To describe the results of the application of AASTRE in
a 17 bed medical and surgical intensive care unit (ICU) and to
address the feasibility of it.
METHODS. Observational clinical study in which all patients
admitted to the ICU between 01/11/2016 and 28/02/2017 were
included. The AASTRE was performed 2 times a week. Patients who
underwent the audits were randomly selected. 10 out of 37 validated
safety measures grouped in 10 blocks were randomized to be
Table 201 (Abstract 0805). Results of study per group
Patient:physitian
ratio
Nurse:physitian
ratio
SOFA score Length
of stay
(days)
Length
of stay
(days)
Length
of stay
(days)
<= 3 > 3 <= 2 > 2 <= 7 > 7 < 7 7-14 > 14
Potential
total
changes
(% of total)
11.25 28.6 12.89 3.57 22.92 23.82 2.94 5.14 5.97
IPR-AASTRE
(% of total)
7.61 2.17 7.89 3.57 13.6 15.42 7.28 7.85 7.23
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 408 of 542checked in the selected patients. Data are expressed in as means,
medians and proportions, and comparisons are made with Chi-
squared test and Fisher´s exact test as needed.
RESULTS. Number of patient-days 302. Number of measures assessed
1984 of which 617 were not applicable. 30 times were these audits
supposed to be made and 25 times (83.3%) were they actually per-
formed. 3 times it was forgotten and 2 times because of lack of time.
Proportion of changes carried out in patient management as a result
of the application of AASTRE (IPR-AASTRE) 7.89%. Potential total
changes that could have been carried out 11.56% with a difference
between both of 3.67% (CI 95% : 1.97%-6.35%, p < 0.001). IPR-
AASTRE and Potential total changes when occupation above the me-
dian (14 beds) Odds ratio = 0.81 (CI 95% 0.46-1.40, p > 0.05). The
blocks in which IPR-AASTRE and potential changes were the highest
were: mechanical ventilation, treatment, hemodynamics and tech-
niques and tests (Table Error! Reference source not found.).
IPR-AASTRE and potential changes were compared by several groups
such as physitian:patient ratio and nurse:patient ratio showing
contrary results. SOFA score and length of stay do not represent
major changes (Table 201).
CONCLUSIONS
1. The power of the real time random safety audits (AASTRE) to
detect potential measures that have to be checked or modified for
the everyday patient care in this unit is high. The real changes made
after this detection (IPRA-AASTRE) hardly ever reach 100%.
2. A patient:physitcian ratio higher than 3 increases potential
changes but reduces IPR-AASTRE while the opposite happens with
patient:nurse ratio higher than 2.
3. Performance of the AASTRE rounds is feasible in an intensive care
unit like the one tested with a high percentage of accomplishment.
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BLOCK IPR-AASTRE
(% of total)
POTENTIAL TOTAL
CHANGES (% of total)
p
Mechanical ventilation 14.29 23.08 > 0.05
Haemodynamics 5.86 13.28 < 0.05
Renal function an CRRT 2.63 2.63 1
Sedation and analgesia 4.21 11.58 0.06
Treatment 25.58 36.88 < 0.05
Techniques and tests 14.77 18.18 > 0.05
Nutrition 3.23 3.23 1
Nursing care 6.51 8.46 > 0.05
Structure 5.56 7.15 > 0.050806
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INTRODUCTION. It is estimated that 1.5 million preventable adverse
drug events occur annually in the USA with the ICU being
particularly at risk. It is estimated that the average ICU patient has
over 150 activities per day. Although medication administration
accounts for most of the errors in the acute care setting, errors in
prescribing, transcribing, preparing and dispensing medications also
occur. The complex nature of healthcare means that the cause of
such errors are multi-factorial [1, 2]. As a result, it is difficult to pin-
point the problem areas and solutions necessary to avoid prevent-
able medication errors in these settings. We decided to tackle this
issue through a multimodal, multidisciplinary approach in a tertiary
level ICU.
OBJECTIVES. To improve medication safety at all stages of the process:
prescribing to administration and recording.
METHODS. A multidisciplinary medication safety group (MRG)
team reflective of the workforce on ICU was convene under the
leadership of a dedicated ICU pharmacists. A process was
established such that every step of the administration of
medication was re-examined. Error reporting was encouraged
through a no blame culture. Investigation pathways were stream-
lined to ensure that reports and lessons were produced in a
timely fashion. Innovative initiatives were rolled out through the
use of named champions on the shop floor.
RESULTS. In the 2 years prior to the establishment of the MRG, there
were 149 reported medication errors with 1 of moderate harm. In
the year following the establishment of the MRG, the number of
reported errors had increase to 131. Non were graded as severe or
resulting in death. The majority of these reports were near misses
rather than actual errors. Where errors had occurred, these were
primarily during the administration phase although prescribing errors
still occurred.
Initiatives introduced during this period included:
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 409 of 542 Smart electronic prescribing software
 Red aprons to prevent nurse interruptions
 Short "At A Glance" notices highlighting key lessons
 Monthly analysis of error trends
 Staff support and reflection when errors occur
 Representation at senior trust level on medical safety initiatives
CONCLUSIONS. Medication errors are a considerable source of
mortality and morbidity on the ICU. Increased reporting of errors
and near misses are reflective of an open, honest culture within
the organisation. A multidisciplinary and multimodal approach is
required to address the issue. Simple, ground-led initiatives have
the potential to reduce the level of harm without significant in-
vestment in resources.
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INTRODUCTION. The preparation and administration of drugs are a
series of complicated technical skills especially in critical care.
Hence, errors are particularly prevalent during this process. The
consequences of such errors vary from relatively harmless to lethal.
OBJECTIVES. To determine the frequency, typology and impact of
medication's administration and preparation errors in a medical ICU.
METHODS. An EPP study was conducted in an 8-bed tertiary medical
ICU. Data were collected by a trained pharmacist observer who dir-
ectly accompanied nurses during intravenous (IV) or per os (P.O.)
drug rounds between October and December 2015. Details of the
process of preparation and administration of the selected drugs were
compared to an informed checklist which was based on reference
books and manufacturers´ instructions. The medication errors
were classified according to the stage of the medication process
and the impact categorized according to the National Coordinat-
ing Council for Medication Errors Reporting and Prevention (NCC
MERP) taxonomy.
RESULTS. 76 patients were managed within the 3 months study
period. A total of 25 drugs (20 IV and 5 P.O.) were selected for this
study. Were inspected 610 preparations and administrations. Of
those, 96(15.7%) errors were identified : 75(78.1%) in the preparation
process and 21(21.8%) in the administration process. IV antibiotics
were involved in the highest rate of error 54(54.2%) followed by the
cardiovascular drugs 12(12.5%). The most common errors in the
preparation process were: wrong amount of dilution for 39% of the
selected IV drugs, crushing problem for 100% of the P.O. drugs and
not inspecting for expiration date for 52% of all the drugs. The most
frequent errors in the administration stage were wrong time (12%)and incorrect administering rhythm (27%). For respectively 64% and
16% of the screened drugs, the errors were categorized as resulting
in the need for increased patient monitoring but no patient harm
and as an error reaching the patient but did not cause patient harm.
CONCLUSIONS. This study shows that there are more medication
errors in the preparation than in the administration stage. This could
have important implications for critically ill patients safety. Further
educational activities, epidemiological knowledge, detection of
errors, and improvements in performance are needed to reduce the
risk of medication errors.
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INTRODUCTION. There is an increasing demand for inter-hospital
transfers due to centralisation of specialist care without universal
availability of retrieval teams and increasing bed shortages. Currently
there is no single recommended national training course in the UK.1
A preliminary survey of trainees in our department (n = 17) found
that 65% had received formal transfer training and less than 50%
were aware of national guidelines. Inadequacies in training along
with human factors such as working in an unfamiliar environment
and poor teamwork are known to perpetrate incidents.2,3
OBJECTIVES. A one-day, inter-professional simulation course was
aimed at trainee doctors and critical care nurses. Bespoke simulation
was provided by South Western Ambulance Service Network in the
form of a clinical simulation vehicle “simbulance.” The model aimed
to address knowledge of transfer processes and human factors such
as familiarity with the non-hospital environment. Objectives aimed to
improve attendees' knowledge of guidelines and confidence in carry-
ing out transfers by defining risks, demonstrating use of equipment
and stabilisation of patients, and completing documentation.
METHODS. A retrospective survey was carried out anonymously
using a 5-point Likert questionnaire to assess whether each learn-
ing objective was met and to determine the usefulness of training.
The mean for each question was calculated and written feedback
was collated.
RESULTS. We distributed 16 questionnaires and received 15 back.
There was strong evidence to demonstrate that all course objectives
were met as respondents declared high confidence in these (all
means were between 4.2 and 4.6). Participants agreed that they had
learnt (mean 4.6) and organisation was high quality (mean 4.7).
Average confidence levels increased by a point (mean before
training 3.3, after training 4.4). Written feedback was positive and
highlighted areas for improvement including the allocation of lead
nursing roles.
CONCLUSION. Evidence shows simulation improves training in
critical care.4 The need to improve staff preparation for inter-hospital
transfers was met through the development of a “simbulance”
course. We have demonstrated improved learning and satisfaction
amongst attendees and aim to roll out this course biannually to
allow accessibility.
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INTRODUCTION. Use of ICU gassedation with the help of AnaConDa
is new in Norway. Our ICU experienced resistance with the
implementation because we were unsure and negative because
of a lack of training and knowledge.
OBJECTIVES. First we needed to identify the knowledge level of the
ICU staff. What kind of information and training did our staff need to
be confident using this form of treatment? Our ICU department has
dedicated 6 workdays for competence development training per
year, in cooperation with the competence development nurse. We
used time at 2 of those days to ensure our staff got sufficient
knowledge and confidence in using gassedation.
METHODS. We have our competence development days put in a
system. There is an intern training, simulations, theory and practical
education. After the analysis and research of the knowledge gap we
could work towards a targeted training. With this evidence based
practice training we have convinced the staff of the benefits. The ICU
nursing staff is now interested to use the AnaConDa system.
RESULTS. These competence development days has resulted in an
increased use of the AnaConDa device. From an insecure start to
turn it into a positive implementation. We are only having 2 laggards
among 90 ICU nurses. It has been proven that 2 hours theory, and
then practical training with the AnaConDa, has been successful.
CONCLUSIONS. With the help of competence development days put
in a system we can make a positive improvement by staff taking
time to read up in the specific subject and teaching their
colleagues. Using Evidence Based Practice thinking and training
in our department, we now wish to develop training of other
rarely used medical devices due to the successful implementation
with the AnaConDa device.
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INTRODUCTION. In London Critical Care Networks are coordinating
level 1–3 transfers. There are several hundreds of critical care
transfers happening yearly in London area and this number is
expected to be on the rise.
OBJECTIVES. Our aim was to audit the quality of all interhospital
transfers happened in year 2015/16 in our Network (NENC-North EastNorth Central Critical Care Network). Also we wanted to see how
accurately transfers are documented in the newly introduced audit
sheets hoping that we can identify incidents and develop further
learning needs along with a new transfer protocol.
METHODS. We have collected one hundred and two audit sheets
from eight different network hospitals. We audited data of transfer
level, referring team, locations, diagnosis, organ support provided,
comments of the teams and incidents.
RESULTS. We have analyzed one hundred and two audit sheets. The
total number of level 3 transfers was sixty eight (67%), level 2 twenty
six (25%), level 1 three (3%) and we had five (5%) patients where the
data was missing.
We have identified seven (7%) incidents where one was linked to
equipment failure one was indicated as incident but no recorded
reason was given and in five occasions patients have deteriorated.
When we checked on the working diagnosis we found that the
majority of the transfers were done due to neurology and cardiology
reasons (13-13%) followed by gastroenterology and liver problems
(11%) renal (8%) and respiratory (7%) problems.
The working diagnosis was not recorded 40% of the cases.
Urgent transfer was carried out in sixty eight patients ((61%) elective
in twenty one (21%) non clinical transfer was done in only five
occasions (5%).
CONCLUSIONS. Our network within London (NENC) has been
reestablished only a year ago. We carried out this audit to see the
compliance to the current practice and identify the areas where
improvement is much needed.Of serious concern was the significant
lack of data capture despite a standardized transfer form. This may
be due to lack of time when managing a critically ill patient or lack
of introduction to transfer processes in frequently rotating doctors.
Last year we have set up a transfer training course and wrote a new
guideline on critical care transfers.We are liaising with the hospitals
within the network to emphasize the need of better documentation
and capturing all patients undergoing inter hospital transfers and
put a lot of effort to train the frontline staff regularly.
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INTRODUCTION. Arterial catheter is used for continuous
hemodynamic monitoring in the ICU. The catheter is often indwelled
in radial artery, and motion of wrist leads to occlusion of the
catheter, hematoma, bleeding, flare and loss of arterial waveform.
The securement device, StatLock® (C.R. Bard, Inc. NJ), fixes the
catheter at constant angle and reduces the catheter shaking by the
motion of wrist.
OBJECTIVES. We investigated if the securement device prevented
complications related to arterial catheters.
METHODS. This was the prospective randomized controlled study in
a 10-bed medical-surgical ICU. We included patients 18 years or older
who were expected to be inserted catheter in radial artery more than
2 days. They were randomly assigned to a securement device group
(StatLock®) or control group. In the control group, catheter was se-
cured by dressing tape (IV 3000 ®, Smith& Nephew). We recorded
complications related to arterial catheters, bleeding, flare, and loss of
arterial waveform. In addition we evaluated bacterial contamination
of the catheters.
RESULTS. From May 2012 to October 2015, the catheters of 183
patients were included in this study. Twenty three patients were
excluded due to short duration of arterial catheter insertion or poor
records. Eighty samples in StatLoc group, 80 samples in control
group were evaluated. Age, APACHEII score and the catheter-
insertion period were not different between the groups. The inci-
dence of complications was significantly lower in StatLoc group
(26.3% vs 12.5%; p = 0.028). Bacterial contamination did not differ
between the groups (7.5% vs 6.3%; p = 0.75).
CONCLUSIONS. We investigated if arterial catheter securement device
prevented the complications at the arterial catheter insertion site. The
incidence of complications significantly decreased with the device.0812
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INTRODUCTION. The use of radiation is associated with a risk of
causing skin or eye damage and inducing malignant disease.
However, most interventional cardiologists neglected protection of
radiation exposure to the patients or operators.
OBJECTIVES. This study aimed to improve protection of radiation
exposure to the patients received percutaneous coronary intervention
via multidisciplinary care.
METHODS. A multidisciplinary team, including interventional
cardiologists, intensivist, dermatologist, radiation technicians and
nursing staffs, was organized since Jan, 2016. The patients were
divided into three groups: pre-interventional group (n = 61) from
March to November 2016, Interventional group (n = 48) from Decem-
ber 2016 to January 2017 and post-interventional group (N = 42)
from February to March 2017. The early mobilization is defined as
mobilization within 48 hours after admission. The key interventions
include reduce frame rate of fluoroscopy with 15 frames/seconds
instead of conventional 30 frames/seconds, reduce frame rate of
video recording with 7.5 frames/seconds instead of conventional 15
frames/seconds, guideline for radiation protection and innovative
head, eye and neck protection device. A P-value < 0.05 was consi-
dered statistically significant.
RESULTS. The baseline characteristic of three groups did not
differ in age, body weight, body height or fluoroscopy time. The
eye radiation dose of patients improved from 4.5 ± 4.0 mSV in
pre-interventional group, to 2.3 ± 2.5 in interventional group and
0.9 ± 0.7 mSV in post-interventional group (p < 0.001). The neck
radiation dose of patients reduced from 17.5 ± 16.6 mSV in pre-
interventional group, to 8.2 ± 8.8 in interventional group and
4.8 ± 4.2 mSV in post-interventional group (p = 0.001). The back
radiation dose of patients reduced from 189.4 ± 292.1 mSV in
pre-interventional group, to 48.2 ± 54.2 in interventional group
and 43.6 ± 56.1 mSV in post-interventional group (p = 0.004).
The radiation dose of doctors reduced from 2.07 ± 1.46 mSV in
pre-interventional group, to 1.30 ± 1.29 in interventional group
and 1.46 ± 0.71 mSV in post-interventional group (p = 0.036).
CONCLUSIONS. This study demonstrates multidisciplinary with
lower radiation protocol and innovative protection device can
reduce eye, neck and back radiation dose at percutaneous
coronary intervention. Furthermore, the radiation dose of doctors
also reduced.
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INTRODUCTION. There is a significant risk associated with infusion
technology in the critical care setting. Due to limited vascular access,
Fig. 270 (Abstract 0813). Physical Effect
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set and catheter. This practice is called multi-infusion. Within the
completed Metrology for Drug Delivery (MeDD) project1, we have
gathered ample evidence that multi-infusion is associated with
dosing errors due to ambiguous physical effects (e.g. Fig. 270).2
Despite the fact that many of these dosing errors are due to
technical properties, they can be mitigated or even prevented if
multi-infusion users (physicians, nurses, technicians) are given
proper and comprehensive training.
OBJECTIVES. To develop a useful multi-infusion training e-learning
course.
METHODS. First, we gained insights in the physical mechanisms of
multi-infusion through systematic literature analysis2, experimenta-
tion and modelling. Next, a “survey of best practices”, in which
healthcare professionals were surveyed, was used to list the current
practices in infusion therapy and identify the potential niche where
education is required. Surveying professionals is continued during
the development of the e-course.
RESULTS. It was decided to develop a multi-infusion training e-
course using the ESICM e-learning platform. From surveying clini-
cians, the consensus was that the course should fundamentally
be presented from a clinical perspective. Consequently, our pre-
liminary results present ten realistic critical care cases resulting in
adverse events due to physical effects. Each case will consists of
approximately ten multiple choice questions. The topics range
from basic drug concentration and flow rates relationships, to a
profound understanding of the implication of the common (dead)
volume, i.e. the volume between a mixing point and the outflow
into the patient. The learners will be supported by illustrative art-
work and some textual theory. We plan to present the prelimi-
nary results of the e-learning course on site and at congresses.
This will enable us to continuously improve the content through-
out the development phase.
CONCLUSIONS. The preliminary results have been presented to
clinicians, who stressed the importance of an e-learning course about
multi-infusion. We will continue development accordingly.
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complication in early postoperative (PO) period after abdominal
surgery. Administration of enteral nutrition (EN) in patients'
undergone surgical interventions is most difficult decisions in
abdominal surgery. IF is one of the cause in development of
multi-organ failure & adverse outcomes.
OBJECTIVES. To evaluate effectiveness of various substrates for early
enteral administration as prophylaxis for IF in PO patients.
METHODS. Study included 52 patients who underwent various
emergency abdominal interventions. Patients are divided into 3
groups using single blind study method:
Group 1: 17 patients who received enterally glutamin (500 ml) on
2nd day, received EN on 3rd day.
Group 2: 17 patients, on 2nd day administration EN (semi-elemental
feeding diets, 100–300 ml).
Group 3: 18 patients, on 2nd day enteral administration of saline
solutions (Trisol: 500–800 ml - consist of KCl, NaHCO3, NaCl), 3
rd
day- EN.
In PO period, following parameters were evaluated: auscultative
assessment of peristalsis, measurement of intra-abdominal pressure
(IAP), ultrasound visualization of intestinal structures, absorption
function of GIT according to amount unabsorbed enteral volume.
RESULTS. IF stage in PO period was determined by classification
developed during study, including clinical signs of intestinal paresis,
IAP & ultrasound imaging of intestines. Suggested 1st, 2nd, 3rd
degrees of IF. At stage 1 of study, when comparing severity of IF on
3rd day of PO period, patients in group 1 were found to have least
signs of IF (mean value- 1.8 ± 0.68). In patients of 2nd group, IF was
more pronounced (2.17 ± 0.2). Differences between groups are not
significant (p > 0.05). Patients of group 3, IF was most pronounced
(2.8 ± 0.3). Differences between 2nd & 3rd, between 1st & 3rd groups
are significant (p < 0.05).
Manifestation of IF is characterized by several factors, such as IAP,
intestinal wall thickness, intestinal lumen diameter. To determine
most informative factor, a correlative analysis was performed. It has
been revealed that strong & medium strength correlations found
between degrees of IF & level of IAP, between degrees of IF &
intestinal wall thickness. Connections are statistically significant (at
the level of 0.01). Since to determine thickness of intestinal wall by
ultrasonic scanning requires special skill of an anesthesiologist &
ultrasound machine, which is not always possible to realize in
intensive care departments, determining level of IAP acquires special
significance. Level of IAP in group 1 is 13.7 ± 1.35 cm. In 2nd group,
16.7 ± 2.4 cm. In 3rd group −19.3 ± 1.6 cm (p > 0.05).
CONCLUSIONS. IAP can be used as prognostic indicator of
postoperative IF & use it to determine PO nutritional therapy, which
must be initiated with administration of enteral glutamine.
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INTRODUCTION. The critical patient care environment is extremely
complex. In Intensive Care Medicine,factors such as the seriousness
of the patient condition,the commu- nication barriers,the invasive
therapeutic and diagnostic procedures used,and the volume of
information managed all contribute to the appearance of
incidents related to patient safety. Some of them can causetemporary damage requiring additional observation and care,
prolonging hospital stay and-in some cases-causing permanent
damage or even death.
OBJECTIVES. Analysis of Regional System of incidents without
damage (SISNOT) registrated in ICU. Evaluate contributing factors
(CF) and improvement strategies to consolidate the safety culture
in our ICU.
METHODS. Prospective observational descriptive study from
December 2012 to January 2017. We describe these variables: types
of incidents without damage (IWD), day of the week and shift with
greatest number, severity of potential damage: Mild (minimum
damage: more observation or minor treatment), moderate (short-
term damage: additional treatment or procedure) and severe
(permanent or long-term damage). We describe CF in each group
and the suggested improvements.
RESULTS. IWD were registered in this period. The most frequent
ones belong to patient care (Group 1: 22.8%), drugs errors (Group2:
22%), related to equipment and devices (Group 3: 16.9%) and
Diagnosis and clinical follow-up (Group 4: 10.2%). About potential
damage: 16.7% without damage, 29% mild severity, 39.2% moderate
and 13.7% severe. Mondays (18.4%) and Thursdays (16.9%) were
days with higher risk of IWD.
In morning shift happens 52.2%. The CF grouped by type of IWD
were: Groups 1,2 and 4: teamwork problems (18.2%, 12.3%, 22.3%)
and lack of communication (16.7%, 33.2%, 32.5%). Group 3: factors
about patients (23.5%), equipment and devices (28.8%).
Suggested improvements were: Log and plan tasks in group 1
(62.6%) and 3 (63.4%). Improve communication between professionals
in group 2 (51%) and 4 (43.8%).
CONCLUSIONS. The most frequent IWD were: patient care and drugs.
The moderate potential damage notifications showed the highest
incidence. An increase of IWD was detected in the highest medical
activity periods. The main CF were the teamwork problems and
communication skills. Suggested improvements were based on the
protocolization, task planning and professional communication skills.
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INTRODUCTION. Peripherally Inserted Central Catheters (PICCs) are
used for long term IV access in critically ill patients1 to deliver
intravenous (IV) medications, parenteral nutrition and govern contrast
administration. PICCs are associated with fewer complications than
central lines and should avoid recurrent phlebotomy2. However,
patients with PICCs frequently receive additional IV access, defying the
purpose of PICCs as alternatives to cannula insertion. Peripherally
inserted cannulas may be unnecessary and associated with increased
infection risk3.
OBJECTIVES. This audit investigates how often IV cannulas are
inserted additionally in patients with PICCs.
METHODS. In February/March 2017 all critical care patients with
PICCs were included. A data collection table was completed for each
patient with new/indwelling PICCs, including identifiers, date of PICC
insertion, additional IV access, and PICC line integrity. Additionally, all
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 414 of 542peripheral IV cannula access was recorded to investigate adequacy
of documentation, insertion origin and time in-situ.
RESULTS. 21 PICCs were inserted in 18 patients. 23.8% of patients
with PICCs required additional intravenous access, most often in the
form of a cannula (19%) or a central line (4.8%). Blocked PICC lumens
were reported in 30%. The most common reason for extra cannula
insertion was for contrast injection (66.7%), followed by intravenous
medications administration (33.3%) for which the number of PICC
lumens were insufficient.
78.4% of cannulas were documented appropriately. 39% of cannulas
were inserted outside critical care, most commonly in the emergency
department (41%), and remained in-situ for a mean of 2 days (SD = 1.41).
CONCLUSIONS. This study suggests almost a quarter of patients with
PICCs receive additional IV access, mainly for contrast injection.
Careful planning of the patients' treatment needs, including contrast
imaging, is required to choose the optimal PICC before insertion.
Patients on numerous intravenous medications may require devices
with multiple lumens. Modern PICCs with options to use high
pressure injection should be chosen for patients requiring imaging
with contrast agents. More attention should be paid to the correct
documentation and timely removal of intravenous devices after
successful insertion of PICCs to further reduce infection risks.
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INTRODUCTION. New sepsis definitions focus on suspected infection
and organ damage (1). No point-of-care tests currently exist to pre-
cisely define infection presence and severity. Inflammation and co-
agulation are closely linked: thrombotic and bleeding complications
often occur during sepsis and septic shock, resulting in increased
mortality. Thromboelastography (TEG®) and point-of-care viscoelastic
methods quickly assess the whole coagulation process and seem to
be correlated with disease severity in septic patients (2,3). Surviving
Sepsis Campaign reconsidered the role of biomarkers, but Presepsin
and Copeptin displayed potential correlation with sepsis and its
complications.
OBJECTIVES. To investigate the diagnostic and prognostic role of
seriated TEG, Presepsin and Copeptin, in patients admitted to
Intensive Care Units (ICUs) with sepsis.
METHODS. This is a multicenter prospective observational study
conducted in 4 Italian Hospitals. Adult patients with sepsis/septic
shock admitted to ICU were included. Conventional blood tests, TEGanalysis and biomarkers were obtained at admission (T0), after 72
hours (T1) and after 7 days (T2). Bleeding events, transfusions
requirement, clinical data and scores were recorded up to day 7.
ICU/hospital length of stay and 28 and 90-days-mortality were
recorded.
RESULTS. The study is currently ongoing, 43 patients (M/F = 29/14;
mean Age = 67, 95%CI 63–72) have been enrolled so far. Preliminary
results report four cases of bleeding at T0 (9%) and 6 overall (14%).
Patients with lower MA values at TEG displayed more bleeding
events and higher need of transfusion at T1 and T2. Patients who
died within 28 days reported lower MA levels than surviving
(56.2 ± 23.8 vs 81.2 ± 5.9, p < 0.05). A pattern of hypocoagulability
(MA ≤ 51mm) seems associated with longer ICU [30 (25–42) vs 11
(9–13) days] and hospital length of stay [37 (29–39) vs 28 (20–33),
p < 0.05]. Data regarding Copeptin and Presepsin are preliminary
and currently under investigation.
CONCLUSIONS. According to our preliminary analysis lower MA
measured by TEG seems to be associated with an increased risk of
bleeding and need of transfusion in patients with sepsis/septic
shock. Moreover, an hypocoagulability status among septic patients
correlates with an increased mortality rate and longer ICU and
hospital length of stay.
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INTRODUCTION. The recent Sepsis-3 provides a change of 2 or more
points in the Sequential Organ failure assessment (SOFA) score and
quick SOFA (qSOFA) as the clinical criteria and risk assessment for
sepsis patients instead of using the Systemic Inflammatory Response
Syndrome (SIRS) by Sepsis-1.
OBJECTIVES. The aim of this study was to validate and compare
performance of SOFA and qSOFA with SIRS to predict the outcomes
in sepsis patients.
METHODS. A retroprospective analysis was conducted of prospectively
collected data from all consecutive sepsis patients admitted to the
medical intensive care unit of a tertiary university teaching hospital
in Thailand from 2007 through 2016. The primary outcome was
hospital mortality and the secondary outcomes were ICU mortality
and organ failures.
RESULTS. A total of 2,234 patients were included. Mean age was
58.7 ± 20.3 years, mean APACHE II was 23.6 ± 9.8 and mean SOFA
score was 8.6 ± 4.4. The sources of ICU admission were from general
wards (58.4%) and the emergency department (41.6%). The most
common sources of infection were respiratory (50.1%). Microorganisms
were isolated from hemocultures in 670 patients (30%) and
documented from any sites of infection in 1,738 patients (77.8%).
The hospital and ICU mortality rate was 44.4% and 32.1%,
respectively. Organ failure was documented in 2,060 patients
(92.2%). The SIRS criteria were met by 2,156 patients (96.5%), 1,998
Fig. 273 (Abstract 0818). Comparison of ROC curves for prediction
of hospita
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met SOFA criteria (Fig. 271). Overall, 1,918 patients (85.5%) had
both criteria for Sepsis-1 and Sepsis-3 definitions. However, 200 pa-
tients (9.3%) and 77 patients (3.6%) met the SIRS criteria but not
the qSOFA and SOFA criteria, respectively, and 39 patients (1.8%)
met neither the SOFA nor qSOFA criteria. In contrast, 66 patients
(3%) met Sepsis-3 criteria but not SIRS. Patient with did not met
SIRS criteria had the highest hospital and ICU mortality as well as
more organ failures (Fig. 272). The SOFA score presented the best
discrimination with an area under the receiver operating character-
istic curve (AUC) of 0.836 (95% CI 0.819-0.853). The discrimination
of the SOFA score for hospital mortality was significantly higher
than the qSOFA (AUC 0.799, 95%CI 0.782-0.816, P = 0.0001) and
SIRS (0.585, 95%CI 0.564-0.607, P < 0.0001) (Fig. 273). The qSOFA
showed better discrimination for hospital mortality than SIRS
(P < 0.0001). Also, SOFA score had better performance than other
scores for the secondary outcomes and all subgroups of sepsis pa-
tients according to age, sepsis severity and admission source.
CONCLUSIONS. The SOFA score presents better prognosis accuracy
for mortality and organ failures than the qSOFA and SIRS criteria
among sepsis patient admitted to ICU. Our findings support for
Sepsis-3 using SOFA in ICU setting.Fig. 272 (Abstract 0818). Mortality and organ failures in ICU
sepsis patient
Fig. 271 (Abstract 0818). Diagram representing distribution of SIRS,
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INTRODUCTION. A decrease in lactate levels during septic shock
resuscitation is associated with favorable outcomes. Previous studies
proposed different desirable rates of lactate decrease (mostly 10-
30%) over a variable time period (mostly 6 hours)1. However, op-
timal change rate of lactate values over shorter time intervals are
not well studied.
OBJECTIVES. The aim of this pilot study was to identify which
percentage of lactate change in a 1-hour period best determined
mortality in septic shock patients. The second aim was to examine
how this hourly rate is associated to other clinical parameters in rela-
tion to mortality.
METHODS. This is a retrospective study of patients admitted in an
intensive care unit (ICU) of a university hospital during 2015. All
patient information was retrieved from ICU and hospital electronic
medical record. Adult (>18 years) patients with a septic shock
diagnosis were included using these criteria 1) infection-related
primary diagnosis 2) hypotension receiving vasopressors 3) initial
lactate at ICU ≥ 2 mmol/L. Lactate values were obtained until
normalization (≤1.5 mmol/L) or last measurement within 24
hours, if no normalization occurred. Percent average hourly
change rates (LAH) were calculated from all consecutive lactate
values of each individual.
RESULTS. Of 693 ICU patients admitted, 60 patients met the
inclusion criteria. The most common source of sepsis was
intraabdominal infection (32%). Median age, Sequential Organ
Failure Assessment (SOFA) score, baseline lactate values were 65(56–
73) years, 10(7–13) and 4.0(2.7-7.4) mmol/L, respectively. ICU and 30-
day mortality rates were 18% and 33%. Within 24 hours, 678 lactate
measurements were used in the analysis. Receiver operating charac-
teristic (ROC, SPSS) curves of LAH, baseline lactate values and SOFA
score demonstrated that LAH was the best indicator of 30-day
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 416 of 542mortality (area under ROC curves (AUC) 0.763, 0.704 and 0.645, re-
spectively). The best cutoff value of LAH was −2.65% with sensitivity
85% and specificity 60%. Univariate comparison of all variables re-
vealed that older age, higher creatinine, higher baseline lactate,
higher lactate at 6 hours and LAH > −2.65% (mean of lactate de-
crease < 2.65% per hour) were significantly associated with mortality
(all, p < 0.05). After adjustment in multivariable logistic regression,
older age, higher baseline lactate and LAH > −2.65% were independ-
ent factors of 30-day mortality (OR 1.139, 95%CI 1.042-1.244,
p = 0.004; OR 1.381, 95%CI 1.078-1.770, p = 0.011 and OR 7.751,
95%CI 1.462-41.099, p = 0.016, respectively).
CONCLUSIONS. Mean lactate reduction less than 2.65% per hour
during first 24 hours, higher baseline lactate values and older age
were independently associated with 30-day mortality in ICU septic
shock patients.
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INTRODUCTION. Prognostic models of illness severity are useful both
clinically and for research purposes. A specific tool for prognostication
in critically ill patients with faecal peritonitis is not available.
OBJECTIVES. We aimed to develop two prognostic models, for the
prediction of 6 months and 28 day mortality of post-operative critic-
ally ill patients with faecal peritonitis
METHODS. Patients admitted to intensive care units with faecal
peritonitis and recruited to the UK GAinS or European GenOSept
studies up to January 2011 were divided into a derivation and an
geographic validation subset; patients subsequently recruited to
GAinS were used for temporal validation. Using all 50 clinical and
laboratory variables available on day 1 of critical care admission, Cox
proportional hazards regression was fitted to select variables for
inclusion in the prognostic model, using stepwise selection and non-
parametric bootstrapping sampling techniques. Using Area under the
Receiver-Operator Characteristic curve (AuROC) analysis, the perform-
ance of the models was compared to SOFA and APACHE II.
RESULTS. Five variables (age, SOFA score, lowest temperature,
highest heart rate, haematocrit) were entered into the prognostic
models. The discriminatory performance of the 6 month prognostic
model yielded an AuROC 0.81 (95% Confidence Interval, CI, 0.76 -
0.86), 0.73 (95% CI 0.69 - 0.78), and 0.76 (95% CI 0.69-0.83) for the
derivation, geographic and temporal external validation cohorts,
respectively. The 28 day prognostic tool yielded an AuROC 0.82 (95%
CI 0.77 - 0.88), 0.75 (95% CI 0.69 - 0.80) and 0.79 (95% CI 0.71-0.87)
for the same cohorts. These AuROCs were superior to those obtained
with the SOFA and APACHE II scores.CONCLUSIONS. The two prognostic models developed for 6 month
and 28 day mortality prediction in critically ill septic patients with FP, in
the post-operative phase, enhanced the SOFA score´s predictive utility
by adding few key variables: age, lowest recorded temperature, highest
recorded heart rate and haematocrit. Before considering introduction
of the scores into clinical practice to inform decision making and the
design of clinical trials, it is necessary to conduct external validation in
larger cohorts of their predictive capability.
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INTRODUCTION. There are no early clinical signs suggesting mild
acute respiratory distress syndrome (ARDS). Lately, pulmonary
vascular permeability index (PVPI) and extravascular lung water index
(EVLWI) are being focused on as indicators of mild ARDS.
OBJECTIVES. Investigating PVPI and EVLWI dynamics in development
of pulmonary oedema in patients with sepsis by PiCCO monitoring.
METHODS. It was a 3-years-duration prospective observational study
at Zagreb University Hospital Center. Examined group: 50 patients
(29 male, age 55 ± 11yrs and 21 female, age 50 ± 10yrs) after urgent
abdominal surgery, with mild ARDS. Control group: 50 patients (28
male, age 46 ± 9yrs and 22 female, age 45 ± 10yrs) after urgent sur-
gery, without mild ARDS. Diagnosis of sepsis was established both
clinically and by laboratory findings, mild ARDS was defined by Berlin
definition. All patients were mechanically ventilated and analgose-
dated with midazolam and sufentanil applied via syringe pump sys-
tem. PVPI and EVLWI measurements were obtained (in both study
groups) three times a day in the same 8-hours interval for seven con-
secutive days by PiCCO monitoring (Dräger Infinity R PiCCO Smart
Pod TM 2005). A 4F arterial thermodilution catheter (Pulsiocath
PV2014L16N) was placed in the aorta via femoral artery using Seldin-
ger technique. Concomitantly, oxygenation ratio (PaO2/FiO2), lung
compliance and albumin levels were assessed. APACHE II score was
22.78 ± 3.62. Both measured and calculated data were statistically
processed using Smirnov-Kolmogorov test and independent T-test.
Values of P < 0.05 were considered statistically significant.
RESULTS. From examined group, 21 patients died before day 28.
There was no statistical difference in PVPI and EVLWI between
examined and control group during first 72 hours. The average PVPI
was 2.2 ± 0.37 and EVLWI at baseline was 11 ± 4. After day 3, PVPI
and EVLWI was significantly higher in non-survivors than survivors
(3.93 ± 0.72 vs. 1.90 ± 0.38; P < 0.001 and 14.67 ± 4.64 vs.
6.41 ± 0.84; P < 0.001). PVPI was correlated to PaO2/FiO2 (r = −0.300;
P < 0.001), lung compliance (r = −0.643; P < 0.001) and albumin
levels (r = −0.375; P < 0.001).
CONCLUSIONS. PVPI and EVLWI in patients with sepsis demonstrated
correlation with markers of mild ARDS. Dynamics of PVPI and EVLWI
could be outcome indicators for patients with mild ARDS in sepsis.
PVPI is more accurate than EVLWI as an indicator and correctly
reveals the degree of pulmonary vascular permeability and levels of
serum albumin. Reduction of PVPI and EVLWI in early treatment
period was associated with better patient outcome.
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BACKGROUND. We aimed to select and combine clinically feasible
parameters comprehensively reflecting the pathogenesis of sepsis to
predict 28-day mortality in severe sepsis, which includes SOFA score
(organ functionality), serum lactate (tissue perfusion), procalcitonin
(PCT) (the severity of infection) and C-reactive protein (CRP) (host im-
munologic response).
METHODS. A total of 124 patients diagnosed as severe sepsis were
finally enrolled in our study. Peripheral blood specimen was obtained
immediately at admission before the administration of antibiotics,
and SOFA score was recorded simultaneously. Serum lactate, PCT
and CRP levels were measured. All the patients were treated
uniformly by our clinical work-team, and followed up to 28 day, with
28-day mortality as the primary outcome.
RESULTS. SOFA score, lactate and procalcitonin were significantly
elevated in non-survivor group and could predict 28-day mortality.
Receiver operating characteristic (ROC) curve indicated that area
under ROC (AuROC) was 0.686 (SOFA score) > 0.67 (lactate) > 0.611
(PCT) > 0.529 (CRP). Combined use of SOFA score, lactate, PCT and
CRP via Cox proportional hazards model revealed the increment of
AuROC from the maximum of 0.686 (SOFA score) to 0.706.
Net reclassification index (NRI) analysis showed that the combination
is superior to any of single use of the parameters, and the addition
of lactate to the combined model could significantly improve the
predictability of the 28-day mortality in severe sepsis.Models NRI (95% CI) P valueSOFA vs. SOFA + Lac + PCT + CRP 0.39 (0.02, 0.75) 0.04Lac vs. SOFA + Lac + PCT + CRP 0.46 (0.10, 0.82) 0.02PCT vs. SOFA + Lac + PCT + CRP 0.58 (0.22, 0.93) 0.002
Fig. 275 (Abstract 0822). AuROC comparisonCRP vs. SOFA + Lac + PCT + CRP 0.55 (0.20, 0.91) 0.004Lac + PCT + CRP vs. SOFA + Lac + PCT + CRP 0.34 (−0.03, 0.70) 0.08SOFA + PCT + CRP vs. SOFA + Lac + PCT + CRP 0.43 (0.08, 0.78) 0.02SOFA + Lac + CRP vs. SOFA + Lac + PCT + CRP 0.10 (−0.28, 0.47) 0.6SOFA + Lac + PCT vs. SOFA + Lac + PCT + CRP 0.17 (−0.20, 0.54) 0.38[NRI]
CONCLUSION. The combination of SOFA score, lactate, PCT and CRP
could improve the predictability of 28-day mortality in severe sepsis,
and was superior to any single use of the parameters. However, the
accuracy for the current biomarkers are still inadequate, and the
combined use of the burgeoning novel biomarker reflecting the
pathogenesis of sepsis may potentially improve the accuracy in sep-
sis diagnosis and stratification, which needs further elucidation.0823
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INTRODUCTION. Sepsis is a clinical syndrome characterized by systemic
inflammation due to infection, with a continuum of severity ranging
from sepsis to septic shock. Timely and appropriate recognition and
treatment can reduce in-hospital mortality and morbidity.
OBJECTIVES. To analyse the impact of duration of hypotension on
mortality of patients with sepsis/septic shock.
Table 202 (Abstract 0824). Severe Sepsis and Septic Shock and
blood lactate
Variables Lactate < 2
N=194
Lac= 2-2.91
N=193
Lac= 2.92-4.34
N=193
Lac>4.34
N=194
Age (years) 63 [46-73.25] 65 [53.5-75] 62 [49-72] 65 [54-72]
*APACHE II 22.5 [16-27] 23 [19-28] 24[20.75-29] 27 [23-31]
*SOFA 8 [7-10] 9 [7-11] 9 [8-11] 11 [9-13]
*Lactate
(mmol/L)
1.53 [1.29-1.84] 2.46 [2.22-2.65] 3.59 [3.2-4] 6 [4.99-7.72]
**28 day-
Mortality (%)
13.7 20.3 24.9 48.2
SSh (%) 75.1 83.9 89.6 91.2
SSh Septic Shock, Lac Lactate
(*) Kruskal-Wallis, p=<0,05, (**) X2 test, p=<0,05
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 418 of 542METHODS. A prospective study performed between September 2010
and September 2012, in medical six-bed intensive care unit in Clinical
Center University of Sarajevo. A total of 116 patients were admitted
to the ICU during the study period. Analysis of clinical and labaratory
variables (including duration of hypotension, creatinin, lactates, dur-
ation of mechanical ventilation) between survivors and nonsurvivors,
was performed.
RESULTS. Analysis of association of procentage of survivors in
relation to time intervals (hours) showed the continual declination of
surviving rate depending on duration of hypotension. Survival was
86% if effective antimicrobials were administered within 60 mins of
initial evidence of hypotension, 71% in the second hour and 20% in
eighth hour. The area under the ROC curve, calculated only for
duration of hypotension, as discriminatory variable for lethal
outcome, was AUC=0.848 (p<0.0001). Duration of hypotension more
than critical 5 hours showed sensitivity of 73.3%, specificity of 84.4%,
positive predictive value (PPV) 88.1% and negative predictive value
(NPV) 66.7% to the lethal outcome, with the + LR 4.7 and -LR 0.32.
Multiple logistic regression analysis showed that basic predictive
variable in this model was duration of hypotension, with age as
contributing factor to the lethal outcome.
CONCLUSIONS. Our data strongly support current international
guidelines, with accent on early validation of hypotension as first
and the most important step in strategy for early recognition,
diagnosis and appropriate treatment of criticaly ill patient.
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INTRODUCTION. The measurement of the lactate levels can be
helpful in the diagnosis and assessment of the sepsis, as well as to
measure its control.
OBJECTIVES. To analyze the relation of lactate as biomarker of easy
measurement with sepsis scores and mortality in critically ill adults
patients who have admitted in intensive care unit (ICU) with organic
disfunction.
METHODS. It is a cohort study in critically ill adults admitted in a
polivalent ICU. Demographic, clinical parameters and Lactate within
24 hours were studied from severe sepsis (SS) or septic shock (SSh)
onset, defined according to the Surviving Sepsis Campaign (SSC)
criteria (2012).
We tested for differences in baseline characteristics by lactate
interval using a Kruskal-Wallis test for continuous data or X2 test for
categorical data and reported the median and interquartile ranges.
SPSS version 18.0.
RESULTS. We analysed 780 consecutive episodes of SS (15.8%) or
SSh (84.2%). The median age was 64 (inter-quartile range [IQR]:51–
73) years old; male: 60.7%. The main sources of infection were:
respiratory tract 36% and intra-abdomen 30.9% and 67% hadmedical pathology. APACHE score was 24 [20–29] and SOFA score 9
[7.25-11], mortality was 27.43%.
The median lactate levels were significantly higher in non-survivors
2.6 [1.8-3.73] vs. 4.21 [2.6-6.86],
p < 0.001. AUC values was 0.75 (95% CI: 0.69-0.81) with an optimal
cut-off value of 3.7 mmol/L (76.3% sensitivity and 62% specificity).
Quartiles of blood LT concentration were quartile 1 (Q1): 2 mmol/L
or less, quartile 2 (Q2): 2.01-2.91 mmol/L, quartile 3 (Q3): 2.92-4.34
mmol/L, and quartile 4 (Q4): 4.35 mmol/L or greater (Table 202). The
median Lactate concentrations of each quartile were 1.53 (Q1), 2.46
(Q2), 3.59 (Q3), and 6 (Q4) mmol/L (P < 0.001).
The differences between these quartiles were that the patients in Q1
had significantly lower APACHE II scores (p = 0.003) and SOFA score
(p = 0.02) compared with patients in Q2, Q3, and Q4. The patients in
Q4 had significantly higher APACHE II scores (p = 0.0001), SOFA
score (p < 0.001) and ICU mortality (p = 0.005) compared with the
others quartiles. Patient in Q1 had majority respiratory tract infection
source (46.6%) and significantly less SSh patients (p = 0.01) and Q4
had significantly more SSh patients (p = 0.03) and the main sources
of infection were intra-abdomen (41.9%), p = 0.042.
CONCLUSIONS. This study confirms the lactate as prognosis
biomarker in sepsis and good relation with severity scores and
mortality.0825
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INTRODUCTION. Lactate can represent tissue hypoperfusion in sepsis
and septic shock. Early identification of patients at greater risk
for a poor outcome may allow for resource allocation to manage
these patients.
OBJECTIVES. The study purpose was to determine the association of
serum lactate values within 24 hours of intensive care unit (ICU)
admission with mortality in sepsis and septic shock.
METHODS. This was an IRB-approved, single-center, retrospective,
observational study of patients admitted to an ICU between Sep-
tember 2012 and May 2015. The primary endpoint was in-hospital
mortality. Patients were at least 18 years of age and possessed a
diagnosis of sepsis or septic shock. Categorical data were analyzed
using Chi-squared or Fisher Exact tests. Continuous data were ana-
lyzed with one-way ANOVA. Multivariate logistic regression analysis
was performed using forward selection (p < 0.05 used for variable
entry into the model) to evaluate variables associated with in-
hospital mortality.
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n = 223), intermediate (2- < 4 mmol/L, n = 141), and high lactate (≥4
mmol/L, n = 125). Patients in the high lactate group had higher
SOFA and APACHE IV scores and rate of septic shock (72.8%).
Average lactate values were 1.29, 2.78, and 8.06 mmol/L,
respectively. Compared to low lactate, high (odds ratio (OR) 2.151,
95% confidence interval (CI) 1.247-3.708, p = 0.0059) but not
intermediate lactate (OR 1.248, 95% CI 0.732-2.129, p = 0.416) was
associated with increased in-hospital mortality.
CONCLUSIONS. Patients with sepsis or septic shock with a high
serum lactate were 2.15-times as likely to experience in-hospital mor-
tality than those with a low serum lactate. Serum lactate monitoring
is useful for risk assessment in patients admitted to the hospital with
sepsis or septic shock.
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INTRODUCTION. Septic shock maintains high mortality. Certain
patient related factors, like lymphopenia, may be investigated in
order to use it as prognostic biomarker.
OBJECTIVES. The objective of this study is to valuate the lymphopenia
as a biomarker of unfavourable prognosis in patients with septic shock.
Our aim is to establish relation between lymphopenia and mortality
and the requirement of vasoactive support on the fourth day of
ICU admission.
METHODS. Retrospective study including patients with sepsis of any
source of infection that requires ICU admission during the period
2008–2014. We defined lymphopenia < 700 lymphocytes x103cells/
microL in those patients with leucopenia (leucocytes < 3000x103cells/
microL). The relation between the presence of lymphopenia and exits
was calculated by Chi Square. To graduate severity of illness we used
APACHE score.
RESULTS. There were included 163 patients with septic shock, with
abdominal focus in 61 cases (37.4%) and respiratory focus in 47
cases (28.8%). Severity at admission in ICU was APACHE median 19
(26.06-11.97). At admission, 94 patients (54.9%) needed vasoactive
support that was maintained on day 4 of admission in 49 of those
patients (34.3%). The mortality rate was 69.65%, 32 cases.
In 46 episodes (28.2%) we found lymphopenia at ICU admission, 19.4%
of those maintained the same situation at day 4 of admission. We found
a statistical significant significance between lymphopenia at admission
and mortality (p < 0.05). In addition, in those cases where lymphopenia
persisted on the fourth day of admission (31 cases, 19.4%),
tendency of mortality reaches 77.4% (24 the cases) (p < 0.05).
CONCLUSIONS. Our results suggest that septic shock patients with
lymphopenia at ICU admission may have higher risk of mortality.
That risk increases if lymphopenia persists on day 4 of admission
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OBJECTIVES. The objective of this study was to evaluate variables
related to mortality of aged patients, with severe sepsis and septic
shock in the ICU of secondary level hospital.
METHODS. This is an observational retrospective cohort from
January 2008 to June 2016, in an ICU of a secondary level
Hospital in Barcelona.
Sepsis/septic shock patients of any etiology, > 70 years old, that
required ICU admission were included. Patients with order DNR or
limitation in vital support at admission were excluded. A descriptive
analyses of the patient's demographic characteristics was performed.
The main group was divided into two groups, below and above 80
years of age.
A multi variate analyses to determinate intra hospital mortality risk
factors and at 90 days of admission for each group was performed.
P < 0,05 was considered as significant. Statistic SPSS 24 Statistics IBM
was used.
RESULTS. 152 patients above seventies were included. The global
mortality intra hospital was 32% and at 90 days was 44%.
The characteristics of each group were: below 80 y: mean age 74,8
+/− 3,1 with intra hospital mortality 33,7% and 46,5% at 90 days,
while above 80 y were mean age 83,65 +/−3,1, with intra hospital
mortality 33,3% and 42,4%, at 90 days.
The multi-variable analyses showed that for all the patients studied,
the independent factors for intra hospital mortality were the
worse PaO2/FIO2 (PAFI) relation, hypoalbuminemia at admission,
leucopenia & diabetes mellitus; while at 90 days was hypoalbu-
minemia at admission.
For patients of the first group (70–80 years old), higher dose of
noradrenaline, and the worse PAFI relation, were statistical
significant as independent factors for intra hospital mortality,
while the hypoalbuminemia at admission was the independent
factor for mortality at 90 days.
For >80 years group the presence of neuropathy, disseminated
intravascular coagulopathy (DIC), and the need for red blood cell
transfusion, were independent mortality factors at 90 days.
CONCLUSION. Our studied population is fragile one, as per age as
per multi pathology and have an elevated death risk compared with
general population.
The mortality in our study population is high (33%), if compared with
general population with sepsis/septic shock, that is around 20-30%
according different series.
As we expected, the mortality was associated with severe respiratory
failure, more hemodynamic instability and worse nutritional status
at admission.
Limitations: One center Study, retrospective, small n, and was not
possible to identify the cause of death at 90 days.
0828
Is uremia a good severity predictor in sepsis?
E. Vendrell Torra1, E.P. Fernández Fernández2, J. Méndez Barraza1, E. Güell
Quintilla1, C.A. Socolich Mansilla3, W.F. Salcedo Medina3, M.C. de la Torre
Terron1, D. Salat Foix4, P. Pujol Valverde1, J.C. Yébenes Reyes1
1Hospital de Mataró, Intensive Care Unit, Mataró, Spain; 2Hospital de
Mataró, Internal Medicine, Mataró, Spain; 3Hospital de Mataró,
Emergency Department, Mataró, Spain; 4Hospital Germans Trias i Pujol,
Intensive Care Unit, Badalona, Spain
Correspondence: E. Vendrell Torra
Intensive Care Medicine Experimental 2017, 5(Suppl 2):0828
INTRODUCTION. Early detection is critical for the management of
sepsis. Urea is elevated in hypovolemic patients, and has been used
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 420 of 542as a biomarker of severity of several diseases, so its measurement
could help in the early detection of sepsis.
OBJECTIVES. To evaluate the significance of elevated urea levels in
the initial phase of sepsis, its usefulness as an indicator of severity
and as an aid to guide early management.
METHODS. Prospective observational study. We collected demographic,
clinical, and analytical data of patients for whom the sepsis code was
activated in our center from January to December 2016. Data were
described (frequency, mean and standard deviation or median and
interquartílic range), and those with possible clinical significance
were analyzed using the Student t-test for independent samples or
the correlation coefficient.
RESULTS. The sepsis code was activated 65 times for 64 patients
(54.6% male, age 74 ± 13.9 years). Fifty-four cases (84.4%) were
community-acquired and the most frequently encountered varieties
were respiratory (22; 34.4%), abdominal (16; 25%) and urinary (16;
25%). Bacteremia was documented in 38 (59.4%) cases. Lactate levels
were 4.0 ± 2.3 mmol/L. SOFA score was 4 ± 2.7. Almost half of the
patients were admitted to the ICU (30; 46.9%) with a mean length of
stay of 5 days. The median duration of hospitalization was 14.3 ± 9.5
days. In-hospital mortality was 23.4%.
Urea level was 63.3 ± 63.9 mg/dL, and 67% of patients had an
abnormal uremia (>50 mg/dL). There was a moderate correlation
between these levels and the severity rating scales such as the
APACHE-II (correlation coefficient [CC] 0.36) or SOFA (CC 0.334). Pa-
tients with urea >100mg/dL were more likely to need ICU admission
(RR 1.34, 95%CI 0.7972 to 2.2621) and had higher intra-ICU (RR 1.09,
95%CI 0.24-4.84), in-hospital (RR 1.19; 95%CI 0.44-3.19) and 30-day
(RR 1.23, 95%CI 0.59-2.56) mortality. Urea values were also correlated
with a higher leukocyte count (CC for leukocyte/neutrophil 0.43/0.39,
respectively) and base consumptions (CC for apH, aHCO3, aBE close
to −0.4, and CC for vHCO3, vBE close to −0.3).
CONCLUSIONS. 67% of patients for whom the sepsis code is activated
had abnormal uremia. Otherwise uremia seems to be associated to
higher mortality at 30 days. This result was not statistically significant,
and should be confirmed in future studies.
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INTRODUCTION. Central venous-arterial CO2 difference (Pv-aCO2)
reflects adequacy of microcirculatory venous flow. Widening of Pv-
aCO2 due to CO2-stagnant phenomenon is described in the low flow
states. Pv-aCO2 was proposed as an additional resuscitation target
for patients with septic shock. (1,2)
OBJECTIVES. The aim of this study was to examine correlation
between changes in Pv-aCO2 and SOFA score as well as different
blood flow indices 12 hours after onset of resuscitation in patients
with sepsis or septic shock. Secondary aim was to evaluate associ-
ation of delta CO2 6 hours after onset of resuscitation and patient
outcomes (length of stay in the ICU, mortality).
METHODS. Prospective observational study included 150 patients
with sepsis. Simultaneous measurements of lactate, mixed venous
oxygen saturation (ScvO2) and delta PCO2 were performed at onset
of resuscitation (T0) and after 6 hours (T6). Delta PCO2 was
calculated as a difference between arterial PCO2 and PCO2 from
mixed venous blood. Organ dysfunction was evaluated with the
SOFA score at T0 and after 48 hours (T48). Mortality was assessed
after 28 days. For data analysis purposes two groups were createdbased on delta SOFA [(1) patients with SOFA score decrease (delta
SOFA < 0); (2) patients without SOFA score decrease (delta
SOFA ≥ 0)] and based on Pv-aCO2 [(1) patients with high Pv-aCO2
(≥0.8 kPa); (2) patients with normal Pv-aCO2 (<0.8 kPa). Repeated
measurements were analyzed with Duncan´s Multiple Range Test.
RESULTS. On overall, 109 patients were male (72.6%), the average
age of patients was 58.7 ± 13.4 years, 75 patients (50%) met criteria
for septic shock. Average length of stay in the intensive care unit was
10.9 ± 10.7 days (4–15 IQR). Average APACHE score on admission to
the intensive care unit was 21.5 ± 7.1 (IQR 16–27). The total 28-day
mortality was 42%. Patients with high and normal Pv-aCO2 differed
only with respect to highest respiratory SOFA score (p = 0.01) Change
in Pv-aCO2 between T0 and T6 was not in correlation with change in
SOFA score between T0 and T48 (p = 0.12). Moderate statistically
significant correlation was found between Pv-aCO2 and lactate at T6
(r = 0.2), and moderate inverse correlation between Pv-aCO2 and
ScvO2 at T0 (r = −0.4) and T12 (r = −0.25) and ScvO2 and lactate at T0
(r = −0.27) and T12 (r = −0.18). Pv-aCO2 at T6 was not associated with
28-day mortality and length of stay in the ICU.
CONCLUSIONS. We did not observe statistically significant correlation
between delta PCO2, different blood flow indices, SOFA score and
patient outcomes. Further investigation is needed to examine delta
PCO2 as a valid resuscitation target.
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INTRODUCTION. Central venous-to-arterial carbon dioxide differences
(PcvaCO2) have been proposed as an additional tool in the hemodynamic
resuscitation process. Correcting PcvaCO2 by the arterial-to-venous oxygen
content difference (PcvaCO2/CavO2), as an approximation of the respiratory
quotient, seems to improve the prognostic performance of PcvaCO2
alone. However, since PCO2 and the content of CO2 (CCO2) might be af-
fected by several factors, such as the Haldane effect, some authors advo-
cate for the use of CcvaCO2/CavO2 instead of the PcvaCO2/CavO2.
OBJECTIVE. To explore the factors that might intervene in the
difference between PcvaCO2/CavO2 and CcvaCO2/CavO2, and to analyze
their association with mortality.
METHODS. Observational study in a 30-bed mixed ICU. Fifty-two sep-
tic shock patients within the first 24 hours of ICU admission were
studied. After restoration of mean arterial pressure, hemodynamic
and metabolic parameters were simultaneously evaluated. A total of
110 sets of measurements were performed. Statistical analysis: Differ-
ences in the studied variables between survivors and non-survivors
were analyzed using the t-Student test. Linear regression tests were
used to explore the association of CO2-derived parameters with other
metabolic and hemodynamic variables.
RESULTS. At inclusion, the variables associated with ICU-mortality
were arterial lactate, pH, PcvaCO2/CavO2, and the difference between
PcvaCO2/CavO2 and CcvaCO2/CavO2 (Fig. 276). Initial central venous
oxygen saturation (ScvO2), PcvaCO2, CcvaCO2/CavO2, and cardiac index
did not show any difference between survivors and non-survivors.
In a multiple linear regression analysis, the difference between
PcvaCO2/CavO2 and CcvaCO2/CavO2 was independently associated with
pH (B −2.73, 95% CI −3.43, −2.03; p < 0.001) (Fig. 277), ScvO2 (B 0.02,
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95% CI −0.46, −0.1; p < 0.01). A stepwise regression analysis showed
that pH was the single best predictor for the magnitude of the
difference between PcvaCO2/CavO2 and CcvaCO2/CavO2 (R Square
0.41), with very limited effect of both ScvO2 and CcvaCO2/CavO2.
CONCLUSIONS. In a population of early septic shock patients, the
PcvaCO2/CavO2 ratio and the difference between PcvaCO2/CavO2 and
CcvaCO2/CavO2 were associated with ICU mortality, whereas CcvaCO2/
CavO2 was not. The main determinant of the magnitude of the
difference between PcvaCO2/CavO2 and CcvaCO2/CavO2 was pH.
Therefore, the effect of pH on the PCO2-CCO2 relationship might
amplify the prognostic performance of CO2-derived parameters in
early septic shock.Fig. 276 (Abstract 0830). CO2-derived parameters and pH at
inclusion, according to ICU-mortality
Fig. 277 (Abstract 0830). Relationship between arterial pH and the
difference between PcvaCO2/CavO2 and CcvaCO2/CavO20831
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INTRODUCTION. The Neutrophil Lymphocyte Ratio (NLR) has been
used to predict both long and short term outcomes in patients, with
high NLR levels being an independent indicator of both in hospital,28 day and 6-month mortality, and has consistently been linked to
prognosis in critically ill patients. Since up to 50% of patients with
bacteraemia can exhibit a normal White Cell Count (WCC) and CRP,
further markers of sepsis are needed for early diagnosis. NLR may
help predict the outcome of critically ill patients.
OBJECTIVES. The aims of this study were to investigate 1. The time
course of NLR over a 4-day period in septic versus non-septic critically
ill patients, and 2. If NLR was predictive of ICU and 28-day mortality.
METHODS. Patients admitted to the ICU department at the Royal
Liverpool University Hospital between January 2008 and December
2012 were included. Demographic data included age, sepsis status,
type of sepsis, date of sepsis/septic shock, length of stay in ICU, 28-
day mortality, ICU outcome and gender. Routine blood results were
recorded for the first four days of ICU admission (WCC, lymphocytes,
neutrophils, platelets, lactate, albumin, CRP, creatinine, urea and
haemoglobin). Acute Physiology and Chronic Health Evaluation II
(APACHE II) score was also recorded on admission and Sequential
Organ Failure Assessment Score (SOFA) was documented daily. Using
the neutrophil and lymphocyte counts patient's NLR values were cal-
culated for the first 4 days of intensive care admission.
RESULTS. A total of 522 patients were included. Mean age was 59.8
[SD ±16.4], 58.3% were male and 58.5% had sepsis on admission. 28-
day mortality was 20.7%, and ICU mortality was 23.8%. Mean NLR in
survivors decreased over a 4-day period, whereas mean NLR in non-
survivors remained high throughout the 4-day period. In both septic
and non-septic patients, the mean NLR decreased over the 4-day
period, showing sepsis was not a main discriminator for outcome.
The area under the receiver operating curve was highest for lympho-
cyte count (0.577; CI 0.517-0.637). NLR, Plt and NC resulted in AUC of
0.560, 0.539 and 0.511 respectively.
CONCLUSIONS. NLR measured on intensive care admission is
predictive of outcome in critically ill patients and its time course over
the first four days differs significantly between survivors and non-
survivors. However, performance is not good enough for introduction
into clinical practice.
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INTRODUCTION. The pharmacokinetic (PK) of β-lactam antibiotics
in critically ill patients with sepsis presents high interindividual
variability. There is an increasing interest in the use of continuous
infusion of β-lactams to optimize antibiotic concentrations throughout
the dosing interval.
OBJECTIVES. To evaluate whether piperacillin/tazobactam (P/T)
administrated by continuous infusion achieved plasma concentrations
(Cp) above the MIC. This study also sought to determine the time
needed to achieve the PK/PD index.
METHODS. A prospective, pilot study was performed in the intensive
care unit of a tertiary university hospital for adults. Patients were
included if they met the following criteria: normal renal function
(GFR CKD-EPI formula > 60 mL/min), sepsis and indication for P/T
therapy. P/T was administered as a 4 g loading dose followed by
intravenous continuous infusion of 12 g/24h. Patients who had
Table 203 (Abstract 0833). See text for description
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switched to continuous infusion without administration of a loading
dose. P/T concentration was determined after loading dose (Cmax)
and at steady state, 24h hours after the continuous infusion was
started (Css). Total plasma concentrations were measured using
Ultra-High Performance Liquid Chromatography-Tandem Mass Spec-
trometry. We used a theoretical MIC breakpoint of 16 mg/L for P/T.
RESULTS. Twenty-one patients were enrolled (41% women); with a
median age of 47 years
(IQR: 41.8- 54.3). Mean GFR was 90 mL/min (IQR: 63–90). Sites of
infection were: lung (n = 17, 81%), central nervous system (n = 2, 9.5%)
and primary bloodstream infection (n = 2, 9.5%). Concentration
measurement from patients was available as follows: Css (n = 12
patients), Cmax and Css (n = 5), and Cmax (n = 4). Median Cmax and
Css were 93.4 mg/L (IQR: 33–143.8) and 51.4 mg/L (IQR: 32.6-73.1)
respectively. Patients who received a loading dose of antibiotic (n = 9,
43%) reached a higher Css than those who did not (70 mg/L vs 46.2
mg/L). Cmax > 16 mg/L was achieved in 89% patients, 78% Cmax > 32
mg/L and 67% Cmax > 64 mg/L. All patients reached Css > 16 mg/L,
76% achieved Css > 32 mg/L and 41% achieved Cmx > 64mg/L.
CONCLUSIONS. In this pilot study, we found that the use of P/T by
continuous infusion allowed reaching PK/PD target in almost all
patients within the first 24 hours of therapy. This target was achieved
immediately after a loading dose in 89% of the patients.
REFERENCE(S)
Felton TW, Hope WW, Lomaestro BM, Butterfield JM, Kwa AL,
Drusano GL, et al. Population Pharmacokinetics of extended-infusion
piperacillin-tazobactam in Hospitalized Patients with nosocomial Infec-
tions. Antimicrobial Agents and Chemotherapy 2012; 56: 4087–4094.
0833
Assessment of enteral paromomycin to eradicate colistin and
carbepenemase resistant microrganisms in rectal colonization to
prevent ICU - acquired infections
C. Sanchez Ramírez1, M.A. Hernández Viera1, L. Caipe Balcázar1, S. Hípola
Escalada1, M. Cabrera Santana1, R.E. Morales Sirgado1, M.E. Gallardo Santos1,
C.F. Lübbe Vázquez1, S.M. Marrero Penichet2, F. Artiles Campelo3,
M.A. De la Cal López4, S. Ruiz Santana1
1University Hospital of Gran Canaria Dr Negrín, Intensive Care Unit, Las
Palmas de Gran Canaria, Spain; 2University Hospital of Gran Canaria Dr
Negrín, Pharmacy Department, Las Palmas de Gran Canaria, Spain; 3University
Hospital of Gran Canaria Dr Negrín, Microbiology Department, Las Palmas de
Gran Canaria, Spain; 4Getafe Hospital, Intensive Care Unit, Madrid, Spain
Correspondence: C. Sanchez Ramírez
Intensive Care Medicine Experimental 2017, 5(Suppl 2):0833
OBJECTIVE. To assess the value of enteral paromomycin to
decontaminate patients with rectal colistin and / or carbepenemase
(CPN) resistant microorganisms colonization to prevent the development
of ICU-adquired infections.
METHODS. All consecutive patients admitted to the ICU from
October 2011 to September 2016, expected to require tracheal
intubation for longer than 48 hours were given SDD with a 4-day
course of intravenous cefotaxime, plus enteral colistin, tobramycin
and nystatin in an oropharyngeal paste and in a digestive solution. Oro-
pharyngeal and rectal swabs were obtained on admission and once
weekly. Patients with rectal swabs colonized by colistin and / or carbe-
penemase resistant microorganisms were treated with enteral paromo-
mycin 1 gr every 6 hours a day, in order to become it negative and
prevent nosocomial infections. Categorical variables were summarized
as frequencies and percentages and the continuous ones as medians
and interquartile ranges (IQR) or means and standard deviations. Statis-
tical significance was set at p ≤ 0.05.
RESULTS. We applied paromomycin treatment to 82 colonized
patients with rectal colistin resistant microorganisms. All of them but
two had colonization by Extended Spectrum Beta-lactamases (ESBLs)
producing Klebsiella pneumoniae. One patient was colonized by ESBL
producing Enterobacter spp and the other by ESBL producing Escheri-
chia coli. Demographic data and type of admission are shown in
Table Error! Reference source not found.Sixty-seven out of 82 (81.7%) negativized the rectal exudate after
paromomycin. Of those negativized, 25 patients received an
appropriate antibiotic during the application of paromomycin.
Five out of the seven patients with CPN were decolonized.
Twenty-seven patients died at ICU discharge and 15 patients died
in the ICU without being negativized two of them with CPN resist-
ant microorganisms. Only 3 patients developed infections after
decolonization.
CONCLUSION. Our data show that enteral paromomycin is
effective in treating rectal colistin and / or carbapenemase
resistant microorganism colonization to prevent the development
of ICU nosocomial infections.0834
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OBJECTIVES. To prospectively evaluate the impact of Selective
Digestive Decontamination (SDD) application on nosocomial
infections and colonization rates, after 5 years in a mixed ICU.
METHODS. This study was conducted in a 30-bed-medical-surgical
ICU. All consecutive patients admitted to the ICU from October 1,
Table 204 (Abstract 0834). Univariate analysis
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ation > 48 hours were given SDD (SDD study group) with a 4-day
course of intravenous cefotaxime, plus enteral colistin, tobramycin,
nystatin in an oropharyngeal paste and in a digestive solution. Oro-
pharyngeal and rectal swabs were obtained on admission and once
weekly. We used ENVIN nosocomial infection criteria. We compared
all patients admitted to ICU with nosocomial ICU infections from Oc-
tober 1, 2010 to September 30, 2011 (non-SDD group) to the SDD
study group. Categorical variables were summarized as frequencies
and percentages and the continuous ones as means and standard
deviations (SD) when the data followed the normal distribution or
medians and interquartile ranges (IQR) when they did not. The per-
centages were compared using the test of chi-square test or Fisher
exact test, means with the t-test and medians with the Wilcoxon test
for independent samples. Those variables that showed statistical sig-
nificance in the univariate analysis were introduced in a multivariate
logistic regression analysis. For each one of the infections (catheter-
related and other secondary bacteremias, pneumonia and urinary in-
fections and antibiotic resistant bacteria (ARB) infections) the inci-
dences per 1000 days of exposure in each cohort and the
corresponding relative risks were obtained using the Poisson regres-
sion. Statistical significance was
p ≤ 0.05.We analyzed colistin and tobramycin resistant colonization
and also antibiotic consumption as Defined antibiotics Daily Doses
(DDD).
RESULTS. Results are shown in Tables 204, 205 and 206.
There were no statistical significant differences between both groups
in type of admission or demographic data. Patients with SDD had
significantly less Extended Spectrum Betalactamase (ESBL), Gram
Negative Bacteria Multirresistant (GNB MR) and Acinetobacter spp
infections. We had also a significant reduction in nosocomial
pneumonias, urinary infections and other secondary bacteremias and
ARB infection rates, in SDD group versus non SDD. There was no
infection by Clostridium difficile. The exogenous infections were
74,8%. Colistin resistant colonization was 17,3% and tobramycin
resistant colonization was 24,6% of samples. There was a decrease
on the DDD/100 ICU stays after SDD.
CONCLUSIONS. After 5 years applying SDD a significant reduction of
infections by ESBL, GNB MR and Acinetobacter, was observed. A
significant decrease of nosocomial pneumonia, secondary
bacteremias, urinary and ARB infections rates was also shown. An
antibiotic consumption reduction was found after SDD. Low rates of
colistin and tobramycin resistant colonization bacteria have been
observed.0835
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INTRODUCTION. Sepsis is still amongst the leading cause of mortality
in intensive care units.Ventilator-associated pneumonia results from
invasion of the lower respiratory tract and lung parenchyma by
microorganisms residing mainly in oral cavity. Trauma victims are at
increased risk of aquiring hospital infections specially when admitted to
intensive care unit.OBJECTIVES. The aim of our study was to investigate the efficacy of a new
probiotic combination, containing 7 bacterial species, against oropharyngeal
bacterial infestation in adult trauma intensive care unit patients.
METHODS. One hundred and fifty patients were placed in the two
treatment groups by computerized random allocation in a 1:1 ratio and
received either probiotics or placebo. Oropharyngeal cultures were taken
on the 1st (before the intervention), 4th, and 6th days of admission.
RESULTS. The culture results of the 1st, 4th, and 6th days were
comparable and no statistically significant difference was noticed in
the two arms of the study.
CONCLUSIONS. Based on the results of our study, Administration of
probiotics to alter early oropharyngeal cavity infestation with PPM in
adult trauma patients admitted in Intensive Care Unit appears to be
non-efficacious, even when a 7- species combination is used.
REFERENCE(S)
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prevention of pneumonia in mechanically ventilated adults:
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Table 206 (Abstract 0834). Nosocomial infection rates
Table 205 (Abstract 0834). Multivariate analysis
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Intensive Care Medicine Experimental 2017, 5(Suppl 2):0836INTRODUCTION. Administration of probiotics is proposed as a novel
approach in decreasing the incidence of ventilator associated
pneumonia. Previous studies utilized 1–3 species probiotics. On the
other hand, trauma patients are at increased risk for infection due to
multiple factors.
OBJECTIVES. The aim of our study was to evaluate the efficacy
of a new 7-species combination of probiotics on the incidence of
ventilator associated pneumonia in adult trauma patients admit-
ted in intensive care units.
METHODS. As a prospective, double blind, placebo-controlled study;
one hundred and fifty patients were randomized into two groups of
probiotics and placebo in a 1:1 ratio. Both groups received the drugs
as suspensions in the oropharyngeal cavity and stomach.
RESULTS. No difference was noted in the incidence of early-onset
ventilator-associated pneumonia between two groups. There was no
adverse event due to probiotic administration.
CONCLUSIONS. This study suggests that administration of probiotics
does not alter the incidence of early-onset ventilator-associated
pneumonia in adult trauma ICU, even when a 7-species combination
is applied.
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INTRODUCTION. In patients with pneumonia, caused by multi-drug
resistant P. aeruginosa, ceftolozane/tazobactam could be a valuable
therapeutic alternative.
OBJECTIVES. We studied, in an animal model of severe P. aeruginosa
pneumonia, the effects of ceftolozane/tazobactam vs. piperacillin/
tazobactam on pulmonary bacterial burden.
METHODS. Sixteen pigs (32.9 ± 1.7 Kg) were anesthetized,
mechanically ventilated for 76 hours, and challenged intra-
bronchially with P.aeruginosa, as previously reported (1)(ceftolozane/
tazobactam and piperacillin/tazobactam minimal inhibitory concen-
tration of 4 and 64 μg/mL, respectively). After 24 hours from bacterial
inoculation, animals were randomized to receive: ceftolozane (50
mg/Kg) /tazobactam (C/T) every 8 hours, saline solution (Control) or
piperacillin (200 mg/Kg) /tazobactam every 8 hours (TZP). These dos-
ages were adjusted, based on preliminary studies to model appropri-
ate humanized pulmonary epithelial lining fluid concentrations.
Tracheal secretions and bronchoalveolar lavage (BAL) fluids were cul-
tured daily. The animals were euthanized after 72 h from bacterial
challenge, and pulmonary lobes biopsied for quantitative cultures.
RESULTS. Five animals were enrolled into the C/T and control
groups; whereas, 4 animals were included into the TZP group. One
animal, in the C/T and TZP group each, died of septic shock, before
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 425 of 542administration of antibiotics. In the C/T group, tracheal secretions
P.aeruginosa concentration was 6.9 ± 0.3, 5.6 ± 0.4 and 4.8 ± 1.3 log
CFU/mL, at 24, 48 and 72 hours of MV, respectively; whereas, in the
TZP group it was 6.9 ± 0.9, 6.6 ± 1.1, and 6.4 ± 1.2 log CFU/mL and
in the control group 7.3 ± 0.3, 7.5 ± 0.6 and 7.6 ± 0.6 log CFU/mL
(p < 0.01). In the C/T group, BAL P.aeruginosa concentration was
4.6 ± 1.7, 3.7 ± 1.2 and 2.6 ± 1.2 log CFU/mL, at 24, 48 and 72 hours
of MV, respectively; whereas, in the TZP group, it was 4.9 ± 0.4,
3.3 ± 1.3, and 3.2 ± 1.8, and in the control group 5.1 ± 0.8, 5.1 ± 0.7
and 4.7 ± 0.7 (p < 0.01). Finally, lung tissue P.aeruginosa burden was
3.7 ± 2.6 log CFU/gr in the C/T group, 4.0 ± 1.9 in the TZP group,
and in the control group 5.2 ± 1.5 (p = 0.06).
CONCLUSIONS. In a pig model of severe multi-resistant P.aeruginosa
pneumonia, ceftolozane/tazobactam swiftly decreases pulmonary
bacterial burden.
REFERENCE(S)
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INTRODUCTION. Patients admitted to the ICU are particularly
susceptible to Candida infection because of the severity of their
underlying illness and the excess use of medical and surgical
interventions. The frequent use of antibiotics, central venous
catheters and other intravascular devices as well as poor gut motility
or abdominal surgery place these patients at high risk of infection,
which contributes to the morbidity and mortality of the already
critically ill patient.
OBJECTIVES. The aim of this study was the identification of risk
factors of extensive colonization or infection by Candida in patients
hospitalized in ICU.
METHODS. The last two years, clinical specimens of 565 patients
hospitalized in General Hospital ICU were examined (blood, wound,
urine, ends of catheters, and bronchial secretions cultures), for
the identification of Candida for colonization and cause of
infection. Specimens were cultured on Sabouraud Dextrose Agar
(Biomerieux,France) with chloramphenicol (0,005%) and incubated
at 37ο C, 72 h, and for the blood cultures, blood culture bottles
Bact/Alert 3D(Biomerieux, France) were used. For the identification of
Candida species, MicroScan WalkAway (Siemens) system was used.
Among the risk factors checked for spread colonization or infection by
Candida were: instestinal colonization by Klebsiella pneumonia (KPC-
Kp) and/or Enterococcus (VRE).
RESULTS. Among 565 patients, 49 patients' (9%) developed at least
one culture.
49 Candida species were identified in 17 blood cultures, 4 wound
cultures, 10 urine cultures, 15 end of catheter cultures, and 11
bronchial secretions cultures.
26 (53%) were C. albicans,23 (47%) were non-albicans[C. Parapsilosis
(12), C. glabrata (6), C. tropicalis(2), C. krusei(2), C. pseudotropicalis(1)].
In multifactorial statistical analysis, hospitalization during summer
months, female sex, obesity, parenteral feeding, metronidazole
intake, transplantation, bacteremia due to KPC-Kp, proved statisti-
cally significant risk factors for extensive colonization or infection
with Candida. Also, the prophylactic use of fluconazole is a statis-
tically significant inhibitory factor in the development of exten-
sive colonization or infection by Candida.CONCLUSIONS. It seems that there are several risks factors for
the development of colonization and infection in ICU patients by
Candida. The use of broad spectrum antibiotics for a long time in
ICU patients infected with KPC-Kp, is a major factor because of
the high incidence of bacteremia due to KPC-Kp in our region.
The prophylactic use of fluconazole reduces the colonization and
infection by Candida significantly.
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INTRODUCTION. The increase of multiresistant germs in the ICU is a
problem of great medical, social and economic impact. The adequacy
of the antibiotic treatment is essential to face this concern.
OBJECTIVES. To describe the evolution of Pseudomona aeruginosa
resistance in our ICU, where an empirical protocol of antibiotic
rotation is used.
METHODS. It is a prospective, observational study, from 2003 to
2016, carried out in a polyvant ICU of 24 beds of a third level
hospital. An antibiotic rotation protocol for empirical coverage of
Bacillus Gram Negatives (BGN) was established based on the
experience of Raymon et al. University of Virginia, 1997–1999,
depending on the infection focus and the time of the year.Period (1st protocol 2003) Nosocomial
pneumoniaOther: sepsis without focus /
peritonitisJanuary, February, March Meropenem CefepimeApril, May, June Ciprofloxacin Piperacillin-TazoactamJuly, August, September Ceftazidime MeropenemOctober, November,
DecemberPiperacillin-
TazobactamCiprofloxacin[Empirical antibiotic rotation protocol]
RESULTS. The protocol has required modifications according to the
characteristics of the microbiota of the moment, being an active and
dynamic process. First modification in 2007: outbreak of
Pseudomona aeruginosa resistant to ciprofloxacin. Action: withdrawal
of ciprofloxacin. Results: decreased resistance to the antibiotic by the
microorganism. Second modification in 2009: outbreak of Klebsiella
pneumoniae ESBL. Action: change of ceftazidime by cefepime and
suspension of aztreonam. Results: control of the outbreak. Third
modification in 2013: outbreak of Klebsiella pneumoniae ESBL during
summer time (period with cefepime). Action: restrict cefepime in the
problematic months, increasing the use of carbapenemics. Results:
control of the problem in the following years with even absence of
outbreaks from 2013 to 2016. Consequences: increase in the
resistance of Pseudomona aeruginosa due to the pressure of
carbapenem use. Fourth modification in 2016: outbreak of Klebsiella
pneumoniae ESBL. Action: class restriction, excluding carbapenemics
from the empirical antibiotic rotation.
CONCLUSIONS. The availability of an empirical antibiotic rotation
protocol has enabled us to control outbreaks by multiresistant
germs. But we know that when the use of one antibiotic is restricted
by replacing it with another, the selective pressure simply shifts, so
resistance to alternative antibiotics may occur.
REFERENCES
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Crit Med J. 2008; 49:207–14.3.
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INTRODUCTION. Infections by multidrug-resistant pathogens (MDR)
is a public health crisis. The Spanish Society of Intensive Care Medi-
cine (SEMICYUC) and Spanish Society of Intensive Care Nursing
(SEEIUC) have endorsed quality security projects known as “ZERO
programmes”. ZERO Resistance (ZR) aims to reduce the incidence of
ICU acquired MDR infections.
OBJECTIVES. The aim of the present study is to know the degree of
implementation of ZERO Resistance project recommendation.
METHODS. Multicenter descriptive transversal study. We conducted a
written survey with 14 multiple-choice questions covering all mea-
sures addressed by the project recommendations. It was sent to all
local nurse and physician ZR responsible of each ICU in Andalusia.
Time of response was thirty days.
RESULTS. Twenty-eight medical-surgical ICU received the question-
naire: twenty-five answered responses were obtained. 68% were ICU
with more than 10 beds. Majority, 80%, were university hospitals,
36% with neurosurgery department and 40% with cardiac surgery
services. 88% had postgraduate medical training EIR residency pro-
gram. 40% responded not to carry out ZR recommendations before
its implementation and 28% partially.
In Table 207 we show degree of implementation of ZR recommendations:
CONCLUSIONS. In Andalusia ZR project has improved the application
of measures to combat bacterial resistance. Two thirds of ICU have
modified the way of working due to ZR project.
We observe a great variability in the participant ICU about the
recommendation of active surveillance of MDR pathogens in time
and samples performed.Table 207 (Abstract 0840). Degree of implementation of ZR project
Intensive care physician/nurse designed responsible of ZR project 92%/80%
Empirical administration of antimicrobials active against MDR
only in cases of septic shock and high risk of MDR pathogens.
80%
Active search for MDR pathogens : All patients on admission and
at least once a week/Patients with risk factors for MDR/
Sporadically/Never
36%/32%/
20%/4%
Microbiological Surveillance sampling: nasal, rectal and
oropharyngeal swabs/Rectal swabs/Oropharyngeal swabs
68% 16% 4%
Checklist of risk factors of MDR pathogens/carriage ZR project
recommended checklist
44% 32%
Isolation precautions close rooms Cleaning protocols for rooms
of patients with MDR pathogens/A file document specifying ICU
equipment and its respective cleaning updated protocols
available.
96% 88% 60%
Molecular typing methods to identify causative outbreak
organism
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BACKGROUND. The use of central venous catheters (CVCs) has
greatly improved the quality of care in ICU patients, despite of its
benefits, CVCs cause serious infectious complications leading to an
increasing risk of Mortality.
AIM. To determine the incidence of CVC-AI and their risk factors among
patients admitted in a Tunisian medical intensive care unit (MICU).
METHODS. A prospective cohort study was conducted between
September15th, 2015 and March 15th, 2017 in an 8-bed MICU were
included all patients with more than 48H of ICU stay. CVC-AI was
?A3B2 show $132#?>defined according to the CDC of ATLANTA cri-
teria. The diagnosis of CVC-AI was based on clinical and/or laboratory
signs/clues. For all subjects, age, sex, underlying diseases, SAPS II
score, ICU length of stay, exposure to CVC (number of CVCsplaced,
insertion site, insertion ward and insertion length) were collected.
Risk factors were analyzed by conditional stepwise logistic regression.
P values of less than 0.05 were regarded as statistically significant.
RESULTS. Among 258 eligible patients, 180(69.9%) had a CVC. 35
patients (19.44%) contracted a CVC-AI accounting for a total of 19.5/
1000 CVC-AI per CVC-days. Among these infections, 17(60.7%) were
systemic CVC-AI (with negative blood culture) and 10(35.7%) were
bloodstream CVC-AI. The mean SAPS II of patients who developed
CVC-AI was 32.8 ± 14.5, their mean Charlson comorbidities index was
2.1 ± 1.9, the mean overall duration of catheterization per patient
was 16.5 ± 10.8 days and the mean CVC insertion-length was 5.4 ± 4
days. Gram negative bacteria were found in 53.5% of CVC-AI
(n = 15) with MDR Acinetobacter baumannii as the commonest
pathogen (n = 7). Staphylococci were isolated in 3 cases. Mortality
rate of CVC-AI was 48.6% (n = 17). Risk factors of CVC-AI in the uni-
variate analysis were: insertion site (p = 0.19), an insertion ward dis-
tinct than ICU (p = 0.18), a high Ramsay score (mean = 4.9 ± 1.2 ;
p = 0.013) and a long insertion length (mean = 6.9 ± 4.7 ; p = 0.01).
The introduction of these respective factors in a binary logistic re-
gression model identified only a high Ramsay score (OR = 1.61,
CI95%[1.138,2.282], p = 0.007) and a long insertion length (OR = 1.11,
CI95%[1.03,1.20], p = 0.007) as independent risk factors of CVC-AI.
CONCLUSION. In a monocenter cohort study, CVC-AI had a high
density and is associated with a poor outcome. A high Ramsay score
and a long insertion length of CVC were the main independent risk
factors associated to CVC-AI.
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INTRODUCTION. Is well known that innappropriate empirically
administered antibiotics in critical ill patients are usually linked to
extended intensive care unit stay and an increased risk of morbi-
mortality.
OBJECTIVES. To describe the apropiate antibiotic therapy rates of
patients admitted in an intensive care unit of 18 beds with
community or nosocomial infections (intra-ICU or extra-ICU).
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 427 of 542METHODS. Prospective study during 7 months (january-July 2016) of
all patients with an infection and positive cultures admitted in ICU.
Variables analized: demographic (age, sex), APACHE II, reason for ICU
admission, infectious syndrome, adequacy of antibiotic treatment to
our hospital empirical guidelines and targeted therapy based on
antibiogram. An “appropriate” antibiotic treatment was considered if
the microorganism was sensible to at least one antibiotic
administered empirically. Analysis was performed by two physicians
independently. In case of disagreement they proceeded to the
evaluation by a third to tie. All rates are presented as percentages.
RESULTS. 612 patients. In 103, 152 infections were recorded; 65 with
positive cultures (30 community infections, 20 nosocomial intra-ICU
and 15 nosocomial extra-ICU or health care related). Mean age was
65.88 years (44–80), 55% males. Empirical treatment was adjusted to
guidelines in all occasions and all types of infection. It was appropriate
by antibiogram in all (15) nosocomial infection extra-ICU, in 28 (93.3%)
comunity infections, and 18 (90%) nosocomial intra-ICU infections. Anti-
biotic de-escalation was performed in a high percentage (66.1%).
CONCLUSIONS. Our appropriate antibiotic therapy rates are
susceptibly high. We only failed with empirical treatment in 10%
patients with nosocomial intra-ICU and 6.7% of community infec-
tions. In the first case due to an outbreak multiresistant Acinetobac-
ter baumanni, and in the second case due to patients without risk
factors for unusual germs.
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INTRODUCTION. Intensive care units (ICU) need to be monitorized
for nosocomial infections. Patients followed in ICUs can be colonized
with resistant microorganisms during their ICU stay and as a result,
they have an increased risk of hospital acquired infections.
OBJECTIVES. The aim of this study was to evaluate the central line
(central venous catheter) associated bloodstream infection (CLA-BSI)
rate, catheter associated urinary tract infection (CA-UTI) rate, invasive
device use rate and causative microorganisms isolated in these
infections, between 2007 and 2016.
METHODS. This study was conducted in an Anesthesiology and
Reanimation Intensive Care Unit. Ten year's surveillance data was
evaluated in this study. Central line associated bloodstream infection
rate per 1000 central venous catheter-days, catheter associated urin-
ary tract infection rate per 1000 urinary catheter days and device
utilization ratios are retrospectively evaluated. Microbiological culture
results of invasive device associated infections were also evaluated.
Hospital acquired infection definitions are made according to the
CDC criteria.
RESULTS. A total of 5406 patients were enrolled in this study. During
the study period, central venous catheter usage ratio was 65.18% in
the ICU for 42452 bed days and urinary catheter usage ratio was
90.19% in the ICU for 42065 bed days. The rate and number of
central venous catheter associated bloodstream infection were
10.45 ± 8.36 and 258, respectively. The catheter associated urinary
tract infection rate and number were 10.63 ± 3.34 and 470,
respectively. Most commonly detected causative agents were
Acinetobacter baumannii (16.58%) for central line associated
bloodstream infections and Candida species (7.71%) for catheter
associated urinary tract infections, throughout the study period.
CONCLUSIONS. Use of central venous catheter and urinary catheter
increase the incidence of invasive device associated infection rate inICU. The high mortality rates in patients with invasive device could
be related to high infection rates and inappropriate antibiotic use.
Incidence of infections can be reduced by education of health care
givers and use of barrier preventive methods.
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INTRODUCTION. With mechanical ventilation widely used in
intensive care unit, the ventilator associated pneumonia (VAP) has
become a common and serious complication in critically ill patients.
VAP can prolong the duration of mechanical ventilation and is
associated with increased mortality. Culture results are used to
confirm the clinical diagnosis and to adjust or sometimes withdraw
antibiotic treatment. Tracheal aspirates have been shown to be
useful for these purposes.
OBJECTIVES. To study the in vitro activity of antimicrobial drugs
against multi-drug resistant pathogens isolated in samples of tra-
cheal secretions in patients in the ICU.
METHODS. We studied 1004 samples of tracheal secretions of
patients in the ICU of our hospital over a 6 years period. The study
was retrospective.
The cultivation of the secretions was semi-quantitative and the Maki
method was employed. Isolates of a growth rate of 10^5 cfu/ml were
evaluated. The identification and susceptibility testing were per-
formed by the Microscan Walkaway system (Siemens) and the evalu-
ation of the results took place according to CLSI directions.
Moreover, the highest antimicrobial sensitivity rates of the most fre-
quently isolated pathogens were recorded.
RESULTS. 881 isolates were identified, 372 out of which were A.
Baumanii strains, 94 were S.aureus strains and 91 were
K.Pneumoniae strains. According to the antimicrobial susceptibility
testing results, the highest antimicrobial sensitivity rates of the
A.baumanii isolates were 100%, 40.7% and 27.9% with regard to
Colistin, Ampicillin/Sulbactam and Gentamycin respectively.
As far as P.aeruginosa isolates are concerned, the antimicrobial
sensitivity rates were: Colistin:100%, Piperacillin/Tazobactam 42.3%,
Cefepime 26.8% and Ceftazidime 23.4%.
As for the S.aureus isolates (77.4%) the antimicrobial sensitivity rates
were: Teicoplanin and Linezolid 100%, Vancomycin 100%, Trimethoprim/
Sulphamethoxazole 96.8%.
Finally,the antimicrobial sensitivity rates of Klebsiella pneumoniae
were: Tigecycline 100%, Colistin 100%, Gentamycin 69.2% and
Cefepime 51.6%.
CONCLUSIONS. The results above provide us with essential
information about the in vitro activity of antimicrobial agents against
multi-drug resistant pathogens isolated frequently in tracheal secre-
tions of patients in the ICU. On gram (+) bacteria there is a high
in vitro sensitivity in different antibiotics. Against P. Aeruginosa and
A. Baumanii the only antibiotic that is effective in vitro is Colistin.
Against K. Pneumoniae are effective Colistin, Tigecycline and maybe
Gentamycin. It is clear that against gram (−) bacteria we have limited
antibiotics at our disposal in our ICU and in Greece in general.
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INTRODUCTION. Nosocomial infections are a major problem with
high morbidity and mortality rates in intensive care units (ICU).
OBJECTIVES. To evaluate the link between epidemiological stool
cultures, later infectious complications and clinical outcomes of
patients after cardiac surgery at the Vilnius University Hospital
Santariskiu Clinics (VUL SK) ICU.
METHODS. A retrospective analysis included 52 post-cardiosurgical pa-
tients, who were treated in the ICU and had stool cultures analysed.
Epidemiological and diagnostic bacterial samples were evaluated to as-
sess the type and multiresistance of bacteria as well as concurrence.
Data on infectious complications, duration of hospitalisation and the
clinical outcomes were collected. Results were analysed in patients with
and without acquired infectious complications. Statistical evaluation
was completed using Mann–Whitney-Wilcoxon test, F and T tests,
Fisher test and Spearman correlation test. P value < 0.05 was used.
RESULTS. There were 52 patients (27 women, 51.9%) with average age
of 66.2 ± 13.3 years included in the study. Thirty eight patients (73.1%)
were diagnosed with infectious complications in the ICU (1st group), and
14 (26.9%) were not (2nd group). The mortality rate was 39.5% (n = 15)
only in the 1st group. Multiresistant bacteria in the epidemiological stool
samples were found in 86.8% and 100%, concurrence of bacteria in
epidemiological and diagnostic samples - in 34.2% and 21.0% of cases in
the 1st and 2nd group respectively. Treatment time before hospitalisation
to ICU was medians 15,5 and 7 days (p = 0.02); duration of the operation
- 342.1 ± 150.5 and 457.8 ± 165.1 min (p = 0.02); duration of artificial
blood circulation - 114.9 ± 96.4 and 193.8 ± 130.1 min (p = 0.021);
duration of the aortic clamping - 66.9 ± 64 and 115.1 ± 78.9 min
(p = 0.028), hospitalization time in the ICU - medians 17.5 and 9 days
(p = 0.014) in the 1st and 2nd group respectively. Statistically significant
correlation between clinical outcomes and bacterial concurrence in
epidemiological and diagnostic samples (r = 0.4, p = 0.003) same as
clinical outcomes and complication occurence (r = 0.38, p = 0.005) was
observed. There was no association between epidemiological and
diagnostic sample concurrence, multiresistant bacterial colonisation
and the occurence of infectious complications.
CONCLUSIONS. Multiresistant bacteria were found in 90.4% of all
epidemiological stool samples. Patients, who had infectious complications
in the ICU, were hospitalised significantly longer and in one third of cases
epidemiological and diagnostic samples concurred. Clinical outcomes had
a direct relationship with the concurrence of epidemiological and
diagnostic bacterial samples and occurence of infectious complications.
GRANT ACKNOWLEDGMENT
N/A
0846
Significantly more de-escalation of empiric anti-infective therapy
in severe sepsis and septic shock without negative impact on
mortality by a goal-directed intervention including feedback of
quality indicators and de-escalation rates
H. Rüddel1,2, D. Schwarzkopf2, D.O. Thomas-Rüddel1,2, C.T. Mathaeus-
Krämer2, K. Reinhart1,2, F. Bloos1,2
1Jena University Hospital, Dept. of Anesthesiology and Intensive Care
Medicin, Jena, Germany; 2Jena University Hospital, Center for Sepsis
Control and Care, Jena, Germany
Correspondence: H. Rüddel
Intensive Care Medicine Experimental 2017, 5(Suppl 2):0846INTRODUCTION. In sepsis, severe sepsis and septic shock administration
of broad spectrum antibiotics is a mainstay of therapy. Guidelines
recommend de-escalation as early as possible following microbiological
findings and clinical improvement [1, 2]. De-escalation is associated
with less resistant microorganisms, fewer side effects, and lower
costs [3]. Yet, de-escalation is practiced in only 10% of cases in
studies of clinical practice [4].
OBJECTIVES. To investigate if a multi-faceted hospital-wide interven-
tion can elevate rate of de-escalation of empiric anti-infective ther-
apy in patients with severe sepsis and septic shock.
METHODS. During the sustainability phase of the MEDUSA-trial [5],
all participating hospitals (40 German hospitals of all levels of health
care) received feedback on quality indicators on the quality of diag-
nosis, treatment and outcome of patients with severe sepsis and/or
septic shock. Hospitals in the intervention group (n = 21) received
change management counselling focusing, amongst others, on de-
escalation of anti-infective regime. Hospitals in the control group
(n = 19) had received counselling without focus on de-escalation for
24 months before the analysis, hospitals in the intervention group
had received only four educational seminars during the same period.
Significance testing by Generalized Hierarchical Linear Models con-
trolling for clustering, interaction effect of intervention was tested by
difference-in-differences-analysis.
RESULTS. 6.576 patients were prospectively included between 07/
2013 and 06/2015. De-escalation rose from 14.4% before to 21.7%
during intervention in the intervention group (OR 1.61 [1.29, 2.00],
p = < =0.001). Change in the control group was not significant
(16.0% to 16.8%, OR 1.11 [0.93, 1.34], p = 0.254). Impact of interven-
tion was significant between groups (p = 0.012).
CONCLUSIONS. A multi-faceted hospital-wide intervention focusing
on de-escalation of anti-infective therapy can significantly raise rate
of de-escalation in patients with severe sepsis and/or septic shock
without negative impact on 28-day mortality.
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INTRODUCTION. Intermittent renal replacement therapy is associated
with dialysis-induced acute myocardial injury, in both chronic1 and
acute2 treatments. Continuous Renal Replacement Therapy (CRRT) is
often favoured in critically ill patients with acute kidney injury (AKI),
hypotension or shock. Lower ultrafiltration rates, characteristic of
CRRT, reduce systemic hemodynamic stress and may be cardio-
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 429 of 542protective. We assessed the impact of CRRT on the development of
acute segmental myocardial injury, in critically ill patients requiring
dialysis for AKI.
OBJECTIVES. To assess the impact of CRRT on global and segmental
left-ventricular function in critical ill patients requring dialysis for
AKI. Out hypothesis was that CRRT, with its charecteristically
lower ultrafiltration rates, would not induce cardiac stunning (i.e.
will be cardioprotective).
METHODS. We used 2D-echo and speckle tracking analysis software
(EchoPAC, GE Healthcare) to measure global and segmental left-
ventricular myocardial longitudinal strain in 12 critically ill patients
presenting with AKI. Measurements were made at baseline immedi-
ately prior to and 4, 8 and 24 hours after initiation of CRRT.
RESULTS. Measurements were completed in 11 patients. 10/11
patients developed new regional wall motion abnormalities, with
8 developing these as early as 4 hours after CRRT start. The
number of affected segments varied from 1 to 11 (out of 12). Of
11 patients, 7 (58%) died in the ICU, with 5 of those dying
within 2 days of CRRT initiation.
CONCLUSIONS. Our results show that CRRT is associated with new
regional myocardial injury. This injury was associated with high
mortality. These results are concerning with respect to the
presumed safety of CRRT (compared to other dialysis modalities) in
critically ill patients. Further direct comparison of CRRT with other
dialysis modalities is warranted to assess the potential for relative
cardio-protection.
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INTRODUCTION. Acute kidney injury (AKI) is estimated to occur in
about 7-18% of hospitalized patients, and approximately 30-50% of
patients admitted to the intensive care unit (ICU). Since more than a
decade, continuous renal replacement therapy (CRRT) has been
settled as part of organ support for patients presenting severe
AKI during ICU stay.
OBJECTIVES. The aim of this study was to describe the changes
in CRRT prescription practices and to assess patient outcomes
comparing different study periods.
METHODS. A prospective observational cohort study was performed
from 2006 to 2016. We enrolled 446 patients receiving CRRT
during ICU admission to the Bellvitge University Hospital intensive
care unit (ICU), which is a tertiary referral hospital in Barcelona,
Spain. Patients were divided in 4 groups according to the year in
which they were admitted to the ICU (2006, 2010, 2014 and 2016),
in order to assess differences in clinical characteristics, RRT
prescription practices, and to analyze outcome differences in
terms of survival at the end of follow-up. Comparisons betweengroups were performed using a two-way analysis of variance
(ANOVA) statistical method.
RESULTS. We observed the following differences among groups:
mean age 63.3 ± 14 years/F 2.48 (p = 0.06), days from ICU to CRRT
initiation (2.5 ± 6/F 4.1, p = 0.007), number of days on CRRT (5.8 ± 6/
F 3.15, p = 0.025), prescribed blood flow (177 ± 38 ml per minute/ F
33.6, p < 0.001) and urine output 24 hours before starting CRRT
(399 ± 47 ml/F 4.43, p = 0.005). The majority of patients were
critically ill surgical patients in the 2006 group as compared to the
other groups (52% vs 36 vs 38% vs 33% of patients, p = 0.04).
Continuous venovenous hemodialysis (CVVHD) was more frequently
prescribed in the 2016 group as compared to the 2006 group
(15.9 ± 8 vs 4.6 ± 7/F 14.5, p < 0.0001). Extracorporeal circuit lifespan
was different between groups [(18.7 ± 18, 22.1 ± 21, 38.8 ± 24, and
38 ± 27 hours/F 14.7, p < 0.0001; in the 2006, 2010, 2014 and 2016
group, respectively]. Event-time distributions were estimated for
overall survival with the use of the Kaplan-Meier method, through
which no differences on survival at 28 and 90 days were found be-
tween groups (log-rank test; p = 0.254 and p = 0.41, respectively).
CONCLUSIONS. Differences were observed in CRRT prescription
practices during the last decade. However, in terms of survival, there
were no differences between groups of patients requiring CRRT
during ICU stay in each study period.
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INTRODUCTION. There has been a recent worldwide drive to
recognize and treat Acute Kidney Injury (AKI) as it is one of the poor
prognostic markers of patient outcomes.
OBJECTIVES. We studied mortality among various subgroups of
patients who required Renal Replacement Therapy (RRT) in the
Intensive Therapy Unit (ITU) at St Helier Hospital, London, UK in the
year 2012–13, to identify at risk groups.
METHODS. We identified 208 patients who required renal replacement
therapy in St Helier ITU between 2012–2013. These patients were
admitted to the ITU from various specialties including General Medicine,
General Surgery, the Renal Unit and Accident and Emergency. We then
collected data from multiple sources including: patients' notes, “Ward
Watcher” (software used in ITU for all admissions and interventions),
intensive care notes and the renal unit haemodialysis input software
(CV5). These patients were then further divided into subgroups as per
their baseline kidney function (i.e.: AKI on no known background of
kidney disease, Chronic Kidney Disease [CKD], End-Stage Renal Failure
[ESRF] and Unknown Baseline [UKB]). We studied their mortality in the
ITU, in hospital after step-down from the ITU, in the renal unit and for a
further 3 months, 6 months and 1 year.
RESULTS. We found that the AKI group had the highest mortality when
compared with the other groups (CKD, ESRF and UKB). 37% of patients
in the AKI group died in ITU compared to 25% of CKD patients. The
outcome of ESRF patients was slightly better than the other groups
with 19.7% mortality. Similarly, the in-hospital mortality of the AKI group
was highest at 44.8% when compared to the other groups. We found
that one year mortality in these subgroups ranges from 33% to 52.5%.
CONCLUSIONS. The AKI group has the highest mortality both in the
ITU and in-hospital, despite Renal Replacement Therapy. Harel Z
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 430 of 542et al. [1] suggested outpatient review for AKI survivors can change
their outcome. Through this study, we recommend that there should
be a framework to identify and treat the AKI group early, as well as
the involvement of a team of experts, including nephrologists, for
consultation in hospital. This is in order to avoid these patients end-
ing up requiring RRT, as the prognosis is poor at this stage.
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INTRODUCTION. The optimal timing for initiation of continuous renal
replacement therapy (CRRT) in critically ill patients with acute kidney
injury (AKI) remains controversial. The generally accepted absolute
indications for starting CRRT in critically ill patients include persistent
hyperkalemia, severe acidosis and hypervolemia.
OBJECTIVES. Therefore, we compared the outcomes of patients who
received CRRT without any of these indications with patients with
one or more of these indications.
METHODS. Retrospective cohort study of patients undergoing CRRT
from 2015 to 2016 in a tertiary university hospital. We defined CRRT
initiated without any absolute indications as early group and CRRT
initiated in the presence of any of these indications as late group.
Patients with chronic kidney disease stage 5 or on dialysis were
excluded. The primary clinical outcome variables were renal recovery,
and 90-day mortality.
RESULTS. Out of 118 patients treated with CRRT, 34 (28.8%) patients
initiated CRRT after meeting at least one absolute indication (late
group) whereas 84 (71.2%) patients started without any indications
(early group). The late group had lower renal recovery than the early
group (8.8 vs. 28.9% late vs early, p = 0.019). At 90 days after CRRT,
the mortality rate in the late CRRT group was 79.4% and that in the
early group was 57.1% (P = 0.023). Delayed initiation of CRRT was
independently associated with greater odds of mortality and renal
recovery in multivariate cox regression analysis. (hazard ratio : 1.729
95% CI 1.017-2.941, P = 0.043).CONCLUSIONS. Our study could suggest that initiating CRRT in
critically ill patients with AKI should not be delayed until fulfillment
of urgent indications.
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INTRODUCTION. Acute kidney injury (AKI) in the critically ill causes
significant morbidity and mortality. There are no local studies to date
about its prevalence in critically ill patients. We performed a
retrospective audit of the renal replacement therapy (RRT) practices
and outcomes in a single tertiary hospital.
OBJECTIVES. The primary objectives were the epidemiology of AKI in
our hospital and its management in terms of incidence of RRT; types of
RRT modalities used; dose prescribed and whether it was delivered.
Secondary objectives include ICU, hospital mortality and length of stay.
METHODS. This is a retrospective audit of case records of all patients
admitted to all intensive care units (ICUs) at a single tertiary hospital
from 1 July 2013 to 30 June 2014. All patients receiving RRT for AKI
were included. Critically ill patients previously on long term dialysis
were also included, unless the admission to ICU was purely for
scheduled dialysis to take place.
RESULTS. Over a 12 month period with 2353 patients admitted to
the ICUs, there were 223 patients (9.8%) requiring RRT resulting in
622 episodes of RRT. The median APACHE II score of our patients
was 35 (range +/− 13) and the median SOFA score 12 (range +/− 7).
The majority of admissions were from general medicine (N = 136,
52.5%). 295 (47.4%) episodes of RRT were in ESRF patients while 357
(52.6%) of episodes of RRT were in patients with AKI according to
RIFLE grading, with 42.8% RIFLE F at initiation of CRRT. 84% of RRT
was prescribed by the renal physicians in our ICUs. Overall mortality
of patients who had RRT was 42.6%. This was considerably higher
than the mortality rate of 19.1% of patients who did not have RRT.
Out of the 257 episodes of CRRT, the most common modality was
CVVHDF (25.56%). The most common modality used amongst the
non-CRRT modes of dialysis was SLED (36.5%). Most patients com-
pleted their prescribed session of RRT (60.13%). For CRRT, the median
duration of uninterrupted RRT was 20 hours (10–25.5h) and the aver-
age delivered dose of RRT was 33.79ml/kg/h correlating to the pre-
scribed dose per kg body weight.
CONCLUSIONS. This first audit of RRT practices in ICUs in a single
Singapore hospital has provided us data for the first time on RRT
practices and outcomes of patients. There exists differences in
epidemiology, practices and prescription between medical and
surgical ICUs even within a single institution. It is reassuring that the
dose of CRRT achieved and outcomes of our patients are comparable
to published centres. We will be embarking on a national intensive
care audit of RRT practices by using this data to help us improve on
management of RRT in the critically ill as well as plan healthcare
resource allocation to improve systems of care for better patient
outcomes.
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INTRODUCTION. The mortality of patients with acute kidney injury
(AKI) has not decreased over the last 60 years and is even higher in
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 431 of 542patients treated with renal replacement therapy (RRT). Recent studies
suggest that fluid overload, immunological impairment and the
cardiorenal syndrome may all contribute to mortality among AKI-
patients.
OBJECTIVE. To determine the most important cause of death among
AKI-patients treated with RRT.
METHODS. We conducted a systematic review according to the
PRISMA statement. We searched Cochrane, Pubmed, Embase and
Web of Science for original articles describing the cause of death in
AKI patients treated with RRT. Studies were analyzed according to
their primary endpoint, either in-hospital mortality or mortality after
hospital discharge. Two by two table analysis was used to compare
incidences between groups.
RESULTS. Eleven studies with a total of 8804 patients were included:
one randomized controlled trial and ten observational studies. The
most frequently reported cause of AKI was ischemia, followed by
sepsis and nephrotoxicity. Both in-hospital mortality and mortality
after discharge occurred significantly more frequently among patients
with Acute Kidney Injury Network (AKIN) stage 3 than among patients
with AKIN stage 1 (40 vs 16% and 34 vs 16% respectively, p < 0.00001).
Patients with AKI had a significantly worse long term survival with 1
and 10 year survival rates of 89% and 44% respectively, compared to
95% and 73% respectively for patients without AKI (p < 0.001).
Among the studies analyzing in-hospital mortality, the cause of death
was documented in more than 90% of the cases. With respect to
mortality after hospital discharge, causes of death were documented
in 95% of the cases in one study and in 4% of the cases in the other.
In-hospital mortality ranged from 17 to 85% and mortality after hos-
pital discharge from 38 to 81%. Among the studies analyzing in-
hospital mortality, infection was the most frequently recorded cause
of death, ranging from 35 to 81%, followed by cardiac causes, ran-
ging from 8 to 32%. Among the studies analyzing mortality after hos-
pital discharge, cardiovascular causes of death were most frequently
reported. However, the incidence of cardiovascular causes of death
among AKI-patients after hospital discharge was similar to the inci-
dence of cardiovascular deaths in the general population.
CONCLUSION. This systematic review demonstrates that for AKI-
patients treated with RRT, the most important cause of in-hospital
death was infection, which may be due to both immunological
impairment and exposure to nosocomial pathogens. After hospital
discharge however, the main cause of death among AKI-patients
was cardiovascular, with an incidence similar to the incidence in
the general population.
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INTRODUCTION. Citrate has been recommended as the first-line anti-
coagulant for continuous renal replacement therapy (CRRT) in critically
ill patients (KDIGO 2012). Citrate inhibits the coagulation cascade by
lowering the ionized calcium (iCa) concentration in the filter. Regional
citrate anticoagulation protocols recommend postfilter iCa monitoring
to adjust citrate flow and optimize anticoagulation to ensure circuit
livespam. Blood gas analyzers are often used to determine iCa concen-
trations. However, these instruments are optimized for physiological
iCa concentrations which might make them less suitable for measuring
low iCa in blood with a high concentration of citrate.
OBJECTIVES. To compare the measurement of very low iCa
concentrations using 2 different blood gas analyzers placed in theintensive care units of our hospital (ICU1 and ICU2) compared to the
general laboratory gas analyzer (Lab).
METHODS. Prospective observational study conducted from May
2015 to June 2016. Analyzed a total of 64 samples from 13 patients
taken from the extracorporeal circuit and collected through syringes
for blood gas analysis (Smiths Medical) balanced lithium heparin.
Samples are processed by the central ABL800 analyzer (Radiometer
Copenhagen) (Lab) and blood gas analyzers point of care
GemPremier 3500 (Lab Instrumentation-IZASA) (ICU1) and GemPre-
mier 3000 (Lab Instrumentation-IZASA) (ICU2).
The analytical method used by blood gas instruments is
potentiometry (electroanalytical technique for determining the
concentration of electro-active species in a solution using a reference
electrode and a working electrode). Statistical analysis was performed
with MedCalc software, version 9.2, using Passing-Bablok regression
(nonparametric test for comparison of experimental methods and
validation measuring instruments) and Cusum test used to establish
a model of linearity between variables.
RESULTS. The correlation analysis between the analyzers ICU1 and
Lab shows the presence of a constant but non-proportional error be-
tween the two methods. There are no constant or proportional errors
between Lab and ICU2 nor between ICU1 and ICU2.Correlation analysis Regression line Intercept (IC 95%) Slope (IC 95%)Lab vs. ICU1 y = −0.1760 + 1.2000X −0.4030; −0.1 1; 1.8Lab vs. ICU2 y = −0.1417 + 1.0556X −0.48; 0.01 0.6; 2ICU1 vs. ICU2 y = 0.0100 + 1.0000X −0.09; 0.1 0.66; 1.33[Results]
CONCLUSIONS.
1. No statistically significant correlation was observed comparing the
Lab blood gas analyzer with ICU1 and ICU2.
2. Measurements obtained by the Lab analyzer are consistently
higher than those obtained by the point of care ICU1 and ICU2
analyzers.
3. ICU1 and ICU2 blood gas analyzers are interchangeable with each
other, so that can be used interchangeably to control low iCa
concentrations in CRRT using regional citrate anticoagulation.
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INTRODUCTION. Microvesicles (MV) are extracellular vesicles
known to be associated with cellular activation and inflammation.
Hemofiltration is an effective blood purification technique for
patients with renal failure and possibly also eliminates
inflammatory mediators in the setting of sepsis. On the other
hand, proinflammatory stimuli are induced by blood contacting
the artificial membrane during extracorporeal blood purification.
Fig. 279 (Abstract 0855). See text for description
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 432 of 542In chronic dialysis patients a systemic increase of MV has been
described.
OBJECTIVES. The aim of the study was to investigate if hemofilter
passage of blood in CVVH alters MV composition and levels in
critically ill patients with sepsis.
METHODS. Pre- and postfilter blood as well as ultrafiltrate samples
from intensive care unit patients with severe sepsis were obtained
during continuous veno-venous hemofiltration (CVVH). MV subtypes
in blood were analyzed by high-sensitivity flow cytometry. Addition-
ally, tissue factor (TF) levels and MV-associated TF-activities as well as
MV-activities were quantified. All parameters were corrected for
hemoconcentration applied during CVVH.
RESULTS. Twelve patients with severe sepsis on hemofiltration were
analyzed. Significant increases of platelet-derived CD41+ MV (1.13
(1.07-2.08) fold, p = 0.0335) and presumably mostly leukocyte-
derived CD31+/CD41- MV (1.65 (1.22-2.24) fold, p = 0.0015) as well as
significantly higher TF-activities (1.20 (1.06-1.50) fold, p = 0.0076) and
TF-levels (1.12 (0.99-1.15) fold, p = 0.0376) were detected postfilter
compared to prefilter. No significant differences concerning
AnnexinV+ MV or MV-Activity were detected. No MV-activity was
measurable in ultrafiltrate samples. Increments of AnnexinV+,
CD41+, CD42b + and CD31+/CD41- MV post- to prefilter corre-
lated with filtration fraction (all p < 0.01).
CONCLUSIONS. Hemofiltration induces the release of MV subsets,
indicating platelet and presumably leukocyte activation during
hemofilter passage. Moreover, TF is generated within the hemofilter.
Increases of MV subsets within the hemofilter correlate with filtration
fraction. No significant clearance of MV by a single hemofilter
passage during CVVH could be detected.
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INTRODUCTION. Regional citrate anticoagulation (RCA) is the optimum
form of anticoagulation for continuous renal replacement therapy
(CRRT). Following technical modifications to the Nikkiso Aquarius
platform a post-dilution CVVHF RCA protocol was introduced demon-
strating significant improvement in filter lifespan for patients contrain-
dicated to heparin [2]. This RCA protocol has been introduced as
routine care in our large ICU providing CRRT for ~250 patients a year.
OBJECTIVES. Assess the clinical impact on filter life of a protocol
with RCA as first line anticoagulation on the Aquarius platform.
METHODS. A retrospective comparison of consecutive patients requiring
CRRT. 41 patients using RCA as first line anticoagulation on the Aquarius
(group 1) versus 24 where heparin was first line anticoagulation (group 2).
RESULTS.
Group 1: 41 patients (141 filters) were included; median age 56.5
(27–75). Of these patients, 29 were medical admissions, 9 surgical
and 2 polytrauma. 18 had end stage renal failure. 61% of filters
clotted, 6% were stopped due to access issues, 7% due to technical
issues, 23% following a clinical decision, 6% reached end of filter life
(72 hours) and 4% were had no reason for cessation recorded. Of the
141 filters, 96 used RCA (68%), 27 (19%) used heparin and 18 (13%)
used no anti-coagulation (100% pre-dilution).
10 (25%) patients did not start RCA as first line anticoagulation. 6
had severe lactic acidosis (>10mmol/L) and 2 had acute on chronic
liver failure which are local policy contraindications to routine RCA
use, it was unclear in the other 2. There were 4 occasions where RCA
was switched to heparin, twice for metabolic alkalosis, once for
hypocalcaemia and once for multiple clotted filters.Group 2: 24 patients (63 filters); median age 61 (27–85) who were
audited immediately prior to the introduction of RCA. 15 were medical
admissions, 5 surgical and 4 polytrauma of which 5 had ESRF. 42 (68%)
of filters clotted and 2 (3%) reached end of filter lifespan. 36 (57%)
received no anticoagulation (100% pre dilution) (p < 0.0001 compared
to group 1) the rest received heparin infusion (aim APTTR 2–2.5).
The median filter life span (censoring for reasons other than clotting) in
all patients increased from 18 to 28 hours following the introduction of
a protocol using RCA as first line therapy (Fig. 279, p = 0.016).
CONCLUSIONS. RCA on the Aquarius platform is safe and effective
when incorporated as standard anticoagulation for critically ill
patients. It allows for significantly fewer filters to be used without
anticoagulation and improves filter life span when compared to
heparin or pre-dilution alone.
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INTRODUCTION. Despite significant improvements in filter life span
through the use of regional citrate anticoagulation and diligence to
anticoagulation protocols, clotting remains the major cause of filter
loss in critically ill patients who require CRRT. In an effort to improve
local practice we looked for other factors in the process of CRRT that
may influence filter life span.
OBJECTIVES. To analyse a cohort of patients receiving CRRT in a
busy trauma heavy, non cardiac, critical care unit with a view to
identifying factors that influence filter life span.
METHODS. A retrospective review of 41 patients using either,
regional citrate anticoagulation (RCA), heparin or pre-dilution alone
as an anticoagulation strategy. A Cox-Hazed Analysis for filter loss
due to clotting was done to identify influences on filter life span.
RESULTS. 22/41 were male. Median age 56.5 (27–75) years. Reasons
for admission: 6 polytrauma; 7 cardiogenic shock; 17 sepsis; 9
haemorrhagic shock, and 2 other. 18 had end stage renal failure. 141
filters were used with a median life span, censored for reasons other
than clotting, of 28 hours. 96/141 (68%) filters used RCA, 27 (19%)
heparin and 18 (13%) used no anti-coagulation (100% pre-dilution).
86 (61%) filters clotted. 15 patients had specific tunneled haemodi-
alysis lines of which 2 were in a femoral vein accounting for 29 and
17 filters respectively. The line tip was positioned in the right atrium
or superior vena cava for 66, the brachiocephalic vein for 26 and
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 433 of 542inferior vena cava in 49 filters respectively. Figure 280 shows filter life
span related to line tip position.
A cox hazard analysis for filter loss due to clotting adjusted for
anticoagulation using RA/SVC as reference demonstrates a hazard
ratio for clotting of 3.37 (1.82-6.26; p < 0.0001) for brachiocephalic and
1.99 (1.17-3.38; p = 0.011) for inferior vena cava tip position. No other
factor, including choice of anticoagulation influenced filter clotting.
CONCLUSIONS. Line tip position has an overwhelming influence on
filter clotting and life span.Fig. 280 (Abstract 0856). See text for description0857
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INTRODUCTION. Regional citrate anticoagulation for Continuous
Renal Replacement Therapy (CRRT) is recommended over heparin in
patients who do not have contraindications for citrate1. This offered
many potential advantages in terms of safety, efficacy and costs2. At
the time of implementation, no other cardiac intensive care units in
the United Kingdom have introduced citrate anticoagulation in this
subgroup of patients.
OBJECTIVES. Assess the benefits, efficacy and safety of regional
citrate anticoagulation in a predominantly cardiac surgical unit in the
United Kingdom.
METHODS. We collected data before and after the introduction
of regional citrate anticoagulation system on the choice of
anticoagulation, reasons for the filters ceasing, filter lifespan, and
blood product usage. Patients who were receiving Extra-Corporeal
Membrane Oxygenation therapy (ECMO) were excluded from the
analysis, as they were systemically anti-coagulated.
RESULTS.
Lifespan of the filtration system (hrs)
Citrate: (N = 132): mean (42.56), SD (26.71)
Heparin: (N = 148): mean (25.99), SD (22.89)
Epoprostenol: (N = 108): mean (15.23), SD (15.74)
Other: (N = 27): mean (18.69), SD (17.78)
ANOVA: p < 0.0005
Red cells transfused while on filtration (units/24 hours)
Citrate: RBC (0.46), FFP (0.21), cryo (0.18), plt (0.11): ANOVA: p < 0.019
Heparin: RBC (0.32), FFP (0.04), cryo (0.09), plt (0.06): ANOVA:
p < 0.025
Epoprostenol: RBC (0.92), FFP (1.85), cryo (1.38), plt (0.02): ANOVA:
p < 0.019
Other: RBC (1.41), FFP (0.24), cryo (0.09), plt (0.00): ANOVA: p < 0.579CONCLUSIONS. The lifespan of the filtration system with regional
citrate anticoagulation was longer than for those using conventional
anticoagulation. In addition, the transfusion of blood products
was reduced when compared when other forms of anticoagulation
for CRRT.
The introduction of citrate anticoagulation has dramatically improved
the lifespan of our continuous haemofilters in our intensive care unit.
It has been assessed as a safe method of anticoagulation with
reduced downtime and overall more effective filtration delivery to
our patients.
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INTRODUCTION. Sepsis is a major causes of death in the intensive
care unit (ICU) and improving its prognosis remains an important
challenge for the physician. Sepsis induced Acute Kidney Injury
(SAKI) is an important complication of sepsis. Immunomodulation
could be beneficial and CRRT with adsorbing membranes may be
useful in this clinical setting. The oXiris filter is a registered product
for CRRT already safely used in routine care to adsorb endotoxin and
remove cytokines.
OBJECTIVES. The aim of the study is to evaluate the inflammatory
and hemodynamic response during CRRT with oXiris membrane.
METHODS. A total of 17 septic shock patients with renal failure (6
women, 11 men), with mean age 67 yr. (range 27–81), were treated
between January and December 2016. Average baseline SOFA was
14.2. Seven patients suffered from intra-abdominal sepsis. Data were
retrospectively analyzed.
oXiris was used as adjunctive therapy in combination with Standard of
Care treatment of septic shock in order to control cytokines storm and
improve hemodynamic stability. Continuous veno-venous haemodiafil-
tration (CVVHDF) was performed within the first 24–48 hours from ICU
admission, using Prismaflex together with citrate anticoagulation.
C-reactive protein, procalcitonin and leukocytes levels, dosages of
vasopressors and MAP were monitored at T00 (admission in Hospital)
T0 (admission in ICU), Ti (start of CRRT), T24 (after 24h of CRRT) and
Tf (end of CRRT).
RESULTS. Seven treated patients survived and were discharged
from ICU.
No significant complications occurred during the CRRT.
Within the first 24 hours of treatment a rapid reduction in vasopressor
requirement was registered in all patients: noradrenaline dose
decreased from 0.40 (0.09-0.90) to 0.21 (0.0-0.69) mcg/kg/min.
Moreover there was a decrease in inflammatory markers: procalcitonin
decreased from 11.01 (2.15-100) to 7.90 (0.11-23.17) ng/dl and
C-reactive protein decreased from 24.19 (2,90-63.95) to 16.05
(2.92-42.21) mg/dl.
An improvement in renal function with a creatinine lowering from
3.32 (0.86-7.09) to 1.54 (0.42-3.04) mg/dl was also observed.
CONCLUSIONS. In our experience, a timely use of CRRT with oXiris
membrane in combination with the Standard of Care therapy was
clinically feasible, improved hemodynamics and had a positive effect
on renal function. We did not detect any significant side effect
related to citrate.
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INTRODUCTION. Persistent acute kidney injury requiring prolonged
renal replacement therapies is becoming more frequent as does the
complexity of patients treated in intensive care. When conventional
hemodyalisis is not available in a cardiothoracic centre, a satellite
hemofilration service led by the ITU team could be an alternative to
a longer ITU stay.
OBJECTIVES. To assess the performance of our ITU led satellite
hemofiltration service for persistent AKI.
The satellite hemofiltration programme in our centre is led by a
highly specialised group of outreach nurses that organise the
filtration regime in conjunction with the medical ITU team. Once our
ITU patients are established on an alternate hemofiltration regime,
they are discharged to the ward where they are followed up by the
outreach team.
METHODS. We collected demographic data of all patients that
continued to require intermittent hemofiltration after their discharge
from our intensive care unit during 2016.
RESULTS. 54 patients required prolonged intermittent hemofiltration
performed outside ITU during 2016 in our centre. The mean age of
these patients was 55 years. The most frequent reasons for admission
were kidney injury during their admission to hospital (16, 29.6%) and
postoperative care of cardiac surgery (16, 29.6%) followed by heart
transplanation (8, 14.8%) and acute heart failure (4, 7.4%).
14 patiens had chronic kidney disease in a hemodyalisis program at
their admission to ITU.
55% were urgent admissions and 10% of the patients required
mechanical circulatory support (ECMO, left ventricular assist devices
or total artificial heart).
10 patients died in hospital before discharge.
2 patients presented haemodynamic instability during the filtration
sessions that required intermitent vasopressor support and one
patient sustained a cardiac arrest during hemofiltration due to severe
metabolic acidosis.
The initial pattern of nocturnal hemofiltration every 48 hours could
be modified (i.e. less frequent hemofiltration sessions) in 25 patients
during their hospital stay due to renal function improvement.
All the14 CKD patients who were on hemodyalisis before their
admission to ITU were eventually transferred back to a renal unit,
plus 7 more patients that did not show renal recovery.
CONCLUSIONS. A satellite hemofiltration programme is an efficient
and safe service development that allows the provision of medium and
long term renal replacement therapies to cardiothoracic specialised
centres where conventional hemodyalisis is not available.
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INTRODUCTION. Continious renal replacement therapy (CRRT) has
become preferred dialysis option to support children with AKI
admitted to Pediatric Intensive Care Unit(PICU).
OBJECTIVES. To determine the use of CRRT and its outcome among
critically ill children.
METHODS. Retrospective observational cohort study including all
children admitted from 1–14 years of age in PICU of King Faisal
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 435 of 542Specialist Hospital & Research centre, Riyadh, Saudi Arabia, who had
underwent CRRT from July 2009 to June 2015.
RESULTS. Over all 96 patients were recruited with mean age of
approximately 6 yrs. (+/− 4.37), with male preponderance. Most
common diagnosis among these patients was Acute Leukemia 19.8%
(19/96) followed by Renal diseases, immunodeficiency, Metabolic
diseases and Lymphoma. The most common indication for CRRT was
fluid overload 67.2% (65/96) followed by tumor lysis syndrome, and
metabolic encephalopathy. We report median length of CRRT/patient
66 hrs (IQR, 34.57-164.2), with median average circuit life 30.86 hrs
(IQR, 16.42-45). Most common CRRT catheter site was Internal jugular
Vein 77.1% (74/96), followed by femoral vein and Subclavain vein
with most common CRRT catheter size 11.5 Fr 38.5% (37/96)
followed by 6 Fr, 8 Fr, and 10Fr. Also the most common CRRT
modality used was CVVHDF 82.3% (79%) followed by CVVHD, and
CVVH with heparin use of 24% (23/96). We report the mortality
among critically ill children admitted in PICU requiring CRRT 50%
(48/96), with 86.6% (26/30) among Stem cell transplant patients. We
also report increased mortality among patients with hematological
diseases (100%), and Immunodeficiency (86.6%), with least mortality
18.75% among patients with primary renal disease. We identified
Patients who underwent Stem cell transplant, presented with septic
shock, use of inotropic support before and during CRRT, Indication of
fluid overload for initiation of CRRT, Patient in Failure as per pRIFLE
criteria and in oliguric renal failure before CRRT, as the risk factors
significantly associated with increased mortality.
CONCLUSIONS. We report CRRT to be a preferred modality of choice
and better tolerated among critically ill pediatric population to treat
AKI and fluid overload.0861
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INTRODUCTION. Fluid overload causes an increased morbidity and
mortality in post resuscitated patients[1]. However, studies to identify
the start point and end point of fluid evacuation are still lacked in
current clinical practice[2, 3].
OBJECTIVES. Create and testify an individualized fluid removal
protocol with ultrasound volume assessment in post resuscitated
critical illness.
METHODS. A prospective controlled clinical trial was conducted.
Fluid removal was performed following either the doctor's clinical
experience with common monitoring (Control group), or an
individualized dehydration stewardship with inferior vena cava
diameter (dIVC), respiratory collapse index (IVC-CI) and lung
ultrasound B-lines monitoring (Ultrasound group). The primary end
points were the start point, end point and the length of fluid re-
moval, and the complications related with fluid overload or over-
dehydration during fluid removal period. The secondary endpoints
were the hospital expense, the length of ICU stay, the length of hos-
pital stay, the mortality in ICU, and the mortality in hospital.
RESULTS. Total 86 patients were enrolled initially and 80 patients
were matched and compared finally. Fluid removal was started
earlier (21.3 ± 14.6 h vs. 34.6 ± 26.3 h, Log-rank p = 0.005), and fin-
ished earlier (69.3 ± 33.3 h vs. 124.7 ± 52.8 h, Log-rank p < 0.001) in
Ultrasound group than in Control. The fluid removal period was
shorter in Ultrasound group than in Control (46.3 ± 29.7 h vs.
91.5 ± 41.8 h, p < 0.001). Daily negative fluid balance was more in
Ultrasound group than in Control (−990.4 ± 636.1 ml vs. -672.6 ± 577.9
ml, p = 0.004) during fluid removal period. Less hypotension occurred
(0/40 vs. 2/40) in Ultrasound group than in Control. Also, greater im-
provement of oxygen index was achieved in Ultrasound group than in
Control (1.0[158.5] vs. 0[142.5], p = 0.009).CONCLUSIONS. Individualized dehydration with ultrasound driven
protocol improves the efficacy and safety of fluid evacuation.
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ARDS: Clinical studies
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INTRODUCTION. Limited information exists about the prevalence,
subsequent management, and outcomes of hypoxemia among
ICU patients
OBJECTIVES. To assess the prevalence of hypoxemia among ICU
patients and to stratify them according to the severity of hypoxemia
(PaO2/FIO2 between 300 and 201 in mild, between 200 and 101 in
moderate, and < 101 mm Hg in severe). Management and outcomes
of hypoxemic patients and the proportion of them who met the
criteria for ARDS were analysed.
METHODS. International, multicenter, 1-day point prevalence study
conducted during the spring of 2016 in 117 ICUs in 6 french-
speaking countries.
All patients, hospitalized or admitted in each participating ICU during
the day of the study were susceptible to be enrolled.
Hypoxemia was defined as ratio of arterial oxygen tension to
inspired fraction of oxygen (PaO2/FIO2) of 300 mmHg or less.
The investigators recorded patient's characteristics (comorbidities,
SAPS-2 score), physiological data during the day of the study and
ICU mortality
RESULTS. Of 1604 patients included, 859 (54%) were hypoxemic, 440
(51%) were mildly, 345 (40%) moderately and 74 (9%) severely
hypoxemic. Among hypoxemic patients, 176 (20%) fulfilled ARDS
criteria (37% mild, 46% moderate and 16% severe). Characteristics of
patients and cause of hypoxemia according to hypoxemia severity
are reported in the Table 208. Pneumonia was the main cause of
hypoxemia (53%) and of ARDS (79%). Oxygen was administrated
using invasive ventilation in 525 (61%) patients, low-flow oxygen in
191 (22%), NIV in 84 (9.8%) and high-flow oxygen in 45 (5.2%). The
proportion of patients under invasive ventilation and high-flow oxy-
gen was greater in severely hypoxemic patients whereas NIV was
equally used across the different severity's classes (Table 209).
Among hypoxemic patients under invasive mechanical ventilation, 77%
received a tidal volume of 8 mL/kg or less of predicted body weight with
a median PEEP level of 6 [5–10] cmH2O. Among ARDS patients, 145
(83%) received a tidal volume of 8 mL/kg or less with a median PEEP of 8
[6–12] cmH2O and a median plateau pressure of 23 [19–27] cmH2O.
Prone position was used in 22 patients, Veno-Venous ECMO in 21
and NO in 19 mostly in moderately and severely hypoxemic patients.
In the whole population, ICU mortality was 20%, 12% of non-hypoxemic
patients and 27% of hypoxemic one (p < 0.001). ICU mortality increase
with hypoxemia severity (21% in mild hypoxemic patients, 26% in moder-
ate hypoxemic patients, and 50% in severe hypoxemic patients, P < 0.001)
In multivariate analysis among hypoxemic patients, severe hypoxemia
remained independently associated with ICU-mortality OR 2.7 (1.7 -4.3).
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(more than the half), ARDS represented only a minority of these
patients. The severity of hypoxaemia is associated with mortalityTable 209 (Abstract 0862). Ventilatory parameters according to
hypoxemia seve
Mild n=440 Moderate n=345 Severe n=74
Low flow O2 136 (30.9) 55 (15.9) 0 (0)
High Flow O2 11 (2.5) 23 (6.7) 11 (14.9)
Non invasive ventilation 43 (9.8) 33 (9.6) 8 (10.8)
Invasive ventilation 239 (54.3) 231 (66.9) 55 (74.3)
TV ≤8ml/kg IBW 165 (71.7) 178 (79.1) 50 (92.6)
PEEP 5 [5-8] 7 [5-10] 10 [8-12]
Plateau pressure* 20 [16-24] 23.5 [20-28] 25.5 [23-29.5]
Sedation 121 (51) 159 (69) 41 (76)
Paralysis 11(5) 44 (20) 28 (52)
Table 208 (Abstract 0862). Patients' characteristics
Mild n=440 Moderate n=345 Severe n=74
Age, years med (IQR) 65 [54-74] 65 [53-73] 58 [47-69]
Female, N (%) 142 (32.3) 109 (31.6) 22 (29.7)
Medical admission 327 (74.5) 281 (81.7) 67 (90.5)
SAPS II 42 [30-56] 43 [31-57] 45 [34-61]
COPD 141 (32.1) 127 (37.1) 20 (27.4)
Pneumonia 189 (43.0) 204 (60.2) 60 (82.2)
Acute on CRF 73 (16.6) 80 (23.5) 13 (17.8)
CPE 64 (14.6) 51 (15.0) 12 (16.4)
Aspiration 30 (6.8) 33 (9.7) 11 (15.1)0863
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INTRODUCTION. Prone positioning (PP) has been demonstrated to
reduce mortality in ARDS. Although PP is considered as a beneficial
and cost-effective therapy, it requires substantial personal resources
and has potential side effects (catheter removal; loss of airway).
Furthermore, a-priori criteria for the efficacy of PP are not clearly
characterized.
OBJECTIVES. Therefore, this study analysed potential predictors of
the efficacy of PP including baseline haemodynamics derived from
transpulmonary thermodilution TPTD (PiCCO; Pulsion Medical
Systems; Germany) and intra-abdominal pressure (IAP).
METHODS. We analyzed 54 cycles of a 16h PP-period in 26 patients
(10 f; 16 m) with ARDS according to the Berlin and AECC-definitions
before 1st cycle of PP (Berlin:14 moderate, 12 severe; AECC: 26 ARDS)
and before all cycles of PP (Berlin: 29 moderate; 25 severe; AECC: 54
ARDS). Ventilator settings, blood gas analysis, TPTD-data and IAP
were recorded immediately before and at the end of 16h of PP.
RESULTS. Mean values of pO2/FiO2 (160 ± 55 vs. 104 ± 29 mmHg;
p < 0.001), oxygenation index OI ((OI = mean airway pressure*FiO2/pO2) 11.3 ± 5.3 vs. 18.8 ± 5.6 cmH2O/mmHg; p < 0.001) and
modified LIS (sum of points without X-ray; 7.7 ± 1.4 vs. 8.9 ± 1.1;
p < 0.001) significantly improved after 16h of PP compared to base-
line, while pCO2 did not change (52 ± 17 vs. 55 ± 15mmHg;
p = 0.170). Decreases in OI of ≥ 3, 5 and 10 mmHg/cmH2O were
found for 42, 28 and 8 out of 54 cycles of PP, respectively. Decreases
in the modified LIS-score of 1 or 2 points were found in 37 and 21
out of 54 cycles of PP. Deterioration in LIS or OI or at least one of
both criteria were found in 5, 5 and 7 out of the 54 cycles of PP.
In univariate analysis improvement of the OI was associated with
higher OI_base (r = 0.535), higher Berlin-category (r = 0.475), higher
LIS (r = 0.407) and higher P_mean (r = 0.523; p < 0.001 for all correla-
tions), but not with P_peak, PEEP, driving pressure, IAP or PCO2.
Among TPTD-parameters there was a trend for an improvement in
OI with higher baseline values of pulmonary vasculary permeability
index PVPI (r = 0.241; p = 0.080). In a binary regression analysis in-
cluding these variables only OI and pCO2 at baseline were independ-
ently associated with an improvement of OI of ≥10 mmHg/cmH2O.
An improvement of OI of ≥10 mmHg/cmH2O was predicted by
baseline OI (AUC = 0.899; p < 0.001), pO2/FiO2 (0.875; p = 0.001),
Berlin-definition (0.815; p = 0.005), modified LIS (0.779; p = 0.013)
and PVPI (0.743; p = 0.029). A model including OI and pCO2 at base-
line provided an AUC of 0.937 (p < 0.001).
Higher values of pCO2 (≥53 mmHg) and GEDVI (≥801mL/m
2) were
the only significant predictors of a deterioration of OI and/or modified
LIS in univariate, multivariate and ROC-analyses.
CONCLUSIONS. High OI and lower pCO2 before PP were the
strongest predictors of successful PP. Among TPTD parameters
high PVPI and a GEDVI below the upper normal range were
associated with pulmonary improvement by PP.
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INTRODUCTION. Prone positioning (PP) has been demonstrated to
reduce mortality in ARDS. Nevertheless, PP carries some risks such as
catheter removal, loss of airway and potential haemodynamic side
effects. While the respiratory effects of PP have been intensely
investigated, there is a lack of data on haemodynamic effects.
OBJECTIVES. This study investigated haemodynamic and pulmonary
effects over time during a 16h period of PP in ARDS-patients with
TPTD monitoring (PiCCO; Pulsion; Germany).
METHODS. We analyzed 54 cycles of 16h PP in 26 patients (10 f; 16
m) with ARDS according to the Berlin and AECC-definitions (before
the 1st cycle of PP Berlin:14 moderate, 12 severe; AECC: 26 ARDS).
Ventilator settings, blood gas analysis and TPTD-values (PiCCO) were
measured immediately before PP as well as after 0.5h, 2h, 8h, 16h of
PP and finally 0.5h after turning to supine position (SP) again.
RESULTS. Overall, a 16h period of PP resulted in significant
improvement of the oxygenation index OI (OI = mean airway
pressure*FiO2/pO2) -5.5 ± 5.0 cmH2O/mmHg), pO2/FiO2 (+52 ± 49
mmHg) and modified LIS (sum of points without chest-X-ray:
−1.13 ± 1.29 points). By contrast, the return to SP resulted in a deteri-
oration of OI (+2.5 ± 3.8 cmH2O/mmHg), pO2/FiO2 (−21 ± 59 mmHg)
and modified LIS (+0.49 ± 1.03 points; all p < 0.001).
Beneficial respiratory effects of PP compared to baseline were
detectable as early as 30 min after PP with decreases of OI
(−3.9 ± 5.0 (30min); −4.2 ± 4.6 (2h); −4.5 ± 4.7 (8h); −5.5 ± 5.0
cmH2O/mmHg (16h)) and modified LIS (−0.52 ± 1.13 (p = 0.002);
−0.74 ± 1.23; −0.78 ± 1.18; −1.13 ± 1.3) as well as with increases
in pO2/FiO2 (+46 ± 58; +48 ± 56; +46 ± 46; +51 ± 49 mmHg)
after 30min, 2h, 8h and 16h of PP, respectively (p < 0.001 except
as indicated).
Table 210 (Abstract 0865). Multivariable analysis for having ARDS
Variable Odds ratio (95% CI) p-value
Diabetes 0.84 (0.72, 0.97) 0.02
Baseline PaO2:FiO2 ratio (per mmHg) 0.995 (0.994, 0.996) <0.0001
Immunosuppression 1.88 (1.48, 2.38) <0.0001
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(−0.22 ± 0.74 (p = 0.015) and 16h of PP (−0.35 ± 0.78; p = 0.003).
Extravascular lungwater index EVLWI slightly increased 30 min after
the start of PP (+0.72 ± 2.4; p = 0.047). However, on the long run
EVLW decreased after 8h (−1.5 ± 3.2 (p = 0.001) and after 16h of PP
(−1.4 ± 4.2; p = 0.007).
Decreases in EVLWI and PVPI after 16h of PP were significantly
associated to improvement in OI (r = 0.513; p < 0.001; r = 0.415;
p = 0.002) and pO2/FiO2 (r = −0.436; p = 0.001; r = −0.270; p = 0.048).
Furthermore, decreases in EVLWI were significantly associated with an
improvement in modified LIS (r = 0.317; p = 0.019). Decreases in EVLWI
and PVPI within 16h provided ROC-AUCs of 0.727 (p = 0.042) and 0.793
(p = 0.009) regarding an increase in OI of at least 10 points during 16h
of PP. PP did not result in changes of GEDVI, CVP or cardiac index CI
after 0.5, 2, 8 and 16h of PP.
CONCLUSIONS.
1.) PP effectively improved OI, pO2FiO2 and LIS without
haemodynamic impairment.
2.) PP resulted in a significant improvement of EVLWI and PVPI.
3.) Changes in EVLWI and PVPI over time were significant predictors
of substantial improvement in pulmonary function.
0865
Diabetes mellitus is protective against the development of ARDS:
an analysis of the LUNG SAFE database
A.J. Boyle1,2, F. Madotto3, J.G. Laffey4,5, G. Bellani3,6, T. Pham7,8,9, A. Pesenti10,11,
B.T. Thompson12, C.M. O'Kane2,13, A.M. Deane14, D.F. McAuley2,15
1Royal Adelaide Hospital, Intensive Care Unit, Adelaide, Australia;
2Queen's University Belfast, Wellcome-Wolfson Institute for Experimental
Medicine, Belfast, United Kingdom; 3University of Milan-Bicocca, School
of Medicine and Surgery, Manza, Italy; 4St Michael's Hospital,
Department of Anesthesia and Critical Care Medicine, Keenan Research
Centre for Biomedical Science, Toronto, Canada; 5University of Toronto,
Departments of Anesthesia, Physiology and Interdepartmental division
of Critical Care Medicine, Toronto, Canada; 6San Gerardo Hospital,
Department of Emergency and Intensive Care, Monza, Italy; 7Groupe
hospitalier des Hôpitaux Universitaires de l'Est Parisien, AP-HP, Hôpital
Tenon, Unité de Réanimation médico-chirurgicale, Pôle Thorax Voies
aériennes, Paris, France; 8Université Paris Diderot, UMR 1153, Inserm,
Sorbonne Paris Cité, ECSTRA Team, Paris, France; 9Université Paris Est
Créteil, UMR 915, Inserm, Créteil, France; 10Università degli Studi di
Milano, Istituto di Anestesia e Rianimazione, Milan, Italy; 11Ospedale
Maggiore, Istituto di Ricovero e Cura a Carattere Scientifico, Milan, Italy;
12Harvard Medical School, Division of Pulmonary and Critical Care Unit,
Department of Medicine, Massachusetts General Hospital, Boston, United
States; 13Belfast City Hospital, Regional Respiratory Centre, Belfast, United
Kingdom; 14The University of Melbourne, Intensive Care Unit, The Royal
Melbourne Hospital, Melbourne, Australia; 15Royal Victoria Hospital,
Regional Intensive Care Unit, Belfast, United Kingdom
Correspondence: A.J. Boyle
Intensive Care Medicine Experimental 2017, 5(Suppl 2):0865
INTRODUCTION. Diabetes mellitus is a prevalent disease affecting
almost 400 million people worldwide, and is therefore a common co-
existing disease in critically ill patients [1]. Previous studies have been
conflicting whether diabetes reduces the risk of the Acute Respira-
tory Distress Syndrome (ARDS).
OBJECTIVES. To evaluate the associations between pre-existing
diabetes and ARDS in critically ill patients with acute hypoxaemic
respiratory failure (AHRF).
METHODS. An analysis of a global, multi-centre prospective observa-
tional study (LUNG SAFE) [2] was performed. All intensive care unit
(ICU) patients receiving mechanical ventilation over a 4-week period
meeting criteria for AHRF were included (n = 4499 patients from 459
ICUs across 50 countries). Important clinical characteristics were in-
cluded in a stepwise selection approach (forward and backward se-
lection combined with a significance level of 0.05) to identify a set of
independent variables associated with having ARDS at any time, hav-
ing ARDS after two days of meeting AHRF criteria, and for 90-day
mortality.RESULTS. Of the 4499 patients with AHRF included in this study,
3022 (67.2%) fulfilled ARDS criteria at admission or developed ARDS
during their ICU stay. In patients with AHRF, diabetes mellitus was less
common in patients with ARDS (n = 657 [21.7%]) than in those who
never developed ARDS (n = 376 [25.5%]; p = 0.005). In multivariable
analysis, diabetes mellitus was associated with a reduced likelihood of
having ARDS (Odds Ratio 0.84 [95% CI 0.72, 0.97]; p = 0.02) (Table 210).
There was no association between diabetes mellitus and likelihood for
developing ARDS after two days of AHRF (OR 0.85 [0.60, 1.22];
p = 0.39). Diabetes mellitus was not associated with a difference in
mortality in patients with ARDS (OR 1.19 [0.92, 1.37]; p = 0.27).
CONCLUSIONS. In a large cohort of patients with AHRF, diabetes
mellitus was associated with a reduced likelihood of having ARDS
but did not protect against ARDS that developed after two days. In
patients with ARDS, diabetes mellitus was not associated with a
difference in mortality.
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INTRODUCTION. A short term beneficial effect of prone position (PP) on
cardiac index has been shown in 50% of 18 ARDS patients, and was
related to an increase in cardiac preload in preload responsive patients 1.
OBJECTIVES. The aim of this study was to evaluate the long term
hemodynamic response to prone position in a larger series of ARDS
patients.
METHODS. Single center retrospective observational study performed
on ARDS patients hospitalized in a medical ICU between July 2012 and
December 2016. Patients included were adults fulfilling the Berlin
definition for ARDS, undergoing at least one PP session, under
hemodynamic monitoring by the Picco ® device, with availability of
hemodynamic measurements performed before (T1), at the beginning
(T2), at the end (T3), and after the prone position session (T4). Prone
position sessions were excluded if they were performed > 10 days after
ARDS onset. The following variables were recorded: demographic,
SAPSII, ARDS severity and risk factor, SOFA score and cumulative fluid
balance at PP onset, delay between ARDS session and PP session,
hemodynamic, arterial blood gas, ventilatory settings, plateau pressure,
catecholamine dose and additional treatments. Statistical analyses were
performed using prone position session as statistical unit and mixed
models. p < 0.05 was chosen for statistical significance. Data are
expressed as mean ± standard deviation.
RESULTS. 99 patients fulfilled the inclusion criteria over the study
period, totalizing 186 prone position sessions (2 ± 2 sessions per
patient). Patients' age was 65 ± 11 y, 67% were male, 73% fulfilled
the criteria for severe ARDS, and SAPSII at ICU admission was
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pneumonia in 32 (32%), and sepsis in 9 (9%) patients. Duration of
prone position sessions was 16 ± 3 h. Hemodynamic measurements
were performed 3 ± 2h (T2) and 13 ± 3h (T3) after PP onset, and
2 ± 2h (T4) after return to supine position. At session onset, SOFA
score was 15 ± 4, and cumulated fluid balance was 2.3 ± 6.6 L.
Vasopressor were used in 86%, inhaled nitric oxide in 22%, and
neuromuscular blocking agents in 92% of the sessions. Hemodynamic
and respiratory parameters before, during and after the PP sessions
are reported Table 211.
CONCLUSIONS. Prone position is associated with a moderate but
sustained increase in global end-diastolic volume, reversible after re-
turn to supine position. This effect could explain a change in cardiac
index induced by postural change in preload-dependent patients.
REFERENCE(S)
Jozwiak M. Am J Respir Crit Care Med 2013;188:1428–33.Table 211 (Abstract 0866). See text for description
T1 T2 T3 T4
Heart rate (min-1) 97 ± 22 † 98 ± 20†,‡ 95 ± 20 94 ± 20
Cardiac index (L.min-1.m-2) 3.5 ± 1.3 † 3.5 ± 1.2 † 3.5 ± 1.1† 3.3 ± 1.1
Global end-diastolic volume
(mL.m-2)
719 ± 193 734 ± 179
*,†
751 ± 194
*,†
713 ± 199
Global ejection fraction (%) 22 ± 7 21 ± 7 * 22 ± 7 21 ± 7
Vasopressor dose
(μg.kg-1.min-1)
0.91 ±
1.70
0.91 ± 2.09 0.83 ± 1.70
*
0.88 ± 1.80
*
Dobutamine dose
(μg.kg-1.min-1)
2.5 ± 5.9 2.4 ± 5.6 2.7 ± 6.0 2.8 ± 6.1
PEEP (cm H2O) 10 ± 3 †,‡ 10 ± 3 †,‡ 9 ± 9 9 ± 3
PaO2/FiO2 (mm Hg) 112 ± 27 - 178 ± 63 *,† 151 ± 57 *
PaCO2 (mm Hg) 45 ± 10 - 44 ± 11 44 ± 10
Multivariate analysis identified as independent predictors of cardiac index:
global end-diastolic volume, global ejection fraction, PaCO2, PaO2/FiO2, heart
rate and PEEP level. Multivariate analysis identified as independent predictors
of global end-diastolic volume: body position, age and sex
† p < 0.05 vs T4,
‡ p < 0.05 vs T3,
* p < 0.05 vs T10867
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INTRODUCTION. Acute respiratory syndrome (ARDS) is a life
threatening condition with high mortality rates. It is characterized by
inflammation of the lung parenchyma leading to impaired gas
exchange with concomitant systemic release of inflammatory
mediators causing protracted inflammation, increased vascular
permeability, increased permeability of alveolar epithelial cells,
extravasation of plasma and leucocyte infiltration, and frequently
resulting in multiple organ failure. Since inflammation is thought to
contribute to the pathogenesis of ARDS, it is rational to explore
modulating therapies for this inflammation, provided the adverse
effect of such treatment is not excessive. (1)
Hypertonic saline nebulization (NaCl 3%) is a potent anti-
inflammatory agent, and immunomodulator, which exert inhibitory
effects in several stages of the inflammatory cascade and would
seem to be a logical choice for treatment of ARDS.(2)
OBJECTIVES. to assess the effect of hypertonic saline nebulizer on
patients with early ARDS as regard morbidity (using Murray lung
injury score [PaO2/ FiO2, lung quadrant infiltration, PEEP,
compliance], and follow up of lung mechanics) and mortality.METHODS. This study included 60 patients according to sample size
admitted to the Department of Critical Care Medicine at the
Alexandria Main University Hospital meeting criteria of ARDS
according to Berlin´s definition. They were categorized into two
groups group I (control group) included thirty patients, and group II
(study group) included thirty patients who received 4ml of
hypertonic saline nebulization once daily for 7 days. All cases were
subjected to history taking, clinical examination, assessment of
disease severity (APACHEII), laboratory investigations, ABG, and chest
X-ray, with measurement of lung mechanics (compliance, airway re-
sistance, peak and plateau pressures, PEEP), hypoxic index, lung in-
jury score (LIS), and SOFA score.
RESULTS. Hypoxic index, LIS and SOFA score were significantly
improved in hypertonic saline group than control group. Also, intensive
care unit (ICU) stay and mechanical ventilation days were reduced in
the hypertonic saline group with statistically significant difference.
Survival was significantly higher in the hypertonic saline group.
CONCLUSIONS. Initiation of hypertonic saline nebulization therapy
for patients with early ARDS appears to be tolerable and may be
beneficial with significant improving in oxygenation with trend to
decrease mortality, ICU stay, and mechanical ventilation days and so
may be added to protective lung strategy.
REFERENCE(S)
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INTRODUCTION. ARDS due to influenza AH1N1 infection had a very
harmful impact around the world but developing countries were
more affected. Prone position (PP) has shown lower mortality in
moderate and severe ARDS patients especially when it's applied
early. Venous-arterial pCO2 difference (CO2 v-a difference) has been
considered as a marker of cardiovascular system efficiency, patients
with CO2 v-a difference >6 mmHg had worse outcome; in the same
way, as long as shunts increase, the severity of disease increase.
OBJECTIVES. Analyze the clinical outcome of AH1N1 ARDS patients
according to shunts and CO2 v-a difference behaviour before and
after prone positioning.
METHODS. A retrospective analysis of severe ARDS patients
secondary to Influenza AH1N1 infection treated in a tertiary hospital
intensive care unit in Mexico city, from January to march 2017,
recording intrapulmonary shunts by Fick method, CO2 v-a Difference
before and after six hours of PP. Clinical outcome was analyzed.
RESULTS. Twelve patients analyzed, (10) 86.4% male and (2) 13.6%
female, a survivor rate of 33.3%, 4 survivors, 8 non survivors. Mean
pre prone position shunts was of 42.2%, 33% in survivors, and
46.65% in non survivors; mean pos prone position (6 hrs) shunts was
of 31.39%, 22.9% in survivors, and 35.64% in non survivors. Mean
CO2 v-a difference pre prone position was of 10.95 mmHg, 8.2 in sur-
vivors and 12.32 in non survivors; mean CO2 v-a difference pos
prone position (6 hrs) was of 7.67 mmHg, 3.5 in survivors and 9.75 in
non survivors by Pearson lineal correlation of CO2 v-a difference and
shunts before prone position was 0.712 with a bilateral meaning of
0.009, this finding were not found after PP. CONCLUSIONS. In AH1N1
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 439 of 542ARDS patients submitted to prone position, we found non survivors
had higher shunts and CO2 v-a difference previously and posterior
to prone position in contrast with survivors, reflecting the severity of
disease. We found a good correlation between shunts and CO2 v-a
difference behavior in pre prone position, statistically significant,
however we didn't found correlation posterior to prone position. The
gasometrical behavior during ARDS patients remains a topic of inter-
est for medical research, so prospective studies with a biggest sam-
ple are needed to elucidate the use of CO2 v-a difference and shunts
as a predictor of mortality in patients in prone position.
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BACKGROUND. Several studies have demonstrated the benefits of
prone position ventilation in patients with severe ARDS (1,2);
however, controversy over the safety of this maneuver continues (3)
especially in morbid obesity (4) and after abdominal surgery (5).
METHODOLOGY. ICU patients with a diagnosis of severe ARDS
treated with prone position were prospectively enrolled from 2014 to
2016. Patients demographics, APACHE II, SOFA and Braden scores,
free days of ventilation (FDOV) and lenght of stay in the ICU (LOS-
ICU), vascular access dysfunction, endotracheal tube occlusion,
unplanned extubations, duration of prone, pressure ulcers (PU) and
complications of surgical wounds were recorded.
RESULTS. Eleven patients with severe extrapulmonary ARDS after
abdominal surgery, were proned 57.2 (±17.2) continuous hours.
APACHE II, SOFA and Braden scores at admission were 25 (±5), 12
(±3) and 10 (±2) points respectively. After 12 h of prone position
PaO2/FiO2 ratio increased (83.82 ± 19.12 vs 180.14 ± 63.95, p = 0.03)
and at 48 h pulmonary shunts decreased (46 to 23% p = 0.03). We
recorded 16 (±3.5) mean of FDOV and 13 (±4) LOS-ICU, all survived.
Two patients had grade II PU in both labial commissures, and another 2
patients developed grade I PU in knees, no central venous catheter
dysfunction was recorded. One arterial line was removed, 1 patient with
a femoral Mahurkar catether had obstruction that required modifications
in limb position. No orotracheal tube oclussions, unplanned extubation
or surgical complications were recorded. None of them presented
complications of the surgical wound (eventration, infection or need of
urgent surgery).
DISCUSSION. Benefits of prone position are clear (1–5), some authors
have proposed limits to the maneuver (3), in spite that obese (4) and
patients with abdominal surgery have been reported to respond well
without increased complications (5). We conclude that prone
position is safe when there are protocols and trained personnel.
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INTRODUCTION. ARDS is a pathology of high incidence in intensive
care units, with a high cost and high morbidity and mortality due to
the difficult management of these patients, since it lacks specific
treatment.(1)
OBJECTIVES. To study the evolution of the ventilatory and gas
exchange parameters in patients with ARDS and to verify if the
recommendations of the last guidelines of the protective ventilation
are carried out in a third level UVI.
METHODS. An observational, prospective study of patients
admitted in a polyvalent UVI at a tertiary hospital since 2015 until
now, who present ARDS according to the Berlin criteria (2). We
recorded the variables of the chosen days, collecting; gravity
scales (APACHE, SOFA), respiratory mechanical variables (peak
pressure, plateau, PEEP, CrsL), gas exchange variables (pafi, pCO2,
ph), until the patients are released from the unit (including
complications / mortality).
RESULTS. A sample of 34 patients with ARDS (age 59.85 ± 13.69
years, 67.6% males) has been analyzed, the severity of admission
according to the APACHE II scale was 19.76 ± 8.7, The cause of the
admission was abdominal in 11.8%, postoperate in 14.7%, respiratory
in 52.9%, VMNI pre IOT was started in 44.1% and GAF in 14.7% with
a duration of both techniques of 0.65 ± 1.45 days. The cause of
ARDS was respiratory in 61.8%, abdominal in 26.5% and 8.8% by
sepsis, with a percentage of extrapulmonary ARDS of 41.2%. In the
Table 212 we can see the evolution of the respiratory and
gasometric parameters in the different days.
Prono was performed in 44.1%, corticosteroid therapy in 41.2%, time
of MV of 16.41 ± 9.9 days, need of reintubation 11.8%, tracheotomy
in 29.4% and barotrauma 11.8%. With all this we obtained a stay in
UVI of 19.76 ± 9.88 days, a mortality of 50% being the causes of
death; respiratory rate in 32.4% and FMO in 14.7%.
CONCLUSIONS. The most commonly used mode is VC. No parameters
are changed, the same PEEP is maintained and almost the same vt. The
pressures have been adjusted to the recommendations, with peak
pressure under 40 cmH2O and plateau under 30 cmH2O. Vt stands at 7
ml/kg, higher than we expected (this may be due to the increase in
obesity in the population and to the low adjustment of this volume to
the ideal weight).
A high mortality could be attributable to the high rate of severity of
these patients, with a non insignificant association with respiratory
failure.
REFERENCE
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Table 212 (Abstract 0870). The respiratory and gasometric parameters
Patients
in VM
Mode VT
(ml/
kg)
Peak
pressure
(cmH2O)
plateau
(cmH2O)
PEEP
(cmH2O)
CrsL
(ml/
cmH2O)
PaFi pCO2
(mmHg)
1°
Day
100% VC
79,4%
PC
20,6%
7±1,2 36,88
±4,6
28,59
±3,6
14,62
±4,44
30,47
±9,9
97,21
±41,7
67,35
±23,4
2°
Day
97,05% VC
70,6%
PC
17,6%
7,34
±1,31
36,39
±5,0
28,06
±4,35
14,45
±3,28
32,94
±13,25
119,94
±53,5
60,70
±17,10
4°
Day
91,17% VC
50,0%
PC
32,4%
7,35
±1,6
33,23
±5,18
26,65
±4,07
14,16
±3,25
33,90
±12,01
161,29
±68
57,13
±16,21
7°
Day
70,58% VC
29,4%
PC
20,6%
PS
17,6%
7,50
±1,70
32,08
±90
24.08
±6,45
13,63
±3,33
40,96
±15,08
182
±70,34
53,38
±13,41
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INTRODUCTION. The pathogenesis of acute respiratory distress
syndrome (ARDS) has been explained by the presence of a direct
(pulmonary) or indirect (extrapulmonary) insult to the lung
parenchyma. Evidence indicates that the pathophysiology of ARDS
may differ according to the type of insult. (1).
OBJECTIVES. To analyze the differences in ventilatory mechanics and
gas exchange between ARDS of pulmonary or extrapulmonary cause
in a polyvalent ICU.
METHODS. 34 Patients with ARDS, according to Berlin Criteria were
studied consecutively since 2015 until now. Population was classified
into two groups according to its cause: pulmonary (ARDSp) or
extrapulmonary (ARDSe). Data were collected on days 1st, 2sd, 4th
and 7th: ventilatory parameters (PEEP, peak pressure and plateau,
tidal volume and compliance), gaseous exchange (pO2/FiO2, pCO2
and pH) and rescue maneuvers (prone, systemic steroids, and
neuromuscular relaxation). There are also recorded, age, gender, days
of mechanical ventilation and ICU admission, SOFA score and mortality.
RESULTS. Both groups were homogeneous in: age, gender, severity
(APACHE II scale, SOFA). The intubation was delayed less than one
day from its admission in the unit in both groups. (60% ARDSe was
used VMNI (p =0,04) and 60% of ARDSp was GAF (p =0,9)).
Ventilatory and oxygenation parameters and the use of relaxants
were similar in both groups.
Tidal volume was different in the 1st after intubation 6,79 ± 1,09 in
ARDSp (compared to 7,47 ± 1,14 ml/kg with p =0,037). 2sd day pO2
was 100,94 ± 33,31 in ARDSp (compared to 75,15 ± 12,15 mmHg
with p =0,003). 4th day no differences were found. Of note, at the 7th
day PCO2 (57,06 ± 14,18 vs 44,43 ± 4,68 mmHg with p =0,014) and
RR (29,88 ± 3,723 vs 25,29 ± 5,05 rpm with p =0,035) were higher in
ARDSp comparing to ARDSe. The ph was lower in ARDSp than
ARDSe 7,37 ± 0,08 vs 7,44 ± 0,056 (p =0,045).
Not differences were observed in the days of MV nor in the length
of stay.
Rescue manoeuvres were performed more frequently in SDRAp;
Prone position in 44,11% of all patients (80% vs 20% in ARDSe
(p =0,026)), corticoids in 41,17% of all patients (71.4% vs 28,6%in ARDSe (p =0,211)). Mortality was higher for ARDSe with
58.8% (p =0,037) (main cause respiratory failure in 54.5% of cases)
compared to 41.2% in ARDSp (being the main cause multiorgan
failure (80%)).
CONCLUSIONS. In these patients, no statistically significant differences
were found in the first week (exudative phase): either in ventilatory
mechanics or in gas exchange. The differences were only found in the
gaseous exchange of the 7th day when the proliferative phase is
initiated. The SDRAp had higher pCO2 values and, therefore, required
higher RR to maintain the pH range.
On the other hand, more rescue manoeuvres were used in ARDSp so
they had less mortality, and their mortality was mostly associated
with multiorgan failure rather than respiratory failure.
REFERENCE
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INTRODUCTION. Despite advances in critical care management of
acute respiratory distress syndrome (ARDS), its prognosis reminds
worse. The aim of our study was to describe clinical and paraclinical
characteristics and evolving therapeutic of ARDS.
METHODS. It was a retrospective cohort study from 1st January 2015
to 30th of November 2016. We described epidemiology, etiology,
treatment and outcomes of patients admitted to ICU during this
period.
RESULTS. 76 ARDS were enrolled; overall incidence was 65 episodes/
1000 admissions. Median age was 59 years [18–87] and sex
ratio = 1.37. Co-morbidities were present in 71% of cases. The mean
IGS II and APACH II scores were respectively 41 and 19. At admission,
Septic shock was observed in 30% of patients, it was associated to
acute renal failure in 29% and to multi organ failure in 32%. Median
pH and PaO2 / FiO2 ratio was respectively 7.35 [6.9-7.5] and 116 [35–
261]. ARDS was classified severe in 54%, moderate in 38% and mild
in 8% of cases. Community acquired pneumonia was the most com-
mon cause (80%). Its origin was bacterial in 54% of cases, viral in
17%, parasitic in 8% and fungal in 4%. All patients underwent echo-
cardiography. It showed an acute cor pulmonale in 17% of patients
with mean PAPS of 35mmHg [15–80]. Mechanical ventilation was
necessar in all cases; it was initially non-invasive in 60%. 52% re-
ceived a positive end-expository pressure (PEEP) less than 12 cm
H2O.The means of PEEP, respiratory rate and plateau pressure were
respectively 10 cm H2O [0–18], 25 c/min [14–36] and 28 cm H2O
[19–47]. Neuromuscular blockers were needed in 65% cases. Prone
position was indicated in 45% (P/F less than 150). Inhaled nitric oxide
was used only in two patients. Evolution was characterized by the
occurrence of acute renal failure in 16% and nosocomial infection in
38% with a predominance of ventilator-associated pneumonia (65%).
Means duration of mechanical ventilation was 10 days [2–46] and
length of ICU stay was 11 days [2–57]. Overall mortality rate was
74%. It was 33% in mild ARDS, 75% in the moderate form and 80%
in the severe one. Common cause of death was refractory hypoxemia
with multi organ failure syndrome (40%). Multivariate analysis showed
that independent factors predictors of mortality were age ≥ 58 years,
IGS II and APACH II scores, presence of coma, PaO2/FiO2 < 150, plateau
pressure ≥28 cmH2O, use of mechanical invasive ventilation, vasopres-
sors, neuromuscular blockers and prone positioning.
CONCLUSION. Our study confirms that ARDS is associated with high
mortality. Presence of comorbidities, multiorgan failure at admission
and degree of hypoxemia were the major factors for worse prognosis.
Fig. 284 (Abstract 0874). See text for description
Fig. 285 (Abstract 0874). See text for description
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BACKGROUND. Prone positioning (PP) has been used to improve
oxygenation in patients who require mechanical ventilator support for
management of ARDS. Randomized controlled trials demonstrated that
survival rate is significantly better with PP.
PURPOSE. We proposed to determine the effect of PP on prognosis
of ARDS.
METHODS. It was a retrospective study, including 76 cases of ARDS
admitted in our respiratory ICU from January 2015 to November
2016. We have defined 2 groups: GI (44 patients positioned in PP),
GII (32 without PP). We compare clinical data, therapeutic, side
effects and outcomes. PP was indicated in severe cases of ARDS with
persistent hypoxemia despite ventilatory optimization. PP was
maintained for 18 consecutive hours daily. Discontinuation of PP was
decided after clinical improvement.
RESULTS. At admission, no significant difference was found between
the 2 groups in mean age (56vs50 years, p = 0,5) and APACHEII score
(20 ± 10vs17 ± 7, p = 0,09). However, sex ratio (1vs2.5; p = 0,03) and
mean IGSII score (44 ± 18 vs 35 ± 13; p = 0,02) were significantly
different. Cardiovascular co-morbidities were more frequent in GI
(75%vs66%, p = 0,3). Septic shock was present in 36% in GI vs 22%
in GII (p = 0,1). Pneumonia was the most common cause in 2 groups
(73% vs 90%, p = 0,053). Patients in GI were more hypoxemic and
significant differences were noted in the means of pH (7.31 ± 0.15 vs
7.42 ± 0.12; p = 0,001), PaCO2 (55 ± 23mmHg vs 43 ± 19mmHg;
p = 0,019), and PaO2/FiO2 (103 ± 51 vs 135 ± 54; p = 0,01). All pa-
tients underwent echocardiography. Acute cor pulmonale was more
frequently observed in GI (27% vs 3%; p = 0,01). Invasive mechanical
ventilation was needed in all patients of GI, otherwise it was pre-
scribed in only 50% in the second group(p < 0,001). Mean duration
of mechanical ventilation was significantly longer in GI (12 ± 9 vs
7 ± 10 days; p = 0,04). Mean positive end-expiratory pressure (PEEP)
received in GI was significantly higher than that of GII (12 ± 5 vs
8 ± 3 cmH2O; p = 0,002). 66% of patients in G1 received a PEEP
more than 12 cmH2O in contrast of 6% in GII (p = 0,002). Mean plat-
eau pressure were similar in 2 groups (29 ± 4 vs 29 cmH2O). Use of
neuromuscular blockers was significantly more frequent in GI (100%
vs 19%; p < 0,001). Most frequent side effects occurred in GI were
pressure ulcer and hemodynamic instability. GI had significantly
more nosocomial infection (48% vs 25%; p = 0,044), longer mean
duration of ICU stay (12 ± 10 vs 10 ± 9 days, p = 0,3) and higher
mortality rate (89% vs 56%; p = 0,001). Multivariate analysis showed
that female gender (p = 0,03), presence of acute cor pulmonale
(p = 0,01), invasive mechanical ventilation with use of sedative and
neuromuscular blockers (p < 0,001), PEEP ≥ 10 cmH2O (p = 0,007),
and nosocomial infection (p = 0,044) were independent predictor
factors of mortality.
CONCLUSION. Our study doesn't confirm the benefit of PP in ARDS.
However, patients who require this technique were more severe,
have more organ dysfunction and consequently a worse prognosis.
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Intensive Care Medicine Experimental 2017, 5(Suppl 2):0874INTRODUCTION. Increase in intraocular pressure (IOP) has been
reported due to prone position in awake volunteers1 and patients
undergoing surgeries in operation room.2,3 Effect of prone
positioning on IOP in critically ill ARDS patients, where it is one of
the lifesaving interventions and is usually for more prolonged
duration compared to operating room, has not been studied earlier.
OBJECTIVES. To evaluate the effect of prone positioning on IOP in
moderate to severe ARDS patients.
METHODS. After ethical approval, this prospectivestudy was done in a
12 bedded ICU of tertiary academic hospital. All adult ARDS (moderate
to severe) patients, ventilated as per ARDS net protocol and planned for
prone ventilation, were considered. Patients having clinical conditions
with suspected raised intracranial pressure, previous eye trauma or
disease or surgery, patients with history of glaucoma and prone
positioning of less than 6 hours duration, were excluded. During prone,
neck was turned to one side with all protective measures. IOP was
measured by hand held applanation tonometer (Tono-Pen AVIA®) in 30-
450 head-end elevation position: before prone (T1), after end of the
prone session at 10 (T2) and 30 min (T3). Tonopen reading displayed
after 10 applanations with 95% confidence limits were recorded. Data
represented as median (IQR) and Wilcoxon test applied to compare IOP
at various time periods with p < 0.05 considered statistically significant.
RESULTS. Sixteen patients, age 61 (51–66) years, medical 15, male 11, SOFA
score 12 (10–14), PaO2/FiO2 ratio of 90 (63–120), all in septic shock (on
norepinephrine at 0.3 mcg/kg/min) were included. Duration of prone
position was 15 (12–18) hours. Median IOP (mm Hg) before prone in right
eye was 12 (9.5-16.7), which was found to increase to (with p value) 18
(0.01) and 15.5 (0.01) at 10 and 30 min respectively after end of the prone
session. In left eye, IOP increased from 13 (12–17.25) to 20 (0.01) and 16
(0.01). Analysis as per eye position during prone: IOP in dependent eye
increased from 13 (10.2-16.7) to 19 (0.02) and 14 (0.015) respectively [Fig.
284a and b]; whereas IOP in non-dependent eye changed from 12 (11–17)
to 20 (0.001) and 16 (0.03) respectively [Fig. 285a and b].
CONCLUSIONS. There is significant increase in IOP due to prone
positioning among ARDS patients. Also, IOP continued to rise even at
30 min, though with decreasing trends, after end of the prone session.
REFERENCE(S)
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INTRODUCTION. In acute respiratory distress syndrome (ARDS),
airway driving pressure (ΔPAW = Plateau pressure (PPLAT) minus total
PEEP (PEEPTOT)) reflects the strain applied to the respiratory system.
ΔPAW below 15cmH2O is associated with increased survival [1–2].
However, transpulmonary driving pressure (ΔPL = end-inspiratory
transpulmonary pressure (PLEI) minus end-expiratory transpulmonary
pressure (PLEE)) is a better assessment of the strain applied to the
lung. Treatment strategy leading to ΔPL below 10 cmH2O is associ-
ated with increased survival [2]. INTELLiVENT-ASV is a full closed loop
ventilation mode that adjusts minute volume according to end-tidal
CO2 and select tidal volume according to respiratory mechanics.
OBJECTIVES. This prospective physiological study assess ΔPAW and
ΔPL selected by INTELLiVENT-ASV after recruitment in ARDS patients.
METHODS. The study was conducted in the general ICU of Hopital
Sainte Musse, Toulon, France. Eligible participants were adults aged
18 or over, with early onset moderate or severe ARDS, invasively
ventilated for less than 24hours. Exclusion criteria were
contraindication to insert nasogastric tube, bronchopleural fistula,
emphysema, pneumothorax, increased intracranial pressure, acute
cor pulmonale, hemodynamic instability, and pregnancy. Patients
were deeply sedated. An esophageal balloon was inserted [3]. A 10s
sustained inflation recruitment maneuver was performed targeting a
transpulmonary pressure at 27 cmH20 during the maneuver. Then a
decremental PEEP trial was performed to determine the level of PEEP
associated with PTPEE at 1-2cmH2O. PEEP was manually set at this
level. Airway and esophageal pressure (PESO) were measured at end-
inspiration and end-expiration using 5s end-inspiratory and end-
expiratory occlusions, respectively. Transpulmonary pressure was cal-
culated as airway minus esophageal pressure at end-inspiration and
end-expiration. ΔPL was calculated as the difference between PLEI
and PLEE.
RESULTS. Nineteen patients were included between February 2016
and March 2017, 9 moderate and 10 severe ARDS, 18 were
paralyzed. Sex ratio = 11/8, Age = 60 ± 18y, SAPSII = 57 ± 22,
BMI = 26 ± 4, 8 patients died.
For the total respiratory system: PEEPTOT = 18 ± 5cmH2O,
PPLAT = 27 ± 5cmH2O, ΔPAW = 9 ± 2cmH2O, VT = 5.8 ± 1.0mL/KgPBW,
CRS = 42 ± 17ml/cmH2O.
For the lungs: PESOTI = 19 ± 6cmH2O, PESOTE = 16 ± 5cmH2O,
PLTI = 8 ± 3cmH2O, PLTE = 2 ± 2cmH2O, ΔPL = 6 ± 3cmH2O,
CL = 73 ± 39ml/cmH2O.
CONCLUSION. After a recruitment maneuver and a PEEP set to
achieve positive PLEE, INTELLiVENT-ASV selected low and safe ΔPAW
and ΔPL in moderate to severe ARDS patients. This strategy seems
lung protective.
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Intensive Care Medicine Experimental 2017, 5(Suppl 2):0876INTRODUCTION. Human adenoviruses cause infections ranging in
severity from mild symptoms to life threatening disease. Previous
studies have demonstrated higher morbidity and mortality in
populations including children and immunocompromised patients
who were infected with the adenovirus.
OBJECTIVES. This study was conducted to investigate the
characteristics and sequelae of patients with severe pneumonia
secondary to adenovirus infections requiring intensive care support.
METHODS. Retrospective analysis of patients admitted in the
medical Intensive Care Unit (ICU) of a tertiary hospital between
January and March 2013 who had community acquired pneumonia
with adenovirus isolated from the respiratory tract. Bronchoscopy
and bronchoalveolar lavage were performed and samples were sent
for viral cultures, antigen and polymerase chain reaction (PCR).
Demographics, comorbidities, initial symptoms and travel history of
the patients were collected. We recorded outcomes including
mortality, ICU stay duration, use of antiviral agents, requirement for
inotropic support, extra corporeal membrane oxygenation (ECMO)
and renal replacement therapy.
RESULTS. Out of fifty patients admitted for severe pneumonia,
eleven (22%) were detected to have adenovirus infection with severe
acute respiratory distress syndrome (ARDS). Adenovirus serotype 7
was identified in 91% (10/11) of the patients. The mean age was 49
years and mean BMI was 28.3. 36% (4/11) of the patients were
immunocompromised. Fever and cough were the commonest initial
presenting symptoms accounting for 82% (9/11) of all patients. The
mean maximum temperature was 38.9 degrees Celsius, although
temperature did not correlate with disease severity. Other symptoms
including dyspnea, sore throat and rhinorrhea were present in less
than half of the patients. 36% (4/11) had rhabdomyolysis. 2 of the
patients had underlying end stage renal disease. Among the
remaining patients 78% (7/9) developed acute kidney injury, of
whom 3 required renal replacement therapy. 36% (4/11) had
disseminated intravascular coagulopathy (DIC). 91% (10/11) required
inotropic support. 3 patients received ECMO, of whom 1 survived. All
5 patients who received anti-viral treatment passed away. Overall
mortality was 64% (7/11) and mean ICU stay duration was 18 days.
CONCLUSIONS. Adenovirus serotype 7 infection is an important
cause of fulminant pneumonia with systemic involvement in both
immunocompetent and immunocompromised patients. Antiviral
agents do not seem to alter the course of the disease. ECMO support
may be considered for rescue ventilation of patients who present
with worsening respiratory failure, but this is often associated with
prolonged ICU stay and overall mortality remains high.
Nutrition, energy expenditure and prognosis
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INTRODUCTION. Elderly patients represent a growing proportion of
critically ill patients with a high nutritional risk. Therefore, estimation
of resting energy expenditure (REE) should be accurate to prevent
over- or underfeeding.
OBJECTIVES.
1) To analyse REE measured by indirect calorimetry (mREE) in
intensive care unit (ICU) patients aged ≥75 years as compared to REE
calculated by predictive equations (cREE).
2) To compare mREE in these patients with mREE in matched healthy
controls
3) To identify variables independently associated with possible mREE
differences between ICU patients and healthy controls.
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 443 of 542METHODS. Prospective observational matched cohort study in a
tertiary medical centre. Eligible were mechanically ventilated patients
aged ≥75 years with an FiO2 of ≤0.6. REE was measured on the first
day of ICU stay using the M-CVOX device (GE Healthcare, Helsinki,
Finland). cREE was calculated using the following equations: ACCP,
Ireton-Jones, Faisy-Fagon, PennState, Müller, and Harris and Benedict.
Bland Altman test was used to analyse agreement between mREE
and cREE in ICU patients. The clinically acceptable range of cREE was
defined as mREE ± 10%. Healthy volunteers from a prospectively col-
lected institutional database were matched to the ICU patients by
age, sex, and body mass index. Measurement of REE in the control
group was performed using indirect calorimetry by a ventilated can-
opy (CareFusion, Yorba Linda, USA). Multivariate linear regression
analysis was performed to identify variables that influence differ-
ences in mREE.
RESULTS. We included 90 elderly ICU patients (median age: 80 years,
25%/75% percentile: 77–84 years). The median cREE differed from
mREE in the equations of Ireton-Jones (Δ mREE - cREE: −109 kcal/d
[25%/75% percentile: −297 kcal/d - 147 kcal/d], p = 0.085; proportion
of patients within ± 10% of mREE: 36.7%; R2 in ICU patients: 0.615),
Faisy-Fagon (−353 kcal/d [−486 - 96], p < 0.0001; 23.3%; 0.318), Penn-
State (+54 kcal/d [−105 - 248], p = 0.023; 48.9%; 0.211), Müller (+105
kcal/d [−82 - 334], p < 0.0001; 41.1%; 0.326), and Harris und Benedict
(+139 kcal/d [23–407], p < 0.0001; 40%; 0.377), but not in ACCP (−33
kcal/d [−247 - 288], p = 0.641; 21.1%; 0.448). In the matched pair ana-
lysis (n = 58), mREE in the ICU cohort was higher compared to the
healthy control (1457 kcal/d [1247–1876] vs. 1351 kcal/d [1187–
1503], p = 0.008). Maximum temperature (p = 0.008), respiratory rate
(p = 0.002) and FiO2 (p = < 0.0001) were independently associated
with differences in mREE in the matched pair cohort.
CONCLUSIONS. REE calculated by established equations systematically
over- or underestimated measured REE, respectively in up to 80% of
elderly critically ill patients. Measured REE in these patients was
significantly higher compared to healthy controls matched by age,
gender and body mass index. Physiological variables independently
associated with a higher mREE may in part explain this difference.
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INTRODUCTION. Resting energy expenditure (REE) is known to
decline with age in healthy subjects. This decline is independent of
the age-related decrease in lean body mass (1). Whether this holds
true in critically ill medical patients has not been investigated so far.
OBJECTIVES. To evaluate the changes of energy metabolism and its
association with age in critically ill medical patients.
METHODS. 200 critically ill medical patients with need for mechanical
ventilation underwent indirect calorimetry within 72 hours of admission
after an overnight fast to determine REE. REE was adjusted for body
weight (aBW). To obtain age groups, patients were divided into quartiles
(I: 18–35 years, n = 21; II: 36–52 years, n = 43; III: 53–69 years, n = 93; IV:
70–86 years, n = 43). Sex, SAPS II score, temperature at time of
intervention, height, weight and BMI were assessed. Kruskal-Wallis Test
was used for group comparisons. Parameters that were significant in uni-
variate regression analysis entered the multivariate regression model.
RESULTS. Groups differed significantly in age (P < 0.01). SAPS II score
(P < 0.01) and BMI (P = 0.01) increased with age, whereas body
temperature was highest in the youngest patients (P = 0.02). REE was
similar in all groups (I: 1927 (1489–2289), II: 1767 (1413–2015), III:
1625 (1348–1819), IV: 1648 (1310–1843) kcal/day; P = 0.09), yet,REEaBW significantly decreased with age (I: 27 (23.4-32), II: 21.4 (19.6-
24.3), III: 20.9 (17.4-23.4), IV: 18.7 (16.7-22) kcal/kg/day, P < 0.01).
In the multivariate model with REE as the dependent variable and
age, height, BW, BMI, body surface area, and temperature as the
independent variables, only age (R = −4.95 (95%CI −7.91 to −1.99,
P = 0.01)) and temperature (R = 108.64 (95%CI 69.03-148.24,
P < 0.01)) remained independent predictors. In a multivariate model
with REEaBW as the dependent variable, both age (R = −0.99 (95% CI
−0.14 to −0.06), P < 0.01) and temperature (R = 1.25 (95% CI 0.64-
1.85, P < 0.01) were significant independent predictors.
CONCLUSIONS. REEaBW decreases with age in critically ill medical
patients. In multivariate regression analysis, age and temperature are
independent predictors of both REE and REEaBW.
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INTRODUCTION. Obesity is a worldwide health issue associated with
increased morbidity and mortality in the general population.
However, the impact of obesity on outcomes in patients admitted to
the Intensive Care Unit (ICU) has not been definitively determined. A
paradoxical connection between higher Body Mass Index (BMI) and
lower mortality has been referred to as the obesity paradox in
critically ill patients.
OBJECTIVE. To evaluate the impact of the body mass index (BMI) on
mortality in patients admitted to the ICU of a general hospital in
Northeast region of Brazil.
METHODS. Prospective cohort study placed in a general ICU. In the
study were included all patients above age of 18 years old admitted
to general ICU, from August 2015 to April 2017. BMI was calculated
using the formula: BMI = body weight/height2 (kg/m2), and patients
were grouped as underweight (<18.5 kg/m2), normal weight (18.5-
24.9 kg/m2), overweight (25–29.9 kg/m2) and obese (≥30 kg/m2). To
determine the hazard ratio of ICU death, we developed a
multivariate Cox regression.
RESULTS. There were analyzed 1177 patients, 605 (51.4%) female.
Mean age was: 67 ± 18 years. The mean BMI was 25.5 ± 5.5 kg/m2,
42.7% had normal BMI, 7.9% were underweight, 32.3% overweight
and 17.1% obese. The ICU mortality rates in the whole cohort was
18.1%. On multivariate Cox regression analysis, being obese (HR:
0.547; 95% CI, 0.338 - 0.888; p = 0.015) was independently associated
with a lower mortality, while underweight (HR: 1.547; 95% CI, 1.055 -
2.269; p = 0.025) showed a higher mortality risk.
CONCLUSION. The results showed that being obese was associated
with decreased risk of ICU mortality, while being underweight
showed a higher ICU mortality risk for this sample.
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INTRODUCTION. Critical illness leads to fat-free mass loss that
worsens prognosis (1). Fat-free mass included muscle mass, bone tis-
sue, and total body water. No standardized method of muscle assess-
ment is validated for the clinical practice.
OBJECTIVES. To assess whether psoas muscle mass is associated
with day (D) 28 mortality in the ICU.
METHODS. Ancillary study of the international PHASE ANGLE (PhA)
PROJECT (1). Inclusion criteria: adult medical / surgical ICU, length of
stay >48h, no pacemaker or defibrillator, routine abdominal CT
within 9 days postadmission. Transversal (TDPM) and axial right
psoas diameters were measured on a single L3 CT image by a non-
expert-operator blinded of D28 mortality. Psoas area index
(PAI) = TDPM*ADPM*1/height(m)2. PhA measured by bioimpedance
analysis (BIA) at admission. Statistics: area under the Receiver Operat-
ing Characteristic (ROC) curve (AUC) evaluating D28 mortality by PAI.
Factors associated with D28 mortality: multivariable logistic regres-
sion (adjusted odd ratio (aOR)
[95% confidence interval]).
RESULTS. Among the 931 patients analysed in PhA PROJECT, 193
were performed abdominal CT; up to date, 154 patients were
included (we plan to show the analysis for 200 patients at ESICM
congress): Ljubljana (n = 49), Geneva (n = 43), Palma de Majorque
(n = 31), Brussels (n = 15), Zagreb (n = 13), Bydgoszcz (n = 3);
64 ± 14 yrs, men 54%, body mass index 26.1 ± 5.1, APACHE II 19 ± 9.
PAI was very easy and quick to be measured by non-expert operator.
TDPM (10 ± 4 vs 14 ± 4 mm/m, p = 0.004) and PAI (245 ± 102 vs
363 ± 158 mm/m2, p = 0.007) were lower in non-survivors than in
survivors in men (non-significant in women). AUC ROC men: 0.75
[0.61-0.88]; women: 0.56 [0.32-0.81]. PAI thresholds associated with
D28 mortality: < 337.3 (men); < 170.1 (women) mm/m2. Were associ-
ated with D28 mortality: admission for pneumonia (aOR 14.84 [1.19-
185.25], p = 0.04), low PAI (5.87 [1.97-17.51], p = 0.001), age (1.05
[1.01-1.10], p = 0.01), and admission PhA (0.52 [0.31-0.87], p = 0.01).
CONCLUSIONS. Muscle mass loss defined by psoas area index on L3-
targeted CT scan is associated with D28 mortality in the ICU patients.
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INTRODUCTION. Vit D insufficiency is common in hospitalized
patients and especially in critically ill patients. Vit D insufficiency in
critically ill patients may worsen immune and metabolic dysfunctions
and may result in worse outcomes.
OBJECTIVES. To assess vitamin D levels during acute and chronic
disease periods in critically ill patients and to investigate its effect on
clinical parameters.
METHODS. His prospective study was conducted at medical
Intensive Care Unit of Erciyes University, Medical School. The study
included patients aged ≥18 years who werea dmiddet to medical
intensive care unitfor > 48 hours. Vitamin D levels were measured at
baseline and on the days 3, 7 and 10.
RESULTS. Overall, 62 patients were recruited to the study, including
30 men (48%) and 32 women (52%). Mean age was 53 ± 20 years.
Median vitamin D levels at baseline and on the days 3 and 7
were12.8 (2.80-104.0) mcg/L, 8.35 (1.80-96.30) mcg/L, 9.30 (4.60-
37.00) mcg/L, respectively. Low vitamin D level was detected in 84%
of patients at baseline whereas in 90% of patients on the day 3. No
significant correlation was detected between ICU mortality and 6-
month mortality rate and vitamin D levels (p > 0.05).
CONCLUSIONS. Vitamin D level was found to be low at admission to
ICU and during follow-up. No significant correlation was detected be-
tween vitamin D levels and mortality.
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INTRODUCTION. Accidental hypothermia is classified into HT I~IV by
Swiss staging system. Patients in HT IV are recommended for
rewarming by ECMO1. The use of ECMO as rewarming method for
patients in HT III may be considered in the situations of life-
threatening arrhythmia, hypotention(SBP < 90mmHg) etc2. But gen-
erally elderly patients are not with no medical justification of ECMO.
in Japan, aging society is proceeding and the age of accidental
hypothermic patients may increase.
OBJECTIVES. To evaluate the mortality of elderly (older than 70
years) patients admitted with accidental hypothermia to our
intensive care unit(ICU).
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 445 of 542METHODS. A retrospective study was conducted in our ICU during
January of 2012 to March of 2017, containing 9 patients admitted
with accidental hyperthermia to our ICU by searching the electronic
medical records database. Demographic variables, core temperature
and Swiss staging system on arrival, rewarming method, neurological
prognosis, ICU mortality and hospital mortality are collected.
RESULTS. The median age of our patient collection was 81.9 years(3
patients were 90 years or older), 30% were male. 2 patients were
CPA on arrival, 1 patients turned to CPA after arrival. In regard　to
Swiss staging system, 7 patients were HT III and 2 patients were HT
IV. Rewarming methods were “active external and minimally invasive
rewarming” in 4 patients, “Intravascular catheter rewarming” in 1
patients and V-A ECMO in 5 patients(2 were 90 years or older).ICU
mortality was 40% and hospital mortality was 50%(1 patients died of
cerebral infarction). 3 of 5 patients for whom V-A ECMO was used as
rewarming method were able to discharged from ICU. In regard to
neurological prognosis, all of 5 patients who were discharged from
hospital recovered from accidental hypothermia almost perfectly.
CONCLUSIONS. For only old age, we should not hesitate to
implement V-A ECMO for accidental hypothermic patients. Further
studies are needed to show the effect of V-A ECMO for very elderly
and accidental hypothermic patients.
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INTRODUCTION. Cortisol is necessary to survive critical illness, but
the optimal level is unclear. Absolute adrenal insufficiency is rare
among critically ill patients and the incidence is estimated to be less
than 3%.
However, relative adrenal insufficiency (RAI) has been reported as a
predictor of mortality in critical illnesses including septic patient, its
effects on clinical outcome and risk factors for critically ill patients
are controversial.
OBJECTIVES. We conducted the present study to assess the clinical
characteristics and risk factors of RAI in critically ill patients.
METHODS. We retrospectively assessed the medical records of 237
patients who checked a random cortisol in the Medical Intensive
Care Unit (MICU) at the Third University Hospital, from January 2016
to February 2017.
RAI was defined a random serum cortisol level of less than 15 μg/dL
or random cortisol level of 15 to 34 μg/dL with post-cosyntropin (250
μg) stimulation cortisol levels to increase less than 9 μg/dL.
RESULTS. Of the 237 cases, 62 patients with a risk of RAI (random
cortisol levels < 34 ug/dL) were included, and ultimately 48 patients
had relative adrenal insufficiency (77.4%).
The length of MICU stay day (12.7 ± 10.2 vs. 10.3 ± 9.6, p = 0.437)
and mortality rate (27/48 vs. 10/14, p = 0.308) were not statistically
different between two groups (RAI + vs RAI -, respectively). There
was no significant difference between the RAI positive group and the
negative RAI group in baseline characteristics such as age, sex and
other clinical features.In subjects who had random cortisol levels of 15 μg/dL to 34 μg/dL
(n = 33), the incidence of RAI was 19 (57.6%) and a positive result of
cosyntropin stimulation test was associated with sepsis-related syn-
drome (16/33, 84.2%, OR 9.27, 95% CI 1.25-68.70).
CONCLUSIONS. In critically ill patients, RAI is relatively common but
it was not associated with deteriorated outcomes in this study.
However, in subjects with random cortisol levels between 15 μg/dL
and 34 μg/dL, sepsis-related syndrome may be a risk factor for rela-
tive adrenal insufficiency.0884
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INTRODUCTION. The modalities and efficacy evaluation of parenteral
nutrition among critical ill patients have been the subject of several
studies which led to recommendations.
OBJECTIVES. We carriedout a study which aims to assess the degree
of our practice adherence to these recommendations, to evaluate
protidemia assay contribution in the assessment of nutritional status
and its impact on morbidity and mortality.
METHODS. It is a prospective observational study spread over 12
months from January to December 2012 in a teaching intensive care
unit including all patients admitted in our ICU for a stay longer than
seven days and required artificial nutrition.
RESULTS: A total of 42 patients aged of 42 ± 17 were eligible;
they were 26 males and 16 females, admitted for medical
reason.Thegravityscoreswererespectively 46.8 ± 14.9 for SAPS II,
19.7 ± 7 for APACHE II and 7.6 ± 3.5 for SOFA.A pre-existing hypo-
protidemia of 51 ± 5.7 g/l was detected in twenty seven patients
(64%), 26 among them responded to nutritional depletion criteria
according to French National Authority for Health score with a
hypoalbuminemia mean of 20.7 ± 4.74 g/l.During week, 1st 24 pa-
tients (57%) had received a total parenteral nutrition, 6 patients
(14%) an entirely enteral feeding and 10 (24%) benefited from
mixed nutrition. A nutritional support was provided during
72 ± 19% of the whole hospital stay.
Descriptive study showed that during the three first days, prescribed
and really received caloric intakes (Kcal) were widely below those
required; with a caloric supply average of 8.67 ± 9.10 Kcal/kg/j.
Caloric supply has steadily increased to reach 15.61 ± 8.58 at the end
of the first week and to stabilize at 21.8 ± 7.74 Kcal/kg/24h at the
second week.Our results concluded that enteral feeding was started
from the second day, and mixed one for 24% of the whole first week
with a caloric supply lower than 20 Kcal/kg/j for 29 patients (69%)
who are considered as undernourished group and an adequate
delivery ≥ 20 Kcal/kg/j for 13 patients (31%). Moreover, protein
intakes average was of 0.52 ± 0.28 g/kg/j during the first week.
The ICU mortality was 45.2% (n = 19). The analysis of risk factors
associated to morbidity and mortality showed that only initial plasma
protidemia level is strongly correlated to infectious complications
occurrence (p = 0.022) with no effect on mortality. No correlation
was noted between plasma protidemia level and energy balance
with R2 respectively of 0.009 (during the 1st weed), 0.2 (during the
2nd week) 0.043 (during the 3rd week) and 0.12 (during the 4th week).
CONCLUSIONS. Despite adherence to the recommendations was not
always respected and our patients were heterogeneous,our results
were similar to those reported in literature. To build on protedemia
rate to evaluate nutrition´s efficiency, can't be definitely
recommended due to the protein metabolism imbalance in the
initial phase of assault. However, it can be considered as a biological
parameter predicting morbidity.
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INTRODUCTION. Vitamin D deficiency is frequent in Northwestern
countries. In critically ill patients, the role of vitamin D can be
important.
OBJECTIVE. The objective was to identify if vitamin D deficiency
could be associated patients' chronic co-morbidity, the severity of
acute illness and ICU- and hospital-related outcomes.
METHODS. Consecutive patients admitted over a 2- month period in
a medical/surgical 32-bed ICU were included. In these patients,
demographic data, Charlson co-morbidity score, severity scores (SAPS
3 and SOFA) and 25-OH vitamin D (chemiluminescence, DiaSorin)
were collected at admission. ICU and hospital length of stay (LOS)
were collected. The coefficients of determination (R2) between 25-OH
vit D and Charlson score, SAPS 3, SOFA, ICU and hospital LOS were
calculated.
RESULTS. 457 patients were included (59 ± 19 years, gender (257
males), category of admission (38% medical, 62% surgical) SAPS III
(44 ± 20), SOFA (3,1 ± 3,7), Charlson (1,9 ± 2,1). 25-OH vit D levels
was measured in 299 patients at ICU admission and was averaged
17,5 ± 10,4 ng/ml ; 61 (20%) patients were moderately deficient
(level >20 - ≤ 30 ng/ml), 80 (27%) patients were deficient (>12- ≤ 20
ng/ml) and 124 (42%) patients were severely deficient (≤12 ng/ml).R2
between 25-OH vit D and Charlson score, SAPS 3, SOFA, ICU and hos-
pital LOS were 0,006; 0.01; 0,002; 0,001; 0,0004, respectively.
CONCLUSIONS. In the population studied, vitamin D deficiency is
frequent. However, there was no correlation between vitamin D,
chronic or acute morbidity and ICU- and hospital LOS.
REFERENCES
Mahato B, Otero TM, Holland CA et al. Addition of 25-hydroxyvitamin
D levels to the Deyo-Charlson Comorbidity Index improves 90-day
mortality prediction in critically ill patients. J Intensive Care 2016;
4:40. doi: 10.1186/s40560-016-0165-0.
GRANT ANKNOWLEGMENT
This research received no grant from any funding agency in the
public, commercial, or not-for-profit sectors.
0886
A systematic scoping review on the incidence and risk factors of
hyperglycaemia in ICU adult patients
M. Miret1, A. Danel1, E. Olariu2, N. Pooley2, J.-C. Preiser3
1Nestlé Health Science, Vevey, Switzerland; 2PHMR Ltd, London, United
Kingdom; 3Erasme University Hospital, Université Libre de Bruxelles,
Department of Intensive Care, Brussels, Belgium
Correspondence: J.-C. Preiser
Intensive Care Medicine Experimental 2017, 5(Suppl 2):0886
INTRODUCTION. Stress hyperglycaemia(SHG) is common in critically
ill patients and is strongly associated with poor outcomes in
intensive care unit(ICU) patients. Many studies have been conducted
to gain an insight into the epidemiology of SHG, but a general
overview of the data is lacking.
OBJECTIVE. To map the literature describing the epidemiology of
SHG in ICU patients to identify the prevalence, the incidence of SHG
and the risk factors(RF) for developing SHG.
METHODS. We followed the Joanna Briggs methodology on
systematic scoping reviews to identify relevant publications in
Medline, Embase, and The Cochrane Library from January 2000 to
December 2015. Two reviewers assessed studies for eligibility.
Studies were included if they reported on either the prevalence or
incidence of hyperglycaemia or risk factors for hyperglycaemia in
adult ICU patients. No definition for hyperglycaemia or RF was set a-
priori. Data extraction was performed by one reviewer and checkedby another. The results presented here are for incidence and RF(if RF
were reported in more than one study).
RESULTS. We identified 3062 relevant records: 385 full-text articles
were screened and 92 studies(8,082,774 patients) were included in
the review. Of these, 10(13,773 patients) reported on the incidence
of SHG in the ICU. The included studies were conducted in general
ICU patients (606 patients), stroke patients (1,385 patients), trauma
patients (1,350 patients), cardiac surgical patients
(1,565 patients), a mix of medical and surgical ICU patients (8,307
patients), and surgical ICU patients (560 patients). Incidence was
defined in most of the studies (seven) as new cases of
hyperglycaemia that developed during the ICU stay without
mentioning a specific time period. Studies were mainly conducted in
samples with mixed diabetic status (five studies;3,026 patients) and
very few in non-diabetic patients (two studies;1,606 patients). Inci-
dence levels varied widely, most probably due to variations in hyper-
glycaemia definitions (109 mg/dl to 240 mg/dl). SHG incidence
ranged from 9.6% (blood glucose level [BGL] > 180 mg/dl) to 99%
(BGL > 109 mg/dl). Studies reporting on the incidence of SHG in ICU
patients are highly heterogeneous limiting the comparability of re-
sults across studies.
RF for SHG were reported in five studies, with diabetes being the
most frequently reported RF
(two studies;3,257 patients).
CONCLUSIONS. Stress hyperglycaemia is frequent in critical care
patients irrespective of their underlying condition. Assessing the risk
factors at admission may help controlling the incidence of stress
hyperglycaemia and setting up appropriate therapeutic and nutritional
measures. Homogeneity in blood glucose cut off points as well as time
of measurement is determinant to compare study results.
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INTRODUCTION. There is increasing interest in the use of ultrasound
to assess and guide the management of critically ill patients.
OBJECTIVES. The objective of this study was to evaluate the novel
use of point of care ultrasound to predict the resting energy expenditure
(REE) measured by indirect calorimetry in critically ill patient.
METHODS. All consecutive patients that were admitted to intensive
care unit (ICU) and required mechanical ventilation were enrolled in
the study. Bed side ultrasound was used to measure muscle layer
thickness (MLT) and cardiac output (CO). MLT was measured within
24 of ICU admission. Two measurements of MLT were made at two
sites; mid-upper arm and thigh anteriorly using linear array trans-
ducer. MLT was determined and summed up. Stroke volume was ob-
tained by placing pulsed wave Doppler in the middle of left
ventricular outflow tract using phased array transducer. CO was cal-
culated by multiplying SV and heart rate. REE was calculated using
indirect calorimetry via metabolic module on General Electric ventila-
tor (Engstrom Carestation and Carescape R860, GE Health care, USA).
A multiple regression analysis was applied to a set of independent
variables to develop the predictive equation of REE.
RESULTS. Forty patients were enrolled in the study. The mean (sd)
REE was 1995 (414) kcal/d. Twenty five (62.5%) patients had septic
shock at ICU admission. A multiple regression model using the
aggregate ultrasound muscle thickness measures with estimates of
CO yields an adjusted R2 of 0.7 (p < 0.0001). REE (kcal/
d) = 128 + 159.7*CO+ 148.5* MLT. Neither age nor gender made
significant contribution in predicting REE.
Fig. 286 (Abstract 0889). Variationbetween 1st and 2ndNB, in grams,
according to the valueof 1st NB. Positive values indicate that the BN valuewas
higher in the 2nd evaluation (5th day) than in the 1st evaluation (admission)
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 447 of 542CONCLUSIONS. This study demonstrated that point of care
ultrasound could be a useful tool in predicting REE of critically ill
patients through measurement of both MLT and CO.
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INTRODUCTION. Optimal blood glucose levels (BG) in critically ill
patients are mostly unknown and could differ according to the
diabetic status. In patients with diabetes, the usual BG level can
be deducted from HBA1c using the formula eAG (estimated
average glucose) = (AG (mg/dl) = 28.7 x A1C - 46.7, R
(2) = 0.84, P < 0.0001)1. As HbA1c doesn't suffer influence from
diseases in acute phase, it is a safe diagnostic marker of
diabetes2, and we could estimate a confiable average glucose
during this period.
OBJECTIVE. Identify if the ratio between admission BG and estimated
average glucose (eAG) was related to the patients' chronic co-
morbidity, severity of acute illness and ICU- and hospital-related
outcomes.
METHODS. Observational study. Consecutive patients admitted
over a 2- month period in a medical/surgical 32-bed ICU were
included. In these patients, demographic data, Charlson co-
morbidity score, frequency of known diabetes mellitus (DM), un-
known DM (HBA1c > 6.5% without prior diagnosis of DM) sever-
ity scores (SAPS 3 and SOFA), BG and HBA1c were collected at
admission. As well as, ICU and hospital length of stay (LOS) were
collected. Glycemia ratio (GR) was calculated as the ratio be-
tween admission BG and eAG (derived from HBA1c)1. The coeffi-
cients of determination (linear regression = R2) between GR and
Charlson score, SAPS 3, SOFA, ICU and hospital LOS were
calculated.
RESULTS. 316 patients were included from 483 admissions
(excluded < 18 years and patients without BG or HbA1c at ICU
admission). The mean age was 59 years (SD 16) and 58, 23%
represented by men. We analyzed the categories of admission
(35, 76% as medical, 53, 2% as surgical), SAPS III average (44,8
/SD 20,07), SOFA in first-ICU day (mean 3,14/SD 3,6) and also
Charlson score (mean 1,87/SD 2,02). Among included patients,
known DM was in 51 patients (15, 6%), unknown DM in 8 (3,
13%). Mean HBA1c, admission BG and GR were 5,78 (SD 1,02);
151 (SD 65,32); 1,28 (SD 0,43), respectively. GR was ≥ 1 in 225
patients (71, 2%). Linear regression between GR and Charlson
score, SAPS 3, SOFA, ICU and hospital LOS were 0,0007, 0,007,
0,02, 0,0004, 0,004, respectively.
CONCLUSIONS. In the population studied, stress hyperglycemia was
frequent as indicated by the value of GR ≥1. However, there was no
correlation between GR, chronic or acute morbidity and ICU- and
hospital LOS.
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INTRODUCTION. Protein catabolism is an important accompaniment
to critical illness, particularly when there is an intense inflammatory
process. Nitrogen Balance (NB) can be a useful tool in monitoring
and individualizing the proteic nutritional delivery in critical patients.
The objective of this study was to evaluate the usefulness of NB in
nutritional monitoring and to identify risk factors related to the
status of protein catabolism, and to evaluate the evolution of NB at
different moments, seeking to correlate with outcomes in the ICU.
METHODS. Retrospective cohort study. Data from consecutive adult
patients admitted to the ICUs of two hospitals were evaluated. NB
was calculated on the 1st, 5th and 10th day, only in the ICU.
RESULTS. A total of 234 patients (63.7% male, 52.7 years old, 17.9%
medical, 15.8% trauma, 60.7% elective surgery, APACHE 18.3) were
evaluated. In the evaluation of the 1st NB, there were no patients with
NB positive. The most of patients had nitrogen loss between 0 and −5 g
(41.0%) or between −5 and −10 g (23.1%); 17.5% had severe
hypercatabolism. This pattern didn't change in the evaluation of the 2nd
and 3rd NB, although in the second evaluation there was a mild trend
(not significant) to less values of severe hypercatabolism. The factors
correlated with a more negative NB were the use and time of invasive
MV, trauma or medical cause of admission, and COPD or cancer
comorbidities. There was no correlation between NB values (at any time
of hospitalization) and higher mortality. On the other hand, when
comparing patients whose 1st NB had higher or lower catabolism, the
variation for the 2nd NB (that is, the maintenance of catabolism or
induction of anabolism) showed that, in patients with initial normal or
mild catabolism, the survivors had a fall (more negative) of NB between
the 1st and 2nd NB, while the patients who died had an increase of this
value (becoming less negative). Among the patients with higher
hypercatabolism, both groups (survivors and death) had a positive
variation, but the survivors had an even more positive difference (that is,
they became less negative in the 2nd NB) (Fig. 286).
CONCLUSION. In critically ill patients, NB evaluation showed almost
universal hypercatabolism. Serial BN assessment could identify
patterns of catabolism and response to therapy.
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INTRODUCTION. Dire period of TBI is characterized by the
elaboration of severe catabolic reactions. However, the level of
catabolism with concomitant traumatic brain injury (SCMT) in
patients is staying insufficiently studied.
AIM. The aim of work is to conduct a comparative analysis of the
severity of catabolic reactions for patients with combined and
isolated TBI.
METHODS. We surveyed 47 patients with serious TBI and oppressed
wakefulness level upon the admitting to hospital up to 10 or less
points on the GCS, 27 of the victims were had a TBI severity
according to the ISS scale - 50 ± 7 points, 20 patients had isolated
TBI. The average age of victims was 38 ± 11 years, the ratio male/
female – 41/6.
All victims was carried out by standard intensive care according to
Russian and international recommendations. At 3–7, 8–14, 15–21
days from the moment of injury, all patients underwent the
assessment of the level of urea in daily urine with the subsequent
calculation of the nitrogen losses.
The obtained findings were compared between groups of patients.
RESULTS. The level of catabolism in victims with combined and
isolated TBI was very high during the whole observation time (the
loss of nitrogen and 23.7 ± 9.3 g/day (n = 125) and 24.9 ± 7,3
(n = 71), respectively). However, in patients with isolated TBI
catabolism was more denominated in the first 7 days after injury (the
loss of nitrogen and 26.5 ± 6.5 g/day (n = 20) compared with
22.2 ± 9 g/day (n = 27) in patients with SCMT). In further period of
observation, the level of catabolism was comparable in victims of
both groups: 8–14 day −28,5 ± 6.2 g/day (n = 27) in patients with
SCMT and 26.5 ± 6.5 g/day (n = 20) in patients with isolated TBI; 14–
21 day - to 26.6 ± 3.8 g/day (n = 25) and 25,9 ± 10.3 g/day (n = 15),
respectively; more than 21 days −20,5 ± 8.9 g/day (n = 46) and
18.8 ± 4.5 g/day (n = 16), respectively.
CONCLUSIONS. Victims have been pointing out with isolated and
concomitant TBI during the first 3 weeks after injury. The level of
catabolic reactions in victims with isolated and concomitant head
injury is comparable in 8–21 days from the date of injury, but in the
first 7 days post-traumatic period, the catabolism is more conveyed
in patients with isolated TBI.
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INTRODUCTION. Dipeptidyl-peptidase-4 (DPP-4) inhibitors are one of
the classes of oral anti-hyperglycemic agents mediated through the
incretin hormones. Previous studies of cardio-protective effects of
DPP-4 inhibitors have not sufficient evidence of the relationship be-
tween DPP-4 inhibition and actual cardiovascular outcomes.OBJECTIVES. The aim of our study is to evaluate the impact of DPP-4
inhibitors on the survival of diabetes patient with first acute myocar-
dial infarction (AMI) through analysis of data from the Taiwan Na-
tional Health Insurance Research Database.
METHODS. This was a nationwide, propensity score-matched case–
control study of patients admitted to hospitals between January
2000 and December 2012 with primary diagnosis of first AMI. Among
the 186,112 first AMI patients, 72,924 patients with diabetes were
identified. A propensity score, one-to-one matching technique was
used to match 2,672 controls to the DPP-4 inhibitors therapy group
for analysis. Controls were matched on the following variables: sex,
age, hypertension, dyslipidemia, diabetes, peripheral vascular disease,
heart failure, cerebrovascular accidents, end-stage renal disease,
chronic obstructive pulmonary disease, and percutaneous coronary
intervention.
RESULTS. DPP-4 inhibitors improve the overall 3-year survival rate
(log rank p value < 0.0001), whether male, female, younger or elder
patients. Cox Proportional Hazard Regression showed DPP-4 inhibitor
is beneficial in diabetes patients after AMI (HR = 0.86; 95%CI = 0.78-
0.95), especially in those patients with hypertension (HR = 0.87;
95%CI = 0.78-0.97; P = 0.0103) and cerebrovascular disease.(HR = 0.83;
95%CI = 0.72-0.97; P = 0.018) and without dyslipidemia(HR = 0.78;
95%CI = 0.67-0.92; P = 0.0029), without peripheral vascular disease
(HR = 0.86; 95%CI = 0.78-0.96; P = 0.0047), without heart failure
(HR = 0.84; 95% CI = 0.73-0.96; P = 0.0035), without end stage renal
disease (HR = 0.86; 95% CI = 0.77-0.95; P = 0.0035), and those with-
out chronic obstructive pulmonary disease (HR = 0.87; 95%CI = 0.78-
0.97; P = 0.0096).
CONCLUSIONS. This study demonstrated DPP-4 inhibitors therapy
had better long-term survival in diabetes patients after first AMI, re-
gardless of gender group.
Cardiac surgery and pulmonary arterial
hypertension
0892
Hypotension after anesthesia-to-intensive care unit drop off in
cardiac surgery patients; frequency and associated outcomes
S. Cengic1, M. Zuberi1, V. Bansal1, E. Rodrigues2, E. Festic1
1Mayo Clinic, Department of Critical Care, Jacksonville, United States;
2Mayo Clinic, Department of Anesthesiology, Jacksonville, United States
Correspondence: S. Cengic
Intensive Care Medicine Experimental 2017, 5(Suppl 2):0892
INTRODUCTION. Hypotension has been reported in up to a third of
post-cardiac surgery patients upon arrival to the Intensive Care Unit
(ICU). This may predispose patients to adverse clinical outcomes.
OBJECTIVES. We aimed to investigate the frequency of initial
hypotension upon arrival to ICU after cardiac surgery, the underlying
causes and associations with clinical outcomes. We hypothesized
that patients who develop hypotension after anesthesia-to-ICU drop
off would have longer mechanical ventilation duration (MV) and lon-
ger ICU and hospital lengths of stay (LOS).
METHODS. This was an IRB approved retrospective study of post-
cardiac surgery patients at a tertiary academic medical center in the
USA in 2016. We excluded patients undergoing transplant surgery.
We abstracted baseline demographics, comorbidities and all pertin-
ent clinical variables including vitals, laboratories, type and urgency
of surgery, bypass and cross-clamp time, medications and blood
products delivered during the surgery and immediately prior to
transfer to ICU. The primary outcome was hypotension defined as
systolic blood pressure < 90 mmHg or mean arterial pressure < 65
mmHg per arterial catheter tracing within first 30 minutes upon trans-
fer from the operating room (OR) to ICU. The secondary outcomes were
duration of MV, ICU and hospital LOS and hospital mortality.
RESULTS. Of 218 patients, 12 were excluded as they lacked detailed
blood pressure recordings. The majority of patients were white
(82%), male (69%), of median age 67 (59, 73). The most frequent
Fig. 287 (Abstract 0893). See text for description
Table 213 (Abstract 0893). See text for description
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surgery (82%). The overall mortality was 4%. A half of the patients
(103) were hypotensive immediately upon transfer to the ICU, while
only 26% were hypotensive before leaving the OR (53). Of 153
patients without hypotension before leaving the OR, 48% (73)
became hypotensive upon arrival to the ICU. Of 53 patients with OR
hypotension immediately before the transfer, 30 continued to be
hypotensive on ICU arrival. One clinical variable that appeared
associated with the observed discrepancies was bolus dosing of
vasopressors around the transfer. About 64% (30) of patients who
became newly hypotensive upon ICU arrival had received
vasopressor bolus prior to the transfer, while 23% (13) of the
hypotensive OR patients didn't receive vasopressor bolus on the
transfer. The patients with the initial ICU hypotension, compared to
those without, had trend for longer duration of MV (5 [3, 17] vs. 4
hours [2, 6]), longer ICU LOS (2 [1, 4] vs. 1 day [1, 2]), longer hospital
LOS (7 [5, 11] vs. 7 days [6, 9]) and significantly higher mortality (9%
versus 0%, p = 0.002).
CONCLUSIONS. Hypotension upon anesthesia-to-ICU drop off is fre-
quent and may be associated with adverse clinical outcomes. Further
research and quality improvement strategies directed towards use of
bolus vasopressors are needed to reduce the rates of hypotension
immediately post anesthesia-to-ICU drop off.
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INTRODUCTION. Staphylococcus aureus is the most common cause of
infective endocarditis (IE) and is associated with a severe prognosis1.
Patients frequently require ICU admission because of acute
circulatory failure or neurological complications, or the need for
emergent valvular surgery2,3. The benefit of early surgery on
functional outcomes remains uncertain.
OBJECTIVES. We aimed to identify risk factors for poor functional
outcomes in critically ill patients with Staphylococcus aureus IE.
METHODS. We conducted a retrospective analysis of consecutive
patients admitted to the medical ICU with acute left-sided de-
fined Staphylococcus aureus IE according to the DUKE criteria,
from January 2007 to December 2016. Factors associated with a
poor functional outcome, defined by a score > 3 on the modi-
fied Rankin scale (i.e., severe disability or death) at 90 days,
were identified by multivariate analysis. The model was built
using clinically relevant variables associated with outcome by
univariate logistic regression analysis (p < 0.2). Organ failures
were defined by a score >2 on each component of the SOFA
score. Data are presented as median (interquartile) or numbers
(percentage).
RESULTS. A total of 110 consecutive patients were studied (age: 62
[52–70] years, SOFA score: 9 [5–13], GCS: 15 [13–15]), of whom 78
(71%) patients underwent early valve replacement surgery 2 [1–5]
days after admission. Mechanical ventilation, renal replacement
therapy, catecholamines were needed in 56 (51%), 22 (20%), 59
(54%) respectively.
At 90 days, 73 (66%) patients had a poor functional outcome (i.e. 60
(55%) deaths and 13 (12%) severe disabilities) (Fig. 287). The only
independent factor positively associated with a poor outcome was
renal failure at ICU admission, (Odds ratio (OR) = 5.52, 95%
confidence interval (95CI), 1.56-19.56). By contrast, early surgery,
performed within 48 hours after admission, had a protective effect
(OR = 0.08, 95CI 0.02-0.34) (Table 213).
Septic shock, neurological complications and IE characteristics were
not independently associated with functional outcome.CONCLUSIONS. Our study suggests that about one-third of patients
admitted to the ICU for Staphylococcus aureus IE have a good func-
tional outcomes at 90 days. The main factor at admission associated
with poor neurological outcome is renal failure. Our study confirms
the benefit of early valve replacement surgery on functional out-
comes, even in the most severe patients.
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INTRODUCTION. A low HLA-DR antigen expression on monocytes
was observed after aortic surgery according to some researchers [1]
and is a marker of complicated postoperative course after aortocor-
onary bypass [2]. A low level of monocytes with HLA-DR+ expression
is considered as a marker of immunosuppression in septic shock and
is associated with the development of an unfavorable outcome [3].
The issue of the impact of preoperative level of CD14+ monocytes
with HLA-DR+ expression on the outcome of cardiac surgery remains
open. This circumstance was the basis for our study.
OBJECTIVES. We examined 40 patients undergoing elective cardiac
surgery, 20 male and 20 females. No one had SIRS criteria or
Table 214 (Abstract 0895). Association of ICU interventions and
mortality
Univariate analysis Multivariate analysis
OR 95% CI p-value OR 95% CI p-value
CPAP 2.151 1.066-4.342 0.033 2.880 1.308-6.339 0.009
NPPV 1.759 0.597-5.178 0.306
IPPV 12.104 1.445-101.369 0.021 10.021 1.070-93.839 0.043
RRT 1.298 0.500-3.374 0.592
Vasopressors 4.483 2.054-9.786 0.000 2.978 1.223-7.254 0.016
Inotropes 4.571 1.942-10.753 0.000 2.746 1.020-7.394 0.046
IV Iloprost 0.947 0.458-1.962 0.884
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 450 of 542infection before surgery. The mean age was 62 years (26; 79); Euro
SCORE II 2.35% (0.4; 13.3). The following operations were performed:
CABG - 10, CABG and valves replacement - 10, valves replacement -
20. The duration of CPB was 103 min (0; 190). Length of stay in ICU
was 48 hours (24; 600). ICU mortality was 5% (2 patients).
METHODS. We analyzed the monocyte CD14+ with HLA-DR+ expres-
sion counts in peripheral blood in all patients before surgery and 24
hours after by flow cytometry. The results obtained were analyzed
statistically in order to identify the predictors of unfavorable
outcome.
RESULTS. According to the results of ROC analysis, the preoperative
monocyte CD14+ with HLA-DR+ expression counts of less than
0.32 × 109/L were a good prognostic marker for lethal outcome (sen-
sitivity 100%, specificity 87%, AUC 0.93, and p < 0.05).
CONCLUSIONS. The preoperative characteristics of the monocyte link
of innate immunity can be predictors of unfavorable outcome of
cardiac surgery.
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INTRODUCTION. Management of pulmonary hypertension (PH) is
challenging, particularly in the context of critical illness. Although
overall prognosis is poor, recent advances in disease-specific treat-
ments have significantly improved 5-year survival 1.
Little is known about outcomes in patients with pre-existing PH ad-
mitted to critical care, and whether the use of ICU-specific therapies
has any significant impact on survival.
OBJECTIVES. To characterise ICU outcomes in patients with PH and
assess the impact of various critical care interventions on mortality.
METHODS. Retrospective observational study of adult patients with
PH admitted to the ICU of a UK national PH referral centre with an
emergency non-surgical diagnosis between April 2000 and Decem-
ber 2016. Data on patient characteristics, indications for ICU admis-
sion and critical care interventions were retrieved from our electronic
patient record (Metavision). Association of interventions with mortal-
ity was assessed by logistic regression analysis.
Results are expressed as median (range), mean (SD) and odds ratios
(OR) with 95% confidence intervals (CI).
RESULTS. One hundred and thirty nine patients (64.7% female) with
a median age of 53 (18–83) were included in this study.
Pulmonary arterial hypertension was the most prevalent underlying
cause for PH (68.3%), followed by chronic thromboembolic disease(12.2%), multifactorial/unclear aetiology (7.2%), and PH associated
with lung (6.5%) and left heart disease (5.8%).
Primary reasons for ICU admission included heart failure (38.1%),
sepsis (31.6%), arrhythmia (9.4%) and acute renal failure (7.9%). The
mean APACHE II score was 15.85 (SD 5.979) and median admission
lactate was 1.250 mmol l−1 (0.4-14.1).
Non-invasive and invasive ventilation, renal replacement therapy
(RRT), vasopressor and inotropic support were provided in 48.9%,
5.8%, 14.4%, 28.8% and 22.3% of patients, respectively.
Critical care mortality was 30.2% and overall hospital mortality was
39.6%. Use of CPAP, invasive ventilation, vasopressor or inotropic
support was associated with increased hospital mortality, whereas
RRT was not (see Table 214).
CONCLUSIONS. Patients with PH admitted to critical care have a
high hospital mortality. Ventilatory and haemodynamic support
appear to be independent risk factors in this patient group, whereas
RRT does not.
These observations might reflect the detrimental effects of positive
pressure on the pulmonary circulation and right heart, and the
strong prognostic significance of worsening acute heart failure. The
use of RRT in patients with PH is an area that warrants further
investigation, as this therapy may have a potential role in optimising
right ventricular preload via tight regulation of fluid balance.
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INTRODUCTION. Pulmonary hypertension (PH) and right ventricular
(RV) failure can be detrimental in the critically ill, post cardiac surgery
and post heart/lung transplantation. The existing haemodynamic
classification of pulmonary hypertension (PH) defines two groups,
pre- and post capillary PH, which can be either isolated post capillary
(Ipc-PH) or combined post- and pre capillary (Cpc-PH).
OBJECTIVES. The aim of this study was to look at the diagnosis and
haemodynamic classification of pulmonary hypertension in a
cardiothoracic intensive care unit (ICU) and how these affected the
use of inhaled nitric oxide (iNO).
METHODS. This was a retrospective and observational study. Thirty nine
consecutive ICU patients who had undergone pulmonary artery
catheterisation (PAC) on admission were included. The following
parameters were recorded from patients´ medical charts: PAC
measurements and echocardiography within the first 6h following
admission, and treatment with iNO. We calculated diastolic pressure
gradient (DPG) as diastolic pulmonary artery pressure-pulmonary
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 451 of 542capillary wedge pressure (PCWP) and classified PH as pre-capillary (mean
pulmonary artery pressure mPAP ≥ 25mmHg and PCWP ≤ 15mmHg),
post-capillary (mPAP ≥ 25 and PCWP > 15mmHg), Ipc-PH
(PCWP > 15mmHg and DPG < 7mmHg and/or pulmonary vascular re-
sistance ≤3WU), and Cpc-PH (PCWP > 15mmHg, DPG ≥ 7mmHg and/or
PVR > 3WU).
RESULTS. Thirty-nine patients (14 female/25 male, age 55.44 ± 14.42),
all of them sedated and mechanically ventilated were included in the
study. Thirty four were postoperative cardiothoracic admissions and
five had cardiogenic shock. According to the PAC measurements PH
was present in 32 patients. A full haemodynamic profile (with cardiac
output, pulmonary artery pressures, PCWP measurement) was available
in 21 of the 32 patients with PH. Of those 21 patients, 6 had pre-
capillary PH and 15 post-capillary PH (12 Ipc-PH and 3 Cpc-PH). Eleven
patients had PH that could not be classified as PCWP measurements
were not available. Twenty two of the 39 (20 of the 32 with PH) had
been started on iNO treatment. Fifty percent of those with Ipc-PH as
well as 82.5% of those with unclassified PH (9 out of 11) were on iNO.
An echocardiography scan was available in 20 of the 39 patients, with
evidence of RV impairment present in 10 out of the 20. Of the 9 pa-
tients with unclassified PH who were on iNO, 3 had echocardiography
scans. These 3 scans showed evidence of RV impairment.
CONCLUSIONS. In the acute setting, the use of PAC as a
haemodynamic monitoring tool in patients at high risk for PH does
not explore the method to its full potential and according to the
international guidelines. When analysed, PAC data show that post-
capillary PH due to left heart disease is the most common from of
PH in the cardiothoracic ICU. Echocardiography as a monitoring tool
is probably underused.
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European Heart Journal 2016:37, 67–119.
0897
Troponin T: an indicator of adverse outcomes following lung
transplantation
J.P. Scott1, B.A. Boilson2, S.G. Peters1, M.E. Wylam1, C.C. Kennedy1,
H. Sekiguchi1, R.C. Daly3
1Mayo Clinic, Pulmonary and Critical Care, Rochester, United States;
2Mayo Clinic, Cardiology, Rochester, United States; 3Mayo Clinic, Cardiac
Surgery, Rochester, United States
Correspondence: J.P. Scott
Intensive Care Medicine Experimental 2017, 5(Suppl 2):0897
INTRODUCTION. Chronically immunosuppressed patients remain at
increased risk of acute illness and of adverse outcomes as reflected
by the chronic health indices of the APACHE scoring system(1).
Although cardiac conditions, including infarction are enumerated in
the APACHE IV system, ischemia is explicitly considered. Evidence
does exist that in ARDS patients elevated troponin T values are
associated with reduced survival and the addition of such values to
APACHE improves the ROC curve in ARDS(2). We have studied the
effect of troponin levels in lung transplant patients, a moderately
immunosuppressed patient group subject to frequent readmissions
and with a high mortality rate following ICU admissions to assess the
effect of such changes on patient survival.
OBJECTIVES. Following the description of the importance of
Troponin T as a prognostic marker in kidney and liver
transplantation; to evaluate the role and specificity of low level
troponin T levels at evaluation for lung transplant and during
episodes of illness.
METHODS. We have studied 90 patients mean age 54.2 (+/− 10.6)
years, 42 female in whom troponin levels were routinely collected
before transplantation, at two months and during acute illnesses.
Analysis of data was by non-parametric testing of survival using
Kaplan-Meier curves for troponin values =/< 0.01, 0.02 - 0.19 and 0.2
or above.
RESULTS. Results demonstrate very poor survival for elevated
troponins pre-transplant, and with maximal troponin values during
acute illness. For pre-transplant serum troponin levels survival falls
with higher troponin group: Median survival 2780 days (Group 0), vs2332 days (Group 1) vs 706 days (Group 2) Log-Rank, p < 0.0001; Wil-
coxon, p < 0.0001. Maximum serum troponin value after transplant
were also highest in patients with the highest mortality after trans-
plantation, p = 0.0006 Wilcoxon and p = 0.0003 Log-rank tests.
CONCLUSIONS. Troponin levels in serum likely reflect some measure
of cardiac injury, most likely ischemia induced by hypoxia in patients
with end stage lung disease awaiting lung transplantation. Maximum
values tend to occur during severe illnesses or prior to death when
hypoxia and ischemia are likely to be present. We conclude that
troponin values before as well as after lung transplantation are
inversely related to patient survival and these observations are
similar to those in renal and liver transplant patient populations.
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INTRODUCTION. After cardiac surgery, atrial fibrillation (AF) occurs at
a frequency of 30-60%. Various research studies have been
conducted about postoperative AF (POAF). According to American
College of Chest physicians the Guidelines, for the prevention of
POAF, the use of β-blockers, amiodarone, and bilateral atrial
pacing are recommended.However, in almost all studies, the ob-
jective was coronary aortic bypass grafting (CABG), and not aortic
valve stenosis (AS).
OBJECTIVES. In this study, we aimed to examine whether right atrial
pacing suppresses POAF, especially among patients with AS.
METHODS. We conducted a single-center, retrospective observa-
tional study of patients with AS, admitted to the general ICU at Kobe
City Medical Center General Hospital, between 2011 and 2016. Pa-
tients who underwent aortic valve replacement were included. We
defined the patients with sinus rhythm or overdrive right ventricular
pacing as the control group (CG), and the patients with overdrive
right atrial pacing as the atrial group (AG). Fisher's exact test was
used to analyze the frequency of POAF between the two groups.A lo-
gistic regression model was used to define the risk factors, including
overdrive atrial pacing with statistical software 'R'.
RESULTS. We included 184 patients. The atrial group consisted of 24
patients; and the control group, 160 patients. No significant
differences in baseline characteristics, including preoperative and
operative factors, were observed between the two groups. Among
the postoperative factors, the use of β-blocker showed a statistical
significant difference (p = 0.039). As for the frequency of POAF, no
significant difference was found (AG 45% vs. CG 45.8%, p = 1.00).
Even when patients were under β-blocker medication, no statistical
significant difference was found (AG 42.1% vs. CG 50%, p = 0.776). In
the condition of the left atrial diameter of >4.0 cm, no significant dif-
ference was found (AG 60.7% vs. CG 33.3%, p = 0.407). By using lo-
gistic regression models that compared AG with CG, we identified
the role of the aorta cross-clamp time (odds ratio [OR] 0.99; 95% con-
fidence interval [CI] 0.03-2.57, p = 0.27), left atrial diameter (OR 1.44;
95% CI 0.92-2.38, p = 0.10), and atrial pacing (OR 0.97; 95% CI 0.40-
2.35, p = 0.95).
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 452 of 542CONCLUSIONS. For patients with atrial valve stenosis, right atrial
overdrive pacing could not suppress the POAF after surgical aortic
valve replacement.
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INTRODUCTION. Patients with infective endocarditis has a high
mortality especially if they required surgery
OBJECTIVES. To know the factors associated with mortality in
patients with infective endocarditis (IE) admitted in the intensive
care unit (ICU) and who were emergency surgically operated.
METHODS. Observational, prospective and cohort study. We
included patients with infectious endocarditis from January 2008 to
December 2016 who needed urgent surgey. We collected
demographic variables, type of valvular surgery, doses of amines at
admission, microbiological results, empirical and target antibiotics
and outcome. Amine doses were classified into two groups: low
doses 0.1-0.3 mcg/ kg/ hr and moderate doses > 0.3 mcg/ kg/ hr.
Descriptive statiscal analysis was performed, presenting the
qualitative variables as frequencies and percentages, and
quantitative as mean (+/− SD) or median (interquartile range ICR)
depending its distribution. We use chi square for bivariate analysis of
qualitative variables.
RESULTS. We included 46 patients, 34 were men (73.9%). Mortality
rate was 30.4%. The most frequent surgery was on aortic valve, in 25
patients (61%), followed by the mitral-aortic valve (8 patients, 19.5%)
and the mitral valve (7 patients, 17.1%). There was no significant rela-
tion between type of surgery and mortality (p = 0.399). A total of 18
patients (39.1%) did not require amines at ICU admission, while
47.8% received low doses and 13% moderate doses. The different
needs of amine were not either significantly related to higher mortal-
ity (p = 0.216). In 43 patients (93.5%), microbiological isolation was
obtained, with 71.7% receiving target antibiotic therapy, significantly
associated with greater survival (81.2% vs 50.0%, p = 0.03).
CONCLUSIONS. Patients who are urgently operated due an IE have a
mortality rate in our series of 30.4%. Preoperative hemodynamic
instability requiring different doses of vasoactive amines does not
seem to be associated with higher mortality, nor the type of valvular
surgery. Administration of target antibiotic therapy by antibiogram
was significantly associated with increased survival.
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INTRODUCTION. The implantation of a percutaneous aortic
prosthesis (TAVI) is the treatment of choice for patients with severe
symptomatic aortic stenosis who are not candidates for surgery or
who have a high surgical risk, in most cases in elderly patients.
OBJECTIVES. The aim of our study was to analyze the results of TAVI
implantation in our center in patients older than 75 years.
METHODS. Prospective and monocentric study of patients submitted
to TAVI implantation at our center between June 2010 and February
2017. Clinical variables, risk scores, variables related to the procedure,
complications and follow-up events were collected.
RESULTS. Among 140 patients in whom this procedure was
performed, 116 patients (82.2%) who were ≥75 years old were
analyzed. The mean age was 81.9 ± 3.3 years. The prevalence of risk
factors and comorbidities was high: hypertension 99p (85.3%),
dyslipemia 60p (51.7%), diabetes mellitus 51p (44.0%), smoking 34p
(29.3%), atrial fibrillation 44p (37.9%), pacemaker (8.9%), COPD 23p
(19.8%), obesity (BMI > 30 kg / m2) 47p (40.5%), chronic renal failure
75p (64.7%), previous neoplasia 13p (11.2%), ischemic heart disease
38p 32.8%). The mean EuroScore was 20.8 ± 12.9 and the STS score
4.7 ± 3.4. The functional grade was: grade II 23p (19.8%), grade III
85p (73.3%) and grade IV 8p (6.9%). 24.1% (28p) had some degree of
ventricular dysfunction, 13.9% had significant mitral regurgitation
(16p) and 25.8% (30p) had pulmonary hypertension. In addition, 31p
(29.0%) had some previous conduction disorder. The immediate
success rate of the procedure was 98.3%. After the intervention,
pacemaker implantation was performed in 38 patients (32.8%), 6
(5.2%) patients developed renal insufficiency (5.2%), atrial fibrillation
in 9p (7.8%), bleeding with need for transfusion in was observed in
10p (8.8%). The percentage of significant mitral regurgitation
reduced to the half (7.7%). The median number of days of admission
was 9 days. The percentage of in-hospital death was 10p (8.6%, tech-
nical complication 2p, arrhythmia 1p, heart failure 5p, other 2p. At
year, of follow-up survival was 83.5% and 72.2% at 2 years.
CONCLUSIONS. The majority of patients undergoing TAVI were over
75 years old, with a high prevalence of risk factors and
comorbidities. Both, success and survival of the procedure at follow-
up in a high-risk surgical population, was high.The most frequent
complication was the need for definitive pacemaker implantation.
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INTRODUCTION. Neurological protection in cardiac surgery for a
good functional prognosis is the main concern of intensive care
physicians and surgeons.
OBJECTIVES. Results of aortic surgery with moderate hypothermia
(18°-26° C), cardiac arrest and antegrade cerebral perfusion:
evaluation of mortality, neurological complications and functional
prognosis at short and mid time.
METHODS. Observational retrospective descriptive study of 46
consecutive patients (20 emergent, 3 urgent, 23 elective) operated as
described above between 2012 and 2016 at Fundación Jiménez Díaz
Table 216 (Abstract 0902). See text for description
Diabetes mellitus 39 (45.3%)
Dyslipidemia 41 (47.7%)
Smokers/Ex-smokers 2 (2.3%)/20 (23.3%)
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Different demographic, clinical, laboratory and intraoperative data
were collected (cardiopulmonary bypass (CPB), cardiac arrest (CA)
and antegrade cerebral perfusion (ACP) times were collected. We
follow patients up to 6 months post-intervention (Table 215).
RESULTS. Eight patients died (17%): seven were emergent aortic
dissection (35% mortality in this group) and one was elective surgery.
Focal neurological deficit was observed in five of the dead´s group
(63%), in two of the survivors (5%) and in six of the dissections (30%).
There were three (37%) cases of abnormal awakening in the dead´s group,
twelve among the survivors (32%) and ten (50%) into the dissections.
Patients with adverse neurological events had higher CPB times with
statistically significant results (T student p 0.018, CI al 95% 6.94-59.8).
The CA and ACP times were higher in this group respect the group
without neurological alterations.
Patients with worst functional outcome (according to the Glasgow
Outcome Scale (GOS) 1–3) were older, had higher body mass index
(BMI), more cardiovascular history, worse EUROSCORE I, and longer
surgical times. Emergent surgery was more common in patients with
GOS 1–3 (Chi2, OR 0.058, 95% IC 0.006-0.557).
CONCLUSIONS. As expected, patients with emergent aortic surgery
had higher mortality and more neurological complications,
associated with longer CPB, ACP and CA. Patients with worse
functional evolution had major preoperative risk, more incidence of
emergent surgery and longer interventions.
Preliminary results of this study suggest the possibility of creating
evolutionary risk scores based on these and other clinical and
surgical variables.
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INTRODUCTION. Transcatheter aortic valve implantation (TAVI) is a safe
and effective alternative to surgical treatment in patients with severe
aortic stenosis (AS) and those who are inoperable or at high surgical risk.
OBJECTIVES. The objective of this study was to evaluate the
mortality of consecutive patients with severe AS treated with TAVI.
METHODS. This prospective single-center registry study from a ter-
tiary hospital included all consecutive patients who underwent per-
cutaneous aortic valve implantation between June of 2015 and
december of 2016. Clinical follow-up was carried out during clinic
visits or via telephone and lasted a minimum of 3 months and a
maximum of 1,5 years. No patients were lost to clinical follow-up.
RESULTS. We recruited 86 patients, 74 (86%) treated with a
transvascular (TV) and 12 (14%) transapical (TA) cathether-based
techniques. The mean age at implantation was 78.1 ± 8.57 years, 43
(50%) were male, the mean logistic EuroSCORE was 15.24 ± 9.6%
and the mean logistic EuroSCORE 2 was 3.83 ± 3.5%. The baseline
clinical characteristics are shown in Table 216 and in-hospital compli-
cations are shown in Table 217. A total of 18 (15.5%) patients died
during the follow-up period: 2 (2.3%) during hospitalization (one TA
in ICU and one TV in hospitalization plant), and 16 (13.2%) during
subsequent follow-up. The most common cardiovascular causes were
heart failure and stroke.
CONCLUSIONS. Short-mid-term mortality in AS patients after TAVI is
aceptable. The main causes of death are cardiovascular in the first year.Hypertension 70 (81.4%)
Left ventricular ejection fraction (LVEF%) 55.6 +-13.15
Chronic obstructive pulmonary disease 22 (25.6%)
Chronic ischemic heart disease 16 (18.6%)
Pacemaker 6 (7%)
Previous stroke 6 (7%)
Previous Kidney injury 38 (44.2%)
Table 217 (Abstract 0902). See text for description
In-hospital deaths 2 (2.3%)
Cardiac Tamponade 2 (2.3%)
Cardiogenic Shock 3 (3.5%)
Septic Shock (catheter infection) 1 (1.2%)
Acute myocardial infarction 4 (4.7%)
New onset Atrial fibrillation 6 (7%)
Permanent Pacemaker 10 (11.6%)
Stroke 1 (1.2%)
Major bleeding and vascular complication 2 (2.3%)
Acute kidney injury/hemodialysis 30 (34.9%)/1 (1.2%)
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INTRODUCTION. Pulmonary arterial hypertension (PAH) is
characterized by the dysregulated proliferation of vascular smooth
muscle cells. In our previous study, the induced pluripotent stem cells
(iPSC)-based therapy showed benefits on the improvement of
hemodynamic function, and on attenuating the inflammation in lung
of monocrotaline (MCT)-induced pulmonary hypertension rats.
However, the underlying mechanisms are still not fully understood.
OBJECTIVES. In this study, we aim to explore whether iPSC-based
therapy can suppress the proliferation of PASMCs in vivo and
in vitro, as well as the underlying mechanisms will also be
investigated.
METHODS. The animal model of PAH was established by
subcutaneous injection of monocrotaline (60 mg/kg) into male SD
rat. The iPSC-based therapy were administrated as (1) immediately
intravenous injection after MCT, or (2) fourteen days after MCT injec-
tion. The types of iPSC-based therapy were further divided into the
iPSCs itself (once per week) and the conditioned medium of iPSCs
(once every 24 hours). The lung tissue of each group would be col-
lected on 28th day following the protocol. The proliferation of
PASMCs will be examined by immunohistochemistry and western
blot with antibodies against different proliferative cell markers. In
vitro, human PASMCs were co-cultured with iPSCs to investigate the
effects of iPSC treatments on the proliferation of human PASMCs.
Meanwhile, the underlying signaling pathways of iPSC-based therapy
on the proliferation of human PASMC will be explored.
RESULTS. In addition to the improvement of the hemodynamic
values of RVSP, Fulton index and the severity of pulmonary vascular
remodeling, iPSC-based treatments critically decreased the expres-
sion levels of Hif-1a, NF-kB and AKT molecules in the lung specimen
of MCT-induced PAH rats. In vitro assay showed that either hypoxia
or PDGF could enhance the proliferation and migration of human
PASMCs (hPASMCs). Interestingly, iPSC-based treatments could at-
tenuate the proliferation and migration of hPASMCs under hypoxic
or PDGF stimulation. For cellular mechanism study, western blot
showed that Hif-1a, NF-kB and AKT protein levels of hPASMCs were
decreased following iPSC-based treatments. Furthermore, iPSC-based
treatments also reduced the hypoxia and PDGF-induced increase of
reactive oxygen species (ROS) level in hPASMCs, whereas western
blot indicated that the decrease of ROS level in hPASMCs might be
through the downregulation of PAK-1 protein in the groups of iPSC-
based treatments.
CONCLUSIONS. In this study, evidence showed that both iPSCs and
iPSC-derived conditioned medium could provide therapeutic benefits
on the reversal of experimental PAH rats. Importantly, the results
further indicated that the iPSC-based treatments could suppress the
abnormal proliferation and migration of PASMCs via the downregula-
tion of PAK-1/ROS/Hif-1a signaling.0904
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INTRODUCTION. PAH is characterized by vascular remodeling of
pulmonary arteries, which is associated with abnormal proliferation of
pulmonary arterial smooth muscle cells, deposition of extracellular matrix
proteins and perivascular inflammation. Matrix metalloproteinases
(MMPs) are critical to the maintenance of the homeostasis of extracellular
environment. Several studies have discussed the role of different MMPs
in the pathogenesis of PAH with the underlying mechanism still unclear.
OBJECTIVES. We try to explore the role of MMP1 and MMP10 in
PAH, and to investigate the molecular mechanisms involved in the
regulation of MMP1 and MMP10 expression.
METHODS. We compared the expression levels of MMP1 and MMP10
in the serum between healthy and PAH group. In vitro, human
monocyte-derived mø from each group were subjected to the induc-
tion of MMP1 or MMP10 expression following LPS/IFNg stimulation.
The expression of mRNA and protein of MMP1 or MMP10 was ana-
lyzed by semi-quantitative PCR and western blot. The human mono-
cyte cell line, named THP-1, in combined with chemical inhibitors,
including PD98059, LY294002, SB203580, SP600125, STAT1, and
STAT3 were used to investigate the signaling pathways involved in
the regulation of MMP1 and MMP10 expression. For in vivo study,
the lung specimens from monocrotaline (MCT)-induced PAH rat were
examined for the expression of MMP1 and MMP10 by semi-qPCR
and immunohistochemistry(IHC), respectively.
RESULTS. In human serum, the level of MMP1 and MMP10 is
significantly higher in PAH patients. The elevated expression MMP1
and MMP10 was confirmed by in vitro cultured primary human mø
that robust up-regulated MMP1 and MMP10 expression was ob-
served from mø derived from PAH patients under the stimulation of
LPS/IFNg. Due to the variation between primary cultured mø, the hu-
man THP-1 cell line, which was polarized by LPS/IFNg stimulation,
provided more convincible data of the up-regulation of MMP1 and
MMP10 expression in pro-inflammatory mø. After treatment of inhibi-
tors, the expression of MMP1 was significantly suppressed when the
ERK signaling was interfered, whereas MMP10 expression was associ-
ated with ERK, JNK, and STAT3 signal cascades. For in vivo evidence,
the expression of MMP1 and MMP10 was elevated in the lung tissue
of MCT-induced PAH rats compared to the PBS control group. IHC
staining revealed the co-localization of MMP1 or MMP10 molecule
with the COX-2-positive mø, which meant the expression of MMP1
and MMP10 was highly associated with the pro-inflammatory mø
phenotype.
CONCLUSIONS. In this study, we provided evidence that MMP1 and
MMP10 were significantly up-regulated in pro-inflammatory mø
in vitro and in vivo in both primary cultured human mø, THP-1 cell
line and MCT-induced PAH rat model. The elevated MMP1 and
MMP10 levels in the serum of PAH patients might be developed as
useful biomarkers for PAH. We further indicated that blockade of JNK
and ERK signaling pathways may be a novel treatment of PAH.
Table 219 (Abstract 0905). See text for description
*p<0,05 Bichat Number Total Number
Postoperative measurement
ScVO2* 10 (8.69) 1134 (36.58)
ScVO2 value (mean) 69.8+/-4.87 71.18+/-10.29
Lactate value (mean) 1.79+/-0.71 1.79+/-1.42
Duration of vasoactive drugs infusion (hours) (mean)
NE 25.62+/-56.8 36.69+/-79.84
Dobutamine* 94.21+/-110.49 59.98+/-68.78
All complications confunded 52 (45) 1338 (43)
Mean ICU stay (days) 4+/-4.8 4.1+/-4.8
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INTRODUCTION. Clinical monitoring and postoperative care for adult
cardiac surgery underwent continuous improvement following
introduction of minimally invasive cardiac output monitoring and
echocardiography in intensive care, with a decline in mortality and
morbidity. However, the last multicentre study reporting the possible
changes in practice was performed in France in 2001.
OBJECTIVES. We present data from a prospective, observational
study, regarding the current clinical practice in cardiac surgery and
postoperative care.
METHODS. After approval from the Ethics and Research Committee,
32 centres in France included patients undergoing cardiac surgery
from 2 November to 20 December 2015. Patients with transcatheter
aortic valve replacement, extracorporeal life support, congenital
cardiac surgery, wound infections or pericardial drainage were
excluded.
RESULTS. Tables 218 and 219 present comparative data from our
centre and the whole cohort. While the populations were similar in
terms of pre-operative risk and co-morbidities, there are significant dif-
ferences concerning type of surgery, mean extracorporeal circulation
(ECC) and cross clamping time.
Compared to other centres, our centre showed remarkable preference
for echocardiography. No patient had invasive intraoperative CO
monitoring, 36% of patients were monitored intraoperatively by
transesophageal echocardiography (TEE), with all patients being
monitored by TEE or transthoracic echocardiography (TTE) in the ICU.
Using this monitoring protocol, there was no significant difference
between the percent of patients receiving vasoactive drugs after
ECC, the mean lactate and ScVO2 values after ICU admission. ScVO2
measurement was performed in 8.6% of patients in our group,
compared with 36.5% in the cohort.
Concerning the duration of vasoactive drugs use, no significant difference
was observed for norepinephrine. However, dobutamine infusion time
was significantly longer in our group, suggesting that repeated
evaluation of cardiac function using echocardiography may be more
accurate in guiding inotrope treatment and maintaining an adequate
cardiac output when compared to other monitoring techniques.
Milrinone and levosimendan remain peripheral in clinical practice in
the whole cohort and their use could not be evaluated.
There were no significant differences in postoperative complications
or duration of ICU stay.
CONCLUSIONS. Our data shows that cardiac output evaluation and
vasoactive drugs length of infusion can be safely guided using
echocardiography as the main postoperative monitoring method in
cardiac surgery. Advanced knowledge of echocardiography should be
a must for all ICU teams involved in postoperative cardiac surgery care.Table 218 (Abstract 0905). See text for description
*p<0,05 Bichat Number Total Number
Included patients 115 (%) 2623 (%)
Mean Euroscore II 3.89+/-2.36 3.75+/-0.5
Mean ECC time*(minutes) 67+/-33 97+/-48
TEE intraoperative/ICU 42 (36)/6 (5) 1139 (36)/250 (8)
TTE ICU* 110 (95) 1327 (42)
CO monitoring intraoperative*/ICU* 0/3 (2.6) 387 (15)/338 (10)
Vasoactive drugs
Norepinephrine (NE) 58 (50.43) 1560 (50.32)
Dobutamine 20 (17.39) 422 (14.25)0906
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INTRODUCTION. Hyperfunction of subcluvian- pulmonary
anastomosis in patients with tetralogy of Fallot (TOF) is known to be a
common condition in the early post-operative period. Morphology of
peripheral blood cells significant changes after the cardiosurgery of
TOF patients.
OBJECTIVES. Come to know to determine morphometry of peripheral
blood cells of TOF patients in the number of pathologically shaped red
blood cells (PS RBCs) as a predictor of development of anastomosis
hyperfunction/hypervolemia and pulmonary edema.
METHODS. 81 TOF patients aged 1–22 years (mean age 8.7 ± 0.9), in
all the cases, the modified Blaloc-Taussig (BT) anastomosis was
formed. Artificial lung ventilation was carried out to the SPA patients
in the standard regimes in early post-operative period. Morphometry
collate control: scanning electronic microscopy (SEM) with elaborated
and patented the methods of studying the discrete structures,
namely the express-method of “thick drop" (TDEM) for practical and
research purposes.
RESULTS. Morphometry of peripheral blood cells in patients with
tetralogy of Fallot demonstrated that the number of
pathologically shaped RBCs has increased up to 41% after the
cardiosurgery TOF, these were mainly erythrocytes with a ridge
(up to 19%).
The early post-operative period after formation of subclavian-
pulmonary anastomosis is characterized by the decrease of erythro-
cytes up to 56-57%, while the number of pathologically shaped
erythrocytes in peripheral blood below 49% is the morphological
predictor of anastomosis hyperfunction development.
CONCLUSIONS. Morphometry of peripheral blood cells of patients
with tetralogy of Fallot has revealed the increase in the number
of pathologically shaped red blood cells, mainly RBCs with a
ridge. The anastomosis surgery leads to the predominance of the
RBCs pathological shapes in peripheral blood. Progressive
deterioration of RBCs morphology is a predictor of the
anastomosis hyperfunction development with hypervolemia of
the pulmonary circulation and pulmonary edema after the
surgery.
REFERENCE
The morphological monitoring of correlation between normal and
pathological forms of erythrocytes can be the criterion of
effectiveness of medical and diagnostic tactics in cardiologic
resuscitation.
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INTRODUCTION. Elevated blood ammonium levels (EAL) is a
potential side effects of valproic acid (VPA) treatment. It has been
described during long-term VPA treatment, but less in critically ill
patients.
OBJECTIVE. Our aim was to evaluate the incidence and the factors
associated with EAL in these patients.
METHODS. We reviewed the data of all adult patients treated in our
mixed 35-bed Dept of Intensive Care over a 9-year period (2008–
2016) who: a) were treated with VPA for more than 72 hours and b)
had at least one measurement of ammonium and VPA levels during
the ICU stay; patients with Child C liver cirrhosis were excluded. EAL
wer defined as ammonium levels above 60 mcg/mL.
RESULTS. Of a total of 1938 patients treated with VPA, a total of 319
patients met the inclusion criteria (median age 64 years; male
gender 77%). More than 75% were admitted for neurological
reasons. Overall ICU mortality was 30%. Median ammonium levels
were 88 [63–118] mcg/dL. EAL was found in 245 (77%) patients;
including 75 (31%) with ammonium levels between 100–150 mcg/dL,
23 (9%) between 151–200 mcg/dL and 18 (7%) above 250 mcg/dL.
Median time from start of VPA therapy to EAL was 3 [2–5] days.
Median maximum VPA level during therapy was 76 [57–93] and was
significantly higher in EAL patients than in the others (79 [63–97]
mcg/mL vs. 61 [45–79] mcg/mL, p < 0.01). In 98/245 (40%) of EAL
patients, VPA was interrupted; VPA interruption was more frequent
in patients with ammonium levels > 100 mcg/dL than others
(p < 0.001). In a multivariable analysis, high VPA concentrations, the
use of mechanical ventilation and the occurrence of sepsis were
independently associated with EAL during VPA therapy.
CONCLUSIONS. In this study, EAL was a common finding during
treatment with VPA in acutely ill patients. VPA levels, sepsis and
mechanical ventilation were risk factors for EAL.
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INTRODUCTION. The insertion of an external ventricular drain (EVD)
is frequently a lifesaving procedure in the neurologic intensive care
unit. EVDs are not devoid of complications: EVD-related infections,
for example, significantly prolong hospital stay, increase costs and
often negatively affect prognosis. To prevent EVD infection the use
of systemic antibiotic prophylaxis is common practice.
OBJECTIVES. We aim to investigate if type of antibiotic prophylaxis
(single shot at insertion vs. continuous) influences the incidence of
EVD-related infections.
METHODS. This observational prospective study was conducted for
24 months at the University Hospital of Bern (Switzerland), Royal
North Shore Hospital and the Alfred Hospital (Australia). Patients over
16 years of age who had an EVD placed were included. EVD-relatedinfection was diagnosed by the treating physician based on clinical
grounds and/or analysis of blood and cerebrospinal fluid samples.
The study was approved by the Ethical Committee of the 3 centers.
Baseline characteristics include patient demographics, medical
history, indication for placement of an EVD and type of antibiotic
prophylaxis used, as well as severity scores. The statistical analysis
included Chi square test for categorical and Student´s T for
continuous variables. Results are presented in average ± standard
deviation. Statistically significant when p < 0,05. Data were analyzed
with SPSS 24.0.
RESULTS. We enrolled 187 patients who required insertion of an
EVD. One hundred and two (54,5%) were males. The average age
was 53,65 ± 17,9 and 6,5% had co-morbidities. The reasons for ad-
mission were subarachnoid haemorrhage (45.5%), intracranial haem-
orrhage (25,7%) and traumatic brain injury (28,9%). The mean GCS
on admission was 8,83 ± 4,1. EVD-related infection was present in 31
patients (16,6%). There was no significant difference in age and LOS
for the presence of EVD-related infection.
A significant difference in GCS score for EVD-related infection
(M = 10,39, SD = 4,01) and no EVD-related infection (M = 8,52,
SD = 4,1) was observed; t(185) = 2,32, p = 0,022, two-tailed. Peri-
procedural prophylaxis was used in 66,8% of patients. There was no
significant association between EVD-related infection and type of
prophylaxis used, c2(1, n = 187) = 0.86, p = .35, phi = −.08).
CONCLUSIONS. Our preliminary analysis of a large cohort of
neurosurgical patients with EVD showed no association between
EVD-related infection and the type of antibiotic prophylaxis used. We
conclude that single shot prophylaxis is as safe as continuous admin-
istration, with evident advantages for costs and possibly less devel-
opment of antibiotic resistance.
REFERENCE(S)
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INTRODUCTION. Seizures frequently result in emergency episodes
(EE) which may require the attention of critical care or may occur in
Intensive Care Unit (ICU) patients. Wide variations in response are
seen with first line antiepileptic drugs (AEDs) 1. When convulsive
Status epilepticus (SE) was analysed in a population based study, it
was refractory in 27%, and, in a retrospective study in an ICU, 43% of
the patients had seizures refractory to first-line AEDs 2. Lacosa-
mide (LAC) is a new AED. Recently experiences shows positive
clinical experience of LAC in SE and acute repetitive seizures
(ARSs) 3.
OBJECTIVES. The primary study objective was to describe the
characteristics related to the use of LAC. Our secondary objective
was to assess the effectiveness of IV LAC in EE and in patients with
SE or ARSs.
METHODS. A retrospective, descriptive and single-centre study in
our ICU was conducted. All ICU patient ≥ 18 years, with the diag-
nosis of seizures for which IV LAC was used (January 2014-
December 2016) were analysed. Demographic data, seizure type,
aetiology, number of AEDs used and order in which they are
used, time from IV LAC initiation to seizure cessation, IV LAC dos-
age and side effects were collected. Qualitative variables are
expressed as percentages and compared using the Χ2-test; quan-
titative ones are expressed as median and inter-quartile range
(IQR), and analysed using Student́s t-test.The level of significance
was placed at p < 0.05.Statistical analysis was performed using
Fig. 290 (Abstract 0909). AEDs treatment order
Table 220 (Abstract 0909). LAC treatment use characteristics
Cessation of seizures after IV Lacosamide, n (%) 26 (86.7)
Further AED therapy needed to control seizures, n (%) 3 (10)
Seizures not controlled, n (%) 4 (13)
Latency time < 6 hours to seizure cessation, n (%) 24 (80)
Loading Dose > 200 mg, n (%) 22 (75)
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Armonk, NY: IBM Corp).
RESULTS. 30 patients; median age 66 (55–77),sex male 46.7%, past
medical history of epilepsy 26%, previous use of AEDs 81%, non-
convulsive SE 16.7%. Figure 288 shows the type of seizure.
Figure 289 shows seizure aetiology.
Figure 290 shows AEDs treatment order.
Tables 220, 221 & 222 shows LAC treatment use characteristics and
efficacy according with treatment order and by type of seizure
respectively.
CONCLUSIONS. Data shows that IV LAC resulted in a fast and
well tolerated cessation of different types of seizures. Our
observations suggest that IV LAC may be a potentially effective
alternative treatment when standard AEDs fail or are not
recommended.
REFERENCE(S)
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Neurocrit Care. 2014 Jun;20(3):484–8.Fig. 288 (Abstract 0909). Type of seizure
Fig. 289 (Abstract 0909). Aetiology
Need to increase Lacosamide dose, n (%) 4 (13)
Lacosamide at hospital discharge, n (%) 12 (40)
Adverse events, n (%) 1 (3)
ICU mortality, n (%) 7 (23)
Hospital mortality, n (%) 9 (30)
Table 221 (Abstract 0909). LAC efficacy according with treatment
order
Fisrt-
Line
Second-
Line
Third-
Line
Fourth-
Line
p
No Cessation of seizures,
n (%)
1 (25) 1 (25) 2 (50) 0 0.56
Cessation of seizures, n
(%)
2 (7.7) 13 (50) 9 (34.6) 2 (7.7) 0.56
Table 222 (Abstract 0909). LAC efficacy by type of seizure
Cessation No cessation P
Aphasic status 0 4 (100) 0.23
Dyscognitive seizures 0 3 (100) 0.23
Generalized tonic-clonic seizures 1 (7) 12 (92.3) 0.23
Motor simple partial seizures 3 (30) 7 (70) 0.230910
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parameters of purine metabolism in acute cerebral pathology,
including stroke, is studied in detail. Meanwhile, a study of
postmortem biochemical processes may provide additional scientific
information on the diagnostic value of the parameters of purine
metabolism in neurointensive care.
OBJECTIVES. Investigate the postmortem parameters purine
metabolism in stroke.
METHODS. In 50 adult ICU stroke patients, in the first 2 hours after
the fact of biological death, the samples of cerebrospinal fluid (CSF)
and venous blood on the were performed spectrophotometric
determination of the concentration of adenine, guanine,
hypoxanthine, xanthine, uric acid, malondialdehyde as a marker of
free radical oxidation.
RESULTS. Postmortem CSF levels of uric acid and malondialdehyde
significantly higher in male patients than in female; uric acid in CSF
significantly lower in the presence of intravital arterial hypertension,
heart failure, pneumonia. Pneumonia is also associated with a higher
postmortem blood concentration of malondialdehyde, and multiple
organ failure with a higher concentration of uric acid and
malondialdehyde in CSF. The ratio of the CSF concentrations of uric
acid / xanthine higher in ischemic, than in hemorrhagic stroke. The
ratio of the concentrations of uric acid / xanthine, xanthine /
hypoxanthine, uric acid / hypoxanthine was significantly lower in the
presence of pneumonia in patients with stroke.
CONCLUSIONS. Oxypurines significantly associated not only with
gender, arterial hypertension or stroke type, but also such
lifethreatening conditions as pneumonia, heart and multiple organ
failure. Possibly, the mandatory inclusion of purines in the vital panel
of monitored biochemical parameters will improve the results of
neurointensive care.
0911
Importance of purine metabolites in preeclampsia and acute
cerebral stroke
E.V. Oreshnikov1, S.F. Oreshnikova1, E.N. Vasiljeva2, T.G. Denisova2
1Chuvash State University, Internal Medicine, Cheboksary, Russian
Federation; 2Chuvash State University, Obstetrics and Gynecology,
Cheboksary, Russian Federation
Correspondence: E.V. Oreshnikov
Intensive Care Medicine Experimental 2017, 5(Suppl 2):0911
INTRODUCTION. Along with the classic triad edema, proteinuria,
hypertension, more than a quarter century, many clinicians as an
indicator of preeclampsia using the high content of uric acid in
blood serum hyperuricemia.
It was also found that the hypoxanthine, xanthine and uric acid (UA)
are present in the brain, and their content is changed after ischemia,
UA is the end product of purine degradation in the brain, xanthine
oxidase is also present in the brain, it catalyzes the oxidation of
hypoxanthine to xanthine, and then in UA and can be a source of
free radicals, inhibition of xanthine oxidase and exogenous
administration of UA accompanied by explicit antiischemic and
neuroprotective effects in the experiment and clinic, while the
endogenous increased its production, with the "side" synthesis of
xanthine oxidase oxygen free radicals, reflects the severity of
ischemic and reperfusion injury. We also know that most fatal path
pathogenesis (and tanatogenesis) in preeclampsia the development
of cerebral stroke.
OBJECTIVES. Our attention was attracted by a comparative
assessment of the features of purine metabolism in women with
preeclampsia and acute cerebral stroke.
METHODS. The study involved 33 patients with preeclampsia and
350 patients in the
acute period of cerebral stroke, in which, in addition to conventional
laboratory parameters were determined in the blood and
cerebrospinal fluid of guanine, hypoxanthine, adenine, xanthine and
uric acid direct spectrophotometry.
RESULTS. It was established that between preeclampsia and cerebral
stroke, thereare clinical and pathobiochemical parallels, including according to
the characteristics of purine metabolism. Hyperuricemia the most
famous and at the same time the most pronounced adverse
metabolic factor (marker, predictor) for preeclampsia, and for
cerebral stroke. High value content oxypurines (hypoxanthine,
xanthine and uric acid) in the cerebrospinal fluid a good sign for a
stroke, and low for preeclampsia.
CONCLUSIONS. Liquor can be seen not only as a medium of
administration of drugs for spinal anesthesia, but also and a source
of valuable diagnostic (and predictive) information, including in
preeclampsia. The level of uric acid and other purine both patients
with preeclampsia, and cerebral stroke, it is desirable to investigate
not only in serum but when possible, and in cerebrospinal fluid.
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INTRODUCTION. Delirium is a syndrome that can develop on the
background of many diseases. The development of delirium leads to
an increase in the length of the patient´s stay in the intensive care
unit and the hospital, and increases the mortality. The frequency of
occurrence of delirium in intensive care units reaches 32.3%
according to a number of authors and in specialized intensive care
units can be much higher [1].
OBJECTIVES. To evaluate the frequency and types of delirium in
patients with ischemic and hemorrhage stroke.
METHODS. We conductedan observational study of 40 patients
admitted to the intensive care unit for patients with acute neurologic
pathology. Patients were divided into 2 groups - the 1st group
(n = 17, 42.5%) patients whom delirium was diagnosed and the 2nd
group (n = 23, 57.5%) - patients without delirium (Table 223).
We studied types of stroke in the groups. The presence of delirium
was carried out on the scale ICDSC [2] in the first 24–48 hours from
the moment of admission; also, we assessed the degree of
depression of consciousness on the CGS and FOUR scales; the
degree of agitation, sedation was assessed on the RASS scale.
Statistical analysis was performed using the Mann–Whitney test for
independent samples and the Pearson´s chi-squared test for non-
parametric variables.
RESULTS. In 1st group, ischemic stroke (IS) was diagnosed - 11 (65%)
patients, hemorrhagic stroke (HS) - 6 patients (35%), of them in the
form of intracerebral hematoma (ICH) - 3 patients (17.5%) and in the
form of subarachnoid hemorrhage (SAH) - 3 patients (17.5%). In the
2nd group, IS was diagnosed in 16 patients (70%), HS - in 7 patients
(30%), ICH - 6 patients (25.6%) and SAH- 1 patient (4, 4%).
The degree of severity of depression on the CGS and FOUR scales, the
degree of sedation / arousal on the RASS scale are presented in Table 224.
The degree of depression of consciousness by CGS and FOUR was
more pronounced in group 1.
In the 1st group subsyndromal delirium was diagnosed in 12
patients (71%), depending on the ICDSC score, and delirium was
diagnosed in 5 patients (29%).
Depending on the RASS score from 5 patients with delirium 2
patients had hypoactivedelirium, 1 patient -hyperactive, and 2
patients had mixed delirium.
CONCLUSIONS
1. The frequency of delirium in patients with Ischemic and
Hemorrhagic Strokes was 42.5%.
2. Subsyndromal delirium developed more often (71.0% of cases) in
patients with Ischemic and Hemorrhagic Strokes (ICDSC score less than
3 points); and types of delirium were hypoactive and mixed variants.
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 459 of 5423. The type of stroke (IS or HS) did not affect the frequency
developmentof delirium.
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2001,27(5):859–864.Table 223 (Abstract 0912). Characteristic of patients
Group Sex, m/f Age, year, M±σ p
1 group 7 (41%)/10 (59%) 60.2±11.0 >0.05
2 group 14 (61%)/9 (39%) 64.1±15.1 >0.05
Table 224 (Abstract 0912). See text for description
CGS FOUR RASS
1 group, Me [25;75] 14 [9;15] 16 [9;16] 0 [-3;0]
2 group, Me [25;75] 15 [14;15] 16 [16;16] −1 [-1;0]
p <0.05 <0.05 <0.050913
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INTRODUCTION. There is evidence that patients with acute cerebral
nervous system injuries have temporary impairment of cellular
immune function placing them at increased risk of infection. Cellular
alterations leading to amplification of the inflammatory cascade and
the various directs effects of T and B cells on neuronal cells have
been described.
OBJECTIVES. Characterize and compare metabolic pathways in acute
critically ill neurosurgical (NS) patients to critically ill burn patients
utilizing metabolomics.
METHODS. Blood samples were obtained at baseline (D0) and day
14 (D14). Samples from 32.
(22 NS and 10 burn) patients were analyzed. Baseline characteristics
were similar between the two groups except age was significantly
higher in the NS group (56.4 ± 14.2 vs 38.5 ± 14.2). We conducted a
metabolomics analysis where an organic extraction resulted in lipid
and non-lipid fractions; these were analyzed by untargeted mass
spectrometry. A database containing publicly available and in-house
spectral data was used to annotate metabolites. Metabolites of D0
NS vs D14 NS, D0 burn vs D14 burn, and D0 NS vs D0 burn were
compared by unpaired t-tests. Statistical significance was set at
p < 0.05 with a fold change of >2.
RESULTS. The change between D0 vs D14 NS patients in the lipid
phase untargeted metabolomics yielded 79 tentatively annotated
with 6 significant pathways: glycerophospholipid (GPL) metabolism,
glycosylphosphatidylinositol (GPI)-anchor biosynthesis, regulation of
autophagy, phospholipid biosynthesis, alpha linolenic acid and
linoleic acid metabolism, and biosynthesis of 12-, 14- and 16-
membered macrolides. The change between D0 vs D14 burn patients
showed 53 tentatively annotated metabolites with 6 significant path-
ways: GPL metabolism, GPI-anchor biosynthesis, regulation of au-
tophagy, phospholipid biosynthesis, sphingolipid metabolism, andarachidonic acid metabolism. Finally, the comparison of D0 NS and
D0 burn patients showed 89 tentatively annotated metabolites with
9 significant pathways: GPL metabolism, GPI-anchor biosynthesis,
regulation of autophagy, phospholipid biosynthesis, alpha-linolenic
acid metabolism, biosynthesis of 12-, 14- and 16-membered macro-
lides, isoquinoline alkaloid biosynthesis, arachidonic acid metabolism,
and biosynthesis of alkaloids derived from shikimate pathway. Tar-
geted analysis of lipid mediators supported a role of arachidonic me-
tabolism and inflammation at D14 NS patients.
CONCLUSION. Our findings suggest there are significant alterations
that occur in several lipid-rich pathways. These differences are seen
over a 14 day period and baseline between NS and burn critically ill
populations. These alterations may describe immunosuppression
seen within acute NS patients. Untargeted aqueous fraction analysis,
bioinformatics analysis, and validation of differential expressions of
cytokines are in progress.
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INTRODUCTION. Traumatic brain injury (TBI) is a leading cause of
death and disability. Ultimate tissue fate is determined not only by
the initial disruptive force but also by a cascade of complex
inflammatory processes that may be long-lived and long-ranged.
Label-free methods for probing the biochemical signatures of injury
processes that are also sensitive to structure may offer insights into
TBI pathophysiology beyond conventional histochemistry.
OBJECTIVES. We have previously demonstrated [1] that Raman
spectroscopy (RS) is sensitive to local biochemical signatures of TBI
across the cortical surface of a mouse model of TBI. In particular, the
technique is sensitive to protein and lipid changes which may be of
particular mechanistic interest. We seek to extend this technique to
cross-sectional imaging to investigate the biochemical effect of TBI
on deep structures.
METHODS. Adult C57BL/6 mice were exposed to a controlled cortical
impact model of severe TBI. Mice were sacrificed at 2 and 7 days after
injury (alongside sham TBI) and perfused with PBS. Fresh frozen tissue
was sectioned and imaged using a Raman microscope (WITec GmbH,
Ulm, Germany) equipped with a 785nm single mode diode laser (XTRA
II;Toptica Photonics Inc., USA), a 300mm triple grating imaging
spectrometer (Acton SpectraPro SP-2300; Princeton Instruments Inc.,
USA) with 600mm−1 grating and a thermoelectrically cooled CCD cam-
era (DU401A-BV; Andor, Ireland).
RESULTS. We were able to produce false-colour images of biochem-
ical fingerprints over time. Strong signals at 1003cm−1 and 1560cm−1
are seen at 2 days and persist to 7 days post injury in the pericontu-
sional tissue. These are likely to be protein signatures either as a re-
sult of vascular injury haemorrhage or leakage, or from the presence
of inflammatory processes in the region of the contusion. At the
same time, we see striking reductions in other Raman peaks such as
1301cm−1 and 1440cm−1 that are associated with lipid components
in the ipsilateral corpus callosum and internal capsule quite some
distance from the lesion at 2 days. These signal partially recover by 7
days.
CONCLUSIONS. We have performed the first RS imaging studies in a
TBI model and have demonstrated not only that RS is sensitive to
temporal biochemical changes, but also that signal changes have an
anatomically sensitive long-range spatial distribution. This approach
is able to detect multiple chemical species simultaneously in the
same sample without the need for staining.
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INTRODUCTION. Early revascularization of ischaemic organs is key to
improved outcomes yet the consequent reperfusion injury may be
harmful in itself. Reperfusion injury is largely attributed to excess
production of reactive oxygen species by mitochondria. As sulphide
inhibits mitochondria and reduces ROS production, sulfide donors
can potentially confer therapeutic utility in this setting.
OBJECTIVE. To determine the efficacy of ammonium tetrathiomolybdate
(ATTM), a novel sulphide donor, on infarct size and functional outcomes,
when given at reperfusion following transient middle cerebral artery
occlusion (tMCAO) in rats.
METHODS. tMCAO was induced by insertion of an intraluminal
filament into the middle cerebral artery of isoflurane-anaesthetised
rats for 90 minutes. Animals were treated with IV ATTM (10 mg/kg
bolus just before reperfusion, then 10 mg/kg infusion over 60 min)
or saline. Animals were then allowed to recover. Infarct size, brain
interleukin (IL)-1 and IL-6, oxidative damage markers and motor func-
tion were determined at either 24 hours or 7 days. Statistical compar-
isons between saline and ATTM-treated animals were performed by
Student's t-test.
RESULTS. ATTM given at reperfusion significantly (p < 0.05)
decreased infarct size, inflammation (IL-1 and IL-6) and oxidative
damage, and improved performance in the rotarod test, a surrogate
of motor function, both at 24 hours and 7 days. Figure 1 shows re-
sults at 7 days post-tMCAO.
CONCLUSION. ATTM given at reperfusion showed both functional
and histological benefit in a clinically realistic stroke model. This was
associated with reductions in brain oxidative damage and
inflammation.
FUNDING. Magnus Oxygen, MRC Newton Fund and Fundação Apoio
a Pesquisa do Estado de Santa Catarina.
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Intensive Care Medicine Experimental 2017, 5(Suppl 2):0916INTRODUCTION. Subarachnoid hemorrhage (SAH) causes high
morbidity and mortality. 50% of patients suffer cerebral vasospasm
and 30% cerebral infarction. PET studies have shown cerebral blood
flow (CBF)-metabolism uncoupling after poor grade SAH.1,2 However,
PET cannot be routinely performed and this limits understanding the
role of metabolic dysfunction in early brain injury.
OBJECTIVES. To utilize Magnetic Resonance (MR) based imaging of
neuronal energy metabolism and determine if cerebral blood flow-
metabolism uncoupling occurs after mild SAH.
METHODS. Patients with Good-grade SAH who underwent aneurysm
coiling and had no clinical deficit or cerebral infarction were in-
cluded. Structural MRI, Multi-slice 1H MRS were obtained. NAA, CSF
lactate were measured and expressed as ratios of root mean square
(RMS) of background and compared to controls from data library
and to CBF from most proximate CT perfusion.
Separately, ASL and QSM sequences were obtained in four patients.
CBF maps were created from ASL sequences, and CMRO2/OEF were
calculated from QSM using Minimum Local Variance (MLV) method.3
RESULTS. Average age was 58 years for MRS patients, Hunt Hess
score was 2.43, modified Fisher score was 2.79. 3 patients had DCI
and none had cerebral infarction. Median discharge GCS was 15.
MRS was done at 9.9 days from admission. SAH patients
demonstrated significantly reduced NAA/RMS in frontal lobes
compared to controls (16.18 ± 4.96 vs. 20.93 ± 5.56, p = 0.042) but
not in temporal (16.49 ± 4.37 vs. 19.37 ± 4.38, p = 0.09) or occipital
lobes (20.62 ± 4.50 vs. 21.05 ± 4.23, p = 0.41). CSF lactate was
significantly higher in SAH patients (7.74 ± 2.27 vs. 4.02 ± 0.76,
p = 0.001). NAA/RMS did not correlate with CBF in pooled data
(R2 = 0.02, p = 0.40) or in frontal lobe rCBF (R2 = 0.001, p = 0.92); nor
with CSF lactate (R2 = 0.02, p = 0.53).
4 patients also underwent ASL, QSM, CMrO2 imaging. Overall grey
matter (GM) CBF was 55.52 ± 1.93ml/100g/min, CMrO2 was
139.25 ± 7.88μmol/100g/min and OEF was 33.5% Mean GM CBF was
55.9ml/100g/min in frontal, 57.0 in parietal, 52.7 in temporal and 56.5
in occipital lobes; GM CMrO2 was 131μmol/100g/min in frontal, 138
in parietal, 150 in temporal,138 in occipital lobes; GM OEF was 32%
in frontal, 32% in parietal, 37% in temporal, 33% in occipital lobes.
Regional CMrO2 and OEF were 10% lower compared to controls.
CONCLUSIONS. MR based spectroscopy and metabolic imaging
shows reduced regional NAA, elevated CSF lactate as well as
depressed CMRO2 and OEF with normal range CBF. This implies
perfusion independent mitochondrial dysfunction (decreased CMrO2
and OEF) resulting in decreased NAA production and increased
lactate generation.This is a novel MR based paradigm that is feasible
and reveals the potential role of mitochondrial dysfunction in early
brain injury after SAH.
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INTRODUCTION. Monitoring the pupillary light reflex is an essential
part of neuromonitoring. In the neurocritical care setting, a sluggish
pupillary response is considered as an early warning sign of brain
injury. Although the term “sluggish pupil” has been widely used at
the bedside for decades, the sluggish pupillary response has not
been well characterised before. Automated infrared pupillometry is
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 461 of 542able to quantify individual components of a pupillary light reflex -
latency, speed of constriction and percentage change in pupil size.
OBJECTIVES. Using automated infrared pupillometry to study the
differences in latency, speed and magnitude of change in pupil size,
between pupils reported as “sluggish” and “brisk” in a pen-torch test.
METHODS. Prospective observational study of children admitted to a
paediatric intensive care unit (PICU) after either traumatic brain
injury or cardiac arrest between November 2016 and March 2017.
Pupillary light reflex was tested using an automated infrared
pupillometer (Neuroptics NPi-200) once a day for the first 7 days or
until PICU discharge by trained nurses or medical staff. Pupillary light
reflex of each eye was assessed with a pen-torch; size of pupils (in
mm) and pupillary response (brisk or sluggish) were documented be-
fore the pupillometry. Characteristics of sluggish pupillary response
were compared against brisk pupillary response using univariable
analysis. Microsoft Excel 2013 and R (version 3.2.2) were used in stat-
istical analysis. Data presented as median (interquartile ranges) or
percentages and non-parametric statistics were used.
RESULTS. 60 pupillary light reflex readings were obtained in 7
patients (median: 4; range: 2–24 readings per patient) during the
study period. On pen-torch assessment 39 were recorded as sluggish
and 21 as. Univariable analysis identified significant differences in
size, speed and magnitude of change but not latency of the pupillary
reflex to a light stimulus. (Table 225)
CONCLUSIONS. When a pupillary response is characterised as “sluggish”,
automated infrared pupillometry commonly reveals a significantly
smaller change in pupil size and a reduced constriction velocity.
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Research Foundation Charity.Table 225 (Abstract 0917). Univariable analysis of pupillary response
Measurement Brisk Sluggish p-value
Pupil size by pen torch (mm) 3 (2-4) 2 (2-3) 0.01
Pupil size by pupillometer (mm) 3.02 (2.3-4.4) 2.26 (2.08-2.41) 0.002
Latency (s) 0.23 (0.2-0.23) 0.2 (0.17-0.23) 0.21
Maximal Constriction Velocity (mm/s) 1.9 (1.5-3.1) 0.8 (0.4-1.1) <0.001
Percentage change in size (%) 31 (21-33) 8 (4-12) <0.001
Fig. 291 (Abstract 0918). Odds ratio of 28-day mortality by ageOral Sessions Wednesday, 27
September 2017
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INTRODUCTION. Current sepsis management guidelines recommend
titration of vasopressor (VP) infusions to an initial mean arterial pressure
(MAP) target of at least 65 mmHg1. Whether and how to individualize VP
therapy for septic shock requires a better understanding of the association
between patient characteristics and response to different MAP targets.
OBJECTIVES. We conducted an individual patient data meta-analysis
of recent trials to determine if patient variables modify the effect of
different MAP targets.
METHODS. We searched MEDLINE, EMBASE, and the Cochrane Central
Register of Controlled Trials for RCTs of higher vs lower blood pressuretargets for VP therapy. We excluded crossover designs, RCTs of
unapproved vasopressors, and experiments < 24h. Pooling individual
patient data, we used a generalized linear (logistic) mixed model with a
random effect for site and fixed effects for treatment assignment and
trial. Tests for subgroup effects used interaction terms between a priori
selected pre-randomization variables (chronic hypertension, congestive
heart failure, age, duration of vasopressor therapy before enrolment)
and treatment. The main outcome was 28-day all-cause mortality.
RESULTS. This analysis includes 894 patients from two multicenter
trials. Controlling for trial and site, the summary odds ratio for 28-day
mortality for the higher vs lower MAP targets was 1.15 (95% CI, 0.87 to
1.52). There was a significant subgroup effect for duration of VP before
randomization (interaction p = 0.017), but not for chronic hypertension,
congestive heart failure, or age (Fig. 291). Odds of death was similar in
higher and lower MAP arms among patients on VP ≤6 hours before
randomization, but odds increased in higher MAP groups in patients
on VP >6 hours before randomization (OR 3.00, 95%CI 1.33-6.74). The
increment in VP exposure associated with higher MAP targets was
more pronounced among patients enrolled >6 hours after initiation of
therapy (interaction p =0.047). The ratio of geometric means of nor-
epinephrine equivalent in the higher vs lower MAP arm was 2.1 (95%CI
1.7-2.6) among patients with ≤6 hours of VP compared to 3.7 (95%CI
2.2-6.2) among patients with >6 hours of VP before enrolment.
CONCLUSIONS. This individual patient data meta-analysis suggests
that higher blood pressure targets may increase mortality for those pa-
tients who do not otherwise respond quickly to therapy. Lower blood
pressure targets were not associated with patient-important adverse
events in any subgroup, including chronically hypertensive patients.
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Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 462 of 542INTRODUCTION. Fluid responsiveness is defined as an increase of
stroke volume after a fluid challenge. However, primary goal of
volume resuscitation in critically ill patients is an increase in oxygen
consumption (VO2).
OBJECTIVE. To evaluate the ability of mixed venous oxygen
saturation (SvO2), lactate and markers of anaerobic metabolism
(mixed venous-to-arterial carbon dioxide tension difference (ΔPCO2)
and ΔPCO2/arteriovenous oxygen content difference ratio (ΔContO2
ratio) to predict whether a fluid-induced increase in oxygen delivery
(DO2) results in an increase in oxygen consumption (VO2).
METHODS. 45 consecutive hemodynamically stable patients after
cardiac surgery were enrolled in this study. Hemodynamic variables,
Lactate and SvO2 were assessed with pulmonary artery catheter
(PAC) before and after a crystalloid fluid challenge of 6ml/kgBW.
Fluid and VO2 responsiveness was defined as increase of stroke
volume and VO2 > 15%, respectively, after fluid challenge.
RESULTS. 28 out of 45 patients were fluid-responders (62.2%). In
these patients, DO2 increased significantly (ΔDO2 98. ± 107.3 ml/min)
whereas DO2 decreased in fluid-non-responders due to a
hemodilution-induced decrease in hematocrit (ΔDO2 -9.3. ± 81.4 ml/
min). An increase in oxygen consumption ≥15% (VO2-responders)
was observed in 29% of these 28 volume-responders. Compared with
VO2-non-responders, VO2-responders were characterized by higher
ΔPCO2 (4.7 ± 1.8 vs. 3.5 ± 1.1, p = 0.04) and ΔPCO2/ΔContO2 ratio
(4.7 ± 1.9 vs. 0.9 ± 0.3, p > 0.001) whereas lactate (2.2 ± 1.3 vs.
1.8 ± 0.8) and SvO2 (66.9 ± 7.1 vs. 65.3 ± 6.7) did not show any group
difference. A fluid-induced increase in oxygen consumption
greater > 15% was not predicted by baseline SvO2, Lactate and
ΔPCO2 but ΔPCO2/ΔContO2 ratio (AUC 0.731 ± 0.091, p = 0.03).
CONCLUSION. Whereas SvO2 and lactate failed to predict VO2
responsiveness, ΔPCO2/ΔContO2 ratio might help to identify patients
that will increase oxygen consumption after fluid administration. This
suggests that after assessing hemodynamic fluid-responsiveness, in-
dicators of anaerobic metabolism e.g. ΔPCO2/ΔContO2 ratio should
be considered to identify patients that will benefit from fluid expan-
sion in terms of an increase in VO2.
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INTRODUCTION. An accurate assessment of the hemodynamic
effects of a passive leg raising (PLR) test and of a volume expansion
(VE) require a direct measurement of cardiac output (CO). On the
waveform of oxygen saturation assessed by plethysmography, the
perfusion index (PI) is the ratio between the pulsatile portion, due to
systolic increases caused by blood flow, and the non-pulsatile por-
tion. We hypothesized that the PI changes could detect the CO
changes during PLR test and VE.
OBJECTIVE. We hypothesized that the PI changes could detect the
CO changes during PLR test and VE.
METHODS. In critically ill patients, we measured PI (Radical 7,
Masimo) and CO (PiCCO, Pulsion Medical Systems) before and during
a PLR test and, in patients in which volume expansion was decided,
before and after the infusion of 500 mL saline.
RESULTS. We included 72 patients. Norepinephrine was administered
in 52 patients (0.5 ± 0.5 μg/kg/min). Three cases were excluded due
to a poor plethysmographic signal.
The PLR test was positive (increase in CO ≥10%) in 34 patients. In these
patients, CO and PI increased significantly during the PLR test by
19 ± 10% and 52 ± 35%, respectively. In the 38 patients with a
negative PLR test, neither CO nor PI changed significantly during PLR.Volume expansion was decided in 27 patients. It increased CO by
more than 15% in 25 patients with a positive PLR test. In these
patients, CO and PI significantly increased during volume expansion,
by 24 ± 11% and 50 ± 52%, respectively. Considering the whole
population, the correlation between the PI changes and the CO
changes for all interventions was 0.67 p < 0.001.
A positive PLR test was detected by changes in PI with a good
accuracy (area under the receiver operating characteristics curve:
0.93 (95% confidence interval: 0.83-0.98, p < 0.001). During the PLR,
if PI increased by >9%, a positive response of CO could be
diagnosed with a sensitivity of 100% (88-100%) and a specificity of
76% (59-88%).
CONCLUSIONS. The changes in PI of the pulse oximetry signal seem to
accurately reflect changes in cardiac output during PLR test and
volume expansion. This could be a reliable way to assess the
hemodynamic effects of the PLR test in a totally non-invasive practice.0921
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INTRODUCTION. The latest consensus on circulatory shock advocates
clinical examination and ultrasonography for diagnosing circulatory
shock. Propagation of daily clinical examination contrasts with
available studies, which are of limited quality and quantity so that its
level of evidence is considered 'best practice'. We hypothesize that
clinical estimation of circulatory shock, should be based on multiple
variables including combinations of clinical, laboratory and
ultrasonography variables.
OBJECTIVES. To evaluate the value of clinical examination,
biochemical and ultrasonography variables in the critically ill,
specifically for estimation which combinations of variables are
associated with cardiac output.
METHODS. We initiated the Simple Intensive Care Studies-I (SICS-I)
which was designed as a prospective cohort study to include all pa-
tients acutely admitted to the intensive care unit. Clinical examin-
ation was performed in a standardized fashion in all patients
according to predefined criteria including variables of heart rate,
blood pressures, central venous pressure, mental state, auscultation
of heart and lungs, respiratory rate, urine output, capillary refill times,
central to peripheral temperatures gradients, skin mottling; biochem-
ical variables including lactate; and ultrasonography of heart and
lungs. These clinical, biochemical, and ultrasonography variables
were recorded following a published protocol (NCT02912624). Circu-
latory shock was defined by the requirement of vasopressors and/or
inotropes and measured by cardiac output using transthoracic ultra-
sonography. All researchers, including medical students, underwent
focused training for recording of all variables, including obtaining
specific ultrasonography images. Cardiac function was clinically esti-
mated as well before being measured by ultrasonography.
RESULTS. Between March 2015 and December 2016 a total of 704
out of 791 eligible patients were included. An independent Core
laboratory assessed that ultrasonography images from 632 patients
(90%) were of sufficient quality. Vasopressors and/or inotropes were
used upon admission in 363 cases (52%). 173 patients (25%) had
died at 90-day follow-up. The data of all patients included until July
1st, 2017 will be analysed to identify combinations of variables inde-
pendently associated with cardiac output. At the congress, these re-
sults will be presented and these variables will inform the second
phase of the on-going registry.
CONCLUSIONS. Standardized clinical examination and ultrasonography
in critically ill patients by novices is feasible. We will be able to answer
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 463 of 542whether clinical assessment of the presence of shock can reliably be
established and if so, which combinations of variables are most
informative for estimation of the patients' cardiac output.
REFERENCE(S)
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INTRODUCTION
Early identification of patients who may need admission to an
intensive care unit (ICU) is a top research priority1. Predicting
patients that are likely to deteriorate and may need admission to ICU
is extremely challenging with current monitoring and scoring
systems as yet unproven in determining outcome2. We hypothesise
that by non-invasively monitoring variables usually only utilised
within a critical care environment, we may build a more comprehen-
sive and timely picture of a patient's physiology.
OBJECTIVES
To assess feasibility of monitoring cardio-respiratory, microcirculatory
and novel renal indices in acute medical patients and observe pa-
tient outcomes including discharge, intensive care unit referral and
admission and renal dysfunction.
METHODS
During a 7-day sprint every 24 hours all acute medical patients were
screened. Testing consisted of: Non-invasive cardiac output (CO), car-
diac index (CI) and systemic vascular resistance (SVRI) measurements
with LIDCO CNAP, a pulse wave power analysis. Microvascular flow
was measured using sidestream dark field (SDF) imaging. Microvascu-
lar flow index (MFI) and POEM scores were performed in addition to
automated measurements (sPVD and sPPV). Other variables included
DO2 and AKI (Nephrocheck).
RESULTS
From 124 screened patients, 58 were included in analysis. Median
age was 65 with 60.3% male vs 39.7% female. Testing occurred a
median of 24hrs post-arrival. Microvascular flow was able to be
assessed in 45/58 (77.6%) of patients, movement artefact being the
significant barrier in those unable to be assessed. Cardiac output
(CO) measurements were possible in 57/58 (98.3%) of patients. Me-
dian CO overall was 4.67l/min with CI 2.57l/min/m2 and DO2I
379.4ml/min/m2. Parameters were assessed in relation to 30 day mor-
tality, whether at baseline or worse on hospital discharge and
whether referred to ICU. Absolute CO, CI, DO2 or DO2I did not correl-
ate with mortality or worse outcomes. However, patients with a DO2I
of < /= 475ml/min/m2 had significantly worse outcomes (p = 0.041).
For microcirculation, parameters were not associated with mortality
or hospital outcome status.
CONCLUSIONS
Single point non-invasive CO and micro-circulation measurements
were not associated with outcome in this feasibility study, although
it should be noted that sample size calculations were not performed
owing to the nature of the study. DO2I cutoffs may be a useful pre-
dictive measure. Testing of the documented variables in acute med-
ical patients was feasible and has indicated areas for more focussed
study in select acute medical patient cohorts.
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Understanding organ failure in sepsis
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INTRODUCTION. The lack of effective specific therapies of sepsis
could be partly explained by the heterogeneity of this syndrome.
OBJECTIVES. The aim of this study was to identify more
homogeneous clusters of patients with sepsis and septic shock
according to their initial clinical and biological characteristics.
METHODS. All patients admitted for sepsis or septic shock, according to
the new Sepsis 3.0 definition, were included from a national prospective
multicenter ICU cohort. A first test set of patients was used in an
unsupervised clustering to build clusters independently of patient's
outcomes. After description of main characteristics of each cluster, risk
of mortality at 28 days was compared using logistic regression before
and after adjustment on SOFA score at admission. A binary tree was
built to assign prospectively a new patient into cluster. Performance of
binary tree was evaluated on the validation set using ROC curves.
RESULTS. The test set included 4,050 patients (67%) with a median
age 65 [53–76] year, a median SAPSII score 46 [34–60] and 28 days
mortality 26% [25%-28%]. Six distinct clusters were identified:
pulmonary sepsis cluster n = 1,603 (40%), meningo-encephalitis clus-
ter n = 149 (4%), surgical sepsis cluster n = 623 (15%), immunocom-
promised patients cluster n = 338 (8%), COPD exacerbation cluster
n = 243 (6%) and extra-respiratory chronic diseases cluster n = 1,094
(27%). Clusters[j1] were different in term of duration of stay and pro-
cedures use (p < 0.001 for all comparisons). Day 28 mortality was dif-
ferent between clusters (p < 0.001), higher for extra-respiratory
chronic diseases cluster OR = 2.6 (IC95%: 2.1-3.0), immunocomprom-
ised patients cluster OR = 2.1 (IC95%:1.6-2.8) and surgical sepsis clus-
ter OR = 1.5 (IC95%:1.2-1.9). The difference in cluster prognosis
persisted after adjustment on SOFA score for immunocompromised
patients cluster OR = 1.4 (IC95%:1.1-1.9) and for extra-respiratory
chronic diseases cluster OR = 1.5 (IC95%:1.3-1.9). Pulmonary sepsis
cluster was used as reference class. Binary tree accurately identified 6
discriminant variables to assign patients into clusters (Fig. 292).
CONCLUSIONS. Using unsupervised clustering, we identified 6 more
homogeneous clusters of ICU patients admitted for sepsis. These
clusters were associated with very different procedure use, duration
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 464 of 542of stay and prognosis even after adjustment on SOFA scores.
Considering these clusters may improve homogeneity of patients
enrolled in future clinical trials.Fig. 292 (Abstract 0923). BT
Fig. 293 (Abstract 0924). Cerebral blood flow in volunteers
and patients0924
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INTRODUCTION. The precise mechanisms underlying sepsis-
associated encephalopathy remain unclear, but reduced cerebral
blood flow (CBF) - alone or in conjunction with altered autoregula-
tion - is proposed as a potential contributor.
OBJECTIVES. The objectives of this interrupted time series study
were to compare CBF in
1) healthy volunteers with and without sedation;
2) septic patients receiving vasopressors to achieve higher vs lower
mean arterial pressure (MAP) targets; and
3) between septic patients and healthy volunteers.
METHODS. We measured CBF using magnetic resonance imaging
(MRI) with arterial spin labeling (ASL) conducted in a 3.0 T MRI
scanner (Philips Ingenia, Philips Healthcare, Best, Netherlands). ASL
detects magnetization from the nuclear spin of hydrogen atoms
induced with radiofrequency pulses within water molecules. By
comparing the T1-weighted contrast obtained by ASL to nonlabeled
images, CBF can be calculated.
CBF was measured in healthy volunteers while awake and under
moderate sedation with a continuous infusion of propofol (titrated
for a Richmond Agitation-Sedation Scale level of −2 to −3). With sep-
tic patients who were sedated with propofol and already treated
with vasopressors (norepinephrine), we measured CBF at a MAP of
65 and 75 mmHg. We randomized the order of allocation for sed-
ation (in healthy subjects) and MAP targets (septic patients) and the
outcome measures (calculation of CBF) were blinded.
RESULTS. Twelve healthy volunteers (7 with chronic hypertension)
and 10 septic patients (4 with chronic hypertension) were enrolled;
mean ages were 44 and 61 years respectively (p = 0.003). The mean
APACHE II score of septic patients at ICU admission was 33 (SD 9.4)
and the study was conducted, on average, 1.5 days following ICU
admission (after the initial resuscitation). In healthy volunteers, we
observed no difference in CBF measured with and without sedation
(24.9 vs. 24.8 mL/100g/min; p = 0.93). Similarly, in septic patients,CBF measured at a MAP target of 65 mmHg (40.4 mL/100g/min) was
not different from CBF measured at a MAP target of 75 mmHg (41.3
mL/100g/min; p = 0.65). We found no interaction between chronic
hypertension and the effect of sedation or MAP targets. CBF
measured in sedated septic patients was 62% higher than in sedated
healthy volunteers (p = 0.001).
CONCLUSIONS. In the subset of septic patients who participated to
this study, CBF was higher than in sedated healthy volunteers and
autoregulatory capacity was preserved. Further research is required
to understand the clinical significance of sepsis or vasopressor-
induced cerebral hyperperfusion and to reassess the neurological ef-
fects of current protocols of vasopressor therapy in sepsis.
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INTRODUCTION. Sepsis is defined as dysregulated host response to
infection, resulting in acute organ dysfunction [1]. While the
condition has been thoroughly studied in the Intensive Care Unit
(ICU), accurate data collection outside of this setting is less well-
developed [2]. OBJECTIVES. Our aim was to prospectively determine
the point-prevalence of sepsis in Emergency Departments and gen-
eral wards according to both SEPSIS-1 and SEPSIS-3 definitions and
determine predictive capabilities of these tools using our previously
developed electronic data collection tool [3].
METHODS. Patients in the Emergency Department or in an in-patient
ward in 13 hospitals with NEWS > 3 and suspected or proven infec-
tion were enrolled over a 24-hour period. Primary outcome was mor-
tality within 30 days of recruitment.
RESULTS. Out of the 5422 patients screened, 431 fulfilled inclusion
criteria and 380 (88%) were recruited. 212 were identified having
sepsis using the SEPSIS-1 definition. Using the SEPSIS-3 definitions
with SOFA ≥ 2, 272 patients, with qSOFA 50 patients were identified.
For the prediction of primary outcome SEPSIS-1 criteria had a sensi-
tivity of 67% (95%CI, 55%-77%) and specificity of 47% (95%CI, 41%-
53%), SEPSIS-3 criteria had a sensitivity of 86% (95% CI, 76%-92%)
and specificity of 32% (95%CI, 27%-38%). SEPSIS-3 and SEPSIS-1 defi-
nitions were associated with an HR of 2.7 (95% CI, 1.5-5.6) and HR of
1.6 (95% CI, 1.03-2.5), respectively. Scoring system discrimination was
highest for SOFA (AUROC 0.70 [95% CI 0.63-0.77], p < 0.001),
followed by NEWS (AUROC 0.58 [0.51-0.66], p = 0.028). SIRS (AUROC
0.55 [95%CI 0.48-0.62]) and qSOFA score (AUROC 0.56 [95%CI 0.49-
Fig. 294 (Abstract 0927). See text for description
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tion (p = 0.21 and 0.09 for SIRS and qSOFA, respectively).
CONCLUSIONS. Sepsis prevalence is between 4% and 5% on the
wards and EDs, depending on the definition used. SEPSIS-3 definition
identified patients with the highest risk. SOFA and NEWS were found
to be better predictors of poor outcome than qSOFA or SIRS.
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INTRODUCTION. Although β-lactam concentrations have been asso-
ciated with worsening neurological status, no data have been re-
ported on electroencephalographic (EEG) findings.
OBJECTIVES. The aim of this study was to assess the association
between b-lactam concentrations and EEG abnormalities in ICU pa-
tients with sepsis.
METHODS. We reviewed all ICU patients over a 4 year period
(2012–2016) who were treated with meropenem (MEM),
piperacillin-tazobactam (TZP), ceftazidime/cefepime (CEF) or aztre-
onam (AZT) and in whom at least one concomitant β-lactam
trough concentration (Cmin) and EEG monitoring were available.
Drug levels were measured using high-performance liquid chro-
matography; Cmin was normalized to the clinical breakpoint of
Pseudomonas aeruginosa (as determined by EUCAST) for each
drug (Cmin/minimum inhibitory concentration [MIC]). EEG abnor-
malities of interest were: a) ictal EEG pattern; b) generalized peri-
odic discharges (GPDs).
RESULTS. We collected 391 Cmin values (168 MEM, 157 TZP, 55
CEF, 11 AZT) in 277 patients. Overall ICU mortality was 40%.
There were no differences in the frequency of EEG abnormalities
between antibiotics (ictal EEG pattern = 14% for MEM, 18% for
TZP, 22% for CEF, 18% for AZT; GPDs = 12% for MEM, 10% for
TZP, 15% for CEF, 30% for AZT). However, the incidence of ictal
EEG pattern and of GPDs increased progressively with increasing
Cmin/MIC ranges (p = 0.14 and p = 0.18, respectively). The
occurrence of at least one EEG abnormality was significantly
higher for higher Cmin/MIC ranges (from 19% for Cmin/MIC ≤1.0 to
44% for Cmin/MIC ≥7.0; p = 0.009).
CONCLUSIONS. There was a significant correlation between high β-
lactam trough concentrations and an increased occurrence of EEG
abnormalities in ICU patients with sepsis. Monitoring of β-lactam
levels should be considered when neurological and/or EEG alter-
ations occur in patients with sepsis.0927
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INTRODUCTION. The new Sepsis-3 definition is based on an acute
change in total Sequential Organ Failure Assessment score (SOFA) of
2 points due to infection [1]. SOFA score ≥2 points is associated with
a mortality rate of 10% and is supposed to offer better and earlier
risk stratification [2]. Former Sepsis-1 criteria failed to recognise SIRS-
negative septic patients. However, in ICU-acquired sepsis the diagno-
sis is challenging because of preexisting organ dysfunction and
therapy.
OBJECTIVES. To determine changes in organ dysfunction measured
by SOFA score during 3 days before sepsis onset according to former
Sepsis-1 criteria.
METHODS. Retrospective analysis of patient data from an
ongoing quality improvement program in sepsis at the University
Hospital of Greifswald, Germany. Between 2010 and 2015 all
patients of a tertiary surgical ICU with ICU-acquired sepsis or sep-
tic shock according to the Sepsis-1 criteria were included. The
development of organ dysfunction measured by SOFA score was
determined retrospectively from the day of former sepsis-1 onset
back to day −3.
RESULTS. 118 patients with ICU acquired sepsis were included.
Because of an elevated total SOFA score 59 patients (50%) fulfilled
sepsis-3 criteria already up to 3 days earlier than sepsis onset based
on sepsis-1 criteria. In 8 patients (6.8%) sepsis onset was postponed
by one day according to sepsis-3 (Fig. 294). Particularly, respiratory
and cardiovascular failure had the highest proportion of all SOFA
subscores but also an alteration in mental status appeared very fre-
quently (Fig. 295). However, the frequency of organ dysfunction
gradually increased in all SOFA subscores from day −3 to former Sep-
sis diagnosis.
CONCLUSIONS. In critical ill patients SOFA score is already higher
than 2 points before sepsis onset. Accordingly, there was a gradual
increase in SOFA-subscores up to 3 days but most obviously one day
prior to sepsis-1 onset. As a consequence, continuous monitoring of
organ dysfunction including all SOFA subscores is required for an
early diagnosis of sepsis. In particular hemodynamic instability and
deterioration of pulmonary function are indicative for impending
sepsis. An automated scoring is recommended to handle the mass of
data, but technical implementation at the bedside may be challen-
ging for most hospitals yet.
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INTRODUCTION. In patients with acute hypoxemic respiratory failure,
noninvasive ventilation (NIV) and high-flow nasal cannulae oxygen
(HFNC) are alternative strategies to face mask oxygenation. Endo-
tracheal intubation is frequently needed in these patients with a risk
of delay and early predictors of failure may help clinicians to decide
early.
OBJECTIVES. To identify risk factors associated with intubation in
hypoxemic patients treated with different noninvasive oxygenation
techniques for severe hypoxemic acute respiratory failure.METHODS. This is a post-hoc analysis of a multicenter, randomized,
clinical trial (1) of patients admitted to ICU for acute hypoxemic re-
spiratory failure with a PaO2/FiO2 ratio ≤ 200 mm Hg and treated by
HFNC, standard oxygen or NIV,.The criteria for intubation were prede-
termined including worsened or persisted respiratory failure, impair-
ment of neurologic status and hemodynamic instability.
Clinical parameters and blood gas samples were collected at
inclusion and H1 in each group of treatment: standard oxygen, HFNC
and NIV.
RESULTS. After adjustment on treatment, two factors were
associated with intubation at baseline: the presence of bilateral
pulmonary infiltrates at admission (aOR 2.33, 1.10-4.94, p = 0.03) and
respiratory rate (aOR 1.04, 1.0-1.09, p = 0.05). Under HFNC or
standard oxygen, patients with a respiratory rate ≥ 30 breaths/min
had a higher risk of intubation (aOR 2.82, 1.05-7.57, p = 0.04 and aOR
5.77, 1.78-18.65, p = 0.003, respectively). Under NIV, a tidal volume
exceeding 9 ml/kg at one hour was independently associated with
intubation (aOR 2.92, 1.05-8.10, p = 0.04) and 90-day mortality.
CONCLUSIONS. Bilateral pulmonary infiltrates upon admission
predicted the need for intubation in patients with acute hypoxemic
respiratory failure breathing spontaneously. The respiratory rate was
a predictor of intubation under HFNC or oxygen, but not under NIV.
A high tidal volume (≥9 ml/kg) under NIV was a strong predictor of
intubation and remained independently associated with mortality.
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INTRODUCTION. Diaphragm function is a crucial determinant of
liberation from mechanical ventilation. However, the level of
diaphragm function required for successful liberation is unknown.
OBJECTIVES. The objective of this study was to identify optimal
threshold values to predict successful liberation for different
measures of diaphragm function.
METHODS. In patients undergoing a first spontaneous breathing trial
(SBT) after at least 24 hours of mechanical ventilation, diaphragm
function was evaluated by twitch tracheal pressure in response to
magnetic phrenic stimulation (Ptr,stim) and by diaphragm ultrasound
(thickening fraction [TFdi] and excursion [Exdi]). The rapid shallow
breathing index (RSBI) was also calculated. Receiver operating curves
(ROC) were computed to determine the best cut-offs predicting suc-
cessful liberation (defined as a successful SBT and extubation without
re-institution of ventilation in the subsequent 48 hours).
RESULTS. 76 patients were evaluated: 43 were successfully extubated
and 33 failed the SBT or required ventilatory support after
extubation. The optimal cut-offs of Ptr,stim, TFdi, EXdi and RSBI to
predict successful liberation were respectively 7.8 cmH2O (sensitivity
81%, specificity 82%), 29% (sensitivity 77%, specificity 94%), 0.95 cm
(sensitivity 68%, specificity 65%) and 50 breath.min−1.l−1 (sensitivity
85%, specificity 64%), respectively. The areas under the ROC were
similar for Ptr,stim and TFdi (0.89 and 0.88, p = 0.74, respectively)
and significantly higher than that of EXdi and RSBI (0.71 and 0.76,
p = 0.51, respectively).
CONCLUSIONS. Successful liberation can be predicted with a lower
value of Ptr,stim than the value defining diaphragm dysfunction.
Ptr,stim and TFdi had similar strong performances in the prediction
of weaning success.
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INTRODUCTION. Ultrasound assessment of diaphragmatic function
has been developed recently providing an easy and safe method for
evaluation of diaphragmatic excursion and thickening. Many
parameters have been developed to aid weaning from MV such as
PO2/FiO2 ratio and rapid shallow breathing index (RSBI). However,
sensitivity and specificity for most variables are still variable in
literature.
OBJECTIVES. We hypothesized that ultrasonographic measuring of
diaphragmatic thickening and excursion may be useful tool to
predict outcome of weaning trials in mechanically ventilated patients
with abdominal sepsis.
METHODS. 30 mechanically ventilated patients with abdominal sepsis
were included. Measurements of diaphragmatic excursion (DE) and
diaphragmatic thickening fraction (DTF) were obtained during
spontaneous breathing trial on both pressure support mode (PS) and T
tube. Outcome of weaning was recorded. Data analysis was done after
dividing patients into 2 groups, successfully weaned, failed weaning.
RESULTS. successful group showed higher DTF and DE compared to
failed group. In successful group, DTF was 53.5 vs. 23.9 for failed
group, Area under the curve of DTF was 1, sensitivity: 100%, and
specificity: 100% at cutoff value of 30.In successful group DE was 17
mm vs. 8 mm for the failed group, Area under the curve of excursion
on PS was 0.882(0.738-1.027), sensitivity: 94%, and specificity: 85% at
cutoff value of 10.4.No difference was found between area under the
curve of DE, DTF and RSBI.
CONCLUSIONS. DE and DTF are valuable tools in predicting outcome
of weaning trial in patients with abdominal sepsis, they proved equal
sensitivity and specificity to RSBI.Fig. 296 (Abstract 0930). Area under the curve of ultrasound
measurements0931
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INTRODUCTION. In 2013 the Centers for Disease Control and
Prevention (CDC) proposed new surveillance definitions for patients
receiving mechanical ventilation, changing the focus from ventilator-
associated pneumonia (VAP) to all events associated with mechanical
ventilation (VAE).
The new surveillance paradigms include ventilator-associated condi-
tions (VAC), infection-related ventilator-associated conditions (IVAC)
and possible VAP.
OBJECTIVES. To determine the prevalence of ventilator-associated
events, to analyze the patients profile, morbidity and mortality com-
pared to patients who did not develop VAE. We also analyzed the
impact of each component of the ventilator bundle on the incidence
of VAEs, duration of mechanical ventilation, hospital length of stay
and hospital mortality.
METHODS. Included in the study were 438 patients admitted to the
surgical (13 beds) and medical.
(32 beds) ICUs of a tertiary hospital from March 2013 to February
2016, aged above 18 years and submitted to mechanical ventilation
for at least 4 days. At admission and daily the following data were
collected by one of the members of the prevention of VAE team:
Head of bed elevated (≥30°); daily interruption of sedation; gastric
ulcer prevention; thromboembolism prophylaxis; oral care with
chlorhexidine gluconate; aspiration of subglotic secretions and
monitoring of endotracheal tube cuff pressure
RESULTS. Four hundred and thirty-eight patients were submitted
to mechanical ventilation for at least 4 days and were analyzed.
Ventilator-associated events developed in 60 (13.4%) patients, 11
(2.2%) of them had IVAC and 19 (4.3%) possible VAP. When pa-
tients who developed VAE were compared with those who did
not, there was no difference between the two groups in demo-
graphic data and severity scores. Patients who had VAE had
worse outcomes including increased duration of mechanical ven-
tilation and higher ICU and hospital mortality (Table Error! Refer-
ence source not found.).
In Table 227 we compare patients with IVAC and VAP with those
without VAE. Patients with IVAC exhibited higher ICU mortality.
Duration of mechanical ventilation was expressively higher in
patients with VAP (p < 0.001). ICU LOS also was higher in patients
with VAP.
The impact of each component of the preventive bundle on the
incidence of VAEs is evaluated in Table 228. The prevention of
gastric ulcer was significantly protective for VAP (OR,0.84; 95 CI,
070–1.01; p = 0.05). When analyzing the association between
components of the preventive bundle and other outcomes, oral
care with chlorhexidine was associated with a significant
increase in hospital mortality (OR, 9.09, 95% CI,1.11-74.25,
p = 0.03).
CONCLUSIONS. VAEs are associated with significant morbidity and
mortality. From all the preventive bundle measures, prophylaxis of
gastric ulcer was significantly protective for VAP. On the other hand,
oral care with chlorhexidine was associated with significant increase
in hospital mortality.
Table 226 (Abstract 0931). Comparison between VAE x Non
VAE patients
Non VAE
(n=378)
VAE
(n=60)
p
value
Abbreviations:
Age, Yr, Mean (SD) 70.2
(18.30)
66.5
(19.7)
0.143 VAE= Ventilator- associated
events;
Male, n (%) 174 (46.0) 32
(53.3)
0.292 APACHE= Acute Physiology
and Chronic Health
Evaluation;
APACHE* IV score,
Mean (SD)
76.0
(25.9)
73.4
(28.7)
0.476 SOFA= Sequential Organ
Failure Assessment;
SOFA** score on
admission, Mean (SD)
5.8 (3.8) 5.5 (3.7) 0.577 MV= Mechanical
ventilation;
Diagnosis at
admission, n (%)
Medical/Surgical
277
(73.3)/101
(26.70
52
(86.7)/
8(13.3)
LOS=Length of stay;
Duration of MV, days,
median (IQR)
9.0 (6.0 -
17.0)
16.0
(11.0 -
30.0)
<0.001 IQR=Interquartile Range.
ICU LOS***, days,
median (IQR)
22.0 (12.0
- 39.0)
25.5
(15.0 -
41.5)
0.150
ICU mortality, n
(%)/Hospital
mortality, n (%)
170
(45.0)/225
(59.5)
41
(68.3)/
46
(76.7)
0.001/
0.011
Adherence to
preventive bundle %
(SD)
85.92
(19.1)
86.2
(18.9)
0.407
Table 227 (Abstract 0931). Comparision between Non VAE, IVAC
and VAP
Non
VAE
(n=378)
IVAC
(n=11)
VAP
(n=19)
p value
(Non
VAE x
IVAC)
p value
(Non
VAE x
VAP)
Abbreviations
Age, Yr, Mean
(SD)
70.2
(18.30)
65.5
(21.4)
62.8
(19.4)
0.405 0.088 VAE = Ventilation
-Associated Events;
Male, n (%) 174
(46.0)
7
(63.6)
9
(47.4)
0.249 0.909 IVAC=Infection-
Related Ventilator-
Associated
Conditions;
APACHE IV score,
Mean (SD)
76.0
(25.9)
76.9
(30.9)
64.6
(28.5)
0.905 0.064 VAP = Ventilator-
associated
Pneumonia;
SOFA score on
admission, Mean
(SD)
5.8 (3.8) 6.1
(3.6)
4.7
(3.5)
0.770 0.255 APACHE = Acute
Physiology and
Chronic Health
Evaluation;
Diagnosis at
admission, N (%)
Medical/Surgical
277
(73.3)/
101
(26.7)
10
(90.9)/
1 (9.1)
17
(89.5)/
2
(10.5)
SOFA = Sequential
Organ Failure
Assessment;
Duration of MV,
Days, Median
(IQR)
9.0 (6.0
- 17.0)
15.0
(9.0 -
25.5)
19.0
(15.0 -
30.0)
0.046 <0.001 LOS = Length of Stay;
ICU LOL, days,
Median (IQR)
22.0
(12 -
39.0)
23.0
(11.5 -
42.0)
29.0
(21.5 -
44.0)
0.882 0.038 MV = Mechanical
Ventilation;
ICU Mortality n
(%)/Hospital
Mortality, n (%)
170
(45.0)/
225
(59.5)
9
(81.8)/
9
(81.8)
11
(57.9)/
14
(73.7)
0.016/
0.137
0.270/
0.219
IQR = Interquartile
Range.
Adherence to
preventive
bundle % (SD)
85.92
(19.1)
93.5
(6.8)
84.7
(22.7)
0.479 0.447
Table 228 (Abstract 0931). Impact of adhesion to preventive bundle
on VAE´s
Outcome, OR (95% IC)
VAE p
value
IVAC p
value
VAP p
value
Abbrevitions
BUNDLE (%) VAE = Ventilator-
Associeted Events;
Head of bed
elevation
0.97
(0.91 -
1.04)
0.39 0.99
(0.87 -
1.13)
0.89 1.12
(0.81 -
1.56)
0.49 IVAC = Infection
-related Ventilator
Events condictions;
Daily
Interruption of
sedation
2.00
(0.0 -
infinite)
0.98 2.61
(0.0 -
infinite)
0.99 Ventilator-Associated
Pneumonia;
Stress ulcer
prevention
0.96
(0.82 -
1.13)
0.62 7.26
(0.0 -
infinite)
0.99 0.84
(0.7 -
1.0)
0.05 DVT = Deep Venous
Thombosis
Oral care 0.97
(0.93 -
1.01)
0.20 1.02
(0.9 -
1.15)
0.68 0.96
(0.84 -
1.11)
0.58
DVT prevention 1.00
(0.96 -
1.05)
0.86 1.02
(0.93 -
1.3)
0.79 1.09
(0.96 -
1.24)
0.18
Aspiration of
subglotic
secretions
1.01
(0.96 -
1.07)
0.62 7.28
(0.0 -
infinite)
0.95 1.00
(0.95 -
1.04)
0.84
Monitoring of
endotracheal
cuff pressure
0.96
(0.91 -
1.01)
0.11 22.2
(0.0 -
infinite)
0.94 0.95
(0.86 -
1.05)
0.33
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 468 of 5420932
Preventing reintubation: role of the different high-risk factors for
reintubation in the selection of appropriate therapy. A post-hoc
analysis
G. Hernandez1, C. Vaquero2, L. Colinas1, R. Cuena3, L. Vargas1, M.L.
Rodriguez1, A. Canabal1, O. Roca4,5, J.R. Masclans5,6,7, on behalf of the
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5Instituto de Salud Carlos III, Ciber Enfermedades Respiratorias (Ciberes),
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INTRODUCTION. A multicenter randomized trial has recently been
publicated reporting that high-flow oxygen therapy (HFOT) is
noninferior to noninvasive ventilation (NIV) for preventing reintu-
bation in patients at high-risk for reintubation1. However, as
HFOT and NIV have different physiopathological mechanisms,
specific subgroups could theoretically benefit with any one of the
two therapies.
OBJECTIVES. Our aim was to assess whether specific subgroups of
high-risk patients for reintubation, classified according to the pres-
ence of any one of the 10 different high-risk factors may benefit with
HFOT or NIV.
METHODS. The 10 different high-risk factors analyzed were: age
>65 years, cardiac failure as the primary indication of mechanical
ventilation, moderate-to-severe COPD, APACHE II >12 points the
extubation day, body mass index (BMI) >30, airway patency prob-
lems including patients at high-risk for developing laringeal
edema, patients considered unable to deal with respiratory
secretions (inadequate cough reflex or >2 suctioning within 8-h
previous to extubation), difficult or prolonged weaning, ≥2
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 469 of 542comorbidities (Charlson index), and prolonged MV defined as MV
>7 days. A post-hoc analysis was performed to assess the reintu-
bation rate according to the presence of the 10 different high-
risk factors, trying to classify patients in term of response to both
therapies. An effect modification or interaction analysis was per-
formed, including an effect measurement on additive and multi-
plicative scale. A normal linear regression analysis (RDI) and Cox
model (RRI) analyses were performed to adjust for the presence
of additional high-risk factors and covariates.
RESULTS. The effect modification or interaction analysis showed a
significant benefit for NIV in patients with a BMI >30 (Table 229). No
differences were obtained in any other high-risk factor. The adjusted
RDI was 7.6 (95%CI 3 to 12.3; p = .001) and the adjusted RRI was 1.3
(95%CI 1.08 to 1.5; p = .005), confirming the results.
CONCLUSIONS. Patients with a BMI >30 could benefit with
preventive use of NIV inmediately after extubation. However, a
randomized trial is needed to confirm this result.
REFERENCE(S)
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Risk factor RDI 95% CI (p) RRI 95% CI (p)
Prolonged MV .06 -.08 to .20 1.15 .62 to 2.13
APACHE II .10 -.03 to .23 1.46 .77 to 2.78
Weaning .04 -.12 to .20 1.03 .56 to 1.90
Age >65 y .04 -.10 to .17 1.22 .65 to 2.28
Air Way -.20 -.59 to .19 .39 .05 to 3.08
Secretions .04 -.14 to .21 1.01 .55 to 1.86
BMI >30 .19 .03 to .35 (.02) 2.51 1.10 to 5.70 (.03)
COPD .16 -.02 to .33 1.83 .89 to 3.80
Cardiac failure .22 -.05 to .50 2.63 .82 to 8.36
Comorbidities .12 -.02 to .25 1.78 .87 to 3.64Trauma and other emergencies
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INTRODUCTION. Chronic substance abuse is an important co-
morbidity factor in the critically ill. Intensive care studies addressing
the combined impact of substance abuse associated with either alco-
hol or illicit substances are needed.
OBJECTIVES.
1) To identify patients with chronic abuse of alcohol, illicit substances
or prescription drugs in mixed population of mechanically ventilated
ICU-patients.
2) To study
a) the distribution of these patients between the medical, cardiologic
and surgical ICUs and
b) the association of chronic abuse and length of stay, duration of
mechanical ventilation and in-hospital mortality.METHODS. Prospective study of mechanically ventilated ICU-patients
in four ICUs at the Oslo University hospital Ullevål during 1 Year
(2014–2015). Chronic substance abuse of alcohol, illicit substances or
prescription drugs was evaluated based on medical records, drug
screening, and the AUDIT-C questionnaire (cut off ≥9 /12 for men,
and ≥ 8/12 for women).
RESULTS. 604 patients were included. 161/604 (27%) were classified
with chronic substance abuse (15 (3%) “unknown”). Of these, 89/605
(15%) were admitted due to substance abuse-related diagnoses,
while 72/605 (12%) had non-drug related admission diagnoses. The
medical ICU had the highest proportion of patients with chronic
abuse with 55/154 (36%), followed by the surgical ICUs 81/328 (25%)
and the cardiologic ICU 25/122 (21%). The main agents of abuse
were: alcohol in 104/ 604 (17%), illicit substances 51/604 (8%) and
prescription drugs 6/604 (1%).
Chronic substance abuse was associated with younger age, median
56 vs 62 years (p = 0.03) and male gender, 132/161(82%) vs. 283/
428(66%) (p < 0.01). The highest prevalence was found among male
patients in the age group 30–60 in the medical ICU where 32/52
(62%) were classified with chronic abuse; 20/52 (39%) with illicit
substances and 12/52 (23%) with alcohol as drug of abuse. We found
no association with chronic abuse and in-hospital mortality (p = 0.4).
In the surgical ICUs, chronic abuse was associated with shorter time
in the ICU 7.6 vs 11 days (p = 0.01) and shorter time on mechanical
ventilation, 4.6 vs 7.7 days (p < 0.01). No such differences were found
in the medical or in cardiac ICUs.
CONCLUSIONS. Chronic substance abuse is common among
mechanically ventilated patients, especially in the medical ICU, but
was not associated with higher in-hospital mortality. In the surgical
ICUs chronic abuse was associated with shorter time in the ICU and
duration of mechanical ventilation. Overall, alcohol was the main
agent of abuse, but illicit substance abuse was more frequent among
male patients in the medical ICU. Future studies of substance abuse
in the ICU should therefore include illicit substances in addition to
alcohol.
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INTRODUCTION. Prolonged ICU admission and excess mortality
following major traumatic injury is consistently associated with an
exaggerated inflammatory response(1,2). Upstream regulatory
elements of this immune response remain elusive. DNA methylation
is a key regulator of gene expression in physiologic and pathologic
states(3) and consequently may be of importance in the regulation
of genomic activity following traumatic injury.
OBJECTIVES. To explore alterations in patterns of DNA methylation
following major traumatic injury and associations with clinical
outcome measures.
METHODS. Consecutive adult trauma patients, requiring ICU
admission following their initial resuscitation, were recruited with
mixed leukocyte buffy coat samples collected within 2 hours of
injury and again 72 hours later. DNA was isolated from buffy coat
samples (Quick-DNA Universal Kit, Zymo) and subject to sodium
bisulfite treatment (EZ DNA Methylation-Lightning Kit, Zymo) to
Fig. 298 (Abstract 0934). See text for description
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methylation was determined using the Illumina HumanMethylation
450k BeadChip (Illumina) which allows methylation-specific
hybridization to an array of ~485,000 CpG sites spanning the entire
human genome. Differentially methylated positions (DMPs) were
identified using a stringent statistical analysis with multiple hypoth-
esis testing and cell proportion correction. We set a false discovery
rate (FDR) of 5%. Ontology analysis was performed using the XGR
tool (eXploring Genomic Relations) on R.
RESULTS. 86 patients were recruited. Median age was 38 (IQR 26–
57), 80% were male, median ISS was 29.5 (IQR 22–38), and admission
base deficit was −4.2 (IQR −7.3–1.3). 62 (72%) of patients developed
a nosocomial infection and 78 (91%) survived to hospital discharge.
152 DMPs were observed between the two time points. 113 CpG
positions were hypomethylated and 39 were hypermethylated (Fig.
297).
Differences were subtle and defined by intermediate methylation
(20% < methylation values < 80%). Interestingly, DMPs were
preferentially found within genes or in genomic locations associated
with regulatory regions such as promoters, transcription factor
binding sites and DNAse hypersensitivity sites. Moreover, the 138
DMPs overlapping gene bodies or promoter regions identified genes
involved in inflammatory pathways, the immune response and
xenobiotics metabolism (Fig. 298). Finally, the DNA methylation
changes were also detected in categories associated with apoptosis,
cell movement and cell proliferation (Fig. 298).
CONCLUSIONS. Severe traumatic injury induces DNA methylation
alterations which have the potential to regulate the post-traumatic
inflammatory response and warrant further investigation as thera-
peutic targets.
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INTRODUCTION. Patients who survive traumatic haemorrhagic shock
(THS) are at risk of developing multiple organ failure (MOF). One
possible mechanism is tissue hypoperfusion leading to endotheliopathy
and inflammatory potentiation. Current resuscitation strategies focus on
pressure based haemodynamic parameters rather than flow based
measures of tissue perfusion. Microcirculatory flow dynamics can be
accurately recorded using hand-held video-microscopic techniques, and
may predict organ failure following traumatic haemorrhagic shock.
OBJECTIVES. To assess the relationship between microcirculatory
dysfunction and organ failure following THS in a multi-center study.
METHODS. A multi-centre prospective longitudinal observational
study was undertaken at three UK Major Trauma Centres. The proto-
col was published [1]. Injured patients who required blood products,
were intubated, and had a lactate >2 mmol/l were eligible for inclu-
sion. Patients were enrolled after initial resuscitation, within 12h of
admission to intensive care (D0) with further time points at +24h
and +72h. Sublingual incident dark field microscopy was performed
at each time point and cardiac output assessed using oesophageal
Doppler. MOF was defined as SOFA ≥6 at day 7 post injury. Microcir-
culatory Perfused Vessel Density (PVD) at D0 was compared between
patients with and without multi-organ failure (MOF). Receiver Oper-
ator Characteristic (ROC) curves were constructed to predict the inci-
dence of MOF at day 7 for different threshold values of PVD, lactate,
cardiac index, and lowest systolic blood pressure (SBP) at D0.
RESULTS. 60 patients were recruited with a median age of 47 (IQR
27–52) years, ISS of 27 (IQR 20–34) and initial lactate of 4.6 (IQR 3.4-
9.0) mmol/l. 6 (IQR 4–10) units of packed red blood cells were
required in the first 24h. Patients who went on to develop MOF had
significantly lower PVD on enrollment than those who did not. SOFA
and Denver scores were significantly higher on day 4–7 in the group
with below average PVD at study enrolment.
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 471 of 542PVD was the best predictor of MOF (AUC 0.81 (0.59-1.0)) when
compared to lactate (AUC 0.75 (0.5-0.99)), cardiac index (AUC 0.69
(0.41-0.97)) and lowest SBP (AUC 0.52 (0.29-0.73)) at D0.
CONCLUSIONS. Microcirculatory hypo-perfusion immediately follow-
ing traumatic hemorrhagic shock and resuscitation is associated with
increased MOF. Microcirculatory parameters are better prognostic in-
dicators for the development of MOF than more traditional global
haemodynamic parameters or biochemical biomarkers. Microcircula-
tory perfusion is a potential end point of resuscitation following THS.
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Quality of life to one year and relation with clinical status at
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hospital mortality, but less attention has been paid to the long-term
functional status and quality of life of traumatic brain injury patients.
OBJECTIVES. To analyze in traumatic brain injury critical patients
admitted to intensive care the relation between the quality of life
after one year and clinical status at intensive care unit discharge.
METHODS. Prospective cohort study of traumatic brain injury
patients admitted in the University Clinical Hospital (Malaga)
between 2004 to 2008. Data were expressed as the mean and
standard deviation for quantitative variables and percentages for
qualitative variables. We used ANOVA to compare means, Newman
Keuls test, Pearson correlation and multiple lineal regression.
Statistically significant differences p < 0.05.
RESULTS. 531 patients. Mean age 40.35 ± 19.75 years, APACHE-II
17.94 ± 6.97, admission GCS 7.53 ± 3.83 points. Computerized tom-
ography (CT) on admission by Marshall score was: diffuse injury type
I (10.4%), type II (28.1%), type III (24.5%), type IV (8.3%), mass evacu-
ated (22.6%), mass not evacuated (6.2%). Hospital mortality 28.6%.
171 patients died at first year (32.2%) (Lost 6.6%) and 181 at 4 years
(34.1%) (Lost: 16.2%).
The evaluation of the quality of life was performed by PAECC
(Project for the Epidemiological Analysis of Critical Care Patients)
QOL (Quality of Life) questionnaire (0 points: normal quality of life,
29 points: worst score). Mean score at first year follow-up 9.44 ± 8.73
points (N = 325), indicating high deterioration in quality of life.
There is an association between between quality of life after one
year with age (r =0,163, p = 0,002), the depth of coma by GCS
(r = −0,373, p < 0,001), APACHE II (r = 0,382, p < 0,001) and ICU stay
(r = 0,401, p < 0,001).
We evaluated the clinical status at intensive care unit discharge
through the analysis of oral communication, 75 patients not present
problems, and their quality of life per year was 3.37 ± 5.05 points,
168 spoke with difficulty, and their quality of life was 7.82 ± 6.24
points and 82 patients not could speak and their quality of life
18.27 ± 9.06 points (p < 0.001). Statistically significant differences
between three groups.
Multivariate analysis by multiple lineal regression found association
between quality of life for one year with functional status by oral
communication, age and ICU stay. There was no statistically
significant relationship with APACHE II, admission GCS and
tracheostomy.
CONCLUSIONS. ICU patients with Traumatic brain injury have an
deteriorated quality of life after one year. Quality of life for after one
year was related with functional status at ICU discharge evaluated by
oral communication.
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INTRODUCTION. The allocation of intensive care unit (ICU) beds for
post-surgical care is widely debated, and there is no consensus as to
whether it improves outcomes. Their availability and disposal are dif-
ferent between countries (1). The role of ICU in the perioperative
management is widely considered to be beneficial (2) but needs
evaluation due to recent findings indicating possible lack of benefit
(3). In Sweden, lower admission rates to ICU do not seem to worsen
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 472 of 542perioperative outcomes (4) however there are few studies with long-
term follow up.
OBJECTIVES. To study outcomes of patients undergoing surgical
procedure prior to ICU admission (operated), comparing them to a
matched population not having surgery (non-operated). The primary
outcome parameters were 30-day and 1-year mortality.
METHODS. Quasi experimental case-matched study on data collected
by the Swedish Intensive Care Registry on adult patients admitted to
ICU during 2012–2014.
RESULTS. A total of 72,242 patients (12,880 operated patient) had
mean 30-d and 1-y mortality rates of 21.0% and 31.2% respectively.
After case-matching with age, sex and Simplified Acute Physiology
Score III (SAPS3), operated patients (8,703) had significantly lower
mortality rates than non-operated patients (33,567). Standardized
mortality ratios (observed to estimated 30-day mortality rates) were
0.91 for operated and 1.07 for non-operated patients. For operated
patients, factors independently associated with 30-day mortality in-
cluded age (OR 1.03), SAPS3 (OR 1.08) and number of transfers to
other ICUs (OR 1.22 per each transfer). For 1-year mortality, inde-
pendent risk factors were age
(OR 1.03) and SAPS3 (OR 1.07). Sex, urgency of operation and
planning of ICU admission were not significant risk factors. Main
diagnosis was an important determinant of 30-day mortality: trauma
(OR 2.79), cardiovascular (OR 2.64), CNS (OR 2.35), gastrointestinal
(OR 2.3), renal (OR 1.99), sepsis or infection (OR 1.88) and so on, but
no such effect was observed for 1-year mortality, where malignancy
was important (OR 1.49 and 1.81 respectively). Medical and surgical
complications had paradoxical effects (OR 1.42 and 0.78 respectively).
Direct admission to the ICU after surgery had a favourable effect in
comparison to later admission from the ward.
CONCLUSIONS. Patients undergoing a surgical procedure prior to
ICU admission have lower mortality rates compared to a matched
population not undergoing prior surgical procedures. Short and long
term mortalities were determined by age and SAPS3 scores. Main
diagnosis was also an important predictor but only for short-term
mortality.
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balanced infusate on the necessity of cardiocirculatory support: a
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INTRODUCTION. Infusion solutions are among the most administered
medications in hospitals.
We present the first randomized-controlled double-blind trial investi-
gating whether the type of crystalloid used has an influence on car-
diovascular stability in patients undergoing major abdominal surgery.
METHODS. Patients received either 0.9% saline or an acetate-
buffered crystalloid for intraoperative volume replacement. Out-
comes were primarily necessity for vasopressors, secondarily the totaldose of catecholamines, total perioperative fluid and unplanned ICU
admissions.
RESULTS. A total of 60 patients were randomized:, thirty to 0.9%
saline and 30 to acetate-buffered balanced crystalloid. Significantly
more patients needed vasopressors for circulatory support in the
0.9% saline group (53% vs 23%,p < 0.033). Mean dose of norepineph-
rine adjusted for body weight and anesthesia-duration was higher in
the saline group [0.000502mcg/kg/min (standard deviation (SD)
0.001047] compared to the balanced group [0.000044mcg/kg/min
(SD 0.000092)],p < 0.003. With ongoing surgery patients in the 0.9%
saline group more often needed vasopressors (p < 0.0194). Cox re-
gression revealed that a high amount of administered fluid
(p < 0.001), allocation to the saline group
(p < 0.006) and a lower mean arterial blood pressure (p < 0.027)
were associated with vasopressor necessity. The saline group
developed hyperchloremic metabolic acidosis. There was no
difference in total perioperative fluid and unplanned ICU admissions.
CONCLUSIONS. Use of 0.9% saline in patients undergoing major
abdominal surgery leads to increased need of vasoactive substances
for hemodynamic support, absolute doses of vasopressors and
hyperchloremic acidosis compared to patients receiving a chloride-
reduced, balanced crystalloid.
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INTRODUCTION. Patients undergoing emergency laparotomy (non-
traumatic) are known to have mortality rates of 15% or more in the
US and the UK. Emergency laparotomy is carried out widely and
significant numbers of patients die following surgery. Audits have
shown standards of care vary greatly and improvements in outcome
might be achieved by using an enhanced recovery model. Previous
small scale studies have suggested that improving standards of care
for these patients can considerably improve outcomes.
METHODS. A care bundle was developed using best evidence to
identify key elements of care that are commonly deficient in the care
of patients undergoing emergency laparotomy. 29 hospitals in the
south of England (population of 8 million people) participated in a
quality improvement initiative using this care bundle and the IHI
Model for Improvement. This included development of regular data
feedback (runcharts, SPC and CUSUM plots), coaching on quality
improvement methodology and leadership and widespread inter-
hospital learning and spreading of best practice ideas.
RESULTS. Early signs suggest a reduction of crude in-hospital mortal-
ity of 15-20% and a highly significant reduction in length of stay
across all hospitals.Improvements in adherence across all elements of
the care bundle have been shown in many hospitals and over 98.7%
of patients have benefitted from one or more improvements of care.
CONCLUSION. This is the first large scale programme to demonstrate
that the use of a simple care bundle, focusing on improving the
quality of care for patients undergoing emergency laparotomy can
result in both substantial mortality and length of stay reductions.
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Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 473 of 542INTRODUCTION. Metabolic syndrome, affecting large population
especially in western countries has negative impact on outcome
after cardiac and non-cardiac surgical procedures.
OBJECTIVES. To investigate the effects of metabolic syndrome on
postoperative morbidity and mortality after coronary artery bypass
surgery (CABG).
METHODS. A total of 1324 CABG procedures under the use of
cardiopulmonary bypass were performed at our institution from June
2012 to March 2017. According to the International Diabetes
Federation definition, 295(22.3%) patients- Group A- fulfill the criteria
for metabolic syndrome. Our institutions' prospectively collected data
were used and the following factors were compared between Group
A and control Group B: acute kidney injury(AKI) defined by RIFLE
criteria, need for renal replacement therapy (RRT), post-op non-
invasive ventilation(NIV), re-intubation, prolonged ventilation defined
as ventilation > 24 hours, postop pneumonia, red blood cells (RBC)
transfusions, post-op atrial fibrillation, sternal wound infections, low
cardiac output syndrome, Multiple Organ Dysfunction Syndrome and
mortality. Univariate logistic regression method was used for statis-
tical analysis.
RESULTS. Group A consisted of patients with metabolic syndrome
mean aged 65.7 ± 8.9 vs 64.9 ± 9.8, percentage of females 16.5% vs
14.4% and prognostic Euroscore II 1.8 ± 1.8 vs 1.6 ± 1.5. From the
above described 12 postoperative outcome indices, postoperative
respiratory complications requiring NIV and the total RBC units
transfused, were found to have statistical significant difference
-defined as p < 0.05 -between the 2 groups.Group A N = 295 Group B N = 1029 p valuePostop NIV (n,%) 51(17.3%) 64(6.2%) <0.01
Table 230 (Abstract 0942). Comparison of mean CRP and WCCRBC units (mean,SD) 3.28 ± 3.2 1.87 ± 1.84 <0.01
Mean
Admission
WCC (109/L)
Mean Peak
WCC (109/
L)
Mean
Admission
CRP (mg/L)
Mean Peak
CRP (mg/
L)
Whole sample (n = 61) 11.2 16.5 99.9 169.9
Delirium Negative (n =
37)
12.4 14.5 78.1 134.9
Delirium Positive (n =
24)
9.7 19.5 128.7 215.4
Low Risk (E-Pre-Deliric
<20) (n = 28)
12.7 18.8 89.8 181.3
Medium - High Risk (E-
Pre-Deliric >20)(n =
33)
10.0 14.6 108.5 160.2
E-Pre-Deliric <20 and
Delirium Positive (n =
10)
9.9 23.5 121.7 214.8
Fig. 301 (Abstract 0942). See text for description[Results]
CONCLUSIONS. Incidence of postoperative NIV requirement and RBC
transfusions in early postoperative period are higher in patients with
metabolic syndrome who undergo CABG.
REFERENCE(S)
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Delirium is a common complication of critical illness(1). Strategies to
reduce the incidence of delirium(2) may be of most benefit if aimed
at patients at the highest risk. E-Pre-Deliric(3) is a tool for predicting
individual risk of developing delirium in ICU using patient character-
istics at admission. We have piloted the use of the E-Pre-Deliric score
in a large teaching hospital ICU.
Data was collected for all admissions over a five week period. E-Pre-
Deliric was calculated on admission (Age, admission type and ur-
gency, mean arterial pressure, serum urea and presence of respira-
tory failure, dementia, alcohol abuse or steroid use). Delirium
incidence, C-Reactive Protein (CRP) and White Cell Count (WCC) were
collected retrospectively. Predictive performance of E-Pre-Deliric was
assessed by calculation of the area under the ROC curve (AUROC)
and logistic regression used to assess association between inflamma-
tion and delirium.
The study included 61 patients. Appropriately 88% of planned twice
daily CAM-ICU scores were recorded. The AUROC of the E-Pre-Deliric
score in our sample was 0.64 compared to 0.76 in the original study.
Differences between our population and the E-Pre-Deliric validation
cohort will be presented. As per Table 230, the delirium populationhad higher admission and peak CRP levels. Mean WCC was initially
lower in the delirium population but on average, reached a higher
peak.
Our sample contained a group of delirium positive patients admitted
after surgery. These patients had relatively low E-Pre-Deliric scores
(due to the elective nature of their intubation) but remained venti-
lated for longer than average, exposing them to the deliriogenic ef-
fects of sedation and ventilation.
Our analysis also suggests an association between the level of
inflammatory response and development of delirium. An increase in
CRP of 50 was strongly associated with an increase in the rate of
delirium (OR 1.45, P = 0.005). An increase in WCC of 5 was more
weakly associated with an increase in the rate of delirium (OR 1.39,
P = 0.039). The distribution of peak WCC and CRP in patients with
and without delirium is shown in Figs. 301 and 302. The burden of
inflammation is not accounted for in the E-Pre-Deliric score, and in
our sample may explain some of the patients with a low E-Pre-Deliric
score who developed delirium (Fig. 303).
Future study will use these results as a baseline whilst we attempt to
create a prediction score more closely tailored to predict delirium
within our ICU population.
1. Incidence, risk factors and consequences of ICU delirium. Ouimet S
et al. 2007, Intensive Care Med, pp. 33:66–73.
2. A multicomponent intervention to prevent delirium in hospitalized
older patients. Inouye SK et al. 1999, N Engl J Med, pp. 340:669–676.
3. Multinational development and validation of an early prediction
model for delirium in ICU patients. Wassenaar A et al. 2015, Intensive
Care Medicine, pp. 41(6):1048–1056.
Fig. 302 (Abstract 0942). See text for description
Fig. 303 (Abstract 0942). See text for description
Fig. 304 (Abstract 0943). See text for description
Table 231 (Abstract 0943). See text for description
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INTRODUCTION. Invasive candidasis (IC) are associated with a high
mortality in ICU. Indeed, treatment is often delayed and the volume of
distribution of antifungal agents is increased in this population of patients.
Consequently, for candins optimal concentration is difficult to obtain,
particularly in sanctuary sites. .1–3 The extensive use of antifungal agents is
nowadays associated with significant trend of increase in the MICs of
yeasts. For candins, an increase of MICs, especially for C parapsilosis and C
glabrata has been repeatedly described and MICs >0.25mg/L became
common4–7 and recently associated with clinical failures.8
OBJECTIVES. To determine the pharmacokinetic (PK) profile of a
caspofungin (CAS) loading dose of 140mg in ICU patients with
multiple organ failure (MOF) and IC.
METHODS. Prospective, single-center, observational study [NCT#02413892].
Inclusion criterions were: adults (>18 yo) admitted in ICU with invasive
mechanical ventilation, receiving epinephrine/norepinephrine for septic
shock and with suspected or proven IC. Intensive PK blood sampling was
performed at the end of 1h-CAS infusion and 2h, 3h, 5h, 7h and 24h post-
infusion. Plasma CAS concentrations were determined using UPLC-MS/MS.8
Pharmacokinetic parameters [estimate (RSE%)] were estimated by non-
linear mixed effects modeling (population-based) approach, using Monolixsoftware. CAS AUC0–24 of CAS of 98mg.h/L was considered adequate. CAS
PK/PD target should be Cmax/MIC ratio > 10.
3 Descriptive results are pre-
sented as median (IQR).
RESULTS. 15 patients were included: 73% men, age 54 yo (34–65),
BMI 26.5 kg/m2 (21.8-29.8), SAPS score 57 (45–78), SOFA score 14 (8–
16). IC was proven in 3 cases (candidaemia), probable in 7 cases
(sepsis multiple colonization and BD glucan >80pg/mL), and possible
in 5 cases. Five patients were on ECMO and 9 were treated with renal
replacement therapy. Among them, 14 completed PK profiles where a
2 compartments model best fitted the data (Table 231 & Fig. 304).
CONCLUSIONS. In our cohort of severe ICU patients with MOF, the
140mg CAS loading dose allowed to achieve plasma AUC0-24 on the
first 24h higher than reported AUC0-24 at 3rd day, in ICU patients re-
ceiving standard administration of CAS (70mg then 50 mg daily).9
High dose of CAS is known to be safe10–11.
Our results suggest that a higher loading dose might help reaching
the PK/PD target in severe ICU patients with MOF.
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Table 232 (Abstract 0944). Main characteristics of IVAC in ESBLE carriers
Variable No
identifiable
infection
(n=361)
Non-VAP
infections
(n=124)
Non-
ESBLE
VAP
(n=73)
ESBLE
VAP
(n=18)
P value,
global
comparison
P value,
non-ESBLE
VAP versus
ESBLE VAP
Carbapenem
therapy on the
day preceding
IVAC onset, n (%)
103 (28) 25 (20) 15 (20) 0 0.01 0.03
Empirical
carbapenem
therapy started at
IVAC onset, n (%)
39 (9) 19 (15) 31 (42) 10
(56)
<0.01 0.43
ICU LOS after
IVAC, days, median
[IQR]
7 [5-10] 8 [5-11] 12 [8-
18]
12 [8-
16]
<0.01 0.61
MV duration after
IVAC, days, median
[IQR]
5 [2-8.5] 7 [3-9] 10 [7-
16]
11 [8-
15]
<0.01 0.78
Death during
IVAC, n (%)
59 (15) 20 (19) 19 (27) 5 (29) 0.05 1.00
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INTRODUCTION. Infection-related ventilator-associated complications
(IVAC) as defined by the Centers for Disease Control and Prevention
are common events in intensive care unit (ICU) patients receiving
mechanical ventilation (MV). The characteristics of IVAC have not
been investigated in patients colonized with ESBLE.
OBJECTIVES. To appraise the correlation between IVAC and (i)
ventilator-associated pneumoniae (VAP) due to ESBLE, (ii) other ICU-
acquired ESBLE infections and (iii) carbapenem exposure in ESBLE
carriers.
METHODS. Inception cohort study from the French longitudinal
prospective multicenter OUTCOMEREA database (1997–2015)
including all ESBLE carriers with MV duration > 2 days and ≥ 1
episode of IVAC after carriage documentation.
RESULTS. Among the 318 ESBLE carriers included in the study, 225
(70%) did not develop VAP, 73 (23%) developed ≥ 1 non-EBLSE VAP,
and 20 (7%) developed ≥ 1 ESBLE VAP (median number of IVAC epi-
sodes, 1 [1–2], 3 [2–4] and 2 [1–5], respectively, P < 0.01). A total of
576 IVAC episodes were analyzed, including 361 (63%) with no iden-
tifiable infection, 124 (21%) related to non-VAP infections (ESBLE in-
fections, n = 20), 73 (13%) related to non-ESBLE VAP (concomitant
non-VAP ESBLE infections, n = 5) and only 18 (3%) related to ESBLE
VAP. Overall, ESBLE infections accounted for 43 (7%) episodes of
IVAC. No significant variation was observed across the 4 IVAC groups
in terms of prior MV duration, requirement for invasive procedures
other than MV, SOFA score values at IVAC onset, episode ranks in pa-
tients with ≥ 2 IVAC, carriage type (imported versus ICU-acquired),
species distribution of ESBLE, and non-carbapenem antimicrobials
use within the 3 preceding days. None of the 143 episodes of IVAC
which arose under carbapenem therapy were related to an ESBLE
VAP (Table 232). The empirical initiation of a carbapenem-based anti-
microbial regimen was frequent in IVAC not related to an ESBLE in-
fection, notably VAP. VAP-related IVAC were associated with a poorer
outcome than non-VAP IVAC (Table 232).
CONCLUSIONS. The occurrence of IVAC in ESBLE carriers rarely
results from an ESBLE infection, especially VAP. No risk factor for
ESBLE VAP as a cause of IVAC could be identified. Rapid diagnostic
tools may help restraining the empirical use of carbapenems in this
situation.REFERENCE
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INTRODUCTION. Infection is frequent in patients treated by
extracorporeal membrane oxygenation (ECMO); however, antimicrobial
concentrations can be significantly altered during ECMO when
standard regimens are used. The aim of this study was to describe the
adequacy of therapy during b-lactams administration in ECMO patients.
METHODS. We reviewed all patients in whom b-lactams (merope-
nem = MEM; piperacillin/tazobactam = TZP; cefepime or ceftazi-
dime = CEF) therapeutic drug monitoring (TDM) was assessed while
on ECMO support (from January 2010 to December 2016). Drug regi-
mens were adjusted on renal function (i.e. creatinine clearance using
the Cockroft-Gault formula). Daily creatinine clearance (CrCL) was
also measured using 24-hr urine collection. Drug concentrations were
measured 2 hours after the onset of a 30-min drug infusion and just
before the next dose and were considered as “adequate” if drug
levels remained between 4 and 8 times the clinical breakpoint of the
minimal inhibitory concentration for Pseudomonas aeruginosa during
40% for MEM, 50% for TZP or 70% for CEF of the dose interval (i.e.
“target”). Using a one-compartment model, b-lactams pharmacokin-
etics (PKs) and concentrations at target time-points were calculated.
Drug concentrations below or above these targets were considered
as “insufficient” or “excessive”, respectively.
RESULTS. A total of 90 TDMs (MEM = 47; TZP = 36; CEF =7) were
obtained in 53 patients treated with ECMO (35 veno-venous and 18
veno-arterial). The proportion of insufficient drug levels was higher
for TZP (15/36, 42%) than for MEM (8/47, 17%) or CEF (0/7; p = 0.01).
Excessive drug concentrations were more frequent in MEM (19/47,
40%) than TZP (8/35, 22%) or CEF (1/7, 14%; p = 0.05). TDMs in pa-
tients on continuous renal replacement therapy (CRRT, n = 39)
showed less frequent insufficient drug levels than those without
CRRT (3/39 vs. 20/51; p = 0.007). Among those patients without CRRT,
Table 233 (Abstract 0946). Risk factors associated to failure
Odds 95% CI p
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 476 of 542there was a significant although weak correlation between CrCL and
drug clearance (p = 0.01; r2 = 0.12).
CONCLUSIONS. The adequacy of b-lactam therapy is highly vari-
able among different drugs and might be influenced by CRRT or
renal clearance.ratio
tAB using carbapenems 2.52 [1.11-
5.70]
0.026
tAB using piperacillin/tazobactam 2.45 [1.26-
4.78]
0.008
tAB using glycopeptides 2.41 [1.06-
5.49]
0.035
MDR bacteria acquired during the ICU stay in
hygiene samples
7.86 [1.73-
35.75]
0.0070946
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INTRODUCTION. Risk factors of clinical failure in the management of
postoperative peritonitis (POP) have been rarely analysed.
OBJECTIVES. From the data collected during the prospective
randomized multicenter DURAPOP study (NCT01311765) addressing
the issue of duration of antibiotic therapy in POP patients (pts), the
risk factors of failure have been analysed.
METHODS. Patients who underwent reoperation for POP, received
adequate surgical and antibiotic (AB) therapies and were alive at
Day-8 after surgery were analysed. Failure between D8 and D45 was
defined as death, need for reoperation, percutaneous drainage and/
or new AB therapy. The following data were collected: demographic
characteristics, underlying diseases (Charlson score), severity at reop-
eration for POP (SAPS II and SOFA scores), surgical and operative
characteristics, microbiologic results, empiric and targeted antibiotic
therapy (tAB), presence of multidrug resistant bacteria (MDR) in clin-
ical and hygiene samples on admission and during ICU stay. At D45,
pts who had a clinical failure were compared with those having a
successful outcome. Potential predictive factors which level of associ-
ation to failure in univariate analysis was < 15% (p < 0.15) were ana-
lysed in multivariate logistical regression. Results are presented in
median (IQR), proportions and adjusted odds ratio (OR) (95% confi-
dence interval (CI)).
RESULTS. Among 236 pts included for POP, 141 (60%) had a clinical
failure (death (n = 30), reoperation (n = 58), percutaneous drainage
(n = 33) or new AB (n = 95)). No difference between groups was
observed for the demographic parameters (age [IQR] : 66 [57:76];
male gender: 64%; no underlying disease: 56%; Charlson score : 4
[2:7]), severity at the time of surgery for POP (SAPS II score 45
[34:54], SOFA 6 [4:8]), surgical and operative characteristics or
microbiologic results (data not shown). In univariate analysis, factors
associated to clinical failure were renal replacement therapy on the
day of surgery for POP (OR 2.90 ; 95%CI [1.0-8.10], p = 0.042), initial
gastro-duodenal surgery (0.50 [0.20-0.90], p = 0.023), tAB using piper-
acillin/tazobactam (1.90 [1.10-3.30], p = 0.031), tAB using third gener-
ation cephalosporins (0.40 [0.20-0.90], p = 0.022), tAB using
glycopeptides (2.20 [1.10-4.50], p = 0.032), MDR organisms cultured
on admission in hygiene samples (2.00 [1.00-4.20], p = 0.055) and ac-
quisition of MDR bacteria during ICU stay in hygiene samples (8.10
[1.90-35.60], p = 0.005). In multivariate analysis, the risk factors asso-
ciated to failures are presented in the Table 233.
CONCLUSIONS. Among ICU pts reoperated for POP and receiving an
adequate AB, clinical failures are frequent. The identified risk factors
reflect situations where the prescribers target difficult to treat
microorganisms in using broad spectrum AB. Similar observations are
made with acquisition of MDR bacteria in hygiene samples during
the ICU stay.GRANT ACKNOWLEDGMENT
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INTRODUCTION. Early and appropriate antibiotic therapy appears to
be the most effective way of improving patient outcomes in sepsis.
Sepsis may induce altered pharmacodynamics due to changes in
renal function, increased capillary leakage and tissue edema.
Therefore, typical dosing may not achieve adequate concentrations
and so the question of what is the appropriate dose and
administration strategy for the chosen antibiotic is generally not well
defined.
OBJECTIVES. The objectives of this study were to describe the
population pharmacokinetics of meropenem in a large cohort of
patients with septic shock and evaluate the probability of target
attainment and the fractional target attainment of different dosing
regimens for treatment of two challenging pathogens that pervade
critical care units (Acinetobacter baumannii and Pseudomonas
aeruginosa).
METHODS. A single centre observational pharmacokinetic study
including adult patients with septic shock treated with meropenem.
Seven blood samples were drawn during one administration period
to create a pharmacokinetic profile. Concentrations of meropenem in
plasma were measured by a validated HPLC-MS/MS method. To de-
scribe total meropenem concentrations, one and two-compartment
models were developed. Monte-Carlo simulations were employed to
determine the probability of target attainment (PTA) of achieving a
PK/PD target of ƒT > MIC = 40%. Fractional target attainment (FTA)
calculations were performed to assess the likely success of treatment
for empirical or targeted therapy of Acinetobacter baumannii and
Pseudomonas aeruginosa.
RESULTS. Fifty patients were included. A two-compartment linear
model best described meropenem pharmacokinetics and including
creatinine clearance (CrCL) improved the fit of the model. A continu-
ous infusion increased the likelihood of attaining the target PTA or
FTA. At the highest creatinine clearence level (CrCL 200 ml/min) 4–
6000 mg was required for intermittent dosing to have a 100% likeli-
hood of attaining the targeted PTA. This could be reduced to 2000
mg with continuous infusion. For empirical treatment of A. bauman-
nii, a daily dose of 8000 mg of meropenem was required for intermit-
tent boluses and prolonged infusion which could be reduced to a
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 477 of 542daily dose of 6000 mg with continuous infusion. For P. aeruginosa, a
daily dose of either 2000 mg q8 (6000 mg) or 1000 mg q6 (4000 mg)
achieved FTA ≥90%. At CrCL of ≤ 100 ml/min, all PTA and FTA targets
could be reached with intermittent dosing of 1000 mg q3.
CONCLUSIONS. In conclusion, meropenem pharmacokinetics is
mostly influenced by renal clearance and less so by distribution
volume. In patients with septic shock and a possible augmented
renal clearance doses should be increased and/or administration
should be performed with prolonged or continuous infusion to
increase the likelihood of achieving targeted plasma concentrations.
In patients with normal to slightly reduced renal function however,
standard dosing seems to be sufficient.
Outcome after intensive care.
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INTRODUCTION. Recent studies and meta analyses suggested that
ICU and hospital admission on different days of the week may be
associated with varying outcomes [1]. Apart from these indirect
effects, little is known about the immediate effects of weekend ICU
stay on treatment, risk of death and chance of discharge.
OBJECTIVES. To assess whether ICU stay at weekends (Saturday -
Sundays) differs from weekday ICU stay (Monday - Friday) in terms of
treatment, mortality risk or discharge chance.
METHODS. Retrospective study in the registry set up by the Austrian
Centre for Documentation and Quality Assurance in Intensive Care
(ASDI). All adult patients, who were admitted to one of the 119 ICUs
participating in the project between 2012 and 2015, were included.
ICU readmissions during the same hospital stay were excluded.
A multivariable competing risk analysis (Fine and Gray proportional
subdistribution hazards model) concerning ICU mortality and ICU
discharge was performed. The following variables were used in the
model: weekday of admission, weekday of event (death or
discharge), SAPS 3 score, year of admission, month of admission,
type of admission, and centre. Intervention rates, both inside and
outside the ICU, as documented by the TISS-28 score, were calcu-
lated for every weekday. All comparisons were drawn using Wednes-
day as the reference day.
RESULTS. A total of 151,268 patients was included in the analysis.
Risk of death in the ICU was significantly lower at weekends than
during the week (HR [95% CI] for Saturday = 0.93 [0.87-1.00] and
Sunday = 0.85 [0.80-0.91]). Chance of discharge was reduced (HR
[95% CI] for Saturday = 0.63 [0.62-064] and Sunday = 0.56 [0.55-
0.57]). Patients received specific interventions at a significantly lower
rate at weekends compared to weekdays. A single intervention was
documented in 11.7% of patients at Wednesdays, 10.0% at Saturdays
and 9.9% at Sundays (p < 0.001). Multiple interventions were
performed in 8.3% of patients at Wednesdays, 7.7% at Saturdays and
7.8% at Sundays (p < 0.001). 15.5% of patients received interventions
outside the ICU at Wednesdays, while only 11.5% and 10.6% did so
at Saturdays and Sundays (p < 0.001).
CONCLUSIONS. Weekend ICU stay is associated with lower risk of
death than during the week. This effect may, at least partly, be
explained by a concomitantly reduced chance of ICU discharge. Risk
of death may therefore be reduced due to improvements in patients'physiology. The lower rate of disease specific interventions at
weekends could also be explained that way. Future research needs
to investigate, whether weekend ICU discharge could be beneficial,
since it is generally deemed safe [2].
REFERENCES
[1] Cavallazzi R et al. Association between time of admission to the
ICU and mortality: a systematic review and metaanalysis. Chest.
2010;138:68–75
[2] Yang S et al. Association between time of discharge from ICU and
hospital mortality: a systematic review and meta-analysis. Crit Care.
2016;20:3900949
Safety climate, process adhesion and outcomes in critical care
units: a secondary analysis of the CHECKLIST-ICU trial
F.G. Zampieri1, L.P. Damiani1, F.R. Machado2, F.A. Bozza3, P. Vendramim4,
J.I. Salluh3, A.B. Cavalcanti1
1HCor-Hospital do Coração, Research Institute, São Paulo, Brazil;
2Universidade Federal de São Paulo, Anesthesiology ICU, São Paulo,
Brazil; 3D'Or Institute for Research and Education, Rio de Janeiro, Brazil;
4Hospital Samaritano, São Paulo, Brazil
Correspondence: F.G. Zampieri
Intensive Care Medicine Experimental 2017, 5(Suppl 2):0949
INTRODUCTION. Safety climate has been suggested to be associated
with better outcomes in critically ill patients, but evidence is sparse.
It is also unclear whether safety climate is associated with adherence
to best practices.
OBJECTIVES. To assess whether safety climate, assessed through
Safety Attitudes Questionnaire - ICU (SAQ-ICU), is associated with
hospital mortality and with adherence to standard-of-care practices
in ICUs.
METHODS. We prospectively collected SAQ-ICU domains (teamwork
climate, safety climate, job satisfaction, stress recognition, perception
of managements and working condition) in the ICUs participating in
the CHECKLIST-ICU trial. Data was grouped for the analysis consider-
ing each phase at each ICU as a distinct cluster. At least 75% of all
health practitioners in each unit answered the questionnaire. The as-
sociation between SAQ components and hospital mortality was
assessed through mixed regression model correcting by SAPS 3 score
at the patient level with each cluster as a random intercept. Model's
selection was done using stepwise Deviance's Analyses. The associ-
ation between SAQ components and adherence to best practices
and support use was assessed through linear regression.
RESULTS. 236 clusters with a total of 13,638 patients and 12,933
health professionals were included; 118 centers (6,877 patients, 6,558
health professionals) on the first phase and 118 (6,761 patients, 6,375
health professionals) on the second phase of the trial. Nurse
assistants were the most common responders (46.2%), followed by
nurses (16.7%) and physicians (15.9%). SAQ values between phase 1
and phase 2 were correlated (lower correlation coefficient was 0.32
for stress recognition domain and higher was 0.61 for working
condition). There was a high correlation between all SAQ
components except for stress recognition that represented a
different domain. There were only weak associations between SAQ
domains and hospital mortality (Fig. 305).
In mixed effect model after stepwise regression, only SAPS3 score
and SAQ safety climate domain (OR 0.987 [0.978-0.996]; p = 0.006)
were associated with outcome. Higher levels of ICU's stress
recognition were associated with higher mean unit SAPS 3 score,
higher use of central venous catheter, increased use of analgesics,
higher use of tidal-volumes bellow 8 mL/kg and longer length of stay
but not with adherence to other practices such as thromboprophy-
laxis and head elevation.
CONCLUSIONS. A better safety climate was weakly associated with
lower hospital mortality. Admission of more severely ill patients was
associated with higher stress in ICU staff. It is unclear whether the
association of stress with best practices may be only due to higher
illness severity.
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INTRODUCTION. The relationship between case volume and
outcomes has been established for a number of scenario in the
intensive care unit (ICU) but never in patients with acute respiratory
distress syndrome (ARDS).
OBJECTIVES. We aimed at determining whether ICUs caring for
higher volume of ARDS would or would not be associated with lower
ICU mortality.
METHODS. ARDS cases were identified from coding system through
a regional database (2004 to 2012). Volume was calculated as the
cumulative annual mean of ARDS cases. Severity (SAPS2) and ICU
mortality between categories of case volume were investigated.
Multivariable analysis using mixed effects models was performed to
adjust for severity of illness and confounding factors.
RESULTS. Over the study period, 8,383 ARDS patients among 31 ICUs
were entered in the analysis. Overall, SAPS2 was 58 (43–74) while
ICU mortality was 53.7%. SAPS2 was significantly higher in high
volume ICUs (>65 ARDS per year) as compared to low (≤29 ARDS peryear) and medium volume ICUs (>29-65 ARDS per year): 61 [46–77]
vs. 55 [41–72] and 55.0 [40–72] respectively (p < 0.01). ICU mortality
was similar across the three ARDS volume categories (53.6%, 54.1%
and 53.3% in low, medium and high-volume categories ICUs, respect-
ively). After adjustment for confounders, ARDS case volume was in-
dependently associated with ICU mortality (Odds ratio for log-
transformed volume: 0.77 [95% confidence interval 0.62-0.96],
p = 0.02).
CONCLUSIONS. ICUs caring for higher volume of ARDS were
associated with lower ICU mortality. The underlying factors driving
this relationship should be determined by further studies.0951
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INTRODUCTION. Pressure on Critical Care (CC) services is significant,
with a progressively more complex patient population with
increasing comorbidities. Admission may be inappropriate if the
patient is unlikely to benefit from it. Guidance published in the past
may no longer reflect current practice [1–2]. Clinical frailty is
associated with worse outcomes in critically ill patients [3].
OBJECTIVES. We aimed to establish the impact of frailty measures
and other factors on the decision to admit critically ill patient to CC.
METHODS. Data on unplanned patient referrals made between
November 2013 and February 2015 were collected, including patient
demographics, acute physiological parameters, prior hospital length
of stay (LOS), comorbidities and indices of frailty. Logistic regression
analysis was used to assess factors influencing admission, using
STATA 10. Results are expressed as median (interquartile range) and
odds ratios (OR) for admission, with 95% confidence intervals
(95%CI).
RESULTS. Data were collected on 943 patients referred to CC, of
whom 411 (43.6%) were admitted. Median age was 65 (50–76) years,
482 (51.1%) were male and the median LOS prior to referral was 0
(0–2) days. The majority of patients were referred out of hours (496,
52.6%). The majority of patients were referred from medical
specialties (384, 40.7%), the emergency department (261, 27.7%) and
surgical specialties (198, 21%). Among those not admitted, 125
(13.3%) were declined as functional status was deemed too poor and
80 (8.5%) because death was deemed certain. At single variable
logistic regression analysis adjusted for age and gender, predictors of
admission were an increase in EWS (early warning score, an index of
acute physiological derangement, OR for each point increase 1.14,
95% CI 1.04-1.26, p =0.007), shorter hospital stay (OR for each
additional day inpatient stay 0.97, 95%CI 0.94-0.99, p = 0.033), lower
frailty score (OR for each point increase in score 0.77, 95%CI 0.68-
0.86, p < 0.001), being self-caring (OR 2.52, 95%CI 1.74-3.65,
p < 0.001). Being housebound (OR 0.34, 95%CI 0.23-0.49, p < 0.001)
or wheelchair-bound (OR 0.35, 95%CI 0.21-0.6, p < 0.001) were both
significantly associated with admission being declined.
CONCLUSIONS. Frailty and functional status appear to be the major
factors in decision making regarding admission to CC, after adjusting
for age and gender. Quantification of frailty is a valuable tool in
admission prediction and may allow risk stratification and adequate
resource allocation, deserving further investigation
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INTRODUCTION. Targeted Temperature Management (TTM) has
multiple potential applications in various ICM settings. The
publication of two landmark trials showing improved neurological
outcome in post cardiac arrest patients who were cooled to 33-
34°C1, 2, led to the practice becoming more widespread. The
publication of the TTM trial3 in 2013 by Nielsen et al. dramatically
changed the landscape. Subsequently, other trials such as the
Eurotherm trial4 has led to renewed debate and discussions on
its use.
OBJECTIVES. A European Society of Intensive Care Medicine (ESICM)
taskforce was put together to survey the practice of temperature
management amongst the intensive care fraternity.
METHODS. An online survey exploring various areas of TTM
including indications, management, duration, method etc. were sent
to all members of the ESICM. The survey was also promoted on the
ESICM website (www.esicm.org).
RESULTS. Overall, 722 responses were received, with representation
from all continents, with the majority from European countries (68%).
A variety of hospital types were represented - although university
hospitals accounted for nearly 50%). The majority of respondents
(92%) applied some form of temperature management strategy for
patients with post anoxic coma. The implementation of TTM for
traumatic brain injuries (28%) or as a treatment for intracranial
hypertension (21%) was lower. The majority of respondents (72%)
had a SOP/protocol when instituting TTM which ensured a more
consistent approach to the delivery of treatment in this patient
group. Although intra- and endo-vascular cooling devices are avail-
able in the market and are utilized by respondents, the majority
(76%) use much less invasive and simple procedures such as surface
blankets/pads and ice packs to initiate and maintain temperature
management. During the rewarming phase, the majority do so at a
rate of 0.5oc/hr (53%).
CONCLUSIONS. TTM is a management strategy which is widespread
amongst critical care physicians. Although there is almost universal
agreement that it should be utilised in post cardiac arrest patients
and that a protocol is used, other aspects are more variable. TTM is
less frequently used in peri-operative and septic patients. A consen-
sus recommendation for the use of TTM in neurocritical care and
other ICU patients is urgently needed.
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INTRODUCTION. Studies conducted in undifferentiated patient
cohorts suggest that patients admitted to hospitals at weekends are
at increased risk of death [1]. Results in critically ill patients, however,
are contradictive [2]. This may be due to differences in severity of
illness, patient disposition or regional variation in organisation and
medical practice.
OBJECTIVES. We investigated whether the day of the week of ICU
admission influences either the hazards of death in the ICU or the
chances of discharge from the ICU.
METHODS. Retrospective study in all adult patients admitted to 119
ICUs participating in the benchmarking project of the Austrian
Centre for Documentation and Quality Assurance in Intensive Care
(ASDI) between 2012 and 2015. Readmissions to the ICU during the
same hospital stay were excluded.
Multivariable competing risk analysis using the Fine and Gray
proportional subdistribution hazards model concerning ICU mortality
and ICU discharge was performed. The model was built around the
following variables: weekday of admission, weekday of event (death
or discharge), SAPS 3 score, year of admission, month of admission,
type of admission, and centre. Wednesday was chosen as the
reference value.
RESULTS. This study included 151,268 patients. Risk of death
following weekend ICU admission was higher compared to
weekdays; HR (95% CI) were 1.15 (1.08-1.23) for Saturday and 1.11
(1.03-1.18) for Sunday, respectively. Chance of alive ICU discharge
after weekend ICU admission was simultaneously reduced; HR (95%
CI) were 0.98 (0.96-1.01) for Saturday and 0.91 (0.88-0.94) for Sunday.
CONCLUSIONS. Patients admitted to intensive care units at
weekends are at increased risk of death in the ICU compared to
patients admitted to the ICU during the week. This effect cannot
solely be attributed to severity of illness or discharge practice.
Further research is needed to identify possibilities for changes in
practice and structures to improve outcomes in the future.
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INTRODUCTION. Septic shock is associated with reduced health-
related quality of life (HRQOL), which may negatively impact the sur-
vivors for years after hospital discharge [1,2]. In long-term follow-up
of HRQOL, a substantial number of patients do not respond, which
hamper interpretation of the results [2,3].
OBJECTIVES. We aimed to assess risk factors for non-response to
HRQOL survey at 1-year follow-up in ICU patients with septic shock.
METHODS. We studied all the Danish survivors in the Transfusion-
Requirements in Septic Shock (TRISS) trial patients who were sent
the Short Form Health Survey (SF-36) 1-year after randomisation
[4,5]. Covariates from the trial database and nation-wide registries
using the unique national identification number were used to ex-
plore risk factors for not responding. Five covariates were pre-
specified to be included in the primary multivariate analysis: age,
number of days in hospital from randomisation to follow-up, and
level of education, cohabitation, and employment status at follow-
up. Survival from 1-year follow-up to the final follow-up (median 2.7
years after randomisation) was compared between non-responders
and responders.
RESULTS. Out of 321 eligible patients; we included 308 of whom 100
(35%) were non-responders. In the primary analysis, lower age (odds
ratio 1.03, 95% CI [1.01-1.05]), more admission days in hospital (1.006
[1.001-1.011]), and living alone (4.33 [2.46-7.63]) were associated with
non-responding whereas level of education and employment status
were not. Non-responders had a hazard ratio of 1.63 [0.97-2.72] for
mortality from 1-year follow-up to final follow-up as compared to the
responders.
CONCLUSIONS. Being younger, spending more days in hospital and
living alone were all associated with non-response at 1-year HRQOL
follow-up among ICU patients with septic shock.
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INTRODUCTION. Post-Sepsis Syndrome and Post-ICU Syndrome
are terms recently adopted to characterise the health-related
quality of life (QoL) issues affecting patients after sepsis or after
treatment in an ICU.1,2 Whether these syndromes are different is
not known.
OBJECTIVES. To determine QoL, late mortality, costs and healthcare
resource use of ICU patients with sepsis compared to those without
sepsis.
METHODS. After obtaining ethical committee consent we
analysed data of ICU patients with sepsis recruited to a
randomised controlled trial in New South Wales, Australia. We
conducted a cohort and propensity score matched (PSM) analysis
using baseline variables including indices of severity of illness
compared to ICU patients without sepsis. We assessed QoL using
the EQ-5D-3L at 6 months and mortality, costs (in $AU) and
healthcare resource use at 2 years.
RESULTS. QoL was assessed in 4975 patients: 1320 with sepsis and
3655 without. There were no significant differences in QoL. For the
analysis of mortality, costs and healthcare resource use, 3442
patients were included: 905 patients with sepsis and 2537 without.
At 2 years, patients with sepsis had higher mortality: 371/905 (41%)
vs 860/2537 (34%) HR1.34, 95%CI 1.18 to1.52, p < 0.01; increased
costs: ICU: 47,206 ± 55,121 vs 34,142 ± 43,175; p < 0.0001; Hospital:
73,516 ± 61,100 vs 64,676 ± 56,293; p < 0.0001; and extended length
of stay: ICU: 10.0 ± 11.9 vs 7.1 ± 9.1 days;
p < 0.0001; Hospital: 22.7 ± 21.6 vs 20.4 ± 19.7 days; p = 0.003.
Patients with sepsis had fewer hospital readmissions: 506/904 (56%)
vs 1597/2563 (63%); p = 0.0002.
1612 patients were included in the PSM analysis: 806 with sepsis and
806 without. 90/905 (10%) patients with sepsis could not be
matched due to high illness severity. There were no differences in
QoL, late mortality or hospital readmissions. Costs were higher for
patients with sepsis: ICU 47,298 ± 53,730 vs 38,952 ± 46,778;
p = 0.009; Hospital 74,120 ± 60,750 vs 65,806 ± 56,856; p = 0.005,
and length of stay longer: ICU: 10.0 ± 11.9 vs 8.0 ± 9.8 days;
p < 0.0001;
Hospital: 22.8 ± 21.2 vs 19.1 ± 19.0 days; p = 0.0003.
CONCLUSIONS. Compared to patients without sepsis, patients with
sepsis report similar QoL but have increased hospital costs, length of
stay and fewer hospital readmissions. Aside from cost, these
differences are not significant when patients are matched for
severity of illness and other baseline variables, notwithstanding the
limitation of our inability to match 10% of patients in the sepsis
cohort.
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INTRODUCTION. ICU mortality rates have decreased dramatically.
Physical complaints, cognitive dysfunction and negative emotional
outcomes become more evident in patients discharged from
intensive care, leading to impaired quality of live. Identifying ICU
related risk factors associated with this so called PICS is therefore of
great importance.
OBJECTIVES. The aim of this study was to examine the incidence of
somatic complaints, cognitive dysfunction, depression, anxiety and
post-traumatic stress disorder (PTSD) after intensive care treatment.
Secondly, we searched for possible ICU related risk factors for anx-
iety, depression and PTSD. Also, we studied the association of som-
atic and cognitive dysfunction with these negative emotional
outcomes.
METHODS. Patients treated in ICU between January 2012 and
December 2016 for a minimum of 4 days were invited to the post-
ICU aftercare program. Six weeks after hospital discharge, patients re-
ceived an invitation letter along with three questionnaires: a health-
related questionnaire for identifying somatic and cognitive com-
plaints, the Hospital Anxiety and Depression Scale (HADS) and the
Impact of Event Scale - Revised (IES-R). Patient characteristics and
ICU characteristics were obtained from electronic patient records.
RESULTS. The population consisted of 439 patients (53,5% male),
with mean age 57 years (SD = 15.8). Median Apache II and Apache IV
were 17 and 55, respectively. Median ICU LOS and hospital LOS were
8 and 21 days, respectively. Sixty nine percent of the patients were
mechanically ventilated with a median of 6 days. The prevalence of
clinically significant anxiety and depression was 24.3%, respectively.
Prevalence of PTSD was 17.3%. Most frequently reported somatic
complaints were muscle weakness (50.1%), fatigue (75.8%) and pain
(41.9%). Concentration problems (53.1%), memory problems (44.6%)
and reduced thinking ability (54.7%) were frequently reported
cognitive complaints. These somatic and cognitive complaints were
significantly associated with anxiety, depression and PTSD. LOS ICU
and hospital LOS were significantly associated (p < 0.05) with PTSD,
showing less PTSD in groups with longer stay in ICU and hospital.
Logistic regression revealed female sex as an adjusted independent
risk factor for PTSD (OR = 1.55, 95%CI = [0.93 - 2.60]) and anxiety
(OR = 1.89, 95%CI = [1.22 - 2.93]). No risk factors for depression were
identified. Delirium, APACHE scores, length of mechanical ventilation
and drugs administered during ICU treatment were not related to
anxiety, depression or PTSD.
CONCLUSIONS. Incidence of PICS related symptoms was high.
Patients with anxiety, depression and PTSD symptoms reported more
somatic and cognitive complaints. Female sex was an independent
risk factor for anxiety and PTSD. Longer ICU LOS as well as hospital
LOS were not associated with increased risk of PICS.
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INTRODUCTION. Several studies from large ICU databases have
reported decreasing in-hospital mortality for sepsis and related syn-
dromes, but data are scarce on outcomes after hospital discharge.OBJECTIVES. To investigate the evolution of crude and adjusted
mortality at 30, 90 and 365 days in patients with severe sepsis and
septic shock treated in Swedish ICUs during the period 2005 to 2015,
and whether age and sex distributions, Charlson Comorbidity Index
(CCI), Simplified Acute Physiology Score (SAPS3), distribution of
admissions between hospital types, proportions of medical and
surgical admissions or selected interventions in the ICU changed
during the study period and if these factors were associated with
mortality.
METHODS. Data were retrieved for all patients with severe sepsis
and septic shock defined according to the SCCP/ACCM criteria,
admitted between 2005 and 2015 (ICD codes R57.2, R65.1 or A41.9)
from the Swedish Intensive Care Registry, SIR, (with data from 48%
vs. 92% of all Swedish ICUs in 2005 vs. 2015). Charlson Comorbidity
Index (CCI) based on discharge diagnoses from year 2000–2015, and
survival were captured after linking with databases from the Swedish
board of Health and Welfare. Multilevel logistic regression was used
to analyze survival, adjusting for patient and admission
characteristics (including SAPS3, CCI, admission type and selected
interventions).
RESULTS. 29864 unique sepsis patients were identified. The crude
mortality was 31.8 vs. 29.5% at 30 days and 40.1 vs. 36.2% (p < 0.05)
at 90 days in 2005 vs. 2015, and 48.6 vs. 44.7% (p < 0.05) at 365 days
in 2005 vs. 2014. SAPS3 adjusted 30 day standardised mortality ratio
was unchanged between 2008 and 2015 (0.88 vs 0.87, n.s.). Median
CCI increased 2005 to 2015 (1 vs 2, p < 0.01), while SAPS3 score
decreased slightly between 2010 and 2015 (68.3 vs 66.8, p < 0.001).
Median ICU length of stay decreased from 2.9 days in 2005 to 2.3
days in 2015, p < 0.001). The CCI was a strong independent predictor
of mortality (Odds Ratio (OR) per point increase was 1.095 at 30 days
and 1.24 at 365 days). SAPS3, age, invasive ventilation, medical
admission and female sex implied higher odds of death at all time
points, while admission year (2008–2014) and hospital type had no
significant impact on mortality in the adjusted regression model.
Findings were stable in a sensitivity analysis with data from units
reporting to SIR during the entire study period.
CONCLUSIONS. Mortality in severe sepsis and septic shock is high,
with more than one in three patients not surviving three months
after ICU admission, and risk-adjusted mortality has remained un-
changed in Sweden 2008–2015.
Organisation issues in intensive care
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INTRODUCTION. Patients with poor prognosis in NICU are not referred
early to palliative physicians to address care needs. This results in missed
opportunities for exploring/establishing patient's and families' priorities and
goals of care when prognosis is poor. As of 2014, only about 30% patients
with poor prognosis in NICU was referred to palliative care.
Poor prognosis is defined as a) Hypoxic Ischaemic Encephalopathy, b)
Severe head injury with poor neurological prognosis, c) extensive
intracerebral/subarachnoid haemorrhage, d) low presenting GCS < =6.
OBJECTIVES. We aim to improve early referral rate from current 30%
to 100% of palliative care patients with poor prognosis in NICU
within 6 months.
METHODS. We did a literature review on this topic. Improving
Palliative Care in ICU (IPAL-ICU) consensus group suggested that a
well-structured palliative care initiative in the form of an integrative
or consultative or a combination of both into standard ICU care can
provide important benefits for patients and families. (1) Systemic
Fig. 308 (Abstract 0958). NICU Results
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ICU decreases hospital and ICU LOS. (2)
Our project is carried out by following Plan-Do-Study-Act (PDSA) tool.
The team first examined the referral process and drew out the cause
and effect diagram. After that, team members voted and identified
the main concerns for action and brainstormed on interventions. As
of a result, a new early NICU-Palliative Collaboration & Intervention
Workflow was designed, along with 5 strategies planned and imple-
mented over the 3 PDSA cycles.
RESULTS. Run Chart or Evidence of Audit and Frequency
Patient's data was gathered every 2 weeks, interventions implemented
over 3 PSDA cycles, with introducing 1–2 new strategies each cycle
every 2 wks. At the 4th PSDA, the percentage of palliative care referrals
in patients who fit criteria for referral sustained at 100%.
CONCLUSION. Palliative care in the ICU has strengthened
interdisciplinary work to improve accessibility of services to the
patients. The importance of buy-in from different level and different
healthcare workers is crucial to the achieved improvement. Continual
engagement of multi-disciplinary teams at all levels and providing
regular feedback to the referring team to ensure continual communi-
cations & feedback are other keys.
Using the same model of care, this project has spread to other ICUs in
TTSH through defining referral criteria/trigger for rest of ICUs as well as
continual engagement & collaboration of involved stakeholders.
REFERENCES
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A report from the IPAL-ICU Project (Improving Palliative Care in the
ICU)* Crit Care Med 2010 September ; 38(9): 1765–1772.
2) Aslakson R, Cheng J, Vollenweider D, et al. Evidence-based pallia-
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INTRODUCTION. Fifteen years after the release of the Institute of
Medicine landmark report [1], patient safety improved, but is still not
enough. According to a recently published National Health Service
-report, many medical systems are still not designed with patient safety
in mind [2]. Most of these safety issues are not due to inadequate
medical knowledge, but to problems in transforming that knowledge
into meaningful clinical actions under real patient care conditions [3]. In
complex systems like intensive care, medical decisions have to be made
under uncertainty and time pressure. Working in multi-professional teams
requires coordination and communication skills. Human factors are attrib-
uted with the majority of adverse events in the ICU. Creating a sound
safety climate is therefore essential [1]. Studies have demonstrated that
simulation and CRM training provide a valuable tool [4] to train the man-
agement of complex medical situations and may increase patient safety.
Little is currently known about the optimal frequency of simulation
and CRM training.
OBJECTIVES. To investigate the effectiveness of simulation training
to improve the CRM skills of ICU providers. A group of ICU-nurses
and physiscians in training were observed over three subsequent
years (2014, 2015, 2016). The providers were asked to rate her skills
(1 = best, 6 = worst) with a self evaluation questionnaire before and
after each training. Nonparametric tests including the Bonferroni cor-
recture were performed. We hypothesized that a one day training
once a year would be insufficient to improve CRM skills in complex
ICU situations.
RESULTS. 65 ICU-nurses and 10 physicians completed a total of 194
questionnaires. We observed a consistent improvement in CRM rele-
vant items between pre and post training evaluation. In contrast to
this finding, the providers rated their baseline skills equal during the
whole observation period.
CONCLUSIONS. Multidisciplinary simulation-based educational training
significantly improves self-estimated competence and awareness of CRM
in a medical complex ICU-setting within one session. However, the sus-
tainability of these efforts is probably poor. We feel, that more than one
training session per annum will be required to influence patient out-
come and safety in daily routine. Further studies are needed to find the
ideal dosage and frequency of a long lasting CRM training effect.
REFERENCES
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INTRODUCTION. Critical illness predisposes patients to physical,
psychological and cognitive complications that impact on their
quality of life and ability to function independently (1). The critical
care follow up service provides support through the journey of
recovery (2). We currently provide an outpatient follow up clinic for
this group of patients. The clinic runs one afternoon per week and
aims to see 4 patients. Criteria for invite to clinic is based on length
of stay (LoS) >4 days. Limited resources meant we were unable to
offer a face to face appointment to all patients within a specific time
frame (3 months post hospital discharge). New criteria were
developed focusing on prioritising the presence of delirium,
prolonged intubation and ventilation, critical illness polyneuropathy
and signs/symptoms of Post Intensive Care Syndrome (PICS) rather
than LoS. Virtual critical care follow up was offered at 3 months post
discharge to triage patients and to reassess those who partially met
follow up criteria. A senior nurse used a structured questionnaire via
telephone to assess domains of PICS. Findings were then discussed
with the consultant. Patients were subsequently discharged or
offered a face to face appointment.
OBJECTIVES. To assess whether “virtual” follow up is a useful tool in
identifying and prioritising at risk patients.
METHODS. A comparative and retrospective study.
RESULTS. Between December 2015 and July 2016, 53 patients met
follow up criteria identified as LOS > 4 days. 66% (n = 35) attended;
34% (n = 18) DNA (did not attend). This equates to four clinic days.
Between August 2016 and March 2017, 62 patients met the new
follow up criteria. Of those, 79% (n = 49) attended clinic, 21%
(n = 13) DNA'd. In addition, 26 patients who partially met criteria
were contacted by telephone. Of those, 69% (n = 18) were
discharged, 4% (n = 1) was invited to the clinic and 4% (n = 1)
declined. 23% (n = 6) were uncontactable.
Post introduction of the virtual clinic 88 patients were followed up
versus the 53 of the first 8 months. In total, 25 clinic slots (6 days)were spared and face to face appointments offered to the most
appropriate patients.
CONCLUSIONS. Intensive care admissions are life changing
experience and patients need adequate support through the journey
of recovery. The introduction of the virtual clinic in conjunction with
meticulous selection criteria allowed us to increase the number of
patients followed up and reduced the DNA rates.
REFERENCE(S)
(1) John A Griffiths et al. Follow-up after intensive care. Continuing
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(2) Richard D Griffiths and Christina Jones. Recovery from intensive
care. ABC of intensive care. BMJ. 1999 Aug 14; 319(7207): 427–429.
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INTRODUCTION. Social media allows for the rapid, effective
dissemination of information between an individual and their
followers. Twitter, an online social media platform, allows the
individual to disseminate information in the form of “tweets” of 140
characters or less. In health education, this allows educators to
rapidly disseminate information in public to a wide and varied
audience. The use of social media has become increasingly common
in medical practice leading to formation of specific committees to
tackle this area in professional bodies and conferences.
OBJECTIVES. To analyse the trends and impact of social media at
two major critical care conference over the years.
METHODS. Symplur analytics were used to review the impact of
Twitter as a means of enhancing education at the ESICM (2014–16) and
the UK Intensive Care Society (2015–16) meetings using their official
hashtags. Information was obtained on number of tweets, impressions
and participants, as well as data regarding the most prolific tweeting
individuals. Those “tweeting” were further characterised by their
professional role, be it physicians, societies, commercial companies or
professional journals.
RESULTS. The use of twitter expanded dramatically over the
specified timeframe. At the ESICM LIVES meeting, both number of
tweets and impressions increased more than eightfold over the
designated timeframe. Online participation also increased; mean
tweets/hour and mean tweets/participant increased eightfold and
fourfold respectively. This implies increased use of twitter among
conference participants. Individual physicians, as opposed to
societies, contributed a higher proportion of the top 10 ranked
accounts by tweets, mentions and impressions in 2016, compared
with 2014. The ICS conference demonstrated similar results;
participants using twitter at the conference, and the official hashtag,
increased from 395 in 2015 to 1107 in 2016. Volume of tweets and
impressions also increased over the two years.
CONCLUSIONS. Twitter is an important and expanding means of
intra- and interdisciplinary communication at major European
conferences and has great potential in continuing professional
development and medical education. The largest contribution
towards this electronic conversation currently comes from individual
physician accounts. An enhanced social media strategy at future
conferences, in particular from intensive care societies and online
journals, will increase engagement and education. Societies and
professional organisation should consider the use of social media an
integral part of their communication and educational ambitions.
REFERENCE(S)
Hillman T & Sherbino J. Social media in medical education: a new
pedagogical paradigm? http://dx.doi.org/10.1136/postgradmedj-
2015-133686
Fig. 310 (Abstract 0961). Trend analysis of ESICM LIVES
twitter activity
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INTRODUCTION. The use of extracorporeal membrane oxygenation
(ECMO) has increased worldwide in recent years. However,
characteristics of adult ECMO versus non-ECMO patients admitted to
the intensive care unit (ICU) have never been studied. The impact of
ECMO volume on survival has also not been investigated in any real-
world cohort
OBJECTIVES. To investigate trend of ECMO use in a nationwide data
base.
METHODS. Retrospective analysis using data obtained from the
Korean Health Insurance Review and Assessment (HIRA) Service for
adult patients with an ICU admission, and those who received ≥1
ECMO run between August 1, 2009 and July 31, 2014. Information
including demographics, ICU and hospital length of stay, cost,
specific treatments, and in-hospital mortality was collected.
RESULTS. During the 5-year study period, 1, 265, 508 patients were
admitted to the ICU and 6078 (0.5%) underwent ECMO. An increas-
ing annual national ECMO volume (218%; 768 cases in 2010 vs. 1675
in 2013) was observed. ECMO patients were younger (median age 59
vs. 64, p < 0.0001) but had more comorbidities such as diabetes mel-
litus, cardiovascular and chronic kidney disease than non-ECMO pa-
tients. The median expenditure and in-hospital mortality of an ECMO
patient were higher (US $24,000 vs. US $5200, p < 0.0001; 63.1% vs.
12.5%, p < 0.05 respectively) than a non-ECMO patient. The number
of hospitals performing ECMO also showed an increasing trend.
Eighty-four such hospitals existed in 2013 compared to 42 in 2009.
Using multivariable analysis, age ≥50 years, the need for continuous
renal replacement therapy, and an annual hospital ECMO volume < 20
were negative prognostic factors for survival to discharge
CONCLUSIONS. The prevalence of ECMO among ICU patients was
0.5%. The expenditure and in-hospital mortality of an ECMO patient
were four and five times higher respectively than a non-ECMOpatient. Our study suggests that an annual hospital ECMO volume
≥20 may improve survival.
Is there research in ethics?
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CONTEXT: Family caregivers of patients with end of life (EOL)
illnesses experience significant emotional distress.
OBJECTIVE. To determine whether ED initiated Palliative Care
meetings led to improved family satisfaction.
DESIGN. Randomized Clinical Trial conducted from March 2016 to
March 2017. Patients were enrolled in the study if they were ED
patients with an ICU consult and had one of the following
characteristics: Dementia, Advanced cancer with metastatic disease,
COPD on home 02, previous Stroke and requiring ventilator support,
greater than 75 years old with 2 life-threatening co-morbidities, or
nursing home patient with either peg tube or tracheostomy.
INTERVENTIONS: Patients in the intervention arm received a PC
consult within 24–48 hours.
MAIN OUTCOMES AND MEASURES: The primary outcome was family
satisfaction as measured by the FAMCARE survey. Results were
obtained 2 weeks after discharge or 8 weeks after death. Secondary
outcomes included hospital length of stay, ICU length of stay, days
on mechanical ventilation, code status, and anxiety and depression
symptoms at enrollment measured by HADS and Zarit Surveys.
RESULTS. A total of 120 patients were studied. 57 received early PC
and 63 usual care (43 hours vs. 162 hours respectively) (p < .0001).
Family satisfaction was significantly higher amongst the group
receiving early PC compared to usual care (14.6 vs 11.0) (max score
20) (p = .001) (95% CI, 1.465-1.566).
Comparing the intervention group with usual care, mortality was not
statistically significant (29.8% vs 34.9) (p = .55). Patients receiving
early PC though had less days on the ventilator (7.1 vs 12.3) (P = .01)
and a decreased hospital length of stay (9.29 days vs 12.54 days)
(p = .02). With early PC, code status was changed sooner (3.2 days vs
7 days) (p = .03) and more frequently (56.1% vs. 36.5%)(p = .03) and
patients were placed on comfort care sooner (4.75 days vs 10.6
days)(p = .01) and more often (44% vs 25%)(p = .03). ICU length of
stay (4.45 days vs 5.5 days) (p = .22) was not statistically significant.
Depression and anxiety scores measured by HADS and ZARIT surveys
at enrollment were not significantly different either (19.9 vs 18.0)
(p = .37) (23.1 vs 20.8) (p = .30).
CONCLUSIONS. Family members of EOL ICU patients benefit from ED
initiated PC consultation. Our results show early PC compared to
usual care lead to improved family satisfaction scores and less ICU
interventions without shortening survival.
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INTRODUCTION. In the past two decades, there has been a
tremendous growth of intensive care medicine in India. The Indian
Intensive Care Case Mix and Practice Patterns Study (INDICAPS
Study) accrued data on several aspects of intensive care
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 485 of 542organization, case-mix and practices in 4038 adult patients from 120
ICUs.1 We analysed data from this study to obtain information on
limitation of life-sustaining treatment (LST) in Indian ICUs.
OBJECTIVES. We aimed to study the proportion of patients as well as
patient and organizational characteristics associated with LIM-LST.
METHODS. The INDICAPS Study (clinical trials.gov NCT01384929) was
an observational, 4-day point prevalence study performed between
2010 and 2011. ICU and patient characteristics, and interventions
were recorded for 4038 adult patients from 120 ICUs present in the
ICU on study day, and outcomes till 30 days after the study day. Any
form of limitation of life-sustaining treatment (LIM-LST), including Full
treatment but no cardiopulmonary resuscitation (No-CPR), withhold-
ing (WH) or withdrawal (WD) of LST, or Terminal Discharges (TDs) to
a location outside the hospital, were recorded. TDs were presumed
to have died, and non-survivors were patients who died in the ICU
as well as TDs. Multivariate logistic regression analysis were per-
formed to determine patient and organizational characteristics asso-
ciated with LIM-LST.
RESULTS. 546 patients died in ICU and 183 were TDs; thus 729 /4038
patients (18.1%) were non-survivors. 453 (62%) non-survivors had no
treatment limitation, while 276 non-survivors had LIM-LST. 183(25%)
were TDs, 35 (4.8%) had No-CPR, 45 (6.2%) had WH and 13 (1.8%)
had WD of LST. Two-thirds of all LIM-LST were TDs.
Non-survivors with LIM-LST, compared to those receiving full treat-
ment, were older (57.8 ± 16.9 vs. 54.3 ± 18.0 yrs, p = 0.008) and had
lower APACHE II scores (22.4 ± 9.2 vs. 24.4 ± 8.7). Fewer non-
survivors with LIM-LST received mechanical ventilation (31.3% vs.
52.7%, p < 0.001), vasopressors (25.5% vs. 46.2%, p < 0.001) and dia-
lysis (30.7% vs. 39.8%, p = 0.04). Results of multivariate analysis of
factors associated with LIM-LST are shown in Table 234. Self-paying
patients, presence of cancer and treatment in a private hospital ICU
were independently associated with LIM-LST, while severity of illness,
cirrhosis, severe sepsis, closed ICUs and ICUs with an ICU-training
programme were not.
CONCLUSIONS. Terminal discharge from the ICU is widely practiced,
while witholding and withdrawal of life-sustaining treatments are un-
common. Limitation of life-sustaining treatment is not related to se-
verity of illness. Self-paying patients and treatment in private
hospitals ICUs are independently associated with limitation of life-
sustaining treatment. This suggests that legal and societal issues re-
lated to end-of-life care need to be resolved.
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Odds
Ratio
95% Confidence
Interval (Upper)
95% Confidence
Interval (Lower)
p
Presence of Cancer 2.20 1.18 3.40 0.011
Self-paying patient 1.70 1.08 2.71 0.023
Private Hospital (vs.
Public Hospital)
1.59 1.01 2.53 0.047
Age 1.01 1.00 1.02 0.04
Receiving
vasopressors/
inotropes
0.60 0.47 0.86 0.005
Mechanical
ventilation
0.53 0.31 0.76 0.0010965
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Intensive Care Medicine Experimental 2017, 5(Suppl 2):0965INTRODUCTION. Well described burdens of disease after intensive
care include cognitive, physical and psychiatric dysfunction. Sexual
health, classified as a human right by WHO, has not been as
thoroughly evaluated after intensive care as symptoms in other
domains, and has not been evaluated using patient-developed out-
come measures. Furthermore, neither SF-36 nor EQ-5D contain ques-
tions regarding sexual health. Previous studies of sexual health after
intensive care (1) and after trauma (2) have shown an increase in sex-
ual dysfunction and a raised level of post-traumatic stress, but have
not correlated this to effects on quality of life.
OBJECTIVES. The primary objective was to test the feasibility of
patient-developed questions on sexual health and intimacy in an
ICU-specific quality of life questionnaire. The secondary objectives
were to compare responses from ICU survivors with those from
healthy controls, to evaluate the prevalence of specific problems re-
garding sexual health, and to correlate the degree of symptoms to
self-perceived quality of life.
METHODS. The creation of an ICU-specific quality of life follow-up
questionnaire through semi-structured interviews with ICU survivors
has been previously described (3). Sixteen questions on sexual health
and intimacy, covering issues such as lust, sexual activity, the ability
to handle closeness from loved ones, sexual counselling and impact
on quality of life specifically from these issues were included.
Survivors from three mixed, adult ICUs were screened. Eligible
patients were all patients with ICU LOS >72 hours, discharged from
ICU six months to three years prior to study start, and with non-
neurological/neurosurgical admission diagnosis. Controls matched for
age and gender from the Swedish Population Register were ob-
tained. Survivors and controls received an invitational letter followed
by a phone call asking for participation. Participants were reminded
by phone, had the questionnaire not been returned in two weeks.
RESULTS. Of 493 eligible patients, 393 has returned the
questionnaire (response rate 79,7%). Response rates for questions on
sexual health and intimacy were similar to those of other questions.
Preliminary analysis of reported symptoms in ICU survivors shows
that a substantial proportion of responders has severe problems
concerning intimacy, lust and sex life, and with a considerable effect
on quality of life.
Data from controls are still being collected.
CONCLUSIONS. The high response rate on questions on sexual
health and intimacy suggests that it is feasible to include these
questions and that these issues matters for ICU survivors.
Symptoms of sexual function should be asked for in post-ICU clinics
as well as in primary care, and sexual counselling considered.
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INTRODUCTION. Difficult end-of-life decisions are frequently required
to be made in the intensive care unit (ICU) for incapacitated patients,
with potential to trigger moral distress. Moral distress is an intense
emotional reaction that occurs when an individual feels constrained
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 486 of 542from taking moral action, and has known detrimental consequences
(McCarthy and Deady, 2008). Prior research was focused largely on
moral distress as an occupational hazard for clinicians and little was
known of the existence and impact of moral distress in patients'
relatives.
OBJECTIVES. This empirical investigation aimed to identify the
triggers and constraining factors involved in the development of
moral distress and of the ensuing consequences for patients'
relatives in the making of end-of-life care decisions in ICU.
METHODS. A qualitative narrative thematic analysis of in-depth digit-
ally recorded interviews with N = 20 ICU patients' relatives closely in-
volved in N = 15 patient cases of non-escalation and withdrawal of
therapy and organ donation following brain-stem death and circula-
tory death. The study was conducted in a large tertiary referral ICU in
Northern Ireland (NI), from August 2012- November 2013. This ab-
stract is part of a larger doctoral study that also included ICU physi-
cians and nurses.
RESULTS. Half of relatives interviewed experienced considerable
moral distress. Relatives, unreconciled with the experience, told
chaotic, anguished stories of constraint and wrong-doing and of fail-
ure of familial obligation. The patient's admission to ICU generated a
hope narrative and futility-based moral distress. Moral distress trig-
gers included: breaches of communication and care giver continuity
at critical junctures; the ICU environment; restricted access and au-
tonomy; prolongation of death versus prolongation of life; failure to
oversee 'the good death´; and organ donation processes. Strategies
to mollify moral distress involved quests for truth and justice. Satis-
faction with communication and care and a sense of the right deci-
sion, made at the right time, staved off moral distress. Moral distress
impacted on relatives' health, personal relationships, working lives
and grieving process.
CONCLUSIONS. Findings have important implications for: (a) the
educational preparation of ICU clinicians to recognise, minimise and
manage the ethical challenges and impact of end-of-life decisions for
relatives; (b) person-centred practices that facilitate relatives' familial
obligations; (c) relatives' support needs during and after the ICU epi-
sode and during and after the death; and (d) ICU design.
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INTRODUCTION. The high number of unregistered potential donors
in the national Donor Register lead to a high refusal rate by the next
of kin, which is one of the major bottlenecks in the donation process
(1).
OBJECTIVES. To determine the influence of different factors in the
family approach for organ donation on consent rates, including the
training Communication about Donation (CaD). This training is
offered to Dutch physicians involved in the donation process since
2012 (2). The results are used to provide tools for physicians on how
to inform a grieving family about donation and make the donation
request.
METHODS. Intensivists specialized in organ donation evaluated all
organ donation requests in the Netherlands with physicians who
made the request, according to a standardized questionnaire.
Different aspects of the family approach were evaluated. Weanalyzed all questionnaires that were retrieved between January
2013 and June 2016. The consent rates were compared by univariate
analysis and entered into the multivariate analysis using a stepwise
binary logistic regression model.
RESULTS. During the 3.5-year study period, 2095 donation requests
were evaluated amounting to 83% of all donation requests. After
excluding the cases in which the potential donor is registered with
consent or objection in the Donor Register, 1322 questionnaires
were analyzed. Independent predictors of consent to donation
included complete understanding of the term 'brain death' by the
family (OR, 2.4; 95% CI, 1.4-4.2; p = 0.002), explicitly asking whether
the family understood 'brain death' (OR, 1.7; 95% CI 1.1-2.5;
p = 0.011), requesting organ donation during bad news conversation
(OR, 1.8; 95% CI, 1.2-2.6; p = 0.004), and consulting a transplant
coordinator prior to the donation request (OR, 3.4; 95% CI, 2.3-4.9;
p < 0.001). The family consent rate was 40.8% for the family
approaches performed by CaD-trained physicians in comparison to
36.3% for the family approaches performed by physicians who were
not trained (p = 0.134). Training seems to have less effect on consent
rates in ICU physicians (41% versus 39%, p = 0.591) than in non-ICU
phyiscians (40% versus 22%, p = 0.072).
CONCLUSIONS. It is of importance to give the family a clear
understanding of brain death and involve a transplant coordinator
early in the donation process. Separating donation request from the
bad news conversation is not necessary when the family accepts the
loss of their loved one and is ready for the next step. Also, ICU
physicians trained in CaD seem to have higher consent rates than
non-ICU physicians who were not trained.
REFERENCE(S)
1. Annual report 2015 of the Dutch Transplant Foundation. Available
at: http://www.transplantatiestichting.nl/sites/default/files/product/
downloads/nts_jaarverslag_2015.pdf.
2. Jansen NE, et al. Organ donation performance in the Netherlands
2005–08; medical record review in 64 hospitals. Nephrol Dial
Transplant 2010;25(6):1992–7.
GRANT ACKNOWLEDGMENT
None
Poster Corner Sessions Wednesday, 27
September 2017
Monitoring invasive and non-invasive ventilation
0968
How to assess FiO2 delivered under oxygen mask in clinical
practice?
R. Coudroy1,2, A.W. Thille1,2, X. Drouot2,3, V. Diaz2,3, J.-C. Meurice2,4, R.
Robert1,2, J.-P. Frat1,2, FLORALI study group
1CHU de Poitiers, Service de Réanimation Médicale, Poitiers, France;
2INSERM CIC 1402, Poitiers, France; 3CHU de Poitiers, Service de
Neurophysiologie, Poitiers, France; 4CHU de Poitiers, Service de
Pneumologie, Poitiers, France
Correspondence: R. Coudroy
Intensive Care Medicine Experimental 2017, 5(Suppl 2):0968
INTRODUCTION. The actual FiO2 delivered under oxygen mask in
patients with acute respiratory failure and the factors that may
influence the FiO2 are poorly known. In clinical practice, different
methods including formula or conversion tables based on oxygen
flow can be used to estimate delivered FiO2.
OBJECTIVES. We aimed to assess first the factors influencing
measured values of FiO2, and second the best method to estimate
measured FiO2 in patients breathing under oxygen mask.
METHODS. We included ICU patients admitted for acute hypoxemic
respiratory failure from a previous prospective trial (1) in whom FiO2
was measured under oxygen mask using a portable oxygen analyzer.
We collected demographic variables and respiratory parameters that
may influence measured FiO2. Low FiO2 was defined according to
median measured FiO2.
For each patient, measured FiO2 was compared to “Calc + 3%”
formula (FiO2 = oxygen flow in liters per minute x 0.03 + 0.21) to
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 487 of 542“Calc + 4%” formula (FiO2 = oxygen flow in liters per minute x
0.04 + 0.21), and to a conversion table (2). A ±10% limit of
agreement for each estimation method was arbitrarily considered
acceptable.
RESULTS. Among the 265 patients included, oxygen flow was 15
[12–15] l/min and measured FiO2 was 65% [60–73]. After adjustment
on oxygen flow, the three variables independently associated with
low measured FiO2 using multivariate analysis were patient's height,
a low PaCO2, and a respiratory rate greater than 30 breaths/min.
Values outside the limits of agreement accounted for 55% of cases
for the Calc + 3% formula, 69% for the Calc + 4% formula, and 94%
for the conversion table (p < 0.0001). As compared to measured
FiO2, an overestimation of more than 10% was observed in 18% of
cases for the Calc + 3% formula, 62% for the Calc + 4% formula and
94% for the conversion table (p < 0.0001).
CONCLUSIONS. The 3 strong predictors of low FiO2 delivered under
mask were tallness, high respiratory rate and low PaCO2. None of the
tested methods estimated accurately measured FiO2 in patients with
acute respiratory failure breathing oxygen through a mask. The
Calc + 4% formula and the conversion table overestimated measured
FiO2 values in most of cases, therefore artificially overestimating the
severity of hypoxemia using the PaO2/FiO2 ratio.
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INTRODUCTION. Electrical activity of the diaphragm (Edi) can reflect
respiratory drive. Edi monitoring during mechanical ventilation
allows clinicians to detect patient-ventilator asynchrony and overas-
sistance. However, interpretation of Edi values following extubation
after pediatric cardiac surgery is difficult because reference values
are lacking. Moreover, no information is available about the time
course of Edi value following extubation in this cohort.
OBJECTIVES. The aim of this study was to investigate the Edi values
of 24-hours time course following extubation after pediatric cardiac
surgery.
METHODS. This was a prospective observational study. Institutional
Review Board approved this study. Children less than 16 years of age
who underwent cardiac surgery were included. A specific nasogastric
tube (NAVA catheter; Maquet, Solna, Sweden) was inserted after
surgery and adjusted the position of catheter by chest radiography
and "NAVA catheter positioning screen" on the ventilator (Servo-I,
Maquet, Solna, Sweden). We recorded Edi values every 1-minute
from 1-hour before extubation to 24-hours after extubation period.
These data included inspiratory peak Edi (Edi-peak) and expiratory
minimum Edi (Edi-min). These data were stored in ventilator soft-
ware. Among these data, we used Edi-peak for analysis.
RESULTS. Thirty-three patients were included in the study. The me-
dian age was 13.5 (IQR: 2.3-27.3) months of age. The median RACHS-
1 score was 3 (2–3). A total of 25 children (75%) underwent correct-
ive operation. Twenty-six children (78%) were extubated in ICU. Dur-
ation of mechanical ventilation was 24.5 (0.6-71.2) hours. All children
received CPAP + PS mode before extubation. High-flow nasal can-
nula ((prophylactic use (n = 3), therapeutic use (n = 3)) was used for6 children (18%). There was no reintubation. Dexmedetomidine was
used for 23 children (70%).
The median Edi value during 24-hours course postextubation period
was 7.3 (6.8-7.8) μV. This value was close to that in patients with nor-
mal pulmonary function as previously reported. No significant
change was observed in median Edi value between 0 to 1 hour be-
fore extubation (6.3 (3.1-10.8) μV) and 0 to 1 hour after extubation
(7.3 (2.6-14.1) μV) (P = 0.12). Against our expectations, no remarkable
change of Edi value was observed throughout the 24-hours course
following extubation period (The lowest median Edi value = 6.0 (3.8-
14.2) μV at 8 to 9 hours, the highest median Edi value = 10.4 (6.0-
14.9) μV at 23 to 24 hours following extubation). There were no cor-
relation on Edi values with age, body weight, and RACHS-1 score.
CONCLUSIONS. No remarkable change of Edi value was observed
throughout the 24-hours course following extubation after pediatric
surgery. Median Edi value of 24-hours course of postextubation pe-
riods was 7.3 (6.8- 7.8) μV in this cohort.
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INTRODUCTION. Transcutaneous (PtcCO2) pCO2 monitoring provide
the measurement of pCO2 noninvasively and continuously. The
oxygen saturation can also be monitorized with these monitors. But
the results of studies on how well PtcCO2 reflects the arterial CO2
pressure (PaCO2) are contradictory.To evaluate the matching of
PtcCO2 measured with PaCO2; and to find out that we can reliably
reduce the need to take arterial blood gases (ABG) with these
monitors.
OBJECTIVES. To evaluate the matching of PtcCO2 measured with
PaCO2; and to find out that we can reliably reduce the need to take
arterial blood gases (ABG) with these monitors.
METHODS. Patients who were referred to the intensive care unit
(ICU) were included in this study, and PtcCO2 measurement and ABG
analysis were performed to determine the consistency between the
results.
RESULTS. Thirty measurements were taken from the deltoid zone
and 26 from the cheek zone of thirty-four patients. Five of 35 pa-
tients (14%) could not be measured from the deltoid region. The sat-
uration and pulse rate were not detected at 8 of the deltoid zone
measurements (26,7%). When it is analyzed that the consistency be-
tween the ABG values and the PtcCO2 measurement; correlation co-
efficients between PtcCO2 and PaCO2 from the deltoid and the
cheek region were r:0,915 and r:0,946 (p = 0,0001). In comparison
with the Bland-Altman method, the mean of the differences in the
deltoid measurements was −1,38 ± 1,18 (p = 0.252) and the mean of
the differences in the cheek measurements was −5,12 ± 0,92
(p = 0,0001). When the saturations were compared, no significant dif-
ference was found between the measurements of each region.
CONCLUSIONS. These results suggest that transcutaneous PtcCO2
and saturation measurements made from the deltoid region can be
used instead of arterial blood gas analysis. With increasing patient
numbers, it will be possible to determine the sensitivity of the
measurement and to determine the conditions such as the weight of
the disease, blood pressure, hemoglobin level, measurement area
that can affect the measurement.
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INTRODUCTION. After extubation, patients are at risk of
complications that could potentially worsen their prognosis. Early
identification of inappropriate diaphragm and intercostal activity
may help to implement preventive strategies.
OBJECTIVES. To describe the level of activity displayed by the
diaphragm and intercostal muscle in extubated patients.
METHODS. Patients who were intubated since at least 48 hours and
who successfully passed a spontaneous breathing trial were enrolled
in the study. Within the two hours following extubation, we used
ultrasound to measure diaphragm (TFdi) and intercostal (TFic)
thickening fraction as surrogates of muscle activity.
RESULTS. Preliminary data concerning the first 39 patients are
presented. Patients were ventilated since 6 (3–8) days on the day of
extubation, SOFA score was 4 (3–5) and pre-extubation rapid shallow
breathing index was 50 (40–70) breath.min−1. TFdi and TFic were ob-
tained in 36/39 patients. TFdi was 17% (14–23) and TFic was 7% (4–
9). TFdi lower than 20% (as a surrogate of diaphragm weakness (1))
was found in 22/36 (61%) patients and TFic higher than 5% (as an ar-
bitrary surrogate of intercostal recruitment) was found in 10/36
(28%) patients.
CONCLUSIONS. These preliminary data confirm that diaphragm
weakness is frequent during the weaning period. Intercostal muscle
recruitment is present in one third of patients being extubated.Whether assessment of intercostal recruitment by ultrasound may
help to identify patients at high risk of post extubation complications
should be now determined.
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INTRODUCTION. Excessive stress and strain during Mechanical
Ventilation (MV) may induce Ventilator-Induced Lung Injury (VILI). Re-
cent studies have asserted the importance of Driving Pressure (ΔP)
and Mechanical Power (MP) when titrating MV [1,2]. However, ΔP
and MP reflect the mean mechanical properties of the lung and can-
not distinguish possible heterogeneity in the parenchyma. Injurious
focal stress and strain levels can occur long before the mean mea-
surements of lung mechanics deteriorate.
OBJECTIVES. The aim of the study was to compute the topographical
distribution of the elastic energy inside lung parenchyma combining
information obtained by Computer Tomography (CT) with spirometric
tracings, quantify the heterogeneity of energy distribution and assess
whether it had any correlation with respiratory parameters sampled at
the Airway Opening (AO).
METHODS. We studied eleven mechanically ventilated patients (age
55–87) without pulmonary pathologies. Flow, volume and pressure
were sampled at AO, together with esophageal pressure. CT-scans
were performed at mid-thoracic level at nine different lung volumes
during hold maneuvers: at Functional Residual Capacity and from 4
to 11 ml/Kg (in steps of 1 ml/Kg), keeping a Positive End Expiratory
Pressure (PEEP) of 5 cmH2O. Image analysis was performed by the
Image Processing Toolbox for MatLab R2016a. Coupling information
from the CT-images with ventilator data allowed to create distribu-
tion maps of compliance, strain and ultimately elastic energy. In
order to assess the heterogeneity of energy distribution we used the
iterative function of Quadtree Decomposition, which can identify
homogeneous areas of the parenchyma. The correlation between the
level of heterogeneity and different global breath parameters (ΔP,
plateau pressure, transpulmonary pressure and tidal volume) was in-
vestigated as well as the correlation between the elastic energy con-
tent derived from the energy maps and the elastic energy of the
respiratory system at the studied volumes measured at AO.
RESULTS. We obtained the energy distribution maps of the eleven
patients. In the single patients we found different patterns of
correlation between the heterogeneity of energy distribution and the
global breath parameters mentioned before (p-value ranging
between 0.004 and 0.7). No statistically significant correlation was
found between the parenchymal content of energy and the mean
elastic energy calculated at AO.
CONCLUSIONS. We found the method of computing distribution of
elastic energy and quantifying parenchymal heterogeneity feasible.
Table 235 (Abstract 0973). The Bland-Altman analysis and R2 for Ers
Ers PSV
vs:
Means differences (SD),
(cmH2O/L)
95% Limits of
agreement
%
Error
R2
Iso* −4.25 (8.76) −21.77 to 13.28 29.66 0,42
MLR −4.15 (8.72) −21.6 to 13.29 29.49 0,43
TC −7.15(7.09) −21.35 to 7.04 24.39 0.65
Occ −8.52(10.94) −30.4 to 13.36 39.94 0.13
fft −1.51(7.12) −15.75 to 12.74 23.05 0.62
Table 236 (Abstract 0973). The Bland-Altman analysis and R2 for Rrs
Rrs PSV
vs:
Means differences (SD), (cmH2O/
L/sec)
95% Limits of
agreement
%
Error
R2
Iso* 1.34 (5.4) −9.47 to 12.15 32.67 0.16
MLR 0.54 (5.59) −10.65 to 11.24 34.66 0.11
TC 3.29 (6.31) −9.07 to 15.65 36.05 0.02
Occ 2.67 (5.6) −8.53 to 13.87 32.57 0.16
fft 0.81 (5.12) −9.45 to 11.07 32.49 0.22
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 489 of 542The fact that correlation between parenchymal elastic energy and
AO parameters can display different behaviors may indicate that at
parenchymal level, elastic energy distribution may be influenced by
another set of local mechanical properties that cannot be
assessed at AO.
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INTRODUCTION. Noninvasive methods have been developed for the
calculation of respiratory mechanics during pressure support
ventilation (PSV), this techniques on based on resistance (Rs) and
elastance (Ers) data of respiratory system obtained during relaxed
ventilation using a linear regression (1), assuming constant
respiratory system Rrs and Ers with linear relationship between flow,
volume and pressure. However, during spontaneous ventilation the
are dynamic nonlinearity relate to frequency dependence (2) and
other phenomena as pendelluft, turbulences and inertial forces (3,4).
OBJETIVES: To evaluate the fit between the respiratory mechanics
obtained during mechanical ventilation controlled (CMV) by five
methods and the data obtained during PSV by a new method based
on calculation of instantaneous muscle pressure (pmus), distending
pressure (DP) and total pressure (TP) by the equation of motion (EM).
METHODS. We studied a group of mechanically ventilated patients
during CMV with constant flow and relaxed, due to acute respiratory
failure of different diseases and at PSV mode. Airway, esophageal
pressure, and airway flow were recorded, sampling 561 Hz. Elastance
(Ers) and Resistance (Rrs) of respiratory system were obtained from
multiple linear regression (MLR), time constant (TC), occlusion (Occ),
fast Fourier transform (fft) and new method variant of isovolume
technique (iso*). This data were compare with obtained with PSV by
calculation pmus by substraction of chest wall elastic load from Pes,
DP, and TP using EM. Data are expressed as mean (SD) in absolute
values, and as a percentage. The comparison of the data was made
using one-way ANOVA, and Bonferroni post-hoc. The Bland-Altman
analysis and linear regression was applied to assess the agreement.
RESULTS. 30 patients were studied. For all data: Ers: Iso*27.41 ± 7.85
cmH2O/L; MLR 27.49 ± 7.83 cmH2O/L; TC 24.5 ± 7.36 cmH2O/L; Occ
23.13 ± 6.32 cmH2O/L; fft 30.15 ± 8.33 cmH2O/L. PSV: 31.65 ± 11.51
cmH2O/L.Rrs: Iso* 17.2 ± 3.58 cmH2O/L/sec; MLR 16.41 ± 3.36
cmH2O/L/sec; TC 19.15 ± 3.61cmH2O/L/sec; Occ 18.53 ± 4.21cmH2O/
L/sec; fft 16.67 ± 3.54cmH2O/L/sec. PSV: 15.86 ± 5.71 cmH2O/L.Ers
PSV vs Tc and Occ: p < 0.05. The mean comparison between Rrs did
not show statistical differences. The concordance analysis is shown in
the Tables 235 and 236 for Ers and Rrs, respectively.
CONCLUSIONS. The wide dispersion and agreement make it
unacceptable to superpose respiratory mechanics data obtained
from controlled ventilation to pressure support ventilation,
particularly in the resistances.
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INTRODUCTION. Airway occlusion pressure (P0.1) is a non-invasive
measurement reflecting the patient's respiratory drive and estimating
inspiratory effort. It could become an important tool to monitor
spontaneously breathing patients under mechanical ventilation. Mod-
ern ventilators display P0.1 but their accuracy is unknown.
OBJECTIVES. To compare P0.1 given by 5 ventilators (P0.1vent) and
P0.1 measured offline from airway pressure tracing (P0.1ref)
1) using a bench simulation study and
2) in patients breathing spontaneously under assisted ventilation.
METHODS.
1) Simulation
A lung simulator (ASL 5000) was connected to 5 ventilators (Maquet
SERVO-i, SERVO-u, GE Engström, Draeger Evita-XL and Puritan-
Bennett 840). Normal and obstructive lungs were used with 24
patterns of inspiratory effort. SERVO-i and SERVO-u give P0.1 for
each breath (5 consecutive P0.1vent recorded and 3 additional
occlusions done). Other 3 ventilators need activation of a P0.1
manoeuver to display P0.1 (3 manoeuvers activated).
2) Patients
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 490 of 542Data from 2 studies on inspiratory effort during mechanical
ventilation were analyzed (STUDY1: 13 patients, 25 recordings using
Evita-XL and STUDY2: 10 patients, 20 recordings using 840). P0.1
manoeuvers were activated randomly, with P0.1vent recorded and
P0.1ref measured. Variability of P0.1 was also assessed.
Bland and Altman method was used to assess accuracy and
precision.
RESULTS
1)Simulation(Fig. 312)
Absolute bias for SERVO-u, SERVO-i, Engström were similar and low
(between 0.3 and 0.4cmH2O). However, for SERVO ventilators bias
was negative (ie underestimation of P0.1ref) and became more
negative at high values. For Engström bias was positive and stable
across the range of P0.1. Limits of agreement for SERVO ventilators
and Engström were large (SD close to 1cmH2O). Accuracy and
precision of SERVO ventilators was improved by using a pressure
trigger.
For Evita-XL and 840, accuracy and precision of P0.1 was good (bias
0.3 and 0.1cmH2O) with narrow limits of agreement (SD 0.3 and
0.1cmH2O).
2) Patients
Both ventilators had low bias: −0.1 cmH2O for Evita-XL and
0.02cmH2O for 840. Limits of agreement of individual comparisons
were considerably larger than in the bench simulation (SD 1.0 and
1.2cmH2O respectively). When the average of 3 consecutive P0.1 was
analyzed, limits of agreement were smaller (SD 0.7 and 0.6cmH2O
respectively).
Coefficient of variation of P0.1ref in patients in STUDY1 was 20% (10-
80%) and in STUDY2 40% (10-90%).
CONCLUSIONS. Bias for all the ventilators was acceptably low.
However, the precision of SERVO and Engström was low. SERVO
ventilators significantly underestimated P0.1, mainly at higher values;
accuracy improved with pressure trigger. Precision of 840 and Evita-
XL was better but lower in patients than on the simulation, and
variability of P0.1ref was very high. The average of at least 3
consecutive values of P0.1 should be recommended in clinical
practice.Fig. 312 (Abstract 0974). Bench simulation-Bland and Altman0975
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INTRODUCTION. Lung protective ventilation (LPV) strategies use
lower end-inspiratory (Pplateau) airway pressures, lower tidal volumes
(VT) and positive end-expiratory pressures (PEEP) and have been as-
sociated with survival benefits in randomized clinical trials involving
patients with the acute respiratory distress syndrome (ARDS) and insurgical populations. Individual lung mechanics is determined by
lung size and lung compliance. Then, a LPV strategy should adjust
ventilation parameters to the factual functional size and compliance
of the lung. There are two common methods to obtain driving pres-
sure (ΔP): the difference between PIP and PEEP (dynamic) and the dif-
ference between Pplateau pressure and PEEP (static). PPlateau were not
available, therefore dynamic measurement were used.
OBJECTIVES. Evaluation of ventilation settings and assessment of ΔP
used during surgery.
METHODS. We prospectively collected self-reported initial ventilator
settings, and those adjustments recorded during surgery, from 140
unselected patients undergoing a variety of surgical interventions.
RESULTS. We obtained 195 matching data (PIP and PEEP) points. The
mean dynamic ΔP was 17.17 cmH2O (9–33). For patients ventilated
with volume assisted ventilation (VAV) the mean pressure was 17.35
cmH2O and for those ventilated with pressure assisted ventilation
(PAV) 17.05 cmH2O (9–28). The median tidal volume used
perioperatively in both males and females was 500 ml, ranging from
450-715ml (males) and 325-575ml (females), There were no statistical
significance differences among volumes delivered between the two
modes of ventilation PAV, VAV or ΔP. However, 33.6% fall outside of
6-8ml/kg PBW range. PEEP was applied in 75% of cases. The level of
PEEP ranged from 0 cmH2O to 11 cmH2O. PEEP of 2-8cmH2O was ad-
ministered in 92 cases (73.6%). The most frequently applied level of
PEEP was 5cmH2O (38.4%) and zero (25%).
CONCLUSIONS. The results are somewhat unexpected as the driving
pressure used was higher than reported for this group of surgical
patients without major lung comorbidities. However, dynamic
measurements are influenced by airway resistance and segmental
pulmonary time constants that may have influenced these results.
Delivered VT were relatively higher in females, in relation to their
predicted body weight; nevertheless, only a third were greater than
8ml/kg and only 15% above 10ml/Kg. The PEEP applied to these
surgical patients was relatively low, comparing with patients
reported with lung injury. Surprisingly, the use of zero PEEP was
relatively high (25%). In conclusion, to comply fully with a current
recommendation for lung LPV strategy a further educational effort
will be necessary.
REFERENCE(S)
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INTRODUCTION. Ideally, assisted ventilation should support
spontaneous work of breathing and normalize the neuro-ventilatory
drive. The diaphragmatic electrical activity (EAdi) can be continuously
monitored at the bedside through the NAVA catheter tool (Servo i
ventilator, Maquet) and is a reliable surrogate of the neuro-
ventilatory drive. Pressure support ventilation (PSV) is the most
widely used mode of assisted ventilation and is commonly set on
clinical basis, by keeping tidal volume (VT) between 5 and 8 ml/PBW
and respiratory rate (RR) between 15 and 30 b/min.
OBJECTIVES. To evaluate to what extent the clinical PSV setting
impacts on the neuro-ventilatory drive, expressed in terms of EAdi.
METHODS. EAdi was continuously recorded in 10 patients during 12
hours of PSV (from 8 am to 8 pm). Patients were kept at a light
sedation level (RASS score from 0 to −1). The total number of
mechanical breaths was calculated. For each mechanical breath the
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 491 of 542EAdi peak, VT and RR were also measured. The EAdi peak was
classified as:
- NO: EAdi below 1 μV
- LOW: With EAdi between 1 and 5 μV
- NORMAL: with EAdi between 5 and 15 μV
- HIGH: with EAdi over 15 μV.
RESULTS. The results are expressed as mean ± SD. Figure 313 shows
that the 48 ± 30% of the breaths presented a”NORMAL” EAdi,
according to manufacturer specifications, suggesting an adequate
neuro-ventilatory drive and hence an optimal PSV assistance.The
LOW EAdi breaths were 28 ± 26%. The NO EAdi breaths were
9 ± 16% (range 0,24 - 50%). The High EAdi breaths were 15 ± 13%.
The breathing pattern parameters (Table 237) were not significantly
different in the 4 breaths cathegories.
CONCLUSIONS. The relevant amount of NO, LOW and HIGH Eadi
breaths suggests that periods of, respectively, over-assistance and
under assistance frequently occur during PSV. Of note, the breathing
pattern parameters did not differ between the “NORMAL” and the
“LOW, NO and HIGH” EAdi breaths and, furthermore, were in the clin-
ical range of “adequate” PSV setting. EAdi monitoring is a promising
tool to reveal the quality of assistance during PSV.
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ratio in invasive mechanically ventilated adults at a tertiary care
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INTRODUCTION. Certain patients may not require invasive arterial
line for blood pressure monitoring... whether there is a
correlation between the P/F ratio, SpO2/FiO2 ratio, OI and OSI,
and hence whether monitoring of SpO2/FiO2 and OSI (in lieu of
P/F) would give equivalent information without compromising on
information. The same idea hold true even for many patients
who are financially non-affording, even for invasive arterial lines.
To know if there is a correlation between PaO2/FiO2 ratio and
oxygenation index
OBJECTIVES. PaO2/FiO2 (P/F) ratio is used to determine
oxygenation status among mechanically ventilated adults, but
requires arterial puncture and does not account for mean airway
pressure (MAP). Oxygen Index (OI = MAP x FiO2 × 100 ÷ PaO2)
may be more representative of oxygenation, while Oxygen
Saturation Index (OSI = MAP x FiO2 ÷ SpO2) can be continuously
measured through non-invasive pulse oximetry. We evaluated the
correlation among P/F ratio, OI, and OSI in adults post-invasive
mechanical ventilation.
METHODS. Data were prospectively collected from hospital
records and arterial blood gases were recorded at the time of
the order for patients ≥ 18 years who were under invasive
(endotracheal intubation) mechanical ventilation at medical or
surgical wardsfrom December 2015 to August 2016. Only patients
with reliable pulse oximetry (SpO2) measurements were included.
FiO2, MAP and SpO2 were recorded at the time of daily arterial
blood gas sampling (PaO2). OI and OSI were calculated based on
these measures. Linear mixed effect models were used to
estimate the correlation coefficients between repeated measures
of P/F ratio and OI, PF/Ratio and OI, and OI and OSI using PROC
MIXED in SAS 9.4.
RESULTS. A total of 203 measurements for 70 patients were
collected over a maximum of 11 days after mechanical
ventilation (day 1). Mean age was 60.4 years (standard deviation
(SD) 14.0) and 62.9% (n = 44) were males. On the day 1 of
mechanical ventilation, 44.3% (n = 31) and 24.3% (n = 17) of
patients had a P/F ratio < 300 and < 200 respectively, and
15.7%, 20%, 18.6%, 20%, 20%, and 5.7% of patients had a SAPS II
score of 0–29, 30–40, 41–52, 53–64, 65–77, and ≥78. Mean P/F
ratio, OSI, and OI was 345.92 (SD 148.51), 0.061 (SD 0.042), 4.88
(SD 5.22) over 203 observations respectively. The relationships
between these measures were non-linear. After natural log trans-
formation, the correlation between P/F ratio and OI (r = −0.94)
and OI and OSI (r = 0.82) were strong, but weaker between P/F
ratio and OSI (r = −0.69).
CONCLUSIONS. There was strong correlation between P/F ratio and
OI, and OI and OSI measurements among adults under invasive
mechanical ventilation. Future studies are needed to evaluate
whether monitoring OSI and/or OI over P/F ratio will impact
treatment outcomes.
REFERENCE(S)
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Table 238 (Abstract 0979). RVM's bias, precision, and accuracy
CPAP 0 CPAP 5 PS 5 P-value
% ml % ml % ml
BIAS 3.5 20.4 −0.2 −7.6 −2.3 −14.9 0.66
PRECISION 4.3 24.1 2.9 14.2 5.9 32.7 0.33
ACCURACY 8.3 51.6 11.8 62.7 9.9 58.6 0.54
Fig. 314 (Abstract 0979). See text for description
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INTRODUCTION. Failure of extubation is associated with high
mortality rate. Cough strength measured with peak expiratory flow
(PEF) is a strong predictor of success or failure (1). The respiratory
assistance in patients with weak cough and risk of extubation failure
can reduce reintubation (2).
OBJECTIVES. We evaluate the prognosis of prophylactic noninvasive
assistance respiratory in patient with high risk (PEF < 60 L/min).
METHODS. Prospectively collected data from December 2014 to
March 2017. PEF was measured with Cosmed Pony Graphic®
spirometer v4.0 before extubation. We included patients
mechanically ventilated >24h, without tracheostomy, who passed
successfully a spontaneous breathing trial at least of 30 min on
pressure support ventilation 5–8 cmH2O, CPAP, or T-T. Weak cough
was defined by PEF < 60 L/min, the patients were then extubated re-
gardless the PEF. We applied prophylactic noninvasive ventilation
(BiPAP/CPAP) or high flow nasal cannula (HFNC) in the patients with
PEF < 60 L/min, and conventional oxygen if PEF > 60 L/min. Demo-
graphic and clinical characteristics data were collected and compared
between boths groups, according to the PEF. Extubation failure was
defined by the need of reintubation within 48h following extubation.
Continuous variables were expressed as mean ± SD or median (IRQ)
and categorical variables as absolute value and percentage. Differ-
ences between groups were assessed using the Fisher exact test;
Mann–Whitney U test or Student´s t -test as appropriate.
RESULTS. 212 Patients were studied, 140 males (66%); 59.75 ± 13.77
years. PEF < 60 L/min was identified in 63 (29.7%) patients. Patients
with PEF < 60L/min presented a higher proportion of underlying
COPD (26.6% vs 9.5%, p =0.04). Prophylatic assistance was effectively
applied to 71% of the patients with PEF < 60 L/min, as CPAP 17,7%
and BiLevel 35,5%, HFNC 46,8%. Extubation failure: Total 40 (18,9%)
patients, PEF < 60L/min 18(28.6%) vs PEF >60 L/min 22(14.8%)
(p = 0.02), RR = 0,4 (0.21-0.88). We found not differences between
diagnosis and extubation failure. Duration of mechanical ventilation:
7.22 days (PEF < 60L/min) vs 5.44 days (PEF >60L/min), p = 0.05. Not
differences in total stay in ICU between both groups, but we found
significant differents in the patients that need reintubation
(p = 0.00). Mortality was more higher in those patients with PEF < 60
L/min (19,4% vs 7,6%, p = 0.017).
CONCLUSIONS. The patients with PEF < 60/L/min had four times
more extubation failure, however, the rates of reintubation are less
than the data public for similar group at risk (2). We could speculate
that application of prophylactic respiratory assistance in patients
with weak cough could be reduce risk of extubation failure, as
mortality. BiPAP mode was the assistance more effective, perhaps
relate to more proportion of COPD in the group of risk.
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INTRODUCTION. Non-Invasive Ventilatory Support (NIVS, e.g., CPAP,
BiPAP, High-flow O2) is currently used across the continuum of care. Inthe critical care setting, NIVS can help reduce the time patients spend
on mechanical ventilation to help reduce complications. Currently, it is
challenging for clinicians to both evaluate the need but also the effect-
iveness of NIVS. We wanted to test the ability of a recently developed
non-invasive respiratory volume monitor (RVM, ExSpiron, Respiratory
Motion, Waltham, MA, USA) that provides continuous measurement of
minute volume (MV), tidal volume (TV), and respiratory rate (RR) to pro-
vide this monitoring in such conditions of ventilation. The RVM has pre-
viously been shown to have better than 10% accuracy for MV, TV, and
RR in both non-intubated and intubated patients.[1,2]
OBJECTIVE. Evaluate the RVM's accuracy when monitoring healthy
subjects under NIVS.
METHODS. Six healthy subjects completed this pilot study (3 males,
BMI = 21.1 kg/m2 (19.1-23.1)). MV, TV, and RR data were
simultaneously recorded by the RVM and Ventilator (Engström
Carestation, GE Healthcare) for 3, 5 min-long trials under different
vent settings: CPAP 0 cmH2O (CPAP0), CPAP 5 cmH2O (CPAP5), and
pressure support 5cmH2O with PEEP 2 cmH2O (PS5). Relative errors
between RVM and Ventilator measurements of expired TV (from
proximal flow sensor) were calculated over 1 min segments and bias,
precision, and accuracy were calculated using Bland-Altman analyses.
All data are presented as mean ± SEM. One-way ANOVAs were per-
formed to compare RVM measurement bias, precision, and accuracy
between the different ventilator modes.
RESULTS. Subjects maintained an average MV of 7.1 ± 0.9 L/min, with
individual breath TVs ranging from 81 to 1371mL and RRs ranging
from 5.0 to 35.7bpm. During spontaneous breathing (CPAP0)
measurement bias in TV measurements between the RVM and the
Ventilator was 3.5 ± 3.1% with a precision of 4.3 ± 1.4% and an overall
accuracy of 8.3 ± 1.5%, corresponding to measurement error of
51.6 ± 9.4mL (Table 238). During NIVS trials (CPAP5 and PS5),
measurement bias, precision and accuracy remained practically
unchanged (p = 0.66, 0.42, and 0.54, respectively). Figure 314a displays
the strong correlation between RVM and Ventilator TV measurements.
Figure 314b shows that the difference between RVM and Ventilator TV
measurements is similar across the range of measured TVs. Figure 315
depicts that volume traces from the RVM and Ventilator are highly
correlated (R ≥ 0.95) for all three Ventilator setting trails.
CONCLUSION. RVM provides clinically-relevant accuracy when moni-
toring healthy subjects under non-invasive ventilatory support in
order to evaluate its effectiveness. This study is consistent with previ-
ous studies evaluating the accuracy of the RVM compared to spirom-
etry and mechanical ventilation.
REFERENCES
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Fig. 315 (Abstract 0979). See text for description
Fig. 316 (Abstract 0980) See text for description
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INTRODUCTION. Recently, ventilators have been equipped with
volumetric capnography (VC), and measuring exhaled CO2 as volume
(VCO2) has become convenient. Because CO2 is an endproduct of the
body's metabolism, VCO2 reflects the patient's metabolic state. To measure
VCO2, all exhaled gas must be collected from the patient. Therefore, studies
are done in a closed circuit, such as intubated patients. The Hamilton G5
(Hamilton Medical, Switzerland) is a VC-equipped ventilator that can also
apply NPPV with a double circuit, which enables simultaneous collection
exhaled gas from the patient and measurement of the amount of leak. It is
better to have no leaks to measure VCO2, but in clinical practice, it is impos-
sible to set the mask without a leak. The leak is also needed to reduce CO2
rebreathing caused by the dead space of the interface.
Therefore, we conducted a study to evaluate the relationship
between measured VCO2 and leaks by using a respiratory model
with known and steady CO2 exhalation and to see if VC can measure
VCO2 in a condition mimicking NPPV.
OBJECTIVES. To evaluate whether VC can measure VCO2 with a leak
mimicking NPPV.
METHODS. The spontaneous breathing model (LUNGOO: Air Water
Safety Service, Japan) was used as a lung model with these
settings:compliance,50 ml/cmH2O; resistance, 10 cmH2O/L/s; inspiratory
time,1 second; tidal volume,500 ml; and respiratory rate,15 breaths/
minute. CO2 was infused in this lung model to reach a VCO2 of 200 ml/
min, measured by the VC in the ventilator connected to the lung
model. The Hamilton G5 ventilator was set on NIV mode with a PS of 5
hPa, PEEP of 5 hPa and a flow trigger of 3 L/min. An adjustable leak
port was inserted between the lung model and the ventilator circuit.
The amount of leak measured by the ventilator was changed from 0
to 80%, and VCO2 measured by the VC was recorded.
RESULTS. VCO2 at a leak rate of 0% was 207 ml,a value equivalent to
measured VCO2 in the IPPV mode. The amount of leak and measured
VCO2 had a strong negative correlation (R
2 = 0.96). With leaks under
25%, there were differences between the actual and estimated VCO2
(obtained by multiplying the collecting ratio [1-leak ratio] by the
actual VCO2, which was 200 ml/min in this model[dotted line in Fig.
316]). These differences were thought to be caused by excess leak
compensation flow that diluted measured CO2 and increased the
leak during exhalation, which leads to an underestimation of VCO2.Therefore, to estimate actual VCO2 with NPPV using a Hamilton G5,
divide the VCO2 measured with a leak over 25% by the collecting
ratio.
This measurement of VCO2 with NPPV may allow us to distinguish
patients with dyspnea, whether they have infection (high inflammatory
status) or not. Further bench and clinical study is needed.
CONCLUSIONS. The VC in an NPPV-mimicking condition may assist in
estimating actual VCO2 when it is considered with the amount of leak.
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INTRODUCTION. A strict correlation between unsuccessful non-
invasive ventilation (NIV) and poor outcome has been suggested,
particularly in de-novo ARF patients [1].
OBJECTIVES. The aim of the present pilot study is to assess whether
diaphragm thickening (DT) as measured by ultrasound may predict
NIV outcome in patients with de-novo ARF admitted to the
Emergency Department (ED) at Gemelli's Hospital, Rome-Italy.
METHODS. All consecutive patients with de-novo ARF requiring NIV
treatment through a facial mask were included into the study. The
exclusion criteria were age < 18 years, pregnancy, diaphragm paraly-
sis, neuromuscular disorders, COPD, severe obesity (BMI > 35), pallia-
tive NIV, ineffective cough and/or inability to protect airways.
NIV success was defined as the improvement in dyspnea and gas
exchange, as well as the decrease in respiratory rate (RR) ≤ 25
breaths/min within the first 96 hours of the study.
NIV failure was defined as the need of ETI and/or failure to reach an
improvement in dyspnea and gas exchange, as well as the decrease
in RR ≤ 25 breaths/min at any point of the study.
DT was measured as previously described [2] by 2 trained operators
at baseline, at 1 hr, at 4 hours and 12 hours in the first 24 hours of
ED treatment and then at any 24 hours until the next 96 hours.
Receiver operating characteristic (ROC) curve analysis was performed
to assess DT ability to discriminate between patients who succeeded
weaning and those who failed.
RESULTS. Nine of the 20 screened patients were enrolled into the
study (5 M and 4 F). The median age and the SAPS II score
(interquartile range) were 77 years (71–83) and 46 (42–53),
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 494 of 542respectively. The NIV treatment was success in 3 of the 9 patients
(33%). We found an overall good repeatability of DT assessment,
with intra-class correlation coefficients well above the 0.96 with 95%
confidence interval from 0.94 to 0.98. The optimal criterion value for
DT that distinguished between NIV success and failure was the cut-
off > 33.3% and 37.3% for the operator 1 and 2 respectively (Figs.
317 and 318).
CONCLUSIONS. DT may represent a valid, feasible and non-invasive
method to predict NIV outcome in acutely ill patients with de-novo ARF.
However, larger studies are necessary to confirm our preliminary results.
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INTRODUCTION. Non-invasive ventilation is commonly used to treat
respiratory failure, allowing to reduce the risk of endotracheal intub-
ation and post-extubation respiratory failure1. A wide range of inter-
faces are available, but some concerns exist about carbon dioxide(CO2) rebreathing due to increased dead space related to the in-
ternal volume of the devices.2
OBJECTIVES. Objective of this study is the evaluation of a novel
mask with different access for inflow and outflow gas, in reducing
CO2 rebreathing.
METHODS. We compared, in a bench test, a traditional mask (with a
single connector with circuit) and the novel mask (DiMaxZero, Dimar,
Medolla, Italy) applied to a mannequin connected to a breathing
simulator (IngMar medical ASL 5000). A know CO2 flow was
delivered in the mannequin's trachea.
We recorded airway pressure, airflow and CO2 concentration (and
CO2 flow as the product of the two), testing all the following
different combinations: CPAP (with 60–90 l/min continuous flow and
Mechanical PEEP valve set at 8 cmH2O), Pressure Support of 6 and12
cmH2O (Medtronic Puritan Bennett 840) with zero and 15 l/min
Flow-By), with respiratory rate 15 and 30 bpm and with VCO2 of 200
and 300 ml/min, tidal volume was set at 500 ml.
RESULTS. Mean volume of CO2 rebreathed and minimum CO2
inspiratory concentration were significantly lower with the novel
mask compared to the traditional one in all condition tested (as
shown by the figure), except for two conditions.
The 15 l/min bias flow significantly decreased the CO2 rebreathing
with the novel mask, whereas it had no effect with the traditional
mask.
CONCLUSIONS. The novel mask design allows a lower CO2
rebreathing, both during CPAP and PSV, effect enhanced by the
adjunct of a flow-by.
Further studies are required to establish the clinical relevance of this.
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INTRODUCTION. Due to increased prevalence of multiresistant
bacteria (MRB), one of the goals of clinicians in recent years has been
to understand patient characteristics that increase the risk for
infection caused by MDR pathogens.
OBJECTIVES. To validate the Spanish Resistencia Zero (RZ) check-list
for MRB detection, as well as to find out other risk factors (RF) for
MRB colonization or infection.
METHODS. A prospective multicentric study during 2016.
Surveillance and/or diagnostic cultures were carried out in patients
admitted to ICU. We analyzed RF and comorbidities. Univariable and
multivariable analysis for MRB RF with binary logistic regression
methodology (p < 0,05) were performed.
RESULTS. A total of 2270 patients from 9 Spanish ICU were included,
288 (12,7%) of whom presented MRB at admission. One or more RF
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 495 of 542according to the RZ check-list were present in 68,1% of them, with
accumulation of risk. Having a RF, increased the probability of being
colonized or infected by MRB by 4,5 (IC 95% 3,5-6,0). The most com-
mon RF was previous hospitalization in the last months (28% of ad-
mitted patients).
Prior colonization by MRB was the strongest association with the
presence of MRB at ICU admission. All RF analyzed reached statistical
significance in the univariate analysis and 4 out of 6 did in the
multivariate analysis. Some comorbidities as immunosuppression, renal
failure and organ transplantation showed significance as added RF
(Table 239). At admission, 71.9% of MRB detected were colonization,
while 28.1% were infections. These findings could not be related with
increased mortality.
CONCLUSIONS. Patients who meet at least 1 RF from the RZ check-
list have an increased risk of being MRB carriers. However, more than
30% of MRB were detected in patients without RF, that lead us to
look for other comorbidities or situations (immunosuppression, renal
failure and organ transplantation) that help us to suspect and early
identify MRB.Table 239 (Abstract 0983). RZ Check list for MRB
RZ CHECK LIST OR (IC 95%)
UNIVARIATE
OR (IC 95%)
MULTIVARIATE
Hospitalization >5 days in prior 3 months 2,8 (2,2-3,6) 1,5 (1,1- 2,1)
Institutionalized patient 4,5 (2,6-7,9) 3,6 (1,9- 7,0)
Prior MRB colonization/infection 31,9 (20,8-48,8) 23,7 (15,1-37,4)
Antibiotherapy >7 days in prior month 4,2 (3,2-5,5) 1,8 (1,2- 2,7)
Chronic kidney disease with dialysis 3,2 (1,6-6,7) NS
Colonization susceptibility (bronchiectasis,
cystic fibrosis)
2,4 (1,3-4,2) NS
Table 240 (Abstract 0983). Comorbidities related to MRB
COMORBIDITY OR (IC 95%)
UNIVARIATE
OR (IC 95%)
MULTIVARIATE
Kidney failure 2,2 (1,7-2,9) 1,8 (1,4-2,4)
Immunossupression 2,3 (1,6-3,2) 1,8 (1,2-2,6)
Organ transplantation 3,9 (2,1-7,1) 1,3 (1,1-4,7)
Liver cirrhosis 1,7 (1,1-2,7) NS
Chronic obstructive pulmonary disease 1,4 (1,1-1,9) NS
Malnutrition 1,5 (1,2-2,0) NS
Diabetes mellitus 1,6 (1,2-2,0) NS0984
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INTRODUCTION. Carbapenem-resistant Klebsiella pneumoniae (CR Kp)
are endemic in Greece, whereas colistin resistant (COL-R) Kp are in-
creasingly reported (Mavroidi et al., 2016).
OBJECTIVES. The investigation of the incidence, spread and
molecular characterisation of CR Kp from bloodstream infections
(BSIs) in the ICU of a Greek hospital during 2014–2016.
METHODS. Identification of the isolates to the species level and
antibiotic susceptibility testing were performed by the semi-
automated system MicroScan® (Siemens Healthcare, PA, USA). The
minimum inhibitory concentrations (MICs) of imipenem, meropenemand colistin were additionally determined using the MIC Test Strips
(Liofilchem S.R.L), according to the interpretive criteria of the Clinical
and Laboratory Standards Institute (CLSI, 2015). Phenotypic screening
for carbapenemase production was performed by the boronic acid/
EDTA combined-disk test. DNA extraction was performed using the
QIAcube (Qiagen, Düsseldof, Germany). The presence of carbapene-
mase- and ESBL- encoding genes was confirmed by polymerase
chain reaction. Genotyping of the isolates was performed by
multilocus-sequence typing (MLST, http://bigsdb.pasteur.fr/klebsiella/
klebsiella.html). Clinical data of ICU patients with BSIs were reviewed
retrospectively and statistical analysis was performed by using the
Fisher exact test and the Mann-Witney U test.
RESULTS. CR Kp producers (n = 235) were isolated from bronchial
secretions (n = 92, 39.3%), blood (n = 50, 21.2%), CVCs (n = 39,
16.7%), urine (n = 28, 12%) and other clinical specimens of ICU
patients. During 2014–2016, a rise of Kp from BSIs was observed
(from 9.4% to 27% of CR Kp); the majority of them were blaOXA-48
(n = 25, 50%) and blaKPC (n = 13, 26%) producers. In 2014, only 3
blaKPC-producers of MLST ST258 from BSIs were documented.
During 2015, COL-R blaOXA-48-co-producing CTXM type enzymes of
MLST ST101 Kp were documented (n = 12, 60% of 20 CR Kp), while
they represented 48% (n = 13) of 27 CR Kp in 2016. All ICU patients
affected by blaOXA-48 producers were put under strict contact
?A3B2 show $132#?>isolation or cohort care, along with appropriate
infection control measures.The last patient affected by a blaOXA-48-
producer was documented on October 2016; thus, we assume that
the outbreak was successfully controlled. No statistical significant
differences were observed for the death rates, the APACHE II score,
the length of stay in the ICU and previous antibiotic treatment with
carbapenems and/or colistin between the blaOXA-48 producing and
other carbapenemase-producing Kp.
CONCLUSIONS. During 2014–2016, the rise in the incidence of CR Kp
from BSIs was mainly due to the emergence and dissemination of
COL-R blaOXA-48 producers of MLST ST101. The outbreak was suc-
cessfully controlled by implementation of strict infection control
measures.
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INTRODUCTION. One of the recommendations of the Spanish
“Resistencia Zero” Program (RZ) is to complete a check list upon
patient admission in Intensive Care Unit (ICU) to identify those
patients at high risk for colonization or infection by multiresistant
bacteria (MRB).
OBJECTIVES. To search the relation between most common MRB and
specific risk factors (RF) for colonization or infection, and the samples
where they are identified, assessing the cultures profitability.
METHODS. A prospective multicentric study, during 2016. Included
patients admitted to ICU to whom surveillance and/or diagnostic
cultures were carried out. It was applied a check list of RF for MRB
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 496 of 542according to the RZ program, and applied contact precaution
measures in patients at high risk for MRB. We analysed other RF and
comorbidities. Univariant and multivariant analysis for MRB RF with
binary logistic regression methodology (p < 0,05) were performed.
The difference between groups of MRB was made by Chi-square test
for qualitative variables and the Kruskal-Walls test for the continuous
ones. Statistical significance was set at P < .05.
RESULTS. 2270 patients from 9 Spanish ICU were included; in 288
(12,7%) patients one or more MRB were detected at admission. A
total of 161 patients (55,9%) were ESBLs carriers, 90 (31,2%) MRSA,
42 (14,6%) P aeruginosa, 7 (2,4%) carbapenemases, 6 (2,1%)
Acinetobacter spp and 14 (4,9%) others MRB carriers. In 81 cases
(28,1%) the presence of a MRB caused infection. There was a strong
association between RF and the presence of P aeruginosa (OR 37,1, IC
95% 8,9-154,0), followed by Acinetobacter, ESBLs and MRSA, in this
order. There were RF in 64,4% of patients with MRSA, 83,3%
Acinetobacter, 68,9% ESBLs, 95,2% P aeruginosa and all (100%)
carbapenemases, although this one did not reach statistical significance
on RF analysis. MRSA was identified in 68,9%, 33,3% and 20% by nasal,
pharyngeal and rectal swabs, respectively, and in 10% by diagnostic
cultures. P aeruginosa was identified in 52,4% by rectal swab, 33% by
pharyngeal swab and in 26,2% by diagnostic cultures. Rectal swab
identified 66,7% of Acinetobacter. And ESBLs were identified mainly by
rectal swab (81,4%), while the diagnostic cultures were positive in
21,1% of the cases these bacteria were present.
CONCLUSIONS. We demonstrated a predominance of ESBLs,
followed by MRSA, most of them present as colonization. There
was a strong association between almost all MRB analysed and
the RF included in the RZ check list, and probably because of
the sample size some of them did not reach statistical
significance in this analysis. The surveillance cultures performed
at ICU admission are important, once the diagnostic ones
detected less than 30% of MRB.
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INTRODUCTION. Multidrug-resistant Gram-negative (MDR-GN) infec-
tions susceptible only to colistin (COL) are emerging in critically ill
patients. Pharmacological studies suggest that a higher COL dose
(i.e. a 9 MIU loading dose followed by a maintenance dose as high as
15 MIU daily) is needed to ensure microbiological and clinical cure.
However, such high dose may enhance COL-related renal toxicity (1).
Since COL is effectively removed from the blood by continuous
veno-venous haemofiltration (CVVH), in particular when membranes
with high adsorptive capacity are used, this technique may allow to
administer high COL doses without inducing or enhancing
nephrotoxicity.
OBJECTIVES. To assess safety and clinical/microbiological efficacy of
high-dose COL treatment under “prophylactic” CVVH.
METHODS. Retrospective study of adult ICU patients with MDR-
GN infections who received COL (colistimethate sodium, Colisti-
neb™), alone or in combination with meropenem, for at least 5
days. COL was administered as a 9MIU loading dose followed by
3 x 4.5MIU daily. CVVH was performed under citrate anticoagula-
tion at a dose of 35mL/kg/h using a highly adsorptive AN69 STfilter with 1.5m2 surface area. Clinical and microbiological efficacy
were assessed at the end of therapy. Clinical efficacy was defined
as favourable (clinical improvement) or failure (persistent or
progressive infection). Microbiological response was defined as
eradication (negative cultures), presumed eradication (clinical
efficacy but no microbiological data) or failure (pathogen persist-
ence). Results were expressed as means ± SD or (range). In survi-
vors, serum creatinine was evaluated before and at the end of
therapy and at hospital discharge.
RESULTS. 16 patients (10 males, age 57 ± 15 years) were treated.
APACHE II and SOFA score were 26 ± 10 and 8.8 ± 3.5, respectively.
Pneumonia was present in 14 and urosepsis in 2 patients. Causative
pathogens were P. aeruginosa (n = 8), K. pneumoniae (n = 6) and
Enterobacter species (n = 2). COL MICs ranged from 0.03 to 3 mg/L.
COL was given as monotherapy in 8 subjects. COL + CVVH was
provided for 13 (6–27) days. A favourable clinical response was
obtained in 14 (88%) patients. Accordingly, microbiological
eradication was complete in 10, presumed in 4 and absent in 2
subjects. Length of ICU stay was 48 (13–128) days. Seven (45%)
patients left the hospital alive. Serum creatinine (n = 6) at the
predefined time points was 2.12 ± 1.52; 1.59 ± 0.96; and 0.91 ± 0.29
mg/dL, respectively. One patient required intermittent dialysis at ICU
discharge.
CONCLUSIONS. In patients with MDR-GN infections, CVVH using an
highly adsorptive membrane may represent a valuable option to
enable safe and effective high-dose COL treatment.
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INTRODUCTION. Active screening of MDR bacteria is one of the key
points of the “Zero Resistance” project - developed by the Spanish
Society of Intensive Care Medicine and Coronary Care Units
(SEMICYUC) - the main objective is to reduce the cumulative
incidence of patients with ICU-acquired MDR infections.
OBJECTIVES. To describe the incidence and most common MDR
pathogens identified at admission and during stay in a medical
surgical intensive care unit of a tertiary class hospital and compare
the results with the national data.
METHODS. Prospective, descriptive study. All patients admitted to the
ICU from june 2014 to june 2016 were included. Nasal, rectal, inguinal
and oropharyngeal swabs (bronchial aspirates in intubated patients)
were collected. Pathogens under surveillance included methicillin-
resistant Staphylococcus aureus (MRSA), vancomycin-resistant Entero-
coccus (VRE), extended-spectrum β-lactamase-producing Enterobacteria-
ceae (ESBL-E), Carbapenemase-Producing Gram Negative Bacilli
(CPGNB), Multidrug-resistant Pseudomonas aeruginosa (MDRP) and
Carbapenem-resistant Acinetobacter baumannii (CRAB). Data expressed
in means and percentages. Same data were obtained from the National
Nosocomial Infection Surveillance Study (Estudio Nacional de Vigilancia
de Infección Nosocomial, [ENVIN]) for the same period of time and both
results were compared.
RESULTS. During the 25 months period 1,554 patients were admitted
to our unit, with a total stay of 13,767 days and 5,304 days of
antibiotic therapy (385 antibiotic´s days / 1000 stays). MDR bacteria
were identified on admission in 144 patients (9.27%), in 115 patients
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 497 of 542(79.9%) was colonization and in 29 (20.1%) an infection. During the
stay in ICU, MDR bacteria were isolated in 48 patients (3.1%), in 32
patients (66.7%) was colonization with a colonization density of 2.39/
1000 stays and in 16 patients (33.3%). Was an infection, with an
infection density of 1.16/1000 stays.
The following tables show the number of patients with each species
of MDR bacteria that were isolated (colonization or infection) on
admission and during their stay in our ICU (Table 241) and the same
data from ENVIN´s database (Table 242).
CONCLUSIONS. Comparing with the national results, in our ICU we
do not have VRE. The highest percentage of MDR bacteria that
produces infection in our ICU is MDRP. We use less antibiotics
(national rate: 611 antibiotic´s days/1000 stays) and our density of
MDR bacteria infection is slightly lower at admission (national
density: 1.43 /1000 stays).
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program. Crit Care. 2015 Mar 16;19:114.Table 241 (Abstract 0987). ICU results. Screening of MDR bacteria
MDR pathogens At admittance Colonization during
ICU stay
Infection during
ICU stay
Total
MRSA 36 (73,5%) 11 (22,5%) 2 (4%) 49
MDRP 13 (43,3%) 9 (30%) 8 (26,7%) 30
CRAB 2 (50%) 1 (25%) 1 (25%) 4
ESBL-E 103 (85,8%) 13 (10,8%) 4 (3,4%) 120
CPGNB 1 (50%) 0 1 (50%) 2
Table 242 (Abstract 0987). National results. Screening of MDR bacteria
MDR pathogens At admittance Colonization during
ICU stay
Infection during
ICU stay
Total
MRSA 2278 (77,1%) 386 (13,1%) 291 (9,8%) 2955
MDRP 963 (42,1%) 592 (25,9%) 734 (32%) 2289
CRAB 402 (32,3%) 496 (39,8%) 348 (27,9%) 1246
ESBL-E 3752 (63,4%) 1380 (23,3%) 782 (13,3%) 5914
CPGNB 594 (46%) 478 (37%) 218 (17%) 1290
VRE 144 (56,9%) 87 (34,4%) 22 (8,7%) 2530988
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INTRODUCTION. Since the 1980s, a particular capsular phenotype of
Klebsielle Pneumoniae (KP) has emerged in Asia, known as
hypermucoid, which is responsible for complicated bacteremia of
multiple septic sites (liver, CNS, muscles). (1)
In New Caledonia, KP is a major cause of infection,about one third of
the strains responsible for bacteremia have this phenotype. (2)
OBJECTIVES. The objective of this study was to compare the clinical
severity of patients with community and nosocomial bacteraemia with
KP according to their hypermucoid (KPHM) or non-KPHH character.
METHODS. This an observational retrospective study including
successively all patients with bacteremia at KP during the period
from May 2013 to March 2015 at the territorial hospital of New
Caledonia. The hypermucoid character of the strains was defined bythe use of the string test followed by molecular analysis to
determine the capsular serotype.
After a double seizure and anonymization of the data, a bi- and
multivariate analysis was carried out according to the mucoid nature
or not of the KP strain and the clinico-biological characteristics of the
patients during their hospitalization.
RESULTS. Fifty-five bacteremic patients were included in the study,
27% of the strains isolated were hyper mucoids. Infected populations
are comparable and have a high incidence of diabetes in both
groups (43.6%). Hypermucoid strains accounted for two thirds of
community infections whereas the non-mucoid profile was predom-
inantly found in nosocomial infections (72.5% vs 33.4%, p = 0.01).
The rate of hospitalization in intensive care units is high (KPHM
46.7%, KPNH 52.5%) with an average IGS2 score (KPHM 54.1 (±20.8)
KPHM 63.9 (±22.3) p = 0.28) without any difference between the two
groups. There was no significant difference in mortality (KPHM 46.7%
vs KPNH 15%, p = 0.07) but patients with a KPHM strain had a longer
hospital stay (73.5 days versus 50.7 days, p = (OR 1.41, CI 95% 1.0-
1.96, p = 0.045), a higher number of infectious metastases (OR 7.06,
CI 95% 1),and a longer persistence of positive blood cultures despite
the implementation of a suitable treatment,
25–39.64, p = 0.026).
Community-acquired or nosocomial KP bacteraemias represent
severe infections where resuscitation is required in half the cases in
patients with high gravity scores. This probably explains why there is
no difference in mortality between the two groups. However, it can
be assumed that the trend of excess mortality in the KPHM group is
not significant due to insufficient sample size.
CONCLUSIONS. Due to their persistent and metastatic nature,
bacteremia with KPHM should be considered severe and should be
closely monitored. Prolonged antibiotic terapy should be discussed.
REFERENCE(S)
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INTRODUCTION. Multidrug-resistant bacteria are common in ICU.
However, the incidence of extended-spectrum beta-lactamase-
producing (ESBL) Enterobacteriaceae currently increases and could
be a threat for the success of empiric antibiotic treatment and the
survival of critically ill patients.
OBJECTIVES. Consequently, we design an observational study to
assess the impact of ESBL-producing Enterobacteriaceae hospital-
acquired infections on mortality in ICU.
METHODS. In a 350-bed general teaching hospital in Lyon (France),
we retrospectively analyse the mortality rate and its factors inde-
pendently associated in our medical and surgical 12 bed-ICU, using a
6-year longitudinal data from January 2011 to December 2016 ?A3B2
show $132#?>collected from the biological, pharmaceutical, hospital
hygiene and medical information departments. Monthly incidences of
hospital-acquired infections concerning ESBL Enterobacteriaceae,
AmpC beta-lactamase-hyperproducing Enterobacteriaceae, methicillin-
Table 243 (Abstract 0990). Patients characteristics in each study period
Standard
Care(n=143)
SDD(n=173) oroCHX-1%(n=142)
Mean Age±SD 61±16 61±16 61±15
Male, n(%) 95(66) 114(66) 82(58)
SAPSII ±SD 50±14 49±16 49±17
Admissions from the community,
n(%)
87(61) 106(61) 93(66)
VAP ratea 16.5 18 17.7
VAT ratea 3.9 8.2 2.3
MDR, n(%) 4(16) 10(50) 7(37)
ICU days until MDR isolation,
mean(±SD)
17±11 12±8 21±15
ICU mortality, n(%) 44(31) 39(22) 26(18)
VAP ventilator associated pneumonia, VAT ventilator associated
tracheobronchitis, ICU intensive care unit, MDR multidrug resistant
aPer 1000 of invasive ventilation
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 498 of 542resistant Staphylococcus aureus (MRSA) with or without bloodstream mi-
crobial identification, are analyzed using generalized estimating equa-
tions with a multivariate Poisson regression.
RESULTS. During the study period, 3279 adult patients are included
in our ICU. Mean age is 64.7 ± 2.4 years-old. Sex ratio is 1.7 ± 0.5.
Mean Simplified Acute Physiologic Score II (SAPSII) is 46.8 ± 7.2.
Mean length-of-stay is 6.7 ± 2 days.
Monthly incidence of monthly ESBL-producing coliforms rectal car-
riage at admission in ICU is 9.8 ± 7.8 cases/1000 patients bed-days
whereas monthly is 4 ± 3.8 cases of ESBL-producing hospital-
acquired infections/1000 patient bed-days. Monthly incidence of
deaths in ICU is 32.3 ± 11.6 cases/1000 patients bed-days.
In multivariate analysis, deaths incidence in ICU is independently predicted
by incidence of ESBL-producing coliforms hospital-acquired infection
(p = 0.005), SAPS II (<0.001), percentage of patients over 80 years-old
(p = 0.001) and central venous catheter use (p = 0.02) whereas carbapen-
ems consumption seems an independent protective factor (p = 0.001).
CONCLUSIONS. The burden of antibiotic resistance currently increases
and should be considered according to the local microbial flora. In
particulary, extended-spectrum beta-lactamase coliforms hospital-
acquired infections could threat the survival of infected critically ill pa-
tients if first-line empiric antibiotherapy is not adequate. Consequently,
improving critical care should include fight against multidrug-resitant
bacteria diffusion combined to progress in availibility of new tools for
fast antimicrobial resistance identification and better knowledges of
trends in local antimicrobial resistance.
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INTRODUCTION. Digestive decolonization strategies have been
associated with lower rates of resistant pathogens colonization, less
antibiotic consumption and better outcomes, probably related to
lower nosocomial infection rates.
OBJECTIVE. To determine the impact of two decolonization
strategies [oral care with chlorhexidine (CHX) 1% (oroCHX-1%) and
selective oropharyngeal and digestive decontamination (SDD)] when
compared to standard care (SC) in the rate of respiratory infections
by multidrug resistant (MDR) pathogens.
METHODS. Prospective interventional cluster study in a 12-bed
mixed ICU of a tertiary care university hospital, including all patients
who were admitted for a minimum period of 48 hours, between
?A3B2 show $132#?>February 2015 and July 2016 (18 months). There
were three study periods: baseline (from February to July 2015)
where usual care was provided (daily bath with CHX and 3 times
daily oral hygiene with CHX 0.12%), SDD with oral care 4 times daily
with digestive and oropharyngeal application of a suspension con-
taining colistin, tobramycin, nystatin antibiotics (in enteral suspen-
sion, no intravenous antibiotic use) (August 2015 to January 2016)
and oroCHX-1% with 4 times daily oropharyngeal application of CHX
in a 1% concentration, until extubation (February to July 2016). MDR
was defined as a pathogen resistant to at least one antibiotic in three
different classes to which it should be sensitive.
RESULTS. During the study period 458 patients were admitted into
the ICU, with a mean (±SD) age of 61 ± 15 years, 291 (64%) were
male. The mean (±SD) SAPS II was 49 ± 15. In 79 patients (17%) a
total of 84 ICU-acquired respiratory infections were diagnosed (66
pneumonias and 18 tracheobronchitis). The number of respiratoryinfections was 26/143 (18%) in the baseline, 32/173 (18%) in the SDD
(p = 0.943) and 26/142 (18%) in the oroCHX-1% period (p = 0.978);
infections by a MDR pathogen were 4/25 (16%), 10/20 (50%)
(p = 0.023) and 7/19 (37%) (p = 0.164), respectively (Table 243).
CONCLUSION. In our unit, decolonization strategies did not result in
a significant decrease in ICU-acquired respiratory infections; in the
SDD period there was a significant increase in the proportion of ICU-
acquired respiratory infections by a MDR pathogen when compared
to the baseline period.0991
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INTRODUCTION. Multi drug resistant bacteria (MDR) is a common
problem in intensive care units. MDR infections are associated with
adverse outcomes such as, increased mortality, length of hospital
stay and health care related costs. Elderly patient are likely to have a
higher incidence of these due to increased colonization.
MATERIAL AND METHODS. Our goal is to describe and to analyse the
incidence of colonization by MDR (MRSA, ESBL-Producing and KPC-
producing) in elderly patients. Describe if these colonization's are asso-
ciated with higher mortality rates or higher length of hospital stay.
We performed a retrospective study. We included all patients with
eighty years and above (+80) who entered in the ICU between April
2013 and August 2016. We collected all the carrier results and we
analysed the variables (sex, mean age, severity indexes, diagnostic
tabulations, and length of stays, mechanical ventilation, the use of
vasoactive drugs, renal replacement therapies and mortality).
Carrier's control were collected at the patient´s ICU admission and
once a week during their stay.
Qualitative variables with normal distribution have been expressed
as number and percentages and were analysed using chi-square
tests. Quantitative variables were expressed as mean ± standard
deviation (Rank) and were analysed using t-student tests and
anova.
RESULTS. A total of 76 patients were collected. 48.7% Women (37)
51.3% Men (39). Mean age 83 ± 2.4 (80–90) years, Severity indexes: SOFA
7.5 ± 4.1 (1–18) APACHE II 19.6 ± 7.9 (7–39) SAPS II 55.1 ± 17 (30–100).
Diagnostic tabulation was cardiovascular (15/76) gastrointestinal (12/76)
Infectious (14/76) Neurocritical (13/76) Surgical (9/76) Respiratory (12/76)
Traumatic (1/76). The mean length of stay was 4.75 ± 5.8 days. 3% of
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 499 of 542patient's required renal replacement therapy (1/76), 60.5% (46/76)
required mechanical ventilation and 60.5% (46/76) required vasoactive
drugs. The mortality rate of this group of patients was 34% (26/76) with
limitation of the therapeutic effort in 9 cases (11.8%).
The incidence of colonization by MDR was 17.1% (13/76) (MRSA (3/
76) ESBL-Producing (8/76) and KPC-producing (2/76)). There is no
statistically significant differences in severity indices between the
two groups. Colonization by MDR bacteria has not been associated
with higher mortality rate, mechanical ventilation, vasoactive drugs
or renal replacement therapy. The mean length of stay of colonized
patients has been 8 ± 8 days vs 4 ± 5 days in not colonized patients.
(P < 0.003).
CONCLUSIONS. The increasing prevalence of MDR bacteria is a
common problem in our intensive care services. MDR infections
are related with higher mortality and length of stay. However
their presence in the carrier control in elderly patients seems to
be associated with higher length of stay in elderly patients in our
study.
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INTRODUCTION. Gram (−) bacteria are the causing agents of severe
infections in patients in the I.C.U. Hospital -acquired infections
caused by multi-drug resistant strains are frequent and despite the
precautionary measures taken, they lead to an increase in the time of
hospitalization, morbidity rates,mortality rates and hospital expenses.
OBJECTIVES. To record and study the antimicrobial resistance of the
most common drug-resistant gram(−) bacteria isolated in the ICU of
our hospital during two years.
METHODS. We studied and recorded 34 drug-resistant strains of
Acinetobacter baumanii, 32 strains of Pseudomonas aeruginosa and
9 strains of Klebsiella pneumoniae isolated in the ICU during two
years. The common culture media were used for the cultivation of
the specimens. The identification of the strains as well as the anti-
microbial susceptibility testing were performed by the Microscan
Walkaway (Siemens) system. The antimicrobial susceptibility testing
was verified by the E-test method according to CLSI directions.
RESULTS. There was no resistance to Colistin and Tigecycline
detected. High resistance levels to Imipenem (A.baumanii 69.7%-
P.aeruginosa 45.2%- K.pneumoniae 55.6%) were noted. Thus,it can
be seen that multi-drug resistant strains with high resistance levels
to Carbapenems have emerged.
CONCLUSIONS. The continual monitoring of the resistance rates of
multi-drug resistant strains of A.baumanii, P.aeruginosa and K.pneu-
moniae isolated in the ICU is inevitable, given the fact that few anti-
biotics can be used against these strains.
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Intensive Care Medicine Experimental 2017, 5(Suppl 2):0993INTRODUCTION. There has been observed an increasing incidence of
resistant Gram-negative strains in Greece in last decade. It is import-
ant for institutions to track rates of antibiotic resistance in their ICUs
and detect any potential risk factors for infection with Multi-Drug
Resistance (MDR) bacteria.
OBJECTIVES. The study of several potential risk factors for infection
with MDR bacteria in patients hospitalized in our intensive care unit.
METHODS. Data from a sample of 294 patients hospitalized in ICU of
general hospital from 1/1/16 to 31/12/16 were studied. The factors that
were studied are: age, sex, main duration of stay in ICU, hospital origin
(the same or other), APACHE II score, PDR, previous MDR bacterial
colonization, previous antibiotics use, duration of mechanical ventilation,
immunosupresion, diabetes, hypoproteinemia and the precense of
central venous catheter.
Mono-factor analysis (χ2-test, t-test, Mann–Whitney test) and multi-
factor analysis (multiple logistic regression) were used for the investi-
gation of the correlation between risk factors and the possibility of
MDR infection.
RESULTS. Between 294 patients, 45 (15,3%) were infected with MDR
bacteria.
Monofactor analysis showed statistical correlation for the following
factors: duration of stay in ICU, hospital origin, APACHE II score,
previous MDR bacterial colonization, previous use of carvapenems,
duration of mechanical ventilation, immunosupresion, diabetes,
hypoproteinemia and presence of central venous catheter.
Multi-factor analysis showed statistically important correlation for the
following independent factors: previous use of carvapenems, hospital
origin, presence of central venous catheter.
CONCLUSIONS. Between potential risk factor, previous use of
carvapenems shows a very strong correlation with MDR infection.
Other important factors are: the presence of central venus catheter,
hospital-to-hospital patient transfer, previous colonization with MDR
bacteria and the duration of mechanical ventilation. Recognition of
these factors and the effort to minimize them contributes to reduce
MDR, hence reduce patient morbidity and mortality hospitalized
in ICU.
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INTRODUCTION. Intensive Care Units are the most affected by the
massive use of antibiotics, which causes the appearance of
multiresistant strains. Nosocomial infections caused by Acinetobacter
species is an emerging threat. Acinetobacter baumannii is an
opportunistic gram negative pathogen with increasing relevance in a
variety of hospital acquired infections especially among critically ill
patients.
OBJECTIVES. The aim of our study was to determinate the pattern of
Acinetobacter infections and its association with length of stay in
patients admitted to our ICU.
METHODS. We made a retrospective and observational study of
patients admitted to the ICU during one year and who have infected
by A. baumannii. On admission, we recorded clinical and laboratory
parameters.
RESULTS. 40 infections were identified. The mean age was
63.75 + 13 years and 65% were men. On admission the mean value
of APACHE II was 23.26 + 5.8. 57.5% came from the emergency
department, 30% from the hospital ward and 12.5% from another
hospital. 72.5% had co-morbidity. Neurocritical illness (32.5%) was
the most frequent cause of hospitalization and the others were 30%
septic, 17.5% post surgical, 12.5% politraumatized and 2.5% with
cardiac arrest. 70% of patients had hemodynamic instability, 52.5%
respiratory failure and renal dysfunction 47.5%. Highest rates of
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 500 of 542resistance (100%) was detected against penicillins, cephalosporins
and even extended spectrum antibiotics including carbepenems and
quinolones. Invasive mechanical ventilation was performed in 39
(97.5%) patients. All patients had had central venous and urinary
catheters and 5% an external ventricular drainage. Pneumonia devel-
oped in 12 patients, and there were 10 tracheobronchitis, 8 bacter-
emias, 6 urinary infections, 3 intra-abdominal infections and 1
ventriculitis. 75% were coinfection with other microorganisms (Gram
negative 35%, Gram positive 22.5%, both 17.5%). 77.5% had previ-
ously colonized, 60% tracheal, 42.5% rectal, 30% nasal, 20% cutane-
ous and 10% urinary. Respiratory system was most commonly
involved. The most frequent infections were pneumonia (30%) and
tracheobronchitis (27.5%) against bacteremia (22.5%) and urinary
tract infection (15%). Overall mortality was 32.5%, significantly higher
in patients with pneumonia (66.7%, p 0.001) than in all other condi-
tions (urinary tract infections, bacteremia or tracheobronchitis). The
average stay in ICU was of 64 ± 41.16 days.
CONCLUSIONS. Multidrug-resistant A. baumannii infections increase
and are related with high clinical severity and with longer duration
of stay in ICU. The use of invasive procedures exhibit an increasing
trend. In more than 2/3 the infection appears after colonization,
mainly if it is respiratory, with a higher mortality in the case of
pneumonia.
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BACKGROUND. Infections with antimicrobial-resistant bacteria
(AMRB) oppose tremendous challenges in the spectrum of critically
ill patients. These infections are associated with higher morbidity,
mortality and healthcare costs.
OBJECTIVES. To assess the incidence of hospital acquired infections
caused by AMRB in an 8-bed Tunisian MICU and to describe/detail
the antibiotic resistance profiles of infecting pathogens.
To determine the independent risk factors of AMRB infections in the
MICU.
METHODS. An 18 months prospective study from September
15th,2015 to March 15th,2017 were induced in the adult medical ICU
of Farhat Hached University Hospital in Sousse-TUNISIA. All patients
with more than 48H of ICU stay.All the resistance pattern were tested
for all isolated bacteria. Univariate and multivariate analysis were per-
formed to identify independent risk factors of AMRB infections. P
values of less than 0.05 were considered as statistically significant.
RESULTS. From 258 eligible patients during the study, 40 developed 45
AMRB infections with a density incidence of 12.7/1000 patient-
hospitalization-days. 24 (53%) of AMRBs were responsible for a Ventilator
Acquired Pneumonia. The most frequent isolated microorganisms
were: MDR Acinetobacter baumannii (only to colimycin and rifam-
picin susceptible) 33(73.33%), Extended-spectrum beta-lactamase
producers 8(17.77%) represented essentially by Klebsiella pneumoniae
and finally Methicillin resistant Staphylococcus aureus 4(8.88%).
Independent risk factors of AMRB acquired infections were the
duration of sedation (OR = 1.15, CI95% [1.05,1.27], p = 0.004) and the
number of antibiotics received prior to the infection (OR = 1.6, CI95%
[1.01,2.52], p = 0.0046).CONCLUSION. The study demonstrated the emerging trend of AMRB
in our MICU with the peculiar presence of MDR Acinetobacter
baumannii.
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INTRODUCTION. Carbapenemase-producing Enterobacteriaceae
(CPE) are an important and increasing threat to public health
worldwide.
OBJECTIVES. To describe intensive care unit (ICU) mortality, patient
demographic data and infection type in patients with CPE isolates.
METHODS. Retrospective observational study between January
2016 to April 2017 in 30 beds ICU of a tertiary hospital center.
Patient (p) and CPE isolates dates were collected included
demographic data, underlying condition, associated infection, CPE
colonization/infection, type infection, resistance to antibiotics,
therapy, mortality and stay in ICU.
RESULTS. The first CPE isolates in our ICU was in February 2016.
During study period 14 p infected and/or colonized by CPE were
detected in our ICU (11 p acquired in ICU). 3 p presented rectal
colonization by CPE without infection. All patients presented
carbapenemase oxa-48 producing Klebsiella pneumoniae and 2 pa-
tients carbapenemase oxa-48 Escherichia coli.
Median age was 63,21 ± 12.86 years old and 71% were male. Median
Charlson score was 3,93 ± 2,58 and median APACHE II was
20,30 ± 6.9. Systemic antibiotic exposure within 90 days before of
isolate was documented in all patients. 85,7% of the patients were
immunosuppressed. Underlying condition: liver transplant 1p, Fournier
gangrene 2p, colorectal surgery 4p, hepatobiliary surgery 1p,
meningoencephalitis 1p, gastroenteritis 1p, SDRA (H1N1) 2p,
pneumoniae 2p. 6p presented several CPE infections. Site for infection
included abdomen 6p (54,5%), lung 5p, ulcer 2p, surgical site 3p,
bloodstream 2p, catheter 1p. 63,6% of patients associated fungal
infection and 100% bacterial infection. All CPE was resistant to
penicillin, cephalosporin, fluoroquinolones, ertapenem and gentamicin.
Resistance to tigecycline was 57%, resistance to imipenem 35%,
resistance to colistin 28%, resistance to meropenem 28%,
resistance to cotrimoxazole 21%, resistance to amikacin 7%.
Combined therapy was used in 9p and monotherapy in 1 p.
Treatment was readjusted in 6p. Definitive therapy in survived
patients was: ceftazidime/avibactam + colistin (1p), ceftazidime/
avibactam + amikacin (1p), meropenem + amikacin (1p),
meropenem + amikacin + colistin (2p). Mortality for patients with
CPE infection was 54,5% (5 medical patients, 1 surgical patient).
Stay in ICU was 28 days (IQR 1–75).
CONCLUSIONS. CPE isolates were carbapenemase oxa-48 producing
Klebsiella pneumoniae and carbapenemase oxa-48 Escherichia coli.
57% patients with CPE were surgical patients. 85,7% of the patients
were immunosuppressed. The most frequent CPE infections were ab-
dominal infections. All patient with CPE isolates presented co-
infections. CPE isolates showed less resistance to amikacin and
ceftazidime-avibactam. CPE infections associate high mortality.
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identified in the mid-1980s. Then it emerged as a significant cause of
nosocomial infections in many intensive care units (ICU) across the
world.
In our 22-bed medical ICU, cases of VRE infections were first identi-
fied in 2013.
OBJECTIVES. The aim of this study is to describe microbiological
characteristics and outcomes of Vancomycin-Resistant Enterococci
infections.
METHODS. Patients who developed VRE infections during their ICU
stay (from January 2013 to march 2017) were included. We recorded
demographic, therapeutic and evolutive outcomes.
RESULTS. During the study period (4 years and 3 months), 16
patients were included. The median age was of 55.5 years [26–82]
with a sex-ratio of 2.2.
At admission, medium IGSII, Apache II and SOFA scores were
respectively of 45, 17.68 and 6.6.
The median duration of hospitalization before VRE infection was of
17.5 days [2, 69]; the hole median of length of stay was 33 days
[2,79].
The infection sites were bacteremia (n = 10), urinary tract infection
(n = 5) and non-bacteremic catheter related infection (n = 1). Species
isolated were E.faecium in all cases.
All patients received antibiotics before this infection episode among
them 62.5% (n = 10) received 4 or more different antibiotics. The
most often prescribed antibiotics were colimycine (n = 12, 75%),
carbapenems (n = 11, 68.8%), amoxicillin-clavulanate (43.8%; n = 7)
and glycopeptides (25%, n = 4).
Other nosocomial infections with multi-drug resistant bacteria pre-
ceding VRE infections were identified in 68.8% of patients (n = 11).
These latter have all Acinetobacter Baumanii nosocomial infection be-
fore VRE's one.
Among all patients, 11(68.8%) received an effective antibiotherapy
with Linezolid from whom only 4 patients survived. Concerning the 5
left patients, VRE identification results were received post-mortem.
In-hospital mortality was of 75% (n = 12).
CONCLUSIONS. Vancomycin-resistant enterococci infections are
emerging and frequently occur after other nosocomial infections,
especially Acinetobacter Baumanii.
Despite effective antibiotherapy, it is associated with high mortality.
Poisoning, toxicology, pharmacology
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INTRODUCTION. Around 30% of emergency department visits for
drug abuse are related to acute vascular complications of cocaine [1].
Levamisole, an antihelminthic drug limited to veterinary use, is
currently used as a cocaine adulterant [2]. In in vitro studies,
levamisole acts synergistically with cocaine, enhancing the
sympathetic response [3], and potentiating the contractile response
to endothelin-1 in rabbit carotid artery [4]. Therefore, levamisole
could aggravate cocaine's actions on vascular tone. However, the ef-
fects of levamisole on relaxant response to acetylcholine (Ach) has
not yet been evaluated.
OBJECTIVES. To evaluate the effects of levamisole on endothelium
dependent and independent relaxant response in rabbit carotid artery.
METHODS. Rabbit carotid rings were mounted for isometric tension
recording in organ baths. Concentration-response curves to Ach (10
−9 to 10−5M) were obtained in the absence and presence (30-minutes
incubation) of cocaine (10−5 and 10−4M), levamisole (10−5 to 10−3M),and the combination of both drugs. In addition, Ach curves in the
presence and absence of levamisole (10−3M) were performed in the
presence of indomethacin (Indo, 10−5M) and L-NG-Nitroarginine
methyl ester (L-NAME, 10−4M) to study prostanoids and NO-
dependent vasorelaxation, and superoxide dismutase (SOD, 200 U/L)
and ascorbic acid (AA, 10−3M) to evaluate free radicals production
and scavenging. To evaluate independent vasorelaxation, curves of
sodium nitroprusside (SNP, 10−10 to 3x10−6M) were performed in the
presence and absence of cocaine 10−4M and levamisole 10−3M.
RESULTS. Neither cocaine nor levamisole 10−5M modified the
relaxant response to Ach. Levamisole (10−4 and 10−3M) significantly
reduced the maximal relaxation (Emax) induced by Ach in a
concentration-dependent manner (85 ± 5% for control, 71 ± 2% and
46 ± 3% for levamisole 10−4M and 10−3M, respectively). Cocaine plus
levamisole did not potentiate the effects of levamisole. Reduced Ach
response in the presence of levamisole (10−3M) was not modified by
Indo or L-NAME. Conversely, both SOD and AA partially prevented
the effects induced by levamisole 10−3M in a similar manner (Emax
70 ± 7% for SOD and 77 ± 4% for AA, p < 0.05 compared to levami-
sole 10−3M). Neither cocaine nor levamisole modified the relaxant
?A3B2 show $132#?>response to SNP.
CONCLUSIONS. Levamisole impairs endothelium-dependent relaxation
to acetylcholine in a concentration dependent manner. This effect is in-
dependent of prostanoids and NO, and is partially mediated by oxida-
tive stress, which is reversed by ascorbic acid. Our results suggest that
levamisole could worsen acute cardiovascular complications induced
by cocaine. Moreover, ascorbic acid could be a promising adjuvant
therapy in levamisole-adulterated cocaine abuse.
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INTRODUCTION. Bone remodeling involves the osteoclast-mediated
bone resorption followed by the osteoblast-mediated bone forma-
tion. Disruption of bone remodeling can lead to pathologic state of
bone structure and function. In a recent study, α-tocopherol in-
creased osteoclastogenesis and osteoclast fusion and the molecular
structure of α-tocopherol is similar to propofol.
OBJECTIVES. Propofol is a commonly used intravenous anesthetic
and sedative agent, and the effect of propofol on bone remodeling
can be critical to the patient who has pathological bone diseases. On
the basis of previous studies, we investigated the effects of propofol
on osteoclastogenesis and bone resorption, as well as signaling
pathway of osteoclastogenic gene expression using bone marrow-
derived macrophages (BMMs).
METHODS. BMMs were cultured with M-CSF alone or M-CSF plus
RANKL in the presence of propofol (0 ~ 50 mM) for 4 days. Mature
osteoclasts were stained for TRAP and the numbers of TRAP-positive
multinucleated osteoclasts were measured. To examine the resorp-
tion activities of osteoclasts, bone resorption assay was conducted.
To identify how propofol affect on the formation of multinucleated
osteoclast, we focused on DC-STAMP, a protein essential for pre-
osteoclastic cell fusion. The mRNA expression of DC-STAMP was ana-
lyzed by RT-PCR and quantitative real-time PCR.
Fig. 321 (Abstract 0999) See text for description
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cleated osteoclasts and the number and size of osteoclasts in a dose-
dependent manner.
In addition, bone resorption assay showed that propofol increased
the bone resorption area on dentin discs.
The mRNA expression of DC-STAMP was upregulated most strongly
in the presence of both RANKL and propofol. However, SB203580,
p38 inhibitor, suppressed significantly the mRNA expression of DC-
STAMP which was increased by propofol.
CONCLUSIONS. We have newly demonstrated that propofol enhanced
osteoclast differentiation and maturation, as well as increased bone
resorption subsequently. Additionally, we identified the regulatory
pathway involving osteoclast cell-cell fusion, which was enhanced by
propofol through p38 mediated DC-STAMP expression.
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INTRODUCTION. Metformin is widely used as oral antihyperglycemic
drug to treat patients with type 2 diabetes. It is presumed that partial
inhibition of complex I of the mitochondria is causative for the
pleiotropic effects of metformin.1 The major mode of elimination is
excretion of unchanged drug in urine.2 Patients with impaired renal
function are therefore at risk to accumulate metformin and develop
lactic acidosis.2 Renal elimination of metformin occurs primarily
through active transport by the proximal tubules, requiring energy to
function.1 Since it is known that metformin inhibits mitochondria and a
high density of mitochondria is present in the proximal tubule to
transport metformin and other compounds, we hypothesize that toxic
concentrations of metformin inhibit its own secretion.
OBJECTIVES. To determine whether addition of increasing metformin
concentrations to an ex-vivo isolated perfused porcine kidney affects
renal elimination of metformin.
METHODS. During four hours of normothermic oxygenated machine
perfusion of six porcine kidneys with autologous blood, we studied
whether gradually increasing the metformin concentration in the
perfusion fluid affects metformin clearance. Creatinine was added to
the perfusion fluid to estimate the glomerular filtration rate. Urine was
collected throughout the experiment and metformin concentration was
determined in both plasma and urine using liquid chromatography-
tandem mass spectrometry analysis. Data are expressed as
mean ± standard error of the mean.
RESULTS. For the first 90 minutes, metformin plasma concentration
remained below 5 mg/L, which approximates the therapeutic range.
Subsequently, the metformin plasma concentration increased every
half hour with 38.1 ± 17.5 mg/L until a peak concentration of
271.2 ± 87.8 mg/L was reached at the end of the experiment, which
is highly toxic. Creatinine clearance remained practically unchanged
with a grand mean of 1.4 ± 0.2 ml/min/100g. Metformin clearance
increased over time with a maximum of 20.2 ± 16.6 ml/min/100g at
90 minutes, and declined steeply thereafter (Fig. 322). Compared to
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 503 of 542six controls, no difference in fractional sodium excretion was found,
suggesting that tubular function was not significantly affected.
Oxygen consumption in the metformin group decreased after two
hours, while oxygen consumption increased in controls within the
same period.
CONCLUSIONS. Our experiments suggest that metformin elimination is
impaired when an isolated perfused kidney is exposed to toxic
concentrations of the same drug. Further studies are warranted to identify
causative mechanisms behind this clinical important phenomenon.
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INTRODUCTION. Uncertainty remains concerning pharmacokinetics
(PK) of antimicrobials in critically ill patients due to the scarcity of
data and the heterogeneity of the patient cohort.
OBJECTIVES. To describe the population PK estimates and the
influence of patient covariates on PK of vancomycin, following
intermittent infusion in critically ill patients receiving CVVHDF and on
different anticoagulant modalities.
METHODS. Vancomycin dose and concentration data (peak, trough)
were collected retrospectively from the electronic health records of
31 critically ill patients (n = 280 levels). A one-compartment model
was used to describe the vancomycin concentration-time profiles,
using Pmetrics software1. Model selection was based on the plots of
observed vs. predicted concentrations, bias, imprecision, and reduc-
tion in −2*LL, AIC, BIC. For brevity, only R2 values are presented here,
from observed vs. population predicted concentration plots. Dosing
intervals were classified according to the dialysis modality for the
majority of the dosing interval i.e. 1) dialysis with citrate anticoagula-
tion (60 levels) 2) dialysis with non-citrate anticoagulation (120 levels)
or 3) not on dialysis (44 levels). Continuous covariates were: cumula-
tive fluid balance, effluent flow rate, blood flow rate, body weight,
albumin concentration and age.RESULTS. An acceptable base model was produced using the
Elimination Rate Constant (Ke) and Volume of Distribution (V) (R2 0.51).
The mean ± SD of vancomycin PK estimates were: V 80.65 ± 22.65 L; Ke
0.03 ± 0.01 h−1. The best population predicted models included
cumulative fluid balance and albumin concentration as covariates
(R2 = 0.59 for both). Furthermore, the population model of the citrate
anticoagulation group correlated best with the population predicted
models as compared to the non-citrate dialysis and not on dialysis co-
horts, with R2 of 0.86, 0.58 and 0.28, respectively.
CONCLUSION. Cumulative fluid balance and albumin concentration
data along with citrate anticoagulation status are suggested as
covariates for further analysis with richer data, to optimise covariate
PK modelling of vancomycin in ICU patients on CVVHDF, and
support dose optimisation. The less variable PK estimates in the
citrate group model suggest that vancomycin dosing while on citrate
anti-coagulation might be more straightforward than in the other
two categories.
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INTRODUCTION. Conditions like trauma, burns, sepsis or acute
intoxications have significant effects on the endocrine status.
Alterations of the pituitary-adrenal axis are long acknowledged but
the hypothalamic-pituitary-thyroid axis may also be affected. The sys-
temic response caused by an acute disease characterized by modify-
ing the thyroid hormonal axis is known as “sick euthyroid syndrome”.
It has previously been established that there is a complex relation-
ship between thyroid hormones and cholinergic function, thus an in-
crease in the acetylcholine levels is expected to produce an
alteration in the thyroid hormone status.
OBJECTIVES. The present study aims to observe the effects of acetyl
cholinesterase inhibition on thyroid hormone status and gland tissue
changes.
METHODS. We conducted a prospective experimental study on
twenty adult male Wister rats. In the first step blood samples were
collected in order to establish normal values for thyroid stimulating
hormone(TSH), tri-iodothyronine(T3) and tetra-iodothyronine(T4). Sec-
ondly, 0.1mg/kg Clorpyrifos was administered by oral gavage to in-
duce acetyl-cholinesterase inhibition. After developing cholinergic
symptoms new blood samples were taken to determine the level of
cholinesterase, TSH,T3 and T4. Hormone levels were quantitatively
determined through ELISA tests and spectrophotometric method
was used for cholinesterase. Thyroid gland was excised in eight rats
for hystopathological examination.
RESULTS. The cholinesterase levels showed a major inhibition
immediately after poisoning compared to standard levels in the
control group, thus confirming the status of intoxication. Comparing
to baseline values determined in the control group, we obtained a
significant increase in T4 levels (p = 0.01) measured both at two
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 504 of 542hours and 48 hours after administration of the organophosphate in
sample rats. Similarly, the T3 almost doubled its values 2 hours after
poisoning (mean 4.2ng/ml versus 2.5ng/ml at baseline). Surprisingly,
the TSH revealed an acute elevation with an afterward slow
descending trend at 48 hours (p = 0.1), approaching initial control
values. Beside serological significant changes in hormone levels,
preliminary results observed in study rats indicate histopathological
alterations of the thyroid tissue caused by organophosphate
exposure.
CONCLUSIONS. The present study demonstrated that acetyl-
cholinesterase inhibition caused major alterations in hormone levels. In-
hibition of acetyl-cholinesterase is associated with alteration of thyroid
response in subjects with no prior thyroid disease, causing the “sick eu-
thyroid syndrome”. This condition is often associated with a poor sur-
vival prognosis, despite adequate hormonal supplementation.
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INTRODUCTION. Irrational use of medicines is a global challenge at
all levels of health care especially in Intensive Care Unit (ICU). Beside
the high proportion of inappropriate use of human serum albumin
(HSA) and intravenous (IV) pantoprazole, the elevated cost, have
prompted interventions aiming to rationalize use of them.
OBJECTIVES. The aim of the present study was to evaluate the
interventions of pharmaceutical care unit in improving the pattern of
use and decreasing the direct cost of two highly cost medications at
ICU wards in a referral teaching hospital in Iran.
METHODS. This prospective, interventional study was performed
during 6 months in ICU wards in a referral teaching hospital.
Indication checklist drafts of HSA and IV pantoprazole as two highly
cost medications were prepared by clinical pharmacists.The head of
different ICU departments were evaluated and approved these
drafts. At the time of ordering these medications, the physician team
was requested to fill out the checklist. The checklists were then
examined by the trained pharmacists according to clinical and para-
clinical conditions of the patients. The clinical pharmacist were
authorized to reject the orders if there was no indication or rational
for giving the studied medications. Six month time period was
considered as pre-intervention phase.
RESULTS. Mean Acute Physiology and Chronic Health Evaluation
(APACHE) III scores on ICU day 1 were not different. The
implementation of guidelines resulted in reduction in HSA and IV
pantoprazole use. The direct cost of HSA and IV pantoprazole
decreased substantially (37.56% and 41.66% respectively). There was
no significant length of ICU stay pre and post intervention.
CONCLUSIONS. Guideline implementation by pharmaceutical care
unit associated with considerable decrease in the amount of use and
direct cost of HSA and intravenous pantoprazole with no negative
impact on ICU outcome in ICUs of a referral clinical setting in Iran.
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INTRODUCTION. Tramadol is an opioid analgesic widely prescribed
all over the world. Its toxicity is poorly documented in both
international and local scientific litterature.
OBJECTIVES. We aimed to study the characteristics of tramadol
poisoning in both suicidal attempt and addiction.
METHODS. It was a retrospective observational study spread over 84
months from January 2010 to December 2014 in a teaching
toxicological center including tramadol poisoned patients.
RESULTS. Ninety four patients aged of 30 ± 10 years were eligible with
an age range peak from 21 to 30.The prevalence of tramadol exposure
has multiplied by three from2010 to 2013. In 67% of cases poisoning
occured in suicidal attempt. Patients were 49 males and 45 females.
23% of them exhibited respiratory failure symptoms requiring ICU
admission. 77% had moderate serotoninergic signs and were
outpatients.The examination revealed that 42 patients (45%) were
addicted to tramadol.In this addictive population, a history of
psychiatric disease was noted in 14% of cases and addiction to another
drug in 19%.Clinical exam showed drowsiness in 54%(n = 23) of cases,
vomiting and nausea in 54%, epigastralgia in 24%.The main biological
abnormalities were hyperglycemia(n = 3) hyperleukocytosis (n = 3) and
respiratory acidosis (n = 2). Sixteen patients were admitted in ICU. Half
of them (n = 8) required mechanical ventilation. Naloxone was used
only in one case. All patients were discharged from ICU in a delay of
12 ± 6 hours.
CONCLUSIONS. Despite the favorable prognosis of tramadol poisoning
unlike other opioid substances, it is imperative to maintain vigilance
and take efficient measures such as awareness, shortening the
prescription period and avoiding its prescription on special grounds as
Health staff, psychiatric patients and other types of addiction.
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INTRODUCTION. Despite therapeutic progress in the management of
the epilepsy, phenobarbital poisoning still constitute a health
problem in developing countries, as a result of suicide attempt or
anesthesia accident.Rarely,intoxication may occur in children or
among drug addicts.
OBJECTIVES. We aimed to assess the frequency and the characteristics
of phenobarbital poisoning.
METHODS. It was a descriptive retrospective study in a teaching
toxicological center over a period of 295 months from January 2004
to July 2016. All patients admitted for phenobarbital poisoning were
included.Diagnosis of phenobarbital poisoning was retained if supra
-therapeutic phenobarbital ingestion was declared and confirmed by
positive serum level.
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were eligible. They were females in 65% (n = 68).A history of
epilepsy was noted in 75% of cases.The frequency of phenobarbital
poisoning was stable at 13% from 2008 to 2012, then decreased
remarqbly to achieve 1% in 2015.The average supposed ingested
dose was 1350 mg [350–5200]. The delay between ingestion and
hospital arrival was 4 hours [1–48].At hospital arrival,clinical exam
revealed drowsiness in 82%, agitation in 11%, coma in 6% and
hemodynamic failure in 8%.Forty four patients (42%) required
mechanical ventilation. Eleven patients (11%) presented inhalation
pneumonia.Gastric lavage was performed in 10% of cases,activated
charcoal was administrated in 23% of cases and alkaline diuresis in
9%.The mean phenobarbital serum level was of 57 ± 39.1 mg/L with
a range of 2 to 214 mg/L. The average duration of mechanical
ventilation was of 2,55 hours [1–30], and the hospital stay of 1.5 [0.5-
18] days. All patients were discharged alive.
CONCLUSIONS. Through this study we demonstrate firstly that
phenobarbital- poisoning must be seriously considered when it
occurs. Secondary, that its frequency is decreasing in our country at
the expense of the emergence of other anticonvulsivant drug
poisoning.1006
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INTRODUCTION. Baclofen is commonly used as treatment of
spasticity, and recently prescribed in treatment of alcohol
withdrawal. It has spasmolytic action resulting from antagonistic
activity at presynaptic GABA receptors of the spinal cord. Because
it´s wide prescription, it became one of the principal agents of
poisoning.
OBJECTIVES. We present a retrospective study that aims to report
the clinical outcomes and management of twenty cases of baclofen
poisoning requiring ICU admission.
METHODS. Retrospective review of medical observations of patients
admitted to our intensive care unit for baclofen poisoning.
RESULTS. Between January 2013 and April 2017, 27 patients were
enrolled in this study. Mean age was 27.2 ± 10 years. Sex ratio was
0.33. Mean APACHE II scale was 9 ± 4. Mean IGSII scale was
21 ± 11.Poisoning severity scale was moderate in six patients and
severe in twenty one. Poisoning was deliberate in 100% of cases.
Mean ingested dose was 458 ± 349 mg. The majority of patients
presented to the emergency room at 4.8 ± 5 hours after ingestion.
Digestive decontamination was performed in 7% (n = 2) of patients.
Clinical presentation was dominated by neurological symptoms;
including coma (n = 17), hypotonia (n = 5), areflexia (n = 7), agitation
(n = 8), seizures (n = 3) and delirium in 1 case. Doses greater than
250 mg were predictive of coma (GCS ≤ 8) AUC = 0.763, with a
sensibility of 80% and a specificity of 75%, Odds Ratio = 0.450 (0.150
1.349) IC 95%. All patients evolved favorably.
CONCLUSIONS. Baclofen overdose causes mainly neurological effects
and except for bradycardia cardiovascular effects were uncommon.
Doses greater than 250 mg were predictive of coma, requiring
mechanical ventilation and long ICU admission. Prognosis is good if
full supportive care is administered properly, except for the length of
stay. Extracorporeal purification may be proposed even on patient
with normal or limited glomerular filtration because baclofen
pharmacological features.1007
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INTRODUCTION. Drug related adverse events are frequently
encountered especially elderly patients.[1] Since 2015 October, Inha
University Hospital Rapid Response Team (INHART) had been
activated. During reviewing cases, INHART activation due to drugs
were collected and analyzed.
OBJECTIVES. We analyzed drugs relate events that activated INHART
and outcomes.
METHODS. From 2016-Jan to 2017-Apr, data were reviewed retro-
spectively. Demographic data, causes of activation, interventions and
immediate outcomes were collected.
RESULTS. In those periods, 17,404 cases were activated by calling
and screening. Sixteen events (0.09%) were considered as drug
related adverse reactions. Male were 8, mean age was 71 (SD, ±15)
years old. Ten patients were received operation such as orthopedics
and two were sleeping endoscopy. Signs of INHART activation were
hypoxemia (13 cases), mental change (2 cases) and respiratory arrest
(1 case). Drugs were sedatives and opioids. Six patients were
performed intubation and two were cardiopulmonary resuscitation.
Others received oxygen therapy. Two patients with malignancy died.
CONCLUSIONS. Though low incidence of drug related adverse
events were noticed, the sedatives and opioids should be used in
caution. Monitoring oxygen saturation and mental status should be
checked continuously.
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INTRODUCTION. Acute poisonings during pregnancy represent a
therapeutic challenge to health care providers because of potential
immediate life threat and possible involvements for both the mother
and fetus.
OBJECTIVES. Our study aims to describe the epidemiological profile
of acute poisonings in pregnant women and evaluate their short-
term effects on the fetus.
METHODS. It is a retrospective study carried out in a teaching
polyvalent and toxicological intensive care unit (ICU) including all
poisoned pregnant women from January 2008 to December 2016.
RESULTS. During the study period, 57 patients aged of 28 ± 5 among
9618 admissions were eligible with a prevalence of 0.6%.The poisoning
was accidental in 66.66%(n = 38) of the cases. Patients were married in
96% (n = 55) and unemployed in 47% (n = 27) of the cases. Carbon
monoxide (CO) was incriminated in 66.66% (n = 38), medical drugs in
21% (n = 12) and pesticides in 7% (n = 7). 38.5% (n = 22) of poisoning
occurred in the first trimester. The clinical status was generally good
with resolutive symptoms. Two cases of pelvic pain and metrorrhagia
Fig. 323 (Abstract 1009) See text for description
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Treatment was symptomatic; activated charcoal was administered to 2
women and gastric lavage was performed in 3 cases, 10 patients
received antidotes and 11 women among 38 have benefitted from
hyperbaric oxygen therapy. One case of maternal death was reported.
Fetal evolution was marked by 3 fetal deaths in utero and 2 threats of
abortion. The long-term evolution was marked by the occurrence of
one pregnancy interruption, one death in infancy and 3 cases of health
problems (sigmoid kidney, heart tumors and strabismus).
CONCLUSIONS. Most cases of acute poisoning during pregnancy were
accidental due to the carbon monoxide exposure. In addition to the
maternal risks associated with the poisoning, fetal complications may
be serious.
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INTRODUCTION. Although safe at therapeutic levels, acetaminophen
(APAP) has been associated with hepatotoxicity at high doses, and is
the leading cause for acute liver failure in the Western World. Drug-
induced oxidative stress exceeds the cell's antioxidant system,
leaving it vulnerable for oxidative damage. The role of mitochondrial
injury in this conditions remains unclear. [1] Currently, the only avail-
able treatment is N-acetylcysteine whose effectiveness depends on
early administration with the aim to prevent liver damage rather
than rescue. Therefore, alternative treatments, especially for late-
stage presenting APAP overdose, are needed. [2]
OBJECTIVES. We evaluated the effect of APAP on mitochondrial
function in human blood cells and hepatocytes to elucidate the role
of mitochondria in APAP-induced hepatotoxicity and, potentially, find
alternative treatment strategies.
METHODS. Human platelets were isolated from healthy donors [3]
and HepG2 cells were cultured in MEM supplemented with FBS,
NEAA, glutamine, penicillin and streptomycin at 37°C and 5% CO2.
Oxygen consumption was evaluated in the presence of APAP and
different protocols were applied to study mitochondrial function. In
permeabilized cells a Substrate-Uncoupler-Inhibitor-Titration (SUIT)
protocol [3] was used to identify the site of mitochondrial damage.
The cell-permeable succinate prodrug NV241 [4] was used as diag-
nostic tool to assess mitochondrial complex II function in intact cells.
RESULTS. APAP inhibited complex I-related oxygen consumption of
intact human platelets and HepG2 cells in a dose-dependent manner.
When the cell-permeable succinate prodrug NV241 was given to in-
tact cells complex II-related oxygen consumption reached levels as
those seen in controls (Fig. 323.). It was possible to exclude complex
II as site of drug-induced toxicity pointing towards direct or indirect
inhibition of mitochondrial complex I-related function by APAP. The
SUIT protocol applied on permeabilized cells further confirmed this
finding.
CONCLUSIONS. APAP induced mitochondrial dysfunction through
complex I in both human platelets and hepatocytes. Bypassing
APAP-induced complex I dysfunction using cell-permeable succinate
prodrugs, such as NV241, presents an alternative treatment strategy
for APAP-induced mitochondrial dysfunction and, potentially, related
hepatotoxicity.
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INTRODUCTION. Metformin is widely used in the management of
patients with type 2 diabetes. MALA is the most dangerous side effect,
characterized by lactic acidosis occurring in patients chronically taking
metformin or in overdose with metformin. The literature assigns an
incidence of 1 to 5 per 100,000 patient/years and mortality up to 50%.
OBJECTIVES. To evaluate MALA's cases and to define the indicators
of greater prognostic weight.
METHODS. Retrospective analysis of patients with MALA, between
2011 and 2017, using the PICIS computer database. In addition to
the demographics and severity indicators at admission and at 24
hours, we compared the deceased and surviving patients trying to
find prognostic markers and mortality markers.
RESULTS. Twenty-three patients were included and there was an in-
crease in incidence per year with a predominance of females (73.9%).
The average age was 68.5 ± 9.4 years, and SAPS II was 63.8 ± 21.6. Of
the included patients, 82.6% were hypertensive, 65.2% dyslipidemic,
39.1% were obese and 43.4% were cardiac insufficient. The values at
admission and at 24 hours were respectively: pH 7.05 ± 0.2 and
7.4 ± 0.1; lactate levels 11.6 ± 5.7 and 7.5 ± 5.8 mmol/l; creatinine
6.8 ± 4.6 and 2.3 ± 1.2 mg/dl; prothrombin time (TP) 17.8 ± 11.1 and
16.7 ± 5.6sec. The average time of hospitalization was 4.4 ± 2.7 days.
Renal replacement therapy with bicarbonate was performed in 95.7%
of the patients, with a mean duration of 39.3 ± 9.9 hours and an effect-
ive effluent dose of 34.5 ± 4.1 ml/kg/h. There was a verified correlation
with mortality for lactate persistence and TP at 24h (odds 1.14 95%
CI:ROC 0.800/odds 1.547 95% CI:ROC 0.952) respectively. Comparing
deceased and survivors, we found statistical significance for age
(p0.001), SAPS II (p0.04) and TP at 24h (p0.001). Mortality was 34.8%.
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 507 of 542CONCLUSIONS. There was an increase of patients with MALA per
year. Hemodialysis initiated on admission appears to be an effective
therapy. The persistence of high TP at 24 hours showed a relation
with mortality. The reduced number of the sample and the non-
dosing of metformin were the main limitations.
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INTRODUCTION. Paracetamol is commonly used in critically ill patients
for both its analgesic and antipyretic properties, however the
understanding of its pharmacokinetics in this population is limited,
meaning current dosing regimens may be insufficient to achieve a
therapeutic effect 1,2. In healthy patients at the end of a 15-minute infu-
sion of 1g IV paracetamol, the maximal plasma concentration is ap-
proximately 30 mg/L. Analgesic effect commences within 5 minutes of
infusion, peaks within one hour, and lasts 4–6 hours. Antipyrexial activ-
ity typically reduces fever within thirty minutes, and lasts around six
hours. Plasma concentrations of paracetamol between 10-20mg/L have
been shown to produce antipyretic effect but the concentrations to
produce analgesia are not well defined 3.
OBJECTIVES. We aimed to determine whether paracetamol
pharmacokinetics and pharmacodynamics in critically ill patients differs
from the currently accepted mechanisms.
METHODS. This prospective study was performed in a mixed medical,
surgical, and neurosciences critical care unit. Patients receiving the
maximum dose of intravenous paracetamol per 24-hour period were re-
cruited. Serum paracetamol levels were measured prior to administration
of IV paracetamol, and then at 15 (end of infusion), 30, 60, 120, and 180
minutes post-infusion. Levels were taken again once daily on each of the
following two days. Temperature, blood pressure, C-reactive protein level
and neutrophil count, were also recorded, along with reason for critical
care admission, APACHE II and ICNARC scores.
RESULTS. Following intravenous paracetamol administration in
critically ill patients, therapeutic and peak levels in plasma are
reached within 15 minutes of administration, but remain therapeutic
only for the first hour following administration. Plasma levels of
paracetamol have been shown to be sub-therapeutic by 120 minutes
post-infusion in 80% of study participants.
CONCLUSIONS. The pharmacokinetics of IV paracetamol appear to be
disturbed in critically ill patients, questioning its utility as an analgesic
and antipyretic agent in this population when used in its current form.
The results of this study will be used to guide further research into the
understanding of pharmacokinetics and pharmacodynamics of
paracetamol in critically ill patients.
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INTRODUCTION. Chronic Obstructive Pulmonary Disease (CPOD) is
an important cause of morbidity and mortality in critical ill, being a
common reason for intensive care unit (ICU) admission. At present,
there is no cure for COPD, sintomatic farmacologic treatmen is based
in b2 adrenergic agonists, however, there is a loss of efficacy after
frequent use due to reduced number of b2 adrenergic receptors and
the induction of increased heart rate. The design of selective ligands,
both agonists and antagonists to b2 adrenergic receptor (β2AR) is a
topic of interest.
OBJECTIVES. Evaluate the interaction with adrenergic b2receptor
and relaxant effect on smooth muscle of a designed and synthesized
salbutamol-boron compound.
METHODS. We performed the design of β2AR related compounds,
evaluating the effect of some substituents added to pharmacophore
group. The structures were evaluated according to their affinity with
three-dimensional models of β2AR. This assessment was performed
using ligand-protein docking methodology, as well as to validate the
estimating procedure and affinity interactions to the receptor. Three
compounds were synthesized, in order to explore the effect of chem-
ical structural changes on biological activity. M compound was ob-
tained with adequate purity to be evaluated in its capability to relax
smooth muscle in the guinea pig trachea rings.
RESULTS. The M compound is 32.26 times more potent than
salbutamol for generating a smooth muscle relaxant effect. ICI
118,551 behaves as a competitive antagonist of the relaxant effect of
the compound M, suggesting that the relaxation was mediated by
interaction with the β2AR. Additionally, the acute toxicity profile of
the M compound in CD1 mice, showed similar or lower toxicity than
other reported arylethanolamines, and Raman spectroscopy studies
showed a lower income to mice's central nervous system compared
with boric acid in equimolar concentrations.
CONCLUSIONS. The presence of boron and exposed hydroxyls of M
compounds increased their affinity with b2AR (as estimated in silico).
Thus, the boron substituent allows interaction with the hydroxyl
groups of the 203, 204 and 207 serines of the receptor, promoting
their activation and resulting in a more potent compound than
salbutamol. Further studies are necessary to determinate the
pharmacodynamic and pharmacokinetic characterization of M
compound, to elucidate other mechanisms that may be involved in
the relaxing effect of this compound.
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INTRODUCTION. Cancer patients requiring intensive care unit (ICU)
admission are increasing. However, need for optimal use of ICU
resources, mandates employement of appropriate triage criteria and
use of prognostic factors especially in critically-ill cancer patients (CICP).
OBJECTIVES. To determine whether classification of CICP according
to admission triage criteria as “full-code” (FC), “ICU-trial” (ICU-T) and
“no-indication” (NI) predicts 28th-day mortality and to determine fac-
tors affecting 28th-day mortality.
METHODS. CICP admitted to an 8-bed oncology-ICU of a university
hospital between 1.10.2013-31.3.2016 were recruited, retrospectively.
Patients were classified to FC, ICU-T and NI groups together with a
medical oncologist, according to time of cancer diagnosis, current
disease status, current treatment plan, anticipation of complications,
pallative care and so forth, as proposed by Azoulay et al. (reference).
Comparisons were done between 3 groups and between survivors
and non-survivors. Kaplan-Meier survival analysis was performed and
logistic regression analysis was done to determine independent pre-
dictors of 28th-day mortality.
RESULTS. Out of 306 CICP, 181 (59.2%) were classified in FC, 46 (15.0%)
in ICU-T and 79 (25.8%) in NI groups. There were no difference between
groups in terms of age, gender, APACHE-II and SOFA score. Charlson
co-morbidity and ECOG performance scores were worst in NI group
(p = 0.0001 for both). More patients in the NI group had solid type of
cancer, progressive disease and metastatic cancer (p = 0.0001 for all).
Among patients, 28th-day mortality rate was 37.6%, 52.2% and 64.6%,
respectively (p = 0.0001). Mortality rate was highest in NI group and
lowest in FC group according to Kaplan-Meier survival analysis (log rank
test, p = 0.049). In logistic regression analysis, NI admission criteria was
an independent risk factor for 28th-day mortality as compared to FC
criteria (OR (95% CI): 2.57 (1.38-4.78); p = 0.003). Other factors affecting
mortality were a high admission SOFA score (for each 1 point increase
OR (95% CI): 1.12 (1.03-1.21); p = 0.006), having a solid cancer as com-
pared to hematologic cancer (2.02 (1.11-3.70); p = 0.022) and an in-
creased admission lactate level (1.15 (1.02-1.30); p = 0.022). Hospital
mortality rate was 59.1%, 76.1% and 78.5%, respectively (p = 0.004).
CONCLUSIONS. Critically-ill cancer patients with no-indication for ad-
mission to the ICU had the worst 28th-day mortality, having a solid
cancer, a high SOFA score and high admission lactate level being
other factors affecting mortality. Therefore, a simple admission triage
criteria as “full-code”, “ICU-trial” and “no-indication” might be used to
predict short term survival in CICP.
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Intensive Care Medicine Experimental 2017, 5(Suppl 2):1014INTRODUCTION. Neurologic complications of human immunodeficiency
virus (HIV) infection remain common, despite effective antiretroviral
treatment (HAART). Neurologic manifestations may be due
opportunistic infection,inmune reconstitution,or the virus itself. In
lower and middle-income countries, where widespread access to
HAART is still an unaccomplished goal, little information exists in
the literature on survival trends in neurologic complications of HIV-
infected patients admitted to ICU.
OBJECTIVES. We describe the epidemiologic profile, outcomes and
mortality predictors of HIV-infected patients admitted with neuro-
logic complications to ICU in Medellín, Colombia.
METHODS. This is a substudy of a clinical, retrospective study of HIV-
infected patients, ≥18 years old, admitted for more than 24 hours to
any of 5 different ICUs in Medellin, Colombia from January 1, 2008
through December 31, 2014. A descriptive analysis was performed.
Variables associated with mortality and those with biologic plausibil-
ity were entered in a logistic regression model constructed in order
to identify independent factors associated with mortality.
RESULTS. A total of 409 patients, 183 (44,7%) were identified with
neurologic complications. It is the second reason for admission to ICU.
The main cause is respiratory failure. In bivariate analysis of neurological
variables, predictors of hospital mortality were: Toxoplasmosis (p 0,039)
and Cryptococcus (p 0,0162). In the multivariate analysis controlling for
age, gender, CD4 count < 350 cells/μL, HAART in the last 6 months,
admission for opportunistic infection and APACHE-II score at ICU admis-
sion,independent predictors of hospital mortality were:vasopressor sup-
port (RR 4,5; 95%CI 2,19-9,2) and invasive mechanical ventilation (RR 2,7;
95%CI 1,12-6,5).Age (years) median (IQR) 37 (19–64)HIV diagnosis on admission (%) 57 (31%)CD4 count (cells/ul) median 129HAART before admission (%) 57 (31,1%)APACHE median (IQR) 18 (3–35)SDRA n (%) 66 (36,1%)mechanic ventilation n (%) 130 (71%)renal failure n (%) 59 (32,2%)Catecholamines n (%) 93 (50,8%)Mortality n (%) 102 (55,7%)[Characteristics of patients with neurologic compli]Occupant space injury n (%) 89 (48,6%)Meningitis n (%) 76 (41,5%)Neurovascular compromiso n (%) 10 (5,5%)Associated dementia n (%) 8 (4,4%)[Etiology of central nervous system involvement]Variable RR 95% CICatecholamines 4,5 2,19 - 9,23mechanic ventilation 2,71 1,12 - 6,55[Multivariate analysis of characteristics associate]
CONCLUSIONS. Neurologic complications are the second reason for
admission to ICU. The main causes of central nervous system
involvement are occupant space injury and meningitis. Toxoplasmosis
and cryptococcus are associated with mortality. Mortality in our cohort
remains extremely high
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Table 244 (Abstract 1015). Comparison of admission to the ICU rates
according
Baseline,
n (%)
P Baseline,
n (%)
P Baseline,
n (%)
P
Intensivist Oncologist Intensivist Oncologist Intensivist Oncologist
Clinical
case #1
120 (100
%)
121
(100%)
121
(100%)
70 (100%) 50 (100%) NS 70 (100%) 51 (100%) NS 70 (100%) 51 (100%) NS
Clinical
case #2
31 (26%) 83 (68 %) <0,001 75 (61 %) 0.001
11 (16%) 20 (41%) 0.003 47 (67%) 36 (71%) 0,68 40 (57%) 35 (69%) 0.2
Clinical
case #3
38 (32%) 94 (78 %) <0,001 70 (58 %) <0.001
21 (31%) 17 (35 %) 0,7 53 (76%) 41 (80%) 0,54 42 (60%) 28 (55%) 0.57
Clinical
case #4
2 (2 %) 24 (20 %) <0,001 60 (50 %) <0.001
1 (1 %) 1 (2 %) 0.38 11 (16%) 13 (25%) 0.18 29 (41 %) 31 (61%) 0,004
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INTRODUCTION. The admission incidence of patients with cancer
to the intensive care units (ICU) is increasing. New targeted
anticancer therapies have changed the prognosis of many cancer
patients with new outcomes but also new adverse events possibly
leading to ICU admission. However oncological prognosis remains
poorly known from intensivists and on the other hand, oncologists
are often not fully aware of the modalities and consequences of a
long stay in the ICU. Two points of view may indeed be in
opposition.
To investigate this point, we performed an observational study,
comparing the answer of both oncologists and intensivists to a
questionary regarding different oncological and acute illness
conditions.
METHODS. Four clinical cases of oncological patients were
presented, and for each of them, two acute clinical conditions
requiring an ICU admission (one reversible illness and one less
reversible). Oncologist and intensivists from 4 university hospitals in
France were asked if ICU admission was relevant according to the
oncological status and the acute clinical condition. When ICU
admission was considered, the ICU therapeutic plan was asked (full
code or ICU trial, as previously published (1).
RESULTS. 121 physicians completed the survey, 70 intensivists and
51 oncologists. Median experience in both groups was the same (7
years [0.5-34] versus 5.3 years [0.5-35]). Apart from the first clinical
case (young women with breast cancer at diagnosis with 100% of
intensivists and oncologists admitting her to the ICU, whatever the
acute clinical condition was), the rate of transfer to the ICU increased
each time a clinical acute situation was described (p < 0.001),
meaning the only oncological status was not enough to decide. The
results are described in Table 244.
There was a no significant difference regarding the rate of transfer to
the ICU between intensivists and oncologists in all but one case
(clinical case 2). In this last case, the difference between oncologists
and intensivists disappeared once the acute complication was
described. However, even though intensivists agreed to take the
patient in charge, they more often decided to introduce therapeutic
limitations, than oncologists.
CONCLUSIONS. Our study shows that the only oncological status
was not enough to make a decision to transfer or not, unless in
extreme good prognosis case or in case of terminal oncological
disease. The reversibility of the acute illness should be carefully
evaluated by intensivist and oncologist together in order to
define the better ICU care plan, particularly regarding the ICU
care with therapeutic limitations. Both specialties recognize a
need for training, especially in the context of new therapeutic
agents.
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INTRODUCTION. Epidemiologic data about hemoglobinopathies in
Tunisia reported a prevalence of 4.48% reaching 12.50% in some
focus regions (1). Progression of such diseases, especially sickle cell
disease, could be complicated; that's how intensivists could be
involved in the management of acute complications (2) considered
as risk factors for early death (3).
OBJECTIVES. We aim to describe the clinical manifestations,
management of complications and outcome of sickle cell disease
and thalassemia in intensive care unit (ICU).
METHODS. We conducted a retrospective and descriptive study,
including patients with a history of hemoglobinopathies hospitalized in
a 22-bed medical ICU of a teaching hospital in Tunisia. The study dur-
ation was of 11 years and 3 months, from January 2006 to March 2017.
RESULTS. During this study, 32 patients were included (Sickle cell
disease (n = 26),drepano-thalassemia (n = 4) and thalassemia
(n = 2)). The average age was 28.9 years ± 8.46 [9–47 years] with a
male predominance (sex-ratio = 2.55). The mean of APACH II score
was 16.7. Hemoglobinopathies were diagnosed at the mean age of
7.9 years ± 7.46 [1–25 years] with a regular follow up in 84.4%. A
family history of hemoglobinopathy was found in 10 cases. 13
patients underwent cheolcystectomy. The delay before ICU referral
was of 184 hours [24–720 hours]. The reason for admission was
acute respiratory failure in 30 cases (93.8%) and coma in 2 cases
(6.8%). The mean LDH was 1666 U/l [11-6950U/l]. Vaso-occlusive cri-
sis were manifested by acute chest syndrom in 15 cases (46,9%) and
osteoarticular pain in 5 cases (15.6%); it was complicated with multi-
organ failure in 2 cases (6.2%).The diagnosis of severe community ac-
quired pneumonia was retained in 16 cases (40.6%) and
pulmonary embolism (PE) in 6 cases (18.8%) with an average ob-
struction index of 27.9% .4 patients were presented with septic
shock (12.5%). A symptomatic treatment based on oxygen, anal-
gesics, hydration and heparin at preventive dose was prescribed
in 62.5% case (n = 20). 18.7% of admissions required blood trans-
fusion (n = 6). Mechanical ventilation was needed in 9 cases
(average duration = 7.12 days [1–18 days]) and vasopressives in 5
cases (average duration = 4.6 days [1–16 days]). Mean length of
ICU stay was 6.5 days [1–31 days]. Five patients (15.6%) died
from multiorgan failure or massive PE.
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 510 of 542CONCLUSIONS. Life-threatening complications in hemoglobinopa-
thies require admission to ICU; especially acute respiratory failure
that could be from various etiologies. Mortality within these patients
remains considerable.
REFERENCE(S)
1: Hemoglobinopathies in Tunisia. An updated review of the
epidemiologic and molecular data. Fattoum S. Tunis Med 2006
Nov;84(11):687–96
2: Critically ill patients with sickle cell disease. Habibi A. Réanimation
16 (2007) 310–317
3: Mortality in sickle cell disease. Life expectancy and risk factors for
early death. Orah S. NEJM 330(1994):1639–44
1017
Incidence, risk factors and outomes of onco-hematological patients
in ICU
C.C. Geremia1, J.S. Seeber2, V.C. Maraschin3, P.A.D. Duarte4
1Universidade Estadual do Oeste do Paraná, Cascavel, Brazil; 2Hospital do
Câncer / UOPECCAN, Cascavel, Brazil; 3Faculdade Assis Gurgacz, Cascavel,
Brazil; 4Hospital do Câncer / UOPECCAN, General ICU, Cascavel, Brazil
Correspondence: P.A.D. Duarte
Intensive Care Medicine Experimental 2017, 5(Suppl 2):1017
INTRODUCTION. Despite medical advances in recent years, cancer
patients have also shown an increase in the incidence of
complications, with life-threatening conditions that have led to
increased demand for intensive care. The present study aims to
establish the epidemiological profile of onco-hematological pa-
tients, as well as to identify the risk factors associated with ICU
mortality.
METHODS. Retrospective cohort study analyzing medical records of
adult patients with hematological malignancies (leukemias, lymphomas,
myeloma, and severe myeloproliferative diseases) who were admitted
to the ICU of a Cancer Hospital in a 2-year period.
RESULTS. In the study period, there were 904 admissions to the
ICU, 68 (7.52%) of patients with hematological malignancies
(63.2% male, age 55.4 years). Most common diagnosis: Acute
leukemia (27.9%), Lymphoma (25%), Multiple myeloma 19.1%,
Chronic leukemia 7.3%. Mortality was 77.9%. 73.5% used MV.
Acute respiratory failure was the main cause of ICU admission,
with 45.6% of patients, followed by neurological causes, with
22.1%. By logistic regression analysis, the main predictors of
death were: time of MV, time of use of vasoactive drugs (VAD),
recent diagnosis of the neoplasia, and no previous chemotherapy.
CONCLUSIONS. The mortality of onco-hematological patients in ICU
was very high, particularly with patients with recent diagnosis (still
without beggining of chemotherapy).
1018
Sepsis code in patients with solid and hematological malignancies
at a tertiary hospital. Risk factors for mortality
I. Romera1, M. Santafe1, J. Baldirà1, L. Fox2, C. Díaz-Lagares1, J.C. Ruíz-
Rodríguez1, M. Pérez1, R. Ferrer1
1Vall d´Hebron University Hospital, Critical Care Department, Barcelona,
Spain; 2Vall d´Hebron University Hospital, Hematology Department,
Barcelona, Spain
Correspondence: I. Romera
Intensive Care Medicine Experimental 2017, 5(Suppl 2):1018
INTRODUCTION. Patients with solid or hematological malignancies
are at high risk of developing sepsis, which is related to a high
mortality. So, efforts are needed in order to improve their prognostic.
OBJECTIVES. To analyze the characteristics and identify risk factors
for mortality in oncological and hematological patients with sepsis,
identified and managed in a protocolized basis (Sepsis Code).
METHODS. Prospective study, including adult (+18 years) patients
with solid or hematological malignancies and sepsis, during the first
fifteen months of activity of the Sepsis Code (15.10.2015 to
31.01.2017), at a tertiary center. Approved by Vall d´Hebron Hospitalethics committee (PR(AG)336/2016). X-Square, Fisher´s test, T-test, U
Mann–Whitney and logistic regression were employed as required.
Quantitative variables are reported as median (IQR) and categorical
as N (%).
RESULTS. Sixty-seven patients were included, 43 (64%) men, with an
age of 67 (52–71) years. Thirty-eight (57%) had hematological malig-
nancies (16 (24%) acute leucemia,16 (24%) lymphoma) and 29 (43%)
solid cancer (lung cancer, 8 (12%)). In 38 (57%) septic shock was di-
agnosed, while 24 (36%) had severe sepsis and 5 (7%) sepsis. The
source of the sepsis was: respiratory in 27 (40%), intraabdominal 20
(30%), urinary tract 10 (7%). In 7 (10%), the source was not identified.
The antibiotics more often employed were meropenem in 32 (48%)
and piperaciline-tazobactam 29 (43%). Combination therapy with an
aminoglycoside was prescribed in 22 (33%). Fourteen (21%) received
specific coverage against gram positives and 8 (12%) antifungal ther-
apy. In 51 (76%) a pathogenic microorganism was found, being the
most frequently isolated, E. coli 13 (19%), K. pneumoniae 11 (16%)
and P. aeruginosa 5 (8%). APACHE II score was 21 (16–27) and SOFA
6 (4–10). According to SOFA criteria, the following organ dysfunction
was observed: hemodynamic 46 (71%), respiratory 33 (53%) and 27
(41%) renal. Twenty-eight (42%) were neutropenic. At sepsis code ac-
tivation, lactate levels were 3 (2–5) mmol/dL, CRP 18 (12–28) mg/dL
and procalcitonin 12 (2–36) ng/mL. Thirty (46%) required ICU admis-
sion, 35 (52%) vasoactive drugs, 13 (20%) mechanical ventilation and
4 (6%) renal replacement therapy. Thirty-eight (55%) died during
hospital admission. The following factors were related to mortality:
lung cancer and acute leukemia (17 (74%) vs 19 (45%), p = 0.03),
APACHE II (24 vs 19, p = 0.008), respiratory dysfunction (26 (77%) vs
10 (32%), p = 0.001), mechanical ventilation (12 (92%) vs 24 (46%),
p = 0.014) and increase of CRP after 48 hours (10 (71%) vs 6 (30%),
p = 0.021). In the multivariate analysis, only mechanical ventilation
(OR: 11.9, IC95%: 1.4-100, p = 0.025) and APACHE II (OR:1.1, 1.0-1.2,
p = 0.024) reached statistical significance.
CONCLUSIONS. Sepsis in patients with solid and hematological
neoplasms has a significant mortality, mainly in those requiring
mechanical ventilation. APACHE II score is also related to mortality.
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INTRODUCTION. Hematopoietic stem cell transplant recipients
(HSCT-R) are a population with a high risk of developing severe
complications that require admission to an intensive care unit (ICU),
which is related to a high mortality. So, efforts are needed in order
to improve their prognosis.
OBJECTIVES. Our aim was to describe the cohort of HSCT-R admitted
to a tertiary hospital ICU and analyze factors that are likely to affect
their survival.
METHODS. Retrospective study, including adult (+18 years) patients
who received an HSCT and required admission to ICU between 1st
January 2010 and 28th February 2017 at a tertiary hospital. Chi-
Square, Fisher exact test, Student T test, Mann–Whitney U-test, and
logistic regression were employed as required. Quantitative variables
are reported as median (IQR) and categorical as frequency (%).
RESULTS. Sixty-four patients were included, 41 (64.1%) men, with a
median age of 52 (35–60) years. The underlying leading conditions
were leukemia, with 27 (42%) patients, and lymphoma with 24 (38%).
Allotransplant was done in 53 (83%). Fourteen (22%) had received a
previous HSCT. SOFA on admission was 9 (7–11) and organ failures
were distributed as follow: respiratory in 31 (48%), hemodynamic in
29 (45%), hematological in 36 (53%), renal in 10 (16%), liver in 9
(14%) and neurologic in 5 (8%). APACHE II score was 23 (17–28). The
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 511 of 542most frequent diagnosis at admission were pneumonia, that affected
to 29 (45%), septic shock in another 29 (45%) and sinusoidal occlu-
sive syndrome in 5 (8%). Neutropenia was present in 32 (50%). Forty-
seven (73%) required vasoactive drugs, 33 (52%) high flow nasal
cannula (HFNC), 37 (58%) mechanical ventilation (MV), 20 (31%)
neuromuscular blocking agents, 9 (14%) prone positioning and 19
(30%) renal replacement therapy (RRT). Twenty-six (41%) were dis-
charged to the ward and 16 (25%) survived at hospital discharge.
SOFA score on admission was related to mortality (OR 1.29 IC
95%:1.0-1.6, p = 0.02). Patients with SOFA on admission > 11 had
100% mortality (p = 0.025). Another factors related to mortality were
MV (OR = 6.6, IC95%:1.8-23.9, p = 0.04) and RRT (OR 9.07 IC95%: 1.1-
74.5, p = 0.04). We did not find any differences related to the type of
HSCT or to the presence or length of neutropenia. Patients on HFNC
on admission who failed and required mechanical ventilation had
similar mortality than patients initially on mechanical ventilacion,
90% and 87%, respectively (p = 1). In the multivariate analysis, MV
(OR = 6.32, IC95%:1.62-24.63, p = 0.008), and SOFA score on admis-
sion (OR1.28 IC95%:1.02-1.61: p = 0.035) maintained statistical
significance.
CONCLUSIONS. Recipients of HSCT admitted to an ICU have a high
ICU and hospital mortality. SOFA score on admission and
requirement of MV are independent predictors of hospital mortality.
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INTRODUCTION. The hematological patient are a continue challenge
to the intensive care because their underlying conditions presents
special characteristic which modify the complications they presents
and their management.
OBJECTIVES. The aim of this study is to assess thrombopenia and
neutropenia as a prognostic factor in oncohematologic patients (pts)
who required admission to intensive care unit (ICU), either at
admission or during their hospitalization, their relationship to the
prognostic scales: SOFA, APACHE and SAPS II, respiratory distress
(ARDS) and mortality.
METHODS. An observational and retrospective study was conducted,
we reviewed all pts with hematology malignances that were
admitted to the ICU between May 2013 to February 2016.
We analyzed the following variables: age, sex, type of hematological
disease, organ failure, SOFA, APACHE II y SAPS, thrombopenia and
neutropenia at admission and minimum values during their stay,
presence of ARDS and ICU mortality.
We used the X2 and the results are shown using the median values
and their range.
RESULTS. A total of 141 pts were admitted, with a mean age of
55.1 ± 14.9 years. Men were 57.1% and 42.1% were women.
The underlying hematological condition was leukemia (53%),
lymphoma (24%), myeloma (15%) and a solid tumor (8%). The main
reason for admission was hemodynamic failure 77.1% and
respiratory failure 71.4%. 26 pts (18.4%) were diagnosed with ARDS.
The mean SOFA severity score was 9.3 ± 4.3 (2–20); APACHE II
22.64 ± 13.15 (3–65) and SAPS II: 50.27 ± 20.82 (2–101). Mortality
rate was 38.6% (54 patients).
Thrombopenia (<50000 platelets), occurred in 59 pts (41.8%) on
admission and during their stay were developed in 100 patients
(70.92%). Neutropenia (<1000 neutrophils) was recorded on
admission in 43 pts (30.49%) and 59 pts (41.84%) were developed
during hospitalization.
Using the X2 test we found that thrombopenia, both at admission
and its minimum value, was related to the mortality (p 0.016 and p0.003); as well as SOFA (p 0.0001; p 0.001) but not with APACHE II or
SAPS II.
Using the same test (X2), there was no statistically significant
relationship between neutropenia at admission and the minimum
value during stay with mortality or prognostic scales: SOFA, APACHE
II and SAPS II.
Statistically significant relationship was found between neutropenia
at admission and the presence of ARDS (p 0.007). Applying X2
showed a relationship between ARDS and mortality (p 0.0001).
CONCLUSIONS. Thrombopenia is related to mortality in oncohematologic
patients in our setting, regardless of the underlying disease and the reason
for admission.
Thrombopenia is only related to the SOFA,
In our study the neutropenia can't be considered an independent
factor of mortality in oncohematologic patients. A larger study could
better assess these results.
There is a relationship between the presence of ARDS and the
presence of neutropenia at admission.
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INTRODUCTION. Hemophagocytic lymphohistiocytosis (HLH) is an
uncontrolled hyperinflammatory state caused by impaired natural-
killer (NK) and cytotoxic-T-cell function, which can lead to multiorgan
failure and death. Triggering factors are infections (EBV, CMV, HIV),
connective tissue diseases, lymphoid malignancy and drugs.
OBJECTIVE. The aim of the present study was to retrospectively
investigate the prevalence of HLH in critically ill patients. We also
studied the possible triggering factors and the subsequent morbidity
and mortality associated with the syndrome.
PATIENTS AND METHODS. Mechanically ventilated patients, treated in
ICU during five years, were included in this retrospective observational
study. Disease severity was estimated by Acute Physiology and Chronic
Health Evaluation (APACHE II) score and the degree of organ dysfunction
was quantified by the Sequential Organ Failure Assessment (SOFA) score.
Clinical and laboratory data were recorded. HLH diagnosis was based on
five out of the following eight HLH criteria: persistent fever,
splenomegaly, bicytopenia (hemoglobin < 9g/dL, neutrophils < 1x109 /L,
platelets < 100x109 /L), hypofibrinogenemia (<150mg/dL) and/or
hypertriglyceridemia (>265mg/dL), hemophagocytosis, low NK cells
activity and high concentration of sCD25 (soluble receptor for interleukin
2). The presence of immunosuppression, the sepsis stage, ferritin levels,
specific therapeutic interventions and morbidity and mortality data were
also recorded. Multivariated analysis was used, in order to evaluate the
risk factors associated with mortality.
RESULTS. During the study period, twelve patients fulfilled the HLH
diagnostic criteria. The mean (±SD) APACHE II and SOFA scores were
20 ± 7 and 10 ± 3 respectively. Septic shock was present in five
patients (41%). Regarding the possible triggering factors, lymphoid
malignancy was present in four patients (30%), while CMV infection
was observed in one patient and systemic lupus erythematosus in
one patient as well. Hemophagocytosis on bone marrow aspirates
was found in seven patients (58%). The mean time from ICU
admission and HLH diagnosis was 7 ± 5 days. Regarding the
therapeutic interventions, intravenous immunoglobulins were
administered in eleven patients, while one patient received
dexamethasone and etoposide. The mean (±SD) ICU stay was
20 ± 18 days, while the observed ICU mortality was 58%. ICU
mortality was significantly associated with SOFA score (p = 0.01) and
advanced age (p = 0.03).
Fig. 324 (Abstract 1022) Patient specifics, by diagnosis
Fig. 325 (Abstract 1022) Number of organs supported
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syndrome in critically ill patients. Malignancies, connective tissue
diseases and several infections might trigger the syndrome. The
intensivist should be aware of this possible diagnosis and timely
proceed to the appropriate treatment, in order to limit the HLH-
related mortality.
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INTRODUCTION. Admission to ICU with a haematological malignancy
continues to be a contentious decision. Previously published data
shows that survival has improved over the last 30 years. We examine
the outcomes of patients admitted with a haematological malignancy
into our ICU over the last 5 years, to understand how survival has
continued to change.
METHODS. We retrospectively examined data for 139 patients coded
with a haematological malignancy who were admitted to our ICU
between 2012 and 2016, who between them had 161 ICU episodes
(22 patients had multiple admissions). Data was analysed in stata.
RESULTS. Overall hospital and 6 month mortality during the study
period were 46.6% and 64.4% respectively. Of those discharged from
ICU, 7.6% died before hospital discharge.
Median ICU LOS was 3.5 days (IQR 1.8 to 7.9 days). Median hospital
LOS after ICU was 19.3 days (IQR 6.75 to 27 days) before death or
discharge.
Figure 324 lists the demographics of patients, divided by
haematological diagnosis. This shows that patients with acute
leukaemia tended to be younger, had more exposure to
chemotherapy around their ICU admission, and more likely to be
bone marrow recipients. Despite this their ICU survival was much
better than other diagnoses.
Virtually all patients received at least one organ support, 88%
requiring at least one advanced level organ support, 23% required
renal replacement therapy. As the number of organs requiring
support increased, so mortality increased (p < 0.001) (Fig. 325).
Overall 71% of all admissions were associated with chemotherapy
treatment. Of those receiving chemotherapy; 49% died, versus 44%
in those not (p = 0.52). Chemotherapy did not increase risk of death
(OR 1.25 CI 0.6-2.5, p =0.41).
72 (45%) admissions were associated with bone marrow
transplantation(BMT), 27 during the index admission, 45 historically.
Hospital mortality in those receiving BMT during the current
admission was 48%, versus 46% in those not (p = 0.83). BMT was
not associated with increased risk of death (OR 1.2 (CI 0.6-2.2,
p = 0.54).
Of those admitted, 23 (14%) had a new diagnosis of malignancy.
Mortality was not correlated with a new diagnosis, 39% vs 47.7%
(p = 0.446), OR of death 0.7 (CI 0.28-1.7, p = 0.44).
CONCLUSIONS. Mortality amongst patients with haematological
malignancy admitted to ICU is higher than general ICU mortality but
is lower than historical data.
Chemotherapy, a new diagnosis of malignancy, or a history of BMT
were not correlated to hospital outcome in our patient cohort. Age
and number of organs requiring support were correlated with
outcome.REFERENCES
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INTRODUCTION. ICU patients with a haematological malignancy
have a higher ICU, hospital and 3 month mortality (46.4%, 59%, 77%)
compared with general ICU patients (22%, 30%,37%) [1]. Despite
Fig. 326 (Abstract 1023) Admission diagnosis
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remains high. Selection for ICU treatment in this group of patient is
important to improving outcomes. Known negative prognostic
factors include underlying diagnosis (acute leukaemia), second line
treatments (chemotherapy or bone marrow transplantation), invasive
ventilation [1] and multiple organ failure (SOFA score > 11) [2]
OBJECTIVES. The aim of the study was to identify factors associated
with survival and construct pre-ICU strategies and selection for ad-
mission to ICU guidelines.
METHODS. We carried out a retrospective analysis of patients
admitted to the adult ICU at the Countess of Chester hospital, UK
with haematological malignancy over a 5 year period (2010 to 2014)
looking at factors that may correlate with mortality.
RESULTS. In total we had n = 28 patients in over a 5 year period.
The data was analysed using Chi squared test with Yates´ correction.Factor Survived Died P
valueSignificanceHaematology consultant
referral14/15
(93.3%)7/13 (53.8%) 0.028 YesInvasive ventilation 6/15 (40%) 12/13
(92.3%)0.006 Yes[Factors affecting ICU mortality]Haematological
diagnosisN APACHE 2
predicted mortality
(%)ICU
mortality
(%)Hospital
mortality
(%)3 month
mortality
(%)Acute
leukaemia/AML5 72.5 80 80 100Lymphoma/
NHL14 59 50 64 86Myeloma 8 58.7 12.5 12.5 50CML 1 97.1 100 100 100[Outcome by haematological diagnosis]
CONCLUSIONS. This study showed that factors associated
significantly with a favourable outcome includes consultant to
consultant referral and a diagnosis of myeloma. Single organ failure
not requiring invasive ventilation had lower mortalities. The results
also show that 53.8% of patients admitted to the ICU had sepsis. Of
the 28.5% of patients admitted with respiratory failure a significant
proportion of these had pneumonia. Sepsis and respiratory distress/
pneumonia make up the majority of reasons for ICU admission.
Hospitalised haematology patients should undergo even more
rigorous screening for sepsis using the qSOFA criteria. The threshold
for referral should be lower in this group of patients as we know that
prolonged pre-ICU stay confers poor prognosis [1]. In the UK this
may be a role for critical care outreach. The referral to ICU should be
consultant to consultant to factor in haematological diagnosis, prog-
nosis, relapse, secondary treatments and recognise futility. In
addition to a clinical assessment, SOFA scoring should be included in
the decision to select for ICU admission.
REFERENCE(S)
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INTRODUCTION. Cardiovascular complications are one of the most
common complications associated with anticancer therapy. Although
treatment- induced cardiotoxicity may occur in up to one-third of
cancer patients, there are very limited data on the management
of chemotherapy induced acute heart failure necessitating ICU
admission. Levosimendan, a calcium sensitizing inotropic agent,
has been shown to improve hemodynamic function in patients
with decompensated heart failure but data in cancer patients are
lacking.
OBJECTIVES. We therefore aimed to characterize the effect of
levosimendan on hemodynamic performance in patients with
anticancer therapy associated acute low-output heart failure.
METHODS. We conducted a retrospective analysis of thirty cancer
patients admitted to ICU with acute heart failure attributable to
chemotherapy induced cardiotoxicity. All patients received levosimendan
as continuous infusion of 0.1μgkg−1min-1 for 24h. Hemodynamic
measurements were performed at baseline and at 6, 12 and 24h
after start of levosimendan using a Swan-Ganz thermodilution cath-
eter. Additional dobutamin was allowed in stable doses and a mean
arterial pressure was maintained at 65mmHg by noradrenaline if
necessary.
Changes in hemodynamic variables over time were analyzed by
Wilcoxon rank test.
RESULTS. Causes for acute heart failure were toxicity due to
anthracyclines (30%), myeloablative conditioning regimen (40%),
tyrosine kinase inhibitors (10%), protein kinase inhibitors (10%) and
carboplatin (10%). Patient demographics were; Median age 61years,
male/female 45% vs.55%, BMI 23.9, allogeneic HSCT recipients 45%
and autologous HSCT recipients 5%. Invasive mechanical ventilation
was initiated in 55%, non-invasive mechanical ventilation in 10%,
CRRT in 50%, VA-ECMO in 20%.
The median ICU severity scores were; APACHE II 20, SAPS II 45.
Overall ICU mortality was 35%.
Fig. 327 (Abstract 1026) Postoperative platelet count in
each group
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increase in cardiac index from 1.6 ± 0.3 to 2.0 ± 0.5 (6h), 2.2 ± 0.5
(12h) and 2.6 ± 0.5 L*min−1*m−2 (24h). Patients showed an increase
(p < 0.001) in stroke volume from 29.8 ± 11.6 to 36.6 ± 15.9 (6h),
41.0 ± 17.3 (12h) and 47.8 ± 15.5 mL/beat (24h). Pulmonary-capillary
wedge pressure dropped from 17.2 ± 2.7 to 15.4 ± 2.5 (6h; p = 0.02),
13.9 ± 2.0 (12h; p < 0.001) and 10.9 ± 3.1 mmHg (24h; p = 0.002).
Systemic vascular resistance index decreased from 3182.7 ± 902.7 to
2894.5 ± 783.1 (6h; p = 0.07 ns), 2637.7 ± 768 (12h; p = 0.04) and
2315.1 ± 773.3 dyn*sec*cm−5 (24h; p = 0.001). Brain natriuretic pep-
tide declined from 3465 ± 1565 to 3162 ± 1476
(6h; p = 0.07 ns), 2135 ± 1364 (12h; p = 0.002) and 806 ± 622 pg/ml
(24h; p = 0.008).
CONCLUSIONS. Levosimendan substantially improves hemodynamic
performance in patients with severe low-output heart failure associ-
ated with anticancer therapy.
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OBJECTIVE. To evaluate the incidence of lymphopenia and the
frequency of values lower than normal in lymphocyte subpopulations
in ICU patients at admission.
METHODS. Cohort study, evaluating the number of total lymphocytes
as well as the different lymphocyte subpopulations the first day at ICU
admission. We excluded coronary and programmed surgery patients.
Data as mean + standard deviation and absolute and relative
frequencies. Satistical Analysis: Pearson correlation. p < 0.05 as ss.
RESULTS. N = 99 patients. Mean age 51.76. Mean APACHE I 17.91
Total number of lymphocytes1197 ± 1758. For the different
subpopulations the values were CD3: 726 ± 635, CD4: 434 ± 355,
CD8: 238 ± 230, CD16: 131 ± 125, CD19: 206 ± 187.
Regarding the number of total lymphocytes, 80% have less than
1,500 lymphocytes on the day of admission, 58% less than 1000,
44% less than 800, 28% less than 600 and 25% less than 500.
Among the lymphocyte subpopulations, 58.6% had low CD3
lymphocytes (less than 690), 57.6% low CD4 (<410), 46.5% low
CD8(<190), 45.5% low CD16 (<90) and 23.2% low CD19 (<90).
There was no ss between the number of total lymphocytes and the
severity assessed with APACHE II
(r = −0.135, p = 0.203), neither between APACHE II and the number
of lymphocytes from different subpopulations.
CONCLUSION. A high percentage of patients presented a low total
lymphocytes and low lymphocytes in the various subpopulations at
admission. Total lymphocytes less than 600 is associated with higher
mortality and low number of lymphocytes in different subpopulations
does not provide additional information regarding mortality. We found
no statistically signification between the degree of lymphopenia and
APACHE II.
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Intensive Care Medicine Experimental 2017, 5(Suppl 2):1026INTRODUCTION. Platelets are innate inflammatory cells and, in
addition to their traditional role within haemostasis, are newly
considered to have a key role within immunity performing a range
of adaptive responses to an antigen challenge. In disease, their
immune role is dysregulated and this has been associated with
adverse surgical outcomes. Studies have demonstrated a
correlation between sepsis and platelet nadir with a platelet
count < 60x109/L predicative for surgical complications following
liver transplantation (LT).
OBJECTIVES. To explore the relationship between platelets, sepsis
and outcome measures within our liver transplant cohort.
METHODS. A case note review of 97 LTs taking place between 2015–
16 within our centre. Data collected included perioperative transfusion,
indices of infection (positive cultures, antibiotic use, CRP and WBC) on
Day 0–7, 14, 21 and 28. Platelet count at the same time points was
collected. Outcome data included acute kidney injury (AKI) and length
of ICU admission.
RESULTS. 13% of patients had a platelet drop from baseline (median
reduction 18% [range 14–34]). The incidence of platelet rise was
87%; median increase was 38% [25–54]. A significantly higher
incidence of AKI (p = 0.032) and longer ITU admission (p = 0.002)
was found when the platelet count dropped below 60x109/L post-
operatively. Platelet counts on post-operative days (POD) 5, 6 and 7
were significantly lower in patients who developed systemic infection
(“sepsis” group) compared to patients who had no evidence of sepsis
("no sepsis" group): POD5 p = 0.021, POD6 p = 0.006, POD7
p = 0.007. Median time to initiation of antimicrobial therapy was
POD 9 (IQR 4–15). Comparison of demographic data, baseline plate-
let, white cell counts and creatinine, intra- and post-operative trans-
fusion were comparable between groups. While the reduction in
platelet count was comparable between both groups, the sepsis
group had a slower recovery of platelet count and a lower peak
upon recovery (Graph 1).
CONCLUSION. Low platelet count is independently associated with
worse outcomes, namely increased incidence of post-operative infec-
tion, AKI and ICU admission. As with previous research, our results
suggest a high suspicion for sepsis is required in patients who are
thrombocytopenic following liver transplantation and in these pa-
tients a lower threshold for commencing antimicrobial therapy is
likely necessary.
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Fig. 328 (Abstract 1028) Logistic regression
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INTRODUCTION. Information about immunocompromised patients
infected with influenza A virus requiring admission to the ICU is
lacking. The objective of this study was to know the clinical
characteristics of these patients and to identify variables associated
with mortality.
METHODS. A prospective multicenter observational cohort study was
based on data from the GETGAG/SEMICYUC registry (2009–2015)
collected by 148 Spanish ICUs. All patients admitted to the ICU with
the diagnosis of influenza A virus infection were included.
Immunosuppression was defined as any primary immunodeficiency
or immunodeficiency secondary to human immunodeficiency virus
(HIV) infection, active malignancy, immunodeficiency secondary to
radiation treatment or use of cytotoxic drugs or corticosteroids (daily
dose >40 mg of prednisolone or the equivalent for >2 weeks),
immunological disease, solid organ transplant, and haematological
disease. Factors associated with mortality in immunocompromised
patients were assessed by logistic regression analysis.
RESULTS. Of 2315 patients with influenza A infection, 289 (12.5%)
were classified as immunocompromised. Mortality was significantly
higher in immunocompromised patients (47.1% vs 20.1%; p < 0.001).
Severity of illness and the rates of health-care infection, early use of
oseltamivir and administration of corticosteroids were significantly
greater in immunocompromised subjects. In this group of patients,
factor independently associated with mortality were: APACHE II score
(OR =1.09, 95% CI = 1.04-1.13, p < 0.001), stage 3 of acute renal in-
sufficiency (OR = 2.33, 95% CI = 1.69-4.63, p < 0.05), use of vasopres-
sor drugs (OR = 4.69, 95% CI = 2.44-9.03, p < 0.001) and the use of
corticosteroid (OR = 1.89, 95% CI = 1.06-3.37, p < 0.05).
CONCLUSION. Immunocompromised individuals with influenza A
admitted to the ICU have a poorer outcome than patients without
immunocompromise. In this population, we should avoid the use of
corticosteroids because it is independently associated with a higher
mortality.
Liver failure: Nutrition and metabolism
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INTRODUCTION. Hypoxic hepatitis (HH) (“ischemic hepatitis” or
“shock liver”) is a common cause of hepatic dysfunction in an ICU, is
histologically characterized by centrilobular liver cell necrosis and is
caused by an insufficient oxygen delivery to hepatocytes. Typical for
HH is the sudden, significant rise (>5x ULN) of aspartate
aminotransferase (AST) in response to hemodynamic failure.
OBJECTIVES. The aim of this study was to identify mortality risk
factors of HH using a multivariate prediction model and to assess the
predictive accuracy of 2 existing models (Fuhrmann et al. [2] and
Raurich et al. [3]).
METHODS. The study cohort consisted of 1177 adults with a first
episode of HH (AST >5x ULN) out of 29874 patients admitted to theICU of the Ghent University Hospital (UZG) between January 1st,
2007 and September 21st, 2015. The incidence of HH was 4.2% and
the hospital mortality 42.8%. Further detailed study results are
described in another report [1]. 29 parameters were retrospectively
collected as potential risk factors based on clinical importance. The
association with mortality was studied using logistic regression at the
time of maximal AST value. Predictive accuracy of the models was
assessed by the area under the receiver operating characteristic
curve (AUC), the calibration curve and the Hosmer-Lemeshow (HL)
test. As the 2 existing models were developed in patients with AST
>20x ULN, only this subgroup (n = 460) was used for their validation.
RESULTS. Resp. 8 and 2 risk factors are excluded based on missing
values and correlation. The remaining 19 variables have 1153
complete cases. After a backward elimination procedure, the
multivariate UZG model indicates that age (OR 1.03 per year), cardiac
failure (OR 8.55), septic shock (OR 12.25), hypovolemic shock (OR
7.99), lung embolism (OR 14.04), acute respiratory failure (OR 2.38),
acute-on-chronic respiratory failure (OR 6.68) and mechanical ventila-
tion (OR 2.24) are most significantly (all P < 0.001) associated with
mortality. Additionally, INR (OR 1.27 per unit, P = 0.002), hyperther-
mia (OR 14.58, P = 0.019) and AST (OR 1.01 per 100U/L, P = 0.05) are
significantly associated. pH (OR 0.56 per 0.1) and trombocytes (OR
0.98 per 104/ml) are inversely associated (both P < 0.001). The UZG
model has a good discrimination (AUC 0.79) and shows a good fit
between the observed and expected mortality (HL: P = 0.67). On the
contrary, the models of Raurich et al. and Fuhrmann et al. have a
weak discriminative capacity (AUC 0.59 and 0.67, resp.).
CONCLUSIONS. This is by far the largest single-centre cohort study
of HH described in literature. 7 mortality risk factors associated with
HH are identified. Unlike the 2 existing models, the UZG model has a
good discrimination and calibration.
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INTRODUCTION. Hypoxic hepatitis (HH) (“ischemic hepatitis” or
“shock liver”) is histologically characterized by centrilobular liver cell
necrosis and is caused by an insufficient oxygen delivery to
Fig. 329 (Abstract 1030) ROC curves of MCF for Child-Pugh groups
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significant rise (>5x ULN) of aspartate aminotransferase (AST) in
response to cardiac, circulatory or respiratory failure. Other causes of
AST rise should be excluded before diagnosing HH. Treatment of HH
relies on the prompt correction of the underlying dysfunction.
OBJECTIVES. The aim of this study is to describe the epidemiology,
cause, evolution and outcome of critically ill patients with HH. More
insight may raise more awareness and could result in a faster
diagnosis, which may contribute to a better prognosis.
METHODS. The screened population consists of all adults (n = 29874)
admitted to the ICU at the Ghent University Hospital between January
1st, 2007 and September 21st, 2015. 4012 patients had at least one
episode of AST-levels above 5x ULN. After exclusion of 2835 patients
with another cause of elevated AST-levels (e.g. liver surgery, toxic hepa-
titis, cholangitis,…), a cohort of 1177 first episodes of patients with HH
were identified. These patients are classified by underlying cause of HH.
The most important outcome variable is ICU and hospital mortality.
RESULTS. The incidence of HH is 4.2%. The male/female ratio is 1.5
and the median age is 66 years. The causes of HH are cardiac failure
(40.2%), septic shock (28.3%), post-anesthesia without overt evidence
of an acute cardiac or respiratory event (11.6%), hypovolemic shock
(8.9%), acute respiratory failure (6.0%), acute-on-chronic respiratory
failure (3.1%), pulmonary embolism (1.4%) and hyperthermia (0.5%).
The hospital mortality associated with HH is 42.8%, of which 90.4%
occurred during ICU stay. Pulmonary embolism and septic shock
have the highest (56.2% and 52.9%, resp.) and fastest (median sur-
vival 5.4 and 12.3 days, resp.) mortality. Contrary to previous studies,
patients with a limited rise of AST (5xULN < AST < 10xULN) were also
included. This subgroup contains 439 patients and has a mortality of
26.2%. Another subgroup of 136 patients appeared to develop HH
after major surgery with general anesthesia despite having no prob-
lem during surgery. This subgroup, with still a considerable mortality
of 7.4%, was not described in previous studies.
CONCLUSIONS. This is by far the largest single-centre cohort study
of HH described in literature. With an incidence of 4.2%, HH is a fre-
quent cause of hepatic dysfunction in critically ill patients and is as-
sociated with a high hospital mortality of 42.8%. The principal causes
are acute cardiac disease and septic shock, which include more than
2/3 of all episodes. Clinicians should search actively for an un-
detected underlying hemodynamic or respiratory problem even in
patients with moderately elevated AST values or with AST elevations
after major uncomplicated surgery.
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INTRODUCTION. The severity of liver disease is assessed by scoring
systems which include the conventional coagulation test PT-INR.
However PT-INR is not predictive of bleeding in liver disease and
thromboelastometry has been suggested to give a better overview
of the coagulation system in these patients. It has now been sug-
gested that coagulation as reflected by tromboelastomety, particu-
larly maximum clot firmness (MCF), may also be used for prognostic
purposes in patients with stable chronic liver disease.
OBJECTIVES. The objective of our study was to investigate if
thrombelastometry may discriminate the degree of liver insufficiencyaccording to the scoring systems Child Pugh and Model for End-
stage Liver Disease (MELD).
METHODS. Forty adult patients with stable chronic liver disease of
different etiologies and stages were included in this observational
cross-sectional study. The severity of liver disease was evaluated
using the Child-Pugh score and the MELD score, and blood samples
for biochemistry, conventional coagulation tests and thromboelasto-
metry were collected at the time of the final assessment for liver
transplantation. Statistical comparisons for the studied parameters
with scores of severity were made using Spearman´s correlation test
and receiver operating characteristic (ROC) curves.Child-Pugh score A + B Child-Pugh score CNo. 22 18Child-Pugh score 8(6–9) 11(10–13)MELD ≤16 MELD >17No. 21 19MELD score 13(7–16) 20(17–27)[Number of patients (No). Scores as median (range).]
RESULTS. Spearman's correlation coefficients indicated that the
thromboelastometric parameters did not correlate with Child-Pugh
or MELD scores. The ROC curves of the thromboelastometric parame-
ters could not differentiate advanced stages from early stages of liver
cirrhosis.
CONCLUSIONS. standard thromboelastometry cannot discriminate
the stage of chronic liver disease in patients with severe chronic liver
disease.
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INTRODUCTION. Candidemia is associated with signficant mortality
in cirrhotic patients admitted to intensive care unit. There is a strong
trend towards higher prevalence of colonization's by candida
albicans and other species of candida in cirrhotic patients. Our
objective is to describe the incidence of candida colonization in this
patients and if their presence is associated with higher mortality or
length of stay in the absence of candidemia.
MATERIAL AND METHODS. A retrospective study has been
performed with all patients admitted to the Intensive Care Unit for
hepatic decompensation between April 2013 and May 2016. The
following variables were collected: Mean age, APACHE II, SAPS II,
SOFA, MELD, cause and stage of cirrhosis, use of vasoactive drugs,
mechanical ventilation and mortality. Presence or absence of candida
(type) in carrier control. Carrier's control has been collected at the
patient´s ICU admission and once a week during their stay. Patients
with candidemia were excluded.
Qualitative variables with normal distribution have been expressed
as number and percentages and were analysed using chi-square
tests. Quantitative variables were expressed as mean ± standard de-
viation (Rank) and were analysed using t-student tests and anova.
RESULTS. 110 patients have been included. 80 men, 30 women. The
mean age has been 57.5 ± 10.35 (34–85) years. APACHE 21 ± 9.4 (5–
50); SAPSII 51 ± 19.3 (10–116); SOFA 10.2 ± 6.9 (1–65); MELD at
admission 18.7 ± 9.27 (6–47) MELD maximum 23.64 ± 11.8 (6–55);
Length of stay has been 8.67 ± 8.7 (1–48) days. The etiology of liver
disease was alcohol in 41 of the patients and viral (HCV) in 40 cases.
77 patients required mechanical ventilation (70%); 75 patients
required vasoactive drugs (68%) 45 patients were diagnosed as
septic shock (41%). Candida colonization has been observed in 44
patients (40%). Albicans: 26; Krusei: 2; Bracarensis: 2; Glabrata: 4;
Guillermondi: 1; Lusitaniae: 1; Parapsilosis: 4; Trompicalis: 4. The
mortality rate of the study has been 30/110 (27.3%). None of our
patients had invasive candidiasis.
There is no statistical significant difference between APACHE II, SAPS
II, SOFA, MELD and length of stay between patients colonized by
candida and non-colonized patients. Patients colonized by candida
do not present higher mortality rates, mechanical ventilation, and
use of vasopressors or septic shock. When performing the sameanalysis in patient whose cause of liver disease was alcoholic or HCV,
we did not objectify differences. There is statistical difference in
length of stay in patients which the cause of hepatic decompensa-
tion was HCV and were colonized by candida and non-colonized pa-
tients. 10.6 vs 5.83. (P < 0.05).
CONCLUSIONS. The incidence of cirrhotic patients colonized by
candida is high. Candidemia is associated with signficant mortality in
cirrhotic patients, however, colonization does not seem to be
associated with higher mortality rate or length of stay during
admission in to ICU.
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INTRODUCTION. Non-selective betablockers (NSBBs) represent a cen-
tral therapeutic principle in management of portal hypertension by
lowering hepatic portal pressure. Deleterious effects of NSBBs in pa-
tients with refractory ascites and spontaneous bacterial peritonitis
have been reported. However, controversial findings regarding bene-
ficial effects in end-stage liver disease set in motion a debate on
when to discontinue betablocker (BB) therapy.
OBJECTIVES. We aimed to assess the impact of BB treatment on
outcome and clinical implications such as course of organ failure in
patients with cirrhosis at the ICU.
METHODS. This retrospective study was performed at the Medical
University Centre Hamburg-Eppendorf. Patients with liver cirrhosis
being admitted to ICU were included in this study. Data on prescrip-
tion of NSBB medication as well as clinical and laboratory findings
were analysed in all patients.
RESULTS. 411 patients with liver cirrhosis were enrolled in this study.
The most common cause of cirrhosis was alcoholic liver disease
(71%) followed by hepatitis C virus infection (18%), and others. 92
patients (22%) had NSBBs and 44 (11%) had selective BBs (SBBs) in
their current medication when being admitted to ICU. Taking
discontinuation and new prescription into account, 82 patients (20%)
received at any time during their stay at ICU NSBBs and 72 (18%)
SBBs. Overall 63% of patients did not receive any BBs after being
admitted to the ICU.
Patients on NSBBs had a lower MELD score than others (p < 0.05).
However, rate of ACLF did not differ between groups NSBB (68%),
SBB (69%), without BBs (66%) (p = n.s.). Administration of NSBBs was
associated with improvement of ACLF during first 48-hours (25%
vs.16%).
In patients on NSBBs, improvement of 28-day survival was observed
compared to SBB group and those without BBs (22% vs. 39% vs.
41%, p < 0.05), as shown in Fig. 331. In multivariate model NSBB
treatment was significantly associated with improved 28-day survival
independently of age, sex and severity of ACLF (grade) (HR 0.49,
95%CI 0.3-0.82; p < 0.05).
CONCLUSION. We observed that NSBB treatment was linked to
improvement of ACLF during course of time. Furthermore NSBBs
were associated with improved short-term survival in liver cirrhotic
patients at the ICU.
NSBBs seem to represent an important therapeutic principle in
patients with ACLF. Early termination of NSBB treatment may be
associated with worse outcome.
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INTRODUCTION. Acid–base disturbances are frequently observed in
critically ill patients at the intensive care unit (ICU). To our knowledge,
the acid–base profile of critically ill cirrhotic patients has not been
evaluated with respect to acute-on-chronic liver failure (ACLF), and
compared to critically ill patients without acute or chronic liver disease.
OBJECTIVES. Assessment of acid–base status and its clinical
implications in critically ill patients with liver cirrhosis.
METHODS. One hundred seventy-eight critically ill patients with liver
cirrhosis admitted to the ICU at the Medical University of Vienna
compared to 178 matched controls. Arterial blood samples were col-
lected on ICU admission. Quantitative physical-chemical analysis was
performed to assess acid–base status.
RESULTS. Median SOFA score on admission was 13 (IQR 10–16) in
cirrhotic and 12 (IQR 8–16) in matched controls without liver disease
(p = 0.105). Patients with and without liver cirrhosis showed
hyperchloremic acidosis, antagonized by hypoalbuminemic alkalosis.
Cirrhotic patients, especially those with ACLF, showed a marked net
metabolic acidosis owing to increased lactate and unmeasured
anions. This metabolic acidosis was partly compensated by
respiratory alkalosis; yet the mechanism of compensatory respiratory
alkalosis became ineffective with progression to ACLF. Accordingly,
acidaemia was present in 62% of patients with ACLF grade III
compared to 19% in cirrhosis patients without ACLF. Acidaemia and
metabolic acidosis were associated with 28-day mortality in cirrhosis.
Patients with pH values < 7.1 showed a 100% mortality rate. Acidosis
attributable to lactate and unmeasured anions was independently as-
sociated with mortality in liver cirrhosis.CONCLUSIONS. Cirrhosis and especially ACLF is associated with
metabolic acidosis and acidaemia owing to lactate and unmeasured
anions. Acidosis and acidaemia, respectively, are associated with
increased 28-day mortality in liver cirrhosis. Lactate and unmeas-
ured anions are main contributors to metabolic imbalance in cir-
rhosis and ACLF.
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INTRODUCTION. Cirrhotic patients who need critical care support
show high morbidity and mortality rates compared with other
critically ill patients. Their prognosis is, in fact, influenced by both the
severity of the underlying hepatic disease and the worsening of
extrahepatic organ function. Because Intensivists require objective
measurements of prognosis when making decisions, such as triage
or treatment limitations, we performed a retrospective study over a
period of 5 years to reassess the prognosis of Intensive Care Unit
(ICU) admitted cirrhotic patients.
OBJECTIVES. To evaluate the hospital and one year mortality of
cirrhotic patients entering our ICU, as well as the development of
organic failure during their admission.
METHODS. We retrospectively collected all patients with clinical and/
or histological diagnosis of hepatic cirrhosis admitted to the ICU
between January 2011 and December 2015. We excluded liver
transplants and collected: demographic and epidemiological data,
reason for admission to the ICU, developed organic failure, need of
organic supports (Mechanical Ventilation MV, Continuous Renal
Replacement Therapy CRRT, and vasoactive drugs) and ICU and one
year mortality.
RESULTS. During this period 4880 patients were admitted to the ICU.
APACHE II mean of 18 points. Of these, 198 patients diagnosed with
hepatic cirrhosis on admission, APACHE II mean: 17. Mean age was
52.5 ± 11 years, 68% were men. The mean stay of these patients was
8.1 days. Reasons for admission: 12% related to complications
directly associated with liver disease; 88% due to habitual causes of
ICU admission: community and nosocomial sepsis, polytrauma, post-
surgical patients, neurocritical, exacerbated COPD, intoxications,
acute pulmonary edema, cardiorespiratory arrest, etc. Cirrhotic pa-
tients, in relation to the total number of patients admitted to the
ICU, required MV in 38% vs 39%, CRRT 18% vs 8% and shock
with need for vasoactive drugs 75% vs 33%. The mortality of cir-
rhotic patients was higher than expected for their APACHE II
(40% vs 17-27%) and in relation to subgroup mortality was 99%
if they required CRRT; 83% with vasoactive drugs and if they
needed MV >48h, 70%.
CONCLUSIONS. The cirrhotic condition in our patients resulted in a
high ICU mortality, higher than expected for their APACHE II,
although the reason for admission was 88% due to extrahepatic
causes. The prognosis proved disastrous if the patient developed
organic failure on admission. Of the patients who survived their ICU
admission, 48% had died at one year.
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INTRODUCTION. Optimal coagulation management remains one of
the greatest challenges in orthotopic liver transplantation. Using
coagulation tests and thrombelastography (TEG) may beneficial in
determining the optimal coagulation management (1).
OBJECTIVES. To evaluate coagulation state after liver transplantation
in patients who was not admitted to transfuse FFP.
METHODS. After local Ethic Committee approval and informed
consent we studied 30 patients with liver cirrhosis, aged 41.3 ± 11.8
(24–56) y.o., weight 58.6 ± 6.9 (48–69) kg. MELD 16.2 ± 2.9. We
studied activated partial prothrombine time (APPT), international
normalized ratio (INR), fibrinogen A (FGA), platelets count (PLT),
thrombelastography (K; R; α angle; MA; LY30), ICU stay and in-
hospital stay duration.
RESULTS. The coagulation tests showed significant impairment of
coagulogramm tests: prolonged of APPT, increased of INR and
decreased of FGA level through 10–12 days after liver transplantation.
While thromboelastography tests showed slight hypocoagulation
status in patients only through 1–7 postoperative days (Table 245).
There was no any bleeding in postoperative period in all patients.
ICU stay duration was 16.4 ± 5.7 days. In-hospital stay duration was
42.7 ± 14.3 days.
CONCLUSIONS. In this trial TEG tests showed a sufficient potential of
haemostasisin in patients after liver transplantation on 4th
postoperative day in contrast to coagulogramm tests. Despite of
impared coagulogramm tests coagulation status in patients after
liver transplantation presents not critical disorders which does not
require active management.
REFERENCE
1. Coakley M, Reddy K, Mackie I, Mallett S. J Cardiothorac Vasc
Anesth. 2006 Aug;20(4):548–53.Table 245 (Abstract 1035). Coagulation and TEG tests after LTx
Day 1 Day 3 Day 7 Day 12
APPT (sec) 58.1±18.3 39.3±9.2 26.3±6.4 32.9±3.7
INR 2.7±0.7 2.2±0.3 2.1±0.7 1.5±0.7
PT (%) 34.8±19.1 36.4±8.3 49.2±5.5 59.0±9.9
FGA (g/l) 0.7±1.3 1.9±0.8 1.9±0.7 2.6±0.5
PLT (10*9/ul) 55.7±26.3 49.3±22.7 53.5±18.2 106.0±48.2
R (min) 8.1±1.9 4.2±2.6 4.2±0.7 5.3±0.7
K (min) 4.9±3.8 4.2±2.0 2.9±1.9 2.2±1.1
Alpha angle 51.6±19.4 56.1±12.4 67.5±9.9 70.3±10.2
MA (mm) 39.7±19.6 53.3±21.3 60.1±15.8 66.9±18.81036
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Intensive Care Medicine Experimental 2017, 5(Suppl 2):1036INTRODUCTION. Sudden cardiac arrest (CA) is one of the leading
causes of death in adults in many parts of the world. Every year
estimated 350.000 to 700.000 people in Europe are suffering CA and
receive cardiopulmonary resuscitation (CPR). Cholestasis can be
found in up to 20% of critically ill patients. To date, data occurrence
and outcome of cholestasis after CA and CPR is scarce.
OBJECTIVES. Aim of the study was to determine occurrence and
outcome of cholestasis in patients after in- and out-of-hospital CA.
METHODS. Assessment of occurrence of cholestasis was performed
in a cohort of 1068 consecutive patients with CA and successful CPR
that were treated at the Medical University Vienna, 266 (25%)
patients with cholestasis could be identified. Patient characteristics,
admission diagnosis, severity of disease, course of the disease and
28d mortality were assessed. Cholestasis was defined as rise of
serum bilirubin over 2 mg/dl.
RESULTS. Overall, 266 (25%) patients developed cholestasis after
successful CPR. Of these 213 (80%) were male with a median age of
59,5 (47–70) years. CA was witnessed in 236 (89%) cases. 213 (80%) of
the patients suffered the CA out-of-hospital. Cardiac events leading
to CA were observed in 176 (66%) of patients. Initial rhythm was
shockable (VT/VF) in 150 (56%), non-shockable (PEA/Asystole) in
107 (40%) and unknown in 9 (4%) patients. Time to ROSC was 18
(9–28) minutes.
133 (50%) of patients with cholestasis were dead or had bad
neurological outcome (CPC III/IV) within 28 days following CA.
CONCLUSIONS. Cholestasis is a frequent finding in patients following
successful CPR. Cause of cardiac arrest is often cardiac.
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OBJECTIVE. Procalcitonin (PCT) is considered a marker of sepsis
although there are publications that claim there are increases not
related to infections. We want to analyze the behavior of PCT after a
liver transplant which causes are related to its alteration.
METHODS. Prospective cohort (n = 158) of patients who received
liver transplant (LT) performed over the period 2009–2014, follow up
until the end of 2016.
We determine PCT (reference 0.5 ngr/ml) and graft liver function
during the first three days. Data as average (mean error). Outcome
variables: graft dysfunction (GD) according to MEAF score, renal
disfunction acording to AKIN and hospital mortality. Analysis: non-
parametric test and Chi-square test for p < 0.05. Approval by Ethical
Committee.
RESULTS. PCT levels were increase in our patients after liver
transplant, with levels of 8.38 ± 0.93 ng/dL on day 1 (range 0.05-
68.26), 13.34 ± 1.28 the second day (range 0.18-68.26) and
9.62 ± 1.23 on the third (0.19-38.35). Only 18 patients (11.4%) had a
PCT below 0.5 ng/dL.
The distribution by percentiles was: Median 3.17, quartiles 1.23,8.3,
95, 27.66 ng / mL.
We analyzed the relationship between renal dysfunction and PCT
levels and although PCT levels were higher according to the degree
of renal dysfunction, this relationship was not statistically significant.
AKIN 0: 11.17 ± 1.47, AKIN I: 12.65 ± 1.12 ; AKIN 2: 19.15 ± 1.17; and
AKIN 3: 21.50 ± 3.24 (p 0.91).
We also found no relation s.s. between graft dysfunction and PCT
levels: 12.42 ± 1.3 in patients without graft dysfunction vs
23.46 ± 7.35 with dysfunction (p 0.25).
We found relation ss between PCT and hospital mortality
:12.26 ± 1.13 ng / dl in vivo vs 23.46 ± 7.35 in deaths (p 0.025).
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 520 of 542CONCLUSION. PCT levels are elevated after liver transplant without
infection, which decrease its usefulness as a marker of infection and
makes it necessary to define a new threshold of normality for this
scenario. Although we can not explain this behavior, this elevation
does not seem to be related to the function of the graft neither to
the presence of acute renal dysfucntion.
1038
Acute liver failure due to Amanita phalloides poisoning: single
centre experiences
E. Kieslichová1, M. Protuš1, S. Fraňková2, D. Merta1, J. Froněk3, J. Šperl2
1Institute for Clinical and Experimental Medicine, Anaesthesiology,
Resuscitation and Intensive Care, Prague, Czech Republic; 2Institute for
Clinical and Experimental Medicine, Hepatogastroenterology
Department, Prague, Czech Republic; 3Institute for Clinical and
Experimental Medicine, Transplant Surgery Department, Prague, Czech
Republic
Correspondence: M. Protuš
Intensive Care Medicine Experimental 2017, 5(Suppl 2):1038
INTRODUCTION. Amanita phalloides poisoning is an uncommon, but
potentially fatal cause of acute liver failure (ALF). In the Czech
Republic Amanita phalloides intoxication occurs in 10–20 patients
per year with 25% lethality. The management of amatoxin poisoning
includes: preliminary medical care, supportive measures and specific
treatments including extracorporeal liver support systems. In selected
patients liver transplantation (LT) is the only successful modality of
treatment.
OBJECTIVES. The aim of the study was to describe the characteristics
of the patients with ALF due to amanita poisoning, analyse the
results of treatment and evaluate their outcome.
METHODS. 24 consecutive patients with ALF due to Amanita
phalloides poisoning admitted to ICU in the Institute for Clinical and
Experimental Medicine (IKEM) in Czech Republic between July 2007
and April 2016 were studied retrospectively. Diagnosis of Amanita
poisoning was based on the recent ingestion of mushrooms with
gastrointestinal symptoms, laboratory markers of ALF and on the
mycological examination. Demographic data, clinical data, laboratory
parameters and therapeutic approach were collected. Standard
medical treatment included oral decontamination with activated
charcoal, intravenous rehydration with balanced crystalloid solutions,
N-acetylcysteine and silibinin, continuous veno-venous hemodialysis
in case of acute kidney injury or hyperammonaemia. In selected pa-
tients fractionated plasma separation and adsorption (FPSA, Prome-
theus, Fresenius Medical Care) was performed. During the study
period, the decision for urgent LT was based on King's College
criteria.
RESULTS. The cohort consisted of 13 males and 11 females (age
48.6 ± 17.4). All patients were already referred to ICU IKEM from
other hospitals, 2.5 ± 1.3 days after mushroom ingestion. Mean time
from ingestion to onset of gastrointestinal symptoms was 12.2 ± 9.7
hours and time to hospital admission was 28.5 ± 22.9 hours. At
admission to IKEM, encephalopathy was present in 9 patients, 2
patients required vasopressoric support and 1 was mechanically
ventilated. In total, 8 patients with poor prognosis were listed for
urgent LT, 7 of them were listed within 2 days after admission. Six
patients underwent FPSA procedure prior LT. One patient died
before LT due to intracranial hypertension. Seven patients
underwent successful LT; in 4 cases AB0 incompatible and in 2 cases,
a split LT was performed. One patient died 2 months after LT due to
mycotic sepsis, one patient underwent re-LT. Seven LT patients and
all patients who had not meet King's College criteria and therefore
were not listed for LT are alive.
CONCLUSIONS. Our results show that early and complex supportive
therapy including extracorporeal liver support and availability ofurgent LT is successful in treatment of patients with ALF induced
by Amanita poisoning. King's College Criteria seem to be suitable
for predicting prognosis and deciding in favour of LT in these
patients.1039
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INTRODUCTION. Acute on chronic liver failure (ACLF) is a recently
defined syndrome involving acutely decompensated cirrhosis and
organ failure. Patients with ACLF who require admission to intensive
care units (ICU) have poor outcomes. O'Brian et al. found mortality
for patients admitted to UK ICUs had a mortality between 65 and
90%1. More recently Baja et al. found the mortality of patients
admitted to North American Liver units with ACLF and sepsis to be
between 28 and 77%2.
OBJECTIVES. To determine if patients with ACLF admitted to our
ICUs had a mortality similar to the published data. To determine if
the commonly used markers/scores of physiological derangement in
these patients were associated with mortality.
METHODS. Hospital electronic information systems were searched to
find patients with cirrhosis and organ failure who were admitted to 2
British ICUs with a combined total of 19 beds in 2014/15. Data was
collected on the cause of cirrhosis, Child Pugh score and Model for
End Stage Liver Disease - Sodium (MELD Na) score on admission,
levels of organ support, 30 day mortality and one year mortality. The
unpaired t-test was used to look for association between the vari-
ables recorded and mortality.
RESULTS. 42 patients were admitted with ACLF. 29 (69%) were male,
32 (76%) had alcoholic liver disease and the mean age was 56. The
median MELD Na score was 28 and the interquartile range was 22 to
33.75. 35 (83%) were Child Pugh grade C and 7 were B. 23 (54%)
patients had an acute kidney injury.
28 (66.6%) patients died within 30 days and a further 4 died within a
year. In total 32 (76%) died within 12 months. There was a
statistically significant association with MELD Na scores (p = 0.027)
and serum creatinine values (p = 0.027) on admission with one year
mortality. There was no statistical association with Child Pugh
score, serum bilirubin and serum creatinine. 11 (26%) patients had
a MELD Na score greater than or equal to 34 and none of them
survived.
CONCLUSIONS. Patients admitted to our ICU's with ACLF had a high
mortality similar to the published data. We found a statistically
significant association between mortality and on admission MELD Na
scores and serum creatinine levels.
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INTRODUCTION. There has been an increasing number of reports on
critically ill patients with secondary sclerosing cholangitis (SC-CIP)
during or after an ICU stay. The development of casts in the
intrahepatic bile ducts, and pronounced cholestasis are pathognomonic
in SC-CIP. In the further course liver cirrhosis with indication for liver
transplantation may develop.
OBJECTIVES. To test the hypothesis that in our institution SC-CIP has
disproportionately often occurred in patients with brain injury during
the last years, and to identify influencing factors.
METHODS. Retrospective data analysis (01/2010 to 11/2015) of
clinical variables from the patient database management system
IntelliSpace Critical Care & Anesthesia (ICCA™). An IT-based database
search with illness specific keywords resulted in 239 patients, 30
thereof fulfilling the SC-CIP criteria.
Recording of clinical variables from the beginning of ICU stay until
the beginning of cholestasis (definition: bilirubin ≥ 2.4 mg/dl and/or
γGT ≥ 1000 U/l). Validation of diagnosis through ERCP/MRCP.
Statistics: Spearman correlation. Statistical significance was assumed
at p < 0.05.
RESULTS. 30 out of 35 SC-CIP patients showed traumatic or non-
traumatic brain injury. 70% thereof were male. 100% were mechanic-
ally ventilated, developed SIRS or sepsis, and 87% continuously
received high doses of ketamine (≥3 mg x kg body weight−1 x h−1).
There was a significant correlation between the beginning of chole-
stasis and days on mechanical ventilation (R = 0.948) as well as the
days on anti-infectives (R = 0.793).
CONCLUSIONS. This is the so far largest report on patients with
brain injury developing SC-CIP. Nevertheless, the number of cases
did not allow statistical evaluation of risk factors. However, formerly
postulated SC-CIP triggers, such as MAP < 65 mmHg, number of
transfused erythrocyte concentrates, obesity, prolonged prone pos-
ition, PEEP > 10 mbar and high doses of catecholamines could be
ruled out for this cohort. SIRS/Sepsis and a low oxygenation index
have been confirmed as potential relevant factors. In addition, neuro-
protective sedation with high doses of ketamine appears to be a
contributing factor to the development of SC-CIP and should be re-
evaluated for this use.
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New methods of extracorporal blood correction and
detoxification in condition of liver failure of patients with
mechanical jaundice need an assessment of their efficiency and
safety, especially against initial hypocoagulation and system
introduction of heparin.RESEARCH OBJECTIVE. Assessment of efficiency of plasma sorption
on Plasorba BR-350 and its influence on the condition of blood co-
agulation system of patients with mechanical jaundice.
MATERIALS AND METHODS. The research is conducted for 18
patients aged 47–67 with the mechanical jaundice which developed
as a result of biliary obstruction (choledocholithiasis). Initial level of
general bilirubin was from 285 μmol/l to 589 μmol/l. The
plasmadsorbtion procedures were carried out on the Octa Nova
device, manufactured by Asahi Kasei Medical, Japan, with use of
Plasorba BR-350 sorbent developed on the basis of anion-exchange
resin for plasma sorption. Each patient had three procedures with
processing of two volume of plasma circulation per procedure. One
procedure was carried out just before operation (one day before),
and another two - in the postoperative period. The duration of pro-
cedure averaged 4 hrs 30 min. The blood flow rate was 130–160 ml/
min. The plasma flow rate was 25–30 ml/min. Anticoagulation was
ensured by washing the bloodlines and a column with a sorbent
with normal saline with heparin - 4,000 units of activity per 1 L. 5,000
units of activity of heparin were injected intravenously at the begin-
ning of procedure. The biochemical values and coagulogram test re-
sults of patients were studied prior to procedure, during procedure
and upon termination of procedure.
RESULTS. As a result of selective plasmadsorbtion after carrying out
procedures with two circulation plasma volumes, by the end of the
procedure, there was a significant decrease in total bilirubin level by
68.6 +/− 3.8%, conjugated bilirubin by 64.6 +/− 6.4%, unconjugated
bilirubin by 66, 9 +/− 9.8%, and bile acids by 51,4 ± 2,8%. Other
blood chemistry parameters did not show any changes. The study
throughout the treatment did not show the decrease in dynamics of
hemoglobin and platelets. There was no negative dynamics in
change of INR (international normalized ratio), APTT (activated partial
thromboplastin time), level of fibrinogen, prothrombin, anti-thrombin
III. No bleeding complication occurred in any patient during the pro-
cedure of plasma sorption. Other biochemical values did not change
significantly.
CONCLUSIONS. The researches showed that Liver Support plasma
sorption is effective in condition of mechanical jaundice as a
detoxication method. Based on the lack of bleeding complications in
patients during the procedure and lack of changes in coagulogram
after the procedure, this liver supporting method can be recommended
for patients with high level of bilirubin in condition of mechanical
jaundice at the stages of preparation for operational treatment of the
bile ducts obstruction and in the postoperative period.
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OBJECTIVE. After liver transplant, CRP has a controversial paper,
because can be elevated (after inflamation) or normal (after
disfunction). We want to analyzed the value of CRP after liver
transplant and his relation with graft disfunction (GD).
METHODS. Prospective cohort (n = 183) of patients who received
live rtransplant (LT) performed over the period 2009–2014, follow up
until the end of 2016.
We determine CRP (reference 5 mgr/l) and graft function during the
first three days. Data as average (mean error); Outcome variables: GD
according to MEAF score and mortality. Analysis: non-parametric and
Chi-square test for p < 0.05; ROC curves, area under the curve (AbC)
and Youden index (best cut point). Approval by CEI.
RESULTS. Mean PCR levels was 57.46 (2.96) mgr/l on day 1, 86.99
(4.06) on day 2 and 64.03 (5.34) on day 3.Lower register PCR was
51.91(2.80) mgr/l.
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(including renal function by AKIN),but we found relation statisticaly
significant with noradrenaline [81,55 (4,10) mgr/l without NA vs
103,17(10,22) with NA, p0.02].
However, CRP was negatively related to mortality [alive 53.94 (2.89)
vs 24.45 (6.72) in deaths, p 0.018; AbC 0.75 (0.60-0.91) p 0.007] and
also with GD [alive 54.43 (3.15) vs 36.68 (4.02) in deceased, p0.026;
AbC 0.61 (0.51-0.71), p 0.078].
The cut-off point detected for GD was less than 68mgr/l, sensitivity
96.15% and specificity 34.4%, Youden index 0.31.
CONCLUSION. Although CRP levels are elevated after liver transplant,
a less elevation (below 68 mgr/l) is associated with graft dysfunction.
However, this marker does not seem to add information to other
scores to detect liver dysfunction.
Rehabilitation and recovery
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INTRODUCTION. Patient/family centered care in the ICU has been
receiving increasing attention over the past few years. One
cornerstone of this approach is patient/family centered
communication 1. Family members of patients in the ICU have been
shown to suffer from high levels of post-traumatic stress long after
discharge from the ICU 2. One possible method to decrease this
stress is to improve staff communication with family members while
the patient is still in the ICU. Few have investigated whether high
quality family centered communication was associated with de-
creased family member stress levels while the patient was still in the
ICU. Finding such an association and eliciting what forms of commu-
nication are most associated with decreased acute stress can be a
first step in designing interventions to decrease family member short
and long term stress.
OBJECTIVES. To determine whether there is an association between
family member perceived acute stress and family centered communication
during ICU hospitalization.
METHODS. Three questionnaires were distributed to family members
while their loved one was hospitalized in the ICU (a demographic
questionnaire, the Perceived Stress Scale3 and the Family Centered
Communication Questionnaire, developed by one of the authors) in
a surgical and medical ICU.
RESULTS. The sample consisted of 100 family members who were
found to be mild/moderately stressed (M = 1.97/4, SD = 0.63)
and were satisfied with their communication with the nurses
(M = 4.29/5, SD = 16.8). The majority of respondents were
children (n = 54, 54%) or spouses (n = 31, 31%) of the patient
with a mean age of 48.4 years. Average patient stay was 6.7 days
(SD = 5.2). Most respondents classified their loved ones´
condition as stable (n = 53, 53%).
Significant negative correlations were found between mean total
acute stress scores and communication (r = −.36, p = .003) and with
the communication sub-scale scores of responding to emotions
(r = −.32, p = .005), managing care (r = −.33, p = .004) and develop-
ing and maintaining relationships (r = −.37, p = .001), but not for
decision-making or exchange of information.
CONCLUSIONS. Good communication is associated with decreased
acute stress levels among family members, especially related to
emotional and relationship issues. It is therefore recommended thatefforts be made to improve communication with family members,
especially in these areas.
REFERENCES
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INTRODUCTION. Any critically ill person is predisposed to extended
physical and psychological ill health1 and should be offered the
support of a specialised follow up clinic2. Research shows that
patients who survive critical illness have complex physical and
mental problems causing persistently poor quality of life, referred to
as 'Post Intensive Care Syndrome'3.
OBJECTIVES. We proposed to pilot a nurse led out-patient follow up
clinic into the role of the current ICU in-patient follow up team.
METHODS. Patients who were ventilated for >3 days and lived
locally were offered an appointment 12 weeks after hospital
discharge. Discretion was also used to invite any patient who may
benefit from follow up. Appointments lasted 1 hour with time to visit
to the ICU. Telephone consultations were also offered. Due to limited
resources we ran a nurse led clinic with ICU consultant support as
required. Physiotherapists were on hand, and clinic space away from
the ICU was used. Clinic format was based on quality of life
assessment tools, and audited through evaluation forms returned to
the clinical effectiveness department for external review.
RESULTS. The number of patients invited was lower than expected.
Out of a possible 54 patients, 31 attended clinic between September
2015 and March 2017. Feedback was received from 18 patients, and
was invariably positive.
Referrals were made to Neuropsychology, Dietetics and Cardiology. The
Follow Up nurse, physiotherapist or Consultant dealt with most other
issues at the time of consultation. A letter was sent to each patient's GP
summarising the appointment and recommendations. Contacting
patients was often difficult so an appointment letter was sent out.
Some clinics had to be re-scheduled due to other work demands. Com-
mon reasons for patients being unable to attend clinic were noted.
CONCLUSION. The pilot was planned to run for 1 year, but numbers
were lower than anticipated and so we aim to review data after 50
patients. Feedback so far suggests that the clinic is beneficial. Once
all data is available consideration will be made to source funding
towards staff resources.
Other expansion ideas include patient support groups. We are
currently exploring the possibility of utilising university resources for
rehabilitation needs. Ongoing qualitative auditing of patient benefit
will be essential to justify the service.
REFERENCES
1. Griffiths J A, Barber V S, Cuthbertson B H, Young J D (2006) A
national survey of intensive care follow-up clinics. Anaesthesia Vol 61
pp950-955
2. National Institute for Health and Clinical Excellence (2009)
Rehabilitation after Critical Illness Guidance.nice.org.uk/cg83
3. Needham D M, Davidson J, Cohen H, et al. Improving long-term
outcomes after discharge from intensive care unit: report from a
stakeholders' conference. Crit care med 2012;40:502–9
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Table 246 (Abstract 1044). Patient Feedback
Table 247 (Abstract 1044). Reasons for Not Attending Clinic
Table 248 (Abstract 1045). Patients admitted to critical care for ≥ 4
days
Baseline Intervention
n 31 9
Age (years) 65.7 69.2
Mobilised within critical care 23/31 (74%) 9/9 (100%)
Time to 1st Mobilise (days) 6.2 4.0
Mean MMS at Critical Care Discharge 3.7 4.6
Critical Care length of stay (days) 9.9 8.7
Ventilation days 4.2 4.7
Ward length of stay (days) 13 9.8
Total hospital length of stay (days) 24 18.5
Table 249 (Abstract 1045).Data for patients ventilated for ≥ 4 days
Baseline Intervention
n 12 4
Age (years) 64.0 66.3
Mobilised within critical care 5/12 (42%) 4/4 (100%)
Time to first mobilise (days) 11.6 5.8
Mean MMS at critical care discharge 3.5 4.0
Critical Care length of stay (days) 17.4 13.5
Ventilation days 11.3 10
Ward length of stay (days) 17 10.3
Total hospital length of stay (days) 34.4 23.8
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INTRODUCTION. Early and structured rehabilitation in critical care
has demonstrated significant improvement in physical and clinical
outcomes [1]. Despite this increasing evidence base, uptake and
delivery of these interventions remain low [2].
OBJECTIVES. We aimed to assess the potential impact of introducing
an already established and effective programme of rehabilitation into
an external critical care unit.
METHODS. All patients admitted to critical care for ≥ 4 days and
discharged to the ward were included in the trial. Baseline data was
collected for a period of 3 months from 01/12/2016 until 28/02/2017 to
confirm current practice. After this period an expert physiotherapist in
critical care rehabilitation worked with the home team for a training
period of 1 month. This training period included an analysis of
potential local barriers to early rehabilitation practice and the
introduction of a structured approach to rehabilitation according to a
previously published protocol. To assess any changes in rehabilitation
practice outcome measures included time to first mobilise and highest
level of mobility achieved within critical care.
RESULTS. Baseline date was obtained for 31 patients over a 3
month period and compared to 9 patients admitted for ≥ 4 days
during the training period of the study (see Table 248). Time to
1st mobilisation was reduced by 2.2 days for patients with a
critical care length of stay of ≥ 4 days, with the greatest
reduction seen for those patients ventilated for 4 days or more
(11.6 vs 5.8 days). This was associated with a slight increase in
Manchester Mobility Scores (MMS) score at critical care discharge
and reductions in critical care and hospital length of stay.CONCLUSIONS. Early results from our quality improvement project
demonstrate a potentially positive impact of introducing a
programme of early and structured rehabilitation in critical care. On
going data collection will now occur for a period of 3 months to
help confirm these findings. If successful this could provide a
framework for introducing similar programmes to other critical care
units nationally.
REFERENCE(S)
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INTRODUCTION. Early mobilization is an important intervention to
prevent or limit Intensive Care Unit (ICU)-acquired weakness,1,2 while
delaying mobilization can adversely influence outcome.3 Nevertheless,
an appropriate timing of initiation is not defined. In addition, patient-
related factors can be barriers for the initiation or continuation of a
mobilization intervention.4
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feasibility of early mobilization in critically ill patients.
METHODS. In this retrospective observational study, data was
derived from electronic patient and mobilization files during a four-
month period. Inclusion criteria were: age > 18 years, BMI < 35 and
ICU admission ≥ 3 weekdays. Timing was investigated with a survival
analysis for the ability to mobilize passively or actively, stratified by
various patient characteristics. If necessary, these were divided by
the 33th and 66th percentiles. The ability to mobilize was based on
cooperation, physical stability and muscle strength using a
mobilization protocol. Contraindications, indicating physical instabil-
ity, included hemodynamic instability, poor oxygenation, elevated
intracranial pressure and recent seizures. Feasibility was presented as
numbers and percentages, for exercise therapy and cycle ergometry
separately.
RESULTS. During the study period 50 patients [36M, 14F] were
included, with a median age of 66 [52–74] and a median Sepsis-
related Organ Failure Assessment (SOFA) score of 10 [8–12]. After 5
weekdays, 90% and 32% of the patients were able to mobilize pas-
sively and actively, respectively (p < 0.0001). Patients with a SOFA
score > 12 were less able to mobilize than patients with a SOFA
score ≤ 12 (p < 0.05). The most common barriers to initiate an exer-
cise therapy or cycle ergometry session were contra-indications (36%
and 31%, respectively) and no physiotherapy visit (23% and 20%,
respectively), while fatigue was the most common reason for the dis-
continuation of a physiotherapy session (33% and 47%, respectively).
CONCLUSIONS. Most critically ill patients were able to mobilize
passively even in the first days of ICU admission. Failure to mobilize
was predominantly associated with severe disease (SOFA > 12).
Feasibility can mainly improve with a more fitting visitation strategy
and the application of passive physiotherapy in case of fatigue.
These findings may contribute to the enhanced implementation of
early mobilization in critically ill patients.
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INTRODUCTION. It seems clear that three basic human needs (i.g.,
autonomy, competence and relatedness), are comprised in patients
that are discharged from an intensive care unit (ICU) to the follow-up
ward. This means; having to deal with loss of control (inflicting au-
tonomy), not having one´s health outcomes in one´s own hands (de-
creasing competence) and feeling alone in recovery from severe
health threats (negatively affecting relatedness). Therefore, it is of ut-
most importance to support ICU patients and their relatives to help
them regain their feelings of control, their self-efficacy and social
contacts.
OBJECTIVES. Aiming to develop an intervention reducing the
emotional impact of the discharge from the ICU that is robust,
effective and useful in practice because it is grounded on theoretical
and empirical evidence.
METHODS. Intervention Mapping (IM), a six-step theory- and
evidence-based approach, was used to guide the development
process. The first step, a problem analysis, comprised a literature re-
view, semi-structured telephone interviews with former ICU-patientsand their relatives, and qualitative roundtable meetings for all eli-
gible nurses (i.e., 135 specialized and 105 general ward nurses). Per-
formance and change objectives were formulated in step 2. In step
3, theory-based methods and practical applications were selected
and directed at the desired behaviors and the identified barriers.
Step 4 designed a revised discharge protocol taking into account
existing interventions. In step 5, a training for nurses addressing the
emotional impact of admission into the ICU was executed. The know-
ledge gained was expressed by change scores before and after the
training on a scale from 1 to 10. The evaluation of the new discharge
protocol (IM step 6) is in progress and not included in this study.
RESULTS. Four former ICU patients and two relatives underlined the
importance of the need for effective discharge information and
supportive written material. They also reported a lack of knowledge
regarding the consequences of ICU admission. The intervention was
designed to target knowledge, attitudes, self-efficacy, and perceived
social influence. Building upon IM steps one to three, a discharge
protocol was developed that is relevant and feasible within current
daily practice. The knowledge raised significantly from 5.7 (±1.6) to
6.7 (±1.5) in ICU nurses and from 4.8 (±1.6) to 7.2 (±1.3) in general
ward nurses.
CONCLUSIONS. Intervention mapping provided a comprehensive
framework to improve ICU discharge by guiding the development of
a theory- and empirically-based discharge protocol that is robust and
useful in practice. In this way, the evidence based renewed practice
enables to respond better to the instrumental and affective needs of
patients and their relatives.
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INTRODUCTION. Physiotherapy services in critical care units are
commonly delivered during traditional daytime working hours
(08:00–16:00). Provision outside of these hours is delivered by a
variety of physiotherapists that may not be specialists in critical care
as part of an overnight on-call service. The demands on this service
are increasing annually with more patients being treated by non-
critical care specialist physiotherapists. Altered working patterns for
critical care physiotherapists have previously demonstrated positive
effects on clinical care with significant additional investment1, how-
ever it is unclear if this is possible without investment.
OBJECTIVES. To assess the feasibility of providing an extended hours
physiotherapy service to ICU with no additional investment.
To assess the impact of extended hours physiotherapy on the
frequency of overnight on-call physiotherapy interventions.
To assess the impact of extended hours physiotherapy on the
delivery of rehabilitation interventions.
METHODS. An adjustment to the ICU physiotherapy team working
patterns at a UK general tertiary adult ICU from May 2016 to March
2017, ensuring one critical care physiotherapist working until 20:00,
Monday to Friday. The feasibility of the change in working patterns
was evaluated by recording the number of uncovered extended
hours shifts. The impact on overnight on-call activity was evaluated
by recording the number of physiotherapy interventions during the
extended hours period (16:00–20:00) that would have otherwise
been covered by the on-call physiotherapist. Information was also
recorded on the number of rehabilitation interventions completed
during the extended hours period that would have previously been
missed.
RESULTS. Extended hours working was provided on 84% of eligible
days, with an average of 4.4 patient interventions per extended
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 525 of 542hours period. There were 136 referrals to the on-call service over the
11 months, with 205 acute physiotherapy interventions provided dur-
ing the extended hours period that would have otherwise resulted in
a referral to the on-call service. This translates into a cost saving of
£5,920 over the 11 month period. There were on average 10 ?A3B2
show $132#?>additional rehabilitation sessions completed per month
during the extended hours period.
CONCLUSIONS. This service development initiative was feasible to
deliver with no additional investment. It resulted in a 60% reduction
in referrals to the on-call physiotherapy service and an additional 110
rehabilitation interventions.
REFERENCE
1. Improvement, N.H.S., 2012. Equality for all: delivering safe care-
seven days a week. Leicester: NHS Improvement. Available at: http://
www.improvement.nhs.uk/documents/SevenDayWorking pdf Accessed,
24, p.12.
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INTRODUCTION. The initiation of rehabilitation in Intensive Care
Units (ICUs) is widely accepted and is supported by NICE guideline
(CG83) published in 2009 [1]. The processes and systems present in
ICUs to ensure compliance with the guideline vary despite an
increasing evidence base. Existing literature tends to focus on the act
of rehabilitation itself rather than how it is achieved. CG83 advocates
a multi-disciplinary team (MDT) approach, the setting of goals and
regular assessment alongside the involvement of the patient and
their family. This project sought to understand how ICUs ensure they
are complying with these recommendations.
OBJECTIVES. To determine the compliance of ICUs in Great Britain
(GB) with CG83 [1] with reference to evidence of goal setting, use of
outcome measures (OMs), MDT, patient and family involvement and
the documentation of these activities.
To recognise areas for improvement, identify best practice and
disseminate findings.
METHODS. Survey questions were developed through an iterative
process. These were emailed to 75 eligible centres in 2016, identified
through the interactive Chartered Society of Physiotherapy forum.
Sole paediatric centres were excluded. The need for informed
consent was waived by the local research and ethics committee.
RESULTS. A demographic representative sample of 48 surveys was
returned giving a response rate of 64.5%. Documentation of goal
setting occurred in 38 (78%) units. Goal setting meetings took place
in 13 (27%) units with 8 (17%) including more than two disciplines
from the MDT. Six (13%) units involved the patient and/or family.
Documentation of goals varied from inclusion in individual notes to
the use of rehabilitation pathways and boards in a patient's bed
space. Utilisation of OMs to aid goal setting occurred in 33 units
(69%) with 29 (60%) using the Chelsea Critical Care Assessment Tool.
Issues with consistency, communication and time were described as
barriers to compliance to CG83. Proposed changes or current
improvement work was reported in 11 (29%) units.
CONCLUSIONS. This small benchmark study suggests that compliance
with CG83 differs between units and that there is a great variation in
the processes surrounding rehabilitation after critical illness. The result
of this study is timely with regards to the current consultation on CG83
and is an opportunity to highlight the importance of considering the
procedures in place to ensure compliance. A few novel practices were
discovered through this project, however, the authors also suggest
collaboration with other areas, such as stroke and older persons, whohave reputable and established rehabilitation care pathways. Review of
current practice will empower staff to drive change and produce more
robust systems that will result in the best care for patients.
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INTRODUCTION. Early mobilization (EM) can benefit ventilated
patients admitted to intensive care unit (ICU) through prevention or
attenuation of ICU acquired weakness. Literature shows that EM is
feasible and safe.
OBJECTIVES. To determine the feasibility and safety of the
implementation of EM protocol in our ICU and to assess the impact
on days of mechanical ventilation (MV), length of ICU and hospital
stay and hospital discharge destination.
METHODS. Retrospective cohort study in a general ICU. Adult
patients who had been on MV for more than 48 h and Barthel
Index > 70 were included in the protocol of EM during 6 month.
These were compared with a historical control who received
standard physical therapy. Three active mobilization events were
defined: sit sitting chair, standing and walking. We defined six
activity-related adverse events as fall to knees, tube removal, systolic
blood pressure >200mmHg, systolic blood pressure < 90mmHg, oxy-
gen desaturation < 80% and extubation. The characteristics were an-
alyzed using median, interquartile range, mean and standard
deviation (SD) for continuous and ordinal variables, and absolute fre-
quency and percentage for categorical variables. Characteristics on
the length of stay (LOS) in ICU and in hospital, duration of MV and
discharge destination of both groups were compared using Pearson´
s T-Student and χ2.
RESULTS. During the study period we included 24 patients in the EM
group and these were compared with 18 historical control patients.
We conducted a total of 82 activity events in the EM group. These
included 31(37.8%) sit in chair, 33(40.2%) stand up and 18(22%)
ambulate. In 44.4% of the ambulation the patients were on MV. The
median distance ambulated was 75.7 meters. Adverse events were
infrequent, occurring in 1 of 82(1.2%) activity events. There were no
differences in baseline characteristics between the groups. The mean
hospital LOS was 32.2(SD26.6) vs 39.2(SD 21.2), p = 0.35, the mean
ICU LOS was 21.7(SD 20.6) vs 22.4(SD12.2), p = 0.8 and the mean
duration of MV was 15.6(SD18.7) vs 13.6(SD 9.13), p = 0.65. The
majority of patients included in the EM were discharged at home
compared with control group (75%vs45%,p = 0.04).
CONCLUSIONS. The implementation of EM protocol is safe. Although
no statistical differences were found regarding the hospital and ICU
LOS and duration of MV, patients included in the EM had less
hospital length of stay and a higher percentage was discharged at
home. The functional improvement of the patients, besides having
clinical significance as the rest of variables, had statistical significance
despite the population limitation.
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INTRODUCTION. Lack of regulated and systematic postgraduate
training or continuous professional development (CPD) for the
physiotherapists in Sri Lanka was identified as the greatest barrier to
the growth of critical care physiotherapy in an island wide survey
involving all state physiotherapists working in critical care
(Sigera et al. 2016).
OBJECTIVES. The aim is to describe the delivery and acceptability of
a short, structured training course for critical care physiotherapy and
its effects on the knowledge and skills of the participants in Sri
Lanka, a lower-middle income country.
METHODS. The 2-day program combining short didactic sessions
with small group workshops and skills stations was developed and
delivered by local facilitators in partnership with an overseas special-
ist physiotherapist trainer.
The impact was assessed using pre/post-course self-assessment, pre/
post-course multiple-choice-question (MCQ) papers and an end-of-
course feedback questionnaire.
RESULTS. Fifty-six physiotherapists (26% of critical care physiothera-
pists in Sri Lanka) participated. Overall confidence in common critical
care physiotherapy skills improved from 11.6% to 59.2% in pre/post-
training self-assessments respectively. Post-course MCQ scores (mean
score = 63.2) and percentage of passes (92.5%) were higher than
pre-course scores (mean score = 36.6, percentage of passes = 13%).
Responses (n = 56) Rating: 8–10
(High)
Rating:4–7
(Moderate)Rating:1–3
(Low)MissingOverall, the course was enjoyable 41(73.2%) 8(14.3%) - 7(12.5%)Overall the course was worthwhile 39(69.6%) 7(12.5%) - 10(17.9%)This course has increased my critical care knowledge 42(75%) 6(10.7%) - 8(14.3%)This course has increased my critical care skills 34(60.7%) 13(23.2%) 1(1.8%) 8(14.3%)The quality of the teaching was of a high standard 42(75%) 7(12.5%) - 7(12.5%)The quality of the educational materials provided was of
a high standard22(39.3%) 26(46.4%) 1(1.8%) 7(12.5%)There was sufficient time allocated in the course to
cover all the material appropriately14(25%) 30(53.6%) 4(7.1%) 8(14.3%)I would recommend this course to a colleague working
in critical care units42(75%) 7(12.5%) - 7(12.5%)[Feedback from participants]
Overall feedback was very positive with 75% and 61% of the
participants were highly satisfied with the course's contribution to
improved critical care knowledge and skills respectively.
CONCLUSIONS. In this setting, with the lack of a formal CPD, there
was limited opportunity for physiotherapists involved in critical care
to improve their knowledge and skills. The positive feedback and the
significant increase in self-perceived confidence to perform skills as-
sociated with critical care physiotherapy treatments, suggests this
method of locally up-skilled faculty delivering practical training may
be of value in this setting and may be of benefit for filling the theory
to practice gap for clinicians where opportunity for more formal spe-
cialist training is limited.
We wish to acknowledge the Government Physiotherapists'
Association, all the physiotherapists who participated in the study
and the staff of National Intensive Care Surveillance for their kind
assistance. We are grateful to Ms. Abi Beane for the assistance given
when preparing this manuscript.REFERENCE(S)
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INTRODUCTION. Flail chest injuries cause significant morbidity and
are associated with prolonged periods of mechanical ventilation and
post traumatic pneumonia1,2. Recent evidence of surgical rib
stabilization has been shown to be associated with reduced
ventilator days, lower incidence of pneumonia, and reduced medical
costs3. Surgical rib stabilisation was introduced at our hospital in July
2015.
OBJECTIVES. To evaluate the impact of surgical fixation of flail chest
on development of post injury pulmonary complications.
METHODS. Data was collected from all patients admitted to a large
West Midlands multi trauma centre with flail chest injury between
November 2015 and August 2016. Primary outcome was
development of pulmonary complications, assessed using the Brooks
Brunn tool. Secondary outcomes included incidence of mechanical
ventilation and tracheostomy rates. Data was analysed using the
Fisher exact test.
RESULTS. A total of 36 patients were admitted with flail chest
injuries during the trial period, of which 10 underwent surgical
fixation (see Table 250). Pulmonary complication rates were
significantly higher in the fixation group (90% vs 35%, p < 0.01), with
higher rates of mechanical ventilation also seen (100% vs 35%,
p < 0.001). No significant differences were seen in terms of ISS or
APACHE II scores between groups at baseline.
CONCLUSIONS. Patients admitted with flail chest injury undergoing
surgical fixation were more likely to suffer with pulmonary
complications and require invasive ventilation. A number of patients
in the non-fixation group did meet the criteria for surgical fixation
and it is not clear why surgery was not performed. It may be that
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 527 of 542only those already developing complications were surgically fixed
hence the higher rates seen.
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Surgical stabilization
(n=10)
Conservative
Management (n=26)
p
Age (years) 65.1 57.9
Male n(%) 9 (90%) 19 (73%)
ISS 26.6 24 0.409
APACHE II 13.9 12.5 0.570
PPC 9 (90%) 9 (35%) <0.01
Mechanically Ventilated 10 (100%) 9 (35%) <0.001
Ventilator Days 11.9 12.8 0.958
Tracheostomy 4 (40%) 8 (31%) 0.701
Fig. 333 (Abstract 1054) Respiratory and hemodynamic monitoring
during and after the procedure (n = 48)1053
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INTRODUCTION. It has been over a decade since studies were
published demonstrating that mobilisation whilst orally intubated is
both safe and feasible. Despite this the incidence of mobilisation
while intubated is variable, with point prevalence studies reporting
rates of 1-8% in patients ventilated for more than 24 hours1,2. A more
recent study has also demonstrated that mobilisation activities make
up only 7% of physiotherapy interventions provided to orally intu-
bated patients3.
OBJECTIVES. To evaluate current mobility practices for orally
intubated patients comparing to previously published data.
METHODS. A retrospective review of consecutive patients admitted
to a single general tertiary ICU between January and March 2017
that required mechanical ventilation. Information was collected on
the number of patients mobilised whilst orally intubated, the type of
mobilisation activity and any adverse events that occurred during
mobilisation.
RESULTS. Information was collected on 69 patients, 10 (14%) of whom
were mobilised whilst the endotracheal tube was still in situ. The
incidence of mobilising whilst orally intubated increased as the number
of ventilated days increased - 27% of the 37 patients ventilated for
three days or greater and 31% of the 26 patients ventilated for greater
than 5 days. The mobilisation sessions consisted of two activities -
sitting on the edge of the bed with or without assistance, or a passive
transfer to a chair (eg. lateral transfer or hoist). They each made up 53%
and 47% of mobility sessions respectively. In those patients ventilated
for more than 5 days, mobilisation activities made up 12.3% of all
interventions delivered to patients whilst they were intubated. There
were no adverse events during any mobility session.
CONCLUSIONS. The proportion of patients who were mobilised whilst
orally intubated was almost double those previously reported.
Mobilisation activities comprised a greater proportion of theintervention provided by physiotherapy. The prevalence of mobilising
orally intubated patients increased as the duration of intubation
progressed to over five days.
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INTRODUCTION. Early mobilization is a strategy that aims to reduce the
time of weaning from ventilation and help in the functional recovery in
ICU patients. It can be performed through therapeutic activities such as
bed motor exercises, transfer to the chair and sit at the edge of the bed,
with progression to orthostatism and ambulation. The objective of this
study was to evaluate the safety of the use of the ergometric bicycle in
patients hospitalized in the ICU of a Cancer Hospital.
METHODS. Pilot interventional study, non-randomized, non-
controlled. Interventions of active lower limb exercises were per-
formed in the cycle ergometer, the duration determined by the sub-
jective perception of effort and sign of fatigue of the patient.
Hemodynamic and respiratory variables were evaluated at three dif-
ferent moments: before, during and after exercise.
RESULTS. 48 patients (72.9% male, age 57.1 years; APACHE 12.8; 87.5%
solid tumours; 43.7% of the patients were using MV at the beggining of
the procedure) participated in the study. Comparing the initial and final
values of the analyzed variables, there was a non significant increase in
the blood pressure after exercise, although the procedure proved to be
safe, without significant hemodynamic or respiratory changes. No
patient needed to discontinue the procedure.
CONCLUSION. The use of the cycloergometer in cancer ICU patients
was safe (including patients in MV), provided that the activity was
performed with adequate monitoring.
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INTRODUCTION. Early mobilization in the ICU is associated with
several positive outcomes, such as reductions in ICU and hospital
length of stay and shorter duration of delirium.
Early mobilization can be defined as the use of physical activity
during the first 5 days of critical illness (1).
The Sara Combilizer® is a modern tilt-table that can lift the patient to
standing position even if the patient is currently not able to stand by
himself.
OBJECTIVES. This study aimed to test, whether the Sara Combilizer
was feasible to use in early mobilization. The objective was also to
describe characteristics of the studied group.
METHODS. Adult patients admitted to a 27-bed general ICU in
Odense University Hospital during a 3-month period was enrolled.
Mechanical ventilation was an inclusion criteria. Patients permanently
without the ability to stand and with contraindications to
mobilization were excluded.
When enrolled, baseline data was collected. The patient was daily
assessed regarding the possibility and appropriateness to use the
Sara Combilizer. If not, the reason was explored.
RESULTS. 214 patients were admitted during the period. 28 met
inclusion criteria. Loss to follow up: 8. 20 were analyzed. 10 of these
did use the Sara Combilizer.
The mean age was 68,9 years. 6 were female.
SOFA scores at admission was 7,6 (SD 3,1) at 1st mobilization 5,9 (SD
2,4) and at 1st mobilization with Sara Combilizer 7,1 (SD 3,2)
APACHE II score was 26,3 (SD 6,0)
Main admission diagnosis was Sepsis (N = 6, 30%), respiratory failure
(N = 5, 25%), Neuological (N = 5, 25%) and Surgical (N = 4, 20%)
Time from admission to first mobilization was 37,5 hours (95% CI
21,4-53,5 h.)
The primary method to mobilization was hoisting to chair (n = 18).
Sitting on edge of bed (n = 1) and Sara Combilizer (n = 1) was also used.
Patients were hoisted to chair before physical training was feasible.
The Sara Combilizer was not used on the day of admission, and the use
was increasing from day 2 to 5. Most patients used the Sara Combilizer
only once, since they were able to train standing position next day.
The reasons for not mobilizing the patient with the Sara Combilizer
was in this study primarily related to patient conditions, but also to
the level of knowledge about the Sara Combilizer.
CONCLUSIONS. The use of the Sara Combilizer is feasible in the first
five days of critical illness for the studied group of adult patients,
undergoing mechanical ventilation. Baseline data for the group was
described. Mobilization to chair took place before the patient began
physical training with the Sara Combilizer.
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INTRODUCTION. Near-infrared spectroscopy (NIRS) has been pro-
posed as a technique to monitor cerebral tissue oxygen saturation
(SctO2) non-invasively and continuously. NIRS-based monitors are in-
creasingly used in perioperative monitoring of children undergoing
surgery for congenital heart disease (1). However, the usefulness of
postoperative NIRS-based monitoring remains unclear.
OBJECTIVES. To assess whether SctO2 is predictive for prolonged
intensive care unit (ICU) stay and for prolonged duration of invasive
mechanical ventilation in critically ill children after pediatric cardiac
surgery.
METHODS. Single-center prospective, observational study (Clinical
Trials.gov, NCT01706497) of 177 critically ill children and infants
with congenital heart disease, younger than 12 years old, admit-
ted to the pediatric ICU between October 2012 and November
2015. Children were monitored with the FORESIGHT cerebral ox-
imeter from ICU admission until they were weaned off mechan-
ical ventilation. Using the first 24 hours of SctO2, we defined a
SctO2 desaturation score, using the percentage of area below
50%, and a low frequency variability, using the standard devi-
ation of a smoothed signal created by taking the median of a
rolling 20-sample window of the initial SctO2 signal.
RESULTS. Outcome was predictive value of postoperative SctO2
for duration of ICU stay (Table 251, median (95% confidence
interval), 4 days (3–8)) and duration of mechanical ventilation
(median (95% confidence interval), 111.3 hours (69.3-190.4)). In a
multivariable bootstrap analysis adjusted for age, weight, gender,
PIM2, cyanogenic cardiopathy and time prior to SctO2
monitoring, risk factors associated with worse outcomes included
increased SctO2 variability and elevated SctO2 desaturation score
below 50%.
Patients with cyanogenic cardiopathy had lower SctO2 (P < 0.001),
stayed longer in the ICU (P = 0.002) and were longer mechanically
ventilated (Table 251, P = 0.002). In these patients, only the SctO2
low frequency variability was a significant predictor of adverse
outcomes. On the contrary, in patients without cyanogenic
cardiopathy, the variability was not predictive for adverse outcome
but the mean SctO2 and the desaturation score below 50% were
predictive.
CONCLUSIONS. Increased SctO2 variability and elevated SctO2
desaturation score are associated with longer ICU stay and with
longer duration of mechanical ventilation after pediatric cardiac
surgery. Further research is required to investigate how these
measures can be used to drive therapeutic interventions and to
investigate additional possible clinical applications.
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Table 252 (Abstract 1056). Association between SctO2 and outcomes
Outcomes Coefficient R-squared P-value
SctO2 predictors ICU LOS
Low frequency
variability
3.26 (3.16-3.35) 0.382
(0.379-0.385)
0.04 (0.03-0.04)
Desaturation score 21.21 (21.01-21.70) 0.382
(0.379-0.385)
<0.0001
(<0.0001-<0.0001)
SctO2 predictors Duration of
mechanical
ventilation
Low frequency
variability
75.60 (73.23-77.36) 0.385
(0.382-0.389)
0.04 (0.04-0.05)
Desaturation score 503.98
(496.42-511.37)
0.385
(0.382-0.389)
<0.0001
(<0.0001-<0.0001)
Table 251 (Abstract 1056). Baseline and outcomes characteristics
All
patients
Cyanogenic Non
cyanogenic
P-value
n 177 70 107 -
Age, month, median (IQR) 4 (1-14) 4.5 (1-11) 4 (1.5-17) 0.15
Male gender, n (%) 107 (60.5) 42 (60.0) 65 (60.7) 0.92
Weight, kg, median (IQR) 5.2 (3.8-8.0) 5.3 (3.6-7.9) 5.2 (3.8-9.3) 0.13
ECMO during ICU stay, n (%) 8 (4.5) 6 (8.6) 2 (1.9) 0.06
SctO2 during first 24 hours,
mean (SD)
70.2 (8.0) 66.1 (8.4) 73.0 (6.4) <0.0001
Duration of SctO2 monitoring
during first 24 hours, median
(IQR)
19.5 (6.7-
23.4)
21.8 (12.3-
23.6)
16.6 (7.0-
23.0)
0.03
ICU LOS, day, median (IQR) 4.0 (3.0-8.0) 6 (4-14) 4 (2-6.5) 0.002
Duration of invasive mechanical
ventilation, hour, median (IQR)
111.3 (69.3-
190.4)
143.0 (92.2-
338.8)
93.9 (49.9-
153.6)
0.002
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INTRODUCTION. Early mobility in intensive care (ICU) is important to
optimise functional recovery whether mechanically or spontaneously
ventilated. Early mobilisation is crucial in the prevention of ICU
acquired weakness and can improve pulmonary function and
decrease ICU length of stay1. However, opportunities to mobilise can
be limited. In-bed cycling (IBC) can enable activity of patients when
mobilising out of bed is restricted. The use of IBC has been found
safe and feasible within adult and paediatric ICU (PICU)2, 3 with fur-
ther research ongoing in Canada for children in critical care4.
OBJECTIVES. The aim of this project was to determine if the use of
IBC was safe and feasible in PICU within Royal Hospital for Children,
Glasgow.
METHODS. An evaluation of the benefit of the RT-300 Paediatric
Moto-Med Bike was completed over 4 months. Eligible patients were
cardiovascularly stable with calf length greater than ten inches, intact
skin integrity and no contraindications to exercise. Active or passive
cycling sessions were completed dependent on patient's ability. Out-
comes measures were heart rate (HR), blood pressure (BP), respira-
tory rate (RR), oxygen saturations and tidal volumes (VT). These were
measured before, during and after treatments.RESULTS. Six patients participated in the evaluation, age range ten
to eighteen years old. Treatments varied from five to ten minutes
with 83% of sessions including active pedalling and a mean of five
sessions per patient. All patients remained clinically stable during the
sessions with no adverse events. All outcome measures remained
within safe parameters according to each child's age and baseline.
87.5% of sessions increased their VT with a mean change of 12.5%
and over 70% of sessions maintained or increased their oxygen
saturations during and after treatments. Participants and families
reported the pedals were enjoyable, motivating and enhanced their
care and experience in PICU.
CONCLUSION. The use of IBC was found to be safe, feasible and
enjoyable in a PICU setting. No adverse events occurred and the bike
was found to be a useful adjunct to increasing physical activity and
early rehabilitation within PICU. Further research is required to
determine if IBC has a benefit on respiratory and physical function.
This may facilitate early weaning of mechanical ventilation or impact
on PICU length of stay.
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INTRODUCTION. Decreased pulmonary arterial compliance (Cpa) is a
sign of pulmonary vascular dysfunction that predicts worse outcome in
patients with acute respiratory distress syndrome (ARDS), even in
presence of normal pulmonary vascular resistance (PVR). Extracorporeal
membrane oxygenation (ECMO) could potentially improve pulmonary
haemodynamics by facilitating the application of protective ventilation
and decreasing hypoxic vasoconstriction.
OBJECTIVES. To describe pulmonary haemodynamics and their
correlation with respiratory mechanics and ventilator settings in
severe ARDS patients on ECMO.
METHODS. Hemodynamic measurements obtained from pulmonary
artery catheter (systolic and diastolic pulmonary arterial pressure = PAPs
and PAPd, pulmonary arterial occlusion pressure = PAOP, cardiac
output = CO), arterial and mixed venous blood gas analyses, ventilator
settings and respiratory mechanics (positive end-expiratory pres-
sure = PEEP, Plateau pressure = Pplat, tidal volume = TV, driving pres-
sure = ΔP) measured during the first 24 hours of veno-venous ECMO
were prospectively collected in 51 consecutive severe ARDS patients
treated between 2009 and 2016 at our center. PVR (= PAPm-PAOP/CO),
Cpa [(CO/heart rate)/(PAPs-PAPd)], intrapulmonary shunt (Qs/Qt) and re-
spiratory system compliance (Crs = TV/ΔP) were calculated. In-hospital
mortality was recorded.
RESULTS. All patients received protective mechanical ventilation
(PEEP 18 [15–22] cmH2O, TV 4.3 [2.9-5.3] ml/kg IBW, Pplat 28 [26–
30]cmH2O,) and ECMO support (blood flow 3 [2.7-3.6] L/min, gas flow
4 [3–6.4] L/min) to achieve adequate gas exchange (pH 7.39 [7.36-
7.42], PaCO2 43 [38–48] mmHg, PaO2 84 [69–96] mmHg) despite
severe lung injury (Crs 28 [18–37] ml/cmH2O, Qs/Qt 50 [42–62]%).
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mmHg and PAPd 25 [19–31] mmHg with a PAOP of 18 [14–21]
mmHg, resulting in low PVR of 159 [122–194] dyn*s*cm-5, but
impaired Cpa of 5.38 [3.28-7.46] ml/mmHg. In the whole population,
Cpa was positively correlated with PEEP (r 0.31, p 0.026). Patients
with PEEP higher than the median value (18 cmH2O, “high PEEP”
group) received ventilation with lower ΔP and TV and showed a
greater Qs/Qt as compared to “low PEEP”. Interestingly, Cpa showed
a trend toward improvement in the “high PEEP” group (Table 253).
When we restricted our analysis to the patients with Crs lower than
the median value (i.e. those who might benefit more from higher
PEEP), Cpa was more significantly correlated with PEEP (r 0.5, p
0.007) and was significantly higher in the “high PEEP” group (Table
254), despite a lower PaO2 (65 [57–75]mmHg in "high PEEP" vs 86
[71–105] mmHg in "low PEEP") with no difference in PaCO2 and pH.
CONCLUSIONS. In this population of severe ARDS patients on ECMO,
PVR was not elevated, but Cpa was reduced. Application of higher
PEEP with reduced ΔP and TV seems to be associated with improved
arterial pulmonary compliance in the subgroup of patients with more
severe lung injury.Table 253 (Abstract 1058). All patients (N=51)
LOW PEEP (n = 25) HIGH PEEP (N =26) p
PEEP (cmH2O) 15 [14-18] 21 [18-22] < 0.001
Pplateau (cmH2O) 27 [25-29] 28 [27-31] 0.007
ΔP (cmH2O) 11 [10-13] 8 [7-8] < 0.001
TV (ml/kg) 4.8 [4.2-6.3] 3.2 [2.3-4.3] 0.001
Crs (ml/cmH2O) 28 [20-36] 29 [18-38] 0.94
Qs/Qt (%) 47 [39-57] 58 [45-67] 0.03
PAOP (mmHg) 17 [13-21] 18 [16-20] 0.63
PVR (dyn*s*cm-5) 162 [118-189] 159 [127-231] 0.57
Cpa (ml/mmHg) 4.9 [3.2-6.7] 6.3 [4.4-7.8] 0.15
Table 254 (Abstract 1058). Patients with lower Crs (n=26)
LOW PEEP (n = 13) HIGH PEEP (n = 13) p
PEEP (cmH2O) 15 [14-16] 22 [20-23] < 0.001
Pplateau (cmH2O) 27 [26-29] 30 [28-32] 0.004
ΔP (cmH2O) 12 [11-14] 8 [8-10] <0.001
TV (ml/kg) 4.2 [3.1-5] 2.3 [1.6-2.8] < 0.001
Crs (ml/cmH2O) 18 [16-22] 18 [14-26] 0.63
Qs/Qt (%) 50 [41-61] 67 [57-80] 0.006
PAOP (mmHg) 16 [13-21] 18 [16-21] 0.34
PVR (dyn*s*cm-5) 183 [123-226] 173 [116-208] 0.59
Cpa (ml/mmHg) 4.9 [3.3-6.4] 7.4 [5.4-9.1] 0.0261059
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Intensive Care Medicine Experimental 2017, 5(Suppl 2):1059INTRODUCTION. Severe acute respiratory failure (SARF) is the most
common and lethal single organ failure in the intensive care unit
(ICU) and has a mortality rate of 45% to 55%. Extracorporeal
membrane oxygenation (ECMO) is an effective rescue support
therapy in those patients who fail conservative management
strategies. According to the database of Extracorporeal Life Support
Organization (ELSO) registry from “The Respiratory Extracorporeal
Membrane Oxygenation Survival Prediction (RESP) Score” study,
mortality rate of VV-ECMO for SARF in adults was around 40%
(Reference).
OBJECTIVE. To investigate pre-ECMO/referral factors predicting the
outcome of patients who underwent VV-ECMO in a tertiary referral
center.
METHOD. A retrospective evaluation of referral characteristics of
SARF patients admitted to one of the five commissioned ECMO
centers in United Kingdom (UK) who received VV-ECMO treat-
ment between 1stJanuary 2010-1st January 2017. Patients' demo-
graphics, co-morbidities, aetiology and other available related
pre-ECMO variables were noted from referral forms. Patients were
separated into survival and non-survival groups in terms of ECMO
run.
RESULTS. Among 861 referred patients, 228 patients were retrieved.
After exclusion, 183 patients VV-ECMO were evaluated. Median age
was 45 years old (IQR; 35–55). 102 patients (55,7%) were male. Mean
BMI was 29,9 ± 8,8. Median Charlson Co-morbidity Index (CCI) was 1
(0–3). Aetiology of SARF was mainly bacterial (53,4%) and viral (27,3%)
pneumonia. ICU mortality was 26,8% (n = 49). Non-survivor patients
were older (p = 0,014) and most were >65 years old (p = 0,039). Pa-
tients in the survivor group tended to have a higher body mass index
(BMI) (p = 0,052) whereas low BMI was associated with the non survivor
group (p = 0,014). The presence of septic shock (p = 0,008) and nitric
oxide (NO) usage (p = 0,01) before ECMO implementation were seen
significantly more in non-survivors. In contrast to this, neuromuscular
blockage (NMB) agents usage (p = 0,045) was high in survivors (Table).
After logistic regression analysis; the presence of septic shock
(p = 0,033, OR: 3,712; 95% CI: 1,115-12,356) and usage of NO
(p = 0,021, OR: 4,989; 95% CI: 1,279-19,462) pre-ECMO were independ-
ently associated with ECMO outcome.
CONCLUSION. We found several variables associated with outcome
in our cohort of SARF patients receiving VV-ECMO at a tertiary refer-
ral centre and mortality was evidently lower compared to ELSO regis-
try. Further comparative study of such variations in larger databases
is important to determine appropriate benchmarking and selection
criteria for successful ECMO outcomes.
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INTRODUCTION. Veno venous extracorporeal membrane oxygenation
(vvECMO) can be proposed in the most severe forms of acute
respiratory distress syndrome unresponsive to prone position.
vvECMO.allows the perfusion into the right atrium of oxygenated blood
with high partial pressure of O2 (PvO2).Therefore, the hypoxic
pulmonary vasoconstriction (HPV) is mainly abolished during vvECMO.
However, vvECMO weaning may be challenging in some patients or
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 531 of 542severe hypoxemia may occur. In those situations, infusion of almitrine,
a selective pulmonary vasoconstrictor, could be of interest by
restoration of HPV,
by reducing intrapulmonary shunt and thereafore increasing
systemic arterial oxygenation.
OBJECTIVES. Main objectives of this study were to describe the
physiological effects and the safety of an almitrine infusion trial in
patients treated by vvECMO. Second objective was to identity
associated factors with response to almitrine infusion.
METHODS. We conducted a retrospective, study at the medical ICU
of the North Hospital (Marseille, France). Between January 2013 and
June 2016, all patients admitted with severe ARDS requiring support
with vvECMOwere screened for inclusion. Almitrine infusion trial was
considered in patients with persistent hypoxemia or after more than
10 days of vvECMO without success for weaning. Contraindications
of the trial were: acute cor pulmonale (ACP), hemodynamic instability
with hyperlactacidemia, and liver failure. Trial consisted of a 30
minutes infusion of 0.5 mg/kg almitrine.
A positive test was defined by an increase in PaO2 to FiO2
ratio > 20%.
RESULTS. During the study period, an almitrine infusion trial was
performed in 25 patients. Five patients received 2 tests, and one, 3
tests. The almitrine infusion trial was attempted after a median of 11
days on vvECMO. Twenty trials (62.5%) were considered as positive.
After a positive trial, the median increase of the PaO2/FiO2 ratio was
35%. After multivariate logistic regression analysis, an inhomogeneous
ARDS was the only independent factor associated with a positive trial
(OR = 10.3; IC95% [1.3 - 84.2]). Eighteen patients (72%) were considered
as responders. The characteristics between the responder and non-
responder patients were not different. More patients were rapidly
weaned definitely from vvECMO
(into 72 hours after the trial) in the responder group: 45% vs. 0%
(p = 0.049). There were no reported complications after the almitrine
infusion trial. However, 4 patients (22%) had adverse events probably
linked to prolonged continuous almitrine infusion, including 2
patients with acute cor pulmonale.
CONCLUSIONS. During vvECMO, a majority of patients are responders
to almitrine infusion trial.
A significant number of patients was rapidly weaned from
vvECMOafter a positive trial. Due to the rate of adverse events, the
clinician must put in balance the benefit-risk ratio before the pre-
scription of a prolonged continuous infusion of almitrine.
GRANT ACKNOWLEDGMENT
None
1061
Incidence of right ventricle failure in patients with acute severe
respiratory failure requiring extracorporeal membrane
oxygenation
A. Fabbri, A. Falvo, J. Powell-Tuck, N. Desai, G. Glover, C. Langrish, D.
Wyncoll, A. Retter, C. Meadows, N. Barrett, S. Tricklebank, N. Ioannou, L.
Camporota
Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom
Correspondence: A. Fabbri
Intensive Care Medicine Experimental 2017, 5(Suppl 2):1061
INTRODUCTION. The incidence of acute cor pulmonale (ACP) in
patients with acute respiratory distress syndrome (ARDS) is around
22% and is associated with a higher mortality[1]. Little is known
about the incidence of ACP in adult patients receiving extracorporeal
membrane oxygenation (ECMO). The gold standard for the diagnosis
of ACP is echocardiography, although there is growing interest in the
assessment of ACP using CT scans.
OBJECTIVES. We studied the incidence of ACP in patients with severe
ARDS requiring ECMO. ACP was assessed using echocardiography and
CT imaging.
METHODS. We included all patients with severe ARDS admitted to our
Severe Respiratory Failure Centre between January 2011 and March
2015 who received a CT scan and an echocardiogram after being
established on ECMO. ACP was defined on CT as a right ventricular toleft ventricular diameter ratio (RVd/LVd) of either >0.9 or >1 [2].
Echocardiogram criteria used to define ACP were RVd/LVd and the
presence of a D-shaped left-ventricle (paradoxical septal movement).
Right ventricular failure (RVF) was diagnosed on visual assessment or
tricuspid annular plane systolic excursion (TAPSE) < 17mm. [3].
RESULTS. we included 107 patients. The prevalence of ACP with
echocardiography was 13.7%. RVF was 37.1% using TAPSE < 17 and
30.8% on visual assessment.
The prevalence of ACP with CT was 54% using a RVd/LVd ratio > 0.9
and 33% with a ratio > 1. Bland-Altman analysis on RVd/LVd ratio
with CT scan and echocardiography showed a Bias −0.13, LOA −0.35
to 0.22. We also compared the ratio between the areas of the RV and
LV (RVa/LVa) using CT scan and echocardiography as a further
marker of ACP. Prevalence of RVa/LVa ratio on CT scan >0.9 was
17.8%. The RVa/LVa shows the greatest agreement (Bias = 0.0079,
LOA - 0.416 to 0.431) compared to other measurements.
CONCLUSIONS. The incidence of ACP in a large population of
patients with ARDS on ECMO support is lower than in mechanically
ventilated ARDS without ECMO. Moreover, CT appears to have great
potential in the indirect assessment of RV function. Integration of the
two investigations could be useful in the detection of RVF,
particularly as many patients with ARDS have CT scans. Further
studies should assess the temporal association between ECMO and
resolution of RVF.
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INTRODUCTION. Right ventricle failure (RVF) in patients with acute
respiratory distress syndrome (ARDS) is associated with a higher
mortality. In these patients, the combination of higher airway
pressures, a severe deficit in gas exchange, and the low lung volume,
may increase their risk of acute cor pulmonale (ACP) and its
associated morbidity and mortality [1]. The most severe form of
ARDS with refractory hypoxaemia and hypercapnia may require
extracorporeal membrane oxygenation (ECMO) support. ECMO may
lead to a reduction of the ventilatory pressure that, in association
with near normal gas exchange, may decrease right ventricle (RV)
afterload and therefore RVF [2].
OBJECTIVES. we studied the risk factors for RVF and the outcome of
RVF in a large population of patients with ARDS on ECMO support.
METHODS. This is a retrospective single-center cohort study of
patients admitted to the ICU of Guy's and St Thomas' hospital
for ARDS on ECMO support. We collected demographic data,
ventilatory settings just before starting ECMO, arterial blood
gases pre-ECMO; presence of comorbidities, therapy with vaso-
pressors before ECMO, laboratory results, length to stay (LOS) on
ECMO and survival. RVF was assessed echocardiographically
using the tricuspid annular plane systolic excursion (TAPSE) and
the visual assessment. [3]
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 532 of 542RESULTS. Of all factors included in a logistic regression model only
body mass index (BMI) was independently associated with lower risk
of RVF with an OR 0.85 (0.73-0.99); p = 0.039.
There was no difference in the median value of the RVF and LOS on
ECMO between survivors and non-ICU survivors.
One of the other possible determinants of pulmonary vascular
resistance and therefore RVF, is represented by the lung volume.
Interestingly, we found that patients that displayed greater increase
in lung volume after increasing airway pressure from 5 to 45 cmH2O
(recruitability), showed a trend towards higher likelihood of RVF
visual: OR 1.29 (0.98 to 1.68); p = 0.06. Similarly, in patients with low
potential for lung recruitment, TAPSE was higher compared to
patients with high potential for lung recruitment TAPSE median (SD)
2 mm vs 1.7 mm, but statistically not different.
CONCLUSIONS. In this study we show that BMI - probably because
of the effect of the chest wall elastance - protects from RVF and
ECMO may protect the right heart by allowing reduction of pressure,
particularly in patients with higher recruitability. In order to
demonstrate the possible protective role of ECMO against RVF
further studies and comparisons with adult ARDS patients treated
with conventional ventilation are required.
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INTRODUCTION. Use of extracorporeal membrane oxygenation
(ECMO) for acute respiratory failure (ARF) has been substantially
increased worldwide since the 2009 A (H1N1) influenza pandemic.
However, because the ECMO therapy is associated with higher
mortality, enormous financial burden and the significant complications
such as bleeding, appropriate selection of the patients who could
benefit from ECMO therapy is important. Recently, several outcome
prediction models for ECMO treatment such as the ECMOnet score, the
PRESERVE score and the RESP score have been developed.OBJECTIVES. The aim of this study was to evaluate the outcomes of
the ECMO patients and to validate the previous outcome prediction
models in Korean cohort.
METHODS. This was a retrospective multicenter study for ARF
patients who did not respond to conventional treatment at 11
hospitals. From January 2014 to December 2015, patients over the
age of 19 years who underwent ECMO support were included.
RESULTS. During the study period, 209 ARF patients were
received ECMO therapy. Successful weaning rate was 147 (70.3%)
and 96 patients (45.9%) were alive at hospital discharge.
Venovenous ECMO mode was used for 72.3% of patients, and
median duration of ECMO support was 7 (3–14) days. In all
patients, the median age was 58 (45–65) years and 138 patients
(66.0%) were male. Acute physiology and chronic health
evaluation (APACHE) II score was 20 (14–27) and sequential organ
failure assessment (SOFA) score was 8 (5–12). Before ECMO
initiation rescue therapies were following; 98 prone positioning
(48.8%), 134 neuromuscular blocking agents (64.1%), 50 nitric
oxide (23.9%) and 31 steroid use (14.8%).
The receiver operating characteristics curve analysis of the each
outcome prediction score was performed: the RESP score,
AUC = 0.66 (95% confidence interval [CI], 0.58-0.74); PRESERVE score,
AUC = 0.63 (95% CI, 0.55-0.72); APACHE II score, AUC = 0.57 (95% CI,
0.49-0.65); SOFA score, AUC = 0.52 (95% CI, 0.44-0.60).
CONCLUSIONS. Our study suggests that the proposed PRESERVE and
RESP score did not predict properly outcome for patients treated
with ECMO for severe ARF.
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INTRODUCTION. Low flow veno-venous extracorporeal carbon di-
oxide (CO2) removal (ECCO2R) is a safe and effective treatment
for hypercapnic respiratory failure that has been successfully used
to enable lung protective ventilation in acute respiratory distress
syndrome (ARDS)1, to avoid tracheal intubation in exacerbation of
chronic obstructive pulmonary disease (COPD)2,3 and as an ad-
junct therapy in life threatening acute asthma.4
Our centre is a quaternary referral centre specialising in heart
and lung transplantation and cardiothoracic surgery with ready
access to many different modalities of extra-corporeal and mech-
anical circulatory support and thus presents a different demo-
graphic to previous published case series.5
OBJECTIVES. To evaluate the use of ECCO2R at a quaternary referral
centre for cardio-thoracic surgery, heart lung transplant and extra
corporeal life support (ECLS).
METHODS. Case notes of all patients receiving ECCO2R at this centre
between February 2014 and March 2017 were reviewed.
Demographic, physiological and outcome data were examined.
RESULTS. 16 adult patients were commenced on ECCO2R using the
Hemolung® (ALung Inc, Pittsburgh, PA) for ARDS, pneumonia, and to
facilitate weaning from extracorporeal membrane oxygenation
systems (ECMO). 9 patients (56%) had previous bilateral lung
transplants.
Median age was 38 years and at commencement of therapy median
SOFA score was 17 points. At instigation of ECCO2R median blood gas
analysis values were pH 7.17, PaCO2 11.47 kPa and PaO2 16.09 kPa.
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 533 of 542At 24 hours lung protective ventilation was achieved in 100% of
patients. The median pH was 7.36 and median PaCO2 6.23 kPa. The
mean time to normal pH, in patients not being weaned from ECMO,
was 14.3 hours.
Median duration of ECCO2R was 121 hours and this was weaned
successfully in eight (50%) patients, withdrawn for futility in six
(37.5%), upgraded to ECMO in one (6.25%) and was ceased for
device failure due to major air entrainment in one patient (6.25%).
No serious adverse outcome resulted from device failure. Median
mechanical ventilation time was 16.5 days and intensive care unit
(ICU) length of stay (LOS) was 23.5 days. All patients successfully
weaned from ECCO2R survived to discharge from ICU.
CONCLUSIONS. ECCO2R has proved a useful addition to the
armamentarium for management of severe respiratory failure in our
centre. The treatment achieved the therapeutic goals of normalising
blood pH (with lowered PaCO2) and attaining lung protective
ventilation in our population of lung transplant recipients and
cardio-thoracic surgical patients.
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INTRODUCTION. Indications for Extracorporeal Membrane Oxygenation
(ECMO) use in lung transplantation (LT) are: bridge to transplantation,
intraoperative extracorporeal respiratory and/or circulatory support and
treatment of primary graft dysfunction (PGD) in postoperative
period. Several mortality risk factors pre-ECMO initiation has been
investigated. Hepatic dysfunction represents an independent risk
factor for poor prognosis in critically ill patients, especially in those
with heart failure. In ECMO patients with LT this risk parameter has
not been studied.
OBJECTIVES. To estimate if liver function parameters and the
presence of liver disease at the beginning of ECMO were associated
with ICU mortality.
METHODS. Retrospective observational study between January 2009
to December 2016 in 12 beds intensive care unit (ICU). Inclusion
criteria for ECMO entry: bridge to PT, intraoperative support and in
PGD. ECMO systems: centrifugal pump and polymethylpentene
membrane oxygenation with Bioline® coated circuits and cannulas.
Demographic data, liver disease and liver function parameters were
collected at the time of ECMO initiation. ECMO indications, type of
ECMO support and ICU mortality were also recorded. Liver disease
and liver function parameters were compared between survivors and
non-survivors. Continuous variables, reported as mean ± standard
deviation (SD) were compared using the Student t-test. Categorical
variables were compared using the X2 test.
RESULTS. 35 patients (p), 23 male (65.71%) were included with a
median age of 49.57 ± 13.14 years. Median APACHE II was
19.85 ± 7.73 and median SOFA was 7.11 ± 3.02. VA ECMO was usedin 22 patients (62.85%) and VV ECMO in 13 patients (37.14%).
Intraoperative support was used in 54.28% (19 p); bridge to LT in
20% (7 p) and PGD was the indication in 25.71% (9 p). Median
Cardiac Output (CO) was 4.74 ± 1.95. Interstitial lung diseases disease
(ILD) were the principal indication for LT in 13 p (37.14%), and
idiopathic pulmonary fibrosis was the most frequent disease. Liver
disease was present in 11 patients and more frequent in survivors
than in non-survivors (45% vs 13.33%; p = 0.046). Liver diseases were:
hepatic steatosis (2 p), Gilbert disease (2 p), hepatitis B (1 p), hepatitis
C (1p), liver transplant (1 p), alpha 1-antitrypsin deficiency (1 p), liver
stasis (1 p), hepatotoxicity attributed to atorvastatin (1 p), hepatic
hemangioma (1 p). Total Bilirubin (mg/dl) was higher in survivors
than in non-survivors (1.03 ± 0.73 vs 0.60 ± 0.45; p = 0.05) and no
significant statistical differences between survivors and non-survivors
was observed in liver enzymes. ICU mortality was 42.85% (15
patients).
CONCLUSIONS. In this review with ECMO patients and LT, total
bilirubin before ECMO initiation was higher in survivors than in non-
survivors (p = 0.05). Liver disease was more common in survivors
than in non-survivors with statistical significance (p = 0.046). ICU
mortality was 42.85%.1066
The efficacy of veno-venous extracorporeal membrane
oxygenation for patients with acute respiratory failure
K. Tokuda1, J. Maki1, T. Fujiyoshi1, N. Kaku2, S. Mizuguchi2, T. Akahoshi2, S.
Hoka3, Y. Maehara1,2
1Kyushu University Hospital, Intensive Care Unit, Fukuoka, Japan; 2Kyushu
University Hospital, Emergency and Critical Care Center, Fukuoka, Japan;
3Kyushu University Hospital, Department of Anesthesiology and Critical
Care Medicine, Fukuoka, Japan
Correspondence: K. Tokuda
Intensive Care Medicine Experimental 2017, 5(Suppl 2):1066
INTRODUCTION. Respiratory management using veno-venous extra-
corporeal membrane oxygenation (VV-ECMO) has been widely used
to rescue patients with acute respiratory failure (ARF), such as acute
respiratory distress syndrome. We investigated the management of
ARF patients using VV-ECMO at our institute.
METHODS. Patients who received VV-ECMO for the management of
ARF between 2013 and 2015 were reviewed in this retrospective ob-
servational study. We collected data regarding patient demographic
characteristics, duration of VV-ECMO management, and the outcome.
We divided the patients into two groups (survivors and non-
survivors) according to the outcome and compared the groups to
determine the prognostic factors.
RESULTS. A total of 11 patients (8 men and 3 women) were enrolled.
The median age was 35 years (range, 1–71 years). The median
duration of VV-ECMO management was 10 days (range, 4–71 days),
with 0–10 replacements of the ECMO circuit. Five patients could be
weaned from VV-ECMO (survivor group). Although there was no sig-
nificant difference in the duration of VV-ECMO management be-
tween the groups (median 8 and 16 days, respectively, in survivors
and non-survivors; p = 0.12), the duration tended to be longer in
non-survivors than in survivors. The causes of death in the non-
survivor group were VV-ECMO withdrawal because of no pulmonary
improvement (n = 4), bleeding tendency that prevented the use of
VV-ECMO (n = 1), and cardiac arrest due to multiple organ failure
(n = 1).
DISCUSSIONS. VV-ECMO may have induced “lung rest” during mech-
anical ventilation until the primary lung condition improved, thereby
preventing irreversible lung injury and allowing weaning from VV-
ECMO in the survivor group. In contrast, in the non-survivor group,
VV-ECMO was withdrawn in some cases because of a worsening
general condition due to emerging co-morbidities, such as infections
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 534 of 542and uncontrolled primary lung disease. Long-term VV-ECMO was
continued for two deceased patients, as the decision to discontinue
VV-ECMO could not be made, despite the unlikely prospect of effect-
ive treatment of the primary disease.
CONCLUSIONS. Although VV-ECMO may be an effective intervention
for patients with ARF, we must also bear in mind that VV-ECMO
should be discontinued when treatment of the primary disease is
unlikely to be successful.Survivors
(N = 5)Non-survivors
(N = 6)P-valueMale: Female 4:1 4:2 1.00Age (years) 27.0 (1–60) 42.5 (14–71) 0.51MV before VV-ECMO (days) 2 (0–5) 4 (0–5) 0.74SOFA score at VV-ECMO induction 9 (5–13) 10.2 (6–13) 0.70P/F ratio at VV-ECMO induction 53 (48–115) 64 (27–76) 0.63Duration of VV-ECMO (days) 8 (5–12) 16 (4–71) 0.12ECMO circuit replacement (times) 1 (0–3) 2.5 (0–10) 0.14MV mechanical ventilaton, SOFA sequential organ failure assessment
Data are expressed as median (minimum - maximum)
[Patient Demographics]
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INTRODUCTION. CO2 removal by ExtraCorporeal Membrane
Oxygenation (ECMO) might control the respiratory drive and effort of
patients with the Acute Respiratory Distress Syndrome (ARDS) and it
could even induce apnea.
OBJECTIVES. We report preliminary data of a study aimed at
assessing effects of extremely elevated CO2 removal by ECMO (i.e.
≥90%) on respiratory rate, effort, transpulmonary pressure and work
of breathing of early severe ARDS patients.
MATERIAL AND METHODS. We enrolled 5 patients with severe ARDS
on veno-venous ECMO since ≤7 days. Esophageal pressure (Pes) trac-
ings were continuously recorded with airway pressure and flow. Rich-
mond agitation sedation scale value of −2 to 0 and inspiratory
trigger were obtained by lowering sedation. Then, patients were
switched to Pressure Support Ventilation (PSV) set to obtain tidal vol-
ume of 4–6 ml/kg while on clinical positive end-expiratory pressure
(PEEP) and ECMO settings. Clinical FiO2 and ECMO blood flow (BF)
were left unchanged. ECMO gas flow (GF), instead, was increased
from clinical baseline to the one removing ≥90% of total CO2 pro-
duction, as testified by ECMO CO2 extraction (VCO2-ECMO, obtained
by analysis of gas passing through the expiratory outlet of mem-
brane lung) divided by total CO2 production (VCO2tot = natural lung
VCO2, assessed by volumetric capnography, + VCO2ECMO). Then, by
offline analysis, we measured respiratory rate (RR), Pes swings (ΔPes),
inspiratory muscular pressure (Pmus), tidal volume (Vt), driving trans-
pulmonary pressure (ΔPL) and the pressure time product (PTPes).
RESULTS. Patients were 53 [48–60] yo and undergoing ECMO since 5
[5–7] days. On the morning of the study: ECMO BF was 3.28 [3.21-
3.29] l/min and GF 6 [4–7] l/min, PEEP was 15 [10–18] cmH2O,
respiratory system compliance (Crs) 28 [18–39] ml/cmH2O and
intrapulmonary shunt 41 [34–53] %.
To reach target CO2 extraction, ECMO GF was increased to 15.0 [12.0-
17.5] L/min, obtaining VCO2-ML/VCO2tot of 98 [91–100] %. With
these settings, blood gas analysis showed PaO2 77 [60–93] mmHg,
PaCO2 42 [41–46] mmHg, pH 7.45 [7.43-7.46] ; RR was 23 [20–31]bpm, minute ventilation 3.4 [3–5.7] l/min, ΔPes 2 [2–4] cmH2O, Pmus
4.3 [4.0-5.5] cmH2O, ΔPL 10 [8–11] cmH2O and PTPes 165.2 [89.7-
221.3] cmH2O*s*min
−1.
Apnea (defined as absence of inspiratory effort for ≥10 seconds) was
detected in only 1 patient.
ΔPes, Pmus and ΔPL don't seem to correlate with extracorporeal
support but rather with more severe lung injury (i.e., lower Crs). RR
and PTPes, instead, decreased with increasing CO2 extraction and
weren't correlate with Crs.Crs VCO2-ML/VCO2totRR r: 0.159 P-value: 0.798 r: −0.796 P-value: 0.107ΔPes r: −0.690 P-value: 0.198 r: −0.101 P-value: 0.871ΔPL r: −0.850 P-value: 0.068 r: 0.293 P-value: 0.632Pmus r: −0.701 P-value: 0.187 r: 0.048 P-value: 0.938PTPes r: 0.189 P-value: 0.811 r: −0.968 P-value: 0.032[Pearson's Correlation]
CONCLUSIONS. In early severe ARDS patients undergoing ECMO,
extremely high levels of extracorporeal support couldn't induce
apnea and didn't seem to correlate with effort and transpulmonary
pressure.
1068
Pulmonary arterial hypertension (PAH) in ARDS patients
undergoing veno-venous extracorporeal membrane oxygenation
C. Valsecchi1, V. Punzi1, S. Spina1, A. Asta1, M. Bombino2, A. Pesenti3, N.
Patroniti1,2
1Università degli Studi Milano Bicocca, School of Medicine and Surgery,
Milano, Italy; 2San Gerardo Hospital, Anesthesiology and Critical Care,
Monza, Italy; 3Università degli Studi di Milano, Department of
Pathophysiology and Transplantation, Milano, Italy
Correspondence: C. Valsecchi
Intensive Care Medicine Experimental 2017, 5(Suppl 2):1068
INTRODUCTION. Veno-venous extracorporeal membrane oxygen-
ation (VV-ECMO) is a well-established therapy in patients with acute
respiratory distress syndrome (ARDS) unresponsive to conventional
therapy. Only few data are available on pulmonary arterial pressure
and incidence of PAH in ARDS patients undergoing VV-ECMO.
OBJECTIVES. To describe the effect of VV-ECMO on mean pulmonary
arterial pressure (PAPm), and to assess association of PAPm with the
severity of native lung dysfunction throughout the ECMO treatment
METHODS. A retrospective analysis of prospectively collected data
was performed in all consecutive ARDS patients undergoing VV-
ECMO from January 2003 to August 2015. All patients were moni-
tored with a pulmonary artery catheter (PAC). In 34 (36%) patients
PAC was available before ECMO starting. In all other patients PAC
was inserted within 12 hours from ECMO starting. PAPm and other
respiratory and hemodynamic variables were collected before ECMO
institution and every day up to disconnection from ECMO. Use of
pulmonary artery vasodilators and dobutamine was recorded. For the
purpose of the study pulmonary arterial hypertension (PAH) was de-
fined as PAPm higher than 30 mmHg.
RESULTS. The cohort is based on 94 patients (65% male, 45.7 ± 13.2
years old, overall mortality 34%).
Before ECMO PAPm was 32.6 ± 7.6 (IQR 24–32, 56% with PAH);
vasodilators, dobutamine, or both were present in 4, 15, and 1
patients respectively. PAPm was correlated with PaCO2, arterial pH
(pHa), and pulmonary artery occlusion pressure (PAOP).
Starting of ECMO was associated with a significant decrease in
PAPm. Changes in PAPm were correlated with changes in PAOP,
PaCO2, and pHa.
During ECMO treatment highest PAPm was 36.6 ± 7.9 (IQR 31–40).
Patients were classified in three groups according to highest PAPm:
PAPm < 31 mmHg (19, 20%), between 31 and 40 mmHg (53, 56%)
and > 40 (22, 24%). Patients of the high PAPm group had a lower
respiratory system compliance (Crs) and higher intrapulmonary shunt
(Va/Q).
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PAPm group respectively.
Pulmonary vasodilators were administered in 26 patients (22
sildenafil, 12 NO, 9 prostacyclin; 12 patients received 2 or more
pulmonary vasodilator).
CONCLUSIONS. Occurrence of pulmonary arterial hypertension was
common both before ECMO institution and during ECMO treatment.
Before ECMO starting the main cause of PAH was left ventricular failure
with increase in PAOP and/or respiratory acidosis with hypercapnia.
Starting of ECMO determined a decrease in PAPm mainly due to the
reduction in PAOP and relief of respiratory acidosis.
Patients with PAPm higher than 40 mmHg showed higher mortality,
had a lower Crs and higher Va/Q. These data suggest that ventilatory
management of the native lung may have a great effect on the
occurrence of APH and mortality.Fig. 334 (Abstract 1068) See text for description
Table 255 (Abstract 1069). See text for description
Crs (#, §) Success Failure
Before 32.03 ± 12.84 (*) 26.77 ± 9.23
After 36.75 ± 15.15 (#) 26.77 ± 9.23
Vt (§)
Before 299.42 ± 90.91 295.92 ± 87.02
After 337.65 ± 118.97 (*) 285.31 ± 94.57
RR (*)
Before 11.55 ± 5.40 12.23 ± 5.63
After 16.60 ± 7.51 19.27 ± 6.62
Crs Compliance of respiratory system, Vt tidal volume, RR respiratory rate
(*) p< 0.05 before vs. after; (#) p< 0.05 success vs. failure; (§) p< 0.05 interaction
Table 256 (Abstract 1069). See text for description
FiO2 (#) Success Failure
Before 0.52 ± 0.14 0.62 ± 0.20
After 0.50 ± 0.14 0.63 ± 0.22
PaO2 (§)
Before 86.12 ± 17.91 82.51 ± 18.87
After 88.43 ±17.66 (#) 77.72 ± 14.06
PaCO2 (*)
Before 48.72 ± 6.95 47.94 ± 7.32
After 46.69 ± 6.29 45.50 ± 7.09
FiO2 inspired fraction of oxygen, PaO2 partial pressure of oxygen in the arterial
blood, PaCO2 partial pressure of carbon dioxide in the arterial blood
(*) p< 0.05 before vs. after; (#) p< 0.05 success vs. failure; (§) p< 0.05 interaction1069
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INTRODUCTION. Protective mechanical ventilation (MV, low tidal
volume and plateau pressure) is the cornerstone treatment of acute
respiratory distress syndrome (ARDS). In this context, veno-venous
extracorporeal membrane oxygenation (VV-ECMO) has become an
important tool. After the acute phase and while still on ECMO, pa-
tients may be switched from controlled to assisted MV with possible
improvement of respiratory muscles function, decrease of diaphragm
dysfunction and reduction of sedation needs.
OBJECTIVES. To assess patients during spontaneous assisted
breathing trial undergoing VV-ECMO to determine
factors predicting success in switching to assisted MV and the effects
on main respiratory and hemodynamic parameters.
METHODS. A retrospective analysis of prospectively collected data
was performed. All consecutive ARDS patients from 2003 to 2014undergone spontaneous assisted ventilation during ECMO were
included. Data are reported as median (interquartile range) or
mean ± SD. Two-way repeated mea- sure ANOVA was used to assess
differences between days (prior to and after assisted ventilation trial)
and between patients who failed and succeed the trial. A logistic re-
gression was used to identify independent factors predicting spon-
taneous assisted breathing success.
RESULTS. During January 2003 and December 2014, 75 among
100 patients receiving VV-ECMO for ARDS, underwent at least
one trial of switching from controlled to assisted MV while on
ECMO (60% male, 44 ± 13.4 years old, BMI 26.5 ± 6.7). A total of
89 trials were performed. Time of trial from starting ECMO was
10 (3.5-16) days; 64, 8 and 3 patients underwent 1, 2 and 3 trials,
respectively.
show main respiratory results. Success patients had a significant lower
inspired fraction of oxygen (FiO2), before the trial. After switching to
assisted ventilation, success patients showed a significant increase
(p < 0.05) in compliance of respiratory system (Crs),
tidal volume and partial pressure of oxygen in the arterial blood
(PaO2). Crs and FiO2 showed to be independent prognostic factors
to predict trial success (OR 1.054 (95% CI 1.003-1.107) and OR 0.008
(95% CI 0–0.414), p < 0.05, respectively). No significant changes on
hemodynamics were recorded.
CONCLUSIONS. Patients succeeding an assisted MV trial during
VV-ECMO show an improvement in respiratory mechanics with in-
crease in Crs, tidal volume and PaO2. A higher Crs and lower
FiO2 independently predict success of a spontaneous assisted
breathing trial in patients with ARDS during VV-ECMO.
Fig. 335 (Abstract 1069) See text for description
Fig. 336 (Abstract 1070) See text for description
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 536 of 5421070
Accuracy of very low tidal volume delivery from ICU ventilators. A
bench study with implications for ventilator setting in ARDS
patients under ECMO
B. Moro1, L. Baboi1, H. Yonis1, M. Aublanc1, F. Lissonde1, A. Louf-Durier1,
Z. Riad1, J.-C. Richard1, C. Guérin1,2, M. Mezidi1
1Hopital de la Croix Rousse, Lyon, France; 2INSERM 955, Créteil, France
Correspondence: M. Mezidi
Intensive Care Medicine Experimental 2017, 5(Suppl 2):1070
INTRODUCTION. Once ARDS patients are under ECMO it has been
claimed that the primary goal is resting the lung. THis can be done
by lowering tidal volume (VT).A 1–4 ml/kg predicted body weight VT
range has been reported in the literature in this condition. We were
wondering whether such low VT can reliably be delivered by ICU
ventilators, an issue which has never been investigated on the
bench. Our hypothesis was that the common 10% accuracy in VT
delivery was not reached by most of them.
OBJECTIVES. To compare VT actually delivered across ICU ventilators
when set at low VT.
METHODS. A pneumatic test lung (TTL, Michigan inc. Grand Rapids,
USA) was set at 20 ml/cmH2O compliance and 20 cmH2O/L/s
resistance. Five ICU ventilators V 500 (Drager), Carescape R 860 (GE
Healthcare), Servo U (Maquet), PB980 (Covidien) and G5 (Hamilton)
equipped with Heated humidifier (Fisher-Paykel MR 850) set off and
adult ventilator circuit (RT 380 EVAQUA Fisher Paykel) were tested.
Each ICU ventilator was set in BTPS condition, at PEEP 12 cmH2O
and FIO2 0.21. Airway pressure and airflow (Hans-Rudolph
pneumotachograph) were measured (Biopac M150) proximal to the
lung model. For each ventilator a 20 ml stepped series of VT ranging
from 100 to 280 ml was delivered for 10 breaths each, at 30 then at
15 breaths/min respiratory frequency (f). VT was measured by
numerical integration of the flow signal. Accuracy was assessed as VT
error (=(VT measured-VT set)/VT set*100). VT error was compared
across ICU ventilators and set VTs by using two-factor ANOVA at each
respiratory rate with Tukey post-hoc comparisons.
RESULTS. There was a significant effect of ICU ventilator, nominal VT
and their interaction on VT error. Figure 336. shows Box and whisker
plots of VT error across ventilators and nominal VT at f 15 breaths/
min. The results were basically the same at f 30. Symbols correspond
to pairwise not significant differences between ICU ventilators at
each nominal VT. Set VT was under delivered with every ventilator.
The 10% limit of accuracy (horizontal broken lines) segregate ICU
ventilators into two groups at every nominal set VT: two ventilators
were within and three were out the 10% accuracy limit.
CONCLUSIONS. The very low VT values investigated were not
properly delivered by common ICU ventilators with marked
differences between them. The inaccuracy was consistent across VTand f. This result has potential clinical implications and should be
confirmed in the clinical setting.
GRANT ACKNOWLEDGMENT
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INTRODUCTION. Postoperative pneumonia (POP) is one of the
most common complications after lung cancer surgery with a
reported incidence ranging from 9 to 25%. POP are associated
with worsen outcome. Identifying risk factors are necessary to
prevent POP. Postoperative lymphopenia (POL) is described for
more than thirty years. Because lymphocytes cells are a major
component of infection control, POL have been proposed as a
risk factor for postoperative infections but was never identified as
such in a multivariate analysis.
OBJECTIVES. We aimed to identify postoperative lymphopenia as a
risk factor for postoperative pneumonia after lung cancer surgery.
METHODS. We have performed a retrospective single center study,
conducted in Saint Etienne University hospital, France, from January
2013 to May 2015. We have included patients admitted for lung
cancer surgery (lobectomy, bi-lobectomy, pneumonectomy) aged ≥ 18
years old and with no history of immunosuppressive state. Lympho-
cyte blood counts were collected the day before the surgery and at
postoperative day 1, day 3, day 7. Patients with POP must met two
majors criteria (fever > 38°C, abnormal radiographic finding) plus one
minor criteria (leukopenia < 4.0 .109 cells.l−1 or leukocytosis ≥ 12.0
.109 cells.l−1, a new rise in the C-reactive protein value, an increase
and modification of the expectorate with purulent aspect) or one
major criteria plus three minors criteria. A logistic regression model
adjusted on risk factors for POP currently described was used to ex-
plain postoperative pneumonia.
RESULTS. Two hundred patients were included. Forty-three patients
(21.5%) developed a POP. The median time to the occurrence of POP
was 2.5 ± 1.5 days. Preoperative lymphocyte count was 1.8 ± 0.6 .109
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 537 of 542cells.l−1 and 2.0 ± 0.7 .109 cells.l−1 (p = 0.09) for the patients with and
without POP respectively. In the two groups of patients, we have ob-
served a decline of lymphocyte cells at postoperative day 1 corre-
sponding to the nadir. In multivariate analysis adjusted on ASA
score ≥ 3, sex, age > 65 years old, COPD, active smokers and
chronic heart failure, postoperative lymphopenia at day 1 was
significantly associated with an increased risk for POP (odd ratio
2.63 CI 95% [1.03 - 5.40]). Using the receiver operating character-
istics curve, we have identified lymphocyte count ≤ 1.19 .109
cells.l−1 at postoperative day 1 as the best risk threshold to
develop a POP (sensitivity = 74%, specificity = 49%, predictive
positive value = 29%, predictive negative value = 88%). POP was
more often seen at postoperative day 7 when patients had a
lymphocyte count below the threshold at postoperative day
1(p = 0.003).
CONCLUSIONS. Our study showed that lymphopenia occurred at
postoperative day 1 is associated with postoperative pneumonia in
lung cancer surgery.
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INTRODUCTION. Sepsis remains the commonest cause of emergency
admission to ICU globally. However sepsis is still a lethal clinical
syndrome with a high mortality rate worldwide. The majority sepsis
patients have coagulation abnormalities. In the pathogenesis of sepsis,
inflammation and coagulation play a pivotal role. Evidence of an
extensive cross-talk between these two systems is increased recently.
However, there are different diagnostic criteria in sepsis and dissemi-
nated intravascular coagulation (DIC). Therefore we defined the new
diagnostic criteria of sepsis induced DIC (SEDIC) as follow; Presepsin
(PSEP) level ≥ 900 pg/ml and Protein C (PC) activity ≤ 45% [1].
OBJECTIVES. In this study, we attempted to validate this scoring
system.
METHODS. A single center, retrospective, observational study was
carried out. Patients who were diagnosed with sepsis were included
in this study. The definition of sepsis was performed according to
the new sepsis criteria named Sepsis-3. The blood samples were col-
lected at the time of admission. The patients were classified into the
following three groups according to PSEP level and PC activity. (1)
SEDIC: PSEP ≥ 900 pg/mL and PC ≤ 45%. (2) non-SEDIC: PSEP < 650
pg/mL and PC > 45%, or 650 < PSEP < 900 and PC > 55%. (3) pre-
SEDIC: the range out of SEDIC and non-SEDIC. The scoring system for
Japanese Association for Acute Medicine (JAAM) DIC was used for
diagnosis of DIC. We examined the severity of illness of the patients
was evaluated according the APACHE II score and organ failure was
assessed by the SOFA score. All patients were followed up for 28
days after enrollment in the study, and 28-day all-cause mortality
was assessed.
RESULTS. Three hundred twenty seven patients were enrolled for
this study from July 2011 to April 2016. Ninety seven patients (29.7%;
97/327) were SEDIC, 136 were pre-SEDIC (41.6%; 136/327) and 94
were non-SEDIC (28.7%; 94/327). SEDIC scoring system significantly
reflected the positive rate of JAAM DIC (SEDIC 72.2%, pre-SEDIC
42.6%, non-SEDIC 22.3%; p < .05), JAAM DIC score (SEDIC 4.7 ± 2.0,
pre-SEDIC 3.7 ± 2.1, non-SEDIC 2.5 ± 1.6; p < 0.05), and SOFA score
(SEDIC 9.8 ± 3.8, pre-SEDIC 8.2 ± 3.3, non-SEDIC 6.3 ± 3.1; p < .05).
The 28-day mortality rate was significantly worsened, depending on
the cutoff points in the respective criteria (SEDIC 27.8%, pre-SEDIC
22.1%, non-SEDIC 6.4%; p < .05).
CONCLUSIONS. From these results, we strongly believed that the
SEDIC scoring system has an acceptable property for the diagnosis ofsepsis induced DIC even if we use Sepsis-3 for the definition of
sepsis. We can measure PSEP and PC with very simply and
quickly within thirty minutes. So, we strongly suggest that this
scoring system can be useful for early treatment in a critical care
setting.
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INTRODUCTION. Septic shock affects a wide range of patients
with non-immune and immune comorbidities. Its prognosis com-
monly relies on the sole vital status, whereas it is also associated
with the development of severe infectious and non-infectious
complications.
OBJECTIVES. We addressed the impact of underlying immune
conditions on the course of septic shock with respect to both
mortality and the development of acute complications.
METHODS. This was an 8-year (2008–2015) monocenter retrospective
study. Patients diagnosed for septic shock within the first 48 h of
?A3B2 show $132#?>intensive care unit (ICU) admission were in-
cluded. Patients were classified in four subgroups with respect to
their immune status: non-immunocompromised and immunocom-
promised distributed into hematological or solid malignancies and
non-malignant immunosuppression. Outcomes were in-hospital
death and the development of ICU-acquired infectious, hemorrhagic
and ischemic complications. The determinants of death and compli-
cations were addressed by multivariate competing risk analysis.
RESULTS. Eight hundred and one patients were included. Among
them, 305 (38%) were immunocompromised, distributed into solid
tumors (122), hematological malignancies (106) and non-malignant
immunosuppression (77). The overall 3-day, in-ICU and in-hospital
mortality rates were 14.1%, 37.3% and 41.3%, respectively. Patients
with solid tumors displayed increased in-hospital mortality (cause-
specific hazard (CSH) 2.16 [95% confidence interval 1.49-3.11],
p < .001). ICU-acquired infections occurred in 211 (33%) of the 3-day
survivors. In addition, 95 (11.8%) and 70 (8.7%) patients exhibited se-
vere ischemic or hemorrhagic complications during the ICU stay.
There was no association between the immune status and the occur-
rence of ICU-acquired infection. Non-malignant immunosuppression
and hematological malignancies were independently associated with
increased risks of severe ischemic events (CSH 1.83 [1.07-3.23],
p = .03) and hemorrhage
(CSH 2.12 [1.06-4.25], p = 0.03), respectively.
CONCLUSIONS. The underlying immune status impacts on the
course of septic shock and the further susceptibility to complications.
This emphasizes the complexity of sepsis syndromes in relation with
comorbid conditions, and raises the question of the relevant
endpoints in clinical studies.
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INTRODUCTION. The mean arterial pressure (MAP) impacts microvascular
blood flow and reflects adequacy of tissue perfusion. The 2016 Surviving
Sepsis Campaign recommends vasopressors target MAP ≥65 mmHg in
patients with septic shock. It is unclear if patients with chronic
hypertension (HTN) achieve target MAP faster and experience different
outcomes.
OBJECTIVES. To evaluate the impact of chronic HTN on outcomes in
patients with and without chronic HTN who developed septic shock
requiring vasopressors.
METHODS. A retrospective cohort study was conducted for critically
ill patients admitted to medical and surgical intensive care units
(ICU) at our institution between May 2014 and July 2016. Patients
were included if they were ≥18 years old, admitted to an ICU for ≥48
hours, and diagnosed with septic shock requiring vasopressors. The
primary outcome was time to goal MAP (≥65 mmHg). Secondary
outcomes included duration of vasopressor use, days free of
vasopressor support, mortality, ICU and hospital length of stay.
Differences between groups were compared using t or Wilcoxon
Rank Sum test for continuous variables and Pearson´s Chi-square
or Fisher's exact test for categorical variables. To adjust for imbal-
ances in baseline characteristics, inverse probability of treatment
weighting (IPTW) procedure was performed, where probabilities
to be in the HTN group were estimated based on baseline demo-
graphic and clinical characteristics of patients using logistic
regression.
RESULTS. In total, 133 patients were included, of which 75 (56.4%)
had HTN. Baseline demographics were similar between groups
except patients with HTN were older (62.8 y vs. 56.2 y; p = 0.011)
and more frequently had ischemic heart disease (28.0% vs. 3.5%;
p < 0.001) and diabetes
(42.7% vs. 8.6%; p < 0.001). Time to goal MAP (HTN vs. no HTN: 12.6
h ± 16.5 vs. 14.2 h ± 29.6; p = 0.692), duration of vasopressor use
(70.7 h ± 65.7 vs. 84.7 h ± 97.0; p = 0.326) and days free of
vasopressor support (14.6 d ± 19.6 vs. 20.4 d ± 24.5; p = 0.131)
were similar between groups. Patients with HTN had higher in-
hospital (49.3% vs. 31.0%; p = 0.034) and 28-day mortality (53.3%
vs. 31.0%; p = 0.010). Duration of ICU stay was shorter (6.6 d ± 6.1
vs. 9.9 d ± 10.0; p = 0.033) in patients with HTN, but hospital
lengths of stay were similar (17.5 d ± 20.2 vs. 23.9 d ± 26.3;
p = 0.115). After IPTW, duration of ICU stay was no longer signifi-
cantly different but in-hospital (50.2% vs. 27.3%, p = 0.004) and 28-day
mortality (52.7% vs. 27.3%, p = 0.001) remained higher in patients
with HTN.
CONCLUSION. The time to goal MAP and vasopressor free days were
similar regardless of HTN diagnosis. Chronic HTN was associated with
a higher mortality rate.
REFERENCE
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INTRODUCTION. Sepsis caused serious disturbances in pituitary-
thyroid axis functions, with an abnormal thyroid hormones releasing,
causing a no thyroidal illness syndrome, also known as low T3 syn-
drome or euthyroid sick syndrome.
OBJECTIVE. To analyze the thyroid function of septic patients and its
relation with outcome.
METHODS. Prospective study in a cohort of 150 consecutive adults
with severe sepsis (SS) Septic Shock (SSh) according to Clinical
Guidelines for Surviving Sepsis Campaign (SSC, 2008) during 20 months
in a polyvalent Intensive Care Unit (ICU). We studied thyrotropin (TSH),
free triiodothyronine fraction (fT3) and free thyroxin fraction (fT4)
serum levels, APACHE II and SOFA score. Statistical analysis was
performed using SPSS 18.0 for Windows (SPSS Inc. Chicago, IL, USA).
RESULTS. We analyzed 150 episodes of SS (16%) or SSh (84%), the
median age of the patients was 64 (inter-quartile range, 48.7-71)
years; the main sources of infection were: respiratory tract (38%) and
intra-abdomen (45%); 70.7% had medical diseases. APACHE II score
was 25 [21–30], SOFA score was 10 [7.75-11] and 28-day mortality
was 22.7%. Our data shown 18.3% with low levels of TSH (<0.2uUI/
mL), 20.3% had low levels of fT4 (<0.75 ng/dL) and 91.4% low levels
of fT3 (<2 pg/mL). The profile of death patients were men (64.7%, n
=22), with significantly higher average age (63 vs. 57 years;
p = 0,049), as well as clinical severity scores, APACHE II (29.8 vs. 24.1;
p < 0.001) and SOFA (12.1 vs. 8.9; p < 0,001) and major dysfunction
organs number (4.6 vs. 3.6; p < 0,001). Non-survivors had significantly
lower TSH 0.85 vs. 1.4 UI/mL; p = 0.042, and fT3 1.2 vs. 1.39 pg/mL,
p = 0.031. However fT4 did not show statistical significance 0.42 vs.
0.58ng/dL, p = ns.
CONCLUSIONS. Most of our septic patients present an altered
thyroid function. Our data indicate that low TSH and fT3 serum levels
could be a significant prognostic factor in patients with SS and SSh.
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INTRODUCTION. Sepsis is a time-dependent process that must be
early detected and treated. Automatic alerts may play an important
role in prompt detection but no data about the role of microbio-
logical documentation has been recently provided.
OBJECTIVES. The aim of this study were to asses the principal
“microbiological” features of the patients with severe sepsis and
septic shock treated by a Sepsis unit in a teaching hospital, to
describe their updated prognosis and specially to analyze the
influence on global mortality of microbiological documentation (MD)
of these septic patients.
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 539 of 542METHODS. During a four years and four months period (October-
2012-January 2017), 2322 severe sepsis and septic shock patients
detected by a sepsis unit form ICU using an electronic automatic
alert in a teaching hospital were prospectively evaluated. Clinical
and microbiological variables were recorded. Any patient with a
confirmed sepsis was potentially eligible through the whole
hospital. Several multivariate analysis was performed to describe
independently factors associated to global mortality in these
patients using SPSS package (16.0).
RESULTS. Among 2322 electronic activations 631 of them
corresponded to septic shock (27.1%) and the rest to severe sepsis
(62.9%). Only 27,9% of patients were admitted to ICU. Their mean
APACHE II and SOFA score were 18.05 ± 6.06 and 5.21 ± 3.3
respectively. The most frequent sources of infections were the
respiratory focus (40,9%), urinary (26,1%) and abdominal (18,6%).
Global mortality was 20.7%. The majority of episodes were
community adquired (57.6%). Associated bacteremia was present in
33,5% of episodes.MD was achieved in 51.3%. The most frequently
microorganism isolated were: Escherichia coli (19.1%), Staphylococcus
aureus (4,6%), Streptococcus pneumoniae (3.9%) and Pseudomonas
aeruginosa (3.8%).In univariate analysis MD was associated to lower
mortality (18.4% vs. 23.1%; p = 0.05). However multivariate analysis
confirmed APACHE II (OR 1,12; p = 0,0001), age (OR 1,02; p = 0,0001)
and origin of infection (OR 32; p = 0,0001) as independently factors
associated with global mortality but no MD (OR 1,15; p = 0,33).
CONCLUSIONS. MD was achieved in a half of patients with sepsis
detected by a sepsis team in a teaching hospital, but had no any
influence on global mortality.
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INTRODUCTION. Lipopolysaccharide (LPS) of Gram-negative bacteria
and inflammatory mediators play a key role in sepsis pathogenesis.
LPS-adsorbers are applied to eliminate LPS. However, there are few
studies of their clinical efficacy, besides they were conducted in small
cohorts of patients.
OBJECTIVES. The aim of the study was to evaluate clinical efficacy
and endotoxin and cytokines elimination by Alteco LPS Adsorber in
patients with septic shock.
The study included 20 patients with confirmed Gram-negative sepsis.
Endotoxin elimination was performed using hemoperfusion with the
Alteco LPS Adsorber (Alteco Medical AB, Lund, Sweden).
Methods. Blood serum samples were taken before and immediately
after the procedure, column washouts were taken as well. Samples
were stored at - 70 °C. The values of IL- 4, IL- 6, IL-8, IL-10, IL-18 in
serum and washout from LPS-adsorber were measured by ELISA.
Concentrations of LPS were measured by LAL-test.RESULTS. 28-day survival rate in patients with septic shock after the
hemoperfusion comprised 25%. All the surviving patients leaved hos-
pital in satisfactory condition. Normalization of hemodynamic param-
eters was noted in the group of the surviving patients after the
hemoperfusion, which allowed significantly lowering vasopressor
load. Moreover, the procedure resulted in decrease of leukocytosis
and numbers of young lymphocyte forms. PCT level also declined on
the average from 14.29 to 8.6 ng/ml. The SOFA score dropped from
14 to 11. Similar but less prominent trend was observed in the group
of nonsurviving patients. Patients diagnosed with septic shock and
with a suspected Gram-negative infection did not always have a high
endotoxin level. High or extremely high LPS level was observed in
50% of the patients. LPS concentration in blood usually decreased 2–
10 folds after the hemoperfusion. Stable LPS decrease required from
2 to 6 hemoperfusion procedures. We did not observe significant
changes of endotoxin level after the hemoperfusion in group of the
patients with low initial LPS level. Drop of IL-6 and IL-8 levels was ob-
served if their initial concentrations exceeded 100 pg/ml.
CONCLUSION. Alteco LPS Adsorber allows effective elimination of
LPS from the blood stream even at its extremely high
concentrations. Stable decrease of LPS level requires more than 2
hemoperfusion procedures. LPS decrease was accompanied with
normalization of clinical and laboratory parameters (patients'
condition). The decrease in the SOFA score indicated significant
improvement in organ function.
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INTRODUCTION. There are currently some contrasting findings
concerning the level of mean arterial pressure (MAP) to target in
septic shock patients in terms of microcirculation.
OBJECTIVES. To compare the microcirculatory reserve at two levels
of MAP in septic shock patients.
METHODS. We measured the cardiac index by transpulmonary
thermodilution and microcirculation parameters by using near-
infrared spectroscopy in 22 septic shock patients receiving norepin-
ephrine, within the first six hours of resuscitation and with a MAP > 75
mmHg. Both variables were measured at MAP > 75 mmHg (so-called
“high MAP”) and at MAP 65–70 mmHg (so-called “low MAP”) after
decreasing the norepinephrine dosage. The muscle tissue oxygen
saturation (StO2) was measured at the thenar eminence and the
microcirculatory reserve was measured as the StO2 recovery slope
obtained after a vascular occlusion test.
RESULTS. The MAP decreased from 81 ± 3 to 67 ± 3 mmHg and
this was associated with a decrease in mean StO2 recovery slope
(3.00 ± 1.40 vs. 2.61 ± 1.46 units/sec, respectively, p < 0.05)
without any change in mean StO2 (81 ± 8 vs. 81 ± 9%,
respectively) and in cardiac index (3.26 ± 1.09 vs. 3.12 ± 1.05 L/
min/m2, respectively). There was a large interindividual variability
in terms of relative changes in StO2 and in StO2 recovery slope.
A significant relative change in StO2 was observed in 19 patients:
StO2 decreased in 11 patients, increased in 8 patients and
exhibited no change in three patients. All patients except one
exhibited a significant relative change in StO2 recovery slope: it
decreased in 16 patients and it increased in 5 patients. Patients
with significant relative changes in StO2 or in StO2 recovery slope
had a similar baseline cardiac index. Changes in microcirculation
parameters were not different in hypertensive patients (n = 17)
and in non-hypertensive patients (n = 5).
Table 257 (Abstract 1080). Laboratory data HOC vs HS
HOC HS
Protein C Reactive(mg/dl)
0h 12h 24h
10 (2-19) 13 (4-22)
11 (5-26)
0,3 (0,1-2,9) 1,8 (0,3-7,5)
1,5 (0,3-5,7)
** ***
***
Hemoglobin (g/dl) 0h 12h
24h
14,3 (1,7) 12,5 (1,7)
12 (1,5)
12 (2,3) 10 (2,4) 10,3
(1,9)
*** **
***
Lactate (mmol/L) 0h 2,1 (1,6-2,9) 2,9 (2,1-4,8) *
Platelets (x103/uL 12h 24h 200 (134-334) 195
(128-319)
150 (112-197) 134 (104-
180)
* *
Fibrinogen (mg/dl) 0h 12h
24h
477 (179) 503 (177)
507 (130
359 (133) 317 (140) 349
(152)
* *** *
Protrombine time (%) 24h 71 (18) 57 (18) **
* p<0,05; ** p<0,01; *** p<0,001
Table 258 (Abstract 1080). Inflammatory mediators & FXa-activity
HV HOC HS
IL-6 0H IL-6 12H
IL-6 24H
1,00
(0,71 -
2,98)
148,79 (17,69 - 589,32) ###
96,39 (5,93 - 236,42)
66,67 (20,23 - 161,25)
95,01 (21,03 - 350,43) ¶¶¶
38,68 (18,15 - 136,34)
23,55 (7,15 - 32,77)
IL-8 0H IL-8 12H
IL-8 24H
2,55
(1,88 -
6,45)
79,93 (10,00 - 174,87) ###
45,58 (4,26 - 82,98)
14,55 (1,94 - 46,82)
29,94 (5,13 - 144,69) ¶¶
22,71 (3,10 - 147,70)
10,66 (6,69 - 36,36)
IL-10 0H IL-10
12H IL-10 24H
4,31
(3,42 -
5,96)
17,93 (8,58 - 95,85) ###
22,45 (7,28 - 95,95)
11,12 (3,37 - 38,73)
81,75 (13,54 - 224,77) ¶¶¶
14,48 (4,46 - 34,00)
5,18 (0,48 - 19,47)
TNFα 0H TNFα
12H TNFα 24H
59,33
(30,66 -
73,66)
217,00 (132,66 - 394,41) ##
175,33 (68,66 - 285,00)
189,16 (164,08 - 343,66)
290,83 (226,16 - 398,75) ¶¶¶
294,41 (236,00 - 368,62)*
296,16 (214,33 - 406,75)*
FXa 0H Activity
FXa 12H Activity
FXa 24H Activity
110,04
(11,45)
88,38 (24,45) ## 87,10
(27,53) 86,54 (13,67)
87,96 (18,19) ¶¶ 77,70
(21,44) 77,54 (18,70)
• * p < 0,05 between HOC & HS • ¶¶ p < 0,01 between HS & HV; ¶¶¶ p < 0,001
between HS & HV • ## p < 0,01 between HOC & HV; ### p < 0,001 between
HOC & HV
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 540 of 542CONCLUSIONS. The mean StO2 recovery slope decreased when
MAP dropped from “high” to “low” values in septic shock
patients, without any change in mean StO2. Nevertheless, there
was a large interindividual variability with two opposite
behaviours: the vast majority of patients had a higher StO2
recovery slope at “high MAP” whereas some other had a higher
StO2 recovery slope at “low MAP”. Thus, monitoring the
microvascular reserve in septic shock patients makes sense in
order to individualize the MAP target.
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INTRODUCTION. Heat stroke is a life-threatening illness characterized
by central nervous system disfunction and severe hyperthermia;
some evidence suggests a relationship between heat cytotoxicity, co-
agulation and multiple organ damage.
OBJECTIVES. To assess differences in inflammatory mediators and
coagulation among a group of heat stroke patients (HS) compared to
a group of healthy volunteers (HV) and a group of patients with
hyperthermia by other causes (HOC).
METHODS. Descriptive and prospective study including all
patients admitted to the hospital with HS diagnosis since July
2009 until September 2016, and a group of HOC admitted in the
same period and a group of HV. We recorded demographic and
clinical data: age, sex, vital constants at admission, risc factors,
APACHE II, daily SOFA, need for respiratory support, renal
replacement therapy, vasoactive drugs, cooling method, length of
stay and evolution. Laboratory data were recorded at 0,12 and 24
hours. We determined baseline inflammatory mediators levels
(IL6, IL8, IL10 & TNFα) and FXa-activity in HV, and basal,12 and
24 hours in HOC and HS patients. The study was approved by
the Hospital Ethic Commitee. Differences between groups were
assessed using chi-square for categorical variables and Student´s
t-test or Mann–Whitney test for continuous variables, considering
p < 0,05 to be significant.
RESULTS. Six HV, 40 HS and 28 HOC patients were included,
similars in age, sex and APACHE II. HOC patients had more
comorbidities (75% vs 50%; p < 0.05), need for ICU admission
(85,7% vs 37,5%; p < 0.001), vasoactive drugs (53,6% vs 20%;
p < 0.01), mechanical ventilation (67,9% vs 25%; p < 0.001),
higher SOFA at admission [8(6–11) vs 4(2–8); p < 0.01], 24 [7(4–9)
vs 2(0–4); p < 0.001] and 48 hours [5(3–9) vs 1(0–3); p < 0.01],
length of stay [17 (5–41) vs 3(1–10); p < 0.001] and mortality
(35,7% vs 7,5%; p < 0.01). They received more antithermic drugs
(92,9% vs 70%; p < 0.05) while HS patients received more
physical cooling measures (67,5% vs 14,3%;p < 0.01). We found
no differences in any of the recorded clinical data at admission.
Liver and kidney function were similar in both groups. No
differences were found in Procalcitonin levels on admission, 12
and 24 hours. Significant differences in other laboratory data and
inflammatory mediators and FXa-activity are shown in Tables 257
and 258.
CONCLUSIONS. HS and HOC patients have high levels of IL6, IL8,
IL10 and TNFα. Only TNFα is higher in HS than in HOC. FXa-activity
decreases in HS and HOC in similar levels, werheas other coagulation
data are worse in HS.REFERENCE
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INTRODUCTION. Recently, it was clarified that Zn2+ plays a pivotal
role of inflammation. According to the several reports that Zn2+ led
to suppression of inflammation and its deficiency resulted in further
deterioration of severe organ dysfunction including coagulopathy in
patients with sepsis. However, there have been no reports that the
relationship between the serum zinc level and sepsis-induced
coagulopathy.
Intensive Care Medicine Experimental 2017, 5(Suppl 2):44 Page 541 of 542OBJECTIVE. The purpose of this study was to investigate the
relationships between serum zinc levels and coagulopathy and the
prognosis of the patients with sepsis.
METHODS. This study was conducted a single-center retrospective
study from June 2016 to March 2017. Blood samples for measuring
the markers were collected on admission. And serum zine level and
platelet counts, PT-INR, FDP, D-Dimer, PIC, TAT, PAI-I, antithrombin
(AT) were measured. The definition of sepsis was performed accord-
ing to the Sepsis-3.
RESULTS. Of the 128 patients, 50 patients were sepsis and 78
patients were non-sepsis. The serum zinc level was significant lower
of sepsis group than that of non-sepsis group (33.4 ± 16.4 vs
62.8 ± 17.8μg/dL, p < 0.01) at the ICU admission. In 50 sepsis pa-
tients, the number of JAAM DIC positive patients (DIC+) and negative
patients (DIC-) was 26 and 24, respectively. In sepsis patients, there
was no significant difference in the serum zinc level between sur-
vivor and non-survivor on day 14 of ICU stay (33.9 ± 16.9 vs
30.8 ± 13.9μg/dl). Similarly, there was no significant correlation be-
tween serum zinc level and JAAM DIC score, APACHE II score and
SOFA score in the sepsis patients. There was also no significance in
the serum zinc level between DIC+ and DIC- (35.4 ± 14.9 vs
31.5 ± 17.9μg/dl). About the relationship between the serum zinc
level and the levels of coagulation molecular markers, we found the
significant positive correlations to platelet counts (r = 0.46,
p = 0.0007), AT activity (r = 0.524, p = 0.001), and the negative corre-
lations to PAI-1 (r = −0.580, P = 0.001).
DISCUSSION. From these results, we confirmed that the serum zinc
level decreased under sepsis condition. Previous study reported
that Zn2+ was involved in the activation of platelets1). Furthermore,
Zn2+ was an essential element for constructing the cross-linked
structure of fibrin and platelets during platelet aggregation2). As
these results, zinc will be consumed under the sepsis-induced coag-
ulopathy. From these reports, we suggest that zinc may be involved
considerably in the coagulation system under the sepsis condition.
CONCLUSIONS. Serum zinc level decreased in sepsis patients. And this
reduction in zinc may be associated with sepsis-induced coagulopathy.
REFERENCE
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OBJECTIVE. To evaluate the effect of different vasoactive drugs on
global perfusion, mesenteric flow and gut injury.
METHODS. Experimental study of endotoxic shock in New Zealand
rabbits treated with different vasoactive drugs and distributed in 5
groups (6 rabbits in each group): A (control), B (noradrenaline), C
(noradrenaline + dobutamine), D (vasopressine) and E
(vasopressine + dobutamine). All animals received adequate fluid
resuscitation. Mean arterial pressure (MAP), aortic blood flow (Qao)
and superior mesenteric artery flow (QSMA) and lactate were
measured at baseline, 1, 2, 3 and 4 hours after endotoxin injection
(LPS - E. coli-055:B5, SIGMA-ALDRICH, 1 mg/kg). In addition,enterocyte damage was evaluated by measurements of citruline and
Intestinal Fatty Acid-binding Protein (I-FABP) at baseline and after 4
hours.
RESULTS. All groups remained with adequate MAP during the whole
experiment. Increased serum lactate was more pronounced in group
D (2,0 ± 0,4 mmol/l to 4,6 ± 0,7 mmol/l; p = 0.002). The largest
reduction of Qao occurred in group D (64 ± 17,3 ml/min to
38 ± 7,5ml/min; p = 0.04). QSMA declined more significantly in groups
D and E and remained lower than in the other groups during four
hours (group D: baseline: 65 ± 31 ml/min; 1h: 37 ± 10 ml/min; 2h:
38 ± 10 ml/min; 3h: 46 ± 26 ml/min and 4h: 48 ± 15 ml/min
p < 0,005; group E: baseline: 73 ± 14 ml/min; 1h: 28 ± 4.0 ml/min;
2h:37 ± 6.4 ml/min; 3h: 40 ± 11 ml/min; 4h: 48 ± 11 ml/min,
p < 0,005). Citrulline significantly decreased in groups D (p = 0.014)
and E (p = 0.019) in comparison to group A.
CONCLUSION. Vasopressin is effective in maintaining MAP during
endotoxic shock in rabbits but may induce intestinal injury, despite
adequate fluid resuscitation.1083
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INTRODUCTION. In 2016, the Third International Consensus
Definitions for Sepsis and Septic Shock (Sepsis-3) were published, in
which the quick Sepsis-related Organ Failure Assessment (qSOFA)
score was proposed (1). A positive qSOFA score is defined as ≥2 of:
respiratory rate ≥22/min, altered mentation, systolic blood pressure
≤100mmHg.
OBJECTIVES. To demonstrate the place of the qSOFA score in risk
stratifying patients on the ward in need of critical care, irrespective
of the meaning behind the score, and to compare it to older
established scoring systems.
METHODS. King's College Hospital inpatients first referred to our
iMobile critical care outreach team (CCOT) between May 2016 and
January 2017 were identified on outreach records, the data was
prospectively collected. Systemic inflammatory response syndrome
(SIRS) criteria (positive if ≥2), qSOFA (positive if ≥2) and National
Early Warning Score (NEWS; positive if ≥5) scores were calculated.
We recorded evidence of likely infection, and whether the referring
nurse or doctor was worried about the patient.
RESULTS. A total of 544 case notes were analysed. The mortality rate
was 21.7%. qSOFA and NEWS scores performed well for identifying
patients with a higher mortality and rate of critical care admission,
whereas SIRS was a poor predictor.
Patients had a significantly higher mortality when qSOFA score
positive [Age adjusted odds ratio (OR), 3.651; 95% confidence
intervals (CI), 2.168-6.148; p < 0.001] or NEWS score positive (OR,
2.743; 95% CI, 1.209-6.227; p = 0.016) compared with SIRS criteria
(OR, 0.583; 95% CI, 0.299-1.136; p = 0.113).
Patients who were positive for either NEWS, qSOFA or both were
significantly more likely to be admitted to critical care (OR, 2.992;
95% CI, 0.024-1.155; p = 0.024). NEWS ≥5 alone did not discriminate
for ICU admission (p = 0.338), and neither did SIRS (p = 0.396).
However, qSOFA alone was highly significant
Table 259 (Abstract 1084). See text for description
SBE<-
2mEq/L
−2mEq/
L≤SBE≤+2mEq/L
SBE>+2mEq/L Total p value
Cl/Na>0.75 28
(82.4%)
11 (50%) 2 (9.1%) 41
(52.6%)
p<0.001
Lac>2mmol/
L
11
(32.4%)
5 (20%) 6 (26.1%) 22
(26.8%)
p=0.569
Alb<3.5g/dl 34
(97.1%)
26 (100%) 24 (100%) 84
(98.8%)
p=0.485
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We analysed the effect of individual variables on mortality, finding
that altered mental state (p < 0.001), lactate >2mmol/L (p = 0.004),
and a worried referrer (OR, 3.366; 95% CI, 1.41-8.039; p = 0.006) were
all significant predictors.
Our results show clearly the benefits of including whether the
referring clinician is concerned when referring to CCOT, a point
promoted by the Sepsis Trust (2) but not included on current scoring
systems.
CONCLUSIONS. For patients with suspected infection, qSOFA
performed better than NEWS, and could be used as a trigger for
referral to CCOT. SIRS is not sufficiently sensitive or specific. The
worried referrer should be a red flag criterion for any deteriorating
patient.
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Metabolic acidosis in patients with sepsis
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OBJECTIVE. To compare increased lactate concentration (Lac) and
decreased strong ion difference (SID) as main causes of metabolic
acidosis in septic patients upon their ICU admission.
METHODS. 94 (35 Female) septic patients were enrolled in the study.
Arterial blood samples were analysed in the blood gas analyser on
the day of admission. Patients were categorized in three groups
based on the base excess (BE) value: < −2 mEq/L (metabolic
acidosis), −2 mEq/L ≤ BE ≤ + 2 mEq/L (normal), > +2 mEq/L
(metabolic alkalosis). Other recorded parameters were: Lac and the
chloride to sodium concentration ratio ([Cl]/[Na]), indicating
decreased SID acidosis when >0.75. We also measured albumin in
plasma (Alb), to assess hypoalbuminemia, which has an alkalinizing
effect that can hide an underlying acidosis when conventional
markers as the pH or BE are used.
RESULTS. Table 259 compares the three forementioned patient
groups in respect to markers indicating the acidotic disorder [Lac > 2
mmol/L, [Cl]/[Na] > 0.75] and also in respect to Alb < 3.5 g/dl. It
depicts the absolute number of patients and the percentage relative
to the total number of patients in each group. Cl levels differed
significantly in the three groups (107.43 ± 5.88 vs 105.77 ± 5.74 vs
102.63 ± 5.41 mEq/L, p = 0.016), being higher in Group 1 patients
while Na levels (137.25 ± 4.63 vs 139.71 ± 4.24 vs 140.05 ± 6.10
mEq/L, p = 0.01) and SID (33.92 ± 4.01 vs 38.16 ± 3.69 vs
41.37 ± 3.20 mEq/L, p < 0.001) were lower in Group 1. Lac showed
no significant difference in the three groups (1.90 ± 1.40 vs
1.64 ± 1.12 vs 1.58 ± 0.67 mmol/L, p = 0.81).
CONCLUSION. Lactate levels did not differ in patients with and
without metabolic acidosis. A decreased SID was mainly noted in
septic patients with metabolic acidosis.
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INTRODUCTION. Sepsis involves a dysregulatory process with an
intense systemic inflamatory response. Platelets have a crucial role in
inflammation and immunomodulation and mean platelet volumen
(MPV) represents a measure of platelet size and reactivity.
OBJECTIVES. To study the value of several platelet indices for
predicting mortality in patients with sepsis and septic shock.
METHODS. We prospectively enrolled patients admitted with sepsis/
septic shock to our Intensive Care Unit during a two-year period
(2015–2016) We measured different demographic, clinical and la-
boratory data at admission, including platelet indices, and we studied
differences between survivors and non-survivors.
Comparison between survivors and non-survivors was made using t-
Sudent, U-Mann–Whitney, Chi-Square o Fisher test as appropriate.
Receiver operating charasteristic (ROC) curves were used to assess
diagnostic accuracy.
RESULTS. A total of 219 patients were studied. Of them, 47 (21.5%)
died within 28 days after ICU admission. Non-survivors were older (70
(IC 95% 66.1-73.8) vs 64.1 (61.8-66.4), p 0.023), had higher APACHE II
(27.3 (25.5-29.1) vs 18.5 (17.6-19.4), p < .001) and higher lactate (4.6
(3.4-5.89) vs 2.6 (2.3-3), p < .001) and SOFA (9.5 (7–12.3) vs 7 (5–9);
p < 0.001) at admission.
No differences were observed in platelets count (164 x 103 (103–253)
vs 152 x 103 (90–259)) and mean platelet volume (11.1 fL (10.8-11.5)
vs 11 (10.8-11.2))at admission between survivors and non-survivors.
The ratio MPV to platelet count was higher in non-survivors (11.2 (IC
95% 7.2-15.3) vs 8.4 (7.2-9.6)) but it did not reach statistical
significance.
ROC curves for predicting mortality at 28 days showed an area under
the curve (AUC) for MPV and MPV/platelet count of 0.525 and 0.547
respectively, while AUC for APACHE II score was 0.829 (IC 95% 0.765-
0.893, p 0.033) and for SOFA score of 0.715 (0.633-0.797, p 0.042).
CONCLUSIONS. In our patients with sepsis/septic shock, mean
platelet volumen and MPV to platelet count ratio measured at
admission, did not predict 28-days mortality.
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